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Abstracts of Original Contributions: 41st Annual Scientific Session 
The American College of Cardiology is pleased to announce that 
5,250 abstracts of original contributions were submitted to the 
Program Committee of the 41st Annual Scientific Session. Space 
and time consideration this year allowed the selection of 1,506. 
Each abstract was peer reviewed by a panel of graders; chosen 
abstracts will be presented in either oral or poster format. 
The American College of Cardiology thanks the thousands of 
abstract participants and the hundreds of category graders and 
701 Advances in the Assessment of Ventricular Function 
by Echocardiography 
Monday, April 13, 1992 
10:30 AM-Noon 
Dallas Convention Center 
East Ballroom A 
701-1 10:30 
Three-Dimensional Echocardiography: In Vivo Validation 
for Left Ventricular Volume and Function 
Samuel C Siu, J Miguel Rivera, J Luis Guerrero, 
Mark D Handschumacher, Song W Xie, Arthur E Weyman, 
Robert A Levine, Michael H Picard. 
Massachusetts General Hospital, Boston, MA. 
While 3-dimensional echocardiographic (3DE) 
reconstruction is extremely accurate in determining 
the volume (vol) of excised LVs, the reliability of 
this method in quantitating LV vol and performance 
~ is not known. We have developed a canine model 
in WhlCh LV vol can be measured continuously through 
the use of an intra-cavitary balloon connected to an 
extr~-cardiac r~servoir. In 5 instrumented dogs, the 
beatlng LV was lmaged in long- and short-axis planes 
using an automated 3DE method which integrates spatial 
data with corresponding images in real time. Systolic 
and diastolic images were obtained at 43 different 
vols (4-68 cc) and in conditions where LV shape was 
altered by either coronary occlusion or RV vol 
overload. LV vol was calculated by an automated 
surfacing algorithm that takes advantage of the full 
3DE data set. LV vol, stroke vol, and ejection 
fractioR (EF) were compared to directly measured 
values (x). Regression line r ~ 
LV Volume y-0.99x - 0.32 .97 4.5 (cc) 
Stroke Volume y-0.94x - 0.21 .94 2.9 (cc) 
EF y-0.98x - 0.59 .94 4.6 ( %) 
Conclusions: 3DE reconstruction allows accurate 
assessment of LV size and global LV function in the 
beating heart. Unlike other echocardiographic 
algorithms, this method is free of geometric 
assumptions and should prove particularly useful in 
assessing LVs of varying shape and size. 
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701-2 10:45 
Three-Dimensional Echocardiography Improves 
Noninvasive Left Ventricular Volume Quantitation 
Samuel C Siu, J Miguel Rivera, Song W Xie, Jean-Paul 
Lethor, James D Thomas, Mark D Handschumacher, Arthur 
E Weyman, Robert A Levine, Michael H Picard. 
Massachusetts General Hospital, Boston, MA. 
Standard methods of calculating LV volume (vol) from 
2-dimensional echocardiograms (2DE) rely on 
assumptions regarding LV shape. Three-dimensional (3D) 
echocardiography can quantitate LV vol without 
geometric assumptions, yet its incremental value is 
un~roven. A previously validated 3D method which 
integrates spatial with imaging data was used to 
reconstruct 13 excised LVs of normal shape and known 
vol (21-101 cc) imaged in intersecting long and short 
axis planes. The LV vol was then calculated by an 
algorithm that takes advantage of the full 3D data 
set. LV vol was also calculated from standard 20E 
images using area-length, cylinder-hemiellipsoid 
(Bullet), and Simpson's methods. Correlation 
coefficient (r) and error (Avol; mean±SD) between 
calculated (y) and true vol (x) were computed. 
Regression 1 ine r Avol {cel 
3D y-l.00x + 0.17 .99 0.2+3.6 
Area-Length y-0.86x - 3.80 .96 -11.9+7.0* 
Bullet y-0.96x - 1.60 .96 -3.8+6.8* 
Simpson's y-0.90x + 1.35 .97 -4.0+6.1* 
* p<0.05 between each method and 3D -
Conclusions: Even in the symmetric LV where 2DE vol 
algorithms should be most accurate, the 3D method 
provides best agreement with actual volume without the 
need for standardized imaging planes. This benefit 
should be even greater in distorted LVs, such as those 
with aneurysms, where shapes do not correspond to 
those assumed by the standard 2DE volume formulae. 
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701·3 11:00 
Heterogeneity of Regional Contractile Function in Normal 
Subjects As Assessed by Acoustic Quantitation 
Mikel D. Smith, Gong-Yuan Xie, Peter M. Sapin, Stephen 
Souther, Stephen Reed, Mark Bates, Edward Morris, Anthony 
N. DeMaria. University of Kentucky, Lexington, KY 
Uncertainty exists as to whether circumferential LV 
contractile function is homogeneous from base to apex. 
Therefore, we used a new system of automatic border 
detection to examine performance at multiple levels of 
the LV chamber. The system analyzes the acoustic 
properties of the radiofrequency echo signal to 
distinguish tissue from blood and provide a continuous 
graphic display of LV cavity size. We scanned 20 normal 
vo 1 unteers (age= 19-38) fronl standard papi llary musc le 
(PAP), mid-LV (MID), and mitral valve (MV) short-axis 
(SAX) planes to compare regional contractility at 3 
levels of the LV. Measurements included: LV end•
diastolic (EDA) and end-systolic (ESA) areas, fractional 
area change (FAC), and m~ximal rate of FAC (dA/dt). 
Results (mean ~ SD in cm ): 
Level EDA ESA FAC (%) 
pAP 17.6+49.5+3 46.4+10 
MID 20.0+6* 9.8+4 51.8+12* 
MV 19.9+5* 8.4+4t 59.1+12t 
(* p<.05 vs-;PAP; t p<.05 vs. J1,ID) 
-dAidt 
51.0+ 17 
60.0+18 
65.4+17* 
Thus, in normal subjects, heterogeneity exists in the 
contributions of apical, mid-LV and basal segments to 
overall systolic performance, with higher FAC and dA/dt 
occurring at the mid and MV levels compared with the 
papillary muscle level. These differences may have 
important implications for quantifying LV function and 
assessing the physiology of abnormal LV performance in 
patients with heart disease. 
701·4 11:15 
Left Ventricular Mass Changes during the Cardiac Cycle 
Sophie D. Barbant, Laura L. Kee, Elyse Foster, Nelson B. Schiller. 
University of California, San Francisco. California 
Evidence suggests that left ventricular mass (L VM) in diastole may 
exceed left ventricular mass in systole because of increased 
myocardial blood content. We hypothesized that 2-D 
echocardiographic (ECHO) measurements of L VM would be greater 
at end·diastole (d) than at end·systole (s). In 18 normal 
subjects a series of three LVMd and LVMs measurements were made 
and averaged on a clneloop equipped off· line analysis system. The 
algorHhms used were the truncated ellipsoid (TE) and area length 
(AL), combining the short-axis view at the level of papillary 
muscle tips, and apical 4- and 2-chamber views (ASE,1989). 
~ (mean±SE) ~ 6l. 
LVMd (gm) 162.4±5.8 IS6.1±5.8 
LVMs (gm) 138.5±4.7 163.6±7.0 
Pifference (LYMd-LYMs) 23 9±4 5 22 6±S 1 
LVMd was largerthan LVMs by both TE (p •. 0001) and AL 
(p •. 0004). LVMd correlated whh LVMs by TE and AL 
methods(r-.67, .70, respectively). 
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Conclysion' In normals LVM measurement by ECHO is dependent on 
cardiac cycle phase with LVMd greater than LVMs. However the 
difference exceeds that expected for increased myocardial blood 
content; changes in LV geometry may be an additional contributing 
factor. Nevertheless, these findings provide normal ranges that 
may be useful to establish internal consistency of measurement 
sets. 
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701·5 11:30 
Identification of Normal and Abnormal Left Ventricular 
Diastolic Filling Using a Real Time Automatic Border 
Detection Algorithm 
Peter M. Sapin, Gungyuan Xie, Mikel D. Smith, Oi Ling Kwan. 
Anthony N. DeMaria, University of Kentucky, Lexington, KY 
Recently an automatic endocardial border detection algoriduil (ABD) 
producing a continuous graphic display of changes in left ventricular 
(LV) area during diastole has been incorporated into standard 
echocardiographic equipment. However, no data exist concerning 
the ability of this system to identify abnormal LV filling dynamics in 
patient subsets. In this study we performed echocardiography with 
ABD within 1 hour of LV cineventriculography (V G) in 17 
consecutive pts with near normal global systolic function (mean 
EF=0.65). Echo was performed in standard parasternal short axis 
(SAX) and apical 4 chamber (A4C) views. The RF echo signal was 
analyzed to distinguished blood from tissue, and ABD performed 
from the resulting image. Wall motion was normal in 10 pts (Norm) 
while segmental contraction abnormalities existed in 7 pts (Abn). 
Sequential changes in LV diastolic volume were assessed frame-by•
frame from RAO VG at 30 frames/sec, with volumes calculated 
using Simpson's rule. A tri-phasic pattern of diastolic LV fIlling was 
seen and the percent of total diastolic filling contributed by early 
rapid filling (RFF) and by atrial filling (AFF) was measured. 
Ventriculography identified clear differences in LV filling dynamics 
between Norm and Abn pts. These results were compared to those 
from ABD in the same subgroups (mean±SD percent of total filling) 
Rapid Filling Fraction Atrial Filling Fraction 
Normal Abnonnal p Yalue Norma! Abnormal p value 
VG 68±12 44±14 .001 21±8 35±12 .01 
SAX 64±10 48±5 .02 27;V 37±7 .02 
A4C 63±12 49±5 .02 30±10 44±8 .02 
Conclusjon: In pts with abnormal segmental contraction in whom 
VG identifies reduced rapid filling and increased atrial filling. ABD 
reveals similar findings. Thus, real time ABD may be of value in 
identifying abnonnal LV filling patterns in pts with cardiac 
disorders. 
701·6 11:45 
FEAsmn..ITY OF GENERATING HEMODYNAMIC PRESSURE 
CURVES FROM DOPPLER ECHOCARDIOGRAPHIC SIGNALS 
Gre" Ensjni MD, James Seward MD. Roben Darragh MD. Donald 
Girod MD, Randall Caldwell MD. Indiana University. Indianapolis IN 
and Mayo Clinic. Rochester MN 
Doppler generation of intracardiac pressure curves would be an 
advancement in the noninvasive assessment of cardiac hemodynamics. 
We studied the Doppler derivation of entire right ventricular (RV) and 
pulmonary anerial (PA) pressure curves in 22 patients with measurable 
tricuspid and pulmonary regurgitation. 18 of 22 had adequate Doppler 
signals. Curves were derived by superimposing Doppler measured 
tricuspid and pulmonary valve gradients at 10 msec intervals on 
assumed right atrial and RV diastolic pressures. Doppler derived RV 
and PA pressures correlated with simultaneous catheter measured 
pressures by the equations: 
Doppler PAP systolic=.92(cath PAP systolic)+4.5; r=.98 
Doppler peak to peak PA gradient=.91(cath measured peak 
to peak gradient)+ 1.0; r=.98 
Doppler PAP mean=.85(PAP mean)+2.6; r=.97 
Doppler PAP diastolic=.45(cath PAP diaslolic)+6.6; r=.83 
Some underestimation of PA diastolic pressures was technique related. 
Excellent correlation at aJI portions of the curve was obtained. 
We conclude that clinically useful RV and PA pressure curves can be 
derived utilizing superimposition of Doppler measured tricuspid and 
pulmonary flow velocities in patients with tricuspid and pulmonary 
regurgitation. (BELOW: Sample curves from pt with pulmonary 
stenosis and mild pulmonary hypenension--dark dotted lines: Doppler 
derived, Lighter solid lines: catheterization measured) . 
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702 Community Practice Patterns in the Management of 
Acute Myocardial Infarction 
Monday, April 13, 1992 
10:30 AM-Noon 
Dallas Convention Center 
East Ballroom B 
702·1 10:30 
Thrombolytic Therapy for Acute Myocardial Infarction: la It Un· 
derueed? 
Christopher Morgan, Howard Oombrower, Edwin Chol, Ronald Baigrie. 
Sunnybrook Health Science Cemre, Toromo, Omario, Canada. 
Because it has been suggested that thrombolytic therapy (T1) may be un•
derused in acute myocardial infarction (AMI) we performed a retrospective re•
view of consecutive patiems with confirmed AMI admitted to the CCU of a 
large teaching hospital in calendar years 1989 and 1990. There were 410 pa•
tiems of whom 88 (21.5%) received TT and 322 (79.5%) did not. patiems re•
ceiving TT were younger (mean age", SO 58.5 '" 11.2 VS. 70 '" 12.0 yrs, p = 
.0001), more likely to be male (82% VS. 62%, P = .0006), had shorter symp•
tom duration (2.1", 1.7 vs.15.2 '" 24.8 hrs, p = .0001) and had a lower hospi•
tal mortality (3.4% vs. 24.5%, P = 0.0005) than those not receiving TT. 
We identHied a subset of 131 patiems meeting generally accepted criteria 
for TT including a) symptom duration" 6 hrs, b) ST elevation ;0 0.1 mV on 
ECG and c) no standard comraindications. Of these 75 (57%) received TT (+) 
and 56 (43%), TT f), did not: 
TT+ (N=75l TT. (N=561 -JL 
Age (yrs): 58.3 ",10.7 70.7 ",11.3 0.0001 
male sex: 62 (83%) 33 (59%) 0.005 
Symptom duration: 1.9 ",1.2 hrs 2.8 ",1.8 hrs 0.0007 
peakCK QUIL): 1530 ",1150 617:t 527 0.0001 
Hospital death: 2 (2.7%) 11 (19.6%) 0.002 
Eligible patients !l21 receiving TT were more likely to have heart failure 
(CHF) reported at presemation (36% vs. 19%, P = 0.05), a history of CHF 
(11% VS. 0%, P = 0.005) or of prior AMI (41·-'> vs. 21%, P = 0.024). Infarct 
location did not differ signHicantly between TT(+) and TT(-) groups. 
Despite widespread acceptance of TT, many potemially eligible patients 
are excluded from treatmem and have a disproportionately high hospital mor•
tality. Patiems who are at higher risk (i.e older, female, CHF or prior AMI) are 
less likely to receive TT. Whether this paradox represents legitimate or mis· 
placed concem re: risk I benefrt of TT in higher risk patients deserves further 
stUdy. 
702·2 10:45 
Gender Differences in the Diagnosis. Management and 
Prognosis of Acute Kyocardial Infarotion. A Statewide 
Database 
John B. (ostis. Alan C. Vilson. Nora M. Cosgrove. Sandra 
Blaohman for MIDAS. UHDNJ-Robert Vood Johnson Medioal 
Sobool. New Brunswiok. New Jersey. 
Reoently attention bas focused on gender differenoes in 
tbe management of myooardial infarotion (MI). The 
Myocardial Infarotion Data Aquisition System (MIDAS) is a 
statewide database including all hospitalizations for MI 
in New Jersey. Among the 49.250 HI bospitali~ations in 
1986-1987. 40.2~ were women (V). In auditing a random 
sample of 726 oharts. a diagnosis of MI could not be 
supported in 9.2~ of the patients (7.8J of men (M) and 
11.7J of v. p(0.005). The information in tbe database 
was correct in 99.3J for gender. 98.1J for age. 98.9J for 
raoe. 98.6J for mortality and 98.9J for invasive 
prooedures • 
Vomen (n=19.812) were older (72.0+12.2 vs 64.4+13.0 
years. p(0.0001). were more likely to bave electrical or 
mechanical complications. (61.3 vs 56.8J. p(0.0001). 
obesity (3.9 vs 3.1J, p(0.0001). hypertension (36.9 vs 
30.0J, p(O.OOOl) and diabetes (28.0 vs 19.9J p(O.OOOl). 
They had longer length of stay (13.~15.4 vs 11.3~11.6 
days, p<O.OOOl) and higber in hospital mortality (23.2 vs 
16.5J. p<O.OOOl). Women were less likely to have bad 
cardiao oatb (13.5 vs 20.3~. p<0.0001). CABG (2.3 vs 
3.7J. p(0.0001) or PTCA (1.5 vs 3.1J. p(O.OOOl). 
Procedures were less likely to be performed in patients 
with oomplications (14.3 vs 22.1J. p(O.OOOl) and in older 
patients (p(O.OOOl). Multiple regression identified age 
(p(O.OOl) and sex (0.003) as independent prediotors of 
procedure use. 
Thus. tbe lower use of procedures in women is due to 
higher age. more frequent oomplications. overdiagnosis 
and otber factors. 
702·3 
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1l:00 
Are Women WIth Acute Myocardial Infarction Managed 
Differently From Men? 
Vivek K. Varma, Patrick L Murphy, William P. Hood, Jr., Edwin L 
Bradley, Jr., William J. Rogers for the Alabama Registry of 
Myocardial Ischemia Investigators. University of Alabama Medical 
Center, Birmingham, AL 
In order to uncover possible gender dHferences In the management 
and outcome of patients with acute Ml's, 691 patients with chest 
pain longer than 30 minutes who were admitted to the CCU were 
studied in a prospective registry during 1990-1991. Comparisons 
were made between the 234 women and 457 men in the registry. 
Upon entry to the CCU, women had a higher rate of pre-existing 
angina (p < .01), diabetes (p < .001), hypertension (p < .001), and rales 
> 1/3 lung fields (p<.OOO1). Also, a greater percentage of women 
were older than 75 (24% vs 9%, p<.001). Even though women had 
an increased number of risk factors, fewer women had ST elevation 
on ECG (44% vs 56%, p<.01), or evidence of myocardial infarction 
by CPK's (55% vs 64%, p<.02). In the group of patients with ST 
elevation on admission, fewer women were given thrombolytic 
therapy (34% vs 51%, p<.OO5). The number of cardiac cath's 
(p<.03) and PTCA's (p<.01) performed during hospitalization was 
also lower in women, though they had a more complicated course 
with a higher rate of CHF (p<.05), cardiogenic shock (p<.01), and 
death (P<.001). When logistic regression analysis was performed, 
adjusting for age, diabetes, hypertenSion, and other baseline 
variable differences, there were no statistical differences (at p < .05) 
between men and women in the percentage of patients receiving 
thrombolytic therapy and the number of cath's or PTCA's 
performed. Only the death rate remained significantly higher in 
women. Thus, although women are given thrombolytic therapy less 
often than men, and undergo fewer invasive procedures, these 
differences may be due to older age and other baseline differences 
on admission. 
702·4 1l:15 
Recent Trends of ThrombOlytiC Agent usage In ClinIcal 
Practice: A Repon from the Minnesota Hean Survey RegIstry 
Wayne O. Rosamond, Russell V. Luepker, Paul G. McGovem, J. Michael 
Spralka. Universtty of Minnesota, MinneapoliS, Minnesota 
Clinical trials of thrombolytic therapy have demonstrated tts efficacy in 
enhancing coronary reperfusion and reducing mortality, creating 
considerable impact on the way suspected acute myocardial infarction (AMI) 
is treated in routine clinical practice. Studies designed to compare the 
relative effectiveness of agems, however have been the poim of some 
controversy. Recemly, the release of preliminary resutts from ISIS-3 have 
created debate regarding the dispartty in cost between streptokinase (STK) 
and tissue plasminogen activator (TPA) in the light 01 evidence suggesting 
similar effectiveness. This debale may impact the selection of thrombolylic 
agents in routine clinical settings. This study reports preliminary data on the 
type 01 thrombolytic agems used in community hospitals before and alter 
the release of the ISIS-3 preliminary findings in March 1991. The Minnesota 
Heart Survey Acute MyocardiallnfarCllon RegistrY is a prospective study on 
the treatment and outcomes of suspected AMI. Under this program, all 
patients over 25 years of age admitted to the CCU with suspicion of AMI are 
registered and interviewed. Their hospital course Is evaluated and a one 
year follow-up interview Is COnducted. From April- September 1990, 981 
cases were enrolled with 76 (8%) receiving thrombolylic therapy. From May 
to July 1991, 767 cases were enrolled and 75 (10%) received thrombolytic 
agents. The following is a breakdown of type of agem used by year. 
April-Sept 1990 May- Jyly 1991 
Ag.e.ot Ece.Q. ~ Ece.Q. !Yo.. 
TPA 53 70% 33 44% 
STK 11 14% 33 44% 
Urokinase 11 14% 4 5% 
APSAC 1 1% 1 1% 
STK tTPA ~ -Ma 
Total 76 100% 75 100% 
- 26% 
+30% 
- 9% 
0% 
This apparem shift in usage from TPA to STK is statistically signHicant 
(p<.001) and suggest that new data from clinical trials dHfuses rapidly in the 
clinical communtty and changes practice. 
lACC Vol. 19, No.3 
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702·5 11:30 
Community Prac:tIce Patterns In the Management of Prolonged 
Ischemic: Chest Pain With or Without ST Elevation 
Thomas D. Paine, Larry E. Maske, Edwin L. Bradley, Jr., William J. 
Rogers for the Alabama Registry of Myocardial Ischemia Investigators, 
University of Alabama Medical Center, Birmingham, Alabama 
To assess practice patterns of physicians caring for patients with 
prolonged (~ 30 min) ischemic chest pain requiring admission to a 
CCU within 12 hrs onset, 7 tertiary care hospitals with capability for 
24·hour coronary angiography and PTCA prospectively recorded data 
on 689 patients over a 9 month period in 1990-91. Patients ranged 
from age 27 to 94 (mean 62 yrs), 66% were males, 17% had prior 
PTCA, 16% had undergone CABG, and most (61%) evolved CK 
evidence of myocardial infarction. Patients presenting with ST 
elevation (~0.1 mV, N = 333), had a lower incidence of prior angina 
(43% vs 67%, P < .001), prior myocardial infarction (25% vs 40%, P 
< .001), prior PTCA (11% vs 23%, P < .001), and prior CABG (8% 
vs 23%, P < .001), and more evolved CK evidence of myocardial 
infarction (84% vs 37%, P < .001). However, during hospitalization, 
invasive procedures were used liberally in both patients with and 
without ST elevation: coronary angiography (84% vs 77%, P = .053), 
PTCA (53% vs 38%, P < .001), CABG (13% vs 13%). During the 24 
hours after admission, procedures were especially common: 
thrombolytic therapy (49% vs 12%, P < .001), coronary angiography 
(53% vs 38%, P < .001), and PTCA (35% vs 15%, P < .001). PTCA 
during the first 24 hours after admission was successful in 91 % of 
patients in whom it was attempted. Hospital mortaJjty was 10% 
among patients with ST elevation and 4% among those without ST 
elevation (p = .002). 
Thus, among patients with ~ 30 min chest pain admitted to CCU's 
in this registry, prior procedures (PTCA, CABG) were common, 
confirmed myocardial infarction was unexpectedly high, and coronary 
angiography, PTCA, and CABG were done very frequently in patients 
presenting both with and without ST elevation. 
702·6 11:45 
Acute Myocardial Infarction in Greater London, 1980.1989, 
Reduced Mortality With General Adoption of Thrombolytic Therapy 
• Scope for Increased use in the Elderly 
Robert Greenbaum. Piyamitr Srilara. Dan Shanil. Koon Lan Chan. 
Cardiovascular Research Unit. Edgware General Hospital. London. U.K. 
AMI mortality following thrombolysis in various clinical studies is about 
10%. This study assesses the impact of the introduction of thrombolysis 
in Greater London during the decade 1980-89. Figures for annual 
admissions and deaths due to AMI were obtained in a health authority 
serving a population of 3.5 million in Greater London. Thrombolysis is 
now given to about 50% of patients with AMI. In 94% of cases the agent 
used is streptokinase. During the decade, 48861 patients, (31 868,65% 
male) were admitted with AMI. The table shows that mortality increases 
sharply with age. In 1989 it averaged about twice the mortality found 
in clinical trials. 
A2e <45 I 45-64 65·74 ! >75 liAII Ages 
1980 Mortality'li> 6.5 I 14.5 29.6 I 49.9 II 27 
1989 Mortality'li> 2.6 ! 8.6 18.4 I 39.2 jL 21.9 
Estimated Live Saved 10 I 89 138 I 168 II 405 
p<O.OOOI between different age groups 
Extrapolated to the national population about 5800 lives per year are 
being saved in England and Wales. In 1989 patients below 65 years had 
a mortality similar to that demonstrated in clinical trials but patients older 
than 75 years stiJI had a mortality of39.2%. Overall mortality in London 
remains 21.9% which is twice the figure achieved in clinical trials. In 
part, at least, this is due to the withholding of thrombolytic therapy from 
the elderly. We conclude that use of thrombolysis has resulted in large 
reductions in mortality in younger patients, there is further scope for its 
use in the elderly. 
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703 Thallium Imaging-Viability and Prognosis 
Monday. April \3, 1992 
\0:30 AM-Noon 
Dallas Convention Center 
West Ballroom C 
703·1 10:30 
Myocardial Viability: Comparison of Thallium 
Reinjection, Rest-Stress Sestamibi, and Positron 
Emission Tomography 
Vasken Dilsizian. Jose A. Marin-Neto, James A. Arrighi. 
Stephen L. Bacharach, Pasquale Perrone-Filardi. 
Robert O. Bonow. NHLBI. Bethesda. MD. 
99mrc Sestamibi (MIBI) and zO'Tl have similar accuracy when 
used for diagnostic purposes, but their relative efficacy 
in assessing myocardial Viability has not been estab•
lished. As MIBI does not redistribute, it may overesti•
mate nonviable myocardium in pts with left ventricular 
dysfunction, in whom blood flow may be reduced at rest. 
To compare the ability of MIBI and Tl to identify viable 
myocardium, we studied 30 pts with chronic CAD. Pts 
underwent stress (S)-redistribution (RD)-reinjection (RI) 
Tl and rest (R)-S MIBI imaging (using the I-day protocol) 
in the same week. using the same exercise protocol and 
achieving the same rate-pressure products. The mean 
ejection fraction at rest was 32±14%, and all pts had 
irreversible defects on Tl S-RD studies. Of the total 150 
regions analyzed. 81 were abnormal during S by both MIBI 
and Tl. and MIBI and Tl were concordant regarding revers•
ible or fixed defects in 64 of the 81 regions (79%). In 
the remaining 17 discordant regions, 16 (94%) were fixed 
by MIBI but reversible by T1. PET studies were performed 
in 13/30 pts, using ,8F-deoxyglucose and Hz'50. In these 13 
pts. MIBl and Tl results were concordant regarding 
reversible or fixed defects in 33 of 42 (79%) abnormal 
regions. However. all 9 discordant regions were fixed by 
MIBI but reversible by Tl. PET confirmed viability in all 
9 regions. which involved 6 of the 13 pts (46%). These 
preliminary data suggest that I-day R-S MIBI and S-RD-RI 
Tl imaging provide concordant information regarding 
viable myocardium in the majority of regions. but MIBI 
underestimates viability in 21% of abnormal regions, 
representing 46% of pts. when compared to 20'Tl and PET. 
703-2 10:45 
Superiority of Resting Thallium Injection Over 4-Hour and 24-Hour 
Redistribution Imaging In the Distinction of Infarction and Reversible 
Ischemia: A Receiver Operating Characteristic AnalySis . 
Kim A. Williams and Linda A. Taillon. The University of Chicago. Chicago. 
IL. 
Comparison of earty and late redistribution wtth resting injection after 
exercise thallium (TL) scintigraphy was perfonned using receiver operating 
characteristic (ROC) analysis in 32 patients wtth prior myocardial 
infarction. Quantitative exercise TL perfusion and glucose metabolic 
imaging (18-fluoro-2-deoxyglucose, FOG) were compared using 
normalized circumferential profiles of 10 myocardial segments in 3 planar 
views. Reversible exercise-induced ischemia. defined as a relative excess 
of FOG in segments with reduced perfusion, was present in 144 of 199 
abnormal segments. The remaining 37 perfusion defects showed no 
metabolic evidence for reversible ischemia. In 178 segments wtth paired 
comparison of 4-hour and 24-hour redistribution images. revealed 
correlated ROC curve areas which were not signHicantly different (p=.38); 
24-hour imaging showed slightly greater sensttivtty at more slringent 
diagnostic criteria. Resting TL was cof1l)ared wtth 4-hour imaging in 137 
segments, and with 24-hour imaging in 127 segments. ROC curve areas 
were signHicantly greater for resting TL than for both 4-hour (p •. 007) and 
24-hour (p •. 030) imaging. with signfficantly greater sensttivily at every 
level of diagnostic certainty: 
T 
" U , ~ O~[ 
t 0.8 
: 0.4// - REST 
- .... 
REST 
ROC Curve Area: 0.89 
Sensttivtty (at 
85% SpecHicity): 0.79 
24-H 
0.70 
0.51 
4-H 
0.68 
0.43 
These data support the use of resting 
injection in preference to redistribution 
imaging after myocardial infarction. as it 
more closely approximates the results of 
metabolic imaging for detection and 
distinction of nonreversible and reversibie 
exercise TL perfusion abnormaltties. 
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703·3 11:00 
Detection of Viable Myocardium by Thallium·201 Compared to 
PET in Patients with Moderate Versus Severe Ischemic Left 
Ventricular Dysfunction 
Jose A. Marin-Neto, Vasken Dilsizian, Pasquale Perrone-Filardi, 
Stephen L. Bacharach, Simone Maurea, James A. Arrighi, 
Robert O. Bonow, NHLBI, Bethesda, MD 
Thallium-20l (TL) reinjection and PET have been shown to provide 
concordant information regarding myocardial viability (VM) in the 
majority of CAD pts with left ventricular (LV) dysfunction. In pts 
with severe LV dysfunction, the identification of VM has important 
clinical implications regarding suitability for revascularization, and it 
has been suggested that TL may be imprecise in this determination in 
such pts. To assess whether PET may be more sensitive than TL for 
identifying VM in pts with severe LV dysfunction, we studied 34 pts 
with chronic multivessel CAD and LV dysfunction. Pts were divided 
into those with moderate LV dysfunction (EF >25%, 56±6 yrs, 16 
men/2 women, group 1) and severe LV dysfunction (EF~ 25%, 
54±5 yrs, 14 men12 women, group 2). All pts underwent exercise TL 
SPECT (with rest reinjection) and PET imaging at rest (using "F_ 
deoxyglucose and H,"O). Studies were performed off all medications. 
Regional analysis of matched transaxial PET and SPECT images 
resulted in similar findings regarding regional VM by both techniques: 
PET TL SPECT 
tms ..EE.. ~ ...YM Non-YM..YM NlID:Y.M 
Group I 18 35±6 481 %% 4% 95% 5% 
Group 2 16 19+5 468 81% 19% 82% 18% 
The overall concordance in individual regions between PET and TL 
SPECT was %% in group I and 88% in group 2. Thus TL reinjection 
provides comparable information to PET regarding the detection of 
VM even in pts with severe LV dysfunction. 
703·4 11:15 
The Prognostic Significance of Reverse Redistribution on 
Thalllum·201 Stress Testing After Thrombolytic Therapy for 
Acute Infarction. 
Frans J. Th. Wackers, BarT)' L. Zaret, Bernard Chattman, AJan Wasserman, 
Bruce Thompson. Yale Universtty, New Haven CT . 
It is controversial whether Thallium-201 (T) stress testing (EX) after 
thrombolytic therapy for acute myocardial infarction (MI) has the same 
prognostic value ,as after conventional treatment of MI. In the TIMI II study 4 
clinical centers performed TEX at hospttal discharge (HD) in 182 patients 
(pts) who received thrombolytic therapy for acute myocardial infarction and 
were capable of exercising. T scans were processed and quantified in a 
central core laboratory. At HD 42 1182 pts (23%) had normal TEX scans. Of 
140 pts with abnormal scans, 50(36%) showed defect reversibility 
consistent with ischemia. The size of post EX defects were quantified as 
large in 68/140 (49%), moderate in 41(29%) and small in 31 (22%). Ischemic 
EX defect reversibilHy was quantified as large(>50% of defect reversible} in 
9/50 (18%), mild (25-49% of defect reversible) in 20 (40%) and 
insignificant«25% of defect reversible) in 21 (42%). High risk T scans (>2 
ischemic regions,or increased lung T and ischemia) occurred in 
21/182(12%} pts. At 1 year follow-up cardiac events (CE) occurred in 13 pts 
(7%):death or MI in 9 pts, hospitalization for angina only in 4 pts. Although 
11 of13 pts wtth CE had abnormal T scans,only 4 had reversible defects. 
There was no statistically significant difference between pts wtth CE and 169 
pts wtthout CE for the following variables: high risk TEX scan, abnormal scan, 
size of defects,presence and degree of defect reverSibility. Only reverse 
redistribution occurred significantly more often in pts wtth CE than in pts 
wtthout CE (6 pts,46% vs 25 pts,15%, p=0.004). 
Thus, in pts who had thrombolytic therapy for MI and were capable of 
exercising CE rate is low. Although TEX defects were large to moderate in 
the majority of pts, ischemic reversibility occurred infrequently and the 
degree was insignificant to mild in 82%. Tradttional high risk features on TEX 
scans (lung uptake,defect size) were not predictive of CEo Only reverse 
redistribution(Le flow to a mixture of viable myocardium and scar tissue) was 
highly predictive of adverse outcome. 
We conclude that following MI the prognostic value of TEX alter thrombolytic 
therapy may be aHered compared to that after conventional treatment.The 
role of reverse redistribution as a predictor of CE needs further study. 
703-5 
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Prognostic Vslue of Bzerci.. SPBCT Tballiu.-201 
SCintigrsphy Late After Coronary Artery Bypass 
Timothy Bateman, JameB O'Xeefe, Jr., Carrie Barnhart. 
Mid America Heart InBtitute, KanBas City, MO 
The prognoBtic value of myocardial perfusion ima~ing with 
thallium-201 (Tl) is eatablished for pta with known or 
Buspected athero8clerotic diaeaBe of the native coronary 
arterieB, but haB not been studied in ptB late after 
coronary artery bypae. graft (CABG) surgery. Ischemic 
events in thiB now large pt population are commonl 
furthermore, the athero8clerotic proce8B can develop more 
rapidly in grafts. To evaluate the progno8tic value of 
Tl in this population, we followed for one year, 252 
conBecutive poat-CABG pte who underwent streBe-rediBtri•
bution SPECT Tl. 75 pta (Group A) ware 1-5 yrs, 109 ptB 
(Group B) were 6-10 yre, and 68 ptB (Group C) were 11-19 
yrs post CABG. Forty-four pts had abnormal Tl that 
influenced immediate Bubeequent therapy and ware excluded 
from further analYBiB. In the remaining 208 pta, cardiac 
events (death-9, MI-14, unstable anginaz 46) occurred in 
69 (33'), between 3 and 12 months after Tl. Event rateB 
were computed for pts with ischemic versus noni.chemic 
scintigramB' 
Group A Group B Group C 
PtB (after exclusions) 62 92 54 
IBchemic Tl 27(44\} 56(61\) 34(63\} 
EventB 6(22'} 35(63\) 24(71\} 
Nonischemic Tl 35(56\) 36(39\} 20(37\} 
EventB 0 1( 3\} 3(15'} 
Conclusion. In pts late after CABG, SPECT Tl i. useful 
in aBseBBing prognosis. The 1-year event rate iSI 1}uni•
formly high in pts with an ischemic Tl; 2}very low in pts 
< 10 yrs poBt-CABG who have a noni.chemic Tl; and 
3) Blightly higher in pta very late POBt-CABG with 
noniBchemic Tl. 
703-6 11:45 
10 Year Follow-up of Patients with Normal Thalliu.-201 
Stress Scintigraphy. 
Eric Steinberg, Jerome Koss, Michse1 Lee, Andrew 
Grunwald, Monty Bodenheimer. LI Jewish Medical Center, 
New Hyde Park, NY. 
Normal myocardial perfusion as determined by 
exercise thallium imaging has been shown to confer an 
excellent prognosis over a 2-4 year (yr) period. 
However, progression of disease could result in cardiac 
death with increasing time. Therefore, we determined 
the vital status of all 309 patients (pts) with a 
normal stress thallium in 1981 after 10 yrs (range 
9.4-10.6). Follow-up was complete in 275 pts (89%). 
Deaths were classified as cardiac or noncardiac. Fatal 
acute myocardial infarction (MI) was verified by 
hospital records using standard criteria of history, 
ECG and enzyme levels. 
Seventeen deaths occurred of which 13 were 
noncardiac, 1 was from an HI and in 3 the etiology was 
unknown. Thus, total mortality was 6.2% at 10 yrs. If 
the 3 deaths of unknown etiology are considered 
coronary artery disease (CAD), cardiac mortality was 
1. 5% in 10 yrs. 
This low long-term cardiac mortality is similar to 
that seen in several studies of pts with angiographic 
normal or minims 1 disease. In those studies with a 7-10 
yr follow-up, cardiac mortality was 1-2% and the total 
mortality 4-6%. 
Thus, a normal exercise thallium retains its high 
negative predictive value and significantly reduces the 
likelihood of cardiovascular death as much as 10 yrs 
from initial testing. This supports the use of stress 
thallium imaging to predict which pts with suspected 
CAD are at low risk for cardiac death and do not 
require invasive testing. 
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704·1 10:30 
Lesion Morphology and coronary Angioplasty' Current 
(1990-91) Experience 
Richard K. Hyler, Richard E. Shaw, Simon H. Stertzer, 
Joseph Rosenblum, Mary C. Murphy, San Francisco Heart 
Institute, Seton Hedical Center, Daly City, CA 
533 consecutive PTS with 764 target vessels (V) and 
1000 lesions (L) had coronary (balloon) angioplasty 
(PTCA). Lesions were classified using the modified 
ACC/AHA classification. Procedural success (S) was 
achieved in 93.3% of PTS, 3% had untoward major cardiac 
events (MCE) and outcome was unsuccessful/uncomplicated 
(U/U) in 4.7% (49% of U/U were occlusions). In the 764 
V, S was achieved in 89.6%, HCE occurred in 2.4% and 
U/U in 8.0I. L analysis results are presented (figure). 
... 
ABC 
Success 
In Bl and B2 sub· 
P.t~';,-533-v,;;,;;,-;;-104·, types: S was obtained 
LesionS'looo in 94.9% and 89.6%, 
A,82 e, .7. C,'" MCE was 1.4% and 
rIIl1lJ; Occlusion 
ABC 
Untoward 
Event 
ABC 
UN 
2.3%, and U/U was 
3.7% and 8.1%, re•
spectively. C type 
lesions had consider•
able outcome vari•
ance: L > 2 em or 
angulated > 90 0 had 
PTCA S of >90% versus 
occlusions > 3 months old with S <60%. Factors associ-
ated with S were absence of occlusion, decreasing L 
length (both p<O.OOOl), and no bifurcation L (p<O.Ol) 
or thrombus (p=0.03) and Type ABC (p=0.03). Only throm•
bus was associated with MCE (p=O.003). Occlusion, in•
creasing L length (both p<O.OOOl), thrombus (p=0.03), 
bifurcation lesions (p<0.05) and Type ABC (p=0.03) were 
associated with U/U. 'Lesion specific' rather than 
'classification type' variables are more predictive of 
current PTCA results. 
704·2 10:45 
Late Outoome Following Coroll&l)' ADgioplasty: A Multivariate and Univariate 
ADalysis of the Risk of Patient-Related 0inic:aJ Variables 
Ben D. McCallister, Robert W. Ligon, James H. O'Keefe, Jr., Oeoffrey O. 
Hanzler, Mid America Hean Institute, Kansas City, MO 
Previous studies of our PTCA dstabase (10,349 procedures, 1980-89}have 
identified that pre.procedural risk factors are associated with procedural 
monality (aU pts = 0.9%, MVPTCA = 0.9%, USA'" 1.7%, 3VD ., 1.9%, >70 
yrs old ~ 2.2%, LVEF <40% - 3.7%, respectively) (MVPTCA .. multivessel 
PTCA. USA .. unstable angina, 3VD - 3-vessel disease). In tbe present study 
we evaluated h 3· and 5.yr survival, angina, and need for repeat PTCA and 
bypass surgery (CABO) in the foUowing oobons: 
Low 3V >70 EF High 
Risk MVPTCA CAD 1M Q&Q m <40 Risk 
n= 107 700 2608 2747 1291 988 6S6 69 
Survival 
lyr% 98 97 91 92 94 90 82 62 
3yr% 98 93 8S 8S 87 81 70 52 
5yr% 98 88 79 79 79 72 62 34 
f;v,nt·Free (freedom from ~O, Infa[£tion, o[ d~thl 
lyr% 87 90 77 77 8S 79 71 54 
3yr% 83 82 64 64 69 66 54 44 
5yr% 78 74 51 53 54 54 42 29 
% Re·PTCA at 1 'iI/.% CMO at 1 ~ 
26111 24/8 28115 29/lS 7:l./9 19110 20/13 8/16 
% of Rts with FC! or II (NYHol AD&ina at F.U. 
92 86 70 67 73 83 79 72 
The 3.yr survival after PTCA in pIS with none of tbe 4 major identified 'risk 
factors' [(1) LVEF <40%, (2) 3VD, (3) USA, (4) >70yrs Old) was 97%; vs. 
52% if all 4 were present; 66% if (I), (2), (3) were present; 52% if (4) was also 
present. AD L VEF <40% and age >70 yrs were the most powerful predictors 
of an adverse late survival. Thus survival, free from late death and cardiac 
events, is related to cenain pre.procedural 'risks: which also affect procedural 
mortality. These 'risks' have an adverse cumulative effect if present in 
oombination. 
ABSTRACTS 
704·3 11:00 
ftlltivessel Coronary Angiq>l.asty in Patients with 'lbree 
Vessel Disease and Depressed reft Ventrirular Furction•
Acute and IiJng Term Qltcane 
Ravinder Kohli, Germano DiSciascio, Michael Cowley, 
Sandeep Bajaj, Kim Kelly, Evelyne Goudreau, Mark 
warner, Nagui Sabri, George Vetrovec,Hedical College of 
Virginia, RichIrond. 
Patients (pts) with 3 vessel coronary disease (3VD) 
and impaired left ventricular ejection fraction (LVEF) 
have traditionally been candidates for surgical 
revascularization. we restrospectively analyzed 
results of multivessel coronary angioplasty (MCA) in 
pts with 3VD and LVEF gl.45 between 1979 and 199[1. 
There were 43 such pts including 3[1 males and 13 
females; mean age was 6l±.Hl years; mean LVEF was 37±.7% 
(range 19-45%). Unstable angina was present in 23 
(54%), stable angina in 11 (26%) and recent «2 weeks) 
myocardial infarction (MI) in 9 (2~%); 16 (37%) pts had 
prior coronary by-pass surgery (CABG). A total of 116 
vessels (mean 2. 7±. ~ .8/pt) and 138 lesions (mean 
3.2±.1.4/pt) were dilated. Angiographic success was 
achieved in 109 vessels (94%). None of the pts hGd 
supported angioplasty. [-!ajor conplications (death, [I'U, 
emergency CABG) were seen in 1 pt (2.3%) who uooerwent 
urgent CABG following arute closure. Follow-up for a 
mean of 41±.2l 00 (range 4-77 00) was available. 
Clinical recurrence was seen in 11 (26%) pts (9 were 
treated with repeat PTCA, 1 with atherectomy, 1 had 
CABG), 7 (17%) pts died and 1 had cardiac transplant. 
Actuarial survival at 6~ oos was 8G% and 79% pts were 
event-free (no CABG, death, MI). Of the 7 who died, 5 
had sudden cardiac death. Thus ~K:A appears to be a 
viable revascularization option in pts with low LVEF 
and 3VD. However, long-term oortality remains elevated 
and needs consideration in decision making. 
704·4 11:15 
Clinical Outcome Of Patients With Rest Angina And 
Multivessel Disease Undergoing Culprit vs Multivessel 
PTCA, And The Influence Of Complete Revascularization 
Peter B. Berger, Malcolm R. Bell, Kirk N. Garran, LaVon Hammes, 
Diane E.Grill, David R. Holmes Jr. Mayo Oinie, Rochester, MN. 
Although culprit lesion PTCA has been advocated among patients 
(pts) with unstable angina and multivessel disease (MVD), little is 
known about the shon and long-term outcome of this strategy among 
pts with rest angina. We analyzed 937 pts with MVD (one vessel 
~70% and another ~50% stenotic) with the recent onset of reslangina 
to determine the outcome of pIS undergoing culprit lesion (Group I, 
n=728) vs multivessel (Group II, n=209) PTCA and the influence of 
whether revascularization was complete (CR)(no remaining lesion 
>70%). Pts were followed for a mean of 19±21 months. 
Group I Grouf II 
Age (years), mean±SD 65ill 6Si2 
Left vennicularejection fraction 58i14 61i12 
Prior myocardial infarction (MI) % 60.3 54.5 
Prior CABG % 20.1 16.7 
Prior congestive heart failure 14.8 12.0 
Number of vessels dilated/pt I 2.1iO.3 
~S 
.007 
NS 
NS 
NS 
Total occlusion attempted,% 15.4 14.4 NS 
Complete revascularization, % 29.4 40.7 .002 
Success/pt ~llesion), % 81.0 90.4 .001 
In hospital: MI, % 1.5 0.5 NS 
Emergent CABG, % 3.7 3.3 NS 
Elective CABG, % 6.6 1.9 .009 
Death, % 3.7 3.8 NS 
Any of the above, % 13.7 9.1 .075 
The 3 year cunliiIallve combmea mcuJence of M1, CABG, severe 
angina or death was 47%. Multivariate analysis revealed that baseline 
variables and IR, but not culprit lesion PTCA, were associated with 
both early and late adverse cardiac events. We conclude that both 
strategies reduced symptoms but were associated with high 
complications rates and were most effective when they resulted in CR. 
23A 
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704-5 11:30 
Prediction Models of Immediate and Long Term Outcome After 
Coronary Angloplasty 
William S. Weintraub, John S. Douglas Jr, Henry A Liberman, Douglas 
C. Morns, Spencer B. King m. Division of Cardiology Emory University 
School of Medicine, Atlanta GA 
The results of coronary angioplasty were reviewed in 10,383 patients 
having a first elective revascularization between 1980 and 1990. The age 
was 58:!: 11, 43 % had hypertension, 39% a prior myocardial infarction 
(MI), 13.3% diabetes, 28.8% multivesseJ disease, the ejection fraction 
(EF) was 58:!: 11, 23.2% had multisite (MS) procedures. Angiograpic 
success per patient of all lesions dilated was achieved in 88% (78.9% in 
MS vs. 90.4% of single site, p<.OO(1). Q wave MI occurred in 1.7%, 
coronary surgery (CABG) in 5.8%, and 0.3% died. Angiographic 
success without complications (CS) was achieved in 84.6%. The 
multivariate correlates (Me) of in hospital death were older age (death 
in 0.1% < age 60, 0.4% 60-69,1.1 over 70, p<.OO1), female gender (0.8% 
of women, 0.2% of men, p = .009), vessels diseased (0.2% in single vessel 
disease, 0.7% in multivesseJ disease, p=.015), and EF (0.9% EF < 50, 
0.3% EF ~ 50, p = .067). The most powerful MC of CS were the number 
of sites dilated (CS in 87.2% single site, 76.5% multisite). Followup was 
available in 9521 (92%). The five year survival was .940:!:.004, MI free 
survival was .81:!:.01, MI and CABG free survival was .70:!:.01, and MI, 
CABG and angioplasty free survival .49:!: .01. The most powerful MC of 
late death was older age (p<.OO1) (see 100l~~~======::::=3 
figure, curves from top age < 50, age 
50-59, age 60-69, age 70-79, ~80). The 
other Me were congestive failure 90 
(p<.OO1) low EF (p<.OO1), diabetes 
(p<.OO1), multivessel disease (p=.036), 80 Survival 
and female gender (p= .057). Models by Age 
have been created using different values 
of the many covariates to predict in 70 
hospital and long term outcomes. 
o 2 3 4 5 
704-6 11:45 
ARGENTINE RANDOMIZED TRIAL CORONARY ANGIOPLASlY Va. BY 
PASS SURGERY IN MULTIPLE VESSEL DISEASE (ERACI). IN HOSPI· 
TAL RESULTS AND ONE YEAR FOLLOW UP. 
Mre!lO Rodrjguez MD: Fernando Boul/on, M.D.; Claudia Paviotti, M.D.; 
RafaelDlaz, M.D.; Marfa I. Sosa Uprandi, M.D.; Nestor Perez Balino. M.D.; 
Igor Palacios, M.D. F.A.C.C("). 
Anchorena Hospital· Praxis Medica, Buenos Aires-Argentina. -(*)Mas•
sachusatts General Hospital Boston - USA. 
The purpose of the present study was to compare immediate outcome and 
freedom from cardiac events (death, angina, myocardial infarction) at 1, 3 
and 5 year follow-up in patients w~h muHipie vessel disease randomized to 
either percutaneous translumina/ coronary angloplasty (PTCA) or to 
coronary artery bypass graft surgery (CABG). Patients were considered as 
candidates for randomization if they had multiple vessel disease with lesions 
sUtable for either form of therapy. One hundred and twenty seven patients 
with muHipie vessel disease and need for myocardial revascularization were 
randomized to either CABG (n=64) or to PTCA (n=63)at the Anchorena 
Hospital (Buenos Aires, Argentina). In this study we report the immediate 
results and freedom from cardiac events at 1 year follow-up. Basal 
demographic, clinical and angiographic characteristics were similar in both 
groups. Unstable angina was more frequent in the CABG group (89.2% 
vs. 75.8%, P < .05); 96.3% 01 patients in the PTCA group had lesions type 
BandC. 
There were no differences in mortaI~ or in the frequency 01 periprocedure 
myocardial Infarction between both groups. However, cornpIete reves•
cuiarization was more frequent achieved in the CABG than PTCAgroup (88 
VS. 51 %, P < .0001). Ifeedom from cardiac events at one year follow-up was 
83.5%in the CABG group and 63.7% In PTCA group (p < .005). 
Thus, although there were no significant differences in morbimortal~ and 
hospital results between both forms 01 therapy, patients with muHipie vessel 
CAD treated w~h CABG more frequently achieved complete revasculariza•
lion and were more frequently free of cardiac events at 1 year follow-up than 
patients treated with PTCA. 
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705-1 10:30 
High Pressure Balloon Angioplasty of Pulmonary Artery Stenosis 
Thomas L. Gentles, James E. Lock. Stanton B. Perry 
The Children'S Hospital, Boston. MA 
Despite technical advances and reduced morbidity, the success rate for 
angioplasty of branch PA stenoses using low pressure balloons (LPB) with 
burst pressures 4-10 atm has remained a disappointing 60%. Because 
failure is often due to the inability to eliminate the balloon waist with 
dilation, we evaluated the efficacy of high pressure balloons (HPB) with 
burst pressures 17-20 atm (Blue Max™, Meditech). 
Using HPB, 42 vessels were dilated in 31 pts between 0.25 and 34 
years of age. Diagnoses were TOF in 5, TOF with pulmonary atresia in 13, 
isolated PPS in 4 and other in 9. As in previous series, criteria for success 
were an increase of > 50% in vessel diameter or > 20% in flow to the 
affected lung. or a > 20% decrease in RV pressure. Of 25 vessels that had 
previously failed LPB dilation (3 due to restenosis). 17 (68%) were 
successfully dilated with HPB. In the 17 vessels that had not been dilated 
previously, 13 176%) were successfully dilated with HPB. Overall. dilation 
was successful in 30 of 42 vessels and in these, the diameter increased 
from 4.0 ± 1 .6 to 7.0 ± 2.2mm. Success was unrelated to balloon to lesion 
diameter ratio 12.8 ± 0.6). Because the largest HPB is 12mm in diameter, 
double balloons were used in 3 pts. Successful dilation of surgical 
anastomotic sites were more common than non surgical branch PA 
stenoses (94% vs 54%). Intimal tears were more common following 
successful dilations (73% vs 25%). Complications occurred in 5 pts 
(16%); 1 died following PA perforation with a guide wire. 1 developed 
hypotension and bradycardia requiring prolonged resuscitation, 1 had minor 
hemoptysis and 2 others had brief episodes of hypotension requiring 
transient ionotropic support. Because the Blue Max™ balloons were 
designed for peripheral arterial angioplasty, they are longer, stiffer and 
therefore technically more difficult to position in the PA's than LPB. 
The results demonstrate an increased success rate with HPB, 
despite additional technical difficulties, both in pts who have failed dilation 
with LPB and in those not previously dilated. Although the complication 
rate· (16%) using HPB may be higher than LPB. a larger experience is 
needed to assess this fully. Availability of shorter, softer and larger HPB 
will make them easier to work with and may further improve results. 
705-2 10:45 
Initial Studies Using the New Transcatheter Gianturco 
Vascular Occlusion Device 
Ronald G. Grifka. Martin P. O'Laughlin, Charles E. Mullins, Texas 
Children's Hosp~I, Houston, Texas 
Transcatheter dosure of several cardiovascular defects has 
become a successful alternative to surgery. However, the present 
occlusion devices have lirnilations, induding complicated delivery 
systems, and occasional residual leaks. In order to overcome these 
limitations, we evaluated the new Gianturco vascular occlusion 
device (GVOD, Cook Inc.) in a canine model. 
The GVOD consists of a nylon sack attached to an end-hole 
catheter. A guide wire is advanced through the catheter into the sack; 
the wire coils in the sack, occluding the vessel lumen and maintaining 
sack position. Then. the sack is released from the catheter. 
As an acute study, we percutaneously implanted a GVOD in 11 
canine arteries (S-carotids, 4-subdavians. 2-renals) from 3.2 to 9.S 
mm diameter. A long·term model was created by placement of an 
aorto-pulmonary shunt in 4 dogs (3-Gore·tex graft 6mm, 1-
subclavian artery), followed by implantation of a GVOD. The 
animals were boarded for 4 to 6 months post·shunt occtusion. 
recatheterized, and euthanized. In all implantations, angiography 
was used to assess vessel occlusion. 
In the acute study, all 11 arteries were immediately totally 
occluded. In the long·term model, immediately after implantation an 3 
Gore·tex shunts were totally occluded and the 1 subdavian artery 
shunt had a small residual leak; at recatheterization, all 4 shunts 
were totally occluded. At necropsy, all 4 shunts were totally 
occluded. and the aortic and pulmonic orifices were covered with 
neointima. No embolizations or complications occurred. The average 
fluoroscopic time for GVOD implantation was 11 minutes. 
CONCLUSIONS: 1.) The GVOD is effective for transcatheter 
occlusion of vessels from 3 to gmm and aorto-pulmonary shunts in a 
canine model; possible indications in children in dude long rubular 
PDA's, aorto-pulmonary collaterals, systemic-pulmonary shunts. and 
AV malformations. 2.) GVOD implantation requires a short 
fluoroscopiC time. 
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Native Coarctation Angioplasty: Medium Term Follow·Up 
Christine Houde, Evan M. Zahn, Patricia E. Burrows, Lee N. Benson, 
Robert M. Freedom. 
Hospital for Sick Children, Toronto, Canada 
Between 6/1988 and 611991, 21 consecutive patients (13M, 8F), ~ 1 
year of age (mean 6.9 ± 4.7 years), underwent percutaneous balloon 
angioplasty of coarctation of the aorta (BA). Sixteen patients had 
isolated discrete lesions and 5 associated mild transverse arch 
hypoplasia. 
BA was successful in all patients with a reduction in peak systolic 
gradient from 29 ± IS to 6 ± 7 mmHg (p<O.OOOI) with an increase in 
coarctation diameter of 82% in the left anterior oblique projection and 
95% in the lateral projection (p<O.OOOI). Two patients (9%) developed 
small aneurysms acutely and 2 had transient loss of their femoral 
pulses. 
Seventeen patients have had at least 6 months follow-up and 10 patients 
~ 12 months (mean 1.8 ± O.6years). No significant change in gradient 
was obtained by arm-leg pressure measurements. Magnetic resonance 
imaging (MRI) was obtained in 18 patients, 7 ± 5 months post BA. One 
aneurysm noted on angiogram post BA could not be seen in I patient, 
did not change in size in the second and in a third a new focal posterior 
aneurysm appeared. No correlation was found between balloon size and 
aneurysm formation. Isthmal hypoplasia persisted in 9 patients, 4 of 
which had hypoplasia of the transverse arch, however all had gradients 
S; 20mmHg. Spin-echo images through the pelvic vessels were obtained 
in 16 patients; 4 had normal sized arterial vessels, 1 had complete 
occlusion of external iliac artery and II had reduced diameters of the 
i1eofemoral vessels ipsilateral to the catheter entry site. 
BA appears safe and, in the medium term follow-up, an effective 
procedure for treatment of native coarctation although results are less 
optimal in presence of mild hypoplasia of the transverse arch. Follow•
up MRI scanning reveals that 75% of patients have stenosis of their 
pelvic vessels with unknown long term consequences. 
705·4 11:15 
Differential Survival After Surgical or Balloon Valvotomy for Critical 
Aortic Stenosis in Infants 
Leo Lopez, Steven D. Colan, Larry A. Rhodes, Stanton B. Perry, Aldo 
R. Castaneda, Stephen P. Sanders. Children's Hospital, Boston, MA 
Differences in survival after surgical and balloon aortic valvotomy 
in infants with critical aortic stenosis (CAS) have been reported. 
Although the reason remains unclear, it is possible that patient 
selection criteria are not the same. Mortality rates were obtained for 
81 infants who underwent surgical (n = 30) or balloon (n = 51) aortic 
valvotomy at < 1 yr of age between 1965 and 1990. There were 2 
deaths (7%) in the surgical group and 12 deaths (24%) in the balloon 
valvotomy group, a statistically significant difference by Fisher's Exact 
Test (p = 0.045). An echocardiogram prior to intervention was 
available and analyzed in 9/30 surgical pts and all balloon pts. 
Indexed end-diastolic volume (EDVi, ml/m2) has been shown 
previously to affect outcome. In a recent study using multivariate 
analysis we identified additional anatomic features that predict survival 
for infants with CAS: indexed LV mass (LVMi) > 35 gm/m2; indexed 
aortic root diameter (ARi) > 3.5 cm/m2 ; indexed mitral valve area 
(MVAi) > 4.75 cm2/m2; LV long axis to heart long axis ratio (LAR) > 
0.8. All pts with 2 or more features below these threshold values 
died. All surgical pts and 37/51 balloon pts had fewer than 2 features 
below threshold. When the comparison was restricted to patients with 
1 or fewer values below threshold, the mortality rates for the 2 groups 
were similar (5% vs 7%). The excess deaths in the balloon group all 
occurred in pts with 2 or more features below the threshold. 
EDVi LVMi ARi MVAi LAR 
Surg Alive 98±42 145±73 4.0±0.7 5.2±1.1 0.94±0.06 
Dead 116±37 100±34 4.2±0.3 4.6±0.6 0.89±0.12 
BV Alive 75±44 102±63 4.2±0.8 6.7±3.0 0.95±0.80 
Dead 46±19 63±27 3.3±0.6 3.8±2.7 0.82±0.12 
The difference in mortality rates after surgical or balloon 
valvotomy appears to be due to patient selection. Although survival is 
similar in standard risk subjects, survival in the high risk patients has 
not been improved by balloon valvotomy and other approaches need to 
be considered for these patients. 
ABSTRACTS 
705·5 11:30 
IalQ Term FbllClloiql of Transcatheter Closure of PDI'._ 
Ziyad M_ Hijazi, Lloyd R. Feit, John T. Fahey, Charles 
S_ Kleinman, William E_ Hellenbrand. Yale University 
School of Medicine, New Haven, CT 
Transcatheter closure ('1"0::) of a PDP. was attempted 
in 104 pts using a Rashkind occluder in 101 and coil 
arbolization in 3 at a rredian age of 3.3 yrs (3 rros - 70 
yrs) and rredian weight of 15 kg (4.3-90.9 kg). Sixteen 
were < one and 11 > 18 yrs of age. 'TWenty-four were < 
10 kg and 12 were in CHF. The PDA diarreter ranged from 
0.5-12.5 nrn at its narr~t. Both clinical (CL) and 
echocardiographic (roD) examination were used for 
follow-up. Eight of the first 30 pts did not have 
successful irrplantation, with the inability to cross a 
small PDA with the closure system in 3. Successful PDA 
closure was achieved in the last 74 pts. Pts with a 
small PDA were either balloon dilated and an occluder 
device placed or the PDA was coil occluded. Angiography 
20 minutes post '1"0:: revealed a 44% corrplete closure 
rate. A residual shunt was detected at one day (n=91) 
post '1"0:: in 28% (17% CL, 11% roD only), at one mnth 
(n=83) in 21% (16% CL, 5% roD only) and one year (n=71) 
in 20% (11% CL, 9% roD only). Embolization (E) of the 
occluder occurred in 8 of the first 30 pts with no E 
episodes in the last 74 pts. Repeat '1"0:: was perforrred 
in 7/8 with clinical evidence of PDA at one yr using an 
occluder in 6 and a coil in 1. Q1 long term followup an 
average of 3.1 yrs (1 rros-lO yrs) following 
iJTplantation, there has been no mrtali ty, J1'Orbidi ty or 
SBE. 
'1"0:: is 8CCXl1panied by 11% CL evidence of a 
residual shunt at 1 yr that can be eliminated by repeat 
closure. Further investigation and developnent is 
warranted to eliminate residual left to right shunts. 
705·6 1l:45 
COMPARISON OF STENT IMPLANTATION WITH BALLOON DILATION 
FOR MAINTENANCE OF DUCTUS ARTERIOSUS PATENCY 
Eric Rosenthal. Shakeel A Qureshi, Ashok P Kakadekar, A Hussein 
Tabatabaie. Edward J Baker, Michael Tynan. 
Department of Paediatric Cardiology. Guy's Hospital, London, UK. 
Prolonged patency of the ductus arteriosus is of importance in children 
with duct dependent congenital heart disease. We have evaluated the 
relative efficacy of balloon dilation and stent implantation for this purpose 
in 26 newborn lambs (age 4.38 +/- 1.7 days; weight 4.56 +/- 1.2 kg). 
In 2 lambs it was not possible to recanalise the ductus. 7 underwent 
balloon dilation alone with balloon diameters of 4 - 10 mm. 6 underwent 
stent implantation alone (3 with additional balloon dilation) using balloon 
expandable or self expanding stents of 4 - 8 mm in diameter. 11 
underwent sequential balloon dilation and stent implantation with the 
aame size device (4 - 6 mm). 
Within 5 minutes of balloon dilation the duct had either closed or 
constricted to a diameter of less than 1 mm in 4 and less than 2 mm in a 
further 2. The only inflation to 10 mm - after a poor result at 8 mm 
ruptured the duct producing tamponade. Duct calibre is shown as mean 
+/- SO (number). 
Balloon dilation 
Stent implantation 
4 mm 6mm 8 mm 
1.8 +/- 1.0 (5) 2.2 +/- 1.3 (9) 3.8 +/- 0.7 (5) 
3.6+/-0.7(4) 5.2+/-1.0(9) 7.1 +/-1.3(3) 
Comparison of those undergoing sequential study showed: 
Baseline 
Balloon dilation 
Stent implantation 
Pulmonary/ OPQS 
Systemic ratio 
0.31 +/- 0.1 1.1 +/- 0.4 
0.41 +/- 0.1 2.2 +/- 1.0 
0.57 +/- 0.2 3.5 +/- 2.1 
Duct size (mm) 
o 
2.1 +/- 1.3 
4.7 +/- 1.0 
25A 
In 6 who have entered into a chronic study with follow up now between 1 
- 6 months (current weight 14 - 45 kg) patency by stenting (3 Medinvent 
- Wallstent and 3 Numed - Towers stent) has been well maintained. 
We conclude that stent implantation with 4 - 6 mm devices produces 
superior haemodynamic and angiographic results than balloon dilation. 
26A ABSTRACTS 
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Catheter Modification of the A V Junction Using a 
Microwave Antenna 
Jonathan J. Langberg, Kathleen Diehl, Marsha Gallagher, Mark 
Harvey, University of Michigan, Ann Arbor, M1 
A microwave (MW) ablation catheter was developed with a coaxial 
transmission line and a helical antenna distally that radiates an 
electromagnetic field into the tissue capable of producing thermal 
injury. The utility of this system for attenuating A V conduction and 
slowing the ventricular response (VR) in atrial fibrillation (AF) was 
explored in IO closed-chest dogs. Baseline A V nodal function was 
assessed and AF induced with rapid pacing. The antenna catheter was 
manipulated under fluoroscopic guidance approximately 5 mm 
proximal to the site of the maximal His bundle electrogram. 
Continuous, unmodulated MW energy (915 MHz) was applied at 20 
Watts and increased in IO Watt increments every 20 secs up to a 
maximum of 50 Watts or until there was 50% prolongation of the PR 
interval or 2° A V block. A V conduction was reassessed and AF re•
induced 1 hr and 6 wks after catheter modification. 
Results: 
Baseline 1 hr after MW 6 wks after MW 
3° AV Block 0/10 3/10 
AH(mscc) 64 ± 12 99 ± 25" 144 ± 80·t 
HV (msec) 31 ± 2 31 ± 3 32 ± 4 
AVBlockCL 204 ± 44 246 ± 40" 326 ± 66"t 
VR in AF (BPM) 244 ± 53 191 ± 40" 133 ± 40"t 
" < 0.05 vs. baseline t < 0.05 vs. I hr 
AutonomIc oc e with atropme and propranolo caus no change 
in mean VR in AF 6 wks after MW ablation (133 ± 40 bpm before 
blockade vs. 134 ± 38 bpm after blockade, p = NS). 
Conclusions. 1) 70% of animals treated with MW catheter 
modification had dramatic slowing of the VR in AF without high-grade 
A V block. 2) This appeared to be due to direct effects on the 
conduction system rather than on autonomic innervation. 3) MW•
induced attenuation of conduction was more pronounced after 6 wks 
than after I hr. 
706·2 10:45 
Radlofrequency Ablation of Intermediate Septal Pathways 
using a Bipolar LV·RV Electrode Configuration. 
Spencer C Heald, Yaver Bashir, Sean O'Nunain, Demosthenes 
Katritsis, James F Sneddon, A John Camm, David E Ward. 
St George's Hospital, London, UK. 
Radiofrequency (RF) ablation has gained acceptance as a highly 
effective mode of treatment for accessory pathway (AP) 
mediated tachycardias. However, it is recognised that 
intermediate septal APs are inherently difficult to localise and 
ablate, often requiring prolonged procedures and multiple 
discharges, with a lower overall success rate compared to free 
wall APs. We describe a novel technique for ablation of septal 
APs using a bipolar LV-RV electrode configuration to deliver RF 
energy across the septum. Six pts, (2 male, 4 female), aged 14-
42yrs, underwent attempted ablation of a septal AP (5 pre· 
excited, 1 concealed). Using standard mapping techniques, 
satisfactory local electrograms (A-V time <4Oms, surface ORS-V 
<10ms) were recorded in all cases from both RV and LV 
approaches, but multiple delivery of unipolar RF pulses (max. 23) 
at these sites failed to abolish AP conduction. With both the RV 
and LV electrodes still optimally positioned, bipolar RF pulses 
were delivered across the septum and in all cases resulted in 
successful AP ablation (2-11 pulses). Local electrogram 
characteristics on the successful delivery were:-
~ ~ 
Surface ORS-V (ms) 0 to -10 0 to -10 
Local A-V (ms) 30-65 30-60 
A:V Ratio 0.1-1.5 0.5-3.5 
Time to block in AP was 2-10 s. Procedure duration was 60-230 
(mean 129) mins and fluoroscopy time was 32·93 (mean 59) 
mins. There have been no recurrences during follow-up. 
Conclusion Delivery of RF energy using a bipolar electrode 
configuration may result in successful ablation of septal APs 
where multiple unipolar discharges from both ventricles have 
failed, potentially shortening procedure duration and radiation 
exposure. 
706·3 
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Determinants of Impedance During Radiofrequency 
Catheter Ablation in Humans 
Mark Borganelli, Rafel El-Atassi, Angel Leon, Steven J. Kalbfleisch, 
Hugh Calkins, Fred Morady, Jonathan J. Langberg, University of 
Michigan Medical Center, Ann Arbor, MI 
During catheter ablation, radio frequency (RF) power is inversely 
proportional to impedance, suggesting that this parameter may affect 
the adequacy oflesion fonnation. Impedance was characterized during 
RF ablation in 27 pts. Mean Impedance was 100 ± 10 Ohms (range 
17·132 Ohms). Using multivariate regression, impedance was directly 
proportional 10 body surface area (p = 0.00(1) and forced vital capacity 
(p = 0.03). Impedance was significantly lower during applications that 
interrupted conduction Iban during ineffective RF applications (p = 
0.01), presumably reflecting better tissue contact and/or tissue heating. 
There was no relation between pts' age or gender and measured 
impedance. Applied power, ablation catheter location, and the type of 
catheter used (Mansfield Scientific vs. EP Technologies) did not 
correlate with impedance. 
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Conclusion. Impedance during RF ablation in humans is quite 
variable and directly proportional to body surface area and forced vital 
capacity. RF output voltage should be adjusted commensurate with the 
impedance of the pt. To achieve a desired power output, RF voltage 
should be adjusted commensurate with the impedance of the patient. 
706·4 11:15 
Radiofrequency Catheter Ablation Results in a Reduction 
in Myocardial Microvascular Blood Floy -Insights Into 
the Pathophysiology of Lesion Extension Over Time 
Sunil Nath, Villiam Glasheen, James G. Vhayne, 
Sanjiv Kaul, David E. Haines. University of Virginia 
Health Sciences Center, Charlottesville, Virginia 
Ve hypothesized that tissue coagulation due to radiofre•
quency (RF) induced hyperthermia vould result in injury 
to myocardial microvasculature. To test this hypothesis, 
the LAD artery vas perfused from the carotid artery via a 
roller pump in 4 open chest dogs. Ten RF ablations vere 
created in the LAD bed and pover vas varied to maintain a 
constant temperature of 85·C for 75 sec. The electrode 
tip and surrounding myocardium vere imaged vith high res•
olution 2-D echo and 0.75 cc of sonicated albumin micro•
bubbles vere rapidly injected into the LAD. Videointen•
sity of contrast echo images vere analyzed offline to 
generate time-intensity functions. Regions of interest 
vere determined by comparing images to pathologic sec•
tions: Zone (1) vithin lesion; Zone (2) 3 mm rim beyond 
lesion; Zone (3) 3-6 mm rim beyond lesion. Calculated 
blood flov in zones vere expressed as a percentage of 
o Tltv£ (SEC) 
normal (NL). RESULTS; Zone 
(1) shoved marked decrease in 
blood flov (15±11%); Zone (2) 
shoved decreased flov (38t20%) 
and both had persistence of 
contrast effect for up to 5 
min; Zone (3) had a normal 
20 vashout contour but mildly de-
creased flov (73±27%) (p<O.OOl 
for all comparisons). CONCLUSIONS: RF induced hyper•
thermia results in a marked reduction in blood flov to 
both the zone of acute necrosis and the perilesion zone 
probably due to microvascular endothelial injury. These 
findings may explain RF lesion extension over time. 
lACC Vol. 19, No.3 
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706-5 11:30 
Incidence of Atrial Fibrillation After Successfu. 
Radiofrequency Ablation of Accessory Pathways . 
Martin Borggrefe, Karlheinz Seidl, Moha.mmad Shenasa, WIlhelm 
Haverkamp, Gerd Hindricks, Giinter BreJthardt. 
Westf. Wilhelms-University Miinster, Germany 
A significant decrease of the incidence of atrial fibrillation (AF) 
following successful surgical interruption of accessory pathways 
(AP) has been described. The effects of r.adiofreq~ency (RF) 
ablation in patients (pts) with WoJff-ParklDson-W~lte-(WP~)­
syndrome have not yet been reported. 45 consecutive pts WIth 
WPW-syndrome underwent successful transcatheter ablation by 
application of RF current. 25 Ets had a manifest and another 10 
pts a concealed AP. 10/35 pts (28%) had a history of spontaneous 
AF. Pts with documented AF were compared to those (n =25) who 
had only a history of circus movement tachycardia (CMT): No 
differences were observed with re~ard to presence or absence of 
heart disease age, sex, left atrial SIze and localization of the AP. 
There was a'tendency of shorter antegrade effe~ive refractory 
period of AP in pts with AF. None of the pts WIth a concealed 
pathway versus 10/25 pts with a manifest pathway (40%) had 
documented AF (p<.OI). At pre-operative EP study 7/10 pts wi.th 
documented AF had inducible AF using only one atnal 
extrastimulus and further 15/25 pts with only CMT had inducible 
AF which was sustained in 6 pts. Thus, the overall inducibility of 
AF was 13/35 pts (37%). Foifowing successful ablation of the AF 
by application of RF 5/35 pts (14%) had documented 
spontaneous AF during a mean follow-up of 10 months. AF 
occurred in 3/10 pts (30%) with previously documented AF and in 
another 2/25 pts (8%) without a history of spont!lDeous AF. 
Thus, the inCIdence of spontaneous AF folloWlDg suc~essful ~F 
ablation of AP is high (14%) when compared to surgIcal senes. 
The incidence of AF in pts with documented AF was 30o/i' as 
supposed to 8% in pts without a history of AF. These observatJ~ns 
indIcate that pts with spontaneous AF may further reqUIre 
antiarrhythmic therapy after successful RF ablation of AP. 
706-6 11:45 
Catheter Approaches to Radlofrequency Current Ablation 
of Posteroseptal Accessory Pathways 
Michael SchlOter, JOrgen Siebels, Wolfgang Duckeck, Karl H. 
Kuck. University Hospital Eppendorf, Hamburg, F.R.G. 
In 39 (15 f, 24 m; 42 ± 18 yrs) of 170 symptomatic pts with 
tachyarrhythmias related to an accessory atrioventricular path•
way (AP) who underwent catheter ablation (CA) of the AP with 
radiofrequency current (RFC), the AP was located in the poste•
roseptal (PS) region. Twenty-one PS APs were located on the 
left (L) side of the heart (defined by an AP potential recorded 
from inside the coronary sinus [CSJ); 14 had overt and 7 had 
concealed conduction properties. Eighteen PS APs (15 overt, 3 
concealed) were located on the right (R) side of the heart (AP 
potential recorded directly outside the CS ostium). For the latter, 
mapping of the atrial aspect of the tricuspid ring was performed 
with the ablation catheter. All 14 R PS APs could thus be 
ablated. Mapping of L PS APs was performed via a catheter 
with an orthogonal electrode configuration in the CS. Ablation of 
L PS APs was attempted in 10 pts with a catheter (steerable, 4-
mm tip electrode) introduced from the R femoral vein and 
curved towards the bottom of the CS; in the last 11 pts of this 
series, the ablation catheter was placed in the left ventricle (LV) 
below the mitral annulus. CA attempts via the CS failed in 4 pts. 
In contrast, the LV approach was successful in 10 of 11 pts. 
Conclusion: R PS APs could be ablated in 100% with a cath•
eter placed at the tricuspid annulus. RFC CA of L PS APs 
appears to be more promising (91% success rate) with the LV 
approach than with the CS approach (60% success rate). 
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Reperfusion Ventricular Fibrillation - Is Washing Out of 
the Ischemic Metabolites From the Ischemic Myocardium an 
Important Trigger? 
William H. Kou*, Dun-Xue Mu, Benedict R. Lucchesi. 
VA Medical Center* and the University of Michigan Medical 
School, Ann Arbor, MI 
Ventricular fibrillation (VF) may occur during 
restoration of arterial blood flow to ischemic myocardium 
(1M). Reperfusion (R) consists of readmission of 
arterial blood to 1M and wash out of ischemic metabolites 
from 1M. We previously demonstrated that R with arterial 
blood at a high rate (6 x basal flow) consistently 
resulted in the onset of VF. To study if washing out the 
ischemic metabolites from the 1M per se, i.e. without the 
presence of arterial blood, during R can cause VF, normal 
saline (NS) (37°C) was used to perfuse the canine 
circumflex artery (CX) after 30 min occlUSion, followed 
by carotid arterial blood (group A) through a carotid 
artery-CX shunt. The R rate was controlled at 6 x basal 
flow by an interposed roller pump and the heart was paced 
at 200/min. Collateral flow to CX was allowed to bleed 
back during ischemia via the cannulated CX. Dogs in the 
control group (group B) received only carotid arterial 
blood during R. Eight of 12 (67%) of group A and 10/10 
(100%) of group B dogs developed R VF (p<O.OS). VF 
occurred in 6 dogs during NS and 2 dogs during arterial 
blood R in group A. There was no difference in LV mass 
(S2±IS gm in group A vs 74±20 gm in group B, p<.OS). The 
CX perfusion area/LV ratio was higher in group A (39±7% 
vs 29+8%, p<.05). 
Conclusions: 1) A high rate of displacing ischemic 
metabolites from 1M per se may often trigger R VF. 2) 
Dissociation of readmission of arterial blood to 1M and 
wash out of ischemic metabolites from 1M during R lowers 
the incidence of R VF. 
707-2 10:45 
Active Compresslon-Decompre .. lon Resuscitation In 
Humans Improvea Cardiopulmonary Circulation 
Todd J. Cohen, Kelly J. Tucker, Keith G. Lurie, Rita F. Redberg, 
John P. DuHon, Kathy A. Dwyer, Theresa M. Schwab, Michael C. 
Chin, Alan M. Gelb, Melvin M. Schelnman, Nelson B. Schiller. 
Michael L. Callaham, and the CPR Working Group, UniversHy of 
California, San Francisco 
Previously, cardiopulmonary resuscHation (CPR) wHh a custom 
designed hand-held suction device incorporating active compression 
and decompreSSion (ACO) of the chest has been demonstrated to 
Improve hemodynamics in an animal model. The purpose of this 
study was to quantitate the effectiveness of ACLJ resuscitation in 
humans during cardiac arrest. The ACO device was applied mid•
sternum in 8 consecutive pts and compared sequentially (in random 
order) to standard CPR. Both techniques were performed for 2 min 
(20 min into cardiac arrest) at 80 compresSions/min, 1.5-2 inch 
compression depth, and a 50% duty cycle. Measurements obtained 
every 30 s during CPR included: systolic arterial pressure (SAP); 
velocity time Integral (VTI), an analogue of cardiac output as 
determined by forward transmitral Doppler flow (leaflet tips); and 
end-tidal C02 (ETC02) via capnometry. 
Results: 
CPR 
Standard 
ACP 
SAplmmHgl 
59.2 ± 10.1 
922 ± 109" 
yr((cmlcompresskml ETC02 Immljg) 
10.0±1.5 3.9±1.S 
266±36" 86 ± 1 6" 
"p<0.007 
Spirometry was obtained in 4 pts during ACO CPR (without 
endotracheal ventilation) resulting In a minute ventilation of 6.6 ± 
0.4 Umin. 
Conclusions: ACO CPR is a simple manual technique which Improves 
Circulation in humans compared to standard CPR during cardiac 
arrest. The mechanism for this augmentation appears to be 
improved ventricular filling during active decompression. In 
addition, this method appears to independently provide physiologic 
levels of minute ventilation. 
27A 
28A ABSTRACTS 
707·3 11:00 
MedlaDlsms 01' the Abnormal Peripheral Vascular Response In Hypertrophic 
Cardiomyopathy (HeM). 
Peter J. Counihan, Elizabeth Klare, Guy A. Haywood, Thomas G Farrell, Philip 
J. Keeling, William McKeDDa. St. George's Hospital Medical Schoo~ LondoD, 
U.K. 
Exercise hypotension 8I1d abnormal peripheral vascu1ar responses during exercise 
have been documented in 1/3 of patients with hypertrophic cardiomyopathy but 
the mechanisms remain unclear. Inappropriate 8I1d/or excessive actiVIty of the 
vagaIIy mediated cardiopulmonary baroreceptors resulting in withdrawal of 
sympathetic tone to the resist8l1ce vessels has been suggested as a potential 
mechanism. To examine the activity of these receptors in relation to vascu1ar 
reOexes, the forearm blood Dow (FBF) response, heart rate and mean arterial 
pressure response to lower body negative pressure (LBNP ·18 mmHg), somatic 
reOa stimulation (sustained h8l1dgrip at 30% maximum) and the interaction of 
these two reOexes (LBNP+ HG) were examined in 13 hcalth controls and Sl pis 
with HCM • 30 with a normal response 8I1d 21 with a previously defined 
abnormal vasodi1ator response during supine exercise. Heart rate fell during 
LBNP by S±3% and increased by 9±2% during handgrip and 6±3% during 
LBNP+ HG. The change in HR was similar in a113 groups. During LBNP, mean 
arterial pressure (MAP) increased by 3± 1% in controls and the 30 normal pts 
wbiJe MAP fell by 4±2% in the vasodilator group (p=O.02). MAP change was 
similar in a113 groups during handgrip and during LBNP+ HG. Forearm vasc:uIar 
responses are shown in the table. 
Control 
NormalHCM 
Vasodi1HCM 
lJllif llii LBNP+HG 
%AFBF %AFVR %AFBF %AFVR %AFBF %AFVR 
·33±20 
·27±23 
·28±23 
63±48 
64±67 
44±52 
60±92 
27±46 
34±61 
-6±30 ·20±29 S9±S7 
1S±61. .2±S8. 64+99 
·10±24 18±SO 16±44·'" 
·p=O.034 from normal control; "',P=O.Ol from control. 
These results suggest that the interaction of somatic 8I1d cardiopulmonary reOe. 
responses is disturbed in patients with HCM who exhibit a vasodi1ator response 
to exercise. HG and LBNP result in augmented activity of cardiopuImonU) 
receptors with consequent withdrawal of sympathetic tone to the resistance 
vessels. Activation of cardiopulmonary vagal afferent fibres appears to play an 
important role in the genesis of the abnormal vascular refe1xes during exercise in 
HCM. 
707·4 11:15 
IIffect of Standard Verau. High Doae IIpinephrine on 
N,ocardial High lIDergJ Phoaphate. During Ventricular 
Pibrillation and Cloaed-Cheat CPR. 
James W. Hoekstra, Robert Griffith, Robert Kelley, 
Robert J. Cody, Charles G. Brown. The Ohio State 
University, Columbus, Ohio. 
Recent animal studies and clinical series have 
documented that high dose epinephrine (E), increases 
resuscitation rates from prolonged cardiac arrest due to 
ventricular fibrillation (V?) compared to standard dose 
II. other experimental data suggest that II causes 
depletion of myocardial high energy phosphatea (HEP) 
during V? and CPR. We therefore evaluated the effects of 
standard and high dose E on myocardial HEP in a swine 
cardiac arrest model. Following anesthesia, 
intrava.cular pre •• ure in.trumentation, and 10 minutes 
of V? arrest, closed-chest CPR was begun. After 3 
minutes of CPR, animala received either E 0.02 mg/kg 
(standard dose, n=8) or E 0.20 mg/kg (high dose, n-9) 
intravenously. 3.5 minutes following E, the animals 
underwent thoracotomy and rapid-freezing transmural 
myocardial core biopsy for HEP analysis. Tiasue HEP's 
were determined using HPLC (values in nmol/mg protein). 
E 0.02 mg/ka E 0.20 malka p value 
CPP 13.0 ± 4.8 23.7 ± 5.5 0.001 
PC 0.4 ± 0.8 6.2 ± 4.4 0.0003 
ATP 9.8 ± 4.7 12.7 ± 5.7 0.30 
ADP 5.4 ± 2.1 6.1 ± 1.3 0.41 
ATPjADP 2.1 ± 1.4 2.1 ± 0.9 0.99 
AC 0.68 ± 0.12 0.72 ± 0.12 0.87 
Legend: CPP - coronary perfUSion pressure, mmHg; PC -
phoaphocreatine; ATP - adenosine triphosphate; ADP -
adenosine diphosphate; AC - adenylate charge. 
Thus, 0.20 mg/kg of E does not deplete myocardial HEP 
during poat-V? CPR. E 0.2 mg/kg increasee CPP and 
repletes phosphocreatine during closed-chest CPR, 
increasing the energy storea available to the 
fibrillating myocardium. 
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Neutrophils and Pulmonary Vasoconstriction 
Caused by Platelet-Acti.ating Factor 
Robert E. Goldstein, Linda M. Bradley, 
and John F. Czaja. 
Uniformed Services University of the Health 
Sciences, Bethesda, MD 
Platelet-activating factor (PAF) causes adhesive 
transformation of cell surfaces and promotes 
neutrophil (PMN) adherence to cultured endothelial 
cells. Microvessel accumulation of PMN has been 
thought to mediate PAF-induced pulmonary hyperten•
sion and shock during sepsis. To evaluate PMN 
participation in PAF actions in~, we 
administered PAF, 0.3-10 ~ i.v., to 5 pigs made 
severely and selectively neutropenic by cyclo•
phosphamide, 50 mg/kg, given 4 days prior to 
definitive study. In 6 control pigs, PAF, 3 ~g, 
i.v., elicited expected rises in pulmonary artery 
pressure (PAP, +19 mmHg ±8[SD) and pulmonary 
vascular resistance (PVR, +1320 mmHg/L/min) and fall 
in cardiac output (CO, -1.6 L/min ±0.9). Despite 
markedly reduced PMN (40/mmJ vs. 11,600/mmJ in 
controls), neutropenic pigs had the same hemo•
dynamic responses to each PAF dose as control pigs. 
For example, 3 ~g PAF in neutropenic pigs increased 
PAP (+23 mmHg ±5) and PVR (+1427 mmHg/L/min ±1016) 
and decreased CO (-2.5 L/min ± 0.3). The 
thromboxane A2-mimetic, U46619, 0.3-3.0 ~ i.v., 
also caused the same pulmonary vasoconstriction in 
neutropenic and control pigs, suggesting unchanged 
pulmonary vascular reactivity after cyclophos•
phamide. Since PAF effects are so similar in PMN•
depleted and normal animals, our data show that 
neither PMN occlusion nor PMN-mediated constriction 
of pulmonary microvessels is likely a major cause of 
acute PAF-induced pulmonary hypertension. 
707·6 11:45 
IIlproved Survival in Prillary PulllOnary 
Hypertension With Higb Dose Calcium Blockers 
Elizabeth Kaufmann, Paul Levy, Stuart Ricb 
University of Illinois, Chicago, Illinois 
We evaluated 61 pts with primary pulmonary 
hypertension (PPH) using high doses of calcium 
blockers titrated to maximum physiologic 
effects. Effective dose was determined by 
giving oral nifedipine or diltiazem hourly 
until response or nonresponse was determined. 
Responders (acute fall in PAP and PVR > 20%) 
were treated and followed up to five years. 
Their survival was compared to the non•
responders, and to the survival of pts from 
the NIH Registry on PPH. Responders (mean 
fall in PAP 36%, mean fall in PVR 50%) were 
treated with either nifedipine (mean daily 
dose 176 ± 39 mg.--11 pts), or diltiazem (mean 
daily dose 720 ± 208 mg.--4 pts). Baseline 
hemodynamics of the responders were similar to 
the nonresponders and to the NIH Registry pts. 
At the end of five years, 14/15 responders 
were alive compared to 24/36 of nonresponders 
(P < 0.01). Five year survival for responders 
was 93% compared to 35% for nonresponders and 
32% for NIH registry (P < 0.01). We conclude 
that some pts with PPH will respond to high 
doses of calcium blockers with marked 
reductions in PAP and PVR. When these pts are 
treated chronically they have a markedly 
improved survival over five years. 
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Effect of Leukocyte Elastase Inhibition on Coronary Flow 
Ileserve After Coronary Artery Occlusion and Ileperfusion 
in Dogs 
WUmer W Nicbols, Jawahar L Mehta, Francesca A Nicolini, WiIIiam 
H Donnelly, Tom GP Saldeen, University of Florida and V A Medical 
Center, Gainesville, FL 
Coronary flow reserve as measured by blood flow response to 
acetylcholine (ACh) and nitroglycerin (NTG) is diminished following 
coronary artery occlusion and reperfusion in dogs. Ilelease of elastase 
during reperfusion may contribute to decrease in coronary flow 
reserve and myocardial ischemic injury. To determine the effect of 
elastase inhibition, 12 anesthetized open chest dogs were subjected to 
total len anterior descending (LAD) coronary artery occlusion for I hr 
followed by reperfusion for I hr. Seven dogs were given saline 
throughout the experiment, whereas the other 5 dogs were given the 
elastase inhibitor ICI 200,880 at 50min of LAD occlusion (JOmin 
before reperfusion) and its infusion continued during 60min of 
reperfusion. Plasma levels ofICI 200,880 were 2545±1899 nglml at 
10min and then gradually declined to 254±183nglml at 90 min. While 
there was a marked decrease (P<0.02) in coronary flow response to 
ACh and NTG after LAD reperfusion in all saline-treated dogs, a 
simUar reduction was not observed in ICI 200,880-treated dogs. 
Ischemia-induced deterioration in myocardial segment length change 
was also preserved by ICI 200,880 treatment. Extensive myocardial 
necrosis, contraction bands and neutrophU infiltration were evident in 
the reperfused regions in the saline-treated dogs. Much less neutrophil 
infiltration and only patchy ischemic injury limited to the 
subendocardial regions was seen in ICI-200,880-treated dogs. 
Myeloperoxidase, measured as an index of neutrophil infiltration, was 
increased (P<O.OI) in reperfused regions in the saline-treated dogs, 
but not in the ICI 200,880-treated dogs (P<O.O I). Thus, elastase 
inhibitor ICI 200,880 protects against deterioration in coronary flow 
reserve as well as neutrophU infiltration in reperfused regions. 
Ileduction in myocardial injury in ICI 200,880-treated dogs suggests 
an important contributory role for elastase in reperfusion injury. 
708·2 10:45 
5-Fluorouracil Induces Protein Kinase C•
Kediated Vasoconstriction of Vascular Smooth 
Kuscle in Vitro 
Morris Mosseri, Lyuba Varticovski, Howard 
Fingert, Saurabb Chokshi, Jeffrey M. Isner, st. 
Elizabeth's Hospital, TUft's University school 
of Medicine, Boston, MA. 
Five-fluorouracil (5-FU) , a commonly employed 
chemotherapeutic agent, has been reported to 
cause cardiovascular toxicity, consisting 
principally of acute myocardial ischemia and/or 
myocardial infarction and has been considered 
to result from coronary vasospasm. Previous 
investigations have substantiated the ability 
of 5-FU to induce in vitro vasoconstriction 
(C). To investigate the cellular mechanisms of 
5-FU induced C, rabbit aortic rings were 
mounted isometrically in Kreb's buffer and 
contracted to 5-FU. Pretreatment of rings with 
10-~ staurosporine, a protein kinase C (PK-C) 
inhibitor abolished 5-FU-induced C. 
Pretreatment of rings with 10-7M phorbol 12,13-
dibutyrate (PDBU), a PK-C activator increased 
the magnitude of 5-FU-induced C 23-fold. 
Pretreatment with neomycin, an inhibitor of 
phosphoinositide turnover, did not alter the 
magnitUde of 5-FU-induced C. 5-FU related 
compounds, uracil and floxuridine did not 
produce C. Finally, 5-FU-induced C was 
abolished by exposure to nitroglycerin. 
Conclusions I 1) 5-FU-induced vasoconstriction 
of vascular smooth muscle involves activation 
of PK-C and is independent of phosphoinositide 
turnover. 2) Nitroglycerin may be considered 
for treatment of patients with cardiovascular 
toxicity. 
ABSTRACTS 
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Calcium Antagonistic Properties of 17 p-Estradiol In the Rabbit 
Coronary Artery in vitro 
Canwen Jiang, Philip Sarrel, David Lindsay, Philip Poole-Wilson 
&. Peter Collins. National Heart and Lung Institute, London, UK. 
The modulation of coronary artery tone has been proposed as one 
mechanism underlying the cardiovascular protective effects of 
estrogen replacement therapy (ERT) in postmenopausal women. 
In this study. we assessed the effect of 17p-estradiol (E) on 
coronary artery constrictor responses to calcium (Ca++) or Bay K 
8644. Endothelium'-denuded coronary artery rings from male or 
female adult New Zealand white rabbits were suspended in organ 
baths containing modified Krebs solution bubbled with 95% 02 
and 5% CO2 at 37
0C for the measurement of isometric tension. 
Dose-dependent constrictor responses to Ca ++ in high potassium 
(90 mM) depolarization-medium were performed after the rings 
were incubated with Ca++-free solution containing 0.5 mM EGTA 
for 20 minutes. The rings were readjusted in modified Krebs 
solution for 20 minutes and incubated with Ca++-free solution 
containing EGTA for another 20 minutes. After incubation with 
E (dissolved in ethanol) or the same concentration of solvent for 
30 minutes. the dose-dependent constrictor responses to Ca++ were 
subsequently demonstrated. E shifted the dose-dependent curve to 
the right in a parallel fashion. The ECSO (-log M) was 3.7±0.09 in 
control, and 3.1±O.lO and 2.8±0.08 after incubation with E (I, 10 
I'M; n-6, mean±S.E.M.). E (I, 10 I'M) also inhibited the 
contraction induced by Bay K 8644 (I I'M), a specific 
voltage-operated Ca++ channel agonist. by 42±6% and 88±4% 
respectively (n-8, mean±S.E.M.; p<O.OI). 
Our results suggest that E may have Ca++ antagonistic 
properties in isolated rabbit coronary arteries. This may be part 
of the mechanism underlying the E-induced coronary vasodilation. 
Ca++ antagonists have been shown to affect the progression of 
atheroma. Therefore if E has a Ca++ antagonistic property in vivo, 
this property may be involved in some of the protective effects of 
ERT. 
708·4 11:15 
Mechanism of Synergy Between Serotonin and Thromboxane A2 In 
Human Epicardial Coronary Arteries 
Adrian H. Chester. Gregory S. O'Neil, Sean P. Allen, Magdi H. 
Yacoub. N.H.L.I. Harefield Hospital, Middlesex, U.K. 
Platelets release two powerful vasoconstrictors, namely thromboxane 
A2 and serotonin (s-HT). We have examined the s-HT receptor 
subtypes involved in the synergistic action of these two substances in 
human coronary arteries. A total of 72 segments of epicardial 
coronary artery were removed from 9 recipient hearts at the time of 
cardiac transplantation. The segments which were free of atheroma 
were set up in isolated organ baths and tested for their response to 5-
HT in the presence of either an ECIO, EC30 or ECsO concentration 
of the thromboxane mimetic U46619. There was no apparent synergy 
between 5-HT and U46619 under these conditions, since the 
maximum response of the S-HT dose-response curve (21.3±4.2mN) 
was unaffected by the presence of any concentration of U46619 
(n=8). However& in the presence of s-HT2 receptor blockade with 
ketanserin (10- M), there was an increase in the response to 1O-6M 
S-HT in the presence of U46619 (n-IO). This potentiation in the 
effect of S-HT was significant in the presence of either an EC30 or 
ECSO concentration of U46619: the EC30 concentration(3xI0-9M) 
produced an increase in the S-HT response from 2.8±0.3 mN to 
12.2±2.8 mN (p<O.OI ~ while segments exposed to the ECSO 
concentration (6xI0- M) increased their response to the amine from 
2.4±0.6 mN to 8.9±2.3 mN (p<0.02S). These data indicate that 
thromboxane A2 increases the response mediated by ketanserin•
resistant non S-HT2 receptors. These non-S-HT2 receptors have 
previously been shown in human coronary arteries to be of the S•
HT I-like receptor subtype, and have been found to mediate 
contraction in atherosclerotic regions of epicardial arteries. This 
demonstrates that platelet contents may act together at specific 
receptor sites in producing vasospasm, which could be more 
pronounced in atherosclerotic vessels. 
29A 
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Cholesterol Feeding and Withdrawl in Pigs: Effect on 
SerWi Cholesterol and in Vivo Coronary Ylso.otion 
Mark W.I. Webster, James H. Chesebro, Diane E. Grill, 
Juan J. Badimon, Valentin Fuster. Mayo Clinic, 
Rochester, MH. 
Hypercholesterolemia for 4 mo is associated with. 
abnormal coronary vasoconstriction to acetylcholine 
(ACh) in pigs. To determine reversibility with 
cholesterol lowering 37 two mo old .ale Yucatan 
minipigs were randomfy allocated to a normal diet for 8 
mo, a 4% cholesterol diet for 4 mo then a normal diet 
for 4 mo, or a 4% cholesterol diet for 8 mo. After 8 
mo, coronary endothelial function was assessed in vivo 
by quantitative coronary ~ngipgraphy. Increasina 
concentrations of ACh (10 -10~/m'n) were sequent,ally 
infused over 3 min into the left anterior descending 
(LAD) artery. Minimum absolute vessel diameter (mid•
LAD), the maximal % vasoconstriction (compared with an 
init,al infusion of 5% dextrose), and serum cholesterol 
were measured. Results (mean1SEM) are below: 
8fMlll Chol~Normll 4% Chol 
P,gs, n2 1 12 
Cholesterol, mg/dl 4 mo. 6114 303157* 285142* 
8 mo. 46t5 70114 242126* 
Vasoconstriction, % 2215 3619 48110t 
Vessel diameter
6 
II1II 1.9tO.1 1.610.2 1.210.2* 
*p<0.05, tp-O. 5 compared with normal diet 
The mediao lllln-platelet deposition was <1.0 x 106 
platelets/cnr in all groups and thus compatible with 
normal intact endothelium. The serum cholesterol at 8 mo 
was not significantly different between pigs on a normal 
diet and p.igs on cholesterol/normal d,et. The 
cholesterol/normal pigs have a vasoconstrictor response 
to ACh intermediate between that of normal and 4% 
cholesterol (for 8 mol pigs. Cholesterol feeding 
induces dysfunctional endothelium which is only 
partially improved after 4 mo on a normal diet. 
708-6 11:45 
Concordant Anti-Proliferative and Anti-Migratory Effects of 
Cardiovascular Drugs on Human Plaque Smooth Muscle Cells 
Gerhard Bauriedel. Shankar Ganesh. Petra Heidemann. Jiirgen Heimerl. 
Samuel DeMaio. Reinhard Kandolf. Berthold H1SfIing. Dept. Int. Med. I. 
Univ. of Munich. FRG 
Smooth muscle cell (SMC) proliferation and migration are considered to be 
involved in plaque fonnation. To assess clinically available drugs as 
potential anti-arteriosclerotic agents. their effects on proliferative and 
migratory activity were compared in SMCs cultured from S coronary. 2 
aortic and 6 femoral primary lesions. SMC proliferation was characterized 
by a population doubling rate (POR) averaging 0.23 ± 0.09 PO/day (X±SO. 
n= 16). SMC motion analysis was perfonned with a standardized video 
system. Mean SMC migratory velocity (MV) amounted to 21.9 ± 2.3 ~/h 
(X±SO. n= 16). For drug testing. the desired agent was examined on its 
effect on POR and MV. as compared to the untreated control (=100%): 
DRUG PDR MV 
Isradipine 
Nifedipine 
Verapamil 
SIN-I 
Heparin 
JO·7M 72% .. 
JO-5M 43% • 
JO·5M 65% • 
JO-5M 95% ns 
lo-5M 45% .. 
100 J.1g/mI 42% .. 
(. = p<0.05; ns=not significant) 
67% • 
62% .. 
78% ns 
5S% .. 
57% .. 
Conclusion: Despite the heterogeneous efficacy of the applied drugs. 
both proliferation and migration of human plaque SMCs were concordantly 
decreased to a comparable extent thereby suggesting the involvement of 
common regulatory mechanisms. The study of SMC migratory activity may 
gain special importance in cases of limited availability of human plaque 
tissue after percutaneous atherectomy. 
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Different Role of T Lymphocyte Subsets In Autoimmune 
Pathogenesis of Primary Dilated Cardiomyopathy 
GOnter Klappacher. Serta Grat, Richard Pacher, DieImar Glogar. 
Department of Cardiology, University of Vienna. Austria. 
To test the hypothesis of autoimmune pathogenesis in dilated cardiomyo•
pathy (OCM) we measlJ"ed ci"culatlng levels of soluble T eel receptors. 
Global T cell activation as Indicated by elevated serum concentrations of 
soIWle IL-2 receptor (sIL-2R) was observed in 46 patients with primary OCM 
as well as in 11 patients with myocarditis. The role of the T lymphocyte 
subsets was different: in myocarditis the release of soluble COS (sCOS) by 
suppressor T cells into the serum was significantly reduced suggesting 
BlWessor T cell dysfunctiOn. In primary DCM the stimulation of C04-poSkive 
T ~ cells was predominart: serun soIlilIe CD4 (sCD4) closely correlated 
wlh the dinical state. 
SERUM LEVEL of sCD4: HIGH (N=12) LOW (N=24) P VALUE 
NYHAf\rlctIonaIcIass(III+IV/II) S/4 5/19 <0.01 
uosernide (mg/day) 128.9t52.8 35.2±11.8 <0.025 
left ventricular ejection fraction 0.13±0.03 0.22±0.02 <0.05 
right ventriCular ejectiOn fraction 0.15±O.04 0.29t0.03 <0.025 
cardiac index (Vminlm2) 2.1±0.1 2.9t0.1 <0.0025 
LVEOP (mm Hg) 24.6±3 16.7±2 <0.05 
RVEOP (mm Hg) 10.6±1.6 5.6±0.6 <0.001 
RAMP (mm Hg) 11.6±1.9 6.2±0.S <0.005 
PAMP(mmHG) 39.1±3.3 23±1.9 0.0005 
PVR (dyn.sec.cm·5) 307.1±50.2 136.4±14.7 <0.0005 
SVR (dyn.sec.cm·5) 1778.6±235.5 12S7±68.5 <0.025 
serum sodiOO! (mmolll) 140. 2± 1 .1 143. 6±0. 5 <0.0025 
BUN (mg/d~ 23.2±2.2 15.5±0.S <0.0005 
serum bilirubine (mg/dl) 1.4±0.3 0.7±0.1 <0.005 
Peripheral blood mononuclear cells of OCM patients secreted sIL-2R. but 
not sCOS into the supernatants in a higher amount than lymphocytes of 
normal healthy controls. These in vitro data again demonstrate T cell 
activation based on the latent defect of the slWessor cell subset. 
Conclusion' Like in other autoimmune diseases the suppressor T cell 
dysfunction in myocarditis may be the responsible bypass mechanism 
leading to ~ T cell stinulatiOn In the clYonic phase. i.B. primary DCM. 
709-2 10:45 
Detection of Enterovirus RNA in Myocardial Biopsies From 
Patients With Idiopathic Dilated Cardiomyopathy and 
Myocarditis Using Gene Amplification by the Polymerase Chain 
Reaction. 
Philip J Keeling, Stephen Jeffrey. Alida LP Caforio, Rohan Taylor. Michael 
J Oavies. William J McKenna. Department of Cardiological Sciences, St 
George's Hospital Medical School, London, UK. 
Enteroviral infection remains an important hypothesiS for the pathogenesis of 
idiopathic dilated cardiomyopathy (DCM). Serological evidence is however 
unreliable and several studies using molecular hybridisation have produced 
conflicting results. In this study we apply a highly sensitive enterovirus 
speCific polymerase chain reaction (PCR) gene amplification technique to 
myocardial biopsies taken from SO patients with clinical DCM and biopsies 
taken from 75 patients with other fonns of cardiac disease (ischemic heart 
disease 15. valvular heart disease 19, specific heart muscle disease 5. 
congenital heart disease 2) and cases of sudden death in the community 
(n=34). A positive enteroviral PCR result was obtained in 6/50 (12%) 
patients with OCM and 13/75 (17.3%) patients from the control population 
(NS). No differences were observed between probe positive and probe 
negative OCM patients with respect to age, duration of symptoms. the 
number of patients with a premorbid acute viral illness. NYHA functional 
class or measures of left ventricular function. All six probe positive OCM 
patients histologically had healed myocarditis according to Oallas criteria. 
however this was not Significantly different from those patients who were 
probe negative. Within the control group positive PCR results were observed 
in 3/15 (20%) patients with ischemic heart disease, 2/19 (10.5%) valvular 
heart disease, 1/5 (20%) speCific heart muscle disease. O{2 (0%) congenital 
heart disease and 7/34 (20.6%) cases of sudden death. Subsequent follow•
up of the 6 probe positive patients revealed the following; 3 patients remained 
unchanged at 7-25 months (mean IS.7 months). I patient was improved at 27 
months. I patient received an orthotopic beart transplantation at 3 months and 
I patient died at 7 months. This was similar to those patients with OCM who 
were probe negative. 
Conclusion: Enteroviral genome was detected within the myocardiumin a 
similar proportion of patients with OCM and controls. These findings 
suggest that enterovirus is a common environmental pathogen which does not 
playa principal role in the pathogenesis of DeM. 
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Virus·Induced Myocarditis in Mice with Severe Combined 
Immunodeficiency (SCID): Pathogenesis of Severe Myo· 
cyte Injury and Prevention by Immune Reconstitution 
Lawrence H. Chow. Paul BOlTon, Kirk W. Beisel. and Bruce M. 
McManus. 
Robarts Research Institute. London. Ontario. Canada and University 
of Nebraska Medical Center. Omaha. NE 
It has been postulated that viral or autoimmune mechanisms. individ•
ually or in combination. operate in the pathogenesis of myocarditis. 
To examine the interaction between virus and host immunity in 
myocarditis. coxsackievirus B3 was inoculated into C3H/HeSnJ mice 
with inherited severe combined immunodeficiency (SCID). Because 
SCID mice lack mature T and B lymphocyte functions. direct viral 
effects may be assessed in the absence of self-specific immune 
response. The outcome of infection in SCID mice was compared to 
that in control animals consisting of con genic non-SCID mice as well 
as SCID mice after immune reconstitution with bone marrow and 
spleen cells. High mortality (50%) developed in non-reconstituted 
SCID mice between 11-14 days after infection. while all non-SCID 
and reconstituted SCID mice survived to be sacrificed at 14 days. The 
histologic severity of myocarditis was assessed semi-quantitatively. 
Mice n Infected Mean Myocarditis 
·SCID 
·Non-SCID 
·Reconstituted 
sao 
10 
10 
4 
yes 
yes 
no 
Score (SEM) 
3.5 (0.2)* 
1.9 (0.3)* 
0.0 
·Reconstituted 5 yes 0.4 (0.4)* 
sao [*p<O.05 vs. each other by Mann-Whitney U test] 
Without immune reconstitution. infected SCID mice developed severe 
myocarditis. with high viral titers in the myocardium and large areas of 
viral cytopathic effect. We conclude that active viral replication in the 
myocardium has direct pathogenic potential and that an intact immune 
response plays a primary protective role in acute disease. 
709·4 11:15 
Identification of a Type-Specific Ipitope of 
Coxsackie B3 Virus: Use for Diagnosis of Myocarditis 
Peter L. Schwiaabeck, Caecilia Haar.ann, Heinz-Peter 
Schultheiss, Bodo I. Strauer. 
University of Duesseldorf, Duesseldorf, Ger.any 
Interoviral infections, especially those with 
Coxsackie B3 virus (CB3), are thought to be the 
initiating event a of .yocarditi.. But auch an 
infection i8 still difficult to diagnose and requires 
RNA hybridization with an endoayocardial biopsy, 
since the serological .ethods used thus far are not 
sensitive nor specific enough. In order to establish 
a non-invasive, serological test syste., we 
synthesized 31 overlapping peptides representing the 
entire sequence of the viral coat protein VP1. These 
peptides were used as antigens for a specific and 
sensitive test for antibodies against the virus. When 
sera fro •• ore than SO CB3-infected .ice were tested, 
all of the. showed binding to a peptide representing 
the .. ino acids 1-15 of VP1, thus identifying it as a 
.ain antigeniC deter.inant. When we subsequently 
tested type-specific aera against Coxsackie B1-6, 
only sera against CB3 reacted with the peptide 
representing the .. ino acids 1-15 of VP1. In 
contrast, the sera against the other types of 
Coxaackie viruses were negative, thus identifying 
this peptide as a type-specific epitope of CB3. Sera 
of patients with .yocarditis were also shown to react 
with this peptide. 
These results de.onstrate the identification of a 
type-specific epitope of CB3. Synthetic peptides 
representing the epitope can be used for a highly 
sensitive and specific antibody screening test and 
allow a type-specific diagnosis. 
ABSTRACTS 
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Does Verapamll Modify the Immune Response in Murine Viral 
Myocarditis? 
Raymond Dong. Sohail Waien. D. Bailey. Michael J. Sole. Jeff 
Davidson. Peter Liu. 
The Toronto Hospital. University of Toronto. Canada. 
Verapamil has been shown to significantly improve the clinical 
and histologic consequences of murine viral myocarditis in our 
previous investigation. To test whether verapamil exerts its 
therapeutic effect through alterations of the immune response in this 
model. we studied 70 DBA12 male mice simultaneously infected with 
10 pfu of i.p. encephalomyocarditis virus. The animals were 
randomized either to receive no further treaUUent (C) or to receive 
oral verapamil beginning 4 days post infection (V). Animals were 
randomly sacrificed from each group (n=5) on days 7. 10. 14.21. and 
28. Lymphocytes were extracted from the peripheral blood. heart and 
spleen of each animal. pooled and labeled with fluorescent 
monoclonal antibodies to helper (CD4+) and T-cytotoxic (CD8+) 
surface antigens. Lymphocyte subsets were analyzed using flow 
cytometry and quantified as to number and specific T-cell markers. 
The percentages of total cell count for each lymphocyte subtype at 
different time duration are as follow: (*p<0.05 V vs. C) 
Blood Heart Spleen 
IID:QJl! ~ em ~ ma ~ w 
7 C 31.7 7.8 0.1 0.2 5.5 1.2 
V 35.3* 9.1 0.3 0.1 8.8* 1.4 
10 C 29.0 6.4 1.5 0.9 11.0 17.3 
V 29.8 10.7* 0.7 0.7 9.6* 14.4* 
14 C 33.1 9.9 8.0 3.6 2.2 0.4 
V 22.4* 10.6 4.5* 0.9* 3.1 1.8 
Lymphocyte counts reverted towards normal by day 21. 
Conclusion: In a murine model of myocarditis. verapamil 
significantly decreased the CD4+ and CD8+ response. Thus 
verapamil may playa novel but important role in inhibiting the cell 
mediated immunity perpetuated by these immune modulating cells in 
myocarditis. 
709·6 11:45 
Analysis of Parametars Affecting Gene Expression Following 
In Vivo Myocardial Transfectlon. 
Dov Gal. Lawrence Weir, John Hogan, Jeffrey M. Isner. Tufts University 
School of Medicine. St. Elizabeth's HospHal, Boston, MA 
Transfection of myocardium by direct injection 01 DNA has been previously 
shown to be feasible and may be potentially applicable to the management 
of a variety of cardiovascular diseases. The factors effecting the efficiency 
of myocardial transfection, however, have yet to be fully defined. 
Accordingly, we designed the present study to determine the effect of 
increasing the volume of injectate (phosphate-buffered saline containing 
5% sucrose (PBS}) on both the efficiency and topographICal distribution of 
direct myocardial transfection. A constant amount (50 Ilg) of plasmid 
containing the firefly lucHerase reporter gene (Luc), driven by the Rous 
Sarcoma Virus long-terminal repeat promoter was directly Injected by open 
thoracotomy into the left ventricular apex of 10 rabbHs using a 28.5 gauge 
needle. Three different volumes of injectate were employed: 50 III (group 
1, 3 rabbits); 100 III (group 2, 4 rabbits); and 150 III (group 3, 3 rabbits). 
Control rabbtts (nc 2) were transfected with 50 Ill! promoterless Luc plasmid 
in 100 III PBS; or 82 Ill! of unrelated plasmid, without Luc In 100 III PBS. 
The rabbHs were sacrificed 5 days fater, at which time the left ventricle (LV) 
was separated from the right ventricle (RV) and "breadloafed" to yield an 
apical (a) portion (site of DNA injection); a mid (m) portion; and a basal (b) 
portion (furthest from the Injection site). Both ventricles were 
homogenized, then centrifuged, and 5% of the supernatants were 
assayed. ResuHs, expressed in m±SEM light units are tabulated. 
~ J:lt:IAW.gl fl3Slu.I) J.lla.. U1D m .Bl: 
1 50 50 516±237 .73±.72 .082±.06 0 
2 50 100 1029±215.63±.54 .290±.12 .03±.01 
3 50 150 1564±738 .38±.26 .002±.002 .07±.02 
The control unrelated plasmid was negative, while the promoterless Luc 
plasmid expressed < 1.0 light unHs. Conclysions· 1) All the rabbits which 
were transfected expressed detectable levels of Luc. 2) Expression of Luc 
was higher with increasing injection volumes. 2) The highest levels of 
expression ':Yere confined to the Site of injection and decreased sharply 
beyond. While data from these three groups has yet to define a "plateau' 
vOlum~ o! Inj~ctate. t~ese prelimin~ry findings suggest that the efficiency 
~nd dl~trtbuhon of dlre.ct m~ocardlal transfection may be optimized by 
Increasing the volume In which a constant amount of genetic material is 
transfected. 
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710-1 2:00 
"Strands" on Mitral Valve Prostheses by 
Transesophageal Echocardiography - Another Potential 
Embolic Source 
Loretta Isada, Allan L. Klein, Julius Torelli, James Nemec, 
William 1. Stewan 
Cleveland Clinic Foundation, Cleveland, Ohio 
Patients with prosthetic mitral valves (MVR) have an 
increased incidence of thromboembolic events.Transesophageal 
echocardiographic (TEE) documentation of left atrial spontaneous 
contrast ("smoke") and left atrial thrombus in MVR provides 
substantive evidence of embolic potential, but such evidence is 
lacking in other patients. Fibrinous-like attachments (strands) 
have been detected on the left atrial side of the MVR in a number 
of patients undergoing TEE, however the significance of this 
rmding is unknown. Therefore, over a 12 month interval, 83 
TEE studies were performed on 76 patients with MVR, including 
39 studies on bioprostheses (47%) and 44 studies (53%) on 
mechanical prostheses. Strands were noted in 15 studies (18% of 
the total number), 14 of which were on mechanical prostheses. 
One of 39 bioprostheses (3%) vs 14 of 44 mechanical prostheses 
(32%) had strands, p= 0.0004 by the Fisher's exact test. 
Embolic episodes (including documented transient ischemic 
attacks, peripheral emboli, or stroke) occurred in 7 of 14 patients 
(50%) with strands compared to 3 of 18 patients (17%) with 
spontaneous left atrial contrast, and 1 of 4 patients with both 
smoke and strands. No association was found between left atrial 
thrombus and fibrinous strands. 
Conclusions: 1) Fibrinous strands were detected in 18% of 
transesophageal examinations on patients with MVR, and appear 
to be associated more commonly with mechanical prostheses. 
2) These strands may represent a potential source of emboli not 
previously recognized. 
710-2 2:15 
Cardiac and Vascular Sources of Cerebral 
Thromboembolism in Patients with Atrial Fibrillation. A 
Combined 'j'ran.oesophageal and Vascular 
Ultrasonographic Study. 
Massimo PozzoH, Raffaele Gibellini, Roberto Tramarin, Alberto 
Ferrari-Bardile, Gerardo Schiavone, Soccorso Capamolla, Egidio 
Traversi, Franco Cobelli. 
Fondazione Clinica del Lavoro IRCCS, Montescano (PV), Italy 
Atrial fibrillation (AF)is associated with an increased risk of atrial 
thrombi and cerebral thromboembolisms. However, because of the 
high prevalence old age and anerial hypertension in patients with AF, 
coexistent vascular sources of embolism might play a role in the 
pathogenesis of thromboembolisms. To assess the relation between 
cardioembolic sources, significant carotid lesions (>50% diameter 
stenosis; irregular and dishomogeneous plaques) and the occurrence of 
cerebral thromboembolism, 91 patients with AF (63 non-valvular and 
28 valvular) were prospectively studied by transoesophageal 
echocardiography (TEE) and high resolution duplex ultrasonography 
(DU) of the carotid arteries. 
Results: TEE showed thrombi andlor spontaneous echocardiographic 
contrast (THlSPEC), either within the left atrial appendage or the main 
atrial cavity, in 32(80%) of the 40 patients who had suffered from a 
recent cerebral thromboembolism. Within this group, significant 
carotid artery lesions were found in 5 patients with and 4 without 
THISPEC. Therefore, combining TEE and DU results, potential 
thromboembolic sources were found in 36 of 40 patients (90%). In 
patients without cerebral embolism the prevalence of THlSPEC was 
significantly lower (24%,p<0.00l). Patients with THISPEC within 
the left atrium were 3.3 times more likely to have had a cerebral 
thromboembolism than those without. 
Concusions: These results indicate that cardiogenic sources are 
involved in most of the AF-related cerebral thromboembolisms, but a 
vascular mechanism may playa role in same patients. Combined TEE 
and DU may be useful in identifying patients with AF at high risk of 
thromboembolism. 
710-3 
JACC Vol. 19, No.3 
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2:30 
Is Transesophageal Echocardlography Mandatory 
In Young Stroke Patients Without Left Heart 
Disease and Significant Cerebrovascular 
Atherosclerosis ? 
Ariel Cohen, Raymond Roudaut, Bertrand Cormier and 
The French Cooperative Study on Stroke, Paris and 
Bordeaux. France. 
The utility of transesophageal echocardiography (TEE) in 
patients (Pts) under the age of 50 with unexplained stoke 
and normal cardiac status remains controversial. We 
prospectively studied 214 Pts (95F and 119M), mean age 
36 ± 10 (13-50 yrs) with CT and/or MRI and/or 
angiographically proven cerebral embolism. All Pts were in 
sinus rythm. Transthoracic echocardiography (TIE) and 
carotid ultrasound examinations were normal. TEE was 
realized with a single-plane 5MHz probe. Contrast TEE 
was performed at rest and during provocative maneuvers 
(Val salva. coughing). TEE revealed the following potential 
cardiac sources of embolism : atrial septal aneurysm in 20 
cases (9%), mitral valve prolapse in 21 cases (10%) and 
ascending aorta and aortic arch plaques in 3 Pts (1.4%). A 
right-to-Ieft contrast shunting consistent with patent 
foramen ovale (PFO) was noted in 79 Pts (37%) by 
contrast TEE. No thrombus or spontaneous 
echocardiographic contrast were detected within atrial 
appendage and left atrium. 
In conclusion. until the significance of a functional PFO 
and other atrial septal abnormalities is established. the 
diagnostic value of TEE appears limited in the evaluation 
of young stroke patients. 
710-4 2:45 
Comparison of Contrast Transesophageal Echocardio•
graphy and Transcranlal Sonography for the Detection of 
Patent Foramen Oval. in Young Strok. Patients 
Frank P. Job, E. Bernd Ringelstein·, Christopher Doherty·, Frederic 
Marenne, Andreas Stockmanns·, Jan H. Weingartner·, Heinrich 
Klues, Frank A. Flochskampf, Peter Hanrath (FACC); Medical Clinic I 
and Department of Neurology·, RWTH Aachen, Germany 
Contrast tronsesophageal echocardiography (cnE) has been shown to 
be the most sensitive tool for the detection of patent foramen ova Ie 
(PFO). To assess the diagnostic value of transcranial sonography (TCD) 
with intravenous echo contrast injection we performed simu/toneous 
cTEE and TCD of both middle cerebral arteries in 71 consecutive 
young stroke patienb (aged 7 . 45 years). All patienb were studied 
under basal conditions and during provocation by Valsalva 
manoeuvre and coughing. Diagnostic criterion for positive cTEE was 
passage of contrast bubbles from the right to the left atrium and distinct 
showers of spikes within 5 • 7 seconds for positive TCD, regardless 
whether they occured at boseline and / or after provocation. 
TCD negah've TCD positive 
TEE negative 35 7 
TEE positive 2 33 
In this specific population neither atrial septol defect nor thrombus 
formation in the left atrium or left atrial appendage were seen. None 
of the patienb had atrial Ruiter. 1 patient was excluded because of 
left ventricular aneurysm. The prevalence of PFO by cTEE was 48 % 
and 48 % by TCD. Concordant resulb between both methods were 
achieved in 97 % of all cases. Conclusion: TCD is a reliable tool for 
the diagnosis of PFO in young stroke patienb with a sensitivity similar 
to cTEE. 
JACC Vol. 19, No.3 
March I, 1992:33A 
710-5 3:00 
Significant Mitral Regurgitation Is Protective Against Left Atrial 
Spontaneous Echo Contrast and Thrombus as Assessed by 
Transesophageal Echocardlography 
Colin Movsowltz, Colin B Meyerowitz, Larry E Jacobs, Leo Podolsky, 
Alfred loll, Morris N Kotler. 
Albert Einstein Medical Center, Philadelphia, PA 
The purpose of the study was to assess the relationship between mttral 
regurgttation (MR), spontaneous echo contrast (SEC) and thrombus by 
transesophageal echocardiography (TEE). The prevalence and semi· 
quan@cation of MR, SEC and thrombus were retrospectively evaluated in 427 
patients undergoing TEE. Indications Included: valve evaluation at the time of 
surgery in 26%, nonoperatlve valve assessment in 19%, source of embolus in 
12%, subacute bacterial endocardttls In 9%, aortic dissection in 8% and 
miscellaneous In 26%. MR was observed In 228 patients (53%), SEC in 21 
patients (4 9%) and thrombus in 11 patients (2 6%) 5 of whom also had SEC 
MR SEVERITY 0 1 2 3 4 
SMOKE (SEC) 10 4 6 
. 
1 0 
THROMBUS 6 4 1 0 0 
NO SECITHROMBUS 184 70 70 38 33 
TOTAL 200 78 77 39 33 
Left atrial SEC and thrombus were slgnHicantly less common In patients wtth 
MR graded 2 3 + on TEE color Doppler compared to patients wtth MR < 2 + 
(p < 0.040). Mixed rheumatic mftral valve stenosis and MR was present in 7 
patients wtth MR ~ 3 + and desptte atrial fibrillation (Afib) in 5 patients, no SEC 
or thrombus was present. 30 patients wtth MR < 2 + had mttral valve stenosis 
and 13 of these had SEC or thrombus wtth 11 of the 13 having Afib. Of 23 
patients assessed for prosthetic valve function 5 had thrombus or SEC and 1 
of these (*) had 3+ MR which was due to a paravalvular leak. 13 of the 21 
patients wtth SEC and 9 of the 11 with thrombus had Afib. 
IN CONCLUSION; 1.) MR ~ 3 + Is protective against SEC or thrombus even 
in patients with Afib and rheumatic valve disease. 2.) Left atrial thrombus and 
SEC are more frequent in patients wtth MR • 2+. 
710-6 3:15 
Diagnosis of Patent Foramen Ovale by 
Transesophageal Contrast Echocardiography 
Interlaboratory comprrative study. 
Claudia ttlillberger, BiI;/<e schneide?, Frjedrich 
Ab"ie1er , Thomas Wollne~, Thomas reinert" , Jorg 
Slany , KA Rudolfstiftung, Wien, 4 ; Allgemeines 
Krankenhaus St. Georg, Hamburg, FRGf. 
The reported prevalence of patent foramen 
ovale (PFO) as assessed by transesophageal contrast 
echocardiography (CTEE) varies considerably (6-32\) 
among echocardiographic laboratories (EL). one 
reason might be a different interpretation of CTEE 
studies. To assess the interobserver variability of 
2 different EL the videorecordings of 200 patients 
(P J, 100 from each EL, 75f, 125m, .. age 60 years, 
were reviewed. All CTEE studies were classified as 
·positive n , "negative" or "questionable" left 
atrial contrast by one experienced observer from 
each EL. In 100 P retrospectively assesed using 
'EL-specific' criteria for diagnosis of PTO the 
prevalence was 19\ (observer 1) vs 33\ (observer 2) 
(pa O.0015). Discrepant results were obtained in 
21/100 P (l0 vs 11 P from each EL) and were not 
related to the contrast material used (agitated 
saline vs gelatine solution). After agreeing on 
certain criteria (lor more bright bubbles 
appearing in the left atrium within 3 heart cycles 
after appearance in the right atrium) a consensus 
was achieved in 15 P. In 6 P the interpretation 
remained controversial. In 100 consecutive P 
prospectively evaluated with special regard to 
technique of CTEE and definition of PFO the 
prevalence was 26\ with both observers. 
Conclusion: Interlaboratory disagreement concerning 
CTEE studies exists and must be taken into account 
when assessing the prevalence of PFO by this 
_thod. There is a need for developing a commonly 
accepted technique and uniform criteria for 
diagnosis of PFO by CTEE. 
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711-1 2:00 
Prolonged Urokinase Infusion for Chronic Total Native 
Coronary Occlusions 
Cindy Grines, Steven Ajluni, Vicky Savas, Joseph Samyn, 
Gregory Pavlides, Sylvia Puchrowicz, Ann Margulis, 
William O'Neill. William Beaumont Hospital, Royal Oak, 
Michigan 
Prolonged thrombolytic infUSions have been useful in 
recanalization of chronically occluded peripheral ar•
teries and saphenous vein grafts. Since angioplasty of a 
chronically occluded native coronary artery is associat•
ed ~ith a low initial success rate and high rate of re•
occlusion, we administered prolonged infusions of intra•
coronary urokinase (UK) to 24 patients with a chronic 
total native occlusion (CTO), (>3 months duration) or a 
more recent occlusion in which a wire could not be pass•
ed. UK (100,000-200,000 U/hr for 8-24 hrs) was adminis•
tered via an infusion wire placed just proximal to the 
occlusion and guiding catheter. The right coronary ar•
tery was chronically occluded in 20 cases, circumflex in 
3 and left anterior descending in 1. Estimated druation 
of occlusion was 2.7 months and angiographic evidence of 
thrombus was present in only 5 (21~) patients. Catheter 
induced proximal dissection with myocardial infarction 
occurred in 1 patient (4~). UK infusion resulted in im•
provement in TIMI flow by ~ 1 grade in 7 (29%) patients. 
Following urokinase infusion, PTCA was successful in 13 
of 23 (56~) attempts. Baseline and nadir HeT (13.7 vs 
11.3) and fibrinogen levels (270 vs 250) changed mini•
mally. One patient experienced a GI bleed (4%) and 1 
patient required transfusion (4%). These preliminary 
data suggest that a prolonged subselective coronary 
infusion of urokinase can be safely performed and may 
facilitate recannaliza-tion in CTO not suitable for 
standard PTCA. 
711-2 
Effect of Gradual ProIoogcd InOation During Augioplasty on 
Inhospital aDd Longtenn Outoome: Reau111 of. Multicenter 
Randomized Trial 
2:15 
E. Magnus Ohman, J-F Marquis, Donald R Ricci, Robert 1.0. 
Brown, Merrill 1.. Knudtson, Dean J. Kereiakes, Joseph K. Samaha, 
James R Margolis, Alan 1.. Niederman, Lany J. Dean, Paul A 
Ourbel, Michael H. Sketch Jr., Nancy M. Wildermann, Keny 1.. Lee, 
Robert M. Califf, for the PBC Study Group. 
Duke University Medical Center, Durham, North Carolina 
To examine the potential benefit of a gradual prolonged inflation 
during angioplasty compared with standard short dilatstions, we 
performed a randomized trial using an autoperfusion balloon catheter 
(ACS Inc., Santa Clara). A total of 547 pIS from 13 hospitals were 
enrolled in the study. The perfusion balloon (PBC) was used as the 
primary device on a single lesion in 478 pIS. The median (25th-75th 
percentile) age was 57 (49-65) years. Baseline ejection fraction was 
58% (50%-65%) and 41 % of pIS had unstsble angina. The median 
pre-dilatation stenosis was 95% (75%-95%). Lesion characteristics 
were type A in 51%, type B in 48%, and type C in 1%. The lesion 
dilated was in the LAD in 40%, RCA in 44% and CxA in 16%. After 
placement of the PBC, pIS were randomized to stsndard (STAND) 
dilatations (up to 4 dilatations 1 min each) or prolonged (PROL) 
dilatations (up to 2 dilatations 15 min each) in phase 1 of the study. If 
pIS had a residual stenosis > 50% they were treated with further 
dilatations in phase 2. The median time per dilatation in phase 1 in 
the STAND arm was 1 (1.0-1.1) mins for a median of2 (2-4) 
dilatations. In the PROL arm in phase 1 the time per dilatation was 
15 (15.0-15.1) mins for a median of 1 (1-2) dilatations. 
1be enrollment was completed in August 1991 and pIS are currently 
returning for the 6 month follow-up, including coronary angiography. 
The primary analysis of a combined angiographic outcome of success 
at the end of phase 1, in-hospital abrupt reclosure and 6 month 
restenosis rate, along with clinical outcomes will be reported. 
33A 
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Angloplasty Outcome Using Long Balloons In High·Risk Lesions 
Vicky Savas, Sylvia Puchrowicz, Lester Williams, Cindy L Grines, 
William W. O'Neill. William Beaumont Hospital, Royal Oak, 
Michigan 
PI'CA of lesions ~ 2 em in length is associated with increased risk 
of major complications (death, MI, CABG). Moreover, risk 
further increases when long lesions are located at ~ 45° bends. 
Long balloons (40 mm) may decrease the incidence of 
complications by distributing pressure more consistently along the 
entire deseased segment and conforming to bends in the vessel. 
To determine the influence of long balloons on long lesions, the 
incidence of dissection, abrupt closure, major complications, and 
procedural success (s 50% stenosis and absence of major 
complications) were determined by a single observer in 109 
lesions (92 pts). Subgroup analysis was performed for 69 long 
lesions located at ~ 45° bends. 
RESULTS: 
Mean length (mm) 
Pre-stenosis 
All (n = 109) 
38 ± 2 
~ 45° (n = 69) 
53 ± 25 
Post -stenosis 
Balloon/artery diameter 
Success 
Dissection 
Abrupt closure 
Complications 
78 ± 1 
31 ± 1 
1.2 ± .4 
98 (90%) 
38 (35%) 
8 (7%) 
2 (2%) 
81 ± 11 
32 ± 16 
1.2 ± .4 
61 (88%) 
22 (20%) 
5 (7%) 
1 ( 1%) 
CONCLUSION: Compared to historical controls, the use of 
long balloons in diseased vessels + / - ~ 45° bends is associated 
with high success and low complication rates. Given these 
favorable results, new devices may have minimaJ impact in the 
management of long coronary lesions. 
711-4 2:45 
Improved Acute Results for PTCA of Long Coronary 
Lesions Using Long Angloplaaty Balloon Catheters 
James P. Zidar, Alan N. Tenaglia, John D. Jackman Jr., Donald F. 
Fortin, David J. Frid, James E. Tcheng, Stephen H. Royal, Mitchell 
W. Krucoff, Christopher M. O'Connor, Richard S. Stack. Duke 
University, Durham, NC 
PTCA of long coronary lesions (>10 mm) has been associated 
with lower procedural success (SUCC) rates and a higher risk of 
abrupt closure (AC). The purpose of this study was to determine if 
the use of longer angioplasty balloon catheters (30 and 40 mm) 
improves acute results of PTCA In long coronary lesions. 
All patients treated with long balloons at our institution 
between 7/90-7/91 were identified (Group C). As a comparison 
group, 728 lesions undergoing native vessel, first-time, elective 
PTCA between 4/86-7/89 with standard length balloon catheters 
were divided into short and long leSions (Groups A and 8). All 
cineangiograms were reviewed pre- and post-PTCA by consensus of 
2 angiographers for morphologic characteristics, Including lesion 
length and major dissection (DIS). SUCC, defined as s50% residual 
diameter stenosis; AC, defined as total occlusion in or out of lab; 
and In-hospital complications are reported below. 
(AI (8) 
Short lesion Long lesion 
Standard balloon Standard balloon 
~ LIl.:..1.!.a.i 
(C) 
Long lesion 
Long balloon 
~ 
SJX 95.5% 89.9% 97.8% 
IC 5.9% 14.1 % 5.6% 
DIS 6.6% 18.1% 8.9% 
CJa3 4.8% t-S 8.1 % t-S 3.3% 
Death 1.2% t-S 0.7% t-S 1.1% 
"1><.05 comparing Group A vs 8, and "1><.05 comparing 8 vs C. 
These results suggest that PTCA of long lesions using long 
angloplasty balloons may be performed with higher acute success 
rates and less risk of abrupt closure and major dissection. 
711-5 
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Non-surgical Treatment of Femoral Artery Pseudoaneurysm 
Complicating Interventional Cardiology Procedures 
Krishna J. Rocha-Singh. Raymond B. Schwend, Richard A. 
Schatz, Shirley K. Otis, Paul S. Teirstein. Scripps 
Clinic and Research Foundation. La Jolla, California 
During a 12 month period 521 interventional cardiac 
procedures were performed using the percutaneous femoral 
approach. Femoral sheaths ranged from #8-12 French; 
periprocedural use of coumadin and anti-thrombotic agents 
(aspirin, dipyridamole, heparin, gentran) varied 
depending on the intervention. All arterial sheaths were 
removed within 48 hrs of the procedure using direct 
manual or mechanical compression. Sixty-one pts were 
referred for noninvasive vascular study because of groin 
pain, swelling and/or bleeding 2-20 (mean-6.7) days after 
arterial sheath removal. Duplex ultrasound evaluation 
revealed femoral artery pseudoaneurysm in 11 pts. Nine 
pts were on therapeutic heparin or coumadin 
anticoagulation during ultrasound examination and 
subsequent treatment. 
Pulsed Doppler localized the arterial communication to 
the pseudoaneurysm in all pts. Direct manual compression 
with the ultrasound probe sufficient to obliterate 
arterial inflow into the pseudoaneurysm was maintained 
for 15-60 (mean-3l) min. Closure of the arterial 
communication was successful in 5 pts (45.4%). In 3 pts 
(27.3%), only partial closure was achieved but 24 hr 
follow-up ultrasound study and repeat compression 
resulted in complete closure. Three pts (27.3%) failed to 
occlude and underwent successful open surgical closure. 
Duplex ultrasound guided direct manual compression of 
femoral artery pseudoaneurysm obviates the need for 
surgical repair in most pts. 
711-6 3:15 
Results of Physiologic Anteroperfusion System to 
Support Prolonged PTCA Inflations in 40 Patients. 
Jean C. Farcot, Jacques Berland, Genevieve Derumeaux,Shahid 
Merchant, Rene Koning, Alain Cribier, Jean P. Bourdarias, B. 
Letac, Paris-Ouest and Rouen France. 
The Physiologic Anteroperfusion System (PAS) is an active 
pulsatile pump which delivers diastolic EKG-synchronized flow•
pressure controlled autologous blood through standard PTCA 
catheter (USCI Profile +). PAS was set up in 39 patients (Pts), 23 
with proximal coronary stenosis without collaterals and 16 high risk 
PTCA candidates. 
In one Pt the balloon catheter did not cross the stenosis. For the 38 
other Pts (28 LAD, 2 ex, 8 RCD), after a short low pressure « 2 
Atm) unprotected inflation (InO producing intolerable ischemic 
manifestations within 2 min, PAS was implemented (in 3 ± 2 min) 
for 634 ± 246 sec (minimum duration> 5 min) at a mean pulsatile 
flow of 45 ± 10 ml through gradually inflated balloon catheter (1 
Atm/min up to 5 ± 1 Atm). As compared to control Inf, EKG ST 
elevation (2 ± 1.5 m V) was normalized during sustained PAS 
assisted Inf (0.3 ± 0.2 mV, p<O.OOI) while 2-D Echo examination 
(22 Pts) showed no regional dyskinesia. Mild chest pain and minor 
ECG changes occured during PAS at the 5th min in 2 Pts, in whom 
a large side branch happened to be occluded by the PTCA balloon. 
All cases were an excellent angiographic result (mean stenosis 84 ± 
10% before and 13 ± 8% after) with only one minimal coronary tear, 
and no other complications. 
In another Pt, with acute LAD closure due to a dissection after 
conventional PTCA, PAS was rapidly activated through the same 
catheter, allowing 25 min balloon Inf without ischemia and leading 
to successful sealing of the flap. 
Conclusion: The Physiologic Anteroperfusion System is a simple, 
safe and efficacious mode to preserve regional myocardial function 
during balloon coronary inflations and therefore proves to be useful 
in high risk PTCA candidates. 
lACC Vol. 19, No.3 
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712·1 2:00 
Exercise·Induced Supraventricular Tachycardia in 
Apparently Healthy Volunteers 
Mathew S. Maurer, Jerome L. Fleg and Elliot A. Shefrin 
Gerontology Research Center, NIA, NIH, Baltimore, MD 
The prevalence, characteristics and prognosis of 
exercise· induced supraventricular tachycardia (SVT) in 
an unreferred, apparently noraal population are unknown. 
Ve therefore assessed the frequency of SVT during 
maximal treadmill exercise in 888 male and 555 female 
co-.mity dwelling asymptomatic volunteers aged 17·94 
years from the Baltimore Longitudinal Study of Aging. 
SVT occurred in 5.9%, 51 men and 34 women. These 85 
individuals were significantly older those without SVT 
(66.0 ± 13.5 versus 49.7 ± 18.1, p<.001). 98% of SVT 
episodes were paroxysmal atrial tachycardia (heart rates 
105 to 290/min, x - 186.3 ± 43.3). Of the III discrete 
SVT episodes, 68% were 3·5 beats, 10% were 6·8 beats, 
4.5% were 9·10 beats and 17% were greater than 10 beats, 
including 4 episodes >30 seconds. Duration of treadmill 
exercise, maXimal heart rate, peak systolic blood 
pressure, and the prevalence of exercise· induced ST 
segment depression or thallium perfusion defects did 
not differ between the 85 SVT subjects and s control 
group matched for age and gender. The incidence of 
subsequent cardiac events (angina pectoris, nonfatal 
myocardial infarction, cardiac syncope or cardiac death) 
was not significantly different between the SVT and 
control groups (10.0% versus 6.0%) over mean follow up 
periods of 7.1 ± 3.6 and 5.3 ± 3.5 years, respectively: 
However, 10% of subjects but no controls developed SVT 
on a subsequent res ting ECG. In summary, exerc ise· 
induced SVT in apparently healthy volunteers (1) is 
usually limited to short asymptomatic runs (2) occurs 
predominately in the elderly and (3) does not portend 
increased cardiovascular morbidity or mortality but may 
predict a higher incidence of future spontaneous SVT. 
712·2 2:15 
The Value of Predischarge Exercise Radlonucllde 
Angiography In Identifying Multlvessel Coronary Artery 
Disease In Patients Post Thrombolytic Therapy 
Wei-Xi Zhu, Bernard J. Gersh, Raymond J. Gibbons. Mayo Clinic, 
Rochester, Minnesota 
Although exercise stress testing is frequently used to predict the 
presence of multivessel coronary artery disease (CAD) after 
myocardial infarction (MI), its value in post MI pts treated with 
thrombolytic therapy remains unknown. We analysed predischarge 
exercise radionuclide angiography (ERNA) In 94 consecutive pts 
(mean age 58±9 yrs, M/F 87/7) treated acutely with thrombolytic 
therapy without angioplasty who also underwent coronary 
angiography during hospitalization. 32 pIS had multivessel CAD (left 
main 1, 3-vessel 10, 2-vessel 21). Six predetermined variables 
were analysed: 1) rest ejection fraction (EF) <40%, 2) reduction in 
EF during exercise (.1EF<O), 3) peak EF<40%, 4) ST segment 
depression (Pos ST), 5) angina during exercise, and 6) severe 
Ischemia (.1EF<O, Pos ST and workload s600 kg-m/min). 
RestEF 
Sensitivity % 38 
Specificity % 7 7 
Myltjyessel CAD 
Peak EF aEF Pes ST Angina Severe ischemia 
41 53 25 19 16 
74 66 74 87 89 
Left Main and a-yessel CAD 
Rest EF Peak EF aEF Pes ST Angina Severe ischemia 
Sensitivity % 27 36 64 27 27 27 
Specificily % 72 7 0 63 75 8 7 89 
For a positive response (~1 predetermined variable positive), the 
sensitivity, specificity, positive and negative predictive values were 
72%, 40%, 38% and 74% in identifying multivessel CAD and were 
64%, 36%, 12% and 88% in identifying left main and 3-vessel CAD 
respectively. In conclusion, predischarge ERNA appears to have 
little value in identifying multivessel CAD In post MI patients 
treated with thrombolytic therapy. 
ABSTRACTS 
712·3 2:30 
The Value of Myocardial Perfusion Sclntlaraphy In Patients with 
Markedly Positive Exercise Tests 
liyuan Lu, Elias H. Botvinick, Michael W. Dae, Rajagopal 
Krishnan. University of California San Francisco, CA 
The markedly positive exercise EKG (++), with ~ 2 mm ST 
depression or elevation beyond the isoelectric baseline is a widely 
accepted marker for high risk coronary disease (CAD). To assess 
the value of exercise myocardial perfusion scintigraphy (MPS) in 
patients (pts) with ++ we evaluated the history, course, exercise 
response and MPS findings in 74 consecutive pIS with ++, S4 with 
selective coronary angiography (SCA). There were 2 evident 
scintigraphic patterns; Group I· with obvious reversible defects in 
multiple vascular areas (38 pts) and Group II· with normal MPS, 
subtle reversible defects in sl vascular area or isolated fixed 
defects (36 Pts). 
Neither age, sex, risk factor, CHF, prior MI, angina severity, 
exercise time, nor time to Imm or 2mm ST depression or to ST 
recovery could separate between groups or differentiate the extent 
of coronary involvement. However, a depressed BP response and 
induced angina, though insensitive, as well as the presence and 
incidence of extensive, high risk CAD were more frequent in 
Group I pts (p < 0.05). 
*V._I d,pmoedBP PTCA/CABG 
W°.:'fsi g~A 0 1 12 fa ~ain lr'POIllt aa 
ilf';-=S6) IS 5 7 4 2 a 2 
Only exercise induced angina and a depressed BP response 
during testing was more frequent among those with 3 vessel CAD. 
Seven of 11 pts with continued ++ after successful angioplasty 
(PTCA) or bypass surgery (CAB G) had dramatically improved 
scintigrams. Eight Group I pts with ++, but initially benign MPS, 
were followed I to 10 years (mean 4.2) without events until image 
progression brought aggressive management, of ten with ambiguous 
clinical findings. No cardiac events were noted among 34 Group 
II pts followed for a mean of 30 months while treated medically. 
Not all pts with ++ are at similar high coronary risk. MPS 
accurately differentiated between high and low risk subgroups as 
did no other parameter. MPS may be useful in management of 
this overall high risk population. 
712·4 2:45 
Silent versus painful ischemia during exerxise testing: 
angiographic findings and prognosis. 
Micon Bijl, Frans C. Visser, Free University Hospital, 
Amsterdam, The Netherlands. 
We studied the extent of coronary artery disease (CAD) and 
the prognosis in two groups of patients (pts) with exercise test 
(XCG) induced ischemia (ST.depression ~lmm). Group 1 
consisted of 264 pts with anginal complaints without prior 
myocardial infarction (MI). group 2 of 161 pIS with a recent 
MI. In both groups with silent ischemia (SI) during XCG were 
compared with pts having angina pectoris (AP) during XCG. 
Baseline variables and duration of follow·up (45 ± 13 months) 
were not different for compared groups. 
Results: 
gr 1·S1 
n 55 
XCG dur.min. 8.9±2.8 
peak HR bpm 157±20 
max.SBP mmHg 186±28 
vessel sl 61 
disease% 2 36 
3 13 
ejection fraction% 67±18 
mortality% 11 
recurrent MI% 11 
• liBllifocanl difference 51 .. AP poop 
gr I·AP 
209 
6.8±2.6' 
138±22" 
177±33 
26" 
2S 
38" 
63±13 
15 
5 
gr 2·S1 
91 
8.4±2.8 
lS3±19 
171±25 
44 
42 
14 
50±15 
12 
21 
gr 2·AP 
70 
6.6±2.2" 
141±19" 
170±29 
23" 
46 
31" 
51±13 
14 
11 
Conclusion: Pts with XCG SI had a better exercise capacity 
than pts with AP correlating with less extensive coronary 
pathology. Despite the difference in extent of CAD prognosis 
is the same in pts with symptomatic and silent ischemia both 
in pts with or without prior MI. 
35A 
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712·5 3:00 
AqiDa-Free TIme OD Treadmill-AD Alternative Method for 
EvalU8tiD& ADti-Aqinal Therapy in Clinical Trials: Results 
from the ACME Study 
I'IImeIa M. Bartiaan, Allred F. Parisi, Edward D. Folland, and the VA 
ACME In'fSliaaton V AMC West Ha,en CT 
In et'aI ... til. anti-qinal therapy (llx) one measure of outcome 
is lillle-to-onset UIIi- (TOA) cIurinI exercise testilll (Ex). Dependilll 
Oft ax ef'fIaq, _ patients (pta) beNne qina free; others do not. 
W. ax aw- an ~ deletion, of ...ma-free pts makes 
TOAalimited -.e of etrlCllq. 
In ACME, a rancIomi2IId trial of Ullioplasty (PTCA) vs medicine 
(Med), we \lied sum,aI analysis techniques to examine TOA lor all 
patients with UllilJll'RpbicaJly conranned SVD and Ex induced ischemia. 
AJIIina-lree exercise time lor IKh Rx is shown below. 
SIX IIOHIII 
By Ibis method, TOA.. ClJlllparabie in both ax aroups at 
bueIine, improYed markedly at loIIow-up in both, but PICA pta 
improted Iipil'lCIIIItIy more than JDedicaJ pta (p •• 01). A mort traditional 
anal,.. \lied data rr- n/lJ8 patieaII: meaD cbaDae from baseline in 
TOA_ 1.6 (PTC!),,'" (Med) mini (p-.07).1ncorporatina data from 
.. wIlD do DOt deYeiop qina is all UIIbiaMd, mort CIJIIIprebenD,e 
etaIuItioD of Rx poupa in ~ studiIs. 
712·6 3:15 
Ie ST segmeDt-Heart Rate Slope Analysis 
superior to Standard ST segment Analysis in 
predictinq the outcome of Ixercise Thallium-
201 Studies ? 
Nieca Goldberg, David Shifter, Rosann Chesler 
Florence Kalman, Richard stein. SUNY Health 
Science Center at Brooklyn, N.Y. 
To ascertain the relative value of ST/HR 
slope in predicting the outcome of thallium 
(Th) studies We studied 114 consecutive 
patients (pts) referred for chest pain with 
graded exercise (N.Y. Hospital protocol) ECG 
Th tests. We excluded pts with significant 
abnormality or M.I. on ECG, or use of digoxin. 
ST/HR was calculated by computer (Marquette 
2000). Standard ST measurment (ST STD) used 
>lmm at .08sec after J point. Planar Th scans 
were read by 2 trained observers. For both ST 
analysis methods sensitivity, specificity and 
predictive value were calculated with respect 
to Th findings. Signifigance was at P <.05. 
29/114 patients had reperfusable Th defects, 
32/114 had positive ST/HR (3.5uv/beat) and 19 
has positive ST seg. by standard method. ST/HR 
had significantly higher sensitivity (88% as 
compared to 56%) and near equal specificity 
(85% vs 86%) when compared to ST STD. ST/HR 
had a signifigantly higher positive predictive 
value (88% vs 73%). Of note is that in 14 pts 
with equivocal ST STD changes, ST/HR analysis 
predicted outcome correctly in 11 (79%). 
ST/HR was superior to STD STD analysis with 
regard to predicting Th findings. This is 
especially apparent when ST STD finding are 
equivocal. 
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Anatomic Repair of Transposition of the Great Arteries 
(TGA) in Neonates. 
Alain Serraf,Fran90is Lacour-Gayet,Jacqueline Bruniaux, 
Juan Comas,Anita Touchot,Jean LosaY,Claude Planche. 
Marie-Lannelongue Hospital, Le Plessis-Robinson, France 
Three hundred and ninety five neonates underwent an 
arterial switch for various forms of TGA. There were 340 
TGA with intact ventricular septum (IVS) , 40 with 
ventricular septal defect (VSD) ; 4 TGA, IVS and aortic 
coarctation (CoA) and 16 TGA, VSD and CoA. Among the 
latter, 12 underwent a single stage repair. The mean age 
and the mean weight were 15.1 ± 4.2 days and 3.0 ± 0.3 
Kg respect i ve 1 y. Coronary artery di stri but i on was 
described according to the origin and to the inital 
course of the artery. Univariate analysis of risk 
factors revealed that only coronary anatomy was the main 
determinant for operative survival.Mean follow-up of 
30.2 ± 18 months was achieved in all survivors. More 
than 95 , were in NYHA class I without medication and 
normal ventricular function at echo. 11 pts were 
reoperated on. Early reoperations (n:2) «30 days) for : 
undiagnosed CoA (1), pulmonary stenosis (PS) (1). Late 
reoperations (n:9) for: PS (4),residual VSD (1), Recur•
rent or neo CoA (3) and superior vena cava syndrome (1). 
Operative Late F....-' .... Surv;va' 
MortaHty Dnths __ ,atlon (S y ..... ) (5 y .. ,a) 
TGA-IVS 7. e X 1.3. 95.5 X 89 • 
TGA-VSO 7. ~ • 0 90. 2~ • 92.5 • 
TelA-Coarct 0 100 100 X 
TGA-VSO-coA 12.5 X 14.3 X 82.5 X 72.2 X 
Total 7.7 X 1.8. 9~.5 X 89.9' 
It is concluded that although immediate and mid term 
resu 1 ts of neon at a 1 anatomi ca 1 repa i r of t ranspos i t i on 
complexes have still to improve. It, already offers good 
mid term results and therefore must be considered as the 
treatment of choice. 
713·2 2:15 
The Bidirectional Glenn Shunt: Staged Reconstruction For 
The Functional Single Ventricle 
Ara K. Pridjian, Alan Mendelsohn, Louise Callow, Edward L. Bove. 
The University of Michigan Hospitals, Ann Arbor, Michigan. 
The bidirectional Glenn shunt (BOG) has been used as an intermediate 
step in patients with a functional single ventricle who are at high risk 
for a Fontan procedure. We, therefore, reviewed our entire experience 
with this procedure in order to assess early and intermediate-term 
results. From October, 1989 to August, 1991,35 patients ranging in 
age from 1 to 45 months (mean, 15 months) have undergone BOG. 
Diagnoses included hypoplastic left hean syndrome in 11 patients, 
univentricular hean in 8, pulmonary atresia with intact ventricular 
septum (PNIYS) in 8, tricuspid atresia in 7 and Ebstein's anomaly in 
1. Mean pulmonary vascular resistance (n=26) was 2.2 Wood units 
(range, 0.5 to 4.0 units) and the mean pulmonary artery index (pAl, 
n=28) was 304 mm2 (range, 148 to 586 mm2). Only 3 patients had no 
palliative surgery prior to BDG. Thiny patients had a previous 
Blalock-Taussig shunt, either alone (n=12) or with other palliative 
procedures (n=18). At the time of BDG, 10 patients required 
pulmonary anery reconstruction. Three patients with a left SYC 
underwent bilateral BOG. Additional procedures were performed in 15 
patients, including 6 atrial septectomies, 3 tricuspid valve excisions, 2 
A Y valve repairs, 1 Damus-Kaye·Stansel connection, 1 outlet foramen 
enlargement, and I pacemaker insertion. Mean duration of hospital 
stay was 9 days (range, 2 to 18 days). Chylous pleural effusion 
occurred in only one patient. There have been 2 operative deaths 
(5.7%), both occurring in patients with PA/IVS and sinusoids. There 
has been one late death from RSY pneumonia. Eight of 9 patients with 
a PAl less than 250 mm2 survived. Mean systemic arterial oxygen 
saturation was 81 % (range, 72% to 92%). The BDG is a safe and 
effective procedure in high risk patients prior to Fontan correction. 
The subset of patients with PA/IVS and sinusoicls represents a high 
risk group in whom transplantation may be preferable. 
JACC Vol. 19, No.3 
March I, 1992:37A 
713·3 2:30 
Modified Ultrafiltration Improves Hemodynamics after 
Cardiopulmonary Bypass in Children, 
Surendra Naik, Seshadri Balaji, Manin Elliott. 
Hospital for Sick Children, Great Ormond Street, London, UK. 
We previously demonstrated a uniform elevation in blood pressure 
(BP) during Modified Ultrafiltration (MUP) performed after 
cardiopulmonary bypass (ePB) in children. 
To determine if this rise in BP is hemodynamically beneficial we 
studied 22 children, aged 4,132 months (median 57 months) surface 
area 0.2,1.1 m2 (median 0.63 m2 ) undergoing open heart 
surgery. Hematocrit (Hct) on ePB was 20%, and was elevated to 
35% by MUP. Heart rate (HR), BP, right and left atrial pressures, 
pulmonary artery pressure, and cardiac output (electro, magnetic flow 
probe) were measured before and after MUP. During MUF the left 
atrial pressure was kept constant. The following results were 
obtained (paired 1·les I): 
n=22 HR eI SBP SVR PVR 
Pre median 129 3.45 68 11.2 1.95 
MUF range 74,172 1.7,5.8 47,119 4.8,25 0.5,5.7 
Post median 115 4.8 95 12.75 1.75 
MUF range 62,153 2.1,5.9 63,120 2.9,28 0.1,4.8 
P value 0.0001 0.0001 0.0001 0.149 0.0004 
Thus Modified Ultrafiltration reduced the HR, increased systolic BP 
(SBP), improved cardiac index (el), had no significant effect on 
systemic vascular resistance (SVR) and reduced pulmonary vascular 
resistance (PVR). Interval measurements at 25 and 30% Hct 
showed linear changes. 
Conclusion: 
MUF markedly improves cardiac hemodynamics after CPB in 
children. These findings may have important implications for the 
management of patients being weaned from ePB. 
713-4 2:45 
Neonatal Myocardial Protection: Comparison of Hypothermia, 
Cardioplegia, Topical Cooling, and Ventricular Fibrillation 
Shigeaki Ohtake, James R. Mault, Mary K. Lilly, Herben J. Stern, 
Ross M. Ungerieider, Duke University Medical Center, Durham, 
Nonh Carolina 
A variety of myocardial protective strategies (MPS) are used 
during repair of neonatal congenital heart defects. This study 
compared the effects of various commonly used MPS. One week 
neonatal piglet hearts (n=30) were randomly assigned to 6 groups 
using modified Langendorf prep and sanguineous perfusate. Pour 
groups were rapidly cooled to 18°C, then exposed to a 90 min period 
of ischemia: Deep hypothermia at ISoC (DH); Cardioplegia (CP) 
using a single dose of St. Thomas solution; Topical cooling (TC); or 
TC + CPo Two groups employed continuous aortic F-rfusion during 
electrical fibrillation for 90 minutes at 18°C (Vf 18 ) or at 25°C (Vf 
25°). Percent recovery (% Rec) of Heart Rate (HR), Cardiac Output 
(CO), Stroke Volume (SV) and Left Ventricular Stroke Work 
(LVSW) were calculated after rewarming as compared to baseline 
values for each heart. 
DH CP T P+TC V 18° Vf25° 
(%~~) ~~7 *~~5 79.4 lI8.4 .1~6 8500. ± 13.7 ±5.4 ± 17.6 +20.3 + 18.6 
(%~ee) 111.5 *76.7 103.5 104.2 120.5 102.9 ± 8.2 ±2.03 ± 7.7 ± 14.2 ±27.4 ± 20.8 
l;VSW IO!5.5 *64.7 94.2 90.2 119.5 87.9 
%Ree) + 8.1 ± 18.2 ± 10.4 ±21.6 + 34.9 + 19.2 
(mean ± SD) * p< U.U5 vs. [Hby ANOVA 
HR did not differ statistically in any group. The data 
demonstrates that for neonatal hearts: 1) CP WlW TC may impair 
adequate recovery of ventricular function (VFx) after a 90 min 
ischemia at 1SoC. 2) TC or DH alone, without CP provides excellent 
protection and may avoid CP,induced injury. 3) Vf at 18°C or 25°C 
allows excellent acute recovery ofVFx compared to all methods (CP, 
TC, DH) that employ ischemia. 
ABSTRACTS 
713·5 3:00 
Specific Sequelae after Fontan Operation at Mid -and Long Term 
Follow-up. 
Adri H Cromme,Dijkhuis", Cilia MA Henkens', Margreet ThE Bink•
Boelkens', Anton Eygelaar', K. HaIllen", Egbert Bos", John Hess". 
Sophia Children'S Hospttal, Rotterdam" and University Hospttal, 
Gronlngen', The Netherlands. 
Patients who have undergone a Fontan-type operation usually have 
elevated right atrial pressures to maintain adequate pulmonary blood 
flow. To evaluate sequelae of this chronic sRuation we examined 64 
Fontan patients, operated because of tricuspid atresia (29 pts) or 
univentricular heart (35 pts) , 1 to 13 years (median 6) eeriier. At the 
time of the survey ages ranged from 2 to 25 yrs (median 12). Cardiac 
catheterisation was performed in 58 pts, ± 1 year after the operation. 
Cardiac indices ranged from 1.2 to 4.2 I.min·'.m·' (mean 2.3 ± 0.7). 
Mean right atrial pressures ranged from 7 to 18 mmHg (mean 12 ± 
2.3), in 18 pts ~ 14 mmHg. In 3 pts an obstruction in the Fontan circutt 
was found. 56 pIS were apparently In good clinical condttlon, leading a 
normal I~e for age, whereas 8 pts had complaints and were restricted 
In their daily Iffe. Three of these had protein losing enteropathy (PlE); 
another 4 pts were treated for PLE, as well. Ambulatory 24 hrs ECG 
recordings now available in 44 pts, were normal In 24 pts. Symptomatic 
dysrhythmias were present in 5 pts, being on antiarythmic treatment, 
asymptomatic dysrhythmias in 12. Three patients had a complete AV 
block, 2 postsurgical and 1 congenttal. Bicycle exercise performance, 
tested in 36 pts ranged from 50 to 110 % (mean 85 %) of the 
predicted values. A decreased tolerance « 85%) in 14 pts was related 
to rhythm problems and the presence of PLE. Abnormaltties of liver 
enzymes and -function tests were present in 36 pts (56%). Coagulation 
factor abnormalRies were found in 41 pts (64%), the most pronounced 
being a protein C deficiency, a known thrombotic risk factor. Serum 
creatinin was normal in all patients. There was no relationship between 
the presence of abnormaltties In liver enzymes and ,function tests, and 
coagulation factors on the one hand and the length of the 
postoperative follow,up, the type of surgery or the underlying 
morphology, at the other hand. It is concluded that even patients wRh 
an apparently good surgical result are at risk for liver and coagulation 
problems, and to a lesser extent for rhythm problems. 
713-6 3:15 
Continuous Measurement of Cerebral Oxygen Saturation 
During Deep Hypothermic Circulatory Arrest 
George Silvay, Robert Koorn, John Bucek, James Flemming. 
Mount Sinai Medical Center, New York, NY. 
Advances in near infrared light technology have made 
possible the continuous noninvasive measurement of the 
oxygen saturation of cerebral blood. The infrared absorption 
of the brain reflects the percentage of oxyhemoglobin in all 
vessel compartments (I.e. venous ~ 75%, arterial ~ 20%, 
capillary ~ 5%) Cerebral regional oxygen saturation (rS02l 
was measured using optical spectroscopy in eight patients 
who underwent hypothermic cardiopulmonary bl'pass with a 
period of deep hypothermic circulatory arrest (OHCA). All 
patients had DHCA to facilitate surgical repair of an ascending 
aortic and/or aortic arch aneurysm. Cooling was accom' 
plished gradually over 30 to 40 mins to ensure that hypoth, 
ermia would be maintained during circulatory arrest. Mean 
esophageal temperature was 1S.0 ± 3.0 (Mean±SO) at onset 
of DHCA. Mean duration of OHCA was 26.5 min ± 12.8 (SO). 
The mean decline in cerebral rS02 per minute was 0.52% ± 
0.35% (SO). The rate of decline of rS02 varied from patient 
to patient,.. but was constant over time for each individual 
patient (r" of slopes = 0.96 ± 0.037 [Mean±SOj). The 
standard error of the coefficient for the rate of decline was 
<0.018% per min for all patients. 
These findings indicate that rS02 declines continuously 
during OHCA. This suggests that regional oxygen con, 
sumption remains stable in the period of OHCA. Continuing 
study may explain what factors influence the rate of oxygen 
consumption and may allow the development of indicators 
that signal the duration of the safe period of OHCA. 
37A 
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Effect of Progression of Left Ventricular Hypertrophy on 
Coronary Artery Dimensions 
Bruno Villari, 0110 M Hess, Deborah Moccelli, Hans P Krayenbuehl, 
Cardiology, University Hospital, Zurich, Switzeriand 
Coronary cross-sectional area (CSA) was determined by a semi•
automatic computer system in 12 controls (C) and 10 patients (pts) 
with aortic valve disease (AVO; 5 aortic stenosis=AS, 5 aortic 
Insufficiency=AI). The AVO pIS were studied before (B) and after a 
follow-up period of 66 months (range 24-122) (F-U). In AS aortic 
valve area decreased from 1.0S to 0.63 cm2, in AI regurgitant 
fraction increa$ed from 26 to 43%. Drugs were withheld 24 hrs 
before angiography. Angiographlc LV muscle mass (LMM) was 
calculated In all pIS. CSA of the proximal left anterior descending 
~LAD)' and the Circumflex (CX), as well as totallell coronary artery LC.1AD+CX) were determined. CSA of the rlQht coronary artery RCA), and the CSA of LC per 100 g of LMM (f, In mm2/100 g) were 
also assessed. 
n LAD (mm2) CX (mm2) RCA (mm2)LMM(g) f 
C 12 7.S 6.3 9.0 135 11 
AVOB 10 13.3** 12.9*** 10.4 269*** 10 
AVO F-U10 16.9***AA 14.9"* 11.2 339***A 9* 
(*p<0.05, **p<0.01, *** p<0.001 vs C, Ap<0.05, Mp<0.01 vs AVO B) 
there was a close relationship between CSA of the LC and LMM 
(n=32, r=0.S6, p<0.001) but not between CSA of the RCA and LMM 
(r=0.3S, NS). An Inverse relationship was found between f and the 
duration of the follow-up period (n=10, r=0.65, p<0.05). 
Conclusions: In secondary hypertrophy from AVO the progression 
of left ventricular hypertrophy is associated with an increase in LAD 
and CX dimenSion, whereas RCA does not change. Despite the 
enlargement of LC dimension, the CSA of the LC per 100 g of LMM 
decreased with progression of LV hypertrophy. Hence the increase 
In coronary artery size appears not to be adequate when the 
severity of LV hypertrophy increases. 
714·2 
Protein Turnover in Stable Cardiac Hypertrophy Due to 
Mild Chronic Experimental Aortic Regurgitation 
Roderick King, Norman Magid, George Opio, Jeffrey S. 
Borer, Cornell Medical Center, New York, New York 
2:15 
We previously showed that normal synthesis(Ks) and 
subnormal degradation(Kd) rates cause the increased total 
cardiac(TCP) and myofibrillar protein found in progressive 
left ventricular hypertrophy(L VH) seen after 1 month of mild 
experimental aortic regurgitation(AR). To assess protein 
turnover in steady state L VH with AR, we infused eHj•
leucine 2-3 yrs following surgery in 12 AR rabbits and in 12 
sham-operated controls(SH). TCP, myosin heavy chain and 
actin Ks were obtained from specific radioactivity of plasma, 
TCP and myofibrillar protein hydrolysates. AR regurgitant 
fraction=25±10%. Kd=[Ks-growth rate(Kg)j%/day±SD, 
• =p<O.Ol. 
~ ~ .K!j 
TCP SH 5±3 0.02 5±3 
AR 3±3 0.01 3±3 
LV WI (~) 
SH 4.7±0.6 
AR 7.7±1.4· 
Myosin SH 7±3 0.02 7±3 
AR 8±6 0.01 8±6 Body wt (k~) 
Actin SH 9±8 0.02 9±8 SH 4.1±0.5 
AR 1O±8 om 10±8 AR 4.3±0.6 
Thus, unlike the progressive L VH seen early in AR, the 
pronounced eccentric LVH responsible for compensated, 
long-term volume overload is maintained without significant 
abnormalities of TCP and myofibrillar protein degradation or 
synthesis. 
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POSTOPERATIVE HYPERTROPHY REGRESSION PA TIERN 
INFLUENCES LATE LEFT VENTRICULAR FUNCTION AND 
SURVIVAL AFTER AORTIC VALVE REPLACEMENT FOR 
AORTIC REGURGITATION 
Roldano ScognamigIio, Giuseppe FasoIi, Andrea Ponchia, Sergio 
Dalla-Volta 
Dpmt of Cardiology, Padua University, Padua, Italy 
Left ventricular (LV) function was studied in 76 pts (mean age 
48, 32-56 yrs) who underwent aortic valve replacement (A VR) for 
aortic regurgitation during a postoperative follow up of 96 
months. Ten pts with prosthesis dysfunction were excluded from 
analysis. One month after A VR ejection fraction (EF) was normal 
in all pts (62±8 vs 48±10%, p<.OI), LV end-diastolic volume index 
(LVEDVI) reduced (94±16 vs 158±20 ml/m2, p<.OOl) and LV 
mass index (LVMn decreased from 134±12 to 164±21 g/m2 (p<.01). 
Twelve months after A VR, two different pattern of LV hypertrophy 
regression may be identified: in group 1 pts (n=40) L VMI continued 
to reduce (90±15 g/m2) together LVEDVI (84±8 ml/m2) and a 
normal mass/volume ratio (MN) was maintained (1.1±.1); in group 
2 pts (n=26) LVMI was higher (1l2±9 g/m2, p<.005) and in excess 
respect to LVEDVI (MN 1.4±.09). After 96 months, L VEF was lower 
in group 2 than in group 1 pts (42±4 vs 60±9%, p<.ool). During 
the follow up, cardiac death occurred only in group 2 (4 pts) determining 
a lower survival (84% vs 100%, p<.ool). 
Thus LV hypertrophy regression pattern in the fIrst year after 
A VR for AR allow to identify high risk pts for late LV dysfunction 
and cardiac death 
714·4 2:45 
Aortic Stenosis and the Hyperdynamic Left Ventricle 
Syndrome: Abnormalities in Relaxation 
Mirek Sochanski, John D. Carroll, Eugenia P. Carroll. Ted 
Feldman, Keith Hellman. 
The University of Chicago, Chicago, Illinois 
The anatomical and functional response of the LV in 
aortic stenosis (AS) varies from compensated hypertrophy 
to a myopathic, dilated chamber. 
Using cath and Echo data we stu~ied 200D 63 patients, mean age 75 * 7, w1th --- ~ pure AS and no Significant CAD. ft~ 
These were 18 patients (14 women 100 I 
and 4 men, p-0.002) with a hyperdynamic 
LV (fractional shortening [FS) > 40%), 
Using LV micronometer in 78%, there .ll.O ___ ~ 
were 9 (7 women) with an abnormal 
pattern of LV pressure decay with a sudden deceleration 
(Fig 1). Those with abnormal relaxation (Grl) were 
compared to those with a normal monoexponential pressure 
decay (Gr2. n-9). 
Gr1 
Gr2 
AVA EDD ESO PWTh 
.6±.2 3.9%.6* 2.0±.5* 15.0±2.5* 
.7±.3 4.6%.7 2.5%.5 12.6%1.4 
SepWTh 
16.7%2.8* 
12.4%1.6 
AVA-valve area cm', EOO-end diastolic dimension, ESO-end 
systolic dimension in cm, PWTh and SWTh posterior and 
septal wall thickness in mm, *-p~0.02, mean % SO. 
While both groups had hyperdynamic FS (48.6% vs 45.1%, 
p-NS) , and similar LV mass, Grl had smaller chambers with 
thicker walls (radius to thickness ratio 1.3 vs 1.9*). 
Conclusions: The hyperdynamiC LV syndrome in aortic 
stenosis is often characterized by markedly abnormal LV 
relaxation, and a very small thick walled LV. 
representing an extreme response to aortic stenosis. 
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Limitation of Doppler.Echocardlography In the Judgement of 
Prosthetic Valves 
Annette Geibel, Wolfgang Kasper, Stavros Konstantinides, 
Nikolaus Tiede, Hanjorg Just. 
Innere Medizin m, Universitiitsk1inik Freiburg, Germany 
Experimental in-vitro data have shown a discrepancy between 
Doppler-echocardiographiy and catheter measurements of the 
transvalvular gradient in prosthetic valves. Of a consecutive 
series of 356 pts studied routinely by Doppler-echocardiography 
after aortic valve replacement, 8 pts (4 men, 4 women, mean 
age 59.±. 6 years) had an elevated transvalvular gradient over 
the prosthetic valve. 7 pts had a St. Jude medical prosthesis, 1 pt 
a Bjork·Shiley-prosthesis. Doppler-echocardiography was perfor•
med using a commercially available machine (Thoshiba SSH 
160A). The maximal instantaneous gradient ranged from 55 to 
92 mrnHg with a mean value of 72.±. 15 mrnHg, the mean 
gradient ranged from 31 to 50 mrnHg with a mean value of 40 
.±. 9 mrnHg. None of the pts had a severe aortic valve regurgita•
tion. All pts were clinically asymptomatic. Angiographic results 
did not show a significant transvalvular gradient over the prost•
hetic valves and the control by X·ray showed also a normal 
prosthetic valve opening. 
These results indicate that a high transvalvular gradient measu•
red by Doppler-echocardiography does not implicate prosthetic 
malfunction; in suspective patients clinical evidence of malfunc•
tion should be used in addition to Doppler-echocardiography to 
guide further invasive evaluation. 
714-6 3:15 
Hanagement and outcome of Patients with 
Prosthetic Valwlar Thrombosis Diaqnosed by 
Tran.esophaqeal Bchocardioqraphy 
Kwan Chan, Randall Sochowski. University of 
ottawa Heart Institute, ottawa, Canada. 
Diagnosis of prosthetic valwlar thrombosis 
(PVT) is difficult and its management remains 
uncertain. Accordingly, we analyzed the 
management and outcome of 22 patients (pts) 
with PVT diagnosed by transesophageal 
echocardiography (TE). There were 13 mitral, 
8 aortic and 1 tricuspid PVT with the majority 
being mechanical valves (16 tilting-disc, 2 
ball-cage, and 1 disc-cage). There were 3 
tissue valves all in the mitral position. The 
major presenting symptoms were systemic 
embolization in 12, increasing heart failure 
in 7, valwlar stenosis in 2, and hemolysis in 
1. Thrombolytic therapy was performed in 5 
pts with complete lysis in 2, partial 
resolution in 2 and no improvement in 1. 
Anticoagulation was intensified in 14 pts, and 
followup TE in 11 pts showed complete lysis in 
7, partial resolution in 1 and no improvement 
in 3. Surgery was performed as primary 
therapy in 3, failed anticoagulation in 3 and 
failed lytic therapy in 1 • 
We concluded that TE is ideally suited to 
the diagnosis and followup of PVT. Although 
treatment of PVT needs to be individualized, 
our data show that intensification of 
anticoagulation can lead to resolution of PVT 
in some of these pts. 
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Dobutamine Versus Exercise Digital Echocardio•
graphy for Detecting Coronary Artery Disease 
Jerald L. Cohen, Srinivas Duvvuri, Ackenkunja 
George, John Ottenweller, Samuel D. Wilchfort, 
Steve Z. Binenbaum, Chung S. Kim. 
VA Medical Center, East Orange, New Jersey 
UMDNJ-New Jersey Medical School, Newark, NJ 
Exercise echocardiography (EE) has become a 
widely accepted technique for detecting coronary 
artery disease (CAD). Dobutamine echocardio•
graphy (DE) has recently been proposed as an 
alternative to EE in patients unable to exer•
cise. This study compares the efficacy of DE 
compared to EE for detecting CAD in 52 patients 
presenting for coronary angiography. Each 
patient had both DE and EE. EE was performed 
with supine ergometry, DE with increasing doses 
of dobutamine (5 to 40 meg/kg/min), both tests 
utilized digital cine-loops. A positive EE or 
DE was defined as a new wall motion abnormality 
not present at baseline. Results were compared 
with angiography: 15 normals, 16 with 1 vessel 
(V), 10 with 2 V, 11 with 3 V-CAD. Specificity 
for both tests was 87%. 
Sensitivity Calculations: 
All 1 V-CAD 2 V-CAD 3 V-CAD Multi V-
Patients CAD 
EE 76% 63% 70% 100% 86% 
DE 86% 75% 90% 100% 95% 
There were no statistically significant differ•
ences in sensitivities between EE and DE. Ac•
curacy was 79% for EE, 87% for DE. + predictive 
value was 93% for EE, 94% for DE. Conclusion: 
DE is as effective in detecting CAD as EE, and 
shows a trend toward being more sensitive and 
accurate. 
715·2 2:15 
Comparison of Dobutamine Stress Echo With Dobutamine Stress 
Thallium For the Detection of Coronary Artery Disease In Patients 
Undergoing Quantitative Angiography 
Tony J. Spaedy. Scon Sharp. Douglas S. Segar, Robert W. Burt, 
Stephen G. Sawada, Thomas Ryan, Harvey Feigenbaum. Indiana 
University School of Medicine. Krannert Institute of Cardiology, 
Roudebush VAMC .. Indianapolis. IN 
The purpose of this study was to compare the ability of dobutamine 
stress echo (DSE) and dobutamine stress thallium (DST) to detect 
coronary artery disease as assessed by quantitative angiography. 
Twenty-nine patients (2:; maie, 4 female, avg. age 65) underwent DSE 
followed by DST. Dobutamine was Infused at Increasing doses and 
echo images were obtained at rest, low (10 mcg/kg/min), and peak 
doses. When the peak heart rate was attained, thallium (3-4 mel) was 
injected and SPECT images were acquired Immediately and at 4 hrs 
post stress. All patients underwent quantitative coronary angiography. 
Significant coronary disease was defined as a lesion with a geometric 
percent diameter stenosis 2,50%. All tests were interpreted by experi•
enced observers who were blinded to all cllncal data. Results: There 
was agreement between DSE and DST in the determination of normal 
versus abnormal in 26 of 29 patients (90 %). Twenty-five of 29 patients 
had at least one vessel with a lesion 2, 50%. DSE and DST were 
abnormal in 23 of these 25 patients (92 %). There were 18 patients 
with 2 or 3 vessel coronary disease. DSE and DST were abnormal In all 
1 B patients. Of 10 patients with 2 vessel disease DSE indicated 2 vessel 
disease in 9/10 pts and 1 vessel di$ease In 1/10 pts. DST Indicated 2 
vessel disease in 2/10 and 1 vessel disease In 8/10. Of B pts with 3 
vessel disease, DSE indicated 3 vessel disease in 4/8, 2 vessel disease 
In 3/8, and 1 vessel disease in I/B. DST Indicated 3 vessel disease in 
2/B, 2 vessel disease in 3/8 and 1 vessel disease in 3/B. Conclusion: 
DSE and DST are equally sensitive methods of detecting significant 
coronary artery disease. DSE appears to be more accurate at detecting 
and correctly identifying multivessel disease. 
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715·3 2:30 
Detection of Myocardial Ischemia by Dobutamine 
Stress with Echocardiography and TcMIBI SPECT: 
Comparison of Accuracy and Defect Size. 
Thomas Marwick, Anne-M D'Hondt, Jacques Melin, 
Bernard Villemart,Martine DeKock,ViIliam Vyns, 
Jaan-M Detry.Univ of Louvain, Brussels,Belgium 
Dobutamine stress echocardiography (DE) is 
an accurate test for the diagnosis of CAD. 
This study compared the accuracy of DE for the 
diagnosis of ischemia with that of Tc99m-MIBI. 
using the same stress in the same pts. 
After exclusion of pts with prior MI, 85 
unselected pts presenting for coronary angio•
graphy with suspected CAD underwent DE. This 
protocol used 5-40mcg/kg/min in 5x3 min stages 
with on-line echo digitlzation. At peak stress 
MIBI was injected, with SPECT 2hr later; rest 
MIBI-SPECT was done on another day. Endpoints 
were; attainment of peak dose, severe ischemia 
or side-effects predicating submaximal testing 
(SBP>220, BP fall >20mmHg, intolerable 
sym~toms). Ischemia was defined by typical 
anglna (AP) and/or ~lmmST depression by stress 
test (AP/ST), a new wall motion abnormality by 
DE~ or development of a MIBI perfusion defect. 
CAu was defined by >50% stenosis. 
The protocol was completed in 63 pts; 7 were 
limited by ischemia, and 15 had submaximal 
stress. There were no major complications. 
~!'~~t~V~1Y c t +PV -PV AP/ST8 77% 39% 
DE 48/59(81%) 22/26 85% 92% 67% 
MIBI 48/59(81%) 17/26 65% 84% 61% 
DE and MIBI results were concordant in 75%pts. 
Extent of ischemia by DE correlated better 
with MIBI (R-0.63) than either DE (R-0.43) or 
MIBI extent (R-O.40) correlated with extent of 
CAD using an angiographic score. Exclusion of 
pts with negative results on beta-blockers, or 
with submaximal tests gave a DE sensitivity of 
94%, with 98% for MIBI. DE and MIBI did not 
differ significantly, but both were more 
sensitive and accurate (p-O.Ol) than AP/ST. 
Conclusiona DE and MIBI have similar accuracy for the iagnosi. of ischemia, and correlate 
better with each other than with angiographic 
indices of CAD severity. 
715·4 2:45 
Comparlaon of Adenosine and Dipyridamole as Agents for Cardiac 
Stren by Simultaneous Echocardiography and Thallium Imaging 
Jeanette M Billett, Edward A Geiser, Clyde Williams, Stephen G Keim, 
Thomas J. Wargovich, University of Florida, Gainesville, Florida 
PURPOSE:To compare adenosine and dipyridamole as pharmacologic 
agents for cardiac stress. 
METHODS: Informed consent was obtained from 24 patients scheduled for 
catheterization for diagnosis of coronary disease. On Day 1 each received 
Adenosine l00mcgfkg/min (Al00) for 4 min followed in 15 min by 
1040mcgfkg/min (A1040) for 6 min on Day 1. On Day 8, each received 
Dipyridamole (DIPR) 0.56 mgfkg over 4 min by IV infusion. Standard 2-D 
Echo views were obtained with AI00, A1040, and DIPR infusions. All 
patients had coronary angiography 1 to 7 days thereafter. Echo, Tha1lium, 
and angiography dats were interpreted by independent observers blinded to 
the other readings. Any echo wall motion defect or thallium perfusion defect 
in a patient with an unrevascularized bed having a > -70% stenosis was 
considered a true positive regardless of anatomic location. Sensitivity 
(SENS), specificity (SPEC), and predictive accuracy (FRED) for each agent 
and imaging mods1ity was cs1culated. 
RESULTS: Aloo produced no side effects. At A140, 6 patients had chest 
pain, 1 patient had AV Block and 1 patient had ST depression. No side 
effect required cessation of infusion. 8 patients had chest pain on DIPR, 2 
with ST changes requiring IV aminophylline. 
2-D ECHO 
SENS SPEC PRED 
A100 53 100 100 
THALLIUM 
SENS SPEC PRED 
A140 67 78 83 87 88 70 
DIPR 78 89 92 93 88 70 
CONCLUSIONS: 1) while no side effects occurred, the SENS of A100 is 
prohably not acceptable, 2) A140 and dipyridamole appear to be equivalent 
stressor&, 8) while the SPEC for thallium is low compared to previous 
reports, 2-D echo stress testing offered similar SENS and improved 
predictive value. 
715·5 
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Correlation of Adenosine Echocardiography, Thallium Scintigraphy 
and Coronary Angiography 
Sheila Kim. Michael Hanson. R. Edward Coleman, Linda Gracey, Joseph 
Kisslo. Duke University Medical Center. Durham. NC 
The purpose of this study was to evaluate the correlation of adenosine 
echocardiography (ecbo) with thallium-201 scintigraphy (T1) and coronary 
angiography. FOrly-two patients (pts) had 2-dimensional echocardiography just 
prior to. and during. a 6 minute intravenous infusion of adenosine at 140 
ug/kg/min followed by immediate and delayed Tl. Twenty-five pts had known 
coronary artery disease (CAD) by prior myocardial infarction (MI) or cardiac 
catheterization (cath). Seventeen pts had suspected CAD. Sixteen pts had 
cath within one month of the echo. Significant CAD was defined as a stenosis 
~75%. The thallium and echo images were reviewed independenUy by 
experienced nuclear physicians and echocardiographers who were blinded to 
the cath and clinical data. The left ventricle was divided into 5 segments and 
analyzed in 4 standard views. Wall motion abnormalities were interpreted as 
ischemic if the resting segment failed to demonstrate augmented motion or 
systolic wall thickening with adenosine. Infarction was present if resting 
akinesis or hypokinesis persisted or became dyskinetic with adenosine. 
~: Echo was concordant with TI in 36 ptS (86%). Three echoes were 
not analyzed due to teChnically inadequate images. TI and echo results were 
discordant in three pts. two of whom had ischemia by TI but normal echo 
results. Both echo and TI revealed ischemia or infarct concordant with regions 
of Significant CAD by cath in 7(87%) of 8 pts with 2-3 vessel CAD. In ptS 
with I vessel CAD. echo and TI were concordant with cath in 3(37%) and 
4(50%) of 8 pts respectively. 
CONCLUSIONS: There is excellent agreement between adenosine echo and 
thallium scintigraphy with highly concordant results when compared with 
coronary angiography in pts with 2 or 3 vessel CAD. However. adenosine echo 
and thallium scintigraphy are less accurate in pts with Single vessel disease. 
715·6 3:15 
Effect of Dobutamlne on Coronary Flow and Left Ventricular 
Function 
Ramon Castello. Elizabeth O. Ofili, Jeanette A. SI. vrain. Patricia M. 
Lenzen. George Kichura, Morton J. Kem, Arthur J. Labovnz. 
SI. Louis Universny School of Medicine. SI. Louis. Missouri 
To evaluate the effect of Dobutamlne on coronary flow (CF) and left 
ventricular (LV) function. we performed Dobutamine echocarcliographic 
studies wnh simultaneous CF recordings in the catheterizatiOn laboratory. 
Twenty·two patients wnh suspected coronary artery disease (CAD) were 
studied. Ten patients had signHicant CAD (>70% stenosis), and 12 had 
no CAD. Dobutamine was progressively increased every 3 minutes up to 
a maximal dose of 40rncgslkg/min. CF measurements were obtained at 
each stage by means of a Doppler tipped catheter placed in the left main 
coronary artery. The increase in CF was similar from base to peak 
Dobutamine in patients with CAD or wnh no CAD. However, a different 
response in LV volumes was seen by two-dimensiOnal echocarcliography: 
~ ~ ~aI!DobutamiD!! ~ 
EF(%) 6317 74110 0.005 
EDV(ml) 115144 92136 0.02 
ESV(ml) 43119 25114 0.009 
CF(mf) 34115 64128 0.01 
~ ~ ~aI!DobutamiD!! ~ 
EF(%) 5719 62116 NS 
EDV(ml) 138160 110147 0.05 
ESV(ml) 63143 46138 NS 
CF(mf) 30120 60120 0.002 
Abbreviations: EF-ejection fraction; EDVKend-diastolic volume; 
ESV-end-systolic volume 
ConclusiOn: Dobutamine induces a significant increase in LV ejectiOn 
fraction and a decrease in LV systolic and diastolic volumes in patients wnh 
normal coronary arteries. A blunted response is observed in CAD 
patients. Differences in LV function seen with Dobutamine are indepen•
dent of changes in coronary flow. 
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Insurance Claims Data Differ Substantially From Prospective 
Clinical Data in Describing Ischemic Heart Disease Characteristics 
James G. Jollis, Marek Ancukiewicz, Linda Shaw, David B. Pryor, 
Elizabeth DeLong, Lawrence H. Muhlbaier, Daniel B. Mark. 
Duke University Medical Center, Durham, NC 
Insurance claims data in the form of discharge International 
Classification of Diseases revision 9 (ICD) codes are being 
extensively used to study outcomes and quality of care in coronary 
artery disease (CAD). To examine the use of such codes, we 
compared prospectively collected information and leD codes in 
13,008 patients referred for cardiac catheterization for suspected 
CAD. Using prospective data as the standard, the sensitivity and 
specificity of leD codes for 12 conditions were tabulated along 
with an accuracy measure adjusted for chance agreement: 
kIIDJ1ili.Qn sensitivity 
acute myocardial infarct 75,9 
old myocardial infarct 29.6 
angina 18.4 
preinfarction angina 14.1 
mitral insufficiency 43,2 
congestive heart failure (CHF) 35.9 
diabetes mellitus 83,3 
hypertension 65,4 
hyperlipidemia 36,5 
tobacco abuse 24.0 
peripheral vascular disease 26,3 
cerebrovascular disease 14,2 
specificity 
97.5 
96.8 
90,7 
79,4 
96.8 
96,2 
97,5 
91.0 
91.0 
97,8 
98,2 
98.8 
-accuracy corrected for chance agreement 
k.aIlRa! 
0.73 
0.33 
0.00 
-0.Q7 
0.48 
0.39 
0,83 
0,56 
0,31 
0.17 
0,33 
0.19 
For illnesses with available severity measures such as CHF. 
agreement between the two data sets increased with worsening 
disease severity, However, for class IV CHF, the most severe 
grade by the prospective data, leD codes were only correct in 54% 
of cases. We conclude that while insurance claims data represent a 
valuable resource, these data differ significantly from 
prospectively collected clinical data, 
716-2 2:15 
A FAST-TRACK TRIAOE SYSTEM IDENTIFIES PATIENTS 
FOR THROMBOLYSIS AND HALVES IN-HOSPITAL 
DELAYS. 
Keith A A Fox FRCP Alastair C H Pell MRCP, Colin E 
Robertson FRCP and Hugh C Miller FRCP, Royal Infirmary of 
Edinburgh, Scotland. 
A previous report from this institution (1987/8) identifted in•
hospital delays to thrombolysis (TI'X) of 93 min (median), 
commensurate with concurrent repons from major cardiac 
centers in USA and Europe. Despite an active 1TX program, 
delays were no shorter during the subsequent baseline study 
period in 1990. A Fast-Track triage system was implemented, 
without the need for additional staff nor resources, based on 
clinical and EKO criteria. In-hospital delays to CCU admission 
and to 1TX were haJved (32 vs 60 min; 49 vs 93 min: p<O.01 
for both; n=359, 112 Fast-Track, 247 non Fast-Track). 
Symptom onset to 1TX measured 2.5 hr (Fast Track), 3.6 hr 
(non Fast-Track). For non Fast-Track patients delays were cut 
by 25% (p<0.01). A Fast-Track triage system identifies patients 
among whom 86% have Ml confirmed. 62.2% of aJl patients 
who subsequently required TI'X were identifted in the E.R. 
using this system. 9 patients received 1TX without subsequent 
enzyme confmnation of infarction; 3 had "aborted" infarcts; 
none had dissection; none had a diagnosis involving another 
organ system. The time savings were achieved in the majoT 
regional referral center with 68,641 new Emergency Department 
(ER) attendances and 1243 CCU admissions in 1990. This Fast•
Track triage system halves in-hospital delays to thrombolysis and 
provides a cost-effective template for adaptation to secondary 
and tertiary cardiac referral centers. 
ABSTRACfS 
716·3 2:30 
Is There a Gender Bias in Referral for Revascularization 
Procedures After Coronary Angiography? 
Malcolm R. Bell, Bernard J. Gersh, Peter B, Berger. Kent R. Bailey, 
Charles J. Mullany, David R. Holmes Jr. Mayo Oinie. Rochester. MN 
Among patients (pts) with suspected or presumed coronary artery dis•
ease, women are reported to undergo fewer diagnostic and therapeutic 
procedures than men, although once coronary angio~phy has been 
performed there are no differences between the sexes 10 the likelihood 
of coronary bypass surgery (CABO). Whether the same is true for the 
likelihood of PTCA is unknown but is important to document since 
women have a higher in-hospital mortality after PTCA. Accordingly, 
we studied the revascularization referral f1:equency of 22,378 Pts (67% 
men and 33% women) who underwent their mitial coronary angiogram 
at this institution between January 1981 and June 1991. Pts who had 
previously undergone either PTCA or CABO were excluded from this 
analysis. The distribution of I, 2 and 3 vessel disease for women vs 
men was 11% vs 12%, 16% vs 22%, and 26% vs 41%, respectively, 
while 47% of women did not have significant disease (no stenosis 
~70%) compared to 25% of men. Within 30 days of the diagnostic an•
giogram, revascularization referral rates for women versus men were 
1) PTCA: 12% vs 14% and 2) CABO: 19% vs 29%, respectively (both 
p <0.001). The unadjusted rates of referral forrevascularization proce•
dures stratified for the number of vessels diseased were: 
Vessels Referral to PTCA RefeITai to CABG 
diseased Males Females Males Females 
0,07 
3 9% 13% <0.001 52% 
After adjusting for age, year of angiography and number of vessels dis•
eased. the differences in the absolute percentage of women being re•
ferred for revascularization procedures compared to men were: 
+1.4±O,5% for PTCA (p=o,005), -l.1±O.5% for CABO (p=O.05) and 
-O.3±O.6% for PTCA or CABG (p=NS). These very small differences 
suggest that there is no major gender bias in the referral for revascular•
ization procedures once coronary angiography has been performed. 
716-4 2:45 
Hospitalization tor Arrhythmias in the United States: Importance ot Atrial 
Fibrillation 
David Bialy, Michael H. Lehmann, Dale N. ScbUIIIIICher, Russell T, Steinman, 
Marc D. Meissner, Harper Hospital/Wayne State University, Detroit, MI and the 
Commission on Professional and Hospital Activity (CPHA), Ann Arbor, MI. 
Relatively little i. known about the contribution of arrhythmias to health care 
costs. As one step toward defininl the mapitude of this problem, we analyzed 
CPHA data based upon 3,806,000 pt discharles in 1990 from 678 hospitals 
<"'Presenting a broad Dational cross section), and statistically projected onto a 
"universe- of some 34,000,000 pt discbar&es from 5,300 short-term, lenera!, 
non-federal U.S. hospitals. An estimated 517,699 discharlles had arrhythmia as 
the ~ diaJllosis - "'Presentinll 10.6" of pts with principal "circulatory" 
diagnoses and 1.5" of all hospital discbar&es. Estimated breakdown by 
arrhythmia catelory (lCD-9-CM classification) is as follows: 
Anbythmia Number Averalle Length Dischareed 
Category ofpts/2\j of Slay IDays) Alive 12\jl 
Arrest 13,9261 2.7 10.9 28.0 
V-Fib 8,5291 1.6 14.0 66.2 
VT 52,013 I 9.6 8.3 95.2 
SVT 
A-Fib 179,018/34.6 5,0 98.3 
A-Flutter 23,420 I 4.5 5.0 98.6 
PATorWPW 30,0111 5.8 4.1 99.2 
Premature Beats 30,5331 6.0 4.5 99.3 
Sick Sinus 44,943 I 8.7 6.S 98.9 
Conduction Abu. 43,368 I 8.4 3.S~.7 94.2-100 
Unspecified 91,938/17 8 4.Q.4,7 94.4-98.4 
We conclude that: 1) Anbythmias are responsible for about 10" of all hospital 
discharles bearing a "circulatory" principal diaJllosis. 2) SVT (comprised 
mainly of A-Fib) accounts for nearly one-half of all arrhythmia principal 
diaJlloses and carries very low in-hospital mortality. These findings sunest that 
development of medical protocol. to optimize A-Fib manallement could represent 
• useful inital slratelY for reducing costs of arrhythmia-re1ated hospitalization. 
41A 
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716·5 3:00 
Mobile Cardiac Catheterization: Comparison with Outpstlent 
and Inpatient Catheterization at Tertiary Facilities 
Charles M. Elliott, A. M. Bersin, A.V. Elliott, J. M. Fedor, J. J. Gallagher, L. 
Jordan, C. A. Simonton, A.H. Svenson, B. H. Wilson, S. H. Zimmem, The 
Sanger Clinic, Charlotte, NC 
1553 consecu1ive pts underwent cardiac catheterizalion by the 
au1hors in areas served by mobile catheterization laboratOries in a one year 
period. The AHAI ACC criteria for outpatient cath were used to screen pts 
for mobile cardiac cath (MCC, n-719). All other outpatients (OPC, nR277) 
and inpatients (IPC, n-557) from the same geographic areas undergoing 
cath at tertiary fixed-base laboratOries were also entered into the registry for 
comparison. The indications (lOr more) for cath were(' denotes 1)<.001): 
IDP cp (%)' ANGINA 10/.,)' ~' posr:M1 (000)' ~
MCC 37.4 43.1 25.9 5.1 8.1 
OPC 22.4 50.5 32.9 4.7 13.4 
IPC 14.4 35.6 9.7 39.3 13.3 
Most MCC were performed for either atypical CP, angina or a +ETT, 
whereas many OPC were performed for other reasons including CHF 
(13.4%), post·PTCA CP (11.9%), and valvular disease (7.2"10). MostlPC 
were performed for recent MI (S10 days) (37.3%) and unstable angina 
(25.5%). The angiographic findings were (' denotes 1)<.001): 
~'W CAP 1%)' NV CAP (0(.)' ~ ~'VALVE (0(,,) 
MCC 23.9 19.1 33.7 4.9 12.5 2.6 
OPC 12.3 26.0 39.7 6.9 4.0 10.1 
IPC 6.3 28.2 50.3 6.6 2.3 9.9 
MCC pts had the lowest prevalence of CAD and IPC pt~ had the 
highest (1)<.001). The need for revascularization procedures andlor valve 
surgery was 27.0%, 32.9%, and 48.1% respectively (p<.OOI). 
Complications Including VTNF, arterial repair, TIAlCVA and MI were seen 
in 0.7%,0.4% and 3.1% (p<.OOI). Most IPC complications were in pts 
with ongoing unstable angina or aCule MI. 
Conclusions: When the AHAIACC screening criteria are applied to 
establish pt eligibility for mobile cath: 1) low·risk patients are effectively 
identHied for MCC and the prevalence of severe CAD/LM disease is low; 2) 
MCC can be performed safely with a low complication rate; 3) MCC allows 
most pts (73.0%) to remain at the referring hospital for their care; 4) 
patients with ongoing unstable angina or recent MI (S10 days) should not 
undergo catheterization wHhou1 back·up interventional faellffies available. 
716·6 3:15 
The Utility of EasiIy-Obtained NoninvasiYe Clinical Data for PredictiDg 
Survival Following Thrombolytic 'lbenIpy 
Kerry L Lee, Kristina N. Sigmon, Eric J. Topo~ Robert M. Califf and the 
TAMI Study Group. Duke University Medical Center, Durham, Ne 
To identify noninvasive clinical factors predictive of in-hospital (IH) 
mortality in acute myocardial infarction (M!) patients (PTS) undergoing 
intravenous (IV) thrombolytic therapy (TI') and combine these features 
into a clinically useful risk predictor, we studied 1,619 PTS from six 
consecutive multiccnter studies (TAMI 1,2, 3, 3A, 5, 7). All PTS were 
treated with either IV tissue plasminogen activator (58%), urokinase 
(18%) or both (24%) within six hours of symptom onset PTS were 
randomly divided into a model development set (n=970) and 8 validation 
set (n=649). Variables examined included age, sex, MI location (LOC), 
heart rate, systolic (SBP) and diastolic blood pressure, and risk factors. 
Overall, IH mortality was 6.2%. Multivariable analysis using logistic 
regression in the training set identified the following prognostic variables: 
Variable Multivariable X2 -lL 
Age 14.6 .0001 
SBP 125 .~ 
MI LOC 9.3 .0023 
SBP x LOC 8.7 .0031 
Advanced age. anterior wall MI, and low SBP in anterior MIs were 
important independent prognostic factors. Validation ofthe regression 
model in the test sample revealed significant (p=.OOOOI) discrimination 
between patients who lived and those who died (receiver operating 
characteristic (ROC) area=0.74), and predicted mortality did not vary 
significantly (p=0.87) from actual mortality rates across quintiles of risk. 
RjskOujntile Predicted(%) ~(%) 
Lowest 1 (n=I28) 2.1 0.8 
2 (n=131) 3.7 23 
Middle 3 (n=130) 5.1 5.4 
4 (n=130) 7.3 9.2 
Highest 5 (n=13O) 13.7 13.9 
Noninvasive clinical features can be useful clinically for predicting the 
risk of in-hospital mortality following TI. and for deriving risk-adjusted 
predictions important in assessing quality of medical care. 
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717·1 2:00 
Influence of Ejection Fraction on the Predictive 
Accuracy of the Signal-Averaged ECG in Coronary Artery 
Disease Patients: A Multicenter Study 
Stephen Hammill, Patrick Tchou, Donald Underwood, 
w. Kenneth Haisty, Yukio Ozawa, Michael Kienzle, 
Mayo Clinic, Rochester, Minnesota 
This study reports signal-averaged ECG (SAECG) 
results with ejection fraction (EF) to predict ventricu•
lar tachycardia (VT) at electrophysiology (EP) in 
coronary artery disease (CAD) pts. 
Methods. EP was performed in 182 pts, age 58 + 12 
yrs,~AD and QRS <118 ms. EP used 3 stimuli-during 
2 drives from 2 RV sites. A positive EP (EP+) was mono•
morphic VT for 30 sec or requiring intervention. SAECG 
used Frank XYZ leads and 40 Hz Fourier transform filter. 
SAECG parameters that defined normal were: filtered QRS 
duration <120 ms, low-amplitude Signal duration <38 ms 
and root mean square of terminal 40 ms >20 ~V. EF <40% 
defined as abnormal. 
Results. Using these criteria, the SAECG and EF 
senSItIvitIes were 87% and 45%, and specificities were 
65% and 77%, respectively. Risk of VT at EP in CAD pts: 
SAECG (1 of 3*) SAECG (2 of 3*) 
+ 
SAECG only 77% 
SAECG + EF >40% 76% 
SAECG + EF (40% 77% 
*Number of criteria abnormal 
(+) for late potentials. 
+ 
20% 85% 30% 
10% 82% 18% 
50% 88% 52% 
for SAECG to be positive 
Conclusion: SAECG is a better predictor of VT at EP 
than EF. USIng both tests, the VT risk is 10% if the 
SAECG is normal and EF >40% and 88% if both tests are 
abnormal. -
717·2 2:15 
Normalization or the siqnal-Averaqe4 
Electrocardioqram During the First Six Konths 
arter Myocardial Infarction, 
Pierre Savard, John Ferguson, Jean Campeau, 
Richard F Davies, Martin Gardner, Sylvain Plante, 
Duncan J stewart, Bruce Sussex, Mario Talajic, 
Wayne J Warnica. The Canadian Multi Centre SAECG 
Study, HOpital du Sacr6-Coeur, Montr6al, Canada 
In order to assess the evolution of late 
potentials (LP) after myocardial infarction (MI), 
signal-averaged electrocardiograms (SAECG) were 
recorded in 578 patients (pts) (58±1l yrs). A 
first SAECG was recorded 5 to 15 days after MI, 
and a second, 6 Dlonths later. Three orthogonal 
ECG leads were averaged (noise <0.3 ~V) and high•
pass filtered at 40 Hz. No significant difference 
in the QRS duration (QRSd, 108±19 vs 108±18 ms) 
or in the average potential of the last 40 ms of 
the QRS (RMS40, 35±31 vs 36±27 ~V) were found, 
but the duration of the terminal QRS (LAS40, 
37±15 vs 35±14ms) decreased (p<O. 01). LP were 
first defined as having QRSd >114 DIS, RMS40 <20 
~v, LAS40 >38 ms and no bundle branch block 
(BBB). Of the 457 pts with a normal initial 
SAECG, 21 (5%) had LP at 6 months post MI, and of 
the 61 pts with LP on the first SAECG, 30 (49%) 
had no LP and 8 (13%) had BBB at 6 months. 
Reducing the QRSd threshold to >110 ms while 
keeping the same other LP criteria, reduced the 
LP normalization rate from 49% to 39%. In 
conclusion: 1) Small SAECG changes occurring 6 
months after MI produced a normalization of the 
SAECG. 2) The normalization rate was quite 
sensitive to the selected LP definition. 
lACC Vol. 19, No.3 
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Peak Late Potential Voltage and Ventricular 
Tachycardia Drug Response 
Archie A. Tyson, Blane W. Yel ton, Pamela Boger, 
~I. Kenneth Haisty 
2:30 
Bowman Gray School of Medicine, Triad Cardiology 
Winston-Salem, North Carolina 
Late potentials (LPs) documented by the signal•
averaged electrocardiogram ( SAECG) in patients 
wi th ventricular tachycardia (VT) represent delay•
ed conduction through arrhythmogenic myocardium. 
We hypothesize that peak LP voltage (PLPV) reflects 
the mass of slow-conducting myocardium. Therefore, 
low peak vol tage LPs represent small, electrically 
homogeneous arrhythmogenic areas susceptible to 
antiarrhythmic drug effects. In contrast, high peak 
voltage LPs represent large areas of electrically 
di verse substrate less susceptible to drug .Accord•
ingly, SAECGs were recorded prior to antiarrhythmic 
drug infusion in 19 consecutive patients with in•
ducible monomorphic VT at electrophysiologic study. 
9 patients were rendered non inducible following 
drug infusion while 10 patients remained inducible. 
SAECGs in each group were analyzed for filtered QRS 
duration (fQRS) , late potential duration (LPD) , RMS 
40,and PLPV. No significant difference between the 
two groups in fQRS, LPD, and RMS 40 was found (133 vs. 
134ms, 45.6 vs. 48.2ms, and 13.7 vs. 15.8 micro•
volts). However, PLPV was significantly less in 
drug responders compared to nonresponders (13.7 vs. 
27.3 microvolts, p<O. 005). Further, 7 of 9 drug re•
sponders had PLPv<15.0 microvolts while 9 of 10 
nonresponders had PLPV> 21.0 microvol ts. 
Conclusion: Peak late potential voltage is sig•
nificantly less in patients with drug responsive 
ventricular tachycardia. 
717·4 
Spectral Turbulence Analysis Of The Signal Averaged 
Electrocardiogram In Patients With Automatic 
Implantable Cardiac Defibrillators 
Emile G. Daoud, Thomas Guamieri, Gordon F. Tomaselli, 
Johns Hopkins Univ., School of Medicine, Bahimore, MD. 
Frequency-domain analysis of signal-averaged ECG's 
(SAECG) determines the inhomogeneity of the wave of ventricular 
depolarization. This inhomogeneity of activation is indexed by the 
speclralturbulence (Sn analysis. In myocardium with areas of 
fibrosis, it is hypothesized that the ST, summed in three orthogonal 
leads, will be high. We studied: Group I, 22 normals; Group II, 29 pts. 
with ooronary artery disease (CAD) and ma6gnant ventricular 
arrhythmias (MV A) requiring an AICD. Resuhs are as follows: 
Mean Summed ST ST> 36 Praaanca of Late Potentials" 
2122 1122 
Group I 26 (9%) (4%) 
Group II 59 
25129 
(86%) 
13129 
(45%) 
• p<.00005 for Group I vs Group II; •• Late potentials were not 
interpretable in 11129 (28"k) of Group II due to a prolonged QRS 
In Group II, the summed ST inversely correlates with the ejaction 
fraction. Also, 3 pts in Group If with an ejaction fraction greater than 
30%, absence of Q-waves on ECG, noninducibility at EPS, and 
normal LP analysis (2 pts), had elevated ST values as the only 
parameter that would identify these pts as being at risk for MVA. 
We conclude: (1) 5T,derived from frequency-domain 
analysis of SAECG's, distinguishes pts with CAD and MVA from 
normals; (2) ST is complimentary to LP analysis and to other 
predictors in identifying the substrate for MVA in pis. with CAD -- a 
5T value greater than 35 has a specificity of 91 % and a sensitivity of 
86% in predicting MV A; (3) there is an inverse relationship between 
the ejection fraction and the magnitude of ST that may relate to the 
volume of infarcted myocardium; (4) ST analysis may be a useful 
adjunct in risk stratifICation of pis. with CAD for MVA and sudden 
cardiac death. 
2:45 
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717·5 3:00 
Signal Average Electrocardiogram in Predicting the Use of 
Implantable Cardioverter Defibrillators 
Khusrow Niazi, Lori Bell, Ramon Raneses, Donovan Bakalyar, 
Douglas Westveer, James Stewart, Gerald Timmis, William O'Neill. 
William Beaumont Hospital, Royal Oak, Michigan 
We attempted to predict the frequency of appropriate implantable 
cardioverter defibrillator discharges utilizing the signal average ECG in 
40 pts (x age 63 :t 9 yrs) at a mean 15 :t 13 months aftcr implantation. 
The following signal average EeG variables were recorded (40 Hz 
bidirectional highpass filter): QRS duration, root·mean square voltage 
of last 40 ms and duration of low amplitude signals <40 /JV. Signal 
average EeG abnormalities were prospectively assigned to four groups: 
I) All normal, II) root-mean square andlor low amplitude signals 
abnormal, ill) QRS abnormal, IV) QRS and root-mean square andlor 
low amplitude signals abnormal. Implantable cardioverter defibrillator 
discharges in series were counted as a single event. Clinical variables 
and implant intervals were similar in all groups. The number of pts in 
each group with one or more (0) versus no discharge (ND) was 
determined. The predicted probability (p) of implantable cardioverter 
defibrillator use per group was determined by probit regression analysis. 
jiJIDlJl ..NIL JL Jl!. 
I (n=7) 4 3 35% 
lI(n=3) 3 0 51% 
ill(n=13) 3 10 66% 
IV(n=17l 4 13 79% 
(*p=0.03) 
The p was 30% and 77%, respectively (p < 0.01) for groups I and II 
versus groups III and IV. On multivariate analysis only the QRS 
duration predicted implantable cardioverter defibrillator use (p=0.03). 
It is concluded that signal average EeG may be helpful in predicting 
the frequency of implantable cardioverter defibrillator discharges. 
717·6 
Changes In The Frequency Domain Of The Signal.Averaged 
Electrocardiogram Post·Experimental Myocardial Infarction 
Daniel Bloomfield. Paul Lander, Jonathan Steinberg 
Columbia University, New York, NY 
3:15 
The effect of MI on the signal-averaged electrocardiogram (SAECG) in 
the time domain has been we)) described. Little is known, however, on 
the effect of MI on the SAECG in the frequency domain. The purpose 
of this study was to characterize the changes in the high frequency QRS 
energy that occur after experimental MI in dogs. MIs were created in 
21 dogs by balloon occlusion of the left circumflex (n= 10) or left 
anterior descending (n= 11) coronary arteries. SAECGs, using three 
orthogonal leads (X, Y ,Z) were obtained before and 4-6 days after the 
MI. Using a spectral filter, we calculated the energy (in mv'sec) of the 
entire QRS as the area under the signal within a number of prespecified 
frequency bandwidths [ 4O-80Hz, 4O-120Hz, 4O-16OHz, 6O-1ooHz, 80-
120Hz, and 120-16OHz]. The QRS energies were then log transformed 
to achieve a normal distribution. RESULTS: Listed below are the 
changes in energy in the 4O-80Hz bandwidth (negative numbers 
represent a loss in energy post MI). 
Absolute Change in 'dogs with 
Change log transform decreasing 
LEAP Energy of energy energy 
x 0.518 0.223 9/21 
Y -1.849 -0.206(p<0.05) 17/21 
z -0.444 -0.012 12/21 
vector -1.402 -0,074 15/21 
The decrease in absolute energy in the Y lead, .1. 849 mv'sec, 
represented an II % decrease in the total energy in the Y lead pre MI. 
Increasing the bandwidth to 4O-16OHz did not change the results. 
Moving the frequency range to 6O-100Hz and up to 120-16OHz resulted 
in slightly smaller decreases in QRS energy (p=ns vs. pre MI). 
CONCLUSION: MI decreases the high frequency QRS energy in the 
SAECG. This change was observed predominantly in the Y -lead and the 
4O-80Hz bandwidth. 
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718-1 2:00 
ACE IDhibitioD .. itb PeriDdoprii Improyes SuniYal ID aD Early 
RepufusioD Model la tbe Pig 
Cees de Laagen, Tom Tobe, Jaa YBn Wijngaardea, Pieter de Graeff, 
Klaas Bel, Harry Wesseliag. Departmeat of Cliaical Pbarmacology, 
Ualversity of Groalngea, Tbe Netberlaads 
laterveatlon witb Perindopril (PER) during Iscbemla and reperfuslon 
was Investigated In a blinded, randomized study In 24 pigs (30 kg). 
ischemia was evoked by Innation for 45 min of a PTCA balloon la tbe 
left anterior duceadlng coroaary artery. Perindoprllat (0.06 mg/kg 
I.v.) or vebicle was administered, 15 min bef9re the end of the 
Iscbemla period. Tbe aut day, oral PER, (0.4 mg/kg/day) or Placebo 
(PLA) was started. Tbe pigs were subjected to programmed electrical 
stimulation (PES) and signal averaged electrocardiography (SAECG) 
after two weeks. Upon reperfuslon, a significant and sustained 10 % 
drop in mun arterial pressure developed In PER only. A 44 : 10 % 
(sd) lacrease In tbe pressure-rate product occurred Immediately after 
reperfusloa ia PLA but not In PER (18 : 7 %, p<0.02, PLA vs PER). 
Apparently, PER prevented the Increase In oxygen demand after 
reperfuslon. Neltber beart rate, cardiac output nor filling pressures 
were dlrrerent. Interestingly, tbe number of arrbytbmic deaths (AD. 
wltbln 24 hr) was reduced after PER (2 AD) versus 7 AD In PLA 
(P<0.04). Tbe inducibility of sustained monomorphic ventricular 
tacbycardla after PES was 1/5 In PLA and 3/10 la PER. The SAECG 
(Slmsoa method, ISO beals, SO Hz) showed an Increase of the blgh 
frequency QRS from 58:Z.7 (sd) to 76:11 ms In PLA vs no Increase 
(63:1.9 to 62:2.Z ms) In PER. 
Tbertfore, Inten'entlon witb Perindoprll did reduce tbe number of 
(arrhythmic) deatbs after experimental Infarction significantly. 
Moreo"er, the development of a substrate for malignant ventricular 
tachyarrhythmlas was reduced. 
By Inference, Perlndoprll might be beneficial as an adjunct to early 
reperfuslon therapy after acute myocardial Infarction. 
718-2 2:15 
Milrinone Prevents Early Left ventriCUlar 
Dilation After Acute Myocardial Infarction 
Praveer Jain, Mark Hughes, Giridhar Korlipara, 
Oneida Lillis, John P. Oervan, Peter F. Cohn. 
SUNY Health Sciences center, Stony Brook, NY 
Milrinone (Mil) attenuates left ventricular 
(LV) dilation when administered after 
completed infarct healing but its effects on 
LV remodeling in the early post-infarction 
period are not known. To study this, rats 
(n=95) underwent sham surgery or left coronary 
artery ligation (MI). Postoperatively, rats 
were further randomized to receive Mil (3.04 
mg/kg/da~or placebo (H20) within 1 hr. Three 
weeks later, rats were killed, the hearts 
removed, and fixed at a constant filling 
pressure (7.5mmHg). Hearts were cut 
transversely into four slices for morphometric 
analysis. Infarct size(IS), LV volwne(LVV) 
and LV wall stress (WS) index (LVV/LV wt) were 
measured. Results are mean+SEM: 
IS 
(%LV) 
LVV 
Sham-H20 Sham-Mil MI-H20 
(n=12) (n=14) (n=17) 
MI-Mil 
(n=25) 
48+4 
(ml/kg) 1. ° 0±.O .1 
WS 1.73+0.1 
'p=NS vs MI.:'Mil; 
MI-Mil 
1.09+0.1 2.16+0.2 2 1.41+0.1 
2.05+0.2 3.39+0.33 2.35+0.3 
2,3p =0-: 002 vs sham-H20 and-
ThUS, Mil therapy begun in the immediate 
post-infarction period alters LV remodeling 
favorably by reducing LV dilation and wall 
stress. 
718-3 
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Hypertrophy Improves Function in Adjacent Non·Infarcted 
Myocardium During Left Ventricular Remodeling 
Christopher M. Kramer, Joao AC. Lima, Linda C. Palmon, Mario R. 
Llanares, Barbara Tallant. Leon Axel, L. Henry Edmunds Jr., 
Nathaniel Reichek. Hospital of the University of Pennsylvania, 
Philadelphia. Pennsylvania. 
Left ventricular hypertrophy and dilatation during post•
infarction remodeling have been well characterized while regional 
changes have not. We utilized magnetic resonance imaging in 6 
sheep studied before (C), 1 week. and 8 weeks after anteroapical 
infarction produced by ligation of the LAD and second diagonal 
branch. Magnetic resonance tissue tagging by spatial modulation of 
magnetization was employed to analyze circumferential segmental 
shortening (%S) compared at the subendocardium (endo) and 
subepicardium (epi) in infarcted (lNF) and adjacent (ADJ) 
myocardium in apical short axis images. Left ventricular mass and 
volume were calculated at end-diastole in 8-10 short axis images. 
Left ventricular mass increased from 69.1±13.5 gat 1 week to 
76.8±14.9 g at 8 weeks post-infarction (p<0.05) while volume expanded 
from 44.1±.13.1 cmS to 57.4±15.2 cm3 (p<0.05), (ANOVA p<0.02 for 
both). 
~ ~ 
INFendo 20.6±7.9 6.9±6.6* 
epi 16.4±5.0 4.5±3.7* 
ADJendo 21.1:6.5 9.1±7.5* 
epi 16.7±5.6 4.7±3.7* 
*p<0.05 vs.C by Scheffe F-test 
.B...lYk...L'&S 
8.6±8.5* 
4.7±3.9* 
15.4;t.9.7*# 
8.5±5.6* 
IIp<0.05 for 8 wk. vs. 1wk. by Scheffe F-test 
ANOYA 0< 
0.0001 
0.0001 
0.0001 
0.0001 
Hypertrophy and dilatation progress from 1 to 8 weeks post· 
infarction. Subendocardial shortening is reduced in the first week 
and subsequently returns towards baseline in adjacent non-infarcted 
myocardium. Parallel trends in shortening occur in the sub•
epicardium. Thus, hypertrophy during remodeling accompanies a 
return towards baseline function in myocardium adjacent to regions 
of anteroapical infarction. 
718-4 2:45 
Aggravation of Left Ventricular Remodeling And Reduced 
Survival With Chronic Exercise in Rats After Infarction 
Peter Gaudron. Kai Hu. Rainer Schamberger. Matthias Budin. Bir•
git Walter. Georg Ertl, Univ. of Wiirzburg, FRG 
Extend of left ventricular (LV) dilatation and infarct expansion 
(remodeling) correlate with mortality after myocardial infarction 
(Mi). To study the influence of exercise (Ex). started early or late 
after coronary artery occlusion ,lIS rats with Mi or sham operation 
were randomized to start with swim training (8 weeks, 6 
days/week, 90 min/day) at 4 (S4) or 21 days (S21) or to remain se•
dentary (SO). After 8 weeks, histologic Mi-size (% of LV) among 
Mi-groups was similar (SO: 47±3, S4: 48±3, S21: 46±2. ns). LV•
volume (LVV:ml, pressure-volume relationship) was similar in se•
dentary (n=33, .38 ± .03) and exercising sham (n=47, .38 ± .04). 
but increased with Mi (SO:.48±.04'+,n=13) and in addition with Ex 
(S4:.56±.04'+,n=11; S21:.65± .04'<+,n=11). Right- and LV filling 
pressures (microtip manometer) were increased and systemic pres•
sures decreased by Mi, but not altered by Ex. Mortality 
(peto/Wilcoxon), not altered by Mi or Ex per se. rose with Ex in Mi 
(p<O.OOOl) and was 42% in MiS4 (p<0.05 vs MiS21, MiSO) and 
27% in S21. Expansion was assessed by measurements of LV dia•
meter at the point of maximal scar protrusion perpendicular to the 
septum and scar thickness from transverse LV-slices. Non-Survi•
vors from MiS4- and MiS21 groups had excessive LV dilatation 
(+240 to 290 %), scar thinning (-47 to 49%) and increase of maxi•
mal LV cavity diameter (+160 to 170 %) as measures ofMi expan•
sion (p<0.05 vs resp. control). Thus, swim exercise. initiated early 
or delayed after Mi, did not affect LV hemodynamics at rest but 
caused aggravation of LV-dilatation and Mi-expansion which most 
likely explain reduced survival. (x±sem, 'Anova, +vs sham,+Vs S4, 
p<0.05) 
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Left Ventricular Remodeling After Coronary Reperfusion is Altered by 
Beta Blockade and Exercise In Rats. 
Bung-Hce Oh, Shiro Onn, 10hn Ross, lr. 
University of California, San Diego, CA 
Bela adrenergic blockade is frequently used after acute myocardial infarction, 
but its cardiac effects following reperfusion therapy are llnknown. 
Nontransmural infarction was produced in rats by 4S minutes of left coronary 
artery occlusion followed by reperfusion, and effects on global and regional 
left ventricular (LV) topography were ItUdied. At S days after coronary 
reperfusion, rats were randomized into 4 groups (n=7S); no Intervention (NI, 
n=2O), daily swimming exercise (Ex, n=21), BB using propranolol, 7SO 
mglliter drinking water (n= 19), and BB + Ex (n= IS). After 3 weeks, 
arrested hearts were perfusion-fixed at an LV cavity pressure of 10 mmHg. 
Mid-ventricular slices 2S ml' thick were used to determine LV cavity area 
(CA), epicardial area of the infarct zone (EpiA-IZ), and wall thickness of the 
normal zone (WT-NZ) and infarct zone (WT-IZ), all expressed In mm' ± 
S.D. 
!lwul I.Y..tA i1li&:IZ lIT:IZ ~ 
NI 33.S±S.9 7.S±3.2 1.36±0.29 1.9S±0.29 
Ex 39.1±6.S 9.9±3.S 1.S1±0.34 1.81±0.23 
BB 41.6±9.7 7.S±2.S 1.29±0.23 l.n±0.33 
BB+Ex 44.6±7.6 7.7±3.3 1.2S±0.26 1. 62±0.19 
As we have previously observed, Ex increased LV CA and caused epicardial 
hypertrophy (Increased EpiA) In IZ by 32% compared to NI (p < 0.01, 2 way 
ANOVA). BB alone increased LV CA and reduced wr-NZ compared to NI 
and Ex (both p<O.OS). Compared to Ex alone, BB + Ex further increased 
LV CA, caused thinning of wr·NZ and wr-IZ, and EpiA IZ failed to 
Increase (all p<O.OS). Thus, 3 weeks of bela blockade and exercise dilated 
the left ventricle at rest, with thinning of the normal wall, and completely 
prevented exercise-induced epicardial hypertrophy In IZ. These findings 
provide evidence that beta blockade causes potentially unfavorable inhibition 
of exercise-Induced remodelinll in nontransmural Infarction associated with 
reperfusion. 
718·6 3:15 
EfTects or Amlodipine on Acute Myocardial infarction, Inrarct 
Expansion and Ventricular Geometry 
lame. M. Hagar, Laurie G. Newman, Robert A. Kloner. The Heort IlIStitute, 
Ho.pital of the Good Samaritan, and Section of Cardiology, Los Angeles 
County+ USC Sdwol of Medicine, Los Angeles C4. 
Angiotensin converting e~e inhibitors (ACEI) reduce 
both early infarct expansion and late left ventricular (LV) 
remodeling after myocardial infarction (MI). Reduction of 
infarct expansion is lielieved to be due to the decreased systolic 
wall stress that results from arteriolar vasodilatationJ.but 
contributions from the venodilator and neurohormonal euects 
of the ACEI cannot be excluded. We evaluated the effect of 
early treatment with the calcium blocker amIodipine, a potent 
arteriolar vasodilator without negative inotropic properties, on 
chronic MI in the rat. Permanent left coronary occlusion was 
created after pretreatment with amlodipine 0.25 mg/kg, (low 
dose), 1.0 mg/k.lt(high dose) orJllacebo IV bid, and contmued 
for 7 d8Y.s after Mt. Hearts (n = 50) were perfusion fixed 21 days 
after infarction and analyzed for MI size, scar thickness, LV 
shape and size, and expansion index. 
Both doses decreased mean BP (119±3 to 99±5 mmH$ 
low dose, p=.OO4; 110±5 to B4±4 mmHg high dose p=.OOO3), 
with reflex tachycardia only after the high dose (HR"395 ± 9 to 
434 ± 11, p. = .001). MI extent was equal m the 3 groups (39 ± 2, 
41 ± 2, ana 41 ± 3% of LV circumference in controf, low and high 
dose). The 3 groups did not differ significantl~ in LV cavity 
cross-sectional area (80±4, 77±3 and1l7±3 mm, control,low 
and high dose,]> = 0.07 high dose vs. control) mean scar thickness 
(O.74±0.06, 0.73±0.05, and 0.65 ± 0.06 mm control, low and high 
dose, p'=NS) and expansion index O.52±0.10). 1.58± 0.12, and 
1.95 ± 0.19, control, low and high do~e~ p = 0.u8 high dose vs. 
control). In the subgroup with larger imarcts (MI extent > 0.39 
of LV), expansion mdex was higner in the hifh dose group 
(2.37 ± 0.23 vs. 1.64 ± 0.17 control, p = 0.04). n this model. 
amlodipine does not limit MI size, mfarct expansion, or 6/ 
dilatation when initiated prior to infarction. The previously 
reported beneficial effects of the ACEI on MI expansIOn are not 
due to their arteriolar vasodilating effects alone. 
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Ionic CUrrents underlying the Bypotheraia-induced 
Prol.oQgation of Ventricular Action Potential 
Makoto Arita, Tatsuto Kiyosue. 
Dept. of Physiol. Med. Coll. of Oita, Oita, Japan 
2:00 
Decreases in myocardial temperature in ischemia or hypo•
thermia lead to prolongation of action potential dura•
tion (APD) or effective refractory period (ERP), while 
little is known about its precise ionic mechanism(s). 
We studied the temperature effect on APD and ionic 
currents of isolated guinea-pig ventricular cells, using 
whole cell-clamp methods. The contribution of each 
current component to the APD change was quantified using 
a mathematical model of the ventricular action poten•
tial. Temperature decrease from quasi-physiologic (33-
340 C) to 24-250 e prolonged the APD (at 0.2Hz) from 
l46±33 (M±SD) to 3l4±83ms or by 115' (Ql02.5). Peak 
amplitude of lea, IK and slope conductance of IKl were 
decreased with Ql0 of 2.3, 4.5 and 1.6 respectively. 
However, the lea at later phase (50-300ms) of depolari•
zation increased due to a delay in its inactivation. 
Effects of low temperature on IK activation were ana•
lyzed in the presence of nicardipine (O.6pM). IK tail 
currents (l83±30pA, at -4OmV) measured after 1 sec 
depolarization (+6OmV) at 340 e was decreased to 39±lO~ 
at 240 e, due to a remarkable delay in IK activation. We 
also found a marked decrease in a novel class of time•
independent outward current (presumably Na,K-pump cur•
rent). Incorporation of these 2 outward current changes 
into the mathematical model explained 43, of the total 
APD prolongation, while the rest (57') was attributed to 
increased lea at plateau phase (due to delayed inactiva•
tion) and a decrease in IK1' Results suggest that even 
a small decline (oQ.5 OC) of local myocardial tempera•
ture, as is the case in acute coronary occlusion, ac•
counts for as much as ~lOms prolongation of APD or ERP. 
719·2 2:15 
Cardiac Sodium Channel Properties During Mammalian 
Embryogenesis 
James J. Merrill, C. Frank Stanner, Augustus O. Grant. Duke University 
Medical Center, Durham, Nonh Carolina 
The kinetics of cardiac sodium channels (N a channels) during mammalian 
embryogenesis have not been well·described. Differences between adult and 
fetal cardiac cells exist in conduction, ion channel selectivity, and response 
to calcium and Na channel blockers. We investigated Na channel propenies 
by recording single Na currents in cell-attached patches of developing rat 
ventricular myocytes at day 11 post-coitus (PC), day 17 pc, and in the 
neonate. After isolation, fresh cells were depolarized in 150 mM K + 
external solution. The voltage dependence of activation and inactivation of 
the Na channel was measured using standard voltage-clamp protocols. 
Two unique channels were present during embryogenesis; a high 
conductance Na channel with kinetics similar to neonatal Na channels, and 
a low conductance channel observed primarily in early embryogenesis. 
lntcnninent low conductance channel bursts clearly delineated this channel 
from possible bandwidth-limited large conductance channels. In four 11-
day pc patches, from a holding potential of -120 mY, testing to -20 mY, 
the following was Observed. 
Channel Type Current (PA) mean open time (ms) % curreDl 
High conductance -1.46±.05* -0.S7±.2It 79±S 
Low conductance -0.94±.04* -0.31±.l3t t,*p <.01 21±S 
The voltage at which 50% Na channel inactivation (hS0) occurred was 
also detcnnincd for each patch. Neonatal cells exhibited an h50 = -S0±6 
mv (n=5), with h50 = -96±19 mv for day 17 pc cells (n=6), and h50 =-
94±17 mv for day II pc cells (n=6). Na channel inactivation in prenatal 
cardiac cells tended to shift to more negative poteDliaIs with respect to 
neonates. TIle large standard deviations seen in younger age groups might 
be explained by mixtures of channels having differing voltage-dependence 
of inactivation. 
Fetal mammalian cardiac cells transiently exhibit a low conductance 
channel distinct from Na channels observed in the neonate, and display a 
trend toward voltage-dependent hyperpolarizing shifts in Na channel 
inactivation. 
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719·3 2:30 
Demonstration of Ca2+ Mediated Feedback Regulation of 
Action Potentials in Canine Epicardial Myocytes. 
Thorsten Beyer*, Bela Szabo, Ralph Lazzara. 
*Department of Cardiology, University of Heidelberg, Gennany, and 
Department of Cardiology, University of Oklahoma Health Sciences 
Center and Dept. of Veterans Affairs Medical Center, Oklahoma City, 
OK 
The notch caused by ITo is followed by a second depolarization (dome) 
in the action potential (AP) of canine epicardial ventricular myocytes. 
Depolarization of membrane potential activates Ca2+ channels and 
causes of transient increase in cytosolic Ca2+ concentration ([Ca2+])i. 
We measured the membrane potential with conventional 
microelectrodes and [Ca2+]i using fura-2 AM simultaneously in order 
to gain insight into the relationship of AP configuration and [Ca2+]i. 
The experimental design was made to influence lsi and Na+:Ca2+ 
exchange current. Ouabain (O.I-I.OILM) dose-dependently reduced the 
dome. When replacing 35.0 mM of NaCI by 70.0 mM sucrose to 
increase [Ca2+]i the dome was eliminated immediately. Following the 
return to normal [Na+lo the dome immediately reappeared but during 
the first 3 min it developed with a considerable delay following 
phase-l repolarization (up to 250 msec) and with an unusually high 
amplitude (up to +65 mY). The late dome was associated with a 
secondary rise in [Ca2+1i. Both the normal and late dome could be 
abolished by nicardipine (1.0 ILM). Caffeine (10.0 mM) as well as 
ryanodine (1.0 ILM) abolished the delay of the late dome. 
We conclude I, the dome can be eliminated by reduction ofNa+:Ca2+ 
exchange current and/or reduction of lsi. 2, a delayed dome occurs 
with abnormally high amplitude under conditions of high [Ca2+ li and 
when Na+:Ca2+ exchange current is also activated. 
719·4 2:45 
The Role of Ca Release from the Sarcoplasmic Reticulum 
in Acetylstrophanthidin·Induced Abnormal Automaticity of 
the Sinus Node Cells 
Takeshi Noda, Tadayoshi Hata, Tomoaki Saeki, Masao Nishimura*, 
Yoshio Watanabe, Cardiovascular Institute, Fujita Health University, 
Aichi, and TeiIcyo University, Tokyo·, Japan 
To evaluate the role of Ca release from the sarcoplasmic reticulum 
(SR) in regulating sinus node automaticity, action potential recording 
and voltage clamp studies were carried out on small preparations 
(O.2xO.2xO.1 mm) of the rabbit sinus node when the spontaneous 
activity was accelerated by acetylstrophanthidin (AcS). Ryanodine at 
concentrations ranging I to lOOILM suppressed the latter pan of phase 
4 depolarization and decreased SFF by 10.8%, but increased the action 
potential amplitude and duration. AcS at I and 3 ILM increased the 
spontaneous firing frequency (SFF) by 11.4% and 23.3% 
respectively, by accelerating phase 4 depolarization (n=6). The action 
potential upstroke was slowed and the amplitude decreased, thus 
giving the action potential an oscillatory configuration. When the 
preparations were pretreated with ryanodine, AcS caused a brief initial 
increase and subsequent decrease in SFF without the induction of 
oscillatory potentials (n=6). Voltage clamp experiments using double 
microelectrode techniques elucidated that AcS increased the inward 
current elicited in the pacemaker potential range of -60 to -30 m V but 
decreased it with a concomitant development of the transient outward 
current (TO) at higher potential levels (n=5). A transient inward current 
(TI) were also induced by AcS (n=5). Conversely, AcS-induced 
increase in the inward current in the pacemaker potential range and 
induction of TI and TO were not observed in the presence of 
ryanodine. 
We conclude that the positive chronotropic effects of AcS in the 
sinus node would require ryanodine sensitive functional Ca release 
channel in the SR, and the increase in the inward current in the 
pacemaker potentials and induction of TI and TO by AcS depend on 
the SR functions. 
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719·5 3:00 
Identification of Canine Atrial Myocytes, TraIIsitioDal, and Pacemaker 
Cells from Intrlu::dlular Potentia1a and Labeling with Horseradish 
Peralidase Iontophoresis 
Dwight E. Hand, Burt I. Bromberg, Richard B. Schuessler, James L. 
Cox, John P. Boineau. 
Washington University, Barnes Hospital, St. Louis, Missouri 
Direct correlation between cellular morphology and electrophysiology 
in the intact myocardium has not been possible in the absence of a 
reliable, permanent, intracellular marker compab.ble with floating 
microelectrode techniques. We used horseradish peroxidase (HRP) 
to label the specific cell from which an intracellular recording was 
made in the isolated, perfused, spontaneously contracting canine right 
atrium (RA) (n = 12). The in vitro RA was prepared so that simul•
taneous extracellular unipolar electrograms were recorded from 250 
fixed endocardial sites as a floating microelectrode was positioned on 
the epicardial surface. Stable transmembrane potentials were 
identified and 5% w Iv HRP was iontophoretically injected into cells 
by passing 100 ms monophasic square·wave pulses of 2.5 nA amplitude 
through the microelectrode. Consecutive 40 /.1m frozen sections were 
collected and reacted with 0.05% diaminobenzidine/O.OI % hydrogen 
peroxide. Light microscopic analysis revealed the preservation of 
cellular detail in the dark brown staining labeled cells allowing direct 
correlation between histologic cellular morphology, transmembrane 
potentials, and extracellular recordings. The percentage of cells 
recorded that were effectively labeled by HRP were tabulated 
according to cell type as determined from transmembrane potentials. 
HRP Intracellular Labeling (L = Labeled, R = Recorded) 
Myoeyte Transitional Pacemaker Total 
LR%LR%LR%LR% 
13 29 45 8 15 53 10 31 32 31 75 41 
41 % of all cells injected with HRP were recovered. Conclusions: HRP 
is an effective intracellular label for floating microelectrode recordings 
in the canine RA and may be useful in localizing and identifying 
cellular components of nodal and extranodal pacemaker tissue. 
719·6 3:15 
Neuropeptide Y Increases Action Potential Duration in 
Isolated Rabbit Right Atrium. 
Sylvie Dinanian, Bruno Le Grand, Edouard Coraboeuf, 
Louis Guize, Thomas Lavergne, Pierre Peronneau, 
Jean-Yves Le Heuzey. Department of Cardiology and 
INSERM U 256, Broussais Hospital, Paris, France. 
Neuropeptide Y (NPY) is present in nerve fibers 
throughout the mammalian heart. Using intracellular 
microelectrode technique in spontaneously beating rabbit 
right atrial preparations, we observed that NPY (10-9 M) 
increased action potential duration (APD) at 50%, 80% 
and 90% of repolarization by 59%, 65% and 56%, 
respectively (p<.OOOl, n=10). Similar results were 
obtained with stimulated (2 Hz) preparations devoided of 
sinus node (n=4) : APD was prolonged by 73%, 74% and 
69%, respectively (p<.OOOl). This lengthening was also 
found in isolated atrial cells. Whole cell recording 
technique was used to investigate the mechanism of this 
lengthening. Long lasting Cai insensitive K+ transient 
outward current was increased and L·type Ca current 
was weakly increased. The Ca current induced by either 
isoproterenol (10-7 M) or Bay K 8644 (10-6 M) was reduced 
by NPY, suggesting the inhibition of adenylate cyclase by 
a Gi protein. The weak increase in Ca current observed 
in basal conditions with NPY might be due to a channel 
phosphorylation different from the adenylate cyclase 
pathway. Finally, we superfused 4 stimulated isolated 
right atrial preparations with NPY + ryanodine (10·6 M) 
and we observed no APD prolongation. In conclusion, the 
APD lengthening observed in basal conditions is 
tentatively attributed to the small increase in Ca current 
and the resulting increase in Na-Ca exchange current 
due to calcium induced-calcium release. 
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901-2 
SIent Complications Are Dependant on the 'Slent Environment" 
• Multlcentre Canadian Experience 
Ian M. Penn, Robert I.G. Brown, Robert MacDonald, Don Ricci, David 
Almond, Jeff Burton, Blair O'Neill, Luke Galligan, Jerome B. Foley, Nancy 
Murray·Parsons, Joanne White, Joan Slivocka. Victoria Hospital, London, 
Ontario, Canada 
PTCA may be unsuccessful due to occlusive dissection, recoil and acute 
closure not responding to multiple or prolonged inflations. We compared 
the elective (E) use of the Palmaz Schatz Stent (PSS) to its use in failed PTCA 
(F). F was defined as PTCA complicated by (1) dissection with > 50% 
stenosis or TIMI 1 or 2 flow, (2) recoil with > 50% stenosis despite accurate 
balloon artery ratio, (3) acute closure with TIMI 0 flow. 
RESULTS: From July 90,162 patients underwent coronary artery stenling in 
S centres. Patients underoing elective stents (n = 137) were compared to 
those undergoing stents in F. There were no differences in the pre PTCA 
variable of age, sex, risk factors, target vessel or lesion. There was a higher in· 
cidence of rest (CCS IV) angina in F (40 vs 18%, p < 0.04). 
IN HOSPITAL COMPLICATIONS E (n = 138) F (n = 24) 
MiIilll· Thrombosis· Acute < 24 hr 2} O} 
Late> 24hr 1 2 
OMI 0 2% 0 U.5%· 
Death· Stent Thrombosis 0 0 
• Other Causes 0 l·p < .05 
MiIwr· Bleed· GI 41 01 
Access 2 6% 00 0% 
Other 2 
Late thrombosis in F was due to incomplete stent coverage of the dissected 
segment. One patient in cardiogenic shock, who underwent salvage PTCA of 
a single remaining graft died of pump failure. The two E stent patients with 
acute stent thrombosis underwent emergency CABG. 
CONCLUSIONS: 
1. During the learning curve of this multicentre study elective stenling was 
found to be as safe and effective as PTCA. 
2. Stenting in failed PTCA prevented urgent CABG in all patients with no 
new 0 wave infarcts or deaths. 
901·3 
Emergency Coronary stenting after Failed 
Coronary Angioplasty: Immediate and Hean Term 
Results with the Palmaz- Schatz Stent. 
Ferdinand Kiemeneij, GertJan Laarman, Jo 
Suwarganda, Ron van der Wieken. Institute of 
Interventional Cardiology OLVG, Amsterdam, The 
Netherlands. 
Coronary stenting is a new technique in the 
treatment of obstructive dissection after PTCA. 
From january 1990 to june 1991, 53/961 PTCA's 
(5%) were followed by stent-implantation because 
of impending reocclusion, due to dissection. 
RESULTS: In 6/53 pts (11%) the stent could not 
be delivered due to mechanical factors. 
Under optimal anticoagulantion, implantation was 
successful in 47 pts (89%). 
CLINICAL COURSE: Mean follow-up 7 mo (1-17 mol 
• Uneventful 23/47 (49%) 
.Coronary artery bypass grafting (CABG) 
prophylactically performed 7/47 (15%) 
.Subacute closure 10/40 (25%) 
.Inhospital mortality 2/40 ( 5%) 
.Late restenosis 4/40 (10%) 
.Late death (stent-related) 1/40 ( 2%) 
In 5/10 patients (50%) no predictors for acute 
or subacute stent-occlusion were found on 
retrospective analysis. Reocclusions were seen 
in 7/10 pts (70%) under adequate 
anticoagulation. 
CONCLUSIONS: 1.Implantation of a Palmaz-Schatz 
stent is effective in stabilizing patients after 
failed PTCA. 2. Subacute stent- closure is an 
unpredictable event. 3. CABG within 24 hours 
after emergency stenting may improve outcome. 
ABSTRACTS 
901-4 
Hirudin vs Heparin for the Prevention of 
Platelet Deposition on Coronary Stents. 
Arnd B Buchwald, Dirk Sandrock. Christina 
Unterberg. Dieter L Munz, Volker Wiegand. 
University Clinic. Gottingen, FRG 
Recombinant hirudin (HIR) has been shown to 
prevent platelet adherence in angioplasty 
models. lll-indium labeled platelet (PLT) 
deposition was measured 12 hours after 
coronary stent implantation in minipigs. 
Prior to stenting. animals in group A (10 
stents) received a bolus of 1 mg/kg Hir and 
250 mg acetylsalicylic acid (ASA). followed 
by an i.v. infusion of lmg/kg HIR / hour. In 
group 2 (11 stents) heparin (HEP. 100 U/kg) • 
ASA (250 mg) and dextran (500 ml) were given 
i.v. before stenting followed by 50 U/kg HEP 
per hour i.v •. PTT was prolonged to above 2x 
control values in both groups. After 12 
hours. hearts were excised and stented 
coronary segments were counted for 1l1-indium 
activity. Histologic examination (5 
slices/stent) showed presence of medial tear 
in 3 stents in group 1, and in 4 stents in 
group 2. In group 1. 18.7 ± 8.7 x 10' 
PLT/stent were present, as compared to 57.7 ± 
64.2 x 10' PLT in group 2. (p>O.l) In stents 
without intimal tear. PLT deposition amounted 
to 15.8 ± 5.4 x lO'/stent in group 1 (n=7). 
and to 17.7 ± 5.0 x 10' in group 2 (p>O.l). 
We conclude that HIR plus ASA do not prevent 
PLT deposition on coronary stents in minipigs 
and are not significantly more effective than 
the combination of KEP. ASA. and dextran. 
901·5 
Predictors of Restenosis Following Stenting for Acute or 
Threatened Closure Complicating PTCA 
Subodh K. Agrawal, Adam D. Cannon, Peter J. Macander, James A. 
Hearn, luc Bilodeau, Sriram Iyer, Jenny Breland, larry S. Dean, William 
A. Baxley, Gary S. Roubin, University of Alabama at Birmingham, 
lriirmingham, Al 
We analyzed clinical, procedural, and angiographic variables in 72 
consecutive patients who received 80 Flexible coil stents (Cook, Inc.) 
for management of acute or threatened closure in 74 vessels following 
PTCA between October, 1989 and October, 1990. Eighty·nlne percent 
of vessels were native, 41 % were RCA, 34 % were LAD, 11 % were 
lCx. 11 % were SVBGs, 3% were protected lMCA; 7% had multiple 
stents. Pre·PTCA lesions at the stented sites were classified per 
ACC/AHA Classification: Type A (17%1. Type B (45%), and Type C 
(38%). Stent sizes used were 2.0mm (1 %), 2.5mm (52%) , 3.0mm 
(30%), 3.5mm (10%), and 4.0mm (6%). Clinical success (angiographic 
success (final stenosis < 50%). no death or CABG) was present in 68 
of 72 patients (94%). Follow·up angiography was performed in 60 
patients at a mean of 4.5 months. Restenosis (diameter stenosis 
~ 50%) occurred in 24 of 60 vessels (40%). Results were as follows: 
I StInt size I Restlnosis I Percent I p value I 
:s;2.5mm (n=37) 19 51% 
:?!3.0mm (n=23) 5 22% p<0.05 
I Stent:Artlry Ratio 
:s;0.90 (n=28) 15 54% 
:?!0.90 (n-29)" 7 24% p<0.05 
"Three stent:artery ratios could not be measured. There was no 
relationship between restenosis and the lesion tortuosity, stent location 
in native arteries or vein grafts, procedural variables (number of 
inflations. maximum pressure, etc.) or history of previous PTCA at the 
stent site. 
Conclusions: Restenosis after coronary artery stenting for acute or 
threatened acute closure is related to local geometric factors. Relatively 
small stent size and stent:artery ratio predisposed to increased risk of 
restenosis. 
47A 
48A ABSTRACTS 
901·6 
EDcouraglDg Acute aDd LODg.Term ADglograpblc aDd CIiDlcal 
Outcome of CoroDar;, SteDtiDg: A Large SIDgle.CeDter ExperieDce 
Joseph Canozz.a, Richard Kuntz. Richard Pomerantz. Raben Fishman. Michael 
Mansour. Michael Gibson. Cynthia Senercbia, Daniel Diver. Roben Satian. 
Donald Baim. HarvanI-lbandike I..abonIIory. Bed! Incl Hospital. Bostoo 
Between 6188 and 7/91. we placed 250 PaImaz-Schatz inaacoronary SlCnts in 220 
patients II Beth Incl Hospital. In the bIB monlbs. SlCnts comprised only 4% 
of lOIS coronary inlUYenlions. but in the last 20 monlbs this rose to 17% of 
1131 procedures. Patients ranged in age from 3S-8S years (mean-6O.t12) and 70% 
had unstable angina. Sixty-five percent of lesions had resrenosis after previous 
PTCA; 34% were in saphenous vein grafts (SVG). Ninety-seven percent of all 
lesions were associalcd with one or more risk facton for reslCnosis (prior PTCA. 
SVG.unsral>le angina, length >IOmm. IOI8l occlusion or calcification). Stents 
were placed successfully in 98% of patients. and mean post -dilatation residual 
stenosis was -2%. There were /10 deatbs or Q-wave myocardial infarctions. I 
emergent CABG (<1%). and 3(2%) clinically silent stent embolizations. No acute 
and I subacute (no cownadin) stent thrombosis occurred. While 26% of initial 
patients had major vascular complication (surgical repair or uansfusion). this 
decreased to 13% in 112 patients Il'ClIed between 9/90-7191 .Six-month 
angiograpbic (ollow-up was available in 88% of eligible patients. RestenOsis (R. 
defined as ;tSO% reduction in lumen diameter) (or single stents is 25% (or both 
SVGs and native vessels. R is 19% (or de novo lesions and 28% for prior PTCA 
lesions. Univariate analysis revealed an increased risk of restenosis for disbelics 
(p=O.OO6). and in LAD vs RCA lesions (p=O.OO2). Fig 1 displays differences in 
R (or RCA (12%). LAD (44%) and SVG (25%). By Kaplan-Meier survival 
analysis (Fig 2). 90% o( patients were free o( cardiovascular evenlS (death. Ml or 
~~'.~-'t= I:: = li 1~' 
I.. --- '.5~ 
Fig I In Fig 2 j". 
n W 
"'.. '., , ., .. ,. .. 
.. .. , ... " It ID1th5 
ID CODcluslonrii"A~te success rate of stenling is 98%. and with no 
residual stenosis. 2) Major complications are rare. and rates o( vascular 
complications have decreased significantly. 3) Aogiographic restenosis rates are 
low despite characteristics associated with an increased risk o( restenosis. 4) 
Diabetes and stenling o( the LAD predict higher likelihood o( restenosis. 
S) Clinical event-free survival is excellent (ollowing SlCnling. 
901·' 
Adjunctive Bxcimer Laser Coronary Angioplasty (BLCA) 
Improves Primary PTCA Results for Lesions ~2Omm Length 
Geoffrey O. Hartzler, Frank Litvack, James Margolis, 
Martin Leon, Frank Cummins, Tsvi Goldenberg and ELCA 
Investigators, Mid America Heart Institute, Kansas City, 
Missouri 
Lesion length is a correlate of failed balloon 
angioplasty (PTCA). Initial excimer laser debulking of 
diffuse lssions (length >20mm) may improve subsequent 
PTCA results. Adjunctive -ELCA + PTCA yielded residual 
lumens <30\ diameter stenoses in 89\ of 241 lesions 
20-29mm, 87\ of 91 lesions 30-39mm, and 89\ of 44 
lesions ~4Omm in length. Accordingly, from the ELCA 
registry, 376 stenoses ~20mm were compared with 1483 
stenoses <20mm, and with 250 stenoses ~20mm from the MHI 
PTCA database. Results: 
ELCA ELCA MHI/PTCA 
<20mm ~20mm ~20mm 
n 1483 376 250 
PTCA use 65\ 69\ 100\ 
Success: 
ELCA + PTCA 90\ 89\ 
PTCA 75\* 
Dissection 13\ 17\ 24\· 
OCclusion 3.2\ 4.1\ 6.8\ 
Perforation 1.8\ 1.5\ 0\ 
·p<.05 
COnclusion: A strategy of ILCA + PTCA is equally as 
effective for lesions >20mm as it is for those <20mm. 
Adjunctive ELCA appears- to improve primary success and 
decrease arterial complications for long lesions 
compared to PTCA alone. A randomized trial is warranted. 
901·8 
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'l'be BUrcpaan MIll tioentar Jlegistry em CcroIIary Excimer 
Laser ADqicp1asty: '1he first year experierre 
'1he Emqlean IIIJltioenter registry trial was initiated 
early in 1991 to evalute efficacy and OCIIplications of 
coronaJ:y excbner laser arqiqllasty (CErA). We report on 
the results adlieved in the first year. 148 patients 
(152 lesions) were treated with CErA at 9 clinical 
sites. '1he majority of the pts had either ooe (44%) or 
two vessel disease (36%). Target vessel was the lAD in 
61%, the right coronaJ:y in 18%, the circumflex arteIy in 
16% and a graft lesial in 4%. Mean energy flueooe was 
48±6 JIl1/lDn' with a repetitial rate of 25 Hz. In 28% a 
1.4 lIJII, in 50% a 1.7 lIJII an:i in 22% a 2.0 lIJII diameter 
catheter was used. stand alooe CEIA was successful in 45 
interventions, failure of CEIA occurred in 24 and 
additional Pn:A was perfomed in 83 procedures. 
Spasm occurred in 22 pts and arqiogrcqhlc dissections 
were fCAIl'd in 48 pts. Vessel occlusions were seen in 10 
pts and oorc.nary perforatial in 6 pts, in 4 of these pts 
a 2.0 lIJII diameter catheter was used. EDergency bypass 
graftin:] was neoessazy in 3 of these carplications. 
'!here were 2 deaths and 7 transnllral myocardial 
infarctions. 
OOnclusian: In contrast to the results of other 
IIIJlticenter trials for coronaJ:y excbner laser 
an::Jicplasty the rate of severe OCIIplications in the 
early experierre of this registry is considerable. To 
iIrprove prooedurale safety in the early leamin;J CUIVe 
the use of largest diameter catheters shoold be avoided. 
901·9 
Cavitation Bubbles and Acoustic transients May Produce 
Dissections During Laser Angloplasty 
Ralph de la Torre, Kenton W. Gregory. Harvard Medical School. 
Boston. MA and St Vincent Hospital. Portland Oregon. 
To study the mechanism of vessel dissection during laser angioplasty, 
we measured cavitalion bubbles (CB) and acoustic transients(AT) 
generated by blood absorption of pulsed dye. excimer and holmium 
laser energy using a PVDF piezoelectric needle hydrophone (rise 
time 50ns). Cavitation bubble size was calculated using observed 
pressures. densities. and cycle times. Rapidly expanding cavitation 
bubbles resulted when blood was exposed to pulsed laser energy at 
energy densities currently utilized with clinical laser and catheter 
systems. CB expanded in 75 to 250 lIS and achieved diameters 
ranging from 0.72mm and 2.Smm. which varied with the cube root 
of the energy delivered. Collapse of these bubbles generated a second 
lower pressure AT which varied as the cube root of the initial CB 
volume. The magnitude of the AT varied inversely with distance from 
the bubble center which generally occurred within 100 I-lm of the 
catheter tip. AT ranged from 100-1.200 atmospheres at a distance 
of 0.5mm and 10-120 atmospheres at a distance of 5mm. 
To test the cliniCal relevance of CB and AT. the effect was assessed in 
vivo in six rabbit carotid arteries (outer diameter 2.2mm). Laser 
angioplasty catheters were poSitioned coaxially in the vessels so that 
catheter conlae! with arterial wall did not occur and laser pulses 
were absorbed solely by blood. Carotid artery perforation occurred 
when a minimal CB radius of l.S8±O.13 mm and an AT of 160±9.9 
atmospheres (measured at a distance of 1mm) were produced. We 
conclude that laser energy absorption by blood produces rapidly 
expanding cavitation bubbles and high-pressure acoustic transients 
which may cause perforation. dissection and other unwanted tissue 
etfects during laser angioplasty and should. therefore, be minimized. 
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Angiographic Complications During Excimer Laser 
Angioplasty in Patients With Complex Coronary Lesions 
Timothy J. Garrand. Jeffrey J. Popma. Lowell F. Satler. Kenneth 
M. Kent. Augusto D. Pichardo Ann Greenberg. Mary K. Kehoe. 
Martin B. Leon. Washington Hospital Center. Washington. D.C. 
To evaluate the frequency. predictive factors. and impact of 
angiographic complications during excimer laser angioplasty (EL). 
we reviewed the cineangiograrns using qualitative and quantitative 
methods in 59 consecutive EL patients with complex lesion 
morphology including 21% total occlusions. 41% >10mm length. 
15% ostial location and 24%>45° bend. Percent diameter stenosis 
(OS) and minimal lumen diameter (MLD) were measured pre-EL. 
post-EL. and post-adjunctive PTCA. Overall procedure success 
(final DS <50% without in-hospital death. MI. or CABG) was 90%. 
Angiographic complications consisted of dissections in 14 (24%) 
which were 17117mm in length (range 3-69mm). and perforations 
in 2 (3.4%). Clinical features and pre-procedure lesion morphology 
were not useful in predicting dissections!perforations. 
Dissection! No Dissection/ 
Perforation Perforation 
0=16 11=43 
PreEL %DS (MLDmm) 79(0.35) 85(0.55) 
PostEL %DS (MLDmm) 62(0.79) 50(1.23) 
PostPTCA %DS (MLDmm) 49(1.28) 32(2.49) 
llpulses/energy/#passes 1001/53/1.3 945/49/1.5 
Balloon:Artery Ratio 1.410.3 1.2±0.2 
DeathlMllCABG(%) 0/12/24 0/0/0 
P 
values 
ns 
. 002 
.042 
ns 
. 012 
Procedure Success(%) 38 100 .001 
A strategy of usmg smaU EL catheters (1.3mm) at high pulse 
energies (>50 rnJ/mm') combined with PTCA (19 patients) did not 
lower angiographic complications. In conclusion: In patients 
with complex lesion morphology treated with EL (1) dissections are 
common and sporadic without identified predictive factors; (2) over•
sizing balloon catheters after EL may be deleterious; (3) angiographic 
complications are associated with significant in-hospital morbidity. 
901·11 
A Randomized Multicenter Study of Low Speed 
Rotational PTCA Versus Standard PTCA for 
Recanalization of Chronic Total Coronary 
Occlusion 
Nicolas Danchin, Yves Juilliere, Jean 
Cassagnes, Jacques Machecourt, Jean P Bassand, 
Jean M Lablanche, Franc;;ois Cherrier. Dept of 
Cardiology CHU Nancy Brabois, 54500 France 
Low speed rotational angioplasty (Rotacs) is 
designed to recanalize total coronary artery 
occlusions ; it is constituted of a rotational 
guide-wire (GW) with a 1.3 mm smooth tip, 
mounted on an 0.014 GW used to bring the Rotacs 
in contact with the occlusion ; the Rotacs is 
slowly rotated (100-200 rpm) to pass the 
occluded segment, after which a regular balloon 
procedure is performed over an exchange GW. 
We designed a prospective, multicenter, 
randomized study of Rotacs (R-PTCA) versus 
standard PTCA (S-PTCA) in chronic (10-365 days) 
total coronary artery occlusion (Timi 0), 
suitable for either technique. To date, 41 pts 
with a clinical indication for an attempt at 
recanalization (30M, llF; mean age : 55 years) 
were included. The occlusion was located on the 
LAD (n=21), RCA (n=18) or LCx (n=2). Initial 
success, defined as recanalization with <50% 
residual stenosis and Timi 3 flow was 75% 
(15/20) in R-PTCA and 48% (10/21) in S-PTCA 
(p=0.07) ; 4 R-PTCA procedures were successful 
only after crossing-over to S-PTCA and 3 S-PTCA 
were successful after crossing-over to Rotacs. 
These preliminary results indicate that 
the Rotacs can be used to recanalize chronic 
total coronary occlusions and might be superior 
to standard PTCA in such indications. 
ABSTRACTS 
901·12 
Mechanical Features and In vivo Behavior of a Polymer Stent 
Will em J. van der Glessen, Cornelis J, Slager, Heleen M.M. van Beusekom, 
Richard A. Wilson, Elma J. Gussenhoven, Pieter D. Verdouw, Patrick W. 
Serruys. Thoraxcenter, Erasmus Universtty Rotterdam, The Netherlands 
Introduction: The clinical evaluation of metallic stents Indicates that these 
devices are thrombogenic, and do not eliminate the occurrence of restenosis. 
Therelore, the study of stents composed of other materials seems a useful 
approach. We Investigated a mesh stent composed of polyethene•
terephthalate (PETP) in vitro and after implantation in peripheral arteries of 
pigs. 
Results: In vitro the polymer stents exhibited elastic expanding forces in the 
same range as self-expanding metallic prostheses. However, after mounting 
on the delivery system (4) 2.6 mm) for only 15 min, the diameter of the stent 
was reduced to 75% of the unconstrained diameter immediately after release 
in vitro, increasing to 85% after 60 min. This hysteresis-like behavior proved 
to be related to the duration on the delivery system before release. We 
therelore chose to place stents wtth an unconstrained diameter of 5.3 mm in 
arteries of approximately 4 mm. 
Implantation of these devices in porcine peripheral arteries (8 stents, 
8 arteries) proved to be easy. But, due to imperfections of our prototype 
delivery catheter 2 stents were incorrectly placed. Four weeks after 
implantation 7/8 stents were patent, wtthout the use of antithrombotlc therapy . 
Quantitative angiographic analysis showed that the stents were not oversized 
(mean diameter of the vessels before, immediately after, and 4 weeks after 
stenting was 3.8 ~ 0.1, 3.8 ~ 0.1 and 3.2 ± 0.1 mm, respectively) . 
Microscopy showed that only a thin neointima (range: 44-113 11m) covered 
the stents. Focally eosinophilic granulocytes and giant cells were observed in 
the neointima. The stent struts did not damage the arterial media. 
This polymer stent is not visible during fluoroscopy. However, using 
intravascular ultrasound, the position and area of the endoprosthesis can 
clearly be visualized in vivo. 
Conclusion: In porcine peripheral arteries PETP polymer stents show good 
patency, wtthout a need for antithrombotic therapy. The extent of neointimal 
proliferation is limtted, with signs of a mild foreign body reaction. 
901·13 
Stenotic Disease of Saphenous Vein Coronary Artery 
Bypass Grafts Treated by Self-expanding Stents 
James Stewart, Miles Williams, Jean-Jacques Goy, Lin 
Denne, Nigel Buller, Anthony Rickards, Ulrich Sigwart. 
Royal Brompton National Heart and Lung Hospital,. 
London SW3 6NP, UK 
Dilatation of stenotic segments of saphenous vein coronary artery 
bypass grafts (CABGs) by conventional balloon angioplasty (PTCA) is 
associated with a high restenosis rate. which may be more than 60% 
for lesions involving the proximal graft segment. Intravascular stents 
may reduce restenosis rates in both native coronary arteries and 
CABGs. We have attempted implantation of 91 self-expanding stents 
into 66 CABGs in 58 patients (mean age 61 years) during 68 
separate procedures. Most patients received only 1 stent. but 17 
patients received 2 stents. and 8 patients received 3 stents. Stent 
diameter ranged from 3.5 to 6.0 (mean 4.7) mm and stent length 
from 15 to 30 (mean 24.2) mm. The majority of stents (62%) were 
implanted in the body of the graft, but 29% were implanted in the 
proximal segment, frequently involving the aortic enastamosis. In 
only 1 of the 68 procedures was there failure to deploy the stent, a 
procedural success rate of 98.5%, although implantation was difficult 
in a further 9 cases (13%). In-hospital occlusion of the atent requiring 
disobliteration occurred in 2 cases, with a wave infarction in 1. 
Bleeding from the femoral puncture site of sufficient severity to 
warrant transfusion with or without surgical repair occurred after 5 
procedures (7.5%). There was 1 in-hospital sudden death in an 
elderly patient with poor LV function, and 4 late deaths (> 3 
months), Autopsy of 2 of these 4 patients revealed stent patency. 
During long term follow up (mean 11 months) restenosis or occlusion 
was shown in 7 (11 %) of stented vessels in 7 patients (12.3%), with 
evidence of myocardial infarction in 1. Four patients (7%) have 
undergone repeat intervention (PTCA or CABG). The use of the self•
expanding stent increases the scope of nonsurgical treatment of 
diseased CABGs, with a much lower restenosis rate than PTCA. 
49A 
50A ABSTRACTS 
902 Pediatric Electrophysiology and Other Techniques 
Monday, April 13, 1992 
2:00 PM-5:00 PM 
Dallas Convention Center 
Lower Level Exhibit Hall 
Presentation Hour: 3:00 PM-4:00 PM 
902-1 
Edlocardiographic Demonstration or Clinical and SulKlinical Carditis 
in PatienlS With Acute Rheumatic Fever. 
Athol Morgan, Priscilla Morais, Janet Scheel, Donald Christian, Robert 
Gray, Doreen Millard, Thomas Traill. 
University Hospital of the West Indies, Mona, Jamaica and The Johns 
Hopkins University School of Medicine, Baltimore, Maryland. 
Pancarditis in acute rheumatic fever (ARP) may be more common than 
is apparent by clinical criteria. We studied 30 pIS with initial attacks of 
ARP (age 4-19, 12 male) by echocardiography and Doppler, and age- and 
sex-matched controls with other acute illness. PIS with ARF were divided 
into two groups, I: 18 pts with clinical carditis manifest by pan-systolic 
murmurs and ll: 12 pts with arthritis but no clinical carditis. In group I, 
LV end-diastolic and end-systolic dimension were increased compared to 
controls (LVEDD = 4.54 vs 3.76 cm.,p <0.0001; LVESD = 2.95 vs 
2.48 cm, p< 0.01), as were MV orifice size (MVO 4.07 vs 3.49 sq cm, 
p <0.02), chord length (14.3 vs 11.6mm, p<O.OI), MV annulus diameter 
(2.99 vs 2.54 cm, p < 0.005) and MV leaflet thicJrness (6.6 vs 5.1 mm, 
p < 0.01). 4 pts had pericardial effusions, all had MR, severe in 12, and 
14 bad AR. To test whether subclinical carditis exists in patients without 
clinical findings, we examined the same parameters in group II patients. All 
bad normal ECG and cardiac exam (including functional ejection murmurs 
in 83%). Doppler revealed mild MR in 50% (controls 10.0%, p<O.OS). 
LVEDD was similar to that of controls (3.98.±.0.59 vs 3.77.±.0.61), but 
L VESD dimension and fractional sbortening showed significant impairment 
of systolic function (2.73 vs 2.35 cm, p = 0.02, 31.6 vs 37.9%, 
p<0.002). Furthermore, increases in LVEDD, MVO, chord length, and 
annulus diameter in individual group II patients were not correlated with 
the presence or severity of MR. We conclude that the pancarditis of ARP, 
demonstrated by ecbocardiography, may otherwise escape clinical detecton. 
MR reflects changes in ventricular, annular and chordal dimensions as well 
as valvulitis. 
902·27 
IDc.idace l1li4 RisIt Factors of Ind"cible VatrlClUlar 
'l'acbyI::ardia After Atrial SWitch 
craig A. Greene, Olr.i.stq:iler L. case, David S. 8Jck.les, 
Paul C. Gillette. Medical university of SC, 
Cl1arlestal, SC 
'Dle an:hythmoqenic lIIEdlanism of late sudden death in 
postqlerative atrial switch patients is ocntrcversial. 
'Dle pJrpOSe of this stmy was to examine the incidence 
and risk factors of :intx:ible ventricular t.ac:nyc:ardia 
(Vl') after atrial switdl procedUres. 'lhirty patients 
(pta), 21 males and 9 females, had stamaxd ventricular 
stiJIulatioo protocols. Nineteen pta had sjnple 
transpositioo of the great arteries ('lQ.) and 11 pta 
had oatplex 'lQ.. FCAlrteen pta had MJstard procedUres 
and 16 had Sennin; procedures. 'Dleir ages at SUIgeIy 
ran;Jed fran 1 to 101 IIr:lI'Iths (median 9) and their ages 
at cath ~ed fran 12 to 306 IIr:lI'Iths (median 109). 
Fwr of the 30 pta (13.3%) had :intx:ible vr. 
Discriminate analysis of IIIlltiple variables Ioobidl 
1ncll.l\:!d ~cs, edlcXardiograpty, EJ<G, stress 
test, heoodynamic ani 24-hcur.EJ<G parameters was used 
to CX1IpU'e these 4 pta to the ral-:intx:ible grcup. 
In:lucibility of vr correlated well with decreased 
IIIOl:P'lologic right ventricular (RV) OCXltractility by 
subjective 2-dimensional edlcXardiogI'ilItly eva!UAtioo, 
and older age at catheterizatioo. 
Cl?Jlclusion: Older pta with diminished IN cootractility 
after atrial switdl procedUres may be at increased risk 
for develq>irg vr. 
902-28 
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Evaluation of Cardiac Injury following Radiofrequency 
Ablation in a Pediatric Population 
J. Edward Hulse, J. Philip Saul, Allison T.Weber, Valerie S. Mandell, 
Edward P. Walsh, Children's Hospital, Boston MA 
Early results in the use of radiofrequency ablation (RF A) for treatment of 
arrythmias suggest low patient morbidity and minimal cardiac damage. 
This rmding is particularly imponant in the pediatric population where 
the outcome of lesion production in growing, developing myocardium is 
unknown. To assess possible cardiac injury following RFA, we 
reviewed evaluations for direct myocardial injury, pericardial effusions, 
valvar damage, ventricular function, electrophysiologic (EP) 
abnonnalities, and coronary artery anatomy in 55 patients (ages 3 mos -
32 yrs) who have had a RFA procedure since March 7,1990. Direct 
myocardial injury was assessed by measurements of creatinine 
phosphokinase (CPK) and by cardiac magnetic resonance imaging 
(MRI). CPK measurements were perfonned prior to ablation (n=42 
cases, 10-85 IU), immediately post-ablation (n=55, 10-481 IU), and at 
12 hours post-ablation (n=35, 10-3788 IU). Fractionated CPK·MB 
values post-ablation ranged from 0-63 IV, or 0%-26% (n=20) of total 
CPK. Post-ablation MRI scans have revealed small discreet areas of 
increased signal after gadolinium-DPT A enhancement in the area 
cOJTesponding to the site of ablation in 6 of 9 patients. Post-ablation EP 
(n=30) and surface ECG (n=55) studies (intracardiac, esophageal, ECG, 
and Holter) have shown no significant new rhythm disturbances and no 
significant ectopy except in 1 patient who had transient brief unifocal 
ventricular ectopy which resolved over several weeks. Coronary artery 
anatomy has been evaluated by angiography in 11 patients post-ablation 
with no abnonnalities found. Echocardiographic evaluations (n=35) 
showed no significant new abnonnalities. Using multiple techniques to 
assess cardiac damage, follow-up of up to 18 months duration sugests 
that RF A has minimal untoward effects in pediatric patients. 
902-29 
Late Eleetropbysiologic Interactions or RV Systolic Pressure and 
Pulmonary Insufficiency Following Right Ventriculotomy 
Jeffrey P. Moak, O'Brien Smith, Arthur Garson, Jr. 
Texas Children'S Hospital, Houston, Texas 
The contribution of elevated riJilit ventricular systolic pressure 
(RVH) and pulmonary insufficiency (PI) to sudden death 
followmg tetralogy of Fallot repair has been controversial. We 
assessed the chronic electrophysiologic (EP) sequelae of RVH 
and PI sin~y, and in combination. Five groups of dogs (21 total) 
were studIed: Gr I control dogs wlo (.) surgery (4); Gr 1/ 
ventriculotomy (Vent) healed - RVH, and - PI (4); Gr III Vent 
healed - RVH, and w (+) PI (5); Gr WVent healed + RVH, and 
-PI (4); and Gr V Vent healed + RVH, and + PI (4). Grps II· V 
had a P A to LA shunt and P A banding perfonned at age 2 mo; 
Vent on cardiopulmonary bypass at age 12 mo; signal·averaged 
(SA) ECG ~;~~h! Gr 4), and microelectrode study (MES) 21 mo 
after Vent. : 1) Total SA QRS duration was longer in + PI 
dogs (Gr III = 92.±. 22 vs Gr II = 69.±. 4 msec, p<0.05). 2) RMS 
40 volta2e was lower in the + PI dogs (Gr III = 102.±. 59 vs Gr II 
= 225 3:. 59 microvolts). 3) MES revealed maximum diastolic 
potential less depolarized (dr II -86 ± 1 mY) when Vent healed 
-RVH -PI than + RVH -PI (Gr V -83 ±1 mV), p<0.05. No 
difference between RV systolic pressure p-oups was evident when 
PI was present. 4) Action potential duratIon (APD) 50 was longer 
in the Vent region when healed w PI (+ PI 146.±. 9 vs - PI 129.±. 
13 msec, p < 0.05). 5) The effects of R VH and PIon APD 90 were 
specific to different regions within the RV. RVH prolonged APD 
90 in the outflow septum, independently of PI. PI prolonged APD 
90 in the Vent region, :~~~ed~dently of RVH (201 .±. 9 vs 185 ± 
11 msec, p<0.05). We that the late EP sequelae of Vent 
produced during RVH is dependent on the level of post repair 
RV systolic pressure and presence of PI. Each contributes 
differently to chronic abnonnalities in conduction and 
refractoriness that could result in late reentrant ventricular 
arrhythmias. 
JACC Vol. 19, No.3 
March 1, 1992:51A 
902·30 
CUdioillhil>itory 8yIICCp8 in IJIfaDta U4 adldrlm -
A Potentially JIali9MDt Disorder? 
Paul. OSlizlok, Mary Allen, MictJael Griffin, Paul C. 
GUlette. Medical university of SC, Olarlestal, SC 
Neurally-mediated synoc:pI (S) is bein} recognize;i 
in::reasin}ly in chlldren. M:lst sho.rI a vaso-depressor 
or mixed response. A daninant caxdioinhibitory response 
(~) is UlICCI1IID'l in chlldren. '1his suny reports al the 
pn!Valenoe, clinical features, management, ani QJt.oane 
of pts with caxdioinhibitory syncope seen aver a 5 year 
pericxi at our syncope service. 1/197 cxmecutive pts 
(3\), 4f, 2m, had a daninant~. Mean age at alSet of 
synptans was 7.2 yrs (0.2-15yrs). Mean age at c:liag!Xlsis 
was 10.1 yrs (1.5-21yrs). All bJt 1pt (s/p Senni.rr;J for 
'lQ., VSD) had normal hearts ani normal Ems. PreviCllS 
diagnoses included: breath ooldiD} (2 pts), seizure 
disorder (3 pts), unknown caxdiac etiology (1 pt). 3/6 
pts had been treated with anti-ocnvulsants. 3/6 pts 
had received CPR ani 5/6 pts had seizures durin} s. 
Autcn:lnic evaluatial was performed in 5/6 pts. on 
orthostatic ~, eaen pt had a sOOden ooset of 
asystole (8 - 28 sees), withalt a prior vasodepressor 
oarp:umt. S followed in each, ani 4/5 pts had a brief 
seizure. '!be 6th pt (aged 18 months) had recurrent 
asystole for >20 sees al Holter m:nitor, associated 
with S. 5/6 pts undertIent pacemaker (Rot) ilrplantation 
(4 lXD, 1 WI). 1 pt is treated medically. 2/5 1M pts 
had :reo.n-renoe of S wen resolved with fludrocortisone 
an:i salt. 1 of these (sip Senni.rr;J) died suddenly 1 year 
after stq:pin} fludrocortisone with normal 1M fUr¥::tial. 
CloDclUsions: 1) Isolated caxdioinhibitory synoope is an 
\llUIS\lal ani potentially malignant cause of recurrent S 
in infants ani chlldren. 2) cardioinhibitory synoope 
is frequently misdiagnosed at this age. 3) 1M +/•
medical therapy may be effective where Wicated. 
902·31 
Prolonged QT Interval In Hypertrophic and Dilated 
Cardiomyopathy In Children 
AmeetaB. Martin,JamesC. Peny,ArthurGarson,Jr., Texas Children's 
Hospital, Houston, TX 
ttisassumedthalproiongaiionofthecorrectedOTinterval(OTc)canbe 
attributed to wntrioJlar hypertrophy andIor dlation alone. The purpose 
of this study was to test thai assumption by analysis of the surface 
electrocardiograms (ECGs) in children with an echocardiographically 
proven spectrum of ventricular hypertrophyldilation. Two independent 
observers analyzed the (ECGs) of 25 children in each of 6 groups: right 
ventricular hypertrophy (RVH), left ventricular hypertrophy (LVH), 
biventricular hypertrophy (BVH), hypertrophic cardomyopathy (HCM), 
dilaled cardiomyopathy (oeM) and normals (NL). All patienlS had QRS 
durations ~1 00 msec and patienlS with wntriculotomies were exduded. 
No patienlS in the NLgrouphadaOTc~O.45sec. 8125 (32%) patienlS 
with DCM had a OTc ~ 0.45s (p=O.OO7), 6/25 (24%) pis with HCM had 
aOTc~0.45s(p=O.03)and2l25p1SeachwithRVH,LVHandBVHhad 
a OTc~ 0.45s (P=NS). There was no relation of the OTcto age, ORS 
duration,Taxis,orHRinanygroup. Twaveswerenotedtobeflattened 
in 518 DCMpatients v.ith long OTand 11/17 DCM patienlS v.ith normal 
OTc. In the DCM group, there was no relationship of OTc to age, 
shortening fraction, or left ventricular end dastolic drnension. 
CONCLUSIONS: (1) A signiflcant number of patients (24-32%) with 
dilated or hypertrophiccardomyopathy may have along OTcintervai on 
the surface ECG, (2) Prolongation of repolarization (QTc ~ 0.45s) in 
patients with hypertrophy may ocx:ur oa:asionally despite normal QRS 
duration, and (3) Diffuse flattening of Twavesisfrequentlyseen in dilated 
cardiomyopathy patienlS. 
ABSTRACfS 
902·32 
lJIdUcible ventricular Tllchyaardia UI4 I'ihriUaticm ill 
~trio Patients with WOlff-l'arki.zIIIoD-White 
Matt Wienecke, Qlristqher case, David ax:kl.es, Paul 
GUlette. SC Olil.dren's Heart center, Charlestal sc 
To evaluate factors related to ventricular arrl1ythmia 
(VTfVF) in:hx:ibUity durin} invasive electrq:hysiology 
studies (EPS) of pediatric pts with WOlff-ParItinsa1-
ltlite (wpw), the ec:ilocardiograpuc ani electrq:hysio•
logic data of 25 manifest WPW pediatric pts with 
st:ruct:urally normal hearts were examined (19 males; 6 
fElllilles ran;Jin} in age fraD 48-246 1IIalths; median 170). 
ventricular stiDulatial included \bibles into paced 
right ventricular rt\ytl1m and/or 8 beat ventricular 
blrsts at rest and/or durin} iscproterenol infusial. 
Fourteen episodes of vrfVF, defined as three 
OCIlSeCUtive beats or greater of ventricular ectqIy, 
were in:iuoed in 9/25 (36\) pts. 'lhirteen of 14 
episodes were in:iuoed at rest while 1/14 required 
iscproterenol infusial. vrfVF cycle lergt:h ran;JE!d fraD 
150-250 DIS (mean 180 +/- 31). vrfVF was sustained in 
3/14 episodes. '!be duration of rnl-SUStained vrfVF 
ranged fran 3-7 beats (mean 4.5 +/- 1.3). pta with 
in:hx:ible vrfVF temed to be older (161-246 months; 
median 186) than these non-irducible (48-219; median 
150). Seven of 9 (78%) pts with in:hx:ible vrfVF had 
elevated left ventricular em diastolic diameters 
c:arpared to 7/16 (44\) Who were nat in:hx:ible. '!here 
was IX) ~ correlatial between iniucibUity an:i 
effective refractory pericxi of the aooessory pathway, 
shortest R to R durin} atrial flutter/fibrUlation, 
ventricular refractory pericxi, presence of DJJl.tiple 
aooessory oonnectiCll'lS or edlocardiograpucally 
determined left ventricular shortening fractiCll'lS. 
o:mclusion: :rmucible vrfVF in pediatric pts with WPW 
is nat an \lIXX1lIIDI1 ooc:urrence arx1 ten:1s to be seen IrOre 
frequently in older pts with dilated left ventricles. 
902·33 
TraJIsYeDous rQ) PtICiDq in the First DaoII4e of Life 
Paul C. GUlette, Vicki L. Zeigler, Qlristqher L. 
case, 1tIJrj W. O'O:::nlor. Medical university of SC, 
Olarlestal, SC 
'l'ransveJnIs dual c:tlaDtler pacin} is the preferred·m:xle 
of pacin} adults am older chlldren because of ilIproved 
survival ani lower incidence of atrial dysrllythmias. 
It has been uroer utilized in ya.1n:1er patients. We 
iJIplanted transveInlS dual c:ilaDiler pacemakers in 24 
chlldren 22 months to 119 months, mean 75.3. 'lbeir 
weight ranged fran 9.2 to 43.0 kg, mean 21.0 kg. '!beir 
diagooses were 7 cxn;JE!Ilital calplete AV block, 14 
surgical AV block, 1 ather acxpired AV block an:i 2 
siralS lXlde dysfUr¥::tion. Eaen pacin} system was 
inplanted via the subclavian vein. 'l\ienty-three were 
bipolar an:i 1 unipolar. 'lWenty-two were .1lJpl.anted in a 
suI:pectoral pocket. '!be pacemaker ranged in weight 
fran 25 to 53 grams. FollOii up ranged fran 1 to 71 
months, mean 34.3. At the most recent fOllOii up 20 of 
21 survivin} patients were in a dual dlarrloer m:xle. 
Five had had recp!ra.tion. 'lhree had died. Recperatial 
oocurred 4 to 69 months, mean 34.8, median 37 months 
after the initial ilrplant. '!be recp!ra.tiCll'lS were for 
battery depletion, atrial lead migration, SHE, ani 
ventricular lead carductor fracture. 'l'ransVeInls dual 
chaItiJered pacin} is safe an:i effect in dlildren aver 9 
kg. 
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902·34 
EFFECTS OF DIFFERENT MODES OF VENTILATION ON 
DIASTOLIC FILLING AFTER ARTERIAL SWITCH OPERATION 
Ion N. Meliones. A. Rebecca Snider. Mary K. Dekeon. Keith C. 
Kocis. Edward L. Bove. FIavian M. Lupinetti. University of 
Michigan. Ann Arbor. MI 
To determine the effects of the different modes of 
mechanical ventilation on ventricular diastolic filling of 
infants who have had the arterial switch operation. 10 
infants were examined with Doppler echocardiography less 
than 24 hrs after surgery. Pulsed Doppler recordings of the 
MV and TV were obtained initially on conventional 
mechanical ventilation (CMV) and then on high-frequency 
jet ventilation (HFIV). A pressure transducer was placed in 
line with the ventilator. and the respiratory cycle was 
recorded superimposed on the Doppler tracing. Doppler 
recordings were obtained from the apical 4-chamber view 
and the following measurements were made: peak E and peak 
A velocities. E/A ratio. and deceleration time. Compared to 
the expiratory phase of CMV. the inspiratory phase of CMV 
resulted in a reduction in TV peak E (.61 ± .08 vs .45 ± .05 
m/s) and peak A (.63 ± .09 vs .37 ± .06 m/s) velocities. an 
increase in MV peak E (.53 ± .06 vs .64 ± .08 m/s) and peak A 
(.47 ± .07 vs .60 ± .09 m/s) velocities. and no change in MV 
or TV deceleration times (p<.OI). Compared to the inspiratory 
phase of CMV. non-phasic HFJV resulted in increased TV 
peak E (.4S ± .OS vs .S8 ± .06 m/s) and peak A (.3 7 ± .06 vs .SS 
± .07 m/s) velocities. decreased MV peak E (.64 ± .08 vs .54 ± 
.06 m/s) and peak A (.60 ± .09 vs .S4 ± .06 m/s) velocities. and 
no difference in deceleration times (p<.OI). No differences in 
the Doppler filling indexes were found between the 
expiratory phase of CMV and HFJV. Thus, HFJV appears to 
augment right heart filling; whereas. CMV augments left 
heart filling. These observations should be helpful in the 
selection of the mode of ventilation in infants post-op 
arterial switch repair. 
902·35 
Intraluminal Ultrasound Imaging Through a Balloon Dilation Catheter in 
an Animal Model of Coarctation of the Aorta 
Fram;ois Ricou. Abraham Rothman. Robert Weintraub. Robert Crowley. 
Robert Archangeli, Takahiro Shiota, Jun Zhang, David J. Sahn. Univ Cald. 
San Diego. CA. and Boston Scientific Corp .. Boston. MA. 
Controversy still exists about balloon dilation therapy for native coarctation. 
Intravascular ultrasound (IVUS) imaging in coronary artery disease has 
yielded Insights into the anatomy of coronary atherosclerotic disease and 
may help guide interventional therapy. Our inttial IVUS observations after 
balloon dilation of coarctation in children have shown prominent dissec· 
tions often associated wtth only minimal angiographic changes and these 
may be the precursors of pseudo-aneurysm formation. We tested a newly 
developed over-the-wire transballoon IVUS imaging system capable of on•
line visualization of vessel lumen and wall structure before. during and after 
balloon inflation. The 6.3 French catheters with 7 mm polyethylene dilating 
balloons were advanced into the femoral artery through a 9 French sheath 
in three, 19-24kg mongrel dogs. anesthetized with pentobarbital in whom 
acute obstruction (> 70%) of the descending aorta was created with I/B" 
strips of teflon gauze cross-sewn wtth 6-0 gauge suture material. The 
ultrasound scanning crystal (20 MHz) rotated in a window at the center of 
the 4cm long balloon. Once the balloon was minimally inflated with dilute 
radiographic contrast material. the balloon cross-section. lumen and wall 
structure of the aorta could be visualized during dilation of the experimental 
discrete obstructions (5-8 in each dog) and for dilating "coarctation" 
segments of aorta with additional induced spasm. Effects of dilation and 
damage induced by multiple crossings of the obstructions with balloons 
and guidewires allowed us to demonstrate by IVUS and later verify patho•
logically, aortic changes including intimal tears and flaps. mural dissection. 
as well as thrombus formation in dissections and around the introducing 
sheath. This technology can be used to guide balloon dilations in a step•
wise fashion such that minimal deflation after graded inflations can show 
the operator the results of dilation and effects of recoil or vessel damage 
wtthout the need for intervening angiography or catheter changes. This 
should be a major step forward in the application of IVUS scanning to 
catheter therapy for congenital heart disease. 
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In Vitro Effect of Vessel Size on Volume Flow From Power 
Weighted Mean Velocities 
L. LuAnn Minich. A. Rebecca Snider. Roger P. Vermilion. Christa 
Yanock. University of Michigan. Ann Arbor. MI 
Volume flow Is related to the power of the backscattered Doppler 
signals. To determine if volume flow calculated from power weighted 
mean velocities (PWMV) Is accurate over a range of arterial sizes 
and under parabolic flow conditions. volume flows were measured in 
a pulsatile flow tank system equipped with a simulated femoral 
artery. USing pulsed Doppler, volume flow was evaluated in 3 
different diameter arteries (.65. .95, 1.25 cm) at sampling 
distances of 20 times the vessel diameter downstream from the 
orifice where parabolic flow would be expected to occur. Sample 
volumes were adjusted to Interrogate the entire vessel diameter. 
Parabolic flow was verified by determining the ratio of mean/peak 
(mn/pk) velocity. Analyses were performed at a pulse rate of 60. 
flow rates of 0.5-3.0 Vmin. and mean driving pressures of 60·100 
mmHg (total runs. 88). PWMV was calculated as the sum of the 
Individual velocities multiplied by their power fractions (the 
fraction of the total instantaneous power represented by the 
individual Signal power). The instantaneous PWMV was plotted 
continuously in time superimposed on the spectral Doppler. 
integrated over the flow period. and multiplied by the known flow 
area to obtain the Doppler volume. PWMV volume was compared to 
volume flow measured with an electromagnetic flow probe: 
.65 cm 
.95 cm 
1.25 cm 
1.00 
.99 
99 
SEE 
.01 
.02 
02 
slope 
.98 
.92 
1 19 
Intercept 
.05 
.14 
16 
mn/pk vel 
.74±.03 
.7B±.04 
74+ 04 
Thus. over a wide range of vessel diameters and hemodynamic 
conditions. PWMV data provides an accurate. automatic technique for 
on-line determination of volume flow. 
902·37 
Magnetic Resonance Imaging of Constant Total Heart 
Volume and Center of Mass in Patients with Functional 
Single Ventricle Prior to and After Staged Fontan Procedure 
Mork A. Fogel. PDIIl M. Weinberg. KefWlh E. Fellows. Eric A. Ho/fmtm 
University of PeNISYIvania Sc/rbOl of MtdiciM. PhilOlklphia. PA 
It has been hypothesized dIat for maximum effIciency. the bean should expend 
minimum energy in mainlaining a constant inllacycle rota! bean volume ('IlIV) 
or center of mass (COM). We studied 25 pts (I week-9 years old) with 
functional single ventricles (SV) by ECG gated. multiphase. muJtislice. spin•
echo and cine magnetic resonance imaging 10 determine whether the hearts 
maintained a consrant THV and COM throughout the cardiac cycle. Volume 
was calculated by summing the 8lIl8S of the bean on each slice multiplied by its 
thickness for 7-8 equally spaced time points obtained over the cardiac cycle. 
referenced by the R wave on ECG. THV variation was measured as a percent 
change from maximum THV. COM of the THV was calculated by weighting 
the centroids of the bean slices by their 8lIl8S divided by THV. Measurement of 
displacement in the antero-posterior. supero-inferior and lateral directions 
(indexed 10 the maximum THV) was perfonned using 2 dimensional 
lnIIIfonnalion. The results are SUIIIIJlari7.ed in the l8b1e below: 
Displacement in mmftiter 
pi surgical no. THV anrero- supero- IaImI 
status of PIS variation It>OSterior inferior 
Pre hemiFonran 10 5.1±2.9% 1.1±4.4 1.2304.6 5.6±21.7 
Post hemiFonran 8 3.6±1.6% 1.3±1.3 1.3±2.5 8.m.8 
Post Fonran 7 8.2307.7% 0.4±3.4 1.5±5.9 0.5±8.0 
No Significant difference was seen m THV vanallon (P=NS) between surgical 
subgroups. however. 5/7 post FonWi. 1/8 post hemiFonWi and 4/10 pre 
hemiFonran pts were found 10 have THV vary by >5%. The one post 
hemiFonran pi whose THV varied by >S% subsequently died. The maximum 
THV variation was 25% seen in a post Fonran pt. 
Conclusion: Preliminary results indicate that SV pIS maintain a consWit 
COM throughout the cardiac cycle although THV variation is observed 10 occur 
more in post Fonran PIS and 10 a lesser degree. in pre hemiFontanS. The post 
hemiFonrans had the smallest THV variation. Long term pump efficiency may 
be dependent on the invariance of the THV and COM relationships It will be of 
great interest 10 evaluate how these panuneten of cardiac effIciency serve as a 
predictor of long tmn pump function. 
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903·38 
The Value Of Tran.oesophageal Echocardlography Belore And After Mitral 
Balloon Valvotomy 
Dylmttr Rittoo, George R Suthertand, Peter Currie, Ian R Starkey, Thomas RD 
Shaw. Western General Hospttal, Edinburgh, UK. 
The aim of this study was to determine whether transoesophageal 
echocardlography (TEE) provided important new information on patients 
undergoing percutaneous mttral balloon valvotomy (PMBV), that could not be 
obtained praecordlally. Thiny three consecutive patients (age 14-82 years) 
were studied prospectively wtth both praecordial and biplane transoesophageal 
imaging, combined wtth Doppler coiour flow mapping (CFM), immediately prior 
to PMBV and 24 hours afterwards. Mttral valve leaflet morphoiogy, the 
subvalvar apparatus, the severtty of mttral regurgttation (MR) and presence of 
atrial thrombus were specifically examined for In detail. Satisfactory images 
were obtained In 25 patients praecordlally and In all patients by TEE. Anterior 
valve leaflet morphoiogy could be assessed equally well by both techniques, 
but the posterior leaflet was far batter visualised by TEE. The longttudinal 
transgastric view of the left ventricle (which usually provides excellent 
Visualisation of the chordae and papillary muscles) gave no new Information 
In this patient group; satisfactory images could only obtained In 18/30 patients 
compared to 25/25 patients praecordlally. Netther the valve orifice nor the 
degree of commissural fusion could be adequately assessed by biplane TEE. 
This was best achieved by scanning In the praecordlal parasternal shon axis 
view. Before PMBV, no patient had more than mild mttral regurgitation as 
judged by clinical, spectral doppler or CFM findings. CFM findings by the two 
techniques were concordant In all patients. After PMBV, 3 patients developed 
severe MR. In 2 of these pts, the MR jet could not be visualised by praecordial 
CFM but was readily detected by TEE. Only TEE correctly diagnosed the 
leaflet tear In 2 of these 3 pts. Atrial thrombus was identified In 6 patients 
during the pre PMBV study and was diagnosed by TEE only. Two of these 
patients had small thrombi In the left atrial appendage and 4 had extensive 
laminated thrombus on either the superior wall (3) or the posterior wall (1) of 
the left atrium. The latter 4 patients did not undergo PMBV as a result of the 
TEE studies. 
In conclusion, TEE Is neccessary for all patients for whom PMBV is planned 
because of tts superior abiltty to detect atrial thrombus. In our experience, 
however, it added little new Information of clinical value on valve morphology 
prior to PMBV when compared to praecordlal studies. After PMBV, its main 
value lies In assessing acute complications, In panicular the development of 
mitral regurgttation and tts underlying aetiology. 
903·39 
Percutaneous Transseptal Introduction of Left Atrial 
Cannula for Left Heart Bypass Usefulness of 
Biplane Transesophageal Echo Guidance. 
Shunei Kyo, Takeshi Motoyama, Naomasa Miyamoto, Yutaka 
Dohi, Ryozo Omoto. Saitama Heart Institute, Saitama 
Medical School, Saitama, Japan 
For quick and safe percutaneous trans septal 
introduction of LA cannula for LA-aortic bypass (LAB) 
support, a transseptal puncture was performed on 5 
patients (male:female=4:I, mean age c 56.4±7.6) with 
biplane transesophageal echo (B-TEE) guidance with (3 
pts) or without (2 pts) concomitant X-ray monitoring. 
LAB support was prepared for 2 patients as a support 
for coronary angioplasty, for 3 patients as an assist 
of cardio-pulmonary resuscitation. The entire image of 
Brockenbrough needle including needle tip was clearly 
observed in RA by longitudinal image of B-TEE in all 
patients (100%), however, only in two patients (40%) by 
transverse image of B-TEE. After transseptal puncture a 
Mullin's sheath (7 Fr.) and a dilator (14 Fr.) were 
inserted into LA in order and finally a new heparin 
coated LA cannula (18 Fr.) designed by us was 
introduced into LA without any difficulty in 4 
patients, but failed in one patient because of 
calcified interatrial septum. With contrast tnJection 
the tip of the LA cannula was clearly confirmed in LA 
cavity by B-TEE. LAB support was performed for average 
29.5 hours (29 minutes - 96 hours) with 2.5 - 2.9 
L/min. of bypass flow. 3 patients were successfully 
separated from LAB support and survived. In conclusion, 
with B-TEE guidance the Brockenbrough transseptal 
puncture and introduction of LA cannula into LA can be 
performed easily even without X-ray monitoring. Thus, 
percutaneous LAB can be set-up quickly and safely even 
in the intensive care unit or in the outpatient 
emergency room without X-Ray arrangements. 
ABSTRACTS 
903·40 
BIPLANE TRANSOESOPHAGEAL ECHOCARDIOGRAPHIC IMAGING OF 
CONGENITAL HEART DISEASE 
Ge.orge R. Suthertand, Plo Ceso. Piotr Hoffman, Kaj Groundstroem, Oliver 
Stumper. Depanment of Cerdloiogy. Edinburgh, UK. 
To deter!'line to what e~ent transoesophageallmaging (TEE) in the longitudinal 
plane might confer addttlonal advantages over transverse plane imaging In the 
evaluati?n of patients with etther simple or complex congenital hean disease, 
we carned out a prospective study In 54 consecutive patients (37 adults 17 
children) with such a lesion. Of the 54 biplane transoesophageal studies: 38 
were preoperative diagnostic studies and 16 studies were carried out in the late 
postoperative period. 19 studies were parformed under general anaesthesia 
(18 during concomttant cardiac catheterisatlon). All the transoesophageal 
ultrasound diagnoses were subsequently confirmed at etther catheterisation or 
surgery. L7sions studied Included 22 atrial septal defects (16 secundum, 2 
prlmum, 1 sinus venosus, 1 coronary sinus. 2 postpatch closure). 5 atrial septal 
aneurysms, 3 iSoiated ventricular septal defects, 3 Tetralogy of Fallot, 4 d-TGA, 
4 !-TGA, 4 unlventricular atrioventricular connections. 4 Bonlc coarctatlons. 5 
miscellaneous complex lesions. 
Anomali~s better defined by long axis (vs transverse) scanning Included a) 
Left superior vena cava (2/2), b) caval obstruction (1/1). c) atrial septal 
morphology (19/22), d) atrioventricular valve morphoiogy and function (12/15) 
e) c~mplex right ventricular outflow tract obstruction (2/2). f) complex left 
ventricular outflow tract obstruction (3/3), g) abnormal aonic valve morphology 
(3/3), h) abnormal ascending and descending aonic morphology (5/6). 
Lesions poorly characterized by longttudinal scans were a) sinus venosus 
defects (1/1): b) prlmum atrial septal defect (2/2), c) trabecular VSD (1/1). 
In conclUSion, transverse plane TEE scanning alone provided the correct 
overall morphologic and haemodynamic diagnosis in 76% of cases studied. 
Howe~er, although the overall diagnostic accuracy of longttudinal plane 
scanning alone was only 68%, the combination of longitudinal and transverse 
plane scanning gave the correct diagnosis in 96% of patients. Thus both 
planes are required for the optimal study of congenttal heen lesions. 
903·41 
Doppler Assessment of Right Ventricular Outflow 
Impedance During PositiVe Pressure Ventilation 
Jan Poelaert, Jan Everaert, Johan Decruyenaere, Francis 
Colardyn. Dep.Int.Care, Univ. Hospital Ghent, Belgium. 
Using transesophageal echocardiography and pulsed 
Doppler, we examined the effects of incremental in•
crease of positive end-expiratory pressure (PEEP) -
steps of 5 till 20 cm H20 - on right ventricular (RV) 
systolic ejection flow. Studies were performed within 
6 h after coronary artery bypass grafting (CABG) in 9 
normoventilated patients. RV fractional area contraction 
(FAC) and end-inspiratory (I) pulmonary artery flow (TVI) 
were determined; 2 time intervals were measured: RV pre•
ejection period (PEP) and RV ejection period (EP). On 3 
consecutive cardiac cycles PEP/EP was calculated. 
Results 
PEEP TV! (cm) PEP/EP (I) RVFAC (%) 
0 49 + 19 .22 + .08 42 + 14 
5 40:;: 17 .21 :;: .08 39:;: 9 
10 40:;: 13 .23 :;: .09 42 :;: 12 
15 41 :;: 28 .25 :;: .06* 39 :;: 12 
20 36 :;: 17* .25 :;: .02* 38:;: 4 
0 50 :;: 18 .21 :!: .06 43 :!: 11 
* P < 0.05 in relation to 0 cm H2O PEEP. 
Conclusions 
Whereas the decrease of TVI is the expression of the 
diminished cardiac output during high PEEP-ventilation, 
PEP/EP rather demonstrates the increase in RV outflow 
impedance: PEP is prolonged in combination with a 
shortened ejection time. 
Decrease of TVI is not caused by RV dysfunction as RV 
FAC did not alter. 
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903·42 
Is Prophylaxis for Infective Endocarditis Really 
Necessary During Transesophsgeal Echocardiography in 
Patients with Prosthetic Valves? 
Rami Gal, University of Wisconsin Medicsl School, 
Milwaukee, Wisconsin 
The current guidelines for transesophageal 
echocardiography (TEE) in pts with prosthetic valves 
include antibiotic prophylaxis for infective 
endocarditis. However, a direct correlation between 
perforuing the procedure without antibiotic coverage 
and subsequent infective endocarditis has never been 
proven. A prospective study included 72 pts age 
57±9 years with 77 prosthetic valves. Sixty-seven 
pta had I prosthetic valve and 5 pts had 2 
prosthetic valves. The pts had 34 biologic valves 
and 43 mechanical valves. Fifty-two valves were in 
the mitral position and 25 in the aortic position. 
Indications for TEE were: follow-up valvular disease 
(35), rule out significant regurgitation (19) and 
source of emboli (18). An average of 11±2 days and 
24±3 days after TEE without antibiotic prophylaxis 
for infective endocarditis, every pt had his 
temperature measured 3 times a day for 2 consecutive 
days and 2 blood cultures were drawn. Sixty-seven 
pts had normal temperature measurements and negative 
cultures. Two pts had 1 positive culture each 
(Staph aureus and Staph epidermidis, respectively), 
and 3 other pts had 1 temperature reading above 
99 0 F. These 5 pts had another set of cultures 
and temperature measurements within a week that were 
negative. 
Thus the likelihood of infective endocarditis in 
pts with prosthetic valves following TEE without 
antibiotic prophylaxis is extremely low. 
903·67 
Relative Contributions of Longitudinal Plane and of Biplane Transeso•
phageal Imaging In Congenital Heart Repairs In Infants and Children 
Paulo Golebiovskl, David J. Sahn, Shunei Kyo, Ryozo Omoto, Mark 
Mttchell, William Mazzei, Stuart Jamieson. Unlv of Calif, San Diego, CA. 
We evaluated the impact of the addnion of longitudinal plane imaging 
and/or biplane TEE for the study of CHD during intraoperative TEE studies 
on 46 infants (weighing 3. t to 7.5Kg) studied with a new 6.Bmm, 40-ele· 
ment high resolution longitudinal plane probe or a new infant biplane probe 
wtth 2B elements for each plane and 15 older children (weighing 10 to 25.2 
Kg) studied with adult biplane probes. Observations available Q!1& on the 
longitudinal plane view included actual visualization of the Fontan and 
cavopulmonary connections in 5 pts, definition of isolated anomalous 
connections of the right pulmonary veins in 5 pts, imaging coarctation 
repair In 4, and imaging of the entire RV outflow tract from the subvalve 
area to the PA bnurcation in 9 pts, (3 undergoing banding, 6 during repair 
of tetralogy or truncus arteriOSUS). The longitudinal plane was also best for 
visualizing perimembranous VSD'S or patch leaks in 23 pts providing a 
view perpendicular to the edges of the VSD and more parallel to flow than 
the transverse view. This was especially true for sub-aortic defects and 
those extending anteriorly towards the right ventricular outflow tract. 
Biplane visualization was most ~ for sizing ASD's, defining the anat· 
omy of complex forms of LV outflow tract obstruction, defining Senning 
baffle obstructions (2) and comprehensively evaluating AV valve regurgi· 
tation when It differed between planes. While the new Infant biplane 
probes have limitations In the number of elements, the availability of 
biplane visualization provides for a comprehensive Intraoperative examlna· 
tion with Image quality very adequate for decision making. 
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An Improved Method to Calculate Regurgitant Volume Using the Proximal 
Flow Convergence Method Applied to Digital Color M-Mode Data: In•
Vitro Studies USing Color Doppler 
Robin Shandas, Bjl1lrn Angelsen, David J. Sahn. Unlv of Calif, San Diego and 
Unlv of Trondhelm, Norway. 
General application of the hemispherical proximal flow convergence method 
to calculate regurgitant flow rate using only one Isoveloclty, the color aliaSing 
IImtt, has been hampered due to the limned range of Nyquist limits available 
clinically on most Instruments, problems of Interobserver variability for the 
short distance measurements, as well as the lack of general hemispherical 
symmetry of the isoveloclty contours over the entire acceleration flow field. 
We have developed a computer implemented algorithm which overcomes 
these problems by utilizing the continuous acceleration flow field digital 
velocity data directly transferred Into the computer from the output of the 
ultrasound system's digital scan converter. The algorithm uses digital color 
M·mode velocities from the flow region proximal to an orifice and calculates 
a veloctty gradient function to determine the distances from the ornlce to any 
number of velocity thresholdS. The algorithm uses the continuous velocity 
stream to unwrap aliasing. Flow volumes obtained by integration over the 
ejection period for each Isovelocity are then cross-correlated against each 
other for greater accuracy and then against Navler·Stokes models of velocity· 
distance relationship for various orHlce geometries at various flow rates. For 
this study we used a VingMed 750 ultrasound scanning system to test the 
computerized algorithm In an in·vltro setting using a variety of ornlce shapes 
(flat, "prolapse" shaped, 3-D concave) and ornlce diameters (0.4 em . 1.5 cm) 
with pulsatile flow simulated by a heart model providing flow volumes from 5 
cc to 42 cc. The in-vitro results showed excellent agreement between actual 
and calculated volumes (y = 096 x + 1.6 cc; r = 0.90, SEE = 5.4 cc) for all 
geometries. This new method also overcomes the problem of visually 
selecting the location of the orifice when color M-mode Is used for flow rate 
calculation since the "vena contracta" is tracked by velocity. This in 
combination with an automatically Implemented time integrated volume 
calculation based on the whole sequence of direct digital velocity data makes 
this method a promising advance for aiding clinical applications of the flow 
convergence concept. 
903·69 
Transesophageal Pacing Echocardiography for Identification of 
Patients With Restenosis After Percutaneous Transluminal Coro•
nary Angioplasty 
Rainer Hoffmann, 'Eduard Kleinhans, Michael Bexten, Frank A 
Flachskampf, 'Udalrich Buell, Peter Hanrath, Medical Clinic I, 
Dept. Nuclear Medicine', Klinikum RWIH Aachen, FRG 
Noninvasive documentation of significant restenosis after success•
ful PICA remains a problem. Thus, transesophageal pacing echo•
cardiography with simultaneous maximal atnal pacing (heart rate 
139±9 nun-l) via the same probe (TPE), was used in 50 consecuti•
ve patients (pts) for detection of restenosis after PICA (47 pts 
with 1- and 3 pts with multivessel PICA). Residual luminal area 
stenosis immediately after PICA was 46± 16%. At control angio•
graphy, 4.4±2.5 months after PICA hemodynamically significant 
restenosis or new stenosis in previously normal vessels (luminal 
area narrowing > 70% or loss of at least 50% of initial PICA 
luminal area gain) was demonstrated in 14 pts and 3 pts, respecti•
vely. Detection of significant restenosis and disease progression b'y 
TPE was compared to exercise-ECG and 99mTC MIBI-radionuch•
de perfusion imaging. 
Maximal bicycle exercise ECG could be performed in only 40 pts 
due to peripheral vascular or joint disease. TPE was non-diagno•
stic in 3 pts due to pacing inability or discomfort of the pt. 
Sensitivity 
Specificity 
Exercise-ECG 99mTc MIBI TPE 
72% 82% 84% 
50% 80% 87% 
Conclusion: TPE compares favorably to 99mTc-MIBI and is supe•
rior to exercise-ECG m the detection of hemodynamically signifi· 
cant restenosis and disease progression after PICA and is 
especially valuable in pts unable to perform a conventional exerci•
se test. 
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Pacing Induced Left Ventricular Diastolic Dysfunction Demon· 
strated by Pulmonary Venous and Mitral Flow Analysis in Coro· 
nary Artery Disease and Hypertrophic Cardiomyopathy 
Rainer Hoffmann, Georg Thonnissen, Frank A Flachskampf, 
Peter Hanrath, RWIH Aachen, FRG 
To assess the incremental value of pulmonary venous flow analysis 
in the detection of LV diastolic dysfunction TEE and simultaneous 
atrial pacing was used. For this purpose 10 normal subjects, 10 pts 
with angiographic proven CAD and 10 pts with HCM without 
mitral regurgitation were studied at baseline (B, heart rate 84 ± 11 
min·1) and immediately (pP, heart rate 82± 12 min-1) after 
maximal atrial pacing (HR 142± 12 min-1). Time velocity integrals 
(f) (in cm) were calculated at B and PP for the following flows: re•
trograde pulmonary venous flow (R), early (E) and late (A) mitral 
flow. 
Normals CAD HCM 
B pp B pp B pp 
fR 0.72 0.69 0.96 2.13 1.16 2.61 
\ / \ / \ / ns p<O.01 p<0.OO1 
fE/fA 1.29, /1.45 1.63 1.10 2.01 1.50 , / \ I ns p<0.05 p<0.05 
In CAD and HCM pts PP vs B Doppler data show a significant de•
crease of fEfj A for the mitral flow and a significant increase of fR 
for the pulmonary venous flow. This can be explained by more vi· 
gorous atrial contraction in the presence of a stiffer ventricle PP. 
Conclusion; Immediate PP pulmonary venous and mitral flow an•
alysis are helpful to unmask left ventncular diastolic dysfunction in 
patients with CAD and HCM not present at baseline recordings. 
903·71 
Intraop.ratlve Monitoring for Myocardial Ischemia: 
Does 12·lead Electrocardiography or Transesophageal 
EChocardlography Have Incremental Value? 
Marl< J. Eisenberg, Martin London, Jacqueline Leung, Mi~on Hollenberg, 
Warren Browner, Dennis Mangano 
Univ 01 Califorria, San Francisco and VA Medical Center, San Francisco, CA 
Purpose: Recently, expensive technologies such as 12-lead 
electrocardiography (ECG) and transesophageal echocardiography (TEE) 
have been widely used Intraoperatively as monitors of myocardial ischemia. 
However, these technologies have not been compared with conventional 
Intraoperative monitoring. Accordingly, we examined whether 12-lead ECG 
or TEE have Incremental value in monitoring for myocardial Ischemia when 
compared with Intraoperative monitoring using 2-lead bipolar Hotter ECG. 
Methods: The 3 techniques were prospectively examined in 332 men 
who underwent noncardiac surgery and who were at high risk for 
intraoperative myocardial ischemia. The data from all 3 monitoring 
techniques were analyzed off-line by blinded investigators, and treating 
clinicians were unaware of all researCh data. 
Results: The Incidence of myocardial ischemia was determined in a subset 
of 285 patients (adequately studied by all 3 techniques). 2-lead ECG 
identified 68 patients (24%) as having ischemia, while an additional 10 
patients had Ischemia detected by 12-lead ECG and 29 additional patients 
had ischemia detected by TEE. Univariate analysis (332 patients) 
demonstrated associations between intraoperative myocardial ischemia and 
postoperative outcome (cardiac death, nonfatal MI, unstable angina, 
congestive heart failure, ventricular tachycardia) (P < 0.02 for each of the 3 
monitoring techniques). However, when monitoring results for 12-lead 
ECG and TEE were added to a muttivariate analysis model which included 2-
lead ECG resutts and preoperative Clinical data, the incremental value of 12-
lead ECG was insignHlcant and only TEE showed a significant incremental 
value (odds ratio. 2.5, 95% CI:1.0·5.9, P~O.04). 
Conclusion: We conclude that TEE, but not 12-lead ECG, appears to 
have an incremental value in monitoring for myocardial ischemia (albeit 
relatively low) when compared with monHoring using 2-lead Hotter ECG 
(analyzed off-line) in patients undergoing noncardiac surgery. The marginal 
incremental value for TEE suggests that further study is necessary to define 
those subgroups who will benefit most by TEE monHoring. 
ABSTRACTS 
903·72 
Transa,ophageal Echocardlographlc Automated Bordar Detection 
for Intraoperative Evaluation of Left Ventricular Pressure-Area 
Relationships 
John Gorcsan III, Thomas A. Gasior, Lee G. Deneault, William 
Mandarino, Robert L. Kormos, Brack G. Hattler. 
Echocardlographlc automated border detection (ABO) can provide on· 
line measurement of leit ventricular (LV) cavity area. Transesophageal 
echo (TEE) has been Increasingly utilized to monitor Intraoperative LV 
function. A feaSibility study was conducted to determine If TEE ABO 
can be utilized to determine on-line LV pressure-area relationships as a 
measure of LV function Intraoperatively. Four consecutive patients, 
aged 71: 5 yrs, who underwent cardiac surgery were studied. Three 
underwent coronary bypass surgery, and 1 underwent aonlc valve reo 
placement. TEE ABO was obtained from the mid-LV shon axis plane. 
Echo transmit and time gain controls were set to maximize traCking of 
the endocardial borders. Simultaneous LV pressure was recorded with 
a high fidelity flberoptlc catheter. LV ABO echo area and pressure 
were Integrated and displayed to construct pressure-area loops on-line 
using a computer graphics workstation through a customized Interface 
with the ultrasound system. Recordings were made at baseline and 
during rapid alterations In preload by Inferior vena caval (IVC) occlu•
sions both before and aiter cardiopulmonary bypass. An example from 
an IVC occlusion prior to car•
diopulmonary bypass Is shown. 
Pressure-area loops were suc•
cessfully acquired In all patients 
pre-cardiopulmonary bypass, and 
In 3 of 4 patients post•
cardiopulmonary bypass. 
In conclusion: TEE ABO coupled 
with a computer graphics 
workstation can be utilized to 
create on-line Intraoperative 
.... ,.', pressure-area loops. TEE ABO 
pressure·area relationships appear to be a promising new technique to 
evaluate LV function Intraoperatively. 
903·73 
I_pact of Intraoperative Echo in Open Heart Surgery: A 
Study Of 1630 Consecutive Cases Over 8 Tears 
Hartin E, Goldman, Theresa Guarino, Barry Zadeh, Andrew 
Rothschild, Juliet Rothschild, Scott Lazar, John 
Fotiades, Hassan Jethabhai, Bruce P. Hindich. Hount 
Sinai Hospital, New York, New York . 
Intraoperative Echo (IOE) is routinely used during open 
heart operations (op), but the technology is expensive 
and requires technical expertise. To determine the 
impact of IOE, we evaluated all preop and intraop data 
in 1630 consecutive IOE's performed between 1983 and 
1990 to determine if: (l)new information was provided 
(NEV) (2)the operation was altered (ALT) based solely 
on the IOE (3) a therapeutic (TRP) change was dictated 
by IOE. Operations included: 396 coronary bypasses 
(CABG), 406 CABG + valve procedure (VP), 747 VP and 81 
others. Patients (pta) were 64 % 13 years old. 643 pts 
had contrast injections, 398 color Doppler studies, and 
146 had both for evaluating valve function. 
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A Double Blind Trial of Glycopyrrolate for Transesophageal 
Echocardlography 
John Gorcsan III. John K. Thornton, Lorrie DILucente, William E. Katz. 
University of Pittsburgh, Pittsburgh, PA 
Glycopyrrolate (GP) , an anticholinergic agent to dry oral secretions, has 
been advocated for routine use with transesophageal echo (TEE). No 
data are available evaluating GP for this unique application. 
Accordingly. a prospective, double-blind, placebo-controlled study of 
GP was performed on 55 Pts undergoing awake TEE. 27 Pts, aged 62 
± 15 yrs were randomized to the standard dose of GP (0.2 mg Lv.), 
and 28 Pts aged 60 ± 17 yrs, received I ml of saline as plac<!bo (P). 
The oropharynx was anesthetized with topical benzocaine In ali 
patients. Intravenous mldazolam was used for sedation In all but one 
patient. Heart rate, ECG, BP, and 02 sat. were continuously monitored 
before, during, and after TEE. Blinded operators scored the ease of 
performing the study (I = Easy, 4 D Difficult). Pts scored their comfort 
Immediately after TEE (I = Easy, 3 = Difficult). Pts were then Interviewed 
at 24 hrs for side effects. No significant complications occurred In 
either group. Changes in vital signs and 02 sat. were similar In both 
groups. Results are means ± S.D. 
Mldazolam TEE Operator Pt.Comfort 
N Dose Duration Score Score 
GP (27) 3±2 mg 14±5 min 1.4±1 1.1 ± I 
P (28) 3±1 mg 13±6 min 1.4± I 1.2± I 
GP 
Sore Throat Dry Mouth Urinary Retention . 
59%· 41%· 7%· p<0.05 
P 17% 7% 0% 
Conclusions: GP when used for TEE Is associated with a higher InCi•
dence of sore throat, dry mouth, and urinary retention than P. No 
benefit from GP was noted In operator ease or patient comfort. GP 
should not be routinely used for TEE. 
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904·59 
prospective Comparison of unstable Angina 
Versus Non-Q Wave Myocardial Infarction During 
Antithrombotic Therapy. . . 
Marc Cohen, Jan Xiong, Gareth Parry, Ph1llp 
Adams, Douglas Chamberlain, Jameelah Ali, Keith 
Fox Ruth McBride, James Chesebro, Janet Str~in, Gilead Lancaster, Valentin Fuster, for 
ATACS. Hahnemann University Hospital, 
Philadelphia, Pa. 
Antithrombotic (A-T) therapy is beneficial 
in patients (pts) with either unstable angina 
(U/A), or non-Q wave myocardial infarcti~n 
(NON-Q). However, there has been no systemat1c 
comparison of the response of these 2 acute 
coronary syndromes to A-T therapy. In a 
multicenter pilot trial of A-T in U/A or NON-Q, 
230 pts admitted within 48. hrs. of pain ,w~re 
randomized to A-T therapy w1th e1ther asp1r1n, 
or aspirin plus heparin/warfarin and 
prospectively followed for 12 weeks. Ad~ission 
cardiac enzyme analyses revealed U/A 1n 182 
(79%) pts, and NON-Q in 48 (21%) pts. 
Observational analysis: U/A and NON-Q pts were 
similar 1n regard to age, ~ex, corona.ry ~isk 
factors, prior anti-ang1nal m~d1~at1on, 
duration of prior symptoms, and adm1s~10n E~G 
changes. End-points were recurrent 1schem1a 
(Rec Is), infarction (MI), and death (MORT). 
Rec Is MI MORT TOTAL 
Unstable angina 13% 5% 2% 20% 
Non-Q infarction 4% 19% 2% 24% 
Conclusion: Pts with U/A or NON-Q on A-T 
therapy have similar baseline characteristics 
and total number of ischemic events by 12 
weeks. However, in spite of A-T therapy, NON-Q 
pts progress more frequently to re-infarction. 
904·60 
JACC Vol. 19, No.3 
March 1, 1992:56A 
Limitation of Infarct Size by Preinfarction Angina 
Through Preconditioning but not Collateral Circulation 
Kazuhiko Nishida, Masayoshi Mishima, Atsushi Hirayama, Naoyuki 
Misaki, Takeshi Masue, Yasunori Veda, Kazuhisa Kodama. 
Osaka Police Hospital, Osaka, Japan 
To elucidate whether preinfarction angina (preAP) can limit infarct size 
through preconditioning (PC) as shown in animal models or collateral 
circulation (Col) as shown in patients with effort angina, we studied 
56 patients of first antero-septal acute myocardial infarction with 
successful reperfusion. They were divided into two groups according 
to the presence of preAP. PreAP was defined as worsening and 
repeated angina within 2-3 hours before onset of myocardial 
infarction_ Infarct size was evaluated by peak CPK (PCK), defect size 
(OS) detennined by TI-201 SPEer at chronic stage and SO/Chord 
analyzed by the centerline method of left ventriculograms at chronic 
stage. The results were as follows. 
pCK (VII) 
OS 
SO/Chord 
Elapsed Time (H) 
no preAP (N=34) preAP (N=22) 
4164±2388 2463±2004 * 
1088±701 701±120 * 
-3.l±L3 ·2.5±L2 * 
4.5±2.1 3.8±2A 
(mean±SO, *: P<O.05 vs no preAP) 
The patients with preAP were divided into two groups according to 
the presence of Col by initial coronary angiography before 
reperfusion. 
preAP s Col preAP c Col 
(N=ll) (N=l1) 
pCK (VII) 2328±1739 2617±2381 # 
OS 479±589 654±485 # 
SO/Chord ·2.4±L2 -2_6±L2 # 
Elapsed Time (H) 3.l±L4 4.6±3_0 # 
(mean±So,#: differences not significant) 
These results indicate that preAP has effects on limitation of infarct 
size through PC but not CoL 
904·61 
ACETYLCHOLINE RESPONSE OF INFARcr-RELATED 
CORONARY ARTERIES WITH AND WITHOUT SIGNIFICANT 
STENOTIC LESION 
Seung-Jung Palt, Seong-Wook Part. Jae-Joong Kim. Jae-Kwan Song, 
Simon Jong-Koo Lee. Asan Medical Center. University of Ulsan. 
Seoul, Korea 
Seven to 10 days after acute myocardial infalttion(AMI). acet}icholine 
(Ach) (lOOug for the left and 50ug fur the right) response of infaitt-rellled 
coronary anery(IRA) was studied in 16pts(mean age 48yrs, 16 males) with 
angiographically nonnal coronary artery(group I) and IS pts(mean age 
57yrs, 13 males) with significant stenotic lesioos(group 2). Ach resopnse 
was also studied in 27 noninfarct-related a rteries(NIRA) of group I and 29 
N1RAs of group 2. The pOsitive resopnse was defined as total or subtotal 
occlusion after Ach injection. In 6 pts of group I with Ach(+), 
irtravenous eIgonovine (Erg) test was also perfunned after completion of 
Ach test 
IRAs NIRAs P 
Group I; Ach(+) 14/16 (87.5%) Sf27(18.5%) <0.001 
Ach( + )Erg( + ) 4/6 I 
Ach( + )Erg( -) 2/6 I 
Group 2 ; Ach(+) 5/1 I (45.4%) 3(l.9 (10.3%) <om 
Co~lusion: I) In the majority of patients with nODllal coronary artery lIId 
AMI. Ach induced vasospasm in the !RAs. 2) Ach(+) response of IRAs 
with or without significant coronary artery disease are more frequent 
(70%) than those of NIRAs( 14%). 3) Ach(+) responses of IRAs with 
angiographically noun aI coronary artery are more common than those with 
significant fixed disease (p < 0.01). 4) These findings suggest that 
coronary spasm may be related to AMI. especially in those patimts with 
nODllai coronary artery. 5) Ach and Erg induced vasospasm II the same 
site in 4 of group I which suggests that local hyperreactivity is related to 
spasm. 
JACC Vol. 19, No.3 
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904·62 
Influence of Serum Lipoprotein(a) Level on the Coronary 
Vasomotor Response of Acetylcholine 
Yukio Tsurumi, Hirotaka Nagashima, Kenichiro Ichikawa, 
Hirohumi Saigusa, Megumu Kanno, Masatomo Honda, 
Tetsuya Sumiyoshi, Kazunori Iwade, Saichi Hosoda 
Honda Memorial Tohoku Cardiovascular Center, Fukushima, 
Japan and The Heart Institute of Japan, Tokyo Women's 
Medical College, Tokyo, Japan 
To assess the influence of lipoprotein(a) on coronary 
endothelial function, we examined the relationship 
between the serum lipoprotein(a) level and the 
vasomotor response of angiographically normal coronary 
arteries to acetylcholine, an endothelium-dependent 
vasodilator. Diameter changes of the left anterior 
descending coronary artery produced by intracoronary 
acetylcholine (50 pg) were measured by videodensito•
metric analysis in 30 patients with angiographycally 
normal coronary arteries. The vasomotor response 
ranged from +23\ dilation to -98\ constriction at two 
minutes after intra coronary acetylcholine injection. 
Because all arteries were dilated by intracoronary 
isosorbide dinitrate (an endothelium-independent 
vasodilator), this diameter change in response to 
acetylcholine was thought to reflect coronary 
endothelial function. The serum lipoprotein(a) level 
was independently associated with the coronary vasomotor 
response to acetylcholine (p<O.OOl). These results 
suggest that high lipoprotein(a) levels impair coronary 
endothelial function, even when atherosclerotic changes 
are not recognizable by angiography. 
904·63 
Effl;lct of Fructose 1-6 Diphosphate on Mortality In Patients 
with Acute Myocardial Infarction. 
Wang Shou Vi, Dai Rui Hong, et al. 
Shanghai Medical University. Shanghai, P.R.China 
Administration of fructose 1-6 diphosphate (FDP) in acute 
myocardial infarction (AMI) has been reported to improve 
hemodynamics, attenuate ECG·assessed injury and reduce 
occurrence of ventricular dysrhythmias both experimentally and 
clinically. In view of these findings, we investigated whether 
FDP treatment can affect mortality in patients with AMI. 
From 10 large Shanghai hospitals over the past 5 years, we 
studied 1417 cases of AMI. Patients were randomly divided 
into two groups: treated with FDP and those not treated with 
FDP. Age, coronary care and therapy were the same for both 
groups. FDP was administered IV as 10% (10mgs) every 12 
hours for 3 to 7 days. To avoid bias by severity of disease, 
patients were stratified into three groups: (1) those without 
beart failure; (2) those with heart failure; and (3) those in 
cardiogenic shock. In the group with normal cardiac function, 
the mortality in the FOP group was 6.15% (8/130) and, in 
the control group, 14.8% (129/874) (p < 0.02). In the group 
with heart failure, the mortality in the FOP group was 34.7% 
(34/98) and in the control group, 51% (161/315). (p<0.005). 
In the cardiogenic shock group, mortality was 58.3% (21/36) 
in the FDP group and 64.3% (110/171) in the control group 
(N.S.). 
Our data indicate that FOP administration in patients with 
or without heart failure in the course of AMI significantly 
decreases mortality, but the mortality in the cohort cardiogt'nic 
shock is not reduced. 
ABSTRACTS 
904·64 
Predictive Value of Serum Magnesium for Ventricular 
Fibrillation Following Acute Myocardial Infarction 
P. Daniel Higham, Philip C. Adams, Alan Cassels-Smith, Alan 
Murray and Ronald W. F. Campbell. 
University Cardiology Department, Newcastle upon Tyne U.K. 
Recent trials have shown a beneficial effect of intravenous 
magnesium (Mg) follOwing acute myocardial infarction (AMI), 
specifically with a marked reduction in the incidence of 
ventricular fibrillation (VF) and hospital mortality. There is 
however little evidence for a positive association between low 
serum Mg levels and VF following infarction. 
We prospectively measured admission serum Mg levels (ref. 
0.70·1.00 mmolJl) in 350 patients with AMI. Early VF (within 
24 hours) occurred in 22 patients, 8 prior to admission and 2 
pacing related. No patient had received magnesium therapy, 
and antiarrhythmic drugs were only given to patients with 
sustained arrhythmias. Mean serum Mg in patients whose VF 
occured after sampling (n=12) was 0.80 :!: 0.07 mmolJl and 
did not differ from patients who did not have VF (0.81 :!: 0.08 
mmolJl), One patient who had VF was hypomagnesaemic 
(0.60 mmolJl) compared with 17 of the remaining 328 patients, 
positive predictive value = 4%. Low serum Mg occurred in 10 
of 71 patients taking diuretics versus 8 of 269 not on diuretics 
(p<0.OO1). Hypokalaemia (K < 3.50 mmolJl) occurred in 8 of 
the 18 hypomagnesaemic patients compared to 66 of the 
remaining 322 (p<0.02). 
Conclusion : Low serum magnesium levels are rare 
following acute infarction, are associated with prior diuretic 
therapy and hypokalaemia and have poor predictive value for 
ventricular fibrillation. 
904·65 
Superiority of the Activated Clotting Time in Monitoring 
Heparin Therapy in Acute Coronary Syndromea 
Giovanni Melandri, Annamaria Traini, Franco Semprini, 
Angelo Branzi, Bruno Magnani. 
Institute of Cardiology, University of Bologna, Italy 
300 simultaneous measurements of the activated clotting 
time (ACT) and aPTT were made in twenty pts with acute 
coronary syndromes who were randomized to maintain either 
the ACT (Group 1) or the aPTT (Group 2) between 1.5 and 
2.5 the control value. At all times during heparinization 
the aPTT ratio to baseline was significantly higher than 
the ACT ratio (p= 0.001) according to the equation: aPTT 
ratio= 0.64 + 2.09 ACT ratio. As a consequence the hepa•
rin dosage was significantly lower in Group 2 (1320 +/-
700 vs 1500 +/- 300 U/hr; p= 0.008). Moreover, due to de•
lay in aPTT results availability, the fluctuations in 
aPTT levels and heparin adjustments (52% vs 40%; p=0.045' 
were significantly larger in Group 2. The two groups did 
not differ in age (59 VB 66 yr), male gender (90% vs 8~~) 
n. of diseased coronary vessels (2.2 VB 2.0) and left 
ventricular ejection fraction (57 VB 55%). Results: 
Refractory angina 
{Re)infarction 
Bleeding compl. 
Group 1 Group-2 p 
o 4_ o 1 _  0 . 05 
1 2 NS 
In conclusion the activated clotting time is prefera•
ble to aPTT in monitoring heparin therapy in acute coro•
nary syndromes. 
57A 
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904-66 
InhlbHlon of ADP-Inducld Platelet Aggregetlon by Protemlne Sulfate In 
the Absence of ProlongeHon of Recelclficatlon nmeln HUmin Plasma 
Rohk Arora, Ravlndra Sharma, Nighat Khan, Asru K Sinha 
Columbia Unlverslty/Albert Einstein College 01 Medicine, New York, NY 
The uae 01 Protamine Sulfate (PS) to neutralize tha anUcoaguiant effect of 
heparin after cardiac catheterization Is suggested to enhance thrombotic 
events, especially In acute Ischemic syndromes. However, the effects of 
protamine on platelet aggregation and clotting are largely unknown. To 
study the effects 01 PS on platelet aggregation, platelet rich plasma (PRP) 
from normal volunteers who had not taken any medications at least for two 
weeks, was Incubated with therapeutic amounts 01 :OS (60 ug/mI) for half 
an hour at 3"oC and aggregation of platelets was studied using ADP and 
I-eplnephrlne (EPI) as agonlsts. Dose response curves showed that both 
ADP and EPI Induced aggregation was Inhlbked 30% and 50% respectively 
by PS (n - 9, P < 0.03) at physiological doses. T emporai response curves 
showed that PS produced ADP and EPI Induced Inhlbklon 01 aggregation 
after Incubation periods 011 to 30 minutes without significant differences (n 
- 6, P - ns). DosImetry studies showed that PS produced ADP Induced 
Inhlbklon 01 aggregation from doses 01 (10 - 180 ug/mI) without significant 
differences (n - 6, P - ns). Pretreatment of platelet rich plasma wtth heparin 
alone resuked In the Inhibition of platelet aggregation by 20% (n - 9, P < 
0.02). However, Incubation of heparin and PS Increased the Inhlbttion by 
40% (n - 6, P < 0.05). Recalcification time to determine platelet related 
clotting was then determined In both platelet rich plasma and platelet poor 
plasma, after Incubation with protamine sulfate at 3"oC for half an hour. 
Addition 01 PS to platelet poor plasma Increased the recalcification time by 
50% (n - 6, 168 :t 24 sec, P < 0.03) In contrast addition to platelet rich 
plasma produced no effect on the recalcification time (n - 6, 110 :t 15 sec, 
P - NS). In conclusion, protamine sulfate causes modest but consistent 
Inhlbklon 01 platelet aggregation without prolonging recalcification time in 
PRP, suggesting that protamine sulfate could be used in the presence of 
heparin In acute Ischemic syndromes wtthout causing platelet activation or 
promoting blood coegulatlon. 
904-91 
Pyruvate Reduoes Free-Radioal Generation 
Follovinq Myooardial Isoheaia and Reperfusion 
in Isolated Rat Hearts 
Laurence W.V.DeBoer, Paul A Be~, Margaret A. 
Rankin, George H. Reed. University of 
Wisconsin, Madison, WI and University of 
Nebraska Medical Center, Omaha, NE 
pyruvate has been shown to have a beneficial 
effect when provided during reperfusion 
following myocardial ischemia. Keto acids, 
including pyruvic acid, react with hydrogen 
peroxide preventing free radical generation. 
Accordingly, we compared glucose (11 mM) with 
glucose (llmM) and pyruvate (2mM) in isolated 
Krebs-Henseleit perfused isovolumic rat hearts_ 
Free radical generation was measured in 
coronary effluent using the spin trap DMPO (100 
mM) added to the KHB. Hearts were subjected to 
45 minutes of ischemia and subsequent 
reperfusion with pyruvate added only during 
reperfusion. In hearts reperfused with 
glucose, DMPO-OH adduct (nM) was 1.4±0.9, 
1. 3±0. 7, 2. O±O. 5, 1. 9±O. 7 and 2. 2±O. 6 in the 
first 5 minutes. The respective values for the 
pyruvate supplemented group were 0.4±0.1, 
1.0±0.2, 0.8±0.1, 0.8±0.2, and O.9±0.2. These 
differences were significant from the third 
through the fifth minute as were samples taken 
at 10 and 15 minutes of reperfusion. 
Mechanical recovery in separate experiments of 
hearts not exposed to DMPO were significantly 
better in the pyruvate supplemented group. 
Reduction of free radical damage by pyruvate is 
an important mechanism of myocardial 
protection. 
904-92 
JACC Vol. 19, No.3 
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Preconditioning Ischemia Attenuates Low-Renow After 
Coronary Occlusion in the Rabbit Heart 
Sharon L Hale and Robert A Kloner, Heart Institute, Hospital of 
the Good Samaritan and Division of Cardiology, University of 
Southern California, Los Angeles, CA 
In the rabbit, ischemic preconditioning (PC) has been shown 
to protect myocardium from irreversible injury after a more 
prolonged ischemic event; however its influence on regional 
myocardial blood flow (RMBF, ml/min/g) has not be tested. We 
measured RMBF with radioactive microspheres, at 30 min of 
coronary occlusion and after 3 hr reperfusion, in 2 groups of 
anesthetized rabbits: PC (2 PC occlusions of 5 min each + 5 
min reflow, n=12) and no-PC (n=12). Expressed as a percent of 
in vivo ischemic risk region (26±2% of LV, PC and 31±2%, no•
PC, p=ns), infarct size was significantly reduced in PC hearts, 
indicating a positive response to PC (30:1:5% vs 53±3'7'0 in 
controls, p<.OO2). RMBF was modified by PC in this model. 
During occlusion, regional flow to ischemic tissue was signif•
icantly higher in PC hearts (.29±.08 vs .09±.02 in no-PC, 
p<.04). However in nonnal tissue, RMBF was significantly 
lower in PC hearts (1.52±.lI) than in no-PC hearts (2.O9±.l8, 
p<.02). After 3 hr reperfusion, flow to the nonischemic tissue 
was similar in both groups (1.95±.34, no-PC and 1.74±.17, PC); 
in contrast, flow to the previously ischemic tissue was signif•
icantly higher in PC hearts (.91±.l1 vs .61±.09, no-PC, p<.05), 
suggesting improved perfusion, with a diminution in low-reflow. 
In conclusion, PC altered RMBF. During occlusion, in PC 
hearts, flow to nonischemic tissue was lower, perhaps due to 
less compensatory hypercontractility in hearts with smaller 
infarcts, while in the ischemic zone, collateral flow was 
preserved, possible due to less microvascular necrosis. During 
reperfusion PC preserved flow to a greater extent in the 
previously ischemic region, resulting in a reduction of low•
reflow. 
904-93 
Fluoso.- Activates Human Neutrophils Via Phagocytosis: A Novel 
Therapeutic Approach to Reduce Myocardial Reperfusion Injury 
David A. Ingram, Mervyn B. Forman, John J. Murray. 
Vanderbilt University, Nashville, Tennessee 
FluosolS , a mixture of oxygen-carrying perfluorocarbons 
emulsified by a detergent, Pluronic F-6S, significantly reduces 
neutrophil (PMNI influx and enhances myocardial salvage after 
reperfusion. To examine the mechanism of Fluosols and its 
components on PMN function, time and dose responses of 
superoxide anion (0 2.' production and lysozyme deg~anulation 
ware parformed. 
PMN Response to 10% Concentration of Fluosols 
~ 
3.S±O.3· 
O.S±O.1· 
15 min 
7.0±O.7· 
2.4±O.4-
~ 
S.9±O.9-
2.5±O.4· 
tnmole/5xl0' PMN; tpg/5xl0' PMN; ·p<O.05 vs. untreated. 
Similar dose and time responses were observed with F-6S 
alone. No stimulation was noted with FMIQ, a new perfluoro•
chemical preparation which does not contain F-6S. Cytochalasin B, 
an inhibitor of phagocytosis, significantly reduced O2• generation 
to Fluosols and F-6S (60 and 90%, respectivelyl. Electron 
microscopy confirmed the cellular uptake of Fluosols within 
phagocytic vesiclas. Fluosols did not affect cell viability as 
measured by trypan blue. Conclusions: Fluosols directly activates 
PMNs by forming Pluronic micelles that serve as phagocytic 
stimuli. Significant PMN activation occurred with concentrations 
lower than those required in vivo to enhance myocardial salvage. 
Thus, activation of PMNs throughout the peripheral circulation 
results in sequestration at sites remote from the reperfused 
myocardium. This form of therapy may prove to be a novel 
strategy for reducing myocardial reperfusion injury. 
JACC Vol. 19, No.3 
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904-94 
Effects of Collateral Circulation In Patients Treated with Primary 
AngiopIasly During Acute MyocardaIInfarction 
Russell J. Ivanhoe, Barton G. Sickinger, Bruce R. Brodie, Cindy L. 
Grines, William D. Knopf, James H. O'Keefe, George J. Taylor, Abbie 
Samuel, Usa G. Berdan, Lynn H. Woodlief, James E. Tcheng, Robert 
M. Califf, William W. O'Neill. Florida Heart Institute, Orlando, FL. 
While collateral circulation (CC) is felt to limit ischemia in 
chronic ischemic heart disease, the effects of CC during acute 
myocardial infarction (MI) on ventricular function and clinical 
outcome are not well described. We analyzed a cohort of 186 acute 
MI pts entered in the multicenter Primary Angioplasty Registry (PAR) 
trial who underwent emergency cardiac catheterization during MI 
prior to angioplasty (PTCA) revascularization. Angiography grading, 
including CC, was performed by an independent observer. CC to 
the epicardial vessel distal to the infarct site was graded from O=no 
visualization to 3=complete coilateral filling of the epicardial 
segment, with a final group demonstrating antegrade flow through 
the infarct site. Pt groups were comparable, although there tended 
to be a higher incidence of preexisting coronary disease in pts with 
greater CC. Selected data are summarized below. 
Collateral grade 0 n{%) 1....!.lClhl ~ 
n 4S 53 33 
Ejection fraction 45.8±10.8 4S.1±9.9 4S.7±10.1 
Multivessel disease 23(50%) 31 (58%) 18(54%) 
Recurrent ischemia 3(7%) 8(15%) 2(S%) 
Reinfarction 0 2(4%) 1 (3%) 
Repeat PTCA 1 (2%) 3(S%) 1 (3%) 
Bypass surgery 4(9%) 3(S%) 2(S%) 
*Death 2(4%) 2(4%) 4(12%) 
antegrade 
54 
54.8±10.4 
29(54%) 
4(7%) 
o 
3(S%) 
S(ll%) 
o 
Individual adverse outcomes and a composite endpoint inclu•
ding successful PTCA and 24 hour bypass free survival were overall 
found to be similar among groups. Notably, mortality was highest in 
the group with grade 2-3 CC (*p=.OSl). In summary, antegrade 
flow was associated with the greatest ejection fraction, but increas•
ing CC did not preserve ejection fraction nor reduce mortality. 
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905-95 
n.tolltlon of Symptoms Does not Necessarily Imply 
Remission of tile Disease In Patlenls WIt! Syndrome X 
Aberico Borghi, Michele Trevisani, Vinc~nza Saccone, 
Smonetla lucarini, Giovanni M. Puddu, Raffaele Bugiardini. 
Instttte (/ Patologia Medica, Unlversty (/ Bologna, laly 
The long-term clinical COLrSe (/ pis wth Synctome X (SX: angina 
and normal coronary arteries) Is stili matter (/ discussion. W~ 
studied a slbset (/ such pis (18) found to hay~ exercise-induced 
rnyocardiallschemia, reduced coronary blood flow response to 
atrial pacing «50% increase at peal< testing), and no evidence (/ 
coronary artery spasm or Ie/t yem-icular hypertrophy. All 18 pis 
W&re followed for 4 to 5 yrs. Clinical data, Hoter montoring (1-tv1) 
and exercise stress testing (EST) W&re obtained when diagnosis 
was fi'st established, then at 6-morth irtervals until the end (/ the 
fOlloW-up (F). None (/ the pis experienced major coronary everts 
or deyeloped Ie/t yentricular dysfunction or bundle branch block 
during F. Ten pis showed complete resohtlon (/ chest pain 
starting 6 to 24 morths alter baseline assessmert (Gr.1). The 
remaining 8 pis continued to presert recllTent chest pain at the 
end (/ F (Gr.2). At baseline, both Gr.1 and Gr.2 pts showed a 
postive EST (anginal pain and ~0.1 mV ST depression) and 1+.1 
(at least 1 episode (/ ST depressio~O.15 mY). At F, all 8 Gr.2 pts 
stili had evidence of Ischemia, both during EST and 1+.1. 
exercise-induced bit not SPOIlaI'leOUS ischemia was also 
detected in 4110 Gr.1 pts. We conclucle that: (1) long-lasting 
regression of S)'I'll>toms is a common finding in SX; (2) this does 
not necessarily ~Iy a remission (/ th& disease, in that 
rnyocardiallschemia is stili inducble in a nlllt>er of asymptomatic 
pts; (3) EST bit not 1+.1 nor chest pain should be used as a gUide 
to management and therapy (/ SX. 
ABSTRACTS 59A 
905-96 
Incidenc. end S.verhy of L.ft Main Coronary Artery DIa .... AlI .... d by 
Intr.v.lcullr Ultrasound 
Thomas Gerber, Raimund Erbel, Junbo Ge. GOnter GOrge. Hans-JOrgen 
Rupprecht. JOrgen Meyer 
2nd Medical Clinic, Mainz University, Germany 
Purpose of the study was to assess the incidence of left main coronary 
Irtery (LMCAI disease using intravascular ultrasound (lVUS). 
In 65 patients (ptsl (55 m, 10 f; age 55.7 :I: 6.S yrs) the left coronary 
artery was examined using a 20 MHz rotational tip IVUS system after 
catheterization for proven or suspected coronary artery disease (CAD). 
AVlrlge examination time was 7.4 :I: 3.1 min. Imaging of LMCA wal not 
poslible in 5 of the pts for technical (2) or patient-related (3) reasonl. 
IV US findings in the LMCA were graded A - normal. B - soft plaque, 
C • calcified plaque. Maximal (01) and minimal (02) vessel diameter. 
veasel area (VA), luminal area (LA) and plaque area (PA) were determined 
using a half-automatic computer system. The 02/01-ratio and PANA-ratio 
were computed as measures for deformation and extent of obstruction of 
the main stem. 
Type A was present in 33 (55%). Type B in 23 (38.3%). and Type C In 
4 (6.7%) of the cases. 
ell normals (A) abnormal. (B. C) 
n 60 33 27 
Dl [cm) O.Sl :I: 0.07 0.58 :I: 0.07 0.S4 :I: 0.07 
D2 [cm) 0.55 :I: 0.07 0.52 :I: 0.06 0.57 :I: O.OS 
VA Icm') 0.27 :I: 0.06 0.24 :I: 0.05 0.29 :I: 0.05 
LA [cm') 0.23 :I: O.OS 0.21 :I: 0.06 
PA [cm') 0.09 :I: 0.06 
D2IOl 0.90 :I: 0.07 0.91 :I: O.OS 0.90 :I: 0.07 
PANA 0.30 :I: 0.17 
Of the SO pts examined 2 showed native LMCA calcifications on x-ray. 
narrowing of the LMCA on the angiogram was leen in 2 cases. 
We conclude that in 45 % of pts undergoing coronary angiography for 
proven or suspected CAD alterations of the LMCA are present that can be 
picked up by IVUS. IVUS is more reliable in delineating soft plaques in the 
LMCA than angiography. 
905-97 
Nitrate Tolerance by Patch Therapy with 
Different Profiles of Nitroglycerin Release 
Hans-Jakob Odenthal, Wolfgang Josephs, Peter Lenga, 
Hans Wilhelm Wiechmann 
Department of Internal MediCine, Marienhospital Herne 
University of Bochum, Germany 
The anti ischemic an~Mhemodynamic effects of non-phasic 
(group 1: Nitroderm ) and phasic (group 2: F 8115, 
Pharma Schwarz) release nitroglycerin patches were com•
pared during acute and sustained therapy. 30 patients 
with angiographically verified coronary artery disease 
were randomized to one of the two treatment groups. Each 
patch released 15 mg nitroglycerin (GTN)/24 hours_ After 
one week without anti anginal drugs hemodynamic data at 
rest and at exercise were measured on day 1 and on day 8 
before and 2 hours after GTN patch application. 
Results: On day 1 both groups showed after GTN-therapy 
significant (p<O,Ol) reduction of exercise induced ST•
segment depression (STD)(group 1: -60%;~oup 2: -55%) 
and of mean pulmonary artery pressure (~)(group 1: 
-10%; group 2: -7%). On day 8 reduction of STD was in 
group 1 (-60%) still significant (p<O,Ol) but no longer 
in group 2 (-30%). At sustained therapy both~oups 
showed no longer a significant reduction of PAP (group 1: 
-6%, group 2: 0%). 
Conclusion: The acute hemodynamic and anti ischemic ef•
fects of phasic and non-phasic release GTN-patches are 
equally significant. At sustained therapy the patch with 
phasic release of 15 mg/24 hours is not superior to the 
non-phaSic release patch in avoiding nitrate tolerance. 
60A ABSTRACTS 
905·98 
No Loss of Action With the NHrate·Uke Substance Molsldomlne 
During Established NHrate Tolerance 
Andrea Beyerle, Gunther Reiniger, Gunter Lehmann, Werner Rudolph 
German Heart Center - Munich, Federal Republic of Germany 
In spite of the comparable antiischemic acute effects, nitrates differ from 
the nitrate-like substance molsidomine with respect to their Iongterm 
action. The Iongterm treatment with molsidomine , in contrast to the 
nitrates, does not lead to tolemace development. 
To determine whether antiischemic efficacy is compromised by the 
presence of nitrate tolerance, in 10 patients with documented CAD, using a 
placebo-controlled, double-blind, crossover protocol, we investigated the 
acute effects 1.5 hours after 4 mg molsidomine prior to and during the 
state of established nitrate tolerance( 2.5 hours after second application of 
the NTG-patch). ST-segment depression was analyzed at comparable 
workloads during exercise testing at 2.5, 10 and 24 hours after the first 
NTG patch (20 mgt24 hours ) and 2.5 hours after second patch. 
Moisidomine or Pacebo was given 1.5 hours after the second patch. 
The reduction in ST-segment depression of 57% at 2.5 hours after the first 
patch diminished markedly to 25% and 14% at 10 and 24 hours, 
respectively. With a reduction of 20% at 2.5 hours after the second patch 
the initial effect was no longer reproducible. The reduction of 56% at 1.5 
hours aller 4 mg molsidomine was completely reproducible at 2.5 hours 
aller the second patch. 
Accordingly, the effect of the nitrate-like substance molsidomine is 
unaltered by rapidly incurred tolerance development during continuous 
nitrate administration. There is no evidence of cross-tolerance. Thus, 
molsidomine can be given concomitantly with nitrates or as an adjunct to 
bridge the therapeutic gap during nitrate interval treatment 
905·99 
Effect of Bamlphylline (a Selective Antagonist of AI•
Adenosine Receptors) on Exercise-Induced Myocardial Ischemia 
Achille Gaspardone, Filippo Crea, Fabrizio Tomai, Maria lamele, Francesco 
Versacl, Anna De Fazio, Luigi Chiariello, Pier Agostino Gioffr~. 
Department of Invasive Cardiology, 2nd University, Rome, Italy 
Theophylline (a non selective adenosine antagonist) markedly improves 
exercise capacity and reduces the severity of chest pain. In order to further 
investigate the machanism of action of theophylline, the effect of 
bamiphylline (B), a new antagonist of AI-adenosine recepton, on exercise•
induced myocardial ischemia was assessed in 10 patients with stable effon 
angina in a single-blind, cross-over, placebo-controlled, randomized trial. 
Coronary angiography showed two-vessel disease in 5 patients and three-vessel 
disease in 5. Patients underwent treadmill symptom-limited exercise testing 
according to the modified Bruce protocol 90 minutes after oral administration 
of placebo (P) or B (1200 mg). Tests were performed on 2 consecutive days 
between 900 and 1100 boon and in the same enviromental conditions. The 
level of the ST segment was calculated after signal averaging by means of a 
computer-assisted system. The severity of maximal chest pain was assessed by 
means of a 100 mm visual analog scale. The results relative to resting heart•
rate (rHR, b/min), resting blood pressure (rBP, mmHg), time to I mm ST j 
(T to STj, sec), heart-rate blood pressure product at I mm ST j (RPP at ST j, 
b/min x mmHg x 10-2) and the ratio angina intensity/peak ST j (A/ST) are 
reporIerd in the following table: 
rHR rBP 
P 71±9 127±13 
TtoSTj 
537±186 
RPP at STj 
157±21 
AfST 
34%24 
Ii 7%13 l27±14 605;;239 lWO· WI7·· 
': p<O.OS; .. p<O.Q1 
Thus, in patients with stable effort angina acute oral administration of B 
moderately improves the ischemic threshold, althoug this beneficia! effect is 
not intense enough to significandy delay the onset of ischemia. Furthermore. 
B markedly reduces the severity of anginal pain normalized for the severity of 
ST j ,thus suggesting that the improvement of the angina! pain is due to 
direct inhibition of cardiac pain recepton. Our results indicate that both the 
anti-ischemic and the anti-anginal action of theophylline are. at least partially, 
mediated by inhibition of A I-adenosine receptors. 
905·100 
lACC Vol. 19, No.3 
March 1, 1992:60A 
Use or Hirulog-l, a Novel Thrombin Inhibitor, to Anticoagulate 
Patients During Cardiac Catheterization 
Christopher P. Cannon, Peter Ganz, Andrew P. Selwyn, Karen Eddings, 
Irving Fox, John Maraganore, Eugene Braunwald. Brigham and 
Women's Hospital and Harvard Medical School, Boston, MA 
Hirudins are a class of selective thrombin inlubitors which, unlike 
heparin, can effectively inhibit thrombin that is clot-bound or localized 
to extracellular matrix. Hirulog-l (HIR) is a small hirudin-based 
synthetic peptide which inhibits thrombin by binding to both its catalytic 
site and its fibrinogen recognition site. To evaluate the anticoagulant 
efficacy and the safety of HIR, we randomized 38 patients to receive 
either HIR or heparin during cardiac catheterization (cath). Patients 
received either: 1) IDR 0.05mglkg l.Y. bolus (!VB) and 0.2 mglkg/hr 
I.Y. infusion until end of cath (HIR 1)(n=12), 2) IDR 0.15mglkg !VB 
and 0.6 mglkg/hr I.Y. until end of cath (IDR 2)(n=14) or 3) Heparin, 
5000 U !VB (HEP)(n=12). After 2 minutes and at 15 minutes (shown 
below), IDR and HEP produced prolongation of all coagulation indexes: 
aPTI(%) PT (%) 11' (%) ACT (sec) 
HIR 1 185±54 123±11 >410±120 171±10 
IDR 2 243±49 147±14 >51O±40 243±19 
HEP >428±90 123±7 >500±30 268±15 
(11'=thrombin time, ACT=activated clotting time) 
IDR's half-life of the anticoagulant effect was approximately 40 min. 
During and following cath, there were no thrombotic or bleeding 
complications in any of the 3 groups. 
Conclusions: 1) Anticoagulation with Hirulog-l is achieved rapidly and 
in a dose-dependent manner, 2) It has a relatively short half-life, 
allowing easy titration, 3) Hirulog-l appears to be a safe and potent 
antithrombin agent during cardiac catheterization. Further study in 
humans is warranted to determine the value of Hirulog-l in the 
treatment and prevention of coronary thrombosis. 
905-101 
Prospective RIsk Slrat1llcatlon In Renal Transplant Candidates 
for Cardiac Death 
Karen Douek, Robert PuI1iam, Diane Tolzman, Douglas Norman, 
William Bennett, Richard Wilson. 
Oregon Health Sciences University, Portland, Oregon 
There is no generally accepted method of cardiac risk stratification of renal 
transplantation candidates with end-stage renal disease who are at high risk 
for coronary artery disease and cardiac mortality. Therefore, consecutive 
candidates for rena1transplantation (n= 195) were prospectively entered into 
a risk stratification algorithm. FtrSt, patients were stratified into low- and 
high-risk groups on the basis of clinical risk factors alone. Clinical high risk 
was defmed as anyone of 1) age~ 50 years, 2) diabetes mellitus, 3) abnormal 
ECG (excluding L VH), 4) CHF, or 5) angina. The clinical low-risk group 
underwent no further cardiac evaluation prior to transplantation. However, 
the clinical high-risk cohort was then further stratified using thallium-W1 
(TI-201) exercise stress testing according to the presence or absence of 
reversible TI-W1 defects. Patients were foUowed for 18 to 33 months. The 
endpoint was cardiac mortality. 
Results: Actuarial survival for clinical low-risk group (n=95) was signifi•
cantly beller than the clinical high-risk group (n = 1(0) (98% vs 85%; 
p<O.OI). In the clinical high-risk group, survival for patients with no 
reversible TI-201 defects was 92% versus 78% for patients with reversible 
TI-W1 defects, p=O.04. 
Conclusion: In this patient popuiati()n: 1) the clinical algorithm effectively 
selected patients at low risk of cardiac death who probably do not need 
further cardiac evaluation prior to renal transplantation, and 2) in the clinical 
high-risk group, reversible TI-W1 defects further risk-stratified patients. This 
combined clinical and TI-W1 risk-stratification algorithm may be clinically 
useful for the evaluation of patients for renal transplantation. 
JACC Vol. 19, No.3 
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905·102 
Does Insul1n Dependant Diabetes (100M) cause Myocerdlal 
Ischaemia: A Study Of 70 IdenUcellwln 'airs With 100M. 
Simon Dubray, FlIWll2 Akhres, Chris Trav111 , Guojle Song, Tim Ii!lralllll'l, 
David Leslie. Aclmnlc Unit of C8rd10VllSCU18l" Medicine, Diabetes Research 
Unit, Cherlng Cross end Westminster Medical School, LonOOn, UK. 
Exercise treedmlll electrocerdl()JrMl (HE) end slmultanoous ('.continuous 
Ww-;e Doppler (CWD) meesurement of IllI'tlc mtIXlmum ~Ieretlon (MA) 
were obtained In two cohorts of Identical twins; 42 100M discordant (for 
1717 yrs) twin (OT) pairs (24 male), ~ 37 (rM\19 25-69) yrs end 
28 100M concordant twin (CT)palrs (10 mele), 8QPX! 34 (rarq3 24-61) 
yrs, with II meen Intra-twin Interval In dl6lJlOSis of 100M of 4.21 3.9 
yrs, end an ~/sex matched non diabetic control (J'OUp. In the Dr cohort 
twelve diabetic twins, 14 non diabetic co-twins and 5 non diabetic controls 
had ErE evidence of myooardlal ischaemill. The HE WIIS positive in both 
members of ten DT P/llrs. There WIIS no sl~lflClll'lt dlffererlCe between 
8Jrlic MA (m/s/s) m8flSUred by CWO In the dl8betic twin (56t H), the 
non diabetic co-twin (54t 15) or the control group (SOt 15). In tt19 CT 
cohort nine ( 161) of the dlabetlc twins had exerCise lnOOced myooardlal 
ischaemia compared to 4 ( 141) of the control group. Botti members of 
four CT pairs had II pos1t1ve Ell. There WIIS no si~lfjClll'lt dlffererICe 
between eortlc MA (m/sls) in the CT cohort (53t 15 end 52t 16) or the 
control group (56t 16). In conclusion, the presenre of Ell inOOced 
ischaemia 00es not relate to dl8betes per se or to Its wretion, but rether to 
a propensity to inherit diabetes end myooardllllischeemia. 
905·103 
IN STABLE ANGINA PATIENTS EJECTION FRACTION FALLS 
OCCUR SPONTANEOUSLY AT REST AND ARE MORE SEVERE 
THAN DURING EXERCISE 
Michael R. Freeman, Lingde Yang, Teny W. Hsia, Paul W. Armstrong. 
University of Toronto, Toronto, Ontario, Canada 
The ambulatory ventricular function monitor (VEST) is capable of 
identifying episodes of ejection fraction (EF) fa1l( ~ ) at rest (R) and during 
exercise (EX) in patients with c:oronary artery disease (CAD). To 
investigate severity of R and EX induced EF ~ and its pathophysiology, 
11 stable CAD patients underwent c:ontinuous VEST monitoring both at 
R (l09±28 min) and during treadmill EX using the Bruce protocol. 
Heart rate am), EF, end ayatolic volume (ESV), end diutolic volume 
(EDV), and peak filling rate (PFR) were derived every 30 sec. An EF ~ 
>7 units for >1 min at R or failure of EF rise ~5 during EX was 
c:onaidered abnormal. Of II patients, 8 had abnormal EXEF response 
and 5 of these 8 patients had episodes ofEF ~ at R. In the 5 patients with 
EF ~ at R, the change (0) from baseline in each veriab1e for the 10 
episodes of EF ~ at R and at peak EX are shown in the table: 
BASELINE 
RESTO 
EX 0 
p 
HR EF 
66±lO 63±12 
+3.8±3.9 ·18±8 
+56±l5 -8±1O 
0.001 0.06 
ESV 
40±18 
+20±12 
+19±14 
NS 
EDV 
107±17 
+0.7±5.9 
+29±15 
0.01 
PFR 
2.4±0.6 
·0.7±0.2 
+1.8±0.6 
0.001 
The EX data in patients with EXEF ~ but without EF ~ at R were 
similar to those with EF ~ at R. 
We conclude that spontaneous resting ischemia results in more 
profound left ventricular dysfunction than during EX. Since EF j at rest 
is associated with minimal HR and EDV change, a reduction in coronary 
blood flow seems a likely etiology. By contrast, EF ~ during EX is clearly 
related to an increase in oxygen demand. Spontaneous falla in EF at rest 
are independent of EX performance and may be ofprognoatic importance. 
ABSTRACTS 
905·104 
Bndothelial Dysfunction in Patients with Microvascular 
Angina (Syndrome X) 
Arshed A. Quyyumi, Richard O. Cannon III, Julio A. Panza, 
Stephen E. Epstein. NHLBI, Bethesda MD. 
A subgroup of patients (pte) with chest pain and angio•
graphically normal epicardial coronary arteries (epa) 
have reduced dilator response to metabolic or 'pharm•
acologic stimuli (microvascular angina). We investigated 
whether microvascular endothelial dysfunction is a cause 
of this observed reduced vasodilator reserve. Micro•
vascular endothelial function was tested in 31 normo•
tensive pte by measuring coronary blood flow during 
intrtcoronar~~!ic.) infusions of acetylcholine (ACH) 
(10- H to 10M); endothelial-independent function was 
measurea using ic. nitroprusside (NTP) and the functional 
response was measured during atrial pacing (AP) at 150 
bpm. Great cardiac vein blood flow increased with ACH 
(mean 54 + 41\) and AP (mean 43 + 27\), but the response 
was heterogenous. Pts with depressed dilation with AP 
(microvascular angina) had reduced endothelium-dependent 
dilation with ACH and vice versa (Fig.l). However, 
dilation with NTP was not different between pts with and 
those without reduced dilation with AP (Fig 2). 
Fig. I 
pons 
•• r-O.67 
p<O.OOI 
: .10 '----~---~ U -50 ~o -3(1 ·10 
... ~ Cbaale ill ResiSllDtc·Paciu! 
Thus, pts with microvascular angina appear to have 
endothelial dysfunction of the coronary microvasculature, 
which may account for their reduced vasodilator reserve 
with AP, and thereby for their anginal chest pain. 
905·105 
OXYllen Free Radicals Mediate Cardiac Myocyte Membrane 
Damage and CK-MB Release durlnll episodes of Transient 
Myocardial ischaemia. 
Y Chandra-Shekhar, Nalini Kaul, Y Vijay-Chandra, Inder S 
Anand, Nirmal K Ganguly. Dept of Cardiology & Medicine, 
Postgraduate Institute of Medical Education & Research, 
Chandigarh, India & V A Medical Centre, Minneapolis, Minnesota, 
USA. 
The role of oxygen free radicals (OFR) in transient myocardial 
ischemia (TMI) is unknown. OFR can mediate myocyte membrane 
damage. TMI occasionally releases intracellular enzymes even in 
absence of myocardial necrosis. We evaluated OFR activity in the 
pulmonary artery blood (with the leukocyte chemiluminescence 
technique) during pacing induced TMI in 16 patients of chronic 
stable angina. This was correlated with CK-MB release and serum 
Malondialdehyde (MDA) levels (a marker of OFR mediated 
myocyte membrane injury). 8 patients (Group A) had inducible 
ischemia (Angina or > 2 mm ST depression in more than 2 surface 
ECG leads) while the other 8 (Group B) did not. Both groups were 
matChed for severity of coronary artery disease & ejection 
fra(,ion. OFR activity incr!ased significantly (from 300 ± 20 x 
10 cpm to 461 ± 42 x 10 cpm) only in group A. OFR levels 
peaked just after the onset & normalised within 20 minutes of 
resolution of TMI. MDA levels rose from 12 ± 2 ug/m1 to a peak 
of 32 ± 7 uG/ml, 10 min after the peak in OFR. CK-MB levels 
rose from II ± I to a maximum of 43 ± 4 u/I, 10 min after the 
peak in MDA. All these changes occurred in absence of 
myocardial infarction. There was no change in group B. 
We conclude that transient ischemia induced by atrial 
pacing can lead to OFR generation, cardiac myocyte membrane 
damage and intracellular enzyme release. It is likely that a similar 
process could occur during spontaneous episodes of myocardial 
ischemia. 
61A 
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905·106 
Can Objective IlIIprovelllent in Patients with 
Refractory Chronic Ischelllic Heart Disease Be 
Delllonstrated with Bnhanced Bxterna1 
Counterpulsation? 
William E. Lawson, John C. Hui, Zhen Sheng 
Zheng, Dawn Sasvary, Harold Atkins, David S. 
Kayden, Harry S. Soroff, Peter F. Cohn. 
SUNY Health Sciences Center, Stony Brook, NY 
Enhanced external counterpulsation (EECP) 
augments diastolic pressure, increasing 
coronary flow. It has been postulated that 
the resulting enhanced coronary collateral 
development lessens provokable ischemia but 
evidence has been lacking. Accordingly, 14 
pts with chronic angina (AP) who had failed 
coronary angioplasty, surgery, or medical 
therapy underwent EECP for 5 d/wk for 6 wks. 
Thallium (Tl) stress testing was performed 
pre-and post-therapy to the same exercise 
duration. Ischemic Tl defects resolved in 9, 
improved in 2, and remained unchanged in 3 
pts, with no significant change in heart rate 
or double product. The symptoms improved in 
all pts. The 11 pts with improved Tl scans 
also had graded exercise tests to determine 
exercise tolerance. Results: (mean+SD): 
PreEECP PostEECP 
8.84+.81 10.95+.68* Exercise min 
Double product 
*p<.Ol 
22,645+2,384 25,945+1,939* 
These results support the hypothesis that 
EECP is effective in decreasing ischemia and 
AP, and improving exercise tolerance in 
coronary pts refractory to medical treatment 
and revascularization procedures. 
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906·90 
Radiofrequency Modification of the Critical 
Isthmus in Atrial Flutter 
Francisco G cosio, Maria Lopez-Gil, Antonio 
Goicolea, Jose L Barroso, Federico Lombera. 
Servicio Cardiologia. Hospital Universitario 
de Getafe. Madrid, Spain. 
Endocardial mapping of common atrial 
flutter (AF) has suggested a right atrial 
reentry circuit with an obligatory passage 
between the inferior vena cava and the 
tricuspid ring (IVC-TR). AF interruption by 
modification of this area could afford proof 
of this mechanism. 
In 6 patients (Pt) with sustained (4) or 
paroxysmal (2) AF and typical activation 
maps, we applied 25-63 radiofrequency (RF) 
pulses (20-30 W x 30 s) in 1-3 procedures, to 
the IVC-TR using stilet or deflector guided 
catheters. There were no complications. 
RF terminated AF in 5 instances in 3 
patients. In 3 Pt RF accelerated and/or 
disorganized AF. In 3 instances there was no 
immediate effect. On follow-up 2 Pt remain 
free of AF off drugs for 6 and 14 months 2 Pt 
were controlled on previously ineffective 
drugs for 24 and 12 mo. In 1 Pt AF has 
recurred and 1 Pt developed paroxysmal atrial 
fibrillation. 
These observations support a critical role 
of the IVC-TR ridge in common AF. RF ablation 
of the IVC-TR may be of therapeutic value in 
AF, and appears to be safe. 
906·107 
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A Randomized Comparison of Propafenone versus Sotalol for 
Treatment of Refractol)' Atrial Fibrillation 
Sharon C. Reimold, Peter 1... Friedman, Catherine O. CantilIon, 
Elliott M. Antman. Brigham and Women's Hospital, Boston, MA 
To evaluate the efficacy and safety of new antiarrhythmic agents for 
symptomatic refractory atrial fibrillation (AF) we randomized 99 
patients (63M:36F, age 61± 12 years) who had failed 2!: 1 Type I 
agents to receive either propafenone (PPFN) or sotalol (SOT). 
Patients were stratified into 4 groups based on AF pattern (chronic 
vs. paroxysmal) and left atrial (LA) size (largt24.5cm vs. small <4.5 
em). The number of patients in each group and the proportion 
remaining in sinus rhythm (±SO) after 6 months of therapy was 
call dbth Kal M' od cu ate y e apJan· eler meth 
GROUP PROPAFENONE* SOTALOL* 
#Pts %NSR #Pts %NSR 
Total 49 41±8 50 4Ot8 
Chronic 25 39±1l 28 45±10 
Paroxysmal 24 43±1l 22 4Ot12 
Large LA 25 46±1l 26 51±12 
Small LA 24 34±11 24 34±10 
(Op=NS for all comparisons between PPFN and SOT). Side effects 
led to discontinuation of PPFN in 4/49(8%) and SOT in 
6/50(12%) cases. Conclusion: PPFN and SOT, 2 phannacologic 
agents with different mechanisms of action, are equally effective in 
maintaining sinus rhythm in patients with AF regardless of 
arrhythmia pattern, LA size, or failure of prior drug therapy. The 
frequency of disabling side effects with these agents compares 
favorably with the known profile of conventional Type I drugs. 
906·108 
Efficacy ard safety of a Haor Selective Class III Anti•
anhytIDic Agent D:>fet.ilide in Patients with Paraxysaal 
Atrial Fil:rill.atim or Atrial. Flutter. 
Maarten suttoIp, Peter Polak, Al:"na.Id van 't Hof, Henrik 
RasnJJssen, Peter DJnselman, Herre ~. Depts. of 
cardiology, st Antalius Hospital, Nieuwegein am st 
Ignatius Hospital, Breda, '!he Netherlands. 
Dofetilide is a 1'lIl!Ii class III antiarmythmic agent lobl.c:h 
selectively pro1Cln]S refractoriness wit:hcut any effects 
00 ClClI1ductioo. Efficacy arr:i safety of :iJltravernJs 
dofetilide was stu:tied in 24 pts aged 38 to 70 (55±lO) 
years, with paroxysmal atrial fibrillation (AF) or 
flutter (AF'L) lasting S6 Dalths. pta with a ventricular 
rate >100 beats,tmin am nonnal LV fun:::t:ion entered the 
stOOy. Mean duration of the anhythmia was 42±46 days 
(range 1-150). Two dose levels lo1ere stu:tied: 8 pts 
received an :iJltravernJs infusioo of dofetilide 2.5 
mo;Vkq/15 min am repeated if necessary after 15 min, 
another 16 pts received 4.0 ~lo-15 min usin;J the 
same dose regimen. pta lo1ere c:i:IServed by oc:nt..irJ.nJs m; 
uaU.torin;J. Of pts with AF 10/19 (53%) cxnverted to 
sims thythm (SR) arr:i in 4/5 (80%) pts with AF'L. In the 
lCllo'-dose graJp 3/6 (50%) pts with AF arr:i 1/2 (50%) pts 
with AF'L cxnverted to SR. In the high-dose graJp 
conversion was d:ltained in 7/13 (54%) AF pts am in 3/3 
(100%) with AF'L. Mean time to conversion was 40±52 min 
(range 3-100). Ql'c intervals increased fran 419±37 to 
496±37 msec [p<O.OOl). QRS duration remained un:mnqe:l.. 
Not a sin;Jle adverse experience was noted in these pts. 
In oonclusion, dofetilide _ a potent am safe 
antiarIhythmic agent for ccnvertin1 paroxysmal AF or 
AFL. In particular, its SUCXleSSful c:utoane in usually 
drug resistent AFL frequently requirin;J DC-cardioversion 
is very pranisin;J, arr:i urxlerscores the iJrpor1:aooe of 
selective class III action for the termination of atrial 
reentry tadlyarrtlythmias. 
JACC Vol. 19, No.3 
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906-109 
The Effects of DofetlUde (UK68, 678) on AtrIal 
Repolarlsatlon In Man: EvIdence of Reverse Usa 
Dependence. 
Sean 0' Nunain. Spencer Heald, Demosthenes Katritsis, Sheila 
Gibson, Joan Ward, Ghazwan Butrous, A John Camm. St. George's 
Hospital, london UK. 
Dofetilide (D) is a new Class III antiarrhythmic agent which in vitro 
blocks the time dependent outward potassium current. We 
assessed the effects of 0 on atrial electrophysiology (EPS) in 12 
patients undergoing diagnostic EPS (2VT, 10 SVT) at heart rates of 
both 120 beats and 240 beats/min. Refractory periods and 
monophasic action potential (MAP) durations were assessed 
simultaneously using a combined MAP recording /pacing catheter. 
At a pacing cycle length (PCl) of 500 ms the atrial effective 
refractory period was prolonged from 194 ± (SD)14 to 223 ± 15 ms 
(p<0.005) and the functional refractory period from 228 ± 18 to 271 
± 9 ms (p<0.005). The MAP50 was prolonged from 149± 18 to 175 
± 30 ms (P<0.005) and the MAP90 from 233 ± 27 to 276 ± 32 
(p<o.o05) . 
The MAP50 and MAP90 of the earliest inducible atrial beat 
increased from 119 ± 36 to 138 ± 40 ms (p< 0.05) and from 197 ± 
32 to 240 ± 35 ms (p< 0.005). 
At a PCl of 250 ms dofetilide increased the MAPSO from 112 ± 14 
to 122 ± 20 ms (p<0.05). The MAP90 was prolonged from 182 ± 17 
to 201 ± 25 ms (p<0.05). The percentage prolongation of MAP50 
and MAP90 at 250 ms was significantly less than at 500 ms 10.6 ± 
20.2% v 21.7 ± 18.8% (p<0.05) and 10.8 ± 15.3 % v 23.1 ± 
10.3%(p=0.05) respectively. 
Conclusions: 1) Dofetilide causes a significant prolongation of atrial 
repelarisation and refractoriness. 2) These effects on repolarisation 
are attenuated with increasing hear1 rate. 3) Dofetilide may have 
significant benefit in the termination and prophylaxis of atrial 
arrhythmias. 
906-110 
Differential Effect of Esmolol on Fast and Slow A V Nodal 
Pathways 
G. Neal Kay, Felipe Chong, Andrew E. Epstein, and Vance J. Plumb. 
University of Alabama at Birmingham, Birmingham, Alabama. 
Whether Beta-blockers have differential effects on fast an4 slow A V 
nodal pathways has not been defined. Since fast and slow pathways 
have markedly different conduction properties, the response to B•
blockers may also differ. Antegrade and retrograde conduction 
intervals, effective refractory periods (ERP), and Wenckebach cycle 
lengths of the fast and slow pathways were determined at baseline and 
following esmolol infusion during electrophysiologic study in 5 pts 
with dual pathways and reentrant tachycardia. Esmolol was infused at 
500 mcg/Kg for I minute, 50 mcg/Kg/min for the next 4 minutes, 
followed by a maintenance infusion of 25 mcg/Kg/min. The major 
effect of esmolol was marked prolongation of the fast pathway ERP 
(antegrade ERP in 2 pts and retrograde ERP in 3 pts). In all pts, the 
effect on the fast pathway was greater than on the slow pathway. The 
antegrade ERP of the fast pathway increased by 43 msec (from 347 ± 
41 msec to 390 ± 79 msec) and the ERP of the slow pathway increased 
by 17 msec (from 288 ± 26 msec to 305 ± 23 msec) following 
esmolol. The retrograde ERP of the fast pathway increased by 90 
msec (from 253 ± 8 msec to 343 ± 68 msec). Retrograde slow pathway 
conduction could be demonstrated in 2 pts following esmolol (but not 
at baseline) following marked prolongation of fast pathway ERP. The 
A V Wenckebach CL increased from 393 ± 32 msec to 437 ± 98 msec 
and the VA Wenckebach CL increased from 353 ± 42 msec to 390 ± 
66 msec. The AH interval prolonged from 84 ± 19 msec to 95 ± 18 
msec and the HA interval increased from 93 ± 6 to 114 ± 9 msec. 
Thus, B-blockers have a quantitatively greater effect on the fast than 
the slow AV nodal pathway, though the effect may be greater on 
antegrade or retrograde conduction in different individuals. 
ABSTRACTS 
906·111 
'Dle Effects of Flunarizine at SUpraVentricular ani 
Ventricular Tacbycardias in Man. 
linton Gorgels, Barbara Dijkman, Jeep Smeets, Marc Vos, 
Hein Wellens. 
Dept. of cardiology, Academic Hospital, Maastricht, '!he 
Netherlands. 
Animal . studies have shc:M1 that the calcium overload 
blocker, Flunarizine (F) selectively suppresses ar•
rhyt:hmias based on triggered activity (TA). The effect 
of F in clinical arrhyt:hmias was evaluated in 51 pa•
tients with supraventricular (N=25) am ventricular 
(N=26) tachycardias (T). We define::l effectiveness of F 
as slo.rIDJ follCMed by termination in sustained T am 
as decrease in number of ectopic beats by >75% in non 
sustained T, 
Results: 
'l\1pe of T N F(+) FH 
Atrial T 16 3 13 
Atrial flutter 2 0 2 
AV Nodal T 3 0 3 
circus movement T 4 0 4 
Idiopathic VT 10 3 7 
Ischemic VT 6 0 6 
AIVR 1 1 0 
other etiology VT 7 2 5 
Digitalis intoxication 2 2 0 
Total 51 11 40 
Abbreviation: AlVR= accelerated idioventricular rhythm 
Ccn::lusioos: 1) F terminated T which are thought to be 
based on TA such as digitalis intoxication, AIVR. 2) F 
did not influence reentry T. 3) The mechanism of other 
T in which F was effective is therefore propably TA. 
906-112 
IONTOPHORETIC DEUVERY OF FLECAINIDE INTO INFARCTED 
MYOCARDIUM: HIGH TISSUE CONCENTRATION AND VENTRICULAR 
TACHYCARDIA SUPPRESSION WITH NO HEMODYNAMIC EFFECTS 
Boaz Avttall, John Hare, Cynthia Lesslla, Mohammad Jazayeri, Jasblr Sra, 
Anwer Dhala, Zalmen Blanck, Mila Sheth, Sanjay Deshpande, Masood Akhtar. 
Sinai Samaritan Medical Center, MUwaukee, Wisconsin. 
It has been shown that IontophoretIc OONTO) delivery of procalnamide results 
In high tissue concentrations and Is effective In 8uppresslng VT. Since high 
systemic levels of lIecalnide (FLEC) may lead to marked hemodynamiC and 
electrical abnormalities which result In death, we wished to detennlne K FLEC 
delivered lontophoretlcally directly Into Infarcted myocardium (MI) In high 
concentrations Is electrically effective and hemodynamically safe. FLEC (Sec 
of 10 mglml) was transported Iontophoretlcally for 20 mIn directly Into 7 day 
old MI in 4 dogs. Effective refractory period (ERP), diastolic threshold (OT), 
conduction time (CT) measured from mapping during pacing of Infarcted (INF) 
and normal (Nl) tissues and systemic pressure were evaluated before FLEC 
IONTO and at 30, 60, 120 and 180 min. after drug delivery. 
CT data represents the change from control In msec. 
INF tlHue peeIng NL liHue peeIng 
zone 30 60 120 180 30 60 120 160 
INF *19±9 *46±40 *11±4 *10±2 *27±15 *43±33 *42±29*21±35 
Nl 8±8 5±3 -1±1 -3±3 6±3 11±2 8±3 -4±18 
*p<O.05INFvs. NL 
After 3 hours post FLEC IONTO delivery, transmural tissue levels in the INF 
and NL tissue were 10±21 ,Ugmlgm and O.34±O.2 ,Ugmlgm respectively. 
Venous concentrations were O.026±O.22 ,Ugmlml. ERP and EDT did not 
change significantly in INF or NL and blood pressure remained stable 
throughout. VT was inducible in 2 dogs at cycle lengths of 160 and 210 msec. 
and was suppressed for over 2 hours. When the VT could be reinduced ~ was 
harder. to initiate and easHy tenninated by overdrive pacing. 
ConclusIons: 1. IONTO delivery of FLEC Into the INF myocardium results In 
marked CT prolongation only In the INF area with no CT prolongation In the 
Nl tissues. 2. IONTO delivery of FLEC Is both effective and hemodynamically 
safe with high INF tissue concentrations and only trace FLEC levels in the NL 
tissue and systemic circulation. 
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906·113 
Frequency of Asymptomatic paroxysmal 
Supraventricular Tachycardia in Patients 
Followed by Trans-telephonic Electrocardiogram 
Monitor 
Richard L. Page, william E. Wilkinson, 
Elizabeth A. MCCarthy, Walter K. Clair, Edward 
L.C. Pritchett, Duke University Medical Center, 
Durham, NC 
Trans-telephonic electrocardiogram monitors 
(TTEM) have been used to demonstrate 
antiarrhythmic drug efficacy for the treatment 
of paroxysmal supraventricular tachycardia 
(PSVT) in randomized trials. We prospectively 
tested for asymptomatic PSVT in patients who 
had PSVT recorded previously with TTEM. Ten 
drug-free patients (40±14 yr; 1 male) were 
followed for 4 wk. Five 24-hour continuous 
ambulatory ECG's were recorded (l/wk) to detect 
asymptomatic PSVT (defined as PSVT > 30 sec); 
patients carried TTEM to record symptomatic 
PSVT. Results; Asymptomatic PSVT was not 
observed. Symptomatic PSVT was seen in 5 
patients (28 events). The mean intensity of 
PSVT, expressed as a point estimate of 
events/100d/patient (95% confidence interval), 
was for symptomatic PSVT 10(7,14) and for 
asymptomatic PSVT 0 (0,7) . The rate of 
asymptomatic PSVT is at most 79% that of 
symptomatic and the mean intensities are 
different (p=0.02). Conclusions; In trials 
using TTEM to evaluate the frequency of 
spontaneous PSVT; 1) symptomatic PSVT is more 
frequent than asymptomatic PSVT; 2) the 
majority of PSVT is recorded; and 3) 
asymptomatic PSVT is infrequent. 
906·114 
Diagnostic Value of the Excitable Gap, Resetting Pattern 
and Site of Entrainment in Elucidation of Reentry Pathways 
in Preexcited Tachycardias in WPW·Syndrome 
Mohammad Shenasa, Martin Borggrefe, Jafar Shenasa, Gerd 
Hindricks, Xu Chen, Wilhelm HaverKamp, Giinter Breithardt. 
Westf. Wilhelms· University Miinster, Germany 
Recent observations during intraoperative mapping suggested that 
in some cases of the so-called antidromic tachycardias, 
atrioventricular nodal (A VN) reentry is the underlying mechanism 
of the preexcited tachycardias. To distinguish the mechanism of 
preexcited tachycardias in WPW-syndrome, in 11 patients (pts), 6 
male, 5 female, aged 17 to 49 years, the diagnostic value of 
excitable gap, resetting fattern and site of entrainment was 
evaluated. The presence 0 excitable gap and resetting pattern was 
examined using extrastimulus technique (V2) during sustained 
tachycardia. V2 was introduced in late diastole and coupling 
intervals were decreased by 10 ms until ventricular effective 
refractory period was reached. Entrainment was attempted from 
hi~ ri2ht atrium, coronary sinus and right ventricular pacing. 
With ~2, 6 pts demonstrated atrial preexcitation during the 
excitable gap, a flat or increasing resetting pattern and 
entrainment was achieved from both right and left atrial sites. 
Following transcatheter or surgical ablation of accessory eathway 
narrow QRS (AVN reentrant) tachycardia was still indUCible and 
required selective ablation of retrograde A VN pathway. The 
remaining 5 pts did not demonstrate excitable gap and 
entrainment only achieved during right ventricle pacing. Ablation 
of accessory pathway preventea induction of sustained 
tachycardia. Non·sustained A VN reentry was induced in 1 pt. 
We conclude that presence of excitable gap, resetting and site of 
entrainment can differentiate A VN reentry tachycardia 
(microreentry) with conduction over bystander accessory pathway 
from true antidromic (macroreentry) tachycardia. These 
observations mar have important diagnostic implications in pts 
undergoing ablation of accessory pathways. 
906·115 
JACC Vol. 19, No.3 
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Further Observations on the Transient Linking of Atrial 
Excitation During Atrial Fibrillation in Han 
Edward P Gerstenfe1d, Alan V Sahakian, Steven Swiryn. 
Northwestern University, Evanston, Illinois 
The tendency foe wavefronts to follow paths of previous 
activation has been termed linking. We have previously 
reported evidence of transient linking in 9 of 15 
patients during 1 minute intra-atrial recordings of 
atrial fibrillation (AF). In the following study, we 
report further observations on this phenomenon. 
An orthogonal catheter with bipo1es in the x, y, and z 
directions was used to calculate a mean vector for each 
electrogram. For this study, linking was defined as six 
consecutive beats with mean vectors within 30 degrees, an 
event unlikely to occur by chance. To examine whether or 
not the amount of linking was consistent during AF, an 
additional minute of data was analyzed in each patient 
and compared to the previous minute. In 3 patients, two 
simultaneous orthogonal recordings were made to 
investigate the relationship of linking at different 
atrial sites. The direction of multiple episodes of 
linking in each patient was also studied to examine 
whether linking was due to constant (e.g. anatomical) or 
transient (e.g. functional) properties of the atrium. 
Lastly, the relationship between left atrial index (LAI) 
and the presence of linking was investigated. 
There was a significant correlation (r-0.90) between 
the number of episodes of linking in each patient during 
the first minute (range 0-18) and second (0-15). In the 3 
patients with two simultaneous orthogonal recordings, the 
amount of linking was consistent at each atrial site, but 
not between sites. The direction of successive episodes 
of linking was always similar in 4 patients and varied in 
4 others. There was no correlation between LAI and the 
presence of linking at a single site. 
Conclusions: The presence or absence of transient 
linking is a consistent and site specific property of AF 
over short time periods. Patterns of similar and varying 
directions of linking in different patients suggests 
participation of both anatomic and functional factors. 
906·116 
Analysis of the Atrial Cycle Length Variations and the 
Mechanism of the Human Rapid Atrial Flutter 
Ravia Ravelli, Marcello Disettori, Fulvio Cozzi, Renzo Antolini. 
IRST, Medical Biophysics Dept., Trento, Italy 
In a previous study we proposed the analysis of the small variations in 
the atrial flutter cycle length as a tool to investigate the 
electrophysiological mechanism of the common atrial flutter. The 
obtained results suggested a large reentry with a partially excitable gap 
as the mechanism of the common attiaI flutter. In the present study we 
investigate the nature of the atrial cycle length variations in the human 
rapid atrial flutter (type m with the aim to elucidate the underlying 
mechanism of this arrhythmia. 
In 8 patients with rapid atrial flutter (320-375/min), the variations in 
atrial flutter interval were measured from the oesophageal lead. A 
mean atrial cycle length variation of 5.3 msec was found. To study 
whether these variations in flutter cycle were related to the ventricular 
activity, a phase-plot was constructed in which the flutter cycles were 
plotted against the time after the previous QRS complex. It resulted 
that the interval fluctuations were strictly coupled to the moment of the 
ventricular activation. After the ventricular beat, the atrial flutter 
interval gradually decreases by an average of 4.2% (p<O.OO I) and 
reaches a minimum about 500 msec after the onset of the QRS 
complex. 
The hypothesis was formulated that these periodic variations in the 
interval of the rapid atrial flutter following a ventricular contraction 
were caused by the influence of stretch of the atrial myocardium on the 
conduction properties of a reentrant circuit. Since stretch is known to 
decrease the refractory period. the shortening of the atrial interval 
following the ventricular beat suggests a functionally determined 
circuit, characterized by a revolution time determined by the refractory 
period, as the mechanism of the rapid atrial flutter in man. 
JACC Vol. 19, No.3 
March 1, 1992:65A 
906·117 
Double Spikes Electrograms as Markers of Slow 
Conduction during Type I Atrial Flutter: Importance of the 
Recording Site. 
Nadir Saoudi, Herve Poty, Fran,<oise Hidden, Rene Koning, Brice 
Letac; Hopital Charles Nicolle, Universite de Rouen, FRANCE. 
Endocardiar double spikes electrograms (DS) during type I 
atrial flutter (A F1) are thought to represent recording of two activation 
wavefronts travelling in opposite direction on each side of a 
functionnal arc of block, but other data suggest that they may also 
represent linear propagation through an area of local depressed 
conduction. We reviewed the mapping data of 15 Patients (pts), mean 
aged 36 to 75 y, referred for transvenous electrical interruption of type 
I A FI. Mean A FI cycle length was 235 ms (210-280). DS were 
constantly found in the low postero septal (LPS) and the high lateral 
area (HLA) of the right atrium with local electrogram duration of 
respectively 108 ± 42 and 91 ± 16 ms (p = ns). Spontaneous second 
degree local block (SDB) between the two components of the double 
spikes were recorded in 7/15 Pts without influencing A Fl. These 
were 7 :6, 6:5, 3:2 and 2: 1 block and were recorded in the HRA (n=5), 
low lateral RA (n=2), and LPRA (n=l). In 3 Pts, HRA SDB was seen 
during transient AF entrainment. Post stimulation cycle after a single 
extrasystole delivered at the DS site yielded a flat pattern of resetting at 
the LPS (5 Pts), and an ascending one (3 Pts), or no effect on AFCL 
(3 Pts) in the HRA. In 11 Pts in whom the procedure was directly 
successfull, we compared electro grams morphology and duration 
during both A FI and sinus rhythm (SR). Double spikes electrograms 
persisted at the same site in the HRA in 8/11 Pts (mean duration = 70 
± 28 ms, p < 0,05 with AF). On the contrary, narrow electrograms 
were seen in the LPRA during SR in 8/10 Pts (mean duration = 49 ± 
13 ms, p < 0,001 with AF, P < 0,05 with HRA during SR). 
Conclusion. The frequent observation of SDB between their 
two components, the possibility of dissociating them from 
tachycardia, as well as evidence for slow propagation during SR 
suggest that double spikes electrograms in the HRA or LLRA most 
likely represent slow yet linear conduction rather than activation of 
both sides of an arc of block. 
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907·82 
Benefit of Intrinsic sympathomimetic Activity 
in patients with Sick sinus Syndrome Treated 
with Beta Blockers S. Adam Strickberger, 
R.David Fish, Kaoru Okishige, Gervasio A. 
Lamas, Catherine cantillon, Satinder Bhatia, 
Noreen McGowan, Elliott M. Antman, and Peter 
L. Friedman. Brigham & Women's Hospital, 
Boston, MA. 
Beta blockers (BB) in patients (pts) with 
sick sinus syndrome (SSS) may prevent 
supraventricular arrhythmias (SVAs) and 
ischemia, but may cause excessive depression 
of sinus node function. BB with intrinsic 
sympathomimetic activity (ISA) in such pts 
might be advantageous. In 8 pts with SSS and a 
permanent pacemaker (PM), the effect of 
chronic oral pindolol (PIND) on sinus rate was 
compared to that of propranolol (PROP) in a 
double-blind cross-over trial. In all pts the 
PM was programmed to a rate of 50 beats/min. 
Holter monitors, obtained at baseline and on 
each drug, were used to calCUlate percent of 
hours paced (% HRS), maximum number of paced 
beats per hour (MAX PB/hr), and average paced 
beats per hour (AVPB/hr). 
~ MAX PB/hr AVPB/hr 
PROP 86±32 1871±1225 837±886 
PIND 64±42 736±1121* 385±737+ 
*,+ p < 0.05,by paired T-test and Wilcoxon 
signed-rank test 
Thus, PIND as compared with PROP, results 
in a reduction of MAX PB/hr and AV PB/hr in 
pts with SSS. BB with ISA, like PIND, cause 
less sinus node depression and may obviate the 
need for PMs in pts with SSS. 
ABSTRACTS 
907·83 
Can Pre-ejection Interval Determined by Right 
Ventricular Impedance Predict Changes in Left 
Ventricular Pre-ejection Period? 
Robert E.Sperry, Carolyn A.Burns, Regina R.Rogerl, Ken A.Ellenbogen, 
JV Nixon, and MarR Wood. Med Coll Virginia, Richllond, VA. 
The pre-ejection interval (PEl) derived 
from impedance measurements in the right 
ventricle (RV) is used as a closed-loop .ensor 
for rate responsive pacing. studies have ahown 
that the RV PEl ahortens with both physiological 
and pharmacological stress. The relationship 
between RV PEl and the left ventricular (LV) pre•
ejection period (PEP) is unknown and could vary 
due to conduction system disea.e or structural 
heart diaease affecting predominantly one 
ventricle. 
We studied 6 patient. with previously 
implanted Precept pacemakers (Cardiac Pacemakers 
Inc., st. Paul, MN). All pacemaker. were 
implanted for Mobitz II or third degree AV block. 
With pacemakers programmed in the DOD mode, PEl 
was determined by pacemaker telemetry of 
intracardiac impedance and the PEP 
echocardiographically as the time from QRS onset 
to doppler flow in the LV outflow tract. Both PEl 
and PEP were determined at AV intervals of 150, 
200, and 250ms at the baseline heart rate and 
during AV pacing at rate 100 b.p.m. This was 
repeated with lower body negative pressure 
(LBNP), and 25\ maximal handgrip (MHG). Using 
linear regression analysis, PEl and PEP were 
found to correlate during AV pacing (p-.006,r-•
.49), LBNP (p<.001,r&-.629), LBNP/AV pacing 
(p=.003,r--.591), MHG (p=.005,r--.459) and MHG/AV 
pacing (p=.041,r--.381). Conclusion; Impedance 
based PEl measurements in the RV and echo 
determined PEP correlate with varying AV 
intervals and physiological maneuvers. 
907·84 
Automatic sensitivity Adjustment 
A New Approach for Cardiac Pacing 
Ludwig Binner, Matthias Kochs, Siegfried Wies•
hammer, Peter Richter, Vinzenz Hombach. 
University of Ulm, Ulm, Germany. 
The feasibility of an automatic sensitivity 
adjustment (autosensing) was studied in 21 
patients (pat). 14 pat were implanted with a 
dual chamber pacemaker (Intermedics Relay 294-
03) and 7 pat had a single chamber unit (Inter•
medics Dash 292-03). The autosensing feature 
was initiated using a special programming 
module. Measurements of P- and R-wave amplitu•
des, exercise tests, Holter monitoring and 
special provocation manoeuvres were performed 
during programmed sensitivity setting and during 
autosensing in the unipolar mode and the bipolar 
mode, respectively. Results: 1) There was no 
difference in P- and R-wave amplitudes regard•
less of whether these values were determined by 
conventional sensitivity setting or by the 
autosensing feature. 2) Ventricular oversensing 
caused by muscle noise interference occurred at 
sensitivity settings up to 3.0 mV during unipo•
lar sensing. No interference was observed using 
the autosensing mode. 3) Muscle noise inter•
ference detected by the atrial channel occurred 
in 9 pat during provocation manoeuvres and in 4 
pat during Holter monitoring. 
Conclusions: Autosensing provides regular detec•
tion of P-waves, R-waves and PVC's. Low P-wave 
amplitudes require bipolar sensing because of 
muscle noise interference associated with the 
unipolar mode. 
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907·85 
Hemodynamic Effects of Ventricular Contraction Sequence by 
AV Junctional Pacing In Patients with SSS 
Changzong Cui, Dingyi Yang, Wen Fu, Quangfa Zhang, 
Yuanzhuan Guan, Peng Hun, Yuben Wang, Yi ngzhuon Huang, 
Cardiovascular Institute, Xian Medical Univ., Xian, China. 
Previous studies indicate that AV sequential pacing may be 
preferable as the result of improved diastolic ventricular 
filling due to synchronized atrial contraction. However, 
the hemodynamic benefits of ventricular sequential activa•
tion and contraction have not been well documented. In 
order to determi ne the importance of ventri cul ar 
activation/contraction sequence on hemodynamic changes, 
we investigated 9 patients with sick sinus syndrome (555), 
aged 55-69 years, heart function normal, mean heart rate 
48±5 (38-56) bpm. AV junction pacing (AVJ) , right atrial 
pacing (RAP) and right ventricular pacing (RVP) at mean 
pacing rate 80±9 (70-96) bpm were done prior to implanta•
tion of atrial demand pacemaker (AAI). The cardiac output 
(CO), Cardiac Index (CI), right atrial pressure (PRA), 
right ventricular pressure (PRV) and pulmonary wedge 
pressure (PWP) were measured by Swan-Ganz thermodilution 
catheter and pressure recorded starting after 5 minutes of 
each pacing. Results follow, with mean ± SO, and t-test 
comparisons of RAP to AVJ and RVP. (*P < .01, #P < .05) 
~ CI(L/m/M2) PRA(mmHg) PRV(mmHg) PWP(mmHg) 
RAP 6.2±1.7 3.4±.7 7.4±1.7 29.6± 6.5 10.4±6.5 
AVJ 5.7±1.7* 3.2±.1* 11.4±4.6# 25.4±11.7 12.9±2.5# 
RVP 5.2±1.6* 2.9±.7* 10.9±5.3# 30.4± 6.0 15.2±3.8# 
Ventricular activation/contraction sequence accounts for 
10% of CO increase and PRA and PWP reduction. AV 
synchrony is responsible for 9% of CO increase and PRA and 
PWP reduction. Therefore, sequential ventricular contrac•
tion is as important as AV synchrony. We conclude that 
with AV synchrony and sequential ventricular contraction, 
RAP (AAI) pacing showed much better hemodynamic benefit 
than RVP (VVI) and AV sequential pacing. 
907·86 
Isolated long PR Interval as only Indication or permanent DDD 
pacing 
Philippe Mabo, Serge Cazeau, Anne Forrer, Corinne Varin, 
Christian De Place, Fran~ois Paillard, Claude Daubert. 
University Hospital, Rennes, France. 
There is general agreement that pacemakers are not indicated in 
isolated I.st degree AV block (ACC/AHA Guidelines, 1991). 
However very long PR interval may result in severe hemodynamic 
impairment in some patients. 
4 pts, mean age 69, only I with organic heart disease, complained of 
severe exercise related symptoms. Resting ECG showed a very long 
and constant PR (410%45 msec) and no A wave was seen on 
Echodoppler Transmitral Flow (ETF). 
Exercise time was very short during cycloergometer testing and there 
was no adaptation of PR to Heart Rate, resulting in a paradoxical 
increase in PRIRR ratio inducing P waves immediately after or 
within the R wave of the preceding cycle. 
After implanting a DDD pacemaJcer to restore normal AV 
synchrony, A wave reappeared at ETF. Hemodynamics were 
measured at rest and during submaximal exercise, before and after 
implant. 
PM OFF PMON 6 P 
NYHA class (II1II1IIIIV) 0/11211 11211/0 
Resting HR (bpm) 92±13 74:1:9 -20% <0.05 
End Exercise HR 113:1:12 111:1:15 ns 
Time of Ex (sec) 303:1:35 520%113 +72% <0.02 
CO Ex.(I/min) 7.6:1:1.3 9.8:1:2.1 +29% <0.05 
PCWP Ex (mmHg) 15:1:12 10%7 -33% <0.05 
These results show that in selected patients, very long PR interval 
may have deleterious hemodynamic consequences and may justify 
alone the implantation ofa DDD pacemaJcer. 
907·87 
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Difference. in Chronic Sensing Thresholds 
during Sinus Rhythm and Tachycardia: 
Implications for Antitachycardia Pacing. 
Janet M McComb. stuart Jameson. 
Freeman Hospital, Newcastle upon Tyne, UK. 
It is important that intracardiac electro•
grams are appropriately sensed during both 
sinus rhythm (SR) and tachycardia by an 
,antitachycardia pacemaker or defibrillator. 
We have measured atrial sensing thresholds 
during SR and supraventricular tachycardia 
(SVT) in 28 patients (pts) with implanted 
pacemakers (Intermedics Intertach 262-12 in 17 
(gp I) and -16 in 11 (gp II». Measurements 
during both SR and SVT are available in 8/17 gp 
I pts and in 8/11 gp II pts. There was no 
significant difference in sensing threshold 
during SR and SVT in either group (gp I 1.8±0.1 
vs 1.7±0.3, gp II 2.6±0.3 vs 2.3±0.3 mv, p=ns). 
However, in individual pts, the threshold fell 
during SVT compared with SR in 6/16 (37%: 3 gp 
I, 3 qp II), remained the same in 6 (37%: 3 qp 
I, 3 gp II), and rose in 4 (25%: 2 gp I, 2 qp 
II). The change in threshold was ~ 2 points on 
the available scale in 8/16 (50%). Measurements 
were made on ~2 occasions in 10 pts. There was 
no significant difference in either absolute 
thresholds, or in changes between SR and SVT. 
Sensing threshold during SVT cannot therefore 
be assumed from the sensing threshold during 
SR. The threshold during SVT may be either 
higher or lower than that in SR. This may lead 
to either failure to detect SVT or to 
inappropriate sensing and pacing during SR with 
induction of SVT. 
907·88 
Distinction of local Latency and Conduction Time During 
Programmed Electrical Stimulation In the Human H.art 
Michael R. Franz, Bellina Koller, Paulus Kirchhof, Allen Solomon, Ross 
D. Fletcher. Georgetown University and VAMC, Washington, DC. 
Current electrophyslologic pacing and reoording techniques cannot 
accurately differentiate between local stimulus response latency (ll) 
and conduction lime (CT) of the propagated response. This limitation is 
due to interference between electrical stimulus artefact (SA) and local 
response as well as to the usually large spacing between pacing and 
recording electrodes. We used a new catheter which combines 
monophasic action potential recording alectrodes and pacing electrodes 
in immediate vicinity (1 mm spacing), yet produces minimal SA due to 
extremely low pacing thresholds. During regular pacing, the SA was 
superimposed onto the upstroke phase of the MAP recording; i.e. LL was 
zero. With extrastlmulation at successively decreasing coupling 
Intervals, there was a progressive separation between the SA and the 
elicited MAP upstroke; I .•. LL occurred. In the presence of class I 
antiarrhythmic drugs LL occurred earlier, I.e. at longer coupling 
intervals, and the magnitude of LL Increased. 
Co"pIjDQ Interval 
Baseline 
Class I drugs 
lOP 
1.6:1: .3 
5.8± 2.12) 
50 20 
1.9± .7 5.5± 1.41) 
7.7± 2.32) 11.4± 3.22) 
o 
11.8± 1.81) 
20 ±5.92l 
all values in msec; 1) p<O.Ol VB. 100 and 50; 2) p< 0.01 VB. baseline; n-12 
Cpnclusions' 1) LL may represent a substantial part of what is usually 
considered CT between pacing and recording sites, I.e. the delivered 
coupling Interval may not equal the true coupling Interval; 2) 
progressive Increase In LL may curb the targeted coupling Interval (gap 
phenomenon); 3) class I antiarrhythmic drugs Increase LL; 4) LL 
should be considered In pace mapping lor accurate comparison of CT 
before pacing with that during pacing. 
JACC Vol. 19, No.3 
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907·89 
Reasons for Reprogrlllllling Dual Chamber Pac_ers to VVI lIOde 
- A Retrospective Review Using a Coaputer Database. 
Rafe Chamberlain-Webber, Ann Ingram, Lyn Briers, Rafique 
Ahmed, Mark Petersen, Richard Sutton. Westminster Hospital, 
London, UK. 
This unit's pacemaker data base (PATlENTLOG - Siemens) was 
used to determine the reasons for reprogramming implanted dual 
chamber pacing systems to the VVI mode following hospital 
discharge after first implant. Out of a total of 771 recorded 
dual chamber implants to the end of 1990 [37.8% complete heart 
block (CHB). 15.4% impaired atrioventricular conduction (AVB). 
29% sick sinus syndrome (SSS), 10.7% carotid sinus syndrome 
(CSS) and 6.8\ vasovagal syndrome (VVS)l. only 35 (4.5%) were 
programmed to VVI. The mean follow up time for these patients 
was 40.37±30.9SD months (range 2 - 116) and the mean time from 
implant to the change of program to VVI was 26. 36±29 months 
(range 0 - 100). The diagnostic category of patients changed 
to VVI was CHB 45. n, AVB 5.7%. SSS 34.2%. CSS 11. 4t and vvs 
2.8%. The reasons for change to WI "mode were atrial 
arrhythmias 71.4\ (atrial fibrillation or flutter·AF). or 
atrial lead problems 28.6 \. 19% of dual chamber implants had 
been programmed DOl from time of implant, of whom 42.8% had 
brady-tachy syndrome and were at excess risk tor AF, but none 
had to be reprogrammed. 
Number AF Atrial lead problem 
at risk 
SSS 224 
CHB 292 14 
AVB 119 
CSS 83 
VVS 53 
conclusions: 
dis•
placement 
2 
o 
sense 
fail 
o 
exit 
block 
1 
o 
o 
o 
o 
lead insulation 
fracture fail 
o 1 
1. In dual Chamber systems the need to reprogram 
to WI for atrial arrhythmias is infrequent. 
2. AF is more common following dual chamber 
implant in patients paced for CHS compared with SSS. This may 
be related to the paCing policy and duration of follow-up of 
this unit. 
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908·77 
Detection of Restenosis After Coronary Angioplasty. Role 
of the Dobutamine Stress Test 
Isabel Coma·CaneUa, Nicolas Sobrino, Luis Calvo. 
La paz Hospital, Madrid, Spain 
To investigate the role of the dobutamine stress test for the detection of 
restenosis following coronary angioplasty (PTCA), 50 patients with 
previous angina underwent the test 15 days, 2 and 6-8 months after 
successful PTCA over 61 arteries (1 artery in 40 patients, 2 in 9 and 3 
in 1 patient). Coronary angiography was perfonned within 15 days 
after the last test. In 14 patients it was done before the 6th month 
because of severe angina or a strongly positive test. Dobutamine was 
infused in doses of 5,10,15,20 and up to 40 v.g!Kg/min every 5 min, 
with 12-lead ECG and cuff blood pressure control (baseline, at the end 
of each dose,S and 10 min after the last dose). The tests were positive 
in case of ST shift ~ 1 nun after the J point or angina. 
Results: the test was positive in 26 patients, 20 of them having angina, 
and negative in 24, all without angina. All but 1 patient with a positive 
test and 9 with a negative one had restenosis or new lesions ~ 50%. 
There was 1 false positive test and 9 false negative: 2 of them had 
restenosis in 1 of the 2 dilated vessels, 3 patients had mild «60% 
lesions, and 4 severe ~ 70%) lesions. The sensitivity of the test to 
detect stenoses ~ 50% (without distinction between restenosis or new 
lesions) was 74%, specificity 94% and diagnostic efficacy 86%. 
Conclusion: the dobutamine stress test with ECG control is useful for 
the detection of restenosis or new coronary lesions after PTCA. It may 
be a good alternative to exercise test. 
ABSTRACTS 
908·78 
Prognostic Value of Serial Exercise Radionuclide 
Angiography in Patients With Coronary Artery Disease 
Hari Chaliki, Todd Miller, Timothy Christian, Kent 
Bailey, Raymond Gibbons. Mayo Clinic, Rochester, MN. 
The aim of this study was to evaluate the prognostic 
value of serial exercise radionuclide angiography. (EXRNA) 
in pts with previous Q-wave myocardial infarction (MI). 
113 medically-treated pts (105 men, B women, median age 
62 years) underwent first EXRNA > 3 months post MI and 
second EXRNA a median duration of 15 months later. There 
were 15 events (6 cardiac deaths and 9 MIs) during a 
medidn follow-up of 38 months after the second EXRNA. 
Worsening exercise performance between the two EXRNA 
studies was defined by 1) decrease in serial exercise 
ejection fraction by > 5% (Lower EXEF > 5%); 2) Worsening 
serial exercise wall motion any region-(Worse RWM); 3) 
Combination of 1 and 2; 4) Change from normal to ischemic 
exercise electrocardiogram (ECG): 
Vari able 
1) Lower EXEF ~ 5% 
2) Worse RWM 
3) Both 1 and 2 
4) Change ECG 
Pts with events 
n=15 {il 
4 (27) 
7 (47) 
2 (13) 
1 ( 7) 
Pts with no events 
n"98 (il 
37 (38) 
62 (63) 
27 (28) 
4 (4) 
A Cox proportional hazards analysis failed to show an 
asso:iation between any of the above variables and 
cardiac events. The results of this analysis were 
unchanged if 19 revascularization procedures after the 
second EXRNA were also counted as events. 
CONCLUSION: Worsening exercise performance on serial 
EXRNA fails to identify pts with prior MI who are at 
increased risk for subsequent cardiac events. 
908·79 
Impreved Accuracy or Se1smocardloarapby Versus ElecIroaIrdloarapby ror the 
Diagnosis or Coroaary Artery Disease During Exercise Stress Testing: 
A Multicenter Study 
Richard Wilson, Virinderjit Bamrah, Joseph lindsay, Markus Schwaiger, Joel 
Morganroth 
Oregon Healtb Sciences University, Port1and, Oregon 
A multicenter study was performed to compare the diagnostic accuracy of a new 
noninvasive technique, seismocardiograpby (SCG), with electrocardiograpby 
(ECG) for the diagnosis of coronary artCl}' disease during exercise stress testing. 
SCG records the seismic waves traasmiued from the systolic and diastolic 
motion of the beart to the anterior chest wall. These seismic vibrations are 
measured by a 1 kg accelerometer placed on the lower sternum before and 
immediately after exercise. Changes in the seismic wave pattern have been 
shown to correlate with changes in ventricular wall motion induced by ischemia. 
Tbere were 5 participating centers that enrolled 129 patients in wbom coronary 
angiography had been performed witbiD 3 months of the exercise test. A past 
history of myocardial infarction was present in 26% of patients. Patients with 
bundle branch block, recent myocardial infarction or angioplasty were excluded. 
ECOs and SCOs were performed during the _e exercise test. Interpretation 
of the ECG and SCO was performed without knowledge of clinical or 
angiograpbic findings. A 50% luminal diameter stenosis in a major epicardial 
coronary artery was considered abnormal and was present in 89/129 patients. 
Peak exercise beart rate averaged 85% of the age-predicted maximum beart rate. 
Sensitivity (sens), specificity (spec), as well as positive (+) and negative (-) 
predictive values (PV) were: 
Sens Spec +PV .pv 
ECG .44 .80 .83 .39 
SCO .73 .78 .88 .56 
P value .0001 NS NS .009 
Conclusion: Exercise SCG significantly improved sensitivity without loss of 
specilicity compared with exercise ECG. Thus, SCQ is a simple, easy·ta-use 
technique which may be a useful adjunct to exercise ECG for noninvasive 
diagnosis of coronary artery disease. 
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908·80 
Correlation of Anglographlc Eatlmates of Myocardium In 
Jeopardy With Computp.r ECG Scores 
Michael Rodriguez, Minas Kochumien, James Wallis, 
Jeffrey Froning, Victor Froelicher. Long Beach VA Medical 
Center, Long Beach, California 
We analyzed the stored digital exercise ECG data on 147 men 
who had undergone exercise testing and cardiac 
catheterization. Using 70% luminal occlusion as criteria, 95 
patients had significant disease. None were receiving digoxin, 
had a myocardial infarction, or exhibited LBBB, LVH, a waves 
or ST depression on their resting ECG. ST measurements 
were made at STO and ST60 with slope measured in between. 
Analysis was performed using our own averaging and 
measurement software at rest, and at every 30 seconds 
through exercise and six minutes into recovery in leads II, V2, 
and V~. An angiographic score from 0-12 based on the 
number and location of coronary artery lesions ~ 70% was 
calculated. This score was correlated with ST integral, ST/HR 
index, the ST areas of the Hollenberg Score, the Hollenberg 
Score, and traditional unadjusted ST measurements. The 
following R values and SEE were obtained (all regression lines 
were significantly different from zero): 
B 
ST Integral 0.19 
ST/HR Index at ST6C in V5 0.22 
ST/HR Index at STO in V5 0.19 
Hollenberg Score 0.36 
Hollenberg Areas 0.33 
Traditional Method 0.34 
SEE 
3.48 
3.46 
3.48 
3.32 
3.35 
3.34 
Conclusion: Simple ST measurements correlated with the 
coronary artery score as well as or better than the more 
complex measurements or scores. 
908·81 
Exercise end Anglographlc Predictors of Disease Severity and 
Survival In Patlenta With Coronary Artery Dlseese 
Takeo Kawaguchi, Paul Ribisl, Jonathan Myers, Charles Morris, Kenji 
Ueshima, Victor Froelicher. Long Beach VA Medical Center, Long 
Beach, California 
In order to determine whethe: disease severity and 5 year survival of 
patients wtth coronary artery disease (CAD) could be predicted using 
clinical and exercise treadmill testing (ETT) data, we analyzed data 
from 595 male patients who ;lad undergone both Err and cardiac 
catheterization. Left main (LM) disease (~50% stenosis) was present 
in 42 patients while 30 patients had left main equivalent (LMEQ) 
disease (~70% stenosis of both proximal LAD and LCX). These 
patients were subdivided Into six anglographic groups: no CAD, one 
vessel disease, two vessel disease, LM/LMEQ wtthout significant 
~70%) RCA'lnvolvement, three vessel disease, and LM/LMEQ wtth 
RCA involvement. Significant differences in clinical, hemodynamic, 
and electrocardiographic measurements were observed wtth 
progressively increasing disease severity. 
*p<0.05, **p<0.01. (mean±SE) 
n EF** maxHR* maxSBP** ST dep*· METS* Survivll 
(%) (lmin) (mmHg) (mm) rate(%} 
no CAD 15265±1 1:30±2 166±3 0.7±0.1 7.0±.3 93.1 
1 vessel 18261±1 124±2 163±2 1.1±0.1 6.9±.2 89.0 
2 vessel 121 58±1 1~'!±2 158±3 1.2±0.1 6.8±.2 87.9 
LM/LMEQ-R 26 61±4 122±5 151±6 1.3±0.3 6.1±.6 90.9 
3 vessel 67 55±2 124±3 152±4 1.7±0.2 6.0±.3 79.7 
LM/LMEQ+R 46 54±2 121±3 148±4 2.4±0.2 5.5±.4 61.9 
Using Kaplan-Meier analysiS, the subgroup wtth the poorest survival 
was LM/LMEQ wtth RCA disease, and the three vessel group had a 
poorer survival than other subgroups (p<0.01). Stepwise regreSSion 
analysis revealed that the most powerful predictor for CAD severity 
was exercise-induced ST depression (p<0.OO1), but it poorly predicted 
survival. Low EF was the strongest predictor of survival by stepwise 
Cox regression analysis (p< 0.001). Thus, ST depression predicts 
disease severity, but not survival, whereas the strongest predictor of 
survival was EF. 
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909·43 
URIDIHE, A NEW MARKER OF VIABILITY Iii THE ISCHEMIC 
MYOCARDIUM:COMPARISON IiITH DEOXYGLUCOSE 
Hiroyuki Yaoita, A. J. Fisch.an., Michito lanke, Tomiyoshi 
Sai to, Yukio Maruyaaa. Fukushin Medical College, Japan and 
*Massachuset ts General Hospital, Boston, USA. 
Uri dine (UR) is a precursor of uracil vhich incorporates 
into ribonucleic acid (RNA) specifically. Compared to 
deoxyglucose (DG), UR may be a lore potent candidate for a 
detector of Iyocardial viability sinre its uptake in the 
viable cell is not affected in the presence of abnormal 
glycolysis. To clarify general characteristics of UR, 
Iyocardial uptake of H-3 UR vas co.pared to that of C-14 DG 
in the non-diabetic but ischemiC heart. The left coronary 
artery of 15 rats vas occluded for 5, 10 or 60 min followed 
by reperfusion. At 5 hours, UR (60uCi) and DG (2 uCi) were 
administered intravenously (Lv.), and then sacrificed 45 
lin later. ThaI I ium-201 (100 uCi) was injected Lv. 2 min 
before sacrifice as a flow marker. Left ventricles were 
divided into 225 segments and ischemic I normal myocardial 
uptake ratios (lIN) were calculated. Histopathological 
examination was erformed to detect ischemic in 'ur .Resul ts: 
~~~~~~~===-i""'=:¥""'"":~""'" Y : liN of Un 
::-'-'--:-:-:'c:...:o!-7""''''-':--:---:---:-:t--::---:'-:::-- x : I I N 0 f D G * r = 0.90 
UR retention was observed in segments of enhanced DG uptake 
while decrease in UR uptake accompanied with decrease in DG 
uptake. Thus, UR is a marker of viability in the ischemic 
heart. Considering the lechanisl of UR uptake, UR laY be a 
new lIYocardial iaaging agent by which viability can be 
detected also under the abnormal glycolytic state. 
909·44 
Effect of Ischemia at Rest on Myocardial 
Sympathetic Nerve Integrity in Humans 
Josef Machac, Shankar Vallabhajosula, John 
Gatley, David Schlyer, Nora Volkow, Alfred Wolf, 
Stanley J. Goldsmith, J. Anthony Gomes, Richard 
Gorlin. Mount Sinai Medical Center, New York, 
New York and the Brookhaven National Laboratory, 
Upton, New York 
Myocardial uptake of 1-l23-metaiodo 
benzylguanidine (M1BG) has been shown to be an 
indicator of the integrity of myocardial 
sympathetic innervation. Experimentally 
produced ischemia has been shown to produce 
sympathetic denervation/dysfunction in dogs. We 
wished to study the integrity of myocardial 
sympathetic innervation in regions of chronic 
resting ischemia in humans. Eight (8) patients 
with a history of ischemic injury and suspected 
hibernating myocardium were imaged with N-13 
ammonia (NH3) and F-18 fluorodeoxyglucose (FDG) 
by positron emission tomography (PET) and with 
1-123 M1BG by single photon emission tomography 
(SPECT). The LV was divided into 5 regions and 
scored visually for tracer uptake. All eight 
patients had regions of scarring by PET (matched 
NH3 and FDG defects). Seven (7) of these had 
impaired regional M1BG uptake. Seven (7) 
patients had a total of 10 regions with resting 
ischemia (FDG/NH3 mismatch). Six (6) of these 
patients had eight (8) regions wi th a 
corresponding defect in MIBG uptake. Thus, 
resting ischemia, as well as scarring, 
documented by metabolic PET imaging, leads to a 
loss of regional sympathetic nerve function in 
humans. (Supported by the HRF,DOE/OHER) 
JACC Vol. 19, No.3 
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909·45 
Myocardial Protein Metabolism: Potential Importance of 
Including Plasma It .Ketoisocaproate in a [l·14C]Leucine 
Model for Positron Emission Tomography 
Edmund M. Herrold, Steven M. Goldfine, Pat B. Zanzonico, 
Arthur J.L. Cooper, Alan S. Gelbard, Norman M. Magid, 
Jeffrey S. Borer, Cornell Medical Center, New York, New 
York 
Positron emission tomography with appropriate metabolic 
kinetic modeling may be useful in non·invasively evaluating 
rates of cardiac protein metabolism~. To develop such 
a model, [1)4C]leucine(1eu) uptake and catabolism were 
quantitated and modeled in the normal rabbit heart. 
Intracellular leu was 3% of total myocardial activity 30 min 
after a 40·min infusion of 100 Ii Ci of [1)4C]leu. It ·keto•
isocaproate(kic), an intracellular leu catabolite, was 2% of 
total activity from the end of infusion to 30 min post-infusion. 
Plasma levels of kic (% soluble counts) were 2% at 5 min 
and 6% at 40 min during the infusion. These levels increased 
to 7.7% at 10 min and 21% at 30 min post-infusion. Results 
were analyzed with the Phelps model for brain leu 
metabolism, which includes plasma(Pl), cytosol(C), and 
protein(Pr) compartments for leu and a cytosol compartment 
for kic. Preliminarily calculated rate constants were: Pl-
leu> C-leu: 0.032 min·l ; PI-leu < C-leu: 0.050 min'l; C-leu > Pr•
leu: 0.16 min· l ; C-leu>C-kic: 1.5 min'\ which predict 
observed data well (p < .002). These results suggest that the 
Phelps model is applicable to heart but might be optimized 
by including a plasma compartment to account for increasing 
plasma activity from kic. 
909·75 
Biochemical Validation of a C·ll Acetate Tracer Kinetic 
Model for Oxygen Metabolism in Ischemic Myocardium 
Chin K. Ng, Sung·Cheng Huang, Heinrich R. Schelbert, Denis B. 
Buxton. UCLA School of Medicine, Los Angeles, California 
A compartment model for [}.IIC] acetate (Ac) has been validated 
biochemically in perfused rat heart only in normoxic conditions (Ng et 
aI., JNM 32(5):910, 1991). To determine the applicability of the 
kinetic model to ischemic conditions, rat hearts were Langendorff 
perfused at a constant flow of 20 % of normal. A bolus of 50 IlCi C-
14 Ac was introduced to the aortic root, and the hearts were then 
freeze-clamped at liquid nitrogen temperature at 2 min, 10 min, 20 
min, or 40 min. Pulverized tissue was assayed for C-14 C02 by 
phenylethylamine absOIption. C-14 aspartate (Asp), glutamate (Glu), 
glutamine (Gin), and non-amino acid (non-AA) were determined by 
HPLC on neutralized tissue extract. Glutamate labelling at the C-I (C•
I G) and C-S (C-S G) positions was determined enzymatically. The 
tissue distribution of each metabolite expressed in % total radioactivity 
is shown below. As in normoxic myocardium, Glu was the major 
component and Gin increased slowly with time. 
2 min 
10 min 
20 min 
40 min 
n C~% non-AA% Asp% C-I G% 
3 7±2 25±5 25±1 0.9±O.l 
3 8±1 28±6 J3±1 10±2 
3 16±2 30±4 J3±3 l2±5 
3 8±2 25±6 14±3 23±2 
C-5G% 
43±7 
41±4 
27±4 
18±6 
Gln% 
-0 
-0 
4±1 
1l±3 
C-lI Ac tissue residue curves were acquired externally in a second 
series of hearts with a pair of Nal detectors. Residue curves were 
fitted well by the kinetic model. Based on the model fitting, the 
predictions for the major compartments agreed closely with the 
corresponding biochemical assay data, supporting the validity of using 
the previously developed tracer kinetic model for ischemic 
myocardium. The model estimated rate constant corresponding to the 
oxidative flux correlated well with myocardial clearance rate (k) 
determined from the tissue kinetics. We conclude that k is a reliable 
index of MV~ in ischemic myocardium in C-II acetate PET studies. 
ABSTRACTS 
909·76 
Abnormal Distal Vessel Bebaviour in Infarcted and Normal 
Myocardium After Tbrombolysis. 
Neal G. Uren. Tom Crake, David C. leCroy, Ranil de Silva. Graham J. Davies, 
Attilio Maseri. Hammersmith Hospital. London, UK. 
Recovery of myocardial blood flow (MBF) after thrombolysis for transmural 
myocardial infarction (MI) was investigated using dynamic positron emission 
tomography (PET). 12 patients (pis) (10 male), mean age 61 years, were 
studied 8.2 days (range 4·13) after MI. PIs received inttavenous streptokinase 
0.5 MU) 4.7 hours (range 2.0·7.8) after the onset of chest pain. Mean peak 
creatine kinase was 2855 iU/I (range 484-6102). Residual coronary stenosis 
diameter (range 59-81 %, 3 occluded) was measured by quantitative angiography 
25 days (range 7·122) post MI. The infarct-related artery was the left anterior 
descending in 7 pts, the right coronary artery in 4 pts and left ciIcumflex artery 
in I pI. Six pis had positive ~Imm ST segment depression) exercise tesls at 7 
days. Regional MBF was assessed by multiple slice PET using H2150 at rest 
(MBFr, in mVmin/g) and after dipyridamole. 0.5 mg/kg over 4 min. and the 
regional coronary flow reserve (CPR; maximum/rest MBF) was determined in 
infarcted areas and in remote areas which were supplied by an angiographica1ly 
normal artery. Regions of interest (ROI) were drawn on the images of 
exttavascular density and dynamic flow. By definition, total anatomical tissue 
fraction [A TFJ (glml of ROI) = perfused tissue fraction [PTF] + non-perfused 
tissue fraction. The ratio of P1F/ A TF fa- each ROI was determined in infarcted 
and remote areas, and expressed as an index of perfused tissue (PTI). Results 
were (mean±SD); 
BQl 
Infarct 
Remote 
Mllli 
0.83±O.21 
1.l1±O.33· 
tfB. 
1.14±O.52 
l.52±O.38· 
fIl 
0.79±0.25 
0.97±O.20· 
• p<O.OS vs Infarct 
The CPR in the infarct region was very variable, 1.0 to 2.1, with no correlation 
between CPR and residual coronary stenosis diameter. There was a correlation 
between CFR and PTI in the infarcted (R=O.62, p<0.05), but not in the remote 
regions. In comparison, in another group of 8 pis with coronary artery disease, 
CPR in myocardial ROIs supplied by angiographically normal coronary arteries 
was 2.94±O.51 (p<0.05 vs. remote ROI after MI). 
In conclusjon CPR in the infarcted region is not dependent on residual 
stenosis severity, but does relate to the amount of perfused tissue. CPR is 
decreased in normal regions remote from the site of infarction. This 
impairment of CPR may be due to alteration in distal vessel reacitvity. 
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910-46 
Age-associated Accumulation of Deleted Mitochondrial 
DNA in the Human Heart: A Contributory Factor to 
Presbycardia 
Kazuki Hattori, Satoru Sugiyama, Mika Hayakawa, Toshihiro 
Obayashi, Masaaki Takasawa, Takayuki Ito, Takayuki Ozawa 
University of Nagoya, Nagoya, Japan 
Although cardiac function is known to deteriorate with age (aged 
heart: presbycardia), the mechanisms remain unknown. Since 
mitochondria produce adenosine triphosphate (ATP) exclusively, 
mitochondrial dysfunction is of primary importance in organs 
demanding a high energy supply such as the heart. Mitochondria are 
unique organelles that contain their own DNA (mtDNA). Recent 
advances in molecular biology revealed that the mutation rate of 
mtDNA is much higher than that of nuclear DNA, and that mtDNA 
mutations and subsequent segregation of these mutations over a 
lifetime seem to be an important contributory (actor to the aging 
process. We demonstrated that myocardial mtDNA with a 7,436 
base-pair deletion existed in all subjects that were over 70 years old. 
Since each mitochondrion has two or three copies of its own DNA, 
quantitative analysis is required for the evaluation of the role of 
mtDNA with deletions in the presbycardia. For this purpose, the 
kinetic polymerase chain reaction (PeR) method was developed. It 
was used in this investigation to detennine quantitatively myocardial 
mtDNA with this 7,436 base-pair deletion in human cadavers of 
various ages. The mtDNA populations with this deletion increased 
exponentially with age (log f (% of deleted mtDNA) .. -3.136 + 
0.0454 x age, r = 0.95, P < 0.01», and was estimated at 3 and 9% in 
subjects 80 and 90 years old, respectively. The deleted portion 
encodes 7 subunits of the mitochondrial A TP production system, and 
signs and symptoms of mtDNA mutation-related disease seem to 
develop in populations of deleted mtDNA over 3 - 5%. Accordingly, 
populations of mtDNA with this deletion over a certain threshold 
might induce a significant deterioration of cardiac energy metabolism, 
which might be a contributing factor to age-related deterioration of 
cardiac performance. 
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910·47 
Phorbol Ester and ATP Potentiate Basal and Stimulated 
Adenylate Cyclase Activity in Bovine Aortic Endothelial Cells 
David C. Lefroy, Louise E. Donnelly, Jean R. McEwan, John 
MacDermot. Royal Postgraduate Medical School, London, UK. 
Bovine aortic endothelial cells (BAEC) in culture were 
pretreated with l00nM phorbol 12·myristate 13·acetate (PMA) 
or SOp.M ATP in culture medium, or culture medium alone, for 
30 min and were then washed and harvested. Basal, fluoride 
(IOmM)- and isoproterenol (lOp.M)-stimulated adenylate cyclase 
(AC) activity (pmol/min/mg protein, mean ± SEM) was 
measured in BAEC homogenates. 
Basal 
Fluoride 
Isoproterenol 
PMA pretreated (n=12) ATPpretreated (n=5) 
Control PMA Control A TP 
12.3±1.3 17.2±1.5* 19.1±7.0 21.l±6.6t 
7S.2±4.210S.3±5.9* 73.3±17.4 S7.5±16.3* 
33.S±2.S 40.7±3.S* 43.7±S.6 S4.S±9.S* 
·P<O.OI tP<O.OS vs. control 
The potentiation of basal and stimulated AC activity by PMA 
and A TP in BAEC was concentration dependent (ECso for A TP 
3.6 ± 2.5 p.M) and was not seen in BAEC pretreated with PMA or 
ATP together with 100nM staurosporin, an inhibitor of protein 
kinase C. Staurosporin pretreatment alone had no effect on AC 
activity. This suggests that PMA and A TP potentiate AC activity 
via protein kinase C, PMA by intracellular activation of protein 
kinase C and ATP via cell surface purinergic receptors. B-ad•
renoceptor density and affinity measured by 125I-iodo•
cyanopindolol binding was unaffected by PMA pretreatment. 
The potentiation of fluoride activation of AC indicates 
modulation at the level either of the regulatory G proteins or of 
the catalytic subunit of AC. In conclusion, these data show 
protein kinase C-mediated modulation of AC activation by 
extracellular A TP indicating crosstalk between the protein kinase 
C and cyclic AMP signal transduction pathways in endothelial cells. 
910·48 
Important Contrasting Actions of Brain Natriuretic 
Peptide Upon the Cardiovascular and Renal System in 
Normals versus Congestive Heart Failure 
David P. Chan, Swama Balasubramaniam, Lawrence L. Aarhus, 
Iohn C. Bumen, Ir., Mayo Oinic, Rochester, Minnesota. 
Congestive bean failure (CHF) is characterized by an attenuated 
renal response to exogenous administration of the vasoactive and 
natriuretic peptide, Auial Natriuretic Peptide (ANP), which is 
elevated in CHF. Such renal resistance may contribute to the avid 
sodium retention of CHF. Brain Natriuretic Peptide (BNP) is an 
ANP-like peptide which share sequence homology with ANP and, 
like ANP, is released from the heart in CHF and is increased in the 
circulation. As the renal action of BNP has not been defined in 
CHF, the current study was undenaken to test the hypothesis that 
the natriuretic response to BNP is attenuated in CHF. Studies were 
performed in anesthetized CHF (n=6) and normal (n=5) dogs in 
which CHF was produced by rapid ventricular pacing for eight 
days. In CHF and despite avid sodium retention and decreased 
mean arterial pressure (MAP), BNP (3On!Vkg/min, IV infusion) 
resulted in an increase in absolute sodium excretion (8.3 ± 4.4 to 
26.4 ± 12.1 I!BqImin, p<O.05) in association with a diuretic 
response (0.15 ± 0.04 to 0.25 ± 0.07 mVmin, p<O.05). 
Concurrently no change in MAP (79 ± 7 to 79 ± 5 mmHg) was 
observed. In contrast, BNP at the same infusion in normal dogs 
resulted in no increase in sodium excretion but did mediate a marked 
decrease in MAP (lOS ± 7 to 77 ± 3 mmHg, p<0.05). The current 
study reportS for the first time the renal actions of BNP in 
experimental CHF. These studies also demonstrate a paradoxical 
natriuresis of BNP in CHF not observed in the absence of CHF and 
a differential response in MAP. In conclusion, the current studies 
suggest a unique role for this ANP-like peptide in the 
pathophysiology and potential therapeutics of CHF. 
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Comparison of the Distribution of Laminin and 
Fibronectin in the Developing Rat Heart 
Paolo Spirito, Ya-Min FU, Zu-Xi YU, Carlo 
Vecchio, Ward Casscells. 
NHLBI, Bethesda, Maryland 
Laminin and fibronectin are major constituents 
of the extracellular matrix of many tissues, 
including cardiac tissues. In the developing 
heart, the biological role of these two 
proteins remains speculative, and their 
distribution has never been directly compared. 
We used immunohistochemical techniques to 
compare the distribution of laminin and 
fibronectin in the heart of rat embryos (11-20 
days of gestation) and postnatal rats (1 day to 
4 weeks). At early embryonic stages (days 11-
13), immunoreactivity for both proteins was 
intensively positive in the cytoplasm of the 
myocytes and endothelial cells. At later 
stages of gestation (days 19-20) and in the 
postnatal stages, immunoreactivity for both 
proteins became more intense in the extracel•
lular matrix than in the cell cytoplasm. In 
the cardiac cushions and in the fully developed 
cardiac valves, immunoreactivity was 
intensively positive for fibronectin but 
negative for laminin, at all stages examined. 
Thus, both proteins are expressed in the 
myocytes and endothelial cells of the rat heart 
at early stages of embryonic development, while 
only fibronectin is present in the cardiac 
cushions and valves. These findings suggest 
that both proteins play a role in the early 
morphogenesis of the myocardium, and that 
development of the cardiac CUShions is more 
dependent upon fibronectin than laminin. 
910·50 
Effects of Slte·speclflc Mutagene.l. on LeAT Actl"atlon by 
Recombinant Human Apollpoproteln A·I 
James R. Boogaerts'·. Jeffrey A. Engler, C. Scott Swindle, Melanie 
West", Michael Lefevre', G.M. Anantharamalah, Kiran B. Gupta, 
Christie G. Brouillette, Y.V. Venkatlchlllpathl and J .. p. Segrest. 
'Alton Ochsner Medcal Foundation, New Orleans, LA., 
°Pennington Biomedical Research Center, Baton Rouge, LA., and 
Atherosclerosis Research Unit, University of Alabama at 
Birmingham, Birmingham. AL. 
In order to define how particular structural elements of human 
apolipoprotein A-I (apoA·I) serve Specific functional roles. plasmid 
constructs have been engineered which yield human apoA·1 as a 
recombinant protein in E· CQl1. Polymerase chain reaction (PCR) 
was used to make specific codon substitutions in the S' region of apoA 
-I cDNA. which was then cloned into a plasmid for expression of the 
protein under the influence of a T7 promoter. Polyacrylamide gel 
electrophoresis. Western blotting with polyclonal antibodies against 
human apoA-I, and analytical reverse-phase HPLC demonstrate a 
protein that Is identical to human serum apoA·1. Yield of purified 
protein is approximately 0.7 mglliter ferment. The recombinant 
protein activates LCAT as well as serum apoA-1. Incubation of 
recombinant apoA·1 with egg phosphatldylcholine (PC) resuhed in 
formation of discoidal apoA-I:PC complexes similar to those formed 
by serum apoA·1 when the complexes were analyzed by nondenaturing 
gradient gel electrophoresis. Previous analysis of recombinant apoA 
-I expressed as a yeast secretory product suggested a 40% decrease 
in activation Of LCAT when glu78 was replaced with ala. Additionally. 
modification of serum apoA·1 with methyl iodide introduced positive 
charges on met residues located in helix 2 and 3. postulated by us to 
be the major LCAT activation sHe. LCAT activation by this modified 
apoA-1 was 47% that of native apoA-I. Mutations are now being 
created at these sites and in other regions suspected to be important 
for LCAT activation in order to study the structure/function of apoA 
JACC Vol. 19, No.3 
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Increment Detection, a Novel Form of Signal Transduction, 
Occurs In Isolated Intact Intracellular Ca2+ Stores. 
L. Allen Kindman, Tobias Meyer, and Lubert Stryer. Stanford 
University, Stanford, CA 94035-5400. 
Inositol (1,4,5) trisphosphate (InsP3) is a second messenger 
of signal transduction by many hormones of cardiovascular interest. 
It causes the release of Ca2+ from intracellular stores in a quantized 
fashion called Increment Detection. In peripheral tissue, the 
intracellular Ca2+ store has not been well characterized. We have 
isolated for the first time intact Ca2+ stores. We used the rat 
basophilic leukemia cell, which is a choice model for the Investigation 
of signal transduction mechanisms in peripheral cells. Ca2+ stores 
are Isolated by osmotic lysis and sucrose gradient centrifugation, 
banding at the 40-50% Interface. By electron microscopy, these 
vesicular structures have a diameter of 0.3-0.5 11m. Biochemical 
marker studies have not convincingly demonstrated the stores to be 
unique structures. Functionally, the stores are exquisiteiy sensitive 
to shearing; simple pipetting or gentle sonication can result in the 
loss of gating by InsP3. However, even after these treatments, they 
retain Ca2+ storage capability. Isolated free of cytosolic contaminants 
by sucrose density gradient centrifugation, the vesicles retain the 
InsP3-gating properties of the intacl cell. Both permeabilized ceils 
and stores become innured to absolute concentrations of InsP3. 
Rather, they respond io changes in InsP3 concentration. InsP3 
causes the release of Ca2+ from cells and from intact stores in a 
quantized fashion. Identical, subsaturating, additions of InsP3 cause 
the rapid release of discrete bursts of Ca2+. Repeated additions result 
in virtually Identical bursts. Increment detection must therefore be 
regulated by either the InsP3-gated channel or by the Ca2+ store. 
Cytosolic factors are not required. This automatic offset in 
sensitivity to InsP3 represents a novel regulatory system. We 
hypothesize that increment detection allows cells to retain complete 
pharmacologiC sensitivity to changes in circulating hormone 
concentrations. It thus represents a third paradigm for modulation of 
pharmacologic signalling, along with inactivation and desensitization. 
910·52 
1.ti tG.ly .~I'~~oldovich }~ord~1J.;':, Vladij.~ir VeEiE.:-:i~lO­
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ci~:~J.ovlla T8elt~:"·.:o, Vl3.dir:,,:ir ;'.ns.tolievici1 C:-~er -
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T::e T'urpose of t~1is work was an experi:.:ental 
sutst5.r..t:'at~Qn of atherosclerosis gene thera•
py possibilities by injection of the arolipo•
protein ",-1 z(me (ApoA-I ,ene) to laboratory 
ani':mls. The eXDeri::1ent he.d been c9.:c'ried out 
on rats. All the ani::1als were divided into 3 
croups. The Irst :::ro~·.p included intacted e.ni•
j:mls, t:,e 2nd .-;roup consisted of rats \":i til 
intrahep~tically injected lip080~e culture 
cOl,tained ApoA-I gene and the 3:'d group \":9.8 
re"resented by t'le anir;Jals ';:i th only i::1jected 
liposo!'1e culture. 'r~le slau,:::hter of the ani,,;a1s 
V!~:;, perfor:;-ced in 24 hours after indice.ted 1:18.•
ninulations. The results of eXDeri~ent show 
tilat inj ected construction v;as - functionally 
active as hu.'?lar.. _\.Do~\.-I aJT)earGS in ;:,las:.-.a of 
croup 2 ani::ia1s and is undeter~.lined in gro:lps 
I and 3. 3e3ic.e t:C_5.t in E.ccor,.~ing to t'1e rla•
telets lur.,irJ.iscence =-::icro,scoJ':'Y fundin8s i:1tre.•
he~atic i~l~ection of liposo~e culture co~tai­
:'led A::,<)A-I [;e:1e had a fa-'lournble i~lfluence Oll 
:,orjjho-fullctiol18.1 c!lar2cteristics of platelet,~ 
in rats cO:lsisting ir. increase of nor::lally -
functioning plo.telets so called discocytec. 
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In Vitro Gene Transfer Into Vascular Smooth Muscle 
Cells by Particle Bombardment 
Guy Leclerc, Geoffrey Pickering, Jeffrey M. Isner, Tufts 
University School of Medicine, S1. Elizabeth's Hospital, 
Boston, MA. 
Direct, simple and rapid transfer of foreign genes with high 
efficiency represents a desirable approach to gene therapy 
of vascular tissues. The purpose of this study was to assess 
the feasibility of genetic transformation of intact vascular 
smooth muscle cells by in vitro bombardment of DNA·coated 
microprojectiles. Rabbit aortic smooth muscle cells grown in 
60 mm culture dishes were bombarded in partial vacuum (5· 
7 in. Hg) with DNA-coated tungsten particles (average 1 11m 
diameter) using a delivery system driven by gun powder 
(Biolistic PDS -1000). The transfected reporter DNA was a 
plasmid construct (5127 base pairs) containing the Rous 
Sarcoma Virus long terminal repeat promoter directing the 
transcription of a luciferase (LUC) cDNA. Cultures were 
bombarded with 2.5 Ilg of DNA per dish. Control plates were 
bombarded with a plasmid lacking the LUC cDNA. 
Luminescence (LUM) assays were conducted 4 days after 
the transfection. LUC activity was found in 70% (7/10) of the 
LUC cDNA treated cultures with a mean 59.53 ± 47.44 
integrated light units (ILU). Dishes bombarded at higher cell 
confluency (CFL) (60-90% CFL, 4/10 dishes) tended to 
express higher LUM (103.77 ± 79.71 ILU) than those at lower 
CFL (40-60% CFL, 6/10 dishes) (0,27 ± 0.10 ILU). Control 
plates showed no LUC activity. Conclusions: 1) particle 
bombardment technology can effect direct gene transfer in 
vascular smooth muscle cells in vitro; 2) vascular smooth 
muscle cells bombarded at higher confluency tend to yield 
greater expression of the new genetic material. 
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PULMONARY CONTRIBUTION TO PLASMA ATRIAL 
NATRIURETIC FACTOR IN CONGESTIVE HEART FAll..URE. 
Mark A, Perrella, Lawrence L. Aarhus, and 10M C. Burnett,Ir. 
Mayo Clinic and Foundation, Rochester, MN. 
Congestive hean failure (CHF) induced by rapid ventricular pacing is 
characterized by a maintenance of elevated ciIculating ANF, despite a 
decrease in atrial tissue concentrations of the peptide and an absence of 
ventricular production of ANF. Independent of cardiac synthesis, two 
potential contributors to increased plasma ANF are decreased metabolic 
clearance rate (MCR) and extta-cardiac synthesis of the peptide. With 
respect to the latter, the lung has been demonstrated to produce ANF 
i!uilm in rodents with chronic CHF. Therefore, the present study 
was designed to investigate a) total metabolic clearance of ANF and 
b) pulmonary clearance and secretion of ANF in experimental CHF. 
CHF was induced by rapid ventricular pacing in dogs for 14 days (n=6), 
while unpaced dogs (n=5) served as controls. During a steady state 
infusion of ANF (10 nglkg/min) total MCR was calculated by the fonnula: 
ANF MCR = infusion rate 1 [ANF] infused • [ANF) baseline. Pulmonary 
ANF clearance was determined by the fonnula (pulmonary artery [ANF] -
pulmonary vein [ANF] 1 pulmonary artery [ANF)) x cardiac output. 
Because the major mechanism of pulmonary clearance of ANF (Pa.ANF) 
is via enzymatic degradation, we administered a neutral endopeptidase 
inhibitor (NEPn SQ 28,603 at 60 mglkg iv to inhibit pulmonary enzymatic 
degradation. 
ANF MCR did not change during CHF as compared to control animals 
(l44l± 240 mVrnin vs 1427±233 ml/min, NS) even though plasma 
concentrations of ANF were greater (330±17 pg/ml vs 146±IS pg/ml, 
p<O.05), suggesting MCR did not contribute Slgnificandy to the plasma 
levels of ANF. In nonnal controls, a significant PcL.ANF is present 
(479±142 ml/min, p<O.OS), which is diminished in CHF (l30±91 mVroin, 
NS). Following NEPI in CHF. we observed a significant increase in 
plasma ANF across the pulmonary circulation (pa.ANF: - 86±29 m1/min, 
p<0.05), consistent with pulmonary secretion of the peptide. In nonnais, 
although NEPI abolished PcL.ANF, there was no evidence of pulmonary 
secretion of the peptide. Thus, in this model of CHF 1) total MCR does 
not significantly contribute to elevated plasma ANF, 2) Pcr,ANF is 
diminished, and 3) pulmonary secretion of ANF may offset the PCLANF, 
and be an extra-cardiac source contributing to plasma ANF. 
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INCREASED BLA-CLASS I AND II ANTIGEN EXPRESSION IN 
ENDOMYOCARDIAL BIOPSIES OF PATIENTS WITH CLINICAL 
SUSPECTED MYOCARDITIS AND DILATED CARDIOMYOPATHY 
Uwe Kuhl, Bettina Seeberg, Heinz-Peter Schulthei£, 
University of Duesseldorf, F.R.C. 
The natural history of myocarditis (MC) and dilated 
cardiomyopathy (DCM) is unknown, however, from recent 
observations it might be concluded that immunologic 
mechanisms contribute to the pathogenesis of these 
suspected viral induced heart diseases. By 
immunohistologic methodes, lymphocytic infll trates have 
been demonstrated in 45% of patients with clinical 
suspected MC and about 30% in DCM. Using monoclonal 
antibodies, we now investigated the HLA-antigen 
expression on capillary endothelium and interstitial 
cells in endomyocardial biopsies taken from 86 patients 
with suspected MC and 91 patients with unexplained 
congestive heart faillure. The clinical diagnosis of MC 
was confirmed in only 4 patients according to the Dallas 
classification. In 66 (38%) patients (MC: 45%, DCM: 29%), 
however, th~ immunohistologic evaluation with antibodies 
directed against lymphocyte markers such as CD3, CD4, 
CDS, CD20, CD25, CDw29, CD45, and CD45R showed 
lymphocytic infiltrates. In CD3-positive biopsies the 
HLA-class I and II antigen expression was increased in 
more than 90% 01C: 90%, DCM: 93%) vs. 25% in biopsies 
without cellular infiltrates 01C: 25%, DCI·!: 26%). 23% of 
biopsies from the MC group showing an increased HLA-I and 
67% with increased ALA-DR expression contained 
lylmphocytic infiltrates, while in DO: 59% of samples 
with increased HLA-l and 63% with increased HLA-DR 
antigen expression showed an CD3 positive infiltration. 
In control tissues neither cellular infiltrates nor 
increased ALA-antigen expression «25%) could be deDon•
strated. Conclusion: These results let suggest that an 
increased ALA-antigen expression is involved in the 
autoimmune regulation of MC and DCM. 
911-26 
Predictive Value of Abnormal Signal-Averaged 
Electrocardiograms in Patients With Non-ischemic 
Congestive Cardiomyopathy 
Donna M. Mancini, Karen Fleming, Nancy Britton, Michael B. Simson 
Hospital of the University of Pennsylvania, Philadelphia, PA 
An abnormal signal-averaged electrocardiogram (SAECG) has predic•
tive value for future arrhythmic events in patients with coronary anery 
disease. To investigate whether an abnormal SAECG could provide 
prognostic information in patients with non-ischemic dilated cardiomy•
opathy (DC), we prospectively obtained SAECGs in 85 patients with 
DC. Twelve-lead ECGs, nuclear ejection fractions (EF), hemodynamic 
measurements, and peak exercise oxygen consumption (V(h) were also 
obtained. An abnormal SAECG was defined as QRS duration >120 
msec, or root mean square of the last 40 ms <20 Il V, or duration under 
40 IlV >38 msec at 25 Hz. Patients were divided into 3 groups. Group 
I (N=47) had a normal SAECG, Group II (N=13) had an abnormal 
SAECG, and Group III (N=25) had an underlying bundle branch block. 
Mean follow-up was 18 months. Age, EF, peak V02, pulmonary capil•
lary wedge pressure, and cardiac index were not statistically different 
between the three groups: 
~ U YQZ 0 
(Yrs.) (%) (ml/kg/min) (L/min/m2) 
Group I 48±17 24±10 16.2±5.3 2.2±O.5 
Group II 49±16 19±10 14.3±5.5 2.1±O.6 
Group III 47±11 21±10 14.6±4.2 2.2±O.5 
In Group I, one patient had a past history of VT and one patient died of 
CHF. In Group II, 7 patients had VT (3 prospectively, 4 retrospec•
tively); 2 sudden death episodes occurred prospectively, and one death 
occurred from CHF. In Group III, 5 patients had a past history of VT 
with I prospective sudden death. Therefore, 4% of Group I, 77% of 
Group II, and 24% of Group III had VT or death. Thus patients with 
an abnormal SAECG had a statistically significant increase in ventricular 
arrhythmias andlor death than patients with a nonna! SAECG (p<O.OOI) 
or bundle branch block (p<O.Ol). This study suggests that an abnormal 
SAECG is a marker of past and future arrhythmic events in patients with 
non-ischemic dilated cardiomyopathy. 
911-54 
The 6-MlnIIe Walk r"l U .. ful In Mild Heart Failure? 
JACC Vol. 19, No.3 
March I, 1992:72A 
Willem Remme, Per-Ake BostrOm, Arne Westheim, John Collier, Mike 
Hayden, for the UK.ol.620 Study Group, Rollerdam, The Netherlands. 
Optimal lest conditions to objectively assess clinical condition and exer•
cise capacity In CHF do not axIst. In moderately sevei'll to severe CHF 
the 6-minute walk test (W) proposedly re1Iects dally exercise routine bet•
ter than unifonn/y ac:cepted incremental exercise protocols. The aensltivJ. 
ty of W and Its potential to assess IntlllVentions in mild CHF was studied 
In a double-blind, panlilel 3 month comparison of 0.5, 1 or 2 mg UK-
61.260 Idd, a novel positive inotrope and vasodilator compound, VI pla•
cebo In 130 pts with mild CHF (NYHA II (80%) JIll (20%) due to ischemic 
cardiomyopathy on chronic diuretic lherapy. Upright bicycle exercise 
duration (BE, Increments of 10 Watt/min) and W distance (seJf..determined 
walking speed In a 3Q.4O mater (m) long, enclosed apace with 3 and 5 
min time Indication) were evaluated at baseline and at 4, 8 and 12 wks. 
Baseline clinical and demographic criteria and values for BE and W were 
comparable In all groups. DUring doubl.blind traatment 5, 3, 3 and 6 pis 
discontinued In the 0.5, 1 and 2 InS UK and placebo group resp. 
Changes (lI) In BE (sec) and W (m) are (*p<.05 va baseline): 
BE:baseline 
t. 4 wk 
t. 12 wk 
W: baseiine 
t. 4 wk 
t. 12 wk 
UK 0.5mg UK lmg UK 2mg 
529 516 474 
27 71* 15 
38* 75* 28 
488 
10 
14 
456 
13 
29 
439 
8 
18 
Placebo 
497 
-2 
11 
463 
.0 
41 
Thus, whereas significant improvements in exercise capacity were d. 
tected with a standard incremental exercise method during active medi•
cation (0.5 and 1 mg UK Idel), W did not indicate any drug effect. If 
anything, the greatest improvement occurred with placebo. In mild heart 
allure the considerable distance already covered at baseline (average 
461 morn mlmin) most Ukely precludes signfficant drug-induced 
changes. To improve Its aensltivity, longer procedures, e.g. a 9 or 12 
minute walking lest, are recommended In patients with mild heart failure. 
911-55 
Therapeutic Response Measured by the Minnesota Living 
With Heart Failure Questionnaire 
Thomas 5 Rector, Jay N Cohn for the Pimobendao Multicenter 
Research Group. University ofMionesota, Minneapolis, Minnesota 
Improvement in how individuals function and feel during their daily 
activities is an important goal of medical therapy for chronic heart 
failure. A new measure of this patient outcome, the 21 item 
Minnesota Living with Heart Iailur~UhFE) questionnaire, was 
evaluated during a randomized, double-blind study of 
pimobendan(PIM) which has inotropic and vasodilator activities. 
PIM has been shown to exert favorable effects on hemodynamics 
and exercise tolerance. All 188 respondents were outpatients with a 
clinical diagnosis of heart failure for at least 3 months and an 
ejection fraction less than 35%. They were symptomatic(96% 
NYHA Class 1Il) despite diuretics, digoxin and vasodilators. The 
median (25th,75th percentile) baseline UhFE scores were 
47(28,61). The self-administered LIhFE score was reliable as 
indicated by a correlation 0(0.93;n-181 between repeated baseline 
scores. LIhFE scores did not change significantly duriog 3 months 
of follow-up in the placebo(PLA) group, 1(-4, 6);n~49, or the 2.5 
mg/day PIM group,-2(-6,8);n-48. The group on 5 mg/day had a 
significant improvement of7.5(O, 18);n-46;p=O.01 compared to 
PLA. This improvement was more evident in a physical dimension 
of the LIhFE identified by factor analysis: PIM 4(0,8) vs PLA 
J(-2,4);p=0.0I, than an emotional dimension, 2(-1,5) vs 0(·1,2); 
p=NS. Only the physical dimension, 3(O,8);p=0.04 improved 
significantly on 10 mg/day ofPIM compared to PLA. Changes in 
the LIhFE physical dimension and concurrent changes in exercise 
duration during a modified Naughton protocol were only weakly 
related: r=0.35;n-185;p<0.0 I. 
Thus the LIhFE score was reliable, insensitive to placebo 
and detected a dose response relationship related primarily to 
physical limitations. These data suggest that the LIhFE questionnaire 
is a valid assessment of the therapeutic effect of pimobendan and is 
independent of maximal exercise capacity. 
JACC Vol. 19, No.3 
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Is There Sex After Heart Failure? Report of a Prospective 
Study of Sexual Desire and Activity in Patients with 
Advanced Symptoms Enrolled in the PROMISE Trial 
Josephine A. Sollano, Janet Vasquez-Johnson, Deborah Ahern, Jane 
L. Bazzell, Larry Gorkin, Eileen M. Handberg, John Novack, Dierdre 
Nauman, P. K. Tandon, Milton Packer, on behalf of the PROMISE 
Study. Mount Sinai School of Medicine, New York, NY 
Although it is commonly believed that heart failure (CHF) impairs 
sexual desire and activity, this issue has not been systematically 
evaluated. As part of the Prospective Randomized Milrinone Survival 
Evaluation (PROMISE Trial), the Nursing Research Committee 
developed a questionnaire to assess the effect of CHF on sexual 
activity. The questionnaire inquired about current and desired sexual 
perfonnance as well as sexual experiences before the onset of CHF. 
Each of these 3 categories had 8 questions, and sexual activities were 
graded on a 5-point scale. The questionnaire was administered to 92 
CHF pts, 71 men & 21 women. At the time of the questionnaire, all 
pts had class 111 or IV symptoms, a LV ejection fraction < 0.35, & 
were receiving digoxin, diuretics and converting-enzyme inhibitors. 
The development of CHF was accompanied by a J. in the sexual 
activity score (2.7 to 2.2 units, p < 0.05). However, despite this J. in 
actual activity, 42 men and 9 women still indicated that they were 
sexually active, and the desire for sexual activity remained high (3.0 
units vs 2.7 units, desired vs prior activity, p = NS). Interestingly, 
among the men, desired activity was strongly correlated with prior 
activity (r = 0.83) but was weakly correlated with current activity 
(r = 0.57), suggesting that men desired (but failed to achieve) a return 
to functioning at pre-morbid levels. In contrast, among women, 
desired activity was significantly correlated with both current and prior 
activity (r = 0.80 and r = 0.68), suggesting that women could more 
easily modify their actual sexual activity to meet desired activity. 
In conclusion, despite the disability imposed by CHF, 50% of pts 
with advanced symptoms still report an active sex life. These fmdings 
have important implications for sexual counseling and the use of 
medications. 
911·57 
Heart Rate Variability in Clinical Heart Failure: Persistence of a 
Circadian Pattern 
Michael Workman, Clayton L. Birkett, Glenn A. Myers, David W. 
Ferguson, Michael G. Kienzle, University of Iowa, Iowa City, IA 
Heart rate and measurements of heart rate variability (HRV) 
normally display a circadian pattern, which some investigators have 
reported is absent in patients (pts) with heart failure (HF). The 
present study was designed to detennine whether a circadian 
pattern of HRV is present in HF patients. We prospectively studied 
24 patients (20 men, 4 women, mean age=48 years, range 22-65) 
off all cardioactive medications (except diuretics) with NYHA 
functional class I (I pt), II (8 pts), III (II pts) or IV (4 pts) heart 
failure. Forty-eight hour ambulatory ECG recordings were used to 
derive hourly average R-R interval, R-R standard deviation (RR-SD) 
and power over 0.05-0.15 Hz (Mid), 0.20-0.50 Hz (High) and 0-0.5 
Hz (Total) portions of the R-R power spectrum. RESULTS: When 
examined as sequential 6 hour averages starting at midnight, the 
R-R, R-R SD, Mid, High and Total power all showed a significant 
circadian pattern over the recording period (p<0.05, ANOVA), with 
maximum values between midnight and 6 AM and minimum values 
between 6 AM and 6 PM. In each patient we applied a cosinor 
regression analysis to each hourly value to determine the statistical 
strength of the circadian pattern. A statistically significant cosine fit 
(p < 0.05) was present in 24124 pts for R-R interval, in 11124 for R-R 
SD, in 15/24 for Mid, 15/24 for High and 16/24 for Total power. 
When data from all patients were combined, all variables showed a 
significant circadian pattern by cosine regression analysis, with 
maximum values (acrophase) between 2 and 6 AM. 
CONCLUSIONS: Small but significant circadian fluctuations in heart 
rate and heart rate variability do persist in many patients with 
congestive heart failure. The circadian pattern observed in HF pts is 
qualitatively similar temporally to that reported in other patient 
groups and nonnal subjects. 
ABSTRACTS 
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Sudden Death In Advanced Heart Failure: Incldence During 
Nocturnal Versus Daylight Hours 
Debra K. Moser, William G. Stevenson, Mary A Woo, Lynne W. 
Stevenson. UCLA Medical Center, Los Angeles, CA. 
Transient hypoventilation and hypoxia occur commonly during 
sleep in heart failure patients and may contribute to arrhythmias. 
We hypothesized that sudden death (SO) incidence would be 
increased during nocturnal hours. Of 566 consecutive patients 
followed after treatment for advanced heart failure, 98 (17.3%) 
had SO. Time of death was detennined for 70 patients (57 males, 
age 48±13 years, left ventricular ejection fraction 19±8%, New 
York Heart Association class 3.4±0.6). Results: The most 
frequent time of death was between 6:00am and 12:oopm 
(p<0.oo5) and not during nocturnal hours. Time of death was not 
different for coronary artery disease (CAD) vs non-CAD heart 
failure patients (p=0.69). 
Conclusion: Oespite a high .. r .... =... =:..:colC!: ... ==-___ -===~ 
incidence of sleep 1 ___ 1 
abnonnalities in advanced 
heart failure, the incidence of 
SO is not higher during 
nocturnal hours. Rather, SD 
in both CAD and non· CAD 
heart failure exhibits the early 
morning increase previously 
shown for ischemic events and 
rm __ 
SD in CAD. The morning surge in sympathetic nervous system 
activity may contribute to SD in both CAD and non·CAD heart 
failure. 
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912·14 
Increased Left Ventitular Mass In The Obese: The Role of Insulin 
Resistance 
Zion Sasson, Yosef Rasooly, Teosar Bhesania, Amir K. Hanna, 
University of Toronto, Toronto, Canada 
To test the hypothesis that insulin resistance (lR) contributes to the 
increased left ven tricular mass (L VM) observed in the obese, 40 
normotensive, non-dlabetic, otherwise healthy obese (BMI>25kg/m2) 
subjects underwent echocardiography and 90 min intravenous glucose 
tolerance test (IVGTI). 
The degree of IR was derived from IVGTT according to the rate of 
glucose disposal (k value), basal insulin, insulin response at 90 mins 
(Ins-90) and insulin integration over 90 mins. L VM was calculated from 
20 echo guided M-mode measurements (Penn convention) using the 
formula of Devereux and Reichek, and corrected for height (L VM/ht). 
The study population consisted of 18 males and 22 females with a mean 
age of 48 ± 13 yrs, systolic and diastolic blood pressure (BP) of 124 ± 11 
and 77 .± 8 mmHg respectively. Mean BMI was 31.6 kg/m2 (range 25 -
44.6), LVM/ht 180 gm/m (67- 169), k value 15 %/min (0.9 - 2.5), basal 
insulin 77 pmol/m (30 -174), 1ns·90 131 pmol/I (25 -672). 
Unear regression analysis revealed good correlations between L VM /ht 
and the following variables: BMI (r = 059, P = 0.0001), Ins-90 (r = 0.61, 
P = 0.0001), k value ( r = 0.55, P = 0.00(3), Ins integration (r = 0.46, P = 
0.003), basal insulin (r = 0.44, P = 0.(05), but no significant correlation 
with BP or age. In multivariate regression analysis, only Ins-90 and k 
value were significantly aSSOCiated with LVM/ht (p = 0.008 and 0.04 
respectively), whereas the assossiacion with BMI became insignificant 
(p =0.12). 
We conclude that the increase in LV mass in the normotensive obese 
population is mediated primarily by the degree of insulin resistance 
and its compensatory hyperinsulinaemla. This effect on LV mass 
appears to be independent of BP and degree of obesity. 
73A 
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A Modelling Analysis of Aging and Vasoactive Drugs on 
the Human Arterial Pulse. 
Michael O'RolU'ke, Mustafa Karamanoglu, Alberto Avolio. 
SI. Vincent's Hospital, Sydney, Australia 
Although many models of the arterial system have been studied, none 
provide comprehensive explanations for the effects of wave reflection 
on pressure contour in different arteries, nor the effect of aging and 
vasoactive drugs on wave contOlU', nor the differences in systolic and 
diastolic presslU'CS between the ascending aorta and upper limb arteries 
of man under different conditions. A model of the entire human arterial 
system was constructed with 137 arterial segments each represented by 
a uniform transmission line. Known age-related changes of pulse wave 
velocity in the aortic trunk and upper and lower limbs were used to 
simulate an age span of 4 decades (20-60 yrs). Vasodilation and 
vasoconstriction were simulated by alteration of reflection coefficients at 
the terminal arterial segments (0.0 to 0.8 respectively). 
Model results for aging and vasoactive changes in impedance patterns 
and pulse waveforms were similar to those observed in clinical studies. 
Reflected pressure waves originating from the lower portion of the 
trunk were transmitted along the trunk and appeared both at the aortic 
root and in the upper limb. Aging caused these reflected waves to 
appear earlier in systole thus increasing left ventricular afterload. Aging 
does not alter the site of these reflected waves but at the aortic root they 
appear earlier due to increased pulse wave velocity. The model 
predicted that aging and vasoconstriction caused closer correspondence 
between central and peripheral pressure. However, vasodilation 
increases the relative discrepancy between central and peripheral 
pressure in the old compared to the young. 
Findings explain the effects of aging and vasodilator therapy on the 
human arterial pulse including the differential effects on the central and 
peripheral pressure waves in the upper limb. 
912-16 
Sympatho-vagal Interaction as Evaluated by Power Spectral 
Analysis of Heart Rate in Hypertensive Patients With and 
Without Left Ventricular Hypertrophy 
Damiano Rizzoni, Maurizio Castellano, Marina Beschi, M. 
Lorenza Muiesan, Giorgio Bettoni, Enrico Agabiti-Rosei 
Cattedra di Medicina Intema, Univer~ita' di Brescia, Italy. 
Power spectral analysis (SA) of heart rate (HR) rna)' provide 
useful informations about cardiac vagal and sympathetic activity. 
Aim of the study was to evaluate SA of HR in normal subjects 
(N) and hypertensive patients (H), at rest and during application 
of a negatIve pressure (LBNP) to the lower body, in order to 
induce sympathetic activation. Twenty-one males, 7 N, 7 H with 
left ventricular hY{lertrophy (L VH), and 7 H without L VH were 
studied while restlDg supine and during LBNP (at -10 and -40 
mm Hg, each for 20'). Venous plasma NE was measured by 
HPLC. Cuff arterial pressure (AP) was measured every 5 min, 
while HR was measured by continuous ECG recording. 
Sequences of 512 R-R intervals were taken for the evaluation of 
SA (Box-Jenkins method). Absolute and normalized power 
spectral density (PSD) of the lleaks at 0.10.±.0.05 (low frequency 
peak: LF) and at 0.25±0.07 (high frequency peak: HF) Hz, as 
well as their ratio (index of sympathovagal interaction: SVl) 
were calculated. H with LVH had a <)VI significantly higher in 
respect to Nand H ~thout LVH (N=3.52±2.18, H with<;lut 
LVH=3.13.±.1.9, H with LVH=8.52±9.51; p<0.05). Dunng 
LBNP plasma NE, absolute and normalized LF PSD, as well as 
SVI increased pro~essivelY (p<0.05 at least). HF normalized 
PSD was reduced <0.05} only at -40. During LBNP, systolic 
AP decreased an HR IDcreased significantly only at -40 
(p<O.OI). In the group of H with LVH, changes in SVI during 
-10 and -40 steps were markedly reduced (p<0.05 in respect to 
Nand H without LVH). The results of this study suggest that H 
pts with LVH have an increased sympathetic drive to the heart 
and, probably, a reduced parasympathetic traffic; changes in SVI 
index during LBNP are clearly blunted in H with L VH. 
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Determination of Left Ventricular Ejection Time From the 
Radial Pulse 
David Gallagher, Michael O'Rourke, Alberto Avolio, Mustafa 
Kararnanoglu, Raymond Kelly. 
St Vincent's Hospital, Sydney, Australia 
It is widely thought that the arterial pulse at the radial artery is of little 
value for analysis of left ventricular load and function, on account of its 
alteration during transmission from the heart. We have successfully 
synthesized the ascending aortic pulse from the radial, using a 
convolutional algorithm. This m~thod smooths high frequency 
components of the waves, including wave foot and incislU'a. Hence we 
investigated the possibility of determining ejection time (ET) directly 
from the radial pulse. 
Comparisons were made from high fidelity pressure waves recorded by 
Millar micromanometers (I) simultaneously; invasively in the ascending 
aorta and non-invasively in the radial artery of 14 patients undergoing 
cardiac catheterization (a) under control conditions and (b) following 
sublingual nitrOglycerin, and (2) non-simultaneously; non-invasively in 
the carotid artery and radial artery of (a) 33 normal subjects and (b) 260 
patients with different forms of cardiac disease attending an out patient 
clinic. Analyses were performed automatically by a computer 
programmed to identify and measure the period between the wave foot 
and the incislU'a of.averaged pressure waves. ETs were aortic or carotid 
c.f. radial (in msec) 
(I a) ill SD 31 c.f. ill SO 52 (n.s) 
(lb) Jll1 SO 41 c.f . .ll.Q SO 48 (n.s) 
(2a).lM SO 33 c.f. ill SO 31 (n.s) 
(2b) ill SD 37 c.f. ill SO 39 (p <0.0001). 
Difference between carotid and radial derived ETs were attributable to 
vagal stimulation causing cardiac slowing. (HR 68.2 c.f. 70.5) 
(p<O.OOO I). 
ET can be determined directly from the radial pulse provided that high 
fidelity manometry is used. 
912-18 
System Identification to Simultaneously Assess Heart Rate 
Barorenex and Ventriculo-Arterial Coupling over 24 Hours 
John K. Triedman, J. Philip Saul, Marvin L. Appel, Richard J. Cohen, 
Giuseppe Mancia, Marco Dj Rienzo, Gianfranco Parati .- Children's Hospital 
and MIT, Boston, MA; LaRC and Centro di Fisiologia Oinica, Milan ,Italy. 
The dynamic gain of the bean rate (HR) baroreflex over 24 hours has been 
investigated previously by means of models which ignore either the closed 
loop or the causal nature of the HR - blood pressure (BP) interaction. To 
address these points, a new approach was recently developed to 
simultaneously quantify the feedback from BP to HR (baroreceptor reflex arch) 
and the feedforward from HR to BP (mechanical coupling). This method, 
making use of autoregressive moving average (ARMA) system modelling, 
provides an estimate of both the gain and the time constants of these 
relationships. We used this technique to analyze continuous 24 hour 
ambulatory BP recordings (Oxford method) obtained in 5 nonnotensive 
subjects (mean BP and HR over the recording period: 76+/-13 mmHg and 
75+/- 6.5 b/min, averages+/-SO). The analysis was dynamically perfonned on 
contiguous 6 min data segments. The average gains of the BP-HR baroreflex 
and of the HR-BP mechanical coupling, expressed as the asymptote of the 
step response (i.e. the steady-state change in HR induced by a theoretical I 
mmHg step in BP, or the steady-state change in BP induced by a theoretical 
Ib/min change in HR), were -0.82+/-0.65 b/min/mmHg (corresponding to a 
change in RR interval of +9.2 +/-6.9 msec/ mmHg) and +0.81+/-0.55 
mmHg/b/min, respectively. The average time constants of these relationships, 
expressed as the time required by the system to reach 63% of the step response 
asymptote, were 7.3+/-3.0 sec. for BP-HR feeback and 4.7+/-2.1 sec for 
HR-BP feedforward. The estimated time constant of the BP-HR feedback falls 
between that reponed for pure vagal (near 1.5sec) and pure sympathetic (near 
15 sec) modulation of sinus node rate, suggesting a balanced involvement of 
both autonomic pathways in modulating the BP-HR baroreflex throughout the 
24 hours. In addition, the data show that baroreflex HR variations are on the 
average slower than the mechanically induced BP changes. This method 
provides a dynamic estimate of the HR-baroreflex gain over 24 hours 
comparable to that obtained by other techniques, and for the first time 
simultaneously accounts for both causality and the closed-loop nature of the 
HR-BP interaction by including the presence of mechanical feedforward 
coupling in the model. 
JACC Vol. 19, No.3 
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Peak Power During Exercise·A New Afterload Independent 
Non·invasive Approach to Left Ventricular Function in 
Hypertension: Impact of Left Ventricular Hypertrophy 
Diwakar Jain, Alon Marmor, Henry R Black, Frans J Th Wackers, 
Barry L Zaret Yale University, New Haven cr 
Left ventricular (LV) ejection fraction (EF) response to exercise (Ex) is 
used for assessing the contractile reserve and for detecting coronary 
artery disease. A higher frequency of abnormal Ex EF response in 
patients (pts) with hypenension (H) poses problem in evaluating LV 
contractility with this parameter. Afterload dependence of EF is 
considered at least partly responsible for this. Consequently, we 
studied Peak Power (PP), a new non-invasive afterload independent 
index of LV contractility at rest (R) and Juring supine bicycle Ex in 10 
pts with H and 8 healthy controls (C). LV volumes, EF and systolic 
flow rates were obtained from radiol1uclide angiography. Central 
arterial pressure (BP) was determined using a validated Doppler 
forearm system. PP (watts/ml) was calculated from peak flow 
multiplied by pressure at peak flow normalized to the end diastolic 
volume. Three pts with H (GpI) had echo evidence of LVH and 7 
(GpIl) had none (LV mass 292±104v 113±18 g). None had ischemia 
on Ex. R and Ex results are: 
Parameter Gp I (n=3) Gp II (n=7) C (n=8) 
LVEF%(RlEx) 59±13/58±11 65±7/75±6 65±7174±5 
PP(RlEx} 6.0±1.0/9.7±1.7 5.7±1.1111.4±3.0 5.3±O.7/10.6±2.8 
SVR (R) 1264±294 1353±464 1177±544 
SVR ( Ex ) 1073±233 676±171 654±201 
Sys BP(RlEx} 146±29/191±9 157±10/201±31 138±7/183±23 
Dias BP(RIEx) 81±10/103±8 92±10189±13 74±12176±12 
(SVR=systemic vascular resistance) Systolic BP at RlEx were similar 
in GpI and GpII. GpI showed significant rise in Diastolic BP on Ex 
(p<O.04) compared to Gp II. GpI pts showed only minimal fall in 
SVR on Ex and no increase in EF, whereas GpIl pts showed an 
appropriate fall in SVR and increase in EF similar to that in C. 
However. Ex PP response was similar in all 3 Gps. Thus, a flat EF 
response in H may result from altered afterload rather than 
contractility. Afterload independent PP has potential for evaluating Ex 
LV function in H. 
912·20 
subthreshold ouabain concentrations affect 
resting tone of aortic atrips contracted by 
norepinephrine (Me) and hiataaine (H) 
Sergii Bova, Gabriella eargnelji, GianPaolo 
Rossi & Achille C Pessina. Dept. of 
Pharmacology & Clinical Hedicine, University 
of Padua, Italy. 
Plasma ouabain-like factors have been suspected 
to playa role in primary hypertension. Ouabain 
(Qua) enhances both in vitro and in vivo the 
responsiveness of vascular smooth muscle (VSH) 
to vasoconstrictors. Accordingly, we have 
investigated if, at concentrations that do not 
elicit per se any contractile response, Qua 
affects the resting tone of aortic strips 
after repeated Me- and H-induced contractions. 
HethQds. Bndothelium-free Guinea pig a~rtic 
strips were contracted (in 2.5 mH (ea +)0) 
using either Me or H (1 ~H) in the presence of 
1 ~H ouabain. Control experiments in the 
absence of Qua were carr ied out in paralle l. 
Results: In presence of Qua a progressive 
increase in resting tone by either agonist was 
observed, whereas no change was seen in 
controls. This increase was completely !eversed 
by wash-out of Oua or by removal of ea +0' but 
not by verap:f.mil (1 ~H), and was enhanced by 
doub~ing lea +)0' In addition, caffeine-induced 
contractions were increased (threefold) in Oua•
treated str ips and not in controls. Thus: 1) 
subthreshold ouabain concentrations prevent 
full relaxation of VSH during repeated Ne- and 
H-induced contractions; 2) the increased 
vascular resting tone appears to be as~ociated 
with an increased caffeine-seDsitive ea + pool, 
presumably mediated by Na+/Ca Z+ exchange. 
ABSTRACTS 
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Mldodrlne, An Alpha Agonist for thl Trlltmlnt of Orthostatic 
Hypotension 
Fetnat Fouad-Tarazl, Masanori Okabe, Hershel Goren 
The Cleveland Clinic Foundation, Cleveland, OhIo 
Neurogenic orthostatic hypotension Is 8 disabling, chronic .Iness due to 
attenuation of adrenergic ll8fVe trafIIc and not a receptor dysfunction. 
Arteriolar vasoconstrictors seem to be appropriate therapeutic agents, 
however the search for an effective compound Is stUI actlva. In this double•
blind study, we compared the safety and elllcacy of the oral Investigational a 
sympathomimetic agent mldodrlne (M; 5-10 mg tl.d.) with a and e ephedrine 
(E: 18-24 mg t.l.d.) in 8 patienla (4 male, 4 female) with refractory orthostatic 
hypotension due to autonomic falure (idiopathic onhostatlc hypotension and 
Shy-Drager syndrome). Baseline cond~lons were astabllshed during a 2 day 
placebo period. Patients were titrated for 3-5 days, then treated with either M 
or E for another 3-5 days, followed by treatment with placebo for 4 days, and 
crossed l:1Ver to alternate therapy. 
Resu~s (mean ± SE): Both drugs elevated supine systolic blood 
pressure (p<O.05 va placebo) 1M: 19:1:4; E: 13t2 mmHg). Midodrlne 
Increased the standing systolic blood pressure 1et 3 mmHg above baseline 
(p<o.oS) whereas E had little effect (0.1±4 mmHg). The Increase In standing 
systolic blood pressure with M was significantly greater than that of E 
(p<O.OOl). The change In standing diastolic blood pressure was -3:1:2 mmHg 
with placebo versus 5± 2 mmHg with M (p<O.Ol from placebo) and 0.21: 3 
mmHg with E. The Increased ablily to stand, Imprl:1Ved In patients treated 
with M but not E (p<O.OO1). Side effects to both drugs were mUd and remitted 
by the end of the study. Neither drug affected clinical laboratory parameters. 
In conclusion, these data indicate that the a adrenergic agonist 
midodrlne Is a safe and effective treatment for orthostatic hypotension due to 
autonomiC failure. 
912·22 
Autonomic Altll1ltlons PrICIcIlng Syncope During Hlld·Up Tilt 
75A 
Jose Brum, Marclo Ribeiro, Carlos Ferrario, FrroNZy ESlafanous, Masanorl 
Okabe, James Maloney, Fetnat FouacI-Tarazl 
The Cleveland Clinic Foundation, Cleveland, Ohio 
Autonomic alterations leading to bradycardia and hypotension are believed to 
be common causes of syncope. However, the autonomic Influer1ces on the 
hean rate that precede the onset of syncope are not known. In this study we 
used the power spectrum of the hean rate variabUlly (PSHR) to assess the 
autonomic changes during head-up tit test (HUT) In 40 patients with syncope 
and 40 healthy volunteers. Subjects were titled consecutively to 15 degrees (3 
min), 30 degr_ (6 min), 45 degreu (3 min) and 60 degr_ (20 min) or until 
the onset of syncope. Hean rate (HR) and anerlal blood pressure (BP) were 
acquired every minute. PSHR was obtained through computer analysis of 
continuous ECG. The power 01 a low frequency (LFa) and a resplratory•
derived frequency (RFa) components determined the. ~
parasympathetic Influences on the HR, respectively. Two groups were 
identified according to the response to tUl: ta/nters (F, n= 13, 33'1(,) and not 
falnters (NF, n=27, 67'1(,). In the F group 7 patients (54'1(,) showed 
hemodynamics 01 vasodepressor syncope (VO) and 4 (30'1(,) had vasl:1Vagai 
syncope (VI/). Within the last minute before fainting there ware differences 
(p<O.05) between the changes In HR of these two groups (VD ~ + 7± 2, W -
-17±7 bpm), whereas diastolic BP decreased In both (VD--54± 13, W.~3 
mmHg, p<O.05). In W patients, before fainting, the LFa (+21±9 bpm2) and 
RFa( + 121: 8 bpm2) Increased (p<O.OS) whBe In YO patients the LFa (-21: 1 
bpm2) and the RFa (li 1 bpm2) were unaltered. In the NF group, the PSHR 
responses to tOt were compared with healthy volunteers matched for age and 
were within the normal range for 10 patients. The responses of the remaining 
17 NF patients were nonhomogeneous. We suggest that PSHR analysis 
during HUT Is usefUl for identifying different autonomic mechanisms 
associated with hemodynamic dlsordera of syncope. The differences In 
responses between W and YO reflect different undellylng pathophysiologic 
mechanisms In these two syncopal entities. 
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C-Peptide Determination in Essential Hypertension 
Augusto Zaninelli, Raffaele Fariello, Enrico Boni, Luciano Corda, 
Carlo Alicandri, Vittorio Grassi. 
Department of Internal Medicine, University of Brescia, Brescia, 
Italy. 
Recent studies showed that hypertension is often associated 
to hyperinsulinism due to insuline resistance. In order to extent 
these observations, we performed the fasting C-Peptide 
dosage (ug%ml), a direct index of plasma endogenous insuline, 
over a group of 115 non-diabetic, non-obese hypertensive 
patients (EHl. 42 males and 73 females, selected from 242 EH 
attending to the same Family Physician office. The features of 
this group were (mean.±. SO): age 57.7.±.9.3 years and body 
mass index (BMI) 25.4.±.2.9 Kg/m2. A control group, studied 
at the same time, consisted of 1 1 5 normotensives (NT), 
matched for sex (43 males and 72 females), age (57.5.±.9.0 
years) and BMI (24.7.±.3.0 Kg/m2). All EH sustained a wash•
out of their treatment for, at least, 2 weeks and NT also did 
not take any drugs, before drawing the blood. In order to 
detect the left ventricular mass index (LVMI, Penn 
Convention), a 20 directed M-Mode echocardiography was 
performed in all subjects. The results showed an increase of 
fasting C-Peptide level in EH compared to NT (3.48.±. 1.04 vs 
1.65.±.O.52, p<O.001). In EH, a positive correlation was 
found between C-Peptide level and LVMI (r=0.74, p<0.0011. 
while it was not observed in NT (r=0.19, NS). Furthermore, 
when we selected 40 EH with left ventricular hypertrophy 
(LVH) from the left 75 patients who haven't it (NOLVH), the 
fasting C-Peptide level was 4.45.±.0.80 for LVH compared to 
2.96.±.0.74 for NOLVH (p<0.05). In conclusion: C-Peptide is 
higher in EH compared to NT and these results may indicate a 
possible relationship between insuline resistance and the 
complex mechanism that induces target organ damage. 
Consequently, these data suggest that the fasting C-Peptide 
determination, easy to obtain at relatively low cost can be an 
useful test to assess the risk profile in EH. 
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Coronary Perforation Following Excimer Laser Coronary 
Angioplasty (ELCA) 
David R. Holmes. John F. Bresnahan. Guy S. Reeder. Spencer B. 
King. Manin B. Leon. Frank Litvack. for the ELCA Registry. 
Rochester. MN 
Coronary perforation (perf) following transluminal angioplastY 
(PfCA) is extremely rare. With new therapeutic devices e.g. ELeA 
perf rates may be increased. The setting in which perf occurs. 
associated factors. and outcome remain unknown. To assess this. the 
£LeA Registry was used to identify cases of perf (defined as 
extravasation of contrast outside the vessel wall) during 13ser 
angioplasty. Of 2,440 lesions treated with ELCA in 2,025 patients, 
perf occurred in 32 (I .6%). The mean age of perf patients was 
62±12 yrs; 25% had prior PTCA while 27% had prior coronary 
surgery (CABG). Perf occurred in 1.3% circumflex, 2.2% left 
anterior descending. 1.4% right coronary and 1.0% vein grafts being 
treated (NS). There was also no difference in perf rate by catheter 
(cath) size 1.8% for 1.3 mm cath, 1.7% for 1.6 mm, 1.0% for 12-
200 cath, and 2.0% for 2.0 mm cath. 
or the 32 perf. 24 pts underwent PTCA. Of these 24 pts treated 
with PTCA, 12 did not develop infarction (MI) death or require 
CABG. Events in perf patients vs the rest of ELCA are: 
F.!;rfllIllliWl NQIl ~rfQ!:lI!iWl P 
N 32 1993 
CABG(%) 41 3.0 <.0001 
MI(%) 16 4.0 .007 
Death % 6 0.4 .007 
Perf is uncommon with ELCA; when it occurs, it is associated with 
significantly increased event rates compared to non perf pati~nts. 
Despite these increased risks. of patients with perf treated WIth 
PTCA. 50% do not require CABG or develop Ml or a lethal 
outcome. 
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Perforation with Directional Coronary Atherectomy 
James Vetter, Gregory Robertson, Matthew Selmon, John Simpson, 
Dennis Sheehan, Bruce McAuley. Lissa Braden. Franklin 
Fleischhauer, Son Le, Julia Munn. Tomoaki Hinohara 
Sequoia Hospital, Redwood City. California 
Vessel perforation is one of the potential significant complications of 
directional coronary atherectomy (DCA). Of 1041 lesions treated 
between April 1988 and June 1991 14 (1.3%) had angiographic 
evidence of perforation (PERF); 12 native vessels and 2 vein grafts. 
Five (0.5%) had moderately large pseudoaneurysms, 8 (0.8%) 
showed minimal perivascular staining and 1 (0.1%) developed an 
A-V fistula. None of the patients developed tamponade and all 
remained clinically stable with no late rupture or occlusion. Four 
patients (0.4%) underwent immediate CABG surgery. Two of the 
PERFs occurred when DCA was used to treat previously normal 
arterial segments involved with extensive spiral dissections. Four 
lesions (all minimal perivascular staining) had no adventitia 
suggesting that in these, the vessel was not perforated by the cutter. 
The 14 PERFs were compared with 100 consecutive lesions without 
evidence of perforation (NO PERF). Lesion length, eccentricity, 
vessel tortuosity, lesion angulation, calcification and vessel size 
were evaluated and found not to be significantly different for the 2 
groups. The following factors were also evaluated: 
PERF(n=14) NO PERF(n=100) p value 
Support pressure (psi) 24.6 26.5 n.s. 
7 Fr device used 64.3% 53.9% n.s. 
Tissue weight (mg) 14.4 ±. 7.6 15.4 ±. 12.5 n.s. 
Presence of media 79% 38% 0.01 
Presence of adventitia 71 % 16% <0.0001 
In conclusion, clinically significant perforation is infrequent with 
DCA and in our experience has not been associated with cardiac 
tamponade. late rupture or late occlusion. 
720·3 4:30 
Acute Complications of Directional Coronary Atherectomy 
Are Related to the Morphology of Excised Stenoses 
Danna Johnson, Tomoaki Hinohara, Gregory Robertson, Matthew 
Selmon, Lissa Braden. John Simpson. Medical College of Virginia. 
Richmond. V A. Sequoia Hospital, Redwood City, CA 
The histology of vascular lesions resected by Directional Coronary 
Atherectomy (DCA) was correlated with acute complications resulting 
from the procedure. Tissues from 377 coronary artery (CA) lesions 
(142 primary stenoses, 235 restenoses) and 86 saphenous vein bypass 
graft (SVG) obstructions (34 primary stenoses, 52 restenoses) were 
analyzed for the presence or absence of thrombus (THR), calcium 
(CAL). necrotic lipid material (LIP), media (MED), and adventitia 
(ADV). Acute complications are enumerated in the table, below. There 
were no deaths. 
Oed Emb MI Diss LoSB Perf CABG 
CA 23 17 8 23 4 8 
(n=377) 
SVG 4 9 5 0 0 
(n=86) 
Occl-occlusion; Emb-embolization; MI=myocardial infarction; 
Diss=dissection; LoSB=loss of side branch; Perf=perforation or 
pseudoaneurysm; CABG=emergency coronary bypass surgery. 
For CA. THR involved 78% oflesions with, and only 31% of 
those without. acute OecJ (p<.OOI). THR was present at 76% of CA 
stenoses complicated by acute MI. but only 32% of lesions without MI 
(p<.OOI). ADV was found in 75% of CA cases where Perf occurred. 
compared to 16% of lesions without Perf (p=.01). For SVG. thrombus 
was present at 100% of lesions complicated by Emb. but only 57% of 
those without Emb (p=.03). No histologic parameters correlated with 
Diss. LoSb. or CABG. and MED.CAL, and LIP were not associated 
with adverse effects. 
Pre-existing lesion thrombus and incision into the adventitia are 
related to some acute complications of Directional Coronary 
Atherectomy. 
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720·4 4:45 
Dissections Associated with Excimer Laser Coronary 
Angioplasty (ELCA): Predictive Factors and Impact on 
Success, Complications, and Long.Term Results 
Martin B. Leon, Kenneth M. Kent. Timothy J. Garrand. David R. 
Holmes. William Untereker. Geoffrey O. Hartzler. Neal Eigler. 
Spencer B. King, and ELCA investigators. Washington Hospital 
Center. Washington, D.C. 
Dissections (0) after PTCA reduce procedure success and increase 
in· hospital major complications. To assess the impact of D on 
procedure outcome after ELCA. a consecutive series of 2,082 pts 
from the multicenter ELCA registry was analyzed. Major or minor D 
appeared after laser therapy or subsequent PTCA in 308 pts 
(14.8%). D were more frequent in native coronaries (vs. vein 
grafts, p<O.OOI) and tortuous lesions (p<0.009) but D were 
independent of lesion length, laser catheter size. energy density, and 
lesion calcification. Procedure success (final diameter stenosis 
<50%) and complications were as fol1ows: 
Procedure Abrupt Perlor- Urgent 
Success Closme ation CABO 
(%) (%) (%) (%) 
0(308) '80 '16 1.7 *9.5 
No 0 (1712 92 6 1.5 2.6 * p < O. 1. + p <6.003 
MI 
(%) 
+6.9 
3.2 
Death 
(%) 
0.6 
0.5 
In 1.381 pts with >6-month fol1ow-up, pts with ELCA-associated D 
had more frequent repeat PTCA procedures (26% vs 18% without 
D. p<o.OO8) but no changes in other failure mode endpoints (death. 
MI, or CABG). Fol1ow-up angiography in 73% of eligible D pts 
(67) and 64% of eligible no D pts (390) indicated a similar frequency 
of restenosis (55% and 50% respectively). In conclusion: 
Similar to PTCA. procedure-related Dafter ELCA 1) significantly 
reduce procedure success; 2) increase in-hospital complications 
(including abrupt closure. urgent CABG. and MI); and 3) are 
associated with more frequent recurrent ischemia requiring repeat 
PTCA. 
720·5 5:00 
Analy8is of Risk Factors for the Occurrance of Subacute Thrombotic 
Events After Intracoronary Implantation of Palmaz-Schatz Stents 
Michael Haude, Raimund Erbel. Hassan Issa. Uwe Straub, Holger Swars, 
Ulrich Dietz, Jurgen Meyer. 
2nd Medical Clinic, University Mainz. Mainz. Germany 
Subacute thrombotic stent occlusion (SAT) up to 1 4 days after implanta•
tion is the most serious complication associated with this technique. A 
total of 101 Palmaz-Schatz stents were implanted in 85 patients (pts), of 
whom 10 pts (12%) developed SAT 3 to 9 days after implantation. Retro•
spective cross-classified analysis of 1 3 anamnestic, 1 5 procedural and 
1 5 angiographic variables was performed to detect risk factors for SAT. 
The following parameters were identified and results on relative risk are 
given as odds ratios (OR). 95% confidence intervals (CI) and p-values: 
bail-outindication(OR-5.2. CI-l.4-25.4, p-O.Ol12), unstable angina 
(OR-4.2, CI-1-11.31. p-0.044), typeClesion(OR-11, CI-2.6-46.6, 
p-0.0005), lesion length > 1.5cm(OR-l1.3, CI-3.8-18.5, p<O.OOOl), 
plaque area >3.5cm2 (OR-9.3. CI-2.2-40.4. p-0.0014), symptomatic 
post-PTCA dissection (OR-6. CI-l.4-25.4, p-0.022), incomplete 
wrappingofdissectionafterstenting(OR-9.1, CI-1.1-13.8, p-0.044), 
residualdistalvesselirregularitiesafterstenting(OR-26, CI-4.8-1 40.4, 
P < O. 000 1 ). Other variables such as multiple stenting per lesion statisti•
cally were not associated with a higher risk of SAT. Results of global 
coagulation tests (prothrombin time, activated partial thromboplastin time, 
thrombin time) were not able to detect latent coagulation as occurs before 
SAT, although pts received aspirin, dipyridamole, heparin and phenpro•
coumon. In contrast prothrombin fragments 1 +2 and coagulation factor 
II were shown to effectively detect latent coagulation. Using this coagula•
tion monitoring SAT was significantly reduced (only in 1 of 32 pts in com•
parison to 9 of the first 53 pts, p<0.05) even in pts who presented with 
one or more of the above listed risk factors for the development of SAT. 
ThUS, the detection of risk factors for the development of SAT 
should be considered in particular. These pts, presenting with one or 
more risk factors, need maximal observation and an optimal coagulation 
monitoring including prothrombin fragments 1 + 2 and coagulation factor 
II in order to avoid SAT. 
ABSTRACTS 
720·6 5:15 
Predictors and Prognostic Significance of CPK Elevation 
After Percutaneous Transluminal Rotational Coronary 
Atherectomy 
Jeffrey J. Popma, Martin B. Leon, Maurice Buchbinder, Simon 
Stertzer, Michael Cowley. Theodore Bass, Raimund Erbel, David 
Warth. Washington Hospital Center. Washington. DC. 
CPK elevations occur in as many as 15% of pts after successful 
PTCA, often developing with little clinical significance. To 
determine the frequency, predictive factors, and prognostic impact of 
CPK elevations after percutaneous transluminal rotational coronary 
atherectomy (PTCRA), we reviewed the serial CPK analysis of 775 
consecutive pIS undergoing PTCRA at 16 centers. Post-PTCRA 
CPK and CPK-MB analyses were available in 705 (91 %) pts (serial 
samplings were less complete for all time points). Total CPK or 
CPK-MB isoenzyme elevation ~ 1.5 above normal was considered 
significant. A total of 66 episodes of CPK elevation (8.5%) were 
identified, of which 2.9% represented larger MI (CPK or CPK-MB 
~ 5 above normal). Age. lesion site, and maximum burr size were 
similar in patients with and without CPK elevation. 
CPK Elevation No CPK Elevation 
(N=66) (N=700) 
Lesion Calcium (%) 34 41 
Lesion Length ~\O mm (%) 26 28 
Tortuosity (%) 14 29 
Post-PTCRA Stenosis (%) 48 37 
Post-PTCA Stenosis (%) 31 22 
CoronruyS~m(%) 9 1 
Abrupt Closure (%) 23 2 
Delayed Closure (%) 3 1 
CABG(%) 9 3 
~~~ 0 1 In Crijusjop: CPK elevation after PTCRA 1) develops In 8.5% 
of pIS; 2) is not predicted by standard lesion morphologic features; 
and 3) is often associated with lesion site consequences (e.g .• abrupt 
closure and vasospasm) and in-hospital morbid events (urgent 
CABO). 
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721·1 
AnalysiS of Early ventricular proarrhythllia in the 
Cardiac Arrhythllia Suppression Trail (CAST) 
D. George Wyse, J. Morganroth, A. Hallstrom for the 
CAST Investigators, Division of Cardiology, 
Uni versi ty of Calgary/Foothills Hospital, Calgary, 
Canada 
Early proarrhythmia (proA) which was unconfirmed 
by drug washout was evaluated in 2330 post 
infarction patients with ventricular ectopy during 
titration with encainide, flecainide and/or 
mor1C1Z1ne. First drug selection was partly based 
on left ventricular ejer:tion fraction (LVEF) . 
Overall rates of major (eg. arrhythmic death) and 
minor (eg. increased ectopy) proA were (95\ CI): 
2.2\ ( 1 .6 to 2.8) and 5.4\ (4.5 to 6.3). Incidence 
of major proA on first drug was greater if LVEF was 
<0.3 (4.7 vs 0.8\) but incidence of minor proA was 
not (4.7 vs 3.4\). Frequencies of proA on second 
drug in relation to presence or absence of proA on 
first are: 
LyEF ~0.3 LYEF <0.3 
~ ~ 
proA No proA proA No proA 
~ proA 23 26 ~ proA 12 12 
1 No proA 18 353 1 No proA 19 164 
P < 0.001 p < 0.001 
Minor proA on first drug did not preclude 
suppression on another drug (21.2\) but was 
associated with higher risk of subsequent death or 
resusci tated cardiac arrest (Relative Risk = 3.3). 
Conclusions' 1. Early proA was infrequent in CAST; 
2. major proA on first drug was related to LVEF but 
minor proA was not; 3_ proA was more likely on 
second drug when it occurred on first drug; and, 4. 
minor proA is a clinically important predictor of 
mortality. 
4:00 
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721·2 4:15 
Does Asymptomatic Worsening of Arrhythmia Predict 
Sudden Death in Heart Failure? Evidence for Clinically 
Significant ProlUThythmia During Milrinone Therapy 
Barry M. Massie, Philip J. Podrid, Grady H. Hendrix, John F. Moran, 
Marrick L. Kukin, P. K. Tandon, James Shannon, Milton Packer for 
the PROMISE Study. Univ of Calif. & V AMC, San Francisco, CA 
Worsening of asymptomatic ventricular arrhythmias is a 
frequent cause for concern in pta with heart failure, but its prognostic 
significance is uncertain. To determine if asymptomatic worsening 
of arrhythmia on serial Holter monitoring predicts sudden death, we 
analyzed Holters performed at baseline and after 1 wk, 1 mo & 6 mos 
in 986 pts with class III & IV heart failure who were enrolIed in the 
PROMISE Trial. Pts were randomized to placebo (PBO, n=480) or 
milrinone (MIL, n=506) and folIowed for up to 20 mos. Three 
proarrhythmia criteria were pre-specified: (1) 1 frequency of ventri•
cular premature beats (VPBs) & (2) 1 frequency of runs of ventricular 
tachycardia (VT) !both defined by Morganroth criteria) & (3) 1 length 
of VT, defined as a > 2-fold 1 in longest run (1 VT length). Holter 
recordings were analyzed blindly after the completion of the study. 
During the study, more MIL than PBO pts had worsening arrhyth•
mia by all 3 criteria (P < 0.05), and MIL increased sudden death by 
69% (P < 0.005). Yet, of the 3 criteria, only 1 VT length independently 
predicted long-term outcome. The finding of 1 VT length at 1-wk was 
associated with a 110% 1 in subsequent sudden death (P=0.OO3), but no i 
in death due to progressive CHF. The strong association between 1 VT 
length & sudden death was limited to pts treated with MIL (131% 1 risk 
with MIL [P = 0.002) vs 25% 1 risk with PBO [P=O.71), between-group 
comparison [P < 0.001]). Of note, the concomitant use of anti-arrhyth•
mics abolished the significance of 1 VT length (135% 1 sudden death 
without anti-arrhythmics vs 8% J. on anti-arrhythmics), P=0.026. 
These results provide the first demonstration that asymptomatic 
proarrhythmias may be clinically significant, i.e., they presage a 
marked increase in the risk of sudden death. However, of available 
criteria, the prolongation (rather than the increased frequency) of VT 
may be the critically important indicator of proarrhythmia. 
721·3 4:30 
Long·Term Suppression of Ventricular Arrhythmia in the 
Cardiac Arrhythmia Suppression Trial (CAST) 
Oavid M. Salerno, AI HaIlstrom, Craig M. Pran, William Williams, Gail 
Morris, Cathy Smith, Jerome O. Cohen, Donald Romhilt, Michael 
Proschan, Jorge Gonzalez-Zuelgaray, Chien-Suu Kuo, Manin Green, 
Richard F. Davies. Hennepin County Medical Center, University of 
Minnesota, Minneapolis, Minnesota 
The Cardiac Arrhythmia Suppression Trial (CAST) included a pro•
spectively planned substudy to obtain Holter recordings 4 months after 
randomization to blinded therapy, to assure that the ventricular ectopic 
depolarization (VEO) suppression hypothesiS was adequately tested. This 
repon analyzes the results of patients assigned to encainide, flecainide, or 
comparable placebo. In this substudy, 301 randomly selected patients had 
three 24-hour Holters obtained: I) at baseline before treatment, 2) on op•
timal dose of encainide or flecainide to evaluate drug suppression, and 3) 
after 4 months of either active therapy (177) or identical placebo (124). By 
protocol design, all patients had ~80% suppression of ventricular ectopic 
depolarizations (YEDs) on their optimal dose (recording #2). The following 
suppression on active therapy or "apparent suppression" on placebo therapy 
was observed at 4 months. 
Suppression 
al4 months 
~80% 
~60% 
<40% 
Increased arrhythmia 
CAST-defined proanbytbmja 
Active 
n(%) 
119 (67%)* 
J3J (77%) 
37 (21%) 
24 (14%) 
3 (2%) 
Placebo 
n(%) 
35 (28%) 
51 (41%) 
69 (56%) 
53 (43%) 
6 (5%) 
p < 0.0001 vs. placebo 
For patients asSigned to active and placebo respectively, the median % 
suppression was 97.3% and 96.9% on initial active dose titration, and was 
91.8% and 31.6% after 4 months of blinded therapy. For active and placebo 
patients, respectively, median VEDs,Ihr were 36 and 43 at baseline, I and 1 
on initial active therapy, and 3 and 31 after 4 months. 
Thus, the majority of patients on active therapy continued to demonstrale 
antiarrhythmic effect at 4 months and the majority of palients on placebo 
continued to manifest ventricular arrhythmia. There was no evidence for 
proarrhythmia on the 4-month recording. The amount of VEO suppression 
on active therapy was suffiCiently different from placebo at 4 months to test 
the VED suppression hypothesis. 
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721·4 4:45 
Safest Antiarrhythmic Drug In Advanced Heart Failure Depends on Heart 
Failure Etiology 
Holly R. Middlekauff, William O. Stevenson,LeslieA. Saxon, Lynne Warner 
Stevenson. UCLA Medical Center, Los Angeles, California 
Atrial and ventricular arrhythmias are cornmon in advanced heart failure 
(CHF) but antiarrhythmic therapy (AAD) is limited by significant risks of 
proarrhythmia and sudden death (SO). Whether these risks are shared 
equally by pts with coronary (CAD) and noncoronary(IDIO) etiologies of 
CHF was studied in 548 pts (ejection fraction (EF) = .2 ± .07, CAD=23S, 
I ~ I 0 = 2 1 ~ ) 40 _ CORONARY ARTERY DISEASE 
WIthout cardIac 
arrest history S 
discharged from U p'O. 02 
CLASS I 
h 0 s pit aID 30 
following heart D 
transplant ~ 
evaluation. 
RESULTS: In D 
CAD pts, AAD E 
were Class I in ~ ::. ~r----+F- NO DRUG J~, ~/~ 60, amiodarone H (AM 10) in n, 
and none in 104 
pts. All 3 groups 
had similar EF, 
60 ,00 '60 200 260 300 360 400 
DAYS 
hemodynamics,and arrhythmias,but serum sodium was slightly higher in the 
no drug group. 1 year actuarial SO was worse for Class I drugs than for 
AMIO or no drug pts (22 vs 12 or 10%, p=.02)(figure). In Cox analysis, 
Class I therapy predicted SO independent of serum sodium and EF. In 
IDIO pts, all 3 AAO groups were similar except fewer pts had atrial. 
fibrillation in the no drug group. 1 year SO risk was not different for Class 
I vs AMIO ys no drug pts (21 ys 16 ys 16%, p=NS). CONCLUSION: In 
advanced CHF from CAD, Class I drugs are associated with increased SO, 
and AMIO may be the safest antiarrhythmic. In contrast, in noncoronary 
CHF pts, Class I drugs and AMIO appear equally safe. 
721·5 
Medical versus SUIgical 'DlercIpy far ~ 
Vent:ria1lar TadIycardia: A:RanbIized  
Willem Beukema, NoIDert van Hemel, Herre Kin;Jma, 
Emile Jessunm, Jo Defauw, Henry van swieten. 
st Antonius Hospital, Nieuwegein. '!he Nether1ams 
5:00 
In the therapeUtic strategy for postinfarction ventricu•
lar tachycardia(VI') ~ded surgery(S) is CXI!IID1ly 
resezved for dIUg(D)-refractmy patients. However, at 
present, S shows sudl favaIrable cutoane that 
oc:mparison between S and D is justified. As of SepteIIb!r 
1987 a prospective rarxianized study was started to 
~ vr freedan and SUIVival of surgeIy versus dIUgs. 
Recurrenoe of vr after S or 2 different dIUg trials 
warranted crossover. Fifty-five patients have been 
enrolled: 26 patients un::1erwent S, 29 patients received 
D_ All patients were eligible for S, deperWn:J 00 the 
presence of ~ 3 normal contractile left ventrirular 
segments (the argiograpu.c wall D¥:Ition score: maxilII.mt 9 
segments), Base line dlaracteristics did not differ in 
both groops_ After a mean follow-up of 23 1IDJ1ths vr had 
recurred in 12/29 (41.4 t) D patients and in 6/26 (23.1 
t) S patients. Actuarial vr freedan (incllXling suckien 
arrtlythmic death) withoot dIUgs in the years beb.'een 
randanization and crossover was IIl.Idl higher in S 
patients (80t) than in D patients (58t) (p=O.05). 
Actuarial survival in this period did not differ in both 
groops (S 84%, D 88t). until crossover 6 of 55 pts died: 
3 of heart failure, 2 suffered an arrtlythmic death. 
'!he first results of this on;JClin;J study irxticate that 
map-guided S can be carried em withalt adtitional risk 
in patients eligible for vr surgery. ltlen haert surgery 
is necessary, additional arrhythmia surgery shc:uld be 
considered first choice in the management of the vr 
patient. 
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Spontaneo.Is ventricular Tad:lycardias in Dogs with 
O1rcnic Heart Failure: Relaticn to Plasma 
NorepinePlrine Ocncentraticn 
Hani N. Sabbah, A. David Goldberg, Tatsuji Ka1o, Paul 
D. stein, sidney Goldstein. Henry Ford Heart and 
Vascular Institute, Detroit, Midligan 
~ syIlplthetic nervous activity has been 
prq:lOSed lIS an iJIportant factor in the genesis of 
ventricular arrhyt:l1mias in patients with heart 
failure (HF). In HF patients, ventricular tad1ycarttia 
(Vl') is associated with in::reased incidence of suQjen 
death. We examined the associaticn of plasma 
~inePlrine (~) ~ticnwith~ 
vr in 18 dogs with dlranic HF produced by sequential 
intracorcnary microembolizations (:EloIB). 1ImI:W.atory 
Em m:mitorirq (6.8:tO.2 boors) was performed at 
baseline and durirq HF (4 months after the last :EloIB). 
None of the dogs had arrhyt:l1mias at baseline b.lt 17 
of 18 dogs (94%) develqled dlronic ventria1l.ar 
arrhythmias durirq HF rargirq fran sinple ventricular 
premature cart:ractions (VPBs) to nonsustained runs of 
vr (>4 beats). None of the dogs develqled electrolyte 
disorders and none received drugs. Six of 18 dogs 
(33%) manifested spontaneo.JS runs of nonsustained vr 
(17±19 runs/hoor). No significant differeras were 
present arrr:x-g dogs with or witllc:ut vr with respect to 
LV ejection fraction (EF), erxi-diastolic volume (EDIT) 
or VPBs/hoor. PNE ocn::entraticn, however, was 
significantly increased in dogs with vr. 
No vr vr P-value 
EF (%) 22 ± 1 20 ± 2 0.20 
EDIT (ml) 98 ± 8 89 ± 4 0.45 
VPBs/hoor 76 ± 34 196 ± 110 0.21 
ENE (pgtmll 594 ± 83 1223 ± 276 0.02 
Conclusion: Spont.arleoos vr in dogs with dlronic HF is 
closely associated with elevated PNE ~tion. 
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722·1 4:00 
Intracoronary Plaque Composition In Non·Lesiobal Segments Differs In 
Unstable Angina and Stable Angiba Patients: Evidence from Intracoronary 
Ultrasound 
John McB. Hodgson, Karan G. Reddy, Randeep Suneja, Helen M. Sheehan, 
Edward J. Lesnefsky, aavi Nair, University Hospitals of Cleveland and Case 
Western Reserve University, Cleveland, OH. 
Patients with unstable angina frequently have ruptured plaques which are felt 
to have a high lipid content. Whether these lipid rich soft atheroma are 
localized or represent a diffuse process is not known. We hypothesized that 
patients with unstable angina (UA) had diffuse vascular abnormalities. 
lntracoronary ultrasound (ICUS) was used to interrogate the non· lesion 
segments in patients presenting for PTCA. UA patients (post infarct, abrupt 
onset or prolonged rest pain, n=22) were compared to stable angina (SA) 
patients (stable angina >2 months, n=29). These two groups did not differ 
in age, sex, or presence of hypertension, diabetes, family history, 
hyperlipidemia, smoking or obesity. ICUS determined % total vessel area 
occupied by atheroma was similar in UA and SA patients. (47±11 % vs 
53±11% p=NS). Patients with UA however had different plaque 
morphology. Plaque was classified as predominantly soft (faint or medium 
intensity echoes), fibrous (bright echoes without acoustic shadowing), calcific 
(bright echoes with shadowing >90" of circumference), or concentric 
subintimallhickening (widened (> 3001') subintimal echolucent band). This 
last pattern and soft echoes have been shown to correlate with loose 
fibromuscular tissue and lipid. (p<O.Ol) 
UA PATIENTS SA PATIENTS 
SUB. THICK. 15 (52%) 8 (38%) 
SOIT 11 (38%) 3 (14%) 
FIBROUS 2 (7%) 4 (19%) 
CALCIFIC 1 (3%) 6 (29%)' 
Soft plaques and subintimal thickening were seen more commonly in UA 
than SA (90% vs 52% p=O.OOO2). Calcified and fibrous atheroma were seen 
more commonly in SA than UA (48% vs 10% p<O.OOI) We conclude that 
despite similar degrees of atheroma involvement, patients with UA have 
plaque morphology in non lesional segments which is different than SA 
patients. This may reflect a higher prevalence of lipid laden atheroma in UA 
patients. 
ABSTRACTS 
722·2 4:15 
Atherectomy Specimens From Patients With Unstable Angina Pectoris 
and Post Angioplasty Restenosis Exhibit Similar Histopathology 
Moshe Y. Flugelman, Rosaly Correa, Renu Virmani, Andrew Farb, 
Zu-Xi Yu, Martin B. Leon, Kenneth M. Kent, Ward Casseells, 
Stephen E. Epstein. NHlBl, Bethesda, MD. 
The mechanisms underlying transformation from stable to unstable 
angina pectoris (UAP) remain obscure. We tested the hypothesis that 
patients with UAP share common pathophysiologic features with post 
angioplasty restenosis patients. Specimens retrieved during directional 
atherectomy procedures from 25 patients with UAP and 19 patients 
with restenosis were compared. The athere~tomy specimens were 
sectioned serially for H&E, Movat's, Masson's and PTAH staining. 
Three independent observers, blinded to the clinical data analyzed the 
atherectomy specimens for: 1) smooth muscle cell (SMC) 
predominance (0·3 scale), and 2) activity of the lesions based upon 
cellularity, matrix composition, and the presence of thrombus or 
hemorrhage. The specimens were further categorized as typical 
restenosis lesions when abundance of disorganized SMC coexisted 
with immature matrix. 
UAP 
Restenosis 
'p=NS 
SMC oredominanceI0·3)' 
1.54±0.Bl 
1.Bl ±O.B7 
Active lesions' 
54%(13/24) 
53%(10/19) 
Notably, five atherectomy specimens from UAP patients were 
classified as typical restenosis lesions. Immunohistochemistry studies 
for acidic and basic fibroblast growth factors (FGF) in a subgroup of 
these atherectomy specimens (n = 25) confirm light microscopy 
findings and indicate similar patterns of FGF expression in UAP and 
restenosis patients. 
We conclude that atherectomy specimens from UAP and restenosis 
patients have Similar histopathology; in particular, SMC can appear 
abundantly in either. Thus, proliferation of SMC may play an important 
and previously unrecognized role in unstable angina pectoris. 
722·3 4:30 
Coronary Angiographic Findings in Patients with Unstable 
Angina and "Normal Coronary Arteries": A Report from 
the TIMI 3A Trial 
Jonathan D. Bier, Daniel J. Diver, Paula E. Ferreira, Barry L. Sharaf, 
David O. Williams and the TIMI 3A Study Group, Rhode Island 
Hospital and Brown University, Providence, RI 
79A 
Patients who present with ischemic chest pain at rest represent a diverse 
group, not all of whom have significant coronary artery disease (CAD). 
We sought to evaluate the ECG and coronary angiographic 
characteristics in a consecutive series of these patients. In the TIMI 3A 
study, 44 of 388 pts (11 %) had a less than 60% coronary stenosis and 
rest pain. Quantitatively, a 0 - < 20% stenosis was present in 23 pts 
(52%), a ~ 20 < 50% stenosis in 15 pts (34%) and a > 50 < 60% 
stenosis in six pts (14%). No pts had angiographic evidence of 
intracoronary thrombus or irregular or ulcerated lesions. A 50 - 60% 
stenosis tended to be present more often in pts with ECG's 
demonstrating primary ST and T wave changes (5{25) than in those with 
normal repolarization (1/19). Abnonnally slow coronary flow was noted 
in 14/44 (32%) of pIS and was found more often when no CAD « 20% 
stenosis) was present (10/23) vs. 4(21). In five pts, slow flow was 
limited to a single coronary anery and was associated with primary ST 
and T wave changes in the distribution of that vessel in three of the five 
pIS. We conclude that I) some pts with rest pain and ischemic ECG 
changes may have no CAD, 2) mild CAD is common, but is not 
associated with morphologic features that would suggest an unstable 
lesion, and 3) a significant proportion of pts demonstrated an unusual 
pattern of coronary flow, a finding which may be associated with 
abnormalities in the coronary microcirculation and represent a possible 
etiology for unstable angina. 
80A ABSTRACTS 
722·4 4:45 
Determinants of Lethal Outcome in Unstable Angina 
Theodore Schreiber, David Rizik, Gerald Timmis, William O'Neill. 
William Beaumont Hospital, Royal Oak, Michigan 
With the changing nature of therapy in unstable angina as weU as the 
hetrogeneous spectrum of ischemic syndromes this disease represents, 
it is important to define the factors prognostic of lethal outcome. To 
this end, we foUowed the hospital course of 1,387 consecutive unstable 
angina pts admitted to our institution during the 26 month period 
ending 6-1·91. Epidemiologic descriptors, incidence of PTCA and 
nature of medical therapy was determined for those who died (n = 24) 
and the survivors (n=1,363). Ventricular function was known in 811 
pts (58.5%). 
Results: A stepwise logistic regression model was constructed and 
showed the independent predictors of death, in order of strength of 
association to be: ventricular function (P=8.64) and diabetes (P=7.7). 
When ventricular function was not available, lack of aspirin use 
(P=13.1), advanced age (P=7.8) and male gender (P=5.3) emerged as 
independent predictors of lethal outcome. 
Use of PTCA, multivessel disease, hypertension, tobacco use, 
cholesterol, use of calcium or beta blockers, heparin or nitrate use were 
not independent predictors of death. 
Two·hundred thirteen of 1,387 pts (15.3%) underwent PTCA Of the 
24 pts dying (2·16 days after admission), only 2 deaths may have been 
related to PTCA Other causes of death were pump failure (37.5%), 
ventricular arrhythmia (50%), heart block (4.1%), hypotension, (4.1%) 
and stroke (4.1 %). 
Conclusion: Thus, the profile of pts who encounter lethal outcome 
in unstable angina includes advanced age, lower ejection fraction, 
diabetes and lack of aspirin use. These findings should facilitate 
appropriate therapy in unstable angina. 
722·5 5:00 
Antecedent Angina Pectoris Predicts Worse Out•
come After Thrombolytic Therapy for Acute Myo•
cardial Infarction - Experiences Gathered in 
the International TPA/STK Study. 
Gabriel I. Barbash, Harvey D. White, Frans van 
de Werf, for the Investigators of the Inter•
national TPA/STK Trial. 
The prognostic significance of pre-infarction 
angina was assessed in 8329 patients (pts) 
with acute myocardial infarction (AMI) who 
received thrombolytic therapy. There were 4447 
pts with out angina, 1512 with Sl mont ante•
cedent angina and 2370 with >1 month angina. A 
long history of antecedent angina was 
associated with significantly worse baseline 
characteristics; pts were older (65 vs 62 vs 
61 yrs old, respectively, p < 0.0001), and had 
significantly higher rate of previous AMI (37% 
vs 28% vs 10%, respectively, p < 0.0001) and 
hypertension (40% vs 31% vs 27%, P < 0.0001). 
Antecedent angina was associated with longer 
hospital stay (11.3 days vs 11.7 days vs 10.8 
days, p < 0.0001), a higher incidence of 
bypass surgeries (2.2% vs 1.2% vs 0.7%, P = 
0.0001), a worse Killip class at discharge 
(9.5% vs 8.0% vs 6.1%, P = 0.0001), and a 
higher in-hospital mortality (12.1% vs 8.9% vs 
6.6%, respectively, p < 0.001). Antecedent 
angina predicts a worse clinical outcome and a 
more intensive utilization of medical 
resources in pts with AMI receiving thrombo•
lytic therapy. 
722·6 
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5:15 
Adverse Prognostic Impact of Unstable Angina Without 
Antecedent Symptoms 
David Rizik, Theodore Schreiber, Lester Williams, Ann Margulis, Cindy 
Grines, Gerald TlDImis, William O'Neill, William Beaumont Hospital, 
Royal Oak, Michigan 
Since unstable angina (UA) represents the leading hospital admission 
diagnosis nationwide, the ability to prognosticate outcome soon after 
admission will facilitate triage and therapy, To this end, we examined the 
influence of the historical pattern of 644 consecutive pIS presenting with 
VA at our institution from April I, 1989 through December I, 1989. 
The "de novo" pattern was defined as angina of new onset in the 30 
days prior to presentation, whereas acceleration of antecedent angina was 
established if exertional angina existing prior to 30 days before presen•
tation was more frequent, prolonged or more easily provoked. The two 
groups did not differ with respect to the foUowing epidemiologic des•
criptors: age, gender, cholesterol, diabetes, tobacco use or hypertension. 
To further enhance clinical prognostication, the impact of presence ( + ) 
or absence (-) of new electrocardiographic ST and T wave abnormalities 
(ECG A) was examined. The incidence (%) of major cardiac events for 
each group, specificaUy death, MI, and intractable angina was determined. 
De Novo Antecedent 
n = 413 n = 231 
+ ECG A (n=297) 42.4% 22.1% P < 0.001 
- ECG A (n=347) 6.6% 4.2% P = NS 
p < 0.0001 P < 0.0001 
The "de novo" pattern of VA appears to carry an ominous prognosis 
which is further exacerbated by new ECG abnormalities_ This obsCrvation 
supports the hypothesis of the unstable atherosclerotic "minimal lesion" 
as the basis of de novo VA 
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723·1 
How Much Prognostic Information Does Catheterization After 
Thrombolytic Therapy Add to NoninwsM: 0inicaJ Facton? 
4:00 
Kerry L. Lee, Kristina N. Sigmon, Robert M. Califf, Eric J. Topol, and the 
T AMI Study Group. Duke University Medical Center, Durham, NC 
To determine the value of acute catheterization (Cath) data relative to 
noninvasive clinical data for predicting in-hospital (IH) mortality in acute 
myocardial infarction (MI) patients (PTS) treated with intravenous (IV) 
thrombolytic therapy (1T), we studied 1,331 PTS from six consecutive 
multicenter TAMI studies where Cath was performed by protocol 90 
minutes from initiation of IT. AU PTS were treated with either IV tissue 
plasminogen activator (63%), urokinase (15%), or the combination 
(22%) within six hours of symptom onset Clinical variables examined 
included age, sex, MI location, heart rate, blood pressure (BP), and risk 
factors. Cath variables included TIM! grade, number of diseased vessels 
(NY) (> 50% stenosis), global ejection fraction (EF) and regional 
ventricular function in the infarct and noninfarct wnes. Prognostic 
relationships were identified using logistic regression in a randomly 
selected training set of 798 PTS and validated in the remaining 533 PTS. 
Overall IH mortality was 6.7%. Of Cath variables, the most significant 
predictor ofsurvival was global EP (X2=39, p=.OOOOl). Also 
contributing independent information were NY and TIMI grade. 
Important noninvasive predictors were age, systolic BP and MI location. 
The relative prognostic value of clinical and cath variables were: 
X2 (lli death) 
Oinical alone 36 
Cath alone 59 
Oinical and Cath 8S 
Clinical data alone provided considerably less prognostic information 
than did Cath. Clinical features contributed less than half of the total 
combined prognostic information, whereas Cath data contained 69% of 
the total information. The added contnbution of Cath variables to clinical 
data was highly statistically significant (X2=49, p=.OOOOl), but clinical 
data also contributed significantly to the Cath (X2=26, p=.OOOO3). 
Although clinical features alone contain useful independent prognostic 
information, prediction of survival is substantiaUy enhanced by the 
addition of early Cath data. 
JACC Vol. 19, No.3 
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723·2 4:15 
Should Every Patient Under 60 With Acute MYocardial 
Infarction Undergo Cardiac Catheterisation~ Experience 
With a Consecutive Series of Patients 
Stephen Cross, Hai Shiang Lee, Alisdair Kenmure, 
Stephen Walton, Kevin Jennings. Aberdeen Royal 
Infirmary, Sco,land, U.K. 
Three vessel and left main stem disease carry a poor 
prognosis following acute myocardial infarction. 
It is desirable to identif¥ these potentially high 
risk patients. A consecut1ve series of 200 young 
patients (all under 60) were electively re-aamitted 
for cardiac catheterisation~ exercise testing! and 
presence of angina (with a "ose Questionnaire at 
a mean (SO) of 60 (30) days following acute myocardial 
infarction. Significant coronary artery disease 
was defined as the presence of a 50% stenosis or 
greater in a main coronary artery, and a positive 
exercise test as horizontal or downward sloping ST 
depression of 1 mm or more. At least 85% of the 
expected heart rate had to be achieved for a test 
to be classed as negative. Normal arteries or single 
vessel disease were present in 98 (49%), 2 or 3 vessel 
disease in 97 (48.5%) and left main stem disease 
in 5 (2.5%). 
The sensitivity and specificity of exercise testing 
in detecting multivessel disease were 50% and 76% 
respectively. For angina these were 63% and 56%, 
and for either 78% and 40% respectively •. If we had 
catheterised only the 174 patients (87% of the total) 
with a positive exercise test, or angina, or those 
with an inadequate exercise test we would have missed 
5 of the 30 patients with 3 vessel and none with 
left main stem disease. Despite the catheter findings, 
none of these 5 patients were referred for surgery. 
If we had catheterised only the 110 patients (55% 
of the total) with either a positive or an inadequate 
exercise test, we would have missed no left main 
disease~ but would have missed 7 patients with 3 
vessel aisease. Two of these 7 were referred for 
by-pass surgery. The young infarct patient with 
potentially threatening coronary artery disease may 
be reliably detected by a history of post-infarction 
angina or a positive exercise test. 
723·3 4:30 
Detection of Residual Ischemia in the Infarct Zone and 
at a Distance in Myocardial Infarction : Comparison of 
Dobutamine Stress Echocardiography With Dobutamine Stress 
Tc-MISI Scintigraphy. 
Luc A. Pierard, Christian Berthe, Marie Paule Larock, 
Michel Hiernaux, Michel Bellekens, Henri Lilet, Pierre 
Rigo, Henri E. Kulbertus, University of Liege, Belgium. 
We have previously shown that dobutamine stress echo•
cardiography (DSE) identifies myocardial viability at 
low-dose and residual ischemia at high-dose. The purpose 
of this study was to compare DSE to dobutamine stress Tc 
99 m - MISI scintigraphy (DSS) for the detection of resi•
dual ischemia after myocardial infarction (MI). Cardiac 
catheterisation, DSE and DSS were performed in 29 pts, 5 
to 10 days after AMI. Dobutamine was infused to a peak 
dose of 40 mcg/kg/min in 2 min stages. At peak infusion, 
15 mci of Tc 99 m - MIBI was injected and imaging was 
obtained 45 to 90 min later. DSE and DSS were interpre•
table in all pts. 13 of the 29 pts had received thrombo•
lytiC therapy. Myocardial viability was demonstrated by 
low dose DSE in 7 of these 13 pts (54 %) and in only 1 of 
the 16 remaining pts (6 %). No evidence of ischemia was 
found in 16 pts with DSE and in 19 pts with DSS. Ischemia 
in the infarct zone was observed by DSS in 5 pts and by 
DSE in 13 pts. 12 of these 13 pts (92 %) had significant 
residual stenosis of the infarct related artery. Ischemia 
at a distance was demonstrated by DSE and DSS in 6 pts. 
Accuracy of ischemia at a distance to predict multi•
vessel disease was 83 % with DSE and 72 % with DSS. 
Conclusions : 1) DSE has the advantage of identifying 
myocardial viability at low dose. 2) There is good 
agreement between DSE and DSS for assessing ischemia at a 
distance and multivessel disease. 3) Ischemia in the 
infarct zone is more frequently detected by DSE, but the 
prognostic significance of this finding has to be deter•
mined. 
ABSTRACTS 
723·4 4:45 
Evaluation of Vlablllty on Infarcted Myocardium by 
Thallium Myocardial Scintigraphy versus New Developed 
Intracoronary Electrocardiogram. 
Kamon Imai, Yasushi Araki, Tomohiko Kamata. Yasuo 
Tamura, Kazuhlra Hibiya, Satoshi Saito, Yukio Ozawa. 
Nihon University, Tokyo, Japan 
Thallium myocardial scintigraphy (TMS) Is used to 
evaluate viability (V) on Infarcted myocardium. Recently, 
intracoronary electrocardiogram (lC-ECG) has been 
developed. To determine whether IC-ECG is useful for 
evaluation of V, TMS was performed before and after 
percutaneous transluminal coronary angloplasty (PTCA) 
In 60 patients with previous myocardial Infarction. A 
short axis image on TMS was divided into 3 layers, then 
perfusion defect (pm was evaluated. Subjects were 
divided into 3 groups according to recovery ratio of PO 
after PTCA: <25", 25-5(»1; and ~50". IC-ECG was recorded 
from a guide wire that was passed through infarct•
related coronary stenosis. V was defined as: (1) either 
redistribution (RD> or reverse redistribution (RR) on TMS 
before PTCA and/or (2) O.lmV 5T elevation during balloon 
inflation on le-ECG. In the <25" recovery group (n=14), 
V was found In 14" on TM5, 57" on IC-EeG (p(O.Oll. In the 
25-50" recovery group (n=14), V was found In 57" on TM5 
and 71" on IC-EeG (n.s.). In the ~50" recovery group 
(n=32), V was found In 100" on both methods. 
According to our data, detection of V by IC-ECG on the 
large recovery of PO (~25") was not different as 
compared with TMS. However, detection of V on the small 
recovery of PO «25") by le-ECG was superior to that 
of TMS. We have concluded that IC-EeG may prove to be a 
useful method to evaluate V of infarcted myocardium, 
especially in the absence of either RD and/or RR on TN5. 
723·5 5:00 
Myocardial Perfusion Reserve and Metabolism Assessed 
by Positron Emission Tomography in Patients After 
Myocardial Infarction 
Juergen vom Dahl, Christine Allman, Ronald Sutor, Markus 
Schwaiger, University of Michigan, Ann Arbor, MI 
Combined evaluation of coronary reserve and tissue viability by PET 
may be used to characterize the success of reperfusion and extent of 
underlying coronary artery disease in patients undergoing thrombolytic 
therapy. 25 patients (pts) were studied after myocardial infarction 
using PET and Rubidium 82 for evaluation of myocardial perfusion at 
rest and during infusion of 0.84 mg/kg adenosine (AD) over 6 min, 
followed by F-18 f1uoro·deoxyglucose (FDG) imaging. Semi•
quantitative analysis of multiple, reoriented image planes was 
perfonned using the polar map approach. Perfusion was defined as 
abnonnal (p A) if> I 0% of a vascular territory demonstrated flow <2.5 
SO of the corresponding region in a previously studied nonnal 
population. Scintigraphic results were correlated with those of 
coronary angiography. 
13/25 pts demonstrated adenosine induced PA in the infarct territory. 
In 11 of these 13 patients, there was preserved FDG uptake in the 
infarct territory. However, there was no correlation between stenosis 
of the infarct artery and adenosine induced perfusion defects. 16/18 
pts with multi-vessel disease had adenosine induced PA remote from 
infarct territory. Overall, resting PA were larger in 18 pIS with multi•
vessel disease in comparison to 7 pts with single-vessel disease 
(27±12 vs. 17±ll% of left ventricular map; p<0.05). By analysis of 
corresponding FOG images, AD induced PA were primarily (95%) 
seen in regions with preserved FDG·uptake indicating maintained 
viability. Thus. these data suggest discrepancy between status of 
infarct artery and scintigraphic results in the infarct territory, but close 
agreement between AD induced perfusion abnonnalities and FOG 
uptake as marker of tissue viability. Rb-82 PET imaging appears 
highly sensitive in the detection of mu1tivessel disease in the presence 
of previous myocardial infarction, but a larger patient population is 
required to define the diagnostic accuracy of this approach. 
81A 
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723-6 5:15 
Acute Myocardial Infarction (AMI) in the Young: Gender 
Specific Etiologies and Treatment 
M Rupp, HP Grill, JE Granato, Allegheny Campus of 
Medical College of Pennsylvania, Pittsburgh, PA. 
Acute Myocardial Infarction (AMI) in the Young (age 
less than 35 years) may have gender specific etiologies. 
Over a 3 year period, 4,467 patients were discharged 
from this hospital with the diagnosis of AMI. Of these 
28 (.6%) occured in young patients. All AMI were 
verified by both CPK-M8 and EKG. Distinct angio•
graphic differences between these groups were noted: 
Normal coronaries 
Partial Thrombus 
Coronary Stenosis> 70% 
EF less than 35% 
Inferior Wall MI 
Males (n-21) 
19% * 
5% * 
76% * 
67% * 
10% * 
* p (.05 
Females 
49% 
49% 
14% 
o 
100% 
(n-7) 
With the exception of birth control pills (67%), there 
was no significant difference in the prevalence of 
coronary artery disease risk factors. Even though 
males presented significantly later than females 
(8.5 hrs vs 3.0 hrs pt..05), they had a significantly 
greater liklihood of receiving thrombolytic or PTCA 
therapy (43 % vs 0% P < .05). There were no deaths in 
either group. 
These data suggest 1) AMI in the young is relatively 
uncommon, 2) AMI in young males is frequently assoc•
iated with CAD and LV dysfunction, 3) AMI in females 
may be related to partial thrombus or coronary spasm. 
These findings may be related to gender specific 
differences and have important prognostic and thera•
peutic implications. 
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724-1 4:00 
Noninvasive Detection of Cardiac Transplant 
Rejection Using Radiolabeled Monoclonal Antibodies 
to Specific MHC Class n Antigens 
Howard 1. Eisen, Sheri E. Belland, Jennifer J. WiJliams, 
Mitchell B. Schwartz, G. Praveen Raju, Leonard J. Perloft'. 
University of Pennsylvania, Philadelphia, Pennsylvania 
Expression of MHC Oass II antigens is enhanced on 
allograft parenchymal cell and T lymphocyte surfaces during 
transplant rejection. To detennine if transplant rejection can be 
detected noninvasively using gamma scintigraphy with 
radiolabeled monoclonal antibodies to specific MHC Oass II 
antigens, P7 n, a monoclonal antibody which binds to Wistar 
Furth strain rat MHC Class II antigens, was labeled with 
indium-lli (In-Ill) DTPA. Seven Lewis strain and six DA 
strain rats received Wistar Furth heterotopic cardiac allografts. 
Six Wistar Furth rats received syngeneic heterotopic cardiac 
transplants. All transplant recipients received 600-1000 IlCi of 
In-Ill- labeled anti-MHC Class II monoclonal antibodies 
intravenously six days after transplantation and were imaged six 
hours later. Scintigraphic uptake of anti-MHC monoclonal 
antibodies was expressed as % injected dose/g tissue weight 
(±SD). Scintigraphic uptake of monoclonal antibodies for 
Wistar Furth allografts in Lewis recipients was 8.1 ± 2.5 vs 2.0 
±.O.9 for native hearts (p<O.OOI). For Wistar Furth allografts in 
DA recipients, scintigraphic monoclonal antibody uptake was 
8.3 ± 2.2 vs 2.2 ± 1.0 for native hearts (p<O.OOI). Scinti•
graphic uptake ofisografts was 2.5 ± 0.9 vs 2.3 ± 0.2 for native 
heans (p=NS). Allograft anti-MHC monoclonal antibody 
uptake measured scintigraphically was significantly greater than 
isograft uptake (p<O.OOI). All 13 episodes of transplant 
rejection were detected scintigraphically with no false positive 
scans. We conclude that immunoscintigraphy with labeled 
monoclonal antibodies to MHC Oass II antigens can detect 
transplant rejection rapidly and noninvasively. 
lACC Vol. 19, No.3 
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724·2 4:15 
Detection of Pediatric Cardiac Rejection by Ultrasound TIssue 
Characterization 
Nina L Gotteiner, William B Burns, Michael J Vonesh, Eric D 
Nordmoe, Chen Keqing, Sonali Mehta, Sue E Pajcic, Shelby J 
Haberman, Susan E Crawford, Vincent R Zales, C Elise Duffy, 
David D McPherson. Northwestern University, Chicago, IL. 
Cardiac ultrasound tissue characterization (UTC) may assist in 
evaluation of allograft rejection. This technique is untested in the 
pediatric population. To determine UTC effi£DCY, we 
prospectively studied 19 children (age 6.5 ±. 6.2 yrs, X ±. SD; 
range 8 days - 17 yrs) (61 right ventricular endomyocardial 
biopsies fEMBx)), post transplant. Echo was performed at the 
time of E:MBx usmg constant gain and depth settings. Two 
regions of interest (ROI) were selected (septum and posterior 
wall) at end-systole and end-diastole. A texture analysis program 
produced 128 parameters for each ROI. EMBx proven retection 
UTC data (severe rejection (SR] 1 episode; moderate rejection 
fMR] 4 episodes) were compared to non-rejection (NR) data. 
Results: Although varying degrees of rejection occured, altered 
hemodynamics were only noted in 1 patient. Two groups of grey 
level parameters were noted to consistently change with rejection 
when data were compared within patients (Coocurrence 
correlation-COOC: grey level non-uniformity - GLN). 
Sample data for 1 patient· septum end-diastole 
NR MR SR 
GLN 94.6 71.78+,58.18+ 47.9' 
COOC 0.51 0.53, 0.57 0.87' 
• difference > 2 SD and + difference > 1 SD 
In the patient with altered hemodynamics and marked 
interstitial edema without cellular infiltrate, COOC and GLN 
both increased, unlike severe rejection with lymphocyte 
infiltration, where GLN decreased and COOC increased. These 
data demonstrate that serial UTC aids in identification of 
allograft rejection in the pediatric transplant population and may 
assist in identifying particular histologic features associated with 
the rejection process. 
724·3 4:30 
Noninvasive Detection of Cardiac Rejection-Low Dose 
1-123 Rlenylpentadecanoic Acid Parametric Metabolic 
Imaging 
Gary Murray, Lynn Magill, Nikolas Schad, James Pitcock, 
Donald Watson, Tim Fournet, Roger Vander Zwaag. 
Baptist Hospital, Memphis, TN, Univ of Siena, Italy, 
Univ of Term and LeBonheur, Memphis, TN 
Within the first year of cardiac transplantation, at 
least 13 myocardial biopsies are performed, and 
thereafter > 1+ biopsies/year are obtained. Since there 
are only l~ clinically significant rejection episodes 
within the first year, and fewer later, it is desirable 
to find a reliable, safe, and inexpensive noninvasive 
screening method for rejection. Accordingly, we 
assessed the value of resting cardiac metabolic imaging 
utilizing 1 mCi 1-123 phenylpentadecanoic acid (IPPA) 
intravenously and a multicrystal gamma camera. 
Using least square fit analYSis, regional rates of 
IPPA washout (4-24 min) were color-coded. The left 
ventricle was divided into 5 segments, with each 
segment's washout qualitatively graded 0-3 by 2 
independent observers, the segmental score being summed 
(maxinrum score of 15 = very poor washout). Twenty-one 
scans were obtained (1 wi< to 5 yrs after transplant) 
within 24 hours of right ventricular biopSies, biopsies 
being graded o-rv (Stanford system). 
The IPPA and biopsy grades correlated significantly 
(p = 0.(02). All 8 biopsies graded> 0 had an IPPA 
score > 5. Using a threshold IPPA score of 6 as an 
indication to biopsy, only 1 grade IA rejection would 
have been missed (sensitivity 88%), and 8/13 grade 0 
biopsies would have been avoided (specificity 62%), 
resulting in an estimated cost-savings of $12,000 (23% 
reduction) without missing treatable rejection (> grade 
II). Therefore, resting IPPA imaging potentially could 
reduce unnecessary biopsies following transplantation. 
JACC Vol. 19, No.3 
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724·4 4:45 
Breath Pentane Levels are Elevated in Orthotopic Heart 
Transplant Recipients with Active Rejection or Infection 
Dinesh K. Gupta, Paul A. Sobotka, Maria Rosa Constanzo•
Nordin, Edwin Zarling. 
Loyola University Medical Center Maywood, Illinois. 
Volatile alkanes, including pentane, are products of 
lipid peroxidation. To determine if breath pentane could 
be used to Identify rejection in cardiac transplant 
recipients, we prospectively measured pentane levels 
(single breath, end-expiratory sample) at the time of 
endomyocardia1 biopsy. The study group included 37 
patients, with cardiac index >2.0 1 min-' m-', more than 6 
weeks post transplant and no rejection on the immediate 
preceding biopsy. Pentane levels were subsequently 
compared in the following patient groups: 1) healthy 
controls, 2) patients without rejection or infection (NR 
n-13), 3) patients with mild rejection (MILD, n-9) 4) , 
patients with moderate rejection (MOD, n-7) and 5)' 
patients with infection without rejection (INF, n-S): 
GROUP PENTANE (lI±sd) RANGE (nmo1/l) 
CONTROL 2.0±1.0 0.61-3.S1 
NR 1. S±1. 0 0.1-3.4 
MILD 4.2±2.S 1.1-9.6 
MOD 5.3±2.6 3.5-10.0 
INF 6.7±3.2 3.4-13.1 
Conclusions: 1) Breath pentane levels are not elevated 
in transplant recipients without rejection or infection 
compared to healthy controls. 2) Breath pentane levels 
are e1e~ate~ in orthotopic heart transplant reCipients 
with reJect10n or infection. 3) Rejection and infection 
are associated with lipid peroxidation. 4) Analysis of 
single breath pent~ne levels may provide a rapid, 
noninvasive screenlng test for diagnosing cardiac 
rejection in the noninfected heart transplant recipient. 
724·5 5:00 
Soluble Interleukin·Z Receptor Levels Predict Subsequent Acute 
Allograft Rejection in the Transplanted Heart. 
Stephen Je.nnis.on, Alida. Caforio,. Taiwo Fashola, Sarah Riley, 
Jan Poloru.e~ki, Cathenne Corblshley, David Holt, Andrew 
Murday, Wllbam J. McKenna. St George's Hospital, London. 
We have s~own. en~othelial MH~ class II expression in 
endomyoc~dlal. bl,?psles. [Bx) pre~lcts su!'sequent significant 
acute card~ac ~eJectlOn Wlth .cellular infi~tratlOn and myocytolysis 
(AR). Activation of T cells IS accomparued by the elaboration of 
Interleukin-2 and its subsequent binding to a specific receptor 
complex (slUR). Monoclonal antibodies to slUR have been 
develc~ped as anti-rejection agents, but studies in humans have so 
far failed to show a correlation between slUR and rejection 
perhaps because of coincident infection, liver and renal 
Oysfunction; we analysed slUR levels at the time of Bx and 
excluded such cases to see if clinically significant rejection could 
be predicted. 
230 biopsies and concurrent slUR levels were obtained from 33 
orthotopic. heart transplant recipients in their first 6 
posto~eratlve months, treated with cyclosporin, azathioprine and 
predrusolone, the latter stopped after 3 months. slUR levels at 
the time of acute infection, drug·induced cholestasis [bilirubin 
.>25umol/l) or a serum creatinine >350 umols/I were excluded 
m 98 samples. 19 episodes of AR occurred in 18 patients. Whilst 
the slUR level was found to be moderately related to the 
concurrent. degree of rejection [Anova p=0.02, regression 
p=0.005), It was more strongly related to the degree of rejection 
1-6 weeks later [Anova 1'=0.003, re$ression=0.OOO8]. Expressed 
as a percentage change from the irutial slUR level taken at the 
first postop Bx, slUR strongly predicted the appearance of AR 
1-6 weeks later [regression p=O.OOOlj. 
This de.mo~trates th~t r,ising slUR levels are part of a 
nonspeCific Immune activatIOn process, but may have a potential 
role as a predictor of clinically significant rejection in the absence 
of infection, cholestasis or severe renal dysfunction. 
ABSTRACfS 
724·6 5:15 
Peripheral Blood and Coronary Sinus Cytokine Levels Cannot 
Detect Significant Rejection in Cardiac Transplant Patients 
Mitchell B. Schwanz. Sheri E. Belland. Rebekah L. Mull. William G. 
Kussmaul III. 10hn E. Tomaszewski. Howard 1. Eisen. 
University of PelUlSylvania. Philadelphia. Pennsylvania 
Cytok.ines including twnor necrosis factor-a (TNFa). interferon gamma 
~y? and interleuk.in-6 (lL6) are elaborated by T cells during transplant 
rejecuon (R). We tested the hypothesis that peripheral blood (PB) and coro•
n.ar>'. sinus (CS) levels ofTNFa. IFNyand IL61evels are elevated during 
slgruficant (moderate or severe) R requiring treatment and could therefore be 
used as a screen for detecting R. CytOkine levels were measured by ELISA 
from PB obtained at the time of endomyocardial biopsy (Bx) in 46 cardiac 
transplant recipients and 13 controls. All transplant recipients with infection 
or receiving steroid or antibody immunotherapy for R at the time of Bx were 
excluded. Data from patients with significant R were compared to those 
with no or mild R (which is not treated). The results were: 
lFNy (pg/ml) 
Significant R 
No/MildR 
Controls 
SJmille..n 
25 
MeanCtSDl 
3.6 ± 9.3 
78.3±478 
o 
~ 
0-46.3 
0-3545 
p(vs 
siiDificant R) 
IL6 (pg/mI) 
Significant R 
No/MildR 
Controls 
TNFa (pg/ml) 
95 
13 
18 
101 
13 
117 ± 338 
24.7 ± 34.8 
0.7 ±32 
o 
0-1468 
0-270 
0-14.6 
SignificantR 29 4.3:1:5.1 .01-17.7 
NS 
NS 
.004 
.004 
No/MildR 95 5.4±9.0 0-67.1 NS 
Controls 13 SS ± 18.8 0-78 NS 
Paired CS and PB samples of TNFa. IL6 and IFNy were measured in a 
second group of21 transplant patients with correlations of 0.97. 0.76 and 
0.56 respectively between the two sites. TNFa and lFNy levels were not 
elevated during significant R. Although statistically significant differences 
were noted. IL61evels were only elevated in 4/18 patients with significant R. 
We conclude that neither CS norPB TNFa. IFNyor IL61evels can 
distinguish significant R from no or mild R. 
725 Valve Surgery 1992 
Monday, April 13, 1992 
4:00 PM-5:30 PM 
Dallas Convention Center 
WIOI 
725·1 4:00 
LATE RESULTS OF HOMOVITAL HOMOGRAFT AORTIC VALVE REPLACE•
MENTS 
E.S. Akl, U. Nkere, A. Khaghani, M.H. Yacoub 
Harefield Hospital NHLI, Harefield, Middlesex, England. 
Between August 1976 and December 1990, 239 homov1tal 
aortic homografts were inserted 1n 236 patients. The 
valves were obtained under sterile conditions either 
from cardiac transplant recipients or brain dead cadavers 
kept in tissue culture medium at 4°C and used within 72 
hours. There were 153 males (64%) and 86 females (36%) 
with a mean age of 41.9118.8 years (range 2:77). Eighty•
nine valves were used within 1 day (37%), 99 within 2 
d~ys (42%) and 51 within 2-3 days (21%). Fifty-two pat•
ients (22%) had previous operations and 70 had associated 
procedures (30%). Free hand aortic valve replacement was 
performed in 115 (48%) and aortic root replacement with 
coronary reimplantation was carried out in 124 (52%). 
There were 8 early deaths (3.3%). The operative mortality 
was 0.6% for the isolated AVR group and 10% for the group 
with concomitant procedures. The actuarial survival rate 
at 10 & 15 years for the isolated AVR group was 90% & 90~ 
and for the group with concomitant procedures was 66.6% 
& 58.7% and for the entire group was 84% & 80% respectiv•
ely. Freedom from re-operation at 10 and 15 years was 91% 
& 80.5% for the entire group. Freedom from graft failure 
at 10 and 15 years was 95% & 89.9% and freedom from bac•
terial endocarditis at 10 & 15 years was 96.5% & 94.6% 
respectively. No embolic episodes related to the homo•
graft were encountered in this group of patients. 
It is concluded that the long term results of homovital 
aortic valve replacement are good with no evidence of 
accelereated damage due to immunological factors. 
83A 
84A ABSTRACTS 
725·2 
Pulmonary Autogrart ror Aortic Valve Disease. Late Results 
Jane Somerville, Simon Abrams, Donald Ross. 
Royal Brompton & National Hean Hospital, London, England 
4:15 
The diseased aonic valve was replaced by the patient'S own pulmonary valve 
(PA) in 149 consecutive patients (pIS.) 1%7·1984 and the fate of the autograft 
replaced right sided valve (PV) and patient studied. PIS. were aged 11·56 
years, 72 below 30 years, and their excised pulmonary valve replaced by an 
aonic homograft (131), fascia lata (11) and other (7). There were 35 late 
deaths in 131 hospital survivors from reoperation (8), myocardial failure with 
intact valv~s (7), 'sudden' (7), PA regurgitation (4) and other reasons (6). 
Reoperation in 43 pts. was done primarily for aortic (PA) regurgitation (21), PV 
(16), mitral disease (4) and other (2) and the PA was always inspected. 28 pIS. 
had serious PA regurgitation due to technical malposition (18), endocarditis (4) 
and other (6) including rheumatic process and dehiscence from one frame 
mount. There were 4 with new holes or tears 6-12 years aJter, which may be 
secondary to degeneration or stress imposed by malposition. None showed 
calcification or stenosis, haemolysis or emboli. All fascia lata valves required 
removal within 5 years and 12 aortic homograflS were changed; 3 in the first 
year for infection and the rest 5-17 years later. 
The cumulative survival proponion for hospital survivors at 10 years is 
88% ± 9.6 (n = 84) and 57% ± 20 (n = 12) at 20 years. The event free 
proportion in those with homograflS is 69'!t at 10 years and 45% at 20 years. 
Autograft cusp histology was normal, suggesting living cells 9 and II years 
later. Malposition of autograft, a technical problem, is the main cause of late 
morbidity and monality and predisposed to further cusp pathology. True 
degenerative changes in PA were uncommon. Despite the technical 
difficulties, which can and have been overcome, and provided homograJts are 
available, the pulmonary autograft may be the operation of choice for the young 
patient with serious aortic valve disease. 
725·3 4:30 
Morphological Findings at Reoperation after Repair of 
Rheumatic Mitral Regurgitation: Mechanisms of Failure 
Edward Turner, Thomas Wisenbaugh, Vania Sinovich, 
Stephanus Cronje, Pinhas Sareli. Johannesburg and Baragwanath 
Hospitals, Johannesburg, South Africa. 
In young pts with rheumatic mitral regurgitation (MR), valve 
repair is more desirable than prosthetic valve replacement, 
~specially in developing countries. However, the durability of 
repair in these pts may not be as good as for those with 
degenerative disease. To determine the potential mechanisms for 
recurrent mitral valve dysfunction following repair of rheumatic 
MR, we reviewed morphological findings at reoperation (reop) in 
53 pts with recurrent symptomatic mitral dysfunction who had 
undergone repair between the years 19S1-1990. During this 
period, repair of MR was performed in 350 pts from Baragwanath 
Hospital using techniques developed by Carpentier. Results: 
Leafle. retraction (n=21) and either chordal rupture (n=7) or 
elongation (n= IS) resulting in leaflet prolapse were the most 
common surgical findings, and were often associated with the 
presence of active inflammation (n=14) at reop. Ring dehiscence 
was found in 11 and was attributed to active inflammation or 
technical problems. Significant stenosis was found in only 3, and 
endocarditis was responsible in 3. Pts who had had active valve 
inflammation (n=2I) at the time of original repair were younger 
(l3±4 yrs) than those with inactive disease (21±9 yrs), as were 
those with active inflammation at the time ofreop (l4±6 vs 23±9 
yrs). Also the interval to reop was shoner when there was active 
inflammation at initial repair (2.4±2.6 vs 3.2±2.5 yrs, p=NS) or 
reop (1.l±1.3 vs 3.5±2.6 yrs). Conclusions: Need for reop 
following repair of rheumatic MR is associated with evidence of 
progressive inflammation which results in leaflet retraction or 
chordal elongationlrupture, and evidence of acute inflammation at 
reop is not uncommon, especially in the adolescent age group. 
lACC Vol. 19, No.3 
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725·4 4:45 
The Long Term Followup of Patients Undergoing Myotomy/ 
Myectomy for russ 
Hemant Trehan, John J. Collins, Jr., Lawrence H. Cohn. 
Brigham and Women's Hospital, Boston, MA 
The long term reSults of patients undergoing myotomy / 
myectomy of the septum for IHSS are not well documented 
particularly regarding persistent ablation of left ventricular 
gradients and persistent functional improvements. 31 patients 
undergoing this procedure (15 F, 16 M; ranging in age 21..8(), mean 
of 55 years, with mean FC of 3.4), underwent a double septal 
myotomy/myectomy procedure. Preoperative gradients measured 
by catheterization or echo ranged from 26-240, mean of 96 mmHg. 
There were no operative deaths. Followup was 1·14 years, 63. All 
patients were restudied, and the mean postoperative FC was 2. 
One patient had >3+ mitral regurgitation. Followup gradients all 
measured by echo were 0-30 with a mean of 4.5 mmHg (p<.OOl 
compared to preoperative values), only one patient had MR > 3 + . 
The 5 late deaths were due to low cardiac output in two, stroke in 
2, and acute respiratory failure in one. Survival at ten years was 
86:t 9% and there were no reoperations for recurrent IHSS. 
The myotomy/myectomy procedure (Morrow procedure) 
provides long term ablation of left ventricular outflow tract 
gradients and mitral regurgitation associated with IHSS, and 
therefore the procedure of choice for this condition. 
725·5 5:00 
Long.term Results After Minale's AnnulopJasty of the 
Tricuspid Valve 
Sigrid Nikol. Harunut Guelker, Heinz Lambertz, Bruno J. Messmer 
Klinikum der RWTH, Aachen and Klinikum Barmen, Wuppenal. 
Germany 
Between 1986 and 1991,55 Patients aged 60±6 years were subjected 
to a new technique for tricuspid valve annuloplasty. The preoperative 
NYHA class averaged 3.7. There were 39 mitral-tricuspid and 13 
aortic-mitral-tricuspid procedures, and three repeat tricuspid 
annuloplasties. The hospital monality rate was 7% with four deaths 
resulting from cardiac failures. Follow-up averaged 2.S±O.8 years 
(0.5-5 years). Two patients died suddenly and five of unknown 
causes. The three year survival rate is SO% with a linearized monality 
rate of 5.3%. All patients but one improved to an average 1.4 NYHA 
class. Thiny patients were reinvestigated by both catheter and 
echocardiographic methods. The gradient over the tricuspid valve 
averaged 1.4±O.6 mmHg. A moderate regurgitation was found in two 
cases and was severe in one. The diameter of the tricuspid anulus in 
the apical four-chamber view decreased from 23.7±3.9 mm/m2 body 
surface area (BSA) preoperatively to 15.7± 1.9 mm2 BSA at late 
follow-up examination. During the hean cycle, the shortening fraction 
of the tricuspid anulus was at least 15%. We conclud, that the Minale 
technique allows a physiologic reconstruction of th.e tricuspid valve 
with a good compromise between stenosis and regurgitation, a low 
overall monality rate regarding the high preoperative NYHA class and 
an impressive functional improvement 
JACC Vol. 19, No.3 
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725-6 
The Results or Reoperation on Prosthetic Valves 
5:15 
Arthur J. Crumbley, III, M.D., Martha R. Stroud, John M. Kratz, 
M.D., Robert M. Sade, M.D., F.A.C.C., Fred A. Crawford, Jr., M.D., 
F.A.C.C. 
Medical University of South Carolina, Charleston, SC 29425 
Reoperative valve replacement (Reop) has been reported to be associated 
with high operative mortality, arguing in favor of initial use of 
mechanical valves. We reviewed our series of valve replacements to 
assess risk of Reop. From July I, 1979 to December 31, 1990, 91 
patients (ages 8-77, meall=39.5) underwent 117 Reops on previously 
implanted prosthetic valves. The most common indications for Reop 
were structural failure in 55, prosthetic valve endocarditis (PVE) in 47, 
and paravalvar leak in 8. In patients with mechanical valves, the most 
common indication for Reop was PVE (27/42), and for tissue valves, 
structural failure (53177; p<O.OOl). Operative mortality for the first 
Reop (6/91, 6.6±2.6%) was not different from that of a concurrent 
series of initial valve replacements (56/814, 6.9±0.9%). This was true 
for both aortic and mitral positions. Second (2/23, 8.7±5.9%6) or third 
(2/3, 66.7 ±27.2 %) Reops did not have a statistically significantly greater 
risk (p=0.22). Operative mortality was associated with emergency Reop 
(4/16 vs 61101; p<0.05) and preoperative Class IV symptoms (8/47 vs 
2170; P < 0.05) but not with age, sex, or indication for REOP. Long-term 
survival was only minimally decreased by the first Reop (63.6±2.4% vs 
59.1±7.4% at 8 yrs; p=0.05). Patients with PVE required additional 
Reops more frequently than those with other indications (5 yr freedom 
from Reop 52.8±11.4% vs 75.0±7.1%; p<0.05) and long-term 
survival was worse (51.4±10.1% vs 61.9±8.3% at 8 yrs; p<0.05). 
We conclude that first or second Reop valve replacement can be 
performed as safely as original operation, so the risk of Reop should not 
influence initial choice of prosthesis. Further, PVE heralds a poor 
prognosis. 
726 Cardiovascular Complications in Hypertension 
Monday, April 13, 1992 
4:00 PM-5:30 PM 
Dallas Convention Center 
W104 
726-1 4:00 
co.parison of Konotherapy Iffects on LV .. ss 
aeqression in Ki14-to-Koderate Hypertension: 
Differences .etween Short and Lonq-Tera 
Therapy 
John Gottdiener, Domenic Reda, Aldo 
Notargiacomo, Barry Materson 
VA cooperative study Group on Anti•
Hypertensive Agents, Georgetown University 
Medical Center, Washington, DC 
Studies of LV mass regression may vary due to 
design and duration of therapy. We report 
results of a 15 center double-blind dose 
titration trial of 6 active drugs and placebo 
(PLAC). In 452 men (av BP 152±14/99±3 mmHg,av 
age 59±10 yrs,av LV mass-ASE 329±93 gm) 
centrally read echos were compared between 
hydrochlorothiazide(HCTZ), atenolol(ATEN), 
captopril (CAPT), clonidine(CLON), diltiazem 
(DILT) and prazosin(PRAZ). At 8 wks, ~ in LV 
mass occurred only with CLON (-16.9 gm, p=.03 
and DILT -16.9 gm, p-.057);pts on ATEN had t 
LV cavity size (+1.65 mm, p=.008). At 1 yr LV 
mass with CLON (-5.9 gm) and DILT (+2.6 gm) 
did not differ from baseline; with PLAC, LV 
mass t 18_4 gm (p=.07). At 2 yrs LV mass ~ 
only with HCT (-31 gm, p=.05);posterior wall 
(PWT) and septal thickness ~ with HCT, and PWT 
~ with CAPT and CLON. With ATEN, LV mass t 
(+38.2 gm, p=.06). Conclusion: (1) Response of 
LV mass at one and two years differs from 
short term despite maintenance of goal BP; 
(2)drugs differ in short and long term effects 
on LV mass;(3)t in LV cavity size early with 
ATEN progresses to frank t in LV mass at 2 
years;(4)HCTZ ~ LV mass only with prolonged 
therapy. 
ABSTRACTS 
726-2 
Evidence That Antihypertensive Agents Lessen yentriOilar 
Hypertrophy by Inhibiting cardiac Expression of Insulin-
like Growth Factor-I 
Thanas J. Donohue, Miriam N. Lango, Lance D. I>.rorkin, 
Veroni ca M. Catanese. 
t-ew York University Medical Center, New York, New York 
4:15 
Although the factors that regulate ventricular growth are 
)Xlor1y understood, we have previously shown that cardiac 
insulin-like growth factor-l (IGF-I) gene expression increases 
in parallel with systemic pressure and heart weight in 
experimental hypertension. To test the hypothesis that IGF-I 
might promote ventricular hypertrophy (YH), we coopared the 
effects of drugs that prevent (ena1apri1 (E) and nifedipine 
(N)) or fail to prevent (hydralazine (H)) hypertensive cardiac 
hypertrophy on: a) VH and b) ventricular IGF-I ~NA levels. 
Prehypertensive spontaneously hypertensive rats received 
either no therapy (e), E, N, or H. Systolic blood pressure 
(SBP), ventricular/body weight ratios (VW/BW), and ventricular 
IGF-I ~NA (percent increase) were examined after 4 and 6 
l<eeks. The C group had significant elevations in SSP and 
VW/BW as well as IGF-I ~NA levels 300% and 200% above 
baseline at 4 and 6 weeks, respectively. Therapy with [ and N 
reduced both SBP and the rise in VW/BW, and IGF-I ~NA levels 
never rose above baseline in these animals. In contrast, 
despite canp1ete nonna1ization of SBP, H treatment resulted in 
CI1 increase in IGF-I ~NA content cooparable to the C group, 
as well as mai ntenance of the hi ghest VW/BW of the treated 
groups. Thus, factors other than efficiency of blood pressure 
control are responsible for the variable effects of different 
classes of antihypertensives on cardiac hypertrophy. The 
close association between ventricular IGF-I ~NA levels and VH 
suggests that this grooh factor is an important detenninant 
of ventricular growth in hypertension. E and N may block 
initiation of VH by inhibiting cardiac IGF-I gene expression. 
726-3 4:30 
"White Coat" Hypert .... ion : No Ba= for the lleart. 
Philippe Gosse, Helene Promax, Philippe Ourandet, 
Modeste Oallocchio. Hopital Cardiologique, CHU Bordeaux, 
Pessac, France. 
The superiority of ambulatory BP monitoring to 
predict target organ damage is now well established but 
the significance of "white coat" hypertension is still 
controversial. For a given ambulatory BP level, is a 
higher office BP level harmful? We measured (20 guided M 
mode echo, "blind" readings according to Penn 
convention) Left Ventricular Mass indexed for height 
(LVMI) in 204 essential hypertensives (140 males, 64 
females, mean age:50+-11 years) without treatment for 
more than 7 days. 24 hours BP monitoring during daily 
routine was performed with non invasive devices. Office 
BP was measured by the same doctor after 10' supine. 
"White Coat"(W) effect was defined as the difference 
between office and average daytime BP. Patients were 
divided into 4 quartiles for office and daytime BP . 
Results for systolic BP are presented on the figure. The 
bars represent average LVMI in each quartile of W for 
each quartile of daytime SBP. 
A two way analysis of variance shows that LVMI increases 
significantly with daytime BP (p<O.OOl) but is 
independent of "White coat" effect. The same analysis 
for diastolic BP and for systolic and diastolic BP in 
the 143 untreated patients allows the same conclusion: 
"White Coat" effect has no influence on LVMI. 
85A 
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726·4 4:45 
The Association of Carotid Atherosclerosis and 
Increased Left Ventricular Mass in Hypertension 
Mary J. Roman, Mariane Spitzer, Riccardo pini, 
Thomas G. Pickering, Richard B. Devereux. 
Cornell Medical Center, New York, New York. 
Since left ventricular hypertrophy predicts 
cardiovascular mortality in hypertension, the 
relation of cardiac and vascular structure was 
examined by ultrasound in 64 pts with estab•
lished hypertension and no clinical evidence of 
cardiovascular disease. Carotid atheroscler•
osis was defined as the presence of a discrete 
plaque (n=10), diffuse wall thickening (intima•
media thickness >=1.2mm; n=5), or both (n=2). 
When the 17 (27%) pts with atherosclerosis 
were compared to the 47 pts without, there were 
no differences (p>0.20) in age (59 vs 57 
years), systolic or diastolic blood pressures 
(173 vs 163 and 94 vs 96 mmHg), serum 
cholesterol (236 vs 234 mg/dl), HDL (58 vs 60 
mg/dl) or their ratio (4.6 vs 4.2), or smoking 
history (47 vs 43%). In contrast, the presence 
of carotid atherosclerosis was associated with 
increased left ventricular (LV) diastolic 
dimension (5.4 vs 5.0 cm; p<0.005) and mass 
(221 vs 170 gm; p<0.05) and carotid absolute 
(1.1 vs 0.8 mm; p<0.005) and relative (0.35 vs 
0.28; p<0.05) wall thicknesses. 
Thus, systemic atherosclerosis in hyperten•
sive patients is associated with cardiac and 
vascular enlargement, independently of standard 
risk factors. This association may contribute 
to the ability of LV geometry to predict 
cardiovascular morbidity and may reflect the 
effects of unrecognized growth factors. 
726·5 5:00 
CJamC"lCation of Hypertension Severity for Predicting 
Ecbocardiograpbk: Markers of Adverse Prognnm: Blood 
~ Level Versus World Health Organization Criteria. 
George A. Mensah, Thomas W. Pappas, Michael J. Koren, John 
H. Laragh, Richard B. Devereux. New York Hospital-Cornell 
University Medical Center, New York, NY. 
Hypertension severity is commonly classified by level or blood 
pressure (BP) or by World Health Organization (WHO) criteria 
that necessitate more extensive clinical and laboratory evaluation. 
To determine whether the WHO system is superior to 
classification by BP level alone in predicting echocardiographic 
markers or adverse prognosis in asymptomatic subjects, we 
studied 222 patients. Statistically Indistinguishable elevation in 
left ventricular mass index (L VMI) and relative wall thickness 
occurred in the highest DBP stratum, WHO Stage II classification 
and in patients with systolic BP ~ 180 mmHg. High total 
peripheral resistance index (TPRI) was best identified by DBP 
level. Receiver operating characteristic curve analysis showed 
similar test perrormance for WHO (e), DBP CA) and SBP (a) in 
the prediction or abnormal LVMI and TPRIas shown below: 
0.?5 0.5 025 
SPECIFICITY 
TPRI>4,260 
dyne-s-m2/cm& 
1.0 0.75 0.5 0.25 
SPECIFICITY 
Thus, classification of hypertension severity by BP level has 
similar. albeit limited effectiveness as WHO criteria in identifying 
patients with adverse prognosis, but does so at much lower cost, 
and for DBP, with greater success in the detection of patients with 
an adverse hemodynamic profile. 
lACC Vol. 19, No.3 
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726·6 5:15 
Systolic Blood Pressure Response to Exercise Predicts 
Incident Hypertension: The fralingham Offspring Study 
Anirban Gupta, Teri A. Manolio, Robert J. Garrison, 
Daniel Levy, National Heart, Lung, and Blood Institute, 
Bethesda, MD 
Blood pressure response to exercise has been shown 
to predict incident hypertenSion in small groups of men 
but this has not been studied in large unse1ected sam•
ples of men or in women. To assess this relationship, 
results of monitored exercise treadmill testing per•
formed by 1184 men and 1385 women (aged 17-77 years) in 
the Framingham Offspring Study in 1979-1983 were studied. 
Participants were free of cardiovascular disease and hy•
pertension, were not taking medications for hypertenSion 
and achieved at least 90% of their age-specific target 
heart rate. 
Exaggerated blood pressure response (ER) was defined 
as ~ 210 mm in men and ~ 190 in women corresponding to 
the 95th percentile of maximum systolic blood pressure 
(SBP) during exercise in a standard population. ER was 
detected in 19.8% of men and 10.6% of women. Incidence 
of hypertension (HBP) was assessed at examination four 
years later as blood pressure ~ 160/95 mm Hg or use of 
anti-hypertensive medications. HBP was detected in 8.5% 
of men and 7.7% of women. Odds ratio (OR) of HBP 
associated with ER was 4.4 for men and 5.3 for women. 
After adjustment for age, alcohol intake, body mass 
index, and pre-exercise SBP, sex-specific multiple logi•
stic regression showed that ER was strongly related to 
HBP in men (OR = 2.2, p < 0.001) but not women (OR ~ 1.6, 
p = 0.11). Similar relationships were observed using 
maximum SBP during exercise as a continuous variable. 
Systolic blood pressure response to exercise predicts 
4-year incidence of hypertension in this cohort of men 
but not significantly so in women. 
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727·1 
Coronary Stenosis Progression does not Affect Left 
Ventricular Function in Chronic Stable Angina Pectoris 
Dimitris Tousoulis, Tom Crake, David C. Lefroy, Juan Carlos 
Kaski, Agha W. Haider, Attilio Maseri. Royal Postgraduate 
Medical School, London, England. 
Although left ventricular function is a major prognostic factor in 
patients with chronic stable angina, it is uncertain whether left 
ventricular function deteriorates in the absence of acute myocardial 
infarction. We studied 28 patients (pts) with stable angina and 
angiographically documented coronary artery disease who 
underwent repeat angiography after a mean (±SD) interval of 
27.3±1.3 months. Ejection fraction and percentage stenosis 
severity were measured on the first and second angiograms using a 
computerized system. Stenosis progression was defined as an 
increase of 2!20% diameter reduction in a pre-existing stenosis of 
2!50% or an increase of 30% in a pre-existing stenosis <50% or any 
increase in lesion severity that resulted in total coronary occlusion, 
or a "new" lesion at second angiography :2::50%. Fifteen of 86 
(17.4%) stenoses progressed in 12 pts, (in 9 of these (32%) to 
total or subtotal occlusion). Ejection fraction was unchanged at the 
time of the first and second angiograms both in pts with stenosis 
progression and in those without (70.1±2.2% vs 67±3% and 
68.3±1.8% vs 67.8±2.1, respectively). In pts with stenosis 
progression the heart rate-blood pressure product at 1mm ST 
segment depression during exercise testing was similar at the time 
of first and second angiography (204±26 x 102 and 193±29 x 102 
beats/min x mmHg respectively). Increased collateral circulation 
(grade 3 according to Rentrop scoring) was observed in the second 
angiogram of 9 pts who developed total coronary occlusion, 
compared WiIh the first. In pts with chronic stable angina coronary 
stenoses may progress even to total occlusion without clinical 
deteroration, modification of exercise capacity or change in the 
resting left ventricular function. Development of collateral vessels 
may contribute to the preservation of left ventricular function in pts 
in whom stenoses progress to total coronary occlusion. 
4:00 
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727·2 4:15 
The Clinical Evolution Of Patients Diagnosed 
With Syndrome X During A pive Year Pollow Up. 
Francesco Romeo; Giuseppe M.C. Rosano; @Vito 
Rosano; Eugenio Martuscelli; @Francesco Miceli; 
Luigi Lombardo; @Bruno Lacquaniti; Antonio 
Valente; Attilio Reale 
Dept of Cardiology II University of Rome, 
Catania; @Vibo Valentia hospital; ITALY. 
The aim of the present study was to evaluate the 
clinical evolution of 30 pts (27 women and 3 men) 
diagnosed with syndrome X (angina pectoris, 
positive exercise test and normal coronary 
arteries) during a five year follow up. Pts were 
followed at six months interval during a mean 
follow up duration of 60±8 months. During 
follow up the chest pain was unchanged in 20 pts, 
decreased in severity and frequence in 9 pts, 
disappeared in 1 pts; 3 pts had prolonged episodes 
of anginal chest pain (>30 min) that required 
hospetalisation. Four pts showed a progression of 
exercise induced left bundle branch block (LBBS) 
to constant LBBB, and 4 continued to develop 
rate-dependent block during exercise but at lower 
heart rate. The rest left ventricular ejection 
fraction (LVEF) decreased significantly from 61+6 
to 51+8 in the 8 pts with LBBB. Exercise LVEF 
was similar in 22 pts at control and follow up 
examinations while decreased in 8 pts. During 
follow up 15 pts remained clinically stable or 
improved, 7 pts become clearly hypertensive, and 
S showed a progressive decline of LV function 
and a progression of intraventricular conduction 
disturbances. In conclusion the phrase syndrome 
X comprises pts with primary myocardial 
ischemia, pts borderline hypertensive and pts with 
early stage cardiomyopathy. 
727·3 4:30 
Do Measurements of Regional and Global Left Ventricular 
Ejection Fraction Hive Independent Prognostic Value? 
Todd Miller, Arnold Weissler, Timothy Christian, Kent 
Bailey, Raymond Gibbons. Mayo Clinic, Rochester, MN. 
A recent study suggested that a quantitative index 
of nonuniform systolic emptying, or ventricular asynergy 
(VA), on rest radionuclide angiography (RNA) has 
prognostic value independent of rest left ventricular 
ejection fraction (LVEF). To determine if VA adds 
prognostic information to LVEF we followed 488 pts (423 
men, 65 women, age 61 ± 10 years) without prior 
revascularization who underwent RNA> 3 months after 
Q-wave myocardial infarction (MI). During a median 
duration of 4.7 years, there were 96 deaths (63 cardiac, 
33 noncardiac). Using regional LVEF from 3 regions, 6 
coefficients of VA were tested for ability to predict 
total mortality. The previously published coefficient of 
VA = 
(JI:(global LVEF-regional LVEF)2/3 x 100/global LVEF) 
proved optimal. Using a Cox proportional hazards model, 
the univariate chi-square for LVEF was 23.7 and for VA 
33.2. After adjustment for LVEF, VA added independent 
prognostic information (chi-square = 7.8, p<O.Ol). 
4-year survival for pts subgrouped by high or low LVEF 
and VA was: 
LVEF < 40% 
LVEF > 40% 
4-Year Survival 
VA < 35 
81% 
91% 
VA > 35 
62% 
89% 
P (log-rank) 
0.004 
NS 
CONCLUSION: Quantitative measures of global and regional 
ventricular function have independent prognostic value in 
pts with previous Q-wave MI. VA can identify a subgroup 
of pts with low LVEF who are at especially high risk. 
ABSTRACTS 
727·4 4:45 
Spinal Cord Stimulation as an Adjuvant Therapy for Otherwise Intractable 
Severe Angina Pectoris 
Mike de Jongste, Arnaud Aerts, Ted Bouwmeester, Wybe Kloppenburg, Pim 
Meyler, Peter Mulder. Michiel Staal. Ger Zijlstra and Henk Lie. 
Thoraxcenter. University Hospital Groningen. Groningen. The Netherlands. 
To study the efficacy of spinal cord stimulation (SCS) on the relief of otherwise 
intractable angina pectoris. a 2 montbs' randomized study with follow-up was 
undertaken. Both subjective parameters as Activities of Daily Life (ADL). 
Nitroglycerine (NTG) intake. Anginal Attacks (AA) and objective parameters 
as Treadmill Exercise Tests (TET). 24 bours EeGs (24hE) were studied. For 
baseline characteristic. Left Ventricle ~ection Fraction (L VEF) was determined 
by radionuclide angiography (Tc""'). After informed consent. 20 pts (14 males. 
mean age 61) were randomized in an active treated group A (implantation < 2 
weeks) and a control group B (implantation after study). For standardized 
stimulation (3hlday and prophylactic) in all pts a Medtronic Itrell was implanted. 
Baseline A Study A Follow-up A Baseline B Study B Follow.up B 
ADL 1.2 --2.1 --2.1 1.3 1.3 --2.2 
NTGlwk 16 --1.5 -+1 17 7' .. 1.5 
AA Iwk 18 -+10 -+7 15 14 --4.5 
RPPxlOO 134 "157 -+158 163 146 -+172 
Eoxt(min) 11 .. 13.4 -+12.5 11.5 11 "14.1 
AAt(min)" 6 .. 8 .. 8 6 5 .. 7.5 
LVEF 53.5 (SD:9) 5\.6 (SD;9) 
-+ with ses .• stopcriterion for 2 pis became fatigUed. ' 1 pt reduced NTG 
intake spontaneously from 58 -+ 131 wk during the study-period. RPP=Rate 
Pressure Product. Eoxt=total exercise time. AAt=time to angina. Mean ST·T 
~ at maximal TET was not consistently influenced by ses. At baseline L VEF 
was comparable for both groups. In 12 of 50 24bE (7 pts) ischemia was present 
before ses and in 6 of 50 24bE (4 pts. 1 with digitalis) after SCS. During the 
study-period no complications occurred. Follow·up demonstrates that the 
favorable effects lasted. 
Based on both subjective (Quality of Life) and objective (TET. 24bE) 
suggested improvement during study-period and follow·up in group A (B only 
during follow-up). ses might be a valuable adjuvant therapy for pts with 
otherwise intractable angina. The study endorses further investigations. 
727·5 5:00 
current Clillica1 Bzperience. Diagnostic Xntracoronary 
ultrasound within a Therapeutic Balloon catheter 
Thomas J. Linnemeier, Donald A. Rothbaum, Ronald J. 
Landin, Michael W. Ball, Zachary I. Bodes, susan D. 
Horgan, Halissa A. Klette, st. Vincent Bospital, 
Northside cardiology, Indiana Bsart Institute, 
Indianapolis, Indiana 
A unique 64 element dynamic aperture array diagnostic 
ultrasound (US) imaging devics (Endoeonics oracleR) 
incorporated within the proximal end of a 2.5, 3.0 or 
3.5 therapeutic polyethylene balloon catheter 
(US-balloon) has recently been developed for clinical 
investigation during coronary angioplasty. It allows 
for 1)examination and quantitation of lumen diameter of 
the more proximal coronary vessel with US pre-PTCA, 
2)dilatation of the diseased segment with the 
US-balloon, and 3)US visualization and quantitation of 
lumen diameter of the dilated segment poet PTCA. 
Thirty-two patients (34 vessels) were examined and 
treated with US-balloon, 21 males, 11 females, mean age 
61 years. Thirteen LAD/diagonal, 6 LeX/OH, 14 RCA/PDA, 
and 1 vein graft were studied. The characteristic 3 
layer US appearance was obtained in 28/34 (82') vessels. 
ultrasound influenced balloon sizing or inflation 
pressures in 6/32 (19') of cases when by ultrasound post 
PTCA lumen diameters appeared more significant than by 
angiography, witbout resulting in clinical 
complications. clOse inspection with intracoronary 
ultrasound showed that in areas of mild angiographic 
luminal irregularities marked thickening, calcification, 
and even stenoses were evident by ultrasound. Therefore 
subtle differences Seen with US are beginning to 
influence our therapy. Whether this will become of 
clinical rather than investigational value remains to be 
proven. 
87A 
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Low BDL Promotes Endothelial Dysfunction in 
Subjects with Normal Total Cholesterol 
Frederick E Kuhn, Emile R Mohler, Kathleen 
Reagan, Charles E Rackley. 
Georgetown University, Washington, DC 
The endothelium-dependent vasodilator acetyl•
choline (ACH) has been used as a marker of endo•
thelial dysfunction and early coronary artery 
disease (CAD). While prior human studies have 
demonstrated that elevated cholesterol is 
associated with endothelial dysfunction, the re•
lationship between (HDL) and endothelial function 
in subjects with normal total cholesterol is 
unknown. The response of coronary diameter to 
graded concentrations of ACH was determined using 
computer assisted quantitative coronary angio•
graphy in 13 subjects with angiographically 
normal coronary arteries and normal total 
cholesterol levels (176±7 mg/dl, range 148-210). 
The response to ACH was then correlated with 
fasting lipid profile results. An inverse 
correlation (r=-.75, p<.003) was observed between 
HDL and abnormal (vasoconstrictive) response to 
ACH. Mild vasodilation or mild constriction was 
observed in subjects with normal HDL levels while 
pronounced vasoconstriction was noted in those 
with abnormally low «30) HDL. Conclusions: These 
data suggest that low HDL promotes endothelial 
dysfunction. This may be related to relative 
enhancement of cholesterol-induced endothelial 
dysfunction in this setting. Since endothelial 
dysfunction is thought to precede atherosclerotic 
CAD, subjects with low HDL may therefore be at 
increased risk of developing CAD despite having 
normal total cholesterol levels. 
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Enhanced, High Speed MR Imaging of the Heart During a Single 
Breathhold 
Ronald M. Peshock, Moriel NessAiver, Geoff Clarke, Michael 
Lipscomb, William Erdman, Jerri Payne, Robert W. Parkey. 
University of Texas Southwestern Medical Center, Dallas, Texas. 
The utility of magnetic resonance imaging (MRI) in the evaluation 
of the heart and great vessels is well established. However, a 
limiting factor in its general application has been the time required 
for standard spin echo or gradient echo cine MRI, typically on the 
order of 4 to 6 minutes per image set. The ability to obtain images 
more rapidly would allow the use of MRI in more unstable patients 
and potentially lower costs. A very high temporal resolution, field 
echo, short TRITE (9·12/4'7) gradient echo sequence with 
symmetric, centrally-ordered phase encoding grouping was developed 
for a standard 1.5 Tesla system with conventional gradients. This 
allowed one to typically obtain a single slice, 10 frame/per cardiac 
cycle, during a single breathhold (15·25 cardiac cycles). Images 
were obtained using a 128x120 matrix and fields of view as small as 
34 x 17 cm. Images were then obtained in 10 normal volunteers for 
comparison with conventional imaging sequences. In addition to 
reducing the scan time, single breathold imaging removed image 
degradation due to (1) motion of the heart due to respiratory motion 
and (2) changes in cardiac volume and flow during respiration. 
Removing these factors led to improved edge definition in the 
visualization of intracardiac structures and the endocardial border. 
Distal tertiary branches of the pulmonary vessels 3·4 mm in size 
were also particularly well visualized. 
Thus, breathhold cine MRI not only reduces the time required 
for scanning, but also leads to improved imaging of the heart and 
pulmonary vasculature due to reduction of motion artifacts. 
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Validation of NMR Phase Velocity Encoding Methods Applied to the Flow 
Convergence Region By Comparisons to "Gold Standard" Hydrodynamic 
Methods and to Color Doppler Methods: In-Vitro Studies. 
Robin Shandas. Robert Weintraub, Dorian Uepmann, Gerald Pohost, Gregory 
Cranney, David J. Sahn. UCSD Medical Center and Univ of Alabama. 
Birmingham, AL. 
NMR phase velocity encoding techniques should ailow quantffication of 
cardiac flows, and veloctty field mapping methods such as proximal flow 
convergence (FC) imaging as used in ultrasound Doppler to calculate 
regurgttant flow rate should be applicable to NMR. We performed com· 
parative studies applying Fe methods using NMR. laser fluorescent particle 
(LFP) tracking which provides 2-dimensional flow velocity maps to allow 
vector by veclor comparison of Ihe veloctty fieids obtained, and color Doppler 
flow mapping. For flow acceierating into circular and "prolapse" Iype ornices 
(areas: 15 mm2 to 30 mm2) imaged wtth a 1.5 T NMR system. 2-dimensional 
NMR veloctty information for the proximal FC region was obtained al a peak 
velocity sensitivity of 25 cm/sec (flip angle 40·, thickness 5 mm. field of view 
160 mm). For both steady and pulsatile flow, calculated and actual FRs, for 
hemispheric (HEM I) NMR isoveloctty contours near 15cm/sec which were 
located between 1 and 3 ornice diameters from the ornice. correlated we" (r: 
0.92-0.95). For isoveiocities outside this range, the FCR HEMI shape was 
altered by entry level flow or by surface or boundary layer effects. NMR 
velocity data directly around the ornice agreed we" wtth LFP derived mean 
streamline angle (r=0.93j and velocity (r = 0.96) measurements. both 
revealing identical spatial acceleration events and verifying NMR FC iso· 
velocity contours. Turbulence events such as boundary and surface effects 
and distal jel dissipalion were less weil reproduced by NMR but tt was able 
to quantify FC events quite accurately. In the same models. color Doppler 
also performed poorly in defining boundary events occurring at an angle to 
the direction of interrogation and was less effective than NMR at delineating 
lower veloctty FC entry events. MRI has deficiencies not unlike color Doppler 
but il can be optimized for low velocity detection and can produce 3· 
dimensional veloctty vector information aboullaminar acceleration events and 
provide accurate flow convergence calculations. 
728·3 4:30 
DIAGNOSIS OF AORTIC DISSECTION: WHY IS MAGNETIC 
RESONANCE IMAGING [MRI] SUPERIOR TO TRANSESOPHA· 
GEAL ECHOCARDIOGRAPHY [TEE] AND CONTRAST CT 
[XCT]? 
Christoph A Njenaber MD. FA C C., Yskert von Kodolitsch, B.M., 
Volker SigIow, Tilman laup, M.D., Angela Piepho, M.D .• Georg M. Stiel, 
M.D., M.Sc .• Rolf Spielmann. M.D. University Hospital Eppendorf, Ham•
burg, Germany. 
The diagnostic potential of MRI. TEE and xcr for exact morphological 
evaluation and anatomical mapping was analyzed in lOS patients with sus•
pected dissection of the thoracic aorta (MJF=69/36; 55±!4 yrs). Results of 
each diagnostic modality were analyzed in blinded fashion and indepen•
dently validated against intraOperative and/or post-monem morphology. 
respectively, in 48 of S9 pIS with true dissections (31 type A. 28 type B) 
and in 25 of 46 pts without dissections; in 21 rule-outs contrast angiogra•
phy and an uneventful I-year follow-up served as "gold standards". 
~: Both location and extent of a dissection in the ascending aorta was 
best identified by comprehensive MRI with 100% sensitivity vs 95% for 
TEE and 90% for xcr. Specificity of MRI was 98% vs 84% for TEE 
(p<.05) and 100% for xcr. There was no difference for the descending 
aorta. MRI proved more sensitive for thrombus formation than TEE 
(p<.05) and xcr (p<.OI), and for an associated aortic regurgitation com•
pared to xcr (p<.05). A surgical intervention was possible by sole MRJ•
guidance in all cases, whereas 74% of TEE and 62% of xcr studies 
required additional diagnostic information before surgery (p<.05). 
Conclusjon: MRI is an entirely non-invasive no-contrast method as com•
pared to TEE and xcr. MRI provides the most sensitive, specific and 
comprehensive information for associated phenomena of aortic dissection. 
Thus, if available, MRI may be savely used as a mono-modality to guide 
any attempted surgical intervention. 
JACC Vol. 19, No.3 
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Assess.ent of Ryocardial Viability Early Following 
Reperfusion Therapy Using Ryocardial Enhancement in 
Computed Tomography 
Mitsuisa Yoshimura, Hikaru Sato, Hironobu Tateishi, 
Takuji Kawagoe, Masaharu Ishihara, Yuji Muraoka. 
Hiroshima City Hospital, Hiroshima, Japan 
To determine the diagnostic significance of myocardial 
enhancement (ME) in computed tomography (CT) 
immediately after reperfusion therapy, 25 pts with 
acute myocardial infarction (infarct related artery 
(IRA): LAD 18 pts, LCX 2 pts, RCA 5 pts) were studied. 
All pts underwent successful emergency coronary 
angioplasty (residual stenosis < 50%) and had no 
significant stenosis in IRA at predischarge 
angiography. Within 90 minutes of reperfusion, CT was 
carried out and the presence of ME in the infarct 
lesion was detected. Pts were divided into 2 groups: 
5 pts without ME (A), 20 pts with ME (B). There was no 
difference in baseline clinical variables in the two 
groups. Changes in the left ventricular ejection 
fraction (AEF) were assessed at predischarge 
ventriculography. 
A (n=5) B (n=20) 
AEF (%) 16±l2 1±13 
peak CK (lUlL) 1288±1409 2709±1305 
CK: creatine kinase 
P value 
P<0.05 
P<O.05 
At control angiography, a total occlusion of IRA was 
more frequent in B than in A (90% vs 20%, P<O.Ol). 
Conclusion: Presence of ME is associated with severe 
myocardial damage. CT immediately after successful 
emergency coronary angioplasty can be used to predict 
the improvement of left ventricular function. 
728·5 5:00 
Non-Invasive Detection of Anetomlc Coronary 01 ..... by Cine CT: A 
Quantitative Pathologic Study of Non-CalcHied Coronary lesion •. 
John A. Rumberger, O. Brent Simons, WUllam Edwards, Robert Schwartz, 
Jerome Breen, Patrick Sheedy, Mayo Clinic, Rochester, Mn. 
Recent clinical studies have suggested cine CT as a non-Invaslve means to 
detect coronary artery disease (CAD) by defining the presence or absence of 
discrete coronary artery calcification (Ca + +). Although tha presence of Ca + + 
has been shown to correlate w~h the presence of CAD, little Is known of the 
extent 01 CAD In non-calclfled lesions. To this end we examined 13 pressure 
fixed post-mortem hearts (patient age 17-83 years, mean 43.5 yrs). 
Contiguous cine CT scans perpandlcular to their cross-sections were dona on 
individually dissected, stretched and pinned epicardial coronary artaries (100 
Msec/scan, 3mm thick). To IacUbte definition olin-situ CAD on a lesion-by•
lesion basis, each vessel was divided Into 3mm Intervals and representative 
histologic sections made corresponding to the CT scans. The absence or 
presence of Ca ++ was defined In each Image by noting the absence or 
presence of voxels with a CT density > 130. A total 01 525 paired histologic 
sectlonslCT Images were analyzed. Of these a total 01 324 were found to 
have no detectable Ca ++ by cine CT. In the figure below Is the distribution 
01 non-calcHied lesions by cine CT and the corresponding pereant area 
stenoses (in parentheses) for all lesions and lesions with or w~hout 
obstructive disease (I.e. stenosis of < 75% or > 75%). 
ALL LESIONS OBSTRUCTI VE VS. 
NON~STRUCTIVE 
2" 
Conclusions: The absence of detectable Ca + + by CIne CT does not Insure 
the absence 01 CAD; however, nearly 98% 01 coronary sections found to.DQ! 
be calcified by cine CT were associated with the~ 01 obstructive CAD. 
ABSTRACTS 
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Noninvasive Detection of Coronary Artery Stenosis: An 
Evaluation of Ultrafast CT and Transesophageal Echo 
Rita F. Redberg, Gary Fazio, Timothy Winslow, Gary Caputo, Mary 
Malloy,John Kane, Charles Higgins, Nelson B. Schiller, University of 
California, San Francisco 
89A 
To compare the detection of critical coronary artery stenosis(CAS) by 
ultrafast computed tomography (UCT) and transesophageal 
echocardiography (TEE) we studied 12 patients (ages 48-81) who 
previously had angiography (angio), using both techniques. Indications 
for angio were: suspected or known CAD(7), a study of 
hypercholesterolemia(3), valvular disease(2). Noncontrast UCT was 
done taking 20 contiguous slices with a lOOms scan time and EKG 
triggering. For UCT, coronary artery calcification was scored by 
multiplying area of lesion(mm2) and peak density (Hounsfield units) 
in each artery. Arteries were considered abnormal if the calcium 
score was above the 50th percentile for age in a group of normals 
previously studied. For TEE, we graded each coronary artery by 2-D 
and color How Doppler criteria. By 2-D, the amount of calcification in 
each artery was graded on a 1-4 scale weighted for irregularities and 
acoustic shodowing. Color flow was considered abnormal if there was 
aliaSing (Nyquist limits .44-.50m/s) and 2-D was considered 
abnormal if there was Grade 3 or 4 calcification. By angio, arteries 
were conSidered abnormal if there was >50% stenOSis. All studies 
were read by an experienced observer blinded to patient identity and 
clinical information. Results: The sensitivity for detection of 
individual coronary artery stenosis by UCT and TEE, respectively, is 
83 and 92%, specificity is 84 and 92%, positive predictive value is 
71 and 86%, and negative predictive value is 91 and 96%. One patient 
with normal coronary angio had extensive calcification in her 
pulmonary veins identified by UCT, which made scoring her coronary 
calcificatio~ diffiCult. The most common source of error for UCT (3 
pts) was high calcium scores in the LMCA in a normal LMCA by angio, 
but CAS in o~h8r arteries. Conclusions: UCT and TEE can identify 
coronary artery stenosis in a high proportion of a group of patients 
undergoing angiography for a variety of reasons. These promising 
noninvasive techniques deserve further evaluation. 
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Reproducible Ventricular Fibrillation Produced by Ischemia Initiated at 
High Extracellular K+ 
William Fleet, Timothy Johnson, Wayne Cascio, Connie Engle, and 
Leonard Gelles. University of Nortb Carolina, Chapel Hill, NC 
Ventricular fibrillation (VF) occurs inconsistently in most models 
of acute myocardial ischemia (I} We have developed a model that 
causes VF consistently and reproducibly during I in in situ porcine 
hearts atrially paced at 100-12O/minute. In this model, KCI was 
infused into the side arm of an arterial sbunt from the carotid 
artery to the mid-LAD to raise extracellular K+ ([K+1.). measured 
by multiple intramural K+ electrodes, to varying levels prior to the 
initiation of no-flow 1 Local activation was measured with 
multiple bipolar plunge electrodes. In 14 experiments, when initial 
[K+1. was normal (3.8 mM ±O.4, SO). eight minutes of I raised [K+1. 
to 9.5 ±ts mM,lowered extracellular pH (pH.) to 6.70 ±O.f17, and 
caused VF in 5 of 20 episodes. After 40 minutes recovery, KCl was 
infused into the carotid-LAD shunt at a rate which reproduced the 
[K+1. rise during I, raising [K+1. to 9.5 ±19 mM This resulted in no 
arrhythmias and no rise in [K+1. outside the shunt-perfused zone. 
No-flow I initiated at this level of elevated [K+1. (K+I) resulted in 
VF in 22 of 22 such episodes after 2.3 ±O.5 milL During K+I, [K+1. 
rose by an additional 0.9 ± 0.6 mM and pH. fell to only 7.30 ±O.Ol 
Tbe development of VF during K+I was related to marked 
activation delay (AD) in the ischemic zone. AD rapidly increased 
from 30 ±29 msec during higb [K+1. alone to 157 y,9 msec during 
K+l AD during I alone reacbed a maximum of only 55 ±14 sec 
(p<0.01~ In one experiment, epicardial longitudinal conduction 
velocity, measured by a plaque of closely spaced electrodes, fell 
from 53 cmlsec to 24 cmlsec during I and to 9 cmlsec during K+l 
Verapamil prevented the marked AD during K+I, producing 
activation block after AD of 60 to 80 msec. Our results suggest 
that very slow conduction mediated by the slow (calcium sensitive) 
inward current is critical to the development of ischemic VF and 
tbat this very slow conduction requires a specific combination of 
high [K+1. witbout a significant decrease in pHc in the ischemic 
zone. 
90A ABSTRACTS 
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Spatial and Temporal Linking of Epicardial Activation 
During Ventricular Fibrillation In Canine Myocardial 
Infarction. 
Roger Damle, Nabil Kanaan, Yu-Zhi Ge, Jeffrey Goldberger, Alan 
Kadish. Northwestern University Medical School, Chicago, n... 
In order to detennine patterns of activation during ventricular fibril1ation 
(VF), the direction of epicardial activation at multiple sites was 
examined by summing computer generated orthogonally recorded 
bipolar electrograms to create vector loops. Nine dogs had VF induced 
by programmed stimulation 5-7 days after creation of myocardial 
infarction by left anterior descending anery ligation. Using a plaque 
electrode array with 2.5 mm interelectrode distance 91 vector loops 
were created for each "beat" of VF. Direction of maximum activation 
was determined at each site for the first 10 consecutive beats of VF and 
for 10 consecutive beats recorded 5 seconds after VF was established. 
Spatial and temporal linking of epicardial activation was evaluated by 
the ability of activation direction at a given site to be predicted by 
activation directions at 8 adjacent sites for the index beat (m) and at 8 
adjacent sites and the site of interest for the previous beat (PB) using 
stepwise linear regression. 
Bu.u.la:. No. significant No. significant r p Value 
predictors IB predictors PB 
Onset 8 1 0.62 <0.0001 
Post 5 Seconds 7 2 0.47 <0.0001 
The r values for each individual animal ranged from 0.51-0.77 
(p<o.oool) at the onset ofVF to 0.31-0.65 (p<O.oool) 5 seconds after 
VF was established. The most powerful predictors for each individual 
animal and for all animals together were the activation directions at the 
same two adjacent sites during the index beat. These sites were aligned 
perpendicular to the normal orientation of myocardial fibers. Activation 
directions during the previous beat were less important although still 
significant predictors. Conclusions; 1) There is spatial and temporal 
linking of epicardial activation during VF in this experimental infarct 
model, 2) Spatial linking is more prominent than temporal linking and 
3) The degree of linking appears to decrease over time. These findings 
suggest that electrical activation during VF is not random. 
729·3 4:30 
Evidence that Organization Increases during the First Minute of 
Ventricular Fibrillation In Pigs Mapped with Closely Spaced 
Electrodes 
Eric E. Johnson, Salim F. Idriss, Candido Cabo, Sharon B. Melnick, 
William M. Smitb, Raymond E. Ideker 
Duke University Medical Center, Durham, NC 
Frequency analysis has demonstrated that tbe onset of ventricular 
fibrillation (VF) is more organized tban previously bas been thought. To 
determine if VF maintains any organization over the first minute of VF, we 
recorded cardiac electrograms from 121 channels at a sampling rate of I 
kHz during one minute of AC induced VF using an 11 x 11 array (total size 
2.8 x 2.8 mm) of Ag-AgCl electrodes spaced 280 ... m apart (center-to•
center) on the epicardium in six anesthetized pigs. Power spectral analysis 
was performed on signals from a single channel using the maximum entropy 
method. Isochronal maps were constructed and beat·ta-beat variability 
compared. 
Temporal organization of VF was actually greater at one minute than 
immediately after VF onset. The peak frequency of the power spectrum for 
the 0 to 2 , interval was 7.9:1.7 Hz (mean:s.d.) with a curve width at 
half-maximum amplitude of 1.9:0.4 Hz. The peak frequency of the power 
spectrum at 60 to 62 s was lower at 5.9:2.0 Hz (peO.OI) with a much nar•
rower curve width at half-maximum amplitude of 1.0:0.8 Hz (p.0.004). 
Isochronal maps at one minute demonstrated slower conduction and less 
conduction block compared to those at the onset of VF. At 0 to 2 s of VF, 
44% of the mapped beats showed some evidence of conduction block (i.e. 
conduction velocity between adjacent electrodes sO.05 m/sec). At 60 to 62 
s, conduction block was evident in only 16% of the mapped beats (p.0.03). 
In two pigs, activation sequences at one minute were highly repeatable 
(mean beat-to-beat correlation coefficients of 0.95 and 0.60). 
Thus at one minute, temporal organization of VF is increased as 
reflected by the sharper peak of the power spectra compared with the first 
few seconds of VF; and spatial organization is also increased as reflected in 
the isochronal maps by less conduction block and in some pigs high beat-to•
beat repeatability of the activation sequences. 
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Does the Sinus Node Participate in tbe Genesis of New Wave Fronts 
during Atrial Fibrillation in the Canine Pericarditis Model? 
Jose Ortiz, Masaki Igarashi, Xavier Gonzalez, Kenneth Laurita, Nancy J. Johnson. 
Albert L. Waldo. Case Western Reserve University, Cleveland, Ohio. 
To test the hypothesis that during atrial fibrillation (AFib), the sinus node (SN) gen•
erates auial activation wave fronts, we studied II episodes of AFib lasting 7.2 min ± 
5 (range 1.7 - 15.5 min) in 8 dogs with sterile pericarditis. We used a multisite map•
ping system 10 record 190 unipolar electrogIams (converted in software 10 95 bipolar 
elecl1Ogrants) from the right atrial free wall (RAFW) along with ECG lead II during 
sinus rhythm (SR) and sustained AFib. AFib was induced by rapid pacing (mean CL 
144 ms ± 13; range 120 - 160 ms) from the posterior-inferior left atrium. AFib was 
conlinned using Slandard ECG and atrial electrogIam criteria. During both AFib and 
SR, the sequence of activation in the RAFW was analyzed for 6 consecutive bealS. 
Activation maps were drawn using sequential time windows of 110 IDS, with an arbi•
tnuy electrode site as a time reference for the AFib, and the earliest activation for the 
SR. In addition, the polarity of unipolar electrogIams recorded from all sites in prox•
imity 10 the SN were examined for 25 - 35 consecutive beats during AFib and also 
during SR. WllLIS;. Sixty 'l& of the activation maps from 7 episodes of AFib in 
5 dogs demonsuated a sequence of activation coming from the SN area, mimicking 
the activation pauern of SR. Negative, monophasic (QS) deflections were uniformly 
recorded from the SN area during SR reflecting origin of activation at the recording 
site. During AFib, however, all unipolar elecl10grants recorded from the SN area ex•
hibited biphasic (+1-) deflections, indicating that the activation wave front initially 
came from another pan of the atria and was simply passing through the SN area 
rather than originating there. Also, during AFib, the conduction velocity of the acti•
vation wave front passing through the SN area was slower (0.36 m/sec ± 0.14 range 
0.20-0.58 m/sec) than during SR (1.33 mlsec ± 0.45 range 0.60-1.80 m/sec) 
(p<O.OOOI). This "pseodo-SR activation wave front" in AFib was always blocked 
close 10 the inferior vena cava or the right atrial appendage by activation wave fronts 
coming from other parts of the atria Double potentials were recorded in these areas 
of block. In one episode of AFib, there was a "pseudo-SR activation wave front" in 5 
of 6 consecutive beats analyzed. CONCLUSIONS' In this animal model I) the SN 
does not activate the RAFW during AFib even though an activation pauem similar 
10 SN activation is recorded; 2) although the activation pattern was similar, conduc•
tion velocity in the RAFW is slower when there is a ''pseudo-SR activation wave 
front" during AFib compared 10 the sinus activation pattern during SR. 
729-5 5:00 
The Importance of Wavefront Curvature for LongitudInal 
propagation and Anisotropy In Myocardium 
Stephen Knisley and Bruce Hill, Duke University, Durham, NC and Research 
Institute, Palo AHo Medical Foundation, Palo AHo, CA 
PreviOus resuhs In isolated myocardial tissue indicate that flat wave/ronts 
propagate along myocardial fibers more rapidly than convex wavefronts. We 
investigated this for propagation along or across fibers in the heart. Rabbij 
hearts were endocardially frozen to produce a 1 mm layer of surviving 
epicardium and then perfused with oxygenated Tyrode's solution at 36-370C 
and paced at a cycle length of 300 ms. The hearts were stained with the 
potentiometric dye WW781 and given 20 mM diacetyl monoxime to eUminate 
contraction artifacts In the optical recordings. A laser scanning system 
mapped activations from 64 spots In a &6 mm region on the upper posterior 
left ventricle. Stimulation was performed at 2x diastoUc strength from bipolar 
electrodes adjacent to the mapped region. Propagation velocity (9) was 
determined lrom the activation times within the region. The fiber direction, 
Indicated by the direction of fastest propagation, was verified histologically. 
RESULTS: For longitudinal propagation, stimulation wijh a single electrode 
produced a convex wavefront with a 9 of 2S±4 cmls (meanisd) while 
stimulation with 7 electrodes in a line perpendicular to the fibers produced a 
flat wavefront with a 9 of 40i4 cmls, I.e., 38% faster propagation than the 
convex wavelront (p<0.01, n-4). Faster longitudinal propagation of flat vs. 
convex wavefronts was observed also In the absence of diacetyl monoxime. 
For transverse propagation, stimulation with a single electrode produced a flat 
wavefront with a 9 of 1a±2 cmls. When tlie number 01 stimulation electrodes 
In a line parallel to the fibers was Increased from 1 to 7, the shape of the 
transversely propagating wavefront In the mapped region did not change and 
the 9 increased only 0.4% (p..0.96, n-2). Hence the faster longitudinal 
propagation of flat vs. convex wavefronts is not explained by the greater 
number of stimulation electrodes. CONCLUSIONS: In these arterially 
perfused hearts;1) Propagation along myocardial fibers is significantly faster 
when the wavefront Is flat than when It Is convex. 2) The curvature elfect is 
negligible for propagation across the fibers. 3) The ratiO of longitudinal to 
transverse velocity, 2.3±0.3 for flat wavefronts, Is underestimated by 28% 
when the wavefront of longitudinal propagation is convex. Thus, curvature 
alfects longitudinal propagation and determinations of myocardial anisotropy. 
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Differentiation Between Slow Conduction And Block 
During Sustained VT In The Canine Epicardium. 
Nabil Kanaan, Nikki Robinson, Yu Zhi Ge, Rodney Brooks, Alan 
Kadish. Northwestern University Medical School, Chicago, n... 
In order to examine techniques used to characterize reentrant circuits, 25 
mongrel dogs underwent programmed stimulation 4-6 days after total 
LAD occlusion. Activation was recorded from the epicardium using an 
8X14 unipolar electrode plaque with a 2.5 mm inter-electrode distance. 
Vector mapping (VM) was performed by summing computer generated 
orthogonal bipolar electrograms to create a loop which describes 
activation direction. Isochronal mapping and electrogram (EG) 
morphology were also examined. Slow conduction was suggested by 
VM whenever vectors were oriented transverse to lines of apparent 
block. Results: Eight dogs (25%) had inducible mono!l1orphic VT, 5 
of which had epicardial reentrant circuits in the form of single loops (4 
animals) or double loops (J animal). In all 5 dogs, reentry occurred 
around lines of block 0.5 to 2.5 em long and parallel to fiber orientation. 
Six different regions of suspected block were identified. In 3 of 6 
regions, isochrones were perpendicular to the arcs of block and EG's 
were characterized by "double potentials". VM confirmed the 
conduction block by failing to show any vectors transverse to fiber 
orientation. In I of 6 regions, isochrones were parallel to the arc of 
suspected block and VM confirmed slow conduction. EG's were not 
fractionated in that region. Isochrones and VM were discordant in the 
remaining 2 regions, where isochrones suggested slow conduction and 
VM suggested block. In one of those regions, histology and 
electrogram data supported the presence of anatomic block. In the 2nd 
region, neither slow conduction nor block could be established with 
certainty but EG's showed double potentials. In regions of slow 
conduction, velocity was as low as 0.13 mls. Conclusion: 1) Lines of 
block parallel to fiber orientation that form during sustained VT in the 
post infarct canine model may be lines of slow conduction in some 
cases; 2) Slow conduction across those lines is not always associated 
with fractionated EG's; and 3) VM may provide a more reliable 
differentiation between block and slow conduction than standard 
techniques. 
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730-1 8:30 
Failure of Aspirin Coapared with Heparin or Hirudin to 
Enhance Lysis by rt-PA of Platelet-Rich Thrombus After 
Deep Arterial Injury in the Pig 
Pierre Zoldhelyi, James H. Chesebro, Jozef S. Mruk, 
Mark W.I. Webster, Diane E. Grill, Valentin Fuster. 
Mayo Clinic, Rochester, MN. 
Recombinant hirudin (CG393931, a specific antithrombin 
agent totally prevents fibrln and platelet-rich 
artertal thrombosis, but aspirin does not. We studied 
the lytic effect (incidence of reperfusion and residual 
platelet and fibrlnogen deposition) of rt-PA p'lus 
aspirin (Smg/kg IV), rt-PA plus heparin (iOOUlkg bolus, 
then 100U/kg/h IV), and rt-PA plus hirudln (1.0mg/kg, 
then 0.7 mg/kg/h lv) in a model of deep arterial inJur¥ 
with occlusive platelet-rich thrombus created by carotld 
balloon dilatatlon and atherecto~ in 20 pigs. rt-PA 
was administered as 0.3mg/k~lbolus, 3mg/kg ov~r 9D min, 
t4!en Img/kg over 129 min. In-l),1atelet lxlO /cm-') ana 
I-fibrinogen (x10 1molecules/cmf) deposition were 
measured after sacrifice at 210 min. Activated partial 
thromboplastin time (aPTT) was measured at basellne, 90 
and 210 min. Results (meaniSEM) are below: 
Ro. reperfused/total plgS 
Time to reperfusion (min) 
Platelet dep'osition 
Fibrinogen ~eposition 
aPTT, tlmes control 
*p<0.05 compared with 
rt-PA+ rt-PA+ 
.s~irin heearin 
16 " 60,80 110131 
328196 47115* 
13891246 170176* 
1.0iO.1 5.310.6* 
rt-PA + aspirin. 
rt-PA+ 
hirudin 
7/7 
33i6* 
13i3* 
4816* 
2.510.1* 
In this model, rt·PA alone reperfused 2/6 arteries. 
Antiplatelet therapy with aspirin failed to facilitate 
reperfusion by rt-PA of occlusive platelet-rich thrombi 
overlying deep arterial injury. In contrast to aspirin, 
thrombin inhibition with heparin or hirudin enhanced 
l¥sis and significantly reduced residual platelet and 
flbrinogen deposition. Hirudin with both antifibrin and 
potent antiplatelet effects at a relatively low aPTT, 
offers excellent therapeutic potential. 
ABSTRACfS 91A 
730-2 8:45 
Reduced HtlIIOrrhagie Complications follov.ing APSAC Tbuapy in Acute 
M)'OCardiaJ Infarction by Withbolcting Heparin 
Christopher M. O'Connor, Roderick Meese, James MacKreU, Erie Conn, John 
Burks, Neal Shadoff, Carl Hartman, Steven Roark, Maurice E. Heard, Brant 
MitUer, Kenneth Hanger, Gary J. Co1Iins. Kathi D. Lucas, Gerri Robens, 
Robert M. Califf for the DUces 1 In_tigators. Duke Uni~rsity Medical 
Center, Durham, North Carolina 
The DUCes 1 trial of heparin \'Ii no heparin follov.ing APSAC therapy in 
acute m)'OC8rdiallnfar<:1ion (AMI) enrolled 250 pIS CMr a ooe year period at 
2S centers. 
Pts randomized to heparin rec:ciwd intravenous weight adpted heparin 
without a bolus 4 hrs after APSAC therapy. The coaguIatioo status was moni•
tored with P1T measurements every 6 hrs for 24 hrs and then e~ry 12 hrs 
W1ti1 time of cardiac catheterizatioo (median da~ • 5). The medial P1T was 
70 sec in the heparin group and 3S sec in the no heparin group. 
Although post MI nOnhemoJTbaiic complications (death, stroke, reinfarction, 
congesti~ heart failure or recurrent Ischemia) were similar in both groups 
(40% \'Ii 38%), bleeding complications were twice as common in the heparin 
treated group (33%) as compared to the no heparin group (16%). Bleeding 
occurred more commonly at the access, genitourinary, gastrointestinal and 
intracranial sites in the heparin group. Moderate bleeding (250 - SOO cc 
observed blood loss) occurred in 21% of heparin treated pts and 9.8% of the 
pts treated without heparin. Se~re bleeding ( > SOO cc blood loss requiring 
transfusioo replacement) occurred in 7.0% of heparin treated pts and in 5.7% 
of the pis treated without heparin. A life threatening bleed, defined as an 
intracranial bleed (ICB), GI bleed, or other internal or external bleed causing 
hypotension was associated with a 57% mortality. These bleeds occurred in 
4.7% of heparin treated pts and 0.8% of pts randomized to no heparin. In 
addition, both pts with an ICB occurred in the heparin treated group. or the 
pts who experienced bleeding complications, ooe half of them occurred !.. 2 
da~ post administration of APSAC therapy. 
In conclusion, withholcting intravenous heparin after APSAC therapy results 
in half the bleeding rate compared to the heparin treated group despite similar 
nonhemorrhagic complication rates. This preliminary anal~ suggests that 
heparin should not be routinely administered alter APSAC therapy. 
730-3 9:00 
The APRICOT Study: Aspirin versus Coumadin in the Preventi•
on of Recurrent Ischemia and Reoc:c:luslon after Successful 
ThrombolysiS, a Placebo-controlled Angiographic Follow-up Study 
Nbert Meij~, Christ J. Werter, Freek W.A. Verheugt, Kong I. Lie, 
Joop MJ. van der Pol, H. Rolf Michels. Free University Hospital, 
Amsterdam, Interuniversity Cardiology Institute, The Netherlands 
The optimal antithrombotic strategy in the prevention of reocc1u•
sion after successful thrombolysis (T) and heparin (H) is unknown. 
In the APRICOT-trial (Antithrombotics in the Prevention of 
Reocclusion In COronary Thrombolysis) patients (pts) with acute 
myocardial infarction were treated with T (iv streptokinase) and 
iv H. Pts were eligible, when angiography (AG) within 48 h showed 
a patent infarct related vessel (IRV), and then randomized to 
start of coumadin and H continuation until the thrombotest 
showed therapeutic anticoagulation (INR 2.5 to 4.0), or 
H discontinuation and start of aspirin 300 mg qd, or 
H discontinuation and start of matched placebo. 
300 pts were randomised. To study IRV patency and LV ejection 
fraction (LVEF) recovery AG was repeated (AG2) at 3 months, 
during which CABG/PTCA, reinfarction and death were scored. 
RESULTS aspirin coumadin placebo 
(n= 107) (n=98) (n=95) 
IRV patency AG2 (% pts) 75 70 68 
LVEF AG2 - AG1 (%) +4.6 ± 9.9 0 + 1.4 ± 10.7 +0.8 ± 10.7 
death (% pts) 1 2 2 
other event(s) (% pts) 6" 15 22 
o P < 0.001 " P < 0.001 vs placebo p < 0.05 vs coumadin 
Thus, after H discontinuation following successful T aspirin leads 
to a better angiographic and clinical outcome than coumadin. 
Coumadin should not be used after H discontinuation follOwing T. 
92A ABSTRACTS 
730-4 
Platelet Aggregation and coronary Artery 
Patency in Patients with Acute Infarction 
treated With Saruplase and Taprostene 
9:15 
Harald Darius, GUnter Gorge, Raimund Erbel, 
JUrgen Meyer, Frits Bar, Hannes Barth, Gwyn 
Hopkins, European Working Group on Taprostene 
The combined effects of the prostacyclin 
analog taprostene and the thrombolytic agent 
saruplase on vessel patency and platelet 
aggregation was studied in patients with acute 
myocardial infarction. In 80 patients treated 
with 3 different doses of taprostene or 
placebo taprostene 12. S or 2S ng/kg/min 
administered for 48 hrs totally prevented 
reocclusion following initially successful 
thrombolysis. Platelet aggregation was studied 
ex vivo in a subgroup of patients (n=17). The 
EDso for ADP-induced aggregation was signi•
ficantly higher in patients with patent 
infarct related coronary arteries (2.6±0.S ~Mi 
n=11) when compared to patients with occluded 
arteries (0.8±0.1 ~Min=4)iP<0.OS). In patients 
treated with taprostene the susceptability for 
the ex vivo inhibitory effects of exogenous 
taprostene was maintained as indicated by the 
ICso-values before thrombolysis (170±S9 nM) 
and after 36 hrs of infusion (200±S4 nMi n=8). 
In contrast, in patients receiving placebo 
platelets became resistent towards exogenous 
taprostene as indicated by increasing ICSO-values (268±123 vs 383±173 nMin=4). 
Thus, combined treatment of patients with 
acute myocardial infarction with saruplase and 
taprostene counteracts platelet activation and 
prevents reocclusion after successful 
thrombolysis. 
730-5 9:30 
Bfficacy ADd Safety of Ridogrel Ver.u. A.pirin in 
Coronary Throaboly.i. Wit~ Altepl... for Myocardial 
Infarction 
Bernardino Tranchesi Jr.", Bruno Caramelli", Otavio 
Gebara", Giovanni Bellotti", Fulvio Pileggi", Frans Van 
De Werf#, Marc Verstraete#. Heart Institute of Sao Paulo 
Brazil(") and University of Leuven Belgium(#). 
This open randomized trial investigates the 
effectiveness of ridogrel (R),a thromboxane synthase 
inhibitor and receptor blocker, versus aspirin (A)in 
terms of speed and rate of coronary recanalization 
(CR),and safety when combined with alteplase and heparin 
in myocardial infarction (MI).Sixty patients who denied 
intake of any antiplateletB drugs in the last 10 days 
were allocated to either A 250mg i.v. immediately before 
thrombolytic treatment (TT) and thereafter 100mg P.O. 
daily (I) or R 300mg i.v. before TT and thereafter 300 
mg P.O. b.i.d. (II).8100d samples for assessment of 
thromboxane B2 were obtained before TT.All patients 
received alteplase 100mg i.v. over 90 min. and had 
infarcted-related artery (IRA) patency determined by 
coronarography (C) before and repeated every 15 min. 
until the end of TT.A final C was obtained 48-72 hours 
later to evaluate reocclusion of IRA. 
Group I Group II p 
nIl to 3 randomiz.) 15 45 
Patency at 90 min(n) 10(67%) 32(71%) ns 
Cor.Recan.at 90 min 8(61%) 21(62%) ns 
Speed of CR(min) 30 32 ns 
Reocclusion at 48-72hs(n) 2 ns 
Small bleeds 3 25 .016 
Cerebral hemorrhage 0 1 ne 
We conclude that R and A are equally effective in terms 
of speed and rate of recanalization, patency and in 
preventing reocclusion of IRA, and where equally eafe 
when combined with alteplase in MI. 
730-6 
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Relationship Between AntIcoagulation Level Ischemic Events and 
Angiographic Characteristics of Infarct·R"lated AMeoy Following 
StreptOkinase In PatIents W,th Acute MyocardIal InfarctIon. 
C.Cuccla. M Volterran.. M Volp"'i. G.Musmecl S.::'calvllll 
M.Campana O.Leonzi LNlccolo. M PaganI 
Fondazione Clinica del Lavoro Medical Centre of G\lss2go ar,d 
Cattedra dl Cardiologla. UniverSIty of B'2SCI" ITAL'r 
The relatIonshIp between the response to heparirl th~rapy. the 
Incidf'nce 01 recurrent ischf?'mia or remiarrtiofl and the 
an,;}lographlc characteristics 01 the in1arcl-relah~d artEry was 
E:xamlned 10 123 patients treated Wilt, Lv. Streptokinase {Sr., 
Within 6 hours from the onset ot th~ first acute O-v-av~ 
myocardial infarction (.dMI). All the patients received an i.v. 
continuous In1uslon of heparin titrated 10 prolong the ~ctlvated 
parlial thromboplastin time (APTT) to ;5·2 tImes contr.>l value 
The InfUSIon ot hepalln started at the end 01 S~. alid thA APTT 
was measured every 6 hours for the first week aUE: r the cnset c·t 
the AMI. All pattents had coronary angioglaphy 3 week. after 
adm,sslon. The prolongatIon of APTT to at least 1.5-2 control 
values was never achIeved in 39 pts (Group 1) whilst 84 pts had 
accurate APTT prolongatIon (Group 2) Ischeml" events 
occurred In 7 pts 01 Group 1 (17.9%; and in 12 pts ·~f Group 2 
(142%) (n s). The patency of Infarct· related artery was hlQher 
in Group 2 (69%) than In Group 1 (46%) (~·O.02\ ano th" 
severl1y ot reSidual st~nosis was higher 10 Group 1 then 10 
Group 2 (73 7 vs 56 5 average cf stenosIs' rank p·.O 02; 
These data suggest that acute IschemiC events allE'r SK in p15 
with AMI do n01 correlate With the response to heparin assf=$s-I?d 
by APTI values It seems that a correel antlcoaculat,e'n w,th 
heparin could play c:. role '" enhancing the ang;ographl,? 
chare:.ctensttcs 01 the Infarct-related artery 
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731-1 8:30 
Strategies for Coronary Revascularization Using 
Different Atherectomy Devices: A NACI Registry Report 
Martin B. Leon, Tom Hinohara, Jeffrey J. Popma, Michael Cowley, 
Maurice Buchbinder, Robert D. Safian, Michael H. Sketch, Ann 
Steenkiste, Donald S. Baim, and the NACI Atherectomy 
Investigators. Washington Hospital Center, Washington, D.C. 
Although different mechanical approaches have been devised to 
remove coronary plaque including: directional (DCA), high-speed 
rotational (ROn, and extraction (TEC) atherectomy (ath), usage 
strategies by experienced operators for .:ach device have not been 
clarified. By 9/91, more than 1000 patients treated with one of these 
ath devices had been enrolled in the NACI Registry. Fully edited 
data fonns in 463 of these patients were analyzed to detennine usage 
differences. 
DCA 
435(385) 
14 
50/21 
3.2 
koT 
47(36) 
o 
66115 
2.5 
68 
o 
66 
TEC 
44(42) 
59 
5/21 
3.3 
14 
23 
48 
In conclusion: (1) Each athevice has a dlsunctive use profile 
detennined by vessel location and size and lesion morphology; and 
(2) although most ath procedures were ~ as sole therapy, 
PTCA was used ~ ath in 35% of DCA cases and PTCA was 
used m ath in 17% of DCA, 74% of ROT and 86% of TEC cases 
(either to treat device-related complications or to optimize angio•
graphic results), Thus, important differences in ath device usage 
pattems must be considered to make valid inter-device comparisons. 
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731·2 8:45 
THE USE OF ATHERECTOMY DEVICES IN CORONARY LESIONS OF 
DIFFERENT MORPHOLOGY AND LOCATION. 
Augusto E.Vina. Irving Franco, Russell E.Raymond, Sue DeLuca, Paul N. Casale. 
Patrick L. Whitlow, Cleveland Clinic Foundation. Cleveland. OU. 
New inlerventional devices may improve results in specifIC subsets of lesions and may 
nOl be efficacious in others. We report the results of our fllSt 44 Directional(D). 36 
Extractional (E) and 44 Rotational (R) atherectomies in the different types of coronary 
.. lesions (AHA/ACC classification). The vessel diamerer was significantly larger in the 
E(3.7+/-0.6) than in the R(3.2+/-0.4) and 0(3.3 +/-0.5) (p=.OOOI) . The overall 
procedure efficacy including the use of sequential devices or PTCA (>20% initial gain 
and<SO% residual stenosis) was 96%(42/44) in 0 and 100% in E(36136) and R(44/44) 
(p=O.16). A sequential device Ill' PTCA was utilized in 11%(5/44) oro. 92%(33/36) of 
E and 77%(34/44) of R (p<O.05). 
Dm.Ii.llIIlIi 1i.3lD1!;;lillllOll RIIIalilmal 
(n=44) (n=36) (n=44) 
YIlS~IlU 
Native 89%(39/44) 8%(3/36) 100%(44/44) 
Graft 11%(5/44) 92%(33/36) 0%(0/44) 
l&~!lIITvnes 
A 32%(14) 0%(0) 0%(0) 
BI 45%(20) 22% (8) 18%(8) 
B2 18%(8) 61% (22) 71%(31) 
C 5%(2) 17% (6) 11% (5) 
Primarv device efficacy (>20%initial gain) 
A 100%(14/14) 
BI 95% (19/20) 87% (718) 100% (818) 
B2 62%(518) 95% (21/22) 84% (26/31) 
C W%C!al 100% (6/6\ 60% (315) 
Conclusions: I) The use of sequential devices or PTCA is high afrer Exttactional and 
Rotational atherectomies, and low after Directional atherectomies. 2) Directional 
atherectomy is used more ofren in simple lesions (A+BI), Extractional and Rotational 
atherectomies in cotnplex lesions (B2+C). 3) Directional atherectomy has a very high 
efficacy in simple lesions (A+BI), Extractional atherectomy in complex lesions 
(B2+C) and Rotational atherectomy in BI+B2Iesions. 4) The straregy of selecting Ihe 
use of this 3 atherectomy devices according to lesion type and vessel, followed by 
sequential device or PTCA can be associated with a very high success rare. 
731·3 9:00 
USE OF NEW DEVICES IN THE NEW APPROACHES TO CORONARY 
INTERVENTION (NACI) REGISTRY 
Gary S. Roubin, Kenneth M. Kent, Robert D. Salian, Timothy A. Sanborn. 
Frank Litvack, Richard A. ScbaIz, Maurice Buchhinder, Michael H. Sketch, Jr., 
Patrice DesvigneoNickens, Katherine M. Delre, Ann R. Steealriste, for the NACI 
Investiaators 
Between 11190 and 9/91, the NACI Reaistry enrolled> 2,000 patients, from 30 
participatina centers, treated with ODe of 6 participating devices: Simpson 
Atherocath(DVI), Rotablator(ROT). Trans1umina\ Extraction Catbeter(TEC). 
Palmaz-ScbaIz stent(pSS), Gillltutco-ROIIbin stent(GRS), and the AlS and 
Spectranetics(SPE) eximer Jasen. Of 748 patients with edited data, anaiogrsphic 
success was obtained in 93.9", with major complications includinll death 1.3". 
emergency CABG 2.1", and MI 5.1". 7" of lesions treated required the new 
device for suboptimal or failed PTCA. Use pattern (e.g., pllllllled or unpllllllled), 
and vessel characteristics differed among devices as follows: 
Total II of lesions 
Pllllllled useIlesions 
Reasons for planned use: 
DVl ROT TEC PSS GRS 
435 47 44 180 36 
418 44 44 162 12 
AlS SHl 
50 44 
48 43 
calcified (") 6 68 14 1 0 8 12 
eccentric (") 71 66 48 32 2S 13 37 
severe lesion (") 15 23 2S 11 17 13 28 
thrombus (") 3 0 23 1 0 4 5 
excess. length (") S 11 0 6 2S 29 42 
Vessel (") LAD 50 66 5 29 28 30 52 
Cx 9 13 7 9 17 16 16 
RCA 21 15 21 36 42 40 16 
SVG 16 0 64 24 11 14 14 
Pt had prior CABG (Il) 23 14 50 34 26 38 9 
Mean Lumen dia pre 0.8 0.5 0.6 0.8 0.8 0.5 0.4 
refer. 3.2 2.6 3.3 3.4 3.1 2.8 29 
In conclusion, 1) the NACI Registry has succeeded to enroll patients treated with 
one of the 6 major investigational devices and document the varying indications 
for their use. 2) preliminary results suggest on average similar overall success and 
complication rates for the Reaistry compared to conventional PTCA. 
ABSTRACTS 
731·4 9:15 
Acute Closure During PTCA: Improved Management With 
Intracoronary Stents, Laser Balloons and Prolonged 
Inflation. 
Neal A. Scott, William S. Weintraub, Sherry F. Carlin, Xudong 
Tao, James A. Hearn, Nicholas J. Lembo, John S. Douglas Jr, 
Spencer B. King III. Emory University School of Medicine, 
Atlanta, GA 
Acute occlusion is a malor complication of PTCA. Recently, 
there have been severa! changes in the management of thiS 
problem. Intracoronary stents, laser balloons and the use of 
prolonged balloon inflation have recently become available for 
treatment of acute closure (AC). This study was performed to 
examine the outcome of patients who suffered AC of the PTCA 
site while in the catheterization suite. Group I comprised those 
patients treated for AC before devices for AC were available 
(1/1/86 - 8/31/88, n=166). Group II comllrised all patients with 
AC that occurred between 9/1/88 and 12/31/90 (n=156). 
There was no difference in age, sex, prior myocardial infarction, 
ejection fraction, presence of multivessel disease, or number of 
sites attempted. There was no difference in the percentage of 
patients who received heparin after the procedure. Group II had 
a lower incidence of Q-wave MI (10.9% vs 19.9%, p=0.OO5), 
peak CPK (517 .± 1050 vs 826.± 1515, p<0.01), and in-hospital 
CABG (29.5% vs 38.6%, p=0.02). There was no siQnificant 
difference in mortality between the two !,lroups. Patients in 
Group II had a longer total balloon inflation time (616.± 547 vs 
313.± 238 seconds, p<0.OO1). Intracardiac stents, laser 
balloons, or perfusion balloons were used in 47% of the patients 
in Group II. We conclude that there was a recent improvement 
in clinical outcome in patients with AC. This improvemnt 
correlated with the use of intracoronary stents, laser balloons 
and prolonged balloon inflation. 
731·5 
A Multi·Device Lesion·Specific Approach for 
Unfavorable Coronary Anatomy 
9:30 
Martin B. Leon, Kenneth M. Kent, Lowell F. Satler, Jeffrey J. 
Popma, Richard H. Cooke, Karen S. Stark, Kathleen M. Donovan, 
Julie M. Witt, Pamela A. Shotts, Augusto D. Pichardo Washington 
Hospital Center. Washington, D.C. 
To evaluate the procedural efficacy and safety of transcatheter 
intervention in patients with unfavorable coronary anatomy, we used 
multiple investigational angioplasty devices (lAD) tailored 10 specific 
lesion characteristics (morphology, location, or behavior to 
present/previous PTCA). As of 9/1/91. 1,256 lesions 0,169 
patients) were treated with various lAD, including excimer or dye 
laser angioplasty (n=209), laser balloon angioplasty (n=36), 
athereclOmy (directional n=437, rotational n=253, extraction n=56), 
and stents (n=250), of which 935(74%) exhibited unfavorable 
anatomy for PTCA or unsuccessful PTCA results (dissections, 
undilatable lesions). Overall angiographic success (<50% residual 
stenosis) for unfavorable lesions was 94%. Angiographic success in 
specific unfavorable lesion categories included thrombus (19) 74%, 
ostial (119) 88%, eccentricity (770) 89%, chronic total occlusions 
(64) 92%, diffuse disease (115) 95%, saphenous vein grafts (130) 
95%, dissections (76) 96%, and undilatable lesions (85) 98%. 
Despite the primary use of lAD, adjunct PTCA was employed in 
71 % either to optimize angiographic results or to manage 
complications. lmponant complications (by event) were death 
0.9%, MI 3.2%, urgent CABG 2.2% and acute or subacute closure 
3.3%. Major complications (death, MI, or CABG) by patient were 
4.8% which reduces final procedure success in these patients with 
unfavorable anatomy to 89%. CONCLUSIONS: 1) A lesion•
specific approach using multiple devices improves procedure success 
in unfavorable PTCA lesions. 2) Complications are acceptable, 
given the complex anatomy and high risk nature of these pIS. 3) 
Adjunct PTCA is often necessary to optimize final results. Thus, 
use of lAD should be targeted 10 unfavorable lesion subsets and 
integrated with current PTCA procedures. 
93A 
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731·6 9:45 
Woaen Rave a Higher Major Coaplication Rate with New 
Devices for Percutaneous Coronary Revaacularization 
Paul N. Casale, Patrick L. Whitlow, Irving Franco, 
Fernando Grigera, Eric J. Topol 
The Cleveland Clinic Foundation, Cleveland, Ohio 
Previous studies have indicated that female gender may 
carry an increased, independent risk for coronary 
bypass surgery and PTCA. To determine if there is a 
higher incidence of acute complication in women 
undergoing coronary atherectomy, we reviewed 379 
atherectomy procedures performed in 357 pts (276 males 
and 81 females). There were 35 rotablator, 36 TEC and 
308 DVI atherectomy procedures. Major complications 
(emergency surgery, death) occurred in 9 pts. Varisbles 
analyzed included age, gender, history of diabetes, 
previous bypsss surgery, heart failure, MI, unstable 
angina, lesion characteristics (calcium, eccentricity, 
length), artery size, vessel undergoing atherectomy, 
ventricular function, and extent of coronary disease. 
In the study group, women were older than men 63 + 
13 yrs vs. 60 ! 10 yrs (p-.023) and had a higher 
incidence of diabetes 36% vs. 18% (p-.002). There was 
no difference in extent of coronary disease or left 
ventricular function between men and women. 
The incidence of major complications was signifi•
cantly higher in women 5/81 (6.2%) as compared to men 
4/276 (1.4%) (p·.016). Multiple logistic regression 
analysis revealed that female gender was a predictor of 
major complication independent of age or presence of 
diabetes (p-.029). No other clinical or angiographic 
variables were independent predictors of major com•
plications • 
Conclusion: Although co-variates tend to confound 
our assessment, female gender carries an independent 
risk of major complication with new coronary devices. 
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732·1 8:30 
lDtracardiac U1trasouDd Determination of LV Volwnes • In Vitro and In 
Vivo Validation 
Carrie A. Wolfberg, John P. Fisher, Robert Kahan, Doris Tummillo, Joseph 
S. Mikan, Francis J. Kiernan, Raymond G. McKay, and Linda D. Gillam 
Hartford Hospital and University of Connecticut, Hartford, CT. 
The accuracy of catheter based ultrasound determinations of planar 
dimensions has been well established. Although well suited to the assessment 
of blood vessels, such measurements provide limited information concerning 
the more complex geometry of the LV. To determine the feasibility of 
calculating LV volumes using intracardiac ultrasound (ICUS), the current 
study applied a Simpson's rule algorithm to cross sectional ICUS images of 
the LV recorded in vitro and in vivo. In vitro studies were carried out on 
14 pig and 5 calf hearts with latex cast volumes providing the gold standard. 
In vivo studies were performed in 11 closed-chest anesthetized pigs. In 
these, LV cineangiographic volumes at end-diastole (EDV) and end-systole 
(ESV) were calculated using the single plane RAO projection prolate 
ellipsoid model of Sandler and Dodge. All ICUS images were obtained 
using a 12.5 MHz single element mechanical device enclosed within a 6 Fr 
catheter. Short aXis images were recorded at 0.5 cm intervals as the catheter 
was withdrawn from apex to base. LV volumes were calculated USing an 
offline analysis system employing a Simpson's rule algorithm which 
reconstructs the ventricle as a stack of up to 20 cylindrical elements of equal 
height. 
~ y = ICUS volume x = cast or cine volume 
In vitro: 
In vivo: 
EDV: 
ESV: 
y = 0.89x + 2.22, r = 0.95 
Y = 0.94x + 5, r = 0.95 
y = 0.9Jx + 5, r = 0.71 
Conclusion: The application of Simpson's rule algorithm to intracardiac 
ultrasound images of the LV permits an accurate determination of LV 
volumes in vitro and in vivo. 
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Improvements In Reliability and Availability for 12.5 MHz Scanning 
Frequencies for Intravascular Ultrasound Imaging Yield New Applica•
tions In CHD Patients: Clinical Experience and Animal Investigations 
David J. Sahn, Fran~ols Ricou, Abraham Rothman, Wanda C. Miller-Hance. 
Achi Ludomirsky. Univ of Cain, San Diego, CA and Texas ChHdren's 
Hospnal, Houston, TX. 
We have pelformed Intravascular ultrasound imaging (IVUS) in 48 pts (age 
3 mo to 28 yrs) wnh CHD using 4.8FR, 20MHz and 6.8FR, 12.5MHz 
(Diasonics) catheters. In our last 22 cases, improvements in catheter 
reliabilny and especially better imaging sensnivny obtained by lowering 
receiver frequency for the ultrasound scanner to 12.SMHz, have facilitated 
the use of IVUS in therapeutic catheterization for CHD. IVUS was used 
during balloon angioplasty for native or recurrent coarctation in 7 pts, 4 of 
whom developed signrrlcant Intimal flaps which marked dissections (1 not 
visualized by angiography). We monitored dilation of peripheral pulmonic 
stenosis in 6 pts, dilation of pulmonary valve stenosis in 4. dilation of 
condutt peel and conduit valve stenosis In 2. dilation of AO valve stenOSis 
in 2 and dilation of Senning baffle obstruction in 2 pts. The IVUS images 
provided calibration, sizing information and details of wall structure before 
and aiter dilation. As Important diagnostic observations. IVUS also demon· 
strated unexpected changes of branch PA thrombus in 2 post Fontan pts 
and in 1 patient wnh pulmonary hypertension after VSD closure, prompting 
a decision to strictly anticoagulate all 3 patients. We also used IVUS to 
define thrombus formation around coils placed in a shunt and tumor 
compression of the RVOT in another pt, as well as to image engagement of 
a Lock-Clamshell device on both sides of the atrial septum during ASD 
closure. Lastly, we have recently tested a new IVUS configuration wherein 
a 9FR polyethytene balloon dilation catheter wnh an ultrasound probe 
inside allowed monnoring of dilation of experimentally induced coarctations 
in dogs and on-line visualization of intimal tears or other vascular damage 
or complications through the dilating balloon. Improved reliability and in· 
creased sensnivity (at lower frequency) and the availabilny of new balloon 
dilation scanning catheters expand CHD application of IVUS. 
732·3 9:00 
IDtracardiac U1trasouDd Imaging of the Heart and Great Vessels With a New 
Low Frequency U1trasouDd Cathet« • Streogtbs and Limitations Based on 
Experieace in 90 patients 
Linda D Gillam, Steven Schwartz, Brenda W Sanzobrino, Gerald Marx, 
Jeffrey A Hirst, John P Fisher, Tsui-Leih Hsu, Andrew Weintraub, David 
Fulton, Raymond G McKay, Natesa Pandian. Hartford Hospital, Hartford, 
CT and Tufts-New England Medical Center, Boston, Mass. 
We have previously shown the feasibility of intracardiac echocardiographic 
imaging (ICE) of the heart using 20 MHz catheters, but noted the shallow 
depth of field and need for lower frequency devices. To assess the degree 
to which a new 12.5 MHz system might overcome the limitations of 20 
MHz catheters, we performed ICE with this lower frequency device in 90 
pts (age 4-78 yrs). 6 or 9 Fr mechanical ICE catheters were introduced 
antegrade into the right heart and either retrograde or antegrade (transseptal) 
into the left heart. Cardiac structures imaged were: RA and LA (including 
the coronary sinus, atrial septum, fossa oval is, and appendages), RV and 
LV, tricuspid, pulmonic, aortic and mitral valves, and ostia of the coronary 
arteries. Pathologic states identified included atrial septal defects, repaired 
Tetralogy of Fallot, RA mass, bicuspid aortic valve, valvular aortic stenosis, 
subaortic membrane, aortic coarctation, LV and RV dysfunction, Kawasaki's 
coronary disease. ostium of a saphenous vein graft, thrombosed aortic 
aneurysm, pericardial effusion, and intracardiac catheters. In contrast to 20 
MHz devices, the expanded field of view of the 12.5 MHz catheters 
provided full images of the atria and transmural myocardium in many pts. 
The valves, large diameter great vessels and many pathologic structures 
were likewise more completely displayed. However, the field of view was 
still often inadequate to fully display nonstenotic valves and basal ventricular 
cross-sectional areas. Average imaging time was 10 min. No complications 
occurred. We conclude that the expanded depth of field of the new 12.5 
MHz ICE catheter conveys a major advantage over 20 MHz devices for 
imaging the heart and great vessels. The technique is easy and safe and is 
a promising clinical tool. However even lower frequencies will be necessary 
if the technique is to provide a viable alternative to transesophageal echo. 
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Improved Visualization of the LeI! Ventricle During Cardiac Catheteriza•
tion by Intr.cardiac Scanning With a New 12.5 MHz Ultrasound Imag•
Ing Catheter: A Study In Pigs 
Fran~ois Ricou, David J. Sahn, Robert Weintraub. Abraham Rothman. Univ 
of CaIH, San Diego, CA. 
Most applications 01 intravascular scanning have been aimed at imaging 
small vessels to provide detail not obtainable from surface echo. While LV 
Images for wall motion and contrast can be obtained using surface echo, 
detail is often sub-optimal and Implementing echo in the cath lab is usually 
cumbersome because of patient posttioning, sterile drapes and intervening 
equipment. To avoid having to use TEE imaging and yet provide high 
quality images for LV wall motion and/or contrast studies during interven· 
tional catheterization, we undertook LV placement of a new 12.5 MHz, 6.8 
French IVUS catheter (Boston ScientHic Corp/Diasonics) in 30-40 kg pigs. 
Catheters were easily passed retrograde across the AO valve and ad· 
vanced to the apex of the LV using the guidewlre. Once posttioned in the 
LV, H the guidewire was left extended, catheter posttion was stable enough 
wtthin the LV cavkyand penetration was sufficient to provide short·axis LV 
visualization at multiple levels. In comparison, images from standard 20 
MHz catheters did not penetrate far enough to encompass the LV walls 
completely out to the epicardium. The 12.5 MHz Images provided excel· 
lent endo- and epicardial detail and wall motion abnormalities concordant 
with LAD and circumflex ligation were visualized. Additionally, myocardial 
perfusion imaging of diagnostic quality could be accomplished both by AO 
root and LMCA injections of Levovist & (SHU508) (a saccharide micropar· 
ticle contrast agent). Contrast echo perfusion images appropriate for 
isolated LMCA injection or defects associated with LAD ligation and AO 
root injection provided clear segmental demarcation. Our study shows the 
potential of using an intracardiac scanning catheter for monitoring LV wall 
motion and/or echo contrast perfusion during interventional catheterization. 
The technique should cause no added discomfort and should provide on•
line monttoring capability for studying changes in wall motion or contrast 
perfusion during interventional catheterizations. 
732·5 9:30 
Impaired Nitroglycerin Induced Vasodilation in Coronary 
Atherosclerosis: Evidence from Intravascular Ultrasound 
Masakazu Yamagishi, Steven E, Nissen, David C. Booth, John 
C.Gurley, Charles Fischer, and Anthony N. DeMaria 
University of Kentucky and VA Med Center, Lexington, Kentucky. 
Intravascular ultrasound is a new technique that enables visualization of 
atherosclerotic changes in coronary wall morphology. However, few 
data are available regarding the relationship between atherosclerotic 
abnormalities by ultrasound and coronary vasoreactivity to nitroglycerin 
(NTG). Therefore, we perfOImed intravascular ultrasound of the left 
coronary arteI)' before and after intraCoronary NTG (250 ~g) in 32 
patients undergoing angiography. All vasodilators were withheld prior 
to study. Intravascular ultrasound employed a commercial 5.5 F, 20 
MHz, 64 element catheter and a synthetic aperture reconstruction 
algorithm. Videotaped images were digitized into a 612x480 pixel 
matrix and cross-sectional area (CSA) measured with an electronic 
cursor. Abnormal ultrasound wall morphology was defmed using 
previously reported 95% confidence values obtained in 15 normal 
subjects for the maximum thickness of the intima\leading-edge (<0.30 
mm) and subintimal sonolucent zone (<0.20 mm). We examined 33 
coronary sites: 10 of which were normal by both ultrasound and 
angiography, 16 of which revealed disease by both methods, and 7 of 
which were normal by angiography, but abnormal by ultrasound. For 
the 10 normal sites, maximal vasodilation occurred within 60 seconds 
following injection of NTG with CSA increasing from 9.4 ± 2.6 to 
11.7 ± 3.0 mm2, or 26 ± 13%, p<O.OOO1. At the 16 abnormal sites, 
NTG-induced vasodilation was reduced with CSA increasing from 9.7 
± 2.3 to 10.9 ± 2.8 mm2, or 12 ± 9.7%, p<O.OS compared to normals. 
At the 7 sites which were abnormal only by ultrasound, CSA following 
NTG increased from 10.1 ± 2.7 to 11.7 ± 3.5 mm2, or 12 ± 4.4%, 
p<O.OS compared to normals. These data demonstrate that vaso•
dilation following NTG is markedly reduced in segments with angio•
graphic lesions. Vasoreactivity is also diminished in angiographically 
normal segments with evidence of disease by intravascular ultrasound. 
Thus, atherosclerosis detected only by intravascular ultrasound is 
associated with functional impairment in coronary vasoreactivity. 
ABSTRACTS 
732·6 9:45 
Use of the 'Smart Needle' for Internal Jugular and Subclavian 
Vein Cannulation 
Paul G. Yock, John S. MacGregor, Ann K Kao, Thomas M. Amidon 
Thomas A. Ports. 
University of California, San Francisco, CA 
The Smart Needle'" (SN) is a new Doppler guidance system for 
rapid arterial or venous cannulation. It consists of a miniature 
ultrasound transducer on the tip of a stylet within a standard 1 B or 
20 gauge needle. The operator inserts the needle under the skin 
and then scans until the vessel is located by its characteristic audio 
signal. The needle is advanced while maximizing the Signal, guiding 
the tip of the needle Into the center of the vessel. 
Our prior clinical studies have shown that discrimination between 
veins M and arteries (A) by the device is straightforward in the 
periphery because the V signal Is steady compared to the pulsatile 
A signal. In the internal jugular (IJ) and subclavian (SC) veins, 
however, the presence of a significant V wave can generate a 
markedly pulsatile signal from the needle. To assess this potential 
difficulty we attempted 22 IJ and 4 SC vein cannulations using the 
SN. In 14/26 patients (pIS) the SN was used after conventional 
access proved difficult or an A was entered inadvertently. Results, 
Pulsatile venous signals from the SN were encountered in 20/26 pts. 
In 12120 pts respiratory variation served as a marker for V. However, 
in one early case a carotid artery signal had respiratory variation 
resulting in an inadvertent A stick. This was the sole guidance 
failure in the group; the IJ was detected and entered on a second 
pass. The most reliable discriminator for V was the presence of an 
"a" wave in the signal (15/20) resulting in a double Doppler sound for 
each QRS on simultaneous EKG monitor. Conclusion. With 
attention to pulse contour and respiratory variation, successful IJ and 
SC vein cannulation can be achieved promptly with the Smart 
Needle even in cases where conventional access has failed. 
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The Predictive Value of Exag~erated Atrial 
Repolarization Waves for a False Posibve Exercise Test 
in an Unselected Population 
Peter M. Sapin, Mary Beth Blauwet, Gary S. Koch, Spencer 
Hinds, Leonard S. Gettes, University of North Carolina, Chapel 
Hill, North Carolina 
Previous study of selected patients has suggested that atrial 
repolarization (AREP) waves may cause false positive (FP) exercise 
tests, recognized by the appearence of markedly downsloping PR 
segments in the inferior leads. Since AREP waves increase as heart 
rate increases, patients with coronary disease (CAD) who attain 
higher heart rates may also display downsloping PR segments. We 
postulated that in an unselected population this would lower the 
positive predictive value (PPV) of downsloping PR segments (pR 
Seg) for a FP test. Therefore we reviewed the standard Bruce 
exercise ECGs of 102 consecutive pts with a normal resting ECG 
and horizontal ST depression ;a 1 mm. and applied predetermined 
criteria to predict a FP test. The criteria for a FP test were exercise 
duration> 4 min plus markedly downsloping PR segments in 2 of 3 
inferior leads. Subsequently 82 patients (mean age 58 yrs, 69% 
male) were classified as follows: Definite FP: normal cath (n=4), 
normal stress nuclear study at high double product (n= 12), or both 
(n=I). Probable FP: normal nuclear study at moderate double 
product (n=3). Definite TP: cath proven CAD + typical angina or 
abnormal nuclear study (n=31). Probable TP: CAD but no angina 
or nuclear study (n=31), 20 pts had no further testing performed 
and were excluded. Definite and probable groups were similar and 
could be combined for analysis. The PR seg criteria identified FP 
tests with sensitivity (Sens)=<l.70 and specificity (Spec)=0.74. The 
PPV of the PR seg criteria in all 82 pts was 0.47. In pts with peak 
exercise HR!>.lS0 and >150 the PPVs were 0.38 and 0.53 
respectively. ConC\usjon: Even in an unselected population, PR seg 
criteria are moderately sensitive and specific for a FP test. 
However, as expected, PR seg criteria have a low positive predictive 
value. Thus, while PR seg criteria are suggestive of a FP test, they 
are less reliable in pts with a high pre-test probability of CAD. 
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Beta-Blockade Mfects the Relative Performance of Heart Rate 
Adjusted ST Depression Criteria for Detection of Severe Coronary 
Disease 
Paul Kligfield, Peter M Okin, Harvey L Goldberg. 
Cornell Medical Center, New York, NY 
The relative performance of the linear regression based ST fHR 
slope, the simple ST fHR index. and the magnitude of ST 
depression alone for the detection of anatomically severe coronary 
obstruction was examined in relation to the presence or absence of 
beta-blockade during treadmill exercise in 172 catheterized 
patients with chest pain. Test criteria were selected to match the 
59% specificity of an STfHR slope partition of 6.0 uV fbpm for 
identification of 3-vessel disease in the total group. Among 109 
patients taking beta-blocking drugs. whether severe disease was 
defined by 3-vessel obstruction, by Gensini scores >35 or >48, or 
by Duke jeopardy scores >6, the 82-100% sensitivities (sens) of the 
STjHR slope criterion of 6.0 uV jbpm were each significantly 
higher than the 63-77% sens of 150 uV of ST depression, while 
the simple ST JHR index criterion of 3.4 u V jbpm had intermediate 
sens of 77-88%. Among unmedicated patients. in contrast. sens of 
each criterion were comparable for each definition of disease 
severity, .lthough specificities were highest for the ST fHR slope. 
These data indicate that the relative performance of the ST fHR 
slope, the ST fHR index, and ST depression for detection of 
anatomically severe disease may vary with the prevalence of 
beta-blockade in populations with symptomatic coronary disease. 
In the absence of beta-blockade. ST depression and the heart rate 
adjusted indexes have comparably high sens for severe disease; in 
the presence of beta-blockade, sens of the ST fHR slope is 
preserved, but sens of the magnitude of ST depression alone is 
reduced and the simple ST fHR index does not adjust for this 
change as effectively as does the linear regression based ST JHR 
slope. 
733-3 9:00 
Does Chronotropic Response During Early Submaximal Exercise 
Identify Patients With Chronotropic Incompetence at Maximal 
Exercise? 
Philip J Keeling, Guy A Haywood, Peter J Counihan, M Elisabeth Klare, 
Sonia Bent, William J McKenna. Department of Cardiological Sciences, St 
George's Hospital Medical School, London, UK. 
The assessment of chronotropic incompetence (CI) is often difficult because 
of the problems involved in determining the time at which the maximum 
workload is achieved using respiratory gas analysis or blood lactate 
measurements. In order to determine if the chronotropic response at 
submaximal exercise could predict that attained at peak exercise 65 patients 
with chronic heart failure (NYHA 11/111) underwent symptom limited exercise 
testing (Bruce protocol) with respiratory gas analysis. The peak respiratory 
quotient achieved at maximum exercise was 1.1 ±O.l (59/65 > 1.0 (90.8%). 
All patients were in sinus rhythm and no patient was taking ~ blockers, 
calcium antagonists or digoxin. or had evidence of exercise-induced ischemia. 
The predicted chronotropic response was calculated for each stage of 
submaximal exercise using Willcoffs method. CI was observed at maximal 
exercise in 8!65 patients, 10/64 at Stage 1,2/33 at Stage 2 and 1/12 patients at 
Stage 3. There was also a strong correlation between maximal and 
submaximal chronotropic response throughout all stages of exercise (R=O.8-
0.9. p=O.OOOI)(specificity 87.5%, sensitivity 94.6%). Analysis of the 
results from stage I of exercise showed a sensitivity of 87.5%. specificity 
96.4%, a positive predictive value of 77.7% and a negative predictive value 
of 98.2%. The only false negative CI result at this stage was a patient who 
achieved a maximal chronotropic response of 80.1 %. 
Conclusion: Using this method the chronotropic response at maximal 
exercise can be accuracy predicted from the chronotropic response during 
early submaximal exercise. 1bis method also takes into account the worKload 
achieved at each stage of exercise and resting heart rate and is thus likely to 
prove superior to the current assessments of CI at maximal exercise. 
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Recovery Time of ST Segment Depression Correlates With 
Both Magnitude of Depression at Peak Exercise and Rate•
Pressure Product During Recovery 
Peter Bogaty, Juan C. Kaski, Stavros Gavrielides, Dimitris Tousoulis, 
Jacques Rouleau, Attilio Maseri. Royal Postgraduate Medical School, 
London, UK and Laval University. Ste-Foy, Quebec. Canada. 
To explore the pattem of appearance and disappearance of ST segment positivity on 
the 12 lead exercise ECG in subjects with ischemic hean disease, we studied 34 
consecutive patients (27 men, 7 women; mean age 58 years) who had: stable 
angina; a normal re<ting ECG; a positive exercise test ~I mm ST depression); 
~70% stenosis of at least one major vessel; normal left ventriculography. The 
number of vessel disease was 1.8;t0.8 (mean;tSD). These patients underwent a 
symptom-limited 12 ECG lead modified Bruce treadmill exercise test while off anti•
anginallherapy and recovered in semi-supine position. 
Workload achieved was 7.4±3.2 METS. Duration of ST depression during exercise 
was 4.3±2.3 min. Maximum ST depression was 2.2±0.8 mm. Recovery time of 
ST depression (loss of positivity) was 3.5±.3.4 min. The rust lead to show 
positivity during exercise also developed maximum ST depression in 25/34 (73%) 
and was the last lead to lose positivity in recovery (94%). The last lead to show 
positivity during exercise was first to lose positivity in recovery (92%). Recovery 
time did not correlate with vessel disease, workload achieved or with rate-pressure 
product at peak or initial positivity. Recovery time did correlate with duration of ST 
depression during exercise (r=0.6; )1=0.001), maximum ST depression (r=0.6; 
p<O.OOI) and rate-pressure product just prior to loss of positivity during recovery 
(r=O.6; )1=0.001). 
Thus, in exercise testing in subjects with ischemic hean disease, I) the rule 
tends to be: first lead positive-last lead negative, last lead positive-rust lead 
negative; 2) the first lead to become positive tends to be the one which will exhibit 
maximum ST depression; 3) recovery time appears to be strongly related to the 
duration of ST depression during exercise, maximum ST depression and rate•
pressure product during recovery. This association suggests that ST depression and 
its recovery may both be related to the intensity of exercise-induced myocardial 
ischemia. 
733·5 9:30 
Izarciae-iDduced QIS Azi. Change.: .ey Criteria for the 
Localiaation of CorODllry Artery Diae .. e_ 
Ant6nio Ventose, Vi tor Gil, Ricardo Seabra-Gomes. 
Hospital de Santa Cruz, Carnaxide, Lisboa, Portugal 
The association between exercise-induced changes of Q, R, 
and S waves and coronary artery disease (CAD) has been 
described. To study exerciee-induced QRS axis (AX) 
changes (AXc) and to evaluate their possible association 
with the localisation of CAD, we analysed rest and peak 
exercise QRS axis in frontal and horizontal planes in 135 
patients (pta) 51 ± 9 yeara old (lZ3 M and 12 P) with 
one-vessel disease and ST segment depreSSion and/or 
elevation on treadmill exercise teat. Previous ~ocardial 
infarction (MI) was preaent in 64 pts (44 anterior, 20 
inferior). Frontal plane (F): D1-Oo, aVP-+900; horizontal 
plane (H): V6-OO, V2-+900. Groups considered: LAD - 97 
pts, LCX - 17 pts and RCA - 21 pta. The only exercise 
teat variable found to be significantly different between 
the groups was AXc. No significant differences were found 
within esch group, between patients with or without MI. 
LAD disease was associated with minor AXc (F: -4 t 24°, 
H: 0 t 15°), which was significantly different (p<O.OOl) 
from the ri&ht and posterior AXc observed with LCX (F: 
+21 ± 22°, H: -24 ± 27°) or RCA (P: +21 t 21°, H: -18 t 
19°), but with considerable overlap. However, the asym•
metric distribution ofAXc by diseased artery disclosed 
criteria that allowed its identification with excellent 
apecificity: Left AXc>5° and/or anterior AXc>So was 47% 
sensitive and 89% specific for LAD (predictive 
value [pvl-92%); and right AXc>20° and/or posterior 
AXc>300 was 53% sensitive and 96% specific for LCX/RCA 
(pv-83%). Thus, in this series, the occurrence of 
exercise-induced QRS axis changes allowed the differen•
tial diagnosis of LAD versus LCX/RCA disease with high 
specificity, suggesting that QRS axis may be a potential•
ly useful information to obtain from exercise testing in 
CAD patients. 
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Significance of Post-Exercise Systolic Blood Pressure to 
Heart Rate Ratio in the Diagnosis of Coronary Artery 
Disease 
Mark W. Surber, Myrvin H. Ellestad, Randy Crump. 
Memorial Heart Institute, Long Beach Memorial Medical 
Center, Long Beach, California 
It has been proposed that post exercise blood pressure 
can predict coronary disease. To determine the value of 
post-exercise systolic blood pressure (SBP)to heart rate 
(HR) ratio as a predictor of coronary artery disease, 
192 patients (mean=57.6 yrs) were studied who underwent 
both an exercise stress test and coronary angiography. 
SBP/HR ratio was analyzed by two separate cutoff points 
(1.4 and 2.2) in order to improve specificity and 
sensitivity when used in conjunction with ST depression 
or the lead strength corrected ST/R·amplitude ratio 
(ST/R). Alone, 1.4 had a specificity and sensitivity of 
35% and 82%, while 2.2 was 80% and 13% respectively. 
Upon multiple analysis: 
Neg ST < lrrm 
Pos ST > lrrm 
Neg ST /R < .1 
Pos ST /R > .1 
Sens/ 
~t%c 
56% 
83% 
62% 
No Di sease N=66 
-SBP/HR +SBP/HR 
1.4/2.2 1.4/2.2 
21%/58% 45%/ 9% 
11%/21% 24%/12% 
27%/68% 56%/15% 
7%/12% 9%/ 5% 
Diseased N-126 
-SPB/HR +SBP/HR 
1.4/2.2 1.4/2.2 
12%/40% 33%/ 5% 
6%/47% 50%/ 9% 
6%/33% 32%/ 5% 
11%/54% 51%/ 8% 
When the variables are used together both the specifi•
city and sesnsitivity decrease. Likewise, a median cut•
off point for the SBP/HR ratio (1.65) also decreases the 
accuracy of the diagnosis (56% sensitivity and 56% 
specificity). Therefore, SBP/HR cannot be used with 
confidence in diagnosing coronary artery disease. 
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Ma1perfusion of the Coronary Arteries In Acute Type A Aortic 
Dissection : Mechanisms and Management 
Mar~us Helnem8lln, ~hlm LIIas, Matthias KarCK, Michael Jurm8lln, 
Hens-Georg Borst. 
Hannover Malical School, Hannover, FRG 
Acute thor8::1c pam IS the leedmg symptom oi coronary artery (CA) dIsease 
Even 11lhls diagnosis Is obvious, myocardial Ischemia may st111 be only a 
symptom 01 Acute Type A Aortlc Dissection (MDA). Delay in the diagnosis 
In! the operative repair of such a malperfusion may leed to irreversible 
myocardial damlrJEi on top of the danger of aortic rupture. 
Out 011 06 patIents \ pts) operatal for MDA between 4179 and 8/90, 16 (= 
15:1:) presental with malperfusion of the CA ( 12 male, 4 female, mean age 
55.5 yrs). 6 pts showal symptoms of acute myocardial Ischemia 
concomitant with MDI>.. In them. constant or intermittent occlUSion of a CA 
ostium by the intimal nap was found. 4 pts underwent venous CA bypass 
~!lfting (CABu) with the proximal anastomosis into an ascending aortlc 
lTeft. In 2. restoration of native CA perfusion could be established by 
resection of the flap and reconstruction of the ostium, In 10 pts without 
clinically evIdent myocardlal lschemla. at least one CA os\1um had been 
disruptal by retrograde extension of the dissection into the CA. In 8 cases 
circular reconstruction 01 the proximal CA was performed. In 2 pts CABGs 
had to be 00ne 
2 pts dial 01 myocardial faHure despite of revascularlzal10n (2/16 = 
125:1:) 3 other pts were lost for different reasons (early mortality 5/16 
= 31:1:, total early mortality 26/106 = 24.S:H The 11 survivors were 
followed regularly ( 11 mos - 7,5 yrs postoP. mean 2,6 yrs) with DSA, echo 
end exercIse ECG. 3 underwent cardIac catheterlzatlOn All reconstructIons 
or lTafts were patent. 
In ostial disruption 01 the CA by MDA, reconstructive surgery Is possible In 
most of the cases. Inst8llt repaIr of such a lesion is mandatory to prevent 
myocardial damlrJEi. Since the prognosis of CASGs anastomosal into 
prosthetiC ~!lfts is eQUivocal, we perform these only In irreversible 
destruction of a proxImal CA. 
ABSTRACTS 
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Op.rativ. Ri.k A ••••••• nt U.ing Bay •• ian Tbeory. Curr.nt 
Standard. Baaed on 21,777 Adult cardiac Surg.ry Pati.nt. 
CO.par.d With 12,614 Hi.torical COntrol 
Loren F. Hiratzka, U. Scott Page, Haurice Adam, William 
Cranor. The Christ Hospital, Cincinnati, Ohio 
Risk for mortality following a variety of adult cardiac 
surgery procedures was assessed in 21,777 patients 
operated within the past 5 years. Data were entered into 
the multi-institutional Herged Cardiac Registry 
(Dendrite) and examined using Bayesian theory which can 
examine multiple risk factors and determine individual 
risk in an additive fashion. OVerall mortality was 4.9\. 
The conditional probability matrix used the following 
factors with ratios of expected mortality calculated 
where >1.0=increased risk and <l.O=decreased risk. Risk 
factors for which the ratio was increased >1.5 included: 
age 70-74 (1.59), 75-79 (1.82), 80-84 (2.39), 85+ (2.79); 
prior cardiac surgery (2.23); LVEF 20-29\ (2.52), <20\ 
(2.99); operation classified as emergent (2.32) or 
desperate (12.94); mitral valve replacement (2.72); LV 
aneurysm (2.13); post infarct VSD (14.21). Risk factors 
for which the ratio was ~ 1.5 included age < 70, aortic 
valve replacement, COPD, diabetes, hypertension, left 
main stenosis, LVEF ~ 30\, female gender, recent acute 
HI and recent thrombolytic therapy. When these risk 
factors were similarly analyzed in 12,614 patients 
operated 5 to 20 years ago, the current risk ratios were 
less particularly with respect to LV aneurysm (3.23 to 
2.13), aortic valve replacement (2.50 to 1.47), left main 
stenosis (1.70 to 1.21), LVEF 30-39\ (1.44 to 0.96), LVEF 
< 20\ (3.68 to 2.99), recent acute HI (3.90 to 0.92), 
prior cardiac surgery (2.74 to 2.24). 
These ratios serve as a basis for calculating 
operative risk for individual patients. Current risk 
appears lower for cardiac factors but not noncardiac 
factors. 
734·3 9:00 
An Aggressive Surgical Approach for Patients 
with "Inoperable" Ischemic Heart Disease 
Lynda Mickleborough, Shunichi Mizuno, 
Gordon Gray 
University of Toronto, Toronto, Ontario, Canada 
Patients with CAD, previous MI and diffuse 
hypokinesis ± LV aneurysm may be considered 
inoperable or candidates for transplantation. 
As an alternate approach in 41 such patients in 
whom most of the LV wall was hypokinetic or 
dyskinetic, we have performed bypass grafting 
(CABG) and extensive scar resection, tailored 
to preserve ventricular geometry, specimen 
>30 cm2• Average age was 58±9 years, 68%(28/41) 
were in NYHA Class IV preop with symptoms of 
CHF 68%(28/41), angina 73%(30/41) and syncope 
51%(21/41). The average EF preop was 23±5%. 
There were no hospital deaths although 
66%(27/41) required inotrope and 22%(9/41) 
required IABP support perioperatively. The EF 
as assessed by nuclear angiography improved 
postop in 95%(39/41) patients (average increase 
7%). During a mean followup of 46 ± 34 months, 
there have been 9 late deaths (22%). All other 
patients have improved and 72%(23/32) are now 
in NYHA Class I or II. 
We conclude that tailored scar resection 
(LV remodelling) + CABG can be performed with 
low risk and good symptomatic improvement in 
selected patients who might otherwise be 
considered inoperable or candidates for 
transplantation. 
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Incidence of Repeat Revascularlzation After Coronary Bypass Surgery 
William S. Weintraub, Ellis L Jones, Joseph M. Craver, Robert A 
Guyton. OMslons of Cardiology and Cardiothoracic Surgery, Emory 
University School of Medicine, Atlanta GA 
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Additional revascularization procedures are uncommon until 5 years, 
after which they are required with an accelerating incidence to at least 12 
years. These data are consistent with the increasing reoperative CABG 
and PTCA after initial CABG noted in many institutions. 
734-5 9:30 
Identification of Unstable Angina Patients Who Have Favorable Outcomes 
With Medical and Surgical Tberapy 
Robert Deupree, Stewart Scott, Robert Luchi, G.V.R.K. Sharma and the 
Principal Investigators and Their Associates of the V A Cooperative Study 
of Unstable Angina. 
VA Medical Center, West Haven, CT 
Of 468 patients (pts) with unstable angina (UA) who were randomized to 
either medical therapy (M) or surgical therapy (S) '}i!,7 pts had either 3-
vessel coronary artery disease or an ejection fraction (EF) S 0.58 (the 
lower tercile of EF) and were classified as high risk on the basis of these 
angiographic findings. The remaining 174 pts had 1- or 2-vessel disease in 
combitUllion willi an EF>0.58 and were classified as low risk. The random•
ization effectively balanced baseline characteristics in M and S pts. 
Cumulative mortality rates after 8 years of follow-up were: 
:j High Risk 
J.~:= • poO.03O 
• 
• 
• • 1 , • " I • 7 • 
y-
101 Low Risk ., -e-_ 
f' "'SurvorY 
l"~'022 .,1 
:1 , ..... '. 
y.,. 
The 287 high risk pts had significantly better survival with S (p=0.030); 
this finding, although not previously reported, is entirely consistent with 
our earlier separate reports of improved survival following S for all UA pts 
with 3-vessel disease and for all UA pts with a reduced EF. In marked 
contrast, the 174 pts at low risk had significantly better survival with M 
having derived no survival benefit with S (p=O.022). 
Conclusion: While S is the preferred therapy for UA pts with 3-vessel 
disease or EF SO.58, M appears to be the preferred therapy for UA pts 
with 1- or 2-vessel disease and EF>0.58. 
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CREATINE KINASE LEVELS MAY BE A DETERMINANT OF PROGNOSIS 
AFTER CARDIOMYOPLASTY - PRELIMINARY RESULTS 
Edimar Alcides Bocchi, Luiz Felipe Moreira, Antonio Barreto, Pedro Seterian, 
Giovanni Bellotti, Noodir Stolf, Alvaro Vilela de Moraes, Fulvio Pileggi, 
Adib Jatene - Instituto do Cor..;80 - University of Sao Paulo - Brazil 
The predictors of prognosis and clinical improvement after cardiomyoplasty 
on one year follow - up has not been well studied yet. We studied the 
one year follow· up of 16 pIS, 14 male, mean age 43 ± 12 years, 
submitted to cardiomyoplasty (CMP) for treatment of refractory heart 
failure (HF) (10 pt in N.Y.H.A, functional class III, 6 pt in class IV) 
due to idiopathic dilated cardiomyopathy or Chaga's disease. The end 
point was survival and improvement of N.Y.H.A. functional class after 
CMP that were correlated with: age; pre operative left ventricular diastolic 
diameters (LVOD) (mm) and LV ejection fraction (EF) (%) by 
achocardiographic studies, right ventricular EF (RVEF) (%) by radionuclide 
method, cardiac output (CO); post operative CK peak levels (U II), degree 
of LV and RV wrapping. The pre operative values were: CO = 2.3 ± 0.7 
Lim, LVDD = 73 ± 7, LVEF = 33 ± 5, RVEF = 23 ± 5. The mean 
values of CK peak levels were 1036 ± 531 U II. Ten pIS had clinical 
improvement (4 pt in class II, 6 pt in class I), 2 did not improve (class 
III) and 4 pIS died due to: pulmonary embolism (1 pt), HF and pulmonary 
infection (1 pt), HF and coma (1 pt), HF and infection (1 pt). The survival rate 
at 1 year was 75%. All pt with CK peak> 1400 U II died (3 pt) or did 
not have clinical improvement (1 pt). Ten pts (83%) with CK peak levels 
< 1400 U II had clinical improvement. The others variables did not have 
correlation with the follow· up. Thus, these preliminarly findings suggest 
that damage of latissimus dorsi muscle, perhaps due to ischemia during 
the surgical procedures, may influence the one year follow· up after 
cardiomyoplasty. 
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735-1 8:30 
Radiofrequency Ablation Guided by Potential Distribution Mapping 
in Canine Septal Tachycardia 
Chris K. Rokkas, Richard B. Schuessler, Barry H. Branham, H. Dieter 
Ambos, Lawrence L. Creswell, James S. Tweddell, Takashi Nitta, John 
P. Boineau, James L. Cox. 
Washington University, Barnes Hospital, St. Louis, Missouti 
Potential distribution maps (PDMs) provide a rapid and accurate 
means for the precise localization of the origin of ventricular tachycar•
dia (VT). PDMs correlate with the concomitant activation sequence 
and can localize the site of reentry. To determine if radiofrequency 
(RF) energy delivered through the mapping electrodes could ablate 
VT of septal origin, septal infarction was produced in 18 dogs. Four 
to six days later, the animals were placed on slightly hyperthermic 
cardiopulmonary bypass (39-40' C). Repeatedly inducible, sustained, 
monomorphic VT was induced by programmed electrical stimulation 
(SIS2S3) in 12 dogs. Form-fitting (endocardial and epicardial) Silastic 
molds containing 250 unipolar electrodes were used to record 
potentials from right and left ventricular endocardial surfaces and the 
epicardium. Ten animals had one morphology each (cycle length CL 
= 192±37 msec) and two animals had a second morphology (CL = 
230±20 msec) after the initial one was ablated. Site of origin of VT 
was localized on the left (n=5), right septal surface (n=6), or 
intraseptal (n=3). RF energy of up to 1500 joules was delivered 
through 3-6 electrodes that recorded the earliest potential minima 
(PM). The electrodes that recorded the earliest PM on the opposite 
side of the septum were used to close the circuit. This method ablated 
all but the deep intramural foci of VT. Conclusions: I) This model 
of VT, similar to human VT, originates from both the RV and LV 
endocardium and intramurally deep within the septum; 2) transeptal 
RF is effective in ablating VT originating close to the endocardial 
surfaces, but is not effective in terminating deep intraseptal VT; 3) 
when unsuccessfuL easily visualized endocardial lesions can serve as 
landmarks to guide application of other ablative methods; and 4) a 
deep intra septal origin of VT may require focusing the RF through a 
transmural needle electrode. 
JACC Vol. 19, No.3 
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Acute and Chronic Effects of Myocardial Ablation Using 
Selective Cardiac Venous System Catheterization and 
Ethanol Injection 
Arun Gadhoke, Frederick 1. Schoen, Jose Zebede, Christopher 
Clyne, Mark Aronovitz, Connor Haugh, N. A. Mark Estes III, 
PaulJ. Wang 
Tufts University School of Medicine, New England Medical Center, 
Boston, MA 
Prior studies have shown that transcoronary ethanol(ETOH) 
delivery may be used for the ablation of sustained ventricular 
arrbythmias(SV A). Because of the absence of stenoses in the cardiac 
venous system, the safety of right-sided catheterization, and dilution 
of ablative agents, selective cardiac venous system catheterization and 
ablation may be a preferable technique. In order to study the acute 
and chronic effects of this method, in 6 closed-chest dogs, a branch of 
the anterior interventricular vein was selectively catheterized using a 
0.014" guide wire and a 2.0-2.Smm angioplasty balloon catheter. 
The angioplasty balloon was inflated at 6-8 atm pressure and Icc of 
100% ethanol was injected through this catheter. Nonsustained 
ventricular tachycardia occurred during injection in all cases. 
Coronary angiography and cardiac venography failed to demonstrate 
any significant abnormalities at baseline, acutely after ETOH, or 
chronically at 28 days. Progratnmed ventricular stimulation at these 
satne 3 time points failed to induce SV A at coupling intervals of 
200ms or more. Gross pathologic examination revealed transmural 
lesions in 2 of 6 animals, non-transmural lesions in 2 animals, and 
only superficial lesions in the remaining 2 animals. Histologic 
exatnination revealed healing myocyte necrosis consistent with the 
time of injUty. In the 4 animals with significant gross lesions, 
histologically the lesions were transmural in 3 animals and 
subepicardial in I animal. 
These findings suggest that myocardial ablation using the 
cardiac venous system may be performed safely without datnage to 
the coronary arteries, cardiac venous system, or distant myocardium 
and without evidence of pro-arrhythmia. 
735·3 9:00 
Vhat is the Radial Temperature Profile Achieved During 
Microwave Catheter Ablation Vith a Helical Coil Antenna 
in Canine Myocardium? 
David E. Haines, James G. Vhayne. University of Virginia 
Health Sciences Center, Charlottesville, Virginia 
Hicrowave (HY) energy has been proposed as an alternative 
source for catheter ablation due to its anticipated 
greater depth of tissue heating compared to radiofrequen•
cy energy. Since the mechanism of HY tissue injury is 
thermal, we measured the radial temperature (temp) pro•
file in serial HY lesions in order to judge efficiency 
and efficacy of HV heating in myocardium. Serial HY le•
sions were produced by a single channel 915 HHz HV gener•
ator (Tex/L Corp, Arlington, TX) via a 7 Fr helical coil 
antenna catheter (EPT, Hountain View, CA) positioned per•
pendicular to the endocardial surface of freshly killed 
canine RV free wall in a temperature controlled chamber 
at 37°C. Temps were measured at the tissue-antenna in•
terface (T-A) and at varius distances from the catheter. 
RESULTS: Power output was held at 100 Y in 37 lesions 
for 120 sec. The peak T-A interface temp was 63±15 with 
a range of 46-107°C. Radial temp profile was an inverse 
proportion to distance from the catheter (p-0.001) but 
the correlation was poor (r.0.75). In 16 additional 
lesions, power was adjusted to maintain T-A interface 
temp of 59±3°C. Hean power required was 10013 Y. Tissue 
temp was inversely proportional to distance (p.0.0001, 
r.0.92). Anticipated lesions radius (48°C isotherm) was 
calculated as 4.1 mm. CONCLUSIONS: HV ablation with a 
helical coil antenna placed perpendicular to the endocar•
dial surface results in significant tissue heating but 
requires a high power output with the present antenna 
design. A fixed power output results in a wide variation 
in T-A temp. Adjusting power to a target T-A temp yields 
consistent radial temp profiles. 
ABSTRACTS 
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Ultrasonic Measurement of Myocardial 
Thermal Coagulation 
Stephan E. Friedl, Eric D. Mathews, Vi-Shin Weng, Anne B. Curtis, 
George S. Abela. University of Florida, Gainesville, Florida, and 
Deaconess Hospital, Harvard Medical School, Boston, 
Massachusetts. 
Catheter techniques for ablation of AV conduction 
supraventricular and ventricular arrhythmias rely on thermai 
coagula!ion of myocardium. Since dept~ of thermal penetration may 
be cruCial for the success of arrhythmia ablation, we investigated 
ultrasonography to assess depth of thermal lesions in myocardium. 
Nd:VAG laser energy was used to create SO thermal lesions in 
fresh, necropsied bovine myocardium Immersed In saline. Laser 
energy was varied from 10 to 20 Watts; exposure time was 20 
seconds. Following irradiation, lesions were Imaged with a S.2Fr, 
20MHz ullrasound calheter. lesion depth by ultrasound(DU) was 
measured and compared to lesion depth(DM) and volume(VM) 
measured morphometrically on light microscopy. 
Results: Regions of thermal coagulation were clearly identifiable 
in the ullrasonic image. 0 U ranged from 0.S7 to 5.1 mm; D M 
from 1.34 to 7.4 mm; VM from 1.S to 150 mm3. DU correlated 
with OM (r-0.78), however DU underestimated DM by O.SOmm. 
DU was also found to correlate with VM (r-0.75). 
Conclusion: DU measures a ~ 8 Y = 1.14x + 0.60, r = 0.78 region of thermal coagulation 
~ 5~ • :' in which the ultrasonic ! ' .. properties of the myocardium 
::Ii E 4 8 ~ have changed. These results 
~ £3 Indicate that ultrasonography 
i may be useful for the 
~ 1 assessment of the size of 
i 0 !:-o--:--~---''''''''---.J catheter-Induced thermal 
e. 3 6 lesions In the myocardium 
(OU) Depth By Ultrasound during arrhythmia ablation. 
735·5 9:30 
Radlofrequency ablation; the effect of temperature·gulded 
RF ablation on myocardium. 
E.KongsgArd, M.D., A. Foerster, M.D.,J.P. Amlie M.D. 
Inst. Surg. Res. and Med. Dept. B, RikshospRalet, Oslo, Norway. 
Radiofreqency (RF) current ablation Is an attemative to DC ablation 
technlque.ln vttro studies have shown good correlation between applied 
energy ,temperature and lesion size. WHh a temp.-guided RF-generator 
(HAT 200, Osypka) and an ablationcalheter with a 2 mm diameter tip 
electrode 16 open chest pigs were studied.The energy was delivered In 
temperature controlled mode using etther bipolar or unipolar electrodes. 
Set temperature; 60- 90 degree C. Pulse duration; 30 sec .. In order to 
obtain a constant electrode I endocardium contact-pressure the passive 
contact was chosen. A passive electrode-tissue contact was Indicated by 
fluoroscopy and by the electrocardiographic iso-electric ST - Hnie recorded 
from the ablationcatheter. Lesions were found in 73 % of the bipolar RF•
applications and In 77% of the unipolar-applic .. Histologic examination 
showed coagulation-necrosis wHh a haemorrhaglc zone. During or short 
after ablation premature ventricular beats and non-sustained VT were 
frequently observed. Total delivered energy (lesion found) ranged from 
5,5-651.4 J. In the bipolar mode we found a pos. cotrelation between 
lesionareallvolume and peaktemperature wHh a r value of 0,48 and 0,59 
respectively ( p<0.05). However no correlation between size and applied 
energy. In the unipolar configuration we could not find any correlation 
between size and these parameters. Mean depth lareal; bipolar; 3,3 mm 
127 mm2 , unipolar; 3,3 mmt 17mm2.ln 5 applications (unipolar mode) we 
found lesions wtth vaporisation (deep excavation). 
Conclusions: 1) In a beating heart tt Is difficuH to predict lesionsize from 
temperature and energy. 2) Bipolar energy-applic. should be easier to 
handle In the Clinical setting for ablating ventricular myocardium than 
unipolar applic .. 
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Radiofrequency Ablation of Diseased 
(-ArrhythJloqenic·) HUlIan MyocardilDl 
Wilhelm Haverkamp, Christiene Hief, 
Hammel, Gerhard Hindricks, Hans H. 
Martin Borggrefe, Gunter Breithardt 
University Hospital MUnster, Germany 
9:45 
Dieter 
ScheId, 
To assess the efficacy and feasibility of 
radiofrequency (RF) coagulation for the 
ablation of diseased human myocardium, 82 RF 
impulses were delivered to isolated 
ventricular preparations obtained from 
patients who underwent anti tachycardia surgery 
for recurrent ventricular tachycardia. 
Specimen were placed in a saline bath at room 
temperature and energy (HAT 100, Osypka, 
Germany) was delivered for 30 sec. using a 7F 
catheter with a built-in thermolelement at a 
constant catheter contact pressure. Delivered 
current, voltage and catheter tip temperature 
(CTT) were continuously monitored: impedance 
(I) and delivered power (P) were calculated. 
Tissue preparations showed a variable degree 
of fibrosis. The extent of the lesions was 
inversely related to the amount of fibrotic 
tissue present. Depth of the lesions varied 
between not measurable and to 4,5 mm. P ranged 
between 2.4 and 18,8 W, I between 77 and 197 
ohms and TTC between 64 and 138 °C. There was 
no correlation between the extent of the 
lesions and E, I and TTC. 
Our results show that coagulation of diseased 
human myocardium is feasible. Measurements of 
physical parameters (including temperature) 
cannot be used to either predict the extent of 
induced lesions or to specifiy the coagulated 
tissue. 
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The Prognostic Value 
Dipyridamole-Echocardiography Early 
Uncomplicated Acute Myocardial Infarction: 
Results of the EPIC Study 
8:30 
of 
After 
Updated 
Giovanni Seve so, Franco Chiarella, Mario Previtali, Leonardo 
Bolognese, Stefano Chiarandil, Patrizia Landi, Franca Margaria, 
Omelia Magaia, Nicola Gandolfo, Maria Grazia Sclavo, Cecilia 
Marini, Eugenio Picano, on behalf of the EPIC study group -
subproject residual ischemia. 
Aim of this large scale multicenter study was to assess the 
prognostic value of high dose (up to 0.84 mg/kg over to') 
dipyridarnole-echocardiography test (DET) in predicting future 
cardiac events early after flTst uncomplicated myocardial infarction. 
Eleven laboratories performing DET for diagnostic purposes 
entered the study; all had an established experience in stress echo 
and fulfliled the quality control procedures for stress echo readings. 
A total of 885 patients performed a DET a mean of 10 days after 
acute myocardial infarction and were followed up for a mean of 12 
months. The 24 months event free survival (considering all events: 
death, infarction, unstable angina, revascularization procedures) 
was 75% in the 503 patients with DET negativity and 41 % in 382 
patients with DET positivity (p<.01). The 24 months survival was 
97% in DET negatives and 90.6% in DET positives (p<.OI). 
Thus, the presence of dipyridamole-induced dyssynergy is 
effective in prognostic stratification of patients early after an acute 
uncomplicated myocardial infarction, even when only survival is 
considered. 
736-2 
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The Prognostic Value of Dipyridamole· 
Echocardiography, Exercise Stress Electrocardiography 
and Coronary Angiography Test in Previous Myocardial 
Infarction 
Silva Severi, Claudio Michelassi, Eugenio Picano, Fabio Lattanzi, 
Palrizia Landi, Antonio L'Abbate. CNR Institute of Clinical 
Physiology, Pisa, Italy. 
Aim of the study was to assess the relative ability of high dose (up 
to 0.84 mglKg over 10') dipyridamole-echocardio graphy test 
(DET) and symptom limited bicycle exercise electrocardiography 
test (EET) in predicting future death in 265 patients (pts) with 
previous myocardial infarction. All pts underwent DET and EET -
on different days and in random order - within 1 week of coronary 
angiography and were followed up for 33±22 months. Criteria of 
positivity were: for DET, a transient worsening or de novo 
dyssynergy; for EET, a ST segment shift >.15 mVoIt from 
baseline. A luminal reduction ~50% in at least 1 major coronary 
vessel was considered significant coronary artery disease. There 
were 11 deaths in the follow-up; 10 deaths occurred in pts with 
positive DET. The univariate analysis was applied to invasive and 
non-invasive variables identified.The Wall Motion Score Index (an 
integrated semiquantitative measure of extent and severity of the 
dyssynergy) at peak dipyridamole was identified as the best 
predictor of death (X2 = 6.4, p<.OI) followed by exercise-time (x2 
= 3.64, p<.05). 
Therefore, in pts with previous myocardial infarction, the extent and 
severity of the dyssynergy induced by dipyridamole identifies pts at 
risk of future death much more effectively than 
exercise-electrocardiography and coronary angiography. 
736-3 9:00 
Prognostic Role of Dobutamine Stress Echocardlography 
Before Noncardlac Surgery 
Patricia A. Pellikka, Jae K. Oh, Kent R. Bailey, Barbara 
A. Nichols, Thorn W. Rooke, A. Jamil Tajik 
Mayo Clinic, Rochester, Minnesota 
Dobutamine stress echocardiography (DSE) was performed in 
144 pts (mean age 68) who were unable to exercise prior 
to major vascular (n=81) or other noncardiac surgery. 
Forty-two pts (29%) had a history of prior MI, 17 pts 
(12%) had angina, and 119 pts (83%) had two or more risk 
factors for CAD. DSE was abnormal in 79 pts (55%): 
infarction (wall motion abnormalities [WMA] unchanged 
with DSE) was demonstrated in 34 pts, ischemia (new RWMA 
with DSE) in 21 pts, and both (rest and new WMA) in 24 
pts. Seventeen (14%) of the 124 pts who underwent 
noncardiac surgery had a cardiac event, including MI in 6 
(1 death), angina in 4, arrhythmia in 6, and heart 
failure in 1. All events except arrhythmia in 1 pt 
occurred in those with abnormal DSE. Of the 20 pts who 
did not undergo noncardiac surgery, 3 of 9 with abnormal 
DSE had cardiac events (bypass surgery in 2, unstable 
angina in 1). The sensitivity of an abnormal DSE in 
predicting cardiac events was 95%, specificity was 52%. 
The risk of a cardiac event in pts with an abnormal study 
was 16-fold greater than in those with normal DSE 
(p<.OOI). Events could not be predicted by clinical 
variables including angina, previous MI, or presence of 
cardiac risk factors. Among those with normal rest 
studies, ischemia by DSE identified 4 of 5 who had 
cardiac events (relative risk 12, p=.003). Among those 
with WMA at rest, ischemia by DSE identified 10 of 15 
with cardiac events (relative risk 3, p=.02). 
Conclusion: 1) Abnormal DSE is an important independent 
predictor of perioperative cardiac events. 2) While WMA 
at rest identifies those at increased risk, demonstration 
of ischemia with DSE confers a further increase in risk. 
lACC Vol. 19, NO.3 
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Comparative Prognostic Value of Rest Two·Dlmenslonal 
Echocardlography, Dipyridamole Stress Thallium Myocardial 
Imaging and Clinical IndiCes For Perloperatlve Cardiac Events 
In Major Nonvascular Surgery Patients 
Bonpei Takase, Liwa T. Younis, Arthur J. Labovitz, Sheila L. Byers, Demis G. 
Caralis, Robert D. Wiens, Bemard R. ChaHman, D. Douglas Miller. 5t. Louis 
University Medical Center, St. LOUis, MO. 
Clinical risk indices (i.e. Goldman class), exercise-induced ventricular 
dysfunction and stress myocardial thallium-201 (n) hypoperfusion (drug or 
exercise-Induced) are recognized markers of Increased perioperative cardiac 
risk in preoperative vascular surgery PIs. The relative prognostic utility 01 
standard resting 2-0 echocardiographic (ECHO) ventricular function 
assessment as col"f1)lred to clinical and SCintigraphic risk stratHication has not 
been determined. We analyzed 36 clinical, SCintigraphic and ECHO variables 
In 52 consecutive major nonvascular surgery (intraabdominal.45%, 
orthopedic.28%. thoracic-9%. other.15%) pts (age 67 ± 13 yrs) 
undergoing preoperative evaluation lor known or suspected coronary artery 
disease (CAD) to determine their relative predictive value lor perioperative 
cardiac events (death, myocardial inlarction. unstable angina, congestive 
heart failure) which occurred in 23% of pts. Dipyridamole-TI redistribution 
defects occurred in 15/52 pts (29%). Resting global and/or segmental ECHO 
LVdyslunction was present in 25/52 pts (48%). Univariate predictors of 
cardiac events were entered for multivariate regression analysis 01 their 
relative prognostic signHicance. Cardiac events were not predicted by 
recognized clinical risk factors or prior myocardial Infarction. The occurrence 
of any cardiac evenf was independently predicted ~ by the presence of 
resting ECHO LV dysfunction (p .. O.Ol) and dipyridamole-n defect 
redistribution (p-0.02). The type 01 perioperative cardiac event was not 
predicted by the preoperative stress n or resting ECHO abnorrnalny. 
We conclude that dipyridamole-TI Imaging and resting 2-0 ECHO LV 
function determination are powerful prognostic tools lor the preoperative 
CAD risk assessment of major nonvascular surgery pts. The preoperative use 
of rest ECHO to detect LV dysfunction is superior to clinical risk assessment, 
and is more widely available than routine dipyridamole-thallium myocardial 
scintigraphy. 
736·5 9:30 
The Prognostic Value of a Normal Dobutamine Stress 
Echocardiogram 
Robin A. Horn, Pamela A. Marcovitz, David S. Bach, Maureen M. 
Stock, William F. Annstrong. University of Michigan, Ann Arbor. 
Ml. 
To determine the prognosis of a normal or non-isch~mic dobuta~ne 
stress cchocardiogram (DSE), follow-up was obtamed on pattents 
who underwent DSE between January and October, 1990. Studies 
were divided into those with resting abnormalities and those with 
normal wall motion at rest. There were 122 patients (62 male) with 
an average fo\1ow-up of 15 months. Events were defined as cardiac 
death, myocardial infarction (MI), PTCA, bypass grafting (CABG), 
admission for chest pain, or CHF. Of 63 patients who had a normal 
resting study and no evidence of ischemia at peak stress. 57 (90%) 
had no events. There were no cardiac deaths, and no 
revascularizations (CABG or PTCA). Six were admined for cardiac 
reasons; 4 for chest pain, 3 of whom underwent cardiac 
catheterization (none with coronary disease) and 1 non-cardiac chest 
pain. One was admined for CHF due to diasto~c dys~unctio~, and 1 
sustained an MI (1.6%). In contrast, of 59 pattents WIth resttng wall 
motion abnormalities but no inducible ischemia, 45 had no cardiac 
events (76%). There were 4 cardiac deaths, 3 of which occurred in 
patients with multiple wal.1 motion abnormalities and r~duced 1:-V 
systolic function, and 1 WIth end stage valwlar heart disease WIth 
pulmonary hypertension. Ten were admined for cardiac reason.s; 3 
were admitted for CHF, 2 with severe resting LV dysfuncllon. 
PTCA or CABG was performed in 5 patients, 4 of whom had limited 
resting abnormalities. Two additional patients with limited resting 
abnormalities sustained non-fatal MI (3.4%), 1 and 13 months after 
DSE. 
We conclude that prognosis following a normal DSE is excellent and 
that adverse events are rare. Conversely, patients with resting 
abnormalities but without inducible ischemia have an increased risk of 
events, the severity of which appears related to the degree of resting 
LV dysfunction. 
ABSTRACTS lOlA 
736·6 9:45 
Can Stress Induced Changes In the Wall Motion Score Indicate the 
Necessity for an Intervention in Patients with Coronary Artery 
Disease? A Stress Echocardiographic Study. 
Klaus SchrOder, Heinz Volier, Birgit Hansen, Roll Schroder. Dept. of Car•
diology. Klinikum Steglitz, Free University Berlin, Germany. 
The increasing success of active intervention methods (PTCA/CABG) 
in patients with a coronary artery dissease (CAD) has created a strong 
demand for imaging techniques not only able to identify coronary 
stenosis but aiso to assess their physiologic significance. Stress echo•
cardiography has been introduced as a usefuli test to assess the pres•
ence and extent of a CAD by inducing new wali motion (WM) abnormali•
ties as an ischemic response to stress. To evaluate Whether changes in 
WM can identify patients (pts) in need of revascularisation procedures, 
we examined 124 pts (32 f, 92 m, mean age 57 yrs) with stress echo•
cardiography (supine bicycle, atrial pacing, Dipyridamole, and/or 
Dobutamine) before an angiography. 26 had a suspected CAD, 67 a 
known CAD with new symptoms, and 31 had an acute myocardial infarc•
tion less than ten days prior to the tests. By dividing the left ventricle into 
15 segments and scoring the WM of each segment (0; normal to 
4;dyscinetic) a wall motion score index (WMSi) could be established. 
RESULTS: 58 pts had a significant CAD (~ 60% stenosis) and recieved 
an intervention (46 PTCA, 12 CABG) following the angiography. We 
compared clinical and historic parameters as predictors of clinical 
outcome lor both groups with and without intervention (group A and B). 
There were no differences regarding age, gender, prior or acute 
myocardial infarction, suspected or known CAD. Stress echocardio•
graphy could significantly differentiate both groups (p" 0.0001) with a 
sensitivity of 94% and a speciflty of 75% to Identify pts in need 01 
revascularisation. The 99% confidence Interval for the stress Induced 
changes in the WMSi showed no overlap for both groups (ranging from 
26-42% in group A and 2·13% in group B, resp.). This difference was 
highly significant (p" 0.0001). 
CONCLUSION: Of all the clinical and historic parameters only the 
stress echocardiography couid significaltly identify those pts In need of 
an active Intervention. The stress Induced changes in the WMSI further•
more clearly assesses the physioiogic relevance of a stenosis. 
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PhoshoUpase D Signaling in Ischemic Heart 
8:30 
Ion I. Moraru, Laurentiu M. Popescu. Xuekun Liu. Nilanjana Maulik, 
Richard M. Engelman, John A. Rousou and Dipak K. Dos. 
University of Connecticut School of Medicine, Farmington, CT 
Enhanced degradation of phospholipids by activation of 
phospholipases A,. and C was shown to contribute to the myocardial 
ischemic and reperfusion injury. We used an isolated perfused rat 
heart model to investigate any possible role of phosphOlipase D (PLD) 
in this process. [14C]arachidonic acid-labeled hearts subjected to 30 
min normothermic global ischemia fo\1owed by 30 min reperfusion 
showed a 49.6±7% increase in isotopic incorporation into phosphatidic 
acid (PA). 100 11M dioctanoylethylene glycol, an inhibitor of 
diacylglycerol kinase, had no effect, but 40 J.1M propranolol. a PA•
phosphatase inhibitor, potentiated this increase to 136±11 %, while 
lowering the amount of ischemialreperfusion-induced diacylglycerol 
(00) generation by 31.2±9%. Microsomal PLD activity assayed 
using [14C]phosphatidylcholine as substrate was 62.3±9% higher in 
ischemiclreperfused hearts. and a similar increase (43.8±8%) was ob•
served when evaluating intact tissue for PLD activity by the trans•
phosphatidylation reaction, measuring the incorporation of [14Clbu•
lanol into phosphatidylbutanol during the 30 min reperfusion. These 
data strongly advocate an ischemialreperfusion.induced activation of 
myocardial PLD with generation of PA and 00 (independent of phos•
pholipase C-generated 00). This PLD-mediated signaling may be 
beneficial since stimulation of PLD with sodium oleate (20 11M) 
attenuated the cellular injury (evaluated by creatine kinase and lactate 
dehydrogenase release in the coronary effluent) and significantly 
improved the functional recovery (monitored by coronary flow and 
left intraventricular pressure measurements) of ischemic hearts during 
reperfusion. 
102A ABSTRACTS 
737·2 8:45 
The Human Myoglobin Promoter Directs Chamber·Specific 
and Transmurally Heterogeneous Transcription in Hearts of 
Transgenic Mice 
William J. Parsons, Randall W. Moreadith, Kathy H. Graves, 
James A. Richardson, R. Sanders Williams. University of Texas 
Southwestern and VA Medical Centers, Dallas, Texas 
Prior studies employing cultured muscle cells indicate that muscle· 
specific expression is conferred by cis elements within the 5' 
flanking region of the myoglobin (MB) gene. To characterize the 
function of the MB gene promoter in a more physiologic context, 
a 2.0 kb MB promoter fragment was fused to an E. coli lacZ 
reporter gene and injected into fertilized mouse oocytes. 
Following sacrifice at a gestational age of 181t days, fetal mouse 
tissues were stained for &·Gal activity and sectioned. Of 12 
offspring, 3 tested positive for the presence of the transgene by 
Southern blotting, and expression of &·Gal was detected in 2 of 
these 3 animals. Staining for &·Gal activity was most prominent 
in the hearts, and also was detectable in skeletal muscle, but not 
in brain, liver, lung or spleen. Skeletal muscle expression was 
more prominent in rostral than caudal muscle groups. Cardiac 
transgene expression was more pronounced within the LV 
subendocardium and papillary muscles than within the 
subepicardium. The LV apex, RV free wall, and atria were 
essentially spared of g·Gal activity. These data indicate that the 
proximal 2.0 kb segment in the 5' flanking region of the human 
MB gene includes cis-acting regulatory elements that determine 
muscle-specific gene expression during prenatal development of 
the mouse. In addition, the distinctive regional distribution of MB 
promoter activity within the heart suggests the presence of 
transcriptional control elements that match MB gene expression 
to transmural heterogeneities in tissue oxygen demand. 
737·3 9:00 
Molecular Cloning and Expression of Platelet· 
Activating Factor Receptor From the Human Ventricle 
Toru Sugimoto, Hidetsugu Tsuchimochi, Takao Shimizu', Yoshihisa 
Kurachi 
Mayo Clinic, Rochester, Minnesota 
'University of Tokyo, Tokyo, Japan 
Platelet-activating factor (PAF) Is an important inflammatory 
mediator, causing cardiac dysfunction and arrythmia. Although these 
actions are believed to be mediated by a receptor In the ventricular 
myocytes, the specific receptor in the cardiac tissues has not been 
identified. As a first step to elucidate the mechanism of the 
interaction between PAF and myocytes, we have cloned a PAF 
receptor cDNA from a human ventricular cDNA library. By 
screening 1 ()6 clones with a polymerase-chain-reaction derived 
probe, three clones were isolated. Two were partial, however, one 
clone (HV3) encoded a full length polypeptide containing seven 
putative transmembrane spanning domains. DNA sequencing revealed 
that HV3 encoded 342 amino acids with a calculated M, of 39219, 
showing 83% identity with the guinea pig lung PAF receptor 
(Nature, p. 342-346. 349. 1991). HV3 hybridized to a 4 kb mRNA 
from the guinea pig atrium and ventricle. When cRNA (synthesized 
in vitro from HV3) was injected into Xenopus oocytes, we observed 
elecrophysiological responses to the application of PAF in a dose 
dependent manner. These results suggest that HV3 Is a functional 
PAF receptor expressed in the human cardiac tissue. Whether HV3 
represents a subtype of PAF receptor specifically expressed in the 
cardiac tissues or is an ubiquitous receptor also expressed in other 
tissues. is now under investigation. 
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Post-Transcriptional Augmentation of Plasminogen 
Activator Inhibitor Type-l (PAl-I) mRNA by Insulin and 
Insulin-like Growth Factor Type-! (IGF-l) in HepG2 Cells 
David J. Schneider, Peter G. Fattal, Charles L. Lucore, 
Joseph J. Billadello and Burton E. Sobel. Washington 
University, St. Louis, MO 
Because increased plasma concentrations of PAI·l occur in 
patients with hyperinsulinemia and may contribute to ac•
celerated vascular disease, we have been characterizing 
modulation of PAI·l gene expression by insulin and IGF-l. 
Initially we showed that insulin and IGF-l synergistically 
increased PAI·l release from HepG2 cells. To determine 
whether the increase reflects altered gene expression and 
would accordingly be amenable to pharmacologic modifica•
tion of insulin dependent PAI·l synthesis the present 
study was performed. In situ hybridization documented a 
9 fold increase (relative to control) in PAI-l mRNA 16 hr 
after exposure of HepG2 cells to insulin (8.7 nM) and 
IGF-l (84.4 nM). To define mechanisms responsible for the 
increase, nuclei from HepG2 cells were isolated 4. 8, and 
16 hr after stimulation with insulin, IGF-l, or both (n = 
2 for each), and nuclear run-on assays were performed. 
Neither insulin, IGF-I, nor both altered the transcription 
rate of the PAI·l gene. Inhibition of transcription by 
Actinomycin D after stimulation with insulin, IGF-l, or 
both demonstrated that insulin and IGF-l increase PAI-I 
mRNA stability reflected by half-life (control a 1.7 hr. 
insulin = 2.3 hr, IGF-l a 2.2 hr, insulin + IGF-I = 5.1 
hr. n = 4 for each). Because the increase in PAlo! mRNA 
induced by insul in and IGF-l is post-transcriptional, 
effects of diverse agonists known to increase PAI-l tran•
scription (such as transforming growth factor-beta), may 
be augmented and contribute to the increased cardiovascu•
lar mortality associated with hyperinsulinemic states. 
737·5 9:30 
Human Growth Hormone Production after In Vivo 
Arterial Gene Transfer in Rabbit Artery: Foreign Protein 
Synthesis Following Liposome Mediated Transrection 
Douglas W. Losordo, Guy LeClerc, Dov Gal, Lawrence Weir. 
Jeffrey M. Isner, Tufts University School of Medicine. St. 
Elizabeth's Hospital, Boston, MA. 
Previous efforts to detect serum levels of foreign proteins produced 
after transfection(TF) of vascular cells in vivo have failed. The 
pmpose of this study was to document the presence in the serum of a 
foreign protein encoded for by a IF gene. The central artery (An) of a 
rabbit(R) ear was selected as L'Ie target site for IF. as this site pennits 
isolation of a selected segment of the Art for both TF and 
measurement of protein production. We used the plasmid vector 
pXGH5(6.7kb) containing the mouse metallothionein-I(mMT-I) 
promoter driving the human growth hormone(hGH) gene. The 
efficacy of this plasmid has been previously demonstrated in vitro in 
a variety of cell lines. Levels of hGH were determined with a highly 
sensitive (O.lng/ml) commercially available bioassay. The circulation 
of both ears of New Zealand white R were isolated by applying a 
tourniquet to the base of the ear. The proximal central An was 
cannulated as was the dorsal lateral vein (V). Serum free medium was 
irrigated through the arterial cannula until all blood was removed 
from the An. A solution of plasmid DNA and Jipofectin was then 
infused through the Art canula. After 20 mins the cannulae and 
tourniquet were removed. Since the mMT-TI promoter is induced by 
heavy metals such as cadmium and zinc the water supply of IF R 
was supplemented with zinc sulfate. After 4&5 days the circulation to 
each ear was again isolated using a tourniquet and after 20 minutes 
the An and V were canulated for blood sampling. Contralateral ear 
was isolated in identical fashion for transfection and blood sampling 
and was used as control. IF of 90ILg of plasmid DNA resulted in 
3.0ng hGH/ml serum vs 0.18ng/ml measured in the non-TF 
contralateral ear. TF with 3D1Lg DNA resulted in hGH level of 
O.3nglml in IF An vs 0.18 in control. Conclusion: hGH production 
is detectable in the serum after IF of rabbit An with 90ILg plasmid 
DNA containing the hGH gene. 
JACC Vol. 19, No.3 
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Influence of Vascular Proliferation on In Vivo Gene 
Transfection of Canine Arterial Walls 
Dwight D. Stapleton, R. Wayne Barbee, Bret D. Perry. Joseph P. 
Murgo, Richard N. Re, Julia L. Cook. 
Ochsner Medical Institutions, New Orleans, Louisiana 
The influence of myointirna1 proliferation on in vivo gene expression 
was examined in canine arterial wall segments. The experimental 
design involved two groups of animals, one of which underwent 
manual denudation of femoral arterial segments (n=5) followed by 72 
hours of vascular proliferation, while the other group underwent direct 
in vivo transfection without prior denudation (n=6). Subsequently, 
50 meg of SV 40 (simian virus) promoterlluciferase construct was 
infused together with 90 mcg lipofectin in 1 ml for 30 minutes. 
Arterial segments were harvested 48 hours following transfection in 
both groups and were assayed for luciferase activity (relative light 
units, mean ± SEM). Luciferase activity was compared with 
background as well as transfection without prior denudation. Results: 
Luciferase Activity 
A B C 
Relative In I~NoPrt?r I~ 
Light Units 244±4 570±69 3052 ± 620 
n/group n= 13 n=6 n=5 
pg).OOOI (Group A vs B; Group A vs C); pg).OO2 (Group B vs C) 
Thus, successful in vivo transfection occurs without prior denudation. 
However, with denudation and subsequent myointimal proliferation, 
luceriferase activity is increased five-fold (570 ± 69 vs 3052 ± 620; 
pSO.OO2). 
Conclusion: Luciferase activity is significantly elevated when smooth 
muscle cell proliferation occurs prior to transfection. This result has 
significant implications for manipulation of in vivo gene expression in 
previously damaged arterial segments such as would occur with 
percutaneous transluminal coronary angioplasty. 
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Reduction in Mortality by Adding Aspirin 
(100 Mg) to Oral Anticoaqulant. in Patients 
with Heart Valve Replacement 
Alexander G.G. Turpie, Michael Gent, Andreas 
Laupacis, Yves Latour, John Gunstensen, Fadi 
Basile, Marian Klimek, Jack Hirsh. McMaster 
university, Hamilton, University of Western 
ontario, London, Hotel Dieu, Montreal, Canada 
A double-blind, randomized trial was 
carried out to compare the relative safety and 
efficacy of aspirin (ASA: 100 mg/day) with 
placebo in the prevention of systemic embolism 
or vascular death in patients with heart valve 
replacements (HVR) treated with warfarin (INR 
3.0-4.5) • 370 HVR patients were put on 
warfarin and randomized to receive ASA 100 
mg/day (186 patients) or placebo (184 
patients) for up to 4 years. The outcomes of 
the study were systemic embolism, vascular 
death or hemorrhage. The results indicate that 
adding ASA 100 mg to warfarin (INR 3.0-4. 5) 
reduces mortality, vascular mortality or major 
embolism but with some increase in hemorrhage. 
ASA+WAR PLAC+WAR p 
(l-tailed) 
Emb/Vasc Death 6 (3.2%) 24 (13.0%) 0.0004 
Major Embolism 5 (2.7%) 13 (7.1%) 0.0419 
Vasc Death 2 (1.1%) 13 (7.1%) 0.0030 
Mortality 9 (4.8%) 22 (11.9%) 0.0106 
Hemorrhage 72 (38.7%) 48 (26.1%) 0.0064 
Major Hemorr 24 (12.9%) 19 (10.3%) 0.2708 
ABSTRACTS 
738·2 8:45 
Acute, Non-invasive, Ultrasound Guided Repair of Vascular 
Injuries Following Cardiac Catheterization 
J. Peter Longabaugh, Joseph Kisslo, Duke University 
Medical Center, Durham, North Carolina 
To test the hypothesis that vascular injuries following 
cardiac catheterization could be treated non-invasively, 
22 consecutive injuries identified in a 5 month period in 
2,363 procedures, (patient incidence: 0.85%) were evaluated 
for ultrasound (US)-guided external compression. These 
included 16 pseudoaneurysms (PA) and 6 arteriovenous 
fistulas (A VF) in 20 patients (2 patients had both A VF and 
PAl. The injuries were noted 2.2 + /- 1.91 days (range 0-6 
days) after catheterization in 20 patients with a single 
outlier at 41 days. All underwent the following 
procedure: The arterial connection (AC) of the PA or A VF 
was precisely located using a 4.5 MHz linear array US probe 
with Doppler color flow imaging. A C-c1amp was then 
positioned directly over the AC and compression was applied 
until the distal arterial flow velocities as measured by 
pulsed-wave Doppler were decreased to one-fifth of the 
original value. Compression was applied for intervals of 
30 minutes and US examination of the AC was repeated after 
each interval. This was carried out for a maximum of 4 
intervals or until Doppler evidence of P A or A VF flow was 
no longer evident. 
All 16 PAs (100%) responded to this treatment by 
thrombosis of the P A cavity and cessation of P A flow as 
demonstrated by US immediately after the end of 
compression. Three of 6 (50%) of A VFs were similarly 
closed. These findings persisted in follow-up examinations 
done 18-24 hours after treatment. These data indicate that 
iatrogenic groin artery injuries, especially PAs, can be 
effectively and non-invasively treated usmg ultrasound 
guided external compression. 
738-3 9:00 
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Atherosclerotic Disease Evolution by Picotamide 
in patients with peripheral vasculopathy (PV). 
rrancesco Violi, Giovanni Leproux and Francesco 
Salsano on behalf of ADEP group 
I Cl inica Medica, Universita' liLa Sapienza ll , 
Rome. Italy. 
In a double-blind placebo-controlled study we 
investigated if Picotamide, an antiplatelet drug 
which inhibits thromboxane (Tx) A2 synthesis and 
antagonizes TxA2 receptors, reduces the vascular 
accidents occurring in PV patien:s. After a one 
month run in 2313 patients were randomly alloca•
ted to take placebo or Picotamide (300mg t.i.d.) 
and followed-up for 18 months. Vascular and non 
vascular death, major stroke, definitemyocar•
dial (MI) and amputation were considered major 
events; effort and at rest angina, probable or 
possible MI, TIA, PV deterioration, minor stroke, 
DVT and severe hypertension were considered 
minor events. During follow-up 177 patients droE 
ped out.Major and minor events were 4.3 and 6.7% 
respectively in the group taking Picotamide and 
4.5 and 9.7 respectively in the group taking pl~ 
cebo.Total events were 11% in the group taking 
Picotamide and 14.2% in the group taking placebo 
(chi-square p<.O.04). This finding indicates 
that Picotamide protects against cardiovascular 
complications and gives support to the use of 
antiplatelet treatment in claudicant patients. 
104A ABSTRACTS 
738·4 9:15 
RecOibinant Desulfato Hirudinl a Specific Antithrombin, in Patients with Chronic, StlDle Coronary Disease: 
Effect on He.ostatic Para.eters 
Pierre Zoldhelyi James H. Chesebro Mark W.I. Webster, 
Diane E. Grill, Dawn Gaspar, Susan J. Edwards, Catherine 
F. Cabot, Valentin Fuster. Mayo Clinic, Rochester, MN 
In animal studies. recombinant desulfato hirudin 
(CGP39393, "hirudIn") prevents fibrin and platelet-rich 
arterial thrombosis at activated partial thromboplastin 
times (aPTT) of 2-3 x baseline. We evaluated the 
hemostatic parameters in 39 patients with chronic, 
stable coronary artery disease in a single-blind 
ascending dose, placebo-controlled study. Throm6in time 
(TTl, aPTT, prothrombin time (PT), and bleeding time 
(BT) were measured in sec before, during and for 1S 
fiours after a 6 hour infusion of hirudin or placebo. 
Antiplatelet drugs were stopped 7 days prior to the 
study. Partial results (mean±SEM) are shown below: 
Hirudin lIg/kg/h 
Placebo 0.02 0.05 0.10 0.20 0.30 
n 9 6 666 6 
aPTTf1hj 29±1 46±4~ 46±4* 59±2*t 75±4*t 7S±4* 
6h 29±1 47±6* 53±3* 67±2*t 77±4* 90±6* 
Sh 29±1 39±4* 40±3* 4S±2*t 53±3* 63±5* 
TTf6h} 23±1 >600* >600* >600* >600* >600* 
BT 5.5h) 225±22 315±5 250±3S 269±26 303±27 271±16 
PT 6h} 11±.3 12±.2 12t.3* 13±.5* 14±.2* 16±.4*t 
*p<0.05 compared with placebo, tp <0.05 compared with 
prior dose, iin 4 of 6 patients, aPTT upper normal = 40 
The only side effect was mild bruising at a 
venipuncture site in one patient receiv1ng 0.1mg/kg/h. 
No antibodies to hirudin were detected 2 weeks after the 
infusion. The anticoagulant effect of hirudin was best 
reflected in the prolongation of the aPTT with a near 
linear dose-response at the dosages tested. 
A short-term Infusion of hirudIn is safe and well•
tolerated at dosages of up to 0.3mg/kg/h which prolonged 
the aPTT to 3.0 x baseline (or 2.2 x the upper normal 
value). Hirudin offers a potentially high benefit to 
risk ratio in the treatment of arterial thrombosis. 
738·5 9:30 
Propionyl Carnitine Improves Walking Capacity in Patients 
with Intermittent Claudication 
Gregorio Brevetti,Sergio Perna and Mario Condbrelli with 
the cooperation of Albano O. ,Andreozzi GM., Bianchi V., ~ 
sella G. ,Consolo F. ,Manganaro A. ,Di Sornra G. ,Marcialis A. , 
Romeo S.,Simonelli P.,Tuscano G.,Vecchiati P. 
Depart:Jrent of Medicine,2nd Medical School,University Fede 
rico II,Naples,Italy. -
In a previous acute study ,propionyl carnitine(PC) was found 
to be rore effective than L-carnitine in improvingwalking 
capaci ty( CW) in patients (pts) with intenni ttent claudica 
tion<IC)' In this double-blind,placebo(P) controlled,muiti 
center study, the efficacy of chronic treat:rrent with PC ~ 
assessed in 245 pts with IC. The initial dose of 19/day p. 
o. was increased,at an interval of 2 m:mths,to 2g/dayand, 
then, to 3g/ day in pts showing improvenent in treadnci.ll peE. 
formance <30% over baseline. Results were analyzed by the 
intention to treat approach. After 6 llDnths of therapy,rna 
ximal WC increased both in P(n=127)and PC(n=118)group,•
from 244±10 to 360±16 m,and from 242±l0 to 417±17 m,respec 
tively. However,improvement with PC(92±10%) was higher -
(p <.02) than that with P(53±l0%). Increase in WC >50%was 
observed in 34 pts(27%) of P group and 61 pts(52%) of PC 
group(p <.01). Treat:rrents did not affect ankle/arm systo 
lic blood pressure ratio both at rest and after exercis;. 
Drop-outs were 11 in P and 20 in PC group. Adverse events 
were 10 in P and 13 in PC group. The final average dose 
of PC was 2.04±,02g/day. Thus this study suggests that PC 
rnay be a safe and effective treatment in patients with IC, 
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Exclmer Laser Thrombolysis for Rapid Clot Dissolution In 
Lesions al High Risk for Embolization: A potentially Useful 
New Application for Exclmer Laser 
Kenneth Rosenfield, Ann Pieczek, Douglas W. Losordo, Bernard D. 
Kosowsky, K. Ramaswamy, John O. Pastore, Jeffrey M. Isner, Tufts 
University SChool of Medicine, St. Elizabeth's Hosp~al, Boston, MA 
Direct and systemic thrombolysis using pharmacologic agents may Involve 
prolonged, high-risk infusion, and thrombus dissolution is often 
incomplete. Furthermore, primary mechanical recanalization via balloon 
angioplasty (BA) in the presence of residual thrombus can resu~ In further 
platelet stimulation and thrombosis, or distal embOlization. While 
mechanical thrombolysis using uHrasound and rotational atherectomy have 
shown promise, no one modal~y has proven to be a reliable,low-risk means 
for rapid recanalization of thrombotic lesions. 
Preliminary laboratory evidence suggests that 308nm exclmer laser energy 
effectively lyses clot; however, little Clinical data is available describing ~s 
use in vivo for thrombolysis. Therefore, we performed excimer laser 
thrombolysis (EL T) as a means of residual thrombus dissolution in 6 
patients (2 coronary grafts, 2 dialysis fistulae, 1 in-situ and 1 reverse 
saphenous vein femoral-popl~eal graft). In 3 pts, trad~ional pharmacologic 
thrombolysiS was contraindicated; the remaining 3 pts had received 
prolonged infusions of a thrombolytic agent (2 direct, 1 systemic), but had 
signHicant residual clot. In all cases, high risk of clot dislodgement and 
distal embolization precluded simple BA. Mean thrombus age was 
estimated at 33 days (range 3 to 84). In 4 pis, thrombus was <14 days Old. 
The 308 nm excimer laser source was coupled to 1.7 (3 pts) or 2.2 (3 pts) 
mm laser catheters. Mean irradiation time was 84 seconds (range 12 to 
185), al lIuence of 40 and/or 50 mJoules/mm2 and frequency of 25 
pulses/second. Results: Thrombus dissolution was successfully 
accomplished in all 6 pIs. Subsequent BA resulted in excellent 
recanalization. No evidence of distal emboli was present, e~her following 
ELTor BA. Conclusion: Preliminary experience wtth ELT suggests thaI 
tt can accomplish rapid Ihrombus dissolution and minimize risk of embolism 
during subsequent BA in high-risk pts. This novel application of excimer 
laser may be useful in cases where rapid recanalization is Imperative, or 
where pharmacologiC Ihrombolysis Is contraindicated or Ineffective. 
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Early Treatment Diabetic Retinopathy Study (ETDRS) 
Aspirin Effects on Mortality and Cardiovascular 
Morbidity 
Genell L. Knatterud, Thaddeus E. Prout, Lloyd M. 
Aiello, and Frederick L. Ferris for ETDRS Research 
Group, Maryland Medical Research Institute, Sal timore, 
Maryland 
The ETDRS is the largest multicenter placebo-con•
trolled study (N - 3,711) of aspirin (650 mg per day) 
therapy in patients with diabetes. insulin-dependent 
and non-insulin dependent. The average follow-up in 
the ETDRS was five years (minimum, four years; 
maximum, nine years). 
The estimate of relative risk (RR) for total 
mortality (the primary end point for evaluating 
systemic effects of aspirin) for aspirin-treated 
patients (N - 1856) compared with placebo-treated 
patients (N - 1855) for the entire study period was 
0.91; this small reduction was not statistically 
significant by study criteria. Larger differences 
were noted for the occurrence of fatal and non-fatal 
myocardial infarction (MI); estimate of RR was 0.84 
for the entire period of follow-up, p - 0.04. During 
the first five years of follow-up, the estimated 
reduction in risk of myocardial infarction was 28', 
(1. e., RR - 0.72, 99% confidence interval 0.51 -
0.95). 
The effects of aspirin on any of the cardio•
vascular events considered in the ETDRS were not 
substantially different from the effects observed in 
other studies which included diabetic and non-diabetic 
patients, although the evidence of beneficial effects 
was not as large as in some of the studies. Further•
more, ETDRS results suggest that the indications for 
aspirin use are the same in persons with and without 
diabetes mellitus. 
JACC Vol. 19, No.3 
March 1, 1992:105A 
739·2 8:45 
Circadian Variability of Sudden Cardiac Death Is 
Caused by Age Dependent Variations In the 
Incidence of Ventricular Fibrillation 
Richard Arntz, Michael Oeff, Matthias Deppermann, Matthias 
Jereczek, Luise Schnitzer, ROdiger Dissmann, Wulf Storch, 
Richard Stern, Anette Heinzmann, Benedikt Matenaer. 
Free University Berlin, Klinikum Steglitz, Berlin, Germany 
Previous studies report an early morning peak of sudden out 
of hospital cardiac death (SCD), but lack detailed information 
on underlying arrhythmias. To investigate the circadian 
pattern of particular arrhythmias causing SCD, we analyzed 
515 cases of SCD of non traumatic origin, in whom the 
underlying arrhythmia was recorded by the documentation 
system of the semi-automated defibrillator used in the Berlin 
EMT-D program. 
Results: An early (6 to 12 am) and a late (3 to 10 pm) peak 
was found in the SCD incidence. The two maxima in inci•
dence are caused by an identical two peak distribution of the 
211 cases with ventricular fibrillation (VF) as the initially docu•
mented arrhythmia (hours of maximal incidence compared to 
the minima p<0.001 ).The two peaks of VF differ distinctly with 
regard to patients age: the morning peak consists mostly of 
patients with an age >70, the evening peak of those <56 
years (p<0.001). In contrast to VF, asystole (n=190) and other 
arrhythmias (n=114, most having electro·mechanical disso•
ciation or high degree AV-block) were equally distributed 
over the daytime and showed no age dependency. The 
circadian variation of SCD (irrespective of underlying 
arrhythmia) was indenpendent of gender. 
Conclusion: A two peak pattern in incidence of SCD was 
found which is caused by age dependent variations in the 
incidence of VF. The age dependency may reflect a different 
pathogenesis of VF. 
739·3 9:00 
Sex and Short-Term Prognosis after Q Wave and Non·Q 
Wave Myocardial Infarction: The Minnesota Heart Survey 
Jasenka Demirovic, Paul McGovern, Richard Crow, Henry Blackburn 
School of Public Health, University of Minnesota, Minneapolis, MN 
It Is widely reported that short-term prognosis for women suffering 
an acute myocardial infarction (AMI) is worse than that for men. 
Less Information is available on sex differences in prognosis related 
to the type (0 vs. non-O wave) and location of AMI. To assess these 
Issues,we examined retrospectively a 50% random sample of all AMI 
cases hospitalized in 1980 and 1985 in 30 Twin Cities metro area 
hospitals (N=1619, 442 women and 1177 men). The AMls were 
validated by a standardized algorithm based on chest pain, enzymes, 
ECGs (coded by the Minnesota Code), and autopsy. A majority of 
cases were classified as 0 wave AMls (76.8% of male and 68.3% of 
female, p<O.OI). Age-adjusted early mortality (within 28 days of 
hospital admission) after a 0 wave AMI was significantly higher in 
women than in men (14.3 % vs. 8.1%, p<0.007). A Similar but not 
significant sex difference was found in mortality after non-Q AMI 
(15.8% vs.l0.0o/., p>0.5). The overall sex difference in short•
term prognosis after 0 wave AMI was not a function of the particular 
location of 0 wave AMI (interaction test X2 .1.5, P > 0.5).The sex 
difference persisted after adjustment for the history of AMI, angina, 
coronary artery bypass graft surgery, hypertenSion, and diabetes 
mellitus (p<O.OI). After stratitying the AMI population by age «65 
and ~ 65) we found that the female/male difference in mortality 
after 0 wave AMI was significant only at ages below 65 (13.3% vs. 
4.6%, p<O.OOI). Moreover, a similar sex difference in this age 
group eXisted for non-O AMI (13.6% vs. 4.7%, P = 0.04 ). Multiple 
logistic analysis including 15 baseline characteristics indicated 
that below age 65, female sex but not the type of infarct was an 
independent predictor of early death after AMI (odds ratio 2.0, 95% 
CI 1.2-3.5, p<O.OI). We conclude that the sex difference in short•
term prognosis after AMI is not a function of type of infarct. 
ABSTRACTS 
739·4 9:15 
CHRONIC COCAINE ABUSE IS ASSOCIATED WITH 
ACCELERATED ATHEROSCLEROSIS IN HUMAN 
CORONARY ARTERIES_ 
Eric 1. Eichhorn.M,D .. F,A.C.C .. Elizabeth Peacock, M.D., Paul 
A. Grayburn, M.D., F.A.C.C., John B. Bedotto, M.D., John E. 
Willard, M.D., James T. Willerson, M.D., F.A.C.C., Saba E. 
Demian. University of Texas Southwestern and VA Medical 
Centers, Dallas, Tx. 
We have previously demonstrated dysfunctional coronary responses 
to acetylcholine infusion in cocaine abusers and a disproportionate 
increase in thromboxane A2 production with cocaine use in rabbit 
aorta. Thus, we hypothesized that cocaine abuse is associated with 
histologic abnormalities in human coronary arteries. We 
prospectively examined 1143 consecutive medical examiners cases, 
and found 24 cocaine abusers. We blindly compared coronary cross•
sections of this group to 14 age and sex matched cases who did not 
use cocaine. A cross-sectional obstruction score was assigned to 
each specimen. There were no differences in age (27±6 vs. 30±8 
years, p=NS) or sex (12/14 males vs 21/24 males, p=NS). The 
mean obstruction in the cocaine group (n=71 sections) was 25 ± 
29% as compared to controls (n=42 sections) 13 ± 12% (p=O.OO8). 
While there were no differences in the incidence of atherosclerosis 
(43% control patients vs $0% cocaine patients, p=NS), there was in•
creased atherosclerotic obstruction in the cocaine group (52 ± 34% 
vs 21 ± 12%, p=O.015). There were no differences in the incidence 
of intimal proliferation or obstruction scores in these arteries. 
Additionally, we found an increased heart mass in the cocaine 
abusers (211 ± 51 vs. 175 ± 22 gm/m2, p=O.021). 
Conclusions- Cocaine abusers have associated accelerated 
atherosclerosis. This may predispose to vasoconstriction and 
thrombus development while an increased myocardial mass may lead 
to decreased coronary flow reserve and increased oxygen demands. 
739·5 9:30 
The Elrect or Aspirin Use on Mortality In Post-Myocardial Wan:tlon 
Smokers In the Program on the Surgical Control or the Hyperllpldemlas 
(POSCH) 
Laurie L. Fitch, John P. Matts, James W. JohnsoD, ChristiaD T. Campos, 
Henry Buchwald 
University of Mim1esota, MiDDeapolis, MN 
The effect of aspiriD use on total mortality (I'M) IlI1d coroaary beart disease 
mortality (CHD) ill cigarette smokers from the low-fat diet control group of 
the POSCH trial was examilled. All subjects had survived one myocardial 
infarctioD, were between the ages of 30-64 years, IlI1d bad elevated total 
cholesterollll1d/or LDL cholesterol. Patients wbo reported lakin;! 
dipyridamole, beparin, or warfarin were omitted from this llI1a1ysis ill order to 
control for the possible confounding effects of these medications. Average 
foDow-up time was approximately 10 years. The percent of foDow-up time the 
subject reported taking aspirin was calculated IlI1d TM IlI1d CHD for the 
resulting groups determilled. 
%TM 
%CHD 
Percent of FoDow-up Time Aspirin Used 
0% 1-49% 50-79% ~% 
(n = 42) (n=20) (n=14) (n=14) 
45.2 
35.7 
15.0 
5.0 
7.1 
0.0 
7.1 
0.0 
TM IlI1d CHD were significantly lower ill aspirin users compared to 
non-aspirill users (p<0.OO1 by Fisher's exact test). The risk of deatb for 
post-myocardial infarction cigarette smokers was dramatically reduced by 
aspirin use over a period of almost 10 years IlI1d was apparent even wben 
patients took aspirin < 50% of the time. 
105A 
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Oifferences in Left Jlain Coronar,. Arter,. Length in 
AfrlclID7~ricans VeMlus Whites: AD ADatOllic Baais for 
Racial Differences in Coronar,. Disease Presentation? 
Sally Caapbell. Thoaas A. Pearson. 
M.l.Bassett Hospital. Cooperstown, New York. 
AfriclID-Aael'icans (AA I have higher rates of coronary 
heart disease (CHDI thllD whites (WI at ages less than 55 
years, with especially high rates of sudden death. 
However. the reason for these differences is unknown. 
One distribution of CHD associated with sudden death is 
len .ain disease, which in turn is associated with the 
len«th of the left &ain coronary arterial se,.ent 
(LMCA I. To exaaine whether UlCA lengths differed 
between AA and W, we coapared the lengths of the LMCA 
aeasured during coronary arteriography in 49 AA Ben, 31 
AA woaen, 637 W aen and 257 W woaen. The UlCA lengths 
were aeasured in two arteriographic views, using the 
catheter diaaeter as an internal standard. The 
frequency distribution of AA Ben vs W aen. IIDd AA WOBen 
VB W woaen showed the LMCA length distribution shifted 
to the ri«ht in AA adults with a suggestion of a biaodal 
distribution. 
__ 1Iean LMCA !&ggth 1+ IS.!;!l 
-',1>- _W_ L 
WOBen 11.61 8.41 .01 
Men 12.94 9.68 .01 
LMCA len«tb is si«nificantly longer in AA thllD in W. 
This lIDatoBie feature could predispose AA to left aain 
disease. Additional studies are needed to explore the 
iaplications of these anatoaie differences between AA 
and W. 
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740·1 
Echocardlographlc Features of Familial Amyloidosis 
8:30 
David A. Foley. Lyle J. Olson, Morie A. Gertz, Robert A. Kyle, A. Jamil 
Tajik, and James B. Seward 
Mayo Clinic and Mayo Foundation, Rochester, MN 
Familial amyloidosis (AF) is a rare Inherited disorder with variable cardiac 
involvement. It is characterized by amyloid deposits composed of genetic 
variants of transthyretin. The incidence and prognostic value of echocar•
diographic findings in a heterogenous group of AF patients have not been 
,,,ell defined. We therefore reviewed our experience with 40 patients with 
Ar: (31 males; ages 34-n yrs). All patients had biopsy proven amyloidosis, 
and AF was documented by at least one of the following criteria: history 
of a first degree relative with AF, identification of variant transthyretin, or 
identification of transthyretin in amyloid depoSits. Four pairs of siblings were 
studied. All other patients were unrelated. Based upon previously published 
criteria, 26 patients (65%) had definite findings of cardiac amyloidosis (CA) 
on their initial echocardiogram, 5 patients had possible CA, and 9 patients 
had no evidence of CA. Patients with CA were older than those without CA 
(mean-54 yrs vs. 55 yrs, p<0.05). Of the patients with definite CA, the 
LV wall thickness was increased in all (16.9 ± 3.4 mm), n% had abnormal 
myocardial texture, n% had increased RV wall thickness, 65% had atrial 
enlargement, and 31% had a pericardial effusion. The LV ejection fraction 
was hyperdynamic (~70%) in 15%, normal in 46%, and mildly to moderately 
reduced (30-52%) in 39%. LV diastolic function was assessed by Doppler in 
20 patients and was abnormal in 65%. No patient had electrocardiographic 
evidence of ventricular hypertrophy and 9 had low voltages. Patients were 
followed for a median of 33.5 mos (range Q-81 mos). Nine patients died: 7 
had echocardiographic evidence of CA. Of the 15 patients with definite CA 
seen before 1989 (including all 7 deaths), the median survival was greater 
than 38.5 months. This is significantly better than the published median 
survival (10.3 mos) of patients with CA in AL. 
Conclusions: 1. Echocardiographic evidence of cardiac involvement is 
common in AF (65%). 2. The spectrum 01 echocardlographic findings in AF 
is similar to that reported for AL. 3. Survival in AF with cardiac involvement 
is better than that reported in AL. 
JACe Vol. 19, No.3 
March 1, 1992:106A 
740·2 8:45 
Clrculltlng Levels of Soluble T Cell "Irkers Correllte With the 
Cllnicil State In Primary Dilated Cardiomyopathy 
GOnter KJappacher, Senta Graf, Richard Pacher, oW. WoIuszczuk, Dietmar 
GIogar. 
Departments of Cardiology and "Medicine II, Universiy of Vienna, Austria. 
The circulating levels 01 four soluble T cell markers (soluble IL-2 
receptor (sIL-2Rj, soItmie CD4 (sCD4), B2-rnicroglobuUn and neopterln) were 
significantly elevated In 36 patients with invasively diagnosed primary dilated 
ca'diomyopathy (DCM) compared to 30 age- and sexmatched controls. 
Moreover patients In NYHA functional classes III and IV had higher serum 
values than incividuals In NYHA fur1ctional class II. 
NYMAIII+IV NYMAII PVALUE 
(N=11) (N=2S) 
sIL-2R (UhTl) 771.2±85.S 516.4±38 <0.005 
sCD4(Uhn~ 28.7±4.7 13.4±2.1 <0.0025 
B2-rnicroglObulin (mWl) 2.7±0.3 1.B±0.1 <0.001 
neopterin (nmoVltter) 1'.S±I.7 8.3±0.7 <O.OS 
Vice versa patients with high cn:ulating levets of all four soluble T cell 
markers (i.e. more than mean + 2 SO of control groups) were in advanced 
clinical stage. SIL-2R, sCD4, 82-rnicroglobulin as well as neopterln correlated 
significantly with various hemodynamic and ctinical values. The table below 
shows the compariSon of ~oups for 82-microgiobulin. 
SERUM 82M: HIGH(N=12) LOW(N=24) P VALUE 
NYHA furlcIionaIciass (III+IV III) 7/S 4/20 0.01 
uosemlde (mg/day) 121.4±4S.S 21±S.2 <0.01 
plasma renin (nglmllhr) 26.1±4.8 8.2±2.2 <0.001 
left ventricular ejection fraction 0.14±0.03 0.24±0.02 <0.02S 
serum sodium (mmolll) 140.6±1.2 143.9±0.5 <0.01 
serum biliniline (mg/dl) 1.4±0.3 O.StO.l <O.OOS 
BUN(mg/d~ 20.7±1.9 14.9±0.7 <0.005 
Conclusion' Significant T cell activation was associated with disease 
progression In prinary DCM. Like neurollormones or hemodynamic values, 
serum soll.i:lle T cell markers can be used to monitor the ctinical course. In the 
context of the hypothesized autoimmune pathogenesis these data support 
T cell stimulation to be a relevant pathophysiologic mechanism In primary 
oeM. 
740·3 9:00 
Description of a new maternally-inherited 
mitochondrial cardiomyopathy: biochemical, morphologic 
and functional cheracterization. 
Fabrizio Villani, Milena Galimberti, Lionella Pizzini, 
Patrizia Piotti, Flavio Crippa, Carlo Antozzi(*), 
Dionisio Pelucchetti(*), Lucia Morandi(*), Cinzia 
Gellera(*), Massimo Zeviani(*). 
Cardiorespiratory Physiopathology Department, National 
Cancer Insti tute, Milan j (*) Neurologic Insti tute G. 
Besta, Milan, Italy. 
We describe a large pedegree affected by a new 
maternally-inherited mitochondrial disorder clinically 
characterized by combination of adult-onset myopathy 
and cardiomyopathy. Muscle speciem from all maternal•
relative of pedegree showed ragged red fibers. 
Biochemical investigation showed a combined defect of 
complex I and complex IV of the muscle respiratory 
chain , An heteroplasmic new point mutation was found 
at the pOint 3260 in the mitochondrial DNA (mtDNA), 
One patient died for hypertrophic heart failure and 
four other patients showed subclinical heart failure. 
We demonstrated a significant correlation between the 
amount of mutated mtDNA genoma (biochemical defect of 
respiratory chain) and physiometabolic and biomedical 
feature during exercise test (maximun oxygen 
consumption, left ventricular contractility and 
exercise tolerance). These data support the hypothesis 
that the described mutation is the genetic cause of 
the myopathy and suggest the possibility that lesion 
of mtDNA should be considered in the differential 
diagnosis of hereditary cardiomyopathies. 
JACC Vol. 19, No.3 
March 1, 1992:107A 
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Right Ventricular Involvement Predicts Arrhythmic Sudden 
Death In Patients With Idiopathic Dilated Cardiomyopathy 
and Relatively Preserved Left Ventricular Function 
Francesco Pelliccia. Cinzia Cianfrocca. Antonio Nigri. Francesco 
Romeo. and Raffaele Bugiardini. Inst. of Patologia Medica. Univ. 
of Bologna and Dept. of Cardiology. Univ. of Rome. Italy 
Death In Idiopathic dilated cardiomyopathy (lDC) is often related to 
an arrhythmic episode rather than an aggraviation of the underlying 
mechanical deficit. Accordingly. we attempted to sort out which 
factors predispose to arrhythmic sudden death (SO) in 73 pts 
(mean age:43;1;13 yrs) found to have IDC and a relatively preserved 
ejection fraction (>30% but <50%). Pts were followed lor 1 up to 2 
yrs. All pis were treated with digoxin. diuretics and vasodilators. 
During follow-up. 13 pts died. Instantaneous unexpected death 01 
the type presumed to be caused by arrhythmias was documented in 
10 pts (Gr.A). The remaining 60 pis (Gr.B) had a benign outcome. At 
baseline assessment. ejection fraction. cardiac index. and LV 
dimension did not significantly differ between the 2 groups. 
Conversely. Gr.A pts had a higher (p<O.OO1) incidence of 
nonsustained ventricular tachycardia during 48-hour ECG 
monitoring (50% vs 9%). a greater (p<O.OOOl) increase in mean 
right atrial pressure (12;1;5 vs 5.:1:.3 mm Hg) and RV end-diastolic 
pressure (11;1;4 vs 7.:1:.3 mm Hg). and a larger (p<O.OOOl) RV end•
diastolic diameter (32.:t.3 vs 19;1;5 mm). as compared with Gr.B pts. 
Noteworthy. a RV end-diastolic diametera30 mm (Kaplan-Meyer 
analysis) was detected in 9110 Gr.A pts but only in 1160 Gr.B pts 
(p<O.OOOl). Multivariate analYSis showed that RV end-diastolic 
diameter was the most powerful predictor of SO (p=O.OOOl). It was 
followed in predictive power by the occurrence of nonsustained 
ventricular tachycardia (p=0.02). In conclusion. (1) pts with 10C may 
manifest different degrees of RV dilatation; (2) the presence of 
disproportionate (a30 mm) RV dilatation appears to precociously 
identify a subset of pts with less severe hemodynamic derangement 
but at high risk of arrhythmic SO. 
740·5 9:30 
Differential Sensitivity of Myocardial Oxygen Consumption to Changes 
in Pulsatile and Steady Power Output in Dilated Cardiomyopathy. 
Richard Marcus. lynn Weinert. Alex Neumann. Kenneth Borow. 
Roberto lang. University of Chicago. Chicago. IL 
l V systolic load. a major determinant of myocardial oxygen 
consumption (MVO,), is a function of the coupled interaction between 
ventricular factors (internal load) and the impedance properties of the 
arterial system (external load). Arterial impedance properties also 
determine the distribution of the totallV power output (PT) into 
pulsatile (Pp) and steady components. It is therefore conceivable that 
for a given PT' changes in the P,JPT ratio might impact on MVO,. This 
hypothesis was studied in 5 patients with dilated cardiomyopathy 
(DCM) in which reduced systolic reserve renders the heart more 
sensitive to changes in arterial load. Cardiac output. PT and !'p/PT were 
altered by infusions of dopamine (2 and 6 Poiko/min). dobutamine (5 
pg/kg/min), amrinone 15pg/kg/min and nitroprusside (2 pg/kg/min. 4 
pts). PT and Pp were determined from digitized continuous ascending 
aortic pressure (Millar micromanometer) and flow (Doppler/2D echo) 
measurements. MVO, was calculated from measurements of coronary 
flow and AV-O, difference (coronary sinus catheter). Results: All 24 
interventions increased cardiac output but only 17 increased PT' In the 
7 cases where PT decreased, MVO, decreased. In those cases where 
PT increased, the MV02 response was variable but could be predicted 
by analysis of the fractional changes in Ppand PT (%APp/%APT). The 
relation between %APp and %APT for interventions that decreased 
MVO, was displaced to the left of that for interventions that increased 
MV02 (Figure), reflecting a greater contribution of Pp to the induced 
change in PT (p < .02). Conclusions: 
These data indicate that in patients with ••• ellvoz j 
DeM the distribution of l V power output 
into pulsatile and steady components lIAPp 
may be correlated with myocardial energy 
expenditure. Disproportionate increases 
in pulsatile power appear to be 
associated with a reduction in MVO,. 
OMVOZ! r-O.ge 
, .. 
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Myofilament Loss Predicts Long-term (5 year) 
Mortality In Idiopathic Dilated Cardiomyopathy 
David L. Kemp. Jeffrey L. Anderson, Ronald L. Menlove. Mark 
P. Burton, Elizabeth H. Hammond. University of Utah. LOS 
Hospital. Salt Lake City, Utah 
Histologic features on endomyocardial biopsy predictive of 
clinical outcome have not yet been established for idiopathic 
dilated cardiomyopathy (IDC). We have previously noted that 
myofilament loss (MFL) on electron microscopy (EM) 
predicted 18 month survival. To evaluate the prognostic 
importance of MFL for long term survival and its relationship 
to initial ejection fraction (EF) we prospectively followed 79 
IDC patients (pts) (52 men; age 51±14 yr; median symptom 
duration 22 mo±44, range 1·360; ejection fraction 30±13%; 
functional class 2.7±O.6) for 60±4 mo (range 52·69) or until 
death or transplantation. MFL was graded blindly and 
prospectively on a scale of 0 to 3 (absent to severe). 
Complete follow up information was obtained for 76 pts 
(96%): 58%(44/76) died (heart failure. n=11; sudden death, 
n=23) or were transplanted (n=10). 5 yr actuarial survival 
progressively decreased with increasing MFL from 82% 
(MFL=O) to 25% (MFL=3)(p~0.0003). On Cox multivariate 
regreSSion analysis, both MFL (p~O.OOOl) and EF (p<0.01) 
predicted outcome. MFL also added independent 
information when stepped into the Cox model after EF 
(P$0.0002). When pts were stratified at the median EF, those 
with EF~30% showed a mortality odds of 15.5 for MFL 2-3 vs 
0-1 (p~O.0001). whereas for EF<30% the odds ratio was 1.7 
(p=0.18). Thus. MFL by EM independently predicts long term 
(5 year) survival in IDC. and adds important. prognostiC 
information to EF, especially in those patients with better 
initial cardiac function. 
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Tne Perforated Balloon Catheter: Assessment and Minimization of 
Arterial Trauma 
Charles lambert and TImothy Grady. 
Univers~y of South Alabama Medical Center, Mobile. Alabama 
.The perlorated balloon catheter (PBC) has been suggested as a possible 
means by which compounds designed to prevent restenosis might be 
delivered locally at concentrations much higher than achievable wHh sys•
temic administration. Use of this catheter has, however, been associated 
wHh sigMicant arterial trauma which appears to limit Clinical applicabilHy. 
The present investigation was designed to 1) assess arterial trauma by the 
PBC using light and scanning electron microscopy (SEM) 2) develop an in 
v~ro system to model orifice mediated jet effects observed with the PBC and 
3) modHy PBC design to minimize orifice related arterial trauma. 
Canine brachial arteries were excised and mounted at in situ length 
in a pressurized perfusion bath. PBC's were inflated using a constant 
pressure source followed by fixation at 80 mmHg for light or SEM. Similar 
studies were performed in sHu for both brachial and circumflex coronary 
arteries. light microscopy revealed endothelial denudation and nonspecHic 
medial changes in all arteries stUdied. Suggestions of jet effects w~h endo•
thelial and medial pitting were seen in some serial sections. In addition to 
endothelial changes, SEM revealed frank crater formation wHh medial 
penetration in all specimens. These craters appeared to correspond to orifice 
related jet effects. In order to study jet effects produced by the PBC, agar, 
agarose or polyacrylamide blocks were molded wtth a central 2.7 mm hole 
into which a 3.0 mm PBC was introduced. Using methylene blue as an 
indicator PBC inflations were performed and serial sections made of the 
block using a vibratome. These section were digHized for reconstruction by 
computer. All PBC's tested produced jet effect mediated dissection tracts in 
this system which occurred at a threshold pressure of 2-3 atmospheres. 
AHhough aHering inflation parameters could not prevent this phenomenon, 
placement of a barrier to allow fluid flow yet prevent orHice effects between 
the PBC and the test media allowed uniform penetration of the indicator 
wtthout evidence for jet related dissection. These findings suggest that 1) 
light microscopy is insufficient to assess arterial damage produced by the 
PBC and 2) use of modified PBC catheters may allow local drug delivery 
wHhout the extenSive arterial trauma observed wtth first generation devices. 
108A ABSTRACTS 
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Intracoronary Ultrasound Patterns of Late Success and Restenosis 
After Directional Coronary Atherectomy 
Jose Suarez de Lezo, Miguel Romero, Alfonso Medina, Manuel Pan, 
Enrique Hernandez, Djordje Pavlovic, Francisco Melian, Amador L 
Granados, Juan Morales, Dolores Mesa, Jose R Ortega. 
Reina Sofia Hospital, University of Cordoba, and Pino Hospital, 
University of Las Palmas, Spain. 
Intracoronary ultrasound seems to be a useful technique for 
guiding and assessing the result of directional coronary atherectomy 
(DCA). However, there is little available information regarding 
characterization of the plaque and the follow-up echographic 
appearance of coronary lesions treated by DCA. In the present study 
we analyze the relationships between ultrasound, angiographic and 
pathologic information obtained from 45 patients (pts) with coronary 
artery disease who were successfully treated by DCA; in 16 of them 
a follow-up echo-angiographic reevaluation was performed 6 ± 3 
months later. Twenty plaques were predominantly echogenic, 18 were 
predominantly echolucent and 7 had a mixed pattern. The retrieved 
material from echogenic lesions had a higher percentage of fibrous 
tissue and calcification (p<0.05), while echolucent plaques showed a 
higher content in cells and fibrin (p<0.05). The percentage of cross•
sectional plaque reduction after DCA, as assessed by echo, correlated 
directly with the specimens weight (r=0.62; p<O.OI). Plaque reduc•
tion was more complete in echolucent and soft plaques, as compared 
with echogenic lesions (79±18 vs 57±22%; p<O.OI). In all 9 pts, who 
developed restenosis at follow-up, the echo-catheter had a wedge 
condition at the lesion site; 7 of them had a 3-layered pattern with a 
thick echogenic inner ring. The echographic pattern of 7 pts who had 
late angiographic success was similar to that observed in non-diseased 
segments, showing a wide lumen as identified by echocontrast during 
hand injections. 
Conclusions: 1) The ultrasound density of the lesion varies 
depending on the tissue components of the plaque. 2) A 3-layered 
pattern in wedge conditions is most frequently observed at follow-up, 
when restenosis develops. 3) The echographic appearance of late 
success can not be differentiated from non-diseased arterial segment. 
913-4 
Platelet Activation During PTCA - Is Current Anti•
Thrombotic Therapy Sufficiently Effective? 
Subodh K. Agrawal, Pradip K. Rustagi, Lynn A. Quarles, Adam D. 
Cannon, Peter J. Macander, James A. Hearn, Luc Bilodeau, Sriram 
Iyer, Gary S. Roubin, UniverSity of Alabama at Birmingham, 
Birmingham, AL 
Acute closure and late restenosis continue to limit the success of PTCA 
despite aspirin and heparin therapy. To determine the extent of 
activation of platelets, we performed ex vivo platelet function studies 
immediately pre· and post·PlCA in 24 patients receiving aspirin, 325mg 
per day, and heparin ~ 10,000U IV bolus prior to PTCA. Platelet 
lumiaggregometry in response to various agonists was performed on 
citrated, peripheral, venous, whole, blood. Plasma p-thromboglobulin 
(PTG) and platelet factor 4 (PF41 were measured by ELISA. Activated 
clotting time was a minimum of 300 seconds in all. All patients 
exhibited platelet ATP release defects in response to arachidonic acid 
pre·PTCA. The responses to ristocetin were normal. Results were as 
follows: 
Pre-PTCA Post-PlCA p value 
Thrombin-induced 
ATPrelease(nmolel 0.9±0.4 0.1±0.1 <0.0001 
Collagen-induced 
Aggregation (ohms) 16±8 14±6 0.03 
plasmaPTG, (ng/ml) 183±11 356±15 <0.0001 
plasma PF4, (ng/ml) 191 ±30 163±25 0.0008 
Plasma PTG levels increased significantly and plasma PF4 levels fell 
slightly during PlCA. The marked reduction in thrombin·induced A TP 
release, associated with an increase in plasma PTG, indicates that 
platelet activation and degranulation occur during PlCA. 
Conclusion: These data indicate that pharmacologic impairment of 
platelet activation during PTCA is limited. These plasma parameters 
provide a basis for testing future drug therapy and/or studying 
thrombosis-related phenomena after PTCA. 
913-5 
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Rapid Ablation of Fresh Thrombus by 8 New Ultrasonic 
Device - In Vitro Assessment 
George G. Hartnell, Janet M. Saxton, Stephan E. Friedl, George S. 
Abela. Deaconess Hospital, Harvard Medical School, Boston, 
Massachusetts. 
Percutaneous trans luminal angioplasty and similar interventions are 
less effective when Intracoronary thrombus Is present. We tested 
the effects of a novel ultrasonic device specifically designed for 
thrombolysis which may prove suitable for use In coronary arteries. 
The device has a flexible ultrasound transmission wire with a 
specially configured 1.6mm lip designed to maximize thrombolytic 
effect. This prototype wire Is connected to an ultrasonic pulse 
generator which can produce lip displacements of 17-40llm 
excursion. The effect of ultrasonic thrombolysis was studied using 
fresh human thrombus In glass tubes (3·7mm diameter). 
Results: With lip displacements of 23-26Ilm, thrombus was 
drawn by a vortex around the device tip and lysed at a rate of 
0.3ml/min. In 31 samples tested the device produced rapid, 
complete ablation of thrombi with volumes less than 0.3ml. For 
larger thrombi(0.3 to 1ml) it produced a greater than 90% 
reduction in volume within 2 minutes. A small «0.5 mm diameter) 
slrongly adherent collar of malerlal (shown on scanning electron 
microscopy to be a mesh of fibrin) remained attached to the center of 
the lip after lysis of larger thrombi. After thrombolysis the 
resultant fluid was translucent, free of visible particles and did not 
reclot within 24 hours. Ught microscopy of centrifuged debris from 
the fluid showed few fragments of up to 40llm diameter, composed of 
fibrin surrounding a platelet core. Gel electrophoresis Showed that 
there were no molecular fragments larger than 107 Daltons. 
Conclusion: This ultrasonic device rapidly ablates thrombus in 
vitro without producing particles likely to cause adverse effects. It 
may provide a rapid, effective method for thrombolysis in patients 
with intracoronary thrombi. This approach may be particularly 
valuable for cases In which pharmacological thrombolysis is either 
ineffective or contraindicated. 
913-6 
A Comparison of the Effects of Intracoronary Diagnostic 
Devices on the Coronary Endothelium 
Helgi Oskarsson, Timothy Hofmeyer, Rene DeVine, James D. 
Rossen, FACC. The University of Iowa and VAMC, Iowa City, IA. 
The endothelium plays an important role in coronary vasomotor 
and hemostatic control. Intracoronary diagnostic devices may 
damage the endothelium. We assessed the extent of coronary 
endothelial denudation after instrumentation with a fiberoptic 
angioscope, an ultrasound catheter system and a .014 in PTCA 
guidewire alone. ~ Coronary angiography was performed 
using femoral technique in 8 anesthetized and ventilated pigs 
(63±2 kg). Fiberoptic angioscopy was performed with a guidewlre•
directed 4.SF catheter (Edwards LIS) Incorporating a compliant 
occlusion cuff. A gUidewlre-dlrected S.3F ultrasound imaging 
system (Intertherapy) was positioned in a different artery. After 
glutaraldehyde pressure perfused fixation, non-instrumented 
control coronary segments (CON) and segments exposed to the 
angioscope occlusion cuff (ASC), the ultrasound catheter sheath 
(US) and the guidewire alone (WIRE) were processed for 
scanning electron microscopy (SEM). 
Bes.u1l.s.: No angiographic abnormalities were observed after 
instrumentation, and coronary diameter was unchanged at the 
ASC cuff site (3.60±O.14 vs 3.68±O.13 mm). Gross examination 
revealed an intimal dissection in one ASC segment and intra•
mural hemorrhage in one US segment and one WIRE segment. 
Marked patchy endothelial denudation was observed by SEM in 
all instrumentation groups but not in control segments. Greater 
denudation occurred with the ASC cuff than with the US sheath. 
Condition ~ A.rui. ~ ~ 
% Endothelium 99±0.3 29±S'§ 5S±S' 45±S' 
present (m±sem) , p < .01 vs CON §P<.OS vs US 
Conclusions: Substantial endothelial denudation results from 
intracoronary placement of diagnostic catheters and conventional 
PTCA guidewires. Catheters with occlusion cuffs appear to 
produce greater endothelial denudation. The clinical significance 
of catheter·induced coronary endothelial damage is uncertain. 
JACC Vol. 19, No.3 
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913·7 
PALHAZ-SCBATZ Intracoronary Stent in the 
Blderly: HACI Bxperience 
Carlos B. Saenz, Joyce F. Killinger, 
Donald S. Baim, R. Charles Curry for HACI 
Palmaz-Schatz Stent Investigators 
At the time of this analysis, 109 PALMAZ•
SCHATZ stent patients were included in the 
HACI registry: 30 (28\) 70 years or older 
and 70 (72%) younger than 70. The elderly 
group had a larger proportion of women 
(p<.OS), triple vessel disease (p<.Ol), 
prior CABG (p<.Ol), CHF (p<.Ol), and were 
more frequently deemed a high risk for 
surgery (p<.Ol). The elderly group had a 
significantly higher percentage of treated 
lesions in bypass grafts (53% vs. 16%, 
p<.Ol) and more residual stenosis after 
stent implantation (6.6% vs. -1.3%, 
p<.05). All the deployments in elderly 
were successful. The total number of 
complications, excluding death, M.I., 
CABG, was significantly higher in the 
elderly (56.7% vs. 16.5%, p<.001). In 
particular, vascular events requiring 
surgery were more frequent in the elderly 
(20% vs. 3.8%, p<.01). 
Conclusions: The HACI Registry shows that 
the use of PALMAZ-SCHATZ intracoronary 
stent has a comparable deployment success 
rate in elderly and younger patients; 
however, the frequency of complications -
particularly vas.cular - is higher in the 
elderly. 
913·8 
Balloon Dilatation ofRestenotic Lesions Within Metallic 
Coronary Stents: Initial Clinical and Histopathologic 
Observations 
Kirk Garratt, David Holmes, Jr., Robert Schwartz, Allan 
Camrud, Michael Jorgenson. Mayo Clinic, Rochester, MN 
Intimal hyperplasia (IH) after placement of balloon ex· 
pandable metallic coronary stents (CS) can result in signif· 
icant restenosis in animals and humans. Appropriate 
management of these lesions is uncertain but may include 
balloon angioplasty (BA). Between 5/90 and 4/91, 9 pta with 
angiographic restenosis in a coronary segment containing 
a CS were treated with BA at Mayo Clinic. Pta received 
heparin and aspirin during BA, but did not routinely re•
ceive cownadin after BA. BA was successful in 8 (89%) pts 
using conventional balloon catheters sized to match the ad· 
jacent unstented segment. There were no deaths or myo· 
cardial infarctions among these pts; occlusion of a side 
branch vessel resulted in coronary bypass surgery in 1 pt. 
To examine mechanisms of BA in such lesions, 5 porcine 
coronary arteries with IH through chronically indwelling 
CS were dilated from an initial stenosis (mean ± SD) of 57 ± 
16% to a residual stenosis of22 ± 10% (measured with elec•
tronic calipers) using standard angioplasty equipment. 
Animals were sacrificed and perfusion-fixed coronary ar•
terial segments examined histologically. Focal intimal 
tears occurred near the thinnest IH. Mild intramural 
hemorrhage was visible adjacent to CS wire sites, but sig•
nificant contraluminal crush injury or tear, indicative of 
further stent wire expansion, was not seen. 
Conclusions: BA may be an effective method of treatment 
for restenosis through metallic CS. Successful BA appears 
to involve remodeling of IH but not significant stent dis•
placement. 
913·9 
Vascular Recoil Immediately After Implantation of Tubular 
Slotted Metallic Coronary Stents 
Martin B. Leon, Jeffrey J. Popma, David L. Fischman, Michael P. 
Savage, Robert F. Bonner, Kenneth M. Kent, Sheldon Goldberg. 
Washington Hospital Center. Washington, D.C. 
Balloon-expandable tubular slotted metallic stents are designed to 
resist the acute vascular recoil associated with PTCA (averaging 
30%). To determine the frequency. magnitude, predictive factors, 
and impact of vascular recoil immediately after coronary stent 
implantation. a consecutive series of 167 pts (177 lesions) from the 
multicenter stent registry was analyzed before and after stent 
placement, and after 6-month follow-up (FU) angiography (141 pts, 
81 % of lesions). Cineanpograrns were qualitatively reviewed for 
lesion calcium. bend ~5 ,eccentricity. complexity. dissection and 
thrombus. and quantitatively analyzed for length, final stent 
expansion balloon (BAL), reference (REF). and minimal lesion 
diameters (MLO). and % diameter stenosis (OS) using an 
automated edge-detection algorithm. % Recoil was defined as 
[(BAL-MLDPost-stent)/BAL] x 100. 
Pre·Stent Post·Stent 
REF (mm) 3.19±O.54 3.18±O.52 
MLO (mm) 0.79±O.46 2.65±O.47 
BAL 3.14±O.53 
FU 
2.97±O.46 
1.64±O.75 
% OS 75±13 16±12 45±24 
Percent recOIl immediately after stent placement was 15±13% and 
was directly related to BAL (p<O.ool), the post-stent (p<O.ool) and 
FU (p=O.12) %OS and the BAL:REF ratio (p<O.OOl). Recoil was 
also indirectly related to the MLD post-stent (p<O.OO 1) and at FU 
(p=O.032). In conclusion: Vascular recoil after coronary stent 
implantation 1) occurs frequently, although the magnitude is less 
than reported after PTCA. 2) the degree of recoil relates to relative 
balloon:artery oversizing during the procedure. and 3) acute recoil, 
by influencing early angiographic results, may be associated with 
increased restenosis during FU evaluations. 
913·10 
I .... edtntl! and Late O'ltcom" of Bail-out Core'Dary 
Str.ntlng 
Jenn Faj.det, Donald Je.,ny, Glulio Guabliumi, Bernard 
Cassagnenu, Gabriel I':"bert, Christian Jordan, Michel 
Flores, ..TeAll H'arco. 
CUnique PAsteur, Toulouse, France. 
Of 427 patients (pts) undeIgoIng coronary stenting from 
tI~1 ch 1991 to July 1991, 34 (8%) had stenting as 
therapy for a larg" OCcl'lsive dissection following PTCA 
(TIMI 0). There were 27 m.,1M, 7 feOlales, mean age 
Sg.6±8.5 years (rang.~ 33-75 yrs). 67% had unstable 
aUf,ina Bnd 6~' a recent myocareliul infa!<:tion (MI). 
LVFF ,,!IS 55±9.5% (rang" 20-70%) and 56% had multivessel 
di~·e8.se. 
72 stents (S) were imp Lanted (2 .1±1. 0 S/pt) and sl1 
weI e suceessfully deploy"d with TIM I 3 flow establlshed 
in slL cns"s. 
Fo] lowing "tent implants cion, no complications occurred 
dUl ing the fit'st 24 henr". 
Ste'nt closure occurreel in 10 pts (29.4~~) 2 to 11 days 
(menn fi±3. I days) aftnr stenting : 7 pts sustained MI, 
1 l't "FlS s1lccessful ly ,.e~analll"d without MI, and 2 pts 
h .. : snod"n cnrd.l~c d"ath on dav 10 and 1.1. 
Anriographlc foLlow-ul' (L27±61 days, rllnge 28-318 days) 
obi ai",·d in 23 pt. slQ1.ed r"stenosis (;t 50% dialreter 
stroog!s) ]n 13 pts (5~.~') : 2/6 pts with single stent 
a~~ 11/17 l'to (65%) "iih multiple stents. 
]'1 cOllclus ion: 
J. Stent i.mplantat l:>II as 9 bail-out procedure 
eifecdvrly l·eestaJ:.lbhes imm"-,linte arterial flow but 
is ASSOc1sted with a h,g~ closure rate within the first 
2 weeks Bnd a resten,,:;is ratp of 56%. 2. Stenting in 
this clinical setting <spedlllly when multiple st~nts 
arc erlployen, sheulel pert'B)'" be considered as a 
hr;dglng procedure for bJPass slirgery. 
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913·11 
Can Restenosis After Coronary Stenling be Diagnosed by Stress Thallium 
Imaging? 
A. Michael Lincoff, David W.M. Muller, Stephen G. Ellis, Jill A. Hacker, 
Eric J. Topol. Oeveland Oinic Foundation, Oeveland, Ohio and University 
of Michigan Medical Center, Ann Arbor, Michigan 
To determine the predictive value of stress thallium imaging (THAL) for 
restenosis (RS) following Intracoronary stenllng. we reviewed our 
experience with 93 pts from 5/88-2/91 (54 PaJmaz-Schatz stent, 39 
Gianturco-Roubin stent). Fifty-one pts underwent protocol THAL (47 
exercise stress, 4 adenosine pharmacologic stress) and cardiac 
catheterization (CATH) at 98 :!: 27 days and 183 :!: 47 days after stenting. 
respectively. Forty-two pts were excluded from study due to non-thallium 
stress testing (9), refusal of both THAL and CA TH (5), refusal to undergo 
CAm (6 with positive THAL, 3 with negative THAL), CATH without 
THAL (4 with RS, 6 without RS), emergent or elective CABC (4 and 3, 
respectively), or death (2). RS (>50% diameter llIl1Towing of the stented 
coronary segment) occurred In 25/51 pts (49%). A positive mAL 
(complete or partial thallium redistribution in the region subtended by the 
stented artery) was significantly correlated with angiographic coronary 
luminal diameter (LUMEN) and diameter stenosis (%05): 
+ THAL -THAL 
LUMEN 1.16 :!: 0.69 mm 2.00 :t 0.81 mm 
%05 65:!: 19% 39:!: 22% 
Nevertheless, the sensitivity of THAL for RS was only 60% 
(specificity=88%); LUMEN, %05, and prevalence of multivessel disease 
(MVD) among pts with true-positive (TP) and false-negative (FN) THAL 
were not significantly different (LUMEN=1.07 :!: 0.72 vs 1.13 :t 0.41 mm; 
%05=69 :!: 18% vs 64 :!: 10%; MVD=35% vs 40%, p=NS). Fixed THAL 
perfusion defects occurred more frequently in pts with false-negative THAL 
(60% vs 7% In FN and TP, respectively, p=0.014). 
We conclude that thallium imaging. while significantly correlated 
with luminal diameter and % stenosis following Intracoronary stenting. is 
not a substitute for coronary arteriography In the detection of RS, 
particularly in the presence of fixed thallium defects. 
913·12 
OUTCOKB IN PATIENTS TREATED WITH MULTIPLE STENT 
IMPLANTS IN A SINGLE VESSEL 
Maurice Buchbinder, Mark Reisman, David Fischman, 
Michael Savage, Steven R. Bailey, UCSD San Diego, CA 
Multiple stents in a single coronary artery have been 
associated with lower primary success, higher 
complications and poor long term patency. Thus far, 
there have been limited reports analyzing the impact of 
stent configuration in a vessel treated with multiple 
implants. We evaluated 875 patients who had undergone 
successful stent deployment. Group A (n=757}consisted 
of pts with single stent implants in a single vessel, 
group B (n=28) had multiple stents in a single vessel 
and group C (n=90) underwent tandem or overlapping 
stent implantation for 10 
Subacute Thrombosis% 
MI , 
CABG , 
Death \ 
Angio Flu , • 
Restenosis % 
ng lesions. 
A B 
n=757 n=28 
1. 2* 0 
1.5 3.6 
4. 4'/\' '/\' 3.6 
1.1 0 
57 75 
26.7'/\''/\'* 33 
C 
n=90 
5.6* 
1.1 
lO*'/\' 
2.2 
74 
49'/\'** 
• p<0.002 ** p<0.02 ***p<0.0002 
'Follow-up 1.6-7.7 months 
conclusion: Single stents and multiple non-overlapping 
implants in a single vessel are associated with a high 
primary success, low complications and lower 
restenosis when compared to tandem or overlapping 
stents. 
913·13 
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Coronary StentlOg: Are Dextran and Dipyridamole Really 
Needed? 
Riidiger Simon, Gunhild Herrmann, Rainer Zahorsky, Bernd 
Wille, Ulrich Nellessen, Gerard Ould 
Depart. Cardiology, University of Kiel, Germany 
We report on a series of 42 pts (age 49 to 78yrs, 6 women 
and 36 men) in whom 51 Schatz-Palmaz stents (9 double, 33 
single stents) were implanted during 46 sessions without any use 
of dextran or dipyridamole. Indications were lesion recurrence 
after previous PTCA (6pts) or bail-out for intermittent or 
imminent vessel closure (40 procedures). Pretreatment included 
aspirin O,lg per day and nifedipine 10 mg t.i.d. PIs received 
15000 to 20000 U.heparin Lv. during and coumadine and aspirin 
(0,2g per day) for 3 months after the procedure, associated with 
full heparinization until coumadine effectiveness. CABG was 
necessary in 2 cases (1 emergency, 1 elective)due to 
inappropriate positioning of the stent, but 44/46 procedures 
(95 %) were successful (average residual diameter stenosis: 18 %) 
and without primary complications. There were no deaths, no 
significant MI, and of particular interest, there was no early or 
delayed stent occlusion. Follow-up angiography at 3 to 6 months 
was available in all but one pt and revealed recurrent stenosis 
(>50% in diameter) in 24% of cases, comparable to other 
series. 
We conclude: 1. Coronary stenting is a safe and effective bail•
out procedure for PTCA complications. 2. Our data do not 
support the dogmatic advocation of dextran and dipyridamole as 
adjunctive treatment during the procedure, since in our series no 
acute or delayed thrombolic events occurred in absence of these 
drugs. 
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914·1 
ROLE OF TRANSTHORACIC ECHOCARDIOGRAPHY IN THE 
CARDIAC INTENSIVE CARE UNIT 
Alvin J Chin Jane M. Vetter, Mohamed A. Seliem, Audrey Jones, 
Beth A. Andrews. 
The Children's Hospital, Philadelphia, PA. 
To investigate the success of subcostal/transthoracic 
echocardiography with color flow imaging (TIE) in the very early 
detection of hemodynamically important sequelae, we reviewed the 
re-operation record during one calendar year, along with the TIE 
data obtained in the cardiac intensive care unit (CICU) on those 
patients. In that 12 month period, SIS pts (a majority of whom 
were < I year) underwent primary or elective secondary surgery. 
Excluding exploration for bleeding or tamponade, pacemaker 
insertions, and pericardial window creation, a total of 37 pts (6%) 
had re-operations (Reop) for correctable, hemodynamically 
important sequelae; 13 (Group A) had Reops during the same 
admission, and 24 (Group B) had Reops during an early re•
admission. Reasons for Reop were residual VSO (3 in A, S in B), 
arch obstruction or aortic stenosis (I in A, 8 in B), too loose a PA 
band (2 in A), shunt stenosis (I in A, 1 in B), PA obstruction after 
switch (3 in B), other residual left-to-right (2 in A, I in B) or 
right-to-Ieft (I in B) shunts, branch PA narrowing (3 in A, I in B), 
aortic regurgitation (I in A, 1 in B), mitral regurgitation (I in B), 
pulmonary vein stenosis (I in B), and LV aneurysm (I in B). 
In Group A, CICU TIE correctly detected sequelae in 10, was 
helpful but not diagnostic in 2 others, and was not requested in 1 
(age 22 yr). In Group B, CICU TIE, requested in only 12, had 
correctly identified sequelae in 7, was helpful in 3 others, and not 
helpful in 2; in those 12 without CICU TIE, later TIE (either prior 
to discharge or as an outpatient) correctly quantitated important 
sequelae in 10 (and detected their presence in all 12). 
ConclusIons: I) For detecting correctable lesions, TIE is remarkably 
feasible and sensitive in CICU pts. These data provide a standard 
against which cleu transesophageal imaging may be compared. 2) 
Residual VSO and arch obstruction appear to be the predominant 
correctable sequelae in our CICU patient population. 
JACC Vol. 19, No.3 
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914·27 
One Year Venous Greft Patency Is Related to Intensity and Stability of 
Oral Anticoagulant Therapy for the First Three Months after Coronary 
Bypass Surgery. 
Jan van der Meer, Hans L. Hillege, Wiek H. van Gllst, Kong I. Ue, CABADAS 
Research Group. Interuniversity Cardiology Inst~ute of The Netherlands, Ut•
recht, The Netherlands. 
To establish the effects of oral anticoagulants (OAC) vs platelet Inhlb~ors on 
venous graft patency, 950 patients undergoing coronary bypass surgery 
were allocated randomly to one year treatment with OAC, aspirin + dipyrl. 
damole or aspirin + placebo. Aspirin (SO mg/day) was started 12·16 hours 
after surgery, dipyridamole (400 mg/day) and OAC (dose adjusted to 
Thrombotest values) 12·16 hours before surgery. Design was open for OAC, 
double·blind for both aspirin groups. Patency was assessed by coronary 
angiography after one year. Mean number of venous grafts was 1.7 with 3.1 
distal anastomoses per patient. Efficacy and Intensity of OAC therapy were 
subjects of an interim analysis on 142 patients. Adequate anticoagulation 
(AA) was defined as INR values of 2.8-4.8. Periods of AA as percentage of 
the follow up period were calculated. Over 100 days follow up, periods of AA 
were significantly shorter in patients w~h at least 1 occluded graft than In 
those In whom all grafts remained patent. This difference was not demon· 
strated for AA over one year follow up. AA for ~ 75% of both 100 days and 
one year follow up, resulted In higher patency rates, compared w~h AA for 
< 75% of time. Results are summarized In the table. 
foillow UP 
100 days one year 
~ 1 occl. graft: AA, % time 37 • 54 
all grafts patent: AA, % time 48 • 54 
AA, % time ~ 75 < 75 ~ 75 <75 
patency/patient(%) 81 74 81 74 
• p<0.05 
In conclusion, one year venous graft patency Is probably related to intensity 
(INR) and stability (% time) of oral anticoagulant therapy, In particular for the 
first three months after surgery. 
914·28 
Vasomotor Response to Ergometrine and Nitrates of 
Venous Grafts and Grafted Coronary Arteries Late After 
Bypass Surgery 
Claude Hanet, William Wyns, 
University of Louvain, Brussels, Belgium. 
Venous grafts implanted to the arterial circulation 
undergo important anatomical and functional changes. 
To evaluate whether the vasoreactivity of saphenous 
vein grafts is preserved several months after bypass 
surgery, 11 patients free of cardioactive drugs were 
studied by quantitative angiography more than six 
months (range 6 to 9B months) after surgery. 
Angiograms were obtained in basal conditions, after 
intravenous bolus injection of 0.4 mg of 
methylergometrine and after intragraft infusion of 1 
mg of isosorbide dinitrate. Methylergometrine reduced 
the luminal diameter of venous grafts by 6.7±7.4% from 
3.26±0.71 to 3.05±0.76 mm (p<O.OI) and that of grafted 
coronary arteries by 9.4±7.2% from 2.09±0.49 to 
1.90±0.49 mm (p<0.005) (venous grafts vs coronary 
arteries: NS). After isosorbide dinitrate, the 
diameter of grafted coronary arteries increased 
significantly to 2.46±0.62 mm (+17.Bt9.8% vs basal; 
p<O.OOOI) and that of saphenous vein grafts returned 
to control values (3.28±0.70 mm; +0.6±3.1% vs basal; 
NS). Thus, saphenous vein grafts and grafted coronary 
arteries appear to be equally sensitive to the 
constrictor influence of methylergometrine but differ 
in their response to nitrates. This suggests that 
differences exist between coronary arteries and 
saphenous vein grafts both in vasomotor range and in 
basal vasomotor tone several months after coronary 
artery bypass surgery. 
ABSTRACTS 
914·29 
calcium Channel Blockers Are Not All Alike In the 
Prevention of Ischemia After Coronary Artery Bypass 
Surgery 
Alyson Owen, Paul Simon, Rainald Seitelberger, Werner 
Zwoelfer, Severin Schwarzacher, Bruno Podesser, Reinhard 
Moidl, Ernst Wolner, Werner Mohl. 
II. Surgical Clinic, University of Vienna, Vienna, Austria. 
Nifedipine (Nif) has been shown to reduce intra- and 
postoperative ischemia in patients (Pt) undergoing coronary 
artery bypass surgery (CABG). However, calcium channel 
blockers are a diverse group of compounds with different 
actions. We examined the effects of 2 calcium channel 
blockers on ischemia after CABG as manifest in regional 
myocardial function. Fifty-three (53) Pt were randomized to 
receive continuous 24 hr infusions of either Nif (N=24) or 
Gallopamil (Gal) (N=29) initiated after release of the aortic 
cross clamp. Transesophageal echocardiography was 
performed pre cardiopulmonary bypass (CPB), 5 min post 
CPB, after chest closure, and 3 hr later. There was no 
difference between groups in clinical or operative characteristics. 
Regional myocardial function was semiquantitatively assessed 
in 5 segments (Seg) (4 mid-cavity cross section and 1 apical). 
17/132 Seg (13%) deteriorated in Gal Pt vs only 11107 (1%) in 
Nif Pt (p<O.OOl). 14/29 (48%) of Gal Pt had deterioration of at 
least 1 Seg after CPB vs only 1/24 Nif Pt (4%) (p<O.OOl). No 
difference between groups in global function was seen after 
CPB, suggesting that this effect was not due to a general 
depression of cardiac function. 
We conclude that Nif is superior to Gal in the prevention of 
perioperative ischemia. 
914·30 
Impaired Endothelium-Dependent Coronary Microvascular 
Relaxation Following Cold Potassium Cardioplegia 
Frank W. Sellke, Tajammul Shafique, Frederick J. Schoen, Robert G. 
Johnson. Beth Israel Hospital and Harvard University, Boston, MA. 
111A 
Reduced myocardial perfusion is a cause of cardiac dysfunction 
following cardiac surgery. Since myocardial perfusion is primarily 
regulated by vessels < 200 J.Im in diameter, endothelium·dependent 
microvascular relaxation was examined in these vascular segments. Six 
pigs were placed on cardiopulmonary bypass. After aortic cross•
clamping, hearts were arrested with cold, potassium [25 mEqII] 
crystalloid cardioplegia for one hour. Hearts were then reperfused for 
I hour (Card. Rep) while the pigs were separated from cardiopulmonary 
bypass. In addition, 5 hearts were arrested but not reperfused (Card•
NR). Seven non·instrumented pigs were used as controls, Coronary 
microarterial vessels (90-190 J.Im in diameter) were studied in vitro in a 
pressurized, no· flow state with video microscopic imaging ~ 
electronic dimension analysis. FolIowing precontraction with 
acetylcholine to 30-60% of the baseline diameter, bradykinin (BK), the 
calcium ionophore A23187(calcimycin, CI), or sodium nitroprusside 
(SNP) were applied extraiuminalIy. KCI was applied to non· 
precontracted vessels. Responses are % relaxation of the precontracted 
diameter, (-) - contraction, *-p<0.05 compared to control. t=p<0.05 
compared to Card·Rep. Values are mean ± sem. 
Groups n. BK (JOnMl CI (JOuMl SNP (JOOuMl KCI (50mMl 
Card·Rep 6 28±11* 33±6* 82±9 -16±3* 
Card-NR 5 83±9*t 66±12*t 91±3 -28±6t 
Control 7 98±2 90±4 94±5 -42±8 
Cardiopulmonary bypass and ischemic cardioplegia significantly 
reduces endothelium-dependent microvascular relaxation to BK and cr, 
while not affecting endothelium· independent relaxation to SNP. 
FolIowing reperfusion, endothelium-dependent relaxation is further 
impaired. Endothelium-independent contraction to KCI is also reduced 
folIowing administration of potassium cardioplegia. These findings 
have important implications regarding coronary spasm and cardiac 
dysfunction folIowing cardiopulmonary bypass and cardioplegia. 
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914·31 
Predictor. of the Antiarrhythmic Action of 
p~ocainamide Following Cardiac surgery 
Mlchael R. Gold, Mary A. Ungaro, Mortimer J. 
Buckley, Roman W. DeSanctis. Massachusetts 
General Hospital, Boston, MA 
Both atrial and ventricular arrhythmias occur 
frequently following cardiac surgery. To 
assess the antiarrhythmic action of 
procainamide (P), we performed a double-blind 
randomized, placebo-controlled trial of 100 ' 
pts undergoing coronary artery bypass surgery 
(CABG). Pts receiving placebo (PLAC) had a 
high incidence of atrial fibrillation (AF) and 
ventricular tachycardia (VT) postoperatively, 
as assessed by telemetry and Holter 
monitoring. Arrhythmias were significantly 
reduced in pts with therapeutic P levels 
(THER) or in those with QTc prolongation > 20 
ms (QT), but not in pts with subtherapeutic 
levels or w~th~ut QTc prolongation. Moreover, 
a very low lncldence of arrhythmia was noted 
when both THER and QT were present. 
!i AF VT 
PLAC 50 38% 20% 
THER 30 14%* 0%* 
QT 36 14%* 6% 
THER+QT 22 5%* 0%* 
*p<.05 vs PLAC 
CONCLUSIONS: QTc prolongation predicts the 
antiarrhythmic action of P as well as serum 
drug levels and should be monitored routinely 
given its ease of measurement. The 
combination of both measures predicts 
antiarrhytmic activity most accurately. 
914·32 
Blood Substitutes and Extended Autologous Blood Donation 
PJ Slanetz, R Page, R Lee, EE Jacobs Jr, PJ LaRaia, WG 
Austen, and GJ Vlahakes. Dept. of Surgery, Massachusetts 
General Hospital and Harvard Medical School, Boston, MA. 
Autologous blood donation is generally limited to elective 
cardiac surgery; blood substitutes may increase the amount 
of autologous blood that can be safely removed immediately 
prior to surgery. Six sheep donated ~80% of their red 
cell mass which was replaced with polymerized bovine 
hemoglobin solution (PBHg). Another six sheep served as 
Controls (no donation). Subsequently, sheep underwent a 
measured surgical stress with a 27% blood loss and 
subsequent return of autologous blood to the PBHg group. 
Data were collected at Fi02-0.2. 
(mean ~ SD) *P<O.OS Control 
Starting Hct (%) 30.3~2.4 
At the start of surgery: 
Ovine Hct (%) 29. 7~2.3 
Total Hgb (g/d1) 9.9~O.S 
Plasma PHgb (g/d1) O~O 
Arterial 02 content (vol%) 12.S~1.3 
02 consumption (m1/min/kg) 7.1~2.7 
pH 7.44fO.Ol 
Final Hct 24 hours post-op (%) 20.Sf2.0 
PBHg 
32.0~3.6 
*4.8~O.S 
*4.4~0.7 
*3.ltO.4 
*S.4~O.S 
7.H2.S 
7.44~O.02 
*2S.7~3.7 
All animals survived long-term without evidence of renal, 
hepatic, or coagulation system toxicity. 
These results indicate overall blood conservation 
in those animals who acutely donated autologous blood 
which was replaced by PBHg. At a mean hematocrit of 4.8%, 
sheep would not survive without a blood substitute. At 
the total plasma hemoglobin achieved. arterial oxygen 
content. while less than that in Control animals. was 
adequate to maintain oxygen consumption and to meet demand 
during surgical stress. Acute blood replacement with 
blood substitutes may permit extensive autologous blood 
donation immediately prior to surgery. 
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Effects of Acad .. lne on Perloperatlve Cardiac Morbidity In a 
Placebo Controlled, Double Blind Study 
Jacqueline Leung, Thomas Stanley, Joseph Mathew, Patrick Curling, Paul 
Barash, Marllku Salmenpera, Gerald Reves, Mi~on Hollenberg, Dennis Mangano 
Uriv of Caifomla, San Francisco; Duke Uriv; Yale Uriv; and Emory Univ 
Acadesine (AICA'riboside) Improves recovery of cardiac function after 
reperfusion in animal models of cardiac surgery by enhancing adenosine 
release in the Ischemic region. To determine whether acadesine decreases 
the freq~ency o~ postoperative adverse cardiac events, 116 patients 
undergoing elecllve CABG surgery were randomized to receive either 
placebo (P) or one of two doses of acadesine [O.OS (L) or 0.1 (H) mg/kgIminj 
starting lS min prior to anesthetic induction and continued for 7h. CABG 
surgery was performed uSing standard bypass techniques and moderate 
systemiC hypoth.ermia. Anesthesia was standardized and intraoperative 
hemodynamcs ngorously controlled. Multl-dose cold crystalloid potassium 
cardioplegia contained acadesine (S uglml) or placebo. ECG was obtained 
preoperatively (control) and daily for the first three postoperative days. 
CPK-MB isoenzyme was measured every 8h for 48h postoperatively. 
Adverse cardiac outcomes Included cardiac death, myocardial infarction 
(new a waves on ECG ana CPK·MB ~ SO U/I), or ventricular failure (cardiac 
index < 2 L.min·1·m-2). The three groups of patients were well matched in 
their preoperative demographic factors, intraoperative hemodynamiC 
control and mean aortiC cross-clamp time [S3 ± 17 (P), 53 ± 16 (L), 54 ± lS 
(H) min, P=0.97). MI and CPK-MB data are shown below. There was no 
mortalilV and 1/36 (3%) Dl tient in arouD P develooed ventricular failure. 
Placebo low Dose High Dose P(vPl L+H P'TvPl 
No. patients (n) 36 41 39 80 
MI(n) S 2 2 0.32 4 0.13 
(%) (14) (S) (S) IS) 
CPK-MB 250 (n) 17 14 9 0.09 1~~) 0.05 (%) (47) (34) (23) 
Mild Increases In plasma unc aCId (a metabolite of acadeslne) were seen In 
the H patients (mean Increase 1.6 ± 0.02 mg/dl) but with no clinical 
sequelae. In summary, acadesine administration appeared safe and may 
have a favorable effect on decreasing the frequency of postoperative 
myocardial infarction (64% reduction L+H v s P) and the extent of myocardial 
injury (CPK-MB elevations) in patients undergoing CABG surgery. Thus, a 
larger, randomized trial Is warranted to establish the validity of these trends. 
914·34 
UNSUPPORTED AHNULOPLASTY FOR RHEUMATIC MITRAL REGURGITATION. 
Reneto A. Kllil, Fernando A. Lucchese, Paulo R.Prates, Jolo R.M. sent , Ann., 
Ed_r Pereir., Ivo A. Nesr.U •. 
Instituto d. tardiologil do Rio Grinde do Sul/Fundl~lo Universit6ril d. 
Cerdiologi. - Porto Alegre - RS - Bras; l. 
Since 1974 • non-supported .itrel IMuLoplasty technique has been 
nploiecl for treat""t of pure .itral regurgitation (PI1R) , in a population 
thlt .... predoooinantly young ond of r_tic ethiology. An eVlluation of lite 
re.u l t. for. the boa i s of thi. report. 
There were '54 potients operlted on for PMR, S5 IOle (36%) Ind 99 fe .. le 
(64X>. """ "" ..... 36 • '6 (5 to 73) yeo... Asoocilted l •• ions w.r.: 47 
eortic, 21 tricuspid and 2 ASDs. Cases with conceait.nt .itrel stenosis were 
not included. Preoperltive functional cll .. WI. I-II in '9% Ind III-IV in 8'%. 
The .. rdiothorecic rltio WI. 0.6' • O. '0. 
All patients vere lubeitted to an unsupported .itrel annuloplastic 
procedure, ,i.ilar to thllt described by WooLer, that consisted in reduction of 
the alraL portion of the annulus obtained with the application of two 
buttre"ed .. ttreSi sutures at the COIIissures without COIIprOlDise to the width 
'of the .eptal leaflet. When nec .. ory, addictionel chordal procedures were 
perforlled. No petienta received ring or posterior annular support. 
Elrly IOrtllity .... 1.9% (3 ..... ): I)IOclrdill flilur. (1) Ind puloonory 
thrcMlboelbolis. (2). LIlt • .,rtality was 5.8% (9 cases); II)'Ocardial failure 
(3), .optic .. il (1), pul_Iry throoboellboli •• (1) Ind sudd.n d.lth (,). 
Twenty-eight ..... ('8.2X) were reoperlted for .itrtl di.function Ind 2 (, .3X) 
for aortic prosthesis disfunction. Residual lat. systOlic auraur was present 
in 48%. lJItt ...-plicltions wer.: .y.teoic thr_li •• S.8X (1/3 with 
oortic prosthesi.), inf.ctive endo .. rdite. '.3% Ind pullOnlry thl'Ollxlelllbolio. 
0.7%. Post-operltive functional cll" WI. I-II in 84% and III-IV in '6%. 
Cardiothoracic ratio va. 0.58 :I: 0.10. Actuarial probabi l ity of late survival 
vas 79.5 :I: 5.3% at 10 years and 71.0 :I: 7.4% at 14 years. Event free survival 
.... 67.9. 8.9% It '0 y,"r. Ind 56.' • ".7% It '4 yeor •. 
Rhtulltic litrll regurgitltion .. n be .ffectively tr.lted by Innulopll.ty 
without prosth.tic InOllllr .upport with lite r.sults _rebl. to tho •• 
obtained with lOr. coopliclted procedur ••. Thi. is porticullrly ioportlnt for 
trHtHnt of chi Ldren and young patients, specially fe_les at chi ld-bearing 
1ge. 
JACC Vol. 19, No.3 
March 1, 1992:113A 
914·35 
Surgery for Significant Mitral Regurgitation Following 
Mitral Balloon Valvotomy . 
Rafique Essop, Edward Turner, Thomas Wisenbaugh, Pinhas 
Sareli. Baragwanath Hospital, Johannesburg, South Africa 
Significant mitral regurgitation (MR) complicates 4-17% of 
mitral balloon valvotomies (MBV) and usually requires 
surgery. Mechanisms of MR, surgical anatomy and techniques 
and outcome are described in 9 of 182 patients undergoing 
MBV who had surgery (5%). All were females, age 33,±4 
years with pliable valve~ by echocardiography (echo score 
5.6±1.8). Combined transthoracic and transesophageal 
echocardiography correctly identified the mechanism of MR in 
8/9 patients. Mean interval from MBV to surgery was 7.1 
months (range 1-18). Surgical findings included: valve 
thickening 6, subvalvular disease 7, calcification 5,leaflet 
retraction 3, commissural fusion 8. MR was due to posterior 
leaflet tears in 5 patients, anterior leaflet tears in 2 patients, 
ruptured chordae in 1 and avulsed papillary muscle in I 
patient. 7 of the 9 patients (78%) who were thought to have 
unfavorable anatomy had mitral valve replacement. Mitral 
valve repair was undertaken in the remaining 2 patients and 
included commissurotomy, leaflet tear suture and annuloplasty. 
Conclusions: 1) Echocardiography may underestimate 
severity of valvar and subvalvar disease but is accurate in 
predicting mechanisms of MR following MBV. 2) Emergency 
surgery is usually not necessary. 3) In suitable cases mitral 
valve repair may be performed with good results. 
914·36 
Is There a Role for Surgical Ablation of 
Ventricular Tachycardia in the Era of the 
Implantable Defibrillator? 
David Wilber, Kala Giri, Siobhan Bremner, Brian 
Olshansky, Jeffrey Baerman, Bradford Blakeman. 
Loyola University Medical Center, Maywood Ill. 
We examined long-term outcome in 90 consecutive 
patients (pts) presenting with coronary artery 
disease, ejection fraction ~ 20%, and medically 
refractory sustained monomorphic ventricular 
tachycardia (SMVT). Surgical ablation (SA), 
including cryoablation ± endocardial resection, 
was undertaken in 26 pts; 64 pts received an 
implantable defibrillator (ICD).Mean age (63±9) 
ejection fraction (33±lO%), diseased arteries 
(2.3±0.8), and frequency of heart failure 
(34/90 pts, 38%) did not significantly differ 
between groups. Revascularization was performed 
in 9 (35%) SA pts and 35 (54%) ICD pts (p=NS). 
postoperative death occurred in 1/64 (1.5%) 
ICD pts and 4/26 (15%) SA pts (p=0.02). During 
a mean follow-up of 17.5 mo,38/64 ICD pts (60%) 
had at least one shock (mean 17/pt), and 18/64 
pts (28%) had at least one symptomatic shock 
(mean 29/pt). One SA pt had postoperative slow 
SMVT suppressed by drug therapy, and 1 SA pt 
was resuscitated from ventricular fibrillation 
at 18 mo. Antiarrhythmic drugs were required in 
30/64 ICD pts and 1/26 SA pts (p<O.OOl). Kaplan 
Meier survival at 2 years was 86±5% for ICD pts 
and 81±8% for SA pts (p=NS). conclusions: SA is 
associated with greater operative risk than ICD 
therapy, but results in improved arrhythmia 
control and diminished need for antiarrhythmic 
drugs. In selected pts, SA remains a viable 
therapeutic option for the treatment of SMVT. 
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914·37 
Reconatructive Surgery for Left ventricular Anterior 
Aneury.a. Barlf Bffecta on BeaodfDaaica and Regional Wall 
Notion. 
Marisa Di Donato,Giuseppe Barletta,Mauro Maioli, Fabio 
Fantini, Philippe Coste, Michel Sabatier, Francoise 
Montiglio, Vincent Dor. Institute of Internal Medicine, 
Cardiology Unit, University of Florence, Italy; Monaco 
Cardiothoracic Center, Monaco. 
The short-term hemodynamic effects of reconstructive sur•
gery for chronic post-infarction anterior aneurysm were 
evaluated by comparing the catheterization data of 35 
consecutive patients, who were studied before and within 
2 weeks after surgery.pts with previous inferior 
myocardial infarct were excluded. Surgical technique was 
performed by applying an endoventricular circular patch 
plasty so as to obtain a more physiological LV shape than 
that given by linear resection. Myocardial revasculari•
zation was performed when indicated. At the postoperative 
control no bypass was occluded and pts were off inotropic 
drugs. Results Showed an impressive improvement in LV 
pump function (EF from 38%13 to 49%15% , p<.001; EDVI 
from 120±55 to 76±22 ml/m2,p<.001; EDP from 17±7 to 13±5 
mmHg, p<.05) .The extent of wall motion abnormalities (% 
LV contour with hypokinesis more severe than 2SD below 
normal) decreased from 42±16% to 29±20%, p<.OOl. 
Segmental wall motion, analyzed with the centerline 
method,showed a significant improvement only at the 
inferior region (chords 42-85) .Six pts (17%) showing no 
increase in postoperative EF had no improvement in 
segmental wall motion. In conclusion. a) reconstructive 
surgery for anterior aneurysm gives better short-term 
hemodynamic results than those commonly reported after 
linear resection;b)the improvement in global EF appears 
mainly related to the increased systoliC shortening of 
the uninvolved inferior regions. 
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915·38 
Human In·vivo Intracoronary Tissue Otaracterization using Gray·Scale 
Texture Analysis: Validation with Excised Tissue from Atherectomy 
Peter j. Fitzgerald, Walter Brisken, Mukesh Gupta, Krishnankutty 
Sudir, Gordon Honda, Thomas M. Amidon, Thomas A. Ports, Brian L. 
Strunk, Paul G. Yock. University of California, San Francisco, CA 
Plaque composition may affect the natural history of coronary disease 
and the outcome of coronary interventions. High-resolution 
intracoronary ultrasound imaging (JCUS) is relatively insensitive in 
diSCriminating different compositions of plaque sUb-types and/or 
thrombus. Statistical indices derived from the ICUS signal, however, 
have shown promise in distinguishing certain plaque types in-vitro. 
Directional coronary atherectomy (DCA) provides a unique in-vivo tool 
for validating these techniques since it provides tissue samples for 
histologiC study. Accordingly, we studied 7 patients undergoing DCA 
with 30 MHz ICUS. A total of 22 regions of interest (ROI) were 
identified on the ultrasound image prior to tissue excision of the same 
region with DCA. Each ultrasound ROI was digitized and stored on 
computer disc. A series of gray-scale difference statistics (GSDS), 
which measure the pixel homogeneity and heterogeneity within the 
ROI was computed. Specimens were immediately fixed, stained and 
independently categorized into two distinct histologic groups: (A) 
Loose connective tissue, histiocytiC infiltration and sparse collagen 
fibrils; (B) Dense connective tissue with variable amounts of fatty 
atheroma and necrotic debris. ~ GSDS parameters provided 
statistically significant discrimination between plaque sub-types: 
A B 
Conclusion: Intravascular tissue characterization by texture analysis 
may provide a convenient method for differentiating plaque sub-types 
in human coronary arteries. The ability to recognize particular plaque 
composition may be clinically important for leSion risk stratification. 
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915·39 
Development of Echogenic Llposomes for TIssue·specific 
Ultrasonic Image Enhancement 
Gregory M. Lanza, M. Hayat Alkan, Michael J. Vonesh, Melvin 
E. K1egerman, Lee J. Frazin, David J. Mehlman, James V. 
Talano, David D. McPherson. 
Northwestern University Medical School and University of 
lIlinois at Chicago, Chicago, IL 
Contrast agents have been developed for improved ultrasonic 
assessment of blood flow and tissue perfusion. However, no 
contrast agents provide tissue·specific ultrasonic image 
enhancement. We have developed a method for producing 
echogenic multilamellar Iiposomes with small particle sizes 
whicli can be conjugated to antibodies and can be targeted to 
specific, pathologic tissues. Four formulations of Iiposomes 
utilizing phosphatidylcholine (PC), phosphatidylethanolamine 
(PE) and cholesterol (CH) were produced by a dried, 
reconstituted vesicle method with a mean particle size of 1 • 8.8 
microns after extrusion. Liposomes were Imaged in vitro with a 
20 MHz intravascular imagmg catheter to identify echogenicity. 
Results: 
Liposome Gray Scale 
Composition Mean GS Heterogeneity 
PC 3.31 3.34 
PC:CH 9.82 8.33 
PC:PE 21.68+ 11.94 + 
PC:PE:CH 23.85 + 13.86 + 
(+ p<0.05 vs PC); GS = gray scale 
PC:PE:CH and PC:PE Iiposomes are markedly echogenic when 
compared to other compositions. Adaptation of these echogenic 
liposomes should provide specific ultrasonic contrast 
enhancement of cardiovascular pathologic tissues. 
915·40 
Sensitivity and Specificity of Ultrasonic Tissue 
0IimIct:erilrat far the IllagrDJis of Acute IIJCCmdial 
IDfm:ct.ial. 
Kooroush Saeian, Theodore Rhyne, Kuan B. Sagar. 
Medical College of Wisconsin, Milwaukee, WI. 
AMI Positive 
AMI Negative 
t1lt 2DE 
Pes Neg Pes Neg 
12 2 10 4 (oontraIlSllllral) 
2 19 1 20 
UTe and 20E had a sensitivity of 86% vs 71% and 
specificity of 90% and 95%, respectively. UTe was 
superior to 2DE for diagoosis of oontransnural AMI and 
similar to 2DE for transmJral AMI. We conclude that a 
combination of UTe and 20E may improve accuracy of 
ultrasound for cIiagoosis of AMI. 
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Demonstration of Cellular Architecture in Thick 
Myocardial Sections by High Frequency Ultrasound 
P. Anthony N. Chandraratna, Para Chandrasoma, Joie P. 
Jones, Shahbudin H. Rahimtoola, Jacqueline Gallet. 
Division of Cardiology, LAC+USC Medical Center, Los 
Angeles, CA and Dept. of Radiology, UC Irvine. 
We have previously demonstrated that high frequency 
ultrasound (200-lO00 MHz) is capable of imaging 
cellular detail in 5 II sections of myocardium. This 
study was designed to assess the feasibility of imaging 
thick sections of myocardium by high frequency ultra•
sound. Three, 30 II sections of myocardium and three 5 
mm sections of myocardium were imaged with a 200 MHz 
transducer. The ultrasound images of 30 II sections 
generated by transmission of the soundbeam through the 
tissue and reflection off the slide revealed cardiac 
myocytes with a dark cell membrane and a light hypo•
echoic cytoplasm. With the thicker 5 mm specimens, the 
ultrasound pulse generated by the 200 MHz transducer is 
brought to a focus in the specimen. The backscattered 
ultrasound is detected by the same transducer. The 
images of myocytes displayed phase reversal, i.e. the 
cell membrane was hypoechoic and the cytoplasm was 
dark. 
CONCLUSION: The data indicate that a 200 MHz trans•
ducer can generate backscatter images of myocardium. 
Thus, this technique is probably suitable for in vivo 
application. 
915·42 
Effect of Coronary Blood Flow on Myocardial Gray Level 
Amplitude in 2·Dimensional Echocardiography: an Experimental 
Study 
Cecilia Marini, Eugenio Picano, Daniele Rovai. Massimo Lombardi, Marco 
PaUlrni. Gianna Ghelardini. Maria Giovanna Trivella. Luigi Landini. Alessandro 
Distante. Antonio L' Abbale. 
CNR. InstitUIe of Clinical Physiology. University of Pisa. Pisa. Italy. 
Mean amplitude (A) and percent systodiastolic variation (%0) of myocardial 
gray level inlensities of echocardiographic images have been proved to be useful 
in identifying ischemic myocardium. which exhibits an increased A and a blunted 
%0; the underlying mechanisms. however. remain elusive. Aims of this study 
were: I) to evaluate A and %0 in different layers (subendocardium and 
subepicardium ) of the canine left ventricle; 2) to assess the dependence of these 
parameters upon local variations of coronary blood flow. In 4 anesthetized 
open.chest dogs the circumflex coronary anery was cannulated and perfused by a 
roller pump with blood from their own femoral artery during maximal 
vasodilatior, oblained by adenosine infusion. The absolute coronary flow values 
and its transmural distribution were measured by radionuclide labelled 
microspheres. Echo images were obtained in shon axis view by a commercially 
available electronic sector scanner with a 5 MHz transducer direclly placed on the 
epicardial surface and digitized off·line. Average gray level was calculated for each 
region of interest and expressed in units on a 1 to 256 scale. In 21 different 
conditions circumflex flow ranged from O.SO to 7.40 ml/min/g and the endo/epi 
ratio of flow from 0.53 to 0.96. In none of these cases a regional dyssynergy was 
detected. In basal Slate. in the circumflex region (subjected to flow changes) 
segmental A went from SI±23 (end-diastole. mean ± SO) to 63±17 (end-systole): 
p<.ool. For all levels of flow. subendocardial and subepicardial regions showed 
similar values of A and %0. No significant relationship was found between 
transmural distribution of flow and segmental A (r=.12. p=ns) or %0 (r=.09. 
p=ns). In conclusion: I) a consistent systodiastolic gray level variation is present 
in the canine left ventricle but subendocardial and subepicardial layers show 
similar values in both A and %0; 2) in the absence of severe underperfusion and 
echocardiographically deteClable dyssynergy. A and %D are totally unrelated to 
changes in coronary blood flow. 
JACC Vol. 19, No.3 
March 1, 1992:115A 
915·68 
DIGITAL THREE·DIMENSIONAL RECONSTRUCTION 
OF THE DESCENDING THORACIC AORTA FROM 
TRANSESOPHAGEAL ECHOCARDIOGRAPHIC 
IMAGING. 
Petros Nihoyannopoulos, Anthony Reynolds, Keith 
Humphries, Darin O'Keefe, Keith Willson. Department of 
Medicine (clinical cardiology) and Medical P'hysics, 
Hammersmith Hospital, R.P.M.S., London, England. 
Transesophageal echocardiography was used to obtain 
three-dimensional displays of the descending thoracic aorta. 
Images were acquired on-line using a 386 microcomputer 
with a 100 Mb hard disc memory and a video capture card to 
translate the composite video signal into a series of arrays 
(grey-scale) of 640X350 pixels, 8 bits per pixel. The distance 
(cm) of the transesophageal probe from the incisors was 
taken as a reference pOint for the transducer depth. Depth 
(cm) from the incisors was substantiated every 5 milimeters, 
commencing from the transgastric position (45 cm from the 
incisors) and slowly withdrawn until reaching the aortic arch. 
Images were transferred to a "context vision" image 
processing computer system and further processed using 
"Analyse", a three-dimensional software analysis package. 
Interpolation techniques were also used to collate and 
register the ensuing data. 
Thus, digital three-dimensional reconstruction of the 
descending thoracic aorta is feasible during routine 
transesophageal examination. This three-dimensional 
reconstruction of the thoracic aorta can allow a better 
appreciation of the spatial distribution of aortic pathology, in 
particular the site and extend of atheromatous plaques and 
aortic dissections. 
915·69 
Is 3-Dia •• Ii.u1I.tncon • .,.,. Oltnle ••• a Giaaick or a 
0 .. '.1 Cliaical Tool7 b,.ri •• co ia Cere • .,.,. AUtoncta.y 
Mart. L. Smucter, Dia.ne Iil, William S. Sarnat, Fra.D.klill C. Wefald, 
Paul F. Bovard, St. joseph's IoIld India.na University Medical Centers, 
South Bend, IN 
Intr&coronary ultrasound UIeSSeS both VlStu1&r lumen IoIld deeper 
VlStu1&r structures, vhich should be uniquely useful in coronary 
atherectomy. Bovever, ultrasound is limited by difficulty in inter•
pretin, cross-sectional arteria.! "donut" imqes, vhich lite JUde con•
Cusin, by imqe "noise", catheter artifacts, vascu1&r calcification, IoIld 
motion. We hypothesized th&t computer reconstruction of sequential 
2-dimensional (2-D) "pullback" imqes into 3-dimensional (3-D) 
imqes vould facilil&te interpret&tion IoIld evalu&tion of atherectomy. 
lIoUt .. : 189 intr&coronary ultrasound studies vere performed in 
46 coronary atherectomy procedures since 1989, usin, either ph&sed 
&tr&y (n-38) or both ph&sed &tr&y IoIld mechanical ultrasound devices 
(n-8). 124 "pullback" 2-D imqes from 38 procedures vere 
reconstructed into 3-D imqes. In8 p&tients"real time" 3-D imqes 
vere reconstructed online, latin, about 90 seconds. 
Ro .. Us: 3-D imqes lite readily reconstructed, either on or offline, 
substantially reducin,2-D imqe "noise". While 2-D imqes shov 
catheter artefacts, arteria.! side bra.D.ches, arteria.! p1&que morphololY, 
and intr&arteria.! calcium deposits, 3-D imqes more c1e&tly 
differentWe these features. The orient&tion of side bra.D.ch to p1&que 
loc&tion m&y be re&dily discerned, enhlollcin, the &bility to remove 
p1&que vith atherectomy. Ultrasound demonstr&tes more p1&que thloll 
an,io,r&phy, and favor&ble loIl,io,r&phic results precede subst&lltial 
p1&que removal. Pro,ressively deep cuts my be seen, providin, loll 
indic&tion to terminate atherectomy. Spiral cuts resultin, from 
rot&tion of the atherectomy catheter durin, a cut m&y be visualized. 
U1tr&sonic "c&ltium" decre&seS the tissue removed IoIld my result in 
recovery of calcified p1&que. 
C..ct.lioa: More thloll a ",immick", 3-D intr&coronary 
ultrasound is a clinic&lly useful tool in coronary atherectomy. 
ABSTRACTS 
915·70 
Direct Measurement of Pleque Volume by Three·Dlmenslonal 
Ultrasound: Potentials and Pitfalls 
Frank C. Galli, Krishnankutty Sudhir, Ann K. Kao, Victor K. Hargrave, Peter 
J. Fitzgerald, Paul G. Yock. University of California, San Francisco, CA. 
Accurate plaque volume measurements in patients could be highly 
valuable in assessing plaque regression and removal. Atthough 
intracoronary uttrasound (ICUS) has been shown to give reliable estimates 
of cross-sectional plaque areas, no study has evaluated the aocuracy of 
three-dimensional (3-0) plaque volume (PV) determinations. Accordingly, 
we tested two methods of PV measurement using ICUS in plaque 
phantoms with precisely calibrated PV's. Direct 3-0 PV measurements 
were made with a commercially available, computer-based 3-0 
reconstruction system (ImageComm) which calculates PV based on an 
automated assignment of lumen borders. This ap;lr08ch was compared to 
an integrated two-dimensional (2-D) volume determination based on semi•
automatic planimetry of cross-sectional images at 1 mm increments. 
Phantoms were created by sculpting an acoustically appropriate 
gelatirv1lour mixture wfthin regular cylinders. ICUS catheters were pulled 
through the phantoms over a central guide wire using a micromanipulator. 
The plaque substance was then extracted and Hs volume determined by 
water displacement. Regression equations for estimated and measured 
plaque volumes were generated from 33 pullbacks in 9 phantoms (3-D) 
and 30 pullbacks in 10 phantoms (2-D). 
3-0: PV(estimated)" 1.27 X PV(measured) - 0.01 (r .. 0.93, p<0.OO1) 
2-D: PV(eslimated)" 1.00 X PV(measured) + 0.53 (r .. 0.97, p<0.(01) 
Thus 3-0 volume estimation was slightly less accurate than the 2-D 
planimetry method, even under ideal in-vftro condftions. The tendency of 
3-0 to overestimate plaque volume may be due to erroneous identification 
of image artifact as plaque. Such errors are likely to be increased in the 
clinical seHing with lower signal:noise images and changing orientation of 
image artifacts wHh the cardiac cycle. We conclude that at the current level 
of technical developement, 2-D planimetry provides more reliable 
measures of plaque volume than direct 3-0 reconstruction. Further 
refinements in ICUS image qualHy, 3-0 threshold algorithms and user 
interface software should improve the accuracy of 3-0 and realize Hs 
advantages in efficiency and convenience. 
915-71 
Lumen Cast Analysis: A Quantitative Format to Expedite On· 
Line Analysis of 3D Intravascular Ultrasound Imeg .. 
Kenneth Rosenfield, JenHer Kaufman, Ann Pieczek, Douglas W. Losordo, 
Bernard D. Kosowsky, K. Ramaswamy, John O. Pastore, Jeffrey M. Isner, 
Tufts Universfty School of Medicine, St. Elizabeth's Hospftal, Boston, MA 
Previous studies from our laboratory have demonstrated the feasibility of 
on-line«100 seconds) 3-dimensional (3~) reconstruction of 2-dimensional 
(20) intravascular uHrasound (IVUS) images, using efther a sagittal (SAG) 
("revolve mode") or cylindrical (CYL) format. While both the SAG and CYL 
formats faCilitate qualitative analysis of pathologic atterations Involving 
plaque and arterial wall, neither format allows quantitative analysis of 
residual luminal stenoSis. We therefore evaluated a novel 3D format, 
luminal cast analysis (LCA), designed to expedite on-line operator analysis 
of 3D IVUS images. Briefly, following acquisition of 20 cross-sectional 
IVUS images during IVUS catheter pullback, a cast of the vascular lumen is 
reconstructed (see below). A previously validated, automated edge•
detection algorithm then performs quantHative analysis (OA) of cross-
I 
sectional area (CSA), displayed as 
a linear plot along the length of the 
reconstructed vessel, rapidly 
identifying Sites of residual 
stenosis. To demonstrate the 
feasibility and potential utility of 
on-line LCA, 30 reconstructions were rendered In 19 patients during 
percutaneous revascularization (8 iliac, 8 femoral, 2 graft, 1 renal). Time to 
30A display was 65 to 100 seconds. Post-intervention, OA disclosed 
mean diameter (mm) and CSA (mJ112), respectively, of 4.9 and 22.2 at sftes 
of residual stenosis, 6.2 and 34.8 at reference sHes. Average residual 
CSA narrowing was 38%. In 4 of the last 9 pts, LCA rapidly detected 
signHicant (>50%) residual CSA stenosis, not readily seen by SAG or CYL 
formats, or IVUS alone; moreover,only LCA provided immediate analysis 01 
residual CSA stenosis. Conclusion: 1) LCA of 20 IVUS Images can be 
accomplished routinely on-line during interventional procedures in a timely 
fashion; 2) the LCA format expedites analysis of 3D IV US Images; 3) 
automated edge-detection and subsequent quantftative analysis provides 
a practical and expedHious means of direct CSA measurement in vivo. 
115A 
116A ABSTRACTS 
915·72 
A New Comprehensive System for Reliable Three· 
Dimensional Intravascular Ultrasound Image 
Acquisition, Reconstruction, and Analysis 
Gary S. Mintz, Martin B. Leon, Sharon L. Eldredge, Terry Laas, 
James Gessert. Washington Hospital Center, Washington, D.C. 
Current intravascular ultrasound (IVUS) devices are limited by 
catheter size precluding imaging severe stenoses or distal vessels and 
inadequate axial and 3·dimensional (0) geometric information. 
Therefore, a new system was configured consisting of (1) a 25 MHz 
ima~-.I1g catheter rotating at 1800 rpm within a 3.9F monorail sheath, 
(2) a prototype mechanism capable of withdrawing the imaging 
catheter within the sheath at a precise constant rate of 0.25, 0.5, and 
1.0 mm/sec, and (3) an image processing computer capable of near 
real-time reconstruction of >200 evenly-stacked cross-sectional 
images. This system was studied in 27 pts before andlor after 
transcatheter therapy. The low-profile catheter negotiated tonuosity 
to image both severe stenoses and distal vessels. Once the assembly 
(sheath + imaging element) was positioned across the lesion site, 
automatic pullback of the imaging element (within the sheath) at 0.5 
mm/sec created image slices 17 microns apart. The withdrawal time 
to the guiding catheter determined the distal position of the lesion (up 
to 10 cm, mean 5.5 cm) and served as a non-angiographic reference 
for comparative (e.g. pre/post intervention and follow-up) studies. 
After initial placement of the assembly, multiple image sequences 
were obtained without fluoroscopic guidance. The average study 
time was <5 minutes. 3D reconstruction utilized a cylindrical arterial 
model; there was greater architectural detail seen in shoner than in 
longer segments as the image slices were stacked closer together. 
The validity of this 3D IVUS system was tested in vitro and in vivo 
by studying vessels and targets of known architecture and geometry, 
including endovascular stents. In conclusion: A new 3D IVUS 
system has been developed which allows easy access to most 
coronary lesions to provide accurate, high resolution, reproducible 
intra-coronary 3D images. Future studies are required to clarify 
clinical applications for this technique. 
915·74 
Increased Echodensity Preceeds Regional Dyssynergy 
During Coronary Angioplasty· a Videodensitometric 
Study_ 
Francesco Faletra, Cecilia Marini, Eugenio Picano, Luigi Campolo, 
Marco Patemi, Luigi Landini, Antonio Pezzano. 
Ospedale Niguarda- Milano; CNR- Institute of Clinical Physiology•
Pisa, Italy 
A transiently increased echoreflectivity of the ischemic dyssynergic 
myocardium has been detected in the animal as well as in man by 
videodensitometric analysis of standard two-dimensional images. 
Aim of this study was to assess the temporal relationship between 
regional dyssynergy and the variation in gray level amplitude 
detectable by digital texture analysis of standard echocardiographic 
images in man. Continuous 2D echocardiographic monitoring was 
performed during 10 balloon inflations in 5 patients with single 
vessel coronary disease undergoing percutaneus transluminal 
coronary angioplasty. Computer assisted determination of gray level 
amplitude was obtained off-line on video digitized images of 10 
ischemic events causing regional transient dyssynergy (reduction of 
regional % systolic thickening ~ 20% versus resting values). In the 
territory dependent upon the transiently occluded coronary, 
end-diastolic gray level amplitude increased significantly (baseline= 
67±20 arbitrary units in a 1 to 256 scale vs occlusion= 76±22, 
p<.05) at peak ischemia (after 45±1O sec of occlusion) while 
remained unchanged in a control remote region (baseline= 54±24 vs 
occlusion= 56±21, p=ns). For shorter periods of occlusion (l5±5 
sec) an increased mean gray level amplitude was also detected in the 
risk zone (baseline= 67±20 vs occlusion= 78±22, p<.05) in the 
absence of regional dyssynergy. 
We conclude that: I) transient myocardial ischemia produced by 
coronary occlusion in man is associated with increased regional echo 
amplitude; 2) the regional increase of echodensity can be detected 
before the development of regional dyssynergy. 
lACC Vol. 19, No.3 
March 1, 1992:116A 
916 Pathogenesis of Acute Coronary Syndromes 
Tuesday, April 14, 1992 
9:00 AM-Noon 
Dallas Convention Center 
Lower Level Exhibit Hall 
Presentation Hour: 9:00 AM-lO:00 AM 
916·59 
The Effect of Endothelln·1 Is Attenuated by Hypoxia 
and Na-H Exchange Inhibition, but Potentiated by 
Reperfuslon and by L-Nltro-Monomethyl-Arglnlne (L•
NMMA). 
S. Neubauer, M. Horn, J. Hofmann, A. Hirsch, S. 
Zimmermann, W. Bauer, G. Ertl. Department of Medicine, 
WOrzburg University, FRG. 
Endothelin-1 (ET-1) causes dose-dependent coronary 
constriction as well as release. Using the isolated, isovolumic, 
buffer -perfused rat heart, we tested whether the constrictor 
effect of ET-1 during control (co; P02=500mmHg) is altered by 
hypoxia (hyp; P02=150mmHg; increase of baseline coronary 
flow (bCF) by 32%), Na-H exchange inhibition (1 mM 
amiloride; bCF unchanged) or reperfusion (rep) following 30 
min of total ischemia (bCF unChanged), and whether it is 
counteracted by EDRF release. ET-1 bolus injections were 
performed at increasing dosages. EDRF production and thus, 
release, was inhibited by L-nitro-monomethyl-arginine (L•
NMMA; 10-4M). 
ET-1 n 10 100 1000ng 
co 9 93±3 84±4# 30±6 
co+L-NMMA 7 88±3 65±3 20±3 
hyp 10 97±1 96±1*# 33±4 
hyp+L-NMMA 6 94±2 84±4 22±3 
rep 8 83±4* 64±7* 37±7# 
rep+L-NMMA 5 80±1 48±3 11±3 
amiloride 5 106±4* 100±11* 73±14* 
Data are % of bCF. #p<O.05 colhyp/rep vs L-NMMA. #p<0.05 hyp/rep vs co. 
Conclusions: The coronary constrictor effect of ET-1 is 
attenuated by hypoxia, mediated in part by Na-H exchange, 
and is enhanced by reperfusion; it is potentiated by L-NMMA 
in contrOl, hypoxic and reperfused heart, suggesting that 
EDRF counteracts ET-1 in normal and injured heart. 
916·60 
Dietary Fish 011 Reduces Infarct Size In Rats 
Bo-qing Zhu, Richard E Sievers, Vi-ping Sun, William W Parmley. 
Christopher L Wolfe. 
University 01 CalHomia, San Francisco, CA 
To test the hypothesis that acute or chronic lish oil administration reduces 
myocardial infarct size in rats, Spague-Dawley rats fed a diet containing 12% 
fish oil (18%EPA, 12% DHA) for 1 week (FO lwk, n=9) or 8 weeks (FO 8wk, 
n=30) and controls (n=8, n=28 respectively) were subjected to 35 minutes 
left coronary artery (LCA) occlUSion followed by 120 minutes of reperfusion. 
Risk area was measured by phthalocyanine blue staining. Infarct size was 
determined by triphenynetrazolium chloride staining. Compared to the 
confrols, infarct size was signHicantly reduced in FO 8wk rats (37±23%, n=28 
vs 14±15%, n=30; P<O.OOI; % Inf.size/Risk area). The reduced infarct size 
was associated wtth greater functional recovery (LV systolic pressure (SP) at 
120 min rellow: 133±8 mmHg, n=10 vs 109±5 mmHg, n=10; p<0.05) and 
Improved survival (94% vs 65%, p<O.OI) in FO 8wk rats compared to 
controls. Furthermore, there was an inverse relationship between Infarct 
size/LV mass and LVSP after 120 min reflow (LVSP = -1.8 x Inf size + 132, 
r=0.46, p<O.05). Prior to and during LCA occlUSion, there were no 
differences between groups in the RPP, the major hemodynamic 
determinant of myocardial oxygen demand. The infarct size in FO lwk rats 
was similar to controls. (39±16%, n=9 vs 35±14%, n=8; p=NS). Myocardial 
EPA and DHA levels were significantly higher in FO Bwk group(I.9±O.I; 
26.9±1.4 respectively) compared to control 8wk (O.3±O.I. 15.3±2.1; 
p<O.OOI) and FO lwk rats (1.7±O.2, p<0.05; 21.7±1.4. p<O.OOI). Bleeding 
time was prolonged in FO 8wk rats (323±313 sec) compared to control8wk 
rats (92±39 sec, p<O.05) and FO lwk rats (147±49, p=0.05). 
Thus, chronic but not acute dietary fish oil supplementation significantly 
reduces the infarct size in this animal model of ischemia and reperfusion. 
This reduction of Infarct size was Independent of the hemodynamic 
determinants of myocardial oxygen demand during ischemia and was 
associated wtth significantly elevated myocardial EPA and DHA levels in the 
FO Bwk group COrTl>ared to control8wk and FO lwk rats. 
lACC Vol. 19, No.3 
March 1, 1992:117A 
916·61 
Coronary Vascular RMlltaneels More Reeponalve to Exogenou. 
Serotonin 11I.n Adenoalne After I Brief Period of lachernll Followed 
by Reperfualon 
Eric K louie, Robert J. Hariman. Yong-Gao Wang, Ming H. Hwang, Henry 
S. Loeb, Patrick J. Scanlon, Loyola Univ Med Ctr, Maywood, IL 
The regional coronary vasodilator responses to adenosine and serotonin 
were compared In the left anterior deacendlng (lAD) territory, which 
underwent ischemia followed by reperIusIon, and In the left circumflex 
(LeX) territory, which served as a control. In each of 10 dogs dose 
response curves were constructed for both drugs to detennlne the 
Infusion rates resulting In maximal LAD blood ftow measured by ultrasonic 
flow probe prior to LAD occlusion. Then the LAD was occluded for 20 
min followed by 20 min of raperfuslon at which tlma, In random order, 
adenosine (HI umoIas/mln) or serotonin (1.1.5 umoles/mln) was Infused 
into the LA at the predetermined maximally vasodDatlng dose rate. 
Regional myocardial blood flow (RMBF) was measured In the LAD and 
LeX territories using 15 u mlcrospheres labelled with "Sc, "Sr, or "'Ce, 
prior to drug Infusion and during a steady state infusion of each drug. 
Regional coronary vascular resistance (CVR) was calculated as the ratio 
of mean arterial pressure (AP) and RMBF. During adenosine and 
serotonin Infusions there were no significant differences In AP (90.±.2O v 
101.±.26 mmHg), HR (147.±.21 v 146.±.19 bprn), or CO (3.2.±.1.0 v 3.5.±.1.4 
IImln). The responses to each drug were expressed as per cent 
decrease In CVR ("CVR) • {(CVR pre drug) - (CVR drug)} x l00/{CVR 
pre drug}. 
"CVR Adenosine "CVR Serotonin ..JI.. 
LAD 43.±.22 56.±.24 <.001 
LeX 64.±.26 63.±.IS NS 
In the control LCX territory both drugs achieved comparable reductions 
In CVR. In comparison to the LCX territory, the reduction In CVR In the 
reperlused LAD territory was blunted for both adenosine (43.±.22 v 
64.±.26", p<.OOI) and serotonin (56.±.24 v 63.±.IS", p<.OI). MaxImal 
adenosine vasodilation In the reperfused LAD territory resulted In a 
slgnHlcantly smaller reduction In CVR then maximal serotonin vasodilation. 
These resUts are contrary to the concept that ischemia and reperfuslon 
preferentially depresses responses to indirect (endothelial dependent) 
coronary vasodilators (such as serotonin) and suggests that alternative 
mechanisms may selectively depress microvascular responses to 
exogenous adenosine. 
916·62 
Intracoronary Injection of basic Fibroblast 
Growth Factor Enhances Neovascularization in 
Infarcted Myocardius of Chronic Swine Model. 
Alexander Battler, Mickey Scheinowitz, Amir 
Bor, Zvi Vered, Elio Di Segni, Nira Varda, 
Moshe Neuman, Devorah Nass, Santiago 
Engelberg, Miriam Biniaminov, Michael Eldar, 
Naphtali Savion. Neufeld Cardiac Research 
Institute, Tel Aviv University, Sheba Med 
Ctr, Tel Hashomer, Israel. 
To evaluate the angiogenic effect of exogenous 
basic Fibroblast Growth Factor (bFGF), chronic 
patchy myocardial infarction was produced in 
close chest swine by intracoronary injection 
of affigel blue beads (75-150 micron) to 
produce multiple distal LAD coronary 
embolizations. The beads served also as a slow 
release vehicle and were injected either with 
bFGF (0.12~gr/kg) - group A (n-6) or without 
bFGF - group B (n-4). Echocardiographic 2D 
regional wall motion score (meantSD) was 
similar at 3h (8.6t5.3; 7.5t4.2) and 2 weeks 
(4.3t2.5; 3.5tl.6) following MI for groups A 
and B respectively. The pigs were sacrificed 
at 2 weeks and microvessels in infarcted areas 
were highlighted by immunocytochemical 
staining of endothelial cells for factor VIII. 
Microvessel count in 0.44mm 2 area was 
significantly higher in the bFGF treated group 
for both microvessels without lumen, 
(A-266.9t26.4 vs B-45.3t5.5; p<0.001) and for 
microvessels with lumen (A-66.7t4.9 vs 
B-49.6t5.3; p<0.05). Conclusions: In the 
swine, direct intracoronary application of 
bFGF to infarcted myocardium enhanc.s 
myocardial neovascularization within 2 weeks. 
ABSTRACTS 
916·63 
Failure of Simulated ischemia 10 Protect Against Efferent Sympathetic DenervaUon 
DurIng Subsequent Acute MyocardIallnlarctlon In Dog Heart 
Michael Ribar!, Dol1Jlas P. Zipes. 
Indiana Universily, Krannert Institute of cardiology, Indianapolis, neliana 
Repeated short term occlusions (OCC) condition the myocardium to withsland the 
ellects, such as sympathetic denervation, of a subsequent long term oce. To elucidate 
the mechanisms by which Ischemic preconditioning reduces eflerent sympathetic 
denervation of noninlarcted myocardium apical to the site of transmural myocardial 
inlarction (MI), anesthetized dogs received lour 5·min Intracoronary perfusions with 
oxygenated, normal Tyrode's (NT; n .11) or Ischemic Tyrode's (IT; 12 mM K+, 10 11M 
adenosine, 6.8 pH; n .11) separaled by 5 min of blood reperfusion prior to OCC 01 the 
diagonal branch of the LAD coronary artery. In a control group (C; n - 5) hearts 
underwent a continuous blood perfusion prior to permanent OCC. Shortening of effective 
re~actory periods (A ERP) induced by sympalhetic stimulation (SS) basal and apical to 
the area 01 MI was determined belore and after perfusions and 20, 60,120 and 180 min 
after OCC to monitor the effects of MI on innervation. 
ms 0 A ERP apical ,Ite, 
·10 
·20 
·30 -I-...-r ........ ,.....-r....,-"r'"' ................. . . . . . . 
b.'.r •• ".r 2 0 6 0 1 2 0 1 8 0 min 
t- occlullon ..... 
I,chemlc Tyrode 
normal Tyrode 
control 
In all groups, A ERP at basal tesl sites was unchanged before and after oce. A ERP at 
apical sites was preserved aller perfusions and became significanUy aftenualed 20 min 
after OCC (p < 0.05) and declined further thereafter. The size in reduction of A ERP 
during OCC was comparable between groups, as was the degree of subepicardial 
involvemenl in MI Ie: 11.0 ± 6 'to, NT: 11 ± 4 'to, IT: 10 ± 5 'to; mean ± 1 SO; the ratio 01 left 
ventricular circumference). 
Thus, exposure to ischemic metabolites prior to a subsequenl permanent coronary 
occlusion does not trigger mechanisms responsible for protection against eflerenl 
sympathetic denervation apical to an area of transmural myocardial ischemia I infarct. 
916·64 
Depiction Of Myocardial Infarction Using Magnetic 
Resonance Tagging and Iron Oxide Contrast 
Susan B. Yeon, Nathaniel Reichek, Barbara A. Tallant, 10ao A.C. 
Lima, Linda C. Palmon, Neil R. Clark, Deanna Brownson, Eric A. 
Hoffman, Leon Axel, Hospital of the University of Pennsylvania, 
Philadelphia, PA 
117A 
Magnetic resonance tagging (SPAMM) permits noninvasive 
assessment of myocardial segment shonening (%S), but infarcted, 
stunned and ischemic regions all show mechanical dysfunction. 
Therefore, we evaluated the feasibility of depicting infarction using 
SPAMM and iron oxide contrast (Fe) which induces signal loss in 
perfused myocardium. In a canine infarct model (n=12), after shan 
axis SPAMM imaging, we administered 10-20 mg/kg Fe, obtained 
matched untagged spin-echo images, and stained shon axis sections 
with TIC. Mean pixel intensity prior to Fe was 76±15. After Fe, it 
was 61±15 in regions of Fe defect and 16±6 in regions of Fe effect 
(p=O.OOOl). Fe defects were readily apparent on image inspection. 
Circumferential %S was 18±11 in regions remote from Fe defects and 
2±9 in regions of Fe defect (p<o.05 vs. remote); adjacent to defects it 
was 11±10 and on slices next to defects it was 15±13 (p<o.05 vs. 
defect for both). A normal transmural gradient in %S was seen in 
remote regions but not in regions of Fe defect. The size (expressed as 
% of slice area) of contraction abnormality detennined by SPAMM 
was greater than that of Fe defects (57±44% vs. 3007%, p=O.OOOI), 
but correlated welI with Fe defect size (%SPAMM defect = 1.5 x 
%Fe defect + 0.1, r=O.87). TIC and rhodamine defect sizes (31±20 
and 3l± 33%) were smaller than SPAMM defects (p=O.OOOI for 
both) but not significantly different in size from Fe defects. 
Rhodamine staining was concordant with Fe results on 21 of 24 
slices. TIC results were concordant with SPAMM defects on 28 of 
30 slices and concordant with Fe results on 29 of 30 slices (p=O.OOO I 
for both). AlI sites of necrosis except one fell within regions of Fe 
defect but were smaller than the defects. We conclude that combined 
SPAMM and Fe imaging may be useful in distinguishing between 
myocardial necrosis and stunning or persistent ischemia. 
118A ABSTRACTS 
916·65 
Ischemic Preconditioning limits Post-Reperfusion 
Myocardial Edema and Preserves Left Ventricular Function. 
Esther Sanz, David Garcfa-Dorado, Juan Oliveras, F~lix 
P~rez-Villa, Mil Josep Carreras, Pierre Th~roux, Jordi 
Soler-Soler. Hospital Vall d'Hebr6n. Barcelona. Spain. 
Ischemic preconditioning (PC) has been documented to 
reduce infarct size but its mechanism is unknown. To 
evaluate its possible protective effect on osmotic 
reperfusion damage and on ventricular function 19 pigs 
underwent a 48-min LAD coronary occlusion (CO) followed by 
30-min reperfusion. preceded (PC group) or not (control 
group). at random. by two 5-min periods of CO followed by 
5 min of reperfusion. Contractile function was monitored 
in control and ischemic myocardium (ultrasonic crystals). 
After 30-min reperfusion the area at risk was delineated 
by in vivo fluoresceine injection. Water content was 
measured in transmural samples of control and reperfused 
myocardium. SystoliC shortening (SS, ,) was monitored. 
A 35' reduction in myocardial edema was found in the 
reperfused myocardium in the PC group: water content was 
475 ± 8 vs 522 ± 7 ml per 100 gr of dry weight tissue in 
control and PC group respectively (p = 0.0004). No 
differences were observed in control myocardium (397 ± 2 
vs 382 ± 12. NS). After 30 min of reperfusion SS in the 
reperfused segment recovered a 20 ± 3 , (p ( 0.02) of its 
basal value in the PC group but no recovery was observed 
in the control group; SS was 3.7 ± 1,13' and 8.S ± 0.7 , 
(p < 0.01) in control and PC group respectively. These 
results suggest that protection against reperfusion edema 
plays a role in the beneficial effects of PC. 
916·66 
Ischemic "Preconditioning" by Repeated Coronary Thrombus 
Formation is Associated with Favorable Alterations in Camitine•
Linked Metabolism in the Heart. 
Boris Z.Simkhovich, Michel Ovize, Robert A.Kloner. 
The Hospital of the Good Samaritan, the Heart Institute; and the 
University of Southern California, Los Angeles,California 
Repeated episodes of coronary artery occlusion protect or "precondition" 
the heart from subsequent sustained ischemia. We have recently 
documented that coronary cyclic flow variations (CFV) induced by 
formation/dislodgement of platelet thrombi (simulating unstable angina) 
also preconditions the heart,causing a decrease in infarct size. During 
sustained ischemia, accumulation of deleterious fatty acid metabolites•
long chain acyl-CoA and long chain acyl carnitine (LCAC) occurs. It is 
unknown whether or not CFV attenuates disturbances in camitine-Iinked 
metabolism during ischemia. Anesthetized dogs underwent 1 hour of 
sustained coronary occlusion and 4.5 hours of reperfusion. For 30 
minutes prior to occlusion, the dogs were randomly assigned to undergo 
coronary stenosis + endothelial injury, resulting in CFV, or no 
intervention (control).Blood flow during occlusion was assessed by 
injection of radioactive microspheres; infarct size was determined by 
tetrazolium staining (expressed as % of risk area). Biopsies from 
nonischemic (NI) and ischemic (I) zones were obtained for fluorimetric 
assessment of LCAC ; 
QBQJ.!E Blood fl ow 
~ 
NI 
1.08±0.09 0.19±0.03"" 9.9±2.7 
0.97±0.12 0.17±0.04"· 3.4±2.1· 
nmo)es/g wet tissue 
NI I 
131±13 219±22"" 
169±31 167±11 
Values are mean±SEM' P<O 05' *-vs control Zroup' **-vs nonischemic ZQne 
Both groups were equally ischemic during occlusion. Control group 
resulted in a site specific accumulation of LCAC. In CFV, a decrease in 
infarct size and blunting of LCAC accumulation in the ischemic zone was 
observed. CFV induced preconditioning resulted in a favorable alteration 
in camitine-Iinked metabolism during coronary occlusion. 
lACC Vol. 19, No.3 
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916·67 
Myocardial Protection with Preconditioning Correlates 
with the Degree of Glycogen Depletion Prior to Ischemia. 
Christopher L Wo~e, Thomas J Donnelly, Richard E Sievers, Frank 
Visseren. Universttyof Calnomia, San Francisco, CA. 
To test the hypothesis that preconditioning (four 5 min episodes of 
ischemia and reflow) reduces infarct Size by depleting cardiac glycogen 
stores and attenuating the degree of intracellular acidosis during 
subsequent prolonged left coronary artery (LCA) occlUSion, 
preconditioned and control rats were subjected to 45 min of LCA 
occlusion and 120 min of reflow immediately after preCOndttioning (Groups 
I and II respectively), or after a 30 min (groups III and IV) or 6 hour (Groups V 
and VI) non-ischemic recovery period after preconditioning but prior to 
prolonged ischemia. In each group, cardiectomy was performed in 
selected rats immediately prior to prolonged ischemia for cardiac glycogen 
assay. Group I rats demonstrated marked glycogen depletion after 
preconditioning compared to controls (0.5416±0.2880, n=5 vs 
4.613±0.S92, n-4, mg glucose/g wet WI, p<0.0001 vs Group II) that was 
associated with attenuation of intracellular acidosis during ischemia, as 
measured by 31 P magnetic resonance spectroscopy (6.8±0.l, n=ll vs 
6.2±0.1 pH untts, n=9, p<O.Ol), and marked infarct size reduction 
(0.3±0.2%, n=7 vs 38.1±4.3%, n=7, % infarct size/risk area, p<O.OOOl). 
During ischemia, there were no differences in myocardial ATP or PCr 
levels or in any hemodynamic determinant of myocardial oxygen demand 
between Groups I and II. Preconditioned rats that had recovered for 6 hr 
prior to LCA occlusion (Group V) had fully repleted cardiac glycogen 
stores (S.S60±0.569, n=ll vs S.021±1.1331, n=10, p=NS vs Group VI), 
marked intracellular acidosis during ischemia (S.8±0.5, n=5 vs 5.7±0.l, 
n=6, p=NS) and no reduction in infarct size (40.4±9.2%, n=ll vs 
35.5±9.9%, n.l0, pENS). Preconditioned rats that had recovered for 
only 30 min prior to ischemia (Group III) had partial repletion of glycogen 
stores (2.267±0.320, n-13 vs 5.018±0.303, n=14, p<O.OOOl vs Group 
VI) and and an intermediate reduction in infarct size (24.1±6.1 %, n= 13 vs 
43.6±6.4%, n=14, p-0.037). There was a direct correlation between 
infarct size and the cardiac glycogen level prior to Ischemia (measured in 
separate groups); [Cardiac Glycogen)-0.26 x Infarct size + 0.12, r=0.96. 
We conclude that glycogen depletion and the attenuation of Intracellular 
acidosis during ischemia are important factors In delaying irreversible injury 
and reducing infarct size in this animal model of myocardial 
preconditioning. 
916·91 
catecholamlnes during Coronary Balloon Angloplasty 
Gert Richardt, Reinhard Blessing, Roger KranzhOfer, Franz-Josef 
Neumann, Bernhard Rauch, Albert SchOmig. Department of 
Cardiology, University of Heidelberg, Germany 
Sympathetic activation of the heart is thought to play an important role 
in the pathogenesis of myocardial infarction. In the first minutes of 
experimental ischemia, the heart has been shown to be protected 
against catecholamine excess by extracellular accumulation of 
metabolites and intact neuronal catecholamine uptake. In order to test 
this finding in human myocardial ischemia, catecholamines, lactate, and 
adenosine as well as the adenosine metabolite hypoxanthine were 
determined In 17 patients subjected to routine balloon angioplasty 
(PTCA) of the left anterior descending artery. Samples were drawn 
simultaneously from the great cardiac vein and the femoral artery over 
SO seconds pnor to and immediately fOllowinll a 2 min balloon inflation. 
During PTCA all patients had angina pectOris. ST-segment deviations, 
and a rise in blood pressure and heart rate. Arterial catecholamine 
concentrations increased significantly following balloon inflation 
(noradrenaline: 0.97±O.09 to 1.71±O.2i nmolt1; adrenaline: 0.40±0.05 to 
O.S9±O.09 nmol/l). Coronary venous· arterial concentration differences 
showed the fOllowing changes (*p< 0.05): 
PTCA NoradrenaUne Adrenaline Adenosine Hypoxanthine 
nrnoVI nrnoVI Il/TIOVI I1rnoVI 
prior +0.04±0.06 ·0.10±0.03 +0.02±O.01 +0.14±O.15 
after ·0.50±0.18 ·0.34±0.09 +0.02±0.08 +1.97±O.58 
* * * 
Lactate 
mrnoVi 
+0.09±0.06 
+0.53±0.12 
* 
The data indicate a net uptake of rioradrenaline and adrenaline in the 
heart during coronary occlusion. In parallel, there was a cardiac 
formation of adenosine metabolites and of lactate induced by ischemia. 
In conclusion, the results demonstrate a systemic sympathetiC 
stimulation induced by a short coronary occlusion, while the ischemic 
myocardium is protected against catecholamine excess. The results 
are in accordance with experimental findings, showing that neuronal 
uptake, adenOSine, and acidosis prevent extracellular catecholamine 
accumulation in early myocardial ischemia 
JACC Vol. 19, No, 3 
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916·92 
Hypollaqn.semia Lowers the Temporal Threshold 
for Myocardial stunninq in Swin •• 
William R. Herzog, Ammar S. Bafi, William B. 
Weglicki, David Alyono. University of Maryland 
Medical Center, Baltimore, Maryland. 
We investigated the hypothesis that 
hypomagnesemia (hypomg) predisposes to 
contractile dysfunction after a brief episode 
of ischemia followed by reperfusion. Hypomg•
swine were produced br dietary restriction of 
magnesium. Serum Mg+ in age-matched control 
swine averaged 1.7 mEq/L compared to 1.0 mEq/L 
in hypomg-swine. A normothermic open chest 
model was used with occlusion of the distal LAD 
followed by reperfusion. Since severe stunning 
was seen after 12 min of ischemia, we studied 
shorter time intervals. Regional contractile 
function was measured with epicardial Doppler 
crystals in ischemic and non-ischemic zones by 
measuring thickening fraction (TF%) of the 
ventricular wall during systole. Ischemic zone 
TF%, was normalized to baseline. 
TF% of Ischemic Zones 
Ischemia n 10 min 20 min 30 min 
Normal 4 min 2 111±17 102±12 95±5 
HypoMg 4 min 2 106±8 96±2 91±7 
Normal 6 min 4 100+8 96+5 90+4 
HypoMg 6 min 3 77±4' 74~' 68±9' 
(X±SEM;'p<0.05, "p<O.Ol hypomg vs normal) 
After 6 min only hypomg-swine were stunned; 
after 4 min no significant stunning was 
observed in either group. These results 
suggest that hypomg-swine have an increased 
susceptibility to myocardial stunning. 
916·93 
Dobutamine Stress May Distinguish Stunned From 
Reperfused Necrotic Myocardium: Experimental Basis 
Albert J. Sinusas, QingXin Shi, Frans J. Th. Wackers, Barry L. 
Zaret. Yale University, New Haven, CT 
Dobutamine(DB) stress in conjunction with perfusion imaging and 
echocardiography have been proposed for the assessment of 
myocardial viability. To evaluate the effect of DB on transmural 
flow(FL) and function in the presence and absence of necrosis, graded 
DB stress was performed in 9 open chest dogs with either stunned 
myocardium (ST, n=5) or infarction (MI, n=4). ST dogs underwent 15 
min of LAD occlusion, while MI dogs underwent 3 hours of 
occlusion. DB was infused incrementally (2.5-10 j.lg/kg) in all dogs, 
after 3 hours of reperfusion(RP). Endocardial (EN), epicardial(EP), 
and transmural(TM) flow (ml/min/gm) was assessed with radiolabeled 
microspheres; during occlusion (OC), following RP, and at peak DB 
stress. EN, EP and TM myocardial thickening was assessed serially in 
the ischemic region with an epicardial pulsed Doppler technique, and 
expressed as % thickening fraction (% TF). Postmortem risk area (RA) 
was comparable between ST (32±2 % left ventricle(LV» and MI (33±3 
% LV) dogs. In MI dogs, infarct size by TIC staining was 44±4 % of 
RA. During OC regional flow and %TF in the central ischemic region 
were comparable in ST and MI dogs. Values during RP and DB were: 
ENFL EPFL TMFL EN%TF EP%TF TM%TF 
ST RP 1.I0±.19 1.93±.40 1.30±.23 11.6±9.9 1.I±2.8 4.0±5.5 
DB 1.80±.50· 3.00±.71· 2.12±.62· 33.4±8.7· 15.4±1.8· 23.9±4.2* 
MI RP O.66±.l8 I.OO±.l9 O.85±.04 -1l.1±3.9 -7.0±1.l -1O.2±l.O 
DB O.59±.22 1.85±.26· 1.I1±.17 -1.8±8.5 -2.S±3.4 -1.5±5.4 
(* p < 0.05 vs reperfusion value) 
In the presence of stunned myocardium, DB increases flow and 
function in EN, EP and TM regions. In the presence of myocardial 
infarction, dobutamine increases only EP flow. Dissociation of EP 
flow and function was observed in the MI dogs during DB, secondary 
presumably to underlying EN dysfunction. 
Thus, myocardial viability and salvage may be detennined early after 
reperfusion by analysis of combined regional functional and vascular 
reserve with DB stress. 
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917·94 
ABSTRACTS 
Effects of Beta Adrenergic Stimulation Versus Exercise on 
Diastolic Function in Nonobstructive Hypertrophic 
Cardiomyopathy 
Albert A. Hagege. Michel Desnos. Francisco Fernandez. Claude 
Guerol. Michael A. Fifer. Robert A. Levine, Boucicaut Hospital. 
Paris, France and Mass. General Hospital. Boston, MA 
119A 
It has been suggested that beta adrenergic blockade improves 
diastolic function in hypertrophic cardiomyopathy (HCM) and 
might therefore alleviate exertional dyspnea. Recent studies. 
however, have shown that beta adrenergic stimulation with 
isoproterenol (ISO) enhances LV relaxation m pts WIth obstructive 
HCM. The purpose of this study was: I) to determine the eHects 
of ISO on LV relaxation in HCM pts without significant resting 
obstruction. compared to atrial pacing at the same HR; and also 2) 
to determine whether ISO simulates the effect of exercise in these 
pts. who had exertional dyspnea (NYHA II). We studied 8 pts 
(mean age 55; normal coronaries. no mitral regurgitation or 
medications) at rest and with ISO infusion, supine exercise and 
atrial pacing. all to HR = 140% of basal. Micromanometer 
catheters measured LVEDP (end-diastolic pressure). peak negative 
dP/dt (-dP/dt) and T (time constant of isovolumic P decline). 
RESULTS (mean): (*: p<.OI; ns: p>.05) 
CO EOP -dP/dt T 
I/min mioHg mm H~/sec msec 
Rest "'T.U" J I -12 6 I --,,--
Pacing 5.3 ~s 17 ~s -1234 ns 64 
Exercise 6.7 I 34 1* -1376 I~S 62 
ISO 7.1 Ins 20 I -1860 I 44 
J* 
Ins 
J* 
Pressure gradient was 20 mm Hg with exercise vs 60 with ISO. 
CONCLUSIONS: I) Beta adrenergic stimulation increases the rate 
of LV relaxation and decreases T to a greater extent than pacmg or 
exeTCIse at SImIlar HRs in arts without resting obstruction. This 
challenges the convention use 01 beta adrenergIc blockade to treat 
heart failure in such pts. 2) ISO differs from supine exercise in its 
effects on LV function (pressure gradient and LVEDP). and 
therefore does not completely simulate exertion in such pts. 
917·95 
Regional Left Ventricular Mechanics in Hypertrophic 
Cardiomyopathy. 
Sandro Betocchi, Otto M. Hess, Hiroshi Nonogi, Hans P. Krayenbuehl. 
University Hospital Ziirich Medical Policlinic, Ziirich, Switzerland. 
Hypertrophic cardiomyopathy (HCM) is characterized by asymmetric 
septal hypertrophy and impaired diastolic function. To assess the 
impact of nonuniform regional mechanics, we studied 21 patienls 
(pis) with HCM and 10 control subjects (C) with LV angiogram and 
high-fidelity LV pressure. Regional function was assessed by dividing 
right and left anterior oblique views into 6 sectors each. Asyr.chrony 
(Ah) was defined as the coefficient of variation of time intervals from 
end-iliastole to end-systole (TES) and to peak filling rate (TPFR); 
asynergy (Ae) as the coefficient of variation of regional wall motion 
(RWM, in % of end-diastolic area) at end-systole (ES) and at mitral 
valve opening (MVO). Despite a modest increase in Ah (AhTES was 
abnormal [>mean in C + 2 SD) in 33% and AhTPFR in 40% of pis), 
HCM pis had an impairment in isovolumic relaxation (time constant 
103±38 vs SO±15 ms in C, p<.01; abnormal in 90% of pis). In contrast, 
high degree of Ae was seen in HCM: AeES was abnormal in 80% and 
AeMVO in 73% of pis. Anterior and posterior LV walls showed 
hyperkinesia (RWM at ES in 3 anterior sectors was 27, 48, and 32% in 
HCM vs SO, 57, and 48% in C, p<.05; and in 3 posterior sectors 41, 44, 
and 43% in HCM vs 51, 54, and 51 % in C, p<.05), whereas septum 
and inferior wall had normal RWM. Furthermore, regional diastolic 
pressure-area curves showed a significantly increased wall stiffness 
in the septum and the inferior region, whereas there were no 
differences from C in the anterior and posterior walls. 
Conclusion: In HCM, wall motion in the anterior and posterior 
segrnenls is hyperkinetic, whereas in the most hypertrophied region, 
i.e. the septum, it is normokinetk with increased wall stiffness. 
Despite this asynergy, asynchrony is not dramatically increased. Thus, 
the impairment in isovolumlc relaxation and regional wall stiffness 
seems to be the result of hypertrophy rather than of asynchrony. 
120A ABSTRACTS 
917·96 
Symptom, Hemodynamic and Kyocardial Benefit of Atrial· 
Synchronized Ventricular Pacing in Nonobstructive 
Hypertrophic Cardiomyopathy 
Richard O. Cannon, Ill, Vasken Dilsizian, Robert O. 
Bonow, Lameh Fananapazir. NHLBI, Bethesda, KD 
Chronic atrial-synchronized ventricular (DOD) pacing 
has been shown to improve symptoms and effort 
tolerance in patients with obstructive hypertrophic 
cardiomyopathy (HCM) , changes associated with 
reduction in left ventricular (LV) outflow gradient. 
To assess the impact of DOD pacing in nonobstructive 
HCM, 7 patients underwent exercise hemodynamic, 
radionuclide angiographic, and thallium scintigraphic 
studies before and 1 to 6 months following DOD pacing. 
All patients improved by at least one functional class 
and increased Bruce Protocol treadmill exercise 
duration (6.7±2.6 to 9.0±1.9 minutes, p<0.02). During 
semi-erect bicycle ergometry, the following parameters 
were measured at matched peak workloads (median 100 
watts): (Data-mean±SD). 
SBP PCW CI svr 
Baseline l74±10 33±9 6.0±1.5 48±8 
Post·DDD l69±17 27±9* 5.9±1.2 46±9 
*-p<O.Ol vs. baseline, SBP-systolic blood pressure 
(mmHg) , PCW-pulmonary capillary wedge pressure (mmHg) , 
CI-cardiac index (L/min/m2), SVI-stroke volume index 
(ml/beat/m2). Rest (59±10 to 63±14%) and exercise 
(59±13 to 6l±7%) LV ejection fractions were unchanged 
by chronic pacing. Thallium scintigraphic evidence of 
myocardial ischemia during matched levels of exercise 
was improved or eliminated in 4 of 5 patients. Thus, 
chronic DOD pacing benefits symptoms and exercise 
capacity of patients with nonobstructive HCM, with 
reduction in exercise LV filling pressures, 
preservation of rest and exercise systolic function, 
and less ischemia during stress. 
917·97 
Electrophysiologic-Guided Procainamide Therapy in Patients 
with Hypertrophic Cardiomyopathy at High Risk for Sudden 
Death. 
Lameh Fananapazir, Anne B. Cropp. National Institutes of Health, 
Bethesda, MO 
Pts with hypertrophic cardiomyopathy (HCM) who present with 
cardiac arrest, syncope, or who have ventricular tachycardia (VT) 
on Holter are at high risk for sudden death (SO). In addition, 
sustained ventricular tachycardia (VT) induced by programmed 
stimulation (PS) is an independent predictor of subsequent SO. 
Empiric antiarrhythmic therapy with type Ia drugs is associated 
with a high incidence of SO (20% at 3 yrs) in HCM pts. We 
assessed the role of PS-guided procainamide (PA) therapy in 47 
consecutive HCM pts who presented with cardiac arrest (n=5), 
syncope (n=8), presyocope (n=20), or VT on Holter. In all pts, 
a sustained VT (2,30 sec duration or requiring DC shock) was 
induced at baseline PS. PS was performed before and after iv PA 
(10.3 ± 1.9 mg/kg). Before PA, VT induced by PS was mono•
morphic (MVT) in 22 pts and polymorphic (PVT) in 25. After 
intravenous PA, VT remained inducible in 34 (72%) pts: 18 (53%) 
MVT and 16 (47%) PVT. The drug facilitated VT induction in II 
(32 %) pts, P < .01. Thirteen pts in whom VT could not be induced 
were discharged on oral PA. During a follow-up period of 34 ± 7 
months, the drug had to be discontinued in 3 pts due to side 
effects. The remaining 10 pts have been asymptomatic and free of 
VT with negative Holters. We conclude that PA prevents induction 
of malignant VT in approximately 28 % of HCM pts who are at 
high risk for SO. This subgroup appears to have a good prognosis 
if they can tolerate PA. However, the drug is ineffective in over 
70% of the pts and pro-arrhythmic in about 30%. 
917·98 
JACC Vol. 19, No.3 
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Pallern of Inheritance of Familial Dilated Cardiomyopathy 
Elisabetta Zachara, Cesare De Rubertus, Alessandro Pompili, Alida LP 
Caf orio, William J McKenna, Gian Piero Carboni, Pier Luigi Prati. St 
Camillo Hospital, Rome, Italy & St George's Hospital, London, England. 
To establish the pattern of inheritance in familial dilated cardiomyopathy 
(FOC) we assessed 117 apparently healthy relatives (R) of 14 patients 
(probands) who had at least one first degree R with documented disease. 
In these patients the diagnosis was based upon WHO criteria; all of them 
underwent ventricular angiography and endomyocardial biopsy. All R were 
screened with standard 12 lead ECG and 2 dimensional echocardiogram 
(2D.E) and were classified either as unequivocally normal or as carriers. 
The latter had either abnormal ECG and/or at least one 2D-E 
measurement of LV cavity dimension or % fractional shortening (%FS) 
outside 2 SO of normal (measurements were corrected by BSA). Fourteen 
of the 117 R (12%) had systemic hypertension and were excluded from the 
study. Thirty four of the remaining 103 R (33%) were classified as carriers 
and underwent 24 hour Holter monitoring (H) and maximal treadmill 
exercise (Naughton protocol). Of these 34 R, 3 (aged 49±13 years) had 
marked left ventricular enlargement (LVE) (45±2% from normal) and 
reduced FS (14±4%) (group A); 9 R (26%) (aged 37q13 years) had 
abnormal ECG and 20·E with 19±25% LVE from normal and 27±7% FS; 
18 R (aged 23±13 years) had normal ECG and abnormal 2D-E with 9±5% 
LVE but %FS within the normal range; 4 R (aged 44±20 years) had only 
abnormal ECG. Only the 3 R in group A had ventricular arrhythmia (Lown 
class 4A or 4B). 
Thus non invasive techniques identified asymptomatic cases of FDC among 
apparently healthy relatives of patients with the disease. Pedigree analysis 
was most consistent with an autosomal dominant pattern of inheritance of 
FOe. 
917·99 
Noninvasive Demonstration of Normal Myocardial 
Perfusion Reserve In Patients With Oilated Idiopathic 
Cardiomyopathy 
Carl Fung, Johannes Czernin, Peter Muller, Lynne 
Warner Stevenson, Michael Phelps, Heinrich R. Schelbert 
UCLA School of Medicine, Los Angeles, CA 
Invasive studies suggested myocardial perfusion reserve 
in dilated cardiomyopathy (DCM) to be decreased when 
coronary sinus flow was compared to patients catheterized 
for other cardiac conditions. To determine noninvasively, 
whether global myocardial perfusion (MBF) and perfusion 
reserve in OCM are reduced compared to healthy age 
matched volunteers (n=16), MBF was quantified with 
dvnamic PET and N-13 ammonia at rest and after iv 
dipyridamole in 7 DeM patients (45±12 years) with an 
average LVEF of 30±9%. MBF in the DCM patients 
averaged O.88±O.37ml/g/min at rest and was similar to 
that in normal volunteers (O.78±O.22 ml/g/min, p=NS). 
Both groups had similar rate pressure products at rest 
(7800±970 vs 6900±1000, p=NS). Hyperemic MBF averaged 
2.8±O.9 ml/g/min in the patients and thus was the same as 
in normals (2.8±O.8 ml/g/min). Accordingly, the 
perfusion reserve of 3.5±1.4 in the OCM patients did not 
differ from that in normals O.6±O.9; p=NS). Thus, 
myocardial rest and stress MBF and perfusion reser\'e are 
similar in patients with OCM and healthy volunteers. 
These findings argue against a significant contribution of 
abnormal myocardial perfusion to the global impairment 
of LV function in DCM patients. 
lACC Vol. 19, No.3 
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917-100 
Verapamil Ameliorates the Effects of Tumor Necrosis 
Factor - a on Myocardium 
Alistair Fyfe, Fayez Dawood, W-H Wen, Peter Liu, VCLA Medical 
Center, Los Angeles, California & The Toronto Hospital, Toronto, 
CANADA. 
Tumor necrosis factor-a (TNF-a) toxicity to cardiac myocytes may 
be Ca2+ dependent. To see if verapamil (V) may inhibit this effect, 
Langendorff rat hearts (n=8) were exposed to V@16nglml in buffer 
(KH), then TNF-a @400 V/ml with or without V for 30 minutes. 
Heart rate, LV pressures & dP/dt were measured. Mechanical 
restitution curves were derived at baseline and after each experiment 
using absolute dP/dtmax to derive plateau (CRmax). Normalized 
dP/dtmax was plotted to derive x-intercept (TO) & time constant (t). 
HR% dP/dt eRmax TO t 
*p<0.05 Baseline mmHg/s mmHgls ms ms 
KH Iu( 2jl2t316 334o±582 95 II':} 
TNF 84* 260o±560 372o±780 115* Jj9* 
KH+V 104 1215±407" 198o±438* 75* 100* 
TNF+V 94 I 69o±366 2534+449"' 99 123 
Verapamil ameliorated the bradycardia & increase in intracellular 
Ca++ as evident from increases in dP/dt and CRmax that were seen 
with TNF alone. The prolongation of intracellular Ca++ recycling 
evident from increases in TO and t, seen with TNF-a alone, was also 
ameliorated. 
The results suggest that verapamil may inhibit the myocardial effem 
of TNF·a as a result of verap:unil' s effect on intracellular calcium. 
917-101 
ByperdyDamic Perf'ar'!!I!!T!C'lp of thinvolved IIyoc:a.miuD in 
Acute Infard:.1an. Olrrelatian Bebieen Beg1Onal. 
Qntractile Punction am Myocardial Perfusion. 
Eldad Rechavia, Ranil de Silva, Luis I. Araujo, Petros 
Nihoyanoopoulos, Mriaan A. Lamnertsna, Terry Jones, 
Attilio Maseri. MRC Cyclotroo an:} cardiovascular Units, 
Hamnersmith Hospital, Iorrlon, UK. 
To investigate whether hyperdynamic perfonnanoe of un•
involved myocardium observed in AMI is ac:oarp:mied I::r:r a 
relative "luxury" of perfusion, the in vivo relation 
bebleen segmental systolic wall thickening (wr) an:} re•
gional myocardial blood flow (IMBF) was examined in 9 
pts within 1-3 days of AMI (gI"QIP A) an:} 7 pts within 
6-8 IOOnths of MI (group B). wr (end-systolic miruls end•
diastolic/end-diastolic) an:} IMBF (measured I::r:r 150_ 
water and PEl' dynamic imaging) data sets were created 
for re=te segments perfused I::r:r angiographically 
detected patent coronary arteries, assignin;J regions on 
the PEl' t.aoograms to equivalent echo segments. 
~ ~ pvalue 
IMBF (ml/g/min) 1.06±0.15 0.89±0.06 0.019 
wr (%) 43±6 34±4 0.005 
In the uninvolved segments, wr and xMBF were 26% and 
20% higher in group A pts, respectively. For both 
groups, a significant correlaticn (r=0.67; p:0.004) 
bebleen %WI' and xMBF was ootained. Infarcted regions in 
groops A and B showed similar wr scores (p-NS). 
'n1ese data illustrate: 1) the in vivo relationship 
bebleen oontractile function and IMBF in man; 2) a 
proportiooate increase in inllces of oontractility and 
xMBF in uninvolved territories followin:J AMI; 3) when 
infarcted zones in both groups are equally affected, 
enhanoed levels of cateoolamines an:} sympathetic drive 
may account for the hyperkinetic performance and oon•
sequently for an increased perfusion level in unin•
volved segments of group A pts ocmpared with gI"QIP B. 
ABSTRACTS 
917-102 
Right Ventricular Dysplasia as a Cause of Sudden 
Cardiac Death : a Study of 1000 Postmortem 
Examinations. 
Georges Atallah, Alain Tabib, Paul Touboul, Philippe 
Chevalier, Pierre Desseigne, Didier Champagnac Robert 
Loire. Hopital Cardiologique. Lyon. France. ' 
Ten thousand postmortem examinations requested by courts 
were conducted between 1980 and 1990. Among the cases of 
sudden death. (30%) 21~8 were found to be of cardiac origin. 
After exclUSion of subjects aged> 65 andlor presenting a 
history of cardiac disease 1000 cases free of any known heart 
disease were selected. 
Pathological examination showed the existence of right 
ventricular dysplasia (RVD) in 54 cases (5,4 % ) : 27 M, 27 F, 
aged 29 ± II yrs, heart's weight 300 ± 89 gr. 
RVD was strictly isolated in 16 cases (Gr I). There were 
associated cardiac abnormalities in the other 38 cases (Gr II) : 
coronary heart ~sease in 4 cases, myocarditis in 1 case, mitral 
val.ve prolapse In I case, pulmonary embolism in I case, 
I~slon~ of the A-V condu7tion system in 33 cases including fibrOSIS (30 cases), distal vessels disease (3) and 
mesothelioma (I) , 
No significant difference between groups I and II could be 
found regarding age, sex, circumstances of death heart's 
weight. ' 
In conclusion: 1) RVD may cause sudden death in apparently 
healthy people. 2) Besides malignant ventricular arrhytmias, 
A-V block may also intervene in the genesis of death. 
917-103 
121A 
Predictive Value of Reactive Hyperemic Response upon 
ReperluSlon on Recovery of Regional Myocardial Function 
Following Coronary Angloplasty In Acute Myocardial 
Infarction 
Harry Suryapranata. Felix Zljlstra, Plm J. de Feyter, Patrick W. Serruys. 
Thoraxcenter, Rotterdam. The Netherlands 
Reactive hyperemic response during reperfusion and Its Impact on the 
recovery of regional myocardial function were Investigated in 22 patients who 
underwent successful coronary angiopiasty within 4 hours of acute 
myocardiat infarction. Papaverine-induced hyperemia was determined 
quantitatively, using computer-asslsted digital subtraction clne-anglography, 
Immediately after angiopiasty (acute) and before hospital discharge. Global 
and regional left ventricular function were assessed from contrast 
angiography. Coronary flO\\! reserve (CFR) Increased signifICantly from 1.8 ± 
0.7 to 2.6 ± 0.9 (p < 0.001) and was associated with a significant 
Improvement In gtobat and regionat myocardiat function (CREF) of the infarct 
zone. A good correlation was found between CFR In the acute stage and 
CREF before discharge (r ~ 0.81, P < 0.00003) 
~~nI~~~':'~~'¥r~~ PTeA Followtng Thrombolysis In AMI CFR _net ~ioMl LV function (CREF) 
~ 3 
j, .. f' ! 1 ... 
~ I, .. .. . . ~ 0 .. S . . ' . . 
'i 5, . ;-., ~ ~ . ~ p<O.OOO3 p < 0.00003 
n ·~,o ·5 5 0 0 10 " 0 10 '0 30 40 50 ChangeS (%) in CREF 01 the tnlarct ZOI'I8 CREF (%) bekml dlSChar~ 
Conclusion: the degree of reactive hyperemic response upon reperfusion has 
a predictive value regarding the ultimate degree of recovery of regional 
myocardial function In patients with acute myocardial Infarction. 
122A ABSTRACTS 
917-104 
IMMEDIATE EFFECT OF SUCCESSFUL PTCA ON LV DIASTOUC 
FIWNG ASSESSED WITH ECHO DOPPLER 
Gregorio S. Martinez, Donato R. Maranon, John C. Gon, Wendy F. Wlppert, 
Avery K Ellis. SUNY at Buffalo and the Buffalo VAMC, Buffalo, NY. 
Significant coronary artery disease often leads to resting LV filling abnor•
malities even In the absence of systolic dysfunction. To determine whether 
relief of ischemia results In the early reversal of LV diastolic dysfunction, we 
studied effects of successful PTCA on Doppler-derlved Indices of trans•
mitral flow. Nineteen patients, aged 54-73 years, underwent a total of 23 
PTCA procedures for either stable angina (n = 10) or acute coronary Insuffi•
ciency (n= 13). Pulsed Doppler studies were performed Irllmedlately pre•
and post-PTeA. and 24 hrs, 48 hrs and 7 days later. There were no signifi•
cant differences In heart rate or blood pressure, and echocardiographically•
derived election fractions were also unchanged (61.±,3.S% [SOl pre-PTCA 
vs. 62.±,6.1% post-PTCA). 
Peak E velocity, the ratio of peak E to peak A velocities (E/A ratio), and 
the peak E velocity normalized to the time-velocity Integral (EfTYl ratio) all 
Increased slgnWlcantly post-PTCA. The EfTYl ratio Is less sensitive to 
sample volume position and correlates well with volumetric peak filling rate 
normalized to stroke volume. 
TABLE 1. Doppler-derived Indices of LV diastolic function. 
~ Imm~ 2!~ §~ 
Peak E vel 0.S42 0.604* O.S94** 0.620* 
Peak A vel 0.651 0.616** 0.638 0.644 
E/A ratiO 0.827 0.984* 0.944* 0.990" 
EfTVI ratio 3.314 3.764* 3.S63** 3.702* 
* p<O.OI, ** p<O.OS (compared to baseline) 
112m 
0.638* 
0.640 
1.02S* 
3.733" 
These findings suggest a rapid Improvement In LV diastolic relaxation 
after PTCA. We conclude that In chronically and acutely ischemic patients, 
successful PTCA Immediately Improves resting LV filling abnormalities and 
that this effect remains sustained for at least 7 days. 
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918-105 
Transmembrane Potential Changes Measured Optically During 
Field Stimulation 01 Ventricular CeUs 
Slephen Knisley, 1imothy Blltchlngton, Bruce Hill, Augustus O. Grant, William 
M. Snith, Theo Pilkington, Raymond E. ldeker, Duke University, Durham, NC 
Effects of an applied electrical field on the myocardial transmembrane 
potential are Important for understanding electrical stimulation and 
defibrillation. Theory predicts that extracellular field stimulation hyperpolarizes 
and depolarizes opposite ends of the cell in proportion to both the stimulus 
potential gradient and the cell length In the direction of the lIeld. We have 
evaluated this In isolated rabbit ventricular myocytes bathed in Tyrode's 
solution. The cells, which were 1os±29 microns long, were stimulated (S1) at 
2x threshold to produce phase zero depolarization. A constant-field S2 with a 
potential gradient of 20 Vlcm or 40 V/cm was then applied during Ihe 
absolute refractory period to avoid excitation during S2. A potentiometric dye 
(di-4-ANEPPS) was used to determine the transmembrane potential during 
S2. The cell ends facing the S2 anode or cathode were selectively 
illuminated with a laser. Recordings were accepted If the fluorescence 
changed at least 5% during the phase zero depolarization. RESULTS: The 
cell end facing the S2 anode became more negative Intracellulariy during S2 
while the end facing the S2 cathode became more positive intracellularly. 
This was observed at opposite ends of the same cell or at one end when the 
S2 leads were reversed. The transmembrane potential changes (6Vm). 
calibrated from the 130mV phase zero amplitude, agree with theoretical 
values predicted (S2 potential gradient x haH of the cell length) to within 27%. 
S2 gradient (V/cm) 20 (0=6) 40 (n.9) 
cell end facing anode cathode anode cathode 
6Vm predicted (mV) -108±29 108±29 -21S±S9 21S±59 
6Vm measured (my) -93143' 7943' -214179' 17744' 
(mean±sd, '-p<O.OOS vs 0 mV and p>0.1 vs6Vm predicted) 
CONCLUSIONS: 1) Field stimulation produces opposite changes in 
transmembrane potentials at opposite ends of a ventricular myocyte aligned 
with the field. 2) The magnitudes of the transmembrane potential changes 
during field stimulation are predicted by the stimulus potential gradient and 
cell length to within 27"10. The resuHs demonstrate quantitatively that the 
transmembrane potential change during a stimulus Is a function of the 
stimulus extracellular potential gradient and the size of the cell. 
918·106 
lACC Vol. 19, No.3 
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Defibrillation Shocks Prolong Refractoriness but Elicit a Bimodal Errect 
on Action Potential Duration of Mammalian Cardiac Myocytes 
Huagui G. Li, Douglas L. Jones, Raymond Yee, George J. Klein. Depts. of 
Medicine and Physiology, University of Western Ontario and the John P. 
Robarts Research Institute, London, Ontario, Canada. 
Although recent studies have found shock-induced prolonged action potential 
durations and refractory periods of frog and embryonic chick ventricular 
myocytes, there is limited information on the cellular electrophysiologic 
effects of defibrillation shocks on mammalian cardiac myocytes. Monophasic 
shocks at 10-75 V/cm (5 IDS duration) were delivered to Guinea pig papillary 
muscles (n = 12) perfused with Tyrode solution and paced continuously while 
monitoring transmembrane potentials using glass microelectrodes. Shocks 
caused prolongation of the shock-induced action potential followed by 
shortening of the subsequent pace-induced action potentials. In spite of action 
potential shortening, I: 1 capture was not achieved after the shock. The time 
to reestablish 1: 1 capture (lTC), was related to pacing rate. TIC (stimula•
tion at twice threshold), following shocks at 75 V Icm were as follows. 
Rate (bpm); 6Q() 300 200 
, TIC (s); 5.5+09 1 4t0 6 l.2±OA 
At a pacing rate of 4QO bpm, the TIC induced by biphasic shocks (5 
IDS per phase, 75 V Icm) was significantly longer than that induced by 10 IDS 
monophasic (75 V/cm) shocks (29.7 ± 9.5 s vs 12.9 ± 4.8 s, n= 13, 
p<0.0025). 
In another 4 papillary muscles isolated from pigs, the preparations 
were stimulated at a fast rate simulating ventricular fibrillation (400 bpm). 
Following shocks of 10-75 Vlcm, the myocyte could not follow rapid 
stimulation for 1.5±0.7 s. 
Defibrillation shock-induced prolongation of action potential duration 
and refractoriness, coupled with the protracted time for the reestablishment 
of 1: 1 capture, prevents mammalian cardiac myocytes from beating at 
ventricular fibrillation rates. Both mechanisms may be important for the 
termination of ventricular fibrillation. 
918-107 
Autonomic Tone Modulation of Internal Cardiac Defibrillation Threshold in Pigs 
Carlos A. Morillo, Douglas L. lones, George I. Klein. Departments of Medicine and 
Physiotogy, U. Western Ontario & Robarts Res. Inst., London, Ontario, Canada. 
Altered autonomic neural tone is known to influence cardiac arrhythmogenesis and 
may alter the efficacy of implantable defibrillators. Although there is conflicting 
evidence of the effects of sympathomimetic agents on defibrillation; there is no 
literature on the effects of parasympathetic agents. The purpose of this study was to 
determine the effects of direct IDd reflex parasympathetic pharmacological and 
electrical stimulation ODd of reflex sympathetic activation on the energy required for 
defibrillation [OFT] IDd ventricular fibriIJation threshold [VFT]. Halothane 
lDesthotized, open chest pigs were randomly usisned to one of: A) methacholine 
[n=12]; B) nitroprusside [n=12]; C) phenylephrine [n=12]; D) carbachol [n=8], 
IDd E) bilateral cervical vaaal stimulation [n= 12]. Triplicate DFT's were obtained 
before and during drug infusion IDd electrical stimulation of the right cervical vagus. 
Cunent and voltage from each pulse were determined IDd delivered energy was 
calculated. The mean DFT's ODd VFT's were as follows. 
Group DIT Before DIT During m Before m During 
A 9.7 ± 0.81 7.7 ± 0.81·· 39 ± 7V 76 ± IIV·· 
B 10.3 ± 0.61 11.3 ± 0.91 33 ± 7V 31 ± 6V 
C 11.3 ± 0.91 9.8 ± 0.91· 38 ± 6V 68 ± 11V·· 
D 12.2 ± 0.81 9.3 ± 0.71··· 30 ± 7V 106 ± 12V··· 
E 10.0 + 0.71 9.2 + 0,81 29 + 3V 62 + 8V·· 
Sinus cycle lengths [SeLl before IDd during the interventions were as follows. 
GrouP SCL Before SCL Dyring 
A 560 ± 34 IDS 528 ± 37 IDS 
B 558 ± 28 IDS 450 ± 26 IDS· 
C 568 ± 20 ma 660 ± 14 IDS·· 
D 542 ± 35 IDS 808 ± 10 IDS··· 
E 538 +22 IDS 600 + 2S DIS· 
[._p<O.OS, •• ~p<O.OOl, ·.·-p<O.OOOl, compared to initiat values] 
The ventricular effective refractory period [VERP] during carbachol infusion [250 
± 11 mal was prolonged compared to control [215 ± 11.5 ma, p<O.OOOl]. These 
data indicate that increased vagal tone, either by muscarinic activation or enhanced 
baroreceptor sensitivity, was beneficiat - increasing VFT and decreasing OFT. The 
increase in VERP in pigs receiving carbachol suggests that increased vagal tone may 
facilitate defibrillation by increasing the ventricular refractoriness. 
JACC Vol. 19, No.3 
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918·108 
left SUIxti~tic llIplantatioo of the FCD 
Defibrillator suwresses the Problematic S~ffects 
of Mky Generators 
Gerard GuirauJoo, George Klein, Raymc:n:i Yee. University 
Hospital, I.c:n:ion, Ontario, canada 
Mky generator of autanatic iDplantable 
defibrillators, iDplanted in the abdaninal wall is 
associated with ami:lersane side-effects. We have 
iDplanted FCD generators in the left suJ:xiiaImagmatic 
regioo in order to abolish the issue of the size an:i 
weight of the generator. '!he l:Wky generator is l::A.Iried 
deep into the body withcut patient's awareness. 
Between June 1987 an:i March 1991, 41 patients had a 
FCD inplanted, usirg either epicardial patdles (27 pts) 
or t.ransvenalS leads (14 pts). 
via a left subcostal incisioo the left 
sub-di~tic pc:u::h was canstructed as follows. 'Ille 
incision was perfonned al~ the oblique .interdlorxhal 
line. '!he antero-lateral abdaninal IIIlSCles were incised 
to expose the ~tic spaoe, wch is easily 
dissected to ocnstnlct the ~ withcut 
disarticulatirg the diaPJragm. '!he generator was 
iDplanted deeply an:i entirely oavered by the ribs. It 
was secured in plaoe by a stay suture attached to a 
costal cartilage. '!be abdaninal lIIlSCles were repaired 
in layers. 
'!here were 00 OCIIplicatioos associated with the 
generator (pleural effusioo, generator bllgirg) • 
Patients were \.U1aware of the l:Wky devioe an:i rot 
:inconvenienced. 
left ~tic iDplantatioo allows the use of 
a large generator withcut patient awareness, an:i 
disoanfort in daily life activities. 
918·109 
Incidence of supr .. entricular Tachycardia After 
Defibrillator Implantation 
John J. Paulowski, James D. Joye, Richard N. Fogoros, James 
J. Elson, Christopher A. Bonnet, John G. Chenarides. 
Allegheny General Hospital, Medical College of Pennsylvania, 
Pittsburgh, Pennsylvania 
Supraventricular tachycardia (SVT) has been noted to occur 
in some patients (pts) after cardiac defibrillator (lCD) 
implantation. We reviewed ICD implants in 150 consecutive 
pts to determine the incidence and significance of 
postoperative SVT. In the 150 pts, 53 (35%) developed 
postoperative SVT: 45 had atrial fibrillation, 6 had atrial 
flutter, and 2 had PAT. The mean heart rate during SVT was 
136 ± 28 bpm (range 84-200). Only 13 of the 53 pIS had a 
preoperative history of SVT. All S3 pts were in sinus rhythm 
preoperatively. During the operative procedure 34 pts had 
patches placed extrapericardially and 19 had patches placed 
intrapericardially. Nine had concomitant CABG with ICD 
implantation. The lCD's were not activated until the pt was 
transferred from the ICU, at a mean of 3.2 ± 3.8 days post 
implant. Forty-six out of 53 pts developed SVT by the fourth 
postoperative day. Only 2 pts received inappropriate shocks 
from the ICD for SVT. All but 3 pts were discharged in sinus 
rhythm. CONCLUSION: Postoperative SVT is a common 
complication after ICD implantation. It would appear that 
leaving the ICD deactivated (or temporarily programming a 
high rate cutoff) until the fifth postoperative day should 
prevent inappropriate discharges for SVT in most pIS. 
ABSTRACTS 
918·110 
Optiaal Post-Operative Tiae for Activation of 
Ventricular Tachycardia Teraination Therapies of 
Tiered-Response Cardioverter-Defibrillators 
John T.Y. Hii, Anne H. Gillis, D. George Wyse, 
Robert S. Sheldon, L. Brent Hitchell. University of 
Calgary, Calgary, Canada 
Immediate post-operative (post-op) activation 
of ventricular tachycardia (VT) termination 
therapies of tiered-response implanted 
cardioverter-defibrillators (ICD) has the advantage 
of beinl] antiarrhythmic therapy for post-op VT and 
the disadvantage of being inappropriate and 
potentially arrhythmogenic therapy for post-op 
supraventricular tachycardias (SVT). 
The probabilities of developing post-op SVT 
and VT were determined in 26 consecutive ICD 
patients (pts) of 59.14 years of age with left 
ventricular ejection fractions of 0.33.0.17. ICDs 
were placed transvenously in 7 pts and by 
thoracotomy in 19 pts. Post-op SVT occurred in 6 
pts (23') and in 5 of these pts, the ventricular 
rates during SVT satisfied VT detection criteria. 
Post-op VT occurred in 11 pts (42'). The median 
times to post-op SVT and VT were both 2 days. No 
SVT occurred in pts with transvenous ICD. By 
actuarial analysis, the probability of developing 
post-op VT was significantly higher than that of 
SVT at all times during hospitalization (p=O.02). 
Two post-op deaths occurred, both related to VT. 
Pts who developed VT tended to have received more 
defibrillation shocks at implant compared to those 
with no post-op VT (22.7 vs 15.11, p=0.06). 
ThUS, ICD recipients are more likely to 
develop life-threatening VT than SVT post-op. 
These observations support activation of VT 
termination therapies of tiered-response ICD 
immediately following implantation. 
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919·111 
Relationship of Spectral Measures of Heart Rate Variability 
to Ventricular EctopiC Activity In Patients with Idiopathic 
Ventricular Tachycardia 
Jaswinder S Gill, lu Fei, David E Ward, A John Camm. 
cardiological Sciences, St George's Hospital Medical School, 
london, UK. 
The autonomic nervous system appears to be of importance in 
the genesis of ventricular arrhythmias. Spectral measures of 
heart rate variability (HRY) allow an estimate of the activity 
sympathetic and parasympathetic efferents to the heart. We 
have studied the relationship of hourly spectral measures of 
HRV to the occurrence of ventricular ectopic (VE) activity in 20 
patients with idiopathic ventricular tachycardia (age range 17· 
60 years). 24 hour Holter tapes were obtained with patients in a 
drug-free state and analysed on the Marquette 8500 laser 
Holter system. Spectral measures obtained from the HRV 
program were the low frequency components (l) (0.04-0.15 
Hz) representing predominantly sympathetic tone (S) with 
some contribution from the parasympathetic and high 
frequency components (H) (0.15-0.4 Hz) representing mainly 
parasympathetic tone (P). High sympathetic tone was defined 
as H < 12 and high parasympathetic tone as l> 30. 
Results: On an hourly analysis of spectral components in 
relation to VE activity, VE's occurred significantly more 
frequently during periods of low S and row P (F =0 20.5, DF =0 3, 
p<0.OOO1). The number of VE's did not differ statistically in the 
other combinations of Sand P tone. 
Mean YE's/hr SE 
High S, high P 204.9 17.7 
low S, high P 338.4 58.9 
High S,low P 180.1 36.8 
Low S, low P 612.8 50.1 
The results suggest that VE's are more frequent during periods 
of low S and low P activity and are diminished when either S or 
P are increased in patients with idiopathic ventricular 
tachycardia. 
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919·112 
Relationship Between Heart Rate Variability and 
Programmed Ventricular Stimulation in Sudden Death 
Survivors and Patients With Ventricular Arrhythmias 
Erwin Raymenants, Aurelio Duran, Kim Miller, Anne B. Curtis. 
University of Florida, Gainesville Florida 
Decreased heart rate variability (HR V), an indicator of autonomic 
cardiac dysfunction, and inducible sustained monomorphic ventricular 
tachycardia (SMVT) have both been associated with an increased risk 
for sudden cardiac death (SCD). To examine the relationship between 
autonomic cardiac dysfunction and the presence of an arrhythmic 
substrate we performed HRV analysis and programmed ventricular 
stimulation (PVS) in 27 male patients referred for electrophysiologic 
study. Of these, 17 had a history of SMVT or sen and 10 had a history 
of nonsustained vr. HR V indices were computed from all normal R-R 
intervals extracted from a 24 hr continuous electrocardiographic 
recording subdivided into 5 min periods, and included the standard 
deviation (SO) of all the means of the R-R intervals during each 5 min 
period (SDmRR) and the mean of all SO of the R-R intervals during 
each 5 min period (mSDRR). PVS was performed from the RV apex 
and outflow tract, using up to three extrastimuli, and was regarded as 
sitive if SMVT was induced. 
SMVT or sen +(n=l7) 
SMVT or sen -(n=lO) 
PVS + (11=9) 
PVS - (n=18) 
mean (±SD) 
54.3 (±19.6) 
83.7 (±15.9) 
(p<O.OOl) 
59.1 (±21.2) 
68.2 (±24.0) 
0.34 
35.1 (±19.6) 
48.3 (±19.7) 
(p=0.103) 
34.7 (±21.4) 
42.6 (±19.9) 
-0.35 
Conclusions: Low HRV is strongly correlated with a clinical history 
of malignant arrhythmias but does not independently predict inducibility 
with PVS. Thus autonomic cardiac dysfunction and the presence of an 
arrhythmic substrate may be two risk indicators for sudden cardiac death 
that are at least partially independent. 
919·113 
The Effects of Hypotheraia on the Signal Averaged 
Electrocardiograa 
Andrea K. Russo, Lou-Anne K. Beauregard, Arleen Strano, 
Harvey L. Waxman, UKDNJ/Robert Wood Johnson Kedical 
School, Camden, NJ 
Early postoperative ventricular arrhythmias following 
cardiac surgery may be related to changes in myocardial 
conduction occurring during hypothermia. We examined 
changes in the signal averaged ECG before and 
immediately after coronary artery bypass or valve 
surgery while patients were still hypothermic. A total 
of 38 signal averaged ECGs were performed on 19 
patients preoperatively and within the first 
postoperative hour before body temperatures returned to 
normal. Nine pts had known prior infarctions, but no 
patients suffered perioperative infarctions. 
High frequency QRS duration (QRSD), root mean square 
amplitude (RKSA) and duration of the late potential in 
the last 40 msec of the QRS (D40) were examined. 
Kean±Std.Dev. Preoperative Postoperative 
Degrees F 98.26 + 0.79 96.70 + 1.41 
QRSD 96.95 + 13.80 100.05 + 14.62 
RKSA 45.99 + 36.04 31.31 + 27.92 
D40 32.26 + 11.80 37.37 + 12.94 
P 
.001 
.08 
.02 
.02 
There was a significant change in temperature from 
baseline and a trend toward increased QRSD 
postoperatively. RKSA decreased and D40 increased 
Significantly following surgery. There was no 
correlation between the degree of hypothermia and the 
magnitude of change in the signal averaged ECG. 
CONCLUSIONS: There is a significant change in the 
signal averaged ECG postoperatively. Early 
postoperative ventricular arrhythmias may be related to 
changes in myocardial conduction, which appear to be 
unrelated to the effects of hypothermia. 
919·114 
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Compariaon of Predictive Accuracy of Spectral Turbalence and 
Time Domal.a AaalyH.lD 101 Patients with Conduction Defects 
Nancy C. Flowers. AnIta C. wylds. Marandapal1l R Sridharan. 
Connle Watts-McGahee, Gershon Y. Perry. Leo G. Horan. Medical 
College of Georgia and VA Medlcal Center. Augusta. Georgia 
The presence of late potentta1s (LPs) In the slgnal-averaged ECG 
(SAECG) IS useful In rtsk stratification for subsequent sustained 
VT In post-MI patients. However. controversy exists as to the pre•
dictive value of LPs In the presence of conduction defects. SAECGs 
were recorded In 101 patients wtth documented absence or pres•
ence of CAD. MI or other organiC heart dISease. All had RBBB. 
LBBB or NCD. Using bldlrectlonal 4-pole Butterworth filters at 40· 
250 Hz. duration of tenn1nal slgnal <40 j1V and RMS voltage In the 
last 40 ms were determined. Using fast Fourier transformation. 
spectral turbulence across the entire QRS region was analyzed us· 
Ing the technique of Kelen et al. When comparing post-Ml patients 
wtth and wtthout VT. the following was noted. In RBBB, although 
EF was lower In the VT group (P<.05), no stgnlficant differences 
were found In time or frequency domain analyses. In LBBB. there 
was no difference found In time domain analysis or In EF. yet 
spectral turbulence score was stgnlficantly hJgher In VT patients 
(P<.05). In NCD. spectral turbulence score was higher (P<.05) and 
EF was lower (P<.OOO5) In the VT group. whlle there was no differ•
ence In time domain analYSis. Encouraged by the differences In 
LBBB and NCD post-Ml groups wtth and wtthout VT. time domain 
and spectral turbulence (frequency domain) predicttve values were 
calculated to estimate the power of a positive finding In an indi•
vidual patient. When only post-Ml patients were compared as to 
risk of VT. the predictive values (PV) were: 
TIme Domain Frequency Domain 
+PV (%) -PV (%) +PV (%) -PV (%) 
RBBB 19 40 40 100 
UlBB 50 07 54 100 
NeD 36 I'K) 47 8l 
Spectral turbulence analySIS offers an Improvement over time do•
main analysIS In post-MI groups wtth conduction defects as to risk 
for sustained VT. Undoubtedly. wtth further refinement of analyt· 
Ic technique. our ability to Identify the patient prone to ventrlcu•
lar tachyarrhythmlas utlllzing SAECGs wtll continue to Improve. 
919·115 
Correlation of Left Ventricular Endocardial Activation 
with the Signal.Averaged ECG in Patients with 
Nonsustained Ventricular Tachycardia and Coronary 
Disease 
Roben B. Kleiman, Mark E. Josephson, Alfred E. Buxton. 
Hospital of the University of Pennsylvania, Philadelphia, PA. 
We have reported previously that the signal-averaged ECG 
(SAECG) identifies patients (pts) with spontaneous nonsustained 
ventricular tachycardia (VT-NS) and inferior myocardial 
infarction (1M1) but not anterior MI (AMI) who have inducible 
uniform sustained VT (VT-S). To examine this disparity, we 
performed left ventricular (LV) endocardial sinus mapping in 32 
pts with prior MI and VT-NS. VT-S was induced in 6/14 with 
AMI and in 9/18 with IMI (p=NS). Pts with IM1 and inducible 
VT-S had longer SAECG duration (144±20 vs 109±l1, 
p=.OO3), but not SAECG amplitude (21±15 vs 23±12 mV, 
p=NS) than pts without inducible VT-S. Pts with IMI and 
inducible VT-S had significantly longer total endocardial 
activation time (169±23 vs 125±23, P=.OI), duration of longest 
EGM (145±24 vs 102±18, p<.OOI), and % late EGM (19±16 vs 
4±6, p=.02) than those without inducible VT-S. In contrast, in 
pts with AMI, SAECG duration and amplitude of the final 40 ms 
did not differ in pts with and without inducible VT -S (117±34 vs 
108±l1, p=NS and 57±42 vs 52±38, p=NS). Pts with AMI 
with and without inducible VT-S did not differ significantly in 
the endocardial mapping parameters. 
Conclusion: Pts with spontaneous VT-NS, IMI and inducible 
VT-S show greater abnormalitiy of endocardial conduction and 
activation than Pts without inducible VT-S. These differences are 
not seen in pts with VT-NS and AMI. This disparity may 
explain failure of the SAECG to identify pts with AMI, 
spontaneous VT-NS and inducible VT-NS. 
JACC Vol. 19, NO.3 
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919·116 
A Comparison of Late Potential Variables Using Three 
CommerCially Available Signal Averaging ECG Systems 
William Saltz$tein, Nawzer Mehta. Nancy C. Flowers. Medical College of 
Georgia. Augusta, Georgia. 
With an Increasing number of commercial signal averaging ECG (SAECG) 
systems. It Is Imperative to establish comparability with respect to the 
accurate documentation of late potentials (LP). 
This study demonstrates the degree of comparability of 3 different SAECG 
systems;· an ART 1200 EPX. a Corazonlx PREDICTOR and a prototype 
Hewlett-Packard Pagewrlter XU SAECG option, In determining the three 
commonly derived late potential (LP) variables; - filtered QRS duration 
(OUR), root rilean square of the terminal 40ms of the filtered QRS (RMS4Q) 
and the duration of low amplitude signals <401JV (LAS). 
We performed 3 SAECG studies on each of 40 patients. The 3 systems 
were used in random order and studies were performed consecutively. The 
Corazonlx PREDICTOR and Hewlett-Packard XU units permitted signal 
averaging to a terminal 0.31JV noise-level. while the ART studies were 
manually terminated at 200 beats. All studies WIIre analyzed with a 4(). 
250Hz BiSpec filter using the Corazonlx PREDICTOR analYSis software 
(version 6.1) and LP variables were derived automatically from the filtered 
vector magnitude waveform. 
The results below describe the mean±SD for all three LP variables. The 
figures In brackets describe the percent concordance using DUR> 114ms. 
RMS4Q<20IlVand LAS>38ms as criteria for LP detection. 
.DlJB..lmsl BMS404M .L.AS..lms1 
CZX Predictor 114.5±21.3 (100) 29.2±20.5 (95) 36.1±20.6 (98) 
ART 1200 EPX 112.8t21.5 (98) 35.5t24.8 (95) 32.7±18.1 (95) 
H-PXU 113.9t20.4 (100) 32.3t21.6 (95) 33.4t16.2 (100) 
By using the same analysis technique on all studies we have normalized the 
filtering and algorithm differences that may exist between these systems. 
however. the mean values and the high level of concordance of LP 
variables. indicate that the signal averaged data obtained with these 
systems are correlated to a high enough degree to allow comparable 
documentation of LP variables. 
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920·85 
Evidence for Increased Incidence of Arrhythmias During 
Pregnancy: A Study of 104 Pregnant Women with Symptoms 
of Palpitations, Dizziness or Syncope 
Enrique Ostrzega, Anil Mehra, Josef Widerhorn, Avraham 
Shotan, Janet Johnson, Shahbudin H. Rahimtoola, Uri 
Elkayam, LAC+USC Medical Center, Los Angeles, CA' 
Although an increased incidence of arrhythmias has been 
suggested during pregnancy, this has not been systema•
tically evaluated. We therefore performed cardiac 
evaluation including 24-hour Holter monitoring in 104 
pregnant women referred to cardiac clinic for symptoms 
of palpitations, dizziness or syncope. Frequent 
arrhythmias were found in 25 pts or 24%: 17 pts had 
frequent premature (>10/hour) and/or complex (multi•
form, bigeminy, trigeminy) ventricular beats and 1 
patient had a nonsustained ventricular tachycardia. 
Four pts had >10/hour premature atrial complexes, 2 pts 
had short runs of supraventricular tachycardia, and 1 
patient had both ventricular and supraventricular 
premature complexes. The number of premature complexes 
(PC) during gestation and post-partum were compared in 
9 pts and were as follows: 
PC/24hrs PC/lhr 
Gestation 9073t9210 459t474 
Post-partum 1345t1997 70t133 
P value 0.03 0.04 
SUMMARY: Atrial and ventricular irritability is common•
ly seen during normal pregnancy in pts with symptoms of 
palpitations, dizziness or syncope. The incidence of 
arrhthymias is significantly reduced postpartum. 
CONCLUSION: These data provide the evidence for an 
increased incidence of arrhythmias during pregnancy. 
ABSTRACTS 
920·86 
The Differential Diagnosis on the Electrocardiogram 
Between Ventricular Tachycardia and Antidromic 
Conduction over an Accessory Pathway. 
Gunter Steurer, Sinan Gursoy, Jacob Atia, Bernhard Frey. 
Olga Souza, Pedro Brugada, Erik Andries. Cardiovascular 
Center, Aalst, Belgium. 
There are no criteria to differentiate on the 12-lead 
electrocardiogram (ECG) ventricular tachycardia (VT) from 
tachycardias with antidromic (ANTi) conduction over an 
accessory pathway. A new stepwise approach with 5 criteria 
was prospectively studied in a total of 128 consecutive 
tachycardias fulfilling ECG criteria for VT (97 VT's and 31 
ANTI's) by 6 independent observers : 1) Predominantly 
negative ORS in leads V4 to V6, 2) A OR complex in one 
precordial lead V2 to V6, 3) AV diSSOCiation, 4) ORS axis in 
the frontal plane (FP) < -60 and > + 150, 5) T wave axis to 
preexcitation discordance. When any criterion was met, VT 
was diagnosed. The cumulative sensitivity (SN) and 
specificity (SP) of the 5 steps were respectively : first step : 
43%, 100% ; second step : 5~"{', 100% ; third step: 52%, 
100% ; fourth step : 63%, 99.2% ; and fifth step : 87%, 
99.2%. Seven VT's were misdiagnosed as ANTI and 1 ANTI 
was classified as VT. 
Conclusion: This stepwise approach, with a final SN of 87% 
and a SP of 99.2% allows differentiation between VT and 
ANTI on the 12-lead ECG. 
920·87 
Site of Origin of Polymorphic and Monomorphic Ventricular 
Tachycardia In Patients With Previous Myocardial Infarction 
12SA 
Arne SippensGroenewegen. Sylvia LC Muilwijk. Norbert M van Hemel. J 
Herre Kingma. Richard NW Hauer. Andre C Linnenbank. Michiel J Janse. 
and Arend J Dunning. 
Academic Medical Center. Amsterdam. Interuniversity Cardiology Instnute. 
The Netherlands 
Localization of postinfarction ventricular arrhythmias prior to ablative therapy 
currently involves mapping of monomorphic ventricular tachycardia (MVT). 
Polymorphic ventricular tachycardia (PVT). however. is frequently initiated. 
but its relation wnh coexisting MVT remains undetermined. Therefore. we 
used 62·lead ECG recordings to examine QRS integrals (MAPs) of 23 PVT 
episodes and 61 distinct MVT configurations in 10 patients with anterior 
myocardial infarction (AMI) and 5 patients wnh inferior myocardial infarction 
(IMI). PVT was defined as a sequence of up to 7 consecutive beats wnh at 
least 3 clearly different QRS morphologies. The endocardial segment of 
origin of MVT and the segments of origin of each PVT episode were 
assessed by correlating PVT and MVT MAPs with an infarct specific 
reference data base of 18 (AMI) or 22 (IMI) mean paced MAP patterns. This 
data base was previously constructed during left ventricular pace mapping. 
Be.auJ1s.;. Compared with the segment of origin of MVT in patients with AMI. 
Similar and/or adjacent segments of origin were found in 6/16 PVTs (38%); 
similar and distant segments were obtained in 6/16 PVTs (38%); and 
adjacent and distant segments were found in 4/16 PVTs (24%). Compared 
wijh the segment of origin of MVT in patients wijh IMI. 5/7 PVTs (71%) 
originated from Similar and/or adjacent segments; 1/7 PVTs (14%) arose 
from similar. adjacent. and distant segments; and 117 PVTs (14%) originated 
from distant segments. 
Conclusions' 1. Nearly half of the PVT episodes arise Irom endocardial foci 
that are snuated in the near vicinity of a MVT focus and are probably related 
to the underlying reentrant circuij that produces MVT; 2. PVT episodes 
occurring in the presence of inferior as opposed to anterior myocardial 
infarction originate more frequently from snes close to the sne of MVT origin; 
3. Mapping of PVT episodes provides additional Intormation which may be 
valuable in improving identification of the arrhythmogenic area in the 
ventricle. 
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920·88 
Diagnostic Value of Electrocardiographic Patterns of Right 
Ventricular Hypertrophy In Children 
E.B. Fretz, H.C. Rosenberg, W. Kennedy, M.D. U. 
Children's Hospital of Western Ontario, University of Western 
Ontario, London, Ontario, Canada 
A number of criteria for right ventricular hypertrophy (RVH) have 
been used in the interpretation of paediatric electrocardiograms 
(ECG). To determine the diagnostic value of these criteria the 
ECGs of the first 1000 paediatric patients studied at The 
Children's Hospital of Western Ontario were reviewed. Because 
of the rapid changes seen in the ECG in the newborn period, 
children under 3 months of age were excluded, as were patients 
with ORS prolongation. 434 patients met aU inclusion criteria. 
The medical records were reviewed for diagnosis. 67% had a 
diagnosis compatible with RVH. Of the ECG patterns evaluated 
a precociously upright T wave in lead V1 was most predictive 
with 99% speCificity. Presence of a OR complex in lead V1 had 
a 96% specificity, but RlS ratio, voltage criteria and rSR' 
incomplete right bundle branch block pattern had intermediate 
specificities of 66%, 66% and 52%. Sensitivities of 12.6%, 
13.2%,34.0%,63.3% and 74.2% were calculated for upright T, 
OR complex, RlS ratio, voltage criteria and rSR' respectively. In 
conclusion, an upright T wave or OR pattern are highly specific 
but insensitive markers of RVH. In contrast, the rSR' pattern, 
when present, is a relatively sensitive but non-specific predictor 
of RVH. 
920·89 
Predictive Value of Negative T Waves Compared 
to ST Segment Changes In Patients With Unstable Angina 
Patrick MJ. Verhorst, Christ J. Werter, Freek WA Verheugt, 
Frits W.Blir, Frank Vermeer for the UNASEM Group, Free 
University Hospital, Amsterdam, NL 
Electrocardiographic changes in patients with unstable angina 
may be related to the difference in extent and severity of the 
underlying coronary artery disease usually present and, thus, 
may be of prognostic importance. 
In UNASEM (a placebo controlled double blind study 
comparing anistreplase with placebo) we studied 196 patients 
(37 patients in the pilot study included) with a typical history 
of unstable angina (duration of pain s 30 minutes) without a 
previous myocardial infarction. We divided them in two groups: 
patients with negative T waves and patients with reversible ST 
segment elevation/depression (6 ST) on the admission ECG. 
ECGs were centrally reviewed and correct ECG criteria were 
present in 161 patients. Within 3 hours after admission corona•
ry angiography was performed and the occurrence of in-hospital 
myocardial infarction was evaluated. 
~ Negative T 6 ST P 
(N = 59) (N = 102) 
> 50% stenosis 44 (75%) 96 (94%) 0.0005 
3 VD + left main 7 (13%) 25 (25%) 0.06 
TIMI flow gr. 0-1 3 ( 5%) 28 (27%) 0.001 
Myocardial infarction 7 (12%) 44 (43%) 0.0001 
Conclusjons: In comparison to ST segment changes on the 
admission ECG negative T waves in unstable angina indicate 
less severe coronary sclerosis and are correlated with a lower 
incidence of in-hospital myocardial infarction. 
920·90 
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<XMPARISCtI OF <XMPUTER VERSUS CARDIOI.£X;IST ANALYSIS 
OF ELECTROCARDICGW1S 
A.W. Friedman, Robin Girdhar, Simon chough, Ricci 
Minella, Saul Silver, Rodney Lipnan, Shadyside Hospital 
and the University of Pittsburgh, Pittsburgh, 
Penney I vania 
During the month of July 1991, 2537 electrocardiograms 
(ECGs) 100Iere perfonned at a large referral cardiovascular 
hospital. The ECGs were catprt.er read via a Marquette 
MUSE-D series catplter system. 4 Cardiologists reviewed 
the ECX;s, b.rt: only 1 was aware of the study. 
The ECGs 100Iere placed into 3 grot.lpB: (A) CCIIplete 
physician agreement with the catprt.er, (B) minor 
disagreanent with the catplter (heart rate, PR and QRS 
intervals, and minor axis abnonnalities) that ~uld not 
affect patient management, (C) major disagreement with 
the catplter. Group C discrepancies included electrical 
axis, conduction, rhytlrn, hypertrop,y, infarction, and ST 
analysis that could affect patient managanent. There 100Iere 
726 P in group A (29%), 1192 P in group B (47%), and 619 
P (24%) in group C. 
Catp.tter analysis of electrocardiograms is a useful 
technique. However, major disagreanent was seen in 
24% of the ECX;s reviewed. Without review of the ECGs by 
a cardiologist, significant changes may be missed and 
patient management may be adversely affected. 
920·117 
Relation of Total QRS Voltage to Cardiac Mass 
Brian Glick, Allen L. Dollar, William C. Roberts 
Pathology Branch, National Heart, Lung, and Blood 
Institute, National Institutes of Health, Bethesda Maryland 
Electrocardiographic indicators of left ventricular 
hypertrophy are known to be relatively insensitive. We 
evaluated the relation between total 12-lead QRS voltage 
and heart weight at necropsy in 6 cardiac diseases. The 
amplitude of the QRS complexes were measured from the peak 
of the R wave to the nadir of either the Q wave or the S 
wave, whichever was deeper. The upper limit of normal for 
total 12-lead QRS amplitude is 175 mm (17.5 mVolts). 
Aortic 
Stenosis 
Aortic 
Regurgitation 
Mitral 
Regurgitation 
IDC 
HC 
Amyloid 
Normal 
n Heart Total Number 
50 
30 
28 
49 
57 
30 
30 
Weight(g) QRS(nun) >175mm(%) 
630,:!;14 
745,:!;132 
572,:!;145 
614,:!;126 
593,:!;189 
532,:!;139 
393,:!;57 
245,:!;56 
274,:!;87 
214,:!;67 
153,:!;48 
197,:!;67 
104,:!;36 
127,:!;29 
43(93%) 
27(90%) 
19(68%) 
16(33%) 
30(53%) 
2 (7%) 
2 (7%) 
Total 12-lead QRS voltage is a sensitive marker for LV 
hypertrophy in patients with aortic valve stenosis, aortic 
r~gurgitation, and mitral regurgitation. Among patients 
wlth hypertrophic cardiomyopathy (HC), this criterion was 
moderately sensitive and with idiopathic dilated 
cardiomyopathy (IDC) and amyloid the sensitivity was low. 
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921·80 
A COMPARISON OF QUANTITATIVE INFARCT SIZE USING SPECT 
Tc-99m-SESTAMIBI AND THAllIUM-201 
Timothy F. Christian, Mona R. Hopfenspirger, Raymond J. 
Gibbons. Mayo Clinic, Rochester, MN 
Tc-99m sestamibi and Thallium-201 (Tl-201) infarct size 
at discharge were compared in 20 patients with myocardial 
infarction (10 anterior, 7 inferior, 3 lateral), 18 of 
whom received acute reperfusion therapy. Sestamibi 
tomographic imaging was performed at rest. Infarct size 
(%lV) was estimated from 5 short axis slices using a 
previously published threshold technique (#pixels 
<60% maximal counts). Exercise testing was performed with 
3 mCi of Tl-201 injected at peak exercise. An additional 
1 mCi of Tl-201 was re-injected 20 minutes prior to 
delayed tomographic imaging at 4 hours. The delayed 
tomographic image was quantitated using the same 5 slice 
threshold technique (Tl-5 slice) used for sestamibi as 
well as by a commercially available polar map compared to 
normal limits (Tl-polar). Ejection fraction (EF) was 
determined at 6 weeks by radionuclide angiography 
(0.53 ± 0.10, range: 0.33-0.77). 
Infarct size(%lV) Correlation with EF 
Sestamibi 12 ± 13 r=-O.81, p<.OOOI 
Tl-5 slice 14 ± 13 r=-0.76, p<.OOOI 
Tl-Polar 25 ± 17* r=-0.69, p=.0007 
*p=.0005 compared to sestamibi & Tl-5 slice 
Correlation of sestamibi vs Tl-5 slice was close 
(0.87, p <0.0001) with a regression line near the line 
of identity sestamibi=[(0.88 x Tl-5 slice) -0.6]. 
Correlation of Tl-5 slice vs Tl polar was similar 
(r=0.90, p <0.0001) but Tl-polar gave significantly 
higher values Tl-polar=[(1.18 x Tl-5 slice) + 8.6]. 
Conclusion: Tl-201 and sestamibi give comparable infarct 
size with the 5 slice technique. Tl-polar yields 
significantly larger estimates. 
921·81 
Myocerdlll Blood Flow QUlntlflcation In Absolute Terms: 
• New Approach Using Rubldlum·a1 1 Krypton-81m 
Hans-Peter Stoll, Wolfgang Bay, Wemer Vogel, Alfred Hanser", Ursula Sahm*, 
Erich Oberhausen, Herrmann Schieffer, Gottfried Harbauer; Unlversltlitskliniken 
0-6650 Homburg/Saar; *Kemforschungszentrum 0-7500 Ka~sruhe; Germany 
Purpose: The use of the K+ -analog Isotope Rubldlum-81 (Rb-81) theoretically 
allows quantWlcatlon of specific myocardial blood flow in absolute terms. Princi•
pie of this measurement is the flow related disturbance of the myocardial equi•
librium between Rb-81 and Its shon IMng daughter Krypton-81m (Kr-81m). In 
order to verily this method we compared myocardial parfuslon measured with 
Rb-81 with coronary sinus effusion In an experimental model. 
Methods: Isolated working rabbit heans were prepared In a modWied Langen•
dorlf technique which allows exact collection of coronary sinus effusion. Heans 
were labeled with ultra pure Rb-81 by Injecting the tracer Into the aonic cannula. 
After a single Injection multipie spectroscopic measurements of Rb-81 and Kr-
81 m gamma radiation were parformed using a germanium detector. Variation of 
palfuslon In the range between 0 and 4 mllmln/g could be achieved by changing 
the aonlc pressure. The actMty ratio KrIRb was calculated In 325 single palfu•
slon measurements and compared with coronary sinus effusion. 
Results: KrIRb actMty ratio correlated excellent (r = 0.98) with the values pre•
dicted by the equation KrIRb = 11 ( (F/3.2P) + 1) as shown In the graph [Kr/Rb: 
actMty ratio batween Kr and Rb, F: specific myocardial parfuslon In ml/mln/g, P: 
panltion coefficient for Kr gas, hyperbolic solid line: theoretical curve). The con•
stant P was found to be 1.051 +1-0.127. 
Conclusion: The actMty ratio KrIRb Is 
proofed to be a valid absolute measure '.0 
for specKic myocardial blood flow In Iso•
lated heans. Appiied In man, the techni-
que could Improve current diagnostics 0.8 
of myocardial perfusion. It may be used 
Activity Ratio Kr/Rb 
~\ . n. 325.r· 0.98 ,,:\ . .. '. ':--' '0, •• ,. ••• 
. ~:.~:: . 
In single photon emission tomography 0.6 
(SPET) or In a non-imaging detector 
technique with Intracoronary Injection. 
By this, blood flow measurements 0.4 .~~~~~~~~~~ 
during Interventional procedures In the a , 2 3 4 
catheter laboratory would be possible. Myocardial Blood Row (ml/min/gl 
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921·82 
Infarct Vessel Patency Beyond the First Four Days Following 
Acute Myocardial Infarction Related to Uptake of Thalllum·201 
and Indlum·l11 Antlmyosln In the Infarct Territory 
Lynne l Johnson, Roxanne Rodney, Robert Vaccarino, Lisa Wasserman, 
Gladys Kusterer, Ketan Bhatia. Columbia University, New York, N.Y. 
It would be clinically useful to know whether jeopardized myocardium may be 
salvaged by opening up a totally occluded infarct related vessel beyond the 
first 4 days following infarction. Simultaneous dual isotope TI·201/In-111 
anti myosin Fab (Am) SPECT imaging performed 72-96hrs post-MI has been 
demonstrated to identify myocardium at further risk based on two ischemic 
patterns: TI-201 defect without Am uptake (mismatch) representing 
hypoperfusion without recent necrosis, and uptake of both TI-201 and Am in 
the same wall (overlap) representing nontransmural necrosis. In 37 patients 
wtth simultaneous TI-201/In-lll Am SPECT imaging at 72-96 hrs post-MI 
and subsequent coronary angiography 4.2 ± 3.5 days later, infarct vessel 
patency was correlated with patterns of uplake of the two tracers. Eleven pts 
received thrombolytic therapy. Eighteen pts had open infarct related 
vessels. Thirteen of 18 pts (72"10) with open vessels had matching patterns 
(Am uptake corresponding in location and extent to TI-201 defect) 
suggesting completed infarction. The mean percenlage stenoses in these 
13 pts was 66.5 ± 32.7%. Of the 5 pts with ischemic patterns and open 
vessels 4/5 had >95% stenoses. Nineteen pts had total (100%) occlusion 
of the infarct related vessel. Twelve of these 19 (63%) had ischemic patterns 
on dual isotope SPECT imaging (match + mismatch and/or match + overlap 
in one vascular lerritory) suggesting incomplete infarction despite total 
vessel occlusion. The remaining 7 pts had matching patterns (Am uptake 
corresponding in location and extent to TI-201 defects). These data 
suggest that dual isotope TI-201/In-lll Am SPECT imaging may be useful in 
identifying pts in the lale inhospital poSI-MI period with viable myocardium 
distal 10 totally occluded vessels for balloon angioplasty. 
921·83 
Separate Acquisition Dual Isotope Myocardial Perfusion 
SPBCT using Pharmacologic Stress 
L. Hatzer, B. Kiat, J. Friedman, V. Palmas, G. Silagan, 
K. Van Train, D. Berman. Cedars-Sinai Hed Ctr, LA, CA 
Separate acquisition rest Tl-201/stress Tc-99m 
sestamibi(Tc) dual isotope myocardial perfusion 
SPECT(DIHPS) substantially shortens myocardial perfusion 
studies. To assess this approach using pharmacologic 
stress, we evaluated 70 consecutive pts undergoing 
pharmacologic stress DIHPS and having coronary 
angiography (CA)(n=32) or a low likelihood(LL) of 
coronary artery disease(CAD)(n=38). Of the CA pts, 26 had 
CAD(LsO% stenosis)(11 had triple, 7 double, 8 single 
vessel disease, 6 with prior HI). All pts had rest Tl 
SPECT(2.s-3.s mCi) immediately followed by either 
adenosine(n=39) or dipyridamole(n-31) infusion and 20-
30mCi of Tc injected at stress with Tc SPECT 1 hr later. 
Blinded consensus reading of 2 observers employed a 5 
point system for each of 20 SPECT segments(O=normal, 
4=absent tracer uptake). A SPECT study was abnormal if ~2 
segments had a Tc score of ~2. Time from rest Tl 
injection to end of Tc SPECT was <150 mins. The normalcy 
rate among LL pts was 90%(34/38). Sensitivity (sn) and 
specificity (sp) for overall CAD and CAD in individual 
vessels were as follows: 
~sO%·CAD OVERALL CAD LAD 
sn 25/26(96%) 10/16(62%) 
sp 416 (67%) 13/16(81%) 
~70%=CAD 
RCA 1Qr 
14/18(78%) 15/21 (71%) 
10/14(71%) 11/11(100%) 
sn 23/24(96%) 9111(82%) 14/16(88%) 15/18(83%) 
sp 518 (63%) 18/21(86%) 12/16(75%) 13/14(93%) 
Tl showed some reversibility in 30/32(93%) with Tc 
defect. Conclusion: Separate acquisition dual isotope 
SPECT with pharmacologic stress agents appears to have 
high sensitivity and specificity for evaluating CAD. 
128A ABSTRACTS 
921-84 
A New Automated Edge Deteclon Algorithm Successfully 
Applied to the Links, Starling, and a New Method of Cardiac 
Volume Determination 
WC Levy, MD Cerquelra, DT Matsuoka, FH Sheehan, JR Stratton, 
Unlverslty of Washington and VAMC, Seattle, WA 
Previous use of commercial edge detection algorithms to determine 
absolute cardiac volumes from planar Tc-99m radlonuclide angiograms 
have been unsuccessful. Thus, manually drawn regions of Interest (ROI), 
which have a lower Interobserver reproducibility than automated ROls are 
routinely used. We have developed and Implemented a new edge 
detection algorithm which can be used with the Links (CIRC 1982). 
Starling (JACC 1984), and a new method. We used a 50% threshold of 
the hottest pixel following a Interpolative background subtraction to 
Identify ROls. The ROls were applied to the raw Images to determine 
cardiac volumes by the Links, Starling, and a new method. The new 
method Is based on the Massardo method (JNM 1990), but assumes the 
ventricle Is a prolate ellipse with the major axis twice the minor axes, uses a 
9-polnt spatial smooth prior to selecting the hottest pixel to reduce noise 
In the Image, and uses background corrected counts. We compared 
cardiac volumes (n-38, and diastolic and end systolic) in 19 patients to 
contrast ventriculograms (mean-126.6ml). 
Links 
Starling 
New Method 
Mean(mI) 
119.1 
118.5 
123.7 
r Slope 
.89 0.95 
.81 0.81 
.89 0.99 
Intercept SEE 
- 0.8 30.3 
12.8 36.4 
- 1.5 32.2 
The Intarobserver reproducibility Is very high (r- .99, mean 
dlfference<S.lml, SEE<10ml) for all three automated methods. The high 
Interobserver reproducibility Is ideal for serial studies. 
We have successfully shown that accurate absolute cardiac volumes 
can be calculated using an automated edge detection algorithm in 
conjunction with the Links, Starling, and a new method. The new method 
assumes a more appropriate geometric shape of the left ventricle, than the 
Massardo method, corrects for background activity, and reduces noise in 
the hottest pixel. The new method requires no additional images, blood 
counts, attenuation correction, or decay correction. It Is fast, reproducible, 
and can be Incorporated Into clinical use. 
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922-43 
Revasrularization Outcome Predicted by Regional Left 
Ventricular Response to Nitroglycerin: Use of Quantitative 
3-0 Wall Motion Analysis and Tomographic 
Ventriculography 
Anatole S. Kim, Robert A. Quaile, Dan M. Meyer, Tracy L. 
Faber, Raymond Josey, James R Corbett. Univ. Texas South•
western Medical Center, Dallas, TX 
Attempts to predict myocardial viability have focused on 
regional assessments of myocardial perfusion and/ or function 
after exercise or pharmacologic vasodilation. Twenty patients 
(pts) undergOing coronary artery bypass grafting or angioplasty 
were studied with tomographic radionuclide ventriculograms 
(TRVG) using a high-resolution 3-detector tomograph. The 
regional left ventricular wall motion response to topical nitrates 
(NTG) pre-revascularization was correia ted with post•
revascularization segmental viability. A sustained reduction in 
systolic BP ~ 15 mmHg was required. Wall motion was 
quantitatively analyzed using an automatic surface-rendering 
technique we have previously described. Thirteen LV anatomic 
segments were considered for each patient. Three patients 
died, 2 refused, and 1 was lost to followup. Seven of the 
remaining 13 pts had repeat studies ~ one month post•
intervention to judge post-revascularization regional viability. 
In these 7 pts, 12 of 13 segments demonstrating quantitative 
improvement with NTG TRVG subsequently showed better 
systolic function after revascularization. Conversely, in 20 
segments without change post-NTG only 2 improved after 
revascularization (p<O.OOt). In 22 of 24 segments, deterioration 
presaged either a lack of improvement or a worsening of wall 
motion after revascularization. Therefore, the use of topical 
NTG and quantitative TRVG pre-revascularization may be used 
as an alternative noninvasive imaging modality which predicts 
regional myocardial viability post-revascularization. 
922-75 
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'mE VALUE CF 24-II':>tR IMI\GI!S AFl'ER REST 'DIALLItJoI 
OOl!C1'IOO 
Ben D. McCallister, Jr., Ian P. Clarents, ~ F. 
Hauser, Raynond J, Gibbons. Mayo Clinic, Rochester, 
Minnesota 
The value of 24-hour delayed views for detecting 
viability on resting thallium studies is unknown. ~ 
studied 30 patients with nonreversible or incarp1ete1y 
reversible defects 4 hours after 4mCi Tl-201 was 
injected at rest. 'lI:m:lgraphic images at 0, 4, and 24 
hours post-injection were prospectively, blindly graded 
by bio readers. Redistrirution (RD) at 4 hours and 24 
hours ..as qualitatively graded as none, minimal or 
significant. 
RD at 4 Hours 
Patients 
16 None 
Minimal 
Significant 
4 
10 
lidded RD at 24 Hours 
~ne Minimal Significant 
745 
2 1 1 
9 1 0 
Of the 20 patients whose RD at 4 hours ..as not graded as 
significant, 6 (30%) had significant RD at 24 hours. Of 
these 6 patients, 4 presented with heart failure, 1 with 
heart failure and angina, and 1 with recent infarction. 
None had angina during the 24-hour study period. 
Increased heart size was present in 6/6 patientsl 4/6 
had increased pulmonary uptake of Tl-201. Ejection 
fraction measured in 4 patients was 20%, 20%, 25%, and 
35%. 
With rest T1-201 imaging, new or additional RD seen 
only on 24-hour images oc:=s frequently. 24-hour 
images are appropriate in patients who do not have 
significant RD at 4 hours. 
922·76 
Delayed Functional Recovmy after Coronary Revucu1arlzation in 
Patients Survived to an Acute Myocardial Infarction: an Example of 
Myocardial Stunnlng. 
Jacopo D. Mule, Giorgio Soravia, Renzo Perelli, Felice Martinelli, 
Baldovino Sponga, Bartolo Zingone, Bruno Branchinl. O. C. Belluno, 
Belluno and University of Trieste, Trieste, Italy 
There is controversy whether 20 I-Thallium (TI) uptake can be used to 
assess the presence of viable myocardium. We hypothesized that the 
change in uptake between exercise and 24 hours delayed images is a 
reliable marker of viable myocardium. We studied 32 consecutive pts 
aged 58±9, who survived to a flnt myocardial infarction and were 
candidates for coronllIY artery bypass surgery (REV). They were 
submitted to rest 2D echo, exercise, 4 and 24 hours redistribution TI 
SPEer Imaging before and every 2 weeks for 4 months after REV 2 
pts were excluded because of a perioperative infarction. From matched 
2D and Tllmages 144 infarcted segments (IS) were analyzed; we 
measured regional systolic wall thickening (WT) from 2D echo and 
the amount of relative TI uptake in each serial Image. 144 IS had 
abnonnal WT pre REV, respectively 75 (52%) and 104 of them (72%) 
Improved WT (>2mm) by month 1 and 3 post REV,40 (28%) 
remained unchanged. The chanaes in relative uptake between stress 
and 24 hours pre REV Tllmages (/iTl) and in post REV WT (/iWT) 
were detennlned in all IS. There was a Significant relationship (r-0.89, 
p<O.OI) between and time to Improvement ofWT, and between the 
degree of WT Improvement and /iTi (r-0.92, p>O.OO). Based on TI 
uptake, defects in IS were classified as fixed «50% of maximal 
activity) (FD) or reversible (>50% of maximal activity) (RD) in 4 and 
24 hours imaaes. The sensitivity and specificity of preoperative 4 and 
24 hours RD for the prediction of postoperative WT improvement 
were 69% 83%, and 86% 75% respectively. 
Time to WT improvement was shorter and Its degree was Significantly 
superior in IS with greater. This study demonstrates the possibility of 
myocardial stunnina after a REV procedure. Its occurrence and time 
to recovery is inversely related to the degree of pre REV /iT!. 24 hours 
TI ia superior to 4 hours post exerciae imaging for the recognition of 
viable segments. 
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922·77 
QUANTITATIVE ANALYSIS OF REST REINJECTION 
COMPARED TO REDISTRIBUTION 
Dennv D Watson, WiJJiam H. Smith, Ellen Vinson, Sanjiv Kaul, Timothy 
Blackburn, George A. Beller. University of Virginia, Charlottesville, VA. 
Myocardial perfusion delects alter exercise with partial or no 
redistribution (RD) at 2.5 hours were quantitatively measured both before 
and after rest reinjection (RNJ) 01 11-201 to test lor further defect 
reversibility. RD and RNJ studies were also blindly interpreted by 2 
observers in random order and then compared unblinded to obtain a 
subjective evaluation of enhanced redistribution by reinjection. Of Ihe 50 
patients studied, 44 (88%) were male and 34 (68%) had a prior history of 
myocardial infarction. The average age of the patient population was 59.5. 
Of the 105 perfusion defects analyzed, sg had RD on either the 
delayed or reinjection images and 47 were persistent defects (PD) on both. 
Average initial RD defect ratio, (normal-defect)/normal (%), was 50.5±1O 
(n=58) post stress decreasing to 36.6±16 at 2.5 hours (p<.OOOl). After 
reinjection, the delect average was 34.9±16 (p<.OOOl compared to post 
stress but p=O.06 comparing 2.5 hour delay to reinjection defect). 
01 the 59 defects graded lixed at 2.5hr, the average defect post 
exercise was 55.2±15 compared to 56.0±15 at 2.5hr (ns) and 54.9±16 (ns) 
alter RNJ. Of these 59 defects, the interpreters found 12 (20%) with 
additional RD after RNJ but of the 46 with RD at 2.5hr, the observers 
graded 9 (20%) as PD after RNJ. The observers on unblinded comparison 
graded 17 defects as improved after reinjection (of these, 10 were already 
graded RD at 2.5hr) and 5 defects as appearing worse after reinjection. 
These data show that redistribution had taken place in most of the 
segments at 2.5 hours and could be demonstrated quantitatively from planar 
images. Reinjection resulted in statistically marginal additional defect 
reversibility. The observers agreed that reinjection helped with the visual 
identification of reversibility but much of the apparent improvement in 
blinded readings was in the range of random error in grading the images. 
The data suggest that imaging technique may be an important limitation to 
the visual detection 01 redistribution. 
922·78 
Long Term Follow-up of Patients With Increased Lung 
Uptake of Thallium in the Absence of Coronary Artery 
Disease 
Yue-Hua Shen, Ronald P. Emerson, Steven C. Port, 
University of Wisconsin Medical School, Milwaukee, 
Wisconsin. 
Increased lung uptake (LU) of Thallium (Tl) during 
stress testing correlates with the presence of and 
prognosis in coronary artery disease (CAD). 
Increased LU is occasionally seen in the absence of 
perfusion defects and the prognosis in this setting 
is unknown. Previously we reported that 1.1% pts 
with normal myocardial perfusion on Tl scans have 
increased LU either during exercise or after 
dipyridamole (JNM 32:959, 1991). In a consecutive 
series of 5,421 pts acquired over a 3 year period, 
2,625 pts (48.4%) had abnormal, 1,999 (36.9%) normal 
and 797 (14.7%) equivocal myocardial perfusion 
scans. Of these pts, 557 (21.2%) of the abnormals, 
22 (1.1%) of the normals and 55 (6.9%) of the 
equivoca1s had increased LU by qualitative analysis. 
Of the 22 normals, LU was 0.53±0.07 (0.44-0.65) of 
myocardial activity. Of those 22, 7 had a history of 
an MI despite the negative scans. Of the remaining 
15, 11 had hypertension (HTN) at the time of T1 
scans. After 2.5 years follow-up, none of these 15 
pts developed CAD and all of the pts still have HTN. 
The results suggest that increased LU of Tl is rare 
in the absence of a perfusion defect. For the pts 
without CAD, HTN (left ventricular diastolic 
function?) may cause increased LU of Tl during stress 
testing. The prognosis of increased LV in the 
absence of CAD appears to be favorable. 
ABSTRACTS 
922·79 
Correlates and Prognostic Significance of ThalIiwn Reverse Redistribution. 
James A. Stone, Linda M. Wright, Peter J. Gladstone, Robert J. Burns. The 
Toronto Hospital, Toronto Western Division, Toronto, Ontario, CANADA. 
Reverse redistribution (RR) of thallium is common after thrombolytic 
therapy for evolving MI and implies relatively rapid washout of thallium from 
the infarct zone. Thallium washout rate is proportional to the myocardial-blood 
concentration gradient. RR is observed both in seements with normal and 
diminished initial uptake. Thus, RR has been postulated to depict normal or 
supernormal coronary flow reserve (thallium input) relative to the amount of 
subtended viable myocardium. We examined this hypothesis by retrospective 
review of 13 8 patients with RR as their isolated stress-redistribution thallium 
abnormality. Independent evidence of regional left ventricular function (contrast 
ventriculography, echocardiography, radionuclide angiography) was available for 
110 patients; 65 patients had coronary angiography within 6 months of thallium. 
Clinical follow-up (28 ± 15 months) was obtsined in all 138 patients. 
129A 
Distribution of RR segment artery stenosis and evidence of RR segmeDi \ 
damage (no evidence, prior MI, PTCA, ACB, global/focal LV dysfunction; 
were: 
50 No. of Patients 
40 
30 
20 
10 
OU---L-~~~--~~~L 
049 50-75 76-99 100 
Percent Coronary Artery Stenosis 
ACB 
PriorMI 
During follow·up, there were 2 Ml's, 2 PTCA's, 4 aort~ronary bypass (ACB) 
procedures and no deaths (2.4 % annual rate of these events). 
These data support the hypothesis that one important mechanism of RR is 
relatively increased myocyte uptake and washout of activity in segments with 
normal or supernormal thallium input (flow reserve) in relation to the amount of 
subtended viable myocardium. Isolated RR is associated with a favorable long•
term prognosis. 
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923·44 
PREVENTION OF TOLERANCE TO A PROLONGED INFUSION OF 
NITROGLYCERIN WITH CAPTOPRIL 
LUCiano Pizzulli,Berndt LOderitz,Dept.of Cardiology 
university of Donn,Germany 
Prel iminary investigations suggest, that ACE-inhibitors may 
Infiuence nitrate tolerance. The aim of our study was t'O 
assess,whetller captopril is a~le to prevent the loss of hemo•
dynamiC effects curing prolonged i.v.nitroglycerin(NTG) ad•
ministration.We studied 18 patients(pts)witnout congestive 
heart failure.9 pts were started on captopriI(50mg/day)(C) 
ana ~ pts on placeoo(P)for 1 week;heart catheterization was 
performed and hemodynamiC values(mean arterial pressure(MAP), 
mean pulmonary artery pressure(PAr) ,pulmonary wedge pressure 
(PCP),carciac index(CI)) ~ere obtainea at baseline and 1,3,5, 
and 10 min after O.tlmg NTG s.I •• Then i.v.NTG was given in a 
dosage of 6mg/h,maintained for 48h and hemodynamic investiga•
tIOn was repeated using the same study protocol. 
Results: 
Day 1 Group C 
pre post 
PAP\mmHg) 17+/-3 12+/-4* 
PCP\mmHg) 10+/-4 5+/-5* 
CI(l/mln/m2) 3.4/+/-1.0 3.2+/-0.9 
SVR(c/s/cm-5) 1240+/-2.!0 1050+/-400 
*:p<0.05; post-NTG:maximum effect 
Day 3 Group C 
PAP 
PCP 
CI 
SVR 
*:p<0.05 
pre post 
13+/-4* 0+/-4* 
8+/-3 b+/-4 
3_6+/-1.3 ~.2+/-1.5 
1100+/-43~ 1015+/-380 
Group P 
pre post(sl NTG) 
18+/-4 11+/-5* 
11+/-5 iH/-3* 
3.5+/-1.1 3.3+/-1.4 
1300+/-300 1140+/-20~ 
Group P 
pre post(sl NTG) 
19+/ -6 17+/-6 
13+/-4 11+/-4 
3.3+/-1.4 3.5+/-1.7 
1380+/-480 1305+/-330 
Conclusion:Captopri I was able to prevent the loss of hemo•
dynamic efficacy during prolonged NTG-infusion.After 48 h 
PAP and PCP were significantly lower compared to the placebo 
group and acute response to additional sl NTG was maintained. 
Our results demonstrate, that captopril may be usefui in 
avoiding tolerance ,<:Ie~elopment to organic nitrates. 
130A ABSTRACTS 
923·45 
Molsidom;ne in Patients Tolerant to Isosorb;de 
Dinitrate 
Philippe Unger, Attilio Leone, Michel Staroukine, 
Serge Degr~, Guy Berkenboom, Universit~ Libre de 
Bruxelles, Brussels, Belgium 
Contrary to or9anic nitrates, molsidomine (M) is a 
sulfhydryl (SH) group independent nitrovasodilator. 
To assess the clinical relevance of this property, 
the hemodynamic effects of a 24 hour M infusion were 
assessed immediately following identification of 
isosorbide dinitrate (IS) tolerance in patients with 
congestive ischemic heart disease, in the absence 
(group I, n = 8) or presence of enalapril 5 mg b.i.d. 
(group 2, n = 6). Entry criteria included a left 
ventricular ejection fraction ~ 35 %, a pulmonary 
artery wedge pressure (PAW) ~ 15 mmHg and a ~ 50 % 
loss of the maximal effect on PAW after 24 h IS 
infusion. IS and M were infused at a rate that 
reduced PAW> 30 % or > 10 mmHg. 
Results Control Peak IS 24hr IS 
Group 1 21:2 11**:2 20:2 
Group 2 22:3 14*:2 21:2 
PAW (mean + sem) in mmHg; 
* p < .05 - ** P < .01 vs control. 
Peak M 24hr M 
12*+2 18+2 
12**~1 13**~2 
M induced only in group 1 a significant increase in 
plasma epinephrine level and a decrease in 
hematocrit. 
In conclusion, M was operative in patients 
tolerant to IS. However, its effects lasted 24 hrs 
only in group 2. These data suggest that both SH 
groups depletion and neurohormonal reactions are 
involved in nitrate tolerance. 
923·46 
Sympathetic Nervous System Activity is Increased by 
Acetylcholinesterase Inhibition in Humans 
Rose M. Robertson, Thomas J. Killian, Italo Biaggioni, 
Virginia Haile, Rogelio Mosqueda-Garcia. 
Vanderbilt University, Nashville, Tennessee 
Acetylcholinesterase inhibitors (AChEls), via an effect at 
the ganglionic level, can enhance both parasympathetic and 
sympathetic nerve activity (SNA) in animals. It has not 
previously been possible to determine whether this also 
occurs in humans. Our recent demonstration that 
edrophonium (ED), a peripherally-restricted AChEl, is pressor 
in patients with autonomic failure (0.1-20 mg iv; maximum 
BP rise of 27/12±4/1 mmHg; p<0.001) and that it 
increases plasma norepinephrine levels in these subjects 
(216±45 to 415±110 pg/ml (p<0.01) suggests that ED 
may indeed cause sympathetic activation in man. To test 
this hypothesis directly, we utilized microneurographic, ECG, 
and intra-arterial BP recordings in 4 healthy normal subjects 
aged 20-26. We determined the response of SNA to a range 
of bolus doses of ED (0.1-10 mg iv) in a placebo-controlled 
design, assessing BP and heart rate (HR) responses to 
control for possible baroreflex-mediated effects on SNA. 
Edrophonium caused a significant and dose-related 
increase in SNA (with a 3.2-fold increase at 6.4 mg; p < 0.01 
vs placebo), as well as clinically-apparent parasympathetic 
activation at higher doses. There was no depressor response 
after ED to implicate a baroreflex-mediated cause for the rise 
in SNA. 
These studies indicate that a primary increase in 
sympathetic nerve activity contributes to the cardiovascular 
effects of this acetylcholinesterase inhibitor in humans. 
923·47 
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Tolerability of Enalapril by Patients With Left 
Ventrioular Dysfunotion 
John B. Kostis, Melvin B. Weiss, Robert J. Capone, Carl 
Pepine, Gilbert Gosselin, Brent Shelton, Linda L. Cahill, 
Dians Dutton for the SOLVD Investigators. DHDNJ-Robert 
Wood Johnson Medical School, New Brunswick, New Jersey. 
Although oonverting enzyme inhibitors are useful in the 
treatment of congestive heart failure, there are concerns 
about adverse reactions especially upon initiation of 
therapy. 
In the Studies Of Left Ventricular Dysfunotion (SOLVD), 
open label outpatient enalapril therapy 2.5 mg BID was 
given for 7 days (mean 6.1, range 2 to 7, median 7) to 
7386 patients with left ventricular dysfunction (ejeotion 
fraction SO.30). 
Small, but statistically significant (p(O.OOOl) decreases 
in blood pressure by 6/4~14/10 mg/Hg and heart rate by 
1~10 beats/min and inoreases in serum K+ by 0.09~4.6 
mEq/L, BUN by 0.6~4.7 mg/dl creatinine by 0.02~0.19 mg/dl 
were observed. 
Four hundred and fifty patients (6J) reported side 
effeots including symptomatic hypotension (in 160 
patients, 2.2J). The large majority (78J, 352 of 450) of 
patients who reported side effects (125 of 160 patients 
with symptomatic hypotension) were willing to participate 
in the study and to continue receiving enalapril. Thus, 
only 1.3J (98 of 7386) were not willing to continue due 
to side effects (35 of 7386 or 0.5J because of 
symptomatic hypotension). 
Women and patients with CHF class III and IV were more 
likely to report side effects. 
Thus, enalapr1l is well tolerated by the great majority 
of patients with left ventrioular dysfunction; treatment 
can be initiated on an outpatient basis. 
923·48 
Severely Depressed Subendocardial Function in Dilated 
Cardiomyopathy is Potentially Reversible. 
Stephen J. Brecker, Chiang H. lee, Han B. Xiao, Margaret E. Fox, 
Derek G. Gibson. The Royal Brompton National Heart & lung Hospital, 
london, United Kingdom. 
Subendocardial fibres are longitudinally arranged in the left ventricle, and 
their function is markedly depressed in dilated cardiomyopathy. To 
assess a possible effect, intravenous milrinone was administered to 12 
patients with severe dilated cardiomyopathy (shortening fraction 
10±4%, age 54±8 years). We performed M-mode echocardiography 
and Doppler before, and 25 minutes after infusing milrinone (bolus 50 
pglkg, maintenance 0.5pglkg/min). We measured isovolumic relaxation 
time (lVRT), cavity dimensions, wall thickness, mitral ring motion (in long 
axis), and derived peak rates of dimension increase and posterior wall 
thinning from digitised M-modes. long axis excursion increased 
markedly (6±3 mm vs 11 ±3, p<O.Ol) (normal:14±3). This was 
associated with an increase in end systolic posterior wall thickness 
(1.5±0.3 em vs 1.8±0.2) and a decrease in end systolic dimension 
(6.4 ± 1.0 em vs 5.9 ± 1.1)(p values <0.001). Peak rates of left 
ventricular dimension increase and posterior wall thinning both increased 
markedly (7.9±2.6 cm/s vs 11.1 ±2.7 and 4.5±1.8 cm/s vs 8.3±2.1 
respectively)(p values < 0.001). IVRT initially short, normalized (37 ± 26 
ms vs 62±32, p<O.01), yet peak E wave velocity was maintained 
(76 ± 27 cm/s vs 82 ± 28, p = ns), and rapid filling duration increased 
(133 ±40 ms vs 174±31, p<O.OI). Cardiac output rose (3.2± 1.3l1min 
vs 4.6±1.7) as did shortening fraction (to 14±6%) (p values <0.03) 
with no change in heart rate (100±13 vs 102±9). 
Conclusion : Severely depressed subendocardial function in dilated 
cardiomyopathy is potentially reversible, with marked effects on systolic 
and diastolic function. These hitherto unrecognised actions of milrinone 
may extend therapeutic possibilities in supporting the depressed 
myocardium. 
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923·49 
THE HEMODYNAMIC ACTIONS OF IPAZILIDE 
FUMARATE IN CONGESTIVE HEART FAILURE. 
Stephen S. Gottlieb, Michelle Weinberg, Michael D. Pressel. 
University of Maryland School of Medicine, Baltimore, MD. 
The hemodynamic effects of ipazilide fumarate (lpaz), a new 
antiarrhythmic agent with in vitro class III actions at low concentrations 
which are joined by class I actions at higher ones, have not been 
evaluated in CHF. We therefore placed a Swan-Ganz catheter> 12 hrs 
prior to administration of 400, 200,or 100 mg Ipaz in IS pts with 
severe CHF. Cardiac output (CO, Vmin), mean arterial, LV filling & 
right atrial pressures (MAP, LVFP, & RAP, mmHg), heart rate (HR, 
bpm), & systemic vascular resistance (SVR, dos-c) were measured 
before & 2 hrs after drug administration. Plasma concentrations (conc, 
Ilg/ml) of Ipaz and its metabolites (WIN 60010 & WIN 58784) were 
measured before & 0.5,1,1.5,2,3, & 4 hrs after Ipaz administration. 
CO J. from 3.4 to 2.9 (p < 0.01) & MAP J. from 96 to 90. The 
hemodynamic response was related to dose, with marked J. in CO & 
MAP at 400 m & minimal change at 100 mg: 
n tCIJ AMAP ALVFP ARAP AHR t\SVR 
400 3 -1.0 -20 - 3 - 2 +3 +S4 
200 5 -O.S - 5 +2 -1 + 1 +174 
100 7 -0.2 - 1 +3 - 1 +3 +210 
Conc of i1 az and itS metabohtes eaked at 2 hrs. I z n w p p pacocere 
1.19±O.44 (range 0.74-1.62) after 400mg, 0.48±O.l1 (range 0.37-
0.54) after 200mg, & 0.22±O.11 (range 0.10-0.53) after l00mg. Conc 
of WIN 58784 and 60010 were 0.09±.04 & 0.12±O.13, respectively. 
~ll 3 pts receiving 400 mg developed clinically significant 
cardiovascular symptoms (hypotension & chest pain) which coincided 
with hemodynamic deterioration. The frequency & severity of 
symptoms J. with decreasing doses, with 2/5 200 mg pts & 3n 100 mg 
pts noting symptoms. 
In conclusion, Ipaz exerts dose-dependent negative inotropic effects 
in pts with severe CHF, perhaps related to varying % of class III and I 
activity at different doses. The therapeutic risk/benefit ratio ofIpaz still 
needs to be established, especially in high risk pts with CHF. 
923·50 
Enhanced Endothelin Production During Myocardial Ischemia 
Stimulates Adenosine Release From Neutrophils: A Possible 
Protective Mechanism Against Reperfusion Injury 
John A. Morrow, Mervyn B. Forman, John J. Murray. 
Vanderbilt University, Nashville, Tennessee 
Myocardial ischemia/reperfusion significantly enhances cardiac 
release of endothelin (ET) and the influx and activation of 
neutrophils (PMNs) in the reperfused bed. To explore the potential 
interaction of ET with PMNs, human PMNs were untreated or 
treated with recombinant human ET-1 (10·· M) for S mins and then 
stimulated with the chemoattractant FMLP for 10 mins. ET 
significantly inhibited the FMLP-stimulated superoxide anion (0,·) 
release without any effect per se. To explore the mechanism of 
the inhibitory effect of ET, PMNs were preincubated with the 
adenosine receptor antagonist DPSPX or adenosine deaminase 
(ADA). 
Q,. Production (nmoles 0,"110· PMN/10 minl 
Pretreatment 
None 
DPSPX 
ADA 
±FMLP 
7.S± 1.5 
11.S±1.8t 
11.1±1.7t 
±ET ± FMLP 
6.S±1.S* 
11.S±1.7t 
11.6±2.0t 
tp<O.OS vs. none; *p<O.05 vs. corresponding FMLP alone 
DPSPX or ADA pretreatment enhanced the 0,· response to FMLP 
suggesting that adenosine release occurred in FMLP-stimulated 
cells. ET potentiated the FMLP-stimulated adenosine release with 
further reduction of 0,· production. Adenosine release was 
confirmed by HPLC separation and quantification of 'H-adenosine 
after labeling the PMNs with 'H-adenine. ET may have beneficial 
effects on myocardial reperfusion injury by stimulating adenosine 
release from activated PMNs, thereby minimizing their cytotoxic 
functions. This adenosine release from PMNs may also contribute 
to the transient vasodilatory action of ET. 
ABSTRACTS 
923·51 
Hemodynamic, Electrophysiolo~ic, and Pharmacokinetic 
Properties of Intravenous Dofetilide (UK 68,198), a Novel 
Class III Antiarrhythmic Drug 
Lameh Fananapazir, Anne Cropp. National Institutes of Health, 
Bethesda, Maryland 
Dofetilide has been shown in..Yitm to have class III anti•
arrhythmic properties. We studied the hemodynamic, electro•
physiologic, and pharmacokinetic properties of the iv drug 
(bolus, 1.95 ltg/kg over 15 min; maintenance, .068 ltg/kg/min) in 
16 pts. Dofetilide did not significantly affect hemodynamic 
indices. The QRS width, sinus cycle length, sinus recovery 
times, and HV interval were also unchanged. The following were 
significantly (p< .01) prolonged: sinoatrial conduction time 
(SACT), AH mterval, AV node (A VN) effective refractory period 
(ERP), and atrial (A) ERP, and ventricular ERPs measured at RV 
apex (RV A), RV outflow (RVOT), and LV at 3 drive cycle lengths 
600, 500, & 4OOms: 
A t ems) A t ems) A t ems) A t ems) 
SACT 18±29 AERP 29±11 AH 11±16 AVN-ERP 37±23 
AERPt ems) AERPt ems) 
RVA/600 35 ± 20 RVOT/600 39 ± 15 
RVA/SOO 30 + 20 RVOT/SOO 33 + 21 
RVA/400 36 ± 17 RVOT/400 33 ± 20 
AERPt ems) 
LV/600 29 ± 16 
LV/SOO 31 + 17 
LV/400 27 ± IS 
Mean plasma concentration at the time of EP studies was 3.3±.77 
ng/m!. The peak plasma concentration varied widely from pt to 
pt (2.5 to 5.2 ng/ml) under identical conditions of drug infusion. 
The Kel was .0679±.02 hr-I corresponding to a mean half life of 
1O.9±3.! hrs (range 7.3 to 18 hrs). 
Thus, iv dofetilide I) is hemodynamically well tolerated, 2) 
has small but significant effects on the sinus node and A VN 
conduction, 3) does not adversely affect His-Purkinje conduction, 
and has important class III effects in human subjects. The 
hemodynamic/EP/pharmacokinetic features of dofetilide makes it an 
attractive alternative to other class III agents in current use. 
923·52 
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Thrombolysis with Saruplase: Pharmacokinetics and Conver· 
slon to Uroklnase·Type Plasminogen Activator In Acute Myocar•
dial Infarction. 
Rudolph Koster, • Adam Cohen, 'Gwyn Hopkins, 'WoHgang GOnzler. Dept of 
cardiology, Academic Medical Centre, Amsterdam, 'Centre Human Drug 
Research, Leiden, Netherlands, "GrOnenthal, Aachen, BRD. 
The pharmacokinetic and pharmacodynamic properlies of unglycosylated 
recombinant single-chain urokinase-type plasminogen activator (saruplase) 
have not been fully defined in patients w~h AMI. 12 consecutive patients with 
AMI received 20 mg of saruplase Lv. over 1 min, followed by SO mg over 60 
min. Bioodsampies were taken w~h special anticoagulants frequently over 4 h 
after start of treatment. Total u·PA and two-chain u-PA: "urokinase" (tcu-PA) 
by immuno-reactivity-linked activity assay (1M), total u-PA antigen by ELISA, 
a-2 antiplasmin (a-2 AP), fibrinogen (fib) and total fibrin(ogen) degradation 
products (tdp) were measured. 
ResuHs: 
Total pia ... conc.ntretton (R9'ml) 
4000 Totel u.PA oct (IAA) 
2000 
1000 
tcu-PAoct(IAA} 
---- totel u·PA ant (ELISA) 
~ Infusion .1 Time (h) 2 
Time a-2 AP fib tdp 
(h) ("!o) (mglml) ()JgIm~ 
o 103 
0.5 36 
1 19 
2 20 
3 25 
4 29 
329 2 
207 44 
79 156 
51 183 
50 142 
49 110 
By total area under curve (AUC) 28±9% (mean ± SD) of administered saru•
plase was converted to tcu-PA , equivalent to a total infused dose of 5.2 MU 
(range 0.98-4.4 MU) of urokinase.Total u-PA activ~y clearance was 427 ± 113 
mVmin (mean±SD) and tll2a 7.8 min, representing 97% of the AUC. 
Conclusion: rscu-PA (saruplase) is converted into a potentially therapeutic 
dose of tcu-PA (urokinase) and plasminaemia is demonstrated at this dose of 
saruplase. Clot specificity was not observed. 
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923·53 
Cholinesterase Inhibitors Blunt the Cardiae 
Effects of Cocaine by a peripheral Mechanism 
Ronald T. Uszenski, Richard A. Gillis, Kenneth L. 
Dretchen, Frederick E. Kuhn. 
Georgetown University, Washington, DC 
Prior studies from our laboratory suggest that 
the cholinesterase inhibitor physostigmine 
(PHYSO) blunts the cardiac effects of cocaine 
(COC). To determine if the beneficial effect of 
PHYSO is due to enhanced stimulation of peripher•
eral or central cholinergic receptors, we compar•
ed the effect of pretreatment with either PHYSO 
or neostigmine (NEO) on the cardiac effects of 
COC (2mg/kg) in dogs. Peak change (mean±SEM) in 
heart rate (HR), mean pressure (MAP), double pro•
duct (RPP) and ejection fraction (EF) after COC 
alone or pretreatment with PHYSO or NEO were: 
N HR MAP RPP EF 
COC 8 10±3 23±3* 2.4±.4* -16±2* 
PKYSO 8 S±7 S±S. 0.4± 1. -6±3. 
NEO 8 -2±6 -S±4. O.O±.S. -3±2. 
PRO+NEO 8 9+6 13+6#* 1.8+.S#* -11+1#* 
(*P<.OS v base, .p<.OS v COC ,#P<.OS v NEO) 
Both PHYSO and NEO blunted the cardiac effects of 
COCo In a 4th group the peripheral cholinergic 
receptor antagonist propanthelene (PRO) inhibited 
the beneficial effects of NEO. CONCLUSION: PHYSO 
which inhibits cholinesterase both centrally and 
peripherally blunts the cardiac effects of COCo 
NEO which only inhibits cholinesterase peripher•
ally has similar effects and these are prevented 
by the peripheral cholinergic receptor antagonist 
PRO. Thus the beneficial effects of PHYSO are due 
to enhanced stimulation of peripheral cholinergic 
receptors and are not due to a central effect. 
923·54 
Cardiovascular Effects of Growth Hormone 
Kenneth Caidahl, Bengt-Ake Bengtsson. Divisions of Clinical 
Physiology and Endocrinology, Sahlgren's University Hospital, 
Gothenburg, Sweden 
Growth hormone (GH) replacement is not routine in adult 
pituitary insufficiency. However, lack of GH has now been found to 
be associated with increased cardiovascular mortality. Therefore 
we studied cardiovascular and renal effects of GH replacement. 
10 patients, mean age 47 years, with GH deficiency, were given 
s.c. recombinant GH (Humatrope®, Eli Lilly) O.S Ulkgl week, in a 
6 month double blind cross-over study. Doppler-echocardio•
graphy, computerized exercise-ECG, and renal function tests were 
performed before and after treatment periods. One patient was ex•
cluded because of atrial fibrillation. 
Left ventricular (LV) mass increased from 211 to 249 g 
(p<O.OS), mainly due to increased LV dimension since wall 
thicknesses did not increase. Systolic, as well as diastolic, LV 
function were maintained during GH replacement, although the left 
atrium increased from 38 to 41 mm (p<0.05). Stroke volume 
increased from 92 to 118 ml (p<O.OOOl) and cardiac output 
increased from S.29 to 7.S8 L I min (p<0.05). Total peripheral 
resistance decreased from 18.9 to 12.4 mmHg x min I L 
(p<O.OS), and diastolic blood pressure from 79 to 72 mmHg 
(p<O.OS). Heart rate and systolic blood pressure at rest were 
unchanged, as was systolic blood pressure during dynamic 
exercise. GH replacement did not cause ST-abnormalities. 5-
Creatinine decreased from 91.4 to 8S.3 I1moi/L (p<O.OS) and 
glomerular filtration rate increased from 89.6 to 99.8 ml I min 
(p<O.Ol ). 
We conclude that GH replacement has favorable cardiovascular 
and renal effects including increase of cardiac output and glomeru•
lar filtration rate with reduction of peripheral resistance. 
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Preconditioning Does Not Prevent Myocardial Stunning 
Michel Ovize, Karin Przyklenk, Robert A.Kloner. 
Heart Institute, Hospital of the Good Samaritan & USC, Los 
Angeles, California. 
Despite numerous reports that one or more episodes of brief'coronary 
occlusion (CO) ·precondition· the myocardium and dramatically 
reduce infarct size produced by a subsequent prolonged ischemia, we 
recently demonstrated that preconditioning does not attenuate 
contractile dysfunction in the peri-infarct tissue. However, the effects 
of preconditioning on myocardium ·stunned" by a short ischemic insult 
(that is, not confounded by necrosis) remains unknown. We 
addressed this issue in a canine model designed to simulate stable 
angina: 12 dogs underwent 15 minutes of CO followed by 3 hours of 
reperfusion (R). Each dog was randomized to either the 
preconditioned group ([2 minutes CO/5 minutes RI prior to the 15 
minute ischemic insult; n=6) or the control group (no intervention; 
n=6). Segment shortening (SS) in the ischemiclreperfused 
midmyocardium was monitored by sonomicrometry, and blood flow 
was assessed during the 15 minute CO by injection of radiolabeled 
microspheres. Both groups were equally ischemic during CO; 
'21) midmyocardial blood flow 1 ': ~-=-~~::c:, averaged .05±.02 vs .07±.04 
S 60 mllminlg in control vs 
D preconditioned groups. In 
; ;~ - addition, 55 was similar in 
;;; 0 both groups throughout the 
'" -20 , protocol. Thus, ischemic 
-40 preconditior,jng does not exert 
-6C Bot t P" 2' '0' ~ '0' '~' 30' .. 2h )h a cardioprotective effect in the 
2'CO ,'reO L_Repe"us..,n---! canine model of stable angina: 
it neither preserves contractile function during the short ischemic 
insult, nor prevents stunning dUiing the initial hours following 
reperfusion. 
924·55 
Coronary Circulation in Dogs with Experimentally 
Decreased Aortic Compliance 
Hideki Watanabe, Sadanori Ohtsuka, Masaaki Kakihana, 
Yasuro Sugishita 
University of Tsukuba, Ibaraki, Japan 
In order to investigate the effects of decreased aortic 
compliance (ACo) on coronary circulation, myocardial 
blood flow was measured with colored microsphere in 5 
dogs with experimentally decreased ACo by aortic bandage 
and in 5 control dogs with sham operation (ACo: decreased 
ACo dogs; O.44±0.l3 ml/mmHg vs control dogs; 0.92±0.42 
ml/mmHg, p<O.Ol). After 4 weeks of the preparation of 
aortic bandage or sham operation, there was no difference 
in mean aortic pressure and aortic flow between two 
groups. LV wall thickness and %fractional shortening 
were measured with UCG and there was no difference in 
them between two groups. At the baseline, there was no 
difference in subendocardial blood flow (Endo), but 
Endo/Epi flow ratio in decreased ACo dogs was lower than 
that in control dogs (LCx: 0.9±0.3 vs 2.2±O,6, p<O.Ol; 
LDA: 0.7±0.2 vs 1.2±0.l, p<O.OI). In the presence of 
LCx coronary stenosis adjusted to eliminate reactive 
hyperemia,LCx Endo in decreased ACo dogs was lower than 
that in control dogs (0.94±0.45 vs l.36±0.20 ml/min/g, 
p<0.05) and Endo/Epi flow ratio was also decreased 
(0.7±0.3 vs 1.7±0.S, p<O.OI). Rapid atrial pacing (HR-
200) further decreased LCx Endo/Epi flow ratio in the 
presence of coronary stenosis (0.4±0.1 vs 0.S±0.3, 
p<0.05). Moreover, in decreased ACo dogs, segment short•
ening in the LCx area with coronary stenosis signifi•
cantly deteriorated during rapid pacing (19±3 to 6±4%, 
p<O.Ol; 24±12 to 22±9%, NS). 
These results indicate that decreased ACo is a great 
additive risk for subendocardial ischemia in the case 
of coronary stenosis. 
JACC Vol. 19, No.3 
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924·56 
Improvement of Ischemic Myocardial Blood Flow and 
Contractile Function by Simultaneous Administration of 
Dobutamine and UL·FS 49, a Specific Bradycardic Agent. 
Patrick D. O'Brien, David C. Warltier, Medical College of Wisconsin, 
Milwaukee,WI. 
When inotropic stimulation by sympathomimetic amines is 
accompanied by tachycardia, ischemic myocardial blood flow (MBF) 
and contractile function (%SS) may decline. We examined the effects 
of dobutarnine (DOB, 10 11g/kg/min) on hemodynamics, ischemic 
zone MBF (microspheres), and %SS before and after the specific 
bradycardic agent UL-FS 49 (ULFS, 0.5 mg/kg), and during atrial 
pacing (PAC) to the pre-ULFS heart rate, in 7 open-chest, 
anesthetized dogs with a severe coronary artery stenosis. Heart rate 
(HR), systolic blood pressure (SBP), dP/dt, and cardiac output (CO, 
L/min) were significantly (*p<O.05 vs control, CON) increased by 
DOB. The subendocardial to subepicardial blood flow ratio (En/Ep) 
was decreased by DOB. %SS (expressed as % of CON) was 
unchanged by DOB. ULFS lowered HR (tp<0.05 vs DOB) without 
changing SBP or dP/dt. En/Ep and %SS were significantly increased 
by ULFS. Atrial pacing to the pre-ULFS heart rate abolished the 
effects of ULFS on En/Ep and %SS. 
HE sae deldl 00 EnlEll ~SS 
CON 12S±2 12O±S 1768±11l 3.0±.2 .74±.O7 100 
DOB 166±5· 139±6* 227S±34· 4.9±.6· .49±.06· 130±29 
ULFS 97±7·t 133±6· 2200±23* 3.8±.4t .78±.09t 216±3S·t 
eAC Hifi+fi* 138+5· 2211;!;2S* ~ 2+ fi· 51;!; Q1· 125+33 
Conclusion: reduction of the tachycardia associated with the use of the 
sympathomimetic amine dobutamine by a specific bradycardic agent 
significantly improves ischemic zone myocardial perfusion and 
contractile function with minimal alteration of the inotropic or pressor 
response to this drug. 
924·57 
CORONARY BLOOD FLOW DURING HYPERCARBIA 
Wanchun Tang. Max H. Weil. Raul J. Gazmuri. Kevin 
Reese. Joe Bisera. UHS/The Chicago Medical School. 
North Chicago. Illinois 
Prior studies (Tang W et al. Crit Care Med 1991;19:218-
224) indicated that increases in PC02 are accompanied 
by decreases in myocardial contractility in the iso•
lated. perfused rat heart and in intact dogs (Walley KR 
et a1. Circ Res 1990;67:628). We therefore examined 
the effects of hypercarbia on coronary blood flow 
utilizing a transonic flow meter for measurement of 
flow through the anterior descending porcine coronary 
artery. Myocardial PC02 and pH were measured simul•
taneously with a miniature pH electrode and an ion 
aensitive field effect transistor CO2 sensor. Inspired 
CO2 was progressively increased from 0\ to 40\ 
whereupon myocardial PC02 increased from 77±6 (mean ± 
S.D.) to 305±14 mm Hg and pH decreased from 7.26±0.07 
to 6.83±0.lO. The left anterior descending coronary 
artery blood flow concurrently increased from 80±7 to 
196±8 ml/min (p < 0.01). Accordingly. hypercarbia 
markedly increased rather than decreased coronary blood 
flow. The previously documented decreasea in 
contrectility induced by hypercarbia were therefore not 
explained by concurrent decreases in coronary blood 
flow. In subsequent studies on the same experimental 
aodel. we demonstrated that increases in coronary blood 
flow. but n21 myocardial hypercarbia. were fully 
blocked by propranolol. These studies therefore demon•
atrated that the striking increases in myocardial PC02 
and the concurrent myocardial hypercarbia induces 
coronary vasodilation by a p-adrenergic action. and 
points to the previously documented endogenous rele~se 
of catecholamines with hypercarbia as the mechanism 
(Reddy SV et a1. Brain Res 1986; 365: 278-288) by vhich 
coronary blood flow is increased rather than decreased. 
ABSTRACTS 
924-58 
Transmural Gradient of Free Cytosolic Calcium During Low Flow 
Ischemia: An INDO-l Fluorescence Study 
Vincent M. Figueredo, Rolf Brandes. Michael W. Weiner, S. Alben 
Camacho. San Francisco V AMC, UCSF. San Francisco. California 
Previous repons have demonstrated transmural differences of coronary 
flow, energy metabolites and contractility during low flow ischemia. To 
test the hypothesis that transmural differences of free cytosolic calcium 
occur during low flow ischemia, endocardial (ENDO) and epicardial (EPO 
Indo-I calcium fluorescence measurements were pelformed on isolated rat 
heans during flow reductions to 75, 50 and 20% of control. EPI data were 
obtained using a 1.57mm diameter quanz fiber bundle placed against the 
EPI sulface of the left ventricle. and ENOO data using a 0.69mm fiber 
bundle passed through the left atrium onto the ENOO of the left ventricle. 
The calcium transient (6Ca). diastolic (dCa) and systolic calcium levels 
were monitored using the 385/454II1II Indo-I fluorescence ratio and 
expressed as % of control. Motion artifact and myoglobin filter effect were 
minimized and data were corrected for NADH changes. 
RESULTS: During mild low flow ischemia (flow=75 and SO% of control), 
ENDO and EPI free cytosoJic calcium levels did not change. During 
moderately severe ischemia (flow=2O% of control), there was a significant 
decrease in the ENOO 6Ca and an increase in dCa. In contrast, the EPI 
6Ca did not change and dCa rose to a lesser degree. Systolic calcium levels 
did not change at any flow reduction. (.=p<O.05) 
CF (% control).lOO ~ ~ 20 
ENDO 6Ca 100 l00±2 (n=2) 98±4 (n=S) 7S±7*(n=4) 
ENDO dCa 100 96±2 l00±2 114±4. 
EPI6Ca 100 lOO±I (n=S) l00±2 (n=9) 97±3 (n=12) 
EPI dCa 100 99±1 101±1 107±3· 
CONCLUSIONS: A transmural gradient of free cytosolic calcium levels is 
present during moderately severe low flow ischemia. These data parallel 
previous repons of transmural gradients of myocardial energy metabolites 
and function during low flow ischemia 
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Myocardial Infarction Management in Canada and the United 
States: A Comparison of Two University Hospitals 
Normand Racine, Louise Pilote, Thao Huynh, Susan Stewart, 
Mark Hlatky. 
McGill University, Montreal, Quebec, Canada &: Stanford 
University, California. 
Canadian and American health care systems differ substantially 
but little is known about differences in practice patterns. We 
studied the in-hospital management of patients with 
myocardial infarction (MI) using a retrospective cohort design 
at McGill University (Canada) and Stanford University (USA). 
All patients diagnosed with acute MI during a two year period 
(1989-90) and treated in the coronary care unit were included 
(McGill n=233, Stanford n=245). Demographic and clinical 
characteristics were similar. Thrombolysis was used slightly 
less at McGill than at Stanford (26% vs 33%); streptokinase 
was used at McGill and t-PA at Stanford. Rates of non-invasive 
tests such as treadmill test, thallium test, radionuclide 
ventriculogram and echocardiogram were higher at McGill than 
Stanford (51% vs 15%, 21 % vs 6%, 43% vs 2%, 72% vs 52% 
respectively, p <0.0001 for each). In contrast, rates of 
invasive tests and procedures such as coronary angiography, 
coronary angioplasty and coronary bypass surgery were lower 
at McGill than Stanford (34% vs 58%, 13% vs 30%. 6% vs 
12%, respectively, p <0.0001 for each). Median length of stay 
was the same (9 days). Death and reinfarction rates were 
similar (11% vs 13% and 2% vs 1%, p ... NS for both). Thus, 
non-invasive tests predominate at McGill whereas invasive tests 
predominate at Stanford with no apparent difference in health 
outcomes. 
133A 
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925·21 
Work Status in Patients With Severe Left Ventricular 
Dysfunction: Importance of the Physician's Decision 
Hubert Pouleur, Sally Shumaker, Dawn Stewart, Larry Gorkin, Joan 
F. Barrett, Isabelle Mottard, Salim Yusuf, for the SOLVO 
Investigators. National Heart, Lung and Blood Institute, Bethesda, 
MD. 
To determine the factors contributing to early retirement in pts with 
LV ejection fraction S 35 %, the work status of 3345 pts enrolled in 
the "Studies of Left Ventricular Dysfunction·SOL VO" was assessed 
as part of a larger health quality of life (HQL) questionnaire. Among 
the 1459 pts who reported taking an early retirement, 618 (42%) had 
no heart failure. The major reason given for early retirement was 
physician's request (57.4%), whereas personal decision (22%), the 
employer's request and various financial incentives (9.6%) accounted 
for a minority of cases. A separate multivariate analysis was 
performed to determine the factors predicting retirement status (as 
opposed to patient's self-reported reasons) in the 2240 retired and 
1205 employed pts with complete HQL data. As expected, older age, 
lower education and type of work were strong predictors of R status 
(all p<0.OOO2). Diabetes (p<0.01l) or angina (p<0.077) were 
marginally predictive of retirement status, but NYHA class 
(p<0.54), use of diuretics (p <0.94) or vasodilators (p <0.23) were 
not predictive of retirement status. In terms of HQL factors, high 
perceived vigor, and current life satisfaction were strongly predictive 
ofretirement status (p<O.OOOI), whereas depression (p<0.52) and 
anxiety (p<0.83) were unrelated to retirement. These data suggest 
that pts are influenced by their physician's recommendations for 
early retirement and that the physicians may be responding to the 
economic and psychological status of their pts, as much as to the 
severity of their heart failure. 
925·22 
In Hospital Costs are Increased with Adjunctive Thrombolytic 
Therapy in the Setting of Primary Angioplasty Therapy of Acute 
Myocardial Infarction 
Steven Almany, Joseph Samyn, Sylvia Puchrowicz, Gerald Timmis, Cindy 
Grines, William O'Neill. William Beaumont Hospital, Rpyal Oak, 
Michigan 
To assess the economic implications of adjunctive thrombolytic therapy 
in the setting of primary angioplasty for AM! we analyzed the costs 
incurred by pts who participated in the Streptokinase and Angioplasty in 
Myocardial Infarction (SAM!) Trial. The SAM! Trial randomized 97 pts 
presenting with 4 hours of a transmural AM! to receive primary 
angioplasty +/- 1.5 Mu of streptokinase. Protocol ancillary test 
requirements were the same in both groups. 
Tot. cost 
Hosp. stay 
Conc 
CCV 
Lab 
Med-solo 
Med-surg 
Bid units 
PTCA alone PTCA+SK 
$19,643 $25,191 
7.7 days 9 days 
1,468 4,481 
3,979 5,509 
3,217 5,881 
978 2,882 
3,018 4,896 
.127 1.305 
1!. 
.02 
.03 
.29 
.02 
.09 
.20 
.03 
.0001 
There was no difference between the two groups in regard to 
demographics or infarct location. Patients receiving adjunctive 
streptokinase however, incurred greater in-hospital costs due to longer 
hospital stays, more time in step down monitored areas (cone care) and 
intensive care units (CCU), increased number oflab draws (lab), greater 
use of post procedural medications (med-solns), higher cath lab charges 
(med-surg), and increased need for blood transfusion (bId units). 
Adjunctive streptokinase in the setting of primary angioplasty does not 
improve outcome and significantly increases in-hospital complications and 
costs. 
925·23 
lACC Vol. 19, No.3 
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Cost-Effectiveness of Antihypertensive Treatment. 
Comparison of a Beta-Blocker and a Thiazide Diuretic 
in Men With Mild to Moderate Hypertension 
John Wikstrand, Magnus Johannesson, Bengt Jonsson, 
Garan Berglund, Jaakko Tuomilehto. 
Wallenberg Laboratory for Cardiovascular Research, 
Gothenburg University, Sweden 
The aim of the present analysis was to calculate the 
cost-effectiveness of metoprolol versus thiazide 
diuretics in men with mild to moderate uncomplicated 
hypertension. The a~alysis was based on the results of 
the MAPHY (Metoprolol Atherosclerosis Prevention in 
Hypertensives) study, a randomized trial of men with 
mild to moderate hypertension showing a significantly 
lower risk for coronary events in patients on metoprolol 
than in patients on thiazide diuretics (Hypertension 
1991:17:579-588). With both direct and indirect costs of 
morbidity included metoprolol is cost saving, and with 
only direct costs included the cost per gained life-year 
is $2400. An analysis calculating cost-effectiveness 
with a simulation model theoretically predicting changes 
in risk for coronary events from observed changes in 
major risk factors during follow-up in the two treatment 
groups grossly underestimates the cost-effectiveness of 
metoprolol versus diuretics. This shows the importance 
of conducting cost-effectiveness analyses directly based 
on specific clinical trials. It is concluded that from a 
cost-effectiveness standpoint metoprolol is to be pre•
ferred to thiazide diuretics in the treatment of mild to 
moderate hypertension in men. The results regarding 
cost-effectiveness should, however, not be extrapolated 
to patients in lower risk groups. 
925·24 
Cost Cattainrent in Acute Myocardial Infarction: 
Evidence Fran a RaOOcm:ized Trial 'lbat Primary PIt:A 
Versus rt-PA Reduces Hospital am Followup Cost 
Marcus DeWood, Debora Westover, Pierre Leimgruber, 
Donald Canaday. William Stifter. 
Sacred Heart and Deaconess Medical Centers, SpJkane, 
Washington. 
To determine whether primary PTCA or rt-PA is more cost 
effective, we analyzed hospital (HOSP) and followup cost 
of therapy for acute myocardial infarction (AMI). Of 54 
patients, 27 were randanized to PI'CA and 27 to rt-PA. 
After initial therapy, patients underwent repeat cardiac 
catheterization at 48 hours following AMI. Additional 
interventions were based on recurrent symptoms or extent 
of stenosis (::90%) in the infarct vessel. 
BASELINE OlARACl'ERISTICS PIt:A rt-PA P Value 
Ejection Fraction (%) 56±lO 57±l2 ~
LVEDP 26±lO 23±1O NS 
AMI - Anterior/Inferior 10/17 11/16 NS 
Collaterals present 6/27 6/27 NS 
Killip Class I 25 24 
II 2 3 
cxsr RESULTS (Followed up to 400 days) 
HOSP cost (in thousands) 14.5±6 19±11 0.06 
Total cost in followup* l8.2±8 25±12 0.03 
.. Followup cost included clinical cost required for 
evaluation and therapy but excluded physician fees and 
research cos t. 
Thus primary PI'CA for AMI is more cost effective than 
rt-PA because additional interventions are more 
frequently required. 
JACC Vol. 19, No.3 
March 1, 1992:135A 
925·25 
Cost Comparison of tPA Versus Direct PTCA for Acute 
Myocardial Infarction: A Randomized Prospective Trial 
Guy S. Reeder, Kent R. BaileyJon Christianson, Bernard J. 
Gersh, Ray G. Gibbons, David R. Holmes, and Mayo CCU and 
Cath Lab Groups, Mayo Clinic, Rochester, MN 
We randomized 104 patients with acute myocardial infarction 
(AMI) (ST elevation; presentation within 12 hrs) to either direct 
PTCA orrtPA as initial reperfusion therapy. Clinical endpoints 
included myocardial salvage by Tc·99m-sestamibi, discharge 
ejection fraction, and mortality. We are prospectively collecting in•
hospital and cumulative one year direct and indirect cost data on 
both groups. In-hospital costs, procedures, and hospital days are 
currently available for 91 patients (88% of study groups). 
PTCA rtPA p Value 
N 52 39 
Total charges ($) 
mean 
median 
Hospi tal days 
mean 
median 
CCUdays 
mean 
median 
Subsequent procedure (%) 
(PTCA or CABG) 
23,587 
18,609 
8.7 
8.0 
4.5 
4 
15 
25,297 
20,674 
10.6 
8.0 
4.5 
3 
31 
NS 
NS 
NS 
NS 
NS 
NS 
NS 
Current results suggest the in-hospital monetary cost, CCU stay, 
and hospital stay of both ~ are equivalent Patients treated 
initially with rtP A had more subsequent in-hospital procedures but 
this difference also did not reach statistical significance. Complete 
one year cost data and an effectiveness/cost analysis will be 
available and presented for the entire study group. 
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Theraodilution Technique. Brroneou.ly Predict 
Flow Alteration. Durinq Cardiac Failure 
Mark P. Anstadt, Mark Tedder, Michael J. 
stonnington, Jeffrey E. Taber, Fred A. Crawford, 
Jr., James E. Lowe, Duke University Medical 
Center, Durham, North Carolina 
Clinically. thermodilution techniques are 
routinely used to determine cardiac output. In 
this study, the accuracy of thermodilution for 
determining flow alterations during myocardial 
infarction (MI) was assessed. Dogs (n=17) were 
instrumented with Swan-Ganz catheters positioned 
in the pulmonary artery. Ninety minutes of LAD 
occlusion with subsequent reperfusion simulated 
conditions during acute MI. Known quantities of 
radiolabeled microspheres (RM) were injected in 
the left atrium while 3 successive iced-saline 
boluses (10 ml) were given via the Swan-Ganz 
catheter at 15, 60, 90 min of LAD occlusion and 
60 min of reperfusion. Cardiac outputs determined 
by RM were compared to those by thermodilution 
[mean (L/min) ±SEMj: 
llJU.D ibiJl ll1Wl lllIIli.Il 
Thermodilution 4. 4±0. 3 4. 4±0. 2 3. 9±0. 2 3 .4±0. 2 
xicro.phere. 3.9±0.4 2.9±0.2 2.6±0.2 1.7±0.2 
The correlation between thermodilution and RM 
flows declined over time as evidenced by Pearson 
correlation coefficients (r2= 0.72, 0.52, 0.40, 
& 0.41, respectively). More importantly, the 
variations in flow over time determined by 
thermodilution siqnificantly differed from those 
by RM (p=O. 0003, MANOVA) • Therefore, 
thermodilution techniques may convey misleading 
trends in cardiac output following myocardial 
infarction and should be interpreted cautiously 
when used to guide therapeutic options. 
ABSTRACTS 
926·15 
Role of Lipid Peroxidation in Acute Adriamicin Toxicity 
Giuseppe Ambrosio, Pietro P. Elia, Plinio Cirillo, Annalisa 
Scognamiglio, Isabella Tritto, • Antonio Basso, Massimo Chiariello. 
Divisions of Cardiology, 2nd School of Medicine, University of Naples, 
and ·Istituto dei Tumori Pascale, Naples, Italy. 
135A 
Oxygen radical formation has been implicated in the pathogenesis of 
cardiac toxicity by adriamicin (ADR). However, the mechanisms of 
ADR toxicity are poorly characterized. Peroxidation of membrane 
lipids is one imponant effect of oxygen radical attaCk. To investigate 
the role of lipid peroxidation in acute ADR toxicity, isolated rabbit 
heans were perfused with ADR (30 mM) for 60 min followed by 20 
min wash out (W-O). Another group received ADR plus the oxygen 
radical scavenger mercapto-propionylglycine (MPG; 2 mM). ADR 
infusion markedly affected left ventricular developed pressure (DP; 
mmHg) and end-diastolic pressure (EDP; mmHg). Administration of 
MPG largely prevented both alterations. These effects persisted after 
MPG wash out. (*=p<O.05 vs ADR). 
EDP base EDP W-O 
ADR (n=6) 
ADR+MPG (n=6) 
DP base 
99±.8 
93±.5 
DPW-O 
49±.14 
79±.6* 
9±.1 33±.9 
Il±.l 12±.2* 
At the end ofthe experiment, the left ventricles were homogenized to 
evaluate lipid peroxidation by malonyldialdehyde (MDA). We have 
previously shown that in normal heans MDA levels typically average 
Sl nMoles/mg protein. ADR infusion was not associated with enhanced 
lipid peroxidation (MDA = O.81±.O.05 nMoles/mg protein). Similarly, 
ihe protective effects of MPG on cardiac function were unrelated to 
prevention of lipid peroxidation (MDA = 0.70±.0.04 nMoles/ mg 
protein; p=NS). Since MPG can also act as a sulphydryl group donor, 
our data suggest that other mechanisms of oxygen radical toxicity, 
'such as oxidation of free sulphydryl groups, rather than membrane 
lipid peroxidation. might be responsible for the acute impairment of 
cardiac function observed during experimental ADR toxicity. 
926·16 
Developnent of a 'lhird Heart So.Ind in Heart Failure 
is Associated with Rapid Deceleration of Early Mitral 
InfICM 
Tatsuji Kono, HCIWard Rosman, Mctlsin Alam, Paul D. 
stein, Han! N. Sal:ilah.. Henry Ford Heart arxl Vascular 
Institute, Detroit, Michigan 
'Jhe relation between the developnent of a third heart 
SClI.ltn (53) arxl mitral inflCM dynamics was examined in 
7 dogs durin;J the evolution of heart failure. Heart 
failure was produced ~ IILIltiPle sequential 
intra=onary microembolizations (EMS). Intracardiac 
~ography, auscultation, heart rate (HR), LV 
ejection fraction (EF) , LV en:i-diastolic volume 
(EDV) , arxl mitral inflCM velocity were evaluated at 
baseline (B), at the time when S3 first develq:ed 
(Tl) arxl 18±1 week thereafter (T2). Early diastolic 
peak mitral velocity (E). deceleration time (IJI') arxl 
mean deceleration rate (E/IJI') were evaluated ~ 
Dq:pler echocardiography. S3 develq:a:l. in all dogs 
9±2 weeks after the initial EMS confirmed ~ 
auscultation arxl intracardiac ~ography. 
HR EF EDV E IJI' E/IJI' 
(min I) (%) (ml) (en/s) (ms) (en/s2 ) 
B 7614 56±2 59±3 7114 122±7 590±40 
Tl 7614 44±2t 63±3 74±4 73±3§ 104Q±90§ 
T2 104±8* 27±2t 75±4§ 74±4 86±3§ 88Q±70§ 
[*=P<.02;§ =P<.Ol; t=P<.001 vs. Bj 
'Jhe above results indicate that durin;J the evolution 
of heart failure, the onset of S3 preceeds overt LV 
dilation. Instead, S3 swears to first develq> in 
conjunction with a significant reduction in IJI' 
suggestin;J a close association between the 
developnent of S3 arxl the develcpIeDt of rapid 
deceleration of early mitral inflCM. 
136A ABSTRACTS 
926-17 
Hearl Rate Variability during Mental Strcu after Myocardiallnlarction. 
Giorgio Mazzucro, Paola Lanlranchi, Amerigo Giordano, Roberto Colombo. 
Fondazione Clinica del Lavoro. Centro Medico di Riabilitazione, Veruno (NO), Italy 
Menial slress (MS) can induce myocardial ischemia and arrh}1hmias via autonomic 
neIVous syslem. Heart rale variabilily (HRY) is a marker of aUlonomic lunelion; 
standard deviation 01 mean fiR interval (sdRR) proved to be a prognostic index after 
myocardial infarelion (MI). Our aim was to lind out possible changes 01 HRV induced 
by MS in post-MI palienls (pts). We studied 27 normal subjects aged 46!8 and 99 pts 
aged 50!9 yrs 41!11 days alter MI. in drug wash-out, at rest, during passive 
orthostatism mit). controlled breathing (CB), and MS provoked by Me.tal Arithmetic 
(MA). ECO signal w ... 1000 Hz sampled and processed oil-line. Time domain indexes 
01 HlIV were sdIUl and number of successive IIRR>50ms (pNNSO) . Autoregressive 
spectral analysis 01 HRV signal identilied low (LF) and high frequency (/IF) 
components of HRV. sympatho- and vagal related respectively. as frequency domain 
indexes of oympatho-vi\f\al balance. Normal subjects showed following Irends: 
mean lUl(ms) sdIUl (ms) pNN50 LF ( •. u.) HF (n.u.) 
Resl (I0min) 957!116 5O!14 S.3!5.2 54!21 26!14 
Tilt (I0min) 746!IOl(*) 38!13(') 1.3!1.9(*) 73!2S(") 1J!9(*) 
Cll (IOmin) 920!123\) 41.t12(*) 4.2.t4.7 37:t I 4(*) 41.t16(*) 
MA (IOmin) 770!105(*) 46!13 2.8!3.1(·) 76!10(*) 13!10(*) 
(Diflerencc< vs Rest: ·p<0.05 ip<O.OI 'p<O.OOI ). 
Post ·MI piS had: 
mean RR(ms) sd({R (ms) pNNSO LF ( •. u.) !IF (n.u.) 
Rest (IOmin) 974!148 49!20 4.7!S.9 5S!22 37!25 
Tilt (IOmin) 766!126(*) 35!12(*) 1.1!2.5(*) 71Z30(*) 26!26(*) 
CB (I0min) 976!160 39!17(*) 4.5!6.50 43!1 9(*) 4O!l8 
MA 110mi.) 817!14W) 46!16 3.4!5.2(§) 71Z1S('" 22!30('" 
IiRV changed during MA: decreasr of pNN50 and HF as well as increase of LF 
indicated shilt 01 autonomic balance towards sympathetic rule during MS. No 
correlation was lound between changes 01 mean RR and those 01 HRV indexes. 
Although absolute values 01 normal subjects did not diller significantly Irom pts values 
at each step. their changes during provocative tests were more marked as a whole. 
In conclusion, these results suggesl the autonomic conlrol of heart, as expressed by 
HRV adaptation to stress, to be slill blunted in second month from MI when HRV per 
Ie recovers. 
926-18 
Relationship of Atrial Late Potential with 
Supraventricular Arrhythmia and Left Ventricular 
Dysfunction after Myocardial Infarction 
Junichi Saitou, Kazuo Matsumoto, Yukio Asano,Keiko Kaneko 
Toshio Yamamoto, Saburou Yamashita, Masatsugu Uchida, 
Yutaka DohL 
The Second Department of Internal Medicine, Saitama 
Medical School, Moroyama, Saitama Japan. 
The atrial late potential (A-LP) and its relationship 
with supraventricular arrhythmia (SA) and left vent•
ricular functions were e~amined in 70 patients that had 
no valvular dysfunction after myocardial infarction. 
A-LP was recorded by the P wave triggered signal averag•
ing method from the third to the fourth week after the 
onset of acute myocardial infarction. As A-LP, filtered 
P wave duration ( ~ 120 msec), low amplitude signal 
duration under 5 ~V ( ~ 20 msec) and root mean square 
last 20 msec ( ~ 3.5 ~V) were adopted, and patients were 
divided into two groups ( group P: A-LP positive, group N 
: A-LP negative) in accordance with these criteria. 
Hemodynamic factors (LVEDP, PCWP) by catheterization, 
LVEF by RI scintigraphy, left atrial dimension (LAD) by 
echocardiography, CTR by chest X rays and supravent•
ricular arrhythmia score (SA score)by ambulatory electro•
cardiography were examined during the same period as A-LP 
examined and compared between the two groups. 
Group P increased in LVEDP (p <0.0005), PCWP (p< 0.005), 
LAD (p< 0.025), and eTR (p< 0.025), decreased in LVEF 
(p< 0.005) that were caused by the left ventricular dys•
functions,in comparison with the group N. However, there 
was no significant differences in SA score between those 
two groups and no relationship between SA score and LV 
hemodynamic functions. These suggested that A-LP might be 
the more sensitve indicator for the left ventricular dys•
function after acute myocardial infarction rather than 
supraventricular arrhythmia. 
926-19 
An Oesophageal Approach to Resuscitation 
lACC Vol. 19, No.3 
March 1, 1992:136A 
David Cochrane, Adrian Stewart, Desmond Allen, George 
Dempsey, John Anderson, Jennifer Adgey. Royal Victoria 
Hospital, Belfast, Northern Ireland 
Electroventilation is inspiration by the delivery of 
current pulses to chest electrodes. Transchest electro•
ventilation (TC), where the current flows between 2 
axillary chest electrodes, was compared with an oesopha•
geal chest system (Oes). In 7 pentobarbitone 
anaesthetised pigs (no spontaneous respiration),the tip 
of a quadripolar oesophageal electrode was positioned at 
the gastro-oesophageal junction and connected to the 
anode of an electroventilation unit producing ramps of 
0.1 ms pulses, frequency 375 Hz and 1 second duration. 
The cathode was linked with 2 low impedance (50) pads 
sited in each axilla. Blood pressure, tissue oxygen 
saturation (SaO.), end tidal CO. and tidal volume (TV) 
were measured continuously for each system as the voltage 
(V) was varied (0-100). The TV (mean+SEM)ml for each 
system at 50 and 100 V was: -
50V 
100V 
TC 
32 (+21) 
211 (-:;:46) 
oes 
278 (+5) 
515 (~63) 
With the oes, the TV is significantly higher at both 
V's (p<0.05). Using the oes at TV >lOml/kg, SaO. was 
maintained at >90% and end tidal cO. did not rise: when 
the respiratory rate increased from 12/min to >18/min, 
end tidal CO. decreased: following VF induced by endo•
cardial stimulation, the TV fell progressively with time 
(time to 50% of initial TV=212s (+SD25.6)). Thus in the 
presence of a circulation an oes when compared with TC 
gives a larger TV permitting SaO. to remain at 
physiological levels and allows hyperventilation. oes 
may have a role in resuscitation during external cardiac 
compression. 
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741-1 10:30 
Comparison of Time to Therapy and Reperfusion Rates 
With Direct PTCA and Thrombolysis in Acute Myocardial 
Infarction: Results of the Mayo Clinic Randomized Trial 
of PTCA and rt-PA 
Peter B. Berger, Malcolm R. Bell, David R. Holmes Jr., Bernard J. 
Gersh, Mona Hopfenspirger, Raymond Gibbons. Mayo Clinic, 
Rochester, Minnesota 
Although time to reperfusion during acute myocardial infarction (MI) 
is believed to be briefer with thrombolytic therapy than direct PTCA, a 
detailed comparison between the time required for these two methods 
of revascularization has not been reponed. We studied 108 patients 
(pts) enrolled in the Mayo Clinic randomized trial of direct PTCA 
(n=51) and n-PA (n=57) within 12 hours of the onset ofMI and 
compared time to therapy in the two treannent anns. The time from . 
chest pain to arrival in the emergency room (ER) (111 min vs 1~ Il!m) 
and ER to randomization (30 min PTCA vs 31 min n-PA) were sunilar 
in the two groups. PIS in the n-PA ann did not undergo protocol 
catheterization. Tune intelVals reported are medians. 
PTCA rt-PA 
RandOmization to start ofn-PA mfusion.*mm 20 
Randomization to arrival in cath lab, min·· 
Randomization to arterial access,·· min 
Randomization to lst deflation, •• t§ min 
Successful PTCA t ~% reduction) 
xc uSlOns: not receIVe rt - (); access not ac lev ; 
t no PTCA due to vessel patency (3); § unable to cross lesion (1). 
If reperfusion is defined as the time of lst balloon deflation among 
successful PTCA pts, 81 % of all PTCA pts had reperfusion by 110 
min, which corresponds 10 90 min after rt-PA was begun in the 
thrombolysis ann. In contrast, reperfusion rates of 70% have been 
reported with rt-PA 90 min following initiation of drug therapy. We 
conclude that the time to reperfusion with direct PTCA. is rapid and 
reperfusion rates compare favorably to those reported With n-PA. 
JACC Yol. 19, NO.3 
March 1, 1992:137A 
741·2 10:45 
Effects of Intraaortic Balloon Pumping and Coronary 
Angioplasty on Coronary Blood Flow in Acute Myocardial 
Infaction. 
Masaharu Ishihara, Hikaru Sato, Hironobu Tateishi, 
Takuji Kawagoe, Yuji Muraoka, Mitsuisa Yoshimura. 
Hiroshima City Hospital, Hiroshima, Japan 
We have previously demonstrated that intraaortic 
balloon pumping (IABP) could prevent reocclusion after 
coronary angioplasty (PTCA) for acute myocardial 
infarction (AMI). Although the speculated mechanism 
has been the production of markedly enhanced diastolic 
coronary perfusion pressure, most studies have 
reported that IABP has little effect on coronary blood 
flow. To assess this issue, 12 patients with anterior 
AMI undergoing PTCA and IABP were studied. After 
successful PTCA, a 3F coronary Doppler catheter was 
positioned immediately proximal to the infarct 
coronary lesion and coronary blood flow velocity 
(CBFV) was measured before and during IABP. 
Results: IABP increased mean diastolic arterial 
pressu;e and decreased peak systolic arterial pressure. 
Mean arterial pressure and heart rate were unchanged. 
Changes in CBFY were as follows: 
Peak CBFY (em/s) 
Mean CBFY (em/s) 
Diastole 
Systole 
Before 
IABP 
34.6±17.3 
16.3±1l.9 
During 
IABP 
46.7±20.1 
16.6±11.5 
P value 
<0.005 
r-:S 
23.5± 14.9 25.8± 15.1 <0.02 
6.3:t9.7 3.1 ±7.9 <0.005 
Conclusion: IABP increased peak CBFY, while mean CBFY 
was unchanged. Such an increase in peak CBFY seemed to 
be a mechanism by· which IABP could prevent reocc1usion 
after PTCA for AMI. 
741·3 11:00 
Bleeding Complications Associated with Direct Angio· 
plasty for Acute KYocardial Infarction: Report of 
Primary Angioplasty Research (PAR) Group 
Cindy Grines, Robert Califf, Bruce Brodie, Russell 
Ivanhoe, William Knopf, George Taylor, James O'Keefe, 
lynn Woodlief, Hichelle Strzelecki, William O'Neill. 
William Beaumont Hospital, Royal Oak, HI 
One potential advantage of direct angioplasty as are· 
perfusion strategy for HI is avoidance of bleeding com· 
plications associated with thrombolytic therapy. In the 
multicenter PAR study, 206 patients with ST elevation 
who were considered candidates for lytic therapy were, 
instead, taken directly to the lab for PTCA mediated reo 
perfusion. Mean age was 59 ± 12 yrs and 74% were male. 
All patients received chewable aspirin, IV heparin ± 
Dextran and underwent PTCA of the culprit vessel only. 
Adjunctive thrombolytics were administered to 23 (11%), 
balloon pumps used in 33 (16%), emergent bypass surgery 
in 12 (6%), and urgent or elective bypass in 11 (5%). A 
significant drop in hematocrit (42.7 ± 4.8 vs 33.3 ± 
7.9%, p-<.OOl) occurred during the hospital stay. Trans· 
fusion was required in 38 (18%) patients, of whom 13 had 
undergone bypass surgery. Groin bleeding was noted in 
136 (66%) but conSidered severe (requiring transfusion) 
in only 2 (1%) patients. Additional serious or life 
threatening bleeds included 1 intracranial (0.5%). 3 
gastrointestinal (1.5%), 2 urinary (1%), 1 oral (0.5%), 
I retroperitoneal (0.5%), 3 perioperative (1.5%) and 3 
mise (1.5%). These data suggest that application of 
direct angioplasty for acute myocardial infarction may 
have risk of bleeding similar to that reported with 
thrombolytic therapy. The precise risk of different 
reperfusion modalities will need to be defined in a 
prospective, randomized trial, which is ongoing. 
ABSTRACTS 
741·4 
Does Failed Direct Infarct AngiopJasty Cause Increased 
Mortality? 
11:15 
John B. Bedotto, Joel K. Kahn, Barry D. Rutherford, David R. 
McConahay, Lee V. Giorgi, Warren L Johnson, James H. 
O'Keefe, Thomas M. Shimshak, Geoffrey O. Hartzler 
Mid America Heart Institute, Kansas City, MO. 
Concern has been expressed over high mortality rates in pts with 
failed direct infarct angioplasty (PTCA). Accordingly, we 
reviewed the characteristics and outcome of all pts with failed 
direct infarct PTCA and compared them to pts with successful 
infarct PTCA. Baseline characteristics and results are as follows. 
Failure Success 
Number 45 ( 6%) 705 (94%) 
Age (years) 63 60 
EF <40% 17 (38%) 203 (29%) 
Shock 9 (20%) • 51 (7%) 
Prior CABG 7 (16%) 74 (10%) 
Diabetes 10 (22%) 90 (13%) 
Prior MI 20 (44%) • 195 (28%) 
Multivessel disease 32 (71 %) • 392 (56%) 
Hospital mortality 14 (31%) •• 34 (4.8%) 
Emergency CABG 11 (24%) ** 4 (0.5%) 
• = p <0.03, ** :: p <0.0001. Using multivariate analysis, the 
presence of multivessel disease (p <0.004) and shock (p <0.03) 
were independent predictors of failure. 
Conclusion: These data suggest that multiple, predominantly 
irreversible high· risk factors unrelated to therapeutic strategy 
contribute to increased mortality in pts with failed direct infarct 
PTCA. 
137A 
741·5 11:30 
Sex-Related Differences In Patients Undergoing Direct 
Aogioplasty for Acute Myocardial Infarction 
James L. Vacek, Paul H. Kramer, Thomas L. Rosamond, Unda I. 
Crouse, O. Wayne Robuck, Joan L. White, Gary D. Beauchamp. 
The Mid America Heart Institute, St. Luke's Hospital, Kansas City, 
Missouri 
Important sex-related differences have been recognized in several 
coronary artery disease presentation and treatment subsets. Uttle data 
exists describing the relative findings and outcome of females vs 
males who received direct PTCA for acute Ml. We studied 670 such 
patients of whom 464 (69%) were male and 206 female. Females 
were significantly older (67±11 yrs vs 61%11, p<.OO1) but had less 
prior CABG (6% vs 12%, p=.02) While prior MI (17% female vs 
22%) and coronary artery disease distribution were not significantly 
different. 41% of females and 43% of males had single vessel 
disease. Both females and males had 1.5 lesions/pt dilated acutely, 
with similar success rates (95% female, 91% male, p=.08). Mean 
ejection fractions were similar (48% both groups) and a similar 
percentage in both had EF<30% (10% female vs 13%). 
Over mean follow-up of 86 weeks, need for repeat cath was frequent 
and similar in both groups (44% female, 47% male, p=NS), while 
documented restenosis was less common in females (20% vs 28% of 
patients, p<.05). Need for CABG was similar (15% female, 17% 
male, p::NS) as was repeat PTCA in the infarct vessel (14% female, 
18% male, p=NS) and overall mortality (7% female, 9% male, 
p=NS). 
Conclusions: Other than older age, clinical features of females 
presenting for direct PTCA for acute MI are very similar to males. 
PTCA success and outcome are also very similar, other than a slightly 
lower incidence of documented restenosis for females. 
13SA ABSTRACTS 
741·6 11:45 
RandomIzad Trial 01 Deferrad AngiopIasty following Thrombolysis for 
AcID MyocardiaIlnfan:IIon 
Marcef van den Brand, Amadeo Betriu, Jacques Col, Jose Delcan, Karin 
Nljssen, Matthias Pfisterer, Lorenzo Saenz Cusi, Felix Zijlstra. 
Thoraxcenter, Erasmus University, Rotterdam, NL and the European 
Cooperative Study Group. 
Coronary angiography was performed 2-5 days after admission for 
myocardial Infarction In 652 patients In 19 European hospitals In order to 
assess coronary patency after alteplase compared with aItepiase plus 
heparin. 218 patients (pts) In 7 hospitals were subsequently randomized 
to either undergo PlCA directly after angiography (113 pts) or not 
(105 pis). 
No differences In age, sex, localization and size of myocardial Infarction 
or coronary perfusion grades (prior to PlCA) were noted between groups. 
Symptoms, additional interventions and left ventricular ejection fraction 
(EF) were compared at 3 months (rnths) follow-up. 
PlCA PlCA In hosp. EF EF (%) Mort. Int.,.. 3 mths 
perf. death (%) 3 mths 3 mths CABG+PlCA 
Group 1 + 64 1 51.5 55.0 1 14 
N·113 
Group 2 - 4 3 50.3 54.6 0 22 
N· lOS 
PlCA was not performed in 49 patients in the PlCA group due to 
angiographlc criteria Oeft main disease, total occluded vessel, extensive 
or minimal disease), whHe on angiographic grounds PTCA was performed 
In 4 patients from the non PlCA group. Data were analyzed on an 
Intention to treal principle. 
Conclusion: Angioplasty in suitable patients, deferred until 2-5 days after 
myocardial Infarction treated with a1teplase ± heparin, does not Improve 
survival, but does reduce the number of (re)interventions within 3 months. 
After 3 months, the EF was significantly Improved (p < 0.05) to the same 
extent In both the PlCA and the non-PTCA groups. 
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742·1 10:30 
AnalYSis of Coronary Angioplasty Practice in the United States Using a 
Private Insurance Database 
Eric J. Topol, Stephen G. Ellis, Eric R. Bates, David W.M. Muller, 
Nicholas Schork, M. Anthony Schork 
Cleveland Clinic Foundation, Cleveland, Ohio 
To investigate geographic differences in PTCA in the U.S., we accessed 
the MEDSTAT database of 172 million claims for 5.4 million privately 
insured individuals during October 1987 through December 1989. For 
each patient a 3 month lead time was available before the index PTCA 
procedure; average follow up length was 420 days for 2,071 pts 
studied. The country was divided into 4 regions: NE = Northeast; MW 
= Midwest; S = South; W = West with the following demographics, 
outcomes, and charges: 
N MW S W 
% Population 19% 34% 30% 17% 
N 249(12%) 987(48%) 507(24%) 326(16%) 
Age (yrs) 54.2±7.4 53.5±8.0 54.3 ± 7.1 54.3±7.1 
Prior PTCA 2.4% 4.4% 3.5% 2.8% 
Single 
Vessel PTCA 95.2% 96.1% 96.9% 94.2% 
CABG 2.4% 3.3% 1.6% 1.2% 
Re-PTCA 13.7% 14.5% 15.6% 16.0% 
Length 
of Stay (d) 7.8±13.5 6.0±5.7 6.5 ± 5.5 4.6±3.5 
Total Cost 
PTCA-hosp. $13,501 $17,491 $20,030 $24,616 
PTCA-prof. $4,879 $4,546 $5,006 $6,030 
Cost follow-up $9,734 $11.404 $12,775 $15,735 
These data suggest that predominantly single vessel PTCA is practiced in 
the U.S.; utilization is highest in the Midwest; although length of stay 
was least in the West, the hospital charges were the most substantial. 
742·2 
JACC Vol. 19, No.3 
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10:45 
Changing Profiles and Late Outcoae of Va.en Undergoing 
PTCA: A Report fra. the NHLBI PTCA Registry 
George Philippides, Alice K. Jacobs, Sheryl F. Kelsey, 
Van!in Yeh, Katherine M. Detre, Thomas J. Ryan, David 
P. Faxon and Registry Investigators. 
Boston University Medical Center, Boston, KA 
Early reports have suggested that vomen (V) have a 
less favorable acute outcome folloving coronary 
angioplasty (PTCA) than men (M). To assess the change 
in long-term outcome during the evolution of PTCA ve 
compared 361 V in the 1977-81 (Old R) vith 546 V in 
the 1985-86 (Nev R) PTCA Registry. Nev R V vere older 
(61.0 vs 55.7 years, p<O.OOI), had a higher incidence 
of hypertension (57.7 vs 42.6X, p<O.OOI), reduced LV 
function (13_7 vs 6.1X, p<O.OI), congestive heart 
failure (8.4 vs 3.6X, p<O.OI), unstable angina (59.7 
vs 46.6X, p<O.OOI) multivessel disease (52.0 vs 27.0X, 
p<O.OOI) and multilesion PTCA (36.1 vs 11.1X, 
p<O.OOI). Despite a higher risk profile, Nev R V had a 
higher initial clinical success (79.2 vs 58.7X, 
p<O.OOI), a lover acute mortality (2.6 vs 6.1X, 
p<O.OI) and similar emergency coronary surgery (CABG) 
(4.9 vs 6.1%) rates. 
Status at 4 years (Freedom from event): 
Old R {Xl Nev R {Xl P value 
Death 93.8+1.3 88.9+1.4 .017 
Myocardial infarct 85.6+1. 9 87.9+1.4 NS 
CABG 61.3+2.6 83.9+1.6 .001 
PTCA 86.5±).8 74.if1. 9 .001 
Thus vomen undergoing PTCA more recently have more 
advanced disease but a more favorable acute outcome. 
The long-term outcome folloving PTCA in V is favorable. 
The higber mortality in Nev R V likely reflects a higher 
baseline risk profile. 
742·3 11:00 
Gender Differences in the Outcome of PTCA Over Time 
Malcolm R. Bell, David R. Holmes, Peter B. Berger, Kirk N. Garratt, 
Kent R. Bailey, Bernard J. Gersh. Mayo Clinic, Rochester, MN 
Women have higher in-hospital mortality following PTCA than men but 
whether this is related to risk factors or illness severity is controversial. 
It is also unknown if this monality difference has changed in recent 
years with improvements in PTCA technology and increased operator 
experience. We compared the acute outcomes of 1157 women and 
3069 men who had PTCA perfonned at our institution between 1979 
and 1990 inclusively. Gender baseline characteristics were significantly 
different (p <0.(01): compared to men, women were older (66fl1 yrs 
vs 61±11 yrs), had higher frequency of class llI/IV angina (79% vs 
65%), unstable angina (75% vs 69%), diabetes (19% vs 12%), 
hypenension (58% vs 41%) and cardiac failure (9% vs 5%) but less 
frequent history of bypass surgery (10% vs 15%). PTCA success was 
similar for women and men (84% and 86%) as were rates of myocardial 
infarction (MI) (1.1% vs 1.4%) and emergency bypass surgery (4.3% 
vs 3.9%). Although the in-hospital monality (all cause monaJity) for 
women was higher than for men (4.4% vs 2.7%; p=O.(05), female 
gender was not found to be an independent predictor of in-hospital 
mortality after adjusting for baseline imbalances. In-hospital monality 
rates were funher examined by dividing the population into two 
cohons: 1979-1988 (n=2013; Gp I) and 1988-1990 (n=2212; GR 11): 
Females Males 
Success Mortality Success Mortality 
Group I 82% 3.0% 82% 2.2% 
Group II 86% 5.6% 89% 3.1 % 
P value (Gp I vs II) 0.05 0.04 <0.001 NS 
Women in the more recent cohon were older, more likely to have dia•
betes, multivessel disease and have had PTCA perfonned S24 hours of 
an acute MI than in the earlier cohon. Therefore, while female gender 
is associated with increased PTCA in-hospital mortality, this appears to 
be related to more advanced disease at baseline compared to men. 
Explanations should be sought for the more advanced disease in women 
at the time of intervention and new therapeutic alternatives evaluated. 
JACC Vol. 19, No.3 
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742-4 11:15 
PlCA in African-American Patients: A Review of the 
NHLBI PlCA Registry. 
Neal A. Scott, Sheryl F. Kelsey, Handan Dingiloglu, Katherine 
Detre, Patrice Desvlgne-Nickens, Michael Cowley, Spencer B. 
King III. 
There are few studies on the clinical outcome of non-white 
patients who undergo PlCA. The clinical variables, in•
hospital event rates and follow-up data of all patients enrolled 
in the 1985-1986 NHLBI PlCA Registry were examined with 
regard to race. Of the patients enrolled in the registry, 1940 
(96.2%) were white and 76 (3.8%) were black. The black 
patients had a higher prevalence of female gender (50% vs 
24%, p< 0.0001), hypertension (54% vs 45%, p< 0.(01), 
diabetes (22% vs 12%, p< 0.05), current smoking (44.7% vs 
27%, p< 0.(01) and unstable angina (75% vs 53%, p<0.(01). 
Black patients were more likely to have multivessel disease 
(72".4. vs 48%, p< 0.(01), and complete revascularization was 
achieved in only 26% of the black patients compared to 44% 
of the white patients (p < 0.(01) After the PlCA procedure, 
branch occlusion was slightly higher in black patients (5.3% 
vs 1.8%, P < 0.05) but there was no Significant difference in 
major complications (death, myocardial infarction or emergent 
CABG) between the two groups. Four year follow-up showed 
that black patients had slightly more angina but lower rates of 
mortality, MI, CABG and repeat PlCA. Despite the 
prevalence of more cardiovascular risk factors, more 
symptoms and more severe coronary disease, black patients 
in the NHLBI PlCA Registry had a similar incidence of acute 
and late coronary events. 
742-5 
Incomplete 
PTCA 
Hartial G. 
Katherine 
Revaacularization 
Bourassa, Wanlin 
K. Detre and 
Investigators. 
11:30 
(ICR) After Hultivessel 
Yeh, Richard 
lfHLBI PTCA 
Holubkov, 
Registry 
Pittsburgh University, Pittsburgh, Pennsylvania 
Clinical factors influencing the degree of revaseu•
larization afler PTCA in pts with multivessel disease 
were assessed in the 1985-86 lfHLBI PTCA Registry. The 
PTCA operator described the treatment plan for each pt 
prior to the procedure. Complete correction (CR) was 
achieved if all lesions wet'e reduced to <50'1.. CR was 
deemed possible in 77~ of 618 pts, but was intended in 
only 34~, attempted in 2~, and achieved in 19~. Uni•
variate preprocedural determinants of ICR were gender, 
unstable angina (UA) , vessel disease (VO) and urg/emerg 
(U/E) PTCA. 
Baseline 8 ~. .lni!m. Attempt . Achiev. 
~. .t..Q..g g g CR 
" " " " Kales 436 75 37* 31* 22** 
Females 182 80 28 21 12 
UA: 80 257 79 46*** 40*** 26*** 
Yes 232 74 25 19 14 
VD: Double 447 79 39*** 33*** 23*** 
Triple 171 71 21 15 9 
UtE PTCA: No 500 74** 38*** 31*** 21** 
Yes 118 86 20 15 9 
*p<.05; **p<.OI; ***p<.001 
In multivariate analysis, UA, triple VD, and UtE PTCA 
remained independent predictors of whether or not CR 
was intended. Thus these three clinical characteristics 
are usually responsible for ICR after PTCA. 
ABSTRACTS 
742-6 11:45 
A Simple ScorlDIl System to Predict PTeA Abrupt Closure 
Alan N. Tenaglia, Donald F. Fortin, David J. Frid, Charlotte L. Nelson, 
Laura H. Gardner, Michael Miller, James E. Tcheng, Robert M. Califf, 
Richard S. Stack. Duke University, Durham, NC. 
This study examined whether a simple lesion scoring system would 
improve on the prediction of PTCA abrupt closure (AC) in comparison 
with the ACC/AHA lesion type. Morphology, location, and severity 
were determined for 727 non-occluded lesions undergoing elective, 
first-time, native vessel PTCA. AC occurred in S5 (7.6%). Using 
logistic stepwise multiple regression analysis, the following variables 
were independent predictors of AC and the regression coefficients were 
used to develop a scoring system: 
Characteristic Coefficient f llUn11 
Branch location 1.43 0.0002 14 
Length ->10 mm 0.50 0.007 10 
-5-10 mm 5 
Right coronary artery 0.69 0.020 7 
Thrombus score--2 or 3 0.56 0.024 12 
-I 6 
Mid artery location 0.60 0.045 6 
-Thrombus score=# of features present that are consistent with 
thrombus (haziness, filling defect, contrast staining). 
Scores for each lesion were obtained by summing the characteristic 
points and predicted AC rates were used to define low, moderate, and 
high risk groups. The actual AC rate in the 3 groups was determined 
and compared to the rate determined using the ACC/ AHA lesion type: 
Risk Group ~ ~ AS;. ACC/AHA Type ~ AS;. 
Low 0-5 22 2.6% A 14 3.9% 
Moderate 6-17 58 6.6 B 82 7.9 
High >17 20 15.9 C 3 16.0 
Thus, in comparison with the ACC/ AHA lesion type, a scoring 
system using fewer variables identified more low and high risk lesions, 
therefore allowing better stratification of lesion risk before PTCA. 
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Intravascular Ultrasound Predictors of Adverse Outcome after 
Coronary Artery Interventions 
Alan N. Tenaglia, Christopher E. Buller, Katherine Kisslo, Mary Peoples, 
Gary P. Miller, Harry R. Phillips, Richard S. Stack, Charles J. Davidson. 
Duke University Medical Center, Durham, NC 
139A 
Compared to contrast angiography, intravascular ultrasound (IVUS) has 
been shown to improve characterization of coronary artery lesion morphology. In 
this study, IVUS was used to determine whether qualitative and quantitative 
lesion descriptors were predictive of adverse short and long-term outcomes after 
coronary artery interventions. lVUS was performed immediately after successful 
procedures in 62 patients (38 balloon PTCA, 14 atherectomy, and 10 laser 
angioplasty). Images were analyzed qualitatively for dissection, plaque composi· 
tion (bard vs. soft), and plaque topography (eccentric vs. concentric). 
Quantitative measurements included minimal lumen diameter, planimetry of 
lumen area, and % area stenosis (internal elastic lamina [IEL] area· lumen 
area/IEL area). Of the 58 patients eligible for pre-planned 6 month angiography, 
52 patients (90%) agreed to recatheterization. Restenosis was defIned as > 50% 
diameter narrowing by quantitative angiography. Adverse outcome was dermed 
as abrupt closure (n= 1), CABO (n=3), or angiographic restenosis (n=24). 
The overall incidence of dissection was 48%, eccentric plaque 43%, and 
hard plaque 63%. The association between patient outcome and lesion 
descriptors is shown: 
IVl.lS Finging a.!lv~rs~ Qyt£Qm~ NQ Adv~r§e QU1£Qm~ .!l 
Dissection 64% 32% .02 
Eccentric plaque 50% 36% .29 
Hard plaque 68% 57% .41 
Lumen diameter~mm) 2.6±0.6 2.5&5 .54 
Lumen area (em ) .01..03 .07±.03 .73 
% area stenosis 54±19 57±15 .48 
Thus, the presence of dissection detected by IVUS after interventional 
procedures is associated with a higher rate of adverse outcomes. Conversely, 
luminal dimensions quantitated by IVUS do not predict clinical events. IVUS can 
potentially be used to identify patients likely to develop adverse events after 
coronary interventions and allow modifIcation of procedures to improve outcome. 
140A ABSTRACTS 
743-2 10:45 
Arterial Imaging Utilizing A New Forward Viewing Intravascular 
Ultrasound Catheter: Initial Studies 
James L Evans, Kok·Hwee Ng, Michael J. Vonesh, Barry L 
Kramer, Terri A Mills, Bonnie J. Kane, William N. Aldrich, Vue· 
Teh Jang, Paul G. Yock, Michael D. Rold, Sanford I Roth, David 
D. McPherson. 
Northwestern University Medical School, Chicago, IL 
Intravascular ultrasound (IVUS) of arteries is limited by the 
inability of current instruments to visualize beyond the catheter 
tip. We have developed a prototype forward viewing IVUS 
catheter (Cardiovascular Imagmg Systems, Sunnyvale, CA) that 
has the ability to provide B-mode cross-sectional ultrasound data 
for a distance of greater than 1 em distal to the catheter tip. 
To study the utility of this device, a prototype 20 MHz forward 
viewing IVUS catheter was used to examine 7 arterial segments (2 
human femoral arteries, 1 human carotid arterr, 4 canine 
arteries) in-vitro and 1 phantom. Following imagmg, all data 
were compared to histology (HISTO). 
Results: In all cases, the IVUS catheter provided forward viewing 
images corresponding to the arterial geometry and demonstrated 
vascular landmarks and atherosclerotic lesions. There was a good 
correlation between HISTO determined luminal diameters (LD) 
and IVUS determined diameters for a distance of 14 mm ahead 
of the catheter tip. 
(IVUS LD = 1.4 HISTO LD - 1.5 r = 0.98) 
These preliminary data suggest that a forward viewing lVUS 
catheter is feasible, accurate and potentially useful for evaluation 
of arterial geometry distal to the catheter tip. 
743-3 
Simultaneous Intravascular Two-dimensional and Doppler 
Ultrasound: A New Technique for In Vivo Assessment of Coronary 
Flow and Vascular Dynamics. 
Krishnankutty Sudhir, John S. MacGregor, Sophie Barbant, Elyse 
Foster, Peter J. Fitzgerald, Kanu Chatterjee, Paul G. Yock. 
Cardiovascular Research Institute, University of California at San 
Francisco, San Francisco, California. 
Catheter-based intravascular ultrasound yields two-dimensional 
images of the coronary arteries from which cross-sectional areas 
(CSA) can be measured. Intravascular Doppler allows measurement 
of coronary blood flow velocity. The simultaneous use of the two 
technologies would theoretically provide measurements of 
volumetric coronary blood flow, but has not been attempted in the 
intra coronary setting. In 8 dogs, we studied coronary flow and 
vascular reactivity in response to pharmacological agents using two 
approaches: (1) a 30 MHz, 4.3F imaging catheter placed alongside 
a 0.018"' Doppler wire in the drcurnflex or left anterior descending 
coronary artery (n=6); (2) the ultrasound imaging catheter 
introduced directly over a 0.014"' Doppler wire (n=2). The Doppler 
transducer was poSitioned 1-2 em distal to the tip of the imaging 
catheter. Vasodilator and vasoconstrictor responses were studied 
using intracoronary nitoglycerin (200l1g) and ergonovine (200l1g). 
Volumetric coronary blood flow per beat was calculated from the 
product of the CSA and velocity time integral. With nitroglycerin, 
a 13±4% increase in epicardial coronary CSA and a 60+..25% rise in 
peak diastolic flow velocity were observed for a 77±30% increase in 
diastolic coronary blood flow. With ergonovine, a 12±2% reduction 
in epicardial coronary diameter was seen, accompanied by a 6±4% 
fall in peak flow velocity, resulting in a 18±4% fan in diastolic 
coronary blood flow. Thus, the simultaneous use of ultrasound 
imaging and Doppler flow measurements is of potential value in 
quantitating volumetric coronary flow, and assessing coronary 
vascular dynamics. Clinically, the combination of techniques 
would also be useful in more complete assessment of coronary lesions 
before and after interventional procedures. 
11:00 
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Mechanisms for False Negative Coronary Angiography: 
Insights from Intravascular Ultrasound Imaging 
Steven E. Nissen, John C. Gurley, David C. Booth, Masakazu 
Yamagishi, Martin R. Berk, Mark Fausch, Mark Bates, Gary Grigsby 
and Anthony N. DeMaria, U of Kentucky and VA,Lexington, Ky. 
Intravascular ultrasound commonly detects evidence of atherosclerosis 
at angiographically normal sites in coronary anery disease (CAD) 
patients. However, the mechanisms for false negative angiography 
remain undefined. Therefore, we analyzed ultrasound wall morphology 
at 168 angiographically normal sites in 72 patients with at least ~ne 
lesion >50% to determine the factors responsible for angiographlcally 
occult CAD. A 5.5 Fr, 64 element, 20 MHz ultrasound probe was 
used. Abnormal wall morphology was defmed using previously 
reponed 95% confidence limits obtained in 15 totally normal subjects 
for the maximum thickness of the intimalleading-edge (<0.28 mm) and 
sub-adjacent sonolucent zone (<0.22 mm). For 62/168 (37%) angio•
graphically normal sites, maximum thickness of the intimal leading•
edge and sonolucent zone were also normal. For 106/168 sites (63%), 
either or both structures were abnonnally thick, despite a normal 
angiogram. Ultrasound images revealed three anatomic patterns to 
explain the false negative angiograms: At 35/H>6 sites (33%), diffuse 
concentric disease was present, defmed as an abnonnalleading-edge 
and/or sonolucent zone for the entire 360 degree circumference of the 
vessel at multiple adjacent sites. For these diffusely diseased segments, 
luminal cross-sectional area (CSA) remained relatively constant (±12%) 
at adjacent sites. At 18/106 sites (17%), a small eccentric plaque, 
undetected by angiography, occupied less than 1/3 the vessel circum•
ference. At 41 sites (39%), outward remodelling of the vessel at the site 
of an eccentric plaque was present, defined an increased radius of 
curvature of the adventitia for the diseased portion of the circumference. 
This process concealed atherosclerosis by maintaining constant luminal 
CSA (±14%) compared to adjacent uninvolved segments. At 12/106 
sites (11%), no explanation for a negative angiogram was apparent. 
These data demonstrate concealment of atherosclerosis on angiography 
is common and is produced by a several phenomena including diffuse 
concentric disease, vessel remodelling and small eccentric plaques. 
743-5 11:30 
Cbanges In Large Artery Compliance Measu""d With Intravascular Ultrasound 
Richard Wilson, Carlo Di Mario, Rob Krams, Li Wenguang, Anne C Laird, Loe 
Kie Soei, Salem The, Elma Gussenhoven, Pieter Verdouw, los Roelandt. 
Thoraxcenler, Erasmus University, Rotterdam, Netherlands 
Previous studies have suggested that the compliance of large arteries (AC) is a 
purely passive phenomenon, dependenl only on elastin and collagen constituents 
of the arterial waIl. However, the presence of smooth muscle fibers in the waIl 
of these large arteries would suggest that AC might change in response to vaso•
active substances. To test this hypothesis, proximal iliac AC was measured in 7 
anestbetized pigs, before and during local infusion of adenosine (AD) and 
norepinephrine (NE). 
Methods: Luminal area (IA) was measured every 40 ms using a 30 MHz intra•
vascular ultrasound catheter and an automatic edge-detection program. 
Simultaneous high-fidelity pressure measurements were obtained using a 
catheter-tipped pressure microtransducer positioned at the origin of the iliac 
artery. If necessary, during NE infusion, arterial pressure was returned to 
baseline by partial inflation of a balloon catheter in the inferior vena cava. 
Regression analysis of the area/pressure relationship in 2 consecutive cardiac 
cycles (systolic phase only) was performed before and during AD and NE 
infusion. The slope of the regression line was defmed as an index of AC. IA 
at a pressure of 80 mmHg was also calculated from the area/pressure regression 
equation. The measurements after 3 min of infusion of AD (5 mg/min) and NE 
(10 IIg/min) were compared with the control measurements: 
Results: (meant semi Controll AD Control 2 NE 
Heart rate (beats/min) 901:4 9Jt3 8'l!:4 821:4* 
Mean art press (mmHg~ 86t6 Tl±6 821:3 88t4 
AC (mm2/mmHg) x 10' l8t4 2!!t61 201:3 l3t3** 
IA at 80 mmHg (mm2) 22!: 3 24t 3 22!: 3 17± 3** 
tp=O.l2 vs controll, *=p<O.05 vs control 2, "=p<O.Ol VS control 2 
Conclusion: AC, as well as IA at a given pressure of 80 mmHg, may be 
modified more by the acute infusion of NE than AD in large conductance arteries 
such as tbe proximal iliac. Thus, in this animal mode~ AC at rest tends to be 
near maximal (i.e., mostly a passive phenomenon). However, AC does not 
remain purely passive since smooth muscle tone can be increased by NE. Intra•
vascular ultrasound allows continuous and accurate monitoring of these changes 
of arterial dimensions, suggesting that this technique can be useful in the 
evaluation of pharmacologica1ly induced changes in AC of large arteries. 
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Development of a Simul taneous Intravascul ar Ul trasound 
and Angioscopy System to Enhance Diagnostic Evaluation 
Robert J. Siegel, Mehrdad Ariani, Gerald Maurer. 
Cedars-Sinai Medical Center, Los Angeles, CA. 
We previously demonstrated angioscopy is more sensitive 
than intravascular ultrasound (IVUS) for thrombi (100 v. 
57%), less sensitive for stable atheroma (90 v. 100%) 
and that neither method is sensitive for disrupted 
atheroma (5 81%). The purpose of this study was to 
deve lop and assess the uti 1 i ty of a prototype coup 1 i ng 
system for simultaneous IVUS and angioscopi c imagi ng. 
We studied human post mortem arterial segments in vitro 
(n=67) , in situ (n=6) and in vivo canine arterial 
studies (n=6) using a prototype coupling device inserted 
through an 8F sheath to permi t concomi tant IVUS and 
angioscopy. Simultaneous side by side images were 
recorded on videotape. The dual images were used to 
prospectively classify vessels as normal (n=12), stable 
atheroma (n=31), disrupted (n=22) or containing thrombus 
(n=14). Angioscopy was used to identify thrombus, IVUS 
was used to di fferent iate normal artery from stabl e 
atheroma and disruption was diagnosed when a discontin•
uity of the arteri a 1 surface was detected by ei ther 
technique. Image classifications were compared to gross 
anatomical classifications. Image classification based 
on the observations from dual imaging and the consensus 
of 2 observers of all arterial images - in vitro, in 
situ, and in vivo canine studies were 100'1. concordant 
with the gross anatomic classification at all 79 sites. 
Dual imaging also facilitated the assessment of the 
plaque subtype, the mass of intra 1 umi na 1 and 1 ami nar 
thrombus as well as the morphology and extent of intimal 
tears and dissection flaps. Conclusions: Simultaneous 
IVUS and angioscopy 1) is feasible in vivo, 2) is 
synergistic and markedly enhances the diagnostic 
information obtained from each technique and 3) using a 
catheter coupling system has potential to increase 
diagnostic sensitivity and specificity in vivo. 
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744-1 10:30 
Myocardium Supplied by Normal Arteries is not Normal in 
Patients with Coronary Artery Disease Elsewhere 
Neal G Uren. Paolo Marraccini. Roberto Lorenzoni. Dina Nevola, 
Roberto Gistri. Ranil de Silva. Tom Crake and Paolo G Camici. 
Hammersmith Hospital. London. UK. and CNR Institute of Clinical 
Physiology. University of Pisa.Italy. 
Most studies of myocardial blood flow (MBF) and metabolism in 
patients (pts) with coronary artery disease assume that remote 
territories subtended by angiographically normal arteries (ANA) can be 
considered normal. MBF in regions supplied by ANA was assessed in 
13 pts (10 male. mean age 60 years) with sin~le vessel disease using 
dynamic positron emission tomography with la-labeled water at rest 
and after intravenous dipyridamole (0.56 mglkg over 4 min). Seven 
pts had left anterior descending disease (LAD) and 6 had right 
coronary artery disease (RCA). Coronary vasodilator reserve (CVR; 
dipyridamole/resting MBF) in regions supplied by a stenosed artery 
was 1.87±O.86. and in regions supplied by ANA was 2.90±1.39. 
Both values were lower than the average CVR (3.92±O.89, p<o.05 for 
both comparisons) measured in 12 control subjects (mean age 30 
years). Another group of 10 pts (9 male. mean age 60 years). 5 with 
LAD disease and 5 with RCA disease. underwent simultaneous arterial 
and great cardiac vein blood sampling during maximal atrial pacing to 
measure glucose extraction (G-E%), alanine extraction (A-E%).lactate 
extraction (L-E%) and myocardial oxygen extraction (02 E%) in 
regions supplied by a diseased artery (LAD) or by an ANA (RCA). 
Controls 
lAD 
RCA 
Q:5 A£& l...:.e& Q2.H 
2±3 -1±3 26±11 64±7 
8±6* 6±6* -18±27* 69±3 
6±3* 4±3* 38±17 67±6 
* p<O.05 vs 6 control subjects (4 male, mean age 47 years) 
Conclusions' I) CVR is reduced in regions supplied by ANA in pts 
with coronary artery disease elsewhere compared to control subjects; 2) 
in addition, regions supplied by ANA are characterized by different 
glucose and alanine handling during pacing although they do not show 
metabolic signs of ischemia. 
ABSTRACTS 
744-2 10:45 
DETECTION OF HIBERNATING MYOCARDIUM USING H21SO AND 
POSITRON EMISSION TOMOGRAPHY (PET) 
Ranil de Silva, Yusuke YamamolO, ChrislOpher G. Rhodes, Hidehiro !ida, Petros 
Nihoyannopoulos. Graham Davies, Terry Jones and Auitio Maseri. 
MRC Cyclotron and Cardiovascular Units, Hammersmith Hospi18l, London, U.K. 
To predict the improvement in regional wall motion after revascularization (REV) 
by either PTCA or CABG, we Slildied 12 pts by 2D«hocardiography (ECHO) and 
H21SO dynamic PET imaging 3-6 days before REV. Follow-up ECHO was 
perfonned 3-S months later 10 assess contractile recovery. Regional myocardial 
blood flow (MBFp : mVmin/g of water perfusable tissue [PTJ) was obtained by a 
previously validaled method, which corrects for partial volume effect. In addition, 
the water perfusable tissue fraction for each region of interest (ROJ) (PTF: g of 
PT/ml of ROI) was estimated. Furthennore, it has been shown that extravascular 
tissue density can be obtained from the image produced by subtracting blood 
volume (C ISO) from a nonnalized transmission scan. Extravascular tissue density 
gi ves the IOIaI analOmical tissue fraction including both water perfusable and 
non·perfusable tissue (ATF: g of IOtaI analOmica1 tissue [PT + non-PTJ/ml of 
ROI). Thus, the ratio PTF/A TF for a given ROI indicates the water perfusable 
fraction of the IOlal tissue. We tenned PTF/ATF as the water perfusable tissue 
index (PTj: g of PT/g of IOtaI tissue [PT + non-PTJ). Melabolic imaging with 
18FDG was perfonned in 9 pts after 75g oral glucose load. Myocardial ROJ's were 
dermed according 10 the ECHO data. 32 segments with wall motion abnonnalities 
(akinelic (A), n=17; hypokinetic (H). n=15) and 26 control segments were 
identified. AI follow·up, 7 A and 14 H segements resumed nonnal contractile 
function; 4 A segments remained hypokinetic (partial recovery, PRj; and 1 Hand 6 
A segments failed 10 improve. Results are expressed as mean±sd. (p<O.OS v H 
and PR (.); v A, H and PR (,); v control (t); v A and PR m by ANOV A and 
Student I tes!). Recovery Non-Recovery Control 
Mn=1l llinilll ~ !D=1l ~ 
MBFp .67±.21 .78±.I9 .70i.11 .45±.11·t .97±.221 
PTI .91±.09 1.07±.12 .87±.I9 .62±.06H 1.I0i.l5* 
Contractile recovery occurred only in segments where PTI was close 10 control and 
>0.7. These dala were consistent with the pattern of 18FDG upta1ce. Therefore 
PTI may be a good predictor of contractile recovery after REV, thus enabling 
myocardial viability 10 be detected using H2 1SO alone and obviating the need for 
lengthy 18 FDG melabolic imaging. 
744-3 11:00 
Quantitative PET Measur"ment of Regional Myocardial Blood 
Flow (13NH3) Identifies Non-viable Myocardium in Patients with 
Healed Anterior Myocardial Infarction 
Henry Gewirtz, Alan Fischman, H. William Strauss, and Nathaniel Alpert. 
Massachusetts General Hospital, Boston. MA and Brown Univen;ity Program in 
Medicine, Providence. RI 
Previous animal studies suggest there is a minimum level of myocardial blood 
flow (MBF) required 10 sustain viability. We tested the hypothesis in patients (PIs; 
nz II) with healed anterior myocardial infarction (AMI) that PET measurement of 
absolute MBF with 13NH3 can identify infarcted, non-viable myocardium. The 
hypotheSis predicts myocardial FDG-uptake in excess ofMBF ("mis-match"; an 
indicator of myocardial viabilit}) will not occur below a threshold level of MBF. 
Tomographic sections of the heart were made with dynamic acquisition over 12 
min after rest injection of -25 n:.Ci 13NH3. A 2 compartment model was IISed to 
obtain K I (flow· extraction fraction) from which absolute values of RMBF 
(mlImin!g) were computed. tlee:, 1 h after an oral glucose load -S mCi 18FDG 
were given and IOmographic images of the heart made 1 h later. 18FDG scans were 
analyzed with regions of interes: over myocardial zones with normal flow (NZ) and 
with infarction (MIZ) as seen ir. the 13NH3 scan. Uptake of 18FDG was 
,10rmaliZed 10 activity in the zone with best RMBF. In NZ RMBF was 1.16±0.52 
(mean±SD) ven;us 0.29±O.21 in MIZ (p<.01). FDG uptake in MIZ correlated well 
with absolute RMBF (Figure; r~0.78. P<.05). An FDG-RMBF "mis-match". 
(nonnalized 18FDG minus nonnalized 13NH3 difference> 0.35) was present in 
only IMlZand I border zone ................ -""-
(nz2 Pts) and was associated 
with RMBF > 0.40 in each. In .GO 
contrast no MIZ with RMBF < 0.40 ~ .... 
mlIminig (n=8) had FDG-RMBF Ii! 
"mis-malCh". Thus. in PIs with i · 
healed AMI PET measurement C'f !. 
absolute RMBF at rest indicates: 
.eo 
, .. 
.aD 
. 
. / .. 
7--. I) viable myocardium is unlikely to 
be present when RMBF is < 041) 
mlIminig and 2) glucose use ,I. MIZ 0.'R.. .... .... .... ..to , ... 
generally is reduced in proro 'til n to RMBF. --
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744·4 11:15 
Rubidium·82 (Rb·82) Kinetics Assessed by Positron 
Emission Tomography (PET) for Characterization of 
Myocardial Viability 
Juergen vom Dahl. Otto Muzik. Edwin Wolfe. Markus Schwaiger. 
University of Michigan. Ann Arbor. MI 
Experimental data suggest different Rb-82 kinetics in reversibly and 
irreversibly injured myocardium. To assess Rb-82 tissue kinetics in 
the human heart. 27 patients with a history of coronary artery disease 
were studied using dynamic PET in combination with RB·82 and F-
18 f1uorodeoxyglucose (FOG) for assessment of myocardial glucose 
metabolism. Rb-82 kinetics were analyzed by dynamic imaging and 
monoexponential time activity curve fitting. corrected for spillover and 
physical tracer decay. FDG uptake was calculated by Patlak's 
approach. Data were analyzed in normal tissue. in segment with 
decreased Rb-82 but maintained FOG uptake (ischemic) as well as in 
segments with concordantly decreased uptake of Rb-82 and FDG 
(scar). Mean values were determined for relative Rb-82 retention 
(ret. %). regional Rb-82 clearance rate (k) and normalized rate (clear 
%). Regional FOG uptake was calculated as % of the maximal heart 
activity. 
normal 
scar 
isch. 
n 
27 
18 
20 
ret. % 
7S±llt 
27±10 
49±llt 
*=p<O.OS. t=p<O.OOI vs. scar. 
clear. k 
.100.OSt 
-.24±.22 
O±.06t 
clear. % 
8S±IOt 
66±12 
77±IS· 
FDG 
78±12t 
40±12 
70±14t 
In II pts demonstrating all three different tissue types. paired 
statistical comparison demonstrated significantly different Rb-82 
kinetics in viable and scar tissue. Rb-82 clearance was below 2 SD of 
normal mean in 17/18 (94%) regions defined as scar whereas 11/20 
ischemic regions displayed values within these limits. These results 
indicate that Rb-82 kinetics are different in ischemically compromised 
but viable and irreversibly injured myocardium and may be useful in 
the assessment of tissue viability. 
744·5 11:30 
Understanding Perfusion and Glucose Uptake Patterns by 
the use of Low-Dose Dobutamine in 29 patients with 
Anterior Myocardial Infarction 
Christian De Landsheere. Luc A. Pierard. Pierre Melon. 
Christian Berthe, Daniel Lamotte, Dominique Comar. Henri 
Ku1bertus. Pierre Rigo. University of Liege. Belgium. 
To clarify the significance of various patterns of perfu•
sion (P) and glucose uptake (FDG). we compared positron 
emission tomography (PET) and 2D-echocardiography (ECHO) 
in 29 patients submitted to thrombolysis (streptokinase 
or rt-PA) and studied within 2 weeks after an anterior 
myocardial infarction and 3-9 months later. P and FOG were 
considered as abnormal (compared to reference values) in 
8 cases (group 1. GR1). An abnormally high FOG relative 
to P was found in 8 other cases (GR2). FOG and P were si•
milarly depressed in 13 cases (GR3). A score describing 
wall motion abnormalities (WMA) was calculated in the 
area at risk (6 segments) in basal conditions (BC) and 
after dobutamine (DB), in the acute phase. Studies perfor•
med in the follow-up (FU) used BC, only. 
GR 1 
GR 2 
GR 3 
P (%) FOG (%) FDG/P ECHO-BC ECHO-DB ECHO-FU 
81±10 82118 1.0It.17 I1t2 711 712 
3819 74t26 1.95%.53 1612 1213 1612 
49±12 54±12 1.12t.21 13±3 12*4 13~5 
WMA abnormalities decreased with DB in all patients of 
GRI. with a persistent low score in the FU. In GR2, WMA 
decreased in 5 out of 8 patients but deteriorated later 
in all 5. In GR3, 4 cases out of 13 showed less WMA with 
DB and functional recovery in the FU, in 3 of them. 
Thus. the best recovery is. observed in the group of pa•
tients with normal perfUSion. Because of its complex na•
ture, myocardial viability assessment requires the com•
bined use of perfusion, metabolism and function data. 
lACC Vol. 19, No.3 
March I, 1992:142A 
744·6 11:45 
Prognostic Significance of PET Assessment of Myocardial 
Viability in Patients with Left Ventricular Dysfunction 
lamshid Maddahi. Marcelo DiCarli. Michael Davidson. Sandeep 
Khanna, Soleyman Rokhsar. Jan Tillisch, Hillel Laks, Heinrich 
Schelben, Michael Phelps. 
UCLA School of Medicine. Los Angeles, California. 
In patient (pts) with left ventricular (LV) dysfunction. assessment of 
regional myocardial viability by PET is highly predictive of the 
potential for recovery of regional contractile dysfunction after 
revascularization. To determine the prognostic significance of PET 
assessment of myocardial viability. 79 pts with severe LV dysfunction 
(average EF = .29±.09) who had cardiac PET studies at the UCLA 
Clinical PET Center were followed up for an average of 342 days. 
Resting N-l3 ammonia PET myocardial perfusion and fluoro•
deoxyglucose (FDG) myocardial metabolic images were reconstructed 
into axial. shon axis. and vertical long axis slices. The LV was 
divided into 20 segments and the presence and size (combined extent 
and severity) of perfusion defect (PD) and hibernating myocardium (H) 
were determined and were expressed as % of the entire LV 
myocardium. NYHA functional class (FC) for heart failure and/or 
angina was determined at the time of PET study (FCI) and the follow 
up (FC2). Fony of 79 pts underwent revascularization (REV) after the 
PET study without surgical mortality. 
#of Pts EF PD H FC 1 FC2 Death 
H+REV - 15 2S% 32% 20% 2.7 2.1 33% 
H+REV+ 27 29% 28% 18% 2.8 0.7 4% 
H -REV - 24 30% 22% O.S% 2.4 1.8 0% 
H -REV+ 13 32% 21% 0.8% 2.8 1.0 0% 
There was no significant difference between the four groups with 
respect to EF. total size of PD and FC at the time of PET. Importantly, 
in H+ pts there was a significantly higher incidence of cardiac death 
among those who did not have REV compared to those who did (33%, 
vs 4%. P<.Ol). REV improved FC both in pts with H+. and H-. In 
conclusion, in patients with LV dysfunction, despite a similar size of 
PD, presence of H by PET identifies high risk for cardiac death if 
revascularization is not performed. 
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745·1 10:30 
Comparison Between Single (Iooue) and Double Balloon (Mansfield) 
Mitral Valvuloplasty: Immediate and Short Term Results 
Muayed Zaibag, Muheeb Abdullah, Murtada Halim 
Lorna Linda University Medical Center. Lorna Linda, California and 
Riyadh Military Hospital, Riyadh, Saudi Arabia 
This study compared the results in the first 60 consecutive patients 
with severe rheumatic mitral stenosis who underwent percutaneous 
double balloon mitral valvuloplasty using a combination of 20 mm + 
20 mm diameter balloon catheters (Group A), with a similar group of 
the first 60 consecutive patients who underwent single Inoue balloon 
mitral valvuloplasty, (Group. B). The parameters compared were 
clinical and haemodynamic improvement, technical failure, inadequate 
dilatation. complications. radiation time and ease of the procedure. 
Both groups were similar with respect to age, body surface area. 
cardiac functional status, severity of mitral stenosis, degree of mitral 
regurgitation and incidence of mitral valve calcification. After the 
balloon mitral valvuloplasties, the haemodynamic measurement 
showed significant improvement in both groups: In Group A and B 
respectively, the mean left atrial pressure decreased from 22 ± 4 to 12 
± 5 (P < 0.001) and from 20 ± 6 to 11 ± 3 mmHg (P < 0.001), the mean 
mitral diastolic gradient decreased from 14 ± 4.5 to 4.5 ± 2.3 mmHg 
and from 12.4 ± 4.8 to 3.5 ± J.7 mmHg (P < 0.001). mitral valve area, 
using Gorlin formula. increased from 0.9 ± 0.2 to 2.1 ± 0.5 em' (P < 
0.001) and from 0.8 ± 0.2 to 1.9 ± 0.4 cm2 (P < 0.001). There was a 
significant improvement in cardiac functional status in both groups. 
There was no significant difference between the groups with regard 
to clinical or haemodynamic improvement, technical failure rate, 
inadequacy of dilatation. or complications. The double balloon 
technique was more complex and cumbersome and involved longer 
screening time - Group A 40 ± 12. Group B 21 ± 10 minutes (P < 
0.001). 
In conclusion, the results achieved by the single balloon technique are 
equivalent to those of the double balloon teChnique and are easier to 
perform with shorter radiation time. 
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Balloon Valvotomy for Pregnant Patients with Severe 
Pliable Mitral Stenosis Using the Inoue Technique with 
Total Abdominal and Pelvic Shielding. 
Paulo A Ribeiro, Mohamed E Fawzy, Mahmoud Awad, Bruce 
Dunn, Carlos G Duran. King Faisal Specialist Hospital and 
Research Centre, Riyadh, Saudi Arabia. 
We attempted balloon valvotomy using the Inoue technique 
(IBV) in 7 pregnant (5-9 months) patients (pts) with severe 
mitral stenosis (MS); the pts mean age was 28.±. 6 years and 
all had echocardiographic (2DE) mitral score (Block) .::: 8. The 
indications for IBY included severe symptomatic MS with a 
mitral valve area (MYA) ~ 1 cm2 and 1) heart failure refractory 
to medical therapy, or 2) absolute contraindication for the use 
of beta blockade, or 3) living a long distance from the Hospital. 
IBY was done with no angiography and total pelviC and 
abdominal shielding; the balloon catheter was introduced to the 
right atrium without the aid of fluoroscopy, that was used for 
the transeptal puncture. Stepwise, 2DE-Doppler mitral valve 
dilatation was done. After IBY the mean Doppler MYA 
increased from 0.8.±. 0.2 to 2.0.±. 0.3 cm2 (P<0.01), and by 
2DE from 0.8.±. 0.2 to 1.9.±. 0.3 cm2 (P<0.01), with no residual 
stenosis (defined as MYA ~1.5 cm2). The mean total 
fluoroscopy time was 16 .±. 7 mins. The degree of mitral 
regurgitation increased in 2 pts to grade 1 + and 2 + 
respectively. There was no mortality or significant morbidity; 
Five pts had an uneventful pregnancy and delivery with no 
mitral restenosis; two pts are well on no cardiac medication. 
We conclude IBY with total pelvic and abdominal shielding and 
echocardiography may be a valid therapeutic alternative for 
pregnant pts with severe symptomatic pliable MS. 
745·3 11:00 
Long Term Results of Percutaneous Balloon Mitral Valvulo•
plasty by Inoue Balloon Catheter Technique 
Chuan-Rong Chen, Ji-Yan Chen, Ying-Ling Zhou, Jia Mei, 
Tie-Zheng Ma, Tsung O. Cheng. Guangdong Cardiovascular 
Institute, Guangzhou, China and The George Washington 
University Medical Center, Washington, D.C. 
We obtained 40.216.4 mos (range, 10-71) follow-up data in 
139 pts with mitral stenosis in whom percutaneous Inoue 
balloon mitral valvuloplasty (PIBMV) was done since Nov 
1985. There were 96 females & 43 males with a mean age of 
35.4111.2 yrs (range, 15-56). Mitral calcification was 
present in 60 pts, atrial fibrillation in 25, mild aortic 
regurgitation in 49 & mitral regurgitation in 20. The 
functional status was NYRA class II in 58 pts, III in 78 
& IV in 3 pre-PIBMV,and class I in 123, II in 13 & III in 
3 at follow-up. Restenosis occurred in 3 pts. The mitral 
gradient (MG) by catheter (C) and Doppler (D), echocar•
diographic mitral valve area (MVA) & left atrial diameter 
(LAD), interval between Q & first heart sound (Q-Sl), 
interval between aortic second sound & opening snap (A2-
OS), voltage of P-loop in frontal plane (P-loop), P-wave 
terminal force in VI (PTF) & maximal oxygen consumption 
(~OJ) changes were as follows: 
Pre-PIBMV Post-PIBMV Follow-up 
MG (mmHg) C 17.4±7.6 2.7±3.1* 3.8±2.7* 
D 17.4±7.6 5.0±4.4* 6.5±3.8* 
MVA (cm2) 1.0610.21 2.02±0.32* 1.9310.56* 
LAD (mm) 43.6±6.3 38.415.6* 38.316.2* 
Q-Sl (ms) 84.1±13.6 73.8±12.4* 72.4±13.7* 
A2-0S (ms) 72.3±18.2 87.9110.6* 92.0114.9* 
P-loop (mV) 0.24±0.03 0.2010.04* 0.1910.03* 
PTF (mm.s) -0.08±0.05 -0.0410.03* -0.0410.03* 
~QJ (ml/min/kg) 19.8±4.3 22.415.1** 27.014.1* 
*p<O.OOl pre vs post & follow-up, **p=NS pre vs post 
Conclusion: The long term results of PIBMV remain good in 
139 pts with mitral stenosis. 
ABSTRACTS 143A 
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Conditioning Effects on Exercise Capacity Following 
Balloon valvuloplasty in Patients With Mitral Stenosis 
Kyoko Miyagi, Hidetsugu Asanoi, Shinji Ishizaka, Osamu 
Wada, Tomoki Kameyama, Hisanari Ishise, Shigetake 
Sasayama. Toyama Med. & Pharrn. University, Toyama, Japan 
Clinical status, ergometer exercise capacity and leg 
muscle mass were serially evaluated in 10 patients 
with symptomatic mitral stenosis following balloon 
valvuloplasty (CBV). We used specific activity scale 
(SAS) to quantify symptom-related physical activity by 
metabolic cost and assessed exercise capacity by peak 
oxygen uptake (Peak VO.) and anaerobic threshold(AT). 
Thigh muscle area (A) was calculated from circumference 
and subcutaneous fatfold of thigh. CBV resulted in 
immediate decreases in mean pulmonary wedge pressure 
(22±8 to 1414 mmHg, p<0.05) and increases in mitral 
valve area (0.810.2 to 1.410.3 ern', p<0.05). SAS and 
exercise capacity were dissociated in the time course 
of improvement. In parallel with hemodynamic improvement 
SAS doubled immediately after CBV but remained unchanged 
thereafter. Peak VO, continued to increase till 6 months 
after CBV. In con•
trast, AT exhibited 
no change for up to 
one month but then 
progressively in•
creased in associ-
ation with increase 
.'" SA. 
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significantly from 6 to 12 months after CBV. Conclusion: 
The rapid relief of symptoms following CBV would gear 
the restricted physical activity towards a greater 
voluntary effort. Consequently, physical conditioning 
results in an increase in leg muscle mass which 
potentially increases the aerobic capacity further. 
745·5 11:30 
IMMEDIATE AND LATE RESULTS OF PERCUTANEOUS MITRAL 
BALLOON VALVULOPLASTY USING INOUE AND DOUBLE 
BALLOON METHODS: 1 YEAR FOLLOW - UP 
Jae-Joong Kim, Seung-Jung Park, Seong-Wook Park, Jae-Kwan Song. 
Simon Jong-Koo Lee, Asan Medical Center, University of Ulsan. 
Seoul. Korea 
In order to compare the success /lite and the late resuh of mitral ballion 
valvuIoplasty(PMY) using Inoue(group I) and double balloon(group D) 
methods, 100 consecutive patients(pts) were randomized for the two 
groups. Echocardiog/llphic follow-up was obtained in 60pts at 6 months 
and I year. The immediate suocess rate was 90 % in group I and 96 % in 
group D. The incidence ofleft to right shunt at the atrial level was 13 % 
in gmup I and 20 % in group D. The mitral valve area(MVA) 
i!lUllediately after PMV was same in the two groups, but the dU/lltion of 
tOlal procedure time(S6±20 vs 84±24min, p < 0.002) and the fluoroscopic 
time( IS±6 vs 2S± 11min, p < 0.(02) was significantly shorter in group I. 
Inoue Double 
mitral orifice mitral orifice 
MY A long short MV A long short 
Prc-PMV 0.9 1.7 0.7 0.9 1.7 0.7 
Post 1.8 2.4 1.1 1.9 2.6 1.0 
6months 1.6 2.3* 1.1 1.8 2.6* 1.0 
I year 1.6 2.3 0.9 1.6 2.4 0.9 
* P < O.OS Inoue vs Double (MVA : cm2, long and short: cm) 
Conclusion: 1) The success /lite was same in the two groups but Inoue 
methods required less time to complete the pmcedure. 2) MV A after 
PMV was well maintained at I year follow-u p in both groups. 3) At 
6mooths. the long diameter was greater in group D but the difference was 
not apparent at 1 year fOllow-up. 
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Improvement in Left Ventricular Chamber Elastance 
Following Successful Surgery for Long-term, Severe Mitral 
Regurgitation 
Mark R. Starling. University of Michigan and VA Medical 
Center, Ann Arbor, Michigan 
Recent animal data suggest that left ventricular (LV) 
chamber elastance (E~) and other measures of contractile 
performance may improve following mitral valve surgery 
for mitral regurgitation (MR). Whether this also occurs 
in man is unknown. To establish the long·term effects of 
mitral valve surgery on LV chamber elastance, 10 patients 
(pts) with long·term, severe MR were studied with 
micromanometer LV pressures and radionuclide angiograms 
over a range of loading conditions during right atrial 
pacing before and one year following successful mitral 
valve surgery. The average heart rates and LV end•
diastolic and systolic pressures before and 1 year 
following mitral valve surgery were unchanged. A 
reduction in LV end·diastolic volume from 264 + 52 ml to 
198 ± 89 ml (p<0.05) was associated with no change in LV 
end-systolic volume. The average LV regurgitant index 
decreased from 2.9 ± 0.9 to 1.4 ± 0.6 (p<O.Ol), and the 
LV ejection fraction decreased from 61 + 9 to 56 + 19% 
following mitral valve surgery. In contrast, LV chamber 
elastance averaged 1.44 ± 0.92 mmHg/ml prior to mitral 
valve surgery, and E .. ~ averaged 2.73 ± 2.46 mmHg/ml 
(p<0.05) 1 year fOllowing mitral valve surgery. 
Following correction for the change in LV mv, E 
continued to improve (pmO.09). These data demonstrate 
that LV chamber elastance will improve following mitral 
valve surgery in patients with long-term, severe MR and 
suggest that, in accordance with recent animal data, the 
increase in LV chamber elastance may reflect an increase 
in contractile function in some pts following mitral 
valve surgery. 
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Therapeutic Endpoints for the Treatment of AV Nodal 
Reentrant Tachycardia by Radiofrequency Energy 
Bruce D. Lindsay, Steven D. DaTorre, Noemi Benitez, Mina 
K. Chung, M. Carolyn Gamache, Michael E. Cain. 
Washington University, St. Louis, Missouri 
Modification of AV nodal physiology by radiofrequency 
(RF) energy can eliminate AV nodal reentrant tachycardia 
(AVNRT); however, the absolute electrophysiological 
criteria used to judge whether a procedure is successful 
have not been established. The purpose of this study was 
to determine if the persistence of dual AV nodal 
physiology, as indicated by discontinuous AV nodal 
refractory curves, is an adverse prognostic sign in 
patients whose tachycardia becomes noninducible. Twenty•
fi ve patients wi th AVNRT underwent modifi cat i on of AV 
nodal physiology by applications of RF energy at the site 
of slow pathway potentials detected along the tricuspid 
annulus between the os of the coronary sinus and the His•
bundle. AVNRT was abolished in all 25 (100%) patients 
without causing complete heart block and remained 
noninducible during an infusion of isoproterenol. 
Following the procedure, AV nodal refractory curves were 
continuous in 15 (60%) patients, and remained 
discontinuous in 10 (40%). Among the 10 patients with 
residual dual AV nodal physiology, no AV nodal reentry 
was inducible in 7 (28%) patients and single AV nodal 
reentrant cycles followed by anterograde block in the 
slow pathway were inducible in 3 (12%) patients. None of 
the patients have had a recurrence of AVNRT during 
follow-up of 1-11 (mean 5) months. Thus, modification of 
the slow pathway refractory properties to the extent that 
repetitive AV nodal reentry is eliminated portends a good 
prognosis despite the persistence of dual AV nodal 
physiology. 
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Lower 'Turn Around" Structure in Atrioventricular Nodal 
Reentrant Tachycardia: lntranodal or Extranodal? 
Sanjay Deshpande, ZaImen Blanck, Anwer Dhala, Carol Gilbert, 
Randy Nest, Kitty Koch, Masood Akhtar, Mohammad Jazayeri, 
Sinai Samaritan Medical Center, Milwaukee, Wisconsin 
The role of the proximal His bundle (PHB) in atrioventricular 
nodal reentrant tachycardia (A VNRT) has always been a subject 
of controversy. During complete electrophysiologic testing of 49 
patients (pts) who underwent radiofrequency (RF) modification of 
the atrioventricular nodal region, the following observations were 
made: 
1. Three pts developed 2:1 AVN block, above the most pHB 
recording site, during A VNRT. The A VN block was produced 
during manipulation of the His bundle catheter (transient trauma) 
in one pt, following a single RF pulse delivery in another, and after 
intravenous Adenosine in the third pt A VN block persisted 
without interruption of the reentrant process or alteration of the 
retrograde atrial activation sequence. 
2. The time interval between the activation of the pHB and the 
atrium during ventricular premature stimulation was at least 10 
msec longer than that during A VNRT. 
These observations strongly favor an intranodal site for the lower 
tum around point of the A VNRTwhich is separated from the His 
bundle by an A VN common pathway. 
746·3 11:00 
Non Captured Burst Stimulation Near the AV Node: 
Selective Influence of Slow Pathway Conduction in AV 
Nodal Reentrant Ta~hycardia in Humans 
Patrick Tchou, Stephen Keim, Robert Kinn, Todor 
Mazgalev 
University of Pittsburgh Medical Center, Pittsburgh, PA 
Non captured burst stimulation near the AV node 
has been previously demonstrated to terminate AV nodal 
reentrant tachycardia. We selectively stimulated a 
region between the His bundle recording site and the 
coronary sinus with noncaptured burst stimulation (1 ms 
pulse width, 7 ms CL, 15 beats) during AV nodal 
reentrant tachycardia. 
The burst impulses were able to slow ante grade 
conduction through the slow pathway (increase AM) 
without affecting retrograde fast pathway conduction 
(HAl. Burst impulses delivered simultaneously with 
atrial activation at the posterior septum were able to 
lengthen AM interval of the synchronized beat. Burst 
impulses delivered 100 ms after onset of atrial 
activation did not affect AM interval of the preceding 
atrial beat, but were able to lengthen AM intervals of 
up to 2 subsequent atrial beats as late as 700 msec. 
after the burst. AM prolongation followed by AM block 
was a frequently seen combination. No effect was seen 
on the retrograde fast pathway. Burst impulses during 
sinus rhythm did not affect AA or AM interval. 
CONCLUSIONS: 1. Noncaptured burst atrial impulses 
delivered near the location of the slow pathway can 
selectively lengthen antegrade slow pathway conduction 
time during AV nodal reentrant tachycardia. 2. The 
mechanism of such slowing is consistent with activation 
of vagal neurons. 3. Such impulse delivery may be 
useful in mapping the location of the slow pathway. 
JACC Vol. 19, No.3 
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A Prospective, Randomized Comparison of Anterior and 
Posterior APrroaches for Radiofrequency Catheter 
Modification 0 A V Node Reentry Tachycardia. 
Angel Leon. Rafel EI-Atassi. Mark Borganelli. Steven J. Kalbfleisch. 
Hugh Calkins. Fred Morady and Jonathan J. Langberg. University of 
Michigan Medical Center. Ann AJbor. MI 
Fourteen consecutive pIS with typical A V node reentry tachycardia 
(AVNRT) were randomized to receive transcatheter delivery of 
radiofrequency (RF) energy either on the anterior and proximal aspect 
of the inter-atrial septum or posteriorly. near the ostium of the 
coronary sinus. At anterior sites. the ablation catheter was 
manipulated until the atrial:ventricular electrogram ratio was < I and 
the His electrogram amplitude was < 150 !lV. At posterior sites, the 
target was an A:V ratio < I with a late and fractionated atrial 
electrogram. After 10 RF applications or 60 min. pts crossed over to 
the other treatment approach. Pts underwent follow-up 
electrophysiology testing 48 hrs after the initial successful ablation and 
if AVNRT was induced. another ablation was performed. Initially. 
the anterior approach was successful in 5n pts and the posterior 
approach in 3n (p = NS). The anterior approach was successful in 
4/4 crossovers and the posterior approach in 2/2 crossovers. 3 pts 
required a second ablation session at 48 hrs. Overall. there were 23 
ablations with no difference in efficacy between the 2 approaches. 
There was no difference in the number of RF applications. 
fluoroscopy time. or duration of the ablation session between the 2 
approaches. The anterior approach selectively eliminated fast pathway 
function in 13/14 cases and the slow pathway in 1. Lesions made 
posteriorly appeared to affect slow pathway function in 9/9 cases. 
A VNRT was eliminated in all pIS without the occurrence of high-grade 
AVblock. 
Conclusions. I) Both the anterior and posterior approaches to 
catheter modification of A VNRT are effective and require similar 
amounts of time and RF applications. 2) Application ofRF anteriorly 
most often interrupts fast pathway fimction. whereas posterior lesions 
eliminate slow pathway function. 
11:15 
746·5 11:30 
Physiology of Atypical A V Node Reentrant Tacbycardia 
Jeffrey Goldberger. M.D .• Rodney Brooks. M.D .• Alan Kadish. M.D .• 
Dept. of Medicine. Nonhwestem University. Chicago. n.. 
Six patienlS (pis) referred for radiofrequency catheter modification of the A V 
node (A VN mod) had inducible atypical AV node reentrant tachycardia 
(A VNRT) before or after AVN mod. Typical A VNRT was differentiated 
from atypical A VNRT by a V A time <61 ms in the HBE recording. 
Atypical A VNRT was divided into two types: I)fast/slow (F/S) defined by 
an AH/HA ratio :!:0.5; 2)slow/slow (SIS)-AH/HA ratio >0.5. ~ Five 
of 6 pIS had typical A VNRT. 2 pIS had F/S A VNRT (I with two types). 
and one pt had SIS A VNRT prior to A VN mod. Following A VN mod for 
typical A VNRT. newly induced arrhythmias were SIS A VNRT (n=3) and 
FIS A VNRT (n=I). The fast pathway or anterior approach to AVN mod had 
been used in all 3 pIS who had SIS A VNRT follOwing A VN mod and the 
slow pathway or posterior approach had been used in the pt with F/S 
A VNRT following A VN mod. Earliest retrograde atrial activation in the 
posterior septum was documented in all 3 pIS with FIS A VNRT and 3 of 4 
pIS with SIS AVNRT. 
AYlSBI l::! J:Q.(nW AH!IW Ioduced fm AN Earliest A- HBE/cS 
Typical 5 377 ± 47 304 ± 4()* 5/3 5/0 
F/S 4 312 ± 49 70 ± 18* 1/2 0/4 
SIS 4 352 ± 71 158 ± 18* 1/3 0/3 
* p < om for all comparisons. TCL-tachycardia cycle length 
Two pts with SIS A VNRT who had undergone fast pathway ablation 
underwent funher slow pathway A VN mod that resulted in V A block. One 
pt with SIS A VNRT had funher anterior approach A VN mod that resulted 
in second degree A V block. We conclude: I)Three distinct types of A VNRT 
exist. 2)The retrograde limb of SIS AVNRT must be a slow. posterior 
pathway since posterior ablation abolished VA conduction. This establishes 
the presence of more than one slow pathway. 3)Delineation of the 
mechanism of atypical A VNRT may help guide the proper approach to 
AVNmod. 
ABSTRACTS 
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Slow Pathway Ablation using A -stepwise•
Approach in Patients with Atrioventricular 
Modal Reentrant Tachycardia: Is Pathway 
-Potential- crucial for SUccessful Results? 
Mohammad Jazayeri, Jasbir Sra, Anwer Dhala, 
Zalem Blanck, Sanjay Deshpande, Mita Sheth, 
Boaz Avitall, Masood Akhtar. 
Sinai samaritan Medical Center, Milwaukee, WI. 
Fifty-one patients (pts) with atrio•
ventricular nodal reentrant tachycardia 
(AVNRT) underwent a slow pathway ablation. 
The retrograde slow pathway was precisely 
mapped in 11 pts during either uncommon AVNRT 
or ventricular pacing. Radiofrequency energy 
(RF) was delivered at the earliest retrograde 
atrial activation sites via slow pathways. In 
the remaining 40 pts, we could not identify 
any antegrade or retrograde slow pathway 
"potentials". In these pts, RF pulses were 
delivered successively in a "stepwise" fashion 
along the tricuspid septal annulus from the 
most posterior aspect (adjacent to the 
coronary sinus ostium) to the anterior site 
(posterior and inferior to the His bundle 
recording site). After each RF application, 
AVNRT inducibility was evaluated. Of 51 pts, 
47 (92%) underwent successful slow pathway 
ablations and complete abolition of AVNRT. 
These data suggest that specific attempts at 
recording slow pathway "potentials" is not 
critical for achieving successful results. 
The "stepwise" approach can effectively 
abolish slow pathways and AVNRT in the vast 
majority of patients_ 
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Failure of Low But Not High Dose Chronic Enalapril 
Therapy To Suppress Serum Angiotensin Converting 
Enzyme (ACE) Activity In Heart Failure 
Randall Vagelos. Gaif Yee. Mary Boyle. Sherry Moore. Lisa 
Prikazsky. Kathy Willson. Michael Fowler 
Stanford University Medical Center. Stanford. California 
Dose of ACE-inhibitor may be an important determinant of benefit 
in heart failure. We hypothesize that this may be related to the 
degree of neuroendocrine suppression. In order to investigate the 
influence of dose on neuroendocrine activity. a subset of 14 
patients randomized to chronic high versus low dose enalapril 
therapy had measurements of ACE activity. plasma renin activity 
(PRA) • and plasma norepinephrine (NE) level. 5 patients on 2.5 
mg bid enalapril were evaluated after a mean of H.B±3 months 
and 9 patients on 15 mg bid were evaluated after a mean of 
14.7±6 months. Baseline clinical parameters were similar in 
both groups. Trough levels of ACE activity. NE. and PRA were 
drawn 12 hrs after the last enalaprif dose. and peak levels were 
drawn 2 hrs after the following dose. 
Bu.IlIa: Enalaprll dose 
2.5 ma bId 15 rna bid 
ACE actlvlty Trough 52 ± 19 50 ± 22 
rm'rri'rrjn Peas 49 + 21 2!l+1O' 
N E Trough 366 ± 212 455 ± 123 
00!Jj Peas 315+ 165 423 + 113 
PRA Trough 7.0±5.7 15.7±6.6 
mllri'rrin F'ea< 6314.3 195+ 4 9' 
, Trough and peak levels statistically different. p<.05 
D:nlla 
NS 
04 
NS 
NS 
.03 
< 001 
ConclUSions: High dose enalapril resulted in more effective ACE 
inhibition and a higher level of PRA. though this was not 
associated with a significant difference in NE levels. These results 
suggest a mechanism for the clinical benefit observed with high 
dose enalapril therapy in this patient group. 
145A 
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Acute Effects of the Angiotensill II Antagonist, OOP 753, 
in Beart Failure 
Michael A.Fitzpatrick, Miriam T.Rademaker, Eric A.Espiner 
Dept of Med, School of Medicine,Christchurch, New Zealand 
DUP 753 (D), an angiotensin II receptor antagonist may 
produce more specific blockade of the renin-angiotensin 
system in heart failure than ACE inhibitors. The acute 
hemodynamic (HD), hormonal and renal response has been 
studied in an ovine model of heart failure {HF)induced by 
7 days of rapid ventricular pacing (LVP - 225/min). Sheep 
(n-6) received IV bolus injections of D (1 and 10 mg/kg) 
or vehicle (V) followed by captopril (12.5 mg bolus, C). 
RESULTS: Baseline D 1mg/kg! D 10 mg/kg! C! 
MAP (mmHg) 61j} 531.2# 46±2I 46±3# 
LAP (mmHg) 24±1 22±1 20±1# 19±1# 
CO (l/min) 1.6+0.1 2.1+0.2* 2.0+0.1 2.1+0.2# 
PRA (nmol/l/hr) 1.6+0.2 1.8+0.4 3.1+0.8** 3.0+0.8** 
ANG II (pmol/l) 57+8 141+37# 227+48# 35+7 
ALDO (pmol/l) 640+162 477+73* 446+87* 278+69# 
ALDO/PRA 920+346 317+69# 303+153# 110+26# 
(Mean + SEM; Baseline - mean-results for time - matched 
period-after V; ! - mean 15-45 minute response; PRA, ANG 
II, ALDO - Plasma renin activity; angiotensin II and 
aldosterone; MAP, LAP - mean arterial, left atrial 
pressure; CO = cardiac output; * p(O.05; ** 
p(O.Ol ;p(O.OOl). No significant effects were observed 
with V. The HD and PRA/ALDO response to D paralleled the 
response to C. In contrast, ANG II rose with D. No 
significant effects on glomerular filtration or urine 
electrolyte excretion were observed. 
CONCLUSION:Apart from ANG II response,the HD and hormonal 
response to D and C appear to be identical in HF. D may 
be a useful alternative to ACE inhibition in treating HF. 
747·3 11:00 
Effects of Renal Endopeptidase Inhibition on 
Sodium Excretion and Renal Hemodynamics in Heart 
Failure. 
Carey D. Kimmelstiel, Ronald D. Perrone, Lori Kilcoyne, 
James E. Udelson, John J. Smith, Adolfo J. de Bold, Eugenia 
Henry, Joseph F. Souhrada, Marvin A. Konstam. Tufts 
University • New Eng. Med. Ctr., Boston, MA. 
Atrial natriuretic factor, a cardiac polypeptide hormone 
with powerful natriuretic, diuretic, and vasodilator actions, 
is cleaved by neutral endopeptidase (NEP). We studied the 
acute effects of a renal NEP inhibitor, candoxatril, on Na 
excretion and renal hemodynamics in patients with NYHA 
class II·III he an failure. We determined the effect of 200 mg 
oral candoxatril (n=8), or placebo (n=4), on urinary Na and K 
(mEq/hr), urine flow (ml/hr), renal plasma flow (RPF, 
ml/min/l. 73m2), glomerular filtration rate (GFR, ml/min/ 
I. 7 3 m 2), and urinary cyclic GMP (cGMP, pmol/hr, n= 10). 
Systolic blood pressure was unchanged. Candoxatril 
significantly increased urine Na compared to placebo 
(p=0.006, examining all time points). Peak effect was 
observed 3·4 hrs post-dosing (mean ±. SO): 
Candoxatrj! ~ 
~ ~ ~.li...llu 
Urine Na 4.5 ± 2.2 7.4 ± 3.8 5.1 ±. 2.5 5.3 ± 3.4 
Urine K 2.9 ± 1.5 2.6 ± 0.7 1.7 ± 0.4 2.6 ± 1.7 
Urine flow 262 ± 121 282 ± 64 259 ± 105 273 ± 41 
GPR 78±23 77±32 98±IS 93±18 
RPF 330 ± 131 260 ± 120 432 ± 121 389 ± 162 
Urinary cGMP 84±47 198±78 49±28 44±21 
Conclusions: I) In patients with heart failure, renal NEP 
inhibition with candoxatril significantly increases Na 
excretion, without altering K excretion; this effect may be 
mediated via cGMP. 2) Effects on renal hemodynamics are 
minimal. 3) Candoxatril may have value in therapy of hean 
fail ure. 
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'·Blockade with Carvedilol Selectively Lovers Cardiac 
Adrenergic Drive in the Pailing Human Heert 
Michael R. Bristow, Stephanie Olaon, Edward M. Gilbert, 
Patricia A. Larrabee, A. Kirk Volkman, Petrice C. 
Mealey, Debra Ferguson, Michel White, Dale G. Renlund 
and John B. O'Connell. University of Utah, Salt Lake 
City, UT 84132 
We evaluated the effect of the & blocker/vasodilator 
cervedilol on cardiac performance (measured by LVEF) , 
systemic adrenergiC drive (measured by erterial and 
central venous plasma norepinephrine), and cardiac 
adrenergic drive (measured by coronary sinus 
norepinephrine) in a placebo.controlled, randomized 
study in subjects with idiopathic dilated 
cardiomyopathy (IDC). 30 subjects were evaluated, 18 
of which received carvedilol 25 or 50 mg bid and 12 of 
which received placebo. Results as change from 
baseline +SEH are reported below (* p< 05 vs placebol' 
~ 
CARVEDILOL 
n-18 
IDI 
+.11* 
±.02 
CS NE Arterial NE Venous NE 
iPiLmll (ps/mll (pgimll 
·203* -13 -38 
±48 ±64 ±54 
PLACEBO +.02 +79 -45 ·25 
n-12 + 02 +39 +39 +26 
Conclusion' Carvedilol improves resting cardiac 
function in heart failure from IDC, and this 
improvement is associated with a selective decrease in 
cardiac adrenergic drive. Interestingly, systemic 
adrenergic drive is not altered by carvedilol 
treatment. This observation indicates that cardiac 
adrenergiC drive must be measured in order to fully 
appreciate beneficial effects of carvedilol, and 
probably other & blocking agents in heart failure. 
747·5 11:30 
~·BJocker Related Improvement in Sub maximal Exercise Tolerance in 
Heart Failure From Idiopathic Dilated Cardiomyopathy (IDC) 
Stephanie L Olsen, Frank G Yanowitz, Edward M Gilben, Patrice C 
Mealey, A Kirk Volkman, Dale G Renlund, Michael R. Bristow. The 
University of Utah Medical Center, Salt Lake City, Utah. 
Since administration of p·blocking agents generally inhibits maximal 
exercise performance in subjects with and without hean failure, maximal 
exercise tolerance testing may be an inadequate method for measuring 
improved functional capacity in heart failure patients treated with p. 
blockade. We measured change in maximal exercise time (max ex t), 
maximal oxygen comsumption (max V02), and submaximal exercise tim£ 
(submax ex t) in patients with IDC and NYHA Class II hean failure 
symptoms randomly assigned to receive the p·blocker/vasodilator 
carvedilol versus placebo for 4 months. Patients with atrial fibrillation 
were excluded from analysis of exercise data. Submaximal exercise 
tolerance was determined by stressing the patients at a workload fixed at 
85% of their baseline max V02, and recording the total duration of 
exercise. Results, expressed as mean ± SEM, are presented below 
(*p < .05 Acarvedilol vs A placebo): 
max ex t 
max V02 
max ex HR 
max ex BP 
suhmax ex t 
Carvedilol 
(n=14) 
base 
603±56 
IS.0±1.2 
145±5 
141±6 
609±35 
4m 
645±49 
18.5± 1.4 
123±5* 
151±7 
98S± 121* 
Placebo 
(n=IO) 
base 4m 
623±52 646±55 
17.9±1.0 17.6±1.2 
158±5 149±8 
147±1O 152±7 
802± 113 817± 167 
Thus, while max ex t and max V02 were not changed, submaximal 
exercise time significantly improved in patients treated with carvedilol 
when compared to placebo. Additionally, of the above exercise indices, 
only sub max ex t correlated significantly with change in left ventricular 
ejection fraction (R=.395; p<0.05). 
Conclusion: Submaximal exercise tolerance is a better indicator of 
improvement in exercise capacity in heart failure patients treated with p. 
blocking agents. 
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747-6 11:45 
Flosequlnan Augments Parasympathetic Tone and 
Attenuates Sympathetic Drive In Congestive Heart 
Failure: Demonstration By Analysis of Heart Rate 
Variability 
Philip F. Binkley, Enrico Nunziata, Patricia Hatton, George 
Proicou, Robert J. Cody. The Ohio State University, 
Columbus, Ohio. 
Flosequinan (FLO) is an investigational vasodilator which has 
symptomatic and hemodynamic benefit in patients (pts) with 
congestive heart failure (CHF).To evaluate the capacity of FLO 
to modulate the abnormal autonomic profile typical of CHF pts 
sympathetic (sym) and parasympathetic (para) tone were 
assessed using the power spectral density (PSD) of heart rate 
variability (HRV) in 40 CHF pts enrolled in a blinded ran•
domized placebo controlled trial of FLO using Holter monitor 
recorded heart rate obtained between 9 and 10AM at baseline 
and after 12 weeks of either placebo (19 pts) or 100mg daily 
FLO (21 pts). Para tone increased with FLO as evidenced by 
a significant (p<.01) increase in the para mediated high 
frequency (>.1 Hz) area of the PSD (bpm2) from 6. 7X1 0-
3j:3.6X10-3 at baseline to 10.7X10-3j:9.8X10-3.Para tone did 
not change in placebo with no change in the baseline high 
frequency area of 7.3X10-3j:3.6X10-3. Sym tone decreased 
with FLO with the proportion of sym mediated low frequency 
HRV decreasing from 86j: 11% to 77j:20% (p<.04) but 
increasing in placebo from 77 j: 25% to 85 j: 18% (2 group 
ANOVA repeated measures p=.02). A moderate (p=.03) 
increase in heart rate was noted with FLO from 90 j: 15 to 
96 j: 15 bpm with no change in placebo. Thus: 1. Positive 
chronotropic effects of FLO are not mediated by autonomic 
mechanisms; 2.FLO augments para tone and attenuates sym 
drive promoting a restoration of autonomic balance in CHF. 
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Three-Dimensional RE'Construction of Ventricular Septal 
Defects: In Vivo Feasibility and Validation Studies 
J. Miguerrovefa. Samuel C. Siu. Mark D. Handschumacher. Jean•
Paul Lethor. J. Luis Guerrero. Gus J. Vlahakes. John D. Mitchell. 
Arthur E. Weyman. Mary Etta King. Robert A. Levine, 
Massacusetts General Hospital. Boston. MA 
Appreciating the 3-dimensional (3D) spatial relations of ventricular 
septal defects (VSDs) could be useful in planning surgical and 
catheter approaches. Currently, however, echo provides only 2-
dimensional (2DE) views. requiring mental integration. We have 
developed a system which automatically combines 2DE images 
with their spatial locations to produce a 3D construct. The purpose 
of this study was therefore: I) to demonstrate the feasibility of in 
vivo 3D reconstruction of VSDs. and 2) to validate Its quantitative 
accuracy for VSD localization in excised hearts (used to permIt 
compansons WIthout cardIac contraction). Surgically-created VSDs 
of varying size and location were imaged and reconstructed along 
with the RV and LV in the beating heart of 6 dogs and 2 gel-filled 
excised hearts. Seven VSDs were also localized in excised hearts 
by measuring their distance to the RV apex. tricuspid valve. LV 
apex and aortic valve directly and in the construct. RESULTS: I) 
The 3D images provided correct spatial appreciation of the VSDs 
(5 muscular inflow. I outflow. I apical. I membranous Gerbode). 
Multiple defects could also be resolved. Projected maps of VSD 
site on the septal surfaces. unavailable from any 2DE view. could 
be obtained. 2) VSD spatial relations in excised hearts agreed well 
with direct measures (y = 1.08x-.05. r= .96). CONCLUSIONS: 3D 
reconstruction of VSDs can be -
achIeved In the beating heart. OUTFLOW 
and prOVIdes an accurate 
a~l?reClatJon of ssatJal relations 
w Ich could be 0 value In 
planning interventions. 
ABSTRACTS 
748-2 10:45 
Comparison Between Tranlesophageal and Transthoracic 
Echocardlographlc Assessment of ShunUng After ASD Device 
Occlusion 
ChrIStine Boutin. John Dyck. Jeffrey Smallhom. Lee N. Benson. 
Bruno Bissonnette. Robert M. Freedorn. 
The Hospital for Sick Children. Toronto. Ontarto. Canada 
In an ongoing study evaluating the sensitivity of transthoracic 
echocardlographlc assessrnent after ASD catheter occlusion. 8 
patients (8.6 ± 3 yrs). have undergone transthoracic (TI'E) and 
transesophageal echocardlograrns (TEE) under neuroleptic general 
anaesthetic, 13.1 ± 4 rnonths post occlUSion. A TEE contrast study 
was perfonned in every case. 
TEE findings: By color flow Doppler. residual shunts were seen in 7 
patients. Five patients had rnultlple shunts. Shunts were moderate 
(2 to 4 rnrn) in 4. smaJJ (1 to <2 rnrn) In 2. and trace (<I mrn) in 1. 
Three shunts were supertor. near the SVC; 4 were antertor. near the 
aorta and 4 were traversing the device rnatertal. Contrast study 
revealed Tight to left shunts. only during a Valsalva maneuver (n= 
2). Device anns were rnalaUgned to the atrtaJ septurn in 6 patients. 
but straddled the defect approprtately in all. 
TTE findings: Shunts by color Doppler were present in only 3/7 
patients with shunting by TEE. Only rnoderate shunts were seen by 
TfE. Small and trace sized shunts were not seen by TfE. Three 
shunts were antertor and 1 superior. RIght ventrtcular dimensions 
returned to nonnal in 2. even in the presence of a srnaJJ or rnoderate 
shunts by TEE. The only patient with paradoxical septal rnotlon 
had a moderate residual shunt not seen by TfE. 
TEE and TTE correlaUons: Overall. 6 shunts were not seen by TIE. 2 
were of moderate size. In 3 patients in whom shunts were 
visuaJIzed with both techniques. good correlation exISted for shunt 
location and Size. 
147A 
Conclusions: More than 1 year after ASD device occlUSion. a 
number of patients retain residual shunting by TEE. TIE appears to 
be less reUable In finding small shunts. TEE prOVides more 
complete and accurate infonnatlon valuable in managernent and 
follow-up of this procedure. 
748-3 11:00 
Usefulness of left Ventricular Inflow Doppler in Predict•
ing Rejection In Pediatric Cardiac Transplant Patients. 
Samuel S. Gidding, Galit Holzman, C. Elise Duffy, Carl 
Backer, Constantine Mavroudis, Vincent R. Zales. 
Children'S Memorial Hospital, Chicago, Illinois. 
In transplant pts, rejection (REJ) affects diastolic 
function, however, use of inflow Doppler to predict REJ 
has given confl icting results. We serially assessed E 
Velocity (EVEL), Pressure half-time (PI/2), and first•
third velocity time integral (1/lVTI) simUltaneous with 
cardiac biopsy in 8 pts [70 normal (1;) biopSies, 17 REJ 
biopsies]. Two data analysis methods were compared: a 
collective comparison of LV inflow variables for REJ 
versus N, and individual comparisons using each pt as his 
own control. Inter- and intra-observer measurement vari•
ability was assessed. No differences were found when all 
N episodes were compared with all REJ episodes. (N vs. 
REJ, EVEL: 0.62±0.15 vs. 0.69±0.20 mis, Pl/,2 49±16 vs. 
48±ll msec, I/lVTI .l5 ±.06 vs .. l4±.07 m/s) When each 
pt served as his own control, significant differences 
emerged. Il/17 (76%) REJ were identified by one or more 
of the following: EVEL > 1 standard deviation (SO) above 
EVEL during N, EVEL < 2S0 below [VEL during N, P1/2 ISO 
> P1/2 during N, or P1/2 ISO < P1/2 during N. Sensitivi•
ty was low, 42/70 (60%), positive predictive value was 
13/41 (32%), and negative predictive value was 42/46 
(91%). 1/3VTI did not aid in identifying REJ. Intra•
and inter-observer variability for P1/2 and 1/3VTI sug•
gested measurement difficulty contributed to their 
imprecision. We conclude that LV inflow Doppler cannot 
replace biopsy in assessment of REJ because inflow Dop•
pler changes during REJ are inconsistent (increases and 
decreases in vari abl es were observed) and not suffi•
ciently sensitive. However, when each pt served as his 
own control, a significant change in [VEL or PI/2 from a 
pre-established baseline makes REJ more likely. 
148A ABSTRACTS 
748·4 11:15 
Echo Predictors of the Need for Infundibular Wedge 
Resection In Infants with Aortic Arch Obstruction, 
Ventricular Septal Defect, and Subaortlc Stenosis 
L. LuAnn Minich. A. Rebecca Snider. Edward L. Bove. Flavian M. 
Lupinetti. University of Michigan. Ann Arbor. MI 
To define echo predictors of the need for subaortic stenosis 
(subAS) resection in Infants with aortic arch obstruction. 
ventricular septal defect (VSD). and posterior deviation of the 
infundibular septum. we reviewed the echocardiograms of 10 
patients (ages 1 day-9 mos. median 13 days) and 15 age-matched 
controls (ages 1 day-2 mos. median 4 days). The diameters of the 
left ventricular outflow tract (LVOT) and descending aorta (DAO) 
were measured in systole (sys) and diastole (dias) from the 
parasternal long axis and subcostal views. respectively. and the 
ratios LVOT/DAO were calculated. Compared to ctrls. the pts had 
smaller LVOT sys (3.4±0.9 vs 6.0±0.5 mm). smaller LVOT dias 
(3.9±0.8 vs 6.3±0.6 mm). similar DAO sys (5.8±O.9 vs 5.4±0.5 
mm). similar DAO dias (5.3±1.0 vs 4.9±0.6 mm). lower 
LVOT/DAO sys (0.59±0.14 vs 1.12±0.11). and lower LVOT/DAO 
dias (0.75±0.15 vs 1.31±0.14) (p<.OI). Because of cardiac 
motion. LVOT diameters could be measured with greater 
reproducibility in dias than sys. All pts underwent aortic arch 
repair and patch closure of the VSD. Seven pts also had wedge 
resection of the infundibular septum. On the most recent Doppler 
exam obtained from 12 days to 11 mos post-operatively (median 
24 days). the LVOT peak gradient ranged from 0-36 mmHg (mean 
15). Only 1 pt had LVOT/DAO dias of 2,1.0 and this pt had no subAS 
resection and no residual gradient. The other 2 pts with no subAS 
resection had LVOT/DAO dias <1.0 and have the highest residual 
gradients (30 and 36 mmHg). All remaining pts had subAS 
resections. LVOT/DAO dias <1.0. and have no significant LVOT 
gradient (mean 10 mmHg). Thus. in infants with severe muscular 
subAS caused by posterior deviation of the infundibular septum. an 
echo LVOT/DAO dias ratio <1.0 suggests that wedge resection of the 
infundibular septum should be performed for adequate relief of the 
obstruction. 
748·5 11:30 
Imaging Pulmonary Venous Pathway Obstruction 
in Patients After The Modified Fontan Procedure 
Mark A. Fogel, Alvin J. Chin 
The Children's HospiIaJ tfPhilOilelphia. Philadelphia. PA 
Pulmonary venous palhway obsbuction (PYPO) is a rare but tteatable cause of low 
cardiac output, persistent effusions and protein-losing enteropathy after the modified 
Fontan procedure (MF). To evaluate the efficacy of CXR and echocanliograms in 
identifying PYPO in these pts. we reviewed the records of 307 MFs performed from 
1984-1990 and identified 10 pIS (age 43±28 months) with 12 PYPO events 
documented by cardiac C81heterization (CC) (9 cases with a·wave gradient ~ 4 mm 
Hg) or autopsy (3 cases with maximum palhway diamerers < 2 standard deviations 
below the IWIlIliII aonic root diameter and were not diagnosed by Ce). PYPO causes 
included pulmonary vein ostial stenosis in 6. left atrial outlet in 4, and atrial baffle 
obslrUCtion in 3 (I event had 2 causes). None had pulmonary venous CXlIIgestion on 
CXR. PYPO palhway diamerers (in mm/mW. indexed to the cube root of the body 
surface area) of 6.B± 1.2 in 
subcostal frontal. 7.9± _ 0 Fontans "Itb PVPO .. Fontan conlrols 
0.6 in the subcostal sag· 1'l 
ittal and 6.S± 1. 7 in the 
apical "4-chamber" views ! 20 
were oIlserved and diIT=I S 
significantly from II age • 15 
matched MF controls (P= '" .. 
~ ]0 
E a $ 
I 
.. 
.6 
o 
.. 
8 
.. u ... 
o 
0.001. see figure). Pulsed 
Doppler showed maximal 
velocily range from 1.3-
2.5 m/s along the pul•
monary venous pathway; 
speclra1 daIa showed non· 
phasic forward now in 
S{7 PVPO pIS. 
: O~ ____________________ ___ 
Subcostal Subcostal Apical 
Frontal Sagittal "4-d1amber" 
Conclusions: Not only are the clinical manifestations of PYPO in Fontan pIS 
different from those with 2-ventric1e physiology but: 1) CXR a/UIJll be used as a 
screening tool. 2) Distal velocities as low as 1.3 m/s can be seen 3) autopsy can 
show a small pulmonary venous palhway orifice even when CC l'IlJI\jent is < 4 mm 
Hg, and 4) Pathway diameters indexed to the 3..J body surface area may be used as 
an "output.independent" parameter 10 cross check doppler data. 
JACC Vol. 19, No.3 
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748·6 11:45 
Biplane Transesophageal Echocardiography (TEE) During Interventional 
Cardiac Catheterization in Infants and Children 
Robert Weintraub, Takahiro Shiota. Jun Zhang. Ryozo Omoto. Shunel Kyo. 
Abraham Rothman. William Hellenbrand. Samuel Ritter. Lilliam Valdes·Cruz. 
David Sahn. Univ of Calif. San Diego. CA. 
The advent of pediatric TEE probes which permit sequential and simultaneous 
biplane imaging has expanded the role of TEE in pediatric cardiology. We 
performed biplane TEE studies during cardiac catheterization in 17 pts aged 
1 day to 14.2 years. Eight patients were studied using a 6.Bmm infant biplane 
probe and 9 were studied with a 96mm "adult" matrix biplane probe which 
images both orthogonal planes simultaneously from 1 multilayer array. TEE 
was employed to measure the baseline and balloon stretched diameters of 
secundum ASDs in 5 pts and also to guide positioning and release of their 
Lock·Clamshell ASD occlusion devices. as well as in 2 other pts following 
surgery for pulmonary atresia. during ASD balloon occlusion studies. In 2 piS 
TEE biplane imaging guided Ihe creation and/or balloon dilatation of palliative 
atrial septal defects and in one patient transseptal atrial puncture was 
facilitated. Two neonates underwent balloon atrial seplostomy with only 
biplane TEE guidance. Other interventional procedures guided by of biplane 
TEE imaging included dilatation of an obstructed Senning baffle in 2 patients 
and intra-cath evaluation of complex subaortic stenosis in one patient 
Biplane visualization was most important for Senning baffle evaluation, 
imaging of the left ventricular outflow tract and sizing of atrial septal defects 
Simullaneous matrix real·time biplane visualization was most important for 
imaging the placement of ASD umbrellas and guiding transseptal procedures. 
since clear imaging of catheters. wires or umbrellas and their relationship to 
the curved atrial septum often alternated rapidly between the imaging planes 
during Ihese maneuvers. Over the short imaging distances that we used. 
matrix biplane image quality was no different from that for the discrete biplane 
probes. Biplane TEE and especially matrix simultaneous biplane visualization 
during cardiac catheterization. is in many ways akin to biplane fluoroscopy. 
Because of the growing applicability of TEE during interventional pediatric 
catheterization procedures. we have recently designed and tested an Bmm 
"baby" matrix probe to facilitate Ihe availability of simullaneous biplane TEE 
in smaller infants and children. 
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749·1 10:30 
Where Does Scar Tissue Form to Inhibit extraction of Chronic 
Pacemaker Leads? 
Heidi J. Sm~h. Neal E. Fearnot. Charles L. Byrd. Charles J. love. T. 
Duncan Sellers. Bruce L. Wilkoff. 
MED Institute. West Lafayette. IN 
To investigate scar tissue as a barrier to extraction. attempted 
extractions of 703 leads from 435 patients were analyzed. Indications 
were endocarditis/septicemia (12%). infection/erosion (41%). 
pacemaker reoperation (37%). and other (10%). The intravascular 
extraction technique used stylets locked inside the lead tips and 
countertraction sheaths advanced coaxially along the lead to disrupt 
scar tissue and avoid potentially dangerous force to the myocardium. 
For 217 patients (50%). significant scar tissue was described at 
particular locations (1.7 leadsJpatient implanted 64,t45 months). vs. 35 
(8%) w~h no signHicant scar tissue (1.6 leadslpatlent implanted 22,t29 
months). 183 patients had inadequate data. locations were: 
Location , Patients Location 'Patients 
Entry/subclavian 173 Atrium 73 
Innominate 101 Valve 26 
SVC 74 Ventricle 143 
174 patients had multiple locations (in 2 for 66 pts. 3 for 57 pts. 4 for 
22 pts. 5 for 20 pts. 6 for 9 pts). Of the 121 atrial and 247 ventricular 
leads. 88% were completely removed. g% incompletely. and 3% not 
removed, comparable to results for the 442 patients (85% completely 
removed. 8% incompletely. ~Io not removed). In 25 of 217. excessive 
scar tissue in superior veins required a Switch to a femoral approach. 
Older leads had more scar tissue than newer leads in the same 
patient; and leads were fibrosed together in at least 2 cases. 
Conclusion: Significant scar tissue is present in at least 50% of lead 
extractions and is not limited to enclocardial encapsulation. When 
extracting chronic pacemaker leads. special consideration must be 
given to the removal of scar tissue at each point to avoid vessel 
rupture. In spite of the scar tissue. leads were successfully removed 
through the use of sheaths to disrupt scar tissue. 
JACC Vol. 19, No.3 
March 1, 1992:149A 
749·2 10:45 
The [erects or Atrioventricular Interval on Left and Right 
Ventricular Diastolic Filling 
Alhanase DritsaS, Jayshree Josbi, George Athanassopoulos, Celia Oakley, Petros 
Niboyannopoulos. Dept. of Medicine, Clinical Cardiology, Hammersmith 
Hospilal, RPMS, London UK. 
The effects of changes in atrioventricular interval (A VI) on left and rigbt ventricular 
diastolic filling were studied using Doppler ecbocardiograpby in II patients (mean 
age 5003) with dual cbamber programmable pacemakers. Six patients bad a bislDry 
of a previous myocardial infarction and good systolic left ventricular function but a 
reduced ratio of peak early (E) to peak late filling (A) transmiuaJ Doppler flow 
velocities (mean E/A 0.66±O.31). Five patients bad normal systoliC and diastolic 
(mean E/A 1.7±O.5) left ventricular ecbocardiographic indices. Indices of syslDlic and 
diastolic right ventricular function were normal in all patients. 
Doppler recordings of miuaJ, tricuspid and aortic flow were undertaken during dual 
chamber pacing at a shon (9O±12 msec), medium (146±5 msec), long (188±13 
msec) A VI and during single chamber ventricular pacing. The beart rate was kept 
constant at 70 bpm. During dual cbamber pacing the maximal stroke volume was 
obtained with the long AVI (13±9% increase in stroke volume versus shon AVI, 
p<O.05 and 26±18% increase versus single chamber ventricular pacing, p<0.01). 
Time velocity integral (TVI) of the early left ventricular filling flow decreased from 
7's±2.7 cm at short AVI to 6.1±2.9 em at long AVI (p<0.01). TVI of late left 
ventricular filling flow increased from 4.1±2.2 cm at sbort AVI to 5.00.2 cm at 
medium AVI (p<0.01) and 5.3±2.8 em at long AVI (p<O.OI). TVI of early rigbt 
ventricular filling flow did not change significantly from short (4.0±3.0 cm) to long 
A VI (3.9±3.5 em). However, TVI of late rigbt ventricular filling flow increased 
from 2.3±1.6 em at sbon AVI to 3.1±1.9 cm at long A VI (p<O.OS). The observed 
increase in TVI of late left ventricular filling flow from sbort to long A VI was 
greater in patients with a reduced E/A ratio (1.8±O.6 cm increase) compared t" those 
with normal E/A (0.7±0.6 cm increase) (p<O.OS). Stroke volume changes from 
short to long AVI were also greater in patients with a reduced EtA (19±10 % 
increase) compared to those with normal EtA (7±5% increase) (p<O.OS). The 
magnitude of changes in the TVI of the late right ventricular filling flow from sbort 
to long AVI was not different between patients with reduced or normal E/A ratio. 
Patients with preserved systolic but impaired diastolic left ventricular function derive 
a baemodynamic benefit from a long A V interval. In the presence of left ventricular 
dysfunction and normal right ventricular function the magnitude of cbanges in the 
left ventricular filling profile can predict the optimal A VI. 
749·3 11:00 
septal Hia-purltinje Pacing: A New concept to 
Improve Paced Ventricular Function 
Peter Karpawich, Kenneth Stokes, James Gates, 
Cheryl Justice. Children's Hospital of Michigan 
Wayne state University, Detroit, MI 
Compared to apical ventricular (V) pacing (P), 
impulse propagation through the His-Purkinje 
system (HPS) normalizes V contraction patterns, 
improves myocardial function, and prevents 
adverse myofiber changes. We report a new V P 
concept with an endocardial septal electrode 
(E). Five beagles (age 6 mos) were 2 used. A 
custom Medtronic E, 4.5mm long, 17.Smm surface 
area, active-fixation, platinum-iridium exposed 
helical screw design with polyurethane covered 
4 filar coil lead was used. A USCI SFr sheath, 
modified to record simUltaneous intracardiac 
pressure (p) and electrophysiologic (EP) 
recordings, was the introducer (I). Following a 
lateral thoracotomy, the I was inserted into 
the right atrial (A) appendage and with con•
tinuous p and EP monitoring, advanced to record 
optimal septal His bundle impulses while main•
taining A p. Low A implant site above the tri•
cuspid valve (TV) was verified by echO/Doppler. 
Acute post-implant ECG showed narrow V paced 
QRS without bundle branch, and AV dissociation. 
Mean implant values: sensed R 6.3mv, slew rate 
O.65v/s, impedance 319 ohms, threshold 0.9V/ 
3.3mA at O.5ms output. Necropsy showed implant 
above the TV annulus with E extension into and 
contained within the proximal V septum. 
Septal P utilizes the intrinsic HPS and 
allows normal V contraction sequences. This new 
E implant concept offers the potential of 
providing optimal chronic V P hemodynamics. 
ABSTRACTS 
749·4 
Esothoracic Ventricular Stimulation for Chronic 
Bradyarrhythmias 
David Cochrane, John Anderson, Jennifer Adgey. 
Royal Victoria Hospital, Belfast, Northern Ireland 
149A 
11:15 
Esothoracic is a new pacing pathway using an oesophageal 
electrode (OE) in conjunction with a chest electrode(CE). 
Under light sedation an OE with a point source distally 
was swallowed. A tensioning system permitted the distal 
segment to swing anteriorly making closer apposition with 
the left ventricle. The cathodic output (5Oms) of an 
external pacing unit (OSYPKA 500 D) was linked to the QE. 
The optimum position and electrical properties of the CE 
were studied. No ventricular capture was obtained with a 
low impedance (50) pad. In 11 patients (pts) in whom 
capture was possible with a high impedance pad (2500), 
2 chest wall positions were investigated. With the pad 
sited over the 4tb interspace at the left sternal edge 
(LSE), 100% of pts had capture compared with 54% when 
sited at the apex. Elective temporary ventricular pacing 
was attempted in 47 pts with chronic bradyarrhythmias 
(CHB 15 pts; 2:1 AV block 15 pts; slow AF 9 pts; SB 8 
pts). Using a 2500 pad at the LSE, threshold currents 
(I's) were obtained for ventricular capture at various 
depths as measured from the lower lip. Stimulation was 
achieved in 40 pts (85%) with a mean I 29.2mA (+SDI0.5) 
at an optimal depth of 40.5 cm (+SD2.4). The highest 
percentage ventricular capture and lowest I occurred 
using a pulse duration of 50 ms. In 14 pts esothoracic 
pacing was compared with bipolar transoesophageal pacing 
using a VYGON OE. Esothoracic pacing was successful in 
13 pts (93%) at a mean I 21.2mA (+SD6.8) compared with 7 
pts (50%) with a mean I of 37.8mA-(+SD12.7)(p<0.02).This 
simple technique of esothoracic pacing using a 2500 
CE placed at the LSE gave 85% ventricular capture. 
749·5 11:30 
Can Impedance Based Pacemakers Accurately 
Changes in Left Ventricular Stroke Volume? 
Determine 
carolyn A. Burns, MD, Robert Sperry, MD, 
Rogers, J. V. Nixon, MD and Kenneth A. 
Medical College of Virginia, Richmond, VA 
Regina R. 
Ellenbogen, 
The PreceptDR pacemaker measures relative changes in 
stroke volume (SV) and pre-ejection interval and uses 
these measures to provide rate-responsive pacing in a 
ebsed loop system. Whether the right ventricular (RV) 
impedance-derived SV accurately reflects changes in left 
ventricular (LV) SV in an individual is unknown. We per•
formed simultaneous impedance-derived SV and stroke vo•
lume integral (SVJ) derived from pulsed-wave Doppler 
echocardiograms of the LV and RV outflow tracts in 6 
patients with PreceptDR pacemakers. Measurements were 
made at varying heart rates and AV intervals at baseline, 
and during lower body negative pressure (LBNP) and sub•
maximal handgrip (MHG). Comparisons were made between 
the relative changes in SV (pacer) and in SVI of the RI! 
and LV. The relative ch~r;,::",,, in SV (pacer) and SVI of 
the LV and RV correlated poorly for all intervomtions. 
However, the optimal !".V i"terval, <>s deter!"in".j by LV 
SVI, during pacing at different heart rates, MHG, and 
LBNP, was predicted correctly by the pacemaker SV in 71% 
of the interventions. 
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In conclusion, impedanCE; based SV measurements may be 
useful for determining the optimal AV interval for 
pacing; however, relative changes in RV impedance 
correlate poorly with LV SVI. 
150A ABSTRACTS 
749·6 11:45 
Hemodynamic Iuterest of preservlug a normal sequence of 
ventricular activation in permanent cardiac paclug. 
Christophe Leclercq, Philippe Mabo, Alain Le HeUoco, Alain 
Kermarrec, Daniel Gras, Claude Daubert. 
University Hospital, Rennes, France. 
To investigate the potential benefit of preserving a normal sequence 
of LV activation by avoiding ventricular capture, hemodynamics 
(Cardiac output : CO ; Pulmonary Capillary Wedge Pressure : 
PCWP ; Systemic Vascular Resistances : SVR) were measured at 
rest and during submaximal exercise (E), in II pts implanted with a 
DOOR pacemaker for sinus node disease with intact AV conduction 
and narrow QRS. 3 pacing modes were tested in random order: -
AAIR which preserved normal LV activation· VVIR - and DOOR 
with complete ventricular capture (A V delay = 142:t 23 ms). Pacing 
rate was maintained constant at rest (70 bpm) and at the end E (120 
bpm). 
at rest AAI p DOD p VVI 
CO (Vmn) 6.6%1.3 <0.05 6:t0.9 <0.001 5:t1.1 
PCWP(mmHg) 7.6:t1.8 <0.05 9.2%3.3 <0.01 11.6%3.5 
SVR(1Ulm') 14.4:t2.3 <0.05 16.1:t2.6 <0.01 19:t3 
end exercise AAI p DOD p VVI 
CO (Vmn) 13.5±2.2 <0.01 12.1:t2.2 <0.001 10.4:t2.2 
PCWP(mmHg) 15.4:t2.6 <0.05 19.5:t5 <0.05 25.8:t7 
SVR(IU/m') 8. 7:t 1.1 <0.01 9.6%1.6 <0.001 10.6%1.6 
The AAIR pacing mode significantly improves hemodynamics 
compared to the DDDR mode with complete ventricular capture. as 
wall at rest as during exercise. 
This clearly indicates that a normal sequence of ventricular 
activation must be respected as often as possible in permanent 
cardiac pacing. 
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750·1 10:30 
Genetic Screening for Risk of Coronary Artery Disease: Prospectus. 
Hiram W. Marshall. Linda Morrison. Labros Karagounis. Pat Corneli. Dora 
Stouffer. Ann Allen. Jeffrey L. Anderson. R. H. Ward 
University of Utah and LOS Hospital. Salt Lake City. Utah 
Since genetiC factors are presumed to underlie the well known 
familial aggregation of coronary artery disease (CAD). it has been suggested 
that common DNA polymorph isms at candidate risk loci might identify high 
risk individuals before the onset of disease. The eight apolipoprotein genes 
which are intimately involved in lipid metabolism. with specific rare mutants 
giving rise to increased risk of CAD. represent extremely promiSing 
candidate loci. In addition. DNA polymorphisms at these Joei have been 
reported to show association with risk of CAD. To determine whether 
genetic segregation at these loci can be used to identify individuals at high 
risk for CAD, we evaluated the distribution of apolipoprotein genetic 
polymorph isms in a large consecutive series of 828 patients (pts) undergoing 
coronary angiography. Presence (>60% stenoSis of any major branch. 
n~430) or absence «10% stenosis, n~398) of disease was determined by 
blinded assessment of angiograms. A total of 11 polymorph isms were 
evaluated at the following loci: Apo AI/CIIVAIV (5 DNA polymorphisms . 
Mspl. Pstl, Sstl. Pvulla. Pvullb). Apo B (3 DNA polymorph isms . Xbal. 
EcoRI. VNTR), Apo All (Mspl DNA polymorphism). Apo Gil (T3ql DNA 
polymorphism). Apo E (protein isoforms). All pts were of Norther~ C::uropean 
descent. Controls and diseased pts were matched for ag~ and sex. 
Results: All 11 loci were in Hardy·Weinberg equilibrium. with no indication 
of population heterogeneity. A series of contingency chi·square and logistic 
regression analyses indicated that there were no associations between 
apolipoprotein polymorphisms and risk of CAD (p values ranged from 0.10 
to 0.90). This lack of association occurred irrespective of whether the 
analysis was carried out for the entire population, or stratified by lipid 
subgroup. Despite the fundamental role played by apolipoprotein genes in 
lipid metabolism. common genetic polymorphisms at these 8 loci do not 
influence the risk of CAD. Hence. we find no support for the notion that 
genetic screening for high risk individuals will help reduce the frequency of 
CAD. Instead. it will be more effective to direct attention towards modifying 
high risk behaviors at the level of the entire population. 
750·2 
JACC Vol. 19, No.3 
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10:45 
Association of Higher Fasting Insulin Levels 
with Angiographically Defined Diffuse Athero•
sclerotic Coronary Artery Disease in Non•
diabetics 
R.D'Agostino, O.Nwasokwa, A.Moschetto, 
G.Friedman, A.Grunwald, J.Koss, B.Schneider, 
J.Spivak, M.Bodenheimer. 
Long Island Jewish Medical Center, New Hyde 
Park, NY and Albert Einstein College of 
Medicine, Bronx, NY. 
There is evidence that insulin promotes 
atherosclerosis. To determine the relevance of 
this observation to clinical coronary artery 
disease(CAD), we tested the hypothesis that non•
diabetic patients with diffuse atherosclerotic 
CAD (DACAD) on angiography have higher insulin 
levels than controls without CAD. We measured 
plasma insulin levels fasting; and also one, 
and two hours after 75 gram oral glucose chal•
lenqe (OGC) in 44 nondiabetic patients: 18 with 
DACAD on angiography, and 26 controls with nor•
mal coronaries on angiography (NCA). Relevant 
clinical char2cteristics and lipid profiles did 
not differ between groups. Insulin levels 
~SE(uU/ml) an21yzed by unpaired t-test were: 
DACAD 
NCA 
p= 
FASTING 
6.27+1.11 
3.55+0.46 
0-:-015 
I-hr post OGC 
61.57+11.31 
44.09+5.33 
0.131 
2-hr post OGC 
57.70+9.56 
43.44+5.77 
0.183 
We conclude that nondiabetic patients with 
DACAD have higher fasting insulin levels than 
controls with NCA. This suggests that insulin 
may play an important role in the development of 
DACAD in nondiabetics. 
750·3 11:00 
COMMON FORMS OF FAMILIAL HYPOALPHALIPOPRO•
TEINEMIA IN PATIENTS WITH PREMATURE CORONARY 
ARTERY DISEASE 
Jacques Genest Jr, Jose Ordovas, Jean-Charles 
Fruchart, Jean-Marie Bard, Ernst Schaefer. 
Tufts University, Boston MA. 
Hypoalphalipoproteinemia (HA) is a common 
finding in patients with premature coronary artery 
disease (CAD). We characterized the common familial 
forms of HA in 102 families of probands with premature 
CAD; 40 probands (39.2%) had HA. Of these, 11 had 
familial hypertriglyceridemia with HA (FTgHA), 10 had 
familial combined hyperlipidemia (FCH) and 4 had familial 
HA (FHA) with no other lipoprotein abnormalities. In the 
remaining 15 families, no lipoprotein abnormalities were 
observed in first degree relatives. We measured 
apolipoproteins (Apo) AI, B, CIII and E as well as 
lipoprotein particles (Lp) LpAI (containing apo AI only), 
LpAI:AII (containing both apo AI and All), LpB:E and 
lpB:CIII. Apo B levels were significantly higher in all 
familial HA groups, when compared with controls; being 
highest in FCH individuals, but not significantly higher 
between FCH, FTgHA or FHA probands. Triglyceride 
levels were higher in FTgHA and FCH probands than in 
controls or FHA. Despite selection of FTgHA and FCH by 
lDl cholesterol, the latter was not significantly different 
between the three groups and the controls. Apo AI, 
lpAI and LpAI:AII were lower in FHA and FTgHA 
probands. lpB:E levels were higher in FCH and FTgHA, 
when compared with controls. There were no significant 
differences between groups for apo E, apo CIII and 
lpB:CIII. Our data suggest that common forms of familial 
HA represent a spectrum of overlapping disorders, 
characterized by an increase in apo B containing 
particles. 
JACC Vol. 19, No.3 
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750·4 11:15 
Lp(a) and coronary atherosclerosis in familial 
hyper cholesterolaemia 
Vincent Maher', Yuri Kitano, Claire Neuwirth, 
Anne Kehely", Gilbert Thompson. 
MRC Lipoprotein Team, Hammersmith Hospital, and 
"Department of Cardiology, "Department of 
Chemical Pathology, Royal Postgraduate Medical 
School, London, UK. 
The influence of lipoprotein(a) (Lp(a» on the 
extent and distribution of coronary athero•
sclerosis in familial hypercholesterolaemic 
(FH) patients was investigated. The coronary 
angiograms of 40 FH patients, 25 with high (H) 
Lp(a) levels, median (range) 56 (30-160) mg/dl 
and 15 with low (L) Lp(a) levels 3 (0-28) mg/dl 
were examined for the extent (no. of vessels 
involved), distribution of coronary athero•
sclerosis (proximal or distal) and the presence 
of complete coronary occlusions. There was no 
significant difference between the groups for 
age (H, 51 ± 10 yrs; L, 53 ± 8 yrs), sex (H, 
40% 9, 60% d; L, 40% ~ 60% d), smokers (H, 38% 
L, 38%) or baseline serum total cholesterol 
levels (H, 11.2 ± 2.9; L, 10.2 ± 1.7 mmol/l). 
The mean number of vessels involved H, (2.6 ± 
0.5), L, (2.4 ± 0.8), distribution of athero•
sclerosis (H, 100% prox. 66% dist.; L, 100% 
prox., 69% dist.) and the % of patients with 
complete coronary occlusions H (29%), L (31%) 
were not significantly different between the 
groups. These findings suggest that high Lp (a) 
levels do not appear to influence overtly the 
extent and distribution of coronary athero•
sclerosis or the occurrence of complete 
coronary occlusions in FH patients. 
750·5 
Job Stress and Coronary Disease 
Mark A. Hlatky, Lai Choi Lam, Kerry L. Lee, Nancy E. 
Clapp-Channing, Redford B. Williams, Daniel B. Mark. 
11:30 
Duke University Medical Center, Durham, North Carolina and 
Stanford University School of Medicine, Stanford, California. 
Job stress is widely believed to cause coronary artery 
disease, but there is little epidemiologic evidence on this 
question. To study this issue, we enrolled 1,489 patients 
referred for cardiac angiography at Duke Medical Center from 
3/86 through 8/89. All patients had clinical and employment 
data collected prospectively. Job stress was measured by the 
method of Karasek, which defines job stress as high 
psychological demands in conjunction with low decision 
latitude (a combination of decision authority and skill 
discretion). 
Age (mean) 
Male (%) 
Typical Angina (%) 
White-Collar (%) 
Heavy Physical Demands (%) 
Job Stress Present (%) 
Psychologic Demands (12-48) 
Decision Lattitude (12-48) 
Decision Authority (4·16) 
Skill Discretion (4-16) 
"My job is stressful" (%) 
Normal 
(n=567) 
48.9 
59 
36 
60 
16 
55 
32.4 
22.5 
11.3 
11.2 
85 
CAD 
(n=922) 
53.1 
86 
69 
48 
17 
43 
30.7 
23 
11.8 
11.1 
82 
Patients with CAD were older and more often male and 
typical angina. Psychologic demands were higher in patients 
without CAD, and job stress was negativelv correlated with 
CAD. After adjustment for differences in risk factors, job 
stress was not predictive Jf CAD (chi-square = 1.6, p = 0.21). 
ABSTRACTS ISlA 
750·6 11:45 
Pectin Administration Decreases Platelet Aggregation in 
Cholesterol-Fed Pigs Without Affecting Cholesterol Levels 
Michael A. Benjamin, Arlene E. Von der Porten, James J. Cerda and 
Jawahar L. Mehta, University of Florida and VA Medical Center, 
Gainesville, FL 
Hypercholesterolemia is associated with increased platelet 
aggregation, and platelet hyperactivity has been implicated in the 
genesis of atherosclerosis. Pectin has been shown to lower plasma 
cholesterol concentrations and to reduce atherosclerosis in 
hypercholesterolemic animals. This study was designed to examine 
the effects of pectin administration on platelet aggregatory activity in 
nine miniature pigs fed a high cholesterol diet (1 % cholesterol and 
15% hog lard) for two years. These pigs were then administered 3% 
pectin for three weeks, while high cholesterol diet was continued. 
Platelet aggregation in response to collagen was determined in control 
pigs and in cholesterol-fed pigs before and during pectin feeding. In 
cholesterol fed pigs (before pectin), platelet aggregation was greater 
than in the control pigs (maximum platelet aggregation 58±7 vs 
45±10%, time to onset of platelet aggregation 3±1 vs 4±1 minutes, 
both P<0.05). With pectin administration, maximum platelet 
aggregation decreased to 35±14%, 18±7 and 5±1% at one, two and 
three weeks, respectively (P<0.02). Time to onset of platelet 
aggregation progressively increased to 4±I, 6±1 and 10±1 minutes at 
one, two and three weeks of pectin administration. Measurement of 
plasma cholesterol showed high levels in cholesterol-fed animals 
(302±38 vs 58±4 mg/dl in control pigs, P<O.OI). However, pectin 
administration had no effect on plasma cholesterol concentrations over 
three week period (412±56, 380±60 and 409±98 mg/dl at one, two 
and three weeks of pectin feeding, respectively, poNS). These data 
indicate that pectin administration rapidly decreases platelet 
aggregability, despite continued high cholesterol diet and before any 
change in plasma cholesterol levels is apparent. Reduction in platelet 
activity may contribute to the anti-atherogenic effects of pectin. 
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751·1 10:30 
Impaired Macro- and Microvascular Growth in 
Hypercholesterolemic Rabbit 
Moises Bucay, Judy H. Nguy, Roberto Barrios, Scott A. 
Kerns, Philip D. Henry. 
Baylor College of MediCine, Houston, Texas 
To determine whether adaptive vascular growth is 
preserved in the presence of hypercholesterolemia. 
growth of ear vessels were stimulated in rabbits with 
(HC; n-9) or without dietary hypercholesterolemia (NC; 
n~10) by a subtotal ear transsection that made perfusion 
of the distal ear dependent upon a single marginal 
artery (MA). Serial in vivo videomicroscopy of the ear 
vasculature showed a progressive increase in the MA 
diameter and the formation of new microvessels (50-250pm 
O.O.) in the distal ear. No vascular changes were 
visualized in the uncut contralat&3,al ear. After 10 
days, the rabbits were pulsed with H-thymidine and the 
ears were perfusion fixed for quantitative microanatomic 
analysis. Vascular measurements for the experimental 
ear were expressed as a percent of corresponding 
measurements for the uncut control ear. Increases in 
the outer and inner diameters of MA were only 45 ± 8% 
(S.D.) and 38 ± 18% for He compared to Ne (p<O.OOl). 
Increases in the number of total and thymidine-labelled 
endothelial nuclei were proportional to increases in the 
MA inner diameter in both He and NC. In standardized 
fields of view, increases in the number of distal 
microvessels (8-20pm diameter; visualized with factor 
VIII. non-muscle actin, and lectin stains) were reduced 
by 84 i 8% in He compared to Ne (p<O.OOI). These 
results demonstrate for the first time that 
macrovascular (marginal artery) and microvascular growth 
(distal ear) are markedly suppressed in the presence of 
hypercholesterolemia, a phenomenon that could play an 
important role in the adaptation to occlusive arterial 
disease. 
152A ABSTRACTS 
751-2 10:45 
Endothelial Modulation of Porcine Coronary 
Microvessels Perfused by Immature Collaterals 
Frank W. Sellke, Yutaka Kagaya, Robert G. Johnson, Taj 
Shafique, Ronald M. Weintraub. Beth Israel Hospital and 
Harvard Medical School, Boston, MA 02215. 
Previous studies have shown that chronic perfusion via mature 
collaterals (CL) reduces receptor-mediated endothelium-dependent 
relaxation in the recipient vasculature of canine hearts. Since 
porcine hearts have few native CL, a condition more similar to 
human hearts, immature CL were stimulated in pigs by the 
ameroid technique. After 4 to 7 weeks, segmental shortening 
was determined in the norma1 (LAD) and the CL dependent (Cx) 
regions using sonomicrometer crystals. Microvessels (90-170 
1JI1I) were studied in a pressurized n~flow state with a 
microvessel imaging apparatus. Microvessels were preconsoicted 
by 30-65% of the baseline diameter with acetylcholine. Although 
myocardium in the CL dependent region showed minimal or no 
anatomical evidence of ischemia, segmental shortening was 
reduced at rest and after pacing compared to the non-CL 
dependent region. Responses of rnicrovessels are summarized: 
(x±SEM, *=p<o.05, % R=% Max. relaxation). 
ADP A23187 Nitroprusside 
log ED50 %R log EDSO %R logED50 %R 
Ameroid(n=6) -6.3±.2* 73±9* -6.6±.2 84±6 -6.2±'2* 1Ol±3· 
Control (n=6) -6.9:1:.2 101±1 -6.3±.2 89±4 -5.5±.2 93±5 
We conclude: perfusion through immature collaterals in the 
porcine heart selectively impairs receptor-mediated endothelium•
dependent relaxation, and increases endothelium-independent 
relaxation to nitroprusside in the porcine coronary 
microcirculation. These fmdings have important implications 
regarding neurohumoral regulation of perfusion to the collateral 
dependent myocardium. 
751-3 11:00 
Differential Effecls of Inlracoronary Adenosine and 
Nitroglycerin on the Conductance and Resistance Coronary 
Arteries of Man 
Steven V. Manoukian. J. larry Klein. David G. Harrison. R. Wayne 
Alexander, Cha~es B. Treasure. 
Emory University School of Medicine, Atlanta. Georgia 
AdenoSine (ADO) and nitroglycerin (NTG) are potent vasodilators that act by 
directly relaxing vascular smooth muscle. In experimental studies, ADO 
maximally dilates both conductance and resistance vessels whereas NTG 
has predomlnanlly conductance vessel effects. In the intact human 
coronary circulation, the comparative dilator effects of these agents are 
unknown. We hypothesize that ADO and NTG have similar conductance 
vessel effects but different reSistance vessel effects in human coronary 
arteries. To examine this. we studied the vasodilator response to 
intracoronary ADO and NTG in 24 patients undergoing routine cardiac 
catheterization. All patients had normal left ventricular function and minimal 
atherosclerotic changes on coronary angiography. Maximally dilating doses 
of ADO (2.2 rng/min) and NTG (16 meg/min) were sequentially infused 
through an intracoronary Doppler catheter placed in the proximal left anterior 
descending coronary artery. Conductance vessel responses were 
assessed using quantHative angiography (% diameter change). Resistance 
vessel responses were assessed by measuring changes in coronary blood 
flow (CBF)(flow velocHy corrected for epicardial cross sectional area). ADO 
and NTG produced similar conductance vessel dilation (ADO, 20±2%; NTG, 
14±2%. p=NS). However. reSistance vessel responses to ADO and NTG 
were markedly different. CBF increased 380±49% in response to ADO. In 
contrast, the CBF response to NTG was 27±19% (paO.OOO1). The NTG 
response in the resistance vessels was only 7% of the maximal (ADO) 
response. We conclude that NTG has negligible effects on coronary 
reSistance vessels while potently dilating conductance vessels in the 
human. A beller understanding of the differential effects of nHroglycerin on 
the coronary circulation will have important cliniCal implications. 
lACC Vol. 19, No.3 
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Alte~ed legional Co~onary Blood Flov in 
Bype~choleste~oleaic Swine 
11:15 
B~uce A. Be~gelson, Tse-Xuan Yu, Thomas J. Ryan, 
Nicholas A. Ruocco, Jr, Boston University Medical 
Center, Boston, KA 
Prior studies have documented altered epicardial vessel 
vasoreactivity in hypercholesterolemic (HC) swine (sw). 
To evaluate whether this defect extends to the 
resistance vessels ve examined regional coronary blood 
flow (RCBF) and coronary vascular reserve during maximal 
pharmacologic vasodilation using papaverine (PAP) and 
during progressive physiologic stress using pacing (110, 
130 and 150 bpm) in 18 consecutive sv [9 normal (NL) and 
9 HC for 1-3 mos). RCBF (ml/min/g) was measured using 
radioactive microspheres in closed chest sw distal to an 
80% LAD stenosis and in the normal circumflex (circ) 
zone. Cholesterol levels vere elevated in HC sw (355+135 
vs 78z22 mg/dl,p<.OOl). Aortic pressure vas maintained 
constant with an intra-aortic balloon. Transmural CBF 
was similar in the 2 groups at control (C) and with 
progressive pacing. RCBF as assessed by the endocardial/ 
epicardial ratio (endo/epi) vas altered as follows: 
Endo/Epi C 110 130 150 
circ NL 1.35+.17* 1.35+.28* 1.20+.241 1.17+.09* 
HC 1.12+.11 1.03+.10 1.00+.14 .99+.13 
(mean Z SD, *p<.02, Ip=.07, NL vs HC) 
A similar trend was present in the LAD zone. Transmural 
and RCBF during PAP were similar in NL and HC sV 
indicating that maximal reserve capacity was the same in 
both groups. These data demonstrate similar physiologic 
recruitment of coronary vascular reserve during stress; 
however, hypercholesterolemia impairs functional 
regional distribution of coronary blood flow eliminating 
normal endocardial dominance. 
751-5 
Aortic Explants From Hypercholesterolemic 
Exhibit Suppressed Microvascular Growth in an 
Model of Angiogenesis 
Chu-Huang Chen, Zheng li, Scott A. Kerns, 
Cartwright, Philip D. Henry. 
Baylor College of Medicine, Houston, Texas 
11:30 
Rabbits 
In Vitro 
Joiner 
Recently, we have demonstrated that various angiogenic 
stimuli are ineffective in evoking macrovascular and 
microvascular growth responses in hypercholesterolemic 
rabbits. To determine whether this 1 imited arterial 
growth refl ects a reduced endothe 1 ia~ growth potent i a 1 , 
explants of aortic media-intima (lmm ) from normo- (Ne; 
n-ll) and hypercholesterolemic rabbits (He; n-ll) were 
grown in a collagen matrix under minimal growth 
conditions (RPMI without serum or growth factors). In 
this three-dimensional culture system, outgrowing 
endothelial cells formed organized capillary-like 
structures (tubes with true 1 umens). Seria 1 computer•
assisted image analysis was used to quantify the length 
and number of outgrowing capillaries. Progressive 
elongation of the capillaries reached a maximum on day 7 
both in Ne and He exp1ants. Maximal growth measured as 
the sum of the lengths of all capillaries in 7 day old 
cultures was 1776 ± 92 pm/explant in Ne (± SE; n-47), 
whereas in He the corresponding value was only 248 ± 24 
pm/explant (n=50) (p<0.005). Thus, endothelial cells 
directly derived from phenotypes expressed in vivo 
exhibited in a culture system not supplemented with 
serum components (growth factors, oxidizable 
1 ipoproteins) markedly decreased growth. Results 
demonstrate for the first time that impaired 
microvascular (endothelial) growth in 
hypercholesterolemia occurs independently of flow•
mediated effects. 
lACC Vol. 19, No.3 
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751·6 11:45 
Endothelium· Dependent Vasodilator Responses are Not Impaired in 
Syndrome X 
Diana Hoidright, Debbie Ciarke, David Lindsay, Philip Poole· 
Wilson, Kim Fox, Peter Collins. 
National Heart and Lung Institute and Royal Brompton National 
Heart and Lung Hospital, London, UK. 
Certain features in patients with Syndrome X (SX, chest pain, posi•
tive exercise test and angiographically normal coronary arteries) are 
suggestive of transient myocardial ischaemia. A functional abnor•
mality at the level of the resistance vessels, possibly due to impaired 
endothelium-dependent vasodilation, may explain the syndrome. 
Using a 3F intracoronary Doppler flow probe to measure epicardial 
coronary blood velocity and quantitative angiography to determine 
coronary artery diameter, the endothelium-dependent responses to 
acetylcholine (ACh) and substance P (SP) were assessed in 8 patients 
with SX and 7 control patients (C). The control group comprised 
patients with normal resting and exercise electrocardiograms and an•
giographically normal epicardial coronary arteries. No patient had 
features suggestive of hypertension or diabetes mellitus. Intracoro•
nary infusi09s (2 min) of 6 )ACh to achieve intracoronary concentra•
tions of 10- M and 10- M and 2) SP at 5, 10 and 25pmol/minute 
were given and the change in coronary artery blood flow from 
baseline calculated. Flow ratios are expressed below as mean±SEM. 
ACh 10-~M 
ACh 10- M 
SP 5pmol/min 
SP 10pmol/min 
SP 25pmol/min 
SA c: ~ 
1.521O.24(na 8) 2.141O.47(n=7) NS 
2.701O.4I(n=8) 2.981O.46(n=7) NS 
1.581O.25(n=7) 1.461O.15(n=5) NS 
1.841O.27(n-4) 1.841O.26(n=5) NS 
1.851O.22(n~4) 2.121O.34(n=5) NS 
This demonstrates that endothelium-dependent vasodilator responses 
are not impaired in SX. If a functional abnormality exists then other 
mechanisms must be considered. 
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Early Predictors of Hospital Mortality in Acute Myocardial 
Infarction 
Peter J. Kudenchuk, Paul E. Litwin, Timothy A. Dewhurst, 
Mary T. Ho, Jenny S. Martin, W. Douglas Weaver for the MIT I 
Investigators, University of Washington, Seattle, WA. 
Early clinical and EGG predictors oi hospital mortality 
in acute myocardial infarction .(AMI) were studied in ~~66 
consecutive patients (Pts) With AMI who were Initially 
evaluated during a trial of prehospital thrombolysis. Overall 
467 Pts (10.2%) died. Mortality was greater in women (14% 
vs 9%, p=.004), and in Pts With previous MI (14% vs 9%, 
p=.01) or heart failure (19% vs 10%, p=.0001), but lower in 
Pts with a history of hyperlipidemia (5% vs 12%, p=.003). 
Pts dying were also older than survivors (75 ± 10 vs 65 
+ 13 years p<.OOOl), had a lower initial systolic blood 
pressure (SSP) (130 ± 36 vs 147 ± 34 mm Hg, p<.OOOl), 
faster heart rate (90 ± 26 vs 82 ± 23 bpm, p=.03), and 
presented later after onset of AMI symptoms (3.7 ± 13.4 vs 
1.8 ± 3.6 hrs, p=.OOOl). ST seg~eryt elevation in >3 leads .of 
the first hospital EGG was predictive of a higher mortahty 
than when seen in <3 leads (12% vs 5%, p=.002). Initial ST 
segment depression or Q waves did not predict mortality. 
By multivariate logisti~ regression .analysis of all these 
factors, a higher AMI mortality was predicted by: age (odds 
ratio (OR) 2.3 per 10 year increase), SBP (OR 1.2 per 10mm 
increase). delay in presentation (OR 1.1 per 1 hr delay) and 
ST elevation in >3 vs <3 leads (OR 2.1). 
High risk AMI-Pts can be identified ~arly. by ~asily 
obtained clinical and EGG parameters. Early Identification of 
such Pts can faCilitate more rapid and appropriate 
interventions on their behalf. 
ABSTRACTS 
752·2 2:15 
Prognostic Value or New CHnicaI Variables In the Thrombolytic Era 
Juan Pollola, Carlos Tajer, Alfredo Hirschson, Martin Bond, Claudia Paviotti, 
Eduardo Szwarcer, Ernesto Paolasso, Rafael Diaz. 
ECLA Collaborative Group, Buenos Aires, Argentina. 
The aim of this study was to prospectively assess the prognostic value of 
several risk variables evaluated before or immediately after thrombolytic 
therapy. The study population involved 1116 consecutive patients admitted 
with Acute Myocardial Infarction (AMI) within six bours from the onset of 
symptoms, all of them treated witb thrombolytic agents (tP A or SK), in a wide 
and heterogeneous net of hospitals widespread in Argentina (the EMERAS / 
ECLAnet), that actually represents the real epidemiological profile of AMI in 
our country. The selected variables were analized before treatment - age, 
previous hypertension (PH), previous diabetes (PD), previous myocardial 
infarction (pMI), previous angina (p A), Killip class (KK), systolic arterial 
tension (SA 1), heart rate (HR) - or 2 hours after admission· clinical markers 
of positive reperfusion (CMPR), a non invasive measure ofreperfusion -. The 
risk for in hospital mortality was established for each variable expressed in the 
odds of death with 95% of confidence interval (CI). 
Variable Death/n ODDS(95%CI) p 
Age <60/>=60 39/541 - 102/575 0.38(0.27.0.54) <0.001 
PH no/yes 62/519·711516 1.16(0.80-1.67) NS 
PD no/yes 95/894 - 40/164 0.29(0.17-0.48) <0.001 
PMI no/yes 109/923 - 32/193 0.65(0.40-1.03) NS 
PA no/yes 55/466·86/650 0.88(0.61-1.25) NS 
KK AlBCD 69/923 - 72/193 0.06(0.04-0.10) <0.0001 
SAT >=100/<100 105/1000 - 36/116 0.15(0.08-0.27) <0.01 
HR <100/>=100 106,1906 - 35/210 0.63(0.40-1.00) <0.05 
CMPR ( +) / (-) 38/544 - 64/407 0.40(0.26-0.60) <0.001 
We can conclude that easily-assessed non invasive markers of positive 
reperfusion evaluated immediately after thrombolytic treatment, must be 
taken into account, adding tbem to those well-known risk factors on admis•
sion. 
752·3 2:30 
Prolnoltic SilnificlUlce of Left Ventricnlar Thrombi After Acnte 
Anterior Myocardial Infarction. Prospective Mnlticenter Study 
Esteban LOpez de sa, Jose LOpez-Send6n, Carlos Perdigio, lnmal:uJada RoId8n, 
Jenaro Froufe, Eva Larandaugoitla, Fernando Pais, Rafael Pay .. Carlos Pare, 
Amilcar Araujo, Higinio Martin, Carlos Ribeiro, Alfonso Medina, Luis Martin•
Jadraque. La Paz Hospital, Madrid, Spain 
The prognostic significance of left intraventricular thrombi (L VT) after acute 
myocardial infarction (AMI) remains unclear. L VT bave been considered as a 
complication after AMI because of higher rates of systemic embolism, but other 
authors bave found lower mortality rates in this group of patients (pts). 
Accordingly we analyzed the short and one-year mortality in pts with and without 
L VT after AMI. A total of 1568 consecutive pts with AMI were prospectively 
lllUdied in 6 hospitals. Full anticoagulation was performed only in patients who 
received fibrinolytic treabnent CJinical8lld 2D-Ecbocardiograpbic parameters were 
analyzed during 0-2 days (d), 3-4 d, 7 d, before and at 1st, 3n!, 6th, 12th month 
(m) after discharge from hospital. Three bundred and eighty eight pts were 
excluded because poor quality 2D-Ecbo and/or previous myocardial infarction. 
Results: 48911079 (45.3%) presented Q-wave anterior AMI. During hospitaliza•
tion 198/489 (40.5%) pts presented LVT. LVT were diagnosed at3.1±2.0 d of 
evolution. In pts with anterior AMI, no differences between pts with and without 
LVT were observed in age (59±12vs 60±13) or fibrinolytic treatment (21.7% vs 
25.4%), but pts with LVT presented more left ventricular aneurysms (67.2% vs 
37.9%; p<O.OOOI) and left ventricular heart failure (38.8% vs 28.3%; p<0.02). 
Mortality 
7d 14d 1m 3m 6m 12m 
LVT 3.5 6.1 9.9 14.9 16.4 20.4 
NoLVT 11.7 14.2 17.9 19.2 21.5 21.5 
ID< 0.002 0.004 002 NS NS NS 
Early mortality was higher in pts without LVT while DO statistical differences 
were observed after 3 m of evolution. Death occurred 84.5±115.9 d after AMI in 
pts with LVT and 27.8±51.6 d after AMI in pis without LVT (p<0.01). 
Conclusions: After anterior AMI in spite of higher prevalence of left ventricular 
heart failure and left ventricular aneurysms, sbort-term mortality is lower in 
presence ofLVT. One-year mortality is similar inpts with and without LVT. 
153A 
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Reduction In ST-Elevatlon at 3 Hours Predicts Outcome In Acute 
Myocardial Infarction Independent of Thrombolytic Therapy 
Ro~ Schroder, Thomas BrOggemann, Rudiger DiBmann, Thomas 
Linderer, Ulrich Tebbe, Karl-Ludwig Neuhaus, ISAM Study Group. 
Klinlkum Steglitz, Free University Berlin, Germany 
In evolving myocardial Infarction (MI) a simple indicator for early 
Identification of patients with either good or unfavorable prognosis is 
required. We tested the predictive value of resolution of I ST elevation 
In 1516 patients of the ISAM study: 715 streptokinase (SK), 765 
Placebo (Pia); 721 anlerior MI (ANT), 795 inferior MI (INF). The best 
predictive magnitude of resolution of I ST was a decrease of at least 
65% for ANT and 50% for INF 3 h after randomization. 
A ~ group with ST resolution (61% of SK, 45% of Pia; 33% of ANT, 
72% of INF). B ~ group without ST resolution. I ST elevation at 
baseline was not different in INF (A ~ 7.7 ± 5 mm, B ~ 7.7 ± 5 mm) 
and slightly higher in A In ANT (A = 15.4 ± II, B = 14.9 ± 9; 
p ~ 0.001). 
Deaths % 
A B 
MBCK 
A B 
no. Q 
A B A 
EF% 
B 
Total 11 20 1.5 2.0 1.8 2.9 60 50 
ANT 12 21 1.5 2.1 1.7 3.2 62 49 
INF 10 16* 1.4 1.9 1.8 2.3 59 53 
SK 10 21 1.5 1.9 1.8 2.8 60 53 
Pia 11 19** 1.5 2.1 1.8 3.0 59 49 
p-values: all differences < 0.0001 
except * ~ 0.02, ** = 0.003. 
Mortality at an average follow-up of 31 months. Enzyme Infarct size ~ 
MBCK area IUlml x h; no. Q ~ Number of Q waves at 4 weeks, EF = 
ejection fraction at angiography at 4 weeks. 
Conclusion: In patients admitted within 6 h of onset of AMI resolution 
of I ST elevation 3 h later of at least 65% in patients with anterior MI 
and at least 50% In patients with Inferior MI strongly predicts short 
and long-term outcome irrespective of thrombolytic therapy. 
752·5 3:00 
What Is the Outcome or Acute MI Patients Who Are Free of Chest 
Pain at Onset of Lytic: Therapy? 
David A. Cox, William J. Rogers, Larry Maske, Sandra Forman, 
Rachel Solomon for the TIMI Investigators 
University of Alabama Medical Center, Birmingham, Alabama 
To compare patients presenting with acute MI who resolve their 
chest pain with standard medical therapy before lytic therapy to those 
who did not resolve chest pain, we divided the TIMJ.II population into 
two groups: 1) PAIN·FREE (free of chest pain at onset of t-PA 
infusion, N-337) and 2) PAIN (chest pain present at onset of t-PA, 
N=3000). In the PAIN-FREE group, 77% ofpts were free of pain for 
15 or more minutes before t·PA was given. Pts free of chest pain were 
0Ider(58.1 vs 56.6 yrs,p=.Ol), more often female(22.8 vs 17.3%,p=.01), 
presented to study later (2.9 vs 2.6 hours,p<.OOl), and had a lower 
average number of ECG leads with ST elevation (3.8 vs 4.1,p<.001). 
PAIN-FREE pts had less arrhythmias within the lst 24 hrs of 
treatment (57 vs 75%,p<.001) and had fewer confirmed MI's(88 vs 
96%,p < .001). No differences were noted with regard to history of 
previous MI or CHF, presence of significant rales, "not low risk" at 
presentation, randomization to B-blockers, loca1ization of ST elevation 
to anterior or inferior leads, or Q waves on initial ECG. 
In-hospital hemorrhagic complications and stroke rates were similar 
in the two groups. PAIN-FREE pts showed a trend towards greater 
in-hospital reinfarction(8.3 vs 5.2%,p=.02), but had less CHF(12 vs 
19%,p ... 002) and a larger percentage had EF>55 (42 vs 29%,p<.001) 
at discharge. At 6 weeks, more PAIN-FREE pts had EF>55 (35.3 vs 
27.3%,p=.OOI) and less CHF(12.3 vs 19.8%). PAIN-FREE pts had 
less CHF at 1 yr(14.8 vs 20.7%,p=.009). No differences existed with 
regard to death, reinfarction, !'TCA, CABG, or anginal class at 1 yr. 
Thus, 1) Lytic therapy given to patients free of chest pain at the 
onset of lytic therapy was safe and without excessive complications. 2) 
The majority of patients who were free of chest pain at onset of lytic 
therapy did evolve enzymatic or ECG evidence of MI but had better 
LV function at discharge and 6 wks and less CHF at 1 yr follow-up 
than their counterparts with pain at onset of lytic therapy. 
lACC Vol. 19, No.3 
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Causes of Death After Thrombolytic Therapy In Acute 
Myocardial Infarction 
Inmaculada Roldan, Jose L6pez-Send6n, Carlos Perdlgio, Esteban 
L6pez de Sa. Hlglnlo Martin. Eva Larandaugoltla, Carlos Pare. Rafael 
Paya, Fernando Pais, Alfonso Medina. Jenaro Froufe. Carlos Ribeiro. 
luis Martln-Jadraque. La Paz Hospital. Madrid. Spain 
The In-hospital cause of death after acute myocardial Infarction was 
analyzed In 2921 consecutive patients admitted to the Coronary Care 
Unit of 6 hospitals during the last six years. Thrombolytic agents (TRL), 
(Alteplase, Anlstreplase. Streptokinase, Urokinase) were given to 662 
patients. A total of 384 deaths were registered and autopsy was 
performed In 131 (34.1%) ofthem. The In-hospital mortality In the group 
of patients wlthout TRL was 34412259 (15.2%) and In 40/662 (6.0%) 
patients who received TRL 
Results: 
Causes of death TRL n-4O no TRL n-344 
Shock 1 cardiac failure 18 (45%) 181 (52.6%) 
cardiac rupture 15 (37.5%) 123 (35.7%) 
Embolism 0 (0%) 9 (2.6%) 
Arrhythmias 4 (10%) 15 (4.6%) 
Electromechanical Dissociation 0 (0%) 4 (1.1%) 
Other causes 3 (7.5'10) 7 (2'10) 
Unknown 0 (0%) 5 (1.4'/,) 
No statistical differences were observed In the causes of death between 
both groups. When corrected for age, gender. old infarct and acute 
myocardial Infarction location. the causes of death also remained similar In 
both groups. 
Conclusions: 
Although several studies have demonstrated that TRL In acute 
myocardial Infarction reduce mortality. this benefit could not be related to 
the decrease of a particular cause of death. 
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Pulsed Doppler Transesophageal 
Echocardioqraphic Description of Left Atrial 
Appendage Blood Flow in Healthy Subjects 
Mikael Kortz, Jan M. van Dantzig, Hans Bot, 
Ben Delemarre, and Cees Visser. 
ACddemic Medical Center, Amsterdam, The 
Netherlands. 
To assess the characteristics of left atrial 
appendage (LAA) flow we performed biplane 
transesophageal echocardiography in 18 normals. 
In 16 ~ubjects with norma! heart rate (HR) LAA 
flow was quadriphasic: 
two diastolic forward 
flows (OFF! and OFF2 
resp.) and two back- LAA 
ward flows: one flow -----l~..,. .... I__ .... 
diastolic (OBF) 
following OFF! and one 
in systole (SBF) 
following OFF2_ 
HR (bpm) and peak 
velocities (cm/s): 
N HR OFFI OBF OFF2 
!6 7B±17 42±14 43±22 62±25 
2 1l~3~±:..:3~ __________ B:::;5,,-±=-1::.;5~_-!..:::.=-:=-
OFF! coincided with early rapid filling phase 
of transmitral (TM) flow. OFFI and OBF were 
absent in 2 subjects with elevated HR; only in 
these 2 diastolic TM flow was monophasic. 
OFF2 and SBF are the results of LAA contraction 
and relaxation resp. 
Thus, in normals LAA flow is quadriphasic with 
normal HR and bifasic during sinus tachycardia 
with concurrent monophasic diastolic TM flow. 
JACC Vol. 19, No.3 
March I, 1992:155A 
753·2 2:15 
Diastolic Doppler-echocardiographic Flow 
Measurements After Cardioversion For Chronic 
Atrial Fibrillation And Maintainance of Sinus 
Rhythm 
Dietrich Kalusche, Abdullah Behroz, Helmut 
Roskamm. Rehabilitationszentrum Bad Krozin•
gen, Germany 
Conventional echocardiographic parameters are 
of little value for the selection of pts for 
cardioversion (CV) who are in chronic atrial 
fibrillation (Afib), since long term outcome 
- maintainance of sinus rhythm (SR) - neither 
correlates with left ventricular parameters 
nor with left atrial size. Therefore we tested 
the hypothesis that dopplerechocardiographic 
measurements of atrial contribution to left 
and right ventricular filling shortly after 
CV would help to predict long term outcome. 
104 consecutive pts with chronic Afib (mean 
duration 218 daysl exclusion of mitral valve 
stenosis and replacement) were studied before 
CV by Echo and within 48 hrs after CV by Echo 
and Doppler. Flow measurements (peak flow ve•
locity [PFV]1 flow velocity integral [FVI]) 
were made during early (E-wave) and late (A•
wave) diastole. The measurements of late dia•
stolic flow across the tricuspid valve corre•
lated significantly with the maintainance of SR 
after 6 and 12 months: only 35% of pts with a 
PFV-A of E 26 mls were still in SR, contrasting 
to 74% of pts with a PFV-A of >26 mls (p < 
0.002). 
We conclude that measuring diastolic flow 
across the tricuspid valve after CV helps to 
predict long term success. It might be pos•
sible to select pts in whom long term antiar•
rhythmic therapy is not necessary, or pts in 
whom a second attempt of CV is not indicated. 
753·3 2:30 
Concurrent Transesophageal Echo and Electrical 
Cardioversion in Patients with Atrial Fibrillation: 
Effect of Cardioversion on Left Atrial Smoke 
Richard A. Grimm, Allan L. Klein, Gerald I. Cohen, James 
D. Maloney, Elena Sgarbossa, Gregory L. Pearce, William 
J. Stewart, Ernesto E. Salcedo. Cleveland Clinic 
Foundation, Cleveland, Ohio 
Electrical cardioversion (DCC) of atrial fibrillation 
(AF) is aasociated with a significant risk of stroke. 
Left atrial (LA) spontaneous echo contrast (SEC) by 
trans esophageal echo (TEE) is thought to be associated 
with an increased thromboembolic risk. To assess this 
association, we studied 33 pts with AF (n=24) and atrial 
flutter (n=9), with a mean duration of 10 months, by TEE 
performed prior to as well as immediately post DCC. We 
assessed for the presence of SEC (absent=O, mild=l+, 
severe=2+), LA thrombus and left atrial appendage (LAA) 
peak contraction velocity by pulsed-wave Doppler. 
~: Fourteen of 24 pts (58X) with AF exhibited SEC 
prior to DCC, while no pts with atrial flutter 
demonstrated SEC (p=0.004). An additional 3 pts with AF 
developed SEC post DCC. Three pts with SEC prior to DCC 
demonstrated an increase in the intensity of the SEC 
immediately post DCC (from 1+ pre to 2+ post). These 3 
pts all had a history of mitral valve repair or replace•
ment. One pt was found to have an LA thrombus and the 
cardioversion was postponed. There was a trend toward 
those pts without SEC post DCC, demonstrating a greater 
LAA peak contraction velocity (m=23 emfs) vs those pts 
with SEC (m=15 emfs), p .. O.07. No cerebro- vascular 
events were detected in the immediate post-DCC period. 
CONCLUSION: 1) Left atrial smoke can be generated or 
intensified by electrical cardioversion in pts with 
atrial fibrillation. This phenomenon may explain the 
underlying mechanism behind the increased thromboembolic 
risk seen in these patients. 
ABSTRACTS 
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Lupus Valve Disease: Characterization by Transesophageal 
Echocardiography 
Carlos A. Roldan, Bruce K. Shively, Frank T. Gurule, 
Erika A. Smith, Chi Chi Lau, Michael H. Crawford 
VAMC and Univ. of NM, Albuquerque, NM 
The true incidence of lupus (SLE) valve disease is 
unknown. Transesophageal echocardiography (TEE) may be 
superior to post-morte~ and transthoracic echo in 
defining the true incidence and characteristics of SLE 
valve disease. Thus, we studied 49 pts with SLE and 25 
normals by TEE. 
Results: In SLE pts valve regurgitation (regurg) was 
seen in 35 pts (71%), leaflet thickening <Th) in 21 pts 
(43%) and masses in 14 pts (29%), as compared with 4 
<tbY,) , I (4%) and none (or.) respectively in the control 
group (p<O.005 for all abnormalities). 
Regurgitant Lesions for Mitral (~), Aortic (AoV) and 
Tricuspid (TV) Valves: 
~ AoV IT Total V (r.) 
Mild 14 4 10 28(57) 
Moderate-Severe 9 2 7 18(37) 
Thickening: Thirteen MV and 15 AoV had leaflet Th. The 
Th was equally localized or diffuse. Localized Th 
involved either the leaflet's base, mid or tip portions 
of MV and AoV. Kasses: A total of 21 masses were seen 
(10 MV, 10 AoV and I TV). MV leaflets and AoV cusps 
were equally affected. Si.ty-si. Yo of MV masses were on 
the atrial side and 80Y. of AoV masses were on the aortic 
vessel side. Most (bOY.) were on the leaflet's base, 
were of variable size (0.2-0.85 cm~) and shape, had 
irregular borders, granular echodensity, were not 
calcified and did not have independent motion. 
Conclusions: By TEE, SLE valve disease: I) is frequent 
(82%) and predominates on the MV and AoV, 2) has 
characteristics that may be unique to the disease, 3) 
TEE may better define the true incidence of the disease. 
753·5 3:00 
Transesophageal Pulmonary Venous Flow Study for Diastolic 
Function Assesment in Cardiac Transplantation. 
Daniel San Roman. Miguel A. Garda·Fernandez, Esteban G. 
Torrecilla, Roberto Munoz, luan L.Delcan. 
Hospital General "Gregorio Maraii6n". Madrid. Spain 
It was suggested that Doppler study of pulmonary venous flow 
(PVF), in combination with mitral flow (MF), is useful to detect 
diastolic dysfunction. 
To analyse the utility of PVF study in patients (P) with cardiac 
transplantation (CT), we performed transesophageaJ echocardio•
graphy with pulsed Doppler of PVF and MF in 42 consecutive P 
(age: 57±12 years, 38 males), 7±7 months after cr, without acute 
cardiac rejection in biopsy (performed no more than 24 hours). In 
PVF, peak systolic velocity (S), peak diastolic velocity (D), DIS rate, 
diastolic deceleration time (DDl) and number of peak atrial reversal 
(PA) were measured. In MF it was measured early peak velocity (E), 
late peak velocity and deceleration time of E (EDT).There were II 
P (26%) with chaotic PVF for analysis. In IS P there were just one 
PA, 9P showed more than one PA and there were no PA in 7 P. D 
was related to E (50±22 vs 74±21 cm/s, r=O.S; p=O.OO4) and DDT 
was related to EDT (16O±S5 vs 146t34 DIS. r=O.4; p=O.02). In 21 P 
(50%) DIS rate was > I, but it was no influenced by time after CT 
(6.2tS.8 vs 7.4t10 months; p=O.3), long LA dimensions (61±11 vs 
66±J3 mm; p=O.12) or the presence of one or more PA (1.4±O.8 vs 
1.6±O.7; p=O.4). It occurred the same for D, S and DDT. The DIS 
rate showed a poor relation with DDT (r= • 0.35; p=O.4). Conclusion: 
1. P with CT without acute cardiac rejection show great variability 
in PVF 2. D is usually higher than S, and 3. A limited relation 
between PVF and MF prevents its clinical application. 
155A 
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Return of Left Atrial Appendage Function Post Electrical 
Cardioversion of Atrial Fibrillation by Transesophageal 
Doppler Echo 
Richard A. Grimm, Allan L. Klein, Gerald 1. Cohen, James D. 
Maloney, William 1. Stewart, Ernesto E. Salcedo. 
Cleveland Clinic Foundation, Cleveland, Ohio 
Left atrial appendage (LAA) function by transesophageal echo (TEE) 
is known to be impaired in atrial fibrillation (AF), however the effect 
of electrical cardioversion (DeC) on LAA function has not been 
examined. We studied 19 pts with pulsed Doppler TEE immediately 
pre and post DCC of AF in order to assess LAA function. Pre and 
post DeC, we measured LAA emptying and filling flow velocities 
(vel), mitral inflow vel, and p to LAA late diastolic emptying (LAA 
"a" wave) intervals as well as p to mitral-A wave intervals (post only). 
Results: Pre cardioversion 95% (18/19) of pts demonstrated a 
fibrillatory pattern (mean LAA emptying vel = 26 crn/s). Out of 17 pts 
successfully cardiovened 13 (77%) exhibited an emptying late 
diastolic (LAA "a" wave,mean vel=l6crn/s) and filling late diastolic 
flow pattern, within 60 ms of the p wave, typical of sinus rhythm. 
However II of these 13 pts demonstrated an additional emptying early 
diastolic flow (LAA "e" wave, mean vel=15 crn/s) coincident with the 
mitral E-wave (sinus-like pattern). 
Sinus· like Pattern Sinus Pattern 
I!G -,Jr~A- I!ll -rJv-~rfl-
w.AA!~ WI A 
.., V V Ii V "'" V V 
The remaining 4 pts (23%) exhibited no flow or persistence of a 
fibrillatory pattern despite p waves on ECG. Two of these 4 pts had 
no evidence of atrial mechanical transpon by mitral inflow pulsed 
Doppler evaluation suggesting electrical mechanical dissociation .. 
CONCLUSION: Left atrial appendage mechanical function usually 
returns immediately post cardioversion of atrial fibrillation and is often 
characterized by a sinus or sinus-like pattern. Funher studies will be 
needed to assess the correlation between earl y return of appendage 
function and maintenance of sinus rhythm. 
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Dobutamlne with Quantitative Thalllum·201 Single Photon 
Tomography: An Alternative Stress Method for Detecting 
the Presence and Extent of Coronary Artery Disease In 
Patients Unable to exercise 
John J. Mahmarian, John T. Hays, Rita F. Ashmore, Angela J. 
Cochran, Mario S. Verani. 
Baylor College of Medicine, Houston, Texas 
We prospectively evaluated whether a dobutamine (DOB) infu•
sion combined with thallium-201 single photon emission 
computed tomography (SPECT) could detect underlying coro•
nary artery disease (CAD) in 84 patients (pts) (40 men, 44 
women, mean age 67±8 yrs) who were unable to perform an 
exercise test and had concomitant coronary angiography. 
Thirty pts had significant (>50% stenosis) single vessel, 19 had 
double vessel and 11 had triple vessel CAD. Fifteen pts had no 
CAD whereas 9 had insignificant (26-50%) stenosis. DOB was 
infused at 5, 10, 20, 30 and 40 ltg/kg/min for 3 minutes/dose. 
Thal/ium-201 was injected after 1 minute at the maximally 
tolerated DOB dose and the infusion continued for an additional 
2 minutes. SPECT images were acquired, reconstructed and 
reoriented in a standard fashion, and using quantitative SPECT 
each pt was compared to a DOB normal data bank consisting of 
low risk pts for CAD. The absolute perfusion defect size as well 
as the percent scar and ischemia comprising the defect were 
computer-quantified with recently developed software. All pts 
tolerated DOB infusion well without complications. The sensitiv•
ity and specificity for detecting pts with CAD by quantitative 
SPECT were 81% and 71%, respectively. Most pts with single 
vessel (80%) and multivessel (83%) CAD were also detected 
with quantitative SPECT. The sensitivity and specificity for 
detecting individual stenoses were 67% and 83%, respectively. 
Quantitative SPECT analysis showed a mean perfusion defect 
size of 17±17%, with most pts (66%) demonstrating ischemia. 
In conclusion, these data show that quantitative DOB SPECT is 
a promising new method for detecting the presence and extent 
of CAD in pts unable to perform exercise. 
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Preoperative and Long-term Cardiac Risk Assessment: Predictive 
Value of 23 Clinical Descriptors, 8 Multivariate Scoring Systems 
and Quantitative Dipyridamole Imaging in 360 Patients 
Jean Lette* .1>, David Waters .1>, Michel Picard. ** Departments of 
Medicine, Nuclear Medicine and Surgery, Maisonneuve Hospital*, 
Montreal Heart Institute.l> and Saint Luc Hospital**, Montreal, Canada 
A total of 360 pts underwent preoperative cardiac risk: assessment using 
23 individual clinical parameters, 8 multivariate clinical scoring systems 
and quantitative dipyridamole-thallium imaging to predict postoperative 
and long-term myocardial infarction and cardiac death after noncardiac 
surgery. There were 30 postoperative and 10 additional long-term 
cardiac events after an average follow-up of 15 months. Clinical 
descriptors and multivariate scoring systems were not useful in 
predicting the outcome of individual pts. The postoperative and long•
term cardiac event rates were I % and 3.5 % in pts without thallium 
redistribution, and 17.5 % and 22 % in pts with reversible defects. 
Using quantitative indices reflecting the amount of jeopardized 
myocardium (JM) pts could be stratified by dipyridamole imaging into 
multiple scintigraphic subsets with corresponding postoperative and 
I-year coronary morbidity and mOnality rates ranging from 0.5 % to 
100% (p=O.OOOI). 
754·3 
Thus, postoperative and long•
term cardiac events cannot be 
predicted with clinical 
descriptors whereas quantitative 
dipyridamole imaging accurately 
stratifies risk, allowing a more 
precise selection of pts for 
preoperative coronary 
angiography. 
2:30 
Enhancement of Goldman Preoperative Risk Assessment With 
the use of Intravenous Dipyridamole Thallium Scintigraphy In 
Patients Referred For Major Nonvascular Surgery 
liwa T. Younis, Bonpei Takase, Sheila l. Byers, Michael Presti, Robert M. 
Heaney, D. Douglas Miller, Bernard R. Cha~man. St. louis University 
Medical Center, St. louis, MO. 
The demonstrated prognostic value of intravenous dipyridamole thallium 
(DIP-Tl) imaging for preoperative assessment of vascular surgery pts has 
not been co~ared to the Goldman clinical classnication in pts undergoing 
major nonvascular surgery. A conserutive series of 100 major nonvascular 
surgery pts with suspected or proven coronary artery disease (CAD) were 
studied to determine signnicant predictors of perioperative cardiac events 
from 32 clinical, ECG, and scintigraphic variables. Twenty-seven cardiac 
events occurred in 19 pts: 7 deaths, 4 myocardial Infarctions, 4 unstable 
angina and 12 pulmonary edema. The cardiac event rates in Goldman 
classes I, II and ~ III were 13%, 30% and 40%, respectively. SignniCant 
univariate predictors of cardiac events were an abnormal DIP-Tl (p<0.001), 
reversible thallium defect (p<0.001), n~rate usage (pcO.006), history of MI 
(p~0.016) and Goldman Class (pcO.06). MuHivariate analysis identHied the 
follOwing sign.leant variables: 
Reversible TI Defect 
Goldman Class 
N~rate Usage 
OIdMI 
~ 
13.2 
7.3 
4.6 
3.7 
--lL.-
<0.001 
0.008 
0.035 
0.057 
Abnormal DIP-Tl predicted 15/19 (79"10) of pis w~h events while Goldman 
class II-IV predicted onty 9/19 (47%). Normal DIP-Tl in combination wHh low 
Goldman class was predictive of an excellent perioperative outcome; 2 non•
fatal events in 54 pts (4%; p<0.001). 
In conclusion, intravenous DIP-Tl Imaging has significantly greater 
prognostic value as compared to Goldman ctassnicalion In major nonvascular 
surgery pts w~h suspected CAD. Clinical crUeria alone underestimate 
perioperative risk in this population. The COmbination of low Goldman class 
and normal DIP-Tl identnies a very low risk pi subset. 
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Use of Echocardiography and TcMIBI SPECT for 
the Detection of Myocardial Ischemia during 
Adenosine Stress. A Combined Imaging Strategy. 
Thomas Marwick, Bernard Willemart, Anne-Marie 
D'Hondt,William Wyns,Jean-Marie Detryl. Jacques 
Melin. Univ of Louvain, Brussels, Belg um. 
Adenosine (A) stress perfusion imaging is 
sensitive for the detection of myocardial 
ischemia. However, use of SPECT in unselected 
pts may be limited by suboptimal specificity -
a problem not reported with stress echocardlo•
graphy (SE). This study examined the accuracy 
of A-SE and A-Tc99m MIB! SPECT, both alone ana 
in combination, for the diagnosis of CAD. 
All pts presenting for coronary angiography 
with suspected CAD were eligible for study. 
After exclusion of pts with prior infarction, 
unstable angina, serious arrhythmias, and 
asthma 71 pts underwent A-SE. The protocol 
used 6.14, and 0.18mcg/kg/min in 3 min stages, 
with on-llne ECG and echo digitization. HIBI 
was in1ected at peak stress, with SPECT 
performea 2hr later, and rest imaging on 
another day. Endpoints were SP fall >20mmHg, 
severe ischemia, intolerable symptoms or 
attainment of peak dose. Ischemia was defined 
by angina (AP) and/or ~lmmST depression 
(AP/ST), abnormal wall motion after stress, or 
deterioration of regional perfusion. 
CAD (defined by >50% stenosis) was present 
in 47 ~ts; 41 were identified by MIBI (87% 
sensitivlty), more (p-.001) than the 22 (47%) 
detected by AP/ST, ana 23 (49%) by ASE. Of pts 
without CAD, 20 had normal A-SE (specificity 
83%), 16 (07%) no AP/ST, and 17 (65%) normal 
MIBI. We compared predictive values (PV) of 
each test with combination of A-SE and MIBI in 
all. Because of the higher specificity of ASE, 
a se9uential approach (A-SE in all, with MIBI 
only ln negative A-~E was also examined; 
Al'l_£'L. ~ B ~ Sequence 
+PV ~ --slYr 80X 
-PV 39%# 45%# 74% 76% 76% 
#p-<.05 versus MIBI, sequence or combination. 
Conclusion. A-MIBI is more sensitive than 
AP/ST or A-SE for diagnosis of ischemia. MIBI 
is used most efficiently in A-SE negative pts. 
754-5 3:00 
'lheq:hylline Does Not Affect 'lhal.lium-201 Imaging 
FollcwiJ'g :rnt:ravenws 1IderKlsine Infusicn. 
GaJ:y V. Heller, Rifat B. Dweik, Josetil J. Com:irq, 
Marilyn M. Barbo.lr, Donna J. Clrutier. C. Ewi.rg 
Garl:ler. Memrial Hospital, Bro.rm. University, 
Providence, RI. 
'lheq:hylline has been sllC1im to markedly reduce the 
diagmstic accuracy of IV dipyri.clanole thallitnn-201 
(Tlr-201) imagin;J. Hc:M!ver, its effect upon IV 
adenosine (Aro) Tlr-201 ilDagin;J is \II'lknc7.m. 'lhirteen 
patients (pts) with reversible Tlr-201 defects were 
ran:ianized in a dolble-blind cross-over study to a 45 
minute infusion of placebo (Plac) an:} t:1'lecPlylline 
('lheo, mean oonoentratioo 16.ll!g/L) followed by a 6 
minute IV Aro infusioo (140!1g.1l<q/min) with Tlr-201 
imagin;J. Olarges in heart rate (HR), systolic blood 
pressure (SSP), syupt:ans (syup) an:} ischemic ECG 
c:han;Jes durin;J Aro infusioo were recorded. Planar 
Tlr-201 images were read in a blinded fashion 
semiqualitatively (50) usin;J segmental analysis an:l 
with CXIIp.Iterized quantitation (CQ). 
HR SSP SYMP ECG 50 CQ 
Plac 7±7 -4±9 23 7 9.4+4.2 53+20 
Thee 11±8 -13±13 8* 0* 7.8t4.1 41±2l 
*P<0.005 
'1l1eq:hylline infusioo did not affect t::. HR or t::. SSP but 
did reduce both synptans an:} ECG response. However, 
there was no effect upon Tlr-201 imagin;J score by either 
50 or CQ analysis. 
Conclusion: Despite re:'luctioo in both synpt:ans an:l 
ischemic ECG c:han;Jes, t:1'lecPlylline does not affect 
planar thallitnn-201 imagin;J followin;J IV adenosine 
infusion, usin;J both visual an:} CXIIp.Iterized 
quantitative analysis. 
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Ia Adanoaine Tballiu.-201 Superior to Kzerci .. 
Thalliu.-201 Scintigraphy for the Detection of corouary 
Di..... in Patient a With Left BuDdle BraDCh Block 
James O'~eefe, Jr., Timothy Batsman, carrie Barnhart; Mid 
America Hsart Institute, Kansa. City, Mi.souri 
pts with left bundle branch block (LBBB) on EKG 
frequently have raversible .aptal perfueion defects on 
exerciee thallium-201 (ExThal) scintigraphy even in the 
absence of significant coronary artery diseaae (CAD); 
adenosine thallium-201 (AdThal) imaging may obviate this 
problem. 133 con.ecutive pts with LBBB were evaluatad 
with either ExThal (n-50 pta) or AdThal (n-83 pt.). The 
demographics of the two groups ware aimilar. Follow-up 
cardiac cathetarization was performad on 29/50 ExThal pta 
(58\) and 35/83 AdThal pts (40\), paNS. The overall 
predictive accuracy in the detection of significant CAD 
(luminal diameter stenosis> 70\) wa. 95\ in the AdThal 
group vs. 69\ in the EXThal group (pa.004). The two 
groups were compared with raspect to localization of CAD 
to the left anterior descending (LAD), right coronary 
artery (RCA), left circumflex (LCX)I 
~ ~ 
Sensitivity 
Exercise 
Adenosine 
Specificity 
Exercise 
Adenosine 
71' (10/14) 
95\ (21/22) 
80\ (12/15) 
100' (9/9) 
73\ (8/11) 
74\ (14/19) 
47\ (7/15) 
69\ (9/13) 
36\ (5/14) 
85\ (22/26) 
84\ (16/19) 
100\ (4/4) 
The combined specificity for the datection of CAD in the 
LAD and RCA was 41' with ExThal and 79' with AdThal 
(p-.002). . 
ConcluaioDBI 1) Adenosine is superior to exerci.e 
thallium imaging in the detection of CAD in pta with 
LBBB. 2) Adenosine obviate •• aptal artifact., thereby 
markedly improving specificity in LAD and RCA regiona. 
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A New 2-Dimensional Echocardiographic Classification of 
Mitral Valve Prolapse Which Relates Mitral Valve Morphology 
to Mitral Valve Function. 
Stefan M Nidorf, Arthur E Weyman, Robert A Levine. 
Massachusetts General Hospital, Boston. 
Since the most significant compl ication of mitr'al valve 
prolase (MVPJ is MV dysfunction, the ideal 2-djmensional 
echocardiograpbic classifjcation of HYP would relate MV 
morphology to MV functjon. To determine whether this was 
possible, we reviewed the studies of 329 consecutive 
patients with evidence of leaflet displacement in the 
parasternal long axis view. Each patient was classified 
into one of 4 groups based upon 3 morphologic features of 
the MV, including: 
(1) the degree of leaflet displacement (Dis), 
(2) the presence of leaflet thickening (Th), and 
(3) the symmetry of leaflet coaptation (Sym) .. 
The extent of MY dysfunction, defined as the degree of 
mitral regurgitation (HR) assessed by Doppler, was also 
exa~ined in each patient. 
Groul! n ~i~* Th* ~~ MR>2+ 
Minimal 70 <Zmm <5mm + 0% 
Non Classic 72 >2mm <5mm + 0% 
Classic-2 leaflet 124 >2mm ~5mm + 22% 
Classic-l leaflet 63 >2mm ~5nvn 73% 
* in parasternal long axis view 
HR>2+ • moderate to severe HR. 
Conclusion: In patients with HVP. there is a clear 
relationship between MV morphology and MV function. In 
particular, leaflet thickening and asymmetry of coapt at on 
become predictors of the degree of MR. The clinical ut11 ty 
of this classification will ultimately depend upon ts 
ability to predict clinical outcome prospectively. 
IS8A ABSTRACTS 
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LIFE-THREATENING VENTRICULAR TACHYARRHYTHMIAS AND 
VENTRICULAR FIBRILLATION IN THE MITRAL VALVE PROLAPSE 
SYNDROME: ELECTROPHYSIOLOGIC ASSESSMENT, TREATMENT AND 
PROGNOSIS. 
Michael Ruder, Zak Vera, A. Hardwin Mead, Nellis Smtth, Roger Winkle, 
Sequoia Hospttal, Redwood Ctty, California. 
The profile of a mttral valve prolapse syndrome (MVP) patient (pt) at risk for 
ventricular tachycardia (VT) or ventricular fibrillation (VF) and ambulatory 
ECG (AEG) monttoring and electrophysiologic characteristics are not fully 
defined. In over 1050 pts undergoing electrophysiologlc (EP) studies at our 
Instttution for VT, VF or syncope (S) in the past 11 years (yr) 18 (9 male, 9 
female, ages 29-87 mean 55.9 yrs) had MVP and absent or minimal coronary 
atherosclerosis; 8 presented wkh documented monomorphic VT and 12 with 
VF (2 pts wtth VT and VF). Left ventricular ejection fraction (LVEF) was over 
50% In 14/18 pts and over 30% In 17/18. Doppler echogram showed mitral 
regurgkation (MR) In 14/18 pts. 
RESULTS: Holter Ambulatory ECG revealed runs of nonsustalned VT In 
17/18 pts. On EP study 8 pts had inducible VF, 5 wkh three extrastimuli 
(EXS) and 3 with two EXS; 10/18 were nonlnducible. None of the pts had 
Inducible VT. Cardiac defibrillator (AI CD) was Implanted in 10/18 pts, all 10 
had clinical VF and 6/10 had EP Inducible VF; remainder underwent 
antiarrhythmic drug therapy. On follow-up (12-104 months) sudden cardiac 
death (SCD) defined as an appropriate shock In AICD pt, or documented 
symptomatic VT or VF in non-AICD pts was observed In 8/10 AICD pts (6 
of whom had EP Inducible VF) and 1/8 non AICD pts (also with inducible VF 
at baseline). There were 2 deaths; both In the AICD group, both non SCD; 
one pt wkh the lowest LVEF in the group (10%) and one following CVA 
CONCLUSIONS: 1. LHe threatening ventricular arrhythmias (VT or VF) in 
MVP can occur in the presence of well preserved LV function. 2. 
Nonsustalned VT on AECG In MVP may be an ominous finding. 3. Patients 
wtth MVP and VT fVF have a high Incidence of associated MA. 4. 
Electrophyslologic study In these patients Is of little prognostic value. 5. Pts 
wkh MVP and VT fVF have a high recurrence rate; aggressive therapy is 
appropriate. 
755·3 2:30 
Atrial Inflow Can Alter Regurgitant Jet Size: In Vitro Studies 
Randall Y. Grimes. Ajit P. Yoganathan. Peter G. Walker. Robert 
A. Levine. Massachusetts General Hospital, Boston, MA and 
Georgia Institute of Technology, Atlanta, GA 
Recent studies have attempted to predict the severity of regurgitant 
lesions from color Doppler jet size, which is a function of'orifice 
momentum for free jets. Jets of mitral and tricuspid regurgitation 
(MR and TR). lloWever. are opposed by flows entering the atria. 
Despite their low velocities. these counterflows may have 
considerable momentum that can limit jet penetration. The 
purpose of this study was to address the hypothesis that 
~hysiOlogiC counterflow fields influence regurgitant jet size. 
teady flow was dnven through .02-.12 cm2 clTcular onhces at .5-
5 m/s. At a constant orifice velocity and flow rate. the velocity of 
a uniform counterflow field was varied from I to 8 em/so Jet 
penetration length was measured by fluorescent dye visualization in 
10 videoframes to average out turbulent fluctuations. RESULTS: 
Despite its relatively low velocities. counterflow dramatically 
curtailed jet length. For example. the length of a 1.8 m/s jet (.05 
em2 orifice) decreased from 20 to 10 em as counterflow velocity 
increased from 3 to 7.5 cm/s. Jet len~h decreased as the ratio of 
counterflow to jet momentum increase . but with a nonhnear 
relatIOnshIp: length dechned steeply for low-momentum jets 
(momentum ratio < .25) and with a more shallow slope for high•
momentum jets (ratio> 2.25). CONCLUSIONS: Counterflow 
fields analo ous to atrial inflow have an im ortant effect on the 
engt 0 resurgltant lets. w-
momentum Jets. such as TR. are more COUNTER FLO~ 1 
sensitive to counterflow. while high- I I I I +, + , 
f~~~~g~ij~;, I ~ 
JET 
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Korpholoqic Feature. of Mitral Valve prolapse 
in Patients with Sudden cardiac Death 
Andrew Farb, Anita L. Tang, James B. 
Atkinson, William F. MCCarthy, Renu Virmani. 
Armed Forces Institute of Pathology, 
Washington, D.C. 
Sudden death occurs in a small but important 
subset of patients with isolated mitral valve 
prolapse (MVP). Clinical criteria for 
identifying patients at risk for sudden death 
have been elusive. Autopsy hearts from 
persons with sudden death (SD) and isolated 
MVP who were previously asymptomatic or had a 
history of cardiac arrhythmias (n=27) were 
compared to: (1) patients with congestive 
heart failure and mitral regurgitation 
secondary to MVP [KR/CHP (n=14»): and (2) 
persons dying from non-cardiac causes in 
which MVP was an incidental (INC) finding 
(n=19). Individuals with SO were younger than 
both KR/CHF and INC cases (37.4±lO.1 years 
versus 64.7±15.8 and 57.5±2l.2, respectively, 
p<O.OOl). Mitral valve annular 
circumference, anterior and posterior mitral 
valve leaflet lengths, posterior mitral valve 
thickness, and presence and extent of 
endocardial plaque were greater in hearts 
from patients with SO compared to hearts with 
INC MVP. Hearts from MR/CHF patients had 
significantly greater heart weight, left and 
right atrial sizes, and left ventricular 
cavity diameter than both SO and INC cases. 
Morphologic cardiac differences among 
individuals with MVP may help identify 
persons with isolated MVP who are at 
increased risk of sudden death. 
755·5 
Predictive Value of Very-Low-FrequeDcy Heart Rate Variability 
ID Mitral RegurKitatloD 
Kenneth M Stein, Jeffrey S Borer, Ctare Hochreiter, Peter M 
Okin, Edmund M Herrold, Richard B Devereux, Paul Kligfield, 
Cornell Medical Center, New York, NY. 
SDANN, the standard deviation of the 5 minute mean RR 
intervals, was examined as a measure of very-low-frequency 
«0.006 Hz) heart rate variability (VLF-HRV) in 39 patients with 
valvular causes of severe mitral regurgitation who were in sinus 
rhythm. Resting left ventricular (L VEF) and right ventricular 
(RVEF) ejection fractions were determined by radionuclide 
cineangiography, and end-points of mortality and progression to 
mitral valve surgery were examined during follow-up of up to 9.2 
years. SDANN was linearly correlated with both L VEF (rE O.4S, 
pzO.002) and RVEF (r.0.43. p=0.006). Using the SDANN 
partition value of 100 ms previously derived by Kleiger, et aI, 
there were 25 patients with normal SDANN (64%) and 14 patients 
with reduced SDANN (36%). By life-table analysis. patients with 
reduced SDANN were significantly more likely to develop end•
point events (p<O.OOI) with increased progression to mitral valve 
surgery (p<O.OOI) as well as increased early mortality (p-0.02). 
Actuarial I-year event-free survival was 96% in patients with a 
normal SDANN but 71 % among patients with reduced SDANN; in 
a multivariate proportional hazards model, SDANN retained 
predictive power for events (p=O.OOI) that was independent of age, 
LVEF, RVEF, frequency and complexity of ventricular ectopy, 
mean RR interval, and measures of low-frequency (0.04 - 0.15 
Hz) and high-frequency (0.15 - 0.40 Hz) heart rate variability. 
VLF-HRV correlates with ventricular performance and can be 
independently related to mortality and progression to valve 
surgery in patients with mitral regurgitation. 
3:00 
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Relationship Between Mitral Annulus Motion and Mitral Regurgita•
tion in Congestive Heart Failure 
Kazuyuki luchi, Tadayuki Nakabayashi, Tadao Ishikawa and Kensuke 
Kaseno. Internal Medicine, Toyama Prefectural Hospital, Toyama, 
Japan 
We studied the relationship between mitral annulus motion and 
mitral regurgitation (MR) In congestive heart failure (CHF). Doppler 
echocardiography was examined in 10 normal SUbjects (nls), 8 pa•
tients with NYHA class ill or IV and functional MR. The mitral 
annul us motion was obtained with M-mode cursor directed from 
the apical long axis view, and the displacement of mitral annulus 
toward the apex during systole (M-n) and during isovolumlc relax•
ation (M-IR) was measured. MR was detected using color and 
pulsed Doppler. Peak transmitral flow velocity during rapid filling 
(E) was measured. After the conventional therapy for CHF, func•
tional class decreased to I or n, and the restudy was done in 
all patients. 
Results: I) Before the therapy, MR continued past the second 
heart sound until the mitral valve opened After the therapy, 
MR was diminished or disappeared 
2) nls CHF (NYHA ill ,IV) CHF (NYHA I, n) 
M-n (mm) 14.6±2.3 6.8±3.0**t II. 0±3 .1* 
M-IR (mm) 14.9±2.2 8.7±3.2**t 11.3±3.2* 
E (em/sec) 60.4±15.3 86.5±22.3*t 60.8±21.5 
*p<0.05. **p<O.OI vs nls. t p<0.05 CHF (NYHAI,n) vs CHF 
(NYHAill.IV). t p<O.OI M-B vs M-IR 
Conclusions: These results suggest that I) the dysfunction of 
mitral annulus motion during systole is one of the causes of MR 
in severe congestive heart failure. 2) the displacement toward the 
apex during isovolumic relaxation shows the dilatation of left 
atrium caused by MR, 3) the higher E wave velocity in severe 
congestive heart failure may be due to the pressure and volume 
overload of left atrium caused by MR and failing to enlarge the 
left atrial size during systole, 4) augmentation of ventricular 
contractility may decrease MR and improve abnormal motion of 
mitral annulus during isovolumic relaxation. 
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Early Changes in the Endothelium and Adrenergic·Mediated 
Responsiveness of Veins Used as Thoracic Arterial Bypass Grafts 
Jeff B. Datil/o, Robert M. Lust, Quanmei Deng, You Su Sun, W. 
Randolph Chitwood, Jr. Department of Surgery, East Carolina 
University School of Medicine, Greenville NC 
The specific effects of venous vascular wall remodeling on the 
autonomic reactivity of vein grafts used in arterial positions are 
unknown. A 5 cm segment of reversed femoral vein was grafted 
between the brachiocephalic and subclavian arteries in 12 dogs, and 
the proximal subclavian unery was then ligated, rendering distal 
perfusion graft·dependent. Patent grafts were harvested from all 12 
animals 2 weeks postoperatively and suspended in an isometric 
tension tissue bath perfused with oxygenated. buffered Krebs· 
Henseleit solution. Tension responses to unblocked norepeinephrine 
(NE), phenylephrine (PE), aI' ~ and endothelium (ACH) specific 
challenge, for the grafts and native femoral vein and artery controls 
are provided (mean ± SD). 
Percent£ontraction (%) 
PE (10·"JIO·3M) 
NE (IO""/IO·JM) 
al (% unblocked 10·~M PE) 
ex, (% un~locked 10· M NE) 
At:H (10· M) 
Vein 
79±7 
93±7 
65±2 
58±4 
·20±3 
Artery 
89±8 
87±7 
94±6 
93±8 
·22±4 
Graft 
23±4 
20±4 
70±4 
74±5 
2.4 ± 1.7 
Loss of ACH response demonstrates lack of endothelium-mediated 
vasorelaxation. Graft responses to PE and NE were reduced by at least 
25% (p < 0.05), but the response to al and a2 specific stimulation 
was enhanced, suggesting significant increases in ~-mediated 
vasorelaxation in these vein grafts. This may partially compensate for 
the loss of endothelium-mediated vasorelaxation and suggests that ~­
blockade early after surgery may promote graft constriction. 
ABSTRACTS 
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Coronary Artery Bypass In Septuagenarians: 
Conduit Of Choice Internal Mammary Artery vs 
Saphenous Vein 
Anthony J Acinapura, Israel Jacobowitz, 
Marshall D Kramer, Zvi Zisbrod, Joseph N 
Cunningham, Jr. 
St. Vincent's Hospital & Medical Center, New 
York, NY, Maimonides Medical Center, Brooklyn, 
NY, USA 
159A 
Pts 70 yrs of age or older are being referred 
for coronary artery bypass (CAB) with increasing 
frequency. The ideal conduit for CAB in these 
pts remains controversial. From 1982-90, 2461 
pts 70 yrs or older underwent iSOlated CAB. The 
left internal mammary artery (IMA) with or with•
out additional saphenous vein grafts (SVG) were 
used in 1846 pts (75%). SVG alone was used in 
615 pts (25%). Mortality was 6.1% for IMA pts & 
6.5% for SVG pts. Complications of bleeding 
(1.2% vs 1.3%), ventilatory support (7.6% vs 
8.1%), infarction (4.2% vs 4.6%) & mediastinitis 
(1.3% vs 1.2%) were similar. Repeat angiograms 
were done in 480 pts (28%) at 1-8 yrs. The IMA 
had a 96% patency rate and SVG 78% (p<O.OOl). 
Angina recurred in 184 pts (10%) in IMA pts & 
110 (18%) SVG pts (p<0.05). Survival at 8 yrs 
was 88% for the IMA pts and 78% for the SVG pts 
(p(0.05). Statistical analysis showed similar 
postop morbidity and mortality in both groups. 
However, long term probability of cumulative 
survival & occlusion free survival were signifi•
cantly greater & probability of recurrent angina 
& reoperative CAB was significantly less in I~~ 
group & should be the conduit of choice for CAB, 
all pts regardless of age. 
756·3 2:30 
Antiplatelet Therapy Does Not Improva Saphenous Vein 
Graft Patency in The Younger Patients Undergoing Coro•
nary Bypass Surgery. 
G.V.R.K. Sharma, Tom Horitz, Diane Lapsley. Shukri 
Khuri, Gulshan Sethi, William Henderson, Jack Copeland 
and Steve Goldman and the VA Coop Study (207/297) 
Group. From the VAHC West Roxbury and Harvard Medical 
School, Boston. MA. 
In a prospective randomized study designed to evaluate 
the efficacy of antiplatelet therapy in the prevention 
of saphenous vein graft occlusion (SVGO) after coronary 
bypass surgery (CABGS) in 780 patients (2405 grafts), 
clinical characteristics and SVGO at 1 year were com•
pared in the younger (~ 50 yrs; n-105) and older (> 50 
yrs: n-675l patients. 
Younser pts Older pts p value 
Age (yrs) 45.2 ± 4.4 60.9 ± 5.2 < 0.001 
Functional class 3.2 ± 0.8 3.2 ± 0.8 0.83 
Prior HI (%) 73 59 0.004 
Smoking (%) 45 26 0.001 
Cholesterol (mg/dl) 229 ± 53 220 ± 48 0.09 
Triglycerides (mg/dl) 218 185 0.01 
HDL (mg/dl) 32.5 ± 9.7 34.9 ± 11.3 0.08 
Distal anastomoses 3.4 ± 1.0 3.4 ± 1.0 0.52 
SVGO at 1 year (%) 22 0 16 2 0.06 
Rates of SVGO at 1 yr in the antiplatelet (aspirin c or 
o dipyridamole) and placebo groups were· 
SVGO at 1 year 
pt group Placebo Antiplatelet Ex p value 
Younger pts 23.5% 21.5% 0.75 
Older pts 19.9% 14 8% 0 04 
The results indicate that younger pts undergoing CABGS 
have a higher rate of SVGO, presumably due to a higher 
incidence of coronary risk factors; in contrast to 
older pts. antiplatelet therapy has no beneficial ef•
fect on SVGO in this group. 
160A ABSTRACTS 
756-4 
Follow-Up Data after Myocardial Rev&'iCularization by Using Both 
Internal Mammary Arteries and the Inferior Epigastric Artery. 
Erwin Schroeder. Michel Buche, Patrick Chenu, Xavier Michel, Yves 
Louagie, Jean-Claude Schoevaerdts, Rene Kremer, Baudouin Marchandise 
University of Louvain. Mont-Godinne Hospital, Yvoir, Belgium 
Since january 1990,82 patients (60 men, 22 women; mean age: 61 years) 
underwent myocardial revascularization exclusively by arterial grafts. the 
mean number of distal anastomosis was 3.65. Both internal mammary 
arteries were used as pediculated grafts. The inferior epigastric graft was 
used as a free arterial graft. The distal anastomosis of this graft was 
performed on the RCA (n = 67), on the diagonal (n = I), on the marginal (n 
= 9) and on the posterolateral branch (n = 5) of the circumflex artery. The 
proximal anastomosis was performed on the ascending aorta (n = 75) with 
interposition of a venous patch in 30 cases, on the internal mammary artery 
(n = 6) and on a patent venous bypass graft (n = 2). Perioperative ischemia 
occured in two patients. Two patients died. Early angiographic control was 
performed in 69 patients (no control was performed in 12 patients: 2 
deaths, 5 refusals, 5 medical contra-indications). 68 of the 69 free 
epigastric arteries grafts were patent, although 2 grafts were diffusely 
narrowed (patency rate : 98 %). I distal anastomosis of an internal 
mammary artery graft was found occluded (patency rate: 99 %). 
During the follow-up period (mean: 7.5 months, range: 1-18 months) only 
I patient ex perienced recurrence of angina. No other cardiac event 
occured. Late (> 6 months) angiographic control was obtained in 27 
patients. In two patients, the free epigastric artery was found occluded and 
in five diffuse narrowing of the free graft was observed. 
During late follow-up, the patency rate of 88 % of the epigastric arterial 
graft was lower than the patency rate of the internal mammary arteries 
(98 %). In two patients, however, marked vessel enlargement of the free 
graft was found at the late angiographic control. 
We conclude that the early patency rate of this new graft is excellent. The 
late patency rate is inferior to the rate of internal mammary arteries. 
Further improvements of the surgical technique are needed, before this new 
material can be proposed as an alternative conduit for internal mammary 
arteries. 
2:45 
756-5 3:00 
Mid-Term Results of Right Gsstroepiploic Artery 
Grafts: Sequential Angiographic Follow-Up 
Takao Ishimura, Takeshi Funauchi, Takashi Umezawa, 
Akira Wakabayashi, Hisayoshi Suma* 
Kitano Hospital, Osaka, Japan and Mitsui Memorial 
Hospital*, Tokyo, Japan 
To examine mid-term results of the right gastro•
epiploic artery (GEA) grafts, follow-up angiography 
of the grafts was performed at mean 1.5 and 15.6 
months(mos) postoperatively in 20 pts (18 males, mean 
age : 57.9). GEA grafts were anastomosed to the 
RCA in 16 pts, to the LAD in 2 and to the LeX 
in 2. The patency rate, diameters and blood flows 
of GEA grafts were evaluated angiographically. All 
grafts were patent, Mean diameters of all grafts were 
2.l:!:0.7mm at 1.5 mos, and 2.0*0.7mm at 15.6 mos 
(p=NS). The diameters of 8 grafts anastomosed to 
the distal segment of the completely occluded 
coronary arteries were compared to the diameters 
of 10 grafts anastomosed to the coronary arteries 
that maintained their native flow. There were no 
differences between the two groups at 1. 5 mos, but 
at 15.6 mos, the diameters of the former group was 
2. 3±O. 6mm whereas that of the latter 1. 6±0. 6mm 
(p 0:::0.05). In two pts, whose collateral flows from 
other coronary arteries increased, there occurred 
a decrease in blood flow of the grafts. 
Conclusion : 1) The mid-term patency rate of GEA 
grafts is excellent. 2) The physiological responses 
are very similar to those of the internal thoracic 
artery graft, suggesting that the longterm results 
will be equally promising. 
756-6 
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Clinical and Angiographic R.sults of COronary Bypas. 
After 15-20 Year. 
Gerald M. Lawrie, George C. Morris, Jr., Michael E. 
DeBakey, Nan Earle. 
Baylor College of Medicine and The Methodist Hospital, 
Houston, Texas. 
We determined the status of 3233 pts who underwent 
CAB between 1964 and 1975. There were 2748 (85\) men 
and 485 (15\) women. The mean age preop was 54Z8.6 
yrs; 1137 (35\) pts had 2-vessel disease (V), 1024 
(32\), 3V and 358 (11\) left main stenosis. Preop 
ejection fraction was 48.7z19.7\. Pts received 1.8z0.7 
vein grafts/pt. overall, 1402 (43\) pts are alive. 
Angina was absent in 66\, but 44\ of pts are taking 
nitrates, 23\, beta blockers and 15\ antiarrhythmics. 
Graft patency was 984/1348 (73\) at 0-5 yrs, 565/904 
(63\) at 6-10 yrs, 344/600 (57\) at 11-15 yra and 
62/112 (55\) at 16-20 yrs. LAD grafts had the highest 
patency at each interval. 75\, 70\, 64\, 57\. Cox 
multivariate analysis indicated that age, left main 
disease or 3V, preop stroke and quality of ventricle 
were major predictors of overall mortality (P<0.001). 
Diabetes was the only metabolic predictor (P<0.001). 
Preop cholesterol and triglyceride levels did not 
predict survival. Overall, at 20 yrs, pts who had 
received 3 grafts had the highest survival (37\) 
compared with 1 graft (30\) or 2 grafts (24\). CAB 
reoperation was performed on 556 pts (17\). Thus, 
despite initial incomplete revascularization and 
absence of mammary grafts, almost half the pts survived 
15-20 yrs, most had persistent relief of angina and 80\ 
of pts still had at least 1 patent graft. These 
results indicate that in selected patient subgroups, 
CAB surgery produces truly long term relief of 
symptoms. Improved techniques now in use should 
further enhance the long-term prospects for currently 
operated patients. 
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Impaired Recovery of Skeletal Muscle Function During 
Repetitive Exercise in Heart Failure 
John R. Minotti, Lauren Wells, Roberta Oka, Ian Christoph, Barry 
M. Massie. VAMC and Univ. of California, San Francisco, CA. 
In patients with congestive heart failure (CHF), exercise and daily 
acttvities are usually limited by muscle fatigue. Since many 
activities are repetitive, impaired interval recovery of muscle 
function could play an important role in these symptoms. Therefore, 
the goal of this study was to compare the recovery of knee extensor 
endurance in 11 patients with NYHA Class 2 and 3 CHF and 10 
age matched sedentary controls (CON). Subjects performed 
repetitive maximal knee extensions (NO. EXT) on an isokinetic 
dynamometer until peak torque (PKTOR) declined by 40%. 
Recovery of endurance was quantified by the ratio of the number of 
extensions (NO.EXT) required for force to decline by the same 
percentage after 90 and 270 sec to the initial number (%INIT). 
90sec 270sec 
PKTOR NO.EXT %INIT PKTOR NO.EXT %INIT 
Con 82±16 19±3# 71±16 86±19 24±5 86±19 
CHF 64±18 1O±4#* 53±17* 65±12 11±6#* 62±20* 
*=P<.05 vs con; #=p<.05 vs initial; PKTOR in ft-lbs 
Although PKTOR, a measure of muscle strength, was initially not 
significantly different between patients and controls (70+/-21 vs 
83+/-20 ft-lbs, p=0.21), the number of extensions before a 40% 
decline in force, a measure of muscle endurance was lower in CHF 
patients (18+/-4 vs 29+1-8, P < .05), When exercise was repeated 
after 90 and 270 sec, PKTOR tended to decline more with repetitive 
exercise in CHF patients (p < .10). Even more impressive was the 
persistent decline in endurance, as assessed by the fewer absolute 
number of extensions during the repeat exercise runs and the lower 
percent of the initial number before force declined to the 
predetermined target. We conclude that not only is muscle 
endurance abnormal in CHF, but its recovery is delayed and could 
be a factor in activity limitation. 
JACC Vol. 19, No.3 
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Post·Exercise Recovery of Phosphocreatine as an Index of 
Oxidative Capacity in Patients With Heart Failure 
Donna M. Mancini, Glen Walter, Kevin McCully, John R. Wilson 
Hospital of the University of Pennsylvania, Philadelphia, PA 
Previous 31p magnetic resonance spectroscopy (MRS) studies have 
demonstrated abnormal skeletal muscle metabolism during steady state 
exercise in patients with heart failure. These metabolic abnormalities are 
influenced by muscle oxidative capacity, muscle mass, and the external 
workload. Recovery of phosphocreatine (PCr) after termination of ex•
ercise should primarily reflect muscle oxidative capacity and not be in•
fluenced by mass or the external workload. Accordingly, we measured 
calf muscle metabolism during and following supine plantarflexion in 14 
patients with CHF (LVEF=17±6%) and 8 normal subjects. Inorganic 
phosphorus (Pi), phosphocreatine (PCr), and intracellular pH were 
measured at rest and at workloads of 0.75 to 6 watts. The slope of the 
relationship between PJPCr and power output (work slope) was used to 
assess steady state metabolism The time constant of recovery of PCr 
was determined following 3 min of exercise at a workload which re•
sulted in PJPCr ratio of -0.7. Eight second spectra were obtained in the 
recovery period. PCr areas were fitted to a single exponential curve to 
derive the time constant of recovery. Vmax, the maximal rate of PCr 
and thus ATP synthesis, was then calculated. Results are as follows: 
*p<0.05 Normal vs CHF 
Work Slope Time Constant Ym2A 
(watt-i) (sec) (mMole/kg/min) 
Normal O.25±O.19 40.4±11.3 43.8±19.0 
CHF O.85±O.70* 82.0±60.5* 25.4±lO.2* 
Three patients, all of whom had muscle atrophy, had markedly abnor•
mal work slopes (i.e. ~l watt·l ) but normal recovery constants 
47.8±10.7 sec. In conclusion, recovery of PCr provides a useful index 
of muscle oxidative capacity. As this index is independent of muscle 
mass and does not require precise quantification of work, it may be a 
better marker of intrinsic muscle abnormalities in CHF. Moreover, re•
covery analysis provides parameters of skeletal muscle metabolic func•
tion which can be easily measured and compared between different labo•
ratories. 
757·3 2:30 
Forearm Exercise Training Partially Reverses Abnormal 
Skeletal Muscle Metabolic Responses During Exercise in 
Heart Failure 
lohn R. Stratton, JeffF. Dunn, Stamatis Adamopoulous, George 
Radda, Bheeshma Rajagopa1an. Seattle V A and University of 
WashingtOn, Seattle, WA, and University of Oxford, Oxford, U.K. 
To determine whether the abnormal skeletal muscle metabolic 
response to exercise in patients with CHF can be improved by forearm 
exercise training, which does not affect systemic hemodynamics, we 
studied 8 malcs(aged 44-83) with stable CHF(NYHA 1·3) before and 
after a 1 month training regimen of the non-dominant arm. Metabolic 
responses were monitored in both the trained and non-trained arms 
during progressive exercise using 31 P magnetic resonance 
spectroscopy with measurement of pH, phosphocreatine(PCr), 
inorganic phosphate(Pi), ADP and the ratio of PCrIPCr+Pi during 
exercise and recovery. Maximal voluntary contraction increased in the 
trained arm(41±11 to 43±llkg, p=O.OS) but not in the untrained arm. 
Similarly, exercise duration increased in the trained (l0.8±3.S to 
12.82;4.3 min, p<O.05) but not the untrained arm. Average submax 
re~ses at the same stages improved for pH and PCrIPCr+Pi (both 
p<O.05). Rest and maximal exercise responses were unchanged for 
pH and PCrIPCr+Pi. ADP was unchanged. (*p<O.OS by paired t) 
pH PCr!PCr+Pi 
PRE POST PRE POST 
Rest 7.03±.02 7.04±.03 .9O±.02 .9O±.03 
Submax 6.73±.-19 6.91±.08* .SO±.l1 .6O±.IZ* 
Max Ex 6.42±.-30 6.S2±.22 .3J±.l4 .28±.16 
PCr recovery half time in the trained arm was unchanged, while Pi 
recovery halftime decreased(46±23 to 33±14 seconds, p<O.OS). 
These results further confirm that 10calized training improves 
exercising muscle metabolic abnormalities in patients with CHF. 
These findings are compatible with the hypothesis that a part of the 
abnormality present in skeletal muscle in CHF is due to inactivity. 
ABSTRACTS 161A 
757·4 2:45 
Pulmonary Abnormalities In Congestive Heart Failure: Reversal 
by the Inhaled Anticholinergic Agent Ipratroplum Bromide. 
L. Allen Kindman. Randall Vagelos, Tammy Drew, Kathy Willson. Mary 
Nejedley. and Michael B. Fowler. Stanford UniversHy, Stanford. CA 94305-
5246. 
Patients with Congestive Heart Failure (CHF) have abnormal 
pulmonary function. Like asthmatics, they manKest an increased sensHivHy to 
inhaled methacholine, a cholinergic agonist which causes 
bronchoconstriction. This suggests that the resting obstructive pulmonary 
abnormalities Observed in patients with CHF resun from the action of the 
neurotransmitter acetylcholine on bronchial airways. 
Ipratropium bromide (Atrovent) is a muscarinic cholinergic antagonist 
administered by inhaler to .patients with chronic obstructive lung disease and 
asthma. We studied the effects of Atrovent on 8 patients (4 female, 4 male) 
with NYHA class 2 or 3 CHF who had Jlin[ smoked and who had Jlin[ had 
clinically apparent lung disease. All patients were free of other systemic 
disease. All were maintained on stable regimens of digoxin, loop diuretics 
and angiotensin converting enzyme inhibHors. Baseline pulmonary function 
tests (PFT) were obtained. A dose of 70 I1g of Atrovent was then 
administered by inhaler. PFT's were repeated 30 minutes later. Resu"s are 
expressed as the mean of the % predicted ± SEM. 
FEF25·75 
MVV 
BEFORE AFTER P(2·taiiTtest) 
78.5±10.6 90.3±12.1 0.02 
82.0±4.2 93.9±4.2 0.025 
The changes observed in the FEF 25.75 and MVV following administration of 
Atrovent represent significant treatment effects and are greater than those 
observed when Alrovent is given to normal subjects. 
Conclusion: Inhalation of Alrovent results in a striking improvement 
in small airway flow in patients wHh CHF. This indicates that abnormal 
pulmonary vagal tone adversely influences lung dynamics in CHF. A large 
scale trial is needed to define the clinical beneftt of inhaled anticholinergic 
agents on breathlessness and exertional dyspnea in patients with CHF. 
757·5 3:00 
Increased Alveolar-Capillary Membrane Resistance to Gas 
Exchange in Chronic Congestive Heart Failure. 
David P. Moore, Adele R Weston, John G.F. Cleland, J. M.B. 
Hughes, Celia M. Oakley. 
Reduced diffusing capacity for carbon monoxide is well recognised 
in patients with acute pulmonary oedema, but in chronic heart 
failure it is generally assumed that increased pulmonary bleod 
volume and prolonged capillary transit time compensate for any 
functional impairment of gas transfer and prevents significant 
impairment of pulmonary gas exchange. We have measured 
diffusing capacity for carbon monoxide (Oleo), the alveolar-capillary 
conductance for carbon monoxide (OMland pulmonary capillary 
blood volume (Ve) using a single breath technique at different 
inspired oxygen concentrations, in 10 male patients (age 48 ± 9 yrs) 
with stable congestive heart failure of more than 6 months duration 
(LV ejection fraction 21.5 ± 6.8%,NYHA Class II-III). All were on 
optimum medical therapy with diuretics and ACE inhibitors. Results 
were compared with 8 sex matched control subjects (44 ± 12 yrs) 
without evidence of cardiac disease. None of the patients or 
controls were smokers. 
CHF 
Ctrl 
OLeo DLco OM Vc 
mmol/min/kPa % predicted mmol/min/kPa mlim' 
5.69 ± 1.41 
9.80±2.03 
57.5± 10.6 
96.0± 10.3 
7.6±2.6 
16.3±3.8 
45.1 ±21.5 
38.0± 12.2 
p <0.0001 <0.001 <0.0001 0.42 
OLeo in patients was significantly reduced both in comparison to 
controls and % predicted for age, sex and surface area. The 
substantial reduction in OM in the CHF patients indicates increased 
alveolar-capillary resistance to gas exchange. Despite severely 
impaired LV function, Ve was not significantly increastld. These 
data confirm recent reports of impaired diifusin~ capacity in 
congestive heart failure, and suggest that long standing pulmonary 
venous hypertension may have deleterious effects on alveolar 
capillary membrane function. 
162A ABSTRACTS 
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EXERCISE TRAINING IMPROVES VENTILATORY 
ABNORMALITIES IN CHRONIC HEART FAILURE 
3:15 
Patrick Davey, Theo Meyer, Andrew Coats, Stamatis Adamopoulos, 
Barbara Cassadei, James Conway, Peter Sleight. Department of 
Cardiology, John Radcliffe Hospital, Oxford, United Kingdom. 
Patients with Chronic Heart Failure (CHF) have an increase in 
minute ventilation on exercise: this may be associated with 
dyspnoea. The effect of exercise training on ventilatory function 
was studied In 22 patients with stable CHF (NYHA class 11/111) in a 
random order cross-over training/detraining program. Training 
comprised home based bicycle ergometer exercise for 8 weeks. 
Assessment was by 4 minute 25 Wall stage exercise test to 
exhaustion. Results are mean±standard deviation. 
Detrained Trained p 
Peak V02 mllkg/min 14.1±2.8 15.4±2.8 0.01 
V0250W 9±1.5 8.7±1.3 ns 
VC02 SOW 8±7.3 7.3±1.1 0.02 
Vi SOW 23.4±6.8 20.9±4.7 0.005 
Vi-VC02 slope 3B.6±11 35.3±B.4 0.01 
ROI minutes 10.9±2.9 13.7±2.B 0.01 
Vi-minute ventilation, V02 or Vco2=minute 02 or C02 fluxes,Vi•
VC02 slope~slope of Vi plolled against VC02, ROlaTime to reach 
respiratory quotient(-VC02/V02) of 1. 
Conclusions 1) Hyperpnoea in CHF is reduced by physical 
training 2) Vi falls more than VC02 indicating improved 
ventilatory efficiency. 
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Substantial Improvement In DefibriUation Thresholds by Using Multiphasic 
Shocks Compared Wilb Sequential Monophasic Shocks In Pigs 
Paul A. Guse, Patrick D. Wolf, Dennis L. Rollins, William M. Smith, 
Raymond E. Ideker. Duke University Medical Center, Durham, NC. 
Low defibrillation thresholds (DFTs) can be produced by two sequential 
biphasic sbocks when delivered to 2 different pairs of electrodes. However, 
since a single capacitor waveform is used, the first 2 phases have the highest 
voltage, but are delivered to the same set of electrodes. This study: (1) 
examined the effect of switching Ibe order of the 2nd and 3rd phases such 
that high voltage would be delivered sequentially to both pair of electrodes; 
and (2) compared the efficacy of both of these shocks to that produced by 
sequential monophasic shocks. In 6 pigs, defibrillation catheters were 
placed in the RV and the superior vena cava (S). A small patch electrode 
(4.2 cm2) was sutured to the LV apex (A) and a 42 cm2 R2 cutaneous patch 
electrode (P) was plaCed on the left thorax. Three electrode configurations 
were tested: (1) a sequential biphasic in which a 3/3 ms biphasic shock was 
delivered to RV-P (1st phase cathode-anode) followed by a 2nd 3/3 ms 
biphasic sbock to A -S; (2) a multiphasic in which a 3 ms shock was 
delivered to RV-P, then a 3 ms shock to A-S, then a 3 ms shock to P-RV 
and finally a 3 ms sbock to S-A; and (3) a sequential monophasic in which a 
6 ms monophasic sbock was delivered to RV-P followed by a second 6 ms 
sbock to A-S. The waveforms were generated from a single capacitor defi•
brillator. Using a modified Purdue technique, DFTs were determined with 
shock steps of 20 volts and expressed as leading edge voltage & total energy 
(1) ±SEM. Multiphasic and sequential biphasic configurations were com•
pared to the sequential monophasic configuration (·.P<.OOI). 
1 3 
Joules S.I±0.6· 4.8±0.S· 10.6±1.0 
Even though all configurations had the same duration, those that used 
sequential biphasic or multiphasic shocks produced lower DFTs than the 
sequential monophasic sbocks. Furthermore, when the shock order of the 
sequential bipbasic was switched, the defibrillation efficacy remained high. 
Therefore, the effectiveness of sequential biphasic shocks for implantable 
defibrillators: (1) can be maintained even if Ibe shock order is altered, and 
(2) are an improvement over sequential monophasic shocks. 
758·2 
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Reduced Defibrillation Requirements for a Single Capacitor Dual Biphasic 
Waveform Given Via Two Current Pathways in Pigs. 
Randolph A S Cooper Dennis L. Rollins, Yohannes Afework, David K. 
Swanson, William M. Smith, Raymond E. Ideker, Duke University Medical 
Center, Durham, NC 
The goal of this study was to see if in pigs a single capacitor dual biphasic 
waveform delivered over two current pathways, which has been shown to 
reduce the defibrillation threshold (DFT) in dogs, results in a lower DFT 
compared to a single biphasic waveform given over one current path. In 6 
anesthetized pigs (weight-35kgs), 2.95 cm2 spring electrodes were placed, 
in tbe RV apex, in the superior vena cava (SVC), and in the RV outflow 
tract (RVO). A 133 cm2 cutaneous R2 left chest wall;atch (P) was placed. 
A median sternotomy was performed and a 4.S cm mesh electrode was 
sutured to the LV apex (LVA). The configurations tested with the dual 
biphasic were: RV-P, then LVA-RVO; RV-P, then LVA-SVC; 
RV-PtSVC, then LVA-RVO; and SVC-RV, then LVA-RVO. Using a 
3.5/2 ms biphasic waveform with a first phase 3.5 ms in duration and a 
second phase 2 ms in duration as well as opposite in polarity to the first 
phase, probability of sucess curves were generated using an up down method 
with 20 volt steps and 15 shocks per curve. Probability of success curves 
were also determined for tbe RV-PtSVC using a single 5.5/5.5 ms biphasic 
waveform. The means and standard deviations of the 50% (V50&E50) 
successful defibrillation voltages and energies are shown. (t= p sO.05 
compared to RV-PtSVC;·= pSO.OS compared to RV-P, then LVA-RVO) 
RV- RV-P, RV-P, RV-P+SVC, SVC-RV, 
P+SVC LVA-RVO LVA..sVC LVA-RVO LVA-RVO 
V50 441:101· 263:67t 277:61t 325:145t 374:113' 
ESO 16.4:7.8' S.4±2.6t S.H2.0t 7.4:4.8t 14.1:8.1' 
In conclusion the two current patb, dual biphasic waveform defibrillation 
configuration had a lower defibrillation reqUirement than the single current, 
single bipbasic wavefrom configuration in pigs which have thoracic ana•
tomies more similar to bumans than do dogs. Furthermore in pigs that have 
undergone median sternomies for the LV apex electrode placement, the 
SVC electrode functions as well as the RVO electrode so that fixation of a 
catheter in tbe RVO is not necessary. 
758·3 2:30 
The Effects of Single and Multiple Pathway 
Monopt"asic Shocks on Defibrillation Threshold. 
Andrea Natale, Douglas L. Jones, George J. Klein, Raffaele 
O'Amelio. Robarts Research Institute, University Hospital, 
London, Ontario, Canada 
Distribution and number of electrodes used for delivery of 
monophasic shocks may be important to optimize current 
delivery for successful ablation. Triplicate DFTs were 
obtained in 10 open·chest anaesthetized pigs using 
monophasic shocks with either 2, 3, or 4 epicardial 
electrodes and the results were compared with biphasic 
shock USing two electrodes. Total electrode surface area 
(10cm2) and shock duration (6 ms) were the same for each 
configuration. All four configuration were tested in a 
randomized order in each pig. Biphasic shocks achieved 
defibrillation with the lowest energy. (*P<O.001). Using 
monophasic shock there was no difference between the 2 
and 3 electrode configurations. However, there was a 
pronounced increase in OFT with the 4 electrode 
configuration (tp<O.001). 
Monophasic Biphasic 
Electrodes 2 3 4 2 
Energy 15.5±7.5 16.6±5.5 44.1±6t 6.7±2.S* 
Ohms 4S.9±8.7 56.9±9.7 60.3±13h 47.8±8.2 
These differences can not be explained solely on the 
basis of impedance although increased impedance may 
contribute to the increased OFT when using the 4 electrode 
configuration (hp<O.05). ConSistent with previous 
observation biphasic shock has the lowest OFT. When total 
electrode surface and shock duration are constant there is 
no advantage to delivering monophasic shocks through 
multiple simultaneous pathways. 
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Denbrillatlon In Pigs Using a Tripbasic Waveform: Comparison With 
Bipbasic and Sequential Bipbasic Waveforms 
Paul A. Guse. Dennis L. Rollins. Yohannes Afework. Ellen Dixon-Tulloch. 
Raymond E. Ideker. Duke University Medical Center. Durham. NC. 
Previous studies have shown that low defibrillation thresholds (OFTs) can 
be produced by two sequential biphasic shocks when delivered to 2 different 
pairs of electrodes. However. little is known about triphasic waveforms that 
are generated from a single capacitor defibrillator and use 2 pair of 
electrodes. The purpose of this study was to compare the defibrillation 
efficacy of triphasic with single biphasic and sequential biphasic waveforms. 
In 6 pigs. defibrillation catheters were placed in the right ventricle (RV) and 
the superior vena cava (S). A stainless steel patch el~ctrode (4.2 cm2) was 
sutured to the left ventricular apex (A) and a 42 em R2 cutaneous patch 
electrode (P) was placed on the left thorax. Three electrode configurations 
(cathode~anode) were tested: (I) a triphasic in which a 4 ms shock was 
delivered to RV~P. then a 4 ms shock delivered to A~S. and finally a 4 ms 
shock to P+S~RV+A; (2) a sequential biphasic in which a 412 ms biphasic 
shock was delivered to RV~P followed by a second 412 ms biphasic shock to 
A~S; and (3) a single biphasic in which a 6/6 ms shock was delivered to 
RV ~P+S. All waveforms were generated from a single capacitor defibrillator 
connected to customized switches. DFTs were determined with shock steps 
of 20 volts using a modified Purdue technique and expressed as leading edge 
voltage & total energy (J) :!: SEM. 
*sP<.OS compared with triphasic; t.P<.OOI compared with biphasic 
Even though all configurations had the same duration. those that used both 
triphasic and sequential biphasic shocks produced lower DFTs than did sin· 
gle bipbasic shocks. In addition. the triphasic voltage was lower than that 
for the sequential biphasic. Therefore. triphasic waveforms are as effica•
cious for defibrillation as are sequential biphasic waveforms. 
758-5 3:00 
Defibrillation Emcacy of Simultaneous Monophasic and 
Biphasic Waveforms in Man 
Werner Jung, Matthias Manz, Rainer Moosdorf*, Christian 
Schneider", Berndt Liideritz. Departments of Cardiology 
and Cardiovascular Surgery", University of Bonn, Germany 
Animal studies have suggested that biphasic waveforms (BW) 
may defibrillate better or worse than monophasic waveforms 
(MW) of the same duration, depending on the duration of the 
two phases of the BW. The purpose of this study was to compare 
the defibrillation efficacy of simultaneous MW and BW in 14 
patients (pts) who received an implantable cardioverter/defibril•
lator. The defibrillating lead system consisted of a left lateral 
subcutaneous patch electrode (anode) and two transvenous elec•
trodes which were positioned in the vena cava superior (anode) 
and in the apex of the right ventricle (common cathode). All 
shocks had truncated exponential waveforms with a duration of 
6.3 ms. The BW consisted of a positive pulse of 4.2 ms followed 
by a negative pulse of 2.1 ms. The leading edge voltage of the 
second phase was equal to the trailing edge voltage of the first 
phase. At implant, defibrillation thresholds were obtained in each 
patient in a ranomized sequence with either the BW or the MW 
tested first. -Results: The mean defibrillation threshold was 
17.5+ /-4.3 J for the BWand 22.3+ /-2.9 J for the MW (p<O.05). 
In 11 pts, the required energy for defibrillation was significantly 
lower using the BW compared to MW. No difference was found 
in defibrillation success rate between BW and MW in 3 pts. 
Conclusion: BW with a longer first and a shorter second phase 
duration required significantly less energy for defibrillation than 
-simultaneous MW. Because of the higher margin of safety for 
defibrillation BW allow a more widespread use of defibrillators 
with a nonthoracotomy lead system. 
ABSTRACTS 163A 
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Endocardial Defibrillation: Efficacy Varies With Shock Wavefonns and 
Induced Arrhythmia 
Huanlin An, Sanjeev Saksena, Paul De Groot. Rahul Mehra, Ryszard B. Krol, 
Davendra Mehta, Edward Burkhardt. Raj Kaushik. Eastern Heart Institute. Passaic 
and UMDNJ-NJ Medical School. Newark. NJ. 
We evaluated clinical efficacy and electrical characteristics of bidirectional 
monophasic and biphasic shocks delivered for endocardial cardioversion•
defibrillation in pts with fast monomorphic ventricular tachycardia [VT] (VT cycle 
length .$.330 ms), polymorphic VT or ventricular fibrillation [VF]. Thirty-four pts 
with mean age of 60.±.12 years and mean LV ejection fraction of 34.±.13 % were 
enrolled. Two defibrillation catheter electrodes were located in RV apex and 
SVCIRA junction respectively. A triple electrode configuration including the 2 
catheter electrodes and a large left thoracic patch was used to deliver shocks from 
the R V cathode to atrial and thoracic patch anodes and shock impedance measured 
Three shock waveforms were examined: sequential monophasic [Seq]. 
simultaneous monophasic [Sim-M)] and simultaneous biphasic [Sim-B]. 
RESULTS: 30 fast VT (mean VT cycle length 283.±.33 ms). 13 polymorphic VT 
and 41 VF episodes were examined. The efficacy of 580V (20J) shocks was: 
~ Sim-M Sim-B 
Fast VT 73% (8111) 73% (11115) 100% (4/4) 
Polymorphic VTIVF 29% (5117) 76% (13/17)* 90% (18/20)** 
• p < .02, •• p= .001 as compared to Seq. 
Paired single shock defibrillation thresholds in 10 pts with Sim-B shocks were 
significantly lower (9.±.5J) as compared to Sim-M shocks (lS.±.4J; p< .02). The 
mean impedance in the RV-atrial pathway was significantly lower as compared to 
the RV-patch pathway for both Seq and Sim-M shocks (p< .001; p=.002 
respectively) but there was no correlation with clinical outcome. 
CONCLUSIONS: I) Simultaneous shocks are more effective in polymorphic 
VT IYF than Seq shocks. 2) Testing fast VT alone may fail to elicit differences in 
endocardial defibrillation efficacy. 3) Biphasic shock waveforms should be 
employed in preference to monophasic shocks by implantable cardioverter•
defibrillators using this endocardial lead system. 
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Lovastatin Fails to Lt.it s.ooth Muscle Cell 
Proliferation in No~lipe.ic and Hyperlipeaic Swine in 
an Overstretch Balloon Injury Kodel of Restenosis 
Joel E. Schneider. Edward C. Santoian. Michael B. 
Gravanis. Gustavo Cipolla. Kristin Anderberg. Spencer B. 
King III. Emory University School of Medicine. Atlanta. 
~ . 
Lovastatin(LOV) has decreased experimental intimal 
hyperplasia in hypercholesterolemic rabbits. The purpose 
of this study is to evaluate the efficacy of LOV in 
normolipemic and hyperlipemic swine in an overstretch 
balloon injury(B1) model of restenosis. 25 pigs 
underwent B1 with a 3.5mm angioplasty balloon in the 
left anterior descending and left circumflex arteries. 
Animals were divided among ~ groups: control. 
cholesterol-loaded. lovastatin. and 
cholesterol+lovastatin. Treated animals received 
LOV(2mg/kg/day) until sacrifice at 28 days. Hyperlipemia 
was achieved by a 2% cholesterol diet beginning 2 weeks 
prior to BI. After H&E and elastin staining. the ratio 
of the luminal to intimal areas(LA/IA) and maximal 
intimal thickness(MIT) were determined using a 
computerized morphometry program and compared with 
controls. 
Group DIET TC n=vessel LAllA KIT( .. ) 
CONTROL normal 89 19 .72+.11 .52+.28 
CHOLESTEROL 2%CHOL 580 1~ .69+.12 .50+.0~ 
LOVASTAT1N normal 7 .68+.1~ .52+.12 
CHOL+LOV 2%CHOL ~50 8 .69+.11 .53+.16 
(TC=mean total cholesterol) mean+SD 
Conclusions l)Total serum cholesterol does not alter the 
extent of intimal hyperplasia following balloon injury 
in the swine model. 2) Lovastatin did not reduce 
intimal hyperplasia in normolipemic or hyperlipemic 
swine following balloon injury. 
164A ABSTRACTS 
759-2 2:15 
Severe Medial Cell Injury Does Not Prevent Neointimal 
Proliferation: Histopathology Following Microwave 
Angioplasty in a Porcine Coronary Restenosis Model 
Kenneth C. Huber, Robert S. Schwanz, William D. Edwards, 
Alan R. Camrud, David R. Holmes. Mayo Clinic, Rochester, MN 
To investigate the effects of thermal injury on neointimal (NI) 
proliferation in a porcine coronary restenosis model, the 
histopathology of 16 coronary arteries in 10 pigs was evaluated 
following microwave (MW) balloon angioplasty. The mean time of 
MW energy delivery was 26 seconds at a mean temperature of 
77.1°C. The animals were sacrificed at either S; 24 hrs (early group; 
3 pigs/4 arteries) or 28 ± 2 days (late group; 7 pigs/12 arteries). 
The histopathologic features for each group were as follows: 
Early Group (S; 24 hrs) 
Intima: Absence of endothelium; intac!, but frayed 
internal elastic lamina (lEL). 
Media: Severe smooth muscle injury characterized by 
pyknotic nuclei with corkscrew appearance; 
intracellular and extracellular edema. 
Adventia: Hyperemia and congestion of microvasculature; early 
mononuclear cell inflltrate. 
Late Group (28 + days) 
Intima: Large amounts of NI proliferation ~ staining with 
a; intact endothelium; intact IEL. 
Media: Hypocellular, atr!Whic media, absent actin uptake; 
mild edema. 
Adventia: Fibrosis; proliferation of myofibroblasts around extemaJ 
elastic lamina; NI proliferation in adjacent branches. 
The observed heat injury pattern was eccentric in a majority and 
extended up to 2.0 mm beyond the IEL. The greatest amount of NI 
occurred at the area of greatest medial injury and atrophy. 
Conclusion: Despite early extensive smooth muscle cell injury and 
late medial atrophy with intact IEL, there is intense NI proliferation 
at 28 days following thermal injury. These findings may have 
implications for restenosis therapies toxic to medial smooth muscle 
cells. 
759-3 2:30 
Trea~ent with Angiopeptin Inhibits the DeveloJlllent of 
S.aoth Muscle Proliferation in a Balloon Overstretch 
Swine Kodel of Restenosis 
Edward C. Santoian, Marie Foegh, Michael B. Gravanis, 
Peter W. Ramwell, Peter A. Kot, Joel E. Schneider, 
Kristin Anderberg. R. Wayne Alexander, Spencer B. King 
III, Emory University School of Medicine, Atlanta, GA 
and Georgetown University Medical Center, Washington, DC 
Angiopeptin(AP) is an octapeptide analog of somatostatin 
that has been shown to decrease experimental intimal 
hyperplasia in rats and rabbits. The purpose of this 
study is to determine if AP could alter the development 
of smooth muscle proliferation following oversized 
balloon injury(BI) in the swine coronary arteries. 
Twenty-five swine underwent oversized(25-35%) coronary 
angioplasty using a 3.5mm balloon in the left anterior 
descending and circumflex arteries. On the day of injury 
10 pigs were started on 14 days of treatment with 
AP(100ug/kg in divided doses subcutaneously). Six pigs 
receiving AP were sacrificed at 14 days and the 
remaining 4 were sacrificed 28 Days after BI. The 
intimal(IA) and luminal(LA) areas and the maximal 
intimal thickness(MIT) were determined using a 
computerized morphometry program. 
Day14 vessels(n) LA/IA 
CONTROL 16 .70+.08 
ANGIOPEPTIN 12 .79+.05 
Day28 -
KIT(a) 
.41+.07 
.34+.07 
CONTROL 18 .72+.11 .46+.16 
ANGIOPEPTIN 7 .78+.08 .39+.08 
Data = Mean-+ SD 
P 
.008 
.n 
Conclusions: Subcutaneous administration of 
AP(100ug/kg) inhibited the development of smooth muscle 
proliferation 2 weeks after BI in swine coronary 
arteries. Two weeks after discontinuing AP, this effect 
was no longer seen. 
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Effectiveness of Specific Factor Xa Inhibition on 
Restenosis Following Balloon Angioplasty in Rabbits 
Michael Ragosta, Lawrence W. Gimple, Howard L. Haber, 
Chris T. Dunwiddie, George P. Vlasuk, Eric R. Powers, 
Ian J. Sarembock. U. of Virginia, Charlottesville, VA 
Thrombosis may be important in restenosis after balloon 
angioplasty (BA). Both recombinant antistasin (rATS), a 
long-acting leech-derived inhibitor of Factor Xa, and 
tick anticoagulant peptide (TAP), a short-acting specific 
inhibitor of Factor Xa, have potent anticoagulant activ•
ity. We evaluated the effect of a 2-hr i.v. infusion of 
rATS and TAP on restenosis following BA. Focal femoral 
atherosclerosis was induced in 43 New Zealand white rab•
bits by air desiccation injury followed by 8 high choles•
terol diet. BA was performed using a 2.5mm balloon and 3, 
60sec 10atm inflations. Rabbits were randomly assigned to 
bolus heparin (150U/kg, n=24), rATS (0.5mg/kg bolus, 0.25 
mg/kg infusion 1st hr, 0.125mg/kg 2nd hr, n~11) or TAP 
(lmg/kg bolus, 2.2mg/kg 1st hr, 1.1 mg/kg 2nd hr, n=8). 
Therapeutic PTT prolongation (>2x control) occurred in 
all groups. Angiograms preBA, postBA and at 28 days post•
BA were analyzed quantitatively (luminal diameter in mm ± 
SD; n = number of vessels). 
PreBA PostBA 28 Days 
Heparin (n=29) 1.11±0.25* 1.60±0.32* 1.00±0.42+ 
rATs (n=20) 1.06±0.20* 1.42±0.21* 1.25±0.24 
TAP (n=14) 1.07±0.28* 1.f4±0.22* 1.17±0.30 
*p<.001 pre vs post, post vs 28d, p=.02 rATS vs heparin 
Restenosis, defined as the reduction in LD (postBA vs 28 
days) was less in the rATS and TAP groups compared to the 
heparin group (-0.17±0.llmm, -0.26±0.22mm vs -0.66±0.58 
mm, p50.02). 
Thus, a 2-hr infusion of a specific factor Xa inhibi•
tor at the time of balloon angioplasty reduces angio•
graphic restenosis in this animal model. 
759-5 3:00 
I-MethoxyplOralen and Lonpave Ultraviolet Irradiation are a Cell Cycle•
Jnclqlmdenl AntiproliferaIive CombinatiOII for Vucular SmooCh Muacle 
Keith L March, Brian L Patton, Robert L Wilensky, David R Hathaway. Indi•
IID8 University School of Medicine and RL Roudebush VAMC, lndianapolis,IN. 
Smooth muscle cell proliferation plays a major role in the ,enesis of 
restenosis following angioplasty or vascular injury. Although the effects of 
arterial exposure to high_ergy ndiation sources such as lasers has been inves•
tigated in detail, the effects on vascular cells of low-intensity radiant energy in 
combination with photoactive aBents have not been characterized. The psonlens 
are photoactive aaents for which use in conjunction with local exposure to ul•
traviolet light in the A band (PUVA) is mown to be well-tolerated in the treat•
ment of various dermatologic disorders. We have investigated the effects of 
PUVA exposure on the proliferation of bovine aortic smooth muscle cells 
(BASMC). Proliferation and viability were assessed over a 14 day period by 
trypan blue exclusion counts. Cell cycle effects were evaluated by thymidine 
incorporation and flow cytometry with DNA quantitation following addition of 
serum or platelet-derived growth factor (PDGF-BB) to subconfluent cells syn•
chronized by serum withdrawal. No effect was observed following exposure to 
8·methoxypsoralen (I-MOP) at concentrations up to 10 I'M or UVA irradiation 
at eneraies up to 2.5 Jlcm'. Longwave ultraviolet light and 8-MOP were found 
to behave synergistically as potent inhibitors of DNA synthesis in BASMC with 
the ECSQ. in combination ranging from 7 I'M at 0.35 Jlcm' to 0.2 I'M at 2.1 
1Icm'. Similar effects may be obtained by inverse variation of dose and energy 
delivered. Flow cytometry of cells treated with PUVA at several times after 
serum stimulation demonstrated for each time-point a block in further cell cycle 
progression for cells in an phases of the cell cycle. This effect was independent 
of subsequent 8-MOP washout. Evaluation of [12SIj_labeled PDGF and EGF 
binding revealed no effect of PUVA on the apparent number or affinity of PDGF 
binding sites present; but a dose-dependent inhibition by PUVA of EGF binding. 
This inhibition occurs at higher PUVA doses than the cell cycle inhibition, and 
accordingly does not appear to represent a critical mechanism for the antiprolif· 
erative effect. Cell counting after a single exposure to PUVA (l"M, 1.51Icm') 
revealed complete stasis of cell proliferalion over a 28 day period with no in•
crease in trypan-positive cells noted. We conclude that PUVA treatment repre•
sents a novel method for locally inhibiting prolifer.,ion of vascular smooth 
muscle cells in a cell-<:ycle independent, non-<:)wlytic fashion. 
JACC Vol. 19, No.3 
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Inhibition of Proliferation of Human Vascular Smooth 
Muscle Cells Using Antisense Oligonucleotides To PCNA 
Geoffrey Pickering, Lawrence Weir, Jaclynn Jekanowski, Jeffrey M. 
Isner. Tufts University School of Medicine, St. Elizabeth's 
Hospital, Boston, MA 
Proliferation of vascular smooth muscle cells is fundamental to the 
development of restenosis. The proliferating cell nuclear antigen 
(PCNA) is a nuclear protein believed to be necessary for cellular 
DNA synthesis. The purpose of this study was to evaluate PCNA 
expression in human plaque and to determine if interference with 
PCNA gene expression could reduce proliferation of human smooth 
muscle cells (SMC) in culture. Plaque material was obtained from 
primary coronary, primary peripheral, and restenotic peripheral artery 
lesions retrieved by atherectomy. SMCs were cultivated by explant 
outgrowth from human internal mammary artery. Immunostaining 
with a mononclonal antibody to PCNA indicated that in arterial 
primary lesions very few (0·1 %) PCNA·positive cells were seen; 
however in restenotic tissue up to 15% of cells were positive. In 
culture, 60·80% of cells maintained in 10% serum·supplemented 
medium showed nuclear positivity; less than 10% of cells were 
immunoreactive after 72 hours of serum deprivation (0.5%). 
Oligonucleotides complementary to nucleotides 4·21 of human 
PCNA mRNA were then used for the inhibition studies. Serum•
stimulated cells were exposed to either the antisense oligonucleotide 
(30IlM), to buffer alone, or to the sense oligo (to assess any 
nonspecific effect). After 24 hours cells were labelled with [3H]•
thymidine, fixed in methanol, and the labelling index (LI) determined 
by autoradiography. LI of untreated cells ranged from 9-18%. This 
was markedly reduced in the cells exposed to the antisense 
oligonucleotide (LI 28-58% of control). Exposure to the sense 
oligonucleotide resulted in a modest and variable reduction in LI (43-
91 % of control). Conclusions: 1. Growth-related expression of 
PCNA is evident in human SMCs both in culture and in arterial 
plaque. 2. Antisense inhibition of PCNA reduces SMC proliferation 
over and above any nonspecific effect. This may therefore represent 
a suitable genetic approach for therapy of vascular restenosis. 
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Proliferating Cell Nuclear Antigen Immunohistochemistry: 
a New. More Sens it ive Method for Detection of 
Proliferating Vascular Smooth Muscle Cells. 
Uwe Zeymer, Michael C. Fishbein, Paul Dimayuga, Mariko 
Ishimori, James S. Forrester, Bojan Cercek. 
Cedars-Sinai Medical Center, Los Angeles, California. 
Prol iferating cell nuclear antigen (PCNAl is a DNA 
polymerase auxiliary protein, correlated with S phase of 
ce 11 cycl e. We compared detect i on of prol i ferat i ng 
vascular smooth muscle cells (SHC) in vitro and in vivo 
with PCNA immunohi stochemi stry and two establ i shed 
methods, [3Hl thymidine (THY) autoradiography and 
bromodeoxyuridine (BrdU) immunohistochemistry. 
In vitro, 2 h pulse labelling with THY and BrdU of rat 
vascular SHC, incubated for 24 h in serum free media 
after removal of 10% fetal calf serum, stained 11.5% and 
11.0% of cells respectively. PCNA invnunohistochemistry 
was positive in 20.6% of cells. In vivo, THY and BrdU 
were injected in rats 18, 6 and 1 h before harvesting 
the aortae. I n the undenuded aortae and 1 day after 
balloon denudation less than 0.15% medial SHe were 
labe 11 ed by any method. The percent 1 abe 11 ed cell s 
(mean±SEM) at later time pOints were: 
Day 3 Day 7 Day 14 
MEDIA THY 4.2±0.2% 1.0±0.1% 0.2±0.02% 
BrdU 3.8±0.2% 1.0±0.1% 0.1+0.03% 
PCNA 4.7±0.5% 1.2±0.1% 0.2io.03% 
INTIMA THY 0% 42.0±0.9% 6.9±0.7% 
BrdU 0% 40.1±2.1% 8.1±0.5% 
PCNA 0% 46.0±4.4% 10.2±1.0% 
With double labelling all THY positive cells were PCNA 
positive, while 'some cells were only positive for PCNA. 
Conclusion; PCNA immunohistochemistry is more sensitive 
than THY autoradiography and BrdU invnunohi stochemi stry 
in identifying proliferating vascular SMC in vitro and 
in vivo. Use of PCNA specific antibodies is further 
advantageous since prior labelling is not required. 
ABSTRACTS 
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Human Vascular Smooth Muscle Cells Express Urokinase· 
Type Plasminogen Activator Receptors. 
Shunlchlro Okada, Katalin Kariko, Alice Kuo, Eva Hozakowska· 
Rubin, Douglas B. Cines, Elliot S. Bamathan. 
University of Pennsylvania and the Wistar Institute of Anatomy and 
Biology, Philadelphia, PA 
Intimal hyperplasia following vascular Injury Is associated with an 
Increase In plasminogen activator (PA) synthesis. PA activity is 
regulated In part through the expression of specific cell surface 
receptors. Radioligand binding studies performed on confluent 
monolayers of human umbilical vein smooth muscle cells (HVSMC) 
using 1125 labeled single chain urokinase-type plasminogen 
activator (scu·PA) demonstrated specific and saturable binding. 
Scatchard analysis of equilibrium binding data demonstrated that 
HVSMC express a maximum of 6.S±I.1 x 10S sites per cell and bind 
scu·PA with high affinity (Kd-3.9±1.0 nM, n-S, ±SEM). Brief acid 
treatment of HVSMC u·PA receptors (u·PAR) prior to radioligand 
binding demonstrated no significant difference In specific binding, 
suggesting <S% receptor occupancy in culture. Preincubation of 
HVSMC with phosphatidylinosltol specific phospholipase C for 1 h 
demonstrated >70% reduction In specifiC binding, but there was 
>90% return of u-PAR after 18 hours. Northern blot analysis of 
total cytoplasmic RNA extracted from HVSMC showed a single -1.4 
kb mRNA for the u·PAR. These studies suggest that HVSMC express 
u·PAR similar In nature to the u·PAR expressed by several other 
cell types. Furthermore, preincubation of HVSMC with thrombin for 
18 hours resulted in augmentation of u-PAR mRNA expression in 
vitro. Down-regulation of u-PAR protein expression was 
demonstrated when serum was withdrawn from the medium. 
Increased cell· associated u-PA activity by vascular smooth muscle 
cells may be pathophysiologic In atherosclerotic or restenotic 
vascular lesions whereas diminished ceil-associated u-PA activity 
might Inhibit migration of these cells and thereby reduce the 
severity of the intimal hyperplasia observed In respollse to vascular 
Injury. 
760·3 2:30 
Free Cholesterol Enrichment Increases L-Type Calcium Currents in 
Vascular Smooth Muscle Cells 
Luyi Sen, Russel A. Bialecki, Erin Smith, Thomas W. Smith, Wilson 
S. Colucci. Brigham and Women's Hospital and Harvard Medical 
School, Boston, MA. 
Since membrane free cholesterol (FC) may be increased in vascular 
smooth muscle cells (VSMC) exposed to elevated cholesterol levels, we 
evaluated the effect of enrichment of cellular FC on Ca ++ currents in rat 
aortic VSMC by whole-cell patch clamping. VSMC FC was enriched by 
addition of cbolestrol (Cbol}-ricb liposomes (Chol:phosphatidylcholine: 
2:1) to the culture medium (1 mg Chollml medium). In VSMC 
incubated with liposomes for 24 hr, FC increased from 13± 2 to 22 ± 3 
"g/mg protein (p<0.01; n=8), without change in Chol ester, 
phospbolipid or protein. Chol-rich liposomes caused a gradual increase 
in L-current wbich was evident at 30 
Contrl (+)PN202-791 min and reached a plateau between 16 
and 24 hr (73±7% increase, p<O.OI, 
n = 18). The bal f inactivation potential 
o • Control cells 
/; & Cbol-enncbed 
for Chol-enriched cells was shifted 
from -21.3±0.6 to -12.7±0.6 mV I (pA/pF) 
(p<O.OI, n=8). The peak L current 
stimulated by (+ )-PN202-79I was 
comparable in Chol-enricbed and 
control cells. Inhibition of L-current by -2 
(-)-PN202-79I was less sensitive in -4 
Chol-enricbed cells. Thus, enrichment -6 
of VSMC FC is associated with a 
steady-state increase in L-type Ca·· -8 
current, suggesting a potential role in -.0 
the vascular hyperreactivity associated -'2 
with bypercholesterolemia. -40 -20 
cells 
20 40 
V (mY) 
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NonmuscJe Myosin: Two Isoforms With Different 
Function in Vascular Restenosls 
Sigrid Nikol, Lawrence Weir,Marianne Kearney, Guy Leclerc, 
Carolyn Donovan, Jeffrey Isner 
Tufts University School of Medicine, SI. Elizabeth's Hospital, 
Boston,MA 
Nonmuscle myosin has been implicated in cell division in cell 
division, migration and secretion. Smooth muscle proliferation has 
been shown to be associated with a change of expression of myosin 
from smooth muscle to nonmuscle myosin. It is now known that there 
are two isoforms. The differential functions of which are unclear. 
Previous studies demonstrated overexpression of nonmuscle heavy 
chain isoform B (NMMHC B) in restenotic atherectomy specimens by 
in situ hybridization (ISH). In order to compare the expression of 
NMMHC A and B in these lesions we have performed ISH using 
probes specific for A and B in specimens examined simultaneously. 
90 sections of 4 restenotic and 4 primary atherosclerotic lesions 
obtained by directional atherectomy from 8 patients with peripheral 
vascular disease were analyzed and sections of internal mammary 
artery were included as a negative contro!. That the sections contained 
intact mRNA available for hybridization was demonstrated on adjacent 
sections using transforming growth factor-betal. Using semi•
quantitative analysis, expression of NMMHC A was lowest in the 
internal mammary artery, increased in primary atherosclerotic lesions 
and only slightly increased in restenotic lesions. In contrast, 
expression of NMMHC B, as observed previously, was much higher 
in restenotic lesions than primary atherosclerotic lesions and was not 
detected in the internal mammary artery. Thus B appears to be a 
marker for restenosis while A seems to be expressed at all stages of 
smooth muscle cells. The differential expression of 2 isoforms of the 
NMMHC suggests as of yet unidentified differences in function. 
760·5 3:00 
Differentiation of Monocytes to Macrophages is Stimulated 
by Secretory Products of Human Vascular Smooth Muscle 
Cells 
Eberhard von Hodenberg, Eva Pestel, Martina Hautmann, 
Christoph Bode, Wolfgang Kubler. 
University of Heidelberg, Cardiology, Germany 
Formation of atherogenic foam cells is dependant on 
differentiation of monocytes to macrophages in the arterial wall. 
Mechanisms influencing macrophage differentiation in the artery 
wall are still not clear. We examined the effect of smooth muscle 
cells (SMC) secretory products on the differentiation of 
monocytes to macrophages. Human SMC, isolated from the 
aorta of heart donors, were incubated until subconfluency was 
archieved. Preparation of SMC-secretory products (SMC 
conditioned medium = SMC-c-medium) was performed by a 
48h incubation of SMC in serum free medium. Freshly isolated 
human monocytes were then incubated in SMC-c-medium, 
medium supplemented with 10 % serum, or medium without 
serum. The grade of monocyte/macrophage differentiation was 
analysed by immunofluerescent techniques with specific 
monoclonal antibodies MAX 1,2, and 11. 
Differentiation of monocytes to macrophages occured after 6 
days, when cells were incubated in SMC·c-medium or in 
medium + 10% serum. Cells incubated in serum free medium 
died after 3 to 6 days and did not differentiate to macrophages. 
Known secretory products of SMC such as PDGF, interleucin 
1,2 and 6 or TNF alpha all failed to induce a comparable 
macrophage differentiation. 
We conclude that SMC can stimulate macrophage 
differentiation via (a) secretory product(s) which still need(s) to 
be characterized. By this interaction SMC can effect 
macrophage foam cell formation and atherogensis. 
JACC Vol. 19, No.3 
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Angiotensin II increases Plasminogen Activator Inhibitor 
activity and mRNA in rat cultur~d vascular smooth muscle 
cells 
Giovanni Sperti, Rene van Leeuwen, Anilio Ma~eri, Comelis Kluft. 
Cardiovascular Unit, Royal Postgraduate Medical School, London, 
U.K., and Gaubius Institute TNO, Leiden, The Netherlands 
Angiotensin II (Ang II) action on the vasculature is not limited to 
vasoconstriction, but includes the induction of vascular smooth muscle 
(YSM) cell hypertrophy and in some species also the stimulation of 
DNA synthesis. PDGF, a known mitogen for these cells, shares with 
Ang II several steps of its intracellular signalling pathway, leading to 
the production of plasminogen activator type 1 (PAl-I). To investigate 
the possibility that Ang Il could also modulate the fibrinolytic balance 
within the arterial wall. we examined the expression of PAl-I and 
tissue-type plasminogen activator (t-PA) mRNAs in cultured rat aortic 
smooth muscle cells. Northern analysis performed with a 2.5 kb 
fragment of a PAI-l cON A from the coding region of the rat gene 
demonstrated a five to tenfold increase in the PAl-I mRNA 3 to 6 
hours after stimulation with 10.7 M Ang II. A similar response was 
observed by using a 2.0 kb fragment of the human t-PA cDNA. 
However, the net result was an increase in PAl-I activity in the cell•
conditioned supernatant, from 4.6± 1.5 IV/OIl in control conditions to 
19.0±2.8 IU/ml 6 hours after the addition of 10.7 M Ang II (mean 
±SE, p<O.003, n=5). The Ang lJ-induced increase in PAl activity was 
dose ~·lated. with an EDso of I nM. 3x IO·6M [Sarl.l1eR)Angiotensin 
II, a specific competitive antagonist of Ang II, blocked 93% of the PAl 
activity induced by 1O-~ Ang 11. The Ang II-induced increase in PAl 
activity in the supernatant of YSM cells is likely to be due to PAl-I, as 
suggested by immunoblolting and fibrin autography. 
Recent research has demonstrated the existence of a localized vascular 
renin-angiotensin system. The finding that its final active product Ang 
II can potentially modulate the plasminogen activation in the arterial 
wall could have important biological and therapeutic implications for 
the evolution of arterial wall thrombi and the migration of cells through 
the vessel wall in the genesis of atherosclerotic lesions. 
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Heart Rate Variability: Focu. on Dellned Cycle Length. 
2:00 
George Monlr, Dan Flntel. Paul Yamold, Jerry Weiss, Nader Sahyounl. Donald 
Singer. Northwestern University Medical School, Chicago. illinois 
Low heart rate variability (HRV) Is associated wtth heart disease and has been 
proposed as an Index 01 risk 01 arrhylhmlc death. However Its potential utUIty 
Is IImked by the wide range 01 HRV values wtthln different clinical populations. 
This may reflect the fact that conventional HRV n.asures Integrate data from 
a 24 hr recording aver a wide range 01 cycle lengths (R-R IntervaJ). Differences 
In the n.an heart rate as reflected by the distribution 01 cycle lengths over the 
24 hours could underlie variation In HRV and intergroup overtap. To test the 
hypothesis that limiting the computation 01 HRV to a defined range 01 cycle 
lengths common to all subjects could Improve discrimination between heatthy 
subjects and patients wtth coronary artery disease (CAD), we analyzed 24 hr 
Holter mon~or recordings for 70 normal subjects( age 24-62, ~ years) and 
35 CAD patients (age 42-71, 57 years). Cycle length range 650-950 msec., 
common to all subjects, was selected for computing the defined cycle length 
range HRV (DR-HRV). Average HRV over the 24 hr recording period (24hr•
HRV) was defined as the n.an 01 the standard deviations 01 all the 5 min, 
normal sinus, RR intervals. 
~ 
Normals 
CAD 
24hr-HRV 
58.3 :t 24.6 
41.5:t 16.1 
.I2B:I::!Bl! 
56.5 :t 20.9 
41.6 :t 15.9 
Stepwise linear discriminant analysis was employed to determine the relative 
Importance 01 the variables DR-HRV. 24hr-HRV and age, In discriminating CAD 
patients from normals. The analysis showed that: 1) DR-HRV is the single most 
powerful variable (p < .0002) for diSCrimination between normals and CAD 
patients; 2) the model Including DR-HRV and age achieved 80% overall 
c!assHication accuracy, a posftlve predictive value 01 67% and a negative 
predictive value 01 89%; and 3) adding 24hr-HRV. In a model Including the 
three variables. did not improve diagnostic performance. Thus. restricting HRV 
analysis to a defined cycle length range common to all the subjects under 
study slgnHicantly improves diagnostic performance and decreases ove~ap 
between normals and CAD patients. 
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761·2 2:15 
Survival Poll-Sudden Cerdlac Deeth: Predictive Value of Heart Rate 
Variability VI. Inducibility 
Mirza Ahmed, Dan Flntel, Fang Zhang, Nader SahYOU!ll, Jerry Weiss, Tim 
Brenauer and 00naId Singer. Northwestern University, Chicago, Il 
Programmed electriCal stimulation Is widely used for predicting risk of sudden 
cardiac (arrhythmic) death (SCO). Low Heart Rate VariabUIty (HRV), a putative 
Index of vagal tone, also has been associated with high risk of SCD. The 
relationship between thasa Indices Is unknown. To assess their comparability 
for predlctlng long-tenn survival post- SCD, we determined HRV from 24 hour 
Holter records of 34 SCD survivors, of 
whom 20 were Inducible (group I), 14 _ ) 
non-Induclble (group II) and for 20 ... l"~ 
age-matched normal controls (group - -
III). HRV wes determined using the .. 
standard deviation of normal sinus R-R .. __ 
Intervals during successive 5 min peri-
ods and averaged over 24 hrs (SO • 
measure). HRV s30ms has been asso- __ _ 
clated with high risk of mortality. Pa-" ........'111 
tlents were followed up to 8 years with - (11) 
mortality as the end-point. Mean HRV ... ~
for group I was 27:t 3(SEM) and 3h 7 .. _ .... _" 
for group II. Both were slgnWicantly 
lower than controls, 61 :t3ms .. 
(p<O.oool and 0.005, respectively). _ ... -
Sixteen patients died, 13 in group I. 01 .. 
these, 9 had HRV S 3Oms. Group II.. ---
had 2 deaths, both with HRV S 3Oms. ........ "., 
Thirteen patients who died had HRV S 
4Oms, the same number as detected by Inducibility criteria. Unear regreSSion 
analysis showed good correlation between low HRV and mortality (r= 0.64). 
Survival curves for InducibUIty and HRV S 30ms were comparable. Combining 
both tests correctly ldentWied all patients who died. We conclude that the 
predictive value of low HRV and inducibility Is comparable with respect to 
survival after SCD. The combination of the two tests provides an even more 
powerful predictor of mortality than etther test alone. 
761·3 2:30 
Changing Patterns of Heart Rate Variability in Patients Suffering a 
First Myocardial Infarction 
AD F1apan, RA Wright, J Nolan, JMM Neilson, DJ Ewing. 
Royallnfinnary, Edinburgh, Scotland, UK 
Heart rate variability can be measured from 24 hour ECG recordings 
by counting the number of times that successive RR intervals 
(counts) differ by more than 50 ms. This measure of heart rate 
variability accurately reflects cardiac parasympathetic activity. 
Twenty patients (mean age 57 years, SO 7.9 years) were studied 
following a first myocardial infarction confirmed by ECG and 
cardiac enzymes. Twenty- four hour ECG recordings were made 
within 48 hours of admission, at 7, 42 and 140 days following 
myocardial infarction. All patients were treated with streptokinase 
and all received oral beta-blockers and aspirin. 
Group mean total 24 hour counts increased from 592 (range 78-
3812) at 48 hours, to 648 (range 109-5473) at 7 days, to 1145 (range 
162-6268) at 42 days and to 1958 (range 344-9632) at 140 days 
following acute myocardial infarction. 
If the patients were divided into 2 groups depending on the site 
of their infarct, a striking difference in group mean total 24 hour 
counts was observed when comparing those patients with anterior 
(277, range 78-2708; n=l1) to those with inferior (2172, range 897-
3812; n=9) infarction after 48 hours (P<0.05). This difference in 
group mean total 24 hour counts was less marked at 42 days (anterior 
1051, range 212-6268 and inferior 1321, range 162-3265) (NS) and 
at 140 days (anterior MI 1655, range 344-9632, inferior MI 2588, 
range 1700-5167 counts) (NS). 
These data suggest that following anterior myocardial infarction 
there is impaired cardiac parasympathetic function which improves 
over the next few weeks whereas in inferior infarction there is 
relative preservation of cardiac parasympathetic function. 
ABSTRACTS 
761·4 2:45 
Fractal AnalYSis of Heart Rate variability 
Ferenc Czegledy, Jose Katz, Richard Steinman, Lawrence Boxt, 
J. Thomas Bigger, Jr. 
Columbia University, New York, NY 10032 
A decrease in heart rate variability Is known to occur after 
myocardial infarction. Usual analysiS of interbeat (RR) variability 
employs power spectrum analysis. An alternate approach, 
however, could potentially be the use of fractal analysis. This 
technique allows the characterization of scale invariant structures 
of non-integer dimension by means of a quantity referred to as the 
fractal dimension(d). We investigated the fractal properties of the 
RR intervals in 24-hour Holter recordings of twenty normal 
volunteers and twenty patients post myocardial Infarction(MI). 
EctopiC beats were removed in the standard fashion and d was 
calculated by use of a box counting algorithm. In all cases 
considered the RR Intervals were shown to be fractal (or,more 
precisely, self-affine). The calculated fractal dimensions were 
1.2675+-.0701 for the normal volunteers and 1.1472+-.0928 for 
the post-MI patients. By use of the unpaired t-test, the difference 
between these two groups was statistically significant (p<0.0001). 
We also compared these results to the usual Fourier power 
spectrum analysis. The spectral measures considered were the 
natural logarithms (In) of the ultralow frequency (ulf), very low 
frequency (vII), low frequency (If), and high frequency (hf) parts of 
the spectrum. The correlation coefficients were as fOllows: 
In/uiP In/viP InOD In(hO 
d Normal 0.033 0.011 -0.027 -0.161 
d Post-MI 0.596 0.700 0.726 -0.597 
Fractal analysis thus provides a tool for the quantitation of heart 
rate variability which differentiates between normal and post-MI 
patients. Furthermore, since there is not a very good correlation 
with the usual Fourier power spectrum analYSis, the fraclal 
dimension may have the potential to provide new information. 
761·5 3:00 
Cycle Length Dependence of Heart Rile Variability 
167A 
George Monlr, Dan Flntel, Paul Yamold, Jerry Weiss, Nader Sahyounl, Donald 
Singer. Northwestem University Medical School, Chicago, Illinois 
Preliminary observations suggest that there Is a relationship between time 
domain 24 hr heart rate variabUlty (HRV) and mean R-R cycle length (Cl). To 
gain Insight Into that relationship, the CL dependence of HRV needs to be 
defined. Thasa data can not be obtained using conventional methods for HRV 
detennlnation, which provide a 24 hr averaged value. To test the hypotheses 
that HRV Increases with Increasing CL and thai this dependence may vary In 
the presence of heart disease, we computed HRV values et different cycle 
lengths for 70 normal subjects (age 24-82, ~ yrs) and 35 patients wtth 
coronary artery disease (CAD) (age 42-71, 57 yrs). For each consecutive 5 
min period In a 24 hr recording we computed the mean R-R and the standard 
deviation of the normal sinus R-R Intervals. 5 min periods with comparable 
mean R-R were grouped In consecutive 100 msec bins. HRVat each Cl wes 
computed from the mean standard deviation of all the 5 min periods In each 
bin for each subject. Than, mean HRV values at each CL were determined for 
normal and CAD groups. Statistical slgnmcance of HRV differences between 
normals and CAD patients and across different Cl (600 through 1100 msec) 
were evaluated using analysis of covariance, wtth age treated as a covariate. 
The resu~s, after correction for the 
contribution of age, showed that: 1) lor 80 lIlY ~ 
both normals and CAD patients, HRV 
slgnWlcantly Increased with increasing Cl 70 
up to CL 1000 (p<.017); 2) normals had 0 0 0 ! ~."' 
consistently higher HRV at each CL SO 0 i """ 
(p<.015) than CAD patients and 3) CAD ! , 
patients did not exhibtt signmcant 30 
Increase In HRV between Cl 800-900 but 
normals did (p<.0001). 
In conclusion, 1) HRV Is crttlcally dependent upon CL 2) This dependence 
permtts clearcut discrimination between normal subjects and patients wtth 
CAD. Thasa data suggest that comparisons between individuals' or groups 
should be performed at slmUer cycle lengths. 
168A ABSTRACTS 
761·6 3:15 
Aging Effect on Circadian Variability of 
Cardiac Vagal Activity 
Tai Sakurabayashi, Hiroto Mochizuki, Hiroyuki 
Ishii, Tetsuya Asakawa, Kohji Tamura. 
Yamanashi Medical College, Yamanashi, JAPAN 
AIM: To assess aging effect on circadian 
variabilities and rhythms of cardiac vagal 
activity. METHODS AND SUBJECTS: 145 clinically 
healthy volunteers were studied with Holter ECG 
(Trendsetter II, Avionics). RR interval and RR-
50 (Ewing method) were assessed. Circadian 
variabilities estimation and rhythmometry by 
cosinor method were performed. RESULTS: 1) RR 
interval and RR-50 showed circadian 
variabilities (mean 24-hour of RR interval 
0.83+0.07 sec., RR-50 477+301 counts/hr.) and 
rhythm. 2) Vagal (RR-50) -reached to the peak 
activity from mid-night to early in the 
morning. 24-hour mF!an and circadian amplitude 
of heart rate were significantly decreased by 
aging. 
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927·1 
Restenosls Rates After Dissection During Angloplasty: A 
Case of Wnhdrawal Bias ? 
Donald F. Fortin. David J. Frid. Charlotte L. Nelson. Michael Miller. James E. 
Tcheng. Robert M. Califf. Richard S. Stack. Duke Medical Center. Dulham. 
NC 
Previous reports suggested a trend towards a lower restenosis rate (RR) in 
lesions suffering dissection (DISS) during angioplasty (PTCA). To 
determine whether withdrawal bias from adverse events (AE) such as 
emergency bypass surgery (CABG). out of lab abrupt closure. or death 
significantly alters the estimated RR in lesions In which DISS occurs. we 
examined 836 native coronary artery lesions in 710 patients undergoing 
first time PTCA for stablelunstable angina for the presence of a major ( > 20 
mm In length) or minor« 20 mm) DISS. All patients were prospectively 
entered Into a 6 month follow-up (FU) angiography protocol with 86% of 
those clinically eligible returning for angiography. Selected AE occurring 
during FU stratified by DISS category on a per palient baSis are listed below: 
Dlss.ctlon Category Major Minor None 
n.Ua ~ rL=..ill 
Myocardial Infarction 6 (8%) 3 (2%) 17 (3%) 
Abrupt Closure 9 (11%) 6 (4%) 24 (5%) 
Repeat PTCA 4 (5%) 6 (4%) 28 (6%) 
Death 5 (6%) 2 (1%) 17 (3%) 
Emergency CABG 12 (15%)' 2 (1%) 19 (4%) 
Restenosis Rate 36% 45% 43% 
Any above event 52% 42% 42% 
('. p < 0.05) 
Conclyslon; While the above rates of MI. abrupt closure and repeat PTCA 
are not significantly different between the three groups. the consequences 
of these AE resutted in significant differences in events (death or bypass 
surgery) which lead to significant withdrawal bias. since these patients 
would be routinely unavailable for the detection of restenosis. While a lower 
estimated RR was seen wHh major dissections. this apparent salutary effect 
is secondary to wHhdrawal bias from an increased Incidence of emergency 
CABG and death. 
927·2 
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Repeat Balloon Injury IIarkedly Increases SlIOOth Huscle 
Cell Proliferation and Alters the Pattern of Intiaal 
Hyperplasia in a Swine Hodel of Restenosis 
Joel E. Schneider, Michael B. Gravanis, Edward C. 
Santoian. Neal A. Scott, Kristin Anderberg, Gustavo 
Cipolla, and Spencer B. King III, Emory University 
School of Medicine, Atlanta, GA 
Early repeat angioplasty is associated with high 
restenosis rates. The purpose of this study was to 
characterize the histopathologic findings of repeat 
balloon injury(BI) in a swine model of restenosis. 8 
pigs underwent overstretch BI with a 3.5mm balloon in 
the left anterior descending and Circumflex arteries 
followed by repeat Bl at the same site on day 7 or day 
14. Animals were sacrificed 28 days after initial Bl. 
After H&E and elastin staining, tbe ratio of luminal to 
intimal areas(LA/IA) and maximal intimal thickness(MIT) 
were determined using a computerized morphometry program 
and compared to single injury controls. 
Results and Conclusion: 
Groups n=vessels LAllA MIT(mm) 
CONTROL 8 .76+.04 .50+.30 
Reinjury day 7 8 .50+.21* .58+.17* 
Reinjury day 14 8 .54+.18* .55+.18 
*P<.05(Reinjury vs Control)- mean+SD 
Repeat Bl markedly increased the overall extent of 
intimal hyperplasia(IH) in a pattern that differs from 
single BI. Light microscopy disclosed that the new 
injury identified by smooth muscle cell proliferation 
occurs at a different segment of the wall circumference 
than the initial injury site. We conclude that the 
initial restenotic lesion is noncompliant. and the 
increase in IH occurs in the opposing normal segment. 
Secondly. tbis method may offer a suitable experimental 
model of angioplasty for restenotic lesions. 
927·3 
Inhibition of Smooth Muscle Cell Hyperproliferation by 
8·methoxy Psora len Activated by Ultraviolet Light 
Kenton W. Gregory. Joanne M. Wimberly, Peter C. Block. R. Rox 
Anderson. SI Vincent Hospital. Portland. Oregon and Massachusetts 
General Hospital. Boston. Massachusetts. 
Inhibition of smooth muscle cell hyperproliferation by 8-methoxy 
Psoralen (MOP) activated by ultraviolet light (UVA). a potent 
inhibitor of cellular proliferation in skin. was evaluated as a 
possible locally-activated treatment for intimal hyperplastic lesions 
caUSing angioplasty restenosis. New Zealand White rabbit aortic 
smooth muscle cells were plated sparsely at 4x104 cells/cm2 and 
incubated 24 hours in 20% fetal calf serum to induce proliferation. 
Proliferating cells were treated with MOP(1 I1g/ml). high-dose 
UVA(200mJ/cm2). or MOP activated with UVA ranging from 10 to 
200mJlcm2. Control cells received no treatment. After 48 hours. 
cells were labelled with tritiated thymidine. harvested and DNA 
encorporated thymidine was assessed in a scintillation ccunter. Cell 
viability was assayed by succinate dehydrogenase activity (MTT). 
GrouP MOP(ug/mll UYAlmJlCm2) CPMx103 MTTlcm-1) 
UVA only 0 200 lS.7±O.9 0.S3±.01 
MOP only 1.0 0 12.9±O.9 O.S1±.Ol 
MOP+UVA 1.0 50 11.9±O.9 0.S2±.01 
MOP+UVA 1.0 100 7.1±1.0 0.60±.01 
MOP+UVA 1.0 200 4.4±O.3 0.59±.01 
Cells receiving only MOP, UVA or no treatment had high levels of 
tritiated thymidine uptake-not statistically different. Cells treated 
with MOP activated by UVA had a dose dependent decrease in 
thymidine uptake with maximal effect at 200mJ(p< .0001)•
similar to levels from confluent, non-prOliferative cells, indicating 
inhibition of cellular proliferation. MTT assays indicated normal 
activity or viability in all groups. This finding may provide the 
basis for a locally active treatment of intimal hyperplasia with 
minimal systemic toxicity for prevention of angioplasty restenosis. 
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927-4 
Intravascular Ultrasound Imaging Predicts Restenosis Following 
PTCA 
Junko Honye, Donald J. Mahon, Ashit Jain, Nathan Wong, 
Jonathan M. Tobis University of California, Irvine, CA; 
Ochsner Clinic, New Orleans, LA 
The incidence of restenosis following PTCA was compared with 
plaque morphology assessed by intravascular ultrasound (IVUS) 
imaging in 66 lesions. IVUS revealed 6 morphologic patterns; 
Type A: partial tear of plaque, Type B: full thickness tear of 
atheroma, Type C: plaque fracture and dissection < 180" behind 
plaque, Type D: extensive dissection> 180", Type E1: concentric 
plaque without tear or dissection, and Type ~: eccentric plaque 
without tear or dissection. Angiographic restenosis ( > 50% lumen 
diameter) occurred in 14 (21%) lesions. The incidence of 
restenosis occurring in each type of morpholo~ was: 
lype A B C D El ~ 
N= 7 11 18 4 14 12 
Restenosis 1 1 2 0 8 2 
Rate (%) 14% 9% 11% 0% 57%" 17% 
Clinical and anatomical factors (location of lesion, lumen cross•
sectional area, % stenosis by angiography or lVUS, and IVUS 
morphological type) were analyzed to determine predictability of 
restenosis. Multiple logistic regression analysis identified Type EI 
morphology as the strongest predictor of restenosis (relative risk 
= 10.4, "p < .01) with no otherfactors emerging as predictive. We 
conclude that plaque morphology determined by lVUS imaging 
predicts the likelihood of restenosis following PTCA Alternative 
therapy may be warranted in patients who have a residual 
concentric, non-fractured plaque post PTCA 
927-5 
Effect of "In Situ" Heparin Delivery by a Porous Balloon 
Catheter on Restenosis Following Balloon Angioplasty 
Lawrence V. Gimple, S. David Gertz, Howard L. Haber, 
Eric R. Powers, Yilliam C. Roberts, Ian J. Sarembock. 
U. of Virginia, Charlottesville, VA; Hebrew U., Jerusa•
lem, Israel; and Pathology Branch NHLBI/NIH, Bethesda, MD 
Heparin has both anticoagulant and antiproliferative 
properties and inhibits intimal hyperplasia following 
endothelial injury when administered by periadventitial 
delivery. Ye therefore hypothesized that direct intra•
mural delivery of heparin may inhibit restenosis follow•
ing balloon angioplasty (BA). Rabbits (n_29) with focal 
femoral atherosclerosis (endothelial injury plus choles•
terol feeding) received bolus heparin (150U/kg) and un•
derwent BA (2.5mm balloon, 3x60sec inflations at lOatm). 
Subsequently, Porous Balloon Arteries (PBA, n.20) were 
treated with heparin (1500U) delivered directly into the 
arterial wall using a USCI 2.5 or 2.75mm porous balloon. 
Control Arteries (CA, n=28) received no additional hepa•
rin. Heparin delivery into the atherosclerotic plaque 
was confirmed using fluoresceinated heparin. Arteries 
were analyzed blindly using quantitative angiography. 
The mean LD in PBA increased from 1.22±0.25mm pre- to 
1.66±0.33mm post-BA and decreased to 1.05±0.48mm at 28 
days (p<O.Ol). In CA, LD increased from 1.12±0.26mm pre•
to 1.57±0.28mm post-BA, and decreased to 0.99±0.45mm at 
28 days (p<O.Ol). Angiographic restenosis (reduction in 
LD post-BA to 28 days) was not different between the 
groups (0.61±0.54mm vs 0.58±0.34mm, p=NS). Blinded analy•
sis of pressure-perfused Movat-stained histologic sec•
tions also showed no differences in extent of arterial 
wall damage or planimetric luminal cross-sectional area 
narrowing (55±19% vs 47±26%, p=NS). 
Thes, heparin can be effectively delivered "in situ" 
in ae r.erosclerotic artery following BA but does not 
inhib;' restenosis in this model. 
ABSTRACTS 
927-6 
Iamunohistocheaical Characterisation of Arterial Injury 
and Re.tenoaia Following ADgioplasty in the Atheroscle•
rotic Rabbit. 
Robert L Wilensky, Leeann Wong, Keith L March, George E 
Sandusky, David R Hathaway. Indiana UniverSity Medical 
Center, Lilly Research Labs, Indianapolis, IN. 
Restenosis may represent • hypertrophic response by the 
vascular wall to angioplasty (AP) induced injury. The 
cellular response following AP of rabbit femoral arter•
ies made atherosclerotic by air desiccation and choles•
terol feeding was evaluated immunohistochemically using 
antibodies to alpha actin (HHF-35, monoclonal 
antibody), activated macrophage. (with RAM-ll) , fibrin•
ogen/fibrin (Frg) and fibronectin (Fn). Arterial cross•
sections were obtained prior to (n-13) and at five 
intervals following AP: 1 (n-12), 3 (n-g), 5 (n-10), 7 
(n-12) and 14 (n-12) days. Prior to AP cell. with HHF-
35 staining were present throughout the media and 
intima and a distinct population of RAM-l1 reactive 
cella waa seen. Little Frg staining was observed. AP 
caused extensive intimal dissection planes with some 
extending into the media and adventitia. Necrotic areas 
within the media were also observed that did not stain 
with HHF-35 but stained for Frg. Within dissection 
planes strong Frg staining was obse~ved up to 7 days 
and Frg and Fn immunoreactivity was noted on luminal 
surfaces. By 14 days the neointimal exhibited a high 
density of HHF-35 cells when compared to the original 
lesions. Few RAM-1l reactive cella were observed. In 
conclusion, AP causes extensive vascular injury charac•
terized acutely by aissection planes which fill with 
Frg. The thrombus forms a framework for subsequent 
smooth muscle cell ingrowth and proliferation which 
heals the vascular wall but also leads to restenosis. 
927·7 
INFLUBNCB OP LONGER BALLOON INFLATION PERIOD 
IN THB INCIDBNCB OP RBSTBNOSIS AFTER CORO•
NARY ANGIOPLASTY 
Martinez Elbal L, Calvo Orbe L, Gomez Recio 
M, Sobrino N, Romero Tejero C, Madero R, 
Sobrino JA. Hospital La Princesa and Hospi•
tal La Paz. Madrid. Spain_ 
The aim of this study was to determine the 
influence of longer balloon inflation 
periods in the incidence of restenosis after 
coronary angioplasty. An open.! prospective 
and randomized study was per:tormed on 153 
patients with single vessel stenosis at pro•
ximal or medium segments: 62 LAD, 48 RC, 43 
CX (p=N.S.). Complete occlusions, tortuous 
or long lesions [>20 mm.), artery diameters 
< 2.5 mm_, intracoronary thrombi and bifur•
cation lesions were excluded. Eighty one 
cases were dilated with standard balloon 
(Sal (mean inflation period:l.3 min.; range 
0.75-10 minl_ Seventy two cases were dilated 
with autoperfusion balloon (PBI with singl& 
inflation (mean inflation ~eriod:13.5 min.; 
range 2-17 minI. No signif1cant differences 
in sex, coronary risk factors, ejection 
fraction, incidence of unstable angina or 
previous myocardial infarction, existed bet•
ween the two groups. There were no differen•
ces either between the morphological type of 
lesion (A,BIC) or the segments treated 
(SB:47% proX1mal, 52% medium) (PB:48% pro•
ximal, 52% medium). Successfui dilation was 
obtained in 77/81 cases with SB (95%) and in 
58/72 with PB (80.5%) (p=O.Ol). Follow-up 
coronariographies were performed in 72/77 
cases with SB (mean:18!6 weeks) and in 54/60 
with PB (mean:17!3 weeks) (f=N.S.). Resteno•
sis was confirmed (arteria diameter reduc•
tion S 50%) in 23/71 cases with SB (32.3%) 
V.s. 22/54 with PB (40.7%) (p=N.S.I. 
CONCLUSIONS: These results suggest that lon•
ger balloon inflation periods do not reduce 
the incidence of restenosis after coronary 
angioplasty. 
169A 
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927·8 
Histological Predictors for Restenoses after Vascular Interventions in 
Primary Arteriosclerotic Lesio~s 
Doris Backa I, Andereils Nerlich ,Brigine Mack I, Benhold HOf1ing 1. 
1 Medical Dept I, 2Institute of Pathology, Klinikum GroBhadern, 
University of Munich; Germany 
The purpose of this study was 10 evaluate whether primary 
aneriosclerotic lesions (=P) show any histological maricers for the 
development of a restenosis after vascular interventions ("predictors of 
restenoses"). 
Histological analysis of 802 atherectomy biopsies from peripheral and 
coronary arteries was performed (peripheral primary lesion n= 108, coro•
nary primary lesion n=31, peripheral restenoses n=17, coronary 
restenoses n=8). The histological findings of primary lesions which 
developed a restenosis were retrospectively compared with primary 
lesions which did not develop a restenosis. Three major differences were 
seen between these two collectives: 
non-restenos.P restenos.P 
intima with high cellularity 
internal elastic lamina 
media 
24,2%* 82.3%* 
42,7%* 91.1%* 
24,3%* 99,2%* 
*p<0.OO2; no significant difference 
peripheral vs. coronary lesions. 
The highest predictive values for the development of restenoses were 
retrospectively found when the primary lesion showed all three 
components (0.76) or when media was excised (0.61). If only intima with 
high cellularity was present, the predictive value solely reached the level 
of 0.33. 
Conclusion: These data indicate that higher rates of restenoses occur 
when primary lesions show intima with high cellularity. when their 
internal elastic lamina was damaged or when media was excised. The 
excision of media seems to be a most stimulating factor for the 
development of a restenosis. 
We conclude that the mode of performing atherectomy (extention of 
trauma, depth of the procedure) may influence its late outcome. 
927·9 
Failure of Increasing Lesion CompleXity Alone to Predict 
Restenosls After Angloplasty 
Donald F. Fortin. David J. Frid, Charlotte L. Nelson. Laura H. Gardner, 
Michael Miller. Joseph Puma. Jose A. Perez. James E. Tcheng. Robert M. 
Califf, Richard S. Stack, Duke Medical Center, Durham, NC 
Data confirming the abilHy of lesion morphology determined prior to 
angioplasty (PTCA) to predict restenosis are scant. To develop a predictive 
model for the risk of restenosls(RES) based on pre-PTCA leSion 
morphology (LM). trained observers examined 536 lesions In 447 patients 
(86% angiographic follOW-Up) undergoing first-time elective PTCA for 
stable/unstable angina. Each lesion characteristic comprising the AHA/ACC 
class~ication was recorded. Total occlusions were excluded since all factors 
could not be recorded. A thrombus score was constructed summing the 
number of features aSSOCiated wHh thrombus - intraluminal defect. haziness 
or contrast staining. RES occurred In 215(40.1%) lesions. Clinical variables 
Including patient presentation. previous MI and traditional cardiovascular 
risk factors were also recorded. Muhiple logistic regression modeling 
examined the relationship ~ each LM characteristic to the risk of R5S, Pre•
PTCA stenosis severHy (X -7.35. p.0.007) and lesion length (X ~5.29, 
p.0.021 were the only Independently signnicant LM. Inclusion of selected 
clinical variables previously examined In this population and shown to be 
aSSOCiated wHh restenosis resuhed in the f~llowing muhivariable model: 
Chacs"'rlSttc % A 
Pre-PTCA Stenosis SeverHy 7.79 0.005 
Tortuosity 5.04 0.025 
leSion Length 4.47 0.034 
Diabetes MeliHus 5.03 0.025 
Unstable Angina 4.24 0.040 
Once these characteristics were known. the AHA/ACe 
classHication (X2_0.87 • P •. 351) and other individual lM characteristicS 
comprising the AHA/ACe score provided no additional significant 
information. 
Conclyslon' In this population. the isolated determination of features 
suggestive of complex lesion morphology appears to lack sufficient 
predictive power for restenosis after angioplasty. These resuHs suggest 
that the accurate determination of clinical status In combination with 
selected rQulinely assessed lM characteristics will resuH In more precise 
assessment of the risk of restenosis for an Individual lesion. 
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Trapidil (PDGF antagonist) VB ASA in the prevention of 
restenosis after PTCA: a double blind randomized trial 
Aleardo Maresta,Marco Balducelli,Luca Cantini,Angelo 
Casari,Raffaello Chioin,Alessandro Fontanelli,Pier A. 
Monici Preti,Silvana Raffaghello,Sergio Repetto, 
Elisabetta Varani 
Servizio di Cardiologia,Ospedale per gli Infermi,Faenza 
(Italy) and Studio Trapidil vs ASA nella Restenosi 
Coronarica group (STARe) 
PDGF seems one of the most powerful agents involved in 
the proliferative process occurring after PTCA and 
leading to restenosis. Trapidil (thriazolopyrimidine)(T) 
is a potent inhibitor of PDGF and has shown to be 
effective in reducIng restenosis after balloon dilahon 
both in humans and in the experimentel animal. Our study 
based on these evidences, is a policentric, double blind 
randomized trial of T (100 mg TID) vs ASA (100 mg TID). 
360 pts are to be enrolled. Both drugs are started 3 days 
before the procedure. At one month a maximal Bruce TT is 
performed. Restenosis is defined as~70% narrowing and/or 
a ~ 50% loss of gain at 6 month control. From April 1990 
until July 1991, 251 pts have been enrolled and 115 
restudied. The global restenosis rate in the T group was 
29% (16/55) vs 37% (22/60) in the ASA group. The initial 
stenosis was 84!11% in both groups, residual stenosis 
21!1l% vs 19!12% and the final was 44!32% vs 52!32% with 
a final gain of 48!36% vs 40!38% and a loss of gain of 
43!41% vs 48!43% in the T and ASA group respectively. 
The preliminary results do not consent any conclusion, 
but a definite trend in favour of T is clear. 
927·11 
Clinical Endpoints After Excimer Laser 
coronary Angioplasty: Bix Month Followup Data 
from the AlB ILCA Registry 
James R. Margolis. Frank Litvack. John 
Bresnahan. Frank cummins. William Untereker 
and the ELCA Registry Investigators 
South Miami Hospital. Miami. FL 
Six month clinical followup was obtained 
on 1381 patients (1662 lesions) who had 
successful coronary angioplasty with a 308nm 
XeCl excimer laser - pulse width >200nsec, 
repetition rate 20hz. fluences 35-65 rnJ/mm2. 
Significant Clinical endpoints (CE) included: 
death 2.2%. MI 2.5%. bypass surgery 8.3%. 
repeat angioplasty 19%. At least one endpoint 
occurred in 29% of patients. 
Pre-angioplasty univariate predictors of 
CE (p<.05) included: pre-ELCA angina class 
(CCSF). LAD lesion. lesion length, and pre•
ELCA total occlusion. RCA lesions were 
associated with a lower CE rate (p=.03). 
Procedure related predictors were dissection 
and final diameter stenosis. Age, prior PTCA. 
eccentricity. calcification, vein graft 
lesion, severity of initial stenosis. ELCA 
catheter size, use of adjunctive PTCA, and 
energy density were DQt significantly related 
to CEo Stepwise multivariate predictors of CE 
included: dissection (p=.OOl). CCSF (p=.OOl). 
and lesion length (p=.005), 
Conclusion: 1) the frequency of adverse CE 
at 6 months after ELCA compares favorably 
with that reported for PTCA; 2) predictors of 
CE post ELCA are comparable to those that 
predict CE post PTCA. 
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927·12 
NATIVE FIBRIN FILM AS A BIOCOMPATIBLE, ABSORBABLE 
MATERIAL FOR INTRACORONARY STENT IMPLANT AND 
DRUG DELIVERY 
Robert S, Schwam, Kenneth C Huber. William D, Edwards, Howard F. 
Taswell. Allan R. Camrud, Michael A. Jorgenson, David R. Holmes Jr. 
Mayo Oinic and Foundation, Rochester, MN 55905 
Many synthetic polymers for coronary arterial stent applications 
suffer from problems of thrombogenicity and biocompatibility. 
Crosslinked fibrin is a native polymer which deposits naturally at sites 
of vessel injury, is readily available and naturally bioabsorbable, and 
can be synthesized ex vivo with excellent elastomeric mechanical 
properties. Because fibrinogen is highly water soluble, the potential 
exists for incorporation of drugs into the resulting precipitated fibrin 
for local delivery. 
To test the biocompatibility and thrombogenicity of fibrin, 
porcine fibrinogen was isolated by standard cryoprecipitation methods 
to a concentration of 50 mg/ml. Polymerization was done using 
bovine thrombin (5,000 u/ml). Metallic tantalum coils (.125 mm) 
were coated by polymerizing the fibrin to form a continuous thin film 
cylinder (2.5 mm diameter, .25 mm thick) which could be crimped 
onto an angioplasty balloon. The coil-fibrin device could thus be 
implanted using routine stent-delivery methods. 
Eight fibrin-coil devices were implanted in the coronary 
arteries of 6 pigs without complication and without acute occlusion. 
All animals survived until sacrifice at 28 days after implant. All 
devices were angiographically patent at 12 days. Histopathologic 
examination showed a variable degree of neointimal proliferation at the 
site of implant. Small residual fibrin clumps were seen only rarely. 
Conclusion; Fibrin film is a biocompatible material which may be 
useful for intracoronary stenting and drug delivery. 
927·13 
Insulin Levels Predict Restenosis After Laser Angioplasty: 
Multivariate Analysis in 100 Patients 
LeRoy E. Rabbani, John A. Bittl, Peter Ganz, Andrew P. 
Selwyn, Elazer R. Edelman, Joseph Loscalzo, Peter Libby. 
Brigham & Women's Hospital and Harvard Medical 
School, Boston, MA 
Restenosis after angioplasty may be related to insulin, 
which affects smooth muscle cell proliferation. To test 
this, we prospectively measured fasting insulin and lipid 
levels and collected 40 other variables in 100 consecutive 
patients who underwent excimer laser angioplasty of 109 
lesions at 6 month angiographic follow-up (obtained for 
92% of the lesions). Angiographic restenosis (>50% stenosis 
in blinded core laboratory evaluation with digital calipers), 
seen at 42/100 lesions at follow-up, did not correlate with 
clinical variables, traditional CAD risk factors (including 
cholesterol, glucose, triglyceride, low-density lipids, etc), 
lesion factors (location, complexity, etc.) or procedural 
factors. Patients with restenosis had lower insulin levels 
(9.5±O.9 flU/ml [mean±SEM)} than those without (15.D±2.1; 
P=0.02). Measures of restenosis correlated exponentially 
with insulin levels (r2=0.37; P=O.OOl). By multivariate 
analysis, insulin levels independently predicted restenosis 
(P=O.Ol). 
In summary, restenosis is only related to insulin levels 
but not lipids or other clinical variables examined. Directly 
or indirectly, insulin may influence vascular wall biology 
and playa role in the pathogenesis of restenosis. 
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928·27 
Preoperative Donor Echocardiognun Does Not Atturately Predict Post 
Operative Transplant Allograft Function 
James D. Bergin, Anthony V. Broccoli, Laura M. Mattox, Sally K. Flanigan, 
Wendell K. Dodd, Curtis G. Tribble, and Irving L. Kron. University of 
Virginia, Charlottesville, Virginia 
Standard donor evaluation includes 12 lead ECG and transthoracic 20 
ecbocardiograpbic (2DE) imaging of the prospective donor. Depressed left 
ventricular (l V) function and wall motion abnormalities are llooerally used to 
exclude potential donors. Due to the limited donor availability, we adopted a 
policy of visual evaluating all potential donors who were hemodynamically 
stable and bad no obvious reason for abnormal LV function regardless of 
reported 2DE fmdings. During a 20 month period, 39 potential donors were 
evaluated. Six 2DE studies (151'£) revealed globally depressed LV function 
andlor significant wall motion abnormalities, and were deemed IIIIlI<X:eptable for 
transplantation; group I (GRI), LVEF = 37.S±12.91'£. Thirty-three 2DE 
studies were interpreted as normal; group 2 (GR2), LVEF = SS.1±1.61'£. 
Donors ofGRI and GR2 were similar with respect to age (GRI: 26±S; GR2: 
27 ± 10, P=DS) and gender, although no patioot in GRI was over 33 years of 
age. All six GR! donors and 32 of 33 GR2 donors were fouod to bave 
acceptable LV function at the time of organ procurement and were used for 
transplantation. Postoperative management was similar in both groups. 
l11ustrated below are the 2DE, pulmonary capillary wedge (PC) pressures and 
cardiac index (CI) after transplantation. 
20E 
PC 
Cl 
p=ns 
day I day 7 
GRI GR2 GRI GR2 
49±ll% 5H5 55±3 55±5 
17±7 17±S 
3.0±.6 2.9±.S 
day 30 
GRI GR2 
S4±2 5S±4 
ISH 17±5 
2.9±.4 3.0±.5 
Of interest, a trend towards longer iscbemic times was noted GRI patients 
(GRI: l83±47 min; GR2: 142±41 min, p=.09). 
We conclude Ibat preoperative donor LVEF assessed by 2DE does not 
accurately predict postoperative allograft function. Therefore, the donor pool 
could safely be expanded by visually examining all youog donors regardless of 
2DE results, potentially expanding Ibe donor pool by 15%. 
928·28 
Rest·redistribution thallium scintigraphy in ischemic 
cardiomyopathy: prediction of survival and improved left 
ventricular function after revascularization 
Lawrence Czer, Sharon Nessim, Keta Hodgson, Peter Barath, 
Alfredo Trento, Jack Matloff, Timothy Bateman, Daniel Berman. 
Cedars-Sinai Medical Center, Los Angeles, CA 
The ability of rest-redistribution thallium imaging (TI) to predict 
a beneficial response to revascularization (CABG) has not been 
established in patients with severe ischemic LV dysfunction, who 
may also be candidates for heart transplantation. We studied 35 
patients with an LV ejection fraction (EF) ~ 30% (mean 
24%..±.6%) and advanced coronary disease (71% triple vessel, 
82% NYHA class IV) who underwent CABG between 6/84 and 
5/89 (mean follow-up 2.7 yrs). Rest and 4 hr redistribution 3-
view planar TI-201 was performed within 6 months before 
CABG. A visual score (0 = normal, 3=severe defect) was 
assigned to 15 segments in 6 regions. Hypoperfusion extent 
(regions), severity (score), and reversibility (change 2, 1 with rest 
score of 2 or 3) were determined. EF was measured by contrast 
or radionuclide (RNV) methods. Results: One-year survival after 
CABG (79%) was related to reversible extent (1.4..±.O.3 vs 
0.3..±.0.2 regions, P < .01, alive vs dead), but not to total 
hypoperfused extent (3.7..±.0.3 vs 3.1.±.0.6 regions, P=NS), 
maximum severity (score 2.6..±.O.1 vs 2.9..±.0.l, P=NS) or EF 
(24..±.6 vs 25..±.6, P=NS) at rest. In 12 pts with postop RNV, 
there was Significant improvement in EF (mean 5%, P < .01) 
which correlated with improved survival (Wilcoxon P < .05). 
Conclusions: Rest Tl can predict survival and improvement in 
LV function after CABG for ischemic cardiomyopathy, and may 
be useful in identifying alternatives to transplantation. 
I72A ABSTRACTS 
928·29 
Bench Coronary Angiography: A New Method to Assess Coronary 
Anery Disease in the Older Donor Heart 
C. Chin Lee, John E. Aruny, Rita O. Laurence, Robert F. 
Appleyard, Lawrence H. Cohn. Brigham and Women's Hospital, 
Boston, MA 
In response to the shortage of potential donor organs for 
cardiac transplantation, an intra-operative, ex·vivo technique to 
study the coronary anatomy of the donor heart immediately prior 
to implantation was developed. 
Sheep hearts were harvested after creating random coronary 
occlusions to assess the diagnostic accuracy of this technique. Two 
groups of hearts were radiographed in the flat (n=6) or upright 
suspended (n=6) position with the aorta cross·clamped. The 
aortic root was cannulated with an 18g needle and flushed with 
cold normal saline. Iodinated contrast media (Hypoque·76) (S mJ) 
was injected under constant hand pressure, and using a 
conventional, portable x·ray machine, three views were taken. The 
aortic root was then flushed with cold normal saline under 
constant pressure. Total elapsed time including film development 
was 7·10 mins. In hearts radiographed lying flat, a ventriculogram 
was obtained due to aortic incompetence. In the upright 
suspended hearts, normal coronary anatomy as well as previously 
placed coronary occlusions were easily detected when read blindly 
by radiology personnel. Five additional rabbit hearts were 
mounted on a Langendorff apparatus for functional analysis at 
controlled LV volumes. Dye was injected and flushed out after 2 
mins. Diastolic and systolic LV function was unaffected by the dye 
injection. Use of this safe, simple and rapid method to intra· 
operatively evaluate coronary anatomy of the donor heart might 
contribute to increased screening of older donor hearts for heart 
transplantation. 
928·30 
Myocardial Sonodensity and Rejection; Real Time 
Color·coded Qualitative Tissue Characterization 
Mark M. Boucek, Janna Clark, Mohammad S. Kanakriyeh, 
Jorge McCormack, Steven R. Gundry, & Leonard L. Bailey 
Loma Linda University Medical Center, Loma Linda, CA 
Echocardiographic rejection surveillance has relied on 
measures of myocardial function; however, noninvasive 
evaluation of myocardial tissue character could offer earlier 
evidence of inflammation. With rigorous measures and 
controls, tissue characterization with back-scatter analysis 
has been used to detect rejection. To evaluate real time 
myocardial tissue characterization, 20 posttransplant infants 
and children (ages' -'2 years) on 2 drug immunosuppres•
sion were studied prospectively on SO occasions with 5 
different gray scale labeled tissue color maps. Real time 
qualitative color-coded sonodensity was calibrated in situ for 
each patient with each study. Serial studies in non-rejecting 
patients were reproducible. Eight rejection episodes 
occurred during the study (4 confirmed by biopsy) and serial 
evaluation demonstrated a shift to a more homogeneous 
lower density pattern which was often initially noted in the 
septum. With rejection, there was a margination of density 
to the endocardial interface. Early recovery from rejection 
showed increased endocardial density and a return of 
myocardial sonodensity. Changes in the color-coded pattern 
were used to successfully predict rejection in 4 children with 
focal-moderate rejection on biopsy and could be used to 
follow response to therapy, despite persisting cardiac 
functional ECHO abnormalities. 
We conclude that rejection is a diffuse process (as 
detected by changes in sonodensity) despite focal findings 
on biopsy. Both discontinuous and overlapping color maps 
were effective in detecting low signal density changes. On•
line color coded qualitative tissue characterization provides 
a new rapid and reproducible noninvasive technique for 
rejection surveillance &/or as an indicator for invasive study. 
928·31 
lACC Vol. 19, No.3 
March 1, 1992:172A 
Exercise Stress Echo In Cardiac Transplant Recipients: 
Detection of Angiographlcally Silent Coronary Disease? 
Catherine A Collings, Fausto 1 Pinto, Hannah Valantine. Shawn L Milton, 
10sephine V Puryear, Ingela Schnittger. 
Stanford University, Div Cardiovascular Medicine, Stanford, CA 
Coronary anery disease is the major cause of death in cardiac transplant 
recipients surviving beyond one year. Coronary arteriography is the gold 
standard to study CAD in this patient population and more recently. 
intravascular ultraSOund has been used to assess progression of intimal 
thickening. Exercise stress echo (EX·ECHO) has been useful in the study of 
patients with native CAD, however its use as a non· invasive test for 
detection of accelerated graft atherosclerosis has not been studied. Twenty•
six cardiac transplant recipients (mean age 47 yrs) were studied to determine 
the sensitivity and specificity of EX-ECHO for detection of CAD. All pIS 
underwent coronary angiography (ANGlO) and 13 were also studied by 
intracoronary ultrasound (lCUS). Abnormal EX-ECHO was defined as 
worsening of wall motion or failure of wall motion to improve with exercise. 
Significant CAD by ANGlO was defmed as >50% stenosis. Measurements 
of intimal thickening were obtained by intracoronary ultrasound and an 
intimal index (intimal area divided by intimal and Iwnen area) was calculated. 
Two pts had significant CAD by ANGlO and both had abnormal EX-ECHO. 
Six pIS with aOOormal EX-ECHO had nonsignificant or no CAD by ANGlO. 
Five of these pts had resting wall motion abnormalities. Eighteen pIS had 
both normal or nonsignificant ANGlO CAD and normal EX-ECHO. Overall 
sensitivity was 100% and specificity 75% for EX-ECHO. Three of the 13 
pts studied by ICUS had abnormal EX-ECHO, and two of them had 
angiographically normal coronary aneries. These 3 pIS showed a 
significantly greater degree of intimal thickening when compared to the 10 
pts with normal EX·ECHO (0.34 vs 0.17: p< 0.03). 
In conclusion, stress echo in hean transplant recipients has overall good 
sensitivity and specificity for CAD, comparable to its use in other patient 
populations. However. the presence of wall motion abnomalities at rest 
decreases the test specificity. The observed increase in intimal thickening in 
pts with abnormal stress echo and angiographically normal vessels sugges:. 
thai stress echo may aid in the the detection of angiographically silent 
transplant coronary artery disease. 
928·32 
Detection of Accelerated Coronary Artery Disease In 
Cardiac Allografts by Intravascular Ultrasound. 
Assaad N. Malouf, Ronald D. Jenkins, John E. Lassetter, and Stephanie 
L. Olsen. University of Utah Medical Center, Salt Lake City, Utah. 
To determine whether intravascular ultrasound can detect accelerated 
coronary artery disease (ACAD) in orthotopic heart transplant 
recipients, 23 patients 3·74 months post transplantation underwent 
intracoronary imaging as part of their baseline and or annual 
angiographic evaluations (n=28). Repeat imaging was performed In 
5 patients averaging 8 months post initial study. A 5.5 Fr Endosonics 
ultrasound catheter was used to obtain images in the distal, mid and 
proximal segments of the LAD (n.20), circumflex (n=2) or ramus 
(n=1) coronary arteries. Arterial wall thickness (AWT) was 
measured in triplicate at each site. Coronary arteriograms were 
categorized as demonstrating normal coronary arteries, possible 
ACAD or definite ACAD. All baseline studies were free of CAD. 
~ AWT (u±SEM) 
baseline anglo. 6 72S±3S 
annual angio. 22 
normal 10 700±S7 
possible ACAD 8 877±46 ·(p<.05) 
definite ACAD 4 9S0±70 ·(p<.02) 
The average wall thickness in patients with both possible and definite 
ACAD was significantly increased as compared to those undergoing 
baseline or normal annual studies. Despite no apparent progression 
01 ACAD by angiography in the 5 follow· up studies, the AWT 
increased by 154 microns. An AWT of SOO microns or more was 
present in all patients with definite ACAD, in 6 of 8 patients with 
possible ACAD and in 2 of 16 patients with normal angiograms. 
Thus, assessment of wall thickness by ultrasound appears to parallel 
angiographic evidence of ACAD, and may prove to be an early and 
sensitive marker of allograft coronary disease. 
JACC Vol. 19, No.3 
March I, 1992:173A 
928·33 
Intravascular Ultrasound: Progression of Allograft 
Coronary Artery Disease in Cardiac Transplantation 
Recipients 
Hector O. Ventura, Ashit Jain, Juan E. Mesa, Tyrone J. Collins, 
Christopher J. White, Stephen R. Ramee, Joseph P. Murgo. 
Department of Internal Medicine, Section on Cardiology, Ochsner 
Medical Institutions, New Orleans, Louisiana 
Allograft coronary artery disease (CAD) is a major cause of morbidity 
and mortality in cardiac transplant recipients (CTRs). The incidence 
and morphological features of allograft CAD were compared by 
angiography and intravascular ultrasound in 21 patients (73 coronary 
sites) following cardiac transplantation. To assess the progression of 
CAD, ultrasound findings were correlated with the time since 
transplantation (1 to 4 years, mean 2.3iO.l years). The ultrasound 
images were classified on the basis of severity of CAD as follows: 
normal, grade I (intimal thickening without stenosis); grade II 
(stenosis <50%); or grade ill (stenosis >50%). 
Results: 
Normal 
Grade I 
Gradell 
Grade ill 
1 year 
11/17 (65) 
0/17 (0) 
6/17 (35) 
0/17 (0) 
Age of Allograft N=sites (%) 
2 years 3 years 
13/23 (51) 5/21 (24) 
7/23 (30) 0/21 (0) 
2/23 (9) 15/21 (71) 
1/23 (4) 1/21 (5) 
4 years 
5/12 (42) 
1/12 (8) 
2/12 (17) 
4/12 (33) 
Thirty six of the 73 coronary sites (39%) were abnormal by ultrasound 
whereas only 5n3 (7%) were abnormal by angiography (p=O.OO2). 
Normal or grade I by ultrasound findings were more prevalent at 1 and 
2 years post transplantation compared to grade II or III at 3 and 4 
years. The severity of CAD assessed by ultrasound correlated 
significantly with years after transplantation (p=O.OO2). Seventeen of 
28 sites imaged of the LAD compared to 14/42 sites of the RCA 
revealed morphological changes of grade I or greater (61 % vs 33%; 
p=O.026). In conclusion, ultrasound is more sensitive in detecting 
allograft coronary artery disease and the spectrum and progression of 
this disease is directly related to the time elapsed post transplantation. 
928·34 
Angioscopy and Ultrasound in Cardiac Transplantation: 
Assessment and Comparison of Intracoronary Morphology 
Hector O. Ventura, Ashit Jain, Juan E. Mesa, Christopher 1. White, 
Stephen R. Ramee, Tyrone 1. Collins, Joseph P. Murgo. 
Department of Internal Medicine, Section on Cardiology, Ochsner 
Medical Institutions, New Orleans, Louisiana 
Coronary intravascular imaging with percutaneous coronary 
angioscopy (PCA) and intravascular ultrasound has been shown to be a 
sensitive method of detecting early changes in coronary morphology in 
cardiac transplant recipients (CTRs). In order to compare the two 
imaging moda1ities, 29 CTRs underwent PCA and ultrasounrf without 
complications during the annual coronary angiography (RCA=19, 
LAD=5, CFX=5). With each procedure we determined the presence of 
plaque, dissection, calcification, and diameter stenosis. Results 
(N=pts, (%): 
Plaque 
A\1giography 3/29 (l0) 
Angioscopy 10/29* (34) 
Ultrasound 11/29* (37) 
*p<O.OI vs angiography 
Dissection 
1/29 (3) 
0(2.9 (0) 
0/29 (0) 
Calcification 
0/29 (0) 
0/29 (0) 
1/29 (3) 
Stenosis 
3/29 (10) 
6/29" (21) 
10/29* (34) 
Both PeA and ultrasound were more sensitive in detecting the presence 
of either stenosis or plaque than angiography. Although both methods 
identified atherosclerotic plaque, only PCA was able to show 
intracoronary surface features and pigmentation of the plaque. 
Conversely, ultrasound was able to detect calcification, dense fibrotic 
plaque, presence of intimal thickening, and was more accurate in 
assessing the severity of stenosis. In conclusion, PCA and ultrasound 
can be performed safely in CTRs and are more sensitive than coronary 
angiography. PCA and ultrasound, in conjunction, provide 
information not only regarding the appearance of the luminal surface 
but also quantitative information regarding the structure and extent of 
the disease in the coronary artery wall. Their role in the clinical 
evaluation and treatment of allograft coronary artery disease remains to 
be defined. 
ABSTRACTS 
928·35 
Utility of a New Classification of Transplant Coronary Disease 
Using Intravascular Ultrasound 
Fausto J. Pinto, Frederick: G. SLGoar, Edwin L. Alderman, Hannah A. 
Valentine, John S. Schroeder, Edward B. Stinson, Richard L. Popp. 
Divisions of Cardiovascular Medicine and Surgery, Stanford. CA 
Transplant atherosclerosis provides a model of accelerated disease with 
morphologic heterogeneity, useful for evaluating the intracoronary 
ultrasound (ICUS) ability to assess coronary disease severity. This study 
offers a new classification of coronary disease based on intimal thickness 
and degree of circumferential vessel involvement Eighty cardiac transpl~ 
recipients undergoing angiography 2 weeks to 14 years after transplantaUon 
were scanned with a 30 MHz ICUS catheter. Four left anterior descending 
coronary artery sites per patient were chosen for detailed ultrasound 
measurements. Patients were classified by their most severe site. The ICUS 
disease severity was defined as: Class 0, no evi~ of intimal.thickening; 
Oass I (minimal), intima less than 0.3 nun thick: measurable m less than 
1800 of the vessel circumference; Class 11 (mild), intima less than 0.3 nun 
involving more than 18fiJ of the vessel circumference; Oass ill (moderate), 
an intimal layer 0.3 mm to 0.5 nun thick: or an intima greater than O.S mm 
thick involving less than 1800 of the vessel circumference; and class IV 
(severe), intima greater than O.S nun involving more ~an 1800 of the 
vessel circumfrence or an intimal layer thicker than 1.0 nun m any area of the 
vessel circumference The following results were observed in patients 
studied immediately after transplantation, 1 year and more than one year after 
transplantation: 
Class Early after TX )Year > 1 year 
0 7 (35%) 0 0 
1 \0(50%) 3 (30%) 7(14%) 
2 0 4(40%) 7(\4%) 
3 3(\5%) 2(20%) 15(30%) 
4 0 1 (10%) 21 (42%) 
Conclusion: The proposed classification shows that disease. severity 
correlaties with duration of transplantation and offers complimentary 
infonnation to assess and monitor progression of transplant coronary artery 
disease. 
928·36 
comparison of Exercise SPECT Thalllum·201 and Sestamlbl 
for the Detection of Cardiac Allograft Atherosclerosis 
Roxanne A Rodney, Lynne L Johnson. Mark Barr, Robert A V8ccarino, 
Dean Barton, Lisa Wasserman, Ted Pozniakoff, David K Blood 
Columbia Univers~y, New York, New York 
173A 
Accelerated graft atherosclerosis is the third most common cause of death in 
patients post cardiac transplant, and it is the most common indication for 
retransplants. Prior studies utilizing exercise planar or oral dipyridamole 
SPEeT thallium·201 scintigraphy found low sens~ivity for the detection of 
graft atherosclerosis. Sestamibi is a technetium based perfusion agem 
which allows the performance of combined first pass LV EF and perfUSion 
imaging. To assess the comparative value of these two perfusion agents, 9 
patients with a mean post-transplant time of 34±t2 months underwent 
treadmill exercise testing utilizing exercise! 4 hr redistribution thallium-201 
SPECT (3.0 mci mean dose) and resU exercise sestamibi SPECT (mean 
doses 9.3 and 25.3 mci, respectively) with first pass LVEF, to equivalent 
workloads and double products within a 14 day period. All patients 
underwent cardiac cath w~hin a mean of 4.1 months of study. There were 8 
males and 1 female with a mean age of 55 ± 9 (range 36-65). None of the 
patients developed ECG cr~eria for ischemia. Patients with angiographically 
normal coronary arteries demonstrated an increase in EF with exercise (rest 
43±t7, ex 63±18) whereas patients with graft atherosclerosis had a flat EF 
response (rest 35±14, ex 35±11). All five patients with angiographically 
normal coronary arteries had normal perfusiOn scans. Three of four patients 
with graft atherosclerosis had reverSible defects. Ischemic defects on 
thallium were larger than those on sestamibi scans which may represent 
crosstalk between rest and exercise sestamibi doses. There was no 
difference for the detection of graft atherosclerosis between the two agents. 
These preliminary data suggest that exercise thallium or sestamibi SPECT 
imaging may be of value for the noninvasive detection of graft 
atherosclerosis. 
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928·37 
Innuence of Graft Rejection on Accelerated Coronary 
Artery Disease: A New Approach to Analysis. 
Shao·Zhou Gao, John Schroeder, Sharon Hunt, Hannah Valantine, 
Irene Hill, Edward Stinson. 
Stanford University Medical Center, Stanford, California. 
Conflicting data exist regarding the role of graft rejection as a risk 
factor for later development of transplant coronary artery disease 
(TxCAD). We analyzed a cohon of 126 consecutive patients (pts) 
who were treated with cyclosporine-based immunosuppressive 
regimens and devised a method which attempts to incorporate the 
number, duration, and severity of rejection episodes (REI) accrued 
by individual pts, resulting in a rejection score (REI Score) for each 
patient. We then correlated the later incidence (mean FlU 4 years) of 
angiographic TxCAD with REJ Score as weJl as its components: 
number, duration (REJ OUR) and severity of REJ, and with the 
number and duration of untreated REJ (N, OUR), and with the 
incidence and duration of delayed REJ therapy (delayed REJ Rx N, 
OUR) 
N REJ REJ REJ Untreaaed REJ Delayed REJ Rx 
Score OUR N OUR N OUR 
TxCAO 60 2.6 110.4 72.4 0.8 13.9 0.4 5.8 
TxNoCAD 66 2 3 96 7 65 8 0 6 9 5 0 2 3 5 
sixty pts (48%) developed TxCAD. There was no significant 
statistical difference between these pts and those without TxCAD in 
any of the seven rejection parameters analyzed and no significant 
difference in time to occurrence of TxCAD between cohorts divided 
at the median REJ Score. Donor age was older, and fasting 
triglyceride blood level was higher in the TxCAD group than the 
TxNoCAD pts. All other clinical characteristics, including HL-A 
mismatches, ischemic time, blood pressure, lipid profile, and drug 
therapy were not different between the two groups. 
Conclusion: Incidence of TxCAD is not correlated with traditionally•
diagnosed myocardial rejection, despite taking into account duration 
and severity as additional parameters. TxCAD may involve different 
or additional mechanisms than the cell-mediated immune response as 
seen on endomyocardial byopsy. 
928·38 
Are Early and Late Cardiac Allograft Arteriopathy 
Different Entities? 
Alain Heroux, Jeanne O'Sullivan, Youlian Liao, Walter 
Kao, Maryl Johnson, Martin Mullen, Roque Pifarre, Maria 
Rosa Costanzo-Nordin. Loyola University of Chicago/Hines 
VAMC, Maywood, lL 
To determine if the pathogenesis and prognosis of early 
and late allograft arteriopathy (AA) differ, we examined 
25 cardiac transplant (CT) pts with AA divided into those 
diagnosed early [<24 (l4±7,x±SD) mos post-CT, n-9j and 
late [>24 (43±12) mos post-CT, n-6j. Pts with AA were 
compared to 50 control CT pts without AA (19 early; 31 
late) matched for CT year, follow-up, and number of 
yearly coronary angiograms. Groups had similar pre-CT 
heart disease, preformed antibodies, and HLA mismatches, 
and post-CT cyc1osporine levels, trig1ycerides, and 
number of total and treated rejection episodes. 
Early «24mos) Late (>24 mos) 
-M-. ~~ Control 
Age 43±17 48±14 SO± 5* 43±15 
Ischemic time (min) l78±33. 152+76 134+46 125+47 
Cholesterol (mg/d1) 207±67 225+46 261+63* 217+35 
% with cytomegalovirus 22.2 15~8 50~0* 12~9 
(*p<0.03 vs Late Control;'p<0.05 vs Controls, Late AA) 
Late AA pts were older, had a higher frequency of 
cytomegalovirus infection, and higher serum cholesterol 
than Late Controls (p<0.03). Early AA pts had longer 
ischemic times than Late AA pts(p<0.02) and Controls 
(p<0.05). Mortality 1 year after diagnosis of early and 
late AA was 60% vs 28% (p<O.OS). Our data suggest that: 
1) Early and late AA have different risk factors and may 
represent different pathologic entities. 2) Early AA has 
a poorer prognosis than late AA and requires a prompt 
decision regarding candidacy for retransplantation. 
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QUANTITATION OF CARDIOPLEGIA FWW DELIVERED 
RETROGRADELY THROUGH THE CORONARY SINUS USING 
MYOCARDIAL CONTRAST ECHOCARDIOGRAPHY 
Flordeliza S. Villanueva, William D. Spotnitz, William P. 
Glasheen. lohn Dent, Sanjiv Kaul. University of Virginia, 
Charlonesville, Virginia 
Retrograde cardioplegia delivery is being used increasingly during 
cardiac surgery. Its potential advantages include bener cardioplegia 
delivery to myocardial regions which may not receive adequate antero•
grade cardioplegia due to severe coronary stenoses. There is, however, 
no clinically applicable method to asses. the adequacy of retrograde 
cardioplegia delivery in terms of the magnitude of myocardial flow nor 
to assess its intramyocardial distribution. 
To test the hypothesis that myocardial contrast echocardiography can 
measure myocardial flow rates and the iotramyocardial distribution of 
retrograde cardioplegia. cardioplegia was delivered at different flow rates 
in 6 dogs. After cardioplegic arrest, sonicated albumin microbubbles 
were injected into the cardioplegia line and two-dimensional echocar•
diography was performed. One minute later, 3 mci of technetium-99m 
was injected into the cardioplegia line. Time-intensity plots were gene•
rated from the contrast images. Videointensity in each of 5 myocardial 
regions within the short-axis image was categorized on a scale of I to 5 
using digital subtraction techniques. Videointensity was correlated with 
extraction fraction of technetium-99m graded on the same scale, within 
these same regions. 
There was a close linear relation between cardioplegia flow rates and 
time to peak contrast effect (r s O.90,p ~ 0.005). When a score of 
> 3 WES defined as adequate contrast and .s.3 as faint contrast, there 
was 88% concordance between contrast images and technetium·99 extrac•
tion fraction. 
We conclude that myocardial contrast echocardiography is ideally 
suited for the in-vivo quantitation of retrogradely delivered cardioplegia. 
929·40 
Detection of Myocardial Contrast following '-V, A1bunex(R) using Digital 
Radiofrequency Echocardlography 
M J Monaghan, J M Metcalfe, S 0 Oduniaml, S D Thomas, A Waaler*, 0 E 
Jewitt. KIngs College Hospital, London, UK and *Nycomed AS, Oslo, Norway 
Conventional contrast echo techniques have proved InadeqU<\te for the 
detection of myocardial perfusion using intravenously Injected echo contrast 
agents because of the limitations and relative insensitivity of standard echo 
equipment. In order to avoid these problems, we have used a modffied 
phased-array ~rasound scanner and an on-lIne computer system to obtain 
pure digital radlofrequency ultrasound (ORF) data (derived from the 
transducer preamplHlers) from the left ventricle and myocardium during IV 
contrast myocardial perfusion echo studies. 
In 30 patients, following coronary arteriography, IV injections of the echo 
contrast agent Albunex(R) (sonicated human serum albumin) In 2 doses of 
0.08 and O.22m1s/kg were given during ORF echo. The ORF data was 
successfully obtained and analysed In 23 patients for a shift In frequency 
spectrum which could be caused by resonance of the Albunex(R) contrast 
mlcrobubbles In the heart - a phenomenon which has been previously 
demonstrated In·vitro. The mean Integrated backscatter (MIS - a measure of 
the total ultrasound energy) was also calculated before, during and after 
Albunex(R) Injection. In segments where reasonable resting perfusion was 
expected, there was 8 significant Increase In MIS from 0.644 to 1.245, 
p<O.OOI and time Intensity curves could be constructed showing \>\'ash-in and 
out of contrast from the myocardium. In 10 segments supplied by 
significantly diseased vessels, MIS Intensity Increased from from 1.044 to 
1.874, p=O.054. In myocardial segments supplied by non-diseased vessels 
contrast microbubble resonance also caused a drop in mean frequency of 
140KHz, p<O.OOI, and permitted similar temporal analysis of myocardial 
perfusion. Frequency changes preceded Intensity changes In both the LV and 
myocardium by 2.3 beats and represent faster pulmonary transm~ of smaller 
contrast microbubbles. In conclUSion, this study shows for the first lime 
that DRF echo .nalysls provides I method of detecting myocardial 
perfusion following IV Albunex(R). 
JACC Vol. 19, No.3 
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929·41 
Contrast Echocardiography: In Vitro and In Vivo Stability of 
Albune~ Contrast Aient 
Jeffrey G. Wiencek, R.obert Walker, Dan GretIer, Antonio 
Montano, Kevin Jones, Paul V. Harper, Solomon Aronson, 
Steven B. Feinstein, University of chicago, Chicago, II.. 
It has been reported that Albune~ stability under 
pressure is related directly to its concentration in vitro. We 
tested this hypothesis both in vitro and in vivo. 
In vitro, it was found that as the concentration of 
Albune~ decreased, the acoustic properties (videointensity) 
decreased when exposed to a pressure of 120 mmHg; however, 
total counts and size distribution of particles as counted by a 
Coulter counter with a 256 channel Channelyzer did not 
change significantly. 
In an in vivo, open chested do~ model, Albune~ was 
injected into a peripheral vein while unaging the LV cavity 
WIth a ultrasound scanner. The following t1free injections with 
varying Albun~ concentrations and injection rates were 
performed: 1) standard concentration Albune~ (3·5 x 108 
bUbbles/ee~ at an inj§ction rate of 1 eels 2) concentrated 
Albune~ 1.2·2 x 10 bubbles/ee) at an inlection rate of 1 
eels and ) concentrated Albune~ at an mjection rate of 22 
CX?/s .. Imag~s. were recorded on videotape and LV cavity 
Videomtensltles were analyzed. Results showed peak intensity 
ya!ue~ of 54, 162 and 170 gray levels for the three respective 
mJectlODS. 
ConeJps!ons: The acoustic properties of Albune~ after 
exposure to pressure are directly related to its concentration 
in vitro and m vivo. This effect may be reduced in vivo by 
increasing the concentration of injectate or by increasing the 
injection rate. Furthermore, particle counts with a Coulter 
counter may not be reliable predictors of the acoustic 
properties of Albune~. 
929·42 
Improved Border Delineation in Suboptimal Stress Echocardio•
graphy by the new Left Heart Contrast Agent SH U 508 A 
Klaus Schroder, Heinz Voller, Rahul Agrawal, Reinhard SChliet", Rolf 
SchrOder. Dept. of Cardiology, Klinikum Steglitz, Free University Berlin, 
·Clinical Research Diagnostics, Schering AG Berlin, Germany. 
Recent studies have shown that the saccharide based echocardio· 
graphic contrast agent SH U 508 A opacities the left ventricle (LV) after 
crossing the pulmonary circulation and thus improves LV endocardial 
border delineation. The aim of our study was to determine whether SH U 
508 A application can enhance the evaluation of the LV wall motion in 
suboptimal echocardiographic images at rest and after pharmacological 
stress test. This would enable better assessment of LV wall motion in 
patients in whom routine echocardiography may be inconclusive. 
METHODS: The study included 10 patients (mean age of 58 years) 
who exhibited 30% or more endocardial border dropout on routine 
resting echocardiography. The LV was divided Into 12 segments, thus In 
each patient ~ 8 segments (i.e. ,; 70%) were evaluable at rest. 5 patients 
were stressed with Dobutamine and 5 with Dipyridamole to evaluate the 
coronary perfusion. Two Iniections of 10 ml of SH U 508 A were applied 
Intravenously in a concentration of 400 mg/ml at rest and after the 
maximal pharmacological stress. 
RESULTS: 
EVALUABLE SEGMENTS (mean+std. dev) 
rest exercise 
pre 
5.7± 1.03 
p,; 0.01 
post pre post SH U 508 A 
9.0:!: 1.77 6.4± 1.84 10.0± 1.51 
p,; 0.01 (Mann-Whitney U test) 
There was no difference between the two types of stress tests. No 
adverse reactions were observed. 
CONCLUSION: After intravenous inletion of 10 ml of SH U 506 A in 
patients with suboptimal echocardlographic Images we observed a 
statistically significant improvement in border delineation at rest as well 
as after a maximal pharmacological stress test. Thus, with the help of SH 
U 508 A the assessment of LV wall motion In patients with suboptimal 
Image quality was greatly improved. 
ABSTRACTS 
929·67 
Regional Myocardial Blood Flow and Function During 
Intravenous Adenosine and Intravenous Dipyridamole 
Elizabeth Olili, Frederick Dressler, Jeanette St.Vrain, Ramon 
Castello. Henry Goodgold, Rita Genlilcor, John Standeven, Bhugol 
Chandel, Lawrence McBride, Arthur Lebovitz 
St. Louis University Medical Center, St. Louis, Missouri 
Conflicting reports on sensitivity and specificity of Intravenous 
adenosine (ADENO) when compared to Intravenous Dipyridamole 
(OIPY) during cardiac Imaging may be due to differences In the 
degree and extent of myocardial redistribution induced by each 
agent. We compared the physiologic and functional responses of 
ADENO and DIPY, In10 anesthesized open chest mongrel dogs 
using a model of critical circumflex (CIRe) stenosis. Ultrasonic flow 
probes on the eiRe and normal left anterior descending (LAD) 
measured flow continuously. Regional myocardial blood flow (MBF) 
was measured by radiolabelled microspheres to determine 
subendocardial (ENDO) and subepicardial (EPI) flows after ADENO 
(0.42 mg/kgx3mins) and DIPY (0.56 mg/kgx4 mlns) with a BASE 
before each drug. Redistribution abnormality (RED 1ST) was defined 
as drug·induced ENDO/EPI flow ratio <0.9. 
Continuous epicardial short axis 20 echocardlography (2DE) was 
performed for analysis of wall thickening (WT). The LV short axis 
was divided into 6 equal carefully matched segments (segs) for 
MBF and 2DE WT. 2DE WT abnormality (abn) was recorded as a 
decrease of 2 standard deviation from BASE. 
RESULTS (Mean±SD) 
HR MAP ft)w (m'&tnin) #Segs #Segs 2DE 
(b'nil) (rmtig) CIRC LAD Recist. wr Abn. 
Adeno 128±19 64±19 56±22 94±5 1.6±O.7 2.3±1.0 
Dipy 124±16 53±17 59±26 107:1:22 1,7±0.5 1.8±1.3 
P 0.04 .01 NS NS NS NS 
CONCLUSION: ADENO induces coronary vasodilation similar to 
DIPY but with significantly less decline in MAP. The extent 01 
REDIST and 2DE WT abn is similar with both agents. 
929-68 
The PrognOlitic Value of Dipyridamole Echocardiography 
Early After Acute Myocardial Infarction: Comparison 
with Exercise Electrocardiography and Coronary 
Angiography 
Mario Previtali, Stefano Chiaranda, Panizia Landi, Giovanni Seveso, 
Leonardo Bolognese, Franco Chiarella, Franca Margaria, Nicola 
Gandolfo, Omelia Magaia, Maria Grazia Sclavo, Cecilia Marini, 
Eugenio Picano, on behalf of the EPIC study group· subproject 
residual ischemia. 
Aim of this large scale multicenter study was to assess the relative 
prognostic value of dipyridamole-echocardiography test (DET), 
exercise electrocardiography test (EET) and angiographicaUy 
assessed coronary artery disease (CAD) in predicting future "hard" 
events (myocardial infarction and death) early after uncomplicated 
myocardial infarction. A total of 376 patients performed DET, EET 
and coronary angiography early «18 days) after an acute myocardial 
infarction and were followed up for a mean of 11.6 months. Criteria 
of positivity were: for DET a transient dyssynergy of contraction 
absent or of a lesser degree in baseline examination; for EET, an ST 
segment shift >.15 mVolt. A coronary stenosis was considered 
significant when a lumen reduction ~50% was present in at least 1 
major coronary vessel. There were 23 events: 11 deaths and 12 
myocardial infarctions. Univariate analysis identified the Wall Motion 
Score Index (an integrated semiquantitative measure of extent and 
severity of the dyssynergy) at peak dipyridamole as a powerful 
predictor of subsequent events (X2=4.53, p<.05) comparable to the 
number of diseased vessels at coronary angiography (X2=3. 7, 
p<.05) and significantly betler than EET positivity (X2=O, II, p=ns). 
We conclude that the presence, extent and severity of dipyridamole 
induced dyssynergy are more effective than 
exercise-electrocardiography and comparable to coronary 
angiography in prognostic stratification of patients early after 
uncomplicated myocardial infarction. 
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929-69 
Dobutamine Bchocardiography Predicts Recovery 
of Hibernating Jryocardium following Coronary 
Revascularization 
Richard Charney, Matthew E. Schwinger, Michael 
v. Cohen, Mark Menegus, Hugo Spindola-Franco, 
Mark A. Greenberg. Montefiore Medical Center, 
Bronx, New York 
To determine whether dobutamine(D) echocar•
diography (E) can identify hibernating myocar•
dium in ischemic hearts, 10 patients with 
stable coronary disease and regional wall 
motion abnormalities undergoing coronary angi•
oplasty or bypass surgery underwent DE (5 and 
10 mcg/kg/min) prior to revascularization 
(revasc). Recovery of regional systolic 
function was evaluated by E 6.9±3.9 days after 
revasc. The left ventricle was divided into 10 
segments and wall motion was graded as normal, 
mildly hypokinetic, moderately hypokinetic or 
akinetic/dyskinetic. Improvement by one grade 
during D infusion or after revasc was consid•
ered significant. 93 of 100 segments could be 
visualized. 2 segments were excluded from 
analysis because of intraoperative infarction. 
56 segments were normal and 35 were abnormal 
before revasc. Contraction of 12 of the ab•
normal segments did not improve after revasc 
and none of these 12 had shown any wall motion 
improvement with D. Conversely, motion of 23 
abnormal segments improved after revasc, and 
17/23 also had improved with D. This difference 
in response to D was significant (p<O.OOl). 
Hence, an improvement of wall motion with D 
is a strong predictor of wall motion improve•
ment after revasc. DE is an effective technique 
to identify hibernating myocardium. 
929-70 
Normalcy Rate of Dobutamine Stress Ecbocardiograpby in a 
Population at Very Low Risk for Coronary Artery Disease 
David S. Bach. Anne Hepner, Pamela A. Marcovitz and William F. Armstrong. 
University of Michigan Medical Center, Ann Arbor, Michigan. 
Dobutamine stress echocardiography (DSE) has been shown 10 be: a highly 
sensitive method for the detection of inducible myocardial iSChemia and the 
diagnosis of coronary artery disease (CAD). A lower specificity noted in previous 
studies has been problematic, with a potentia! selection bias for patients referred 
for cardiac catheterization a confounding factor. Among the cohort of 141 patients 
referred for clinically indicated cardiac cathelerization, the specificity of DSE was 
found 10 be only 66%. The current study was intended 10 derme the normalcy rate 
of DSE independent from catheterization referral bias by utilizing a patient 
population at low risk for CAD. 
Clinical characteristics of 828 patients referred for DSE were reviewed. 
Utilizing previously described nomograms for the estimation of the likelihood of 
significant CAD, patients were identified with a <10% risk of CAD. 
75 patients (27% male, age range 19-65, mean 41.8 years) were identified with 
a <10% risk of CAD. 37 (49%) bad a history of atypical chest pain and only 11 
(15%) bad one or more risk faclOr for CAD. Five patients (6.7%) had a DSE 
positive for iSChemia. One DSE (20%) was abnormal in the distribution of the 
anterior circulation, and 4 (80%) in the posterior circulation. Three of these 5 
patients underwent coronary angiography; none bad CAD. AIl 5 are presumed to 
represent false.positive DSE examinations. 
Of 39 patients with a <5% risk of CAD, 4 (10.2%) bad a positive DSE (1 
anterior and 3 posterior circulation abnormalities). One abnormal DSE was 
performed 4 days foUowing pericardiocentesis. Excluding patients with underlying 
cardiomyopathy, pericardia! or valvular disease, 3 of 38 patients (7.9%) with a 
<5% risk of CAD bad an abnormal and presumed false·positive DSE. 
The use of normalcy rates may help 10 overcome the selection biases inherent 
in a university·based population study on the specificity of DSE. DSE has a 
normalcy rate of 90-92%, with false positive tests predominantly involving the 
posterior circulation. We conclUde that in this setting, DSE is a highly specific 
test for the diagnosiS of CAD. 
929-71 
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Does Quantitating Rest and Exercise Ejection Fractions 
During Stress-Echocardiography Aid in Predicting 
Prognosis 
Janine Krivokapich, John S. Child, Richard S. Gerber. 
UCLA Medical School, Los Angeles, California 
Development of new or worsened regional wall motion 
abnormalities (WMAs) has been used to define myocardial 
ischemia in patients undergoing stress echocardiograms 
(SEs). The added value of quantitated rest and exercise LV 
EF has not been determined. Historically, EF has been of 
prognostic value in CAD. We added these measurements to 
the routine assessment of WMAs in catheterized patients 
undergoing stress echocardiography. An abnormal EF 
response (clEF) was defined as <5% increase. Myocardial 
infarction, angioplasty, bypass surgery, or death were 
considered significant cardiac events during the 
subsequent 12 months. Rest and exercise EF's averaged 
56±12% and 66±12% in 161 SEs. Twenty-three pts each had 
an abnormal clEF and a cardiac event; only 6 pts had both. 
#SEs Rest EF% Exercise EF% clEF% 
normal dEF 138 56±12 (18-79) 66±16 (23·91) 10±7 
abnormal dEF 23 47+12 (27-65) 45+12 (29-66) -2±6 
nl dEF +event 17 53tll (28-68) 63±13 (39-83) 10M 
abn clEF+eyent 6 46+11 <26-65) 42±12 (24-65) -5+7 
In studies with an abnormal dEF, the EF's were not 
significantly different among those with and without a 
cardiac event. Twenty-six % of SEs (6/23) with an abnormal 
clEF had a event, whereas only 12% (17/138) of SEs with a 
normal dEF had an event. However, no SE followed by an 
event had an abnormal clEF without also having a positive 
SE based on WMAs. Therefore, there is no definite 
evidence that the addition of quantitative EF improves the 
ability ofSE to predict prognosis. 
929-72 
Do Thrombolytic Therapy And Intravenous Heparin In 
Acute Myocardial Infarction Affect The Incidence Of Left 
Ventricular Mural Thrombus Formation? 
David W. Grambow, Vallerie V. Valentini, William F. Armstrong, 
University of Michigan, Ann Arbor, Michigan 
Left venlricular mural thrombus(LVMT) has been reported 
following 15-20% of all myocardial inlarctions and after 30·50% 
of anterior a wave infarctions in studies performed prior to 
widespread utilization of IV heparin and thrombolytic therapy. The 
purpose of this study was to determine whether the use of aspirin 
and IV heparin with or without thrombolytic therapy during acute 
myocardial infarction affects the incidence of LVMT. We studied 165 
patients with acute myocardial infarction with 1W0 dimensional 
echocardography. IV heparin or aspirin were administered in 87% 
of patients with 75% of patients receiving both. Thrombolytic 
therapy was used in 42% of patients. Overall incidence of L VMT was 
16% and was not reduced in patients receiving thrombolic therapy. 
Anterior a wave infarctions occured in 72 patients of whom 32% 
developed LVMT. Administration of thrombolytic therapy did not 
reduce the incidence of l VMT in anterior infarctions. 
LVMT + 
LVMT· 
(ALL MI 
+ LYTICS 
13(19%) 
56(81%) 
Il..:.l..Ul 
• LYTICS 
13(14%) 
83(86%) 
(ANTERIOR 
",LYTICS 
14(33%) 
28(67%) 
MI n=721 
• LYTICS 
9(30%) 
21 (70%) 
LVMT was aSSOCiated with akinesis or dyskinesis of the anteroapical 
wall in 89% of cases. Patients with thrombus had worse left 
ventricular function (LVEF 29% vs 43% p=0.0001). No embolic 
complications occurred during hospitalization in any group. 
Conclusion: The incidence of LVMT after myocardial infarction is 
nol reduced by the use of IV heparin and aspirin alone or in 
combination with thrombolytic therapy. Anteroapical wall motion 
abnormalities and left ventricular dysfunction remain important 
features in the developement of lVMT. 
JACC Vol. 19, No.3 
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929·73 
BOTH RISK AREA DURING CORONARY OCCLUSION AND IN•
FARCT SIZE AFTER REPERFUSION CAN BE DETERMINED 
DURING MYOCARDIAL CONTRAST ECHOCARDIOGRAPHY 
FOLLOWING RIGHT ATRIAL INJECTION OF CONTRAST 
Flordeliza S. Villanueva. William P. Glasheen. Jiri Sklenar. 
Sanjiv Kaul. University of Virginia. Charlottesville. Virginia 
We have previously demonstrated that when a concentrated solution of 
50nicated albumin microbubble! Is delivered Into the right atrium 
following Intravenous infusion of dipyridamole. myocardial opacification 
can be detected close to 90% of the time. In this study we hypothesi•
zed that this approach could be used to define risk area in the pre•
sence of coronary occlusion and infarct size following reperfuslon. 
Accordingly, a concentrated solution of sonicated albumin micro•
bubbles (50 billion, 4.511 in diameter) was injected after 0.56 mglkg of 
dipyridamole into the right atrium of 5 dog! during baseline. following 
3 to 6 hours of left anterior descending anery occlusion. and after 15 
minutes of reperfusion. Twenty mCi of technetium-99m was injected 
into the left atrium during coronary occlusion and post-monem auto•
radiography was performed 10 measure risk area. The slice of the 
hean corresponding to the echocardiographic shon-axis slice was stained 
with triphenyltetrazolium chloride (TIC) to determine infarct size. The 
conlrast images were processed using digital subtraclion and color 
coding techniques. 
Risk area on myocardial conlrast echocardiography ranged from 27% 
10 43% of Ihe myocardium al Ihe mid-papillary muscle shon-axis level. 
There was a linear relation between contrast echo and lechnetium 
autoradiography derived risk areas: y - O.99x - 4.1. r - 0.73. After 
reperfusion, the perfusion defect ranged from 0% 10 37% of the myo•
cardium in the shon-axis view. There was a close linear relalion 
between contrasl echo and TTC-derived infarct sizes: y - 0.93x + 
2.8. r - 0.92. 
We conclude that right atrial injection of contrast can be used to 
define both risk area during coronary occlusion and infarcI size follow•
ing reperfusion. This eXciting new finding sets Ihe stage for assess•
menl of risk area and infarct size using myocardial contrasl echocardio•
graphy during peripheral venous Injeclion of contras!. 
929·74 
Improved Echo Contrast Production wHh Temperature-based Versus Time•
based Sonication. Gian Paolo Bezante, Karl Q. Schwarz, Kevin J. Schiller, 
Carolyn Calalang, Richard S. Meltzer. Univ. of Rochester, Rochester,NY. 
We hypothesized that echo contrast agent production is improved by tem•
perature (T)-based rather than time (I)-based sonication of hUl!'an albumin. 
The sonication process produces air filled microbubbles (MB) With denatured 
albumin shells. Denaturing of albumin occurs at T > 600 C. There were 2 
groups (Gp): sonicated for 60 sec (time based, Gp t) and sonicated to a 
maximum T of 5aoC (T-based, Gp T). The size and the concentration of the 
MB was evaluated by light microscopy. The following protocol was used: 1) 10 
cc of refrigerated 5% albumin (11.7±O.6 °C) was sonicated (22 KHz 
continuous wave ultrasound) for 60 sec (Gp t) or until the T increased to 50 
·C (Gp T), 2) 5 cc of air was then injected over 15 sec while still sonicating, 
3) after 3 min, 10 cc of unsonicated refrigerated 5% albumin was added to 
the mixture, it was stirred and 1 a cc was withdrawn from the bottom of the 
chamber. The unpaired Student's t-test was used for statistical comparisons. 
Results: The MB size reported represents the mean of 645 MB measured for 
Gp t and 825 MB measured for Gp T (15 measurements for each of 98 runs). 
The MB concentration reported is the mean of 215 measurements for Gp t 
and 275 measurements for Gp T (5 for each run). The time of sonication in 
Gp T was shorter than in Gp t (46.B±2.4 VS 60.0±0 sec, p < 0.001). The 
maximum T reached in Gp t was greater than in Gp T (63.5± 1.0 vs. 52.4± 
1.0 °C, P < 0.001). The size of MB was reduced in Gp T [6.2±1.6Ilm (Gp t) 
vs 4.9±1.5Ilm (Gp T)], the MB concentration in Gp t was not statistically 
different from those in Gp T [32.3±4.4 x106/ml vs 31.2±4.2 xl a6/mll. De· 
naturation of albumin was noted microscopically in no T-based run and in 4 t•
based runs. Conclusion: Temperature monitoring during sonication permits: 1) 
reduction of MB diameter, 2) reduction of sonication time, 3) decrease of 
maximal temperature, 4) production of MB with the same concentration as 
time based sonication, and 5) avoidance of denaturation. Thus, safety may 
be enhanced without decreased efficacy. 
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930-61 
prebospital Thrombolysis is Feasible. Safe and is 
ASsociated With a Low Mortality. 
Ton Hooghoudt and Marcel Pasch. Canis ius Hospital 
Nijmegen, The Netherlands. 
In an ongoing study to test the feasibility and safety 
of prehospital thrombolysis. between August 1987 and 
April 1991. 363 patients with acute myocardial infarc•
tion of < 6 hrs duration received thrombolytic therapy 
at home (n=59) or in hospital (n=304). Close cooperation 
between General Practitioners (GP). ambulance crews (AC) 
and cardiologists appeared essential to perform pre•
hospital thrombolysis. The diagnosis of acute myocardial 
infarction (AMI) is made on clinical grounds by the GP. 
The 9 AC's are provided with a cardiophony transmitter 
and a cool box with Anisoylated Streptokinase Plasmino•
gen Activator Complex (APSAC). The 12-lead ECG is trans•
mitted to the hospital by telephone (cardiophony) and 
read by the cardiologist. After confirmation of classical 
signs of AMI. 30 mg of APSAC is administered i.v. Results 
of the prehospital group (home) are compared with those 
of patients who received thrombolysis in hospital (hosp.) 
One year follow-up is completed for 43 home and 207 hosp. 
patients. 
home 
hosp 
p-value 
n= 
59 
304 
age 
62±9 yr 
61111 yr 
NS 
mortality 3 wk 
O.Ot 
7.6t 
0.015 
1 year 
0.0\ 
12.8\ 
0.007 
No serious adverse events occurred in the home group. 
Although patient selection can not be excluded it can be 
stated that prehospital thrombolysis is not only feaSi•
ble and safe but also is associated with a low mortality. 
930-62 
Thrombolytic Therapy in the Treatment of Complete Heart 
Block Complicating Acute Myocardial Infarction 
John Purvis, Michael Roberts, Albert McNeill, Norman 
Campbell, Mazhar Khan, Gee ge Patterson, Carol Wilson, 
Samuel Webb, Jennifer Adgey. Royal Victoria Hospital, 
Belfast, Northern Ireland 
Thrombolytic therapy is often withheld from patients(pts) 
with complete heart block (CRB) complicating acute myo•
cardial infarction (AMI) because of a perceived risk of 
hypotension and bleeding if temporary pacing is required. 
We treated 21 pts (12M,9r) with thrombolytic therapy for 
AMI (20 inferior, 1 anterior) in whom the initial 
electrocardiogram showed CHB (median systolic BP=70mm.Hg, 
range 50 to 180). Thrombolysis was started at a mean of 
154 minutes after the onset of symptoms: 12 pts received 
pre·hospital thrombolysis. All pta received IV atropine 
initially. Of the 12 pts who remained in CHB at the time 
of receiving thrombolysis, 10 reverted to 1:1 atrioventr•
icular (AV) conduction and 1 to chronic atrial 
fibrillation within 2 hours (h) of treatment. Thus 20/21 
(95%) pts returned to 1:1 AV conduction within 2h. 
Temporary transvenous pacing was required in only 4 pts. 
No bleeding complications occurred with pacing. One pt 
with anterior MI died from pump failure and ventricular 
dysrhythmia. These results were compared with a histor•
ical control group. 
CRE (AMI) 
Atropine only (1968) 
Atropine+Thrombolysis 
% 1:1 AV Conduction 
40% (8/20) at 24 h 
95% (20/21) at 2 h 
957. CI 
19-64 
76·99 
Atropine and thrombolysis are significantly superior to 
atropine alone in promptly restoring 1:1 AV conduction 
(X'=14.4, p=0.0002). Thrombolytic therapy should not 
therefore be withheld when CRE complicates AMI. 
178A ABSTRACTS 
930·63 
Coronary Stentlnll' in Unstable Angina: 
No Greater Risk Than in Stable Angina 
Richard R Heuser, Robert K. Strumpf, 
Craig M. Walker, Michael W. Cleman, Richard A. Schatz 
Arizona Heart Institute, Phoenix, Arizona 
The current restenosis rate for percutaneous transluminal coronary an•
gioplasty (PTCA) is 39.6%. Patients with unstable angina are at greater 
risk for abrupt occlusion, bypass, and death, as well as having a higher 
restenosis rate. Coronary stenting has been proposed as a possible solu•
tion to these problems. We sought to evaluate whether stenting, like 
PTCA, presents even greater risk in patients with unstable angina. In a 
multicenter trial, the Palmaz-Schatz stent was placed successfully in 
650 patients. Of this group, 312 had unstable angina and 338 had sta•
ble angina. A total of 447 patients underwent protocol-mandated repeat 
angiography for assessment of restenosis. The table lists acute compli•
cation and restenosis rates: 
Subacute thrombosis 
MI 
CAB 
Death 
Restenosis (all pts) 
Restenosis (single 
stent de novo) 
Unstable Angina 
.Eta: .212 
17 5.4 
5 1.6 
16 5.1 
5 1.6 
63 30.7 
11 19.6 
x· significant for 2 x 2 at ~ 3.84. 
*NS 
Stable Angina 
~ .212 
26 7.7 
7 2.1 
25 
2 
74 
6 
7.4 
0.6 
30.6 
12.5 
1.32* 
0.20* 
1.41* 
1.56' 
0.001* 
0.96* 
These data show that stenting in unstable angina is as safe as in stable 
angina, and unlike PTCA, the restenosis rate is the same in both 
classes ofangina. Compared with PTCA, the low restenosis rate for sin•
gle Stent de novo lesions suggests this approach may be the preferred 
therapy in patients with unstable angina. 
930·64 
Do the Management and Outcome or Elderly Patients with 
Prolonged Chest Pain Differ from Younger Patients? 
James M.Parks, Robert P. Robichaux, Silvio E. Papapietro, Edwin 
L Bradley, William J. Rogers, UAB Med Center, Birmingham, AL. 
To compare age related patterns of treatment and outcome in 
patients admitted to the CCU with prolonged chest pain, data were 
prospectively collected on 692 patients (14% 76+ yrs old) in 1990-
1991 at 7 hospitals with acute PTCA capability. Patient ages 
ranged from 27 to 94 years. Elderly patients were much more 
likely to be female (58% vs 30% p< .001) but less likely to 
demonstrate STelevation (> I mm in 2+leads) on their initial EKG 
(41% vs 53% p<.03). However, there was no difference in the 
incidence of CPK-confllllled myocardial infarctions in the two age 
groups (62% vs 55% NS) or in the time from the onset of chest 
pain to presentation (218 min vs 202 min NS). Despite their age, 
10% of elderly patients received thrombolytic agents compared to 
33% of younger patients (p<.OOI). Following admission, elderly 
patients were more likely not to undergo angiography (38% vs 15% 
p<.OOI); however they underwent acute PTCA (21% vs 19% NS) 
as frequently as their younger counterparts. Complications such as 
cardiogenic shock (12% vs 6% p<.03) and CHF (21% vs 10% 
p<.002) were more common in the elderly. Cardiac arrest was 
uncommon in both age groups (5% vs 7% NS), but when it 
occurred it did so later in elderly patients (mean day 1 vs day 6 
p < .004). Finally, mortality was more frequent in elderly patients 
(16% vs 6% p<.OOI). 
Thus, in this contemporary registry from tertiary care 
hospitals, elderly patients who present with prolonged chest pain 
differ in their sex distribution as well as the incidence of ST 
elevation, cardiogenic shock, CHF, and mortality. They also differ 
in the frequency that angiography and thrombolytic agents are used. 
Importantly however; they do not differ in time from the onset of 
pain to presentation or in the use of acute PTCA. 
930·65 
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Results of HALI (Heart Attacks in London) Study. Potential for 
Earlier Treatment by Prehospital Initiation of Thrombolytic Therapy 
Robert Greenbaum, Piyamitr Sritara, Dan Shanit, Koon IAn Chan. 
Cardiovascular Research Unit, Edgware General Hospital, London, U.K. 
We investigated the potential time to be gained by prehospital treatment with 
thrombolysiS in London. Over a three month period London Ambulance 
Service crews filled in a questionnaire in cases of suspected AMI. 1200 fonus 
were returned, 780 (65%) were male. Mean age was 66±16 yrs. 156 (13%) 
required immediate CPR. In the remainder, symptomatic data were available 
in 934. The major symptoms were severe chest pain in 394 (42%): 257 (28%) 
had chest tightness, 158 (17%) had pressure in the chest, 392 (42%) had 
dyspnoea. In 97 (10%) cases a doctor was present at the time of ambulance 
arrival. Exact infonuation on time of onset was available in 887. 466 (52%) 
calls were made within the frrst hour, mean 21±17 min. For this group, the mean 
time for ambulance arrival from onset was 31±19 min offering the feasibility 
of optimal timing for the initiation of thrombolysis. The mean time from 
ambulance arrival to arrival at hospital was 25±1O min. The mean time from 
onset of symptoms to hospital arrival was 52±22 min. In this subgroup of 
patients 414 (89%) were seen by an ambulance crew within an hour from the 
% of Patients 
so 
30 
" 
10 
.' .... Onsello Call 
onset of symptoms 
unfortunately only 
285 (61%) arrived 
at a hospital within 
this time. Other re•
cent studies, con•
ducted in the UK 
have shown further 
o :::::~: ':. ::~~I1~W~::~~s~ 
o -l---..--~-~-..--.---, pital arrival before 
o 15 T! (min) ~ 60 thrombolysis is ad-
ministered. 
We conclude that in London, initiation of thrombolYSis by trained ambulance 
personnel could save about 90 min in those patients calling the anlbulance 
service within one hour of the onset of symptoms. 
930·66 
Determinants of the Circadian Pattern and PhYSical 
Activity at the Onset of Myocardial Infarction 
Geoffrey Tofler, James Muller, Sandra Forman, Rachel 
Solomon, Eugene Braunwald, and the TIMI Investigators, 
Harvard Medical School, Boston, MA. 
To provide insight into the mechanisms of onset of 
acute myocardial infarction (MI), we determined the 
modifiers of the circadian pattern and physical activity 
at onset of MI in 3,339 patients entered into the 
Thrombolysis in Myocardial Infarction (TIMI II) Study. 
A significantly higher frequency of onset of MI was 
observed between 6 a.m. and noon (34%) compared to other 
times (15% between midnight and 6 a.m., 28% between noon 
and 6 p.m. and 23% between 6 p.m. and midnight). 
Characteristics independently associated with an MI 
between 6 a.m and noon (p < 0.01) were: no use of beta 
blockers in the 24 hrs prior to MI, no chest pain in the 
prior 48 hrs, not a current cigarette smoker, and the 
index MI occ~rring on a weekday. Of the patients who had 
an MI and had all 4 characteristics, 44% (253/577) 
experienced their index MI between 6 a.m. and noon. 
Since HI may be triggered by physical activity, we 
also determined the activity level at onset. In 19% of 
patients, HI began during moderate or marked activity. 
Independent predictors of infarction onset during 
activity (p < 0.01) included no chest pain in the prior 
48 hrs, the absence of rest pain in the 3 weeks prior to 
MI, the presence of exertional pain in the 3 weeks prior 
to MI, male gender, no use of calcium antagonists or 
nitrates in the prior 24 hrs, no history of hypertension, 
being of white race or a nonsmoker. 
These multivariate analyses provide a characteriza•
tion of patients at high risk of developing MI in the 
morning and during activity and suggest possible 
pathophysiologic mechanisms. 
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931-59 
When is it Safe to Re-adm1nister Streptokinase for Acute 
Myocardial Infarction? - Measurement of Early and Late 
Ahtistreptokinase Antibody and Neutralisation Titres 
Hai Shiang Lee, Stephen Cross, Ronald Davidson, 
Tom Reid, Kevin Jennings, Aberdeen Royal Infirmary, 
Aberdeen, Scotland, U.K. 
Streptokinase (SK) reduces mortality in myocardial 
infarction. rts antigenicity can cause allergic 
reactions and/or SK neutralisation resulting in 
suboptimal or ineffective treatment. Our study aim 
is to determine when SK can be re-administered safely 
for re-infarction. Antistreptokinase antibody (AB) 
and neutralisation titres (NT) were measured in 2 
groups of patients:- 1. EARLY - 36 patients [18 
received hydrocortisone (HCO group) before thrombolysis 
and 18 did not (Non HCO group)] whose titres were 
measured before and daily for 5 days after thrombolysis. 
2. LATE - 32 patients thrombolysed 12-38 months 
previously. 
Results:- 1. EARLY: In 33% of Non HCO and 5.6% of HCO 
patients, the AB and/or NT were raised by day 4. 
One patient neutralised 1.97 MU (million units) of 
SK at day 4 and 15.75 MU by day 5. 2. LATE: 16 
gatients (50%) had either AB> 160 and/or NT >1.5 MU. ther results: (mean + SEM).-
Patients Groups Days n NT (MUI AB 
Early Non 4 18 0.2442+0.1021 57.2+19.21 
HCO 5 18 1.3314+0.8531 226.1!76.32 
HCO 4 18 0.1311+0.0061 20.6+8.26 
5 18 0.1637!0.0275 47.8+17.06 
Late 12-17 mths 12 0.8309+0.2465 230.0+51.43 
18-29 mths 15 0.5040+0.1562 193.0+54.76 
30-38 mths 5 0.1615+0.0273 56.0+26.38 
Conclusion:- Streptokinase or anistreplase should 
not be re-admlnlstered between 3 days and at least 
3 years 2 months after a previous dose. 
931-60 
Intravenous Nitroglycerin Does Not Decrease the Efficacy of t•
PA in Patients with Acute Myocardial Infarction 
Paul R. Eisenberg and Allan S. Jaffe. Washington University. 
Sl Louis, MO 
A recent experimental study has reported that administration of 
nitroglycerin (TNG) with t-PA decreases the peak 
concentrations of t-PA achieved and adversely affects the rate of 
clot lysis. To detennine whether similar effects occur in 
patients. we studied 42 patients treated with 100 mg of t-PA 
administered over 3 hours for evolving acute myocardial 
infarction. The dose (range: 10 to 180 ~g/min) and usage of 
nitroglycerin were determined by standard clinical criteria. The 
peak concentration of t-PA antigen 1 hour after initiation of t-PA 
was 1198 ± 312 ng/ml (SE) in patients given TNG (n=18) 
compared to 745 ± 114 ng/m1 in those not receiving TNG 
(n=24) (p=NS). There also were no significant differences 
between the two groups of patients in the concentration oft-PA 
at 2. 3, and 4 hours. The concentration of BB 1-42. a peptide 
specific for the proteolysis of fibrinogen by plasmin. incteased 
in all patients after treatment with t-PA but the concentrations 
were not significantly different between patients given TNG 
(539 ± 190 pmoVml) compared with those not given TNG (842 
± 535 prnoVrnl). Similarly. the concentrations of cross-linked 
fibrin degradation products measured with a new specific 
immunoassay were not significantly different between the two 
groups (peak concentrations were 627 ± 122 ng/ml with TNG 
compared to 595 ± 75 without TNG). Based on the results of 
coronary angiography and serial assay of the concentrations of 
creatine kinase-MM isoforms and myoglobin in plasma. 13 of 
17 (76%) of patients receiving TNG met criteria for early 
recanalization compared with 19{24 (79%) not receiving TNG. 
These data indicate that the efficacy of t-PA-induced 
thrombolysis is not impaired by administration of TNG in 
commonly used doses. 
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931-91 
Outcome of Thrombolytic Therapy with Streptokinase 
Appears to be Independent of Plasminogen Activator 
Inhibitor (PAI-l) levels. Johan Briigemann, Erwin GObel, 
Sandra Geraards, Victor JJ Bom and Jan van der Meer. 
Depts. of Cardiology and Haemato1ogy, University Hospital 
Groningen, The Netherlands. 
Elevated plasminogen activator inhibitor (PAI-1) 
levels have been associated with non-successful treatment 
with recombinant tissue-type plasminogen activator 
therapy (rt-PA) in acute myocardial infarction. We 
studied 47 patients (age 28-78. mean 57 years) with AMI 
who were treated with streptokinase i.v. ~ 4 hours after 
onset of chest pain. To determine patency. coronary 
angiography was performed approximately 24 ($48) hours 
after therapy. Blood samples were collected on ice before 
therapy and on day 1 and 2 at 12.00 AM. The mean results 
are summarized below (t-PAag and t-PAact- t-PA antigen 
and activity. respectively; PAlag and PAIact- plasminogen 
activator inhibitor antigen and activity respectively). 
patency (n-37) non-patentcy (n-lO) 
time before day 1 day 2 before day 1 day 2 
fibrinogen 3.5 1.2 3.1 3.6 1.4 4.3 (g/l) 
plasminogen 104 51 70 103 47 68 (%) 
antiplasmin 97 67 90 95 68 93 (%) 
t-PAag 9.3 20.9 13.2 6.0 19.1 10.4 (ng/ml) 
t-PAact 1.5 0.9 1.0 0.9 1.1 1.0 (IU/m1) 
PAlag 17 24.1 13.1 lJU ll....l U (ng/m1) 
PAl act 3.5 4.8 2.4 U U 1...1 (AU/ml) 
We conclude that PAl is paradoxically ~ in 
patients with a non-patent vessel. This finding implies 
potential susceptibility for subsequent therapy with rt•
PA and might explain the promising results of combined 
administration of different thrombolytic agents. 
931·92 
Are Persistent High Neutralization Titers After 
Streptokinase Due to Intercurrent Streptococcal 
Infection? 
John M Elliott. Barbara F Williams. David B Cross, 
Stewart Cederholm-Williams. Harvey D White. 
Green Lane Hospital. Auckland, New Zealand. 
Streptokinase is antigeniC. inducing long-lasting 
increases in in vitro neutralization titers and specific 
IgG titers. 
In this study we have correlated neutralization 
titers (NT. Behringwerke) and specific IgG titers to 
streptokinase with antistreptolysin (ASO). antiDNaseB 
(DNB). antihyaluronidase (AH) and antistreptokinase 
(ASK. hemagglutination) titers in 122 patients who had 
received streptokinase up to 48 months previously. 
ASO titers were ) 200iu/ml in 43% and ) 250iujml in 
30% of all patients. Neutralization titers were not 
correlated with ASO or with ASK titers. 
In the 35 patients who had received streptokinase 
between 37 and 48 months previously. 49% (95% Cl 37-66) 
had an NT of ) 450iujml. sufficient to neutralize a 
conventional 1.5 million unit dose. Of those with a high 
NT. 81% had an ASO titer) 200iu/ml. 6% had a raised DNB 
titer and 11% had a raised AH titer. Six percent had 
elevations in at least twe titers suggestive of recent 
streptococcal infection. 
These findings suggest that persistently high in 
vitro neutralization titers may in part be due to 
subsequent streptococcal infection. The importance of 
elevated titers or recent streptococcal infection in the 
safety and effi-' acy of intravenous streptokinase is not 
known. 
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931-93 
Lack of Influenoe of Pretreatment Antl-Streptoklna .. Antfbody on 
Early Coronary Patency Achieved by Anlatrepl_ and Streptokinase 
Robin Fears and Ruth Standrlng 
SmHhKllne Beecham, Epsom, Surrey, UK. 
The potential Influence of the pretreatment level of anti-streptokinase (SK) 
antibody on the response to Intravenous SK and anlstreplase (APSAC, 
Emlnase) was examined by analysiS of a pooled database complied from 
thrse randomlsed double-blind comparisons 01 efficacy In patients with 
acute myocerdlallnfarction (n-473). Patients were not entered Into these 
trials H they had recefved SK or anlstreplase within the previous 6 months. 
Baseline antl-SK antibody levels were measured as specillc antigen 
binding to IgG, early patency wes measured W angiography, usually 1.5-
2.5 hours after administration 01 SK (1.5 x 10 IU Inlused over 1 hour) or 
anlstreplase (30U by 2-5 min. Injection). The distribution of pretreatment 
anti-SK igG levels within groups of patients subsequently assessed as 
patent (TIMI grade 213) and occluded (011) was similar In an three studies 
lor both SK and anlstreplase. 
Pretrealment antibody levels did not Influence early coronary 
patency alter treatment. Median values (Ilg/ml) for patients receiving 
anlstreplase, with TIMI grades 0, 1,2,3 were 1.00 (range 0.001-27.4; 
n-65), 1.34 (0. 18-4.n; 18), 1.14 (0.13-11.3; 34),0.91 (0.001-22.4; 136). 
Corresponding values for patients receiving SK, with TlMI grades 0, 1, 2, 
3 were 1.04 (0.01-5.4; SO), 0.82 (0.01-13.1; 19),0.73 (0.01-6.88; 41), 0.93 
(0.20-25.2; 108). There were no statistically significant dillerences 
between these values, nor when results were combined 10 compare 
patients whose vessels remalned occluded (0/1) versus those who were 
patent (213) Irrespective 01 treatment. Allergic-type reactions were 
recorded In 23 patients. The median anU-SK IgG level In the group 01 
patients with allergic-type reactions (0.90 Ilg/ml) was nol significantly 
dillerenl from the antibody level In the other patients (0.99 Ilg/ml). The 
palency responses were also similar (78%, 67%, respectively). j,: 
conclusion, from an analysis of a pooled database, antl-SK IgG within the 
range found In these populations of palienls did not Influence thrombolytic 
efficacy or safety. 
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932-94 
Prevalence of Cardiac Involvement in Primary 
Antiphospholipid Syndrome_ 
Genevieve Derumeaux, Catherine Le: ormand, Jeanne Y. Borg, 
Herve Levesque, Fran90is Tron, Brie" : ·;tac, Rouen, France. 
"Primary" Antiphospholipid syndrome (PAPS) is defined as the 
occurence of recurrent arterial or venous thrombosis, recurrent fetal 
loss, thrombocytopenia with raised levels of antiphospholipid 
antibodies such as "lupus" anticoagulant or anticardiolipine antibody, 
in the absence of lupus erythematosus or other disease. 
To evaluate the prevalence of cardiac involvement in PAPS, 
transthoracic (TTE) and transesophageal (TEE) echocardiography 
were performed in 18 patients (Pts) with PAPS (11 female, 7 male, 
mean age: 39 ± 11 years). None of these Pts had criteria for systemic 
lupus erythematosus or for malignancy. Clinical features were 
recurrent fetal loss in 3 Pts, arterial thrombosis in 6 Pts, venous 
thrombosis in 5 Pts, haemorragic disorders in 9 Pts and 
thrombocytopenia in 1 Pt. 12 Pts had raised levels of serum 
anticardiolipine antibody (> 8 U.I.n) and 15 Pts had lupus 
anticoagulant. Valvular involvement, defined as a verrucous 
thickening of more than 5 mm for the mitral valve or 3 mm for the 
aortic valve, was detected in 10 Pts (55%). 
TIE TEE 
thickening <: 5 mm 4 4 
regurgitation S; grade II 3 3 
regurgitation <: grade III 1 1 
thickening ~ 3 mm 3 5 
vegeta~on 0 4 
stenosIs 1 1 
Mitral Valve 
Aortic Valve 
regurgitation S; grade II 4 7 
A circumferential pericardial effusion was visualized in 3 of the~e Pts 
with valvular involvement and an impairement of the left ventricular 
diastolic function (E/A < 1) was detected in 1 Pt free of any valvular 
involvement. 
Conclusion: Cardiac involvement is of common occurence in PAPS, 
and TEE, because of its greater accuracy than TIE, should be 
recommended for PAPS. 
932-95 
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DETECTION OF DIFFERENT TYPES OF ATRIAL 
SEPTAL DEFECTS BY TRANSESOPHAGEAL 
ECHOCARDIOGRAPHY 
Dirk Hausmann, Andreas Miigge, Claus Bargheer, 
Jobst Niedermeyer, Werner G. Daniel. 
Hannover Medical School, Hannover, Germany. 
Atrial septal defect~ (ASD) are commonly diagnosed hy trans•
thoracic color Doppler echocardiography (ITE). In some cases, 
however, ITE fails to visualize the ahnormal shunt or it~ exact 
localization. We therefore compared the value of ITE and color 
Doppler transesophagea1 echocardiography (TEE) for detection of 
different types of ASD in 121 pt~ with 129 defect~ (including 8 pt~ 
with partial anomalous pulmonary venous return (PAPVR) com•
hined with secundum type or sinus venosus type ASD): 6 primum 
type ASD, 97 secundum type ASD (40 with ASD diameter <5 
mm, 18 with diameter 5-10 mm, 39 with diameter> 10 mm), 11 
sinus venosus type ASD, 15 pt~ with PAPVR. TEE detected 127 
(98%) and TIE detected 71/127 (55%) defect~: TEE missed 2 cases 
ofPAPVR, and ITE missed 32/40 (80%) of ASD II <5 mm, 3/18 
(17%) of ASD II 5-10 mm, 10111 (91 %) sinus venosus type ASD 
and 13115 (87%) PAPVR. All ASD I and ASD II > 10 mm were 
correctly diagnosed hy TEE and TIE. When the 77 defect~ with 
independent conftrmation of the ASD (surgery and/or cardiac 
catheterization) were considered, TIE and TEE showed a sensitivity 
for ASD detection of 70% and 97%, respectively (p< 0.(01). 
Thus, compared to TIE, TEE is superior in the detection of small 
ASD 11, PAPVR and sinus venous type ASD. Therefore, TEE 
should he performed when atrial shunting is diagnosed hut not 
visualized hy TTE or when small ASD should he excluded (after 
transseptal mitral valvuloplasty or ASD closure). However, even 
TEE has limitations in detecting PAPVR. 
932-96 
Effects of Chronic, Severe Aortic Regurgitation on 
Ventriculo-Vascular Coupling Relations 
Mark R_ Starling_ University of Michigan Medical Center, 
Ann Arbor, Michigan 
The application of ventriculo-vascular coupling relations 
in the human heart has been limited. In addition, the 
effects of long-term, severe left ventricular (LV) volume 
overload on these relations in unknown. To assess the 
effects of chronic, severe aortic regurgitation (AR) on 
ventricul o-vascul ar coupl ing relations, 27 pts with AR 
were studied with micromanometer LV pressures and 
radionuclide LV volumes under basal conditions. LV end•
systolic pressure (PK ) -volume (Ves) relations were 
calculated, and the slope (E~) was compared to arterial 
volume elastance (E I ) calCUlated as POll/stroke volume. E~E varied over a wide range from 0_11 to 2.73 under 
basaf conditions. In II pts with compensated AR, E • .lE .. 
averaged 1.55 ± 0.61 (SO) and the average stroke worK 
(SW) was 74 ± 25 gram-meters. In 13 AR pts with LV 
dysfunction, EItS/E\ was reduced to 1.00 ± 0.55 (p<O.OOI 
vs. compensatea AR} and LV SW was increased to 107 ± 105 
gram-meters. The transformation of LV pressure-volume 
area (PVA) to SW was 0.64 ± 0_01 in compensated AR pts. 
In contrast, in AR pts with LV dysfunction, it was 
reduced to 0.53 ± 0_15 (p<O_OS vs. compensated AR). In 
three AR pts with myocardial dysfunction, E.~E\ averaged 
only 0.38 ± 0.28 with a stroke work OT z43 ± 91 
gram/meters. The conversion of PVA to SW was further 
reduced to 0_35 ± 0.24. These data suggest that the LV 
operates at near maximal conversion of total mechanical 
energy to external work in pts with compensated AR, 
rather than at maximal stroke work. This is similar to 
the normal LV. In contrast, AR pts with LV dysfunction 
adapt by increasing SWat the expense of inefficient 
conversion of total mechanical energy to external work. 
JACC Vol. 19, No.3 
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932-97 
Can Timing for Aortic Valve Replacement in Patients 
with Severe Chronic Aortic Regurgitation be Delayed by 
ACE Inhibitors? 
Hans R. Scht\n, Roben Dom, Maria Fischer,Hans Blamer. 
Div. Cardiology, Technical University Munich, Germany 
Acute and long-term effects of afterload reduction with the ACE•
inhibitor Quinapril (Q) were investigated in 12 asymptomatic 
patients with isolated severe chronic aonic regurgitation. All 
patients were studied during right hean catheterization and 
simultaneously performed radionuclide ventriculography at rest (R) 
and at supine bicycle exercise (E) under control conditions and 2 
hrs after oral administration of 10 mg Q on day 1 of therapy as well 
as after a 90 day treatment with 20 mg Q per day. Q on day 1 
significantly lowered mean blood pressure at Rand E without 
affecting heart rate, and decreased systemic vascular resistance at R 
from 1078±206 to 888±190 dyn·s·cm·s (p<O.OO5). Cardiac index 
at Rand E was improved (p<O.OI, resp.), while LV-EF at R 
(0.65±0.10) was not affected by Q. LV-EF response to E was 
unchanged at control and increased with Q (p<0.05). On day 1 Q 
further significantly reduced mean PA pressure (p<O.OO5) as well 
as PCWP during E (p<O.OO5). LV-EDV at R on day 1 fell with Q 
from 150±33 to 130±35 ml/m2 (p<0.05) and was also decreased at 
E (p<0.05). There was funher a Q induced significant decline in 
LV -ESV at Rand E. Regurgitant volume ~t R fell on day I in 11/12 
patients with a mean of 29 % (p<O.OI) and at E was reduced to 
25% of control (p<O.OI). After a 90 day treatment with Q 
hemodynamics revealed similar or even better unloading effects 
compared to day 1. Moreover, LV-EDV at R was 19 % and LV•
ESV at R 23 % lower than on day 1 (p<O.OOI, resp.), while 
regurgitant volume at R showed a 43 % reduction (p<O.OOI). 
In summary, afterload reduction with Q improved hemodynamics 
by reducing aonic regurgitation and decreasing LV volumes thus 
being beneficial in order to delay development of LV dysfunction 
and subsequently the timing for aortic valve replacement. 
932-98 
~ OF PmIPHmAL RESISTANCE IN N:RI'IC 
REroRGITATICIi . 
Rmlato Razzolini, Angelo RanaJdo, Gianbattista Isabella, 
Fabio Bel lotto, Paolo Cardaioli, Giampaolo Pasquetto, 
Raffaello Chioin. 
Opt of cardiology and Hem:xiynamics, University of 
Padova, Italy. 
Peripheral Resistance (PR) is usually rreasured dividing 
mean aortic pressure by mean aortic flow. This 
statement holds true as far as flow and resistance are 
constant throughout the heart cycle. This is not the 
case in aortic regurgitaticn (AR), because during 
diastole - and not in systole - a conduit is open to 
blood flow through. the regurgitating valve. We tried to 
measure PR in 12 pts with AR (group A) and in 23 normal 
subjects (group B) solving for R the '\iindkessel" 
equatian: 
P=PD*EXP(-S/(R*C»+R*F*(1-EXP(-S/(R*C» 
where P is aortic pressure at the dicrotic notch, PO is 
aortic diastolic pressure, S is systolic interval, C is 
peripheral compliance and F is velocity of left 
ventricular systolic flow. We compared this resistance 
(R) with that rreasured with standard methods (RES). In 
group B, R and RES are alrrost identical (R=.96{RES) + 
.12, r=.95), while in group A there is no correlation 
(R=.64(RES) + 1.4, r=.2). RES in group B is increased 
respect to RES in group A (32 vs 22, p=.0019), while R 
in group A is decreased respect to both R and RES in 
group B (13.5 vs 21 and 22, p= .0063). The difference 
between R and RES in group A is related to the 
regurgitating voh.lIle. '!'hus in severe AR PR is usually 
less than normal, and standard methods of rreasurement 
fail to detect this fact. 
ABSTRACTS 
932-99 
Mismatch Between Left Ventricular Elastance and Arterial 
Elastance in Long-Term Mitral Regurgitation 
Mark R. Starling. University of Michigan and VA Medical 
Centers, Ann Arbor, Michigan 
The effects of long-term, severe mitral regurgitation 
(MR) on the relationship between left ventricular (LV) 
chamber elastance and arterial elastance are unknown. To 
further investigate the effects of long-term MR on left 
ventricular-vascular coupling, 21 patients (pts) with MR 
were studied with micromanometer (LV) pressures and 
radionuclide LV volumes under basal conditions. LV end•
systolic pressure (P.) -volume (V •• ) relations were 
calculated, and the sTope (Evl was compared to arterial 
elastance (E.) calculated as r..lstoke volume. LV stroke 
volume was calculated as LV stroke output/regurgitant 
index. E • .tE. varied over a wide range from 0.16 to 3.08 
under basal conditions. In e1ght pts with compensated 
MR, E • .IE. averaged 1.16 ± 1.04 (SO) and the average 
stroke work (SW) was 180 ± 47 gram-meters. In nine pts 
with MR and LV dysfunction, E-IE. was reduced to 0.45 + 
0.29 (p<0.05 vs. compensated HR), and LV SW was further 
increased to 198 ± 35 gram-meters. The transformation of 
LV pressure-volume area (PVA) to SW was 0.71 ± 0.13 in 
compensated MR pts. Similarly, 1n MR pts with LV 
dysfunction, it averaged 0.63 ± 0.09. In contrast, in 
four MR pts with myocardial dysfunct10n, E • .IE. averaged 
only 0.16 ± 0.05 and LV SW fell to 137 ± 32 gram-meters. 
The conversion of LV PVA to SW was further decremented to 
0.45 ± 0.03. These data suggest that, 1n contrast to the 
normal heart, pts with long-term, severe MR~operate with 
impaired left ventricular-vascular coupling relations 
under basal conditions. Nevertheless, LV stroke work is 
augmented because of near optimal conversion of LV PVA to 
SW even in pts with reduced LV chamber elastance. 
932-100 
18lA 
Technetium-99m Labeled Anti-Granulocyte AntibOdies for 
Immunoscintigraphy in Subacute Infective Endocarditis 
Andreas J. Morguet, Dieter L. Munz, Guido Sold, Dirk 
Sandrock, Hans R. Figulla, Dieter Emrich, Heinrich Kreu•
zer. Dept. of Cardiology and Dept. of Nuclear Medicine, 
Georg August University, Gettingen, Germany 
This study was performed to assess the diagnostic value 
of immunoscintigraphy (IS) using Tc-99m labeled monoclo•
nal anti-NCA-95 anti-granulocyte antibodies (AGAb) in pa•
tients (pts) with subacute infective endocarditis (SIE). 
Twenty-nine pts aged 7 to 80 years with suspected SIE 
and 6 pts with another inflammatory disease were i.v. in•
jected with 10 MBq/kg of Tc-99m AGAb. Single-photon emis•
sion computed tomography (SPECT) of the chest was per•
formed 20 - 24 hr p.i .. Three pts were studied 3 times, 3 
pts twice. Each pt underwent transthoracic and, if no ve•
getations could be detected, transesophageal echocardio•
graphy. Twenty-one/29 pts presenting at least 6 of B dia•
gnostic criteria (fever, elevated sedimentation rate, an•
emia, leukocytosis/shift to the left, splenomegaly, posi•
tive blood culture, cardiac murmur, systemic emboli) and 
showing a prolonged clinical course were considered to 
have SIE. In 7 pts, the diagnosis was confirmed on subse•
quent valve replacement. Fourteen pts served as controls. 
Scintigraphic tracer accumulation in prOjection to the 
valve plane was found in 16/21 pts. IS was true negative 
in 11/14 pts. Echocardiography revealed vegetations in 
14/21 pts with SIE and was true negative in 13/14 pts. IS 
and echocardiography were discordant in 12 pts with SIE. 
In all pts with SIE, however, either IS or echocardio•
graphy was positive. Tracer accumulation decreased in all 
6 pts followed-up along with clinical improvement. 
In conclusion, IS in SPECT technique following Tc-99m 
AGAb administration may provide valuable diagnostic in•
formation in suspected SIE particularly in pts with equi•
vocal echocardiographic findings. 
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932·lO1 
Cardiac Involvement In the Carcinoid Syndrome 
Bergh C-H, Caidahl K, Jansson S, WAngberg B, BlomstrOm P, 
Ahlman H. Divisions of Cardiology, Clinical Physiology and 
Surgery, Sahlgren's University Hospital, Gothenburg, Sweden 
The relationship between carcinoid heart disease, S,hydroxy•
indoleacetic acid (S-HIAA) excretion, and Clinical outcome was 
studied among 48 consecutive patients with the midgut carcinoid 
syndrome. 
Patients were subjected to routine cardiologic examination, 
Doppler-echocardiography, bicycle exercise-ECG, and Holter 
monitoring. Application of a strict tumor reduction program 
resulled in anatomical and biochemical cure by surgery alone in 
11 patients (Grp 1), and in the remaining patients paliiation was 
achieved by hepatic arterial embolization and a somatostatin 
analogue, 24 being alive (Grp 2) and 13 dead (Grp 3). Clinical 
outcome (mean observation time S4 months) was related to the 
S-HIAA level (p<0.02), ST-depression at rest (p<0.02) and 
during maximum exercise (p<0.02), and NYHA functional class 
(p<0.02). Tricuspid valve abnormalities were found In 22%, 
59% and 63% In groups 1-3, while holosystollc tricuspid 
regurgitation was present in SO%, 76% and 59%, respectively. 
No patient had pulmonary stenosis, but 21-25% in each group 
had holodiastolic pulmonary regurgitation. The extent of tricuspid 
abnormalities correlated with S-HIAA-Ievels (r=0.40, p<O.OI) 
as did the late to early peak ratio (NE) of diastolic tricuspid 
Doppler flow (r.0.36, p<O.OS). There was an inverse 
relationship between peak systolic blood pressure during dynamic 
exercise and 5-HIAA level (r=-0.42. p<O.OS). 
II is concluded that signs of ischemic heart disease is a better 
prognostic predictor of clinical outcome than right heart failure 
in the carcinoid syndrome. Tricuspid abnormalities are only 
partly related to 5-HIAA levels, suggesting a pathogenetic role 01 
other tumor products than serotonin. 
932·102 
Significance of Doppler Echocardiographic Peak Valve 
Gradients of Greater Than 50 mmHg in Otherwise Normal 
St. Jude Aortic Valve Prostheses (SJAV) 
Wes R. Pedersen, Jeanne D. Olson, Fredarick L. Gobel. 
Susanne K. Roeller, Irvin F. Goldenberg. Minneapolis 
Heart Institute, Minneapolis, Minnesota 
Doppler echocardiographic valve gradients are a 
primary means by which SJAV function is evaluated. 
The purpose of this prospective study was to determine 
the effect of Doppler echocardiographic peak gradients 
(PG) > 50 mmHg in 5 pts with otherwise normal 
functioning SJAV on LV mass index. Each pt was 
controlled against an age and sex matched pt with a 
similar LV ejection fraction (EF) and LV mass index 
who had received SJAVs identical in size, during the 
same time period, but had a PG of < 50 mmHg. All pts 
in both groups had baseline LV hypertrophy. The 
folloWing are mean baseline values obtained one to two 
weeks post-SJAV replacement: 
Pt Group ~ ~ LV Mass Inde~ 
PG > 50 59 ± 5 mmHg 62 ± 4% 159 ± 22 gm/m2 PG < 50 24 ± 9 mmHg 69 ± 11% 142 ± 8 gm/m 
SJAV sizes--(6) #19, (2) #21, (2) #23. After a mean 
follow-up of 21±11 mos, all pts were alive and free of 
symptoms of valve dysfunction. Follow-up LV EF and 
PGs did not change significantly in each group. LV 
mass index. however. decreased significantly in the 
control group ~nly--mean red~ction in control group 
was 41±17 gm/m vs. 9±7 gm/m in the case group 
(p < .005). Although a PG of> 50 mmHg has been 
described as consistent with normal SJAV function for 
smaller valve sizes, persistently elevated LV mass 
index postimplant in this group suggests it is of 
pathophysiologic importance and therefore requires 
more careful follow-up. 
932·103 
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Value an4 Limitations of Transesophaqeal 
Echocar4ioqraphy for Evaluation of Prosthetic 
Valve Dysfunction 
Kevin Mulhern, David Mehlman, Robert A. 
O'Rourke, Miguel Zabalqoitia. 
The University of Texas Health Science center, 
San Antonio, Texas 
One hundred nineteen prosthetic valves (72 
mechanical, 47 biological) in 3 anatomic 
positions (47 aortic, 67 mitral, 5 tricuspid) 
were studied with transthoracic (TTE) and 
transesophageal echocardiography (TEE) _ The 
purpose of the study was to define the value 
and limitations of each technique in the 
assessment of aortic (AR), mitral (MR), or 
tricuspid regurgitation (TR), in the detection 
of vegetations (VEG) or source of emboli (SOE). 
Compared with angiography, TTE graded MR 
correctly in 6 of 23 valves (26%), whereas TEE 
was accurate in 21 of 23 (91%), p<.OOl. In 7 
cases of severe MR, surgery was performed based 
on the TEE information alone. TTE and TEE 
grading of AR and TR were equivalent. TEE was 
more sensitive than TTE in detection of flail 
leaflets in any position (14/15 [93%) vs. 5/15 
[33%)), paravalvular regurgitation (6/6 [100%J 
vs. 2/6 (33%), SOE (8/12 (67%) vs. 2/12 
[17%)), and VEG (8/11 (73%) vs. 5/11 (45%). 
In conclusion, TEE is the method of choice 
for assessment of prosthesis MR. TEE did not 
provide additional information for AR and TR. 
TEE is superior to TTE in identifying structur•
al abnormalities compromising prosthetic valve 
function. In selected cases, TEE may avoid 
angiography and help in timing reoperation. 
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933·104 
Effect of the Atrioventricular Relationship on Atrial 
Refractoriness in Humans 
Hugh Calkins, Rafel El-Atassi, Angel Leon, Steven Kalbfleisch, 
Mark Borganelli, Jonathan Langberg, and Fred Morady 
University of Michigan Medical Center, Ann Arbor Michigan 
Changes in the mechanics of myocardial contraction may alter 
refractoriness by the mechanism of contraction-excitation coupling 
(CEC). Although extensively investigated in the ventricle, less is 
known about the presence and electrophysiologic imponance of CEC 
in the atrium. The aim of this study was to evaluate the influence of 
alterations in atrial pressure, induced by varying the A V interval, on 
the atrial absolute refractory period (ARP), the atrial effective 
refractory period (ERP), and on the incidence of induction of atrial 
fibrillation. Twenty-seven patients (11 M, 16 F, 43±22 yrs) were 
studied either in the baseline state (N=16) or following autonomic 
blockade with intravenous propranolol and atropine (N=II). The atrial 
ERP and ARP were detennined to within 2 msec using the incremental 
method during continuous pacing at AV intervals of 0, 120, and 160 
msec. Refractoriness at each A V interval was detennined following 
three minutes of continuous pacing at a cycle length of 400 
msec(steady-state). Results: Under baseline conditions the mean and 
peak atrial pressure was significantly greater during pacing with an 
AV interval of 0 msec (7 & 16 mm Hg) than during pacing with an 
AV interval of 120 msec (3 & 7 mm Hg) or 160 msec (3 & 7 mm 
Hg). The atrial ERP measured during pacing with an A V interval of 0 
msec (196±19 msec) was not different than the ERP measured with an 
AV interval of 120 msec (197±19 msec) or 160 msec (195±20 msec, 
p>O.l). The atrial ARP also did not change. Following autonomic 
blockade the atrial ERP and ARP were not significantly different at 
varying A V intervals. The frequency of induction of atrial fibrillation 
also did not differ at varying AV intervals. In conclusion, under 
steady-state conditions alterations in atrial pressure induced by varying 
the A V interval results in no imponant change in atrial refractoriness 
or ease of induction of atrial fibrillation. The effect of alterations in 
atrial pressure in abnonnal atrial tissue or under non steady-state 
conditions remains to be detennined. 
lACC Vol. 19, NO.3 
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933·105 
A Prospective, Randomized Comparison of Direct· 
Current Shocks vs. Radioirequency Energy for 
Catheter Ablation of the Atrioventricular Junction 
Fred Morady, Hugh Calkins, Jonathan J. Langberg, Rafel EI•
Atassi, University of Michigan Medical Center, Ann Arbor, MI 
Fony pts (mean age 60 ± 16 yrs) with drug-refractory, 
uncontrolled atrial fibrillation/flutter w,derwent catheter ablation of 
the atrioventricular (A V) junction with the intent of inducing 3° A V 
block. The pts were randomized to receive either up to 4 cathodal 
shocks of 200-300 joules through th'! distal electrode of a 6 Fr 
uscr quadripolar catheter or UI- to IS applications of 
radiofrequency energy (RF) (16-30 Watts for 30-60 sec through 
the 4 mm distal electrode of a Mansfield "Polaris" catheter). The 
ablation catheter was positioned across the tricuspid annulus to 
record the largest possible His and atrial electro grams. If the 
method selected by randomization was ineffective, the other 
method was used. A permanent pacemaker was implanted and 
each pt was followed for ~ 6 mo. 3° A V block was successfully 
induced in 13/20 pts (65%) assigned to receive shocks vs. 19/20 
pts (95%) assigned to receive RF (, < 'lOS). RF was effective in 
each of the 7 pts in whom shock failed, and shocks were 
effective in the I pt in whom RF faik~. Two days later, an escape 
rhythm was present in 14/14 pts whl- received shocks vs. 23/26 
pts in whom 3° AV block was indr<:ed by RF (NS); the mean 
escape cycle lengths (CL) were 170;' :t 967 and 1368 ± 272 msec 
in the shock and RF groups, resp.:~:;vely (NS). At 6 mos of 
follow-up, all PIS were still in 3° AV block and all pIS had an 
escape rhythm, with escape CL's l'll j38 ± 243 and 1509 ± 214 
msec in the shock and RF groups, ICfpeclively (NS). The only 
complication was sudden death in a 4 i year old woman without 
structural heart disease 7 mos after ablation with shocks. 
In conclusion, RF is more effective and may be safer than 
direct-current shocks for ablation of A V conduction Both 
techniques result in similar long-tern' P.;I ape rates. 
933·106 
Effect of Radiofrequancy Catheter Ablation For Supraventricular 
Tachycardia On the Signal Averaged Electrocardiogram and Response to 
Programmed Ventricular Stimulation 
F. Kevin Hackett, William M. Miles, Douglas P. Zipes, Lawrence S. Klein, 
Krannert Institute of Cardiology, Indiana University School of Medicine, 
VAMC, Indianapolis, Indiana 
The risk of ventricular tachycardia (VT) or sudden death after 
radiofrequency catheter ablation (RF) for non life-threatening arrhythmias 
is not known. We used right ventricular programmed electrical stimulation 
(PES) and signal averaged electrocardiograms (SAECG; time domain) to 
investigate the risk of VT in 24 patients (pts) without structural heart 
disease who underwent RF for Wolff-Parkinson-White syndrome (n=16) or 
atrioventricular nodal reentry tachycardia (n=8). All pts had at least one 
SAECG following RF; 18 of the 24 patients had SAECG within 48 hours of 
the ablation (POST) and 21 of the 24 pts had SAECG at a late follow-up 
study (LATE; mean 44.0 days). Twenty-three of 24 patients had SAECG 
prior to RF (PRE). There was no change in filtered QRS duration (QRS), 
terminal root mean square voltage (RMS), or terminal low amplitude signal 
duration (LAS) of the SAECG after RF, and all SAECG were normal 
(mean±SD). 
QRS (ms) 
RMS (IlV) 
LAS (ms) 
PRE 
(n=23) 
112.0::22.0 
46.4±31.3 
2B.1±9.3 
POST 
(n=17) 
106.1±16.4 
40.5±24.10 
29.9±6.B 
LATE 
(n=21) 
105.0::9.6 
35.0±23.B 
33.O::B.7 
p value 
ns 
ns 
ns 
All 24 pts had PES LATE and none had inducible VT with up to 3 
ventricular extrastimuli. None of our patients have died suddenly after RF 
(mean follow-up 13.1 weeks, range 5-25). In conclusion, SAECG and 
response to PES remain normal after RF, and there does not appear to be 
an increased risk of sudden death. 
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933·107 
Electrocardiographic and Electrophyslologic Characteristics of 
Anterior, Mid-septal and Right Anterior Free Wall Accessory 
Pathways 
Melvin M. Scheinman, Yin-Shi Wang. George Van Hare, 
Michael Eldar, Michael D. Lesh. University of California, San 
FranCiSCO, California 
The fully preexcited 12-lead surface electrocardiograms (ECG's) 
as well as ECG's during orthodromic atrioventricular reentrant 
tachycardia were compared for 13 patients with anteroseptal 
(AS), 7 with mid-septal (MS), and 7 with right anterior (RA) free 
wall pathways. Pathway sites were confirmed by endocardial 
mapping. surgery or radiofrequency (RF) catheter ablation. 
Routine electrophysiologic studies were performed in all and 
stimulation of the right ventricular summit (RVS) and apex 
was accomplished in 10 patients. Differences in the preexcited 
surface ECG's or in P wave morphololgy during taChycardia 
were not sufficiently sensitive to distinguish these pathway 
locations. Premature ventricular complexes induced from the 
right ventricular septal summit (RVS) but not the right 
ventricular apex (RV A) during ventricular activation either 
advanced the succeeding atrial depolarization or terminated the 
tachycardia in 4 of 6 with septal pathways and in none of the 4 
with RA pathways. Changes in the ventriculoatrial (VA) with 
development of right bundle branch block (RBBB) were ~40 ms 
for those with RA 15-30 ms for anteroseptal and none for mid•
septal pathways either in response to RBBB or left bundle 
branch block patterns. RVS stimulation during the QRS during 
tachycardia which either advances the next atrial complex or 
terminates the tachycardia was observed only in patients with 
septal pathways. Patients with mid-septal pathways were 
categorized by a lack of change in the V A interval during 
bundle branch block. 
933·108 
Non-lnvaslve Detection of pre-P Activity by P Wave-Triggered Signal•
Averaged SUrface E1ectroc.dlogram. Comparison WIth Results Furnls· 
hed by Direct Intrutrlal Recording of Sinus Node Electrogram 
Anna Toso, Alessandro Mezzani, Luigi Padeletli, Attllio 01 Crecchio, Giuseppe 
Fredella, Simone SaM, Fabio Fantini, AntonIo Micheluccl. 
Cardiology Unit, Cllnica Medica I, University of Florence, Aorence, I1aIy 
In order to evalum if pre-P actMty can be detected by surface electrocardiogram 
(ECG), 200 consecutive sinus beats were collected by each of the 3 bipolar 
orthogonal leads (horizontal, vertical, and sagittal position, according to Simson 
me1hod for late potentials) In 17 patients. During recording, each lead signal was 
Independentty avereged using P wave as a trigger (ELP·Ncwamedlca device). 
The algorithm allowed us to reject ectopic beals. Each lead aignal was then 
filtered (0.5-25 Hz) and amplified (up to 30 times). Amplification revealed the 
presence in each of tht!se patien1s (not necessarily In all leads or In the same 
lead) of a progressive and linear upstroke slope beginning during the Dlectrlc 
Une and ending at 1he onset of P wave. This onset WIIS delimited using all 3 leads. 
The length of this pre-P signal was compared In each patient with that fUmlshed 
by direct intraatrlal recording of slrus node electrogram (SNE, 0.05-30 Hz, mean 
of at least 20 measurernen1s). Mean values (t lS0) of non invasive and Invasive 
pre-P signal lengths were respectively: 77.8 t 36.3 me and 76.7 t 36.8 ms. The 
correlation coefficient utilizing linear regression analysis (see figure below) was 
0.9932 (p< 0.001), 
200 
§ 100 
SHE ",. 
Our data indicate that length of pre-P potential oblalned from surface ECG is 
strictly correlated with that obtained by direct Intraatrial recording of SNE. ThUs, 
pre-P activity can be easily and reliably determined IlOTHnvasively IlIJ1)llfyIng P 
wave-triggered signal-averaged ECG. 
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933·109 
Delayed Cure of the of Wolff.Parkinson·White 
Syndrome After Radiofrequency Catheter Ablation 
Mark Borganelli. Rafel El·Atassi. Angel Leon. Steven J. 
Kalbfleisch. Hugh Calkins. Fred Morady. Jonathan J. Langberg. 
University of Michigan Medical Center, Ann Arbor, MI 
Two hundred sixty-eight patients with two hundred eighty-four 
accessory atrioventricular connections (AP's) underwent 
radiofrequency (RF) catheter ablation. The accessory pathway (AP) 
locations were left free wall in 169. posteroseptal in 50. right free 
wall in 48, anteroseptal in 12. and midseptal in 5 patients. RF 
energy using 25 to 36 Watts for 10 to 30 seconds was delivered 
using a 4 mm distal tip steerable 7Fr electrode catheter. 15 of 268 
(5%) failed to have the AP ablated and 16 of 268 (6%) had 
recurrence of AP conduction after an initially successful procedure. 
One patient who failed radio frequency ablation was found to have no 
AP function at the time of follow up electrophysiology study (EPS) 
seven weeks later. Two of II patients with recurrence of pre•
excitation after an initially successful RF ablation had the delta waves 
disappear within 16 hours and have remained free of recurrent 
symptoms. Followup EPS revealed no evidence of an accessory 
pathway. 
Conclusion: 1.) Radiofrequency catheter ablation occassionally 
produces a delayed cure of the Wolff-Parkinson-White syndrome 
2.) Recurrence of pre-excitation is only transitory in 18% of patients, 
suggesting that they should be monitored for 1 day before 
undergoing repeat RF ablation. 
933·110 
Short- and Long Term Complications of Cathc:ter A!,lation 
Using Radiofrequency Energy - Observations In 192 
Consecutive Patients 
Gerhard Hindricks, Martin Borggrefe, Wilhelm Haverkamp, 
Ulrich Karbenn, Xu Chen, Thomas Budde, Mohammad 
Shenasa, Giinter Breithardt. 
University Hospital Miinster, 4400 Miinster. Germany 
From 6/1986·8/1991 radiofrequency (RF) catheter !iblation or 
modification of the atrioventncular (AV) conduction system 
(n = 57), ablation of atrioventricular a,ccessory pathwa~ 
(AP)(n = 86), atria! (n=2) or ventnC1;ilar l!ichycar~la 
(VT)(n .. 47) was attempted in 192 consecutIve patients ~lDg 
HAT 100 or HAT 200 RF generator. All pts. were effeCtIvely 
heparinized during and for at least 48h after ablation followed 
by randomized treatment with aspirine or cumarine for at least 
three months. In one pt. a large right atria! thrombus was 
observed 24 hours after attempted ablation of the A V 
conduction system. The pt. was treated with cumarine and no 
thrombus was detected at surgical interruption of the A V 
conduction 5 months later. In two pts. pericardia! tamponade 
occured resolved by pericardia! drainage: in one pI. with right· 
sided AP mechanical perforation of the right atrium unrelated to 
RF and in one pI. with left·sided AP fO.lIowing RF-d.elivery. One 
pI. with left sided AP delveloped transIent amaurosIs dunng the 
ablation session and completely recovered within 2 hours. In two 
pts. treated for VT cerebra! embolism occured 2 and 24 hours 
after catheter ablation, respectively. One pI. developed 
ventricular fibrillation during RF-energy application to the left 
ventricle. There was no signifcant difference in the number .of 
impulses delivered, ap(>lied power or energy between pts. WIth 
and without complicatIons, respectively. No procedure related 
long·term complications occured. 
Thus, RF-catheter ablation carries a small (3.1 %) risk of 
procedure related complications. Major complications seem to 
be related to the thrombogenic potentia! of RF-currenl. 
933·1ll 
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Expanding the Spectrum of Arrhythmias Curable with 
Radiofrequency Catheter Ablation: Experience with Primary 
Atrial Tachycardias 
G. Neal Kay, Felipe Chong. Andrew E. Epstein. Vance J. Plumb. 
University of Alabama at Birmingham. Birmingham, Alabama. 
Radiofrequency (RF) catheter ablation is highly effective for the 
permanent elimination of arrhythmias related to the WPW syndrome 
or A V nodal reentrant tachycardia. However, experience with RF 
ablation of primary atrial arrhythmias is more limited. RF energy was 
used to ablate the atrial site of origin in 3 pts with ectopic atrial 
tachycardia (EAT). 2 pts with sinus node reentrant tachycardia 
(SNR), and 1 pt with atria! flutter (AA). The mean age of pts with 
EAT was 14.6 years (13. 14, and 17 years) and the site of origin was 
in the right atrium in each pt. The local electrogram at the site of 
ablation occurred 20-28 msec prior to the surface P-wave. RF energy 
was applied using 12-30 watts for 30 sec. In followup of 7-240 days, 
EAT recurred in 1 pt at 3 weeks (initially ablated with 12 watts), and 
was successfully ablated in a second session (30 watts). Sinus node 
reentry was ablated successfully in 2 pts (ages 72 and 78 years) by 
application of RF along the inferior aspect of the SA node. Sinus node 
reentry recurred in 1 of these pts at 2 days and has remained ablated in 
the other. The region of slow conduction in AA was ablated by the 
application of RF energy immediately caudal and anterior to the 
coronary sinus ostium where the local electrogram demonstrated a 
discrete double potential (-52 and +70 msec in relation to the surface 
flutter wave). In all pts the atrial tachycardia was terminated within 
4.5 seconds following initial application of RF energy and could not 
be reinduced with programmed stimulation. burst pacing, or 
isoproterenol. Thus, RF energy can be used to successfully ablate 
primary atrial arrhythmias with a high rate of success. 
933·112 
Radiotrequency Catheter Ablation of Ectopic 
Atrial Tachycardia Using Activation Pace 
Happing 
Cynthia M. Tracy, John F. swartz, Harry G. 
Hoops, Allen J. Solomon, Pamela E. Karasik, 
Ross D. Fletcher, Georgetown University 
Hospital, Washington, DC. 
Radiofrequency (RF) energy catheter ablation 
has not been established for ectopic atrial 
tachycardia (EAT). Eight patients (13-47 years) 
were referred with refractory EAT. Mapping 
techniques included: identification of earliest 
atrial activation, confirmation of concordance 
of p wave morphology during spontaneous 
tachycardia and pacing from the ablation 
catheter, and activation pace mapping. 
Activation pace mapping compared the activation 
sequence in at least 3 atrial sites during 
spontaneous tachycardia and during pacing from 
the ablation catheter. The catheter was 
navigated to a point where pacing reproduced 
the spontaneous activation sequence. Foci were 
right atrial in 6 (septal 3, junction of 
appendage 1, anterolateral 2), and left atrial 
in 2 (superior septal). In 6 of 8 pts 2534±1364 
J, and 5.1±2.3 RF applications ablated the 
ectopic focus. Ablation was unsuccessful in 2 
pts with multiple foci. No complications 
occurred. A focus recurred in 1 patient after 2 
months and was ablated in a second procedure. 
The 6 pts remain symptom free after 6.7±3.7 
months. We conclude, utilizing mapping 
techniques including activation pace mapping, 
RF ablation is safe and effective in EAT. 
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933-113 
Unexpected Emergence of Ventricular Preexcitation 
following Transcatheter Ablation of Concealed Accessory 
Pathways 
Karlheinz Seidl, Mohammad Shenasa, Martin Borggrefe, Xu 
Chen, Wilhelm Haverkamp, Gerd Hindricks, Giinter Breithardt. 
Westf. Wilhelms·University Miinster, Germany 
Of 17 consecutive patients who underwent ablation of concealed 
accessory pathway (AP), 3 patients (1 male, 2 female, aged 27 to 
34 years) with concealed AP that following successful endocardial 
catheter ablation of the retrograde AP developed anterograde 
conduction over AP. During electrophysiologic studies there was 
no evidence of ventricular preexcitaton during sinus rhythm, right 
and left atrial stimulation, induced atrial fibrillation before and 
after isoproterenol infusion. Orthodromic tachycardias were 
inducible in all three patients and AP were localized at right 
lateral, left posteroseptal and left lateral regions. Radiofrequency 
current was used in 2 patients and direct current in 1 patient. 
Anterograde conduction over AP emerged immediately following 
energy delivery in 1 patient, after 4 and 14 days in the other 2 
patients. Endocardial catheter mapping was repeated and 
revealed that site of anterograde conduction over AP 
corresponded to the same location of the concealed AP. In 2 
patients AP potentials were recoJded before and after ablation. 
Subsequently, 2 patients underwent successful radiofrequency 
ablation of anterograde AP and 1 patient had surgical interruption 
of AP. Following mean of 16 months follow·up, there was no 
recurrence of preexcitanon and patients remained symptom free. 
Although not comparl!d here, such phenomenon has not been 
reported following surgical interruption of AP. This observation, 
not previously reported, suggest that direct injury to the 
ventncular site of insertion of AP may result reversal of 
anterograde AP conduction. It may be speculated that direct 
endocardial injury at AP-ventricular junctIon has modified the 
anterograde conduction over AP. 
933-114 
Radiofrequency Ablation of Accessory Pathways Guided by 
On-Line Body Surface Potential Mapping. 
Marc Dubuc, Teresa Kus, Pierre Savard, Gaetan Tremblay, 
Pierre Le Guyader, Reginald Nadeau. Hopital du Sacrt~-Coeur, 
Montreal, Canada. 
Sixteen consecutive patients (7F ,9M) each with one accessory 
pathway showing antegrade conduction underwent an attempt at 
catheter ablation with radiofrequency energy guided by body 
surface potential mapping (BSPM). Accessory pathway locations 
were left free wall in 9, posteroseptal in 4, anteroseptal in 2 and 
right free wall in 1. BSPM was performed using 63 leads and 
color maps were generated at each 2 ms during the QRS of 
selected beats. The location of the potential minimum during the 
first 10 to 40 ms of the delta wave on body surface potential 
maps recorded in sinus rhythm guided the initial approach to the 
site of the accessory pathway. A 4 nun-tipped deflectable 7Fr 
ablation electrode catheter was then positioned near the presumed 
accessory pathway location so as to record a good atrial and 
ventricular electrogram. BSPM was perfonned during ventricular 
pacing by the distal pair of electrodes on the ablation catheter at 
multiple sites in this area (pace mapping). 
RESULTS: A similar location of the potential minimum 
during sinus rhythm and ventricular pacing was found in less than 
2 hours in 14 patients (87%), and radiofrequency energy applied 
to the distal electrode of the catheter (unipolar mode) at this site 
produced a successful ablation of the accessory pathway. 
Accessory pathway potential was recorded in only 2/14 patients. 
CONCLUSIONS: 1) This pilot study has shown the feasibility 
of using BSPM to guide radiofrequency catheter ablation of 
accessory pathways with antegrade conduction. 2) Further 
studies are justified to assess the usefulness of on-line BSPM for 
reducing the duration of the ablation procedure. 
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933-115 
Selective Bandpass Filtering of Intracardiac Electrograms During 
Radiofrequency Catheter Ablation of Accessor)' Pathways 
Michael J Silka, Jack Kron, Blair 0 Halperin, John H McAnulty, 
Brian Crandall, Jeanny K Park, Ronald Oliver, Charles G Walance 
Oregon Health Sciences University, Portland, Oregon 
Radiofrequency catheter ablation (RFCA) of accessory pathways 
(APs) results in alteration of the eccentric temporal sequences of 
local atrial and ventricular activation. However, due to the high 
voltages applied, standard biopotential amjJlification and filtering 
systems do not permit monitoring of local intracardiac electro•
grams during RFCA In this stuay, we evaluated the feasibility 
and clinical utility of recording intracardiac electroMams duri~ 
RFCA, utilizing custom designed selective bandpass filters (SBt) 
for frequencies <2 KHz. 
The temporal relationship and amplitudes of local atrial and 
ventricular electrograms were analyzed in 25 patients with APs 
during preexcited sinus rhythm or ventricular pacing. 10 APs 
conducted retrograde only. Signals were acquired durin$ standard 
filtering (30-500rIz), SBF prior to RFCA, and SBF dunng RFCA 
Filtered electrograms were recorded from the high right atrium 
(n=7), His bundle area (n=4), and coronary sinus (n= 14), with a 
distance 0.5-6.0 cm between the record and ablate electrodes. 
Results: No alteration in the temporal relation of electrograms 
or attenuation of signal amjJlitude was observed with the adaition 
of SBF to standard filtering. SBF of electrograms allowed 
immediate recognition of successful RFCA of retrOjrade only APs 
as an abrupt increase in the local V·A interval n=5) or V·A 
dissociation (n=4) during ventricular pacing. In pabents with 
subtle preexcitation, RFCA of the AP dunng sinus rhythm was 
identified by an abrupt increase in the local A-V interval. In the 
other 10 patients with APs, loss of surface preexcitation 
corresponded to an increase in the local A-V interval. 
Conclusions: SBF permits accurate monitoring of intra cardiac 
electrogram during RFCA, without signal distortIOn. SBF allows 
the immediate recognition of successful RFCA of retrograde or 
subtle ante grade APs, which cannot be determined from the 
surface ECG. 
934 Arrhythmogenesis, Pacing, Ablation 
Tuesday, April 14, 1992 
2:00 PM-5:00 PM 
Dallas Convention Center 
Lower Level Exhibit Hall 
Presentation Hour: 3:00 PM-4:00 PM 
934-88 
Comparison of Cellular Electrophysiologic Changes 
Induced by Radiofrequency and High·energy 
Electrical Ablation 
Yu-Zhi Ge,M.D., Pei-Zhen Shao, Jeffrey Goldberger, M.D., 
Alan Kadish, M.D. Northwestern University,Chicago, n.. 
The cellular electrophysiologic effects of direct current ablation 
(DC; 1 0 J) were compared to those using radiofrequency 
current (RC;20 sec at 40 V) in 26 canine eph ... "lial strips 
measuring 4 cm x 3 cm. DC was used in 15 tissues and RC in 
Il.Energy was delivered via a 6 Fr. catheter. Action potential 
amplitude (APA) and action potential duration (APD) were 
determined at various distances (DIST ) from the lesion center 
before (CTL) and after ablation. Tissues were paced at 1 Hz. 
Data were compared by ANOV A. 
Results (Mean Data): 
# sites APA(mV) APD(ms) 
DlST p·2mm 2·5mm 5-IOmm p-2mm 2-5mm 5-IOmm 
cn. 222 84 84 83 165 156 147 
RC 107 28" 70 76 65" 116 132 
DC 220 0"+ 21"+ 51"+ 4"+ 62"+ 101" . - <O.J:l Rc or lJC vs elL; + - )<O.u5 KC vs lJC p P 
Two 10 8 mm from the ablation site, 30% of cells were 
inexcitable after DC vs 1 % after RC (p<0.05). Early 
afterdepolarizations were seen in 2 preparations after DC but in 
none after RC. 
We conclude' 1) RC ablation leads to more focal abnonnalities 
than does DC. 2) Following ablation using DC but not RC, 
excitable and inexcitable cells are interspersed and 
afterdepolarizations are occasionally seen, both of which may 
be substrates for arrhythmias. 3) Using RC rather than DC 
ablation might decrease the incidence of arrhythmias such as 
polymorphic VT following clinical ablations. 
186A ABSTRACTS 
934·89 
Precise Location of Endocardial Pacing Site Bued on Serial Cross•
Section ModelofMRI-8canned Qmine Tono 
Leo G. Horan, Patricia C. Orander, Jerry D. Allison, Marandapalli 
R. Sridharan, Nancy C. Flowers. VA Medical Center and Medical 
College of Georgia, Augusta, Georgia 
Our goal was to utilize the exact geometric relationships between the 
boundaries of the ventricular myocardium and body surface to pre•
dict and distinguish the electrical sequelae to site·specific heart 
sources. 
Serial cross-sections were obtained from gated MRI imaging of the 
large canine torso and heart. From the ventricular endocardial 
(right and left) and epicardial boundaries and the torso boundary, we 
constructed 4 closed surfaces to form a model of ventricular activa•
tion and recovery. For each surface, 35 orthogonal templates were de· 
veloped from the expanded Gabor-Nelson equations for the character· 
ization, reconstruction and inter-surface transfer of potential 
distributions. Body surface potential maps were recorded during pac•
ing from 40 different sites on the right and left ventricular endocar•
dium of 5 dogs weighing between 20 and 25 kg. 
Corresponding sites on the model were treated as activation sources 
and expected torso-surface distributions were calculated for each. 
The calculated and observed body surface patterns were compared by 
constructing a 40 x 40 cross-correlation matrix. The diagonal of the 
matrix correctly identified the site of origin of the paced beats from 
the high correlation between predicted and observed patterns in 37 of 
40 instances. The findings not only confirm the applicability of the 
Helmholtz superposition theorem to the living animal, they also pro•
vide a method of direct transfer of the patterns of electrical signal be•
tween heart surface and body surface with high anatomic accuracy. 
As such, the explicit 3-surface heart model promises to become a far 
more direct, powerful and comprehensive paradigm for the genesis 
of the ventricular electrocardiogram and whole body surface poten•
tial image than the long-used, ambiguous heart vector. 
934·90 
Induction or Manifest, Concealed and Latent PrHXcitation in the Normal 
Dog Heart 
Benjamin J. Scherlag, Hiroshi Nakagawa, Anand Munsif, Xanzhung Wang, Ralph 
Lazzara. 
University of Oklahoma Health Scieoces Center and Department of Veterans 
Affairs Medical Center, Oklahoma City, Oklahoma 
In our previous studies, subthreshold stimulation (55), delivered to the RV apex 
ean induce all the features of pre",xcitatioD, shortened PR and H-V intervals, delta 
waves and aberrant ventriculardepolarizaJions. In 12 dogs, anesthetized with Na•
pentobarbital, we recorded Leads n and .VR, as well as a His bundle electrogram 
(Hbell) from the aortic root. Using a deflectable tip electrode catheter (4 rings, 
5 mm apart), SS was delivered under the septal leaflet of the tricuspid valve as 50 
msec pulse trains, 1000 Hz (av: 1.3 ±O. 7 mal or as DC constant current. Plunge 
wire electrodes were placed into the RV outflow tract and apex for induction of 
premature ventricular beats (PVB, every 8th beat) during S5 to the septal crest 
area. During vagal induced A V block no sustained ventricular pacing resulted 
from SS. Threshold stimulation of the septal crest induced beats showing delta 
waves and a LBBB pattern. With SS alone, 3 responses were seen: 1) Manifest 
pre-excitation in both ECG and Hbeg (4/12); 2) Concealed pre-excitation, ie. 
premature activation of the septal cresl in the Hbeg and an unchanged ECG 
(6/12); two showed concealed and manifest forms; 3) No pre-elcitation changes 
in either the Hbeg or ECG (4/12). During alrial pacing at a cycle length of 400 
msec, early coupled (l60±30 msec) but not late coupled (330±4S msec) PVBs 
produced manifest pre",xcitation in the lst to the 3rd besl after the PVB even 
when S5 alone showed concealed pre",xcitation (3/12). In 2 cases this effect of 
the early coupled PVB was observed only in the 2nd beat after the PVB. These 
effects were obtained by pacing from either sile in the RV. In one case S5 plus 
PVBs manifested pre-excitation even when S5 alone showed no changes in either 
the Hbeg or ECG. Thus, in this case, 55 alone induced a lalent tendency for pre•
excitation which was manifested only by the early coupled PVB. We postulate 
that SS during normal rhythm and 55 plus intermittent early coupled PVBs induce 
various forms of pre..,xcitation by summation of eleclrotonic effects of these 
combined beats. These electrotonic effects may alter excitability and induce 
anomalous propagation between the conduction system and the septal crest. 
934·116 
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Natural Anatomical Obstacles and Anisotropy Modulate 
Functional Conduction Block during Atrial Flutter. 
Hua Yang, William B. Gough, Wolfgang Schoels, Nabil 
EI-Sherif, Mark Restivo. SUNY Health Science and VA 
Medical Centers, Brooklyn, NY 
In an experimental model of pericarditis, we have 
found that during single loop atrial flutter (AF), functional 
conduction block (FCB) commonly joins with anatomical 
obstacles (OBST) to form the central barrier of the circuit. 
Spatial disperSion of refractoriness (RP) or anisotropy may 
cause FCB but the mechanism of FCB during AF Is 
unknown. Because of the Inherent difficulties of studying 
AF in-vivo, we investigated FCB during AF in a computer 
simulation. AF was induced by premature stimulation of 
the atria in which a thin zone of graded RP extended from 
the AV annulus to the IVC and another zone of varying 
length extended from IVC. oaST or line of RP alone was 
insufficient to produce sustained AF. Following induction 
of AF, both lines of RP was removed. Yet during AF, the 
line of FCB persisted and up to 78% (0.7-1.8 cm) of the 
length during initiation. The spatial excitable gap (GAP) 
was always minimum in the Immediate vicinity of FCB. 
Closer examination of the activation sequence of this area 
showed a thin zone of slow circuitous conduction on either 
side of the FCB. Anisotropic conduction ratios of 1-3 were 
tested. Anisotropy Increased the GAP (0.3-15.1 msec) and 
reduced the length of FCB (8-52%). CONCLUSION 1) 
natural anatomical obstacles are necessary and stabilize 
AF, 2) FCB depends on the activation sequence during the 
Initiating beats while maintenance of FCB Is due to the 
constant bidirectional collision of impulses from both sides 
of the FCB, 3) Anisotropy can decrease FeB by 
increasing the gap of excitability during AF, 
934·117 
Hypokalemia Ind Ventricular Dilatation Hive Synergistic Effect. on 
Inducible Ventricular Arrhythmia. In tha Isolated Heart, 
Michael J. Retter, Gerald R. WIlliams, David E. Mann, University of Colorado 
Health Sciences Center, Denver, Colorado 
Potassium (I<) depletion Is Implicated In the genesis of ventricular 
arrhythmias (yA), especially in patients with CHF. In order to study the 
Interaction of K and ventricular dUatatlon, we studIed the effects of 
hypokalemia (hypol<) and dUatatlon in 24 isolated rabbtt hearts retrogradely 
perfused wtth Krebs-Henselett media with K of 4.9 mM, 3.5 mM, or 2.5 mM. 
Left ventricular (LV) volume was adjusted with a fluld-fiUed Intracavitary 
balloon. LV and right ventricular (RV) effective refractory period (ERP) and 
conduction velocity (CV) balWeen electrodes on the LV and RVepicardium, 
were measured during continuous ventricular pacing (250 msec). Wave 
length ()o.) was calculated as the product of ERP x CII. 
K+conc LV Vol LVERP CV >-- Ind VA 
.!mMl .!!!l!l ~ ~ k!D) .00 
4.9 0 (n=24) 119.±3 81.±2 9.6.±0.3 0 
4.9 1.25 (24) 105+3* 79.±2* 8.4.±0.3: 38* 
3.5 0 (12) 110:±4 75.±2+ 8.4.±O.4 42+ 
3.5 1.25 (12) 94+3* 74.±3+ 6.9.±0.4*+ 75+ 
2.5 0 (12) 121.±'4 70.±2+ 8.3.±O.5 + 25 
2.5 1.25 (12) 1 02.± 4* 68.±2+ 7.0.±0.4*+ 92*+ 
* ~ p<O.OS compared to 0 ml; + = p<0.05 compared wkh K=4.9 mM. lnd 
VA = incidence of induced VA. 
LVERP decreased with dilatation but was not Influenced by hypoK. CII was 
not changed by dilatation, but decreased at low K. No spontaneous VA 
occurred. VA were Induced more frequently In the dilated heart, and 
Increased markedly with coexisting hypoK. Frequency of Induced VA was 
best and Inversely correlated with>' (p<O.OO1). We conclude that dilatation 
and hypokalemia interact synergistically to shorten )0.. and predispose to 
reentrant arrhythmias In this model. 
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935-43 
1 H NMR One Dimensional Chemical-Shift Imaging of the 
Myocardium: Upid Changes In Reperfuslon 
James A. Balschi, Hoby Hetherington, and Gerald M. Pohost 
Center for NMR Research and Development, Division of 
Cardiovascular Disease, University of Alabama at Birmingham, 
Birmingham, AL 35294 
~ To measure transmural changes of myocardial lipids in a 
model of stunning with 1 H NMR surface coil spectroscopy we have 
implemented a 10 CSI sequence that incorporates water suppression 
and semi-selective B1 composite pulses. 
~ The intact open chest canine heart (n = 8) was employed. 
Left ventricular pressure was monitored and a 2cm surface coil (SC) 
sutured to the epicardium. Control spectra were obtained; ischemia 
induced by restriction of the LAD and branches of the LAD and LCA 
outside the magnet; following reperfusion (REPER) the animal was 
returned to the magnet. 1 H NMR (200 MHz; 4.71) specroscopy timing 
was adjusted so that semi-selective excitation began in mid·diastole. 
~ Two experimental variations were employed. In the first, the 
myocardium under the SC underwent ischemia with REPER in the 
presence (CASE 1) or absence (CASE 2) of norepinephrine (NOREP). 
In the second, the ischemic region was not under the coil. REPER 
was without presence of NOREP (CASE 3). Normalized (to baseline) 
areas of the methylene resonance (-CH2) from the subendocardium 
(3.75 mm) at 3 hours of REPER were as follows: CASE 1 = 200%; 
CASE 2 = 57%; and CASE 3 = 66%. 
Conclusion. These results indicate that lipid changes during REPER 
do not simply depend upon the duration or the degree of ischemia. 
Accumulation of lipids occurs in the presence of NOREP (CASE 1) 
which increases blood latty acids. Lipids can decrease during REPER 
in the absence 01 NOREP (CASE 2). Lipids in the non-ischemic part 
01 the regionally ischemic heart also decrease during REPER in the 
absence of NOREP (CASE 3). lH NMR spectroscopy can provide 
insight into lipid metabolism following ischemia in the intact heart. 
935-75 
Low Calcium Reperfusion Improve Recovery Of 
Myocardial Function But Not High Energy 
Phosphates Af~Ir Repetitive Ischemia. 
-- A P NMR Study --
Takashi Konishi, Isao Morii, Yasuyuki Nakamura 
Chuichi Kawai, Toshirou Inubushi 
Kyoto University Hospital and Shiga College of 
Medical Science, Kyoto and Shiga, JAPAN 
To study whether reduction of Na+-Ca++ 
exchange by low calcium reperfusion prevent 
myocardial stunning by repetitive ischemia 
(three times of 10 min ischemia), we examined 
the effects of repetitive brief periods (three 
times of 5 min reperfusion) of low calcium 
reperfusion (LCa) (0. 5mM) on the recovery of 
myocardial function, ATP, creatine phosphate 
and intracellular pH (pHi) after 30 min of 
reperfusiog in isolated rat hearts (balloon•
in-LV) by Ip NMR spectroscopy. 
n ATP(%) CP(%) pHi DP(%) EDP(mmHg) 
CON 6 48+2 112+9 7.13+0.05 79+4 36+6 
LCa 7 48+4 120+9 7.13+0.14 96+4* 18+2* 
DP:developed pressure-; EDP:~nd-diastolic 
pressure, CON:control, *:p<0.05 
Repetitive LCa did not change the recovery of 
ATP, CrP and pHi but improved the myocardial 
functional recovery. Thus, we conclude that 
decreasing Na+-Ca++ exchange by LCa in each 
brief period of reperfusion prevent 
myocardial stunning in repetitive ischemia. 
ABSTRACTS 
935-76 
Quantitation of Myocardial Tissue Iron Contents Using NMR 
Relaxation: Validation in a Novel Murine Thalassemia Model 
Peter Liu, Mark Henkelman, J. Joshi, Sohail Waien, Jack Butany, 
Nancy Olivieri. 
Toronto and Sunnybrook Hospitals, University of Toronto. Canada. 
Nuclear magnetic resonance (NMR) is a new imaging technique 
that is sensitive to tissue iron, and can be used to assess cardiac iron 
distribution. To determine whether NMR relaxation measurements 
can non-invasively quantitllte tissue iron levels in vivo, we created a 
novel murine model of hemochromatosis by parenteral iron (Fe) 
loading in heterozygotic thalassemic mice containing a single 
mutation at the globin locus; and compared to non-iron loaded 
co' '-01 animals (No Fe). At time of sacrifice, samples of heart, as 
we" as Ilver and peripheral muscle were immediately subjected to 
NMR relaxivity interrogation in a small bore NMR spectrometer. 
The tissues were then sent for pathological examination, and 
determined for elemental iron content by flame atomic spectrometry 
and ferritin iron content by enzyme-linked immune adsorbance assay. 
Pathology confmned extensive iron deposition in the heart and 
liver cells in addition to the reticuloendothelial system, with little iron 
in the muscle in the Fe group. The NMR relaxation and iron contents 
are as follows: [Mean±(SEM), *p<O.OI Fe vs. No Fe] 
Heart Liver Muscle 
NQ.ft ft No Fe ft NQfi ft 
T2 (msec) 54.2 19.4 39.5 7.2 49.0 27.0 
(±6.0) (±3.9) <±1.9) <±2.3) <±1.0) <±3.8) 
Iron (mg/g) 0.073 1.640 0.387 10.20 0.012 0.763 
<±.029) <±.233) <±.l20) <±1.25) <±.003) <±.263) 
Ferritin levels paralleled that of total iron. RegreSSion analysis 
showed 1fT 2 to be linear to total iron contents for all organs including 
the heart ranging from 1-30 mg/g of iron (r=O.91, p<.OOl, SEE<3%). 
T2 relaxivity was calculated to be 28.7/sec/mg[Fe)/g. 
Conclusioll: NMR relaxometry can assay tissue iron in the range 
of 1-30 mg/g. NMR imaging can accurately localize and quantitate 
ill vivo iron, including that from the heart. 
935·77 
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Heterogeneity of Normal Myocardial Signal Intensity In Spin-Echo 
Magnetic Resonance Images. 
Steven R. Fleagle, Daniel R. Thedens, Trudy L. Burns, 
Thomas D. Scholz, David J. Skorton, The University of 
Iowa, Iowa City, IA 
Changes in regional myocardial intensity in magnetic 
resonance (MR) images have been shown to be indicators 
of infarction or transplant rejection. This use of MR 
is based on the assumption that normal regional myocar•
dial MR image intensity is uniform. However, technical 
and biological factors may be exppcted to produce 
regional heterogeneity of intensity. To test the 
postulate of regional uniformity, we performed axial 
spin-echo MR on 9 normal volunteers at 1.5 tesla, with 
TE-20 and TR-R-R interval. We attempted to minimize 
acquiSition artifacts by acquiring single, 1 cm thick 
sections at mid-ventricle. After defining the endo•
cardial (ENDO) and epicardial (EPI) borders with our 
automated edge detection procedure the myocardium was 
automatically segmented into four quadrants, and each 
quadrant divided into EPI and ENDO regions. Results: 
Mean ME Intensity (mean + SDl 
All EPI Regions All ENDO Regions ~ 
Diastole 285 ± 62 264 ± 52 <.05 
Systole 294 + 52 273 + 43 < 01 
*EPI regions vs. ENDO regions 
Analysis of variance also revealed that there were 
significant changes in myocardial intensity among other 
regions and with contraction. These results indicate 
that regional myocardial signal variations may not be 
due solely to disease states. These Signal variations 
must be corrected or accounted for to perform intensity•
based magnetic resonance tissue characterization. 
I88A ABSTRACTS 
935-78 
Cine Nuclear Magnetic Resonance Assessment of Aortic 
Regurgitation Using the Proximal Flow Acceleration 
Zone 
Gregory B. Cranney, Gilbert J. Perry, Halima Benjelloun, Jerry 
G. Blackwell, Chaim S. Lotan, Gerald M. Pohost. Division of 
Cardiology, University of Alabama at Birmingham, 35294 
Previous nuclear magnetic resonance (NMR) studies to assess 
aortic regurgitation (AR) have focused on the size of the 
regurgitant jet, a parameter which relates only poorly to 
regurgitant flow. This study evaluated a rapid single plane cine 
NMR approach (scan time < 10 min) and a new grading system 
for AR, which is based on the presence, size and persistence of 
not only the regurgitant jet but also the zone of proximal signal 
loss (PSL) in the flow convergence region. 
Compared to color Doppler echocardiography (CDE, n=42), this 
NMR approach detected AR with a specificity of 100% and 
sensitivity of 95%. The maximum area of NMR signal loss in the 
regurgitant jet correlated with the regurgitant jet area measured 
by CDE (n=20,r=0.81,p<0.01), but the jet area alone did not 
discriminate well between all grades of AR when compared to X•
ray contrast aortography (CAm, n'" 14). Using the new NMR 
grading criteria, AR grade by NMR agreed with CAm grade in 
12 patients, differing by only one grade in the remaining 2. NMR 
agreed within one grade of CDE in all patients compared (n=20). 
Assessment of the proximal flow zone was especially useful in 
patients with eccentric regurgitant jets. 
This cine NMR approach permits assessment of the presence and 
severity of AR using a short scan time. The same scan also 
assesses LV function and could be cost effective in patients 
undergoing NMR studies for evaluation of the thoracic aorta. 
935-79 
Acauac:y or Estimates or End-Systolic Left Ventricular Volumes Using 
Gradient Echo Clne-NMR 
Louis J. Dell'Italia, Gerald G. Blackwell, Douglas J. Pearce, Gerald M. 
Pohost, UAB, Birmingham, Alabama 
Calculation of LV volume (V) using an area length formula from a 
long axis (LAx) image or Bullet formula from a LAx and short axis 
(SA) image is conventionally performed using various techniques. 
However, these approaches may provide inaccurate L VV especially at 
end-systole and during increased afterJoad when the LV may deviate 
from a standard geometric configuration. Magnetic resonance imaging 
generates high resolution images of the LV and provides accurate L VV 
values independent of geometric assumptions. Addition of high-fidelity 
LV pressures with a nonferrous catheter-tip manometer allows further 
assessment of LV performance. Accordingly, we compared end-systolic 
LVV using a LAx image (area length), a LAx and SA image (Bullet), 
and serial SA images (Simpson's Rule) in 6 autonomically blocked, 
intact dogs during graded angiotensin infusion. High-fidelity LV end•
systolic pressure (ESP) and end-systolic volume (ESV) were as follows: 
ESP (mmH&.l LAx llllLLEI SIMPSON 
Low (L) 8S±9' 84± 10 83±9 
Med (M) 121± 17' 122± 14 123± 13 
High (H) 149±9' lSO±9 lS1±10 
• z P < 0.001, H > M > L for l.Ax, Bullet, Simpson 
~ LAx lll.!LlJll: SIMPSON 
Low 27± 10· 29±9 32±8 
Med 3S±10· 43±11 46±10 
High 46± 12· Sh 14 S7± 13 
• .. P < 0.05, LAx < Bullet and Simpson 
We conclude that LAx area length end-systolic LVV underestimates 
Bullet and Simpson rule L VV at all loads. However, Bullet and 
Simpson's Rule L VV's do not differ at three widely disparate LV end•
systolic pressures using gradient echo cine-NMR to derive LV volumes. 
935-80 
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Cine Computed Tomography and Nuclear Magnetic 
Resonance are Equally Accurate In Defining Cardiac 
Volumes: A Phantom Study Marcus DeWood, Andrew Monroe, 
Robert Short, Rodney Raabe, Paul Shields. The Heart Institute of 
Spokane, Spokane Cardiology, Deaconess Medical Center, Spokane, WA. 
To determine the accuracy of various imaging modalHies in defining cardiac 
volumes (VOL), we performed a study using symmetrfc and asymmetric 
heart-shaped latex-gelatin phantoms wHh known VOL defined by water 
displacement. Nuclear magnetic resonance (NMR), cine computed 
tomography (CT), cardiac echo and cath labs determined phantom VOL in 
a blind manner. Phantom VOL were defined by NMR (1.5 T magnet) in 
10mm slices (no skips) using a track ball to define edges at S-15 short-axis 
levels. NMR VOL were defined by addition of all levels. CT VOL were 
obtained in the cine mode at Smm levels from apex to base. Each slice area 
was reconstructed to yield CT VOL. Echo VOL were defined using a 5 MHz 
transducer and the formula: O.S5A2 IL. Cath V L w r fined by 
Simpson's rule after imaging in the ca lab. ..mm •• ", ' ••• tom 
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Thus when compared to known VOL, CT and NMR are equally accurate in 
determining the VOL of symmetric and asymmetric cardiac phantoms. 
Echo was less accurate, especially at high VOLS. 
935-81 
Determination of Left Ventricular Mass by Ultra Fast 
Computed Tomography in Human Hearts Deformed by 
Hypertrophy. 
Elie Mousseaux, Farzin Esmail-Beygui, Paul Fornes, Albert Hagege, 
Michel Desnos, Jean-Claude Gaux, Pierre Peronneau. 
INSERM (U256), Radiologie, Hopital Broussais, Paris, France 
Ultrafast Computed Tomography (UFCI') has been reported as an 
accurate and reproducible method of measuring left ventricular mass 
(L VM) in dogs and healthy male volunteers. Aim of this study was to 
determine the accurency of UFCI' L VM measurements for evaluating 
hearts distorded by hypertrophy, whether hearts were dilated or not. 
Correlation (r),Variability Index (VI=SEF/mean of two measurements) 
and L VM measured by UFCI' has been compared -in..ri1m with post 
mortem weight (Wg) in two groups of humans hearts: Non 
Hypertrophic (NH) {n=10,mean Wg = 164 g, range 107 to 20S}; 
Hypertrophic (H) {n=lO, mean Wg = 260 g, range 212 to 388}:in.:mQ 
between two observers (inter 0) and two successive measurements of 
same observer (intra 0) in three groups of patients: Non Hypertrophic 
Patients (NHP) {n=10, mean LVM=157 g, range 103 to 204}; 
Hypertrophic Dilatated Patients (HOP) {n=lO, mean LVM=379 g, 
range 225 to 639}; Hypertrophic Non Dilatated Patients 
(HNDP){n=13, mean LVM=339 g,range 218 to 669}.Myocardial 
edges were manually determined by the regional half-contour method 
and L VM calculated using Simpson'rule. ~ were in....riu:l2 
respectively for NH & H: r= 0.96 & 0.96; LVM UFCI'= 1.04 Wg-
4.1 g & LVM UFCI'= 0.96 Wg + 24.9 g; VI = 6.4 % & 8.6 %·In 
~ 
Inter 0 Intra 0 
r SEE (g) VI (%) r SEE (g) VI (%) 
NHP .97 7.7 4.9 .99 4.7 3.1 
HOP .98 26.4 7 .99 13.8 3.4 
HNDP .99 14.5 4.3 .99 10.4 2.8 
Results strongly support the opinion that UFCI' provide reproductible 
and precise global L VM measurements in hearts whether distorted or 
not by hypertrophy. Determination of L VM by UFCI' does not require 
assumptions about ventricular shape or uniformity of wall thickness. 
JACC Vol. 19, No.3 
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935-82 
Cardiopulmonary Dynamics With EKG Gated Ventilation 
C. William Hanson III. Michele T. Haywood. and Eric A. Hoffman. Univ. of 
Penn. Medical School. Philadelphia. PA 
Extrapolating from the mechanisms by which CPR generates and the 
intra-aonic balloon pump augments cardiac output. we theorized that timing 
high frequency ventilation to the appropriate point in the cardiac cycle 
would enhance left hean function. Using dynamic cr scanning (Imatron). 
we were able to non·invasively evaluate cardiopulmonary dynamics in a 
dog model. A programmable jet ventilator was variably gated to the 
electrocardiogram. We measured anerial blood gases, carotid blood flow, 
stroke volumes, ejection fraction. and myocardial blood How (MBF). 
Like other investigators, we found that inspiration synchronized to 
cardiac systole was preferable to diastolic gated respiration. In 6 mongrel 
dogs, systolic· gated inspiration significantly increased ejection fraction 
(13.4%16.5%, pdXlI). stroke volume (3.7±2.7cc/stroke, pdXll) and 
cardiac output (37%±28%, p<.OOI) over standard ventilation. This degree 
of improvement was evident in 1l!l!h nonnal animals and animals given 
propranolol (1 mglkg) to simulate cardiac pump dysfunction. Blood gas 
values. carotid blood flow, and hean rate did not vary significantly. 
Preliminary data to date has shown that in changing from standard 
ventilation to respiratory gating in phase with ventricular systole, MBF 
increased from 84 to 195 mVmin/lOOgm (132%). A shift to diastolic gating 
resulted in a drop in MBF to lOS ml/min/lOOgm. In the same dog, a second 
change from standard ventilation to systolic gating caused an increase from 
103 to 150 mVmin/lOOgm (50%). 
Of panicular interest was the surprise finding that pulmonary mechanics 
also changed substantially depending on the gating relationship of ventila· 
tion to the cardiac cycle. With systolic gating, static and dynamic compliance 
were nonnal, whereas air trapping (auto PEEP) resulted from diastolic gating 
• eventually causing decreased venous return and cardiac output. This pre· 
sumably results from decreases in airway caliber during the expiratory 
phase, which occurs in systole. when the pulmonary vasculature is engorged. 
935-83 
Can the Absence of Coronary Calcification on 
Ultrafast CT be Used to Rule Out of Non•
significant Coronary Artery Stenosis? 
William Stanford, Jerome Breen, Brad Thompson, Robert 
Schwartz. Jeffrey Galvin, John Rumberger, Kevin 
Berbaum, Patrick Sheedy 
University of Iowa, Iowa City. IA and Mayo Clinic, 
Rochester, MN. 
Ultrafast computed tomography (UFCT) is an established 
method for detecting and quantifying coronary artery 
calcification. Calcification increases with age and with 
the severity of the atherosclerotic process however 
attempts to quantitate the extent of the calcification with 
the extent of angiographically proven stenosis has not 
been totally successful. This study attempts to correlate 
the absence of calcification with the absence of 
angiographically proven stenosis. 
150 subjects (age 25-59 years) undergoing elective 
coronary angiography for questionable coronary disease 
were studied by UFCT imaging. Coronary calcification 
was defined as >2 pixels with CT density of > 130 HU. 
Significant angiographic disease was defined as any 
stenosis> 50% on the angiogram or a > 70% cross 
sectional area on quantitative coronary artery 
angiography. 
Results: Only one subject had a significant coronary 
artery stenosis in the absence of coronary calcification; 
ali the remaining subjects with significant stenosis had 
calcification. 
Conclusions: The absence of coronary calcification 
on UFCT appears to be a useful indicator to rule out 
significant luminal coronary stenosis. 
ABSTRACTS 189A 
935-84 
REPRODUCIBILITY OF CORONARY ARTERY CALCIUM 
SCORING WITH ULTRAFAST CT 
Vljay Shah, M.D., Jose Claudio, R.T., Christopher J. WoHklel, 
Ph.D., Stuart Rich, M.D., FA.C.C., Stephen R. Devries, M.D., 
FA.C.C., University of illinois; Chicago, illinois 
Determination of the reproducibility of coronary artery calcium 
(CAC) scores measured with CT is essential in order to evaluate 
the results of serial scans for evolution of atherosclerosis. In 
order to determine the reproducibility of the measurement of 
CAC, 50 pts. (31 M, 19 F; mean age 54) underwent two 40 level 
cardiac CT scans within 72 hrs. The calcium score was derived 
from the peak CT density ~ 130 Hounsfield units) and area of 
the lesion measured by one experienced reader. CAC C±. SO) 
scores for the 1st and 2nd group of 50 scans were similar: (Total 
CAC score: 172.±. 430 vs. 162.±. 443; LAD: SO.±. 184 vs. 89.±. 
236; LCX: 36..±. 116 vs. 29.±. 89; RCA 56.±. 188 vs. 42.±. 176. 
Despite the similarity of mean scores, considerable variability was 
noted in individual pt. scores from scan to scan. To further 
define the variability, the differences of each pair of CAC scores 
were computed when calcium was present in at least one scan. 
The mean and standard deviation of the differences between 
scans were [Total CAC (n=33): 11.±. 94; LAD (n=23): 24.±. 106; 
LCX (n=17): 18 .±. 57; RCA (n=26): 25 ..±. 113]. Thus, 
consideration of the reproducibility of CAC scores is important 
when evaluating the results of serial scans. Although Ultrafast CT 
holds promise as a method to evaluate the evolution of 
atherosclerosis, relatively large differences in serial CAC scores 
may be required in order to demonstrate that a true change in 
coronary calcium has occurred. 
935-85 
Nephrotoxicity following Cardiac Angiography in Patients 
over 70 in a Randomized Double·Blind Multicenter Trial of 
Ionic and Nonionic Contrast Media 
Michael Winniford MD F.A.C.C .• lames A. Hill MD F.A.C.C .• Mary 
1. Murphy MD, Elkan F. Halpern PhD for the Iohexol 
Cooperative Study. U of Iowa, Iowa City, Iowa 
The effect of contrast media on renal function following 
cardiac angiography was studied in a subset of 369 pts over 70 
years of age randomly assigned to receive meglumine 
diatrizoate (D) or iohexol (10). Pts were prospectively 
stratified into 4 groups (Op) based on risk [Op 1: baseline 
serum creatinine (C) < 1.5mg/dl, no diabetes me11itus (DM); Op 
2: C < \.5mg/dl. DM; Gp 3: C ~ 1.5mg/dl. no DM and; Gp 4: C ~ 
1.5mg/dl. DM]. All pts received standard hydration and C was 
followed for ~ 48 hrs. &l:..s..u.J.n There were no differences in 
age. reason for catheterization. NYHA class. or contrast 
volume administered between those receiving D and 10. 
!m..l 0lL2. ~ ~ J:Qal 
#(%) pts with Increase in C ~ 50% above baseline * 
D 3(8) 6(16) 9(13) 10(29) 28(15.7) 
10 5(10) 1(3) 3(4) 6(15) 15(7.9) 
#(%) pts with Increase in C ~ 0.5 mg/dl • 
D 5(14) 5(13) 23(33) 19(56) 52(29.2) 
10 4(8) 2(7) 7(10) 15(37) 28(14.7) 
#(%) pts with Increase in C ~ 1.0 mg/dl .. 
D 0(0) 0(0) 6(9) 9(27) 15(8.4) 
10 0(0) 1(3) 4(6) 7(17) 12(6.3) 
Diff between D & 10 ·ps. 0.02 ··p=NS (across groups) 
Age > 70 was not found to be an independent risk factor for 
nephrotoxicity. Overall relative risk of nephrotoxicity 
comparing D & 10 is between \.3·2.0. 
~ In pts over 70 undergoing cardiac angiography, the 
risk of nephrotoxicity (increase in C ~ 50% or ~ 0.5 mg/dl 
above baseline) is lower with 10 than D. 
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935·86 
Can on-line QuanIItaIIve Coronary AMysIs AccInleIy Meastn VascUar 
DImensIons? A ~wtIh Off-Jine CInEngIographIc Measuraments 
Stlneka K Nugteren. Juergen Haase. Senno J.w.M. RenslllQ. Walter R.M. 
Hermans. Carto 01 Marta. Jos R.T.C. Roeland!. Patrick W. Serruys 
Thoraxcenter. Erasmus University. Rotterdam. The Nathertands 
Geometric measurements acquired on.Jlne with the Automated Coronary 
Analysis package 01 the Phllps Digital Cardiac Imaging system (DCI) were 
compared with off-Jlne measurements using the previously validated 
Coronary Artery Analysis System (eMS). 
Methods: In a group 0131 patients who underwent control angiography 
six months after successful coronary angloplasty. 34 coronary segments 
have been recorded In different projections (5' field) with DCI (pixel matrix: 
512x(12) and 35l1l11H:ineflIm. 69 enddiastolic frames were selected 
visually for quantitative analysis on-line (OCI) and off-lIne (eMS). WIth the 
eMS system a cine-video conversion of the cineframe Is performed and 
a 6.9x6.9 mm region 01 Interest Is optically magnified into a 512x512 
digital matrix. In both systems the vascular contours were assessed uslng 
an operator Independent edge-detectlon algorithm. The anglographic 
catheter was used for calibration. The values of minimal luminal diameter 
(MLD). reference diameter (RO) and percent diameter stenosis (OS) were 
compared. lesions of the left anterior descending artery were Involved in 
2B of the 69 frames (41%). lesions of the circumflex artery In 18 (26%) and 
lesions of the right coronary artery In 23 frames (33%). According to the 
statistical approach proposed by Altman and Bland. mean value and 
standard deviation 01 the differences of MLD. RO and OS between both 
methods were calculated and a t-test for paired values was applied. 
Resdts: ULD (mm) RO (mm) OS (%) 
DC! 1.76±0.54 2.82±0.59 39±15 
eMS l.SS±O.44 2.81±0.49 41 ± 13 
Mean dlf...:e 0.10 0.01 -2 
8d .±.0.32 .±.0.39 .±.12 
p<0.05 n.S. n.s. 
Conclusion: No Significant differences were observed between the mean 
values of RO and OS obtained with the two methods. However. the 
measurements of MLD provided significantly higher values when the on•
line quantitative analysis was performed on the DC! Philips system. 
935·87 
Sensitivity and Specificity of a Digital Angiographic Index 
for the Assessment of the Functional Severity of Coronary 
Stenoses in Comparison with Direct Flow Measurements 
Helmut Schuhlen. Neal l. Eigler, J. Martin Pfaff, James S. 
Whiting. Department of Cardiology, University of Freiburg, 
Germany and Cedars-Sinai Medical Center, Los Angeles, CA 
We developed a digital angiographic technique to determine 
microcirculatory contrast media mean transit time IT micro) by 
impulse response analysis of a single contrast injection 
under resting flow conditions. In previous studies, the 
inverse of T micro correlated linearly with flowmeter coronary 
flow reserve (CFR; r = 0.S1) over a wide range of proximal 
stenoses; our data suggested that T micro reflects autoregula•
tory changes of the microvascular bed. The present goal 
was to compare sensitivity and specificity of T micro and CFR 
by ROC-analysis relative to a 4-grade stenosis classification 
(O = no stenosis; 1 = angiographic stenosis without reduc•
tion of resting flow; 2 = stenosis with > 25% flow 
reduction: 3 = TIMI-flow 0-1), assessed for acute stenoses 
in 24 dogs (CX: n = 13S: LAD: n = 43). Discriminating 
between the four grades yielded the following ROC-curves, 
expressed by their areas (± SEM): 
ROC-curve area 
for Tmicro 
for CFR 
Discriminating stenosis grade 
1 from 0 2 from 1 3 from 2 
0.98±0.01 O.77±O.OS 0.9S±0.03 
0.99±0.01 0.S9±0.05 0.91 ±O.OS 
Both T micro and CFR reliably discriminate the four grades of 
stenoses with comparable sensitivity and specificity (p = ns; 
z-Testl. Thus, the applied digital angiographic technique 
yields a valid index to assess the functional severity of 
stenoses, requiring only a single injection and measurement 
under resting flow conditions. 
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ACE-Inhibitors Potentiate Endothelium-Dependent Relaxations to 
Threshold Concentrations of Bradykinin in Coronary Arteries. 
WoUgang Auch-Schwelk, Claus BoSSlller, Matthias Gaus, Kristof 
Graf, Michael Grafe, "Stephan Schiiler, Eckart fleck. Departments of 
Cardiology and "Cardiac Surgery, German Heart Institute Berlin,FRG. 
Invivo studies suggest a role for bradykinin (BK) in the vasodilator 
effect of ACE-inhibitors. The aim of the study was to elucidate, 
whether ACE-inhibitors augment the bradykinin-induced release of 
endothelium-derived relaxing factor(s) by other mechanisms than by 
reducing the degradation of BK. Rings of isolated human (from 
explanted hearts) and bovine coronary arteries were mounted in 
organ chambers for recording of isometric force (in the presence of 
indomethacin to·5 M). The rings were contracted with PGFla and 
incubated with threshold concentrations of BK (~ 10-10 M, causing 
22±5 % relaxation, n=28). ACE-inhibitors caused further relaxations: 
ICso maximal relaxation 
Usinopril: 7.6 x 1~ M 75±5% n=28 
Enalaprilat: 5.6 x 1~ M 86±5% n=5 
Captopril: 59 x 1~ M 63±7% n=9 
The relaxations to the ACE-inhibitors were not observed in rings 
without endothelium nor in rings treated with other vasodilators 
(acetylcholine H)"' M, ADP 1cr M, substance P 1(t8 M, or SIN-1 10-$ 
M). The response was blunted after incubation with I-nitro-arginine 
(10-1 M), methylene blue (l0·5 M) and the selective BK2-antagonist Hoe 
140 O(t8 M). The incubation time with BK (10, 30 or 60 minutes) did 
not affect the response to the ACE inhibitors. BK concentrations in 
the organ bath measured with a specific BK-RIA were not affected by 
the ACE-inhibitors. Thus, ACE-inhibitors enhance the release of nitric 
oxide in response to submaximal stimulation of BK2-receptors. This 
effect cannot be explained by a reduced degradation of BK and 
represents an new potent mechani~m contributing to coronary 
vasodilation in response to ACE-inhibitors. 
936·45 
Role of Differu1 Medi810n ia die Respoue at Coroury Blood 
FI_ to TacQ-C8t11ia. 
MlIgda Heras, p~ Perez-Villa. ElIlaua R~. Marcos Paz. JOII1 Cines. Anna 
CIrreiIo. Jordi Soler. Gines Sanz. Hospatal Oinic and Lab«atori de 
CardioiogiaElperimemal Valld'HebrOJ1. BarcelOll&. Spain. 
TheillfluenceofendogenousJl'Ollll7'clin.iatactccronaryendotheliumand 
endothelium -derived relaxing fact« (EDRF) in tbe inc:reae of ccronary bJood 
flow (CBF) induced by progressive cial pIcing was assessed in. porcine 
model. 
Sixteen pigs '!ritb a mean wei~ of 31 kg. were anesthetized '!ritb 
peatobarbital i. v. An eJecttomllgllellC flowmeter was positioned around tbe 
middle segment of the LAD and a pacemaker was SIJtUI'ed in the right atrium. 
Arterial pressure and ECG were moail«ed contiJIcrasly. Heart I'Ite WIS 
inc:reaed 20 bettsl5 min. CBF was measured blSa1.ly and II each pIcing 
inIerYaIbefcreandaftermeclofenamlte(5mgltgli. v. )(n=5), LAD endothelium 
balloo.n denudatioo (BD) (n=5) and N-L-Arginine (20 JLglKglmil11i.c.) (n=6). 
Corollary reserve (CR) and tbe tltio of 11 CgF I 11 dobJe Jroduct [(maximum -
basal CIIFlmuimum - basal dobJe Jroduct) l[ 1,0001 were also calculated. 
VallIes are eJp-essed IS mean * SD. 
Meclofen. 
SD 
N-L-Argin. 
CR (Ji) IlCBFllldobJe p-oduct 
Basal Post Basal Post 
154*17 
2~J02 
167*32 
152*13 
152t36 
142*J7' 
7.5*2.8 
8.1f3.6 
9.6:1:4.1 
9.7:1:6.2 
6.6%4.8 
4.1*1.0' 
']1< 0.05 comt*'edwith basal values. 
Maximun CBF was signifiCSD1ly reduced from 66:t20 to 45:t21 mllmin. 
p--{).016 after BD and from n*30 to 59! 18 mllmin, p=O.054 duri.og N-L•
Arginine. but did not changeaftermeclofenamlte. 
Thus, thep-esence of a normallyfunctiOllillg endothelium is of importance 
in tbe mediation of tbe CBF changes observed duri.og taebycsrdia. These 
changes are It least in part mediated by the EDRF released by a normal 
CIX'OIIII')' endothelium but not by endogenous p-ostacyclin. 
JACC Vol. 19, NO.3 
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936·46 
Adenosine Concentrations in Normal and Ischemic 
Regions of the Human Myocardium. 
Stephen W. Ely, Curtis G. Tribble, Joel Linden, and 
Robert M. Berne. University of Virginia Health Sciences 
Center, Charlottesville, VA 22908 
Interstitial adenosine (ADO) plays an important role in 
maintaining the myocardial O2 supply/demand ratio in a 
variety of animal models. We employed a previously 
described epicardial disc technique to estimate 
int.erstitial ADO concentrations in eleven patients with 
one or two vessel ischemic coronary artery disease at the 
time of coronary bypass surgery. ADO measurements 
were made from the normal (nl) and ischemic (lsch.) 
right ventricle (RV) and left ventricle (LV). These sites 
were determined from pre·operative coronary 
angiography and TL-201 scintigraphy. ADO was 
measured by RIA. 
ADO HR CI PAPorAOP 
JID1 hLmin liminLm2 mmfu: 
nl RV 0.4±06 68:19 2.5±0.2 15±2 
Isch. RV 1.87±.34* 67±2 2.9±0.5 14±4 
nl LV 1.09±.05* 72±6 2.5±O.2 70±3* 
Isch. LV 3.69±.53*t 68±3 2.8±0.2 73±4* 
Mean ± SEM, *p<.05 vs. nl RV, tp<.05 vs. nl LV 
(ANOVA), PAP or AOP= mean pulm. or aortic press., 
CI = cardiac index, HR = heart rate. 
These data demonstrate that: 1) ADO is >2-fold higher in 
the nl LV vs. nl RV consistent with the known 
differences in metabolic activity; and 2) ADO is 
significantly higher in the ischemic vs. the normal 
regions of the myocardium. These data support a role 
for ADO as an important metabolic mediator in response 
to a change in the O2 supply/demand ratio and 
represents the first known study of interstitial adenosine 
inman. 
936·47 
Enhancement of Coronary Collateral Blood Flow by 
Intracoronary Injection of Vascular Endothelial Growth Factor 
Shmuel Banai, Matie Shou, Michael T. Jaklitsch, Napoleon Ferrara, 
Stephen E. Epstein, Ellis F. Unger, NHLBI, Bethesda, Maryland 
Vascular endothelial growth factor (VEGF) is an endothelial cell•
specific mitogen that is angiogenic in vivo. It has been hypothesized 
that VEGF plays a critical role in myocardial collateral formation; 
however, the effects of VEGF on the vasculature of ischemic 
myocardium are unknown. We studied the effect of VEGF on 
collateral blood flow in dogs subjected to ameroid·induced occlusion 
of the left circumflex coronary artery (LCX). Beginning 10 days 
after ameroid placement, VEGF 45 /lg (n = 9) or saline (n = II) was 
administered as a daily bolus injection directly into the distal LCX 
at a point just beyond the ameroid. Myocardial blood flow was de•
termined with radiolabeled microspheres 3 days after ameroid place•
ment and weekly for 5 weeks thereafter. Collateral blood flow was 
quantified during chromonar-induced maximal vasodilation and ex•
pressed as an ischemic/normal zone (IZ/NZ) ratio. Final IZ/NZ 
blood flow ratios were 0.46±0.12 and 0.34±0.OS in the VEGF•
treated and control groups, respectively (p < 0.05). 
~ 0.5 
Ii: 0.4 
-g 0.3 
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IZ/NZ Flow vs. Time 
(mean ± SEM) 
o 2 3 4 5 Time (weeks) 
We conclude that intracoronary VEGF enhances collateral blood flow 
in this canine model of myocardial ischemia caused by single 
coronary occlusion. 
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936-48 
Activity of Angiotensin Converting Enzyme and Neutral 
Endopeptidase in Human Coronary Endothelium 
Michael Grafe. Kristof Graf, Clau. BossaUer, Wolfgang Auch·Schwelk, C. R. 
Baumgarten', Eckart Fleck. 
Department of Cardiology, German Heart Institute Berlin, 'Department of 
Clinical Immunology, FU Berlin: . F.R.G. 
Endothelial angiotensin converting enzyme (ACE) and neutral endopeptidase 
(NEP) are involved in the regulation of vascular tone by metabolizing 
vascular peptide •. In order to investigate the role of these enzymes in the 
coronary circulation we determined the activity of ACE and NEP in 
endothelial ceUs of human coronary arteries (HCEC), obtained from 
explanted hearts and in human umbilical venous endothelial ceUs (HUVEC). 
The enzyme activities in endothelial ceUs were calculated from the inhibitory 
effects of the ACE inhibitor lisinopril (L,10-6M) and NEP inhibitor 
phosphoramidon (P,IO-8M) on degradation of exogeneous bradykinin (10.000 
pg/ml). Bradykinin concentrations (pg/ml) were measured at various times 
with a radioimmunoassay (12SI_Tyr_Bk, minimal detection limit 20 pg/ml, 
cross reactivity to des-arg9-Bk < 1%). The calculated half-life of bradykinin 
in presence or absence of different inhibitors were (minutes, x+ /-SEM): 
HUVEC HCEC 
total activity 30+ /·2 105+ /-10 
+lisinopril 230+ /-23" 208+/-22' 
+phosphoramidon 44+ /-3 128+ /-6 
+ Ii'inopril+ phosphoramidon 403+ /-6S" 280+ /-22' 
(n=6-18.' = p<O.OS and" = p<O.01 vs. total activity) 
The calculated ACE activities were 4,7 pmol/min/l06 ceUs in HCEC and 
30.9 pmol/min/l06 cells in HUVEC. The NEP activity in both, HUVEC and 
HCEC, was 1,7 pmol/min/l06 ceUs. 
Thus, ACE activity is present in human coronary endothelial ceUs, but 
corresponds only with 20% of ACE activity found in HUVECs. NEP is 
present in both endothelial ceUs with similar enzymatic activity. Our results 
suggest that both enzymes may affect coronary vascular tone by modulating 
local concentrations of vasoactive peptides such as angiotensins, bradykinin 
and substance P. 
936·49 
Deferoxamine Prevents Dysfunction of Canine Coronary 
Endothelium Following Brief Ischemia 
Kurt F. Heim, Jonna S. Fomsgaard, R. Michael Danchak, 
George Thomas, Peter W. Ramwell, and Young D. Kim 
Georgetown University Medical Center, Washington, D.C. 
Deferoxamine (DEF) protects the myocardium from injury due to is•
chemia and reperfusion, presumably through inhibition of oxygen•
derived free radicals. Since the coronary endothelium may sustain 
similar injury, we sought to demonstrate that DEF protects the endo•
thelium as well. To investigate this, DEF was administered i.v. to 6 
adult mongrel dogs beginning 30 min prior to a 15-min period ofliga•
tion of the left anterior descending coronary artery (LAD). An initial 
dose of 10 mg/kg was infused over 1 hr, followed by 1.5 mg/kg/hr. 
Coronary blood flow (CBF) was measured in m1/min in response to 
LAD infusion of 21lg/min acetylcholine (ACh) and coronary vascular 
resistance (CVR) was calculated before LAD ligation and after 15 min 
of reperfusion. CBF values were obtained as well from 12 dogs not 
treated with DEF. The following table shows % change in CBF from 
baseline in response to ACh (* denotes p<O.05): 
Pre-ischemic 
Post-ischemic 
Control (-DEFl 
104.6 ± 19.7 
35.9 ± 6.S * 
Treated (+DEf) 
76.33 ± 22.01 
90.S3 ± 12.47 
Post-ischemic decreases in CVR were similar to pre-ischemic trends in 
the treated group. Mean arterial pressure values in treated and control 
groups were similar, confirming that changes in CBF were not due to 
alterations in global myocardial function. 
Since 15 min of ischemia caused a significant decrease in dilatory 
response to ACh without morphologic damage in coronaries of un•
treated dogs, these results suggest that DEF may prevent coronary 
endothelial dysfunction following brief periods of ischemia. Thus, the 
use of DEF during an ischemic episode and the subsequent reperfu•
sion period may be of some benefit due to the antioxidant properties of 
this compound. 
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936-50 
Non-Inva.ive Detection of Early Endotbelial Dysfunction 
in Cbildren and Adults at Risk of Atberosclerosis. 
David Celermajer, Keld Sorensen, Vanda r~ocb, Owen Miller, 
Ian Sullivan, John Deanfield. 
Hospital for Sick Children, London, England. 
Flow mediated dilatation (FMO) in systemic arteries (SA) 
depends on normal endothelial function. Using high 
resolution ultrasound we studied arteries of 23 subjects 
(age 9-50 yrs) without vascular risk factors (VHF) 
(14 superficial femoral and 9 brachial), and measured 
vessel diameter in response to increased flow (reactive 
hyperaemia atter ischaemia) and to sublingual glyceryl 
trinitrate (GTN) (a non-endothelial dependent dilator). 
Scans were analysed independently by 3 observers (mean 
interobserver ditference 2~). There was an inverse 
relationship between vessel diameter and percent 
dilatation; SA)7. Omm dilated only 1-3%, but tbose (5. 5mm 
dilated 10~2~ (range 7-17) in response to a flow increase 
(doppler estimated) of 260-400% in femoral and 500-700% 
in brachial arteries, and by 16+2% (range 12-22) to GTN. 
15 arteries (3 femoral, 12 brachial) ~ 5. 5mm were 
therefore studied; 9 from subjects with VRF (2 children 
with homozygous hypercholesterolaemia, 7 smokers aged 36-
52 yrs) with no clinical vascular disease and smooth 
arteries on ultrasound, and 6 subjects (age 54-67 yrs) 
with known coronary disease. In those with VRF, FMD was 
markedly reduced (3+2%), with only one subject showing a 
normal response. I~ those with coronary disease, FMD was 
absent (-1~2~). In contrast, a normal response to GTN 
was observed in all these patients (14+3%). 
Non-invaslve study of systemic arteries shows 
endothelial dysfunction in subjects with risk factors for 
artherosclerosis, before anatomical evidence of disease. 
This technique permits acreening for early disease, and 
will enable assessment of the impact of risk factor 
modification. 
936-51 
Hypoxia-Induced Relaxation of Rabbit Coronary Arteries is 
Mediated by Neurogenic and Endotbellal Mechanism 
Can wen Jiang, Philip Poole-Wilson &. Peter Collins. National 
Heart and Lung Institute, London, UK. 
The role of autonomic nerve endings, endothelium and 
endothelium-derived relaxing factor (EDRF) on hypoxia-induced 
coronary artery relaxation was assessed. Coronary artery rings 
from male adult New Zealand white rabbits were suspended in 
organ baths for the measurement of isometric tension. In the 
presence of indomethacin (10 I'M). Prostaglandin F2a (3 I'M) 
precontracted endothelium-intact or -denuded rings by 0.9±0.1 
and 0.9±0.2 g (mean±S.E.M., n-8, p>0.05). Hypoxia, induced by 
bubbling the solution with 95% N2 and 5% CO2 instead of 95% 
02 and 5% CO2 (PO~-20 torr), caused a transient relaxation by 
3S±3% and 17±2% ID endothelium-intact or -denuded rings 
(comparison with time-matched controls, p<O.OI; between 
endothelium-intact or -denuded rings, p<O.OI), the relaxation 
lasted for 6± I minutes and was followed by contraction. 
Incubation with tetrodotoxin (3. 10 I'M) for 20 minutes decreased 
the relaxation to 31t3% (p<0.05) and 21±4% (p<O.O I) in 
endothelium-intact rings. and 14±2 (p>O.OS) and II±I% (p<O.05) in 
endothelium-denuded rings. Atropine. propranolol and 
phentolamine did not affect the relaxation. The relaxation was 
a'lf reduced to 30±2% (p<O.OS) and J6±2% (p<O.OI) by 
N -monothyl-I-arginine (30, 100 I'M) and restored by L-arginine 
(I mM) in endothelium-intact arteries. the two agents did not 
affect relaxation in endothelium-denuded rings. Incubation with 
terodOloxin did not affect the relaxing responses 10 acetylcholine. 
Our results suggest that rabbit coronary artery relaxation 
induced by hypoxia is partially mediated by a neurogenic 
mechanism which is possibly noncholinergic and nonadrenergic. 
and by the endothelium via the release of an EDRF. 
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Lack of Magnification of Constrictor Response by Subintimal 
Plaques in Patients with Chronic Stable Angina 
Hassan EI-Tarnirni, Michel Bertrand, Attilio Maseri. Cardio•
vascular Research Unit, RPMS, London, UK and Hopital 
Cardiologique, Lille, France. 
It is generally assumed that the coronary constrictor response 
is magnified by subintimal plaques, but the magnification may 
be prevented by plaque rigidity and smooth muscle atrophy. 
We analysed the angiograms of 51 patients with single vessel 
disease and chronic stable angina (CASS system) in basal 
conditions (B) follOwing ergonovine (E) and isosorbide dinitrate 
(ISDN). In B the visually detectable stenoses analized were 
49.±.16% (range 13-78%). Vasomotor potential (>0.2mm 
change between E and N) was detected in 75%. Compared to 
B dilatation following ISDN was not correlated with constriction 
following E in reference or stenotic segments: most segments 
that constricted less, dilated most and vice versa, suggesting 
differences in basal vasomotor tone. 
Most stenoses constricted much less than predicted by the 
geometric magnification theory: from B to E only 5 segments 
with the mildest stenoses constricted as predicted, occlusion was 
predicted in 10 segments which constricted only 26% (range 0-
56). The discrepancy between observed and predicted stenosis 
constriction was even larger from N to B and from N to E. 
Thus in most stenoses with vasomotor potential the 
magnification of the constrictor effect by the subintimal plaque 
predicted by the geometric theory is prevented by peristenotic 
rigidity and smooth muscle atrophy of the arterial wal!. 
Occlusive spasm can only be caused by very strong constrictor 
stimuli or by enhanced local reactivity. 
936-53 
Platelet Activating Factor Constricts Canine Coronary 
Arteries Following Endothelial Damage Caused by Brief 
Ischemia 
R. Michael Danchak, Kurt F. Heirn, Adam K. Myers, 
John W. Connors, and Young D. Kim 
Georgetown University Hospital, Washington, D. C. 
Platelet activating factor (P AF) may be an irnponant mediator of coro•
nary spasm and acute myocardial ischemia. However, PAF has both 
coronary dilator and constrictor activities according to various studies. 
Since the endothelium is irnponant in modulating vascular lOne, we 
hypothesized that changes in endothelial function could be responsible 
for conflicting activities of P AF. To investigate this point, P AF was 
infused into the left anterior descending coronary anery (LAD) of nine 
adult mongrel dogs at a dose of 0.D3 lLg/min before and after 30 min•
utes of LAD ligation. Coronary blood flow (CBF) was measured in 
ruVmin using a Doppler flow probe and coronary resistance (CR) was 
calculated before and during P AF infusion. The following results are 
expressed as % change from control (* denotes p<O.O I and ** 
p<0.05): 
Pre-ischemic Post-ischemic 
20.37 ± 11.58 -28.72 ± 7.08 * 
-16.79 ± 6.08 56.96 ± 22.57** 
Since 30 minutes of ischemia caused endothelial damage, as shown by 
a decrease in dilatory response to acetylcholine and by morphological 
changes, these data suggest that the response of the coronary artery to 
P AF after brief ischemia depends upon functional integrity of the endo•
thelium. This may help to explain the occurrence of persistent coronary 
spasm following acute myocardial ischemia, since the liberation of 
PAF from residual thrombi would continue to constrict the coronary 
artery in the absence of functional endothelium. 
JACC Vol. 19, No.3 
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937·23 
Two-chamber Model of the Arterial Circulation: Evaluation of 
Performance and Sensitivity to Wave Reflections. 
Richard Marcus. Sanjeev Shroff. Claudia Korcarz. Gary McCray. Roberto 
Lang. University of Chicago. Chicago. IL 
Single-chamber lumped parameter models of the arterial system do not 
adequately describe aortic pressure-flow [Pltl-Olt)) relations. particularly 
in the presence of prominent wave reflections. Accordingly. performance 
of a two-chamber model. consisting of proximal and distal compliance 
and transverse resistance elements ICp. Cd. rp and rdl separated by an 
inertance parameter ILl. was compared to that of a single-chamber 
model with Single compliance and transverse resistance elements. 
Performance indices included a measure of each model's ability to 
describe Pltl-Oltl relations and the sensitivity of model parameters to 
reflected waves. Ascending aortic Pltl IMiliar catheterl and Oltl 
(Transonic flow probe I were recorded in 5 anesthetized open·chest dogs 
at baseline and during augmentation of wave reflections by inflation of 
a balloon in the abdominal aorta. With Oltl as the input, model 
parameters were estimated by an iterative procedure that minimized the 
error IRMSEI between measured and model-based Pltl over the entire 
cardiac cycle. Results: 111 The two-chamber model accurately described 
Pltl-Oltl relations even in the presence of wave reflections IFigurel. 
RMSE was lower for the two-chamber model than for the single-chamber 
model both at baseline 11.2 vs 1.9 mmHg, p< .051 and with augmented 
wave reflections 11.1 vs 2.5 mmHg, p< .011; 121 All parameters for both 
models changed significantly when wave reflections were augmented. 
Conclusions: The two-chamber model is superior to its single-chamber 
counterpart in describing aortic Pltl-Oltl relations. especially in the 
presence of prominent wave reflections. However. the sensitivity of all 
parameter values for both 
models to wave reflections 
indicates that they are not 
true measures of arterial ~ 
physical properties; instead . \ ... 
they are composite descriptors
68
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937·24 
Histologic Asseument of Dilated CardiolllJOpathy: Limitations of 
Right Ventricular EDdomyocantial Biopsy_ 
Randall C. Starling, David B. Johnson, Craig J. Leesman, Peter B. 
Baker 
The Ohio State University, Columbus, Ohio 
It is unknown whether right ventricular septal endomyocardial biopsy 
(RV bx) fmdings reflect the histology of the left ventricle. The 
purpose of this investigation was to compare the pre·transplant RV 
bx in 13 patients with dilated cardiomyopathy (OCM) and the global 
histologic findings from their explanted hearts (EX). Using light 
microscopy, percent fibrosis was measured using the point overlying 
method and cell diameter (microns) with a scaled ocular. RV bx 
underestimated the degree of fibrosis in the LV, RV, and IVS when 
compared to the transmural biopsies. Cell diameter in the LV 21.7, 
IVS 20.5, and RV 21.4 were all significantly greater (p < .(01) than 
the RV bx 16.8. When the time from RV bx to transplant was < 
180 days, (n=6), percent fibrosis was accurately depicted by the RV 
bx, however, cell diameter was still underestimated. When compar•
ing cell diameter from EX RV trabeculae (14.7) and RV bx (1S.7). 
there was no significant difference. In conclusion: 1) RV bx depicts 
the percent fibrosis in the LV in OCM, however, RV bx underes•
timates the degree of LV myocyte hypertrophy; 2) the natural 
history of DCM demonstrates a progressive 
increase in myocardial fibrosis. 
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937·25 
Effects of Ou:mic ~ ~ 'l'act1yc:atdi. 
(SVT) en IJI f\Ud:iCI'I ani Sb:uctm:e: Nablm VB 14l1t Pigs 
Ryuhei Tanaka, Francis Spinale, Fred crawford, Midlael 
Zile. Medical University of SaJ:t:h carolina, <llarlestcn,SC 
O1rcnic SVT causes a dilated cardianyqlathy in 
experiJnent.s usin;J adult anllDals. HcM!ver, clinical SVT 
ocx:urs JOOSt frequently in c:hlldren ani newborns. Because 
sane cardiac diseases (such as aortic stenosis) may cause 
IN myocal'dial failure in adults rut rarely cause 
myocal'dial failure in c:hlldren, we hypothesized that the 
effects of SVT 00 IN strocture ani functial may differ in 
newborns ocmpared with adults. 'lberefore, IN volume, 
mass an:i functioo (ed1ocardiogralily/catheterizatioo) ani 
myocardial strocture (lightjelectral mic::rosoc:py) were 
assessed in 2 grrups of newbom(n=6 SVT [3 wk atrial pace 
240 tpn]; n=6 littermate control) ani 2 grrups of adult 
pigs (n=6 SVT; n=6 age-matdled control) * p<0.05 VB 
control, Ded=en:i diastolic ctiJnension (an), FS -fractional 
short:enin3' (%), ~ systolic stress (gfan2), IN/&! 
=LVIbodv weight ratio(g/I<g), 'm::: vol=t:.ot:al myoc::yte volume 
(/RII'3 x io12), 'lMF vol=t:.ot:al myofibril volume(1AD"' x 1012). 
~ ~ 
CDItrol SVT CDItrol. SVT 
Ded 3.1±0.1 4.4±0.3* 3.8±0.2 5.6±0.8* 
FS 33±2 19±2* 31±2 1S±3* 
ESS 61±8 127±ll* 37±3 12o±20* 
IJI/&! 3.1±0.1 2.9±0.3 2.6±0.2 2.6±0.1 
~ 25.5±1.5 27.4±3.5 54.3±1.8 54.2±2.7 
~ 16.4±2.8 11.6±2.8* 33.6±2.8 23.8±3.2* 
SVT, in both newbom an:i adult pigs, caused a dilated 
cardic::.myqathy. 'lhese dlarges in IN systolic function 
were associated with a decrease in cellular OCIltractile 
proteins in both newbom an:i adult pigs. 'Ihus, it 
appears that newborn anllDals do rot have protective 
mechanisms wc:h prevent the develq:ment of 
cardic::.myqathy durin;J chronic SVT. 
937·26 
Hypomagnesemia aesults In aesting Myocardial 
Systolic Dysfunction . 
Ammar S. Bafi, William R. Herzog, and Dav1d 
Alyono. George Washington university Medical 
center, Washington, DC 
Hypomagnesemia (lowMg) is a common problem 
in diabetics, alcoholics and in patients taking 
diuretics. We hypothesized that (lowMg) is 
associated with myocardial systolic 
dysfunction. LoWMg swine were produced by 6 
weeks of dietary Mg restriction. Mean serum Mg 
level was 1.7 ± 0.1 mEq/L among age matched 
controls compared to 1.0 ± 0.1 mEq/L among 
lowMg swine. A normothermic open chest model 
was used. A high fidelity micromanometer 
tipped catheter was used to measure left 
ventricular (LV) pressure and LV dP/dt was 
calculated instantaneously. Regional 
contractile function, as measured by thickening 
fraction percentile (TF%), was obtained by 
placing an epicardial Doppler crystal in the 
mid portion of the left ventricle. 
In the resting state, heart rate (RR) and 
mean aortic blood pressure (BP) were similar in 
both normal (Nl) and lowMg swine. However, LV 
dP/dtmax and systolic TF% were significantly 
decreased in lowMg swine. 
n TF% dP/dtmax BP HR 
Nl 8 39+/-5 1138+/-83 83+/-2 85+/-5 
LowMg 6 32+/-4* 777+/-65** 80+/-4 84+/-6 
(X±SEM;*p<0.05,**p<0.001 lowMg vs normal) 
These results suggest that magnesium 
deficiency results in significant myocardial 
systolic dysfunction in swine. 
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937·54 
Ab~ c:alciua '!rauieuta and CoutrllCtile DyDlUIIiC8 
in Rat xyocytea bpoaed to Cocaiu 
David L. Grod.n, Xai-Oi zhang, sh.reif Rezkalla, 
Har.hfield clinic , Re •• arch Foundation,Harshfield, WI 
cocain. ha. be.n .hown to depre.s myocardial 
contractility, but the mechanism of it. action i. 
unknown. To teat the hypothe.ia that abnormal 
intracellular ca2+ handling i. re.pon.ibl. for 
cocaine'. toxic .ffect on the myocardium, calcium 
tran.i.nt. (fura-2 fluor •• c.nce) and c.ll motion 
(vid.o edg. d.tection) were recorded .imultaneou.ly 
from normal l.ft v.ntricular myocyt •• (n-8) under 
control condition. and following challenge with 
cocain •• cumulativ. dose-r •• pon.e .tudie. r.vealed a 
progr ••• iv. d.cline in peak cytosolic [ca2+) (as 
a •••••• d by peak fluoresc.nce ratio) with increaaing 
cocain. concentration during all beat. of a 
.timulation train at 0.5 Hz (mean±SEH, *p<0.05, 
**p<0.005 compared to control). 
Control 
10" M 
10-7 M 
10" M 
P.ak Fluor •• c.nce Ratio 
JuLt.l !W...ll Seat flO 
1.76±.18 1.78±.20 1.71±.21 
1.50+.16** 1.55+.19* 1.55+.17* 
1.14+.11** 1.18+.12** 1.09+.11** 
0.98±.12** 0.94±.11** 0.98±.13** 
A concurr.nt concentration-dependent decline in cell 
.hort.ning al.o was noted, which clos.ly correlated 
with chang.s in peak Ca2+ (r-0.95, p-0.0002). Unloaded 
.hortening was 13.00±1.35t under control conditions, 
but only 9.10±1.50t (p<0.05) following 10-7 M cocaine. 
Furth.rmor., no contraction was elicted in 7 of 8 
cell. at a conc.ntration of 10-3 M. Ther. were no 
.ignificant difference. in the kinetic. of calcium 
tran.i.nt. or the rat. of c.ll relaxation. When 
.xt.rnal [ca2+) wa. increa.ed fourfold, the inhibitory 
.ff.ct. of cocain. wer. partially offset. 
We conclud. that cocain. induce. contractile 
dysfunction by altering intracellular ca2+ handling, 
po.sibly through blockad. of sarcolemmal calcium 
channela. 
937·55 
Left Ventricular Hypertrophy Does not Regress 
With Enalapril in a Canine Model of Valvular 
Aortic Stenosis 
Peter M. Scholz, Reuben S. Mezrich, Villiam C. 
Chiu, Christopher C. wright, Frank Douglas. 
UMDNJ·Robert Vood Johnson Medical School, New 
Brunswick, NJ and CIBA-GEIGY, Summit, NJ 
Ve examined the ability of an angiotension 
converting enzyme (ACE) inhibitor to induce 
regreSSion of hypertrophy (LVH) in a model of 
valvular aortic stenosis created in puppies. Ve 
determined left ventricular mass and function 
serially with MRI over a 6-month period 
following valve plication. Fourteen LVH dogs 
(group 1) were given 10 mg/kg/day enalapril 
maleate (ENA) starting one month and 6 LVH dogs 
(group 2) 3 months after plication. Six LVH 
dogs (group 3) and 5 dogs (group 4) with and 7 
dogs (group 5) without ENA served as controls. 
Left ventricular weight!body weight ratios for 
LVH (7.7±1.48 g/kg) and LVH with ENA (group 1: 
6.44±l.45, group 2: 6.65±1.69 g/kg) were similar 
and significantly greater than those of group 4 
(3.90±O.69 g/kg) and group 5 (4.34±O.39 g/kg) 
dogs (P<O.05) 6 months after plication. Plasma 
renin activity increased significantly with ENA 
in group 1 from 1.26±1.l2 to 3.39±2.38 ng/ml/hr 
(P<O.05). Ve conclUde that in this model of 
aortic stenosis ACE inhibition did not cause 
regression of LVH suggesting that direct effects 
on the myocyte are less important than reduction 
in blood pressure. 
937·56 
POSITIVE INOTROPIC EFFECTS OF ANGIOTENSIN II 
IN HUMAN ATRIAL r~USCLE PREPARATIONS UNDER 
PHYSIOLOGICAL CONDITIONS 
Ch.Holubarsch, S.Schmidt-Schweda, A.Knorr, 
G.HasenfuB, B.Pieske, H.Just. 
Medizinische Universitatsklinik Freiburg 
Hugstetter Strasse 55, 7800 Freiburg 
JACC Vol. 19, No.3 
March 1, 1992:194A 
AngiotenSin II receptors are known to exist in 
atrial and ventricular human myocardium. However, 
the function of these receptors is currently not 
very well understood. Although some positive 
inotropic effects of angiotenSin II have been 
found in animal studies under non-physiological 
conditions (low temperature, low stimulus rate), 
no information is known about its functional role 
in the human heart. VIe studied the effect of 
angiotenSin [Ion atrial human myocardium at a 
temperature of 37 0 C and a stimulus rate of 60 
beats per min. The preparations had been 
pretreated with BDM in order to prevent cutting 
injury during the preparing procedure. Under 
control conditi~ns, the muscels (n=10) developed 
8.0 ± 6.8 mN/mm (100%). At a concentration of 10-' 
the tension was increas,d to 116 ± 20% and this 
effect was maximum at 10- with 126 ± 31% (p<0.01, 
respectively). Therefore, at physiological 
conditions, angiotensin II has significant 
influence on contractility of the atrium. 
In contrast, neither in feiling nor in non•
failing myocardium of the left ventricle, angio•
tension II had any inotropiC dfect. This differ•
ence between atrial and ventricular myocardium may 
have clinical relevance. 
937·57 
Age Related Changes in 61 and 62 Adrenergic Receptors and Adenylate 
Cyclase Stimulation in Nonfailing and Failing Hurnan Hearts 
Michel White. Mary M. Wollmering. David Handwerger, Jana Klein, Patricia 
Lanabee. Michael R. Bristow. University of Utah. Salt Lake City. Utah 
Congestive hean failure (CHF) in humans with idiopathic dilated 
cardiomyopathy (lOC) is characterized by ventricular BI-adrenoreceptor 
(Baf!) downreguJation. as well as uncoupling of B2-adrenoreceptors (B312) 
from adenyl ate cyclase (AC) stimulation. In model systems. aging is 
associated with a decrease in cardiac Bar responsiveness. In the present 
study we investigated the age related effectS on Bar subtypes and AC 
stimulation in material prepared from left ventricular (LV) myocardium 
taken from 40 nonfailing hearts (NF) procured from organ donors. and 41 
failing hearts removed from transplanted patients with IOC. Subjects were 
divided into <40 (young. y) and >50 years (old. 0) of age. Y (mean age, 
26 ± 2) and 0 (mean age. 56 ± 4) groups with IOC had similarly depressed 
ejection fractions (15.9 ± 1.5% [Y] vs 16.4 ± 1.3% [0]). Receptors and 
adenylate cyclase data were: 
Group (n) Receptor density (frnol/mg) 
TotalS SI ~ 
NF [Y](32) t·9l.1 ±4.2 t·70.4 ± 3.4 21 ±1.3 
NF [O](S) t63.S HI t44.1 ±3.S 19.6 ± 2.9 
IOC[Y](2S) Sl.1±3.! 33.3±2.617.S±1.4 
IOC [0](13) 49.l± 7.6 30.2 ±L2 19.4 ±1.6 
AC (pmol cAMP/minImg) 
ISO(S I +82) ZINT(S2l NAP 
t·3S.3 ± 2.3 t·IO.S ± 1.2 44.4 ± 3.0 
27.l± 1.9 6.0± 1.4 43.S±S.4 
28.2± 2.6 S.4 ±LO 41.S± 7.2 
2S.7± 9.9 8.S ±6.2 36.6 ± 12.9 
Data are in mean ± SEM; • p < 0.05 within group; t p < 0.05 between 
respective group (NF vs IDC). 
Conclusions: I) With aging there is selective Bar! downreguJation and 
uncoupling of B312 from AC. The degree of uncoupling is comparable to 
failing hearts with IOC. 2) There is no age related change in Bar or B agonist 
mediated AC stimulation in end-stage CHF due to IOC. 3) In LV 
myocardium. the catalytic unit of AC as probed by NaF is not altered by 
either age or severe CHF due to IOC. 
lACC Vol. 19, No.3 
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937-58 
Direct Evidence That Lipoprotein Lipase is Produced by 
Cardiac Myocytes Rather Than Interstitial Cells in Human 
Myocardium 
Kevin 0' Brien, David Gordon, Samir Deeb, Marina Ferguson 
and Alan Chait 
University of Washington, Seattle, Washington 
Lipoprotein lipase (LPL) may play an important role 
in myocardial metabolism by releasing free fatty acids 
from triglycerides for oxidation by cells. Others have 
reported recently that, in rats, LPL mRNA is produced 
by interstitial cells, but not by cardiac myocytes, as 
determined by in ~ hybridization. Further, LPL mRNA 
production by interstitial cells was increased by 
treatment with cholera toxin, which increases 
intracellular cAMP levels. To determine whether cardiac 
myocytes produce LPL in humans, we performed in situ 
hybridization on myocardium obtained from 25 patients 
undergoing cardiac transplantation using a 35S-labelled 
antisense riboprobe transcribed from a 1.4 kb fragment 
of the human LPL gene. Control hybridizations also were 
performed using a sense riboprobe. LPL mRNA was clearly 
localized to cardiac myocytes, and not to interstitial 
cells. Furthermore, in 4 patients who had been 
receiving continuous i.v. dobutamine ± dopamine (i.e., 
conditions likely to stimulate cAMP) prior to 
transplant, hybridization was still confined only to 
cardiac myocytes. 
Thus, this is the first direct evidence that in human 
myocardium, LPL is produced in vivo by cardiac myocytes, 
and that LPL is not detectable by in situ hybridization 
in interstitial cells, even in patients treated with 
agents that may increase cAMP levels. 
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938-14 
Regression of Left Ventricular Hypertrophy 
Pro.otes a Reduction in Further Antihypertensive 
Medication 
Ingomar-W Franz, Reinhard G. Ketelhut, Ulrich 
Behr, Ulrich Toennesmann. Wehrawald Clinic, 
Todtmoos, Germany 
Twenty-two previously untreated hypertensive 
patients (aged 44.6 years) were studied to 
determine the effect of regression of left 
ventricular hypertrophy (LVH) on dosing of 
further antihypertensive medication. 
Echocardiographic assessment showed a continuous 
decrease in LV mass index throughout a 7 year 
treatment period with a beta-blocking agent 
(metoprolol) from 151±29g/m2 before treatment to 
94±15g/m2 (p<O.OOl) after 3 years of treatment, 
and to 82±14g/m2 (p<O.OOl) after 7 years of 
treatment. There was a total reduction in LV 
mass of 45.7\. Indices of left ventricular pump 
function (fractional fiber shortening) increased 
from 40.5±5\ to 46.5±4\ (p<O.OOl) after 7 years 
of therapy. In 10 patients with unchanged body•
weight throughout the treatment period medi•
cation could be reduced or even discontinued 
accompanied by an unchanged reduction in blood 
pressure (BP) at rest and during exercise. In 
contrast, in 12 patients with increasing body•
weight (p<O.Ol) former dose of medication had to 
be continued to maintain the reduction in BP. 
These findings underscore the concept that a 
regression of LVH after long-term antihyper•
tensive treatment promotes a reduction of dose 
or even a termination of antihpertensive medi•
cation in patients with a stable body-weight. 
ABSTRACTS 
938-15 
Significance of Exercise-induced ST Segment Depression in 
Hypertensive Patients With Left Ventricular Hypertrophy. 
Alberto Margonato, Andrea Macchi, Gabriele Fragasso, Sergio L 
Chierchia. Istituto Scientifico H San Raffaele, Milano, Italy 
In patients (pts) with arterial hypertension, electrocardiographic 
signs of left ventricular hypertrophy (L VH) and normal epicardial 
coronary arteries, the significance of exercise-induced ST segment 
depression is still controversial. To clarify the pathophysiological 
meaning of these changes, we studied 15 pts (mean age 55.5 years 
±15.7) with systolic/diastolic hypertension (168 mmHg ±8.4/103 
mmHg ±4.6), evidence of LVH on the ECG (SI + R6 ~ 35 mm), 
angina and ST segment depression (1 mm rectilinear or 
downsloping) during exercise stress test (EST) and normal 
epicardial coronary arteries. In all pts 2D echocardiography, 
stress/rest myocardial perfusion with 99mTc-MIBI SPECT and 
coronary angiography were performed. 
RESULTS: echocardiography showed symmetrical LVH 
(interventricular septum 12.9 mm ±1.7; posterior wall 12.6mm 
±1.1), no regional wall motion abnornlalities nor valvular disease. 
During EST, time to I mm ST segment depression was 9.1 min 
±1.9, total exercise duration was IU! min ±2.1 and maximal ST 
segment depression was 2J mm ±OJ SD. On EST, myocardial 
perfusion tomography showed regional, reversible perfusion 
defects in all pts which involved the anterior/septal wall in 10 and 
the inferior/posterior wall in 5. 
CONCLUSION: in hypertensive pts with documented LVH and 
normal epicardial coronary arteries exercise-induced ST segment 
depression is associated with transient, myocardial ischaemia, 
possibly related to and/or functional abnormalities in small arteries, 
consistent with regional microvascular disease. 
938-16 
Prevalence of ECG and JOITI Evidence of Silent Ischemia in 
Asymptomatic Hypertension: A Case-Controlled Study 
Barry M. Massie, Jadwiga Szlachcic, Brian F. O'Kelly, Susan E. 
Ammon, William L. Chin, Julio F. Tubau. VAMC and University 
of California, San Francisco, CA 
Coronary disease (CAD) remains the major cause of morbidity and 
mortality in mild-moderate hypertension, but the prevalence of 
physiologically significant CAD in asymptomatic patients is 
unknown. We prospectively studied 226 hypertensives (age 61± 
yrs; 69% White, 20% Black) without symptoms, history or ECG 
evidence of CAD and 26 age-matched controls from other VA 
clinics. Medications were withdrawn and patients underwent 
exercise (89%) or dipyridamole (11 %) 2nn scintigraphy, exercise 
ECG, 48 hr ambulatory ECG, and echocardiography. All tests 
were read conservatively by 2 blinded observers. 73/186 (39 %) 
patients with satisfactory echocardiograms had mild to moderate 
LVH (LVMI 134 to 216 g/m'). 
HTN,no LVH HTN+LVH Controls 
Reversible 3l'n 17% 20% 8% 
+ Exercise ECG 27%* 41 % 12% 
+ Ambulatory ECG 13%# 23% 0% 
* p<.05, # p<.IO - no LVH vs LVH; all p<.OS vs Con 
The validity of 3lln scintigraphy for diagnosing CAD was 
confirmed in 30 patients who a~eed to angiography (positive and 
negative predictive accuracy of In for CAD 89% and 81 %), but 
false positive exercise ECGs were common. These results indicate 
1) silent but physiologically significant CAD occurs in 15-20% of 
high risk hypertensives, but far fewer comparable normotensive 
controls; 2) although L VH is associated with more frequent ECG 
chan*es, it is not an independent predictor of CAD, as diagnosed 
by 31 n scintigraphy. 
195A 
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938·17 
Cardiac Function aDd Structure in Elderly Patients With 
Isolated Sfstolic B)perteaaioD 
Tomasz Grodzicki, Franz H. Messerli, Hario McLoughlin, 
Edward D. Frohlich. 
Ochsner Medical Institutions, New Orleans, Louisiana 
Left ventricular structure and both systolic and diastolic 
function were assessed by 2D-guided M-mode echocardiography 
in elderly (>60 yrs) normotensive (NT) (n=28) and hyperten•
sive (nz28)-patients. Hypertensive patients were divided 
into 2 groups: 1) isolated systolic hypertension (ISH) (n= 
12; systolic blood pressure [SBPJ>160 mmHg, diastolic blood 
pressure [DBP]<85 mmHg); 2) systolo-diastolic hypertension 
(SDH) (n=16; DBP >100 mmHg). Results (mean + SD): 
- NT SDH -ISH 
SWT 1.07+0.1' 1.32+0.2 1.26+0.3 
PWT 1.02;0.1 1.17;0.2+ 1.09;0.3 
SBP 143;12.9- 186;22.3 173;13.6 
DBP 76.5+6.6 105+6.0- 79+3.9 
CO 5326+1838 5044+1619 3898+1367+ 
TPR 20.9;7.8- 29.1;11.5 31.6;11.2 
LVH 177!55 233!86+ 191~79.3 
FFS 1.31+0.2 1.32+0.3 1.06+0.3-
VCF 39.9+6.1 41.1+7.6 34.6+6.8-
ESWS 37.2+11- 49.2+20.3 60.3+27.1 
DRF 325!121 360+105 374+95 
SWT=septal wall thickness; PWT=posterior wan thickness; 
CO=cardisc output; TPR=total peripheral resistance; LVH= 
left ventricular mass; FFS=fractional fiber shortening; 
VCF:velocity of circumferential tiber shortening; ESWS= 
end-systolic wall stress; DRF=duration ot rapid tilling. 
-p<.05 vs other groups; +p<.05 va NT group. 
Patients with SDH had the highest lett ventricular mass and 
well-preserved lett ventricular pump function. In con•
trast, patients with ISH had an inadequate increase in left 
ventricular mass, as documented by increased wall stress 
and diminished lett ventricular pump function. 
938·18 
Relationship Between Left Ventricular Diastolic Filling and Systolic Function 
During Stress In Hypertensive Patients 
M. Lorenza Muiesan, Damiano Rizzoai, Roberto Zulli, Silvia Calebieh, Enrico 
Agabiti·Rosei. 
Calledra di Medicina Interna, Universita' di Brescia, Italy. 
We evaluated the relation between left ventricular (LV) diastolic filling (Diast 
F) at rest and systolic function (Syst F) during stress, induced by hand-grip 
(HGT) and cold pressor (CPT) tests, in 16 essential hypertensive patients 
(EHP) before therapy and 30 days after treatment withdrawal (Ca-antagonists 
or ACE inhibitors for 6-ll months), wben LV mass index was significantly 
reduced (from 138.±.31 to 118.±.21 g/m2, p<.05) while BP was raised again to 
pretreatment values. LV dimension (Dim )-time curves divided in 3 phases 
(rapid filling.RFP-, slow filiing-SFP- and atrial contraction·ACP-) were 
analyzed and measured. In aD these EHP the percent (%) increase of LV Dim 
was significantly reduced during RFP (p<.05) and increased during ACP 
(p<.Ol) in respect to normal subjects, thus indicating an abnormal Diast F 
pattern. A significant correlation was observed between the % increase of LV 
Dim during RFP at rest and stroke volume (SV) at the peak of HGT (r=0.50, 
p<.05) and CPT (r=0.48,p<.05) while an inverse correlation was found 
between the % increase of LV Dim during ACP and SV at the peak of HGT 
(r=-O.41,p<.05) and CPT (r=-O.43, p<.05). After treatment withdrawal, 
despite the increased pressure load to the heart, Syst F was maintained at rest 
as weD as during HGT and CPT. LV Diast F was improved, since the % 
increase of LV Dim during RFP was greater (p< .01) and during ACP was less 
(p< .05) in respect to basal conditions; a correlation was stili observed between 
the % increase of LV Dim during RFP and .,,, at the peak of HGT (r=O.46, 
p<.05) and CPT (r=O.46, p< .05); similarly, the % increase of LV Dim during 
ACP was inversely related to SV at the peak of HGT (r= -0.53, p<.Ol) and 
CPT (r= -0.69, p<.Ol). These results strongly suggest that in EHP, both before 
and after reduction of LVH, Syst F during stress is regulated, at least in part, 
by diastolic mechanisms. 
938·19 
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Effects of various Antihypertensive Agents on Cardiac 
Hypertrophy and Ventricular Arrhythmias in Patients 
with Essential Hypertension. 
Haruhiko Iwatsubo, Takeshi Hata, Hiroshi Mikami, 
Toshio Ogihara. 
Higashi-osaka City Hospital and Osaka University 
Medical School, Osaka, Japan. 
We examined effects of four antihypertensive 
agents on cardiac hypertrophy and ventricular 
arrhythmias in 49 essential hypertensive 
patients with cardiac hypertrophy. Ca•
antagonist (Nicardipine, n = 11), ACE inhibitor 
(Enalapril, n = 14), B-blocker (Atenolol, n = 12) 
or (q-blocker (Terazosin, n = 12) was given for 
one year. Left ventricular mass index (LVI-lI) 
was evaluated with M-mode echocardiography and 
ventricular couplets or tachycardia (complex 
arrhythmias) were checked with 48-hour ambula•
tory ECG monitoring. 
Results: Each drug equally reduced blood 
pressure. 
LVMI (9/m2 ) 
Complex arrhythmias 
(No. of Eatients) 
before one ::lear before one vear 
Nicardipine 191 ± 14 142 ± 12* 4/11 0/11 
Enalapril 190 ± 14 127 ± 7* 5/14 0/14# 
Atenolo1 160 ± 7 132 ± 9* 5/12 0/12# 
Terazosin 194 ± 13 140 ± 9* 4/12 0/12 
Mean ± S.E. liP < 0.05 *p < 0.01 before vs one year 
The antihypertensive treatment with either Ca•
antagonist, ACE inhibitor, B-blocker and al•
blocker is effective on reversal of cardiac hy•
pertrophy and reduction in complex arrhythmias. 
938·20 
Hydrochlorothiazide Therapy and Ventricular Arrhythmias 
in HypertenSive Patients With Advanced Left Ventricular 
Hypertrophy 
Puneet Narayan, John Colleran, Peter Kokkinos, Aldo 
Notargiacomo, Edward Freis, Vasilios Papademetriou, 
VAHC, Washington, D.C. 
Hypertensive left ventricular hypertrophy (LVH) is an 
independent risk factor for various cardiovascular 
complications including sudden cardiac death. Although 
several studies have assessed the effects of diuretic 
therapy on arrhythmias in hypertensive patients, data in 
patients with advanced LVH is scarce. Therefore, in this 
trial, 45 hypertenSive men (mean age 62±13) with 
moderate to severe LVH (LVPWT 14 to 19 mm, mean l5±1.1 
mm) underwent 48 hr Holter monitoring before and after 
hydrochlorothiazide (HCTZ) therapy. All other anti•
hypertensive medications were discontinued for at least 
2 to 4 wks before entering the study. Arrhythmias were 
quantitated as premature ventricular contractions (PVC), 
couplets (C) and runs of ventricular tachycardia (VT) 
per hour. Systolic blood pressure averaged 16S±18 before 
and l46±15 after HCTZ therapy and diastolic blood 
pressure was 103±6 before and 89±9 after HCTZ. HCTZ was 
given in a dose of 50 to 100 mg for 2 to 4 wks. 
Results are as follows: 
Placebo 
HCTZ 
P value 
K+ PVC 
4.23 21.88 
3.66 24.57 
0.00 0.515 
C VT 
2.S2 0.178 
0.75 0.178 
0.27 NS 
No. of Pts in 
Lown Class 2-5 
19 (42%) 
18 (40%) 
NS 
Of these patients 16 on placebo and IS on HCTZ had 
couplets and/or runs of VT (p-NS). It is concluded 
that short term HCTZ therapy does not increase 
ventricular arrhythmias in patients with advanced LVH. 
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938-21 
Improved Left ventricular Filling Post•
Treatment Does Not Alter Exercise Capacity in 
Hypertension 
Thomas P. Rocco, Angel M. Flores, Charles A. 
Boucher, Randall M. Zusman 
Massachusetts General Hospital, Boston, 
Massachusetts 
Abnormalities of left ventricular (LV) filling 
associated with impaired exercise capacity 
have been reported in patients with systemic 
hypertension. Twenty-one asymptomatic 
hypertensive patients (pts) with abnormal LV 
filling manifested by a fall in LV end•
diastolic volume (EDV) during upright exercise 
(ex) were restudied by radionuclide 
angiography after short-term medical 
monotherapy (beta blocker, calcium antagonist 
or ACE inhibitor). Fifteen pts (group I) had 
a normal ex-EDV response post-treatment, while 
6 pts (Group II) had a persistent abnormality 
of the LV EDV during ex. Pre and post•
treatment restjex-EDV, ejection fraction (EF) 
and ex-capacity are presented below (mean ± 
15D) : 
EDVrest EDVex 
(ml) (ml) 
I pre 137±30 114±27 
post 133±28 145±33* 
II pre 162±21 133±27 
post 156±29 138±32 
*p = .001, pre vs. post 
EFrest 
(%) 
57±8 
58±7_ 
56±9 
60±13 
EFex 
(%) 
63±9 
64±8 
65±13 
67±15 
Ex-cap 
(Watts) 
94±34 
95±33 
103±44 
90±39 
Thus, unlike symptomatic pts with hypertrophic 
cardiomyopathy, normalization of the LVEDV 
response during exercise is not associated 
with improved exercise capacity in 
asymptomatic hypertensive subjects. 
938-22 
Isovolumic Relaxation Period is the Best Predictor of 
Diastolic Dysfunction in Hypertensive Left Ventricular 
Hypertrophy 
Roxy Senior, Shoumo Bhattacharya, Bangalore S Sridhara, 
Edward B Raftery, Avijit Lahiri. Northwick Park Hospital 
and Clinical Research Centre, Harrow, UK 
Left ventricular (LV) diastolic dysfunction alone is 
thought to be predictive of adverse cardiac events in 
hypertensive (HT) patients (pts) with LV hypertrophy 
(LVH). It is unclear which of the Doppler 
echocardiographic (DOP) parameters best identify 
diastolic abnormalities. \/e have studied 24 pts with 
untreated HT and LVH [mean (SO) age: 52(5)yrs; blood 
pressure: 163(17)/102(7) mmHg; LV mass: 150(26)gm/Sqm] 
and compared this group with 14 age and sex matched 
normals (N). The diastolic DOP parameters measured were: 
acceleration (AT) and deceleration (DT) times (ms), ratio 
of early and late peak filling velocities (A/E) and the 
ratio of their integrals (A/E Int) and isovolumic 
relaxation period (IVRP) (ms). Systolic function was 
normal in all pts. 
Mean(SD) LVH pts Normals p-value %ahnormal 
AT 63(16) 73(120) NS 4 
DT 165(34) 126(14) <0.0005 58 
A/E 1.30(0.40) 0.74(0.16) <0.0001 71 
A/E Int 0.90(0.47) 0.50(0.16) <0.01 62 
IVRP 121(20) 74(6) <0.0001 96 
IVRP was significantly better than all other 
parameters for predicting diastolic dysfunction in these 
patients. Thus, IVRP is the most sensitive index of LV 
filling abnormalities in hypertensive LVH pts and may be 
used to assess prognosis and the effects of therapeutic 
interventions. 
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4:00 
SERIAL ANGIOGRAPHIC FOLLOW-UP AFTER PALMAZ-SCHATZ STENT 
IMPLANTATION:RETROSPECTIVE COMPARISON WITH CONVENTIONAL 
BALLOON ANGIOPLASTY. 
Takeshi Kimura, Hideyuki Nosaka, Masakiyo Nobuyoshi, 
Kokura Memorial Hospital, Kitakyushu, 802, JAPAN 
One hundred and eight patients(109 stents) were 
prospectivelly enrolled into a serial angiographic 
follow-up protocol(day I, 1 month(mo), 3 mos, and 6 
mos). From a cohort of 229 patients followed-up on the 
same protocol after conventional balloon angioplasty, 
179 patients(192 lesions) were selected by a criteria 
of final balloon size ~3.0mm and lesion length < 2Omm. 
Coronary diameter was measured by a caliper, and 
restenosis was defined as ~ 50% diameter stenosis at 
fo 11 ow-up. 
n Stent(mm) n Ba11oon(mm) 
RO 109 3.5±0.7* 192 3.0±0.6 
MSO 
pre 
post 
3·6mos 
109 
109 
77 
0.8±0.5 
3.0±0.5 
2.4±0.7 
192 
192 
191 
'" MSD 
0.B.±0.8 p< 0.001 
2.lfO.5 p<O.OOl 
1.5±0.7 p< 0.001 
post-day1 77 0.0±0.2 155 -0.2±0.4 poe 0.001 
dayl-lmo 68 -0.2±0.S 155 O.l±O.S p< 0.001 
Imo~3mos 68 -0.3±0.4 183 -0.4±0.S 
3moSv6mos 39 -0.1±0.3 129 0.0+0.4 
Restenosls rate 77 10% 191 3~% p<O.OOl 
RD=Reference diameter, MSD=Minimal stenosis diameter. 
Thus, Palmaz-Schatz stent was shown to be effective in 
reducing late restenosis in this retrospective 
analysis. Reduction in restenosis rate was dependent 
on a large lumen obtained acutely and lack of diameter 
loss within 24 hours. Late loss of diameter was of 
similar degree in both technology. 
762-2 4:15 
Long-Term Angiographic and Clinical Follow-Up After 
Placement of Coronary Stents 
Martin B. Leon, Donald S. Bairn, Sheldon Goldberg, Paul S. 
Teirstein, John W. Hirshfeld, Stephen G. Ellis, Augusto D. 
Pic hard, Richard A. Schatz, and ]JIS coronary stent investigators. 
Washington Hospital Center, Washington, D.C. 
The utility of coronary stents will require risk vs benefit assessments 
incorporating both acute procedure results and long-tenn clinical 
endpoint analyses. To more clearly define late outcome, we 
followed a consecutive series of 430 patients who were treated with 
balloon-expandable Palmaz-Schatz coronary stents in native vessels 
with angiographic (angio) study ~3.5 months (mean 6.2 months) 
after stent implantation. Angio restenosis (Res) defined as ~50% 
diameter stenosis (DS) was present in 112 patients (26%). 
Subsequent therapy in these Res patients included elective CABG in 
17%. repeat PTCA in 46%, and no intervention in 37%. 1n the no 
intervention Res subgroup, 37 of 46 patients (80%) were 
asymptomatic and none of these had late clinical events. Of the 318 
patients without angio Res, 84 had ~1 additional angio study at least 
5.5 months after the flTst angio (flTst to most recent angio averaged 
15.7 months). There were no significant changes between the first 
and most recent follow-up angio (flTst angio DS 23% vs most recent 
DS 24%, pns); only 2 patients (2.4%) "crossed-over" to the angio 
Res category. Clinical follow-up for the entire angio no Res group 
(average 11.4 months from stent placement, range 3.5 - 34.2 
months) revealed few symptoms (88% without angina) and only 
1.9% had late clinical events during follow-up (none of which were 
associated with stent implantation) In conclusion: Long-tenn 
follow-up after coronary stent implantation reveals (1) patients Elh 
angio Res who were not treated aggressively and remained 
asymptomatic had no risk of late clinical events; (2) patients ElhSlII1 
angio Res manifested long-tenn angio and clinical stability - minimal 
changes during subsequent angio study and rare late clinical events 
(which were all non-stent related). 
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762·3 4:30 
INITIAL CLINICAL EXPERIENCE WITH STRECKER CORONARY 
STENT. 
Takeshi Kimura, Hideyuki Nosaka, Hiroatsu Yokoi, Naoya 
Hamasaki, Masakiyo Nobuyoshi, Kokura Memorial Hospital, 
Kitakyushu, 802, JAPAN 
Strecker coronary stent implantation was performed in 
47 patients(48 lesions). Stent implantation was 
attempted electively in 28 lesions(2: De novo, 26 
Restenosis) and urgently in 20 lesions(9: Occlusion,ll: 
Dissection). Target lesions were LAD 48%, RCA 31%, CX 
17%, and SVG 4%. Sixty-two percent were restenotic 
lesion, 83% eccentric and 46% had irregular coutour. 
Lesion length was 14.1±8.1mm(3.7-45.1mm) and in 13 
lesions it was > 15mm. Reference diameter was 
3.0±0.4rrm(1.9.±4.1mm), and in 21 lesions it was < 3.0mm. 
Multiple stents were implanted in 4 patients. Length 
of stent was 15rrm in 32 lesions, 20mm in 3 lesions, and 
25rrm or more in 13 lesions. Primary success was 
achieved in 46 lesions(96%). TIMI3 flow was restored 
in all patients with successful emergency stenting. 
Minimal stenosis diameter improved from 0.6±0.4mm(pre) 
to 1.7!0.6mm(post balloon), 2.7±0.4mm(post stent) and 
2.7±0.3rrm(next day). Causes of failure were stent 
migration(retrieved) in 1 lesion and proximal 
deployment in 1 lesion. There was no acute closure 
within 24 hours. Subacute thrombotic closure was 
documented in 2 lesions(4.3%) and resulted in sudden 
death in one patient. There was neither emergency CABG 
nor stent related myocardial infarction. Hemorrhagic 
complication requiring transfusion was found in one 
patient(2.1%). Follow-up study is ongoing. 
Thus, initial result of Strecker stent implantation was 
acceptable. Results of long stent and stenting for 
small sized arteries should be evaluated further. 
762·4 4:45 
Outcome after Emergency Implantation of Coronary Stents 
Albert SchOmig, Rainer Dietz, Wolfgang KObler, Eric Hsu, Roger 
KranzhOfer. Dept. of Candlology, University of Heidelberg, Germany. 
Stent implantation following acute coronary complications during 
PTCA such as occlusion or extended dissection has become an 
alternative to emergency coronary artery bypass surgery. The 
present study summarizes the outcome of the first 127 patients 
treated with coronary stents for acute complications during elective 
PTCA (n-2314) In Heidelberg between 6/89 and 7/91. 140 Palmaz· 
Schatz stents were Implanted. In 96% of the patients acute patency 
of the vessel was achieved. The patients in whom stent placement 
was unsuccessful (group A) were either managed conservatively 
(n=2) or subjected to emergency CABG surgery (n=3). Patients with 
persistent angina or stent delivery into the very proximal part of a 
dominant vessel were treated by non·emergency CABG surgery 
(group Bl' The other patients were treated conservatively with 
dicumaro plus ASS for 3 months accompanied by continuous 
Intravenous heparin (PIT 2 to 3 times normal) until full oral 
anticoagulation (INR 2.8 to 4.3) was achieved (group C). 
Complications Q.iring 4 weeks after stent IlI1lIantation 
group n mortality myocardal severe 
A 
B 
C 
5 
22 
100 
infarction bleeding 
1 (20%) 2(40%) 
1 (4.5"10}* 3 (14%) 1 (4,5%) 
1 (1%) 6(6%) 10 (10%) 
'not stent related 
restenosis 
after 5 month 
(>50%) 
24m (30%) 
The myocardial Infarcts in group C were due to stent thromboses 
which all occured during the phase of heparin treatment prior to effec•
tive oral anticoagulation (3 to 11 days after implantation). During the 
later follow-up (up to 2 years) no further death or myocardial infarction 
and only 1 bleeding were observed. 19 patients with restenosis 
underwent successful repeat angioplasty, 2 elective CABG surgery. 
762·5 
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EMERGENCY CORONARY STENTING FOR ABRUPT CLOSURE AND 
DISSECTION AFTER BALLOON ANGIOPLASTY. 
Takeshi Kimura, Hideyuki Nosaka, Hiroatsu Yokoi, Naoya 
Hamasaki, Masakiyo Nobuyoshi, Kokura Memorial Hospital, 
Kitakyushu, 802, JAPAN 
To evaluate efficacy and safety of emergency coronary 
stenting(S), 47 patients(pts) undergoing this procedure 
(27 Palmaz-Schatz, and 20 Strecker) were compared with 
I11pts undergoing elective S (84 Palmaz-Schatz, and 27 
Strecker). Emergency S was successful in 21(91%) of 23 
pts with occlusion and 22(92%) of 24 pts with complex 
dissection. All pts with successful S achieved TIMI3 
flow. Dissection was completely repaired in 23 pts and 
improved in 20 pts. 
Emer~encx Elective 
Success Rate 1% 98% pc 0.05 
Comp'lcabons 
Closure« 24hrs) 0% 0% 
Closure « 2wks) 9.3% 1.8% p< 0.05 
MI(stent-related) 8.5% 1.8% p< 0.05 
CABG 0% 0% 
Death 2.1% 0% 
Hemorrhage 2.1% 2.7% 
Restenosis Rate 17% 17% 
(Z 3months) 
Adverse clinical events during follow-up was limited to 
elective CABG in one pt. Although emergency S showed 
good short- and long-term effect in the setting of 
occlusion and dissection after balloon angioplasty, 
higher incidence of subacute thrombosis warrants 
consideration of elective S for lesions predisposing to 
abrupt closure. 
762·6 5:15 
Dor.s the Indicatioo for Co,.",nary StP..1Iting Influpnce 
CHnicoo1 R"8u1ts 1 
Jeun F.jsdet, Donald Je~ny, Giulio Gusgliumi, Bernard 
Ca~.8agne.8u, Gabriel Rc.hert, J,~an Marco. 
Cl:inique. Pasteur, TOll]ouse, France. 
427 patients (pts) lInoerwent Pa1maz-Schatz coronary 
st(.nting between Hal:ch 1989-Ju1y 1991. Acute and 
suL-acute closure rate" in this group were as follows 
Inr.icatiQill! I.'l.]!Q.~lli.~! Post discharge Overall 
De novo (n=170) 
Re~tenosis (n=112) 
Sub optimal PTCII 
results (n=111) 
BaiJ-out (n=34) 
(t) <1 month (%) (%) 
2.4 2.3 4.; 
2.7 1.8 4.5 
3.6 
17.6 
3.6 
11.8 
7.2 
29.~ 
270 (83%) d the 325 FlIt lents eligible for the 6 mcnths 
( U9. 2±50 days ; ranE.I! 25 - 33!1) angiogrsphic follew-up 
deMonstrlltf~d restenosj:; rates as summarizes 
Indicatj'lls, . .l"~.&k._~ .J;ultiple S 
De novo (n=1l4) 
Re~tenosis (n=76) 
Sui, optimal PTC" 
:esults (11=57) 
Ball-out (n=23) 
(%) (%) 
16.5 20 
21. 9 100 
22 
33 
28.6 
64.7 
Over6ll 
(%) 
16.; 
25 
22.E 
56.5 
In cOTu:lusi.01'l. : 1. Thl! jnr..idellc~ of acute and subacute 
clnSlITC and rate of rer,tnnosi.9 is similarly low when 
COlon.ory st.ent:l.ng is enploy~d for de novo lesions, 
re,.tenosis, or suboptimll1 PTGA results. 2. Stent 
implantation for ball'out pr.ocedures, however, is 
8S!'ociatod with nellrly ., tim.s higher overall clesure 
ral e and It re~teno.is rate t~'ice that of the other 
groups. 
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763·1 
Failure of Treatment With Morlclzlne to Improve Survival In a 
Randomized Trial of Arrhythmia Suppression After Myocardial 
Infarction (MI): The Cardiac Arrhythmia SuppreSSion Trial (CAST) 
By CAST investigators 
University of Washington, Seattle, Washington 
4:00 
The CAST tested the hypothesis that suppression of asymptomatic or 
mildly symptomatic ventricular premature depolarizations (VPOs) after a 
MI improves survival in patients w~h ejection fraction !O.40 and l!6 VPOs 
per hour on a 24-hour Holter. Although the first phase of CAST 
determined that suppression of VPOs ~h encainide or flecainide 
worsened survival, CAST-II continued to test the hypotheSiS w~h 
moricizine (MOR) compared to ~s placebo. 
CAST II was divided Into two phases (1) an eariy two week exposure 
phase, which evaluated the risk of starting an antiarrhythmic drug after MI, 
and (2) a long-term phase, which evaluated the ability of suppression of 
VPOs by moricizine after MI to improve survival. 
CAST was stopped on July 30, 1991 because ~ was highly unlikely 
that long-term treatment w~h MOR would Improve survival compared to 
placebo. In add~ion, the first 14 days of exposure to MOR after MI was 
associated w~h exesss mortality, compared to no treatment or to 
treatment w~h placebo. 
arihy- total non unclas-
thmic cardiac cardiac sWied total 
2 wk early MOR (665) 11 14 0 2 16 
exposure Placebo (660) 3 4 0 0 4 
suppressed MOR (581) 45 64 11 7 82 
long-term Placebo (574) 37 52 6 6 64 
No benef~ from MOR was seen for nonfatal events. e~her during the 
early exposure or the long-term follow-up trial. Conclusion - MOR has not 
been shown to reduce mortality: e~her sudden arrhythmic or total, in the 
CAST population, and may Increase mortality during the in~ial treatment 
phases. 
763·2 
Prevalence and Significance of Nonsustained 
Ventricular Tachycardia in Post-MI Patients Treated 
with Fibrinolysis: the GISSI·2 trial. 
Giulio Zuaneni, Lidia Staszewsky, Maria Grazia Franzosi, 
Eugenio Santoro, Aldo P Maggioni on behalf of the GISSI 2 
Investigators, Milano, Italy. 
Non-sustained ventricular tachycardia (NSVT) has been 
recognized as an independent risk factor for subsequent 
monality in post-MI patients. Its prevalence and prognostic 
value in patients treated with fibrinolytic agents is not known. 
We have analyzed pre-discharge 24hr Holter recordings 
performed in 8,676 post-MI patients of the GISSI-2 study 
followed for 6 months. NSVT ( defined as ;:::1 runes) of 3 or 
more premature ventricular beats at a rate> 100 b/min) was 
present in 586 (6.8%) of the recordings. Prevalence was 
higher in patients with symptoms or signs of left ventricular 
damage (10.5 vs 6.4%, p< 0.(01). Patients with NSVT had a 
higher monality rate ( 4.9 vs 2.9%, RR 1.99,95%CI 1.21-
3.27) and sudden cardiac death rate (1.9 vs 0.9%, RR 2.78, 
95%CI 1.18-6.55) . However, with multivariate analysis 
including indexes of left ventricular damage (Cox proponional 
hazard method) the risk of death of patients with NSVT was 
only slightly and not significantly higher (RRI.20. 95%CI 
0.80-1.79). In conclusion: I) NSVT is present in 6.8% of the 
recordings of post-MI patients treated with fibrinolytic agents, 
a value lower than that observed in pre-fibrinolysis studies; 2) 
prevalence of NSVT is higher in patients with signs of left 
ventricular damage; 3) presence of NSVT has a minor 
independent impact on subsequent monaIity in these patients. 
4:15 
ABSTRACTS 
763·3 4:30 
Doe. Ventricular Tachycardia Predict Mortality in 'atient. 
With Left Ventricular Dyafunction After an Acute 
Myocardial Infarction? 
rran~ois Sestier, Milton Packer, Jean Rouleau, Thomas 
Cuddy, Jacques Rouleau, Marc Klein, Gregory rlaker, Lemuel 
Moy' , Edward Geltman, Steven Goldman, Victoria Bernatein, 
Patricia McEwan, Bruce Suesex, Sandra Lewis, John Farnham, 
David Hayes, Theodore Biddle, Marc Pfeffer (SAVE Trial) 
Notre-Dame Hospital, MontrAal, OUAbec, Canada. 
Although ventricular arrhythmias predict survival after 
an acute myocardial infarction (MI), it ie unknown whether 
such arrhythmias merely reflect the degree of left 
ventricular (LV) dysfunction or contribute independently 
to mortality. Previous studies have only evaluated the 
importance of relatively benign arrhythmias (e.g., 
frequent ventricular premature beats) in small numbers of 
patients with a wide range of values for LV ejection 
fraction (EF). To re-evaluate this question, we examined 
the prognostic importance of ventricular tachycardia (VT) 
seen during 24-hour ambulatory ECG monitoring within 3-16 
days of MI in 582 patients with LVEF ~ 40\, who were 
followed for a minimum of 18 months. 
VT was observed in 102 patients (18\). By multivariate 
analysis, the most powerful predictor of VT waB poor LV 
function [assessed by radionuclide LVEF (P.0.012)J_ The 
presence of VT was also independently related to advanced 
age (P=0.032), prior HI (P=0.033) and use of anti•
arrhythmic drugs (P-0.034). 
Within 6 months, 45 patients died (7.7\) and an 
additional 40 thereafter. AS in previous studies, the 
presence of VT predicted survival (P.0.027), but VT did 
not provide independent prognostic information (either 
within or after 6 months) once LVEF was considered. Only 
advanced age (P=O.OOl) and mechanical factora 
[specifically, lack of thrombolysis at the time of HI 
(P=0.003), low LVEF (P-0.023) and prior HI (P.0.026) J, 
were independent predictors of mortality (by multivariate 
analysis). 
The finding that repetitive ventricular arrhythmias 
(such as VT) fail to independently predict mortality and 
merely reflect poor ventricular function suggests that VT 
may not be an appropriate target for therapeutic 
interventions in post-HI patients with low Er. 
763-4 4:45 
199A 
The Prognostic Velue of Late potentiall after Myocardial Infarction .. 
Multivariate AnaIYIII. 
Olulola Odemuylwa, Marek Malik, Jan Polonlecki, Tom Farrell, Terl 
Millane, Piotr Kulakowakl, Anne Staunton, AJ camm. Department of 
cardiological Sclenell, St George's Hospital Medical School, England. 
The addttional prognostiC Information provided by the signal averaged ECG 
(SAECG) over clinical variables and the left ventricular ejection fraction In 
postlnfarctlon patients is stili controversial. Therefore, given age, gender, KlIlip 
class and the left ventricular ejection fraction during first hospital admission, 
the prognostic Imponance of late potentials for I) sudden death (SO), II) 
ventricular techycardla (VT) and III) arrhythmic events (VT + SO) were 
examined using Cox's proportional hazards model In 509 survivors of acute 
myocardial Infarction aged between 33 and 75 years and who were followed 
up for between 1 week and 58.2 months. Signal-averaged ECG recordings 
were undertaken just before hosp~1 discharge and were analysed at a high 
filter setting of 25Hz. Late potentials were diagnosed using Simson's criteria. 
During follow-up, there were 16 SOs, and 18 patients developed VT. 
RESULTS. 1) The presence of late potentials gave a relative risk of 10.5 for 
sudden death (95% CI 3.4-32.1), the estimated probabll~ of SO In the first 
year after Infarction was 1 % ~hout late potentials and 13% In patients with 
late potentials. 
2) The presence of late potentials gave a relative risk of 12.3 for VT (95% CI 
4.5-33.9), the estimated probabll~ of VT In the first year was 3% wtthout late 
potentials and 27% In patients wtth late potentials. 
3) The presence of late potentials gave a relative risk of 8.9 for arrhythmic 
events (95% CI 4.5-33.9), the estimated probebility of AE In the first year was 
3% wtthout late potentials and 17% In patients with late potentials. 
CONCLUSION. The slgnal-averaged ECG provides addttlonal Information to 
clinical variables and the left ventricular ejection fraction for predicting both 
sudden death and ventricular techycardia after myocardial Infarction. 
200A ABSTRACTS 
763·5 5:00 
PrognostIC Value .of Cardiovascular Reflex Tests In Patients 
Following Myocardial Infarction 
Dietrich Andresen, Thomas Briiggemann, Beate Kaiser, Michael Goerl<e, RoW 
SchrOder 
Free University of Berlin, Germany 
Reduction of hean rate variability detected during 24-h Hofter-Monftoring in 
Post-MI-pts has been shown to be predictive of risk for subsequent monalfty. 
However, little Is known about the value of standard non-invasive 
cardiovascular reflex tests (CRT) in these pts. 
In 110 consecutive MI-pts CRT were performed evaluating hean rate 
response to deep breathing(B) and valsalva manoeuvre(V) 5-8 days after the 
acute event. 44% of the PIS. showed an abnormal B, 47% an abnormal V. 
Pts wfth and those wfthout abnormal BN were comparable wfth regard to age 
(69vs63 y),ejectlon fraction(42%vs45%),frequent VBP during Holter•
ECG(13%vSI6%),previous MI(22%vSI6%), ST-depression during Holter•
ECG (32%vs27%), antiarrhythmic (8%vs6%) and betablocker (21%vSI6"1o) 
therapy. - During the 9 months-Follow up 221110 (20%) had cardiac events 
(cardiac death, sudden cardiac death, reinfarction or symptomatic ventricular 
tachycardia) 
...... 
... 140 ..,. su 
-•"" 
". 
.... -
Conclusion: CAT are useful indicalors of autonomic cardiac nervous 
dysfunction. They are simply done and can be used to predict clinical 
outcome of Post-Mi-Patients. 
763·6 
pto.ol 
5:15 
Prognostic Paradox or Increased I·Year Mortality in Small Enzymatic 
Non-Q-Wave Myocardiallnrarction Complicated by Heart Failure 
William E. Boden, Robert E. K1eiger, Kenneth B. Schechtman. Boston VA 
Medical Center and Tufts University School of Medicine, Boston MA 
In a large prospective follow-up trial of non-Q-wave (NQ) MI, we noted an 
unexpected mortality (M) increase in patients with heart failure (CHF) , 
despite the fact that 63 % sustained a fiIS1 NQMI. Because of the important 
prognostic role of ischemia in NQMI, we hypothesized that a "prognostic 
paradox· might exist in certain pts, ie., a small NQMI accompanied by 
CHF = a critical mass of ~ myocardium culminating in higher late 
M. We performed a post-hoc subset analysis of late outcome in SIS 
MBCK-confirmed NQMI pts, 21 % of whom had CHF/pulmonary 
congestion (PC). I yr M (%) was assessed for 3 categories of peak CK 
release l:!>,SOO; 501-1000; > 1000 LU.) using 2 independent measures of 
CHF: a) NYHA2,Class Il.s.,1 mo post-NQMI (n= Ill); and b) CCU PC 
> Killip Class I (n= 108) complicating acute NQMI: 
I yrM: No CHF 
KiJ.I.illJ (.)CHF Hx 
8% 6% 
5% 7% 
13% 13% 
NQMI SIZE 
~ 
<500 
501-1000 
> 1000 
I yr M: CHF 
( + )CHF Hx Ki!l.iIl2I 
27% 21 % 
21% 19% 
13% 9% 
Conclusions: I) 1 yr mortality in large (CK> 10(0) NQMI with or without 
CHF is similar, suggesting "completed" MI; 2) small (CK<500) NQMI 
with CHF results in 2·3 rold higher late mortality than in patients without 
CHF, suggesting "incomplete" MI; 3) these findings indicate that a 
paradoxical, inverse relationship exists between peak CK release and late 
survival in NQMI patients with CHF; 4) such patients may represent a high•
risk subset of NQMI. 
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764·1 4:00 
Pulmonary Venous Flow DynamIcs Before and After Acute Incr ..... 
In Afterloaclln Patients With Mitral Regurgitation 
Steven N. Konstadt, Eric K louie, Susan Black, T.LK Rao, Patrick J. 
Scanlon, Loyola University Medical Center, Maywood, IL 
Systolic pulmonary venous flow Is decreased In patients with elevated 
pulmonary capUlary wedge pressure (PCW) or mttral regurgitation (MA) 
and reversed In patients with severe MR. In this study the Impact of an 
Increase In afterload (achieved by bolus administration of phenylephrine 
40-80 meg followed by I.v. Infusion at 20-30 meg/min) on peak 
pulmonary venous systolic (Vs) and diastolic (Vd) velocities measured 
by transesophageal pulsed Doppler was evaluated In 20 pta (mean age 
54.±.11 yrs) with varying anglographic grades of MA (2.3.±.1.3 out of 4) at 
baseline. Systemic arterial pressure (AP), pew, qualitative color Doppler 
grade of severity of MR (scale of 1-4), and short axis cross sectional LV 
wall motion were measured simultaneously. Phenylephrine was tttrated 
to achieve a 30% Increase In AP (Increasing from 101.±.17 to 137.±.17 
mmHg). WIth this Increase In afterfoad the color Doppler estimate of the 
severity of MA Increased In 16 PIS (2 grades In 5 pta and I grade in 11 
pts) and remained unchanged In 4 pta. Of these latter 4 pts, 3 had 
grade 4 MA prior to phenylephrine administration. Global and regional 
echocardiographlc estimates of LV systolic function were unchanged wtth 
phenylephrine administration while pew rose from I 5.±.7 to 22.±.7 mmHg. 
J!m!.i!:!§ 
Vs (m/s) .36.±..16 
Vd (m/s) .43.±..14 
Phenylephrine 
.19.±..32 
.56.±..18 
...JL 
<.05 
<.01 
The acute Increase In afterload resiJted In a significant decrease In Vs 
and increase In Vd. The Increase In Vd was directly proportional to the 
Increase In pew (r=.63 p< .003) reflecting more rapid diastolic filling of 
the LV and LA at higher filling pressures, but the decrease In Vs did not 
correlate with the rise In pew (r=.{).15 p=.52). The peak systolic 
pressure gradient across the mitral valve (AP-PCW) also did not correlate 
wfth the decrease In Vs (r=0.18 p=.44). Thus k appears that In patients 
wfth MA, acute Increases In afterload are transmitted across the 
Incompatant mttral valve resulting In reduced Vs but that this fall In Vs 
Is not a simple function of Increased LA pressure with increasing MR. 
764·2 4:15 
Continuous Wave Doppler Measurement of Mitral Valve Area 
and Gradient from the Esophagus: Are Monoplane Probes 
Sufficient? 
Andreas Miigge, Dirk Hausmann, Klaus Bargheer, Werner G. 
Daniel. Hannover Medical School, Hannover, Germany 
Recently, transesophageal echocardiography (TEE) probes became 
available with continuous wave (CW) Doppler. A potential 
application of TEE-CW could be measurement of mitral valve 
(MV) gradient (G) and area (A) in patients (pts) with MV disease 
in whom the transthoracic technique (TIE) failed to produce 
sufficient images and Doppler spectra. We studied 43 consecutive 
pts with MV stenosis (n=31) or MV prosthesis (n=12) by TIE 
and monoplane TEE (Hewlett Packard, Sonos 1000; steerable CW) 
and compared CW Doppler-derived MV A and MVG. Sufficient 
CW velocity spectrum was obtained by both techniques in 37 pts. 
In these 37 pts, comparison of both approaches revealed strong 
correlation for MVA (r=0.98), and somewhat weaker correlations 
for maximal MVG (r=0.85) and mean MVG (n=0.83). In the 
remaining six pts, Doppler spectrum obtained by TIE (n=2) or 
TEE (n =4) was too poor for quantitative analysis. In the case of 
TIE, both pts had recent cardiac surgery. In the case of TEE, 
one pts with calcified MV and three pts with MV prosthesis 
showed extreme excentric MV flow not allowing sufficient CW 
beam orientation from horizontal views. 
Conclusion: TEE-CW may be a valuable approach in 
selected pts for quantification of MV stenosis. However, 
monoplane TEE is not sufficient to allow optimal CW beam 
orientation in all pts: additional planes, at least biplane views, are 
desirable for TEE-CW. 
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Compari.on of Trans •• ophaq.al continuous Wave 
Doppl.r with Tran.thoracic Doppl.r in the 
A ••••• m.nt of Mitral st.no.i. 
Kwan Chan, Randall Sochowski. University of 
ottawa Heart Institute, ottawa, Canada 
Transesophageal echocardiography (TE) is 
superior to transthoracic echocardiography 
(TT) in assessing mitral valve (MV) anatomy. 
Application of TE in mitral stenosis (MS) has 
been limited by inability to obtain 
hemodynamic measurements. Imaging TE 
continuous-wave Doppler (CW) has become 
available. We compared TE-CW with TT-CW in 22 
patients (pts) with MS. There were 17 women 
and 5 men with a mean age of 55 ± 13 years. 
12 pts were in atrial fibrillation. 
TE-CW TT-CW P 
Peak gradient(mroHg) 14+ 5 16+ 6 NS 
Mean gradient (mroHg) 8± 4 8± 4 NS 
MV area (cm2) 1.3±.4 1.2±.3 NS 
Catheterization results, available in 12 
pts, were compared with values by TE and TT. 
While both TE and TT predicted MV area, both 
underestimated MV gradient. (p<O. 01) This 
appeared to be related to the presence of a 
significant azimuthma1 angle of intercept 
during CW examination by TE and TT. Thus, TE•
CW is comparable to TT-CW in the assessment of 
MS and can obviate the need for the latter in 
most cases. Doppler determination of MV area 
appears to be relatively independent of the 
angle of CW alignment. 
764-4 4:45 
Value and Limitations of Transesophageal Echocardio•
graphy for Assessing Prosthesis Dysfunctions: Surgical 
Correlates in a Series of 184 Operated Prosthetic Valves 
Benoit Diebold, Bertrand Cormier, Raymond Roudaut, 
Pascal Gueret, Christophe Tribouilloy, Jean Rene 
Lusson and FESFC, Filiale d'echocardiographie de la 
Societe Fran~aise de Cardiologie, Paris, France. 
In order to study the value and the limitations of trans•
esophageal echocardiography (TEE) for assessing 
dysfunctions of prosthetic valves (V), we have compared 
TEE imagp.s to surgical data in a series of 184 operated 
V: 80 bioprosthetic V (BP), 41 bileaflet V, 39 ball V, 24 
tilting disc V. (111 mitral V, 70 aortic V, 3 tricuspid V). 
The clinical condition was: cardiac failure (100), suspi•
cion of endocarditis (43), embolic event (16), other (10) 
(including systematic examination before operating ano•
ther valve). For the detection of aortic ring abscess or of 
atrial thrombus (thr) on atrio-ventricular valves, the 
sensitivity (sens), the specificity (spec), the predictive 
value of a positive (+ pred.) or negative (- pred.) test were: 
lesion sens spec + pred - pred number 
abscess 92,3 97,4 100 98,7 ~ 
thrombus 1:9 93 8) 79 'Zl 
For thr, discrepancies were noticed in the case of thin 
flotting image (2) and pannus (5), mainly in deteriorated 
BP and 4 ventricular extensions were missed. For regur•
gitations, we studied the accuracy of the detection and of 
the assessment of the site (intra, para). TEE and surgi•
cal data agreed in 81% of the cases: 14 small para V 
leaks were not mentioned by surgeons and regurgitant 
jet images were absent or equivocial in 8 aortic V. As 
concerns, vegetations (10), 8 false positives images were 
found on deteriorated BP. 
Thus, TEE is a potent tool for 8ssessillg prosthetic valve 
dysfonctions. It has only a few well defined limitations. 
ABSTRACTS 201A 
764-5 5:00 
Acute vs. Chronic Atrial Fibrillation: 
Incid.nc. of Appendag. Thrombus, spontan.ou. 
Contrast and Embolic Event. 
Phillip R. Dawkins, Marcus F. Stoddard, Norman 
E. Liddell, Rita A. Longaker 
University of Louisville, Louisville, Kentucky 
Prophylactic anticoagulation is not routinely 
used prior to cardioversion in patients (pts) 
with acute (~ 4 days) vs. chronic (> 4 days) 
atrial fibrillation (AF) because the incidence 
of left atrial thrombus is felt to be 
clinically insignificant. We prospectively 
studied 97 consecutive pts, age 64 ± 13 years 
with acute (n=36) and chronic (n-61) AF (100% 
nonrheumatic heart disease) by transesophageal 
echocardiography to determine the incidence of 
left atrial appendage (LAA) thrombus and left 
atrial (LA) spontaneous echo contrast (SEC). 
Embolic events (Emb) were defined as 
nonhemorrhagic CVA, TIA, and peripheral embolus 
(PE). Results: 
Acute 
Chronic 
*p<O.OOl. 
LAA clot 
11% 
25% 
LA SEC 
17% 
52%* 
New Emb 
39% 
42% 
Old Emb 
33% 
28% 
Embolic events in the acute AF group were 9 
CVA, 4 TIA, and 3 PE. Embolic events in the 
chronic AF group were 16 eVA, 6 TIA, and 4 PE. 
LA diameter was greater in the chronic vs. 
acute AF group (4.7±1.1 cm vs. 3.7±0.9 cm, 
p<O.Ol). Conclusions: Although LA SEC is more 
common in chronic vs. acute AF, the incidence 
of LAA thrombus and new embolic events did not 
differ. These data suggest that pts with acute 
AF should be considered for prophylactic 
anticoagulation. 
764-6 5:15 
Transesophageal Echocardiography in Lung Transplantation: 
Assessment of Distribution of Blood Flow and Adequacy of 
Pulmonary Venous Anastomosis 
Marcelo Vassolo, David Ross, Robert Siegel, Gerald 
Maurer. Cedars-Sinai Medical Center, Los Angeles, CA 
To evaluate the utility of Transesophageal Echo (TEE) for 
measuring blood flow distribution (QD) between the native 
and transplanted lungs and for assessing the pulmonary 
venous anastomosis site, we studied 6 patients after 
single lung transplantation (obstructive/restrictive 
disease in 5, primary pulmonary hypertension in I). 
Pulmonary vein diameters (PVD) and flow velocities (PVV) 
were measured on the left and right side. QD to the 
native and transplanted lungs were calculated as PV 
cross-sectional area x mean PVV at the corresponding 
site, and expressed as percentages of total pulmonary 
blood flow. QD by TEE was compared to QD by nuclear 
quantitative Tc-99m MAA perfusion lung scans. 
PVD (mm) 
PVV mean (cm/sec) 
QD-TEE (%) 
QD-Nuclear (%) 
Native Lung 
IO±2 
27+8 
3 Of) 5 
23±16 
Transplant Lung 
(Mean±SD, * p<O.OI; ** p<O.OOI) 
QD by TEE correlated highly with QD by nuclear scan 
(r-O.94, p<O.OI, y-4.8+0.98x). Furthermore, PV 
anastomotic narrowing and gradients (12 mm Hg, 8 mm Hg) 
were observed in 2 patients in whom surgical anastomosis 
of the left atrial cuff had been difficult. 
Conclusion: TEE provides accurate QD determination after 
lung transplantation and is useful in identifying sites 
of PV anastomotic narrowing and pressure gradients. 
202A ABSTRACTS 
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765·1 4:00 
Accuracy of Separate Acquisition Dual Isotope MYocardial 
Perfusion SPBCr: JesuIts of a Large Clinical Trial 
Daniel Berman, John Friedman, Bosen Kiat, Fan P. Vang, 
James Bietendorf, Ken Van Train. Cedars-Sinai Kedical 
Center, Los Angeles, CA 
Ve have previously documented the feasibility of separate 
acquisition rest TI-201 (TI)/exercise Tc-99m sestamibi 
(Tc) dual isotope myocardial perfusion SPECT (DIKPS) as a 
highly efficient protocol. To test the accuracy of DIKPS 
in a large clinical trial, we assessed 170 consecutive 
pts undergoing DIKPS and having either coronary 
angiography (n-63) or a low likelihood (LL) « 5%) of 
coronary artery disease (CAD)(n-l07). Pts with prior 
infarction by history or EOG were excluded. By 
angiography 55 pts had ~50% stenosis, and 52 had ~70% 
stenosis. Pts had rest TI SPECT (2.5-3.5mCi), 
immedia'tely followed by 15-30 mCi of Tc at peak treadmill 
exercise with Tc SPECT 30 mins later. Images were 
interpreted visually using a 5 point system (O-normal 
(nl), 4- absent uptake) in 20 segments (segs), with ~ 2 
segs with score ~2- abnormal. Five pts were excluded 
because of motion on DIKPS. Of the 107 LL pts, 102 (95%) 
were nl by DIKPS. Sensitivity (sn) and specificity (sp) 
for overall CAD and CAD in individual vessels were as 
follows: 
~50%-CAD OVERALL CAD LAD RCA LCX 
sn 
sp 
~70%=CAD 
50/55/(91%)* 22/36(61%) 33/34(97%) 15/27(56%) 
6/8 (75%) 25/27(93%) 25/29(86%) 35/36(97%) 
sn 50/52(96%) 22/27(81%) 30/31(97%) 15/24(63%) 
sp 9/11 (82%) 34/36(94%) 25/32(78%) 40/41(98%) 
*all 5 pts missed had single vessel disease. DIKPS showed 
reversibility in 48/50 (96%) CAD pts with stress defects. 
Conclusion: separate acquisition dual isotope myocardial 
perfusion SPECT provides high accuracy for detection and 
localization of CAD in a diagnostic population. 
765-2 4:15 
Nonlnvellve AI_Iment of Restenoel, by Simuitaneoul Exercl .. 
Perfullon and Functional Me .. urementl: A ComparilOn wtth 
OuIIntltatlve Coronary Angiography 
Salvador Borges-Neto, R. Edward Coleman, L Richard Smith, David Rendall, 
Thomas M. Bashore, Richard Stack, Robert H. Jones. 
Duke University Medlc:al Center, Durham, North Carolina 
The purpose 01 this Investigation was to assess the relative Importance r:J 
quantitative tomographic perfusion Imaging (SPECT), Initial-transit 
radlonucllde angiocardiography (RNA), exercise treadmUI testing (ETT) and 
the presence 01 angina for diagnosing restenosls 6 months after 
percutaneous transiumlnal coronary angloplasty. Accordingly, 96 patients 
were prospectively studied at a single testing Interval USing technetlum-99m 
sestamlbf less than 24 hours prior to cardiac catheterization. Stepwise 
logistic ragrasslon modeled noninvasive variables against the presence of 
70% diameter restenosis as measured by quantitative coronary angiography. 
Angina and m variables were not predictors 01 the outcome (X" = 1.1 and 
~=0.8, respectively). Multlvariable enalysls demonstrated that SPECT was 
the most slgnlflcent pradlctor of restenosls (X"=12.6, p<O.OOO4). However, 
RNA was an eddklonal significant predictor (X"=5.1, p<O.03) and contributed 
Independent Information beyond that provided by SPECT. Therefore, tt Is 
concluded that optimal noninvasive assessment r:J restenosis 6 months after 
percutaneous trenslumlnal coronary angloplasty requires determination of 
cardiac function In addttlon to myocardial perfusion meesurements. 
lACC Vol. 19, No.3 
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765·3 4:30 
Myocardial Imaging with Technetium 99m P53. Comparison 
with Thallium in Suspected Coronary Artery Disease. 
Pierre Rigo, Simon Braat, Roland Ittl,Marle Paule Larock, 
Laurence Bontemps, Bangalore Srldhara,Paul Cload, 
Avljlt Lahlrl. 
Multicenter P53 Study Group, University of Liege, Belgium 
Tc-99m P53 (Amersham International) (P53) Is a lipophilic 
cationic disphosphlne proposed for myocardial Imaging in 
man. We have analyzed Its ability to detect Ischaemia or 
Infarction In comparison with thallium. 
50 patients (pts) (37 with previous Infarct) have been 
studied after Injection during graded bicycle exercise and 
rest (4 hrs later and another day). The thallium rest, 
redistribution and P53 planar Images at 30' and 60' were 
processed on a single computer and read separately In a 
randomized fashion by a pannel of observers unaware of 
the clinical and exercise data. Results were categorized 
as normal, Ischemic, Infarcted or mixed both per pts and 
per scintigraphic territories (anterior, Inferior, lateral or 
apical; apical abnormalities were only counted when non 
contiguous). P53 one day and 2 days protocols provided 
Identical Information In all but 2 pts In whom minor 
variations were observed. P53 separated infarct and 
ischaemia (type of abnormality) more often than thallium 
resulting In a less frequent mixed pattern. 
n=pts Normal Ischaemlc Infarcted Mixed 
P53 9 8 22 11 
Thallium 10 5 19 16 
Diagnostic disagreements between P53 and thallium were 
noted in only 3 pts. Complete regional agreement was 
observed In 31/50 pts (43170 areas) while variations were 
noted in extent (6 pts) or type (10 pts) of abnormalities 
(18 areas). 
We conclude that P53 is a promiSing new agent to 
evaluate pts with coronary artery disease. 
765-4 4:45 
Early and Late Myocardial Imaging with a new Technetium-
99m Diphosphine (PPNlOll) in Coronary Heart Disease 
Bangalore S Sridhara, Simon Braatt, Ronald Itti, Pierre 
Rigo, Paul C10ad, Avijit Lahiri. Mu1ticentre Study 
Group, Northwick Park Hospital, Harrow, UK 
Tc-99m (PPN1011, Amersham International) is a lipophilic 
cationic diphosphine (Tc-D) which has been developed for 
myocardial imaging in man. We have studied the ability 
of Tc·D to detect myocardial ischaemia (ISC) or 
infarction (KI) early (5 min) and late (4 hrs) after 
injection, following graded, ergometric exercise (EX) in 
23 patients with coronary artery disease (CAD). Tc-D was 
reinjected (RE) at rest on the same day (4 hrs) and on a 
separate day. Tl-201 imaging was also performed after EX 
and redistribution (RED) at 4 hrs. Multiple planar views 
were acquired and the images were read semi•
quantitatively to obtain a count of abnormal segments 
(total: 460 segments). CAD was correctly identified by 
Tl-201 in 83%, by early and late Tc-D in 80% and 83% 
respectively. There was no difference in the diagnosis of 
CAD between the same day and separate day Tc-D protocols. 
(n-abnorma1 segments) (n-patients) 
EX RE RED ISC MI 
Early Tc-D' 140 
Late Tc-D 156 
Tl-201 161 
70 
80 
83 
13 
13 
13 
8 
9 
9 
The quantitative Tl-201 lung uptake increased on 
exercise whereas no significant increase was noted with 
Tc-D. These data suggest that Tc-D is a unique new Tc-
99m agent which compares with Tl-201 for its diagnostic 
ability. Early and late Tc-D images show absence of 
reversibility and early diagnostic power is retained. 
Tc-D has an attractive and versatile profile, and merits 
further clinical evaluation. 
JACC Vol. 19, No.3 
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765·5 5:00 
Comparison of Iodine-123 Methylhexadecanoic 
Acid Imaging Versus Exercise-Redistribution 
SPECT Tl201 with Rest-Reinjection to Assess 
Myocardial Viability After Infarction 
Pierre Y Marie, Nicolas Danchin, Gilles 
Karcher, Yves Juilliere, Olivier Perrin, Pierre 
Olivier, Alain Bertrand, FranQois Cherrier. 
Dept of Cardiology, CHU Nancy 54500 France 
Experimental studies have demonstrated that 
certain labelled free fatty acids might be more 
accurate markers of myocardial viability than 
Tl201 after MI. The aim of this study was to 
compare myocardial uptake of Tl201 after 
redistribution and rest-reinjection with that 
of rest-injected Iodine-123 Methyl-hexadecanoic 
acid (IMHA) in pts with recent MI. A mean of 
32±26 days post MI, 42 pts (53±8 yrs) underwent 
exercise SPECT Tl201 with 4-hour redistribution 
and lmCi rest-reinjection, followed by rest 
SPECT wi th IMHA (3 to 5 mCi). Resul ts were 
scored using a 20 segments division of the left 
ventricle. Of a total number of 253 ischemic 
stress segments, 45 (18%) normalized after 
redistribution, 69 (27%) after either 
redistribution or rest-reinjection, compared 
with 85 (34%) on IMHA images. All but 1 
ischemic segments identified as viable on 
redistribution or rest-reinjection scans were 
also identified as viable with IMHA, whereas 16 
additional ischemic segments were detected as 
viable on IMHA scans only (+23%). 
After MI, IMHA rest SPECT is superior to 
redistribution and rest-reinjection SPECT Tl201 
to identify presumably viable myocardial 
segments. However, the clinical relevance of 
these findings remains to be assessed. 
765·6 5:15 
Imaging Arterial Thrombi in Humans: Comparison of Te:· 
99 Monoclonal Antifibrin Antibodies and In·ll1 Platelets 
John Stratton. Manuel CeIqueira, Ted Kohler, Wayne Levy, Thomas 
Schaible. Seattle VA and Univ. of Washington, Seattle, WA 
To assess the ability of Tc-99m labeled 1'20 Is monoclonai 
antifibrin antibody fragment(Fab') to detect arterial thrombosis in 
humans, we studied 18 subjects with either left ventricular thrombi 
(n=2), abdominaJ aortic aneurysm thrombi (n=3) or large vessel arterial 
grafts(n=13,7 Dacron and 6 PTFE). The mean injected Tc-99m dose 
was 19±3mCi. Planar and tomographic (tomo) images were obtained 
at 0-24 hours post injection. Seventeen subjects also had In-Ill 
labeled platelets(mean dose 319±I5uCi) with imaging at 2-72 hours. 
Images were visually graded as 0, 1,2 or 3 (no, faint, moderate or 
marked) uptake. In addition, quantitative analysis using a tomographic 
target/background ratio was done on 13 SUbjects. 
On visual analysis of planar studies, 44% of antifibrin and 94% of 
platelet studies were ~1.0 (p<.05). On visual tomographic analysis, 
61 % of antifibrin and 100% of platelet studies were ~1.0 (p<.05). 
Antifibrin images were positive early(0-2 hrs) but platelet images were 
late(24-48 hrs). The meanCiSD) of the highest visual scores for each 
subject are presented. By both planar and tomo, 81atelet imaging was 
more positive than antifibrin imaging (*both p<. 1). 
MEAN SCORE MEAN SCORE 
Antifibrin PLANAR O.9±1.1 Antifibrin TOMO 1.2±1.0 
Platelet PLANAR 2.3±Q.8* Platelet TOMO 2.4±O.6* 
The quantitative tomo target/background ratio was also less with 
antifibrin imaging than with platelelS(1.8±1.0 VI 2.5±1.4, p<O.05). 
In the thrombi studied, Tc·99m antifibrin imaging was positive less 
often than platelet imaging. However, positive antifibrin images, when 
present, occurred earlier than with platelet imaging. The higher rate of 
positive images with platelet imaging may be due to a preponderance of 
platelets in arteriaJ thrombi. 
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766·1 4:00 
Initial Results of RS-61443 for Refractory Cardiac Rejedion 
Jon A. Kobashigawa, Dale G. Renlund, Stephanie L. Olsen, Lynne 
Warner Stevenson, Susan V. McDiarmid, Sandy Swanson, Elaine 
Albanese, David O. Taylor, Diane Dunn, Erica Brownfield, Robert S. 
Kauffman, Hillel Laks. UCLA Medical Center, Los Angeles CA and The 
lITAH Cardiac Transplant Program, Salt Lake City, lIT 
The new immunosuppressive agent RS·61443 (mycophenolate 
mofetil) inhibits de novo purine synthesis and blocks T and B 
lymphocyte proliferation. Animal studies have shown it to reverse 
cardiac rejection (RE.!) without nephrotoxicity or marrow suppression. 
Initial experience at 2 transplant centers involved 15 cardiac 
transplant pts treated during refractory/persistent REJ (moderate REJ 
in 9 pts and mild REJ in 6 pts). Therapy with RS-61443 was added, 
with cydosporine and prednisone continued, and azathioprine 
stopped. Initial RS·61443 dose was 750-1500 mg p.o. b.i.d, 
increasing to 1750 mg b.Ld. for an inadequate therapeutic response. 
Of the moderate REJ pts, all 9 pts had improvement in subsequent 
biopsy (bx), and 6 pIS eventually had complete resolution of REJ. 
The remaining 3 moderate REJ pts without complete resolution of 
REJ are still <40 days on therapy. All mild REJ pts had improvement 
to a lower grade mild REJ or resolution of REJ. 5/6 mild REJ pts had 
complete resolution of REJ, the remaining patient being on RS-61443 
for 24 days. No side effects necessitated alteration of therapy, and no 
nephrotoxicity was seen. 
Ave Initial 
N RS mg/day 
Mod REJ 9 2556 
Mild REJ 6 2250 
Subseq Improved BlI: Subseq Resolved Bx 
~ Ave days to t..l!!! Ave dm to 
9 16 6 39 
6 19 5 47 
In this initial experience, RS·61443 appeared effective in humans with 
refractory/persistent cardiac rejection without major side effects. 
Relative efficacy and side effect profile will require controlled trials. 
203A 
766·2 4:15 
Hemodynamics, Renal Function and Allograft Coronary Disease In 
Cardiae Transplant Patients Immunosuppressed with FK·5O(i 
Tulia Estrada-Quintero, Srinivas MuraU, Barry F. Uretsky, John M. 
Armitage, Randall C. Starling, Robert L. Kormos, Robert L. Hardesty, 
Bartley P. Griffith. University of Pittsburgh, Pittsburgh, PA 
Cyclosporine A (CY A) immunosuppression is associated with mild 
hemodynamic abnormalities, systemic hypertension and renal insufficiency. 
To determine if FK-506 immunosuppression has similar sidHffects, we 
compared 18 cardiac transplant (Tx) pts (transplanted between 10/1/89 and 
911190) receiving FK-506 and prednisone to 20 pts (transplanted between 
2/1189 and 10/1/89) treated with CYA and prednisone. Data at 3 mos and 
12 mos post-Tx are tabulated. 
CYA ~ 
3 mos 12 mos 3 mos 12 mos 
RA (mmHg) S±3 4±2 4±2 3±2 
PAM (mmHg) 18±3 17±4 21±5* 19±4 
PAW (mmHg) 9±3 9±3 1l±4 10±3 
CI (I/minlm') 3.0+0.6 2.7±0.6 3.1±0.3 2.8+0.4 
*p < 0.05 FK-S06 vs CYA at 3 mos; RA, PAM, PAW = right atrial, 
pulmonary artery mean, PA wedge pressures; CI = cardiac index. FK-S06 
pts had lower prevalence of systemic hypertension requiring therapy at 3 
mos (17% vs 65%, P < 0.05) and 12 mos (50% vs 75%. p < 0.05) than 
CY A pts. Renal insufficiency (serum creatinine ~ 2.0 mg/dl) was more 
frequent in FK-506 pts at 3 mos (83 % vs 30%, P < 0.05) and 12 mos 
(61 % vs 15%, P < 0.05) than CYA pts. Prevalence ofsignlficant ~ SO% 
luminal narrowing) allograft coronary disease (CAD) at 12 mos was 6% in 
FK-506 pIS and 10% in CYA pIS (p = ns). CONCLUSION: Cardiac Tx 
pIS receiving FK·506 have similar hemodynamics, lower prevalence of 
systemic hypertension, higher frequency of renal insufficiency and similar 
prevalence of allograft CAD in the first post-Tx year when compared to pts 
treated with CY A. 
204A ABSTRACTS 
766·3 
Effect of Orthotopic Cardiac Transplantation on Forearm Vascular 
Dynamics in Heart Failure: Influence of Cyclosporine Therapy. 
Krishnankutty Sudhir, Patricia Cavero, Frank C. Galli, Fraser 
Keith, Teresa DeMarco, Kanu Chatterjee. 
Cardiovascular Research Institute, University of California at San 
Francisco, San Francisco, California. 
Vascular dysfunction and disease are common complications after 
heart transplantation (Tx). Venous occlusion plethysmography is a 
useful technique to study resistance vessel function in these 
patients. We measured venous capacitance (VC) as well as forearm 
blood flow (FBF) and forearm vascular resistance (FVR) responses 
to cold, maximal hyperemia (Hyp), and handgrip exercise (Exer) in 
5 patients with end-stage heart failure who underwent heart Tx. 
Studies were done at 4 time points: (1) Pre-transplantation (Pre· 
Tx); (2) Immediately post-transplantation before cyclosporine 
therapy was started (Post-Tx, CSP-); (3) 6-8 days post-transplant 
with therapeutic cyclosporine levels (Post-Tx, CSP+); and (4) 6 
weeks post-transplantation (Post-Tx, 6 wks). 
Results: Pre-Tx Post-Tx Post-Tx Post-Tx 
CSP_ cse:t: Ii »:ks 
Cold (FVR rise %) 96.6±31.6 16.8:1:8.7· 41.6±12.3· 46.0:1:9.2 
Hyp (FBF m1%lmin) 10.7:1:9.9 19.9:1:3.0· 22.3:1:5.9· 20.6:1:5.1· 
Exer (FBF m1%/min) 1l.7±l.7 19.1:1:0.9· 26.8:1:3.4" 
YC lil 18+!ll Bj;!l8 l2+!l1 18;!;!l:l 
• indicates signiflC8!lt difference from Pre-Ix at p<O.05 
Thus, the vasodilator responses to hyperemia and exercise improve 
significantly after Tx, up to 6 weeks. Cold-induced reflex 
sympathetic activation is transiently decreased immediately post 
Tx, but is enhanced again after starting CSP. In conclusion, 
vasodilator reserve is restored post-Tx, but sympathetic 
vasoconstriction In resistance vessels recurs as an adverse effect of 
immunosuppression, a result of CSP and possibly steroid therapy. 
766·4 
4:30 
4:45 
AZitbloprlne.Cyclosporine or Cyclosporlne IDlDluDosuppression 
After Pediatric Heart TnDspl.DlatioD: Mid·ter. Resllill. 
Ugolino Livi, Giovanni Battista Luciani, Giuseppe Faggian, Bartolomeo 
ChiominlO, Omelia Milanesi°, Alessandro Mazzucco 
Department of Cardiovascular Surgery and PediaIric .. , University of Padova, Padova, 
Italy. 
The side effects of steroid-free immunosuppression (IS) bave limited the clinical 
application of heart transplantation (HTx) to children. In order to assess the safety of 
steroid-free IS, the mid-term results of pediatric HTx without maintenance steroids 
were analyzed. From January 1987 to August 1991 13 pts, 7 males and 6 females. 
aged 2 mos to 16 yrs (mean 9±6 yrs), underwent orthotopic HTx 81 our Institution. 
Indication to HTx was primitive cardiomyopathy in 7 pts (54%). complex cardiac 
anomaly in 5 (38%) (3 previously corrected) and left ventricular fibroma in I (8%). 
Weight of all pts was below the 25th %i1e for age and sex; 3 pts (23%) were on i. v. 
inotropic infusion and! or mechanical assistance pre-HTx. IS initially included 
Cyclosporine (CyA) 5-40 mg/lcg/day and Azathioprine (Aza) 0.5-3 mg/lcg/day: in 5 
pts (38%) Aza was later withheld leaving eyA as sole IS. There were 3 early deaths: 
I (8%) post-operatively because of irreversible brain damage following pre-HTx 
mechanical assistance and 2 (I S%) because of acute rejection I and 2 mos after HTx. 
FoUow-up averaged 21:t:16 (range 4-54 mos). with an actuarial survival of 76% 814 
yrs. Overall incidence of acute rejection was 2.0 episode (ep)/pt (1.8 eplpt in adults. 
p"ns): 1.2 ep/pt in children <2 yrs vs 2.4 epipt in children >2 yrs (p<O.OS). There 
were six viral infections (3 CMV, 2 HZV, I RSV), with an incidence of 0.5 epipt 
(0.1 ep/pt in adults. p<O.Ol): 1.00 ep/pt in pts <2 yrs and 0.25 in pts >2 yrs 
(p<0.01). One pt developed a non-HD hepatic lymphoma; she underwent 12 cycles 
of chemotherapy and suspension of the IS. with clinical regression of the lesion. All 
pts were frcc from diabetes and hypertension at follow-up. with preserved renal 
function (mean serum creatinine 63. 60. 84 mmole/L at 1.12. 24 mos). Psycho•
affective development and growth (weight and height between 2Sth and 90th %i\e) 
were also normal in all. Angiography performed in 4. 4. 2 and I pts at I. 2. 3 and 4 
yrs. respectively, demonstrated normal cradiac function and absence of chronic 
rejection in all. In conclusion. pediatric HTx with steroid-free IS shows: 1) good 
mid·term survival and cardiac function, 2) incidence of acute rejection comparable to 
adults. though higher in children >2 yrs, and higber incidence of infection. 
particularly in children <2 yrs. 3) low incidence of major complications. with 
normal growth. 
766·5 
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6·a·Methyl Prednisolone Inhibits Endothelial Migration in 
Response to In Vitro Injury 
Alistair Fyfe. Alan Rosenthal. A vrum Gotlieb. UCLA Medical Center. 
Los Angeles. CA & The Toronto Hospital, Ontario. CANADA. 
Endothelial repair is imponant in spontaneous atherosclerqsis but its 
role in transplant arteriosclerosis is not well understood. Repair 
involves cell spreading & migration. We studied the impact of 
immuno-suppressive agents on aonic endothelial healing. Porcine 
mono layers were exposed to clinically relevant concentrations of 
cyclosporine A (CsA). 6-mercapto-purine (MP) & 6-a-methyl 
prednisolone (MPred) alone or in combination. Once confluent. the 
surface was wounded & wound closure measured at 24 hours. 
Surface area of wound edge cells was measured. Immunofluorescence 
microscopy was used to assess centrosomes. actin. tubulin & 
vimentin which panicipate in migration. 
While CsA was toxic @ 1600 nglml. no effect on closure was seen 
@ 100-800 nglm!. MP had no effect@ 25-50 nglm!. MPred showed 
dose de endent inhibition of wound closure * <0.OD5. 
Pred uM I. 5 2.5 5 I 5 
Wound 55 54* 
Closure urn 
imilar decreases were seen wah MPre added to sA . ell 
surface area increased with MPred (4.57±O.79 vs 3.74±O.84 XIO-3 
mm2)* suggesting that cells were spreading to close the wound since 
migration was reduc.:d. Centrosomal orientation towards the wound 
edge was reduced at 24 hours in prednisolone treated monolayers 
(52vs74% p<0.02). The persistence of F-actin dense peripheral bands 
in rows 3 - 5 behind wound edge with MPred also suggested delayed 
migration. Vimentin intennediate filaments were unchanged. 
These results suggest that MPred inhibition of endothelial migration 
and repair may contribute to arteriosclerosis after endothelial injury 
associated with tr'dnsplantation. 
766·6 5:15 
Success of Steroid Weaning Late After Cardiac Transplantation: 
Relation to HLA-DR Matching 
Jon A. Kobashigawa. Lynne Warner Stevenson. Erica D. Brownfield. 
Jaime D. Moriguchi. Nobuyuki Kawata. Roxella Fandrich, Davis C. 
Drinkwater. Hillel Laks. UCLA Medical Center. Los Angeles. CA 
Steroid-free maintenance immunosuppression is frequently initiated 
early after transplantation. There is concern that later steroid 
withdrawal. particularly after previous rejection (REJ). may cause 
more serious REJ. To detennine the safety of gradual weaning of 
steroid maintenance. 68 pts > 6 mos post-op were weaned from 5 
mglday by decreasing the daily dose by 1 mg each month. with 
monthly biopsies. Asymptomatic moderate REJ occurred in 13 
compliant pts. REJ with hemodynamic compromise occurred in 2 pts 
(both with 1 DR match) with documented medication non-compliance 
who are excluded from further analysis. Successful weaning without 
REJ was possible in 53/66 (80%) compliant pts. Compared to the 
REJ group there were no differences in the number of females. 
previous REJ episodes. or time from transplant. Of 19 compliant pts 
with at least 1 DR match. all (100%) were successfully weaned from 
steroids without REJ. For the 47 pts without a DR match. successful 
steroid weaning without REJ was 72%. All moderate REJ responded 
to oral steroid pulse therapy. (The 2 serious REJ after non•
compliance responded to O1a3.) There were no steroid withdrawal 
symptoms which required taper alteration. 
# with # prev # months # pts ~1 
N Prev REJ REJ/pt post OHT DR match 
REJ 13 11 (85%) 1.3±1.0 23±14 0 
No REJ 53 37 (70%) 1.2±1.3 23±12 19 
Regardless of previous REJ. weaning of maintenance steroids can be 
attempted safely if guided by· frequent biopsy. but compliance is 
critical. Late steroid withdrawal may be most successful in pts with 
at least 1 DR match. 
lACC Vol. 19, No.3 
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767·1 4:00 
INDEPENDENT AND INTERACTIVE PROGNOSTIC INFORMATION OF 
NEUROHORMONES AND ECHOCARDIOGRAM IN HIGH RISK POST-MI 
PATIENTS 
Sussex B A, Arnold J M 0, Parker J 0, McEwan P, Rouleau J L, St. John•
Sutton M, Bernstein V, Rouleau J R, Cuddy T E, Klein M, Nadeau C, Delage 
F, Sestier F, McCans J, Lamas G A, Gottlieb S S, Gellman E, Plappert T, 
Moye L, Braunwald E, Pfeffer M A, Memorial University, st. John's, Nfld., 
Canada 
Both left ventricular (LV) dilatation and neurohormone (NH) activation have 
been shown to predict prognosis in patients with heart failure or acute MI. We 
postulated that echocardiogram (E) measures of LV size would predict NH 
activation and higher risk in patients after acute MI. In 486 patients with L VEF 
< 40%, mean 11 days after acute MI, with no signs of congestive heart failure, 
we correlated the foUowing plasma NH by univariate analysis with subsequent 
survival (mean 3 years): norepinephrine (NOR) p<O.04, epinephrine p<0.14, 
atrial natriuretic peptide (ANP) p<0.OO1, arginine vasopressin p<0.01, renin 
activity (PRA) p<0.02. NH activation (2 SD above normal) occured in 22 to 
62% depending on NH studied. A quantitative E done on the same day in 284 
patients measured LV chamber diastolic area, systolic area, area change and 
extent of abnormal wall motion. All measures correlated with survival (p<0.01) 
by univariate analysis. Unexpectedly, there was no correlation between the 
above E parameters and any of the NH measured. (Range of r values 0.003 to 
0.048 N.s). However, their interaction significantly improved the prediction of 
mortality with a marked additive effect, ego NOR p< .01, ANP p< .05, (Chi2 
analysis). 
%MORTALITY BY NH STATUS AND 
ECHO DlASTOUC AREA « or > 50th Centile) 
NH Status 
Non-activated 
Activated 
NOR 
<50th >5Oth 
8.0 16.4 
12.5 39.5 
ANP 
<50th > 50th 
7.4 12.5 
103 25.9 
Conclusion: E derived indices of LV size do not account for or predict NH 
activation 3-16 days post MI. However, large LV size and NH activation are 
independent and interactive risk factors for mortality after MI. Together they 
powerfuUy predict those at highest risk. 
767·2 4:15 
Survival and Ventricular Enlargement (SAVE) Quantitative 20 Echo Sub•
study: Effects of ACE Inhibition Therapy on Ventricular Enlargement 
Martin SI. John Sutton, Marc A. Pfeffer, Ted Plappert, J. Malcolm O. Arnold, 
Lofty L Basta, Neville Bittar, Steven Goldman, Stephen S. Gottlieb, Marc 
Klein, Gervasio A. Lamas, Lemuel A. Moye, Jean L Rouleau, Eugene 
BraunwaJd. Brigham and Women's Hospital, Boston, Massachusetts. 
The SAVE study was designed to determine whether prognosis following MI 
wtth LV dysfunction (radionucllde EF ;::40%) could be improved by captopril 
therapy. A 20 quantitative Echo substudy was conducted on 512 SAVE 
patients to test the hypothesis that captoprD exerts a clinical beneftt by 
attenuating progressive left ventricular enlargement. 20 Echo required at 
least 3 of 5 technically satisfactory views for quantttation which included both 
apical long and short axis. Demographics of echo patients were similar to 
the overall cohort. Summated diastolic and systolic cavtty areas, fractional 
change of area and percent of total perimeter which was akinetic or 
dyskinetic were prospectively defined as major echo variables designating 
extent of enlargement, systolic dysfunction, and infarct damage respectively. 
Baseline determination (11 days post-Mil of each of these echo measure•
ments correlated significantly In a univariate manner whh both survival and 
the development of refractory congestive heart failure. A multiple logistic 
regression model for survival which included age, sex, prior MI, diabetes, 
hypertension, use of thrombolytic therapy, and radionucllde ejection fraction, 
was significantly improved by adding any of these four echo variables. In 
addhion, the contribution of the echo variables In predicting mortal tty or the 
development of CHF was consistently Independent and In many Instances 
provided the strongest prognostic Information of adverse clinical outcome. 
Repeat echo on 1 year survivors demonstrated further enlargement which 
was much more pronounced In patients manHestlng CHF: !Diastole 2.7:t0.6 
vs 0.8±0.4, !Systole 3.3±0.7 vs 0.9±0.3 (increase In area above baseline 
cm2jm2, p<O.OOl CHF vs stable). The unblinded results of the SAVE echo 
sub-study will be presented to address directly the question of whether 
captopril therapy attenuated ventricular enlargement following MI and 
whether this was associated wtth an improvement In clinical outcome. 
ABSTRACTS 
767·3 
Effect of Thrombolysis and Prolonged Captopril and 
Nitroglycerin on Infarct Size and Remodeling in 
Transmural Myocardial Infarction 
4:30 
Bodh I. Jugdutt, Wayne J. Tymchak, Dennis P. Humen, 
Sajad Culamhusein, Shou-Bai Tang, University of Alberta, 
Edmonton, Canada 
The effect of acute thrombolysis (T) on creatine kinase 
infarct size (CRIS, gEq) , LV remodeling and function 
(serial two-dimensional echocardiograms), Rillip scores 
(RS) and other outcome parameters by captopril (CL) and 
nitroglycerin (NTC) in transmural acute myocardial 
infarction (TAMI) was asessed in a double-blind trial of 
SO patients who were randomized (2x2 factorial design; 
n-20/cell) 4S hours after a first TAMI and iv NTC ± T, 
to placebo (P), NTC (buccal 1-3 mg 5 hourly, with S h 
washout), CL (6.25 - 25 mg tid), or NTC+CL for 6 weeks. 
Measurements were made serially at 2, 4, 6, 10, 42, 90, 
ISO and 360 days. 
Results: 
P m; CI. HIG+<:I. 
NoT T NoT T NoT T NoT T 
CRIS 70 39 28 44 69 39 52 41 
KS: 2 days 1.7 1.6 1.5 1.3 1.4 1.2 1.4 1.2 
RS: 10 days 1.2 1.0 1.0 1.1 1.0 1.1 1.0 1.0 
Prolonged NTC, CL and NTC+CL decreased (p<O.OOl) all 
remodeling parameters (expansion index, thinning ratio, 
LV volumes, aneurysms) and improved LV regional and 
global ejection fraction compared to P but the effect 
was more marked (psO.05) in T than no T subgroups. 
The greater benefit in T persisted at 1 year. 
Thus, successful T and decreased CRIS had a positive 
impact on outcome in all TAMI groups, although 
adjunctive iv NTC might have contributed. 
767·4 4:45 
CATS: Captopril during Thrombolysis In Myocardial IDfarctlon, • Double•
blind P1acebo-controUed Acute IntervenUon Study 
Wiek van Gilst and Herre Kingma for the CATS Group. Dept of 
Clinical Pharmacology, Groningen, and St Antonius Hospital, 
Nieuwegein, Interuniversity Cardiology Institute, Tbe Netherlands 
Despite experimental evidence, tbe value of converting enzyme 
inhibition in improving clinical outcome after acute myocardial 
infarction is unknown. In CATS (Captopril And Thrombolysis 
Study), patients with first anterior myocardial infarction treated 
with IV streptokinase were randomized to either oral captopril or 
placebo at the end of tbe streptokinase infusion. Initial dose was 
6.25 mg and increased to 25 Irg TID during the next two days. 
Primary endpoints are LV-volumes assessed by echocardiography, 
occurrence of ventricular arrhythmias and neurohumoral changes. 
The trial started April lst, 1990 and mid november, 1991 the 
planned 310 patients will 
have been randomized. So 
far, LV -endsystolic and 
diastolic volume index of 
total population increased 
during 3 month follow•
up with 4.S (O.S-S.S) and 
7.8 (2.5-13.1) mil m2 
resp, the incidence of 
runs of ventricular 
tachycardias in the acute 
phase was 46% and nor•
adrenaline levels de•
creased 31% during the 
first 12 hours. Three 
month echo was not 
available in 18%, due to 
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refusal (7%), death (7%) or other reason (4%). Symptomatic 
hypotension after first dose was observed in 2 out of 243 patients; 
maximal decrease in diastolic blood pressure was 7 (4-10) mmHg. 
Therefore, considering lhe findings in CONSENSUS II (5.5 % 
hypotension after first dose), oral captopril seems to be well 
tolerated in patients with first anterior myocardial infarction. 
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767·5 5:00 
IMPORTANCE Of fIRST DOSE HYPOTENSION WITH ENALAPRILAT IN 
ACUTE MYOCAROIAL INfARCTION 
John Kjekshus and Karl Swedberg for the CONSENSUS II study 
group. Baerum Hospital, Sandvika, Norway. 
In CONSENSUS II, 6090 patients were randomized to receive 
1 mg. enalaprilat or placebo i.v. during 2-3 hours within 
24 hours after acute myocardial infarction, followed by 
oral enalapril (E) up to 20 mg/day or placebo (P). first 
dose hypotension (FDH) (blood pressure <90/60 mmHg) was 
observed in 10,5% vs 2,5% among E and P respectively.(p< 
0.001). Subsequent 6 months mortality rate among E 
patients with FDH was higher (17,3%) than among other E 
patients (9,3%) and higher than the mortality among P 
patients experiencing hypotension (10,8%). Multivariate 
analysis identified the following independent predictors 
of FDH: Age, country, inferior infarction, low pretreat•
ment systolic blood pressure, history of heart failure, 
history of peripheral vascular disease, prior used to 
compute a risk score for FoH. The score was used to 
~ompared P and E patients with respect to FDH and 
mortality. 
Risk score FDH(?O) 6 mnts. 
Quartiles PEP 
I 1 4 7 
II 2 4 6 
III 4 10 9 
IV 3 24 14 
mortality 
E 
8 
8 
9 
16 
P (PvsE) <0.01 n.S. 
The mortality within each risk quartile was the same 
among patients on P and E despite large difference in FDH. 
Therefore rather than causing excess mortality, FDH with 
E served to identify high patients destined to die 
regardless of treatment. 
767·6 
Small-to-Moderate Infarctions Remodel Without 
Hypertrophy: A Two Year Cine Computed Tomography 
Study. 
5:15 
Zina D. Hajduczok and Robert M. Weiss. Department of 
Internal Medicine, Univ. of Iowa, Iowa City, IA. 
In order to determine the time course and threshold 
infarct (MI) size at which ventricular dilatation and 
hypertrophy occur, we studied 17 patients without pre· 
existing hypertrophy, NYHA Class I-II, not on ACE•
inhibitor therapy, with cine computed tomography (CCT) 
at I wk, 6 wks, 6 mos, and 2 years following a first 
Q-wave MI. There was no clinical evidence of 
reinfarction during the study period. We computed 
three-dimensional volumes (EOV), ejection fraction 
(EF), mass, and abnormal wall motion zone (AWM) size 
from CCT. AWM averaged 20±3% of LV mass (range 2% to 
55%). Global mass showed no change over the entire 
study period: 1 wk: 164±5, 6 wk: 156±5, 6 mo: 156+7, 
2 yrs: 154+6. Patients were stratified by initial EF 
« or > 50%). Low EF: AWM· 31±6%, LVEF s 39±4%, High 
EF: AWM = 14+2%**, LVEF = 62+3%** (*p <.05,**p <.01 
low vs high IF). No hypertrophy was seen in either 
group by 2 yrs. EOV was greater in the low EF group 
at 1 wk (163±15 vs 125±6*) and 6 wk (171±20 vs 
110+9**) but not at 6 mo (183+27 vs 128+16) or 2 yr 
(185±14 vs 152±17). EDV/mass-; an indicator of wall 
stress, was greater in the low EF group through 6 mos 
but did not increase. Infarct artery patency tended 
toward greater patency in the high EF group due to a 
higher rate of angioplasty. Conclusion: Ventricular 
remodeling by dilatation occurs early in moderate 
sized infarction. In patients without pre-existing 
hypertrophy who have small-to-moderate sized 
infarction and EF > 30%, no global hypertrophy is seen 
even by 2 years. 
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768·1 
Vasomotor Control or Femoral Artery Blood Flow is Impaired in 
Chronic Heart Failure 
David Lindsay, Debbie Clarke, Diana Holdright, Inder Anand, 
Philip Poole-Wilson, Peter Collins. 
National Heart & Lung Institute, London, UK 
4:00 
The peripheral vascular resistance at rest is increased in Chronic 
heart failure (HF), and there is reduced limb blood flow on 
exercise. The cause of this limitation is poorly understood. In this 
study we measured femoral artery (FA) blood flow velocity in 16 
subjects with HF, and 26 patients with normal LV function (Con), 
using a 20 MHz intravascular Doppler probe positioned 
antegradely in the FA. Femoral artery blood flow (F ABF, ml/sec) 
was determined by the product of velocity x FA area, as measured 
by quantitative angiography. The FABF was recorded after a 3 
min. infusion into the FA of acetylcholine (ACh6 or AChS, blood 
concentration = 10-6 or IO-SM), substance P (SP, Spmol/min), or 
an B mg bolus of papaverine (PB). 
The mean L VEF in the Con was 73% (SEM 2.9%) and in the HF 
was 2B±4%. Baseline blood flow was lower in the HF than the Con 
(2.9±0.4 vs 4.S±0.3, p<O.OOS), and increased to lesser levels after 
P8 (B.2±1.2 vs 12.9±I.l, p<O.OOS), ACh6 (4.B±1.0 vs B.O±O.B, 
p<0.02), AChS (B± I.B vs 13.4± 1.9, p<O.OS) and SP (6.3± 1.1 vs 
B.9±0.9, p<0.05). There was a significant correlation between the 
L VEF at rest and baseline blood flow in the HF group (r=0.7B, 
p<0.002). There was a significant correlation between the LVEF in 
the HF patients, and their peak blood flow with P8 (r=0.6I, 
p<0.05), ACh6 (r=0.66, p<0.02), ACbS (r=O.79, 0<0.01) and SP 
(r=0.B7, p<O.OO I). 
There is reduced lower limb blood flow at rest in chronic HF. 
The response to both endothelium-dependent and -independent 
vasodilators is impaired. This may account for the failure to 
adequately increase lower limb blood flow on exercise in chronic 
heart failure. 
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768·3 4:30 
Nitroglycerin and Endothelium-Dependent Vasodi•
lation in Patients with Congestive Heart Failure 
Michael Schwarz, Stuart D. Katz, Rhonda 
L'Heureux, Thierry LeJemtel, The Albert Einstein 
College of Medicine, Bronx, NY. 
Acetylcholine (Ach)-mediated endothelium-depend•
ent vasodilation is impaired in patients (pts) 
with congestive heart failure (CHF). To deter•
mine whether direct activation of soluble guany•
lase cyclase with extremely low dose of nitrate 
can restore endothelial-dependent vasodilation 
toward normal in these pts, the local vasodila•
tory responses to brachial arterial infusions of 
graded concentrations of Ach were studied in the 
forearm circulation of 11 pts with CHF (mean age 
54, mean EF 24%) prior to and during a brachial 
arterial infusion of nitroglycerin (NTG) at a 
very low dose which did not exert an~ detectable 
direct local hemodynamic effect (10- M). Fore•
arm blood flow (ml/lOOml) was measured using 
venous occlusion plethysmography. NTG 10-9H in•
fusion alone did not change resting forearm 
blood flow from baseline (6.3 vs 6.1, peNS). 
Forearm blood flow responses to Ach were as 
follows: 
Ach 10-7M 
Baseline 6.5 
NTG 10-9M 8.9* 
* p<.05 vs baseline 
10-6M 
8.1 
10.8* 
10-5M 
16.4 
26.2* 
In 5 control pts, responses to Ach before and 
after placebo infusion were similar. In con•
clusion, low dose NTG infusion potentiates endo•
thelium-dependent vasodilation in pts with CHF. 
Interaction with endothelium-dependent vasodila•
tory mechanisms may contribute to the hemodynam•
ic benefits of organic nitrates in pts with CHF. 
768·4 4:45 
Effects of Chronic Captopril Therapy on Endothelium· 
Derived Relaxing Factor Activity in Heart Failure 
Michael T. Ontkean, Richard Gay, Barry Greenberg. 
Oregon Health Sciences University, Portland, Oregon 
In order to assess the effects of angiotensin-converting 
enzyme inhibition on endothelium-derived relaxing factor 
(EORF) activity in chronic heart failure (CHF) , we 
administered captopril (2g/1 in drinking water) to 
groups of rats follOWing either coronary ligation or 
sham operation. After 10 weeks, rats were sacrificed 
and relaxation to acetylcholine (ACh) was assessed in 
pulmonary artery (PA) segments from sham (n-14), 
sham+captopril(n-7), CHF(n-7) or CHF+captopril(n-7) 
rats. Infarct area was >25% of the left ventricle in 
the CHF and CHF- captopril groups. CHF rats demonstrated 
diminished maximal relaxation to ACh compared to sham 
(80 ± 5% vs 95 ± l%;p<O.OOl) and a significantly higher 
EC,o value (-log M) for relaxation (5.9 ± 0.3 vs 6.8 ± 
0.1; p<O.OOl). The dose response curve for relaxation 
to ACh was nearly normalized in CHF-captopril rats and 
the ECso was significantly less than in CHF rats (6.6 ± 
0.1 vs 5.9 ± 0.3;p ~ 0.05). No significant differences 
in response to ACh were seen between sham and sham•
captopril rats. Neither acute incubation with L•
arginine (lOOuM), the substrate for nitric oxide (NO) or 
captopril (lOuM) had any significant effect on the 
response to ACh. These data show that in rat PA (l)ACh 
mediated EORF activity is diminished in CHF, (2) an 
abnormality in NO substrate does not appear to be 
involved (3) chronic administration of captopril 
abolishes this defect and (4) enhanced EORF activity 
with captopril is not due to an acute drug effect on the 
vessel. 
ABSTRACTS 
768·5 5:00 
Elevated Endothelium-Derived Relaxing Factor Assayed Directly in 
Sera From Heart Failure Patients 
Cregg C. Fonarow, Lynne Warner Stevenson, Catherine Chelimsky•
Fallick, Russell Byrns, Louis C. Ignarro. UClA Medical Center Los 
Angeles, CA 
Endothelium-derived relaxing factor (EDRF) has been shown to be 
nitric oxide (NO) or a related nitroso compound which is 
synthesized also in mononuclear cells and has been studied in 
bioassay systems. EDRF release produces vascular smooth muscle 
relaxation and occurs in response to a variety of stimuli such as 
bradykinin. histamine, and substance P as well as physical stimuli 
such as increased vascular flow. The role of EDRF in the altered 
peripheral circulation of heart failure is not known. This study 
measured nitric oxide directly in sera from 18 patients with 
advanced heart failure on oral therapy and 16 healthy controls using 
a sensitive chemiluminescence assay. After plasma nitrite content 
was reduced in a refluxing chamber with Nal and glacial acetic acid, 
the NO formed was allowed to react with ozone to release light 
measured by a photomultiplier. Inter-assay variation was 8%. 
The patients studied had advanced heart failure (mean LVEF 20%) 
and were on a stable regimen of digoxin, furosemide. and oral 
vasodilators with no evidence of infection. These patients had 
elevated NO levels of67±19 pmolesll00 ul as compared to 29±14 
pmolesllOO ul in control subjects (p<.OOOl). 
The elevation in EDRF levels in advanced heart failure patientS 
may reflect a compensatory increase in endogenous EDRF formation 
or the result of vasodilator therapy. 
768-6 5:15 
Circulating Twnor Necrosis Factor and Endothelial-Derived Relaxing Factor 
in Severe Heart Failure: Effects After Cardiac Transplantation. 
Jibo Han, Sandra Leeper-Woodford, David Drenning, Daniel Bechard, Rebecca 
Quigg, Jeanne Salyer, Hassan Ibrahim, Albert Guerraty, Alpba Folwer III, 
Pramod Mohanty. Medical College of Virginia, Richmond, VA. 
Cachexia and hypotension are prominent features of severe end stage heart 
failure. Although left ventricular dysfunction i. • major contributor to 
hypotension, Tumor Necrosis Factor (TNF), a pluripotent cytokine which 
activates the vascular endothelium to release Endothelial-Derived Relaxing Factor 
(EDRF), may also contribute to the hypotension. We hypothesized that TNF &. 
EDRF levels would be increased in severe heart failure and would decrease 
following successful cardiac transplantation. Accordingly, we determined plasma 
TNF and EDRF (indirectly measured by its stable metabolite, NO,) in 5 NYHA 
CI.".. IV heart failure patients (mean age 55yo) and compared them with four 
patients following cardiac transplantation (mean age 55 yr), and 5 age matched 
control subjects. Plasma NO, was measured using an automated microplate 
assay based on the Griess reaction (R'=O.99);plasma TNF activity was measured 
by the L929 cytotoxicity bioassay. TNF levels were significantly higher 
(p<O.05, ANOVA) in heart failure and returned to levels that were 
indistinguishable from control patients following cardiac transplantation. Mean 
arterial pressures were 91.6 (± 14) control, 74.0 (±7) heart failure, and I07.7(± 
17) torres post transplant. There were no significant differences between the 
groups with respect to plasma 
ED RF IN 0ilevels although it tended to 
be lower in heart failure 
(see fig). These results suggest that 
cardiac transplantation reverses the 
elevated levels of circulating TNF. This ,!! 
reduction was Dot associated with ~ 0.7:1 
changes in the circulating level of EDRF 
metabolites. Thus, hypotension in severe 
heart failure cannot be explained hy 
excessive release of EDRF. 
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769·1 
estimated Cendldacy Rates for Implantable C8rdloverter 
Defibrillators In a Defined Population 
4:00 
Thomas E. Kottke, Marshall S. Stanton, Kent R. Bailey, Mayo Clinic, 
Rochester, MN 
Because the population of Rochester, Minnesota is demographically 
similar to the white population of the United States, and all local 
Inpatient, outpatient, and emergency medical service records are 
available through the Rochester Epidemiology Project, it is possible 
to use this population to estimate national needs for medical care. 
To !lstlmate IhA potential candidacy rates for implantable 
cardloverter defibriilator:; (iCDs), wa ra.iawed ail rt/curtis with 
diagnoses of cardilic arresi (CA), ventricular tachycardia (VT), and 
ventricular fibrUiatic:'1 (VF), pius c:l3es treated with amiodarone and 
cases thai had undergone electrophysiologic (EP) testing. Paiienis 
were considered candidates for iCDs if they had experienced CA, 
sustained VT, or nonsustained VT with syncope that was not due to 
an acute myocardial infarction or other secondary causes. To be 
definl:J cand.;Jates, patients also had to have undergone an EP 
study to show either that they were not inducible at baseline if the 
clinical event was CA or that ;;:2 drugs failed to suppress inducible 
VT during serial testing if the clinical event was VT. For the years 
1981·1988,24 patients were definite candidates. An additional 6 
patients were considered possible candidates because they met the 
criteria for a clinical event but did not have full EP testing. ICD 
candidacy rates (age and sex adjusted to the 1980 US white 
population) were 6.45/100,000 for definite candidates and 
1.71/100,000 for possible candid(lt&s. Extrapolation from the 
pop'Jlatlon of Rochester, Minnesota to the entire 1980 US population 
produces a.1 estimate of 14,609 new definite candidate:; IIn"l anothp.r 
3.851 new possible ICD candidates each year. 
769·2 4:15 
Significance of Ventricular Function In 
Implantable Defibrillator Patients: Montetiore 
Hospital and Cleveland Clinic Experience 
Soo G. Kim, Sergio L. Pinski, James D. Maloney, 
Seymour Furman, Chung Whee Choue, Jay Gross, 
Richard Brodman, James Roth, Kevin J. Ferrick, 
John D. Fisher, Montefiore Hospital and Cleveland 
Clinic, Bronx, N.Y. and Cleveland, Ohio 
Prognostic significance of ventricular (LV) 
function was studied in 378 pts treated with 
implantable defibrillator (ICD) at Montefiore 
Hospital (68 pts) and Cleveland Clinic (310 pts) . 
The LV ejection fraction (EF) was measured in 364 
pts, and was ;;:30% in 215 pts and <30% in 149 pts. 
Surgical mortality (SM) was 4.0% in all(1.8% in 
pts with EF ;;:30%, 7.0% in pts with EF <30%). 
Total arrhythmia-related death (TAD) '" sudden 
death (SCD) + nonsudden arrhythmic death + SM. 
Total cardiac death (TCD) = TAD + nonarrhythmia•
related cardiac death . Duration of follow-up was 
25±20 months (mos) (mean ± SO). Actuarial survival 
rates of pts with EF ~30% and <30% are compared. 
-EL ~ ~ l.L!!lM ~ £ 
SCD ;;:30% 99% 99% 99% 99% ~.M 
<30% 98% 95% 92% 90% 
TAD ~30% 97% 97% 96% 94% <0.001 
<30% 88% 84% 82% 80% 
TCD ;;:30% 96% 94% 90% 88% <0.0001 
<30% 85% 79% 74% 68% 
Thus, outcomes of ICD pts are strongly influenced 
by LV function. In pts with EF ;;:30%, SCD, 
surgical mortality and total arrhythmia-related 
deaths are rare. In pts with EF <30%, although 
SCD is relatively low (10% at 3 yrs) , surgical 
mortality (7%), total arrhythmia-related deaths 
and total cardiac deaths remain substantial. 
769·3 
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Is Implantable CanIIoverter DeIIbrlIJator IDterveatiou TnIy UfesaYiDg ID 
Patients ReceIvIDg Such 'lbenIpy? 
Sanjay Oeshpande, A1fredJ. Anderson, KathiAxleIl, Mohammad Jazayeri, Jasbir 
Sra, Boaz AvitaJl, Anwer OhaJa, Zalmen Blanck, Masood Akhtar, Sinai 
Samaritan Medical Center, Milwaukee, WISCOnsin. 
Criticism of data On survival statistics with the implantable defibrillator (ICD) 
stems from the assumption that the first "appropriate shock" (AP·SH) saved a life 
from an otherwise uniformly lethal tachyarrhythmia. 
Conventionally, a survival curve is generated assuming a fatal outcome with the 
firstAP-SH and compared to actua1sudden death (SO) freesurvivaJ. ID this study 
we analyzed survival statistics in our population of ICD recipients at various 
"levels" of benefit from the first AP-SH by serially diminishing it's assumed 
lifesaving efficacy from 100% to 0%, and recomputed survival at 5 years of 
fonow-up. 
ID our population of 315 consecutive patients (pi) with ICDs, (mean age of 61.9 
years, mean ejection fraction 34.6%), there were 3 perioperative deaths, and 
during a mean fonow-up period of 28 months, 10 pt died suddenly. AP-SH were 
recorded in 116 pt (associated syncope, presyncope or documented ventricu1ar 
tachyarrhythmia). The table below depicts various 1eve1s of lifesaving efficacy. 
Assumed ICD efficacy 100% 50% 30% 20% 15% 
Actual SO rate (%) 6 6 6 6 6 
Anticipated SO rate (%) 55 28.5 20.3 15 14.6 
based on lCD efficacy 
pvalue <0.0001 <0.0001 < 0.001 < 0.01 <0.05 
Standard Error 4.9 3.8 3.6 3.4 3.3 
Coocluslou: The positive impact of ICD therapy On SO survival remains 
demonstrable even if a mere 15% of AP-SH are considered truly lifesaving. 
769·4 4:45 
What Results Can Be Expected From Implantable Cardioverter·Defibrillator 
(lCD) Therapy in Coronary Artery Disease (CAD) Patients Presenting 
Excl .... ively with Ventricular Fibrillation (VF)? 
Timothy Lessmeier, Michael H. Lehmann, Barbara Fromm. Masood Akhtar. 
10hn DiMarco, Andrew Epstein, Richard Fogoros. Stephanie Stevens, David 
Wilber. Wayne State University, Detroit. MI & Participating Ctrs. 
Previously reported ICD series have combined pis with differing organic heart 
disease and presenting anhythmias. It is not clear, however, whether the 
favorable actuarial resulis apply to specific subsets of cardiac arrest survivors. 
Hence, we studied outcomes of ICD therapy in 234 CAD pis presenting 
exclusively with VF (unassociated with acute MI): 81 % male, mean age 62 .:t 
9 years, mean EF 33 .±. 13 %, and concomitant CABO in 40%. Operative (30-
day) mortality was 2.1 % overall (091 in 136 pis with EF ~ 30, and 1.5% in 138 
pis without concomitant surgery). Estimated cumulative event rates (%.:tSE) 
over a median follow-up ofS vIS II dav - 7.9 vIS) post-ICD implantation were: 
Incidence At I Y r Incidence At 4 Yrs 
Event EF>30 EF<30 EF>30 EF<30 
Sudden Death 0.8.±. .8 4.0.:t2.3 6.8.±.3.6 8.4.:t4.8 
Any Cardiac Death 3.4.±..2 9.0.±.3.1* 16.8.±.S.6 32.9.±.7.7* 
Any Death 4.2.±.1.9 11.0+3.3* 2S.1.±.6.8 38.9.±.7.7* 
~1 Shock (appropriate) 28.9.:t4.O 28.8.:t4.9 43.9.:t5.3 63. 6.±.7. 7 
~I Shock (any) SO.2.±.4.5 49.0.±.S.4 79.7.±.4.7 89.1.±.S.9 
"p < .OOS for difference between EF> 30 and EF < 30. 
Although pis with low EF ( < 30) bad higher cardiac-nonsudden and total death 
rates ("I' < .(05), no significant difference was seen for sudden death. Total 
mortality was 38.±.7%, overall, at 5 years. Actuarial survival curves for shocked 
vs non-shocked pis were superimposable. Shock occurence was similar in pis 
with and without concomitant CABO. 
Conclusions: In CAD pis presenting exclUSively with VF and treated with ICD: 
(I) Operative (30-day) mortality is negligible for EF ~ 30. (2) Device 
utilization is high with low sudden death rates, ~ of EF. (3) Low EF 
« 30) predicls higher cardiac and total mortality, due to an increased incidence 
of non-sudden cardiac death. (4) Similar mortality in shocked and non-shocked 
pis, together with low sudden death rates, implies that ICD therapy improves 
survival in shocked pis to • level observed in comparable pis who lack 
ventricular tachyanhythmia recurrence. 
JACC Vol. 19, No.3 
March 1, 1992:209A 
769·5 5:00 
Early Survival and Follow·up Characteristics of 151 
Patients Undergoing Transvenous Cardloverter 
Defibrillator Lead System Implantation 
Stephen Ehrlich, for The ENOOTAK Investigator Group. 
Hospital of the Good Samaritan, Los Angeles, California 
Transvenous lead systems offer potential advantages over standard 
automatic implantable cardioverter defibrillator (AICO) lead 
systems and implant techniques. We report the short term 
survival and follow·up data on 151 patients (pts) who received a 
transvenous AICO system with or without a subcutaneous patch 
(ENOOTAK . CPI) during phase I and II clinical investigations. 
Two hundred fifteen pts were evaluated for implantation. Sixty 
pts had prohibitively high OFT's (greater than 25 joules) and in 4 
pts the lead could not be placed for technical reasons. One hundred 
fifty·one (70%) pts eventually received AICO pulse generators. 
Intraoperative testing of these pts revealed successful conversion 
of induced arrhythmia in all pts (100%). Predischarge testing in 
142 (94%) pts demonstrated appropriate detection and 
conversion of induced arrhythmia in 139 pts. Evaluation of 49 
pts at 8 . 12 weeks of follow· up revealed successful termination 
of induced arrhythmia in all pts. Clinical follow· up for a mean of 
3.4 months (range - 0.5 to 9.5 months) revealed 3 deaths and an 
actuarial 6 month survival of 98.4%. There were no 
perioperative deaths. One pt died suddenly, one of progressive 
heart failure, and one from noncardiac causes. There were 257 
spontaneous shocks in 30 pts. Two hundred thirty four (91%) 
shocks in 24 (87%) pts were felt to have been clinically 
appropriate shocks. 
These data suggest that transvenous AICO lead systems may be 
an excellent alternative to open thoracotomy placement of standard 
lead systems for appropriate patients. 
769·6 5:15 
Survival In Patients With Ventricular Tachyarrhythmias Treated 
With Programmable Tiered Therapy Implantable Defibrillators 
Roger A. Winkl~ ~c S. Fain, Michael B. Sweeney, Kathi M. 
Senelly and the \.-aOence" Investigators, Sequoia Hospital, 
Redw60d City, CA 
Three hundred thirty-seven (337) patients at 19 implanting centers 
received a Ventritex Cadence" tiered therapy defibrillator for 
treatment of ventricular tachycardia (VT) andlor fibrillation 
(VF). The device is fully programmable, noncommitted) can detect 
up to 3 different rate tachyarm~mias, and is capable or 
antitachycardia pacing, high and low energy cardioversionl 
defibrilfation and backup VVI pacing. The mean age of the 
patients was 62 years (range 14 to 90 years~ 86% were male, and 
the mean ejection fraction was 32% (range':J to 78%). The 
presenting arrhythmia diagnosis was VT In 250 patients, VF in 21 
patients and both VTIVF In 66 patients. The patients had a mean 
follow-up of 177 days (1 to 601). Spontaneous VT or VF, as 
documented by stored intracardlac eTectrograms, occurred in 167 
patients; with a time to first therapy of less than 30 days in 68 % 
(range 1 to 330 days). There were a total of 17 deaths among 
patients with devices programmed to deliver tachyarrhythmia 
therapy; 9 were non-cardiac, 6 were non-sudden cardiac, and 2 were 
sudden cardiac deaths. There were 3 additional peri-operative 
deaths with the device programmed off; these were excluded from 
the analysis. Kaplan-Meier actuarial analysis demonstrated one 
year sudden death-free survival of 99%, one year survival from all 
cardiac causes of95%, and one year survival from all causes of 
92%. These survival rates were unchanged out to 20 months of 
follow-up. There were no significant differences in these 
survival rates when analyzed for patients by presenting diagnosis 
(VT, VF, VT/YF), treatment with antiarrhythmic drugs (276 on 
drugs; 61 off drugs), or treatment with antitachycardia pacing 
(232 programmed on; 105 off). Therefore, excellent sudden death· 
free SUrviVal rates can be attained using more complex, 
programmable tiered therapy devices. 
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Xedical, surgical and Angiopla.ty survival 
Outcome. in 7655 coronary Di •• a •• pati.nt. 
Daniel B. Mark, Charlotte L. Nelson, Frank E. 
Harrell, Jr., David B. Pryor, Robert H. Jones, 
Richard S. Stack, Donald D. Glower, Harry R. 
Phillips III, Kerry L. Lee, Robert M. Califf 
Duke University Medical Center, Durham, N.C. 
To evaluate the survival outcomes associated 
with modern revascularization strategies, we 
studied 7,655 consecutive patients (pts) with 
symptomatic, significant (~ 75% stenosis) 
coronary disease referred to Duke for cardiac 
catheterization between 3/84 and 7/90. pts 
with left main disease, 3+ to 4+ mitral 
regurgitation, and previous revascularization 
were excluded. Within 60 days of cath, 1908 
pts underwent coronary angioplasty (PTCA), 
2764 pts underwent bypass surgery (CABG), and 
the remaining 2983 were treated medically. 
PTCA pts were younger than CABG or medical 
patients and had more unstable angina (43%, 
32%, 26%, respectively). Multivessel disease 
was present in 38% of PTCA pts, 90% of CABG 
pts, and 54% of medical pts; and ejection 
fractions (EF) were higher in PTCA pts (median 
EFs 55,52,50, respectively). After adjusting 
for all known baseline imbalances (Cox model), 
initial analyses indicated that revasculariza•
tion improved survival relative to conserva•
tive therapy (p<.05). CABG provided the most 
benefit for 3 vessel disease, while PTCA was 
most beneficial for less severe CAD. ThUS, 
modern revascularization strategies with PTCA 
and CABG provide significant survival benefits 
to a large spectrum of patients with coronary 
disease. 
770·2 4:15 
Effect of Selective and Nonselective TxAz 
Blockade on Events after PTCA: M-HEART II 
Carl Pepine, Robert Macdonald, Theodore Bass, 
George Vetrovec, Hall Whitworth, Michael Cow•
ley, Sheldon Goldberg, Michael Savage, Alfred 
Bove, John Hirshfeld, Ezra Deutsch, James 
Margolis, James Hill, Jeffrey Granett for the 
M-HEART Group; Univ. of Florida, Gainesville. 
Platelets and TxA2 are implicated in prolifer•
ative and vasoconstrictive processes occurring 
after PTCA. To study whether selective (sul•
otroban, S) or nonselective (aspirin, A) TxA2 
receptor blockade prevents events after PTCA, 
a multicenter, double-blind, placebo-con•
trolled trial was conducted. A total of 755 
pts. were randomized to receive placebo (P), S 
(3200mg/d), or A (325mg/d). A and heparin were 
given during PTCA and the study drug was 
started <1 but not >6 hrs. before PTCA. 519 
patients had successful PTCA and were compli•
ant for follow-up. There were fewer (p<0.05) 
total adverse ischemic events (deaths, nonfa•
tal MIs, symptomatiC restenoses and repeat 
revascularizations) after 26 weeks follow-up 
in the A pta. Nonfatal MIa occurred in 15 pta 
(P 10, S 3, A 2, p<0.05). There were no Sig•
nificant differences in angiographic resten•
osis rates (minimum lumen diameter P=1.43, 
S=1.43, A=1.54 pns). 
Conclusions. Outcome data indicate that TxA2 
blockade with A, and to a lesser extent S, 
prevents ischemic events for up to 6 months 
following PTCA without an angiographically 
detectable effect on cellular proliferation 
responsible for restenosis. 
209A 
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770·3 4:30 
TIlt Btneftll of Upld-LClWtrlng Therapy In Men With Elevalld ApoIlpoprotaln B Is Not 
ConfIned to ThaIt WIth High LOLoCIIoIest8rol 
B. Fendley Stewart, B. Greg Brown, Xue.Qlao Zhao, Lynn A. Hillger, Allan D. Snidennan, 
Alice Dowdy, Lloyd D. Fisher, John J. Albers, University 01 Washington School of 
Medicine, Seattfe, WA 
The FATS trial is a randomized, fully blinded, quantitative ar1eriographic comparison of 
3 lipid·altering strategies. Men, age S62 yrs, with disease, a family history of 
premature cardiovascular events, and with apoliproprotein B ~ 125 m~ were shown 10 
have net regression of disease and fewer cliniCal events (death. proven MI. or newly 
refractory Ischemic symptoms requiring bypass surgery or angiOpiasty) with intensive 
lipid-lowering therapt (INT). INT patients were counseled In diel and assigned to 
colestipol 30gmld and either niacin 4 gmld or Iovaslatin 4OmgJd. A conlJ'ol group 
received conventional therapy (CONV • placebo;l; colestipof for high LDLd. Bimonlhly 
visilS spanned 2.5 years belween coronary arteriograms. Stenosis change (d'loS) was 
averaged over the same 9 proximal segmenlS in each patient. Lesion d'loS was 
'progression' H ~ 10% or 'regression' If oS ·10%. We examined disease progreSSion, 
lipid responses, and clinical events in patienls with and without high LDL -cf1Oleslerol 
levels at baseline (LD~ ~90th percentile for age). Of the 120 patienlS completing the 
2112 year protocol, 59 had high LD~ (mean 222mgJdl), 61 did not (mean 152 mgJdl). 
~: 
Mean (mgJdl) Patients 
Clinical LDLc /HOle Mrirl with only 
&. .LIlLc H ~ Base!joe in·Ax W prggn ~'n 
CONY High 20 2 215144 185146 +1.80 10 
IIiI I:ttl as 3 2251!1 13Z1lil ·022 S II' 
CONY not high 26 8 145135 144136 +2.36 11 3 
IIiI IlIlItiltI 35 2t 158135 SB/!5 _]3fiu B 15" 
¥146 patienls, Inlention 10 treat analysis 
versus conv: ANOVA· • p •. 025, "p •. 01; Fishe(s exact :til •. 01 
~: Although those patients with and without high LD~ benefitted from lipid· 
lowering therapy, the latter appear to have oblained greater benefit. This may be 
explained by their truly 'nonnal' in-lJ'eatment LD~ levels. 
770·4 4:45 
II There a POlt·Telt Gender Bfal In the Management of 
Patlenll With SUlpectld Coronary Artery Disease Referred for 
Nonlnvallve Teltlng? 
Leslee Shaw, D. Douglas Miller, Llwa Younls, Deborah Kargl, Karen Stocke, 
John Pargulskl. Bemard Chaitman. St. Louis Unlv. Med. Ctr., 51. Louis, MO. 
Recent evidence suggests sex differences in the use of Invasive diagnostic 
procedures and ooronary revascularization (REV) In men (M) and women (W) 
wHh known coronary arlery disease (CAD) or myocandial Infarction (MI). To 
determine whether a post·test gender bias also exists In the noninvasive 
evaluation and management 01 pts wHh suspected CAD. 481 oonsecutive pts 
(age 55±6 years, 47% W) undergoing exenelse testing (ETT; n-157),exeneise 
thallium (E-TI; n-218), or dipyridamole thallium·201 (D·TI; n.106) imaging lor 
evaluation of suspected CAD were retrospectively studied for their subse•
quent REV,addHional diagnostic procedures (i.e. ooronary angiography), and 
candiac death (D) or MI during 24±7 months of follow·up. Atypical angina was 
more oommon in W (57 vs 43%;p<0.01 ),while typical angina was similar (23% 
W vsI7%; p-NS). Cardiac risk profiles were comparable,excepting 
hypertenSion which was more frequent in W (52 vs 42"10; P.0.03). 
24% W (n-54) and 26% M (n-66) had a posHlve Initial test, defined as ST 
depression ~ 1.0 mm and/or ~ 1 reversible TI delect. 01 these pts, M were 
relerred more olten for fOllow-up diagnostic testing than W (see graph): ! :~ilP'O'OI ~P<O'OOI ~P<005 : :::lllum 
'0 [J Angiogram 
... o~ 
Initial Test M ETTW ME_TI W MO_TI W 
The majority of W (70%) with an initial positive test had no further CAD 
evaluation. REV were more frequently performed in M (3 vs <1%; 1>'0.02). D· 
MI occurred more olten in W (2.5 vs <1%; p.0.03). 
We oonclude that a post-test gender bias exists in the application of 
noninvasive studies among pts wHh suspected CAD. with W undergoing 
fewer additional diagnostic studies despite oomparable Incidences 01 typical 
angina, candlac risk factors and inHialtest posHMty rates oompared to M. The 
Impact of this gender bias on subsequent REV and D-MI was signfficant. 
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770·5 5:00 
EFFECT OF ENALAPRIL ON THE DEVELOPMENT OF 
MYOCARDIAL INFARCTION AND UNSTABLE ANGINA 
Salim Yusuf, Carl J. Pepine, Martial Bourassa, 
Carlos Garces and Bertram Pitt for the SOLVD 
investigators; Bethesda, Me 20892 
Recent data suggest that elevated renin levels 
predict future myocardial infarction (MI). We 
therefore studied the effects of enalapril (E), 
an angiotensin converting enzyme (ACE) 
inhibitor, or placebo (P) on the development 
of HI or hospitalization for angina (A) in 
6797 patients with an ejection fraction <-0.35 
entering the studies of Left Ventricular 
Dysfunction (SOLVD). Data on 2569 patients 
requiring treatment for heart failure 
(Treatment Trial) are currently available. 
P E' Risk P 
Endpoint n~1284 n-1285 Reduction 
No. MI 150 124 18 0.10 
No. A 239 186 24 0.01 
No. HI or A 341 280 20 0.01 
No. Cardiac deaths 
or HI 506 428 19 0.001 
No. Cardiac deaths 
MI or A 658 544 23 0.0001 
Data analyses among 4228 patients in the 
Prevention Trial (not requiring treatment for 
heart failure) will be completed later this 
year and will be included in the presentation. 
Conclusions: The SOLVD Treatment Trial 
indicates that enalapril reduces the incidence 
of unstable angina and perhaps MI. If these 
observations are confirmed in the Prevention 
Trial, then ACE inhibitors would be useful in 
preventing major ischemic events in a variety 
of cardiac diseases. 
770·6 5:15 
BeDeUt. iD QUality of Life Score. ill PatieDta Treated 
with ADgiopla.ty ••• Medical Therapy 
William Strauss, Terry Fortin, Pam Hartigan, Edward 
Folland, Alfred Parisi. VAHC West Roxbury, Massachusetts 
The VA ACME (6ngioplasty ~ompared to Hidicine) trial is 
the first large comparison of optimized medical therapy 
vs. PTCA in patients with symptomatically stable coronary 
artery disease. Three hundred twenty.eight patients with 
70, or greater obstruction of one or two major vessels 
were randomly allocated to either therapy. The primary 
endpoints for efficacy were mean change in exercise 
tolerance and monthly angina attack rates at 6 months 
compared to baseline. 
In the single vessel disease population (n-212), PTCA 
patients increased duration of exercise to greater degree 
(2.1 vs. 0.5 min p <0.0001) and experienced a greater mean 
decrease in angina (15 vs. 7 episodes per month). 
At entry and 6 months, patients completed a quality of 
life questionnaire (QOL) comprised of a standard 
psychological profile with the addition of physical 
activity score. The QOL measured the following 
parameters: anxiety, depression, positive attitude, self•
confidence, general health, Vitality and physical 
activi ty. At baseline, overall scores were equivalent 
between the cohorts (72.67 vs. 72.02 p-ns). However at 6 
months single vessel disease patients receiving PTCA 
showed a greater overall improvement than medically 
treated patients (82.18 vs. 74.10 p-.03). PTCA patients 
showed a slight improvement in all 7 categories and 
significant differences p < .05 in general health and 
Vitality. 
Patients with single vessel disease who received PTCA 
had a greater improvement in overall QOL than when treated 
medically, and such QOL changes parallel those of exercise 
duration and angina attack rate. 
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Mechanism of NTG·Induced Vasodilation of Coronary 
Stenoses: Expansion of the Non·Involved Vessel Wall 
Masakazu Yamagishi, Steven E. Nissen, David C. Booth, John C. 
Gurley, Charles Fischer, and Anthony N. DeMaria 
University of Kentucky and VA Med Center, Lexington, Kentucky. 
Although angiographic studies have demonsttated that nitroglycerin 
(NTG) can dilate atherosclerotic coronary lesions, the mechanism of 
vasodilation is undefined. Inttavascuiar ulttasound enables visualization 
of the 360 degree circumference of the vessel wall to determine the 
mechanism ofvasoreactivity to NTG in coronary artery disease (CAD). 
We perfonned ulttasound of tl>e left coronary before and after intta•
coronary NTG (2S0 I1g) using a S.S F, 20 MHz, 64 element catheter 
system. Videotaped ulttasound images were digitized and the thickness 
of vessel wall structures measured with an electronic cursor. The cross 
sectional area (CSA) and perimeter of the lumen were also measured. 
Wall morphology by ulttasound was classified as abnormal if the 
intimalleading-edge was thickened (> 0.3 mm) or the sonolucent zone 
was expanded (> 0.2 mm). Atherosclerotic lesions were c1assifed as 
circumferential if the entire wall was diseased and non-circurnferential if 
wall abnormalities involved only a portion of the vessel perimeter. Of 
33 examined sites, 10 were normal and 23 revealed CAD by intra•
vascular ulttasound. For the 10 normal sites, NTG produced a large 
increase in CSA, 26± 13%, within 60 seconds following injection. In 
the 23 atherosclerotic segments, NTG-induced dilation was impaired 
with CSA increasing only 12 ± 8%, p<.OS compared to normal sites. 
In 12/23 diseased segments, a non-circumferential lesion was identified 
and CSA following NTG increased by 17 ± 7%. In 11/23 sites, 
circumferential disease was present and CSA increased only 6 ± 6%. In 
non-circumferential lesions, the increase in the perimeter of the normal 
portion of the wall was significantly greater than the increase in the 
CAD ponion, IS ± 9% vs. 4 ± 3%, p < 0.01. Thus, although lesions 
vasodilate following NTG, vasoreactivity is significantly reduced 
compared to normals. Non-circumferentiallesions exhibit greater 
dilation than circumferential, and expansion is significantly greater for 
the non-diseased perimeter. Thus, vasoreactivity in atherosclerotic 
aneries is primarily produced by expansion of the non-diseased wall. 
771·2 
In Vivo Demonstration of a Role for Nitric Oxide in the Regulation 
of Coronary Vascular Tone by Simultaneous Intravascular Two•
Dimensional and Doppler Ultrasound. 
Krishnankutty Sudhir, John S. MacGregor, Sophie Barbant, 
Mukesh Gupta, Paul G. Yock, Kanu Chattetjee. 
Cardiovascular Research Institute, University of California at San 
Francisco, San Francisco, California. 
Nitric oxide (NO) is released from endothelial ceUs and mediates 
acetylcholine (ACh) induced vasodilation in arteries. Using 
simultaneous intravascular 2-dimensional and Doppler ultrasound, 
we examined the role of nitric oxide in the maintenance of coronary 
vascular tone in vivo in 6 dogs. A 0.018" Doppler wire was 
introduced into the mid-segment of the left anterior descending or 
circumflex coronary ariery to measure flow velocity (FV). To 
measure cross-sectional area (CSA), a 4.3F, 30MHz ultrasound 
imaging catheier was placed in the same vessel with its tip 1-2 cm 
proximal to the Doppler transducer. Drugs were infused directly 
into the left main coronary ariery over 1 minute periods to minimize 
systemic effects. ACh caused a dose dependent vasodilation, while 
NO>-nitro-L-arginine methylesier (L-NAME), an inhibitor of nitric 
oxide synthetase caused a dose-dependent vasoconstriction that 
was partially reversed by L-Arginine (L-Arg). 
4:15 
ACb(%rise) 
Dose (lQg Ml -7 -6 -5 
L-NAME(% fall) 
-6 -5 -4 
L-Arg(% rise) 
-4 
t\CSA HI B±3 13±4 
t\FV 19±7 22±15 55±25 
t\FIow 31±13 43±19 96±32 
-5±2 -lOB -12±2 
-B±4 -13±9 -12±11 
-15iS -19±5 -24±10 
6±2 
15±12 
22±13 
In conclusion, endogenous NO formed from L-Arg appears to 
influence the maintenance of coronary vascular tone. The 
vasoconstrictor effect of inhibition of NO synthesis suggests a role 
for NO in basal coronary flow regulation, especially in the 
epicardial coronary circula tion. 
ABSTRACTS 21lA 
771·3 4:30 
Endothelium.Dependent Modulation of Pulmonary 
Vascular Tone In Man 
Michael J. Landzberg, Joseph A. Vita, Alan C. Yeung, 
Christopher P. Cannon, Peter Ganz, Andrew P. Selwyn, 
Brigham & Women's Hosp. Boston, MA. 
The role of the endothelium in modulating pulmonary 
vasomotor tone in conscious man is unknown. To examine 
the control of pulmonary vascular reactivity in both resting 
and preconstricted states, we infused the endothelium•
dependent (ED) vasodilator, acetycholine (ACH 10-6, 10-' 
M), and the endothelial indefendent (EI) vasodilator, 
nitroprusside (SNP 10-7, 10- M), into one segmental 
pulmonary artery (PA) in 11 patients without pulmonary 
disease. Changes in segmental PA blood flow (inttavascular 
doppler) and vessel diameter (quantitiative angiography) 
were measured. To determine whether preconstriction 
affects the degree of ED vasodilation, phenylephrine (PH 10-
6M) was infused into each segment, alone, and with SNP or 
ACH, in S patients. The % change in flow (doppler 
velocity x cross sectional area) over baseline (SNP, ACH), 
or preconstricted control (SNP+PH, ACH+PH) was 
(*p<O.OS, **p<O.OI): 
SNP ACH PH SNP+PH ACH+PH 
94±8S* 63±5S* ·37±32* S27±5S7** 282±49*· 
Diameter of the conduit PA segment did not vary with 
intrapulmonary infusions. We conclude that in normal 
human subjects,: 1) basal tone in pulmonary resistance 
vessels is minimal, but permits demonstration of ED dilation 
with ACH; and 2) this ED vasodilation is markedly 
accentuated by preconstriction of the pulmonary vasculature. 
These clinical measures of ED dilation in the pulmonary 
microvasculature may permit further study of new 
pathogenetic mechanisms of. pulmonary hypertension in a 
variety of clinical settings. 
771·4 
Coronary Flow Reserve is Not Impaired In Syndrome X 
4:45 
Diana Holdright, Debbie Clarke, David Lindsay, Philip Poole•
Wilson, Kim Fox, Peter Collins. 
National Heart and Lung Institute and Royal Brompton National 
Heart and Lung Hospital, London, UK. 
Several studies have reported a reduced coronary flow reserve 
(CFR) in patients with chest pain, a positive exercise test and an· 
giographically normal epicardial coronary arteries i.e. Syndrome X. 
Differing methods have been used to measure CFR but dipyridamole 
has consistently been the stimulus for eliciting coronary vasodilation. 
We have evaluated CFR using intracc.ronary papaverine, a well es•
tablished drug for this purpose. 
Epicardial coronary blood velocity was measured using a 3F 
intra coronary Doppler flow probe and coronary artery diameter was 
determined by Quantitative angiography. Estimates of coronary 
blood flow were made before and after intracoronary bolus injec•
tions of Bmg papaverine in 7 patients fulfilling the above criteria for 
Syndrome X (SX) and 8 control patients (C). The control group 
comprised patients with normal resting and exercise electrocar•
diograms and angiographically normal epicardial coronary arteries. 
No patient had features suggestive of hypertension or diabetes mel•
litus. 
Coronary flow was measured as the product of mean velocity and 
vessel area. CFR was expressed as the ratio of peak papaverine flow 
to baseline flow. CFR was 3.98:tO.74 (mean±SEM) in SX and 
3.70:tO.49 in C patients, showing that CFR is not impaired in SX 
[SX v C,p.0.75). 
Using papaverine as the vasodilator agent CFR is not impaired, in 
contrast to reports of reduced CFR in SX using dipyridamole. This 
suggests that SX patients might have an abnormality of the adenosine 
receptor which may explain some of the manifestations of this 
syndrome. 
212A ABSTRACTS 
771·5 5:00 
Fish Oil Attenuates the Vasoconstrictor Response to 
Angiotensin and not Alpha.Adrenergic Stimulation in Man 
Dennot Kenny, David C Warltier, Ted L Goodfriend, Brent MEgan. 
Medical College of Wisconsin, Milwaukee, WI. 
The effect of dietary fish oil (FO) on blood pressure (BP) is 
controversial and the effect on regional vascular reactivity in man is 
unknown. We examined the effect of FO substitution on BP and 
forearm blood flow following an intra-brachial artery infusion of 
norepinephrine (NE, 0.OOI2S-0.2I!gldI/min), angiotensin (All, 
0.12S-24.0 ngldI/rnin), and phentolamine (12I!gldI/IOmin) in 8 
normotensive subjects. In this double-blind placebo-controlled cross•
over study diet was controlled for 2, 3 wk periods separated by a 2 
wk wash out period. During wk 3 either FO (2.S gm eicosapentaenoic 
acid (EPA) and 1.1 g docosahexaenoic acid) or safflower oil was 
substituted for unsaturated fat in the diet. On day 8 of wk 3. 24 hr 
ambulatory BP and forearm blood flow measurements were obtained 
and plasma renin. NE and EPA levels measured. 24 hr BP was 
identical in both groups 122/68±3/3 vs 122/68±3/2 mmHg. FO 
significantly (*P<O.OS) increased plasma EPA levels. 
Forearm blood flow mlsldUmjn 
All ngldllmin PLACEBO FISH OIL 
Baseline 2.88±0.28 2.93±O.24 
0.125 2.49±0.27 3.01±O.36* 
0.5 2.11±0.24 2.52±O.26* 
2.0 I. 62±O.13 2.01±0.21* 
8.0 1.37±0.14 I.5S±0.22* 
24.0 1 15±O.1 0 I 36±O 10* 
NE (pglml) 14S±14 137±11 
Renin (nglAI/mVhr) I. 66±O.19 1.46±O.lS 
EPA (101M) O.SI±O.2S 1.72±O.3S* 
FO attenuated (*P<O.OS) the vasoconstrictor response to All but not 
NE nor the vasodilator response to phentolamine. Thus FO may be 
more efficacious in the treatment of hypertension in renin-<iependent 
states than in hypertension mediated by excess neurovascular tone. 
These results may explain the variable hypotensive effects of FO. 
771·6 
Effect of Selective Angiotensin II (ATt) Receptor Antagonism and 
ACE Inhibition on the Coronary Vasculature In Vivo: an 
Intravucular Two-Dimensional and Doppler Ultrasound Study. 
Krishnankutty Sudhir, John S. MacGregor, Sophie Barbant, 
Thomas Amidon, Rita Redberg. Paul G. Yock, Kanu Chatterjee. 
Cardiovascular Research Institute, University of California at San 
Frandsco, San Frandsco, California. 
Although angiotensin converting enzyme (ACE) inhibitors have 
been reported to increase coronary blood flow, the effect of selecti ve 
angiotensin n (ATI) receptor antagonism on the coronary drculation 
has not been well defined. We examined the effects of an ATI 
receptor antagonist (DuP 753, 0.2-3.0 mg/kg), and an ACE inhibitor 
(enalaprilat, 2.5 and 5 mg) on coronary arteries in vivo in 5 dogs, 
using a combination of 2-dimensional and Doppler ultrasound 
technology. A 30 MHz, 4.3 F imaging catheter was placed in the 
mid-segment of the left anterior descending or circumflex coronary 
artery to measure cross-sectional area (CSA). A O.OIS" Doppler 
wire was placed with the transducer 1-2 em distal to the tip of the 
imaging catheter, to measure coronary flow velocity (FY). Drugs 
were administered directly into the left main coronary artery to 
minimize systemic effects. At the top of the dose-response curve (1.7 
mg/kg), the ATI antagonist caused a 15±2% increase in coronary 
CSA and a 79±44% increase in peak diastolic FY, resulting in a 
1.8±O.16 fold increase in diastolic blood flow (CSA X velocity time 
integral). The maximal effect of the ACE inhibitor (2.5 mg) was a 
4±2% increase in CSA and a 33±IS% increase in peak FV with a 
1.23±O.13 fold increase in diastolic blood flow. Relative to maximal 
hyperemia with adenosine (6mg intra-<:oronary), the flow response 
was O.46±O.1 with the AT1 receptor antagonist and 0.17±0.06 with 
the ACE inhibitor (P<0.05). These effects were seen without 
changes in systemic arterial pressure. Thus, stimulation of AT1 
receptors in the coronary circulation results in vasodilator responses 
greater in magnitude than ACE inhibition. The exact role for these 
receptors in coronary pathophysiology remains to be defined. 
5:15 
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Can ACE inhibitors Reduce the IndcIence 01 Coronary ArIwy 
DiIM .. (CAD) In Hyperin.ullnemlc PatIents ? 
Frank P. Job, Judith Wolfertz, Horst Kuhn, Bielefeld Medical Clinic II, Dep. 
of Cardiology; Germany. 
Recent studies have demonstrated that significan~y higher fasting 
immunoreactive insulin levels IIRI) are found in patients Ipts) with CAD 
compared to those without CAD due to a reduced peripheral insulin 
sensitivity. Concepts for the treatment of hyperinsulinism in CAD patients are 
not yet developed. In a prospective study we screened the drug history, 
major corOllary risk factors and fasting IRllevels of 268 mole pts. They were 
recruited consecutively after left heart catherizotion hod been performed. Pts 
with CAD revealed significan~y Ip < 0,05) higher lRllevels than those without 
CAD. A detailed analysis of the medication of each patient showed that IRI 
levels were significan~y Ip < 0,01) lower in the.41 pts on ACE inhibitors. To 
further study this phenomenon the data of the 36 diabetic pis were analysed 
separately. Whereas significant results Ip < 0,01) were obtained for the 
whale study group and for diabetic patienls alane, this difference was no 
longer significant in the non diabetic group although there was still a marked 
difference between the CAD and nan CAD pts. IRI levels of hypertensive pis 
on B blocker therapy In ~ 35) when compared to hypertensive pis on ACE 
inhibitors In = 21) were significan~y higher Ip < 0,051 than in the ACE 
inhibitor group (mean IRI 7,94 + SEM 0,62 vs 11.1.4 + SEM 0,72 IIU 
ml·1). This result remained significant also after elimination of the 
diabetics. Acetylsalicylate, nitrates, cakium chana I blockers and 
diuretics were also analysed but did not show Significant differences 
between IRI levels when the CAD group was compared to the non 
CAD group. Conclu.ion: ACE inhibitors can significanrly lower IRI 
levels in diabetic CAD pis and might also be able to inRuence the 
progression of CAD in this group. Hypertensive CAD pis with elevated 
insulin levels benefit from ACE inhibitors rather than from beto blockers 
because the loiter support hyperinsulinism, which is polentially harmful. 
772·2 4:15 
Hemodynamic Mechanisms of Postprandial Hypotension: 
Role of Impaired Vascular Responsiveness 
Lewis A. Lipsitz. Sheila M. Ryan. Margaret Kelley. Robin 
Ruthazer, Roy Freeman. J. Anthony Parker. Jeanne Y. Wei. 
Hebrew Rehabilitation Center for Aged, Beth Israel Hospital, 
Boston. Massachusetts. 
A~hough postprandial hypotension (PPH) is a common cause of 
falls and syncope in elderly persons and in patients with 
autonomic insufficiency. the pathophysiology of this disorder 
remains unknown. We examined the hemodynamic and splanchnic 
blood pool responses to a standardized 400 kcal mixed meal in 11 
hea~hy young (26 ~ 5 yrs) and 9 healthy elderly (80 ~ 5 yrs) 
subjects, 11 elderly patients with postprandial syncope (82 ~ 5 
yrs), and 10 patients with autonomic insufficiency (65 ~ 16 
yrs). Cardiac and splanchnic blood pools were determined by 
radionuclide scans. and forearm vascular resistance (FVR) was 
determined using venous occlUSion plethysmography. 
Blood pressure (BP) remained unchanged after the meal in 
hea~hy young and old subjects. In the young, cardiac index (CI) 
and FVR increased. in compensation for a 12% increase in the 
bowel blood pool and reduction in end diastolic volume index 
(EDVI). In hea~hy elderly subjects CI did not change after the 
meal. but systemic vascular resistance (SVR) and FVR increased. 
Elderly syncope patients had a significant postprandial fall in BP 
by 45 minutes after the meal associated with no change in CI. 
SVR. or FVR. Patients with autonomic failure had marked PPH 
associated with an increase in CI but an impaired FVR response, 
and decrease in SVR. 
Thus. healthy young subjects defend postprandial BP by 
increasing CI and FVR while the healthy elderly rely on increased 
FVR and SVR. In contrast, elderly syncope patients with PPH fail 
to increase CI or vascular resistance. Autonomic failure patients 
have marked vascular insufficiency that cannot be offset by their 
increase in CI. Our results suggest a potential role for 
vasoconstrictor therapy of PPH. 
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safety and Diagnostic yield of Read-Up Tilt 
Testing in Elderly Patients with syncope of 
Undetermined Etioloqy 
George Kichura, Carey Fredman, Preben 
Bjerregaard, Paula Washington, Harry Genovely, 
Dorothy Holt, Denise Janosik, St. Louis 
University Medical Center, st. Louis, MIssouri 
The safety and diagnostic utility of head-up 
tilt testing (HUT) in elderly pts with syncope 
(S) has not been established. We performed HUT 
in 49 pts ~ 65 yrs (mean 74 yrs) with S. All pts 
were tilted to 800 upright position for 20 
minutes or until symptoms occurred. If HUT alone 
did not provoke S, Isoproterenol was infused 
unless contraindicated. Heart rate (HR), 
systolic (SBP), and diastolic blood (DBP) 
pressures were recorded every minute. In 14 pts 
(29%) clinical symptoms were reproduced by the 
HUT protocol (HUT+) while 35 pts remained 
asymptomatic (HUT-). No adverse effects 
occurred. 
HUT+ 
HUT•
P 
N 
14 
35 
% Change during 
HR 
29±25 
9±10 
NS 
SBP 
-65±22 
-15±22 
.0001 
HUT 
DBP 
-23±13 
-2±12 
.0001 
CONCLUSION: In elderly pts with S of unknown 
etiology, HUT with low dose Isoproterenol 
infusion is a safe procedure with a high 
diagnostic yield. 
772·4 4:45 
The Correlation between Aortic Valve Calcification and 
Carotid Artery Disease: an Ultrasound Study. 
Harold Poehlmann, Daniel Levy, Jane Evans, Emel ia 
Benjamin, Deborah Fuller, Daniel O'Leary, Philip Wolf. 
From the Framingham Heart Study, Framingham, MA 
Echocard iograms and carot id dupl ex ul trasound examina· 
tions were performed on 1001 elderly subjects (598 
females and 403 males) of the Framingham Study who were 
under continuous medical surveillance for 40 years. The 
mean age of subjects was 76 years (range 67 to 93). 
Hemodynamically significant carotid artery stenosis 
(CAS) defined as ~50% cross·sectional narrowing, oc· 
curred in 7.7% of subjects and marked aortic valve 
calcificat ion with reduced cusp excursion (AoCalc) was 
observed i~ 12.5%. Rates of marked AoCalc in subjects 
with differing severities of CAS are presented below. 
AoCalc n 
% 
~ ~ ArYlrl Stenosis 
0% 
(n:269) 
23 
(9%) 
1-24% 25-49% 
(n:341) (n:314) 
31 43 
(9%) (14%) 
50%+ 
(n:77) 
20 
(26%) 
After adjusting for age, hypertension, diabetes, body 
mass index, smoking, and total cholesterol level, a 
significant association between AoCalc and CAS was 
observed in both sexes (p<0.0003 for men and p<0.03 for 
women). These data indicate that carotid artery disease 
is significantly associated with aortic valve disease. 
Although the prevalence of marked AoCalc and hemodynam•
ically significant CAS are low in a free living elderly 
population, there is a tendency for these two condi•
tions to aggregate in the same individuals. The clus•
tering of CAS and AoCalc is not fully explained by the 
presence of common atherogenic risk factors. 
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no HeartR stiffen 8S They Age? 
Carolyn A. Burns, Thomas R. Porter, Valerie Roy, James A. 
Arrowood, Catherine S. Guard, and J.V. Nixon, Medical 
College of Virginia, Richmond, VA 
It has long been held that aging of the human heart 
results in an increased stiffness of the left ventricle 
(LV). Animal data would also suggest that physical 
conditioning can reduce the increase in stiffness seen 
with age. No direct measurements of chamber stiffness 
in a normal aged population have been done. We measured 
LV chamber stiffness in 20 normal older subjects (mean 
age 71 yrs) and in 9 normal young controls (mean age 25 
yrs). LV chamber stiffness was derived from end•
diastolic pressures (P) and end-diastolic volumes (V), 
(normalized for wall volume V/Vw), obtained serially from 
simultaneously recorded pulmonary capillary wedge 
pressures and doppler echocardiograms. Data were 
obtained at baseline, after 90 min of 5° head down tilt, 
and during graded lower body negative pressure to -40 
mmHg. P-V curves were then plotted and K (a 
dimensionless chamber stiffRV~ constant) was derived 
from the equation: P:Ae I VW. In addi tion, the 
correlation between K and the level of physical fitness, 
as determined by V0
2 
max, was evaluated in 14 older 
subjects. Results are as follows: 
Old Young 
K mean 7.7 6.6 p:NS 
range (1.2-28.8) (1.1-9.3) 
K 7.7 (1.3-38.8) vs. V02 25.3 (17.8 -32.9) r:0.3 
Our results Ruggest that aging does not necessarily lead 
to an increase in LV stiffness, nor does it appear that 
stiffness correlates with the degree of physical fitness. 
772·6 5:15 
Diastolic Filling Is Improved with Intensive Exercise 
Training In Healthy Elderly Malss 
WC Levy, MD Cerqueira, IB Abrass, RS Schwartz, VG Larson, JR 
Stratton, Seattle VAMC and University of Washington, Seattle, WA 
The elderly have Impaired diastolic filling as manifested by a 
reduced peak early filling rate (PEFR) and an Increased peak atrial filling 
rate (PAFR) and a reduced PEFRlPAFR (ElA) compared to young 
subjects. It is unknown If intensive exercise training Influences diastolic 
filling In the young or the old. 
Diastolic filling (expressed as end diastolic volumes/sec) was 
measured using fifteen million count resting radlonuclide 
ventriculograms (20mslframe) acquired before and after 6 months of 
intensive exercise training In 11 young (age 24-32) and 13 older males 
(age 60-82). At baseline, the PEFR was lower and the PAFR was higher 
In the older subjects (p<O.OOOl). Following exercise training, the 
maximum V02 Increased by 17"1. In the young and 21% In the older 
group. The heart rate (HR) decreased In both groups. PEFR was 
unchanged in both groups. Following exercise training the young had 
no changes in diastolic filling. In contrast, In the older males the PAFR 
was decreased and the ElA was increased. 
HR PEFR PAFR E/A 
Young PreET 60t5 2.5±0.4 0.810.2 3.211.1 
Post ET 5215 •• 2.610.4 0.910.3 3.111.0 
Older PreET 63111 1.710.4 1.710.5 1.010.4 
PostET 5318" 1.610.2 1.210.4 .. 1.410.3 • 
Pre/Post ·p<O.05, "p<O.OOl 
IntensiVe exercise training has no effect on diastolic filling as 
measured by radionuclide techniques In the young but Improves 
diastolic filling In healthy older males with a reduction In the PAFR and an 
increase In the ElA ratio reflecting a reduced atrial contribution to left 
ventricular filling. 
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Calculating Mitral Inertial Mass in Patients: a Critical 
Parameter in the Assessment of Diastolic Function. 
David S. Aghassi, Pieter M. Vandervoort, Mark S. Adams, 
Arthur E. Weyman, James D. Thomas 
Massachusetts General Hospital, Boston, MA. 
The initial acceleration of mitral (MV) inflow varies 
directly with the rate of left ventricular (LV) 
relaxation as well as inversely with the effective mass 
of the blood column passing through the MV, termed the 
mjtral inertance M. Before MV acceleration can be used 
quantitatively to assess LV relaxation, M must be 
characterized in vivo. We have previously shown that M 
depends critically on the effective length L over which 
blood accelerates and decelerates passing through the MV. 
L may be calculated by integrating all velocities along 
a streamline v(s) from the atrium to the ventricle 
S
divided by the peak velocity v~ along that streamline: 
~ALV v(s)/v ds. Multiplying L by blood density p then 
Yle1ds M, t~e inertial term retarding blood acceleration. 
To measure L clinically, 10 subjects with norroal 
echocardiographic findings were studied. Doppler velocity 
maps of 1 eft ventri cular i nfl ow were obta i ned from an 
apical window and output via a digital data port. The 
central streamline through the MV was identified at peak 
flow, and L calculated for all diastolic frames from one 
cardiac cycle. RESULTS: The mitral length L during E-wave 
was 4.75±1.07 cm (mean±SD). At peak A-wave L was 
3.67±1.24 cm (mean±SD). During diastasis mitral length 
decreases to 1.72±1.31 cm which is due to near closure of 
the mitral leaflets. CONCLUSION: I) This study shows the 
in vivo feasibil ity to calculate mitral inertance from 
color Doppler flow maps. 2) Calculating mitral inertial 
mass is a critical step towards more quantitative 
assessment of LV diastolic function. 
773-2 8:45 
Mitral Prosthesis Effective Orifice Area By A New Method 
Using Continuity Of Flow Between Left Atrium And 
Prosthesis 
Fletcher A. Miller, Jr., Bijoy K. Khanderia, William K. 
Freeman, James B. Seward, A. Jamil Tajik. 
Mayo Clinic, Rochester, Minnesota 
The pressure halftime (til method for mitral effective 
orifice area (EOA) is inaccurate in several clinical 
Situations, including at least some mitral prostheses 
(MPl. The standard continuity method (EOA stand) is a 
useful alternative, but is invalid with significant aor•
tic and/or mitral regurgitation (AR; MR), or when 
measurement of LVOT or pulmonary artery (PA) diameters 
(D) is technically difficult. We investigated a new 
method (EOA new) for MP EOA, using continuity of flow in 
the left atrium (LA) just above the MP sewing ring (SR) 
and flow across the MP. EOA new was compared with EOA 
stand and EOA ti. 
LA diameter (D) was approximated by the external MP SR 
D. LA TVI was measured by PW Doppler, placing the sample 
volume in LA, just above SR. MP EOA was calculated as: 
EOA new = 0.785 x (SR D)Z x LA TVI + MP TVI 
19 studles were performed for 18 patlents (pt) wlth 
normal MP (1 pt was studied in atrial fibrillation, and 
later in NSR). There were 17 bioprostheses (bio) and 1 
ba11cage with SR 2.7 - 3.5 cm. For 17 pts with bio, all 
EOAs were from surface echo; EOA new was from TEE (USing 
PW and
2
CW Doppler) for the ballcage MP. EOA new (1.7 ± 
O.~ cm ) compared favorably with EOA stand (1.6 ± 0.4 
cm ): r = 0.94; SEE = 0.15 cm2• EOA tt (2.2 ± 0.5 cm2) 
compared less favorably with both EOA stand (r = 0.41; 
SEE = 0.49) and EOA new (r = 0.36; SEE = 0.50). 
This is a promising new method for MP EOA. It should 
be valid even with Significant AR and MR. Furthermore 
all information for this new MP EOA method is readily 
available from TEE with PW and CW Doppler. 
773-3 
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Pressure-Compliance Relationship in Mitral Stenosis as 
Assessed by Echo-Doppler 
David H. Thoreau, Brian P. Griffin, Pieter M. 
Vandervoort, J. Miguel Rivera, Arthur E Weyman, James 
D. Thomas. Massachusetts General Hospital, Boston, MA. 
We have previously demonstrated theoretically and in 
vitro that the mitral pressure half-time (1\) is 
inversely proportional to mitral valve area (MVA) but 
also varies directly with net atrioventricular 
compliance (Cn) and the square root of the peak 
transmitral gradient Ap. In the cl inical setting, 
however, compliance and pressure are likely to be 
coupled, so the impact on Ti by changes in Ap or C 
will be unpredictable. To investigate this issue, w~ 
used atrial fibrillation (AF) as a model of varying 
loading conditions and analyzed 30 to 50 consecutive 
beats in 4 patients with mitral stenosis, measuring 
T~, Ap, and velOCity deceleration slope (v'). C was 
calculated as A/pv', where A is planimetered MV~ and 
p the density of blood (1.05 g/cm3). ~: There was 
substantial variability between and within patients as 
shown by: Ap ranged from (mean±SD) 4.9±0.68 to 
2B.9±4.29 mmHg, mean Ti ranged from 83±21 to 17~±37 ms 
and mean Cn ranged from 2.3±0.54 to 4.9±1.42 cm /mmHg. 
In all patients, Cn was inversely related to Ap (r -
.62 to .75), ranging 7.B fold with variation in Ap. 
1\ was closely related to C? (r • 0.88 to 0.98) but 
inversely related to Ap Ir - -0.18 to -0.58). 
However, when Cn was adjusted for, 1% and Ap became 
directly related, as predicted theoretically. 
CONCLUSION: 1) Ti varies significantly on a beat-to•
beat basis in AF; 2) Ti shortens with rising Ap since 
the reduction in CI). with rising Ap overcomes the 
independent effect Of Ap on Ti. 
773-4 9:15 
Lateral Resolution and Wall Filtering Critically Impact 
Reconstruction of Flow Profiles by Color Doppler Mapping. 
Pieter M Vandervoort, David S Aghassi, David H Thoreau, 
Arthur E Weyman, James 0 Thomas. 
Massachusetts General Hospital, Boston, MA 
Reconstruction of vascular velocity profiles from digital 
Doppler flow maps has been proposed as a possible method 
to assess severity of stenotic lesions, but the impact of 
machine factors on velocity (Vel) accuracy has not been 
examined critically. To assess the effect of pulse repeti•
tion frequency (PRF), wall filtering (WF) and lateral 
resolution, we analyzed the reconstructed flow profiles in 
a pulsatile flow phantom with known flat profiles and 
calibrated peak Vel. Flow was imaged using a color Doppler 
flow mapper with a digital dataport. With true peak veloc•
ity (v,) held constant, PRF was varied to shift v, to 
different percentages of the Nyquist velocity (vN). For 
each PRF, flow was imaged with the lowest and highest WF, 
and flow profiles were reconstructed from digital maps. 
RESULTS: For the lowest WF, peak Vel of the reconstructed 
profiles correlated closely with v, (r=.99) with a mean 
error of -0.9±5.4% (mean±SD). For the highest WF, this 
correlation was poor with r-.57 and mean error of 15.3 
±29.2%. Vel's between 25% and 55% of vN were QYgfestimated 
by 20% to 50%. Below 25% of vN' peak Vel was under•
estimated by 40%. Vel's >60% of vN were most accurately represented. Overall, the reconstructed profiles were 5mm 
wi der than the known diameter of the tube and were not 
fl at but rather parabol iC, consi stent wi th s igni fi cant 
spatial averaging due to limited lateral resolution of the 
Doppler map. CONCLUSION: I) Wall filtering significantly 
distorts the displayed Vel's in Doppler flow maps; 2) use 
of the lowest WF is recommended for accuracy; 3) Vel 
profiles are significantly distorted by spatial averaging, 
which should be considered in profile interpretation. 
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Accuracy of Flow Rate Calculation in Oblique Tunnel Orifices 
Using an M-Mode Color Doppler "Proximal Isovelocity Surface 
Area" Method 
Shiro Yamachika, Christopher M. Meckel, Devang Savani, 
Julius M. Gardin. University of California, Irvine, CA 
The color Doppler proximal isovelocity surface area (PISA) 
method is known to be accurate in calculating flow rate across 
planar and straight tunnel orifices. However, in patients, 
regurgitant jets are often eccentric and stenotic tunnels may be 
oblique to their proximal orifices. The aim of this study was to 
evaluate eccentric flow by the color Doppler PISA method. 
~: A pulsatile flow system was used with oblique tunnel 
orifices (7 and 10 mm diameter) to produce eccentric flow 
(angle of tunnel to orifice = 60" and 30"). Color Doppler was 
performed using zero-baseline shift to produce lower aliasing 
velocities «27cm/sec), which resulted in a hemispherical PISA 
shape. Color Doppler MO mode was used to record 1st 
aliasing radius (AR) vs time through center of PISA Peak flow 
rate was calculated as 2x(peak AR)2*aliasing velocity. Stroke 
volume was calculated by correcting peak flow rate by the time 
integral of AR derived from color Doppler MO. 
~: 1) AR (center axis of PISA) PIliA 
was perpendicular to the proximal ~
orifice. 2) Stroke volume correlated 
well with actual flow rate at aliasing " / 
IJ1' 'It velocities of 13-27 cm/s (r = 0.92 - (Y1'), 
0.98; % error = 4.1 - 8.9%). , 
Conclusion: The PISA method is accurate for pulsatile flow 
rate calculation in oblique tunnel orifices and should also be 
useful in eccentric jets. 
773-6 9:45 
INFLUENCE OF CARDIAC MOTION ON DOPPLER 
MEASUREMENTS, USING AN IN VITRO MODEL 
Tiesheng Cao, Shelley M. Shapiro, Malcolm M. Bersohn, Chi-Kong 
Liu, Leonard E. Ginzton, Harbor-UCLA Medical Center, Torrance, and 
VA Medical Center, Los Angeles, CaJifornia 
Blood flow velocities measured by Doppler ultrasound represent the net 
motion of the blood relative to the transducer and it is assumed that the 
measured velocity represents the actual flow. However, if the cardiac 
chamber surrounding the blood has independent motion relative to the 
transducer, the measured flow will be the algebraic sum of the two 
velocities. We developed an in litro model to simulate and investigate this 
phenomenon. A cornstarch-water slurry was driven by a pulsatile pump 
through tubing to simulate the blood flow within the heart, and the 
tubing was cyclically moved by a piston to simulate the heart motion. 
The tubing was moved at either the same or 112 the frequency of the 
pulsatile flow. When the tubing motion and fluid flow were in line and 
synchronized, peak velocities summed algebraically. Moving the tubing 
at 10 cmlsec while pumping the slurry at 30 cmlsec changed the apparent 
velocity of the slurry 33%. Shifting the phase of the two motions resulted 
in alteration of both the amplitude and acceleration time of the Doppler 
flow signal. The results of our experiments demonstrated that the Doppler 
velocities generated by flow of the cornstarch-water slurry were 
significantly altered and distorted by the motion of the chamber (tubing). 
In low velocity flow across the mitral or pulmonic valves for example, 
the relative contribution of cardiac motion may be substantial and could 
dramatically alter apparent ratios of early and late filling velocities or 
acceleration times. These results have implications for the understanding 
and use of Doppler velocities in hemodynamic assessment. 
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STUDIES OF LEFT VENTRICULAR DYSFUNCTION 
(SOL YO): SUBGROUP RESULTS. 
Bertram Pitt, M.D., Salim Yusuf, M.D. for the SOLVO 
Investigators, University of Michigan Medical Center, Ann 
Arbor, Michigan, 48109. 
The studies of left ventricular dysfunction (SOL YO) 
randomized 6797 patients with a left ventricular ejection 
fraction (EF) :s. 35% to placebo or enalapril (E). Patients 
requiring treatment for heart failure (HF) were allocated to the 
Treatment Trial (TT), n=2569 and those who were 
asymptomatic to the Prevention Trial (PT), n=4228. The IT 
showed a 16% reduction in mortality (p=O.OO36) and a 26% 
reduction in patients dying or being hospitalized for HF 
(p<O.OOOI). There was no heterogeneity of effects among 
subgroups defined by baseline serum sodium, vasodilator use, 
etiology, or NYHA class. The effect of E on mortality and 
hospitalization for HF was, however, greater in patients with 
the lowest EF (chi square for interaction p = 0.06 for mortality 
and p = 0.03 for the combined end point). There was no 
significant heterogeneity in the benefits of E among other 
subgroups such as: use of digitalis, diuretics, calcium channel 
blocking agents, age, race, or gender, but there was a trend 
toward less benefit of E in patients using antiplatelet agents at 
baseline. The results of the combined IT and PT in regard to 
mortality, morbidity and effect of E on predetermined and 
adhoc subgroups will be presented to determine the consistency 
and applicability ofE in patients with HF. 
774-2 
Long-Term Bffects of Bnalapril on NYBA 
Punctional Class in Patients with Left 
ventricular Dysfunction 
8:45 
Barry Greenberg for the SOLVD Investigators. 
Oregon Health Sciences Univ., Portland, Oregon 
Although short-term studies show that 
angiotensin-converting enzyme inhibition (ACEI) 
improves NYHA class in symptomatic pts with 
congestive heart failure (CHF), data from long•
term studies or from asymptomatic pts have been 
lacking. In Studies of Left ventricular 
Dysfunction (SOLVD) pts with LV ejection 
fractions (EF) :s.35% were randomized to either 
enalapril or placebo and followed over 3 years. 
Depending on the absence or presence of CHF 
symptoms, pts were assigned to the Prevention 
(n=4228) or Treatment (n=2569) arms of SOLVD. 
For the entire study population enalapril had 
significant beneficial effects on NYHA class 
after 1, 2 and 3 years of therapy (all p:s..005) 
which persisted even after deaths were excluded 
from the analysis. Significant effects were 
seen in both Prevention and Treatment arm pts 
and an interaction between symptomatic status 
on entry to SOLVD and change in NYHA class was 
seen only at 1 year. No significant 
interaction between EF or the use of non-ACE! 
vasodilators and change in NYHA class was seen. 
Thus, ACE! wi th enalapril has sustained 
beneficial effects on NYHA class in both 
symptomatic and asymptomatic pts with LV 
dysfunction. Neither extent of LV dysfunction 
nor use of non-ACE I vasodilators alter this 
response. 
216A ABSTRACTS 
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Short-Term Effects Following Withdrawal from 
Enalapril In Patients with Heart Failure 
Marvin A Konstam. Marvin W Kronenberg. James E Udelson. 
Noreen Dolan. Donna Howe. Lori Kilcoyne. Tonya R Edens. 
Debra Kinan. Dawn Stewart. Deeb N Salem. Salim Yusuf. for 
the SOL VD Investigators. Tufts University. Boston. MA. 
The effects of withdrawal of angiotensin converting enzyme 
(ACE) inhibitors from patients with symptomatic LV systolic 
dysfunction have not been systematically investigated. At 
the completion of the Treatment Trial of Studies of Left 
Ventricular Dysfunction. 20 to 36 months post•
randomization to enalapril (E; n=15; 2.5-20 mg/day) or 
placebo (P; n=7). 22 clinically stable patients with baseline 
ejection fraction s...0.35. underwent radionuclide 
ventriculography. with plan for repeat study 2 weeks after 
withdrawal from study drug. In P but not E patients. LV end•
diastolic volumes had increased compared to pre•
randomization. Four patients had major cardiac events 
between 11 and 19 days after withdrawal (4 from E; 0 from 
Pi: 2 deaths. 1 non-fatal MI. 1 unstable angina requiring 
emergency bypass. The remaining patients showed 
significant increases in LV end-diastolic volume (ml/m2) 
following E withdrawal (mean ±.. SD; *p<0.05 vs pre•
randomization; #p<O.O 1 vs pre-withdrawal): 
Pre-randomization Pre-withdrawal Post-withdrawal 
Placebo 132 ± 14 155 ± 23* 157 ± 25" 
Enalapril 139 ± 28 131 ± 34 138 ± 35# 
Conclusjons' 1) In patients with symptomatic LV systolic 
dysfunction. ACE inhibition with enalapril prevents chronic 
L V dilatation. 2) Early LV distension after enalapril 
withdrawal indicates that chronic response to enalapril is 
due to ongoing drug effect as well as prevention of adverse 
chronic remodeling. 3) The observed frequency of adverse 
events in patients withdrawn from enalapril deserves 
additional evaluation. 
774-4· 
Response of Plasma Norepinephrine to Long-Term 
Administration of EnaJapril or HydraJazine-ls05orbide 
Dinitrate in Heart Failure: V-HeFT II 
9:15 
Jay N. Cohn, Gary S. Francis. Ada Simon, Gary Johnson, and the 
Veterans Administration Study Group. Minneapolis, Minnesota and 
West Haven, Connecticut 
In V-HeFT IT 804 patients with chronic bean failure (cardiac 
en1argement + Ieduced exercise tolerance) treated with digoxin + 
diuretic were randomized to m::eive enalapril (E) or hydralazine + 
isosorbide dinitrate (H-I). Mortality at two years in the E group 
(18%) was significantly (p=O.016) lower than in the H-I group 
(25%). Plasma norepinephrine (PNE) was measured at 13 weeks 
and annually after randomization. At baseline median PNE in E was 
SOl pg/ml (n=372) and in H-I 483 pg/mJ (n=371). At 13 weeks 
after randomization PNE increased in H-I by 68 pg/mJ (p=O.OOOI) 
(n=300) but by only 9 pg/ml in E (p=NS) (n=312) and the 
difference between H-I and E was significant (p=O.OO3). At 1 year 
the PNE increase in H-I (n=240) was still greater than in E (n=265) 
(p=O.04). Thereafter PNE rose progressively in both treatment 
groups and at 4 years had increased from baseline by 186 pg/mJ in 
H-I (p=O.OOOI) and by 127 pg/ml in E (p=O.OOOI). 
These data suggest that E comparerl to H-I results in a lower PNE 
for the first year after initiation of treatment for chronic heart failure. 
This suppression could contribute to the preferential effect of E 
compared to H-I on survival. However, the gradual rise in PNE 
ClVer 4 years with both treatments indicates that these therapies did 
not prevent long-term progression of the syndrome. 
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Multicenter Randomized Trial of Epoprostenol in Patients 
with Severe Heart Failure 
Mihai Gheorghiade, Carla A. Sueta, Kirkwood F. Adams, 
Robert C. Bourge, Srinivas Murali, Barry F. Uretsky, Marc 
R. Pritzker, Michael D. McGoon, Randall C. Starling, 
Samuel M. Butman, Steven Grossman and the Epoprostenol 
Multicenter Research Group, Henry Ford and Vascular 
Institute, Detroit, MI. 
Hemodynamic and clinical effects of Epoprostenol(EPO)were 
studied in 33 patients(pts) with heart failure(HF)in NYHA 
Class III:14,IV:19 pts, refractory to standard therapy 
(Rx); mean ejection fraction 16+3%. Cardiac index(CI), 
pulmonary capillary wedge pressure (PCWP), heart rate(HR), 
mean blood pressure(SBPm), systemic(SVR) and pulmonary 
(PVR)vascular resistance were measured in all pts. EPO was 
titrated to a tolerated dose of 9.1+3 ng/Kg/min. Results: 
C. 1. PCWP SAPm HR SVR PVR 
L/m/m2 mm Hg mm Hg B/min dynes's'cm-5 
Baseline 2.0+.5 24+10 82+13 86+15 1704+625 271+171 
EPO 2.8+.6 19+7 73+9 90+14 1040+320 160+104 
P value <0.0001 <0.008 <0.0001 0.034 <0.0001 <0.0001 
After completion of the acute studies pts were randomized 
to receive continuous EPO using an indwelling Hickman 
catheter (16 pts) or standard Rx (17 pts) for 12 weeks. 
Hemodynamic measurements are being repeated at 12 weeks. 
At 6 weeks the 6 minute walking distance (meters) in•
crease in EPO pts (144+140 to 226+130) and remained the 
same in standard Rx pts (208+198 VS 208+162). There were 8 
deaths in the standard Rx compared to 2-deaths in the EPO 
pts (p=0.07). Five pts in EPO group did not complete the 
study: cardiac transplantation:2, vasovagal:l, cardiac 
arrest:l, increase in HF:l. Conclusions: EPO produced 
significant acute hemodynamic improvement and was well 
tolerated in HF pts refractory to standard Rx. There was a 
trend towards increased exercise tolerance and decreased 
mortality in the EPO group compared to standard Rx. 
774-6 
Coenzyme 010 as an Adjunctive in Treatment of Congestive Heart 
Failure. 
9:45 
C Ho!man-~M p .. N. Rehnqvist. M.D .• Ph.D .• K. Swedberg. M.D .• Ph. D .• 
FA-C.C .• H. "m, M.D .• Ph.D .• KaroIinska Hospital. Danderyds Hospital, 
Stockholm and Ostra HospItal. Gothenburg. Sweden for the 01 O-study Group. 
As a member 01 the "respiratory chain" Coenzyme 010(Co 010) plays an 
Important role of the energy transformation in the cell (ATP-fonnation). Results 
havebeen published that shows Iowerconoentrations of Co 010 In heart 
musclecells compared with controls. " has been claimed that oral_I 
with CoOl0 Improves function (Ejection traclion, NYHA class) and reduces 
mortality. 
In a double bind cross-over placebo controlled study with 3-months intervals 
were 80 patients with chronic stable congestive heart failure (CHF) rando•
mized. The patients were included from 8 centers In SWeden and DenmarK. 
Thestudywasterminated with 3 months of open treatrnentwith Co 010. 
Mean age was 61:1:10 years. ejection traclion at rest (EF) 22±1 0% and maximal 
WOf1doacl at bicycle ergometer test (Wmax) 91:1:30 waIts.Of the patients 
Included belonged 17% to NYHA II. 76% to NYHA III and 8% to NYHA IV. 
Ischemic heart disease was present in 42% of the patients. Treatment with 
digitalis. diuretics and ACE-inhlbitors was present In 60. 71 and 60%. 
The patients were IoIIO\Yed by clinical examination. EF (primary goal). eXllrcise 
test. quality of IWe questions (OL). and plasma conosn1rations of Co 010. Daily 
dose was 100 mg. 
ResUlts· Placebo 010 D 
EF (%) rest 23:1:12 24:1:12 n.S. 
EF (%) legs up 23:1:12 25%13 0.025 
EF (%) work 22±11 23:1:11 n.S. 
Wmax(watt) 94:1:13 100:1:34 0.016 
OL(totaiscore) 107:1:23 113:1:22 0.016 
MOrtalitv (n) 4 5 n,s. 
~ In patients with moderate to severe congestive heart failure oral 
treatment with Co 010 has a small but significant beneficial effect on BlCIIICIse 
capacity, OL., and EF at volume load. 
lACC Vol. 19, No.3 
March I, 1992:217A 
775 Technologies Under Development for 
Coronary Intervention 
Wednesday, April 15, 1992 
8:30 AM-IO:OO AM 
Dallas Convention Center 
East Ballroom A 
775-1 8:30 
Clinical Evaluation of Collagen Plugs: Single Institution Experience 
After Coronary Angloplasty and Diagnostic Angiography. 
Simon Gibbs, Paul Gunnes, Julian Blake, James Stewart, Miles 
Williams, Lin Denne, Nigel Buller, Ulrich Sigwart. 
Royal Brompton National Heart and Lung Hospital, London, UK. 
Interventional cardiology has brought about an increase in femoral 
arterial morbidity. This may be related to the time the arterial sheath 
is in situ, the larger catheter size and concomitant anticoagulant 
treatment. Coronary stenting is associated with 10-20% incidence of 
femoral bleeding complications. We have investigated the efficacy 
and safety of immediate sealing of the puncture site using 180 mg of 
purified bovine collagen immediately after the procedure. At the end 
of the procedure the collagen was administered via a prototype 
applicator onto the femoral artery entry site without interuption of 
anticoagulant therapy. Inadvertant introduction of collagen into the 
arterial lumen was avoided by a color coded blunt tip probing device 
designed to measure the skin to artery distance. 
Patients undergoing PTCA and anticoagulated with heparin, aspirin 
and dextran were compared with patients undergoing diagnostic 
coronary angiography on aspirin only. The results showed that femoral 
hemostasis was successful in both groups. 
PTCA Angiography 
Number of Patients 41 
Mean ACT (sec) ± SD 424 ± 189 
Manual compression (min) ± SD 8.9 ± 11.0 
21 
normal 
3.9 ± 1.2 
Delayed bleeding occurred in I patient and I patient who had undergone 
coronary atherectomy required surgical revision of the femoral artery 
due to plaque dislodgement. 9 patients had coronary stents implanted: 
there were no local complications. 
In conclusion the collagen plug proved to be safe, simple to use and 
secured hemostasis quickly. These findings may have important 
implications for interventional procedures and for early mobilization 
after routine catheterization. 
775-2 8:45 
I1eraJtanecu; ~ of Qnllagen to seal. Feumal 
Arterial PUn::ture Sites in FUlly Anti.cxB]ul.ated Patients 
Sjef Ernst, Melvyn Tjon Joe Gin, Gijs Mast, F);Ibert Bal, 
carl Ascoop, 'lhijs Plokker. st Antalius Hospital, 
Nieuwegein, 'lhe Netherlards 
A.chievin;J heroostasis at the p.n-x:ture site, directly 
after perwt:aneous transluminal :i.nteIventions, is 
usually not only time COllSUIIlin;J, rut also has a high 
inciclenoe of early an:i late vasa.Il.ar oc:trplications, 
especially if the patients require oart:inued full anti•
coagulation. 'lhe awlication of biodegradable collagen 
is ~l aCXlE!pt:ed in vasa.Il.ar surgical practice. 'lhe per•
cutaneo.Js insertion of plrifiEd absortlable bovine colla•
gen ha.Iever, was first perfonned in oor institution on 
January 31, 1991. since then in 93 pts who un::lenient 
percutaneoos cardiac interventions a collagen plu:J was 
advance:i onto the fE!llDral artery via a special blunt 
tiwed 11.5 F device to avoid intra arterial insertion. 
All pts 1oIel"e fully anticoagulated at the time of inser•
tion (APIT >6). Hemostasis was achlevEd in less than 5 
minutes in 95%. '!here 1oIel"e 00 vasa.Il.ar occlusions. '!here 
1oIel"e 20 small hematana without swellin;J, 1 patient re•
quired blcx:dtransfusion an:i 1 patient required surgical 
closure of a persistin:J defect. 1 patient showed a small 
pseudo-anew:ysm at the pmcture site at local D.lplex 
~ after ale hem" , which had disarpeared after 4 
weeks. 1 patient showed a large pse1.Xio aneurysm after 1 
week which was successfully treated by perwt:aneous in•
sertion of 3 plu:JS into the aneurysm, with an excellent 
result. Othe!:wise D.lplex ~ in 26 pts revealed 00 
aboonnalities. 
we ooncllXie that it is possible to seal the pmcture 
site inmediately after cardiological :i.nteIventians 
within 5' even in fully anticoagulated pts with a newly 
develc:p!d collagen plu:J without the risk of placement of 
this highly thraIi:logenic material into the vessel lumen. 
ABSTRACTS 217A 
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In Vivo Radiofrequency Balloon Angioplasty of PorciDe Coronary Arteries: 
Histologic Effects and Safety 
Daniel B Fram, Thomas A Aretz, John P Fisher, Joseph S Mikan, Adam 
Reisner, Joseph F Mitchel, Linda 0 Gillam, Raymond G McKay. 
Hartford Hospital, University of Connecticut, Hartford, CT. 
It has been previously demonstrated that radiofrequency-powered, thermal 
balloon angioplasty (BA) of the peripheral vasculature can result in greater 
luminal dilatation with less vascular disruption than conventional BA. To 
assess the safety and histologic effects of this modal ity in the coronary 
arteries, we performed thermal BA in 27 arteries of 13 non-atherosclerotic 
pigs. All inflations were done at SO, 60 or 70° C for 30 or 60 seconds, at 
two atms of pressure and with a balloon:artery diameter ratio of 
approximately 1.3. Histologic analysis was performed to assess the effect of 
temperature on vessel wall morphology, degree of intracoronary thrombus 
formation and depth of periarterial myocardial heat necrosis. The following 
additional data were also collected: pre and post intervention HR, rhythm, 
BP, LVEDP, 12-lead ECG, 2-D echocardiogram and coronary angiogram. 
RESULTS: At 70° C there was significantly more intracoronary thrombus 
formation, compression and thinning of the vessel wall, straightening of the 
normally buckled elastic tissue fibers and significantly less separation of 
myocyte layers than at SO or 60° C. There was no difference between the 
50 and 60° groups with respect to these parameters. Depth of periarterial 
myocardial heat necrosis paralleled the increase in TO with an average depth 
of 24021' at 70·, 5851' at 60° and 371' at 50° C. There was no significant 
change in the BP, LVEDP, rate, rhythm, 12-lead ECG or ECHO post 
dilatation. Coronary angiography demonstrated transient vasospasm in one 
vessel without histologic evidence of myocardial infarction. 
CONCLUSION: Radiofrequency coronary angioplasty can be performed in 
vivo without significant electrical, hemodynamic or iscbemic cbanges. Depth 
of periarterial myocardial beat necrosis and degree of intracoronary 
thrombus are directly related to the temperature. In addition, there is a 
temperature dependent effect on the extent of vessel wall compaction, 
straightening of the elastic tissue fibers and degree of myocyte separation. 
775-4 
Improvement of Coronary Dissection with a 
Removable Flow Support Catheter: Acute Results 
Patrick Whitlow, Philippe Gaspard, Kenneth Kent, Donald 
Bairn, James Cbapman, Richard Heuser, William Knopf. 
Cleveland Oinic, Oeveland, Ohio 
9:15 
Coronary dissection remains a leading cause of emergency bypass 
surgery and ischemic complications with coronary angioplasty 
(PTCA). Permanent stents have been reported to stabilize the 
obstructive flap and improve flow with coronary disection, but are 
associated with significant thrombotic complications. A reversably 
expandable metal flow support catheter (FSC) delivered over a 
guidewire with a rapid exchange system has been utilized to 
provide stenting for 30-60 minutes in 17 cases of coronary 
dissection after PTCA (6 Left Anterior Descending, 4 Circumflex, 
7 Right Coronary Artery). Angina score (0-10) significantly 
improved from 3.3 ± 0.8 to 0.9 ± 0.5 with the the FSC (p=O.05) 
and 1.1 ± 0.5 after removal of the FSC (p=O.OO3 compared to 
baseline). TIMI flow was Grade 3 during FSC utilization in 16/17 
cases, improved in 8/9 with TIM! flow < 3 at baseline (p=O.OO4), 
and remained improved after removal (p=O.Ol). Coronary 
stenosis was 68 ± 6% before FSC and 40 ±..8% after FSC 
(p=0.025). ST elevation was not present during FSC in 16 
patients and improved from baseline in the remaining patient. No 
thrombosis developed or worsened during FSC. After removal of 
the FSC, 6 patients required no further treatment, 3 improved 
further after repeat PTCA despite prolonged PTCA attempts with 
residual flap prior to FSC, 1 improved after atherectomy, 1 
improved after laser balloon angioplasty, and 1 stabilized after 
permanent stenting. Three pts (18%) required emergency bypass 
surgery and 2 patients had elective surgery 24-48 hours later. We 
conclude that the flow support catheter is effective in reducing 
stenosis caused by coronary dissection as well as in improving 
angina and coronary flow. Further studies are necessary to define 
the role of temporary stenting in the management of patients with 
coronary dissection. 
2I8A ABSTRACTS 
775·5 9:30 
IMPLANTATION AND RECOVERY OF BALWON 
DELIVERED REMOVABLE STENTS 
Mehran J. Khorsandi, Neal L Eigler, Robert L Hess, 
Jeff P. Callister, James S. Forrester, Frank Litvack. 
Cedars-Sinai Medical Center, Los Angeles, CA 
Forty removable stents were deployed and recovered 
from the coronary arteries of 10 anesthetized dogs. The 
metalIic wire stent is radiopaque and 15 mm in length. 
The stents were serially deployed and recovered from the 
proximal and distal segments of the LAD and LCX 
arteries. Using standard balloon angioplasty equipment 
and technique, stents were expanded to diameters of 2.5 
to 4.0 mm and left in situ for 1 to 6 hours. To remove the 
stents a 3F recovery catheter was inserted over a 0.014 
wire into the stent. Brief injection of warm dilute contrast 
material through this catheter produced a phase change 
in the metal, with instantaneous recovery to its original 
dimensions onto the catheter. All 40 coronary segments 
remained angiographically patent without evidence of 
dissection or thrombosis for the duration of implantation 
and after recovery. Final angiography showed that the 
expanded artery segments remained larger in caliber than 
untreated adjacent segments. Histologic examination 
revealed patent vessels. Medial tearing and 
periadventitJal hemorrhage was observed when the 
expanded stent to vessel ratio exceeded 1.4:1. 
Conclusions: Our data demonstrates that metallic stents 
deployed on a balloon may be removed at a later time. 
These data suggest that coronary stenting may be feasible 
without the need for permanently implanted prosthesis. 
775·6 9:45 
Anglographlc and Morphologic Analysis of 
Atherosclerotic Arteries Exposed to a Slte·Speclfic 
Percutaneous Gene Transfer Procedure Post.Angloplasty 
Guy Leclerc, Dov Gal. Sigrid Nikol. Jeffrey M. Isner. Tufts 
University School of Medicine. St. Elizabeth's Hospital, Boston, MA 
The purpose of this study was to determine the contribution of the 
angioplasty procedure (PTA) and the extent of the atherosclerotic 
plaque to the outcome of a percutaneous site-specific gene transfection 
procedure in atherosclerotic arteries treated by PTA. W e performed a 
PTA in 9 atherosclerotic external iliac arteries of 9 New Zealand white 
rabbits to obtain a residual lumen diameter of ~ 50%. Immediately 
following the post-PTA angiogram, a DNA-liposome solution was 
infused in the isolated PTA site using a dual balloon-catheter system 
under fluoroscopic guidance, for a period of 30 minutes. The reporter 
DNA was a plasmid construct containing a luciferase (LUC) gene 
driven by the Rous Sarcoma Virus long terminal repeat. Animals were 
sacrificed at a mean 5.3 days post transfection. 3 out of 9 arterial 
segments exposed to the foreign gene showed LUC activity with a 
mean level of 7.54 ± 2.50 integrated light units. Computer-assisted 
analysis of pre- and post-PTA maximal stenosis disclosed no 
significant difference in percent luminal diameter narrowing between 
LUC positive and LUC negative arteries pre-PTA (47.3 ± 7.8 vs. 
42.8 ± 4.5, p=ns) or post-PTA (34.3 ± 3.8 vs. 37.3 ± 6.3, p=ns). 
Histologic analysis of contiguous segment immediately distal to 
transfection site revealed highly cellular neointimallesions covering 
nearly 100% of the luminal circumference in all sections examined. 
The mean neointimal thickness on a total of 54 sections examined was 
302.8 ± 47.2 ~ . Again. there was no significant difference in the 
neointimal thickness of the LUC positive (259.0 ± 9.0 11m) and LUC 
negative (324.7± 71.0 11m) arteries. Conclusions: 1) in vivo liposome•
mediated gene transfer can be effected in atherosclerotic arteries treated 
by PTA; 2) these preliminary data suggest that neither percent 
angiographic stenosis pre- andlor post-PTA. nor neointimal thickness 
by light microscopy determine the outcome of the transfection. 
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Hemodynamic Effects of Closure of the A4ustable Interatrial 
Communication After the Fontan Proc:edura 
Bnal Harake. Amir Elami, Jeffrey M. Pearl, Vasser AI-Khatib, 
Hillel Laks, Roberta G. Williams. 
UCLA School of Medicine. Los Angeles, California 
The snare-controlled adjustable interatrial communication (lAC) is a 
modification of the Fontan procedure designed to improve cardiac 
output (CO) and reduce systemic venous pressure in the early post•
operative period. In 10 pts (0.8-14.5 years) we assessed the acute 
hemodynamic effects of lAC closure performed 8 hrs-4.6 days post•
operatively under local anesthesia in the intensive care unit. lAC 
was closed when mean right atrial pressure (RAP) was < 15 mmHg 
and arterial 02l8turation (02Sat) was <80% on Fi02<40%. RAP 
was 13 ± 3 mmHg immediately after the operation and decreased to 
10 ± 2 mmHg(p = .02) just before lAC closure. lAC closure resulted 
in a decrease of CO by 24 ± 8%(p = .003), 21 ± 8% (p = .0001). and 
20 ± 9%(p = .0002), calculated from differences of arterio-venous O2 
seturationl (AV02), ventricular volumes by 20 Echo, and Doppler 
aortic flow, respectively. There was only a mild decrease in 
systemic O2 delivery (SOD) of 13± 10%(p= .02), due to improved 
02Sat. None of these patients showed clinical signs of low CO state. 
Pre-closure Post-closure p 
RAP(mmHg) 10 ± 2 11 ± 3 NS 
LAP(mmHg) 5 ± 2 6 ± 2 NS 
02Sat(%) 82 ± 5 94 ± 4 .0001 
AVOz (%) 26 ± 8 34 ± 9 .0001 
(mean ± SO; p < .05 = significant difference by paired t-test; 
LAP = mean left atrial pressure). 
These data demonstrate that the controlled right to left shunting 
through the lAC improves CO and SOD and facilitates the post· 
operative management after the Fontan procedure. A decrease in 
systemic venous pressure allows early closure of the lAC without 
thoracotomy. 
776·2 
Total Correction of Nonconfluent Pulmonary Arteries 
Charles J. Shanley, Flavian M. Lupinetti, Louise B. 
8:45 
Callow, Edward L. Bove, The University of Michigan, Ann 
Arbor, MI 
From 1982-1991, 20 patients with nonconfluent pulmonary 
arteries (NP A) underwent complete operative correction at 
our institution. NPA was associated with pulmonary atresia 
in 14 patients, truncus arteriosus in 3, and tetralogy of Fallot 
in 3. There were 33 palliative operations performed prior to 
total correction, including 29 systemic-pulmonary artery 
shunts in 13 patients. Ten patients received 2-4 shunts. Two 
patients underwent 2 unifocalization procedures and 2 
underwent 1 unifocalization. Age at definitive repair was 6.9 
± 1.4 years (range 4 days-22 years), and 6 patients were less 
than 1 year of age. Operation established continuity between 
the right ventricle and both pulmonary arteries; this was 
achieved with valved aortic or pulmonary allografts in 16, 
with a porcine valved Dacron conduit in 1, and with no 
conduit in 3. The RV ILV systolic pressure ratio in the 
oper?ting room following definitive repair was 0.48 ±. 0.03 
(range 0.33 to 0.80). Postoperative lung scans in 12 patients 
demonstrated a mean right lung:left lung perfusion 
distribution of 64:36 (range 46:54 to 87:13). Two patients have 
required conduit replacement because of obstruction at 20 
months and 45 months after initial repair, and one required 
reoperation for branch pulmonary artery stenosis 6 years 
after corrective operation. All patients survived operation 
and remain alive 5.5 ± 0.5 years (range 0.5-9 years) after 
operation. Operative treatment of NP A can be performed 
with low operative risk and excellent functional results. 
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Ventriculo-Coronary Arterial Connections in Pulmonary 
Atresia witb Intact Ventricular Septum: Innuences upon 
Ventricular Performance and Clinical Course 
Teiji Akagi, Lee N. Benson, Roben M. Freedom, 
William G. Williams, George A. Trusler. 
Hospital for Sick Children, Toronto, Canada 
Ventriculo-coronary anerial connections (VCC) in patients with 
pulmonary attesia and intact ventricular septum are associated with a 
poor prognosis due to myocardial ischemia. To evaluate the influence 
of VCC upon ventricular performance and clinical course, 32 of 59 
patients, evaluated from 1983-91, with (+) or without (-) VCC we!"C 
studied in newborn period (1.0±0.2 day) and 16 (3.9±0.8 years) In 
follow-up with biplane left ventriculography (RAO/LAO) ass7ssing the following variables: end-diastolic volume (EDV); end-systolic volume 
(ESV); ventricular mass (VM); ejection fraction (EF). and right 
ventricular systolic pressure (RVSP). Regional left ventncular wall 
motion was evaluated in all patients in follow-up using a center line 
method. EDV, ESV and VM were normalized by body surface area. 
Follow-up Period 
VCC + VCC-
1 5 
72±5 NS 107±12 106±13 
34±3 NS 51±8 51±8 
62±6 NS 108±11 128±17 
52±2 NS 53±2 52±2 
125±9 NS I1Ot17 92±28 
no onon I p<. 
During follow-up, 5 with VCC, all having abnormal wall motion, died, 
however, no deaths were found in patients without VCC or with normal 
wall motion (p<O.05). EF in patients with abnorntaI wall motion was 
significantly lower than that of normals (50±2 vs 56±2%, p<0.05). 
Although ventricular performance was not different between groups, 
patients with VCC have a higher incidence of wall motion 
abnorntaIities, which may reflect ongoing ischemia and be at risk for 
late death. 
776-4 9:15 
Systemic Ventricular Outnow Obstruction Progresses 
After the Fontan Operation 
Kathleen M. Finta, Roben H. Beekman, Amy L. Lindauer, Edward 
L. Bove. C.S. Mott Children's Hospital, University of Michigan, 
Ann Arbor, MI 
To evaluate the prevalence and course of systemic ventricular outflow 
(SVO) obstruction following the Fontan operation, the records of all 
57 hospital survivors from January, 1988 to December, 1990 were 
reviewed. Post-Fontan SVO obstruction was identified in 7 patients 
(Group A), and was absent in 50 patients (Group B). Group A 
diagnoses included: d-transposition with a hypoplastic RV (n=3), 
double inlet LV with an aortic outflow chamber (n=3), and double 
outlet RV with a hypoplastic RV (n=I). Only four Group A patients 
had a SVO gradient pre-Fontan, furthermore only two had a gradient 
of >10 mmHg (13 and 20 mmHg). Both of these patients had the 
VSD enlarged and subAS resected at the time of Fontan. The SVO 
gradient in Group A was 6.3±2.9 mmHg pre-Fontan and was 
7.6±3.9 mmHg at hospital discharge from Fontan. In six of the 
seven Group A patients, SVO obstruction has subsequently pro•
gressed to 49.4±12.9 mmHg (16-110 mmHg, p<O.02) at a mean of 
25 mos (5-47 mas) post-Fontan. One patient died 2 mos post-Fontan 
of severe progressive SVO obstruction. Three others have undergone 
LV-Ao conduit. Group A did not differ from Group B in age ~t 
Fontan, dominant ventricular morphology, presence of a subaomc 
outflow chamber, prior shunt or length of follow-up. Group A more 
commonly had the aorta arising from a hypoplastic ventricle (odds 
ratio=7.8, p<O.Ol) or had undergone prior PA banding (odds 
ratio=14.7, p<o.OOI). We conclude that SVO obstruction occurs 
commonly after Fontan (prevalence 12%,70% CI: 9-18%), and is 
progressive in the majority of patients. Patients at highest risk for 
developing SVO obstruction post-Fontan are those with th7 aona 
arising from a hypoplastic ventricle or who have had pnor P A 
banding. 
ABSTRACTS 
776-5 9:30 
Systemic Ventricular Size and Perfonnance Before and After 
Bidirectional Cavopulmoll8l)' Anastomosis (BCPA) 
Norman B. Berman, Thomas R. Kimball 
Children's Hospital Medical Center, Cincinnati, Ohio 
In patients eventually requiring Fontan operation, pre•
operative ventricular dilatation is a risk factor for poor post•
operative outcome. First stage BCPA has been advocated to 
achieve ventricular unloading and reduce preload in these 
patients; however, this has not been documented. To determine 
effectiveness of the operation in reducing preload and improving 
ventricular function, we reviewed preoperative and immediately 
post-operative (4-9 days post-op) echocardiograms in 16 patients 
undergoing BCP A Heart rate, preload assessed by systemic 
ventricular end-diastolic area (A..s), end-systolic area (A.), and 
systemic ventricular function assessed by area shortening ([A..s -
A.J/ A..s) were measured before and after operation. 
Patient diagnoses were double inlet single ventricle in 6, 
tricuspid atresia in 3, mitral atresia with double outlet right 
ventricle in 4, and other complex congenital heart lesions in 3. 
Age at BCPA was 7-95 mos. (mean = 36 mos.). ~ after BCPA 
was significantly smaller than before (10.2 ± 4.3 em vs 13.0 ± 7.2 
eml , p = 0.009). A. was also smaller after BCPA (5.7 ± 3.4 cm 
1 vs 7.1 ± 4.1 eml , p = 0.(03). Area shortening was unchanged 
and within normal limits at both time periods (45 ± 8% vs 46 ± 
14%, p = NS). Heart rate was not significantly different before 
and after BCPA (112 ± 17 bpm vs 120 ± 17bpm). 
We conclude BCPA results in significantly reduced systemic 
ventricular preload and size, while maintaining normal ventricular 
performance. These hemodynamic changes should improve future 
Fontan risk and long-term prognosis. 
776-6 9:45 
Myocardial Perfusion, Function and Exercise Tolerance 
After The Arterial Switch Operation 
Steven N. Weindling, Gil Wernovsky, Susan M. Mone, Janice Costello, 
Steven D. Colan, Anthony Parker, Aldo R. Castaneda, S. Ted Treves. 
Children's Hospital and Harvard Medical School, Boston, MA 
The anerial switch operation (ASO) for transposition of the great aneries 
(TGA) requires mobilization and 'translocation' of the coronary aneries to 
the reconstructed neo-aona in early infancy. 
In order to investigate the potential for late myocardial ischemia, resting 
and peak·exercise (modified Bruce prOlocoQ myocardial perfusion scans 
were performed in 15 asymptomatic children (ages 6.1:1:1.0, range 4.5·8 
years) who previously underwent a primary ASO, 2 also having ventricular 
septal defects closed. Methylisobutyl isonitrile (Tc-99m MIBI) was used for 
tomographic (SPECT) myocardial perfusion sCintigrams. In addition, all 
patients (pts) had standard two·dimensional and M-mode echocardiograms. 
Honer monitor recordings were performed in 13. 
Echocardiography showed normal left ventricular function In all pts. The 
mean duration of exercise was 9.7:1:1.0 (8.5·11.75) minutes, representing 
~50 percentile in 1, 25th to 50th percentile in 10 and 10th to 25th percentile 
in 4. During excercise. all were asymptomatic and without ectopy or ST-T 
wave changes. Honer recordings showed no signHicant ectopy (occasional 
APB's in 10 and VPB's in 7; 2 pts had rare ventricular couplets). 
Minor myocardial perfUSion abnormalities were common at rest; 14/15 pts 
had small areas of decreased uptake. At peak exercise, 1 pt had 2 small 
areas of mildly decreased perfUSion in the lateral free wall of the LV. In 6 
pts. previously identHied areas of decreased uptake showed somewhat 
increased perfusion. 
In conclUSion, exercise tolerance and ventricular function are normal up 
to 8 years after an ASO. No patient had symptoms, electrocardiographic 
evidence of ischemia or signHicant arrhythmia at peak exercise or during 
24-hour ambulatory ECG monitoring. Although myocardial perfusion 
'abnormalities' are common both at rest and during exercise following an 
ASO, this finding is of uncenain slgnHicance and must be Interpreted 
cautiously. Continued prospective follow·up is essential in this group of 
patients. 
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THE TIME COURSE OF AMIODARONE'S FREQUENCY -DEPENDENT 
ELECTROPHYSIOLOGIC EFFECTS IN HUMANS. 
Philip Sager, Mike Antimisiaris, Terrie Neiditch, Parveen Uppal, Clara 
Pruitt, Bramah Singh. West LA VAMC and UCLA, Los Angeles, CA. 
To assess the time course of frequency dependence of 
amiodarone (AM) action, the RV monophasic action potential 
duration (APD), QRS duration, and RV effective refractory period 
(VERP) were measured during RV pacing in 2 pt groups undergoing 
EPS for VT: 1) Drug-free baseline and after 10 days of AM 
loading(n" 1 1), end 2) After ~ 1 year AM Rx(n = 10) Both groups 
had similar clinical variables. 
Compared to baseline, AM at 10 days 
and ~ 1 year prolonged (p<.01) the APD 
at all pacing cycle lengths by a fixed 
amount (approx. 33 ms for Am at 10 
days). The effects of AM on APD, an 
index of refractoriness, were similiar at 
long and short cycle lengths. In contrast, 
QRS duration, an index of conduction, 
exhibited rate related increases after AM. 
Increases in VERP were similiar to those 
of APD. There were no differences 
between AM at 10 days and ~ lyr. 
Conclusion' The APD prolonging effect 
of AM did not demonstrate reverse use 
dependence and the APD remains 
significantly prolonged at short cycle 
lengths. AM's effects on APD, RV ERP, 
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and ORS duration are similiar after 10 days loading and ~ 1 yr. 
AM's divergent effects on APD (ie. refractoriness) and ventricular 
conduction may be important determinants of its high clinical 
efficacy and low proarrhythmic potential. 
777-2 
Intravenous Sotalol for the Treatment of Supraventricular 
Tachyarrhythmlas: Safety and Efficacy 
8:45 
Ruey J. Sung, Labros Karagounis, Gopas Das, Rodney Falk, Edward Platia, 
James Hanyok, Donald Archibald and Sotalol Multicenter Study Group. 
Stanford University, Stanford, California 
Sotalol (S) is a new antiarrhythmic agent with class 1II antiarrhythmic 
properties and beta-adrenergic blocking effects. To assess its efficacy and 
safety in the treatment of sustained supraventricular tachyarrhythmias 
(lasting ~ 10 min, non self-terminating), we studied 93 pts, with a 
ventricular rate (VR) of ~ 120 beats/min. 45 pts had supraventricular 
tachycardia (SVT) and the remaining 48 pts had atrial 
flutter/fibrillation (AFF). Intravenous S at 1.0 or 1.5 mg/kg body weight 
was first administered in a double-blind, placeixH.'ontrolled study design 
followed by an open-labelled S study protocol at 1.0 or 15 mg/kg if SVT or 
AFF did not convert to sinus rhythm (SR) or did not have VR reduction of 
~ 20% within 30 min. Result of the double blind phase: 
SVTgroUD ~ S (1.0 m&/k&) S(15m&/k&) 
Conversion to SR 2/14 (14.3%) 10/15 (66.7%) 10/15 (66.7%) 
Conversion to SR or 
~20% J.inVR 
~ 
Conversion to SR 
Conversion to SR or 
p=0.008 p=0.008 
2/14 (14.3%) 12/15 (80%) 
p=O.OOO7 
2/14 (14.3%) 2/18 (11.1%) 
p=NS 
11 /15 (73.3%) 
p=0.003 
2/16 (125%) 
p=NS 
~ 20% J. in VR 2/14 (14.3%) 15/18 (83.3%)14/16 (875%) 
p<O.OOl p<O.OOl 
Results of the open labelled phase showed conversion to SR or ~ 20% J. in 
VR with Sat 1.5 mg/kg in 2/3 (66.7%) SVTptsand in 6/6 (100%) AFFpts. 
Transient adverse events such as hypotension and dyspnea were common 
but these occurred in pts receiving S as well as in those receiving placebo 
(17% vs 14%). We conclude that intravenous S is a safe and effective 
antiarrhythmic agent for managing pts with supraventricular 
tachyarrhythmias. 
777-3 
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Does Ejection Fraction Predict the Li~elihood of 
Ventricular Tachycardia Suppression as well as 
Invasive Hemodynamic Measurements? 
Craig Pratt, Lemuel Moye, Marilyn Francis, James B. 
Young. 
Baylor College of Medicine, Houston, TX 
We compared rest and exercise invasive hemodynamics 
(H) at baseline to non-invasive measurement of 
eject i on fraction (EF) to the outcome of 
antiarrhythmic drug (AD) ventricular tachycardia (VT) 
suppression, (4 drugs, including electrophysiologic 
classes lA, B, C) analyzing 61 patients (pts) (EF-
36±14%) with 449±184 runs of VT/day. 
AD outcomes analyzed were: I} VT suppression and 2) 
1 ife-threatening toxicity (heart failure, potentially 
lethal proarrhythmia AD tox). Results: VT 
suppression occurred in only 34%, whereas AD tox 
occurred in 28% within 2 weeks. AD tox occurred 5x 
more frequently in pts with LVEF <40% (p~.008), 3x as 
commonly in pts with rest pulmonary wedge pressure 
(PWP>22 mmHg; p:.009), 3x as frequently in pts with 
rest cardiac index (el) 5.2.0 L/min/m2 (p-.04). Uni 
and multi variate (V) analysis of the relative 
contribution of eacg H variable compared to LVEF: 
VARIABLE UNI V-P- MULTI V-P R VALUE 
LVEF .017 .17 
PWP .016 .61 .49 ·P-P-value 
CI .02 .56 .41 
Conclusion: Invasive H variables (rest or exercise) 
are univariately associated with AD ou2come. Pts with PWP >22 mmHg or rest CI <2.0 L/min/m are likely to 
have AD tox. However, none make an independent 
contribution in identifying pts likely to develop 
life-threatening toxicity. LVEF is as powerful a 
predictor of AD tox as any invasive H variable. 
777-4 9:15 
Electrophysiologic Effects of Intracoronary Quinidine 
Infusion in Humans 
Jose Zebede, Christopher Clyne, James Udelson. Nicholas 
Mandalakas, Marvin Konstam, Deeb N. Salem, John Smith, Carey 
Kimmelstiel, Laurie Butts, Carol Colburn, Antonis Manolis, Arun 
Gadhoke, N. A. Mark Estes III, Paul J. Wang 
Tufts University School of Medicine, Boston, MA 
To determine the direct electrophysiologic(EP) effects of minute 
quantities of quinidine(Q) on the human myocardium, 200 
micrograms/minute of Q was infused for 10 min through a 2.2F 
catheter in the right coronary anery ostium in 4 patients. 
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Right venoicular effective 
refractory period(RVERP) was 
measured in oiplicate at 
baseline and every 2 min for 
30 min. Peripheral levels of Q 
were not detectable. The 
mean R VERP increased from 
246±17.5ms at baseline to 
264±35ms at the end of the 
infusion(p=O.08) The mean 
R VERP returned to baseline at 
16 minutes(RVERP 
245±17.3ms). 
We conclude that even minute amounts of quinidine(total dose of 
2mg) delivered via the intracoronary route result in a substantial EP 
effect. This is the flTst demonstration in...YiYQ of the rapid onset and 
offset of action of Q, as has been shown previously in virro. This 
preliminary data suggests that intracoronary infusion may be used 
to study the direct EP effects of antiarrhythmic drugs in humans. 
JACC Vol. 19, NO.3 
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777-5 9:30 
Hypolipidemic Effect of Type IA Antiarrhythmic Agents in 
Postinfarction Patients 
Arthur J. Moss. William E. Boden. David Oakes. University of Rochester. 
Rochester. NY 
We retrospectively evaluated the effect of antiarrhythmic agents (AA) on 
blood lipids in 1567 postinfarction pts who were part of a clinical 
multicenter study. Blood samples were collected at baseline. and at6 mo. 
and 30 mo. after the index infarction and lipids were analyzed at a core 
laboratory. AA were categorized as Type IA (procainamide. quinidine. 
disopyramide; n=76). Type IB 11=21). and Type IC (n=6). The total 
cholesterol level progressively increased from 165 ± 47 mg/dl at baseline 
to 226 ± 47 mg/dl at the 30-month contact. At each contact the average 
cholesterol level was lower (p < 0.001) in those on Type IA AA. compared 
to those who were nol. The effect of Type IA AA on lipids at the 30-mo. 
contact. adjusted for relevant clinical variables and concurrent medications 
(multiple linear regression; BMOP-2R); 
Lipid % Reduction 95% c.I. t score P value 
Cholesterol 8.6 4.1. 13.0 3.64 <0.0003 
Triglycerides 22.3 11.4.31.9 3.75 <0.0002 
Apo B 14.8 9.4.19.9 5.09 <0.0001 
Apo A II 10.1 3.9.15.9 3.13 <0.001 
Apo A I 6.2 0.9. 11.2 2.29 <0.02 
HOL-Cho!. -1.4 + -8.1. 4.9 0.42 0.67 
+negative sign indicates elevation in HOL-Cho!. 
Procainamide. quinidine. and disopyramide gave similar reductions. but 
Type 18 and IC AA had no effect on the lipids. The mechanism of the 
hypolidemic effect of Type IA AA is undefined. but it may relate to an 
alteration of ionic membrane currents at the hepatyocyte level with 
reduction in production/secretion of Apo B. Conclusion: Type IA AA 
are associated with a meaningfully significant. independent reduction in 
the blood level of cholesterol. triglycerides. Apo B. and Apo A II lipids. 
777-6 
Electrophyslologlc Effects of the Anesthellc-Propofol 
at Postoperallve Defibrillator Tesllng. 
Isabel G. Mendoza. Robert B. Kleiman. Francis E. Marchlinski. 
University of Pennsylvania. Philadelphia. Pennsylvania 
Limited information is available on the electrophysiologic (EP) 
effects of anesthetic agents used at the time of evalualion of 
Implantable cardioverter defibrillators (ICD). To determine the EP 
effects of the short acting anesthetic propofol (Diprovan®). we 
studied 12 patients before and after the administration of propofol at 
postoperative (8-60 days) ICD (Cadence™) testing. Bipolar pacing 
for ORS duration and threshold determinations and programmed 
stimulation to determine the ventricular refractory period (VRP) were 
performed through the rate sensing/pacing ICD lead system via the 
CadenceTN programmer. The programmer allows for adjustment of 
output in 1 volt increments and in coupling intervals of 10 ms. A 1 
ms pulse width was used for all stimulation. Defibrillation testing X2 
was performed only after propofol using shock energy equal to (10 
ptS) or 50 volts> (2 ptS) the defibrillation threshold determined 
intraoperatively. Propofol was sufficient to produce general 
anesthesia at a dose of 123 mg ± 71 mg. median 100 mg. 
.B.w.t.I!a.; ~ fJm1jQI 
Systolic Pressure (mmof Hg) 131±25 97±20' 
Sinus cycle length (ms) 772±119 785±130 
VRP 600 ms (ms) 240±25 254±26' 
DiastoliC threshold at 600 ms (mA) 2.3±1.2 2.6±1.6 
Diastolic threshold at 300 ms (mA) 2.7±1.3 2.7±1.6 
ORS duration (ms) at 600 ms 200±25 201±25 
ORS duration (ms) at 300 ms 205±28 207±32 
·P<.OOl; all others - P~NS 
Ventricular fibrillation was always terminated at described energy 
values and no adverse effects of propofol were noted. 
In summary. using the described protocol. propofol 1) modeslly 
increases ventricular refractOriness but has no significant effect on 
indices of conduction or excitability; 2) does not appear to increase 
energy needed for defibrillation and 3) is well tolerated. Propofol 
may be a useful anesthetiC when evaluating ICD function 
postoperatively; the significance of its demonstrated modest effect 
on ventricular refractoriness remains to be determined. 
9:45 
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778-1 
Skeletal Muscle Blood Flow is Modulated by 
Prostaglandin Release 
John R. Wilson. Shiv C. Kapoor, Laura Farrell 
Hospital of the University of Pennsylvania, Philadelphia, PA 
8:30 
During exercise, prostaglandin release from the vascular endothe•
lium may augment blood flow to exercising skeletal muscle. To test 
this hypothesis, we placed brachial arterial and venous catheters into 
II nonnal subjects. We then measured forearm blood flow by ve•
nous plethysmography and arterial and venous prostaglandin E2 
(PGE2) and 6-keto prostaglandin Fla (PGFla) concentrations 
during two levels of wrist flexion exercise (0.2 and 0.6 watts). In 8 
of the subjects, exercise was repeated following intra-arterial infu•
sion of indomethacin (0.3 mg/IOO ml forearm volume). Exercise in•
creased foreann blood flow (ml/min/IOO ml) and the forearm release 
ofPGE2 and PGFla (pg/rnin/IOO ml). Indomethacin virtually 
abolished forearm prostaglandin release and reduced forearm blood 
flow both at rest and during exercise (*p < 0.05 Control (C) vs 
Indomethacin (I». 
Be.s.t. Q 2 liatts Q fi liatt:l 
FBF -C 2.2±O.2 6.0±O.3 l2.l±1.7 
-I 1.7±O.2* 5.l±0.7* lO_l±1.5* 
PGE2 -C 26±6 7l±14 l25±17 
-I O±l* -5±4* -56±4l* 
PGFl<x-C l62±28 605±196 766±193 
-I O±lO* 8±lO* -26±34* 
These data suggest that prostaglandin release helps to increase 
skeletal muscle blood flow during exercise. 
778-2 8:45 
Skeletal Muscle Phosphate Metabolism Abnormalities in Heart 
Failure are Closely Related to Exercise Capacity but not to Ventricular 
Function 
Faiez Zannad, Zukai Chatti, Brigitte Robin, Gabriel Nizan, Jean-
Philippe Simon, Jacques Robert, Etienne A1io!. . 
Departments of Cardiology and Biophysics - HOpital Central - Nancy -
France 
Previous studies have shown skeletal muscle energy metabolism 
abnormalities in patients with congestive heart failure (CHF). We 
studied the relevance of these abnormalities to exercise capacity 
limitation in 19 patients with CHF (10 ischemic and 9 primitive 
cardiomyopathy). They performed a graded leg exercise into a NMR 
magnet with a surface coil on the calf muscle. Inorganic phosphate to 
creatinine phosphate ratio (Pi/PCR) were determined using a 31P 
spectrometer (Briicker, areas under spectres). We measured the 
workload producing total PCR depletion (TDWL) and the one producing 
a non linear increase of Pi/PCR (threshold : TWL) and calculated the 
initial PCR depletion rate (DR = slope of Pi/PCR vs workload) and 
terminal recovery rate (RR : slope B of Pi/PCR vs time). Exercise 
capacity PCR was determined using symptom limited exercise time 
(ETT), peak V02 and anaerobic threshold (AT) (20 W /2 min 
cycloergometer, CPx medical graphiCS gas analysis). Results: 
-------------ETT~---p\l~(mJ7~~-AfmJ~7k8-Ag;~-----
(497 ± 203) (15.5 ± 6.5) (9.5 ± 2.9) (56 ± 10) 
TWU6.2± 2.8W) 0.74+++ 0.68+++ 0.63+++ - 0.51+ 
TOWL (8.4± 3.1 W)O.74++ 0.63++ 0,62++ -0.46+ 
DR (0.08±0.06) -0.7Q++ -0.68* -0.64++ 0.65++ 
RR (-1.7±0.75) -0.81+++ -0.89*+ -0.68+++ 0.61++ 
C~~~~H~;~~~d;;fs(~j;~-~o57~~-i<-o.oI7~~~-p<-o.OOV-------
Left venlricular ejection fraction (26 ± 7 %) was not related to any 
variable. Thus skeletal muscle phosphate metabolism abnormalities in 
CHF seem to be a factor limiting exercise capacity and is not related to 
the severity of left ventricular dysfunction. 
221A 
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778-3 9:00 
Optimizing Linear Metabolic Incremental Changes During 
Exercise Testing: A Comparison of Four Protocols 
Leslee J. Shaw, Arthur M. Stelken, Liwa T. Younis, Bonpei Takase, 
D. Douglas Miller, Bernard R. ChaHman. St. Louis University Medical Cemer, 
SI. Louis, MO. 
Standard treadmill exercise protocols wHh relatively large incremems 
between stages render ST/HR changes non-Unear and weaken the 
correlation between heart rate and the onset of ischemic ST segment 
change during exercise testing and ambulatory ECG. We compared 4 
different exercise treadmill protocols using gas exchange measurements in 
15 patients (pts) wHh a mean age of 45 years, 60% of whom were men. The 
4 protocols tested were the Bruce (BR), Cornell (COR), and two 
modnications of the Balke protocol, designed for use in a mutticenter trial to 
linearly increase metabolic workload by 1.5 METs per stage, at a walking 
speed of 2 mph (MB-2) and 3 mph (MB ·3). The protocol sequence was 
randomly determined, and all tests were co~leted wHhin 2 days. Exercise 
time in minutes at submaximal (60% and 80%) and maximal (100%) oxygen 
consu~tion values (V02) was signnicantly shorter for BR (8.0±2.5) vs other 
protocols (MB·2.11.2±3.1, MB·3-10.6±3.6, COR.12.4±3.2, all p<0.05). 
Peak heart rate (HR) and V02 values were similar at submaximal (60 and 
80%) arx! rnaxjma! (100"10) 'NO!Istm;. 
60% 
HR 
Bruce 129±22 
MB·2 123±12 
MB·3 124122 
Cornell 121±23 
ycg 
16.3±7 
16.3±5 
15.5±6 
15.8±7 
% Maximal V02 
fK)"/. 
HR 
143±22 
144±19 
143±22 
140±23 
21.7±7 
21.5±7 
21.0±8 
20.0±8 
HR 
100% 
y02 
167±21 
167±19 
166±19 
165±21 
26.4±11 
27.4±10 
25.6±10 
25.1±11 
Optimal correlation between peak V02 and total exercise time was noted 
wHh the MS·3 protocol (r=0.98), p<0.001), followed by the BR protocol 
(r:0.95, p<0.001), the MS·1 protocol (r .. 0.93, p<O.OOI), and finally, the 
COR protocol (r.0.60, p-0.02). Thus, mocmications of the Balke protocol 
(i.e. MB·3) which provide more gradual increments in exercise workload 
optimize the linear correlation between exercise time and V02 
measurements. 
778·4 9:15 
Left Ventricular Hypertrophy in Chronic Cocaine Abusers 
is Related to an Exaggerated Pressor Response to Exercise 
Carlos G. Cigarroa. James D. Boehrer. M. Elizabeth Brickner, Eric J. 
Eichhorn. Paul A. Grayburn. University of Texas Southwestern and 
VA Medical Centers. Dallas. Texas. 
Chronic cocaine abuse and left ventricular hypertrophy (L VH) have 
been shown to be associated. although the mechanism by which 
cocaine might cause L VH is uncertain. We hypothesized that chronic 
cocaine abuse, which is known to deplete dopamine stores, might lead 
to an exaggerated pressor response to sympathetic stimuli. and that 
this might be manifested by an abnormally high blood pressure (BP) 
response to treadmill exercise. Accordingly. we performed Bruce 
protocol exercise tests in 32 chronic cocaine abusers and in 30 normal 
control subjects. All subjects were normotensive at rest. Age. race. 
body surface area, and resting BP were not significantly different 
between groups. Concentric L VH was present by 2·0 echo (posterior 
wall thickness ~ 1.2 cm and LV mass index ~ 105 g/m2) in 10 cocaine 
abusers and 3 normals (p=O.04). All subjects exercised to 85% of 
maximal predicted heart rate and none had chest pain or ECG changes. 
Exercise BP was monitored by an observer blinded to the 2-D echo 
findings. An exaggerated pressor response to exercise. defined as a 
peak systolic BP ~ 210 mmHg, was present in 8 of 10 cocaine 
abusers with L VH and no normals with L VH. By 2-factor analysis of 
variance, the combination of cocaine and L VH was the most important 
predictor of an exaggerated exercise BP (mean ± S.D .• * p=O.OOO4). 
irQl.IR 
cocaine with LVH 
cocaine without L VH 
normal controls 
peak systolic BP (mmHg) 
214 ± 9 * 
182 ± 18 
185± 17 
Conclusions: Chronic cocaine abusers with concentric LVH have an 
exaggerated pressor response to treadmill exercise. This is likely to be 
an important factor in the pathogenesis of cocaine-related L VH. 
lACC Vol. 19, No.3 
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778·5 9:30 
Improved Ventilatory Response to Exercise After 
Cardioversion of Chronic Atrial Fibrillation to 
Sinus Rhythm. 
Torbj~rn Lundstr~m, 5sten Karlsson. 
Central Hospital, Sk~vde, Sweden. 
Hemodynamics and respiratory gas exchange during 
exercise were studied in 15 patients (NYHA class 
I-II) before and one month after cardioversion of 
chronic atrial fibrillation (AF) to sinus rhythm 
(SR). 
Prior to cardioversion maximal exercise 
capacity (WIWt ) in AF had been assessed, and 
ventricular rate regulation had been optimized 
with verapamil. Return of atrial function after 
one month was documented by doppler technique. 
Pts were studied during bicycle ergometry at low 
grade work (40% of WIWt : WI), at work above the 
anaerobic threshold (65% of WHAlt : W2) and at 
maximal tolerated exertion (Max). After resto•
ration of SR heart rate was reduced by 16-20% 
(p<.Ol) during exercise. Cardiac output increa•
sed by 9% (WI: p<.Ol) and 7% (W2: p<.05) where•
as minute ventilation (VE) decreased by 7% (WI: 
p<.Ol) and 9% (W2: p<.05). The ratio between VE 
and CO, production was reduced (p<.Ol) indica•
ting improved efficiency of ventilation. Max 
oxygen uptake (+8%: p<.Ol) and exercise capacity 
(+6%: p<.05) improved. 
This coupling between improved hemodynamics 
and significantly reduced ventilatory work during 
exercise after cardioversion of AF to SR has not 
been described previously. Less dyspnea during 
daily acti vi ties should be one important 
explanation of symptomatiC improvement after 
restoration of SR. 
778-6 
Physiologic Basis of Intravenous Adenoslne·lnduced 
Segmental Wall Thickening Abnormality 
9:45 
Elizabeth Ofili, Frederick Dressler, Jeanette St.Vrain, John 
Standeven, Ramon Castello, Henry Goodgold, Rita Gentilcor, Bhugol 
Chandel, Morton Kem, Arthur Labovitz 
SI. Louis University Medical Center, SI. Louis, Missouri 
Preliminary clinical studies suggest a potential role for adenosine 
(ADENO) in conjunction with myocardial imaging for the diagnosis of 
coronary artery disease (CAD). In order to define the phYSiologic 
basiS underlying the effect of ADENO on myocardial function, we 
used an open chest dog model of critical circumflex (CIRC) stenOSis. 
Ten anesthesized mongrel dogs were studied at baseline (BASE) 
and following ADENO (0.42 mglkg/x3 mins). Ultrasonic flow probes 
around the stenosed CIRC and normal left anterior descending 
(LAD) measured coronary ffow continuously. Regional myocardial 
blood flow (MBF) was measured with radiolabelled microspheres at 
BASE and ADENO to determine subendocardial (ENDO) and 
subepicardial (EPI) flows. 
Continuous epicardial short axis 2-D echocardiography (2DE) was 
performed at the papillary muscle level for analysis of wall thickening 
(WT). The LV short axis was divided Into 6 equal carefully matched 
s?gments (segs) for MBF and 2DE WT of CIRC and LAD perfusion 
zones. 
RESULTS (Mean ± SD) 
FO.v (n1s'rrin) MBF (~) ENOO/EPI 2DE WT(%) 
CIRC BASE 61125 
ADENO 56±22 
LAD BASE 54122 
ADENO 94±53' 
'P<O.OS 
ENOO EPI 
1.3±0.4 1.3±0.4 
o 9#l 2' 1 8±0 4' 
1.3±O.4 1.3±0.4 
2.2±1.1' 2.3±0.9' 
1.0±0.2 
o 8±0 2' 
1.0±02 
1.0±02 
26±4 
7+17' 
44±14 
55±27 
CONCLUSION: In the presence of critical stenosis, ADENO causes 
significant decrease in ENDO and a decline in ENDO/EPI ratio which 
results In abnormal 2DE wall thickening. 
JACC Vol. 19, No.3 
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779·1 
Initial Report of the "GUIDE" Trial for Intravascular Ultrasound 
Imaging in Coronary Interventions 
The GUIDE Trial Investigators 
University of CalifOrnia, San Francisco and Stanford University, CA 
The GUIDE Trial (Guidance by Ultrasound Imaging for Decision 
Endpoints) is a 10 center, prospective, randomized study to explore the 
utility of intravascular ultrasound (US) imaging in percutaneous coronary 
angioplasty (PTCA) and directional coronary atherectomy (DCA). This 
preliminary report documents differences between the angiographic 
(AN) and ultrasound (US) assessment in 51 lesions from the first 42 
patients entered in the imaging arm. Among 26 PTCA and 16 DCA 
patients, interpretable pre-intervention US images within the lesion 
were obtained in 42% and post-interventional images in 92%. 
Quantitative AN analysis revealed that diameter stenosis decreased 
from 87.3% to 22.6% post intervention. Residual area stenosis by US, 
however, was 58.6%. Mean stenosis in the proximal segment chosen as a 
"normal" AN reference was 38.6% by US. US allowed measurement of 
the change (A) in lumen and plaque area with intervention as well as 
assessment of total vessel expansion (area bordered by media). 
PTCA 
DCA 
Lumen Area (4l Plague Area (4) Total Vessel Area (4) 
+ 4.42 mm2 - 0.89 mm2 + 4.80 mm2 
+ 3.78mm2 - 2.4Smm2 + 2.10mm2 
These data show DCA improves lumen area by a combination of plaque 
removal and vessel expansion, whereas PTCA primarily causes 
expansion. Dissections were seen in 25/51 (49%) patients by US and 9/51 
08%) of lesions by AN. A total of 17/25 dissections by US was not 
appreciated by AN. Lesion calcification was seen in 35/51 (67%) by US 
and 12/51 (23%) by AN. In 10/12 AN calcifications, a minimum calcium 
arc of 180° was seen on US cross-section. Of 22 lesions with a calcium arc 
less than 90° by US, none was detected on AN. Lesion eccentricity was 
also underestimated by AN compared to the US eccentricity ratio (ER = 
ratio of thinnest to thickest plaque depth). The average US ER in lesions 
judged concentric by AN was 0.35. No in-hospital complications have 
been reported in the US arm. Recruitment continues (8 cases/week); US 
and AN measurements will be analyzed with 6 month follow-up data. 
779·2 8:45 
Coronary Stenting With Angioscopic Guidance 
Paul S. Teirstein, Richard A. Schatz, Krishna J. Rocha•
Singh, S. Chiu Wong, Robert Strumpf, Richard R. Heuser. 
Scripps Clinic and Research Foundation, La Jolla, CA 
Angioscopy was evaluated in 11 pts; 8 native coronary 
stenoses, and 3 vein graft (SVG) lesions. High-resolution 
images were obtained in all vessels at baseline, after 
balloon angioplasty (PTCA) or atherectomy, and final 
result after Palmaz-Schatz stenting. PTCA produced small 
mural tears with localized hemorrhage. In one pt thrombus 
not seen angiographically was identified angioscopically 
prior to stenting and disappeared after urokinase 
infusion. Transluminal extraction atherectomy of SVG 
caused debulking of the stenosis with numerous torn 
tissue strands waving in lumen. After stenting, the 
angioscope was easily advanced over a 5 cm vessel segment 
allowing continuous inspection of entire length of each 
stent. Stent struts were uniformly expanded, some struts 
were embedded into intima. One bent strut protruded into 
lumen at the proximal stent-artery margin. Luminal 
diameter was significantly increased in all stented 
regions except at stent articulation sites, where, in all 
pts, stenotic segments bulged into lumen. In one pt 
attempts to further expand articulation site with an 
oversized balloon did not improve angioscopic appearance. 
In native vessels all mural tears seen post PTCA were 
absent after stenting. In SVGs mural tears were markedly 
reduced but, occasionally, tissue flaps protruded 
through the stent into lumen; elsewere, tissue bulged 
through diamond-shaped inter-strut spaces producing a 
"cobblestone" effect. 
Angioscopy demonstrates findings not seen or only 
suspected from angiography including: l)presence of 
thrombus that can be treated pre-stenting, 2)stents "tack 
up· mural tears, 3)stent struts are occasionally damaged, 
and 4)persisting stenosis at the articulation site 
suggests the need for stent design modification. 
8:30 
ABSTRACTS 
779-3 9:00 
Combined AtherectomylUltrasound Imaging Device Reduces Subintimal 
Tissue Injury 
Peter j. Fitzgerald, Krishnankutty Sudir, Mukesh Gupta, Gordon Honda, 
W. M. Belef, Paul G. Yock. University of California, San Francisco, CA 
Although directional atherectomy is an effective approach to reducing 
plaque burden, subintimal injury occurs in some cases and may accelerate 
restenosis. We have designed and tested a prototype combined 
atherectomy /imaging device (AID) which provides real-time 
ultrasound imaging of plaque and vessel wall during atherectomy. We 
studied 18 excised, human pressure-perfused iliac and femoral vessels 
using AID ~nd compared this approach to tissue excision using a 
standard atherectomy catheter (A TH). A total of 39 tissue samples 
were excised in the AID group and 36 in the A TIi group. For nonguided 
A TH the housing was positioned toward the area of maximal plaque 
accumulation as judged by direct inspection and / or angiography. 
Multiple catheter passes were made until the target lesion resulted in 
an angiographic residual stenosis of less than 20%. Each excised 
sample was cut into serial cross-sections and prepared with 
hematoxylon-eosin and elastin von Gieson's stains. Light microscopic 
views were stored on video tape and the area of each vessel layer 
determined with computer assisted planimetry. The contribution of 
intimal and subintimal tissue layers was expressed as a percentage of 
the entire exdsed tissue volume. 
RwiliI; In the A TH group 15/36 (42%) of the sampled tissue contained 
plaque/intima alone and 21/36 (58%) contained varying amounts of 
subintimal tissue. In the AID group, 31/39 (79%) samples contained 
plaque/intima alone whereas 8/39 (21%) had evidence of subintimal 
resection. Additionally. the relative amount of subintimal tissue per 
excised tissue volume in the AID group (12.5%±6.2%) was significantly 
lower (p<.OOl) than the relative amount of subintimal tissue resected in 
the ATH group (34%±11%). 
Cgnclusion' These results strongly suggest that ultrasound guidance of 
atherectomy reduces the incidence and amount of subintimal excision 
during catheter debulking in-vitro. Clinical application of AID may 
help minimize the extent of medial injury . 
779·4 9:15 
Intravascular Ultrasound Assessment of High Risk 
Lesions After Excimer Laser Coronary Angioplasty 
Thomas E. Schryver, Timothy J. Garrand, Gary S. Mintz. Jeffrey J. 
Popma, Lowell F. Satler, Augusto D. Pichard, Kenneth M. Kent, 
Martin B. Leon. Washington Hospital Center, Washington, D.C. 
A,n intJ'!lvascular ultraso~nd (IVUS) imaging system (including 3-
dimenSIOnal reconstruction) was used to evaluate excimer laser 
angioplasty (EL) in II patients with complex lesion morphologies 
including calcification (Ca) (55%), total occlusions (36%), and long 
lesion length (average l6.4±14.0mm). IVUS, obtained after 
successful EL + PTCA procedures, was assessed for both qualitative 
findings and quantitative parameters at the lesion site and proximal 
reference segments. All lesions exhibited marked Ca at the lesion 
site by IVUS; calculated circumferential intimal arc of Ca was 
196±76°. IVUS revealed that treatment with EL + PTCA resulted in 
frequent intimal disruption including dissections in 7 lesions (64%) 
of which 4 (36%) were extensive ~2 dissection planes, at least 1 
extending into the media) and 3.1±1.8 fissures per lesion site. 
These results were compared to a group of 13 patients with matched 
lesion characteristics treated by PTCA alone who had post•
intervention imaging and analysis by identical IVUS techniques. 
PTCA alone resulted in more frequent dissections (100% of treated 
lesions, p<O.05 vs EL + PTCA) which were more extensive (69% 
of sites, p<O.03 vs EL + PTCA) but somewhat fewer fissures 
(2.2±1.1). Importantly, plaque area at treatment sites (normalized 
for vessel size) for EL + PTCA (8.4±6.Omm2) was similar to PTCA 
alone plaque area (9.4±5.5mm2, pns). In conclusion: IVUS 
examination of EL procedures indicates (1) significant disruption of 
the intimal surface, but less than comparable PTCA alone treated 
lesions; and (2) substantial residual plaque mass with little evidence 
of significant atheroma debuIking. Thus, an important mechanism 
for lumen enlargement after EL + PTCA is probably acoustic 
shockwave effects to the vessel wall which facilitates subsequent 
mechanical balloon dilatation. 
223A 
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779·5 9:30 
On·llne Three·dlmenslonal Reconstruction from 20 IVUS: 
Utility for Guiding Interventlonal Procedures 
Kenneth Rosenfield, Jenifer Kaufman, Ann Pieczek, Jeffrey M. Isner, 
Tufts Medical School, SI. Elizabeth's HospHal, Boston, MA 
eo~ter-based three-dimensional (3~) reconstruction (R) of vessel from 
serial Intravascular uHrasound (IVUS) images generated during a pullback 
of IVUS catheter, now routinely available on-line, represents a solution to 
the IimHed spatial display of 20 IVUS. To date, we have performed on-line 
30R In 27 patients undergoing percutaneous revascularlzation (2 
coronary, 10 iliac, 13 femoral, 2 bypass grafts, 2 renal, 1 dialysis fistula). 
Procedures included balloon (21) andlor laser(4) angioplasty, thrombolysis 
(3), atherectomy (9), and stent deployment (2). MuHiplanar sagittal views, 
rotating the vessel about the IongHudinal axis of the IVUS catheter, were 
performed in all 27 patients. This format provided views similar to 
angiography In orientation, but with unlimited orthogonal angles and more 
arterial wall detail. The latest software iteration shortened time to image 
rendering from 70 to 15 seconds, enabling practical use of the sagittal 
Images. Moreover, a new on-line format, lumen cast analysis, which 
reconstructs a 3D cast depicting the shape and dimensions of the vascular 
lumen, was employed In 9 pts. This 3D fonmat incorporated automated 
quantitative analysis of cross sectional area (eSA), based on an edge•
detection algorHhm, and facilitated detection of residual eSA narrowing. In 
12 pts, 3D views were 
employed to assess 
procedural outcome and 
determine the need for 
adjunctive therapy: in 5/12 
pts, adjunctive balloon 
dilatation (3) or stent 
deployment (2) was 
performed, either partially or 
wholly as a resuH of 3DR data. 
Conclusions: 1) On-line 3DR of IVUS provides detailed muHiplanar sagittal 
Images of vessel wall and cast-like depiction of lumen; 2) automated edge•
detection enables direct quantHication of eSA; 3) on-line 3DR may further 
enhance the ability of IV US to guide Interventional procedures. 
779·6 9:45 
Three·Dimensional Intravascular Ultrasound 
Reconstruction of Endovascular Stents 
Gary S. Mintz, Martin B. Leon, Jeffrey J. Popma, Fadi Matar, 
Lowell F. Satler, Augusto D. Pichard, Kenneth M. Kent. 
Washington Hospital Center, Washington, D.C. 
Angiographic and clinical responses after implantation of endo•
vascular coronary stents (S) may be dependent upon expansion geo•
metry which determines radial compressive strength. Conventional 
imaging techniques are limited by inadequate S visualization and 
poor delineation of 3-dimensional (D) expanded S geometry. 
Therefore, we configured a new intravascular ultrasound (IVUS) 
imaging system incorporating (I) a low-profile (3.9p) monorail 
sheath surrounding a 25 MHz imaging catheter rotating at IS00 rpm, 
(2) an automatic motorized imaging catheter pullback mechanism (at 
0.5 mm/sec). and (3) computerized software for 3D reconstruction 
of >200 cross-sectional images stacked in cylindrical format. The 
expanded geometry of 6 different S (Palmaz-Schatz. spring-coil, 
Wiktor. Strecker. Medinvent, SciMed biodegradable) was imaged in 
vitro and compared to 7 implanted Palmaz-Schatz 
S (3 native coronary. 4 saphenous vein grafts) in 
vivo. 3D reconstruction of IVUS images repro•
duced each stent's precise spatial geometry in vi•
tro and in pts (Figure. from native RCA) to allow 
measurement of longitudinal, oblique, circum•
ferential. and radial dimensions. Importantly. 3D 
images from pts provided valuable insights into 
(I) non-uniform circumferential and axial S 
expansion patterns in both acute and chronic 
implants (especially in areas of lesion fibrosis and 
calcification); (2) adequacy of S-vessel wall 
contact; and (3) chronic vessel wall responses. 
In conclusion: Reliable analysis of in vitro and in vivo stent 
expansion geometry is feasible and practical using an automated 3D 
IVUS imaging system. These findings may have important 
implications for stent deployment and long-term clinical results. 
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Ability of Dual Chamber Pacing to Relieve Syncope and 
Presyncope Associated with Left Ventricular Outflow Tract 
Obstruction in Patients with Hypertrophic Cardiomyopathy 
Lameh Fananapazir, Richard 0 Cannon III, Dorothy Tripodi. 
National Institutes of Health, Bethesda, MD. 
Pts with obstructive hypertrophic cardiomyopathy (HCM) are 
prone to syncope and presyncope (PS). We determined the ability 
of dual chamber pacing (DOD) to relieve S and PS in 23 pts with 
obstructive HCM: IS pts had significant basal LV outflow (LVOT) 
gradient (>30 mmHg), and 5 pts had significant LVOT gradient 
(>50 mmHg) after iv isoproterenol, Valsalva maneuver, or amyl 
nitrite inhalation. All 23 pts had a history of prior syncope: 
7 pts had experienced 2. I episodes every 2 months, and in 22 pts 
I to 6 episodes of syncope had occurred during the year prior to 
pacemaker implantation. In addition, 19 pts had frequent episodes 
of PS - often induced by exercise and/or postural changes. Cardiac 
catheterization fmdings after 6-8 weeks of pacing was as follows: 
PA pcw LVS Grad CO 
Baseline 21±8 13±7 182±46 76±48 5.0±1.l 
Post-DOD 19±6 11±4 155±41* 35±39* 5.2+1.3 
*=p< .001; PA=mean pulmonary arterial pressure (mmHg); CW 
=pulmonary capillary wedge pressure (mmHg); LVS=LV systolic 
pressure (mmHg); Grad=LVOT gradient (mmHg); CO=cardiac 
output (l/min). During a follow up of 8.5±3.0 months (maximum, 
14 months), only 2 pts experienced syncope which was related to 
exertion in both cases (one had a history of almost daily episodes of 
syncope prior to pacing; the other presented with 3 episodes of 
syncope in the 3 months prior to DOD pacing). During follow up, 
II pts were free of PS, 9 had fewer and milder episodes, but in 3 
pts PS was not improved. Thus, DOD pacing reduces syncope and 
PS, associated with reduction in L VOT obstruction in HCM pts. 
780·2 8:45 
Dofetilide (UK 68,798) Prevents Ventricular Tachycardia on 
Holter and Inducible Sustained Ventricular Tachycardia in 
Patients with Hypertrophic Cardiomyopathy 
Lameh Fananapazir, Anne Cropp. National Institutes of Health, 
Bethesda, Maryland 
Dofetilide is a new antiarrhythmic drug with class III properties. 
Pts with hypertrophic cardiomyopathy (HCM) with ventricular 
arrhythmias are prone to sudden death and syncope. Currently, 
these pts are treated with amiodarone. However, amiodarone has a 
long half-life and may cause serious side effects. Moreover, it 
suppresses induction of sustained ventricular tachycardia (VT) in 
only 30% of HCM pts, and ~ induction of VT in 50%. As 
alternative therapy, we evaluated the effects of dofetilide on Holter 
VT, and VT induced programmed stimulation (PS) in 16 HCM pts: 
10 had prior cardiac arrest or syncope, 15 had VT on 4S-hr Holter, 
4 had family history of sudden death. PS was performed before 
and after iv dofetilide (bolus 1.95 "g/kg; maintenance •. 068 
"g/kg/min), was repeated after 3 days on oral drug (.25 or .375 mg 
tid). PS involved the use up to 3 extra stimuli at 2 RV and I LV 
sites, and 3 drive cycle lengths. End-point of PS was refractoriness 
or induction of a sustained VT (> 30 sec duration or requiring 
rapid termination). At baseline, all pts had inducible sustained VT: 
9 monomorphic, 7 polymorphic. In contrast, after iv dofetilide, 
VT was not induced in 10 (63 %) pts (p < .00 1). A partial response 
was noted in the remaining 6 pts as shown by the need for a more 
aggressive PS to induce sustained VT. On oral drug, no pt had VT 
on Holter. Sustained VT was not induced in II (69%) pts 
(p< .001), was induced but only with more aggressive PS in 4 pts, 
and induced more easily in I pt. We conclude that dofetilide I) is 
highly effective in suppressing both Holter and inducible VT. and 
2) in contrast to amiodarone. increased VT inducibility is rare. 
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780·3 
Apical Preexcitation Reduces Gradient in 
Hypertrophic Obstructive Cardiomyopathy 
(HOCM) 
Lukas Kappenberger, Xavier Jeanrenaud. Martin 
Fromer. Jean-Jacques Goy. 
Division of Cardiology. CHUV. Lausanne. Switzerland 
9:00 
The mechanism by which pacing can lead to 
hemodynamic improvements in HOCM as well as 
quantification of these effects have never been 
analyzed in detail. We investigated 15 patients (pts) (4 
women. 11 men) with a mean age of 56 +1- 14 years. All 
had severe symptomatic HOCM refractory to medical 
therapy. During various pacing modes (AAI. VVI. VAT 
and DOD with varying PR interval) the subaortic 
pressure gradient (SAG) and the cardiac output were 
measured with left and right heart catheterization. 
In 2 pts with important mitral valve incompetence • no 
hemodynamic improvement could be demonstrated. 
However. in 13 pts SAG could be significantly reduced 
from 82 +1- 42 to 47 +1- 34 mm Hg (p<O.OOI). The effect 
was optimal if right ventricular apical stimulation was 
synchronized to the atrial systole with a PR-intervai 
activating the left ventricular apex before the septal 
contraction = apical preexitation. 
Emptying of the apical chamber before septal bulging 
seems the explanation of this beneficial effect. as 
demonstrated by left ventricular angiography. Cardiac 
output. aortic systolic and diastolic pressures remained 
unchanged. 
In conclusion pacing induced apical preexcitation 
significantly reduces obstruction in HCOM. the amount 
being comparable to surgical series. This might be a 
new approach to treat HOCM. 
780·4 9:15 
Diastolic Function in Chronic Mitral Regurgitation: A Pre· 
and Post.Operative Study 
William J. Corin. Otto M. Hess. Tomoyuki Murakami. Otto N. 
Krogmann. Hans P. Krayenbuehl 
Philadelphia Heart Institute. Philadelphia. Pennsylvania and University 
of Zurich. Zurich. Switzerland 
In chronic mitral regurgitation (MR). the left ventricular (LV) response 
to the volume overload increases LV end-diastolic volume index (EDVI. 
mVm2) and decreases passive chamber stiffness (b*. 11m!) and end•
diastolic eccentricity (Ecc). To evaluate the effect of surgical correction 
on LV geometry and diastolic function. we performed simultaneous 
micromanometry and biplane ventriculography in 14 patients (PTS) both 
pre- (PRE) and an average 21 months postoperatively (POST). The 
parameters: b*. myocardial stiffness (b). EDVI. ejection fraction (EF. 
%). Ecc. LV muscle mass index (LMMI. g/m2). and maximal 
circurnferentiallengthening rate (dC/dt. cm/sec) during passive diastole 
were calculated in PTS. and compared to 10 controls (CONT). There 
were no significant differences between the 8 PTS who underwent 
mitral valve reconstruction and the 6 PTS who had valve replacement. 
except in their POST EF (reconstruction 63%. replacement 51%. 
p<0.05). 
Qwm J2! ..b EOYl EE .f&k 
PRE .018& 19.7 175& 64 1.39& 
POST .0261 17.4 107&# 58&# 1.64# 
CONT .031 13.7 82 65 1.83 
&p<O.05 vs CONT; #p<O.05 PRE vs POST. 
LMM1 
128& 
101&# 
86 
lICilI1 
32& 
17# 
18 
PRE. b* and Ecc were decreased, and dC/dt was increased compared to 
CONT. They all returned to normal POST. b was normal both PRE 
and POST. EDVI and LMMI decreased POST, but did not normalize. 
Conclusions: In MR, the preoperative decrease in LV chamber 
stiffness and eccentricity are reversible, and the increased preoperative 
filling rate returns to normal postoperatively. The decline in ejection 
fraction associated with mitral valve replacement does not result in a 
change in myocardial stiffness. 
ABSTRACTS 
780·5 9:30 
Mitral AmIuloplasty Alters Left VentricuIar Relasation in the Conscious, 
<bed Ou:st Dog 
Luis J. Castro, Stephen C. Rayhil1, Marc R. Moon, Marek Niczyporuk, Terry 
L. Tye, Neil B.lngels, George T. Daughters, Geraldine C. Derby, Cynthia E. 
Handen, D. Craig Miller. Stanford University, Stanford, CA 
Diastolic LV filling dynamics were analyzed in 16 dogs randomized to undergo 
annuloplasty with a Carpentier-Edwards rigid ring, Duran flexible ring, or 
'sham' procedure. Twenty-eight miniature tantalum markers were inserted 
into the LV wall for computation of LV volume and geometry. Intra•
operative epicardial cchocardiography verified ring position, ruled out mitral 
regurgitation and systolic anterior motion, and assessed Doppler flow 
dynamics. After 7-10 days of recovery, atrial pacing at 120 min- with 
autonomic blockade was performed, and computer-aided biplane 
videofluoroscopic images were obtained. Left ventricular pressure was 
measured with a micromanometer. Doppler mean pressure gradient (pG) 
and peak filling velocity (V) were calculated. Filling dynamics were assessed 
by calculation of stroke volume (SV), filling time (FT), mean filling 
rate (MFR5jl) during first 50% of diastolic time interval, and peak filling rate 
(PFR). ActIve LV force decay was assessed by tau (.), the LV pressure 
relaxation time constant. Results (mean :!: SD): 
PGmmHg 
V em/sec 
SVml 
FTsec 
MFR50 ml/sec 
PFR inl/sec 
• msec 
.sham ~ .Ri8ilI 
0.49+0.21 2.48+ 1.38' 2.41+ 1.1S· 
47.9+9.6 985+32.9' m+25.3· 
19.1+25 20.1+45 lS.8~+5.3 
.219+ .031 .253+ .023' .261 +.014' 
81.7 + 32.3 75.9+ 26.6' 51.6+ 14.2*1 
163+59.7 137+23.2 l21:t8.9· 
35.7"+5.8 32.2+9.4 28.8+3.2' 
'Significantly different from sham [p<.03 (ANOVA)) 
t Significantly different between Rigid vs. f1cDbIc [p<.OO3 (ANOVA») 
Conclusion: Mitral annuloplasty alters LV diastolic dynamics by decreasing flow 
rate. lengthening the diastolic filling period, and augmenting active decay of 
LV pressure in normal dogs. 
225A 
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.arly Dia.tolic DriYing Forcal A New Inde. for Separating 
Rela.ation fro. CDapliance Abnoraalitie. 
Ahmed war, Talat Tavli, Maylene wong, zaguig 
Univer.ity, Zagazig, Egypt, We.t LA VAMC and UCLA, Los 
Angele., CA 
The .eparation between left ventricular (LV) relaxation 
and compliance abnormalities remains ill-defined. Hence, 
early diastolic force (DF) wax derived from Newton's 
.econd law of motion: force • mass x acceleration. Mass 
wa. calculated from mitral diastolic-velocity time inte•
gral and cro.. ..ctional area from 220/P ~ tim. to give, 
Dr • O. O.004(paak • vaye .elocity)'/deeeleration tia. (N) 
The index wa. applied to 10 age-matched normals (NL) and 
98 patient.: 12 with coronary artery diseaee (CAD), 5 
hypothyroidi.m (~THY), 15 obstructive cardiomyopathy 
(OCM), 12 aortic .teno.i. with CAD (AS+), 11 without (AS), 
13 hyperten.ive heart di.ea.e with CAD (HHD+), 14 without 
(HHD), and 7 re.trictive disease (RCM). The meane for 
::t ~~i;:~:: : ~'~ ··i 'i =r~ , 
.~ ~ ~ ~ ~ ~ M _ ~ 
DF in all patients was significantly different from NL, 
either higher or lower (P<O.001). Patient. with lone CAD, 
nHY and OCM had low vdues; AS, HHD and RD had a high 
index. othera have shown that LV .tiffness is associated 
with f early dia.tolic filling and fE wave, and abnormal 
relaxation, with ~ early filling and ~E wave. Ischemia 
.uperimpo.ed on .tiffne.. changed the fE pattern towards 
delayed relaxation and ~E, "normalizing" the E wave ampli•
tude and ob.curing the abnormalitie.. In our patients, Dr 
differentiated normal luaitropic function from abnormal•
itie. of compliance, relaxation and their combination_ 
Thu., Dr a. a meaaure of diastolic dy.function deserve. 
further .tudy and validation. 
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Endothelium-Dependent Vascular Relaxation in Humans is 
Potentiated by Increased Availability of EDRF Precursor 
Julio A. Panza, Diane M. Badar. Philip R. Casino, Arshed A. 
Quyyumi, Stephen E. Epstein, NHLBI, Bethesda, MD 
L-Arginine is the natural precursor of endothelium-derived ·relaxing 
factor (EDRF), a mediator in the regulation of vascular tone by 
endothelial cells. To determine whether availability of EDRF 
substrate is rate-limiting for endothelium-mediated vascular relaxation, 
we studied the effect of L-Arginine (40 pmol/min) on the vascular 
response to acetylcholine (Ach; 7.5, 15,30 pg/min), an endothelium•
dependent vasodilator; and to sodium nitroprusside (SNP; 0.8, 1.6, 
3.2 pg/min), a direct smooth muscle dilator, in 12 normal subjects (7 
male; age 49±7 years). The effect of D-Arginine (an isomer that is 
not an EDRF precursor) on the response to Ach was studied in 8 of 
these subjects as a control. Ach and SNP were infused into the 
brachial artery in conjunction with either 5% Dextrose, L-Arginine, 
or D-Arginine. Forearm blood flow (ml/minl 100 ml volume) was 
measured by strain gauge plethysmography. 
Acetylcholine (J£g/min) 
Basal 7 5 15 30 
5% Dextrose 3.4± I 6.9±4 10.0±4 15.7±6 
L-Arginine 3.5±1 1O.5±6* 15.0±6* 21.4±8* 
L-Arginine did not change blood flow, but significantly 
potentiated the endothelium-dependent vasodilator response to Ach 
(*P<0.00l). L-Arginine, however, did not modify the response to 
SNP. The response to Ach was not altered by D-Arginine (max flow 
15.7±6 vs. 14.5±6). Thus, the availability of precursor for EDRF 
synthesis appears to be rate-limiting, and importantly influences 
endothelium-dependent vasodilation in humans. Substrate availability 
might therefore playa pathophysiologic role in the abnormal vascular 
tone of certain cardiovascular conditions. 
781-2 8:45 
Normalization of endothelial dysfunction of hypertensive 
mesenteric resistance arteries by chronic therapy with 
benazepril or nifedipine. 
Yasuaki Dohi, M.D., Leoluca Criscione, M.D., Karl Pfeiffer, 
Thomas F. LUscher, M.D., FESC. 
Departments of Medicine and Research, University Hospital and 
Cardiovascular Research Department, Ciba-Geigy Ltd., Basel, 
Switzerland 
Endothelium-derived nitric oxide and endothelin-l (ET) are 
imponant local regulators of vascular tone, which are altered in 
hypenensive resistance arteries. We studied the effects of different 
antihypertensive therapies on endothelial function in perfused 
mesenteric resistance arteries (til 200 IL). Drugs were infused intra- or 
extraluminally and vascular diameter was monitored with a video 
dimension analyzer. Spontaneously hypenensive rats (SHR; 6 
weeks of age) were treated with the angiotensin convening enzyme 
(ACE) inhibitor benazepril or the calcium antagonist nifedipine (each 
10 mg/day p.o.) for 8 weeks. Blood pressure was lower in treated 
vs. untreated SHR (25 and 23 mmHg, respectively; p<O.05); both 
drugs reduced, but did not normalize medial hypertrophy. 
Endothelium-dependent relaxations to intraluminal, but not 
extraluminal acetylcholine (Ach) were reduced in SHR as compared 
to Wi star-Kyoto rats (WKY), but normal both in SHR treated with 
benazepril or nifedipine. In contrast, the response to extraluminal 
Ach (which was unimpaired in SHR) remained unaffected by the 
drugs. The sensitivity (pD2), but not the maximal response to ET 
was paradoxically reduced in SHR. After treatment with nifedipine, 
the sensitivity normalized, while with benazepril it remained 
depressed as compared to WKY. 
Thus, hypenensive resistance arteries are associated with a specific 
dysfunction of intraluminal formation of endothelium-derived nitric 
oxide and reduced sensitivity to ET, which is improved by ACE 
inhibition or a calcium antagonist 
JACC Yol. 19, No.3 
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Abnormal Endothelium-Dependent Vascular Relaxation in 
Patients with Essential Hypertension is Not Modified by 
Increased Availability of Substrate for EDRF Production 
Julio A. Panza, Diane M. Badar, Philip R. Casino, Arshed A. 
Quyyumi, Stephen E. Epstein, NHLBI, Bethesda, MD 
Pts with essential hypenension (HT) have abnormal endothelium•
mediated vascular relaxation. In another study, we showed that 
availability of L-Arginine, a precursor of endothelium-derived 
relaxing factor (EDRF), is normally rate-limiting to EDRF-mediated 
vasodilation. To determine whether the impaired endothelium•
dependent vasodilation of HT pts is due to reduced EDRF precursor, 
we studied the effect of L-Arginine (40 pmollmin) on the response to 
acetylcholine (Ach; 7.5, 15, 30 pg/min), an endothelium-dependent 
vasodilator, and to sodium nitroprusside (SNP; 0.8, 1.6,3.2 pg/min), 
a direct smooth muscle dilator, in 14 pts (9 male; age 48±7 years) 
and 12 controls (7 male; age 49±7 years). Drugs were infused into 
the brachial artery and forearm blood flow (mllminlloo mI volume) 
was measured by strain gauge plethysmography. The vasodilator 
response to Ach was reduced in HT pts compared with controls 
(maximum [max] flow 8.9±5 vs. 15.7±6; p<0.007); no difference 
was observed in the response to SNP (max flow 11.3±6 vs. 11.7±4). 
L-Arginine augmented the response to Ach in controls (max flow 
increased from 15.7 ±6 to 21.4±8; p<O.ool), but did not modify the 
response to Ach in HT pts (max flow 8.9±5 vs. 8.4±4). L-Arginine 
did not change the response to SNP in either controls or HT pts. 
Thus, the augmented endothelium-dependent vasodilation normally 
observed with increased availability of EDRF precursor is absent in 
HT pts. This indicates that the abnormal endothelium-dependent 
vasodilation of HT pts is not due to decreased EDRF substrate 
availability, and funher suggests a defect in the synthesis and release 
of EDRF or its subsequent breakdown. 
781·4 9:15 
The Blphaslc Vascular Response To Endothelln: 
Modulation Of Peripheral Vascular Resistance But Not 
Conduit Vessel Compliance 
Philip F. Binkley, Garrie Haas, Douglas Brown, Robert J. 
Cody. The Ohio State University, Columbus, Ohio. 
Endothelin exists as a family of peptides with varying receptor 
affinities and vasoconstrictor potencies. We therefore tested 
the capacity of endothelin 3, the peptide sequence initially 
described in the rat, to modulate a differential regional 
vascular response by measurement of conduit vessel 
compliance (aortic characteristiC impedance) as compared to 
peripheral vessel resistance in 9 Sprague-Dawley rats. In all 
rats, the aortic input impedance spectrum was derived from 
simultaneous measurement of instantaneous blood flow and 
high fidelity pressure using an ultrasonic cuff flow probe and 
micromanometer pressure transducer. Bolus administration of 
endothelin 3 resulted in the expected initial hypotension, with 
decrease in systemic vascular resistance (SVR) from 
2.55:!:.76X10· to 1.32:!: .78X10· dynes-sec/em5 and mean 
blood pressure (BP) from 120:!:24 to 69:!:14 mmHg 
(p=.OOO1) with subsequent increase in SVR and BP to 
3.30:!:1.76X10· dynes-sec/cm5 and 137:!:17 mmHg 
respectively during the sustained hypertension phase 
(p = .0001). In contrast, aortic compliance did not change as 
reflected by the characteristic impedance which measured 
8.7:!:2.7X10' dynes-sec/cm5 at baseline, 9.9:!:.9X10' dynes•
sec/cm5 during reduction of SVR, and 8.1:!: 1X10' during 
increase in SYR(p=NS). Therefore, conduit vessel 
compliance is relatively unaffected by endothelin 3 and these 
data support a differential regional vasoconstrictor potency of 
endothelin 3 in which conduit vessels exhibit a relative 
insensitivity to endothelin 3 mediated vascular control. 
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Use of Transfer Functions to Determine Central From 
Peripheral Pressure Pulse 
Michael O'Rourke, Albert Avolio, Mustafa Karamanoglu. 
SI. Vincent's Hospital, Sydney, Australia 
9:30 
Amplification of the pressure pulse between central and peripheral 
arteries renders pressure values in the upper limb an inaccurate measure 
of ascending aortic (Asc.A) pressure. We examined the possibility of 
synthesizing the central from peripheral pulse from a single transfer 
function which might be applicable under a variety of physiological and 
phartnacological conditions. 
Transfer functions for pressures between Asc.A and brachial artery 
(BA TF) and between Asc.A and radial artery (RA TF) were derived 
from high fidelity pressure recordings obtained at cardiac catheterization 
in 14 patients under control conditions, and after sublingual 
nitroglycerin 0.3 mg. There was no significant difference in BA TF 
under control conditions and with nitroglycerin; hence results were 
pooled. Control and nitroglycerin results were also pooled to obtain a 
single RATF. BATF and RATF moduli peaked at 5.0 Hz and 4.0 Hz 
reaching 2.5 and 2.8 times the value at zero frequency respectively. 
BA TF and RA TF were compared to transfer functions derived from 
analysis of aortic and brachial or radial pressure waves recorded under 
different conditions in previous publications of other investigators. 
Results were similar. Our BA TF and RA TF were used to synthesize 
Asc.A pressure waves from these pulses, using a convolution algorithm 
derived from the transfer functions. Correspondence was close, 
especially for systolic pressure which differed by 2.4±5.1 (mean±SD) 
mmHg whereas recorded systolic pressure differed by 20.4±13.2 
(mean±SD) mmHg between central and peripheral sites. 
Results indicate that in adult humans a single transfer function can be 
used with acceptable accuracy to determine central from peripheral 
pressure under different conditions provided that the contour of the 
peripheral pressure is known. 
781-6 9:45 
Arterial Compliance in Clinic, Daytime and Sustained Hypertension. 
Roberto M. Lang, Richard Marcus, James Bednarz, Lynn Weinert, Dan 
Gretler, Michael Murphy. University of Chicago, Chicago, IL 
Hypertension (HTN) has been associated with reduced arterial 
compliance (AC), but the relationship between circadian blood 
pressure patterns and AC in pts with HTN has not been characterized. 
Accordingly, AC was determined in 36 hypertensive pts and 71 
control subjects specifically selected from a pool of 305 individuals 
who had been classified according to 24 hour ambulatory BP 
measurements into 4 groups: (i) normotensives (nl), (ii) clinic HTN 
(clin); (iii) dayt;me HTN (Day); and (iv) sustained HTN (Sust). AC was 
determined noninvasively from aortic flow (CW Ao Doppler/2D echo 
for Ao annulus) and pressure (calibrated subclavian pulse tracings) 
data using a 3-element Windkessel model. It has been shown that AC 
determined by this method is influenced by age and arterial pressure•
volume relations (APVR). In order to eliminate the confounding 
effects of these variables on comparative analyses, hypertensive pts 
were matched for age and mean systemic blood pressure (MBP) at the 
time of AC determination (MBP-AC). Values were compared with 71 
age-matched normotensive volunteers (NI). 
MBP-AC Day-MBP Nlght-MBP AC (mVmmHg) 
NI (n~711 91 ±10 93±7 79±8 1.25±.29 
Cli" (n=12) 110±7" 98±6 89±4" 1.13±.31 
Day (n=121 111 ±9" 113±S"t 89±6" 1.16±.25 
Sust (n= 121 113±9" 113 ±6"t 103±5"U .83 ±.23"U 
"p < .05 vs NI, tp < .05 vs Clin, *p < .05 vs Day 
Arterial compliance tended to be lower in all HTN groups but 
was significantly reduced only in pts with sustained HTN. Since 
BP at the time of arterial compliance determination was 
matched between HTN groups (MBP-AC), the decrease in AC in 
sustained HTN cannot be entirely attributed to changes in 
APVR, and may reflect structural alterations in the arterial wall. 
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Cardiac Mortality Durinq Antiarrhythmic Druq 
Therapy in the Stroke Prevention in Atrial 
Fibrillation (SPAF) Study 
Greg C. Flaker, Joseph L. Blackshear, Ruth 
McBride, Richard A. Kronmal, Jonathan L. 
Halperin, Robert G. Hart and the SPAF 
investigators_ University of Missouri•
Columbia. 
227A 
To determine if antiarrhythmic druqs (AD) are 
associated with increased cardiac mortality in 
patients (pts) with atrial fibrillation (AF) we 
studied 1,330 pts in the SPAF study. AD were 
not randomly assigned but were qiven to 244 pts 
with 189 pt years of exposure. 
Cardiac mortality was increased 2.5 fold 
(p=.006) in pts receivinq AD: arrhythmic 
mortality was increased 2.6 fold (p=.015). 
After adjusting for variables predictive of 
cardiac mortality, AD were associated with a 
2.7 fold (p=.007) and 2.3 fold (p=.04) 
increased risk of cardiac and arrhythmic death. 
Pts with a history of heart failure had a 4.7 
fold (p<.OOl) and 3.7 fold (p=.Oll) increased 
risk of cardiac and arrhythmic death. 
After elimination of 23 pts who received AD 
for ventricular arrhythmias and adjustment for 
variables predictive of cardiac death, AD did 
not significantly increase the risk of cardiac 
mortality. Arrhythmic death was increased 2.2 
fold (p=.08). In pts with a history of heart 
failure, AD increased the risk of cardiac death 
3.3 fold (p=.05) and arrhythmic death 5.8 fold 
(p=.009) 
This analysis suggests that the risk of AD in 
pts with AF may outweigh the potential benefit 
in those pts with a history of heart failure. 
782-2 8:45 
Initiation of Atrial Fibrillation In the Wolff· 
Parkinson-White Syndrome: Importance of the 
Accessory Pathway 
Mark S. Wathen, George J. Klein, Raymond Yee, Kevin 
Wolfe, Andrea Natale. University Hospital, London, Ontario, 
Canada 
The occurrence of atrial fibrillation in the Wolff-Parkinson•
White syndrome may be related to atrial microreentry in the 
vicinity of the accessory pathway. We examined the mode of 
onset of atrial fibrillation in 17 patients with overt Wolff•
Parkinson-White before and immediately after catheter 
ablation of the accessory pathway to assess the accessory 
pathway's contribution to the induction of atrial fibrillation. 
Atrial fibrillation occurred during the course of routine 
electrophysiologic testing. There were 14 men and 3 
women aged 14 to 65 (mean 30) years. Accessory 
pathways were left lateral (11), right anteroseptal (1), right 
free wall (3) and posteroseptal (2). Atrial fibrillation 
invariably began as repetitive atrial firing at an atrial 
electrogram near the accessory pathway (n = 4), remote 
from the accessory pathway (n = 12), or indeterminate (n = 
1). Complete electrophysiology study 30 minutes after 
ablation revealed persistent inducibility of atrial fibrillation in 
8 patients beginning at the former accessory pathway site in 
no patient. Following ablation, atrial fibrillation was 
nonsustained in 4 patients and sustained (> 30 sec) in 5 
patients. All began as atrial repetitive firing at a site remote 
from the accessory pathway. 
These data suggest that the accessory pathway is 
generally not directly necessary for the onset of atrial 
fibrillation in Wolff-Parkinson-White, at least as assessed by 
electrophysiological testing. 
228A ABSTRACTS 
782·3 
Determinants of Left Atrial Dilation In Patients 
with Non·Valvular Atrial Fibrillation 
Howard C. Dittrich, Carol Hagenhoff, Kristin Fossum for the 
SPAF Investigators. 
University of California, San Diego 
Left atrial (LA) size Is said to Increase with time in the 
setting of non·valvular atrial fibrillation (AF). It is not 
known however, whether this Is true regardless of baseline 
variables such as LA size, associated left ventricular (LV) 
dysfunction, underlying etiology, duration .of, or constancy of 
AF. To evaluate this further, we analyzed clinical features 
and paired echo variables In 243 pts with non·valvular AF 
due to various causes and of varying duration. The Interval 
between echoes was 20.4 ± 10 mas (mean±SD). For all pts, 
LA size increased from 4.69±0.78 to 4.88±0.8 cm 
(p<O.OOl) by m·mode and from 6.06±1.05 to 6.34±1.04 
cm (p<0.02) by 2·0 long axis. No significant difference in 
LA dilation was noted according to patient age or duration, 
constancy, or etiology of AF. However, there was an 
important difference in change of LA size for pts according to 
baseline LA size. Those with baseline LA < 4 em had dilation 
of +0.59 cm while those with LA > 5 cm had a slight decrease 
In LA size (·0.07 cm), p < 0.001. The presence of mitral 
regurgitation (MR) by Doppler was marginally important; 
those without MR demonstrated a greater dilation than those 
with MR (+0.31 vs +0.15, respectively, p - 0.08). LA 
size Increased in pts with normal LV function while it 
decreased in those with abnormal LV function (+0.25 vs . 
0.15 cm, respectively, p - 0.01). Therefore, although LA 
dilation in AF does occur In those pts with a small LA, the 
same Is not true for pts with a large LA or LV dysfunction, 
where the atrial size may actually decrease over time. 
782·4 
9:00 
9:15 
D:Ies left Vent:riallar Eject:icn FractiCll C2lan;Je after 
Abl.atic:n of AV Nodal O;nU:tiCll in Patients with Atrial 
Fibrill.at.ial ? 
Baiyan Xie, IllZ-Maria Rodriguez, Jilrg Schlapfer, 
Olristian de Olillou, BaJ:bara Dijkman, hiri van den 
0001, Jeep Smeets, Rein Wellens. 
Dept. of cardiology, Academic Hospital, Maastricht, 
'!he Netherlan:!s. 
left ventriollar ejection fraction (LVEF) was studie1 
in 31 patients (pts) with medically uncontrollable 
atrial fibrillation (AF) before am after ablation (Ab) 
of AV nodal OClI'duction. Ab was acxx:tl'plished by OC-shock 
in 23 pts am transcoI'Ol'lal:}' ethanol in 8 pts. LVEF was 
cbtained by ec:hocardiogrcqily before, 1 week (w) am 30 
Dalths (M) after Ab. Before Ab, LVEF was <50% in 13 pts 
(GrOJp A) am ~50% in 18 pts (GrOJp B). '!he duration of 
documented AF in group A was 10n:}er than in group B (11 
yrs VB 5.4 yrs p<0.05). No differences between A am B 
10Iere present in age, left atrial diJnension, Ab pr0-
cedure am chan;Je of cardiac enzymes post Ab. 
BfI511J ts; 
Groop lib pts Before Ab 
LVEF(%) 
A 13 35±9* 
B 18 59+3 
Abbreviation: Nb= number 
After Ab 
LVEF(%) 
1 W 30 M 
49±8 55±8* 
58+6 57+7 
p value 
<0.001 
NS 
CQnclusions: 1) LVEF increases significantly after Ab 
in pts with AF ani LVEF <50% am does not chan;Je in pts 
with LVEF ~50%. 2) LVEF terds to be ICMer in pts with 
AF of IOn:} duration. 
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Observations on the Termination of Atrial Fibrillation in 
Man 
Haris J. Sih, Kristina M. Ropella, Steven Swiryn, Edward P. 
Gerstenfeld, Alan V. Sahaldan. Northwestern Univ., Evanston, IL. 
The circulating wavelet hypothesis suggests that fibrillation 
could tenninate by either progressive fusion or simultaneous block of all 
wavelets. Intra-atrial recordings were made during procainamide in•
duced (n=8) or spontaneous (n=4) termination of atrial fibrillation 
(AFib) in 12 patients. Rate, mean magnitude squared coherence 
(MMSC), cycle length, and instances of "linking" of sequential electro•
grams were measured. Termination was directly to sinus rhythm (II 
patients) or to atrial flutter (I patient). Rate and MMSC were calculated 
from the earliest point within 5 min prior to termination as well as from 
the 4 sec interval just prior to termination. For 3 patients (all non·pro•
cainamide), AFib recordings were shoner than 5 min (3.3 min, 
2.3 min, and 51 sec). For 8 patients with procainamide, rate decreased 
between the first measurement and the measurement just prior to termi•
nation, from 463±115 BPM to 330±120 BPM. For the 4 non·pro•
cainamide patients, rate increased by 46 BPM, increased by 16 BPM, 
increased by 40 BPM, and decreased by 163 BPM, respectively. Of 
the II patients where MMSC could be measured, no consistent change 
in MMSC was observed. Atrial cycle lengths measured during the 
4 sec just prior to termination did not change consistently. In 5 pa•
tients, recordings were made using orthogonal bipoles in the x, y, and z 
directions, allowing linking of vector loops to be measured as previ•
ously reponed by our laboratory. In these 5 patients, two patients (1 
with procainamide) showed multiple instances of linking while the other 
three (all with procainamide) did not. There was no linking in any of 
the 5 patients within the last 4 sec just prior to termination. 
Conclusions: AFib usually terminates directly to sinus rhythm. 
While we have previously reponed that the rate of AFib decreases with 
procainamide infusion, a decrease in the rate of AFib is not required for 
the rhythm to terminate. Coherence does not show a progressive in•
crease in the organization of AFib. Atrial cycle lengths and linking mea· 
surements fail to provide evidence of fusion of wavefronts at a particular 
site in the last few electrograms just prior to termination of AFib. 
782-6 9:45 
Predictive Cllaracteristic for Realrn!rxle of ParaKysmal. 
Atrial Fibrillaticn or Atrial Flutter. 
Maarten suttorp, Egbert Kocmen, Al:ncu:i van 't Hof, Jan 
Tijssen, Herre I<in;Jma. Depts. of cardiology am Clinical 
EPidemiology, st Antalius Hospital, NiE!U\iOE!gE!in, am 
Academic Medical Center, Amsterdam, '!he Nethe.r1an:3s. 
We studie1 124 consecutive pts with paroxysmal atrial 
fibrillation (PAF) am 21 with paroxysmal atrial flutter 
(PAFl) after ilImediate pw:macoloqical CX1'lVerSion to 
sinus Ihythm (SR). '!he mean age was 59±13 years (range 
23-79). After restoratiCll to SR, all pts 10Iere followed 
for recurrence of PAF or PAFl. '!he mean follow-up period 
was 23.2±16.4 Dalths. Of pts with PAF the median cardiac 
event free period was 1.3 Dalths (0-41) ani 1.7 Dalths 
(0.4-27) in pts with PAFl. Q1e or IIDre episodes of PAF 
or PAFI 10Iere seen in 74 (51%) pts. Univariate analysis 
showed that the follCMin;J variables 10Iere associated 
with an increase:i risk for recurrence of PAF or PAFl: 
RR 95%-cr 
Hypertension 1.4 (0.6-2.8) 
CoI'Ol'lal:}' artery disease 1. 9 (0. 9-3 .9) 
Ristory of PAF or PAFl 2.1 (1.0-4.5) 
Female gender 2.3 (1.1-4.6) 
Pulmonary disease 3.9 (1.9-7.6) 
Valwlar heart sfueaM 4.4 (2.2-8.9) 
CI=Conficlence Interval, ~ative Risk. 
!lll.tivariate analysis identifie1 a histol:y of PAF or 
PAFI as the ally in:Iepenjent predictor for recurrence of 
PAF or PAFI. 
We oonclude that especially a histol:y of PAF or PAFl, 
blt also hypertensioo, coronaIY artery disease, female 
gender, p.Wnonazy disease am valvular heart disease 
were risk factors for recurrence of PAF or PAFl. '!he 
preserre of these characteristics should be taken into 
aCXXQlt when the need of antiarrtlythmic therapy to 
prevent recurrence of PAF or PAFI is considered. 
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939·4 
Does Delayed Elastic Recoil Increase the Severity of 
Residual Stenosis 24 Hours After Angioplasty ? 
Claude Hanet, Xavier Michel, Erwin Schroeder, 
William Wyns, 
University of louvain, Brussels, Belgium. 
Elastic recoil largely contributes to the residual 
lumen reduction immediately after percutaneous 
coronary balloon angioplasty (PICA). 10 evaluate 
whether gradual elastic recoil could result in a 
further luminal narrowing during the first 24 hours 
after a successful PICA, 72 patients were studied by 
quantitative angiography. Angiograms were obtained in 
two identical near orthogonal projections before PICA, 
within the 5 minutes after the last balloon deflation 
and 24 hours (range: 18-48 hours) after the procedure. 
10 minimize the influence of vasomotor tone, 1 mg of 
isosorbide dinitrate was given by intracoronary 
injection before cine recordings. Severe dissections 
were not included in the study. Immediately after 
PlCA, minimal lumen diameter (MlO) increased from 
I.Ol±O.33 to I.87±O.37 mm and percent diameter 
stenosis was reduced from 63±12 to 34±9 %. 24 hours 
after the procedure, no significant change in MLD 
(1.9l±O.36 mm) or in percent diameter stenosis (35±9%) 
was observed. lhus, the severity of the residual lumen 
reduction does not increase during the first 24 hours 
after a succesful PlCA. Progressive or delayed elastic 
recoil is unlikely to play a significant role in 
restenosis after PlCA. 
939·5 
Patients with Multivessel Disease Successfully 
Treated with PTCA to the Proximal Left 
Anterior Descending Coronary Artery Show 
Favorable Event-free Survival_ 
Michael J. Curtis, Todd J. Anderson, P. Diane 
Galbraith, James L. Hansen, David L. Roth, 
Frank P. Spence, Mouhieddin Traboulsi, Merril 
L. Knudtson. University of Calgary, Calgary, 
Alberta. Canada 
While PTCA has been supported as an acceptable 
form of revascularization for patients (pts) 
with multivessel disease (MVD), dilation of a 
proximal left anterior descending (pLAD) 
stenosis has been reported to be a risk factor 
for adverse outcomes of MVD PTCA. To further 
assess the effect of PTCA to pLAD during MVD 
PTCA, we analyzed 1617 pts with MVD (2 vessel 
disease:75.9%) who underwent PTCA (x = 1.39 
procedures, 1.65 vessels dilated) from 1981-89 
of which 395 involved the pLAD. (Group I-MVD 
without pLAD:II-MVD with pLAD) Mean follow-up 
was 23.2 .±. 19 mos. Primary success rate was 
92.6% (n=1494). Mortality is shown below. 
Time (yrs) 1 2 3 4 p~ 
Death I 96.7 95.3 92.3 91.6 NS 
II 96.4 93.4 92.0 89.7 
Mortality (successful and unsuccessful PTCA): 
Time (yrs) 1 2 3 4 p~ 
Death I 95.8 94.5 91.6 90.1 0.045 
II 92.6 89.9 87.9 85.9 
The need for subsequent surgery or further 
PTCA was not different in groups I and II. 
Unfavorable long-term results in MVD pts 
treated with PTCA appears to be confined to 
those with an unsuccessful procedure. 
Patients undergoing successful proximal LAD 
PTCA have a favorable event free survival. 
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939·6 
Results of PTCA in More Than 5000 Patients Without Surgical 
Standby in the Same Center 
N. Reifart, F. Schwarz, W. Preusler, H. Stllrger, M. Hofmann 
Red Cross Hospital, Frankfun/Main, FRG 
Five thousand and seven patients were treated with percutaneous 
coronary angioplasty (PTCA) from 1986 (n=372) to 1990 (ri=2374) 
with surgical standby 5 to 10 min from our institution. 71 % of the 
patients were suffering from stable angina pectoris or silent 
ischemia, 26 % from unstable angina and 3 % from acute 
myocardial infarction. 4360 patients had stenoses (S), 17 % type A. 
50 % type B, and 647 patients had a chronical occlusion (Occ). 
Multivessel disease (2 vd, 3 vd) increased continuously from 5.2 % 
(1986) to 52.7 % (1990) and multistenosis or multivessel 
angioplasty from 3.7 % to 72 %. 
Results: 1 vd 2vd 3vd 
Incidence 59% 31 % 10% 
Success 94% 92% 87% 
Non-Q 
S Occ 
87% 13% 
92% 55% 
All 
100% 
87% 
infarction 
Q infarction 
Emergency 
CABG 
1,6% 1,1 % 0,9% .1,3% 1,2% 1,3% 
0,7% 0,4% 0,9% 0,6% 0,5% 0,6% 
0,1% 0,3% 0,0% 0,2% 0,2% 0,2% 
Death in 
hospital 0,0% 0,2% 1,6% 0,3% 0,6% 0,3% 
Conclusion: In high volume institutions the complication rate of 
PTCA may be very low even when cardiac surgery is not available 
within the same institution. 
939·7 
Beneficial Effect of Successful Late PTCA on LV Ejec•
tion Friction In Pltlents with I Recent Infarct Rellted 
Coronary Artery Occlusion 
Vladimir Dzavik, Donald S. Beanlands, Richard F. Davies, 
Terrence D. Ruddy, Jean-Francois Marquis. 
University of Ottawa Heart Institute, Ottawa, Ontario, Canada 
The purpose of this study was to determine whether late 
PTCA of a totally occluded (TiMI 0 or TlMI 1) infarct·related 
artery (IRA), performed in addition to medical therapy including 
an angiotenSin converting enzyme inhibitor, has a beneficial 
effect on left ventricular ejection fraction (LVEF) in patients 
with a recent (5 days to 6 weeks) first transmural MI. Patients 
were randomized to PTCA or NO PTCA. LVEF was determined by 
radionuclide ventriculography at baseline and 4 months. Repeat 
coronary angiography was performed at 4 months to determine 
IRA patency. Follow-up is complete in 18/29 patients (10 with 
and 8 without PTCA). 
Primary success rate in the PTCA group was 76.5% (13/17). 
Mean baseline LVEF was 52.9±9. vs. 46.5±14.6 (PTCA vs. NO 
PTCA; paNS). Mean change in LVEF was +1.7±9.7 vs. +4.3±9.4 
(PTCA vs. NO PTCA; paNS). At 4 months the IRA was patent in 
SilO (50%) of the PTCA group. and in 1/8 (12.5%) of the NO 
PTCA group. Comparison between patients with a patent versus 
those with an occluded artery at 4 months follows: 
Patent IRA Occluded IRA p value 
number 6 12 
baseline LVEF 50.7±10.4 49.8±13.1 NS 
change LVEF + 9.0±4.5 -0.2±9.7 0.04 
In conclusion, long-term patency was achieved in 50% of 
patients who underwent late PTCA. Continued late patency of a 
previously totally occluded IRA is associated with an 
improvement in LV ejection fraction. 
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939·8 
Evaluation of Myocardlal VlabWty In. Patients With g·wave 
MyocardJallDfarction md no Residual Ischemia 
GUles Montalescot. Marc Faragg!. Gerard DroblnSki. 
Daniel Thomas. Olivier Messlan.Yves Grosgogeat. 
Salpetrlere Hospital. Paris. France 
To detennlne whether there Is viable myocardium In the 
Infarcted area when there Is no evidence of myocardial 
Ischemia. 15 asymptomatic patients with g·wave 
myocardial Infarction (MI) older than one month. single•
vessel disease (>75% stenosis) and persistent anterograde 
blood flow were randomized to coronary angloplasty 
(group A) or conservative treatment (group B). At two 
months of follow-up. mean coronary blood flow In the 
Infarct related artery measured by Doppler catheter was 
higher In group A (33±6 ml/min. n=8) than In group B 
(16±4 ml/min. n=7. p<O.05 ). Thallium pathologlcal/ 
normal ratios measured on post-exercise Images 
Increased slgnlflcantly In group A (from 52±3% at baseline 
to 61±5% at two months. p<O.Ol) while they did not 
change In patients of group B. Segmental wall motion 
Improved on left ventricular angiography two months after 
PTCA (~= 11.5±2.2%) and significantly differed from group 
B (~=4.1±1.4%. p=O.Ol between groups). Global left 
ventricular function barely Increased In group A (from 48± 
3% at baseline to 54±3% at two months. p=O.04) and did 
not change In group B. Improvements of thallium ratios 
and segmental wall motion Indexes correlated 
slgnlflcantly (r=O.73. p=O.002). We conclude that In 
patients with a g-wave MI and no persistent Ischemia. 
myocardial viability may last several weeks. as long as a 
residual blood flow exists In the Infarct related artery. 
PrCA of a severe stenosis In this artery Improves coronary 
blood flow. thallium uptake In the Infarcted area and left 
ventricular function. 
939·9 
Short and Long Term Outcome 01 Diabetic Patients Undergoing 
Coronary Angloplasty 
Bernardo Stein, William S. Weintraub, Suzanne Gebhart, Caryn L. 
COhen, RilJph Grosswaid, Henry A LIberman, Douglas C. Morris. 
Divisions of Cardiology and Endocrinology, Emory University School of 
Medicine, Atlanta GA 
In order to define the outcome of PTCA in diabetics, we reviewed our 
experience. Of 1281 patients (PIS) with diabetes undergoing elective 
angioplasty, the mean age was 59:!: 10, 62% were male, 32% were 
insulin-requiring (IR), mean duration of diabetes was 9:!:8 years, 39% 
had a previous myocardial infarction (MI), 69% had class ill or IV 
angina, 6% had congestive failure, 33% had multivessel disease, and the 
ejection fraction was 57:!: 11. Angiographic success was achieved in 88%. 
In hospital mortality was 0.6%, 1.5% had a Q wave MI, and 5% in 
hospital coronary surgery. In·hospital mortality was 0.3% in non-IR and 
1.1% in IR PIS (p=.067); Q wave MI occurred in 0.7% of non-IR and 
2.6% of IR Pts (p = .00(2). Multivariate correlates of long term mortality 
were congestive heart failure (p<.OOI), multivessel disease (p<.OOI), 
advanced age (p ... OO4), and reduced ejection fraction (p=.021). Overall 
5 year survival (see figure) was 88% (curve 1), MI free survival was 72% 
(curve 2), MI or CABG free survival 
was 58% (curve 3) and MI, CABG or l00~::::::::::::===:::::::::-tll 
PrCA free survival was only 36% 
(curve 4). Insulin requiring diabetics 80 '\ 2 
have more in-hospital complications 
than non-insulin requiring diabetics. 60 
Long term outcome is limited both by 40 
fatai and non-fatal cardiac events and 
'~ 
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From 
Events 
3 
4 
the need for additional revascularization 20 
procedures, probably related to a 
combinatiun of restenosis and 0 +_;---iy,~ear=sr-........ --I 
progression of disease. o 2 3 4 5 
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Relationship Betveen Recent Rest Pain and Acute 
Complications of PTCA in Unstable Angina 
Sabino R. Torre, John A. Ambrose, Samin K. Sharma, 
Yilliam J. Untereker, Melvin B. Yeiss, Craig Monsen, 
James Marshall, Andrew Grunwald, Jeffrey Hoses, 
Douglas Israel. Mt. Sinai Medical Center, New York, NY 
PTCA has proven useful in the treatment of unstable 
angina (UA), however, acute complications are more 
frequent. Previous retrospective analyses have 
demonstrated a correlation between both a short 
duration of UA and recent rest pain with the acute 
complications of PTCA in UA. To test this hypothesis 
prospectively, all patients from the placebo arm of the 
thrombolysis and PTCA in UA (TAUSA) pilot study were 
divided into groups based upon duration of symptoms and 
interval between last episode of rest pain and PTCA. 
All patients were given ASA and 68X were on heparin 
prior to PTCA. Angiographic complications (AC) included 
definite intracoronary thrombus or acute closure 
following PTCA. Ischemic complications (IC) included 
recurrent rest angina with EKG changes, HI, CABG or 
death in-hospital following PTCA. Results: Duration of 
symptoms <1 vs. 1-2 vs. >2 weeks was not predictive of 
PTCA complications (p-NS). Analysis of the occurrence 
of rest pain <48 hrs (Group I) vs. >48 hrs (Group II) 
rior PTCA -ielded the followin (* <0.05) 
nterva (rs AC. ~ 
31:181 5(!5), 
* * 
II 61.4SJ O( O)J 
us, A 
episode of rest pain experience significantly more 
angiographic and ischemic complications. This increased 
risk is probably due to an active thrombogenic process 
within the lesion prior to PTCA which is accelerated by 
PTCA induced vascular injury. These observations will 
be reassessed in the larger ongoing TAUSA trial. 
939·11 
The Clinical Importance of ACT Monitoring During Non-emer•
gent PTCA. 
Stephen J Voyce, Louis I Heller, Bonnie H Weiner, Kevin M Carey, 
Lawrence I Laifer, Michael Jolie, Danielle Bajakian, Richard C 
Becker. University of Massachusetts Medical School, Worcester, 
MA. 
In order to detennine the clinical importance of peri-procedural 
monitoring of the activated clotting time (Acr) during coronary 
angioplasty (PrCA), we evaluated the results of 1035 consecutive 
patients (PrS) (1313 lesions) undergoing non-emergent PrCA from 
January, 1988 to December, 1990. AllPrS received an intravenous 
bolus of 10,000 U heparin at the time of arterial cannulation. In the 
871 PrS (1040 lesions) undergoing PrCA prior to July 1, 1990, a 
strategy of empiric heparin administration was employed (Group 1). 
Since that time, 164 PrS (273 lesions) have undergone PrCA with 
heparin dosages guided by ACT detenninations (Group 2). The Acr 
is measured at regular intervals and intennittent boluses of heparin 
are given to maintain the Acr >300 seconds. There were no signifi•
cant differences between groups with regard to age, gender, ejection 
fraction or the presence of multivessel PrCA. Major procedure•
related endpoints are tabulated: 
QrQwLl QmJ.IR.l ~ 
Lesion Success 853(82%) 239(88%) <0.05 
Abrupt closure 65(6.2%) 12(4.4%) NS 
Late closure 23(2.2%) 6(2.2%) NS 
Emergent CABG 39(4.5%) 4(2.4%) NS 
Death 11(1.3%) 2(1.2%) NS 
Myocardial Infarction 55(6.3%) 13(7.9%) NS 
Although there was a trend towards a decreased incidence of abrupt 
vessel closure and emergent CABG in Group 2 as compared to Group 
1, a significant difference between groups was not appreciated. Thus, 
a strategy incorporating Acr monitoring during non-emergent PrCA 
does not significantly reduce the rates of abrupt or late vessel closure, 
emergent CABG, MI or death in this population. Factors other than 
Acr monitoring, such as equipment evolution, may in part be re•
sponsible for the difference in lesion success. 
JACC Vol. 19, No.3 
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939·12 
Is Antithrombotk: Therapy with Heparin During PTCA ElTective? 
Lucie L.-Lacoste, Iules Y.T. Lam, Luc Bilodeau, Gilles COt6, 
Pierre TMroux, Tack Ki Leung, Pierre DeGuise, Michel Joyal, 
Gilbert Gosselin, Jacques Cn!peau, Raoul Bonan, Martial G. Bourassa. 
Montreal Heart Institute, Montreal, Quebec, Canada 
Platelet deposition and thrombus formation occurs after arterial 
angioplasty and heparin is routinely and empirically given during PTCA 
with aspirin but it is unclear whether heparin provides effective 
antithrombotic coverage. Thus, platelet deposition (PD) (n=20) onto 
aortic media and whole blood platelet aggregation (P A) (n = 12) were 
measured in pta on chronic aspirin (325 mg/day) (baseline) and after an 
intravenous bolus of heparin and PTCA (heparin). For PD, femoral 
arterial blood was drawn over porcine aortic media in flow chambers of 
I.S mm diameter at 20 mUmin for 3 min at 37'C. Whole blood PA 
(amplitude-ohms) with ADP and thrombin, and quantitative 
morphometric PD (jim2) are shown: 
PD: 
PA: ADP20"M 
ADP 15 "M 
Thrombin 0.10 U 
Thrombin 0.75 U 
Partial Thromboplastin Time 
* p < O.OS, baseline vs heparin 
Baseline 
7.57±1.37 
14.S3±1.67 
14.25±t.75 
13.33±2.46 
S.75±t.97 
3t.SO±1.75 
Heparin 
t.75±O.55* 
11.33 ± 1.12* 
10.S3±0.91* 
O.OS±O.OS* 
O±O* 
143. ±7.0* 
In addition, there was an inverse relationship between the dose of 
heparin utilised and its antithrombotic efficacy; a dose ~ 130 It/kg was 
the most antithrombotic and 20-50 It/kg the least. Thus, the heparin 
given to pts on aspirin undergoing PTCA can significantly inhibit platelet 
aggregation and platelet thrombus formation. However, a dose 
~ 130 po/kg appears to be associated with the most antithrombotic effects 
which may contribute to reducing periprocedural PTCA complications 
due to thrombosis. 
939-13 
Is it Necessary to Heparinize for 24 Hours After 
Percutaneous Translumlnal Coronary Angloplasty? 
N. Reifart, A. Schmidt, W. Preusler, F. Schwarz, H. Stllrger 
Red Cross Hospital, Frankfurt/Main, FRG 
Heparin is frequently administered after PTCA for hours in order to 
prevent acute re-occlusion due to thrombi. 
In a prospective randomized study with 332 patients (P) 165 
received 1000-2000 units/h of Heparin (H) and 1000 mg Aspirin for 
24h and 167 P only Aspirin (C). Both groups had the same 
distribution with regard to age, sex, unstable angina, type and 
location of stenosis, concomitant medication, balloon size / vessel 
diameter, balloon pressures and rate of angiography after four 
months (84,8 % vs. 83,2 %). 
Results: 
H C 
stenosis before PTCA 80% 78% n.s. 
stenosis after PTCA 21 % 22% n.s. 
dissection 20% 34% n.s. 
abrupt closure 2,4% 2,4% n.s. 
severe hemorrhage 1,2% 0,6% n.s. 
stenosis after four months 38% 40% n.s. 
rate of recurrence: 25 % 27% n.s. 
However in patient with obvious dissection a trend towards lower 
incidence of abrupt closure was noted in group H. 
Conclusion: Heparinization after PTCA is not necessary in P 
without large dissection. 
ABSTRACTS 
940 Pediatric Cardiovascular Surgery-Results and 
Follow·Up Intervention 
Wednesday, April IS, 1992 
9:00 AM-Noon 
Dallas Convention Center 
Lower Level Exhibit Hall 
Presentation Hour: 10:00 AM-I 1:00 AM 
940-1 
231A 
Effectl of Homograft Blood Tvpe and Anatomic Type on 
Stenolls, Inlufflclency and Calcification In the Pulmonary 
Position In 39 Consecutive Children 
Robert E. Shaddy, Jane E. Sturtevant, Lloyd Y. Tanl, Unda M. Lambert, 
Edwin C. McGough. University of Utah and Primary Children's Medical 
Center, Salt Lake City 
To determine whether homograft ABO Incompatibility or 
anatomic type resulted In a greater Incidence of stenosis, 
Insufficiency or calcification, we reviewed 39 consecutive children 
(S.8 ± 0.7 yrs at time of surgery) who had placement of an aortic or 
pulmonary homograft into the pulmonary poSition for treatment of 
pulmonary outflow tract obstruction. No attempt was made to 
prospectively ABO match the homograft to each pt at surgery. 23 pts 
had pulmonary stenosis or atresia with V5D, 7 pts had pulmonary 
stenOSis with D· TGA, and 8 pts had truncus arteriosus. 14 pts had an 
identical homograft ABO match, 10 were compatible but not identical, 
and 1S were a mismatch. Doppler homograft stenosis at 16.6 ± 2 
months after surgery was not significantly different between ABO 
groups: identical·22.S ± S mm Hg, compatible·24.6 ± 8 mm Hg, and 
mismatch·18.7 ± 4 mm Hg. Doppler estimates of homograft 
insufficiency (none, mild, moderate, or severe) were similar in all 
ABO groups. Two homografts were replaced: one at 43 months for 
stenOSis (compatible) and one at 2.S months for aneurysm of outflow 
tract (mismatch). Radiographic calcification was noted 14 ± 3 months 
after surgery in 10 pts and the incidence was not significantly 
different between ABO groups: identical·3 (21%), compatible·2 
(20%), and mismatch·S (33%). 13 homografts were aortic, and 26 
were pulmonary. There were no differences between aortic and 
pulmonary homografts with regard to stenosis (2S.3 ±6 vs 19.4 ± 3 
mm Hg) or insufficiency. However, radiographic calcification was 
seen more often with aortic homografts (54%) than pulmonary 
homografts (12%) (p<O.OS). We conclude that homograft ABO 
Incompatibility does not increase the Incidence of stenosis, 
insufficiency or calcification in the pulmonary poSition In children. 
However, radiographic calcification is more common in aortic 
homografts than pulmonary homografts. 
940-2 
The Role of TranselOphageal Echocardlography FoUowtn, Repair 
of Total Anomalous Pulmonary Venous Connection 
David Coleman. Jeffrey Smallhom. John Dyck, Norman Musewe. 
Wlll1am G. Wlll1ams. Geoffrey Barker. 
The Hospital for Sick Children. Toronto. Ontario. Canada 
One of the major lim1tatlons of transthoracic echocardlography 
In the evaluation of postoperative total anomalous pulmonary 
venous connection (TAPVC) relates to the poor echocardlographlc 
window In the inUnedlate postoperative period. Transesophageal 
echocardlography (TEE) may permit evaluation of the pulmonary 
veinS and pulmonary venous anastomOSiS (PVA) at this time. 
Between November 1989 and July 1991, 16 chlldren underwent 
repair of TAPVC. Seven pts had supracardlac, 5 Intracardlac, 3 
tnfracardlac and 1 had mixed type of TAPVC. A total of 21 TEEs 
were performed on these pts: 3 In the operating room and 18 in the 
paediatric ICU. At the time of TEE the mean patient age was 63 days 
(range 1·545) and mean patient weight 4.0 kg (range 2.0-9.9). A 
single plane 6.8 nun TEE probe was used to evaluate 15 pta, whUst a 
prototype Single plane 4 nun TEE probe was utUlsed In one patient. 
The PV A and the rest of the pulmonary venous confluence up to 
insertion of the pulmonary veins was adequately demonstrated in 
all postoperative pts. In its maximum diameter the PVA was a 
mean of 58% of the mitral valve annulus. Four pulmonary veins 
were seen in 5, three In 9 and two In 2 pts. Pulsed and 2·D Doppler 
revealed no obstruction at pulmonary vein, PVA or mitral valve 
level. One patient with TAPVC to the right atrium developed 
superior vena cava obstruction postoperatively. 
No mortality or morbidity was assOCiated with the studies. 
We conclude that TEE In paediatriC patients with repaired 
TAPVC allows adequate assessment of the results of surgery In the 
operating room and ICU, and should be pari of the routine 
evaluation of this patient population In the early postoperative 
period. 
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940·3 
Regional Ventricular Wall Motion Abnormalities in 
Tricuspid Atresia After the Fontan Procedure 
Teiji Akagi. Lee N. Benson. Robert M. Freedom. 
Hospital for Sick Children. Toronto. Canada 
Normal ventriculadunction is critical for a successful Fontan repair. 
As waJl motion abnormalities may reflect underlying myocardial 
dysfunction. we evaluated using biplane ventricular angiography (RAO/ 
LAO) 23 patients (lO:M 13:F. mean age 1O.3iO.7 years) >2 years after 
surgery using a center line method for regional wall motion assessment. 
The foJlowing variables were also calculated: end·diastolic volume 
(EDY); end-systolic volume (ESY); ejection fraction (EF); ventricular 
mass (YM); mean velocity of circumferential shortening (mYcf) and 
mean normalized systolic ejection rate (MNSER). EDY. ESY and YM 
were normalized by body surface area and mYcf and MNSER 
normalized to the R-R interval. Normal ranges for wall motion and 
other variables were established from 25 normal patients. Wall motion 
abnormalities were observed in II (48%) patients. 5 with apical. 3 with 
anterolateral. 2 with diaphragmatic and 1 with postero-Iateral wall 
hypokinesia. Comparison of data between normal (NWM) and 
abnormal (A WM) wall motion patients demonstrated the following: 
NWM AWM Control NWM vs AWM 
EDY(m!/m2) 68±3 60±3 64±3 NS 
ESY(m1/m2) 300 33±2* 26±2 NS 
EF (%) 55±2* 45±2** 6O±1 .p<O.OO5 
YMWm
y
2) 86±7** 104±5** 63±3 p<O.05 
YMIED' 1.3iO.1·· 1.8iO.2** 1.0±0.04 p<O.05 
mYcf(circ/sec) O.87iO.08 O.S9±O.04** O.9IiO.03 p<O.OI 
MNSER(EDV/s) l.5iO.I 1.2±O.1 ** I.SiO.2 p<O.05 
(Values are mean±SEM. • p<O.OS. ··p<O.OO5. compare to Control) 
Although there were no significant differences between ventricular 
volumes. patients with abnormal wall motion had significantly 
increased ventricular mass and decreased systolic function compare to 
normals. These observations suggest post-operative regional wall 
motion abnormalities in this setting arc not rare. may be related to 
excessive hypertrophy and contribute to systolic dysfunction. 
940·27 
The Damul-Stanlel·Kaye Procedure: Current Indlcationl 
& Resultl 
Richard Gates. Hillel Laks. Amir Elami, Jeffrey Pearl, Barbara 
George, Jay Jarmakani, Josephine Isabel-Jones, Alvaro Galindo,and 
Roberta Williams 
UCLA Medical Center, Los Angeles, California 
Between October 1983 and August 1991 twenty-nine 
consecutive Stansel procedures were performed. Indications for 
operation included restrictive bulboventricular foramen or sub•
aortic stenosis associated with double-inlet left ventricle (15), 
single ventricle of right morphology (7), other single ventricle 
anatomy (4), Taussig-Bing type transposition of the great arteries 
(2), or coronary anatomy precluding arterial switch (1). Twelve 
patients underwent concurrent Fontan procedures. Average age was 
38.3 months ( range 1-132 months). There were 23 males and 6 
females. There were 3 operative deaths (10%), two associated with 
a Fontan procedure. Three patients have required reoperation: two 
for aortiC valve insufficiency ( 5 days and 2.75 years), and one for a 
gradient across the Stansel ( 5.75 years). One patient is being 
followed with moderate aortic valve insufficiency which may require 
reoperation. Mean follow-up is 3.5 years (range .1-7.7 years). 
There were no late deaths. 
The Damus-Stansel-Kaye procedure provides excellent relief 
of outflow tract obstruction in selected patients and avoids 
ventriculotomy, heart block due to subaortic resection, and the use of 
apical to aortic conduits. When combined with right ventricle to 
pulmonary artery conduits, the procedure allows for the systemic 
use of the left ventricle in patients with Taussig-Bing transposition 
of the great arteries or patients with transposition of the great 
arteries, ventricular septal defect. and coronary artery anatomy 
precluding arterial switch. The procedure may be performed 
concurrently with a Fontan in selected candidates. but may be 
associated with increased operative risk. Careful selection of 
patients and recent modifications in technique may improve these 
results further. 
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Does the Modified Blalock-Taussig Shunt Provide 
Long-term Palliation? 
Anne Marie Schaap, William Neches, Jose Ettedgui, 
Sang Park. Univ of Pittsburgh. Pennsylvania 
Between October 1981 & December 1989, 74 patients(pts) 
with cyanotic congenital heart disease underwent 80 
modified Bla1ock-Taussig(B-T) operations(OP). A 
polytetraf1uoroethy1ene graft was used between the 
subclavian and ipsilateral pulmonary arteries. Graft 
diameter was 4 mm (9 pts), 5 mm (64 pts), 6 mm (6 pts) 
and 8 mm (1 pt). The age range at OP was 1 day to 17.83 
yrs (mean 0.89 ± 2.43) and 37 patients(46%) were less 
than 1 month old. There were 14 deaths, 7 of which were 
perioperative (2 intra-operative and 5 within 30 days). 
Two of the 14 deaths were related to shunt malfunction; 
1 at 28 days due to severe congestive heart failure and 
1 at 1.75 yrs following a severe hypoxemic spell (during 
a mild viral infection) due to marked stenosis of the 
shunt. The duration of palliation was determined from 
the date of the initial operation to: another shunt 
procedure, subsequent open heart surgery, end of the 
study period, or death. Twenty four pts underwent an 
open heart OP of which 11 were elective; while 23 pts 
needed a second palliative procedure 2.12 (± 1.51) yrs 
postop. The mean duration of palliation for the entire 
group was 2.14 (± 1.71) yrs. Postop catheterization and 
angiography were performed in 53 pts. Shunt occlusion 
was found in 4pts and 6(11%) had occlusion of the 
subclavian artery distal to the conduit with the 
development of subclavian steal syndrome. 
The modified B-T shunt provides good short term 
results, although the palliation period remains limited. 
It may be necessary to ligate the vertebral artery at OP 
to avoid the risk of subclavian steal syndrome. For 
patients with lesions that may require long term 
palliation, a classic B-T shunt should be considered. 
940-29 
Evaluation of Total cavopulmonary Qxmection in 
Itldified l'I:ntan cpu:ation frail Bapatic Ci.rculation 
Hikaru Matsuda, Jun Arisawa, Yasuhisa Shirnazaki, 
Masahiko lio, Keishi Kadoba, Tetsuya Sano, Hiroshi 
Takano, SUsumu Nakano. Osaka Univ., Osaka, Japan 
In modified Fontan operation(MF), benefit of total 
cavo-pulnalary connection ('IQ>C) to atrio-pulnalary 
oonnection (APC) is unclear. Because liver dysfunction 
and G-I-tract problems remain as post-MF problems, 
hepatic circulation was analyzed in 25 pts who 
urilerwent MF (APe:n=16, 'IQ>C:n=9). Single ventricle was 
the lesicn in 10 in APe and 6 pts in 'IQ>C. Others were 
mainly tricuspid atresia. Age and preope-PVR were 
oanparable between 2 groups. Doppler study was made for 
pulnalary artery (PA) , hepatic vein (HV) and portal vein 
within 1 mc:nth. Post-MF PA pressure was 13:t5 III!IHg in APC 
and 14:t~ III!IHg in 'IQ>C (ns); CI was 2.4:t1.0 and 3.0:t1.0 
l/min/m (ns). In 'IQ>C PA flCM was al!rost pulseless in 
contrast APe. APe-pts(n=9) shc7.oled higher regurgitaticn 
fraction (RF) than TCPC-pts(n=7) in HV: (RF: 
reverse/forward flCM area, APC:0.53:t0.11, 'IQ>C:0.09:t0.08, 
p<0.01). In portal vein, CCClStant forward flCM was 
detectable in all of 7 pts in TCPC, while it was 
possible in 3 out of 9 pts with APC. Early 
postoperative hepatic venous 02 saturation was lower in 
APe pts (APe: n=6, 28:t24%, TCPC: n= 5, 48:t15%, p.0.1) 
suggesting hypoperfusion in APe pts. Maximum serum GPT 
early after MF was higher in APC than 'IQ>C (1 ,063:t1, 124 
vs 106:t120 ro/L, p<0.01). Early m::rtality was 17.6% for 
APe and 11.1% for 'IQ>C. 
'!hese results suggest that 'IQ>C has a beneficial 
effect to hepatic perfusion fran its nonp..ll.satile flCM 
canpa.red to APC in spite of less effect cn increasing 
cardiac output in MF for complex anomalies. 
JACC Vol. 19, No.3 
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940-30 
Calcification of Heterograft Porcine Aortic Valves and 
Conduits in Children 
Steven Ritz, Susan Crawford, Farouk Idriss, Constantine 
Mavroudis, Carl Backer, Catherine Webb. Children's 
Memorial Hospital, Chicago 
The use of glutaraldehyde-preserved bioprostheses (GPB) 
in young patients is limited by early calcific degenera•
tion. The purpose of this study was to examine calcifica•
tion (CALC) of GPB valve leaflets as well as proximal and 
distal conduits In relation to patient age and implant 
duration. Calcium content (Ca2+) of 11 right-sided GPB 
leaflets and endothelium of 7 associated synthetic con•
duits was determined by atomic absorption spectroscopy. 
Age at implant was 4 month-IS years (mean 40 months) and 
implant duration was 20 months-12 years (mean 73 months) 
(male· 7; female· 4). Diagnoses were: truncus arteriosus 
(4), pulmonary atresia with VSD (3), and other (4). Valve 
orifice size ranged from 12-25 mm. All GPB were stenotic 
with a gradient of 29-100 mmHg (mean 63 mmHg) in RV-PA 
conduits and 5-~ mmHg in RA-RV/PA conduits; 3 were also 
regurgitant. Ca' (median, range) was greater in leaflets 
(124, 27-315 119/m9) than in proximal (7, 4-232 IIg/mg) or 
distal (10, 2-103 119/m9) conduits (p <0.05). There was no 
significant relationship between degree of GPB C~LC and 
age at implant or implant duration. Leaflet Ca + ~124 
IIg/mg was associated with pre-op gradient ~60 mm~ in RV•
PA conduits. RA-RVjPA leaflets contained less Ca (30-83 
119/m9). CALC of proximal or distal conduit endothelium 
was not predicted by degree of valve CALC. Leaflet CALC 
is influenced by hemodynamic environment, but the dissoci•
ation of leaflet and conduit CALC may have important 
implications in pathogenesis of GPB CALC. 
940-31 
Evaluation of the Sub·Aortic Region in Interrupted 
Aortic Arch 
Elizabeth Goldmuntz, Jeanne M. Baffa, Paul M. Weinberg. 
The Children's Hospital of Philadelphia, Philadelphia, PA 
Measurement of the size of the sub·aortic(suhAo) region in pts 
with interrupted aortic arch(lAA) is critical to the surgical 
approach. Options include aortopulmonary anastomosis Or repair 
of the arch and closure of the VSD (primary repnir). To compare 
preoperative measurement of the subAo region hy 
echocardiogram with angiogram, and to correlate outcome with 
pre'Jperative measurements, a review of 21 pts with IAA was 
undertaken. Fourteen pts had echocardiograms from which the 
subAo region was measured in the subcostal long axial 
oblique(LAO), parasternal long axis (LAx) and/or apical(Ap) 
views. Eight angiograms were available for measurement of the 
subAo region in the long axial oblique projection. 
Linear regression analysis demonstrated good correlation 
between LAx echocardiographic and angiographic measurements 
(r=0.90). The LAO and Ap views correlated poorly with 
angiographic values (r=0.62 and 0.42 respectively). Surgical 
repair and outcome were compared to the size of the suhAo 
region measured in the LAx view in 13 pts. Two of 3 pts with 
regions !>.3mm in the LAx view and !>.5mm in the LAO and Ap 
views had an aortopulmonary anastomosis and did well. The one 
pt that had primary repair had severe subaortic stenosis and 
died. Nine pts with a region ~4mm in the LAx view and ~5mm in 
the LAO and Ap views underwent primary repair with mild or no 
subaortic stenosis post·operatively. One pt with a subAo region 
equal to 4mm in the LAx and LAO views, and 5mm in the Ap 
view had an aortopulmonary anastomosis and died of infection. 
Cnnclusions: EChoeardiographic measurements of the suhAo 
region in IAA in the LAx view with supportive data from the LAO 
and Ap views may obviate the need for cardiac catheterization to 
evaluate the subAo region. These findings support primary rcpair 
when the subAo region measures ~4mm in the LAx view and 
~5mm in the LAO and Ap views. 
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940-32 
Strain Analysis or Single Ventricles Prior to and After Staged 
Fontan Procedure using Magnetic Resonance Imaging 
Marie A. Fogel, Krishalw B. Gupta, PaMl M. Weinberg alld Eric A. HoffmIUI 
University of PeMSYlvania School of Medicillt, PlUladelphia. PA 
Cardiac efficiency may be evalual.ed in several ways. The concept of eonsI8IIt tota1 
heart volume (THV) throughoul tile cardiac cycle «5'1> variation froni maximum 
volume) allows for minimal energy expenditure in moving extracardiac structureS. 
Systolic regional wall deformation may also be used as an index of mechanical 
fWletion. To measure regional strain distribution, a non· invasive JJ\IiIIetic resonance 
tagging technique which lays down stripes on \he myocardium (SPAMM) was 
utilized 10 examine 2S single righl ventricle pIS (lweek-9 years old) 81 various stages 
of the modified Fontan procedure. Finite suain analysis was applied 10 \he grid lines 
of 8 pts (3 pre hemiFontan, 2 post hemiFontan, 3 poSI Fontan), using Dclaunay 
triangulation and the 20 strain tensor 10 derive prirK:iple strains (E I). Basal and 
apical short axis planes through \he ventricular wall were categorized inlO 4 distincl 
regions equally spaced around the slice as well as into surgical subgroups. 
Observations of the analysis of particular interest are: 
1. There is a greater regional heterogeneity of strain in pIS past the hemiFontan stage 
and in pre hemiFontan pIS with a non-constant mv relationship (standard deviation 
of the strain triangle~.1 in 22/44 regions) as eompared 10 the pre hemiFontan pIS 
with a constant THY (standard deviation <.1 in 11/12 regions) 
2. Similar 10 the normal adult, in the pre hemiFontan pt showing constant mv. 
epicardial compressive strain was eonsistcndy less than endoeartlial (5/6 regions with 
epicardial/endocardia1 strain ratio <1). However, the other subgroups among the 4 
basal and apical regions were mixed (17 (22 regions with reversal of the ratio), 
3. Contrary 10 the normal adult studied by the same method, \he single righl 
ventricle patienl showed greater compressive strains at the apicall8lher than the basal 
regions aaoss all surgical subgroups and intrasliee regions (e.g .• .12±.03 vs • .19± 
.04 base 10 apex in the anterior free wall of the prc hemiFontan group). 
4. Compressive SUllins appear 10 decline in both apical and basal slices as pts 
progress through the stages of the Fontan procedure (e.g. ·.24±.06 vs ·.17±.04 on 
the diaphragmatic surface from pre hemiFontan 10 post Fontan). 
Conclusion: Complex interwoven biomecltanical properties are being altered with 
single ventricle reconstructive surgery thai go beyond pressure and volume measure· 
ments. The signiflC8DCC remains 10 be elucidated with more daIa and correlation with 
outcome however, long term cardiac mechanics may be affected. Detailed regional 
wall function analysis may help 10 understand the complex factors t1ettnninina long 
term survivability in both the reconstructed as weD as the native congenital heart. 
940-33 
Anatomical Correction For Transposition of the Great Arteries: 
Assessment of Myocardial Perfusion with Tc99-MIBI 
Alison Hayes, Edward Baker, Ashok Kakedeker, John Parsons, 
Rosemary Radley-Smith, Shakeel Qureshi, Magdi Yacoub, 
Michael Maisey, Michael Tynan. Guy's and Harefield 
Hospitals, london, UK. 
The inCidence of late myocardial ischaemia following 
anatomical correction ("switch" operation) which can be 
attributed to coronary artery transfer remains unknown. We 
studied 10 children using Tc99-MIBI at a mean interval of 6.9 
years post "switch". 19 other children were also imaged, 10 
preoperatively and 9 after other open heart procedures. In this 
latter group the mean interval from surgery was 5.2 years. All 
children had a planar study (29). Tomographic studies were 
performed in 25. 
Perfusion abnormalities were demonstrated with either planar 
or tomographic imaging in all the children following 
anatomical correction. Except in one child these were fixed. 
7 of the 9 children post·cardiopulmonary bypass also had 
perfusion abnormalities. Comparison of the frequency of 
abnormal segments in both groups showed that 25% of the 
tomographic segments were abnormal after either anatomical 
correction or other open heart procedures. 7% of segments 
were abnormal in the pre-operative group. 
Conclusion: Late perfusion defects are present following 
anatomical correction for transposition of the great arteries. 
However, a similar incidence of perfusion abnormalities are 
found in children after open heart procedures which do not 
involve coronary artery transfer. 
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940-34 
Angiographic Assessment of Coronary Artery Luminal 
Diameter in Children after Cardiac Transplantation 
Kimberly A. Krabill, David W. Hunter, Thomas C. Edwards and 
Elizabeth A. Braunlin, University of Minnesota, Minneapolis, MN 
Although diffuse coronary artery disease may occur after cardiac 
transplantation (CIX), its presentation may be subtle and its detection 
difficult. To objectively assess coronary artery anatomy we measured 
the CA luminal diameters from 69 selective coronary arteriograms 
performed in SS children (age 0.3-18.3 yrs, wt 4.8-81.3 kg) obtained 
between 1984-90. Among these were 20 yearly coronary angiograms 
obtained in 8 pts after CTX. Other diagnoses included 
cardiomyopathy in association with the mucopolysaccharidoses (12 
pts); Tetralogy of Fallot (13 pts); coronary artery fistulae (11 pts); and 
miscellaneous acyanotic lesions (11 pts). Left (LCA), right (RCA), 
anterior descending (LAD), posterior descending (PO), and 
circumflex (CX) CA diastolic diameters were measured at their origin 
and corrected for magnification and body surface area 
LuiliD AU£:t:t1 I CA· I. A II· ex· BCA· Ell· 
A1ICTX 12.S±l.4 3.4±.3 2.4±.2 2.4±.2 2.S+.1 l.8±.1 
CTX·yr I 1l.4±2.2 3.3±.4 2.S±.3 2.4±.3 2.6±.3 l.7±.2 
CTX-yr2 12.S±2.1 3.6±.4 2.3±.3 2.3±.3 2.S±.2 l.7±.1 
Other S.7±.8 4.4±.3 3.S±.2 3.3±.2 4.l±.2 2.l±.1 
·Mean (mm/M2) ± SIlIIIdard error of the mean 
Regardless of diagnosis, each indexed CA luminal diameter decreased 
with increasing age (p=O.OOOI). By multiple regression indexed CA 
luminal diameters from CIX recipients were not significantly different 
from those with other diagnoses. In the CIX pts no first year CA 
luminal diameter differed significantly from its corresponding second 
year diameter. We conclude: 1) indexed CA luminal diameter 
decreases with increasing age in children; 2) CA diameters from crx 
recipients cannot be distinguished from pts with other diagnoses and 
3) CIX CA diameters do not decrease within the first two years of 
follow-up. 
940·35 
Late Cardiac Function After Infant Cardiac Transplantation 
Mark M. Boucek, Cheryl M. Mathis, Mohammad S. 
Kanakriyeh, Jorge McCormack, Joyce K. Johnston, 
Steven R. Gundry, and Leonard L. Bailey 
Loma Linda University Medical Center, Loma Linda, CA 
Infant cardiac transplantation can now be performed with 
an 85% actuarial one-year survival but questions remain 
about late graft survival and function. To address the issues 
of late graft function, we reviewed 23 patients transplanted 
in infancy « 1 year). maintained on cyclosporine and 
azathioprine, and having invasive and noninvasive cardiac 
evaluation ~ 18 months after transplantation. Complete 
heart catheterization with selective coronary angiography 
was performed. None were on anti-hypertensive agents at 
the time of study. The mean age at transplant was 47 
(range 0-179) days; the time posttransplant was 42.±.12 
months (range 20·68 months). There were no late deaths 
or retransplantations. The mean cardiac index was 3.9 
Llmin/m2 with a LVEDP of 8.6.±.1.7 mmHg. Peak right 
ventricular pressure was 26.±. 4 mmHg and peak LV pressure 
was 98.±.15 mmHg. The aortic pressure was 97.±.16/56.±.9 
mmHg. The mean pulmonary artery and right atrial 
pressures were 15.±.3 and 4.±.2 mmHg respectively. 
Selective coronary angiography demonstrated coronary 
lesions in 1/23 (4%). Mild residual coarctation was present 
in 2/23 (9%) and was successfully dilated in both. 
Echocardiographic study showed a left ventricular end•
diastolic volume that was 77.±.21 % of predicted normal. a 
left ventricular mass 90..±.15% of predicted normal. and a 
left ventricular shortening fraction of 44.±.5 %. 
We conclude that late invasive cardiac evaluation after 
infant transplantation (> 3 years average follow-up) indicates 
normal hemodynamics and only rare coronary artery 
pathology. LV dimensions were within the normal range in 
the majority of children and LV function was normal. Late 
graft failure (> 3 years) has not occurred. 
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941·36 
Development and Initial Clinical Experience of Small 
Standard and Matrix Biplane Transesophageal Echo Probes 
for Pediatric Cardiac Patients 
Shunei Kyo, Ryozo Omoto, Makoto Matsumura, Toshiki 
Kobayashi, Eiko Takanawa, *Toshiyuki Matsunaka, Saitama 
Medical School, Saitama & *Aloka Co.LTD, Tokyo, Japan 
A single plane transesophageal echo (TEE) probe has 
large limitation to evaluate congenital heart diseases 
(CHD) in pediatric patients (pts), especially in the 
case of complex CHD to evaluate the three-dimensional 
(3-D) anatomical structure of the cardiac anomalies. 
Therefore, we developed two kinds of new small biplane 
TEE probes of 5 MHz transducer with 24 elements. One 
is standard two transducer biplane (SB-TEE, ED-7mm) 
system and another is matrix biplane (ME-TEE. ED-7mm) 
system. These probes were used in 16 pts with VSD 
(5pts), pulmonary atresia (3pts), TGA (3pts). Tetralogy 
of Fallot (2pts) ,TAPVC (2pts), and ASD (2pt). There 
were 5 females and II males, age 1123 month-old (range 
6 day- 7 year), weight 6.1 4.7 kg (range 2.2-18.5 kg). 
TEE examination was performed for 29 times including 
pre- (4 times), during (13 times), and post-(12 times) 
operative evaluation. Biplane TEE was especially 
effective for the evaluation of RV outflow tract (13 
pts), aorto-pulmonary shunt (7 pts), and repair of 
TAPVC (2 pts). Although maximum frame rate of MB-TEE is 
half of SB-TEE, ME-TEE could provide almost equal real•
time side-by-side orthogonal biplane images which is 
quite advantageous to have a 3-D orientation of the 
cardiac anatomy. Thus, ME-TEE probe is acceptable for 
perioperative evaluation of complex CHD under 10 kg of 
body weight. 
941·37 
Panoramic Tran,esophageal Echocardlography: 
Clinical Potential of Two Methods: (1) Realtime Wlde·angle 
(2700) Imaging With an Annular Array TEE Probe and (2) Off•
line Digital Tomographic Reconstruction 
Tsui·Lieh Hsu. Andrew Weintraub, Steven Schwartz, George Gordon. 
Samuel Ritter and Natesa Pandian. 
Tufts·New England Medical Center, Boston, Massachusetts 
Conventional transesophageal echocardiography (TEE) provides images 
with a maxirrum sector angle of gOO at any given time. We explored the fea· 
sibitityof simultaneous visualization of the entire heart. great vessels and 
thoracic structures In a tomographic fashion using 2 approaches. In the first 
approach, we systematically steered the conventional TEE image sector by 
graded 36oo rotation of the probe In 20 pts. These images were then digi· 
tized and 3600 tomographic Images (similar to computed tomography) were 
reconstructed. This method, a"hough not real·time, allowed us to visualize 
simuHaneously the whole heart and great vessels and paracardiac structu· 
res and other adjacent intrathoracic pathology in entirety. Localized pericar· 
dial effusions, paracardiac tumors Invading the heart, aortic aneurysms, ana· 
molous chambers and vascular connections, pleural effusIons, and collap· 
sed lungs could all be visuafized in the same tomographic images depicting 
cardiac chambers. The second approach involved the use of a prototype 
annular array 4 MHz TEE probe which yielded real·time Images in a wide· 
sector (2700 angle for 2·0 echo and 1800 for color Doppler) providing pano· 
ramic views of cardiac and thoracic structures. In addition to the wide·angle 
views, this system also allowed us to examine in detail any given region in a 
magnified Image using a narrowed sector and improved resolution. We 
were able to visuaUze the entire left atrium, pulmonary veins and ascending 
and descending thoracic aorta sirru"aneously in realtime in the same wide 
image sector without any need for probe rotation. Biventricular function 
could be assessed simuHaneously. Flow jets across various cardiac struc· 
tures could be seen at the same time; aortic, mitral and tricuspid insuffici· 
ency were easily detected. Transgastric images depicted not only the car· 
diac chambers but also the Over and kidneys. We conclude that both off-line 
tomographic digital image reconstruction and on·line real·time panoramic 
TEE aid in the simultaneous visuafization of cardiac and thoracic pathology 
presenting a wider perspective on the extent of pathology and ns spatial 
relations; Real·time panoramic TEE is eaSier to perform and requires less 
probe manipulation. Both approaches appear to have excellent clinical 
potential and may also aid in three-dimensional imaging of the entire heart. 
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941·38 
An New 8MM Matrix Probe Suitable for Providing Simultaneous Biplane 
Transesophageal Visualization in Pediatric and Adult Patients 
Ryozo Omoto, David J. Sahn, Shunei Kyo. Robert Weintraub, Takahiro 
Shlota. Sattama University, Japan and Unlv of Calif, San Diego, CA. 
By cross-sawing an array in two directions, the capability exists for using 
line-sharing and frame-sharing to produce simultaneous visualization of two 
transesophageal echo (TEE) planes at right angles. The ability to segment 
and wire these matrix bi-P!ane arrays represents an engineering triumph 
but they have been difficult to produce consistently. A problem encoun•
tered In using this technology has been the slow frame rates imposed 
when using color Doppler Imaging at large depths in 2 planes at once. We 
report an 8mm 24 x 24-element matrix biplane TEE probe mounted on a 
6.8mm esophagoscope which has been recently tested at both Saitama 
Medical School and at UCSD Medical Center. Application has been direct•
ed towards evaluation of children and adults; specifically for imaging the 
near field, regardless of patient size. We used the new probe on 24 pts 
from 6 days of age through 70 years of age whose cardiac conditions 
Included repairs of aortiC dissection, mitral and aortic valve repairs and 
repairs of paravalve abscesses in adults; closure of ventricular septal 
defect, repairs of tetralogy of Fallot and AV septal defect and anatomical 
correction for transposition in infants. Simultaneous biplane near field 
visualization wtth diagnostic quality color Doppler was achieved at dis•
tances of 6-8 cm or less from the probe which could be introduced with 
ease even in babies < 3.5 kgs of weight. Our results suggest that this 
probe will have wide applicability not only in children but in many adults 
where tts small size and biplane capability can reduce the discomfort 
associated with outpatient awake TEE or TEE in the catheterization lab and 
where the ability to examine two planes at once should reduce Imaging 
time and improve efficiency of TEE. This technology also has unique 
applications in intraoperative or cath lab contrast TEE where looking at 2 
planes at once reduces the number of contrast injections required for 
perfusion, shunt or valve integrity evaluations. For the near field applica· 
tions for which it was designed, this new echo probe provides high quality 
imaging and color Doppler despite the reduction in the number of elements 
needed to achieve its 8mm low profile configuration. 
941·39 
Realtime Multlplane Transesophageal Echocardlography 
Using a Prototype Phased Array TEE Probe With 180 
degree Scan Plane Steering Capability: Method, Echo· 
Anatomic Correlations and Early Clinical Experience 
Natesa Pandian, Tsui-Lieh Hsu, Andrew Weintraub, Steven SChwartz, 
Janet Simonetti, and George Gordon. 
Tufts-New England Medical Center, Boston, Massachusetts 
To assess the potential of a prototype muhiplane transesophageal echo•
cardiography (MPTEE) probe, we studied 25 pts with a variety of cardiac 
disorders. The scan head of this probe (ATL) conSists of a 48 element pha•
sed array mounted at the end of a 2-way articulating hollowscope. The pha•
sed array, constructed in a cylinderical shape, is capable of being rotated 
1800 about ns cylinderical axis (clockwise & counter clockwise) by a handle 
knob without moving the probe shaft, thus yielding a vast array of imaging 
planes including transverse and longitudinal planes. Coupled to the 1800 
rotational range, alterations In probe position and mild rotations of the shaft 
further Increase the assembly of imaging planes. To understand the new 
imaging planes available, we first sectioned 10 hearts along multiple planes 
and identified the cardiac structures visualized in various orientations. Cor•
relation of the echo images to anatomic sections yielded a baSis for image 
interpretation and display. In pts we used contrast injection to further con•
firm the structures imaged. The ear1y experience in 25 pts indicated that the 
strength of multi plane TEE is the ease and convenience in the ability to 
visualize almost every segment of every major cardiac structure, thus trans•
lating the versatility of transthoracic echocardiography to the TEE techni•
que. We were able to image the ventricles in mu~iple orientations including 
a new TEE view that is analogous to aplcaVparasternallong-axis view, inter•
rogate RV inflow and outtlow regions easily, visualize ascending aorta, right 
pulmonary artery and pulmonary veins to greater extents, and scan valve 
apparatuses all around. When compared to biplane technique, MPTEE 
allowed better assessment of regional and global LV function, enhanced 
detection of vegetations in the aortic and mitral valves, easier discrimination 
of torn chords from vegetations, Immediate recognition of ruptured papillary 
muscle, unmasking of LV clots, and better delineation of native and pros•
thetic valve Insufficiency jets and ASD shunts. Also, we were able to ex•
clude vegetations, clots and VSDs with greater confidence. We conclude 
that MPTEE, by providing easily obtained newer imaging planes, aids in 
unmasking many cardiac abnormalities and, importantly, enhances the 
confidence level in TEE interpretation and thus the diagnostic assurance. 
ABSTRACfS 
941·40 
Multiplane Transesopbageal Ecbocardiograpby: 
Initial Experience and Potential Applications 
Werner G. Daniel, Alan S. Pearlman, Dirk Hausmann, Klaus 
Bargheer, Andreas Miigge. Hannover Medical School, Germany. 
Transesophageal echocardiography (TEE) has become an accepted 
technique to improve cardiac ultrasound information in selected 
patients (pts). We evaluated a prototype multiplane (MP) phased 
array TEE transducer (5 MHz, 48 elements; transducer size: 15 by 
13 mm; standard 2D, B-color, Doppler capability; Advanced 
Technology Laboratories). From a fixed transducer position, 
mechanical rotation of the scanhead rotates the image plane from 
0-180 degrees, thereby including multiple plane orientations in 
addition to the standard horizontal and longitudinal image planes. 
Twelve consecutive pts (15-63 years) with congenital or acquired 
heart disease were studied. The following advantages in compari•
son to biplane (BP) TEE were observed: Mp· TEE imaging allo•
wed a) more detailed interrogation of endocarditis associated 
abscess cavities, b) improved visualization of small atrial septal 
defect (missed by BP-TEE), patent foramen ovale and attachment 
point of atrial myxoma, c) individualized imaging of the dissecting 
membrane in aortic dissection, clear estimation of the amount of 
thrombus in thrombosed aortic aneurysm and imaging of aortic 
arch branch vessels, d) identification of a small postero-lateral•
apical left ventricular thrombus (missed by BP-TEE), e) 3-D esti•
mation of cardiac chambers, great vessels, and regurgitant jets. In 
addition, angle orientation for spectral Doppler interrogation (all 4 
pulmonary veins, mitral/tricuspid/pulmonic valves) could be opti•
mized. Conclusion: MP imaging with the potential of unlimited 
scan planes from a fixed transducer position seems to have 
significant advantages for individualized evaluation of pts requiring 
TEE examination. 
941·41 
Intraoperative Monitoring of Cardiac Output Using 
Biplane Transesophageal Echocardlography 
Joel S. Raichlen, David F. Cowling, Hector V. Ortega, Perry J. 
Weinstock, Rakesh Gupta, Maureen E. McDonald. Thomas 
Jefferson University, Philadelphia, Pennsylvania 
235A 
We developed a method of measuring cardiac output using 
biplane transesophageal echocardiography that utilizes 
stroke volume measurements made in the thoracic aorta. 
Stroke volume was calculated as the product of the cross 
sectional area (CSA) of the aorta and the flow velocity integral 
(FVI) within it, which was determined as the vector sum of the 
Doppler flow velocities measured at the extremes of the 
longitudinal image. The method was validated in an in vitro 
model of pulsatile flow using stroke volumes from 40 to 90 ml. 
Calculated stroke volume correlated well with measured 
stroke volume (r=.99; p<.001). The method was applied 
intraoperatively in 9 patients undergoing cardiac surgery. 
Serial measurements were made of thermodilution cardiac 
output and the diameter, CSA and Doppler flow velocities in 
the thoracic aorta, before and after cardiopulmonary bypass. 
The calculated flow volume in the descending thoracic aorta 
averaged 51% of the cardiac output. Measurements could be 
simplified by estimating FVI as the product of a constant and 
the peak flow velocity (r ... 98; p<.001), and by estimating CSA 
from the diameter of the aorta (r=.91; p<.001). In individual 
patients, changes in cardiac output correlated well with the 
product of heart rate and the peak velocity measured at a 
single point in the aorta (r=.95, p<.02). These results suggest 
that accurate cardiac outputs can be determined from 
relatively simple measurements made using biplane 
transesophageal echocardiography. These techniques have 
great promise for measuring stroke volume and for monitoring 
cardiac output changes in the operating room. 
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941·42 
Buckling of the ;:Cn~ftbe Tnmsesophageal Echo Probe: 
A Dangerous ~ • cal Malfunction 
Itzhak Kronzon, David Cziner, Edward S. Katz, Paul A. 
Tunick, Robin S. Freedberg, and Werner Daniel. New 
York University Medical Center, NY, NY, and Hannover 
Medical School, Hannover, Germany 
Buckling of the tip of the TEE probe is a previously 
unreported technical problem which could result in 
injury to the patient. Buckling of the tip was observed in 5 
pts studied in 3 different institutions by experienced 
operators. In each pt, after the probe was inserted, images 
could not be easily obtained, manipulation became 
difficult, and resistance was felt when withdrawal of the 
probe was attempted. The knob controlling the flexion of 
the tip became fixed in the extreme anteflexion position. 
All of these findings suggested that the tip of the probe had 
buckled forward during insertion and had doubled upon 
itself to form a narrow "u·turn." The buckled tip wedged 
into the esophagus, and it was impossible to straighten it 
within the narrow lumen. Fluoroscopy confirmed the tip 
buckling in one pt. In 1 pt it was possible to withdraw the 
probe and confirm the buckling. In the other 4, it was 
possible to advance the probe into the stomach where the 
wider lumen permitted unfolding and later careful 
withdrawal. Two pts complained of pain, and blood·tinged 
saliva was noted in 1 pt, but there were no further 
complications. Evaluation of the probes by the 
manufacturers revealed stretching and elongation of the 
steering cables resulting in tip flaccidity. 
Clinical Implications: The operator should be familiar 
with the normal flexion of the TEE probe. A probe with a 
flaccid tip should not be used. The manufacturers should 
issue guidelines for probe inspection and design a 
maintenance plan to prevent such occurrences. 
941·70 
What is the Most Appropriate Variable for Estimation of Mean 
Pulmonary Capillary Wedge Pressure by Transesophageal Pulsed 
Doppler Echoc:ardiography ? 
Hirofumi Habu, Takeshi Sasaki, Takeo Naito, Yutaka Hirano, Hiroshi 
Ikawa. Ryo Katori. Kinki University. Osaka·Sayama.lapan 
It has been reported that left ventricular inflow parameters and 
pulmonary venous flow parameters by the transesophageal pulsed 
Doppler echocardiography reflect mean pulmonary capillary wedge 
pressure (PCWP) in some degree. But these parameters are also 
affected by cardiac function. The purpose of this study is to detect the 
most appropriate parameter for estimation of PCWP by the 
transesophageal pulsed Doppler echocardiography. We compared the 
variables of left ventricular inflow and left upper pulmonary venous 
flow with PCWP in 36 pts with ischemic heart disease. Velocity·time 
integrals of early diastolic filling wave (E) and atrial contraction wave 
(A) were me;lsured from mitral inflow profiles. Velocity·time integrals 
of systolic forward flow(S). early diastolic forward flow (D), and 
retrograde flow at atrial contraction (PVA) were measured from 
pulmonary venous flow profiles. Then, SIS+D ratio and PV A/A ratio 
were calculated. Correlation coefficients between the velocity·time 
integrals and PCWP were as follows. 
E A E/A S D PYA StS+D PYAtA 
0.01 ·069.... 0.39" ·0.54 .... 0.07 0.46** 0.61.... 0.84"· 
·p<0.05, .... p<O.OI 
S is influenced by left ventricular systolic function and both A and PV A 
are affected by atrial pump function. Therefore, there is a limitation for 
the estimation of PCWP by only S, A. or PYA (previously reponed 
parameters). On the other hand, PVA/A ratio does not reflect atrial 
pump function. because the augmentation of atrial pump function 
increases PYA as well as A. This will be the reason why PVA/A 
correlated most closely with PCWP. Conclusion: PVA/A ratio by 
transesophageal Doppler echocardiograpby is a new useful variable for 
estimating PCWP without influence of cardiac function. 
941·71 
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CbIpar:iam IIe'-t na&!llC41...,.al aid na stlul£ic 
~~ in~ IIi8Tt Ventriallar 
Ilyqllaaia 
Bnro De Piccoli, Fausto Rigo, F'r!n:esco Caprioglio, QJerrino Zuin, 
Paolo Millosevidl, Eligio Piccolo 
Ospedale UrtJerto 1°, CBrdiologia, Venezia-Mestre, 1talia. 
In ordPr to evaluate the diSOJlOStic capabili 1;;' of In!nseSq:i1agea 
ecMcardiOl?fllli1y ('lEE) CCITpBI'ed to transthoracic ecMcardiOl?fllli1y 
(TIE), far ~c riglt ventricular c\Ysplasia (ARIID), we 
evaluated allln'i\YtlJnic patiente (pte), 14 nele, 6 fEllBle, ~ age 
42 1: 14 yrs, suspected to have ARIID. We CCI'lSidP.red the segnental 
wall anatanic arxl lIDticn (akinesia=2 qyskinesia=3) aI:rlornBli ties 
arxl the fraCticnal area change (FAe) of RV as well as ~ presen::e 
of ~c patterns &.Idl as rroderatar band thickening, focal 
wall th~ arxl trabecular disarray analysed by TIE wi th 
parasternal, SJbcostal ax! <pical ~ arxl by 'lEE with the 
fQJl" cha'riJers arxl the transgastric views at the triClBpid, papillar 
arxl apical level. We obtained the follo.Ting res.ll te: by TIE VB 'lEE 
FAe was ~ VB '37£7% (P=I1S), ~ wallllDticn scare was 3,~1,8 VB 
4.~2.l (p < O,03)~ distl:Irp'1ic soare was 3.8;t1.5 VB 6.1::1.2 (p< 
0,005). Ccnsldering RV cineventriculClgl"B!ijy as the gold standard 
far ARIID ..., ccn::luded: 
TIE pool ti ve 13 pte ~ti ve 3 pte tn::ertain 4 pte 
'lEE pooi ti ve 18 pte ~ti ve 1 pte tn::ertain 1 pte 
AN:llOORAHiY pooiti ve 18 pte ~ti ve 2 pta tn::ertain 0 pta 
In QJl" opinicn 'lEE can represent an adequate cli.a,\\mBtic tool for a 
RV pathologfax! it _ a.periar than trediticnal TIE in 
detec~ the ARIID. 
941·72 
Diagnostic Accuracy of Transesophaqeal Echocar•
dioqraphy in the Detection of Left Atrial 
Thrombus in Rheumatic Mitral Valve Disease 
Juey-Jen Hwang,Shen-Chang Lin,Meng-Huan Lei, 
Jun-Jack Cheng,peiliang Kuan,Wen-Pin Lien. 
Department of Internal Medicine,National Taiwan 
University Hospital, Taipei, Taiwan, ROC 
Transesophageal echocardioqraphy(TEE) has 
become an efficient modality to detect the left 
atrial thrombus(LA Th) in recent years. The 
diagnostic accuracy will be evaluated in this 
study. TEE was performed in 152 consecutive 
patients(pts) with rheumatic mitral valve 
disease during a period of 30 months. All pts 
underwent open heart surgery within 3 days of 
the TEE study. The presence of LA Th was 
confirmed at surgery by direct inspection of 
the LA, especially the LA appendage, and proved 
by histopathologic examinations. Of the 152 pts, 
114 had isolated or predominantly mitral steno•
sis(MS) and 38 had predominantly mitral regur•
gitation(MR). All 24 pts who demonstrated LA Th 
at TEE were eventually confirmed at surgicopa•
tho logic studies(specificity 100\). In 2 pts, 
however, LA Th were present, but failed to be 
detected by TEE (sensitivity 92.3\). The posi•
tive predictive value was 100\, the negative' 
predictive value was 98.4\ and the diagnostic 
accuracy was 98.7\. The inCidence of LA Th in 
pts with significant MS was 22.8\, and most of 
these pts were in atrial fibrillation(25/26, 
96.2\). No Th were found in pts with predomi•
nantly MR. 
It is concluded that TEE is an excellent 
tool for the detection of LA Th in pts with 
rheumatic mitral valve disease. 
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941·73 
Cl i nical Impact of Transesophageal Echocardiography in 
the Diagnosis and Management of Infective Endocarditis: 
Significance of a Negative Finding. 
Richard W. Lowry, William A. Zoghbi, William B. Baker, 
Richard A. Wray, Miguel A. Quinones, Baylor College of 
Medicine, Houston, Texas 
The sensitivity of transesophageal echocardiography 
(TEE) for detection of vegetations in patients (pts) 
with infectious endocarditis (IE) is superior to trans· 
thoracic echo and reaches 90% or greater. Such a high 
sensitivity might allow one to exclude clinically sus· 
pected IE with a negative TEE examination. To further 
assess this, we reviewed the hospital records of 70 pts 
undergoing TEE as part of an evaluation for IE. TEE was 
positive in 25 pts; 22 with clinical evidence of IE (13 
native, 9 prosthetic valves), 2 with previous IE and 1 
false positive (myxomatous valve). IE diagnosis was 
based solely on TEE results in 9 pts (6 native; 3 pros•
thetic valves) with non-diagnostic blood cultures. TEE 
was negative for IE in 45 pts (27 native, 18 prosthetic 
valves); IE was the final diagnosis in only 2 of the 45, 
both with prosthetic valves. A negative TEE resulted in 
a change in diagnosis and antibiotic regimen in the re•
maining 43 pts. Duration of antibiotic therapy follow•
ing TEE averaged 38±22 days in the positive TEE group 
versus 17±26 in the negative group (peO.OI). TEE re•
sults contributed to clinical management by confirming 
or excluding IE (n=56), assisting in the choice and 
durat i on of anti bi ot i c treatment and determi ni ng need 
for surgical intervention [perivalvular abscess (n=3); 
severe valve regurgitation (n=5); large vegetation and/ 
or embolic episodes (n=4)]. We conclude that TEE has a 
significant impact in the diagnosis and overall manage•
ment of pts with suspected IE. In pts without valvular 
prosthesis, a negative TEE virtually excludes IE. 
941·74 
The Mechanism of Airway Obstruction During 
Intraoperative Transesophageal Echo In Infants 
Gregory Sorensen, J. Geoffrey Stevenson, Joseph Siebert, 
and John Mulroy, Jr. Children's Hospital & Medical Center 
and University of Washington, Seattle, Washington 
While the incidence of transesophageal echo (TEE)-induced 
morbidity has been very low in the adu~ population, few data 
are available for intraoperative pediatric TEE (PTE E). Using 
a Siemens CF system, we performed a prospective study of 
130 intraoperative PTEE examinations to determine PTEE 
complications. Probe passage was uneventful in all and the 
only complication was airway obstruction occuring in 3 
patients (weights 5.0, 9.8, &10.4 kg). In all 3, the 6.8 mm 
probe remained non·flexed, in situ during cardiopulmonary 
bypass. Obstruction occured following bypass, resolved 
upon removal of the probe and not recurr with reinsertion of 
the probe. Surprisingly, obstruction did not occur in any of 
the 14 smallest patients. To test the hypothesis that 
obstruction was related to compression of the anatomical 
membranous trachea (MT) below the endotrachteal tube 
(ETT), the trachea of an infant cadaver was examined using 
continuous air flow at a mean airway pressure (MAP) of 25 
cmH20. Application of only 7.7 gm/mm2 to the MT increased 
MAP to 35 cmH20, consistent with obstruction. We 
conclude that obstruction results from probe impingement 
upon MT and speculate that surgical manipulation provided 
sufficient force to cause obstruction. Further, the smallest 
patients may not obstruct due to a relatively larger 
ETTltracheal ratio with the ETT stinting open the trachea. 
PTEE is remarkably free of complications but one must be 
aware that obstruction may occur at any time during PTEE. 
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942·62 
Lethal and Non·lethal Events (Moricizine Versus 
Encainide/flecainide) In the CAST I and CAST II 
Alfred Hallstrom, James Kammerling and Henry Duff for the CAST 
Investigators 
University of Washington, Seattle, Washington 
Encainide/flecainide (ElF) were associated with increased mortality 
during long term blinded therapy (relative risk • 2.5 versus placebo 
p<0.OO03) whereas moricizine (M) was not (rr_ 1.2 versus placebo 
p. NS). However, for patients who did not die, non-lethal events 
(disqualifying ventricular tachycardia, proarrhythmia, disqualifying ECG 
abnormal~y, recurrent nonfatal myocardial infarction, new or worsening 
congestive heart failure) were less common on ElF than placebo but 
more frequent on M than on placebo. 
Patients ElF vs Placebo M vs Placebo 
N 795 798 691 683 
With Deathl 
Cardiac Arrest 66 27 100 79 
With Only 
Nonfatal event 74 82 107 80 
With Any Event 146 109 rr.l.28 207 159 rr.l.30 
Conclusion: In this subset of patients M appears to have the same rr as 
ElF for some serious cardiovascular event with more of those events 
being fatal on ElF. Thus though M may be safer than ElF, the risk of 
total cardiovascular events is equal to ElF. 
942·63 
Independent Long-Term Prognostic Importance of Ejection 
Fraction And Infarct Artery Patency After Myocardial 
Infarction. 
Harvey D White, David B Cross, John M Elliott, 
Robin M NorriS, Barbara F Williams. 
Green Lane Hospital, Auckland, New Zealand. 
237A 
Left ventricular function is a major prognostic factor 
after thrombolytic therapy. Patency of the infarct 
artery may also be important by reducing 
arrhythmogenesis, limiting remodelling and providing 
collaterals. We followed 312 patients for mean 39 
(15-73) months after cardiac catheterization 3 weeks 
after thrombolysis. An occlusion score reflecting the 
amount of myocardium supplied was used. Cardiac death 
occurred in 5.8%. There were 2 non-cardiac deaths. 
Revascularization was performed in 12%. Univariate (Uni) 
and multivariate (Multi) Cox analyses were used. 
Cardiac 
death Alive p 
(n=18) (n=292) Uni Multi 
Ejection fraction (%) SlU8 59tll 0.006 0.006 
Occlusion score 3.1t3.6 1.3t2.2 0.01 0.017 
When the ejection fraction was )50%, only occlusions in 
arteries supplying >25% of the left ventricle were 
important; whereas when the ejection fraction was <50%, 
all occlusions affected prognosis. 
Conclusion: Ejection fraction and occlusion score are 
independent long-term prognostic factors following 
thrombolytic therapy for acute myocardial infarction. 
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942·64 
Comparative Efficacy of Exercise Echo and Thallium 
Imaging for Identifying High Risk Patients Early After 
Myocardial Infarction 
Andrew J. Boulet, Ann D. Walling, Tubin K. Chaudhuri, 
Michael A. Graceffo, Robert A. O'Rourke. Univ Tx Hlth 
Sci Cntr, San Antonio, Tx. 
No prior prospective study has compared blindly Tl 
imaging & exercise echo (ExE) , performed simultaneous•
ly, in post MI patients. Thus, we studied 38 pts 7-10 
days post MI with ExE & quantitative Tl imaging using 
treadmill exercise. Jeopardized myocardium (JM) (ar•
teriography within 7 days) was defined as contracting 
wall motion (WK) distal to a ~70% stenosis. Subseq•
uent cardiac events were unstable angina, MI or death. 
Digitized ExEs were quadscreen analyzed for worsening 
WK. Less than 7 of 23 segments were interpretable by 
ExE in each of 10 pts. Sensi tivity, specificity, 
positive & negative predictive accuracy (PPA & NPA) & 
overall accuracy for JM were (p-NS, X2 analysis): 
ExE 
Tl 58% 
~ 
18%* 
73% 
UA 
62% 
79% 
W 
29% 
50% 
~ 
Accuracy 
39% 
63% 
*Sens 67% & Spec 25% for only interpretable ExEs. 
The same assessment for 13 events in 38 pts during 
months followup is indicated below: ~ 
~ ~ f£A HfA Accuracy 
ExE 56% 31% 26% 100% 37% 
Tl 67% 61% 35% 85% 62% 
*Sens 100% & Spec 41% for only interpretable ExEs. We 
conclude: (1) ExE & Tl imaging have similar accuracy 
for identifying JM when both studies are interpret•
able; (2) ExE is limited by a lower # of pts in whom 
most segments can be assessed & gives more false 
positives; & (3) worsening WM by ExE & redistribution 
by Tl imaging equally predict subsequent events. 
942·65 
Effects of Trapidi1, a New Inhibitor of Thrombo•
xane A2 Synthetase, in Patients With Unstable 
Angina. 
Stefano Reggiani, Giorgio Mattioli. 
Opt of Cardiology, Modena University, Italy. 
There is considerable evidence suggesting that platelet 
activation and formation of thrombi in coronary vessels 
are the bases for unstable angina (UA). To further 
investigate the role of platelets in UA, we studied if 
therapy with Trapidil (TXA2I) pyrimidin-derived molecule 
recently introduced into therapy which inhibits 
Thromboxane A2 synthetase, influences the clinical course 
of UA. We enrolled in a randomized trial 144 pts with UA 
of which 73 were allocated to conventional therapy (CT) 
(Ca-antagonists, nitrates, etc.) and 71 pts were treated 
with CT+T (300 mg. t.i.d.) within 48 h. of recovery. 
Baseline demographic and angiographic aspects were similar 
in two groups. The follow-up was 5 months. Myocardial 
infarction (AMI) and cardiovascular death (CD) were the 
primary end points. The results of the intention-to-treat 
analysis are shown in the table. 
CT n=73 CT+T n=71 Risk reduct. p value 
AMI 10 (13.6%) 2 (2.8%) 79.4 % p < 0.05 
CD 5 (6.8%) 1 (1.4%) 79.4 % n.s. 
TOTAL IS (20.5%) 3 (4.2%) 79.5 % p < 0.01 
These data underline the role of platelets activation in 
UA and suggest that TXA21 improves the prognosis of UA. 
942·66 
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Unexplained Increase of Postmyocardial Infarction 
Long-term Kortality among Less Educated Patients 
Geoffrey H. Tofler, James E. Muller. Peter H. Stone, Vicki 
G. Davis, Glenn Davies, Eugene Braunwald, and the MILlS 
Study Group. Harvard Medical School, Boston, MA. 
To determine the reasons for the increased mortaU ty 
following acute myocardial infarction (MI) among less 
educated patients, we analyzed results from the Multicen•
ter Investigation of Limitation of Infarct Size (MILlS). 
The clinical course of 363 patients who did not complete 
high school education « H.S.) was compared with that of 
453 patients who graduated from high school (~ H.S.). 
Age (years) 
Black (%) 
Female (%) 
Diabetes mellitus (%) 
Prior congestive 
heart failure (%) 
Prior MI (%) 
Left ventricular ejection 
fraction (admission)(%) 
In-hospital mortality (%l 
Quit smoking (6 months) (%) 
Return to full-time work (%) 
(6 months) 
~ H.S. < H.S. p-value 
55±1 59±1 < 0.001 
9 28 < 0.001 
21 37 < 0.001 
13 26 < 0.001 
6 
22 
47±1 
5 
49 
64 
12 
25 
46±1 
13 
38 
48 
< 0.01 
NS 
NS 
< 0.001 
< 0.05 
< 0.01 
48-month mortality (%l 17 36 < 0.001 
Adjustment for baseline differences accounted for 
the increased in-hospital but not long-term mortality 
among the less educated patients (p - 0.006 after 
adjustment). The long-term differences result at least in 
part from less successful modification of risk factors 
since the less educated patients were not as likely to 
quit smoking. More intensive risk reduction programs are 
needed for these high-risk patients. 
942·67 
Sex Differences in OutcOie Following the Onset of Overt 
Coronary Heart Disease: The Fraainghaa Study 
Joanne M. Murabito, Jane C. Evans, Daniel Levy, Fram•
ingham Study, Framingham, MA. 
We examined sex differences in risk for adverse out•
comes following the onset of cl inically overt coronary 
heart disease (CHD) in subjects who were enrolled in 
the Framingham Study in 1948. From 1951 to 1985 overt 
CHD developed in 741 men (mean age 62 yrs) and 580 
women (mean age 66 yrs). Presenting CHD events includ•
ed stable angina, unstable angina (UA), recognized 
myocard ia 1 infarct ion (RMI), and unrecogn ized myocar•
dial infarction (UMI). Cox model ing (adjusting for age 
and CHD risk factors) was used to examine the impact of 
gender on 10 year risk for MI and CHD death following 
each CHD presentation. Relative odds and 95% confi•
dence intervals (CI) for HI and CHD death in men vs. 
women are presented below for each CHD presentation. 
NI tHO Death 
DIm m II DIm m II 
Angina 2.20 (1.45, 3.34) 2.11 (1.33, 3.36) 
UA 1.42 (0.45, 4.49) 1.03 (0.31, 3.38) 
RHI 0.82 (0.43, 1.54) 0.90 (0.58, 1.39) 
UMI 1.04 (0.51, 2.14) 1.83 (0.96, 3.46) 
Important sex differences in outcome following the 
onset of CHD were observed. Men with new onset of 
angina had twice the risk for MI and CHD death compared 
with women, however, no sex differences in outcome were 
observed following UA. Although men and women shared 
comparable risk following RMI, men were marginally more 
prone to CHD death following UMI. 
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942-68 
An Open Infarct·Related Artery May Improve Long 
Term (5 Year) Survival In Certain Patients With 
Single Vessel Left Anterior Descending Coronary 
Disease 
Robert McCully, Faten EI-Zeky, Roger Vander Zwaag, K.B. 
Ramanathan, Jay Sullivan. Baptist Memorial Hospital and 
The University of Tennessee, Memphis, TN 
To assess the impact of infarct-artery patency on survival, we 
analysed longterm survival of patients with LAD (SO-100%) 
single vessel (RCA<E;O%, Circ<SO%, LM<2S%) coronary 
artery disease who were treated medically. The study group 
was selected from a cardiac disease registry consisting of 
21,786 consecutive patients undergoing cardiac 
catheterization. A closed LAD (99-100%) was present in 223 
patients and an open vessel (SO-98%) in 603. Five year 
survival (SYSR) was significantly better in those with open 
vessels (p=0.023). Of the 308 patients (MI group) with a 
history or EKG evidence of infarction who had no collateral 
formation, the difference in SYSR was found to be significant 
in patients aged less than 70 (open-94%, closed-81%, 
p==0.018). 
The MI group was divided into low «50%) and normal (~SO%) 
EF subgroups. The SYSR for patients with a low EF and an 
open artery (n=43) was 92%, compared to a SYSR of 81 % in 
patients with a low EF and a closed artery (n=S6) (p=NS). 
Patients with a normal EF had similar SYSR's; open 92% and 
closed 91%. 
Conclusion: This retrospective study suggests that longterm 
survival is adversely affected in medically-treated survivors of 
myocardial infarction with single vessel LAD disease and a 
closed infarct-related artery (compared to an open, but 
stenosed, artery) when there is (1) no collateral formation, or 
(2) LV dysfunction. 
942·69 
Long-term Mortality After Early Coronary Intervention Following 
Fibrinolytic Treatment With Streptokinase In Acute Myocardial In•
farction (Results of a randomized trial: SIAM·I). 
Bernd Hammer, Cem Ozbek, Jan Dyckmans, Semi Sen, Benno Hennen, 
Frank Bleymehl, Hermann Schieffer and the SIAM Study Group. 
Medlzinlsche Unlversltiitskllnik Homburg/Saar, Germany. 
324 pts with acute myocardial Infarction were treated with Intravenous 
Streptokinase « 4 hrs after onset of symptoms, t.500.000 U/1hr) in 13 
acute care hospitals and were centrally randomized by phone call to the 
university hospital In two groups during fibrinolysis: 
GROUP A: (Invasive strategy) CA with PTCA/CABS 14 to 48 hours after 
start of treatment and predischarge control CA. 
GROUP B: (control group) no CA within the first 21 days, unless there is 
evidence for Ischemia and predischarge CA. 
In Gr·A 14/158 (= 9%) pts, In Gr·B 10/166 (= 6%) pts died before hospi· 
tal discharge (n.s.) All other patients (n = 300; Gr·A: 144, Gr·B: 156) were 
followed for at least 24 months after randomization (24 . 53 months, Me· 
dian 35 months). 13/144 (= 9%) pts (Gr·A) and 14/156 (= 9%) pts (Gr· 
B) died after hospital discharge (2 • 40 months, Median 20 months after 
randomization). Median time between randomization and death was 21 
months In Gr-A and 18 months In Gr·B (n.s.). 
Cumulative number of deaths In Gr-A and Gr-B : 
Time Gr-A Gr-8 p-value 
< 14 hrs 3 (= 2%) 3 (= 2%) n.s. 
14·48hrs 9 (= 6%) 8 (= 5%) n.s. 
In·hospital 14 (= 9%) 10 (= 6%) n.s. 
after discharge 27 (= 17%) 24 (= 14%) n.s. 
CONCLUSION: The number of deaths after discharge up to three years Is 
comparable to the in-hospital mortality after myocardial infarction. There 
Is no difference In mortality after discharge between patients with an early 
coronary Intervention and patients with Initially a more conservative ap· 
proach. 
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943·59 
Training Effect Is Positively Correlated to Infarct Size 
in Post·myocardlal Infarction Exercise Training 
Magnus Heldal, Svein Sire, Jon Dale. Aker University Hospital 
and State Rehabilitation Institute, Oslo, NOIWay 
239A 
There is a large variation in effect of exercise training after 
myocardial infarction (MI), but most earlier works have failed to find 
predictors for training effect (TE). Purpose: To assess the predictive 
value on TE of 25 variables in pt history, in·hospital clinical data, 
medication and baseline exercise (BE) capacity; in an intensive, four 
week exercise training programme early after MI. Material: 105 pts, 
mean age 54 years, 79 % men, mean peak ASAT 200 un, 60 % Q. 
wave MI,75 % on beta-blockers. Method: TE defined as absolute 
increase in cumulated work (CW). Variables with significant 
correlation to TE in univariate analysis were correlated to TE in linear 
multivariate regression analysis with backwards variable selection. 
CW increased by average 49 %. Results in multivariate analysis: 
Parameter estimate p 
Peak ASAT + 0,042 0,0018 
Age • 0,530 0,0017 
Female gender • 10,6 0,0042 
Betablocked - 7,89 0,0241 
Not exercised to exhaustion at BE • 9,00 0,0124 
To further support the findings regarding the relation to infarct size, 
judged by peak ASAT, the maierial was divided into ASAT quartiles, 
giving a near linear positive correlation to TE. 
Thus, on the basis of five simple predictors a model can be created 
that predicts 33 % of the total variation in TE (r 0,33). In conclusion, 
patients with the larger Ml's should not be excluded from intensive 
ET since they seem to benefit most from such programs. 
943·60 
Incremental Prognostic Value or Dlpyrldamole.Ecbocardiography 
Test in Patients With Suspected Coronary Artery Disease 
Claudio Michelassi, Silva Severi, Patrizia Landi, Eugenio Picano. CNR Institute 
of Clinical Physiology. Pisa, IUlly. 
Aim of the study was to assess whether high dose 
dipyridamole.echocardiography test (DET: 2D·echo monitoring during 
dipyridamole infusion up to 0.84 mg/kg over 10') provides incremenUII prognostic 
infonnation with respect to historical variables. risk factors, maximal symptom 
limited bicycle exercise electrocardiography test (EET) and angiographically 
assessed coronary anery disease (CAD). We studied 391 consecutive patients (pts) 
with no previous myocardial infarction. All ptS underwent DET, EET and 
coronary angiography and were followed up for 26 ± 22 months. considering death 
and infarction as end·points. Criteria of positivity were: for DET, a transient 
regional dyssynergy absent in the baseline examination; for EET, an ST segment 
shift >.15 mVolt from baseline; for CAD. a luminal reduction ~50% in at least I 
major coronary vessel. There were 13 deaths and 7 myocardial infarcts during the 
follow up. Data were analyzed according to a clinically realistic hierarchy, 
whereby the individual variables were considered for inclusion in the Cox model 
in the same order in which they actually become available to the physician: fust, 
the historical·; second. the EET-; third, DET· and finally angiographic variables. 
According to this hierarchical analysis. the following variables were found to be 
independent and additive predictors of events: gender (X2=6.7. p<.OI). 
exercise·time (X2=9.95. p<.OI) and the Wall Motion Score Index (an integrated 
semiquantitative measure of extent and severity of the dyssynergy) at peak 
dipyridamole (X2 = 6.79, p<.O I). The number of coronary vessels narrowed ~50% 
was selected by univariate analysis, but not by multivariate analysis. 
Therefore, in pIS with suspected CAD and good resting left ventricular function, 
DET adds significant prognostic infonnation to that provided by historical and 
exercise electrocardiographic variables. Angiographic daUi supply redundant 
infonnation when non·invasive stress testing with BET and DET is considered for 
prognostic stratification. 
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943·61 
IDcrealed Tumor Necrosll Factor-a aDd IDterferoD-y 
SecretloD by MODoDuclear Leukocytes in Ischemic: Heart 
Dlleale 
Krishna Yaddj. Francesea A. Nicolini, Paulette Mehta, lawahar L. 
Mehta, University of Florida and VA Medical Center, Gainesville, 
FL 
To investigate cytokine production in coronary artery disease, 
we measured kinetics of secretion of tumor neurosis factor a (TNFa) 
and interferon-y (IFN-y) by mononuclear leukocytes from 5 control 
subjects, 10 patients with stable angina and 10 patients with unstable 
angina. Mononuclear leukocytes were isolated and stimulated with 
plant lectin mitogen concanavalin A (I Onglml) for 48 hrs. TNFa and 
IFN-y secretion were measured by ELISA. In preliminary studies, 
serum levels of TN Fa and IFN-y were not found to be different in the 
three groups. TNFa secretion by mononuclear leukocytes increased 
progressively over 48 hrs and the maximal value was consistently 
higher(P<0.02) in patients compared to control subjects (5.18±1.47 
and 5.70±1.50 ngll06 cells in stable angina and unstable angina 
patients, respectively, and 3.07±1.31 ngll06 cells in controls). IFN·y 
secretion by mononuclear leukocytes also progressively increased 
over 48 hra, and the secretion was greater (P<0.02) in patients 
(l86±52 and 208±57 unit~1 06 cells in stable angina and unstable 
angina patients, respectively, and 119±21 uniWI06 cells in controls). 
Release ofIFN-y from unstimulated cells was also greater (P<O.03) in 
patients with stable or unstable angina. There was no difference in 
cytokine secretion by mononuclear leukocytes from patients with 
stable or unstable angina. Also there was no relationship between 
severity of coronary disease by angiography or intake of medications 
and increased cytokine secretion. These cytokines promote 
coagulation, free radical generation, hemorrhagic necrosis and angio· 
genesis. Increased cytokine secretion by mononuclear leukocytes in 
coronary artery disease may playa role in the progression of 
atheroma. Similar increases in cytokine secretion in stable or unstable 
angina indicate that this phenomenon is not just a non-specific 
inflammatory response following acute myocardial ischemia. 
943-91 
Comparative Evolution of Spontaneous 
Obstruction of Tight Versus Mild Coronary 
Stenoses. A Long Term Angiographic Study 
Veronique Berder, Nicolas Danchin, Yves 
Juilliere, Christine suty-Selton, Nicolas 
Sadoul, Michel Cuilliere, FranQois Cherrier. 
Dept of Cardiology, CHU Nancy, France 
To study the impact of spontaneous obstruction 
of coronary stenoses of various severity, we 
retrospectively studied 30 consecutive pts 
(25M, SF ; age : 5S±12 years) with 2 coronary 
angiograms (angio 1 : baseline, angio 2 : 
follow-up) showing evolution towards total 
occlusion of the right or LAD coronary artery 
between angio 1 and 2. All pts had LV 
angiography in the RAO 30 0 view at both angios. 
Pts with intercurrent CABG/pTCA were excluded. 
Nineteen pts (gr1) had spontaneous occlusion of 
a mild coronary artery stenosis (0-50%) ; 11 
pts (gr2) had occlusion of a severe stenosis (> 
50%). At baseline, LVEF was 60± 14% in gr1 and 
58±11% in gr2. The time period between angio 1 
and 2 was similar in both groups (54±57 mths vs 
S8±43 mths, ns). During follow-up, 9 pts in gr1 
(47%) vs 2 in gr2 (18%) had an episode of MI 
(ns) ; LV angiograms showed worsening of 
regional wall motion in the occluded artery 
territory in 16/19 gr1 pts (84%) vs 4/11 gr2 
pts (36%)(p<0.02) ; decrease in LVEF from angio 
1 to angio 2 was -10±13% in gr1 vs -1±9% in gr2 
(p<O.OS) ; 9/19 gr1 pts (47%) vs 1/11 gr2 pts 
(9%) had> 10% decrease in LVEF (p<O.05). 
Spontaneous occlusion of tight coronary 
stenoses causes less impairment of LV function 
than occlusion of mild stenoses, presumably due 
to the protective role of collateral vessels. 
943-92 
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Does Low Level Carbon Monoxide Exposure Worsen 
Echocardlographlc Determined Le" Ventricular 
FunctIon at Rest and During Exercise In Patients 
With Ischemic Heart Disease? 
Liwa Younis, Sheila Byers, Patricia Lenzen, Thomas Dahms, 
Arthur Labovitz, Bernard Chaitman, St. Louis University 
Medical Center, St. Louis, Missouri 
The effect of low level carbon monoxide (CO) exposure on 
echocardiographic determined left ventricular systolic and 
diastolic function was eVAluated in 12 patients (pts) at rest (R) 
and during exercise (EX), all of whom had documented 
coronary artery disease. The pts performed symptom-limited 
treadmill EX in an environmental chamber before and after 
being randomly exposed to room air, and carbon monoxide 
which produced levels of 3.2%, and 5.2% carboxyhemoglobin 
(COHb) after 1-2 hours. Doppler echocardiography was 
performed at R and immediately post EX. The low levels of CO 
did not affect ventricular function at R or immediately post EX, 
HR (blmin) 
EF(%) 
ET(msec) 
PV(m's) 
EJA 
113 FF 
R 
64±14 
50±13 
101:.34 
.81:..3 
1.69:..5 
5O±11 
AIR 3.2% COHb 5.2"k COHb 
EX R EX R EX 
114:22· 62:13 119;t.19· 60:.11 116;t18· 
55:.14 49:.12 54:.14 47:.11 53;t13 
58:.25· 87:.20 57:.19· 103:.35 65:.39· 
1.1:..2· .87;l:..3 1.27;l:..4· .98;l:..3 1.28;l:..3· 
t.32±.4 1.6;t.3 1.5±.6 1.5±.3 1.4±.4 
38;t5" 47%.11 39;t.l0· 50±9 39±7· 
PV-Aortic peak veloc~y; ET -LV ejection lime; FF - Filling Fraction 
(·95% confidence lim~ R vs EX) 
Thus, in pts with documented coronary artery disease, low 
level CO exposure does not worsen left ventricular systolic or 
diastolic function as determined by Doppler echocardiography 
at R or immediately post EX. 
943-93 
Interleukin-': A Marker for coronary Artery 
Di.ea.e 
Jeffrey A. Leavy, Mark L. Barr, Charles C. 
Marboe, Eric A. Rose, Jerry Brett, David J. 
Pinsky and David Stern. Colwnl:>ia University 
College of Physicians and Surgeons, NY, NY. 
Many factors are involved in the development of 
coronary artery disease (CAD). Interleukin-6 
(IL-6) is a mi togen which induces PDGF 
production by smooth muscle cells and blood 
monocytes. In vitro studies of mice subjected 
to hypoxia and reoxygenation revealed IL-6 
production in the myocardium of hypoxic and 
reoxygenated mice, but not in normoxic animals. 
We therefore postulated that IL-6 might serve 
as a marker for the development of CAD in pts 
with and without CAD. The explanted hearts from 
10 pts with ischemic cardiomyopathy undergoing 
cardiac transplant were studied with 
immunOhistochemical techniques for the presence 
of IL-6 in myocardium and coronary arteries. 
Three pts without CAD were also identified and 
studied. All 10 pts with CAD had 
immunostainable IL-6 in myocardial sections; in 
6 of the 7 pts with coronary segments available 
for analysis, IL-6 was found within the medial 
layer and within the intimal plaque itself. No 
IL-6 was found in either the myocardium or the 
coronary arteries of pts without CAD. We 
conclude that IL-6 is a marker for the 
development of CAD. 
lACC Vol. 19, No.3 
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943·94 
DECREASED PLASMA CYCLIC GUANOSINE MONOPHOSPHATE 
CONCENTRATION IN PATIENTS WITH VARIANT ANGINA PECTORIS 
Takayoshi Tsutamoto. Toshiyuki Kanamori. Atsuyuki Wada. Osamu Yamaoka. 
Masahiko Kinoshita. Shiga University of Medical Science. Otsu. Japan. 
The mechanism of vasospasmus of the coronary artery in patients with variant 
angina pectoris (VA) has not been elucidated. We compared plasma cyclic 
guanosine monophosphate (cGMP). atrial natriuretic peptide (ANP) and endothelin 
(ET)-I concentrations in patients with exertional angina pectoris (EA) with organic 
coronary stenosis (>7S%) to those in patients with VA without organic coronary 
stenosis and with coronary spasm by ergonovine. 
cGMP ANP ET-I SSP PCWP RA EF 
(pmol/ml) (pg/mJ) (pg/mJ) (mmHg) (mmHg) (mmHg) (%) 
VA (n=12) 2.5} 29} 2.1 137 7.6 3.6 69 
EA(n=12) 4.8 57 2.3 131 6.4 2.6 70 
('; p<O.OS) 
There were no significant differences in hemodynamic parameters. such as systolic 
blood pressure (SBP). pulmonary capillary wedge pressure (PCWP). right atrial 
pressure (RA) and left ventricular ejection fraction (EF) between VA and EA 
patients. There was also no significant difference in plasma ET-I levels between 
the two groups but plasma cGMP and ANP levels in VA patients were significantly 
lower than in EA patients. 
cGMP is thought to be the second messenger of endothelium derived relaxant factor 
(EDRF) and ANP. Therefore. these results indicate that the lack of endogenous 
coronary vasodilators such as ANP or EDRF may cause vasospasmus of the 
coronary artery in patients with VA. 
943·95 
AnU-isciIaDic Effect of'Dleq:hylline: 
A OlrrJEllb:aticn-DepelJdEnt Iben:DeiUI 
Marilyn M. BarIxm", C. Ewin1 Gertler, Alan W. Ahlberg, 
Ila'lna J. ClCA.Itier, JOSE!Pl R. McClellan, GaIy V. 
Heller. Menm"ial Hospital, Brown University, 
Provideooe, ani the University of RI, ~, RI. 
'Iheqnylline has previOlSly been cleaalstratEd to delay 
the a1SE!t of isdlemi.a usin1 sin1le doses of the 
medication. It is unknown if a OCln::lentration-depen:lent 
respcn;e exists with t:hec:plylline. In a rarrlatdzed, 
crossover trial, 7 patients received intravenous saline 
placebo (PIAC) ani three doses of thec.¢ylline (as the 
salt, IIIIIinc:PlYlline) at 1 week intetvals. Mean 
oc:n:len1:ratioos achieved were low (3. 5IrgJL), medium 
(7.9Dr;!IL) ani high (14 .lng/L) • Bruce protocol exercise 
testing was performed at baseline (BASE) ani 
.imDediately foll~ the 45 minute (min) infusions. 
Tillie to 0.1 mV Err 
(n-6) (min) 
Tillie to An;j'ina 
(n=5) (min) 
Exercise D.lration 
(min) 
V02max 
(mlJkgfmin) 
BASE PIAC I.aiI MEDIUM HIGH 
4.7 4.3 5.0 6.1* 5.7* 
5.1 4.4 5.8 6.1* 
7.5 7.9 8.7* 8.9* 9.4* 
18.5 18.4 20.5* 21.0* 21.7* 
Peak Heart Rate 126 125 132 136* 140* 
* P<0.05, c::x:IIpBred to baseline 
Analysis revealed a quadratic dose-response cw:ve with 
the anti-isdlauic effect plateauin;J following the medium 
oc:n:len1:ration of 7. 99Dr;!IL. 
COoclusW: An anti-ischemic dose-response 
relationship exists with thec.¢ylline. unlike its use 
in bronchcspasm, the anti-isdlemic benefit ~ to 
plateau at oc:n:len1:rations less than 101!g/L. 
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943·96 
Proplonyl.L·C.,nHlne Preventa Metabollo and Hemodynamic: 
ColIMque.-e of Ac:ute Myoc:arllial lac:hemla In Man. 
Loui& Bartell. Willem RIIII1IM, Nicole Knulman. Zuidarzlekll'lhull and 
Stic:area Foundation. Rottardam. The Netherlands. 
L-c:amJtine ]a eaaentlal for mitochondrial fatly acid IIanIpOIt and ATP/ADP 
exchange. Repletion of ilehtmla-Induc:ed lola of L-oamJtine may limit 
myoc:ardial ilehtmia through enhar1c:ecI mltoc:honcliral fret CoA levels 
and pyrwate-ac:atate c:onvnon. Its derivative, propIonyI-L-c:annJtine 
(PLC) , may be lIIOI'8 optimal In thil rtspect, btc:aUSII of Its rapid ac:c:es•
aibility to the c:ardiocyte and a potentIaJ anapltrotlc eIIect through 
proplonyl CoA - aucclnyl CoA c:onvnon. In humans, long-term oral ael•
ministration of PLC limits exlll'Ciae-lnduc:ed ilehtmla. To investigate 
whether Iv PLC may alae: aflect acute myocardial 1Ic:hernIa, 28 fasting and 
untreated patill'ltl with left oc:ronaIY arteIy d"ae __ studied during 2 
IcIentic:aI Inc:rementaI pacing *- tea, 4S min before (P1) and 15 min 
after (P2) 15 mg/kg PLC or plaotbo (P and C reap, both n-13). Mer 
PLC. c:ardiac total c:annJtine uptake changed from ........ to a aignlfic:ant 
5O-fold uplake. No auch chang.. ocx:urrect with P. HemodynamiC. meta•
bolic: (myocardial lactate and hypoxanthine extraction) and nuclear 
angiographic: variables __ lludied at oontrol. during and for 10 min 
after pacing. All varlabl .. __ compIIIabie In P and C during P1 and ... 
producible In C during both testa. In PLC chang.. In h .. rt rate. double 
product, an Index of myocardial 0, demand, ooronary ftow and 0, eon•
lumption __ comparable beIwMn P1 and P2. PLC reduc:td pacing-In•
duced Jschtmia, objadlvated by a aignlfic:ant 15% and 50% reduction In 
ST depression and LV II'Id diastolic pressure. Moreover, LVejaction frag. 
lion Inc:raased by 16% during P2 (p<O.05 VI P1) and Ischemia-Induced 
aegmll'ltal wall motion abnormalitl .. dec:reased In all but 2 patill'ltl. Also. 
although PLC did not modulate myocardial lactate produc:tion. Ilgnlfic:ant 
hypoxanthine release during P1 (-3.1 :1:0.8 IlrnoVmin) was prevll'lted 
during P2. Furthtnnort, PLC Improved reoovery of myocardial function 
post-pacing with a 6% reduction In time to peak filling and a 23% 
Inc:reast In both peak ejection and filling rattl at 10 min post-pacing 
(p<O.05 VI P1). Thus, PLC reduces myoc:ardlal ilehtmla and prevll'ltl 
Ischemia-Induced ventrlcuiar dysfunction, not by aflactlng myocardial 0, 
lupply-damand. but presumably through Its Intrinsic: metabolic: actions. 
943·97 
Effects of Spinal Cord Stimulation on Left Ventricular 
Function in Patients with Severe Angina Pectoris 
Vuk Kujacic, Per Albertsson, HAkan Emanuelsson, Tore Eliasson, Clas 
Mannheimer, Lars-Eric Augustinsson and Dalia Jablonskiene. 
Division of Cardiology, Depatment of Neurosugery Sahlgrenska 
Hospital and Pain Section, Ostra HOSpital, GOteborg, Sweden. 
Spinal Cord Stimulation (SCS) has been intrOduced as an altemative 
treatment in patients with severe Angina Pectoris (AP) and who are 
not candidates for Coronary By-pass Surgery (CBS). We studied the 
effect 01 Spinal Cord Stimulation (SCS) on left ventricular function 
detected by eChocardiography (20 ECHO) at rest and during Adenosine 
Infusion (Adl) in: 
Group A:15 pts (14 men, mean age 64, range 49-70) with severe 
chronic post-CBS angina and angiographlcally proven widespread 
coronary atherosclerosis; 
Group B:9 pts (3 men, mean age 64, range 46-71) with Syndrome 
X (typical anginal chest pain, positive stress test, normal coronary 
angiography); 
Group C:10 healthy volunteers(10 men, mean age 29.range 20-54) 
Adenosine was infused in a peripheral vein In incremental doses to 
maximal 200j.lg/kg/min(average150j.lg/mllmin)and simultaneously 
20 ECHO was performed. The investigations without SCS in both 
groups of pts were compared with results obtained In group C. 
Results: 
EF rest EF Adl 
Group A 44 37'/1 
Group B 53 49'/1 
Group C 60 68' 
'rest vs. Adl; /lAd I vs. AdI+SCS 
EF rest+SCS EF AdI+SCS 
48 44' 
59 57' 
p 
<0.05 
<0.01 
<001 
In conccluslon: Adl induced left ventricular dysfunction associated 
with typical anginal chest pain In all patients with angina pectoris 
(group A and B), but in none in group C. SCS seems to have a 
protective effect on Adl induced ischemic LV dysfunction In both 
group 01 pts with severe angina pectoris. The mechanism of 
protective anti ischemic action of SCS Is not yet fully understood. 
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943·98 
Determination of the Hemodynamic Significance of 
Anglographlcally Intermediate Coronary Steno.e. by 
Intra coronary Doppler Flow Velocity 
Thomas J. Donohue. Morton J. Kern. Frank V. Aguirre. Calvin Bell. 
Danny Penick. Jerome Segal. Elizabeth Ofili. Richard Heuser. 
5t. Louis University Medical Center. 5t. louis. MO 
Determination of the clinical and hemodynamic significance of 
angiographically intermediate (40·60%) coronary stenoses is 
often difficult and inexact. A previously accepted criterion of 
lesion significance was a transtenotic pressure gradient of >25 
mmHg which required the use of Intracoronary catheters for 
pressure measurement. To assess the Intermediate stenosis. 
intracoronary flow velocity was measured (0.018" Doppler•
tipped guidewlre) in 33 patients. Group I patients (n.17) had 
gradients s25 mmHg and lesions s600/0. Group II patients 
(n.16) had gradients >25 mmHg andlor lesions l!80%. Flow 
velocity (cm/sec) waveforms were analyzed proximal and distal to 
the stenosis for average velocity (A V). diastolic velocity (DV). and 
the ratio 01 the proximal and distal average velocities IAYPlAym 
proximal Distal 
~ AY.. m£ AY.. m£ A'iPl&o 
Group I 1219 27±10 5H8 24±8 46±12 1.2±0.5 
Group II 46±20 37±24 62±23 11 ±7 20±8 3.S±I.3 
p valye 0001 NS NS 0001 0 001 0001 
Thare were no differences between groups in the proximal average 
or diastolic velocities. The distal average and diastolic velocities 
were both maintained in hemodynamically insignificant lesions 
with a maximum proximal to distal velocity ratio of 1.7. 
Significant stenoses were aSSOCiated with a loss of distal velocities 
with a minimum AVp/AVo of 2.3. These data demonstrate a new and 
easier method to determine the hemodynamic significance of the 
angiographically intermediate lesion at the time of diagnostic 
catheterization. 
943·99 
Acetylcholine-Induced Constrictor Responses of 
Anglographlcally Normal Coronary Artery segments 
Invariably Predict the Presence of Atherosclerotic Plaques 
Andreas M Zeiher. Stefan Hohnloser. Rainer Fritz. Thomas Bleile. 
Volker Schllchlnger. Helmut Drexler. Hanjorg Just. 
Medical University. Freiburg. F.R.G. 
In patients with angiographically smooth coronary arteries (CA). 
acetylcholine (ACh) has been reported to produce both vasodilation 
and constriction. To test the hypothesis that ACh-induced constric•
tion of smooth CA segments reflects early atherosclerosis not 
detectable by angiography, we prospectively compareg the v~o­
motor response (quantitative angiography) to ACh (1 ()' to 10- M. 
subselective infusion into the LAD) with CA wall morphology 
assessed by Intracoronary ultrasound (ICUS, 30 mHz. 5F catheter) 
in angiographically normal CA segments of 21 patients. In response 
to the highest dose of ACh. 18 CA segments dilated by 14.9±8.9%. 
whereas 96 CA segments constricted by -31.2±8.9%. At all sites 
with a dilator response to ACh. ICUS revealed either no evidence of 
coronary wall layering (N.7) or a 3-layer appearance with a thin 
echo-dense zone at the lumen·tissue interface and a very thin 
medial echo·lucent zone. Mean wall thickness (WTh = echo-dense + 
echo-lucent zone) was 0.19±0.11mm (N=11) at dilating CA sites. In 
all 96 constricting CA segments, ICUS demonstrated wall thickening 
due to increased thickness of the echo-dense zone at the lumen•
tissue interface. Wall thickening was eccentric In 48196 segments. 
11/96 segments had ultrasonic evidence of calcification. Mean WTh 
at constricting CA sites was 1.0±0.48 mm (p<0.001 vs dilating sites). 
There was no relation between the extent of WTh and the amount of 
ACh-loduced vasoconstriction. Thus. ICUS demonstrates that -up to 
a 10-6M dose· ACh-induced constrictor responses of smooth CA 
are invariably associated with coronary arterial wall thickening 
Indicating the presence of early atherosclerotiC lesions not 
detectable by coronary angiography. The Intracoronary infusion of 
acetylcholine,therefore. Is a highly sensitive test to delineate the 
presence of early coronary atherosclerotic disease. 
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944·100 
JACC Vol. 19, No.3 
March 1, 1992:242A 
Relation or Intraoperative to Postoperative DeftbrlIIation 
Threshold in Patients With a Nonthoracotomy Lead System 
Werner Jung. Matthias Manz, Rainer Moosdorf*, Christian 
Schneider·, Berndt Uideritz. Departments of Cardiology 
and Cardiovascular Surgery·, University of Bonn, Germany 
Patients (pts) undergoing implantation of a cardioverter/defi· 
brillator with a nonthoracotomy lead (NTL) system have, in 
general, higher or even marginal defibrillation thresholds (OFf) 
compared to pts with an epicardial patch·patch lead configura· 
tion. The purpose of this study was to determine the relation 
between the intraoperative and postoperative OFf in 16 pts who 
received an implantable cardioverter/defibrillator. OFf testing 
was performed intraoperatively and prior to hospital discharge 
after a mean follow·up 10+ /·3 days. After 15 s of ventricular 
fibrillation, the initial shock with an energy of 25 J was delivered. 
If successful, OFf testing was stepwise repeated using energies of 
20, 18, 15, 12, 10 and 5J until defibrillation was unsuccessful. 
Results: The mean intraoperative OFf was 22+ /·3.8 J (range 
from 15 to 25 J). The mean postoperative OFT was significantly 
(p<O.05) lower with 18+ /·2.5 J (range from 15 to 25 J). A de•
crease in defibrillation energy requirements could be documented 
in 11 of 16 pts. In 5 pts, no change in OFf occurred. 4 of these 
5 pts had acceptable OFTs ( < 18 J) at initial implantation. In one 
of these pts, the initial OFT was determined at 25 J. An increase 
in OFf could not be demonstrated in any of the pts. 
Conclusions: In this study, the defibrillation threshold (OFf) 
decreased postoperatively in a significant number of patients 
(pts) with a nonthoracotomy lead (NTL) system. Apart from one 
patient, a decrease in OFT was observed in pts with initial high 
OFTs only. Thus, the NTL approach should be considered in pts 
despite a borderline intraoperative OFf. 
944·101 
Antitach)"Cardia PacinI: in Defibrillators: Loss of Stimulation With Epi•
cardial Screw-in Le.ads 
J(irg~n Si~bels. Maik Jiirgensen. Karl H. Kuck. Univ~rsity Hospital Eppen•
dlllf. Hamburg. F. R. Gennany 
Since June 1989,38 pts (30 m; 8 f; 55 ± 13 yrs) received an implantable 
Pacer/CardioverterlDetibrillator (PCD; Medtronic Inc.) for recurrent ventri•
cular tachycardia/fibrillation. The underlying cardiac disease was coronary 
artery disease in 24 pts, hypertrophic in 2 and diiative cardiomyopathy in 9, 
armythmogenic dysplasia in one, and in 2 pIs there was no evidence of an 
organic heart disease. For pacing and sensing. epicardial screw-in leads 
(ESL) were implant~ in 13 pts and transvenous bipolar leads (fBL) in 25 
pt,. Intraoperatively (iop). 2 pts with ESL and 4 pt with TBL had a pacing 
threshold higher than requested (1.5 V for ESL; 1.0 V for TBL (0.5 ms 
pulse width)). One week after implantation. 2 pts with ESL (iop pacing 
threshold < 1.5 V) developed pacer exit block (PEB) with total loss of stimu•
lation (>5.4 V; 1.59 ms pulse width) for antibrady- and antitachycardia pac•
ing. Pacing threshold increased chronically in 3 other pts with ESL (2 pts 
iop pacing threshold < 1.5 V; I pt pacingthreshold > 1.5 V) with I total loss 
of stimulation after 12 month (> 5.4 V; 1.59 ms pulse width) and two partial 
loss of stimulation (:> 2.8 V; 1.59 ms pulse width) after 6 and 9 months. 
respectively. The 3 pIS with total loss of stimulation after ESL implantation 
underwent operative revision; 2 pts received new ESL, 1 pt TBL. Seven and 
12 months after ESL revision. the PCD had to be explanted in 2 pts because 
of system infection. During a mean follow-up of 16 ± 12 months, pacing 
threshold was unchanged in 8113 pts with ESL and 25/25 pts with TBL 
despite an high intraoperative pacing threshold in 4 pts. Conclusion: 3/13 
(23%) pts with ESL developed PEB with total, and 2113 (15%) with partial 
loss of stimulation for antibrady- and antitachycardia pacing. These 2 pts 
still have an high pacing threshold. After revision (3 pts), the PCD had to be 
explanted because of system infection in 2 pts with ESL. TBL is recom•
mended instead of ESL for PCD implantation to ensure full anti bradycardia•
or antitachycardia pacing capabilities of the device. 
JACC Vol. 19, No.3 
March 1, 1992:243A 
944-102 
Comparative Defibrillation Efficacy of Various 
Nonthoracotomy Lead Configurations 
Andrea Natale, Raymond Yee, George Klein, Mark Wathen, Kevin 
Wolfe. 
University Hospital, London, Ontario, Canada 
We examined the value of testing alternative triple electrode 
nonthoracotomy lead (NTL) configurations (C) involving a cutaneous 
patch (CP) when a totally transvenous lead system failed to achieve 
the required defibrillation threshold (DFT) for implantation 
(D FT ~18J). Fifty-one patients (pts) underwent implantable 
defibrillator NTL testing under general anesthesia. Defibrillation 
electrodes were placed in the right ventricle (RV), superior vena 
cava (SVC), coronary sinus (CS) and an adhesive CP on the left chest 
wall. Up to 4 NTL configurations were tested in consecutive order 
using the 3-electrode sequential pulse method until the DFT criterion 
was met. 
C I RV-, CS+l, SVC+2 
C2 RV-, SVC+l, CP+2 
C3 RV-, CS+l, CP+2 
C4 CS·, RV+l, CP+2 
n 
51 
19 
20 
14 
DFTs.18J 
18/51 (35%) 
6/19 (31%) 
9/20 (45%) 
7/14 (50%) 
Cumulative % 
35 
39 
51 
57 
When C2 was tested in pts where Cl failed, only 2 (10%) further 
pts met the implant criterion. C3 and C4 were acceptable for NTL 
implantation in 6 further pts (30% and 42% respectively) where Cl 
and C2 were not. In addition, with C4 3 pts (25%) were elegible to 
receive a defibrillator when all other C failed. 
In conclusion, 35% of candidates for an implantable defibrillator 
met the DFT implant criteria using a totally transvenous NTL 
configuration. Partially transvenous NTL configurations improved 
defibrillation efficacy allowing a conservative total success rate of 
57%, and should be tested when a totally transvenous NTL system is 
not acceptable. Replacing the SVC lead with a subcutaneous patch 
provides the most productive results. 
944-103 
Pacing Parameters and Myocardial Activation 
Sequence Using Epicardial Patch Electrodes 
Michael Rubart, Zak Vera, Edwin G. Duffin, Harald P. Pride, 
Douglas P. Zipes. 
Indiana Univ., Krannert Inst. of Cardiol., indpls., Indiana 
We hypothesized that ventricular pacing via large surface 
area epicardial patch electrodes (EPE) creates more 
homogeneous ventricular depolarization. We compared in 
5 ~ogs the. myocardial activation pattern during bipolar LV 
apical pacing (2-msec rectangular stimulus twice diastolic 
threshold via intramyocardial plunge electrodes) to that 
during pacing via EPE (model 6897 S, Medtronic) placed 
on the left (LV; cathode) and right (RV; anode) ventricles 
(pacing generator: model 1946 A, Medtronic, custom 
deSigned to pace into a 50 Ohm load; constant output: 5 V). 
ECG leads I, 1\ and III, bipolar electrograms (EG) from RV 
apex and 4-6 LV sites, and arterial blood pressure were 
simultaneously recorded. Pacing capture via EPE was 
achieved at pulse widths of 0.5 ms and sensing at 0.75 mV 
in all dogs. Pacing via EPE decreased QRS duration (130 ± 
10 msec to 85 ± 8 msec, mean ± SEM, p < 0.05), and the 
time from pacing stimulus to the RV-EG (83 ± 10 to 37 ± 9 
msec, p < 0.05) and to the latest LV-EG (56 ± 8 to 39 ± 8 
msec, p < 0.05) compared with bipolar pacing. Mean 
arterial blood pressure during pacing via EPE (71 ± 12.7 
mmHg) was not different from mean arterial blood pressure 
during bipolar LV pacing (77 ± 10 mmHg). 
Thus, pacing via EPE does not afford hemodynamic 
advantages compared to bipolar LV apical pacing but it 
results in a more synchronous depolarization of a large 
ventricular mass than bipolar stimulation of LV. EPE may 
facilitate sensing and pacetermination of ventricular 
tachyarrhythmias in implantable cardioverter I defibrillators. 
ABSTRACTS 
944-104 
High Defibrillation Thresholds (OFT) With 
Transvenous-Subcutaneous Defibrillation Leads 
Michael Block, Dieter Hammel, Frank Isbruch, Dietmar Wiet•
holt, Martin Borggrefe, Hans H. ScheId, Guenter Breithardt. 
Westfaelische WilhelmS-Universitaet, Muenster, Germany. 
Out of 43 pts, in whom implantation of transvenous•
subcutaneous (t.v.-s.c.) leads was attempted, 12 pts (28 %) 
had at least one failure of defibrillation at 20 J (high OFT) for 
all tested lead configurations. In 4 pts (3 on amiodarone = 
amio) with a high but none with a low OFT, VF could not be 
defibrillated for a prolonged time and intermittent cardiac 
massage was required. Pts with low and high DFTs differed 
with regard to ejection fraction (EF, p~.025) and amio therapy 
(p~.01) but not for age, presence of coronary artery disease 
CAD) orj>rior cardiac sur~eryJsurg}. 
OFT n EF[%) amio CAD surg age 
High 12 41±12 42% 75% 67% 56± 9 
Low 31 52±17 3% 68% 57% 52±17 
Average values for gender, weight, overweight and body 
surface showed no significant difference. Pts, in whom amio 
had been discontinued 158±238(5-976) days before 
implantation, showed significantly (pS.05) less frequent high 
DFTs (6/18 pts, 33%) than pts implanted on amio (5/6 pts, 
83%), but significantly more (p~.05) than pts never been on 
amio (1/19 pts, 5 %). Two pts on amio with borderline OFT 
during implantation showed a sufficient OFT after 
discontinuation of amio. 
We conclude that high DFTs with t.v.-s.c. leads are 
associated with depressed EF and amio therapy. 
Discontinuation of amio therapy should enable a higher 
success rate with t.v.-s.c. leads and reduce the possibility of 
hard to defibrillate episodes of VF during implantation. 
944-105 
Interaction aetween Magnetic Resonance IlIIaglng and 
Implantable Defibrillators 
Marshall s. Stanton, Wyatt Stahl, Joel E. Gray 
Mayo Clinic, Rochester, Minnesota 
Magnetic resonance imaging (MRI) has been shown to 
result in rapid cardiac pacing in animals with 
pacemakers but the mechanism is unclear. Further, the 
effect of MRI on implantable defibrillator systems is 
unknown. 
A model Simulating the human chest was created. Two 
pace/sense epicardial screw-in leads were connected to a 
500 ohm noninductive resistor (Ch 1) and two epicardial 
defibrillation patches were attached across a 50 ohm 
noninductive resistor (Ch 2). Voltages (V) generated 
during MRI scanning ~ere recorded on an oscilloscope. 
At baseline, with the steady state magnetic field of the 
MRI active, less than 2 mV of noise were recorded from 
both the pace/se\!ise and defibrillating leads. When the 
time varying field of the MRI was activated, voltages 
were induced wfth pulse width 1.6 ms, cycle length 37 ms 
and peak voltage that varied with the test situation: 
No leads 
Leads 
Leads + Ventak 1600 
Leads + Ventak 1700 
Ch 1 -,-V 
17.5 V 
12.2 V 
35 V 
Ch 2 
I8V 
28 V 
14 V 
20 V 
In conclusion, MRI generates voltages on implantable 
defibrillator lead systems with or without attachment of 
a pulse generator that are of sufficient strength and 
frequency to cause ventricular fibrillation. 
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945·106 
Acute Antiarrhythmic Efficacy of i.v. and Oral d·Sotalol in 
Patients With Sustained Ventricular Tachyarrhythmias 
Johannes Brachmann, Claus Schmitt, Wolfgang ScMls, Thorsten 
Beyer, Maria Montero, Thomas Hilbel, Birgit Enders,Wolfgang 
KUbler 
Department of Cardiology, University of Heidelberg, Germany 
The use of class ill antiarrhythmic drugs has greatly increased as a 
result of the CAST study. D-sotalol (d-sot) appears to be a promising 
class ill agent without major B-blocking activity but profound class ill 
potency. To evaluate the clinical efficacy of d-sot, 73 patients with a 
history of sustained vennicular tachycardia/fibrillation (VTNF) who 
were inducible into sustained VT/VF at the baseline 
elcctrophysiological study were investigated after i.v. d-sot (1.5 to 2.5 
mg/kg). 33 patients were also tested on oral d-sotalol (400 to 600 
mglday). Acute success of antiarrhythmic therapy was defined as 
suppression of inducible sustained VTNF. The overall success rate of 
Lv. d-sot was 41% (30n3) after a mean of 4.2 drugs failed to 
suppress inducibility prior to investigation of d-sot. The success rate 
for 1.5, 2.0 and 2.5 mg/kg Lv. d-sot were 43, 34 and 55% 
respectively. In 33 patients who were also tested using oral d-sot (400-
600 mgld), a concordant response was obtained in 80% (26/33) of the 
patients. Concordance was 75% for successful suppression and 89% 
for failure to prevent the arrhythmia induction. Torsade de pointes type 
VI was seen in 2 patients, one developed the arrhythmia after severe 
hypokalemia, the second patient after onset of acute left heart failure. 
Conclusion: Intravenous d-sotalol prevents induction of sustained 
VTNF in a significant number of patients who have failed 
conventional drug therapy. The response to intravenous and oral 
formulation was concordant in approximately 80% of the patients. 
Proarrhythmic effects were rare and possibly attributible to changes of 
the underlying disease process. D-sot appears to provide an effcctive 
antiarrhythmic Lv. formulation that is highly predictive of oral 
treatment using elcctrOphysiological testing. 
945·107 
Is IV Procalnamide Testing Clinically Useful For 
Predicting the Response to Subsequent Oral Drug Therapy 
In Patients with Sustained Ventricular Tachycardia? 
James H. Kappler, Stephen C. Hammill, Bernard J. Gersh, Marshall 
S. Stanton, Douglas L. Packer, Mayo Found., Rochester, Minnesota. 
The utility of the response to IV procainamide (PROC) during 
programmed stimulation (PES) to predict subsequent response to 
oral antiarrhythmic therapy In pts with sustained monomorphic 
ventricular tachycardia (VT) remains unsubstantiated. Therefore, 
to evaluate the predictive value of IV PROC testing at the time of the 
baseline EP study, we prospectively evaluated 111 pts with 
inducible sustained monomorphic VT who underwent PES. Each 
patient received 10·15 mg/kg of IV PROC and underwent repeat 
PES. Of these pIS, 21 were rendered noninducible with PROC, while 
90 had persistently inducible VT. There was no significant 
difference in age (66±16 vs 67±9), baseline VTCL (289=.60 vs 
269=.56), average PROC dose (13±3 vs 13±3 mg/kg), or LVEF 
(41 ±17 vs 33±12, p-.054). Multi·variable logistic regression 
analysis identified noninducibility following IV PROC (X2-13.9, 
pz.0002) and the presence of CAD (X2.4.8, p-.028) as the only 
predictors of subsequent non·inducibility on oral therapy observed 
in 33 pts. Age, sex, baseline VTCL, and LVEF failed to predict 
ultimate response. Nevertheless, the sensitivity of PROC 
noninducibility was only 42%, specificity 91%, + predictive value 
67%, and the· predictive value was 79%. Incorporating an LVEF 
>40% into the model marginally improved sensitivity to 64%, + 
predictive value to 78%, without changing specificity or • 
predictive value in this patient population. From this information, 
we conclude that although the response to IV PROC is predictive of 
subsequent non inducibility, this finding is insuffiCiently 
discriminating to be of significant clinical utility in managing an 
individual patienl. 
945·108 
lACC Vol. 19, No.3 
March I, 1992:244A 
Clinical Characteristics, Electrophyslologlc Observations, and 
Long·term Follow·up In Children and Young Adults with 
Prehospltal Ventricular Tachycardia or Ventricular Fibrillation 
Marc Roelke, Richard R. Liberthson, Hasan Garan, Jeremy N. Ruskin, Brian 
A. McGovern 
Massachusetts General Hospijal, Boston, Massachusetts 
One hundred and one consecutive patients aged 40 or less (mean 29, 
range 3-40 years), who presented from In7 to 8/91 wijh nonsustained 
ventricular tachycardia (VT,19), sustained VT (37), or ventricular fibrillation 
(VF, 45), underwent electrophysiology (EP) study, and were available for 
follow-up. Underlying cardiac abnormalities included mijral valve prolapse 
(16), Idiopathic dilated cardiomyopathy (16), myocardnis (5), and Long OT 
syndrome (5). Coronary disease andlor left ventricular aneurysm were 
present in 16 patients; 13 of these aged 35 or older. Other abnormalities 
included: congenital valvular disease (4), pre· or post-op Tetralogy of 
Fallot(4), RV dysplasia (3), transposHion post repair (2), Ebstein's anomaly 
(I), WPW (1), hypertrophic cardiomyopathy (I), and anomalous origin of the 
right coronary artery (1). No structural cardiac disease could be identnied in 
24 patients. 
Sustained VT was induced in 37 (37%) and VF in 14 (14%) during an 
electrophysiologic stUdy in the absence of antiarrhythmic drugs. Inilial 
treatment was Honer-directed or empiric therapy(30), anti-arrhythmic drug 
therapy based on the results of serial EP studies(56),or implantation of an 
automatic defibrillator (AleD, 10). Five patients had surgery alone. 
Eventually, 24 patients received AICDs. and 5 patients underwent cardiac 
transplantation. After a mean fOIlOW,Up of 55 months (range 1-156),29 
patients (29%) have had a recurrence of sustained VT, VF, syncope, 
appropriate AICD discharge, or death. Eleven have died (11%). 
We conclude that in this young population referred for EP evaluation. 1 ) 
VTNF resuHs from diverse cardiac abnormalities, 2) atherosclerotic 
coronary artery disease is an unusual cause of VTNF before age 35, 
3)sustained VT or VF in this group is frequently not inducible by 
programmed cardiac stimulation, and 4) since there is a high recurrence 
rate, management wijh aggressive therapy is appropriate. 
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946·109 
ATP·Sensltlve PotasSium Channel Opener Protects 
AutonomiC Denervation After Acute Coronary Occlusion 
Makoto Ito, Harald P. Pride, Douglas P. Zipes, Krannert Institute of 
Cardiology, Indiana University School of Medicine, Indianapolis, IN 
To Investigate the role of ATP-sensitive K+ (K-ATP) channels in 
modulating the autonomic denervation after acute coronary occlusion, 
we studied the effects of a K-ATP channel blocker, glibenclamlde (G), 
and a K-ATP channel opener, pinacidil (P) on efferent sympathetic 
response In anesthetized dogs. Each animal received either 
intravenous vehicle (V. n.l0). G (0.3 mglkg, n-7), P (0.15 mglkg 
bolus + 0.23 mglkg/hr, n-7) or both G and P (G+P, n.7) before 
diagonal branch (DB) occlusion with latex (OC). G, P and G+P did 
not affect baseline effective refractory periods (ERP) or sympathetic 
nerve stimulation (SS) induced shortening of ERP (~ERP) before OC. 
~ERP was unchanged at all sites basal to DB during OC. Denervation 
(~ERP s 2 msec during 55) apical to B was Significantly less In P 
(3/32 sites) and in G+P (4/34 Sites) than In V (14/41 sites) or In 
G (17/29 Sites) at 3 hr after OC. The ischemic area, determined by 
the ratio of the width of subepicardial infarction to the epicardial 
circumference of left ventricle using triphenyl-tetrazolium staining 
after 3hr CC, was not significantly different between 4 groups 
(14±8 % In V, 12±10% In G, 9±4 % In P and 9±3 % In G+P). 
Changes of ~ERP at Sites apical to DB are shown below as mean±SE 
('p<0.05 vs. V). 
AERP (msec) 
GROUp Before OC OC·30mln OC-lhr OC·2hr OC-3hr 
V(41 sites) 25±2 14±1 13±2 lal 9±1 
G(29 sites) 23±2 10±2 6±2' 6±1' 6±1 
P(32 sites) 29±2 18±1 17±2 17±1' 18±1' 
G+P134 sites) 22+1 14+1 l.'HI 12+1 12tl 
These results suggest that the K-ATP channel opener, P, may provide 
protection against denervation after acute myocardial 
ischemialinfarction. 
JACC Vol. 19, No.3 
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946·110 
Flecainide and Ischemia-Induced Ventricular Arrhythmias 
Marco Stramba-Badiale, Marina Lazzarotti, Mario Facchini, 
Peter J Schwartz. 
Clinica Medica 2, University of Milano, and Department of 
Medicine, University of Pavia, Italy. 
The CAST study has generated questions concerning the 
mechanisms of the proarrhythmic effects of flecainide 
(F). Premature ventricular contractions (PVCs), 
ventricular tachycardia (VT) and ventricular 
fibrillation (VF) can be induced in anesthetized cats by 
a 1 min left stellate ganglion stimulation during a 3 
min coronary artery occlusion. After 3 control trials 
yelding consistent results, 2 mg/Kg of F iv (n-16) were 
injected and 3 additional trials performed 
NO ARRHYTHMIAS PVCs VT VF 
Control 2 2 6 6 
Flecainide 0 0 16 0 
After F, the 4 cats with PVCs or without arrhythmias in 
the control trials, developed VT during ischemia and 
sympathetic stimulation; this VT was prevented by 
propranolol in 3 subsequent trials. F did not modify 
blood pressure but reduced heart rate by 22 ± 15 b/min 
(p<O.005). These data show that F has an antifibrillatory 
effect during acute myocardial ischemia, but does not 
prevent and may actually favor the occurence of VT. The 
latter, in case of a prolonged ischemic episode, may 
degenerate into VF. The detrimental combination of 
elevated sympathetic activity with the exacerbation of 
the ischemia-induced conduction delay due to F, may 
contribute to explain the mortality data in CAST. 
946·111 
Age Dependence of Nicotinic Sympathetic 
Ganglion Transmission in Neonatal Swine 
Brian D. Hanna and J. Andrew Armour, Dalhousie 
University, Halifax, NS, CANADA 
The hypothesis that nicotinic ganglionic 
transmission is deficient at birth and matures 
with age was tested by recording extracellular 
spontaneous activity (SA) of 148 intrathoracic 
sympathetic ganglion neurons in 36 chloralose 
anesthetized swine (1-85 days of age). 
The number of neurons with SA, and the 
reduction in SA caused by nicotinic ganglionic 
blockade (hexamethonium, 10mg/kg:HEX) increased 
with age (pS.05). In the neonate few neurons 
were affected by HEX but added B-adrenergic 
blockade (Timolol Img/kg) silenced most SA. 
Reflexly generated activity also exhibited 
maturational differences with HEX blockade. 
Cutaneous mechanoreceptor activation caused 
inhibition in the neonate and excitation in the 
oldest: both before and after HEX. Hypercapnia 
activated some neurons before HEX; HEX decreas•
ed this activation less in the young than in 
the old (pS.05). With some neurons cutaneous 
mechanoreceptor and hypercapnic excitation was 
changed to inhibition after HEX blockade. 
These data indicate: (1) neonatal swine 
exhibit nicotinic and non-nicotinic synaptic 
transmission in sympathetic ganglia; (2) 
nicotinic ganglionic transmission increases 
with increasing age; (3) non-nicotinic trans•
mission maintains most of the sympathetic 
ganglion SA in the neonate; and (4) a changing 
balance between nicotinic and non-nicotinic 
transmission may be involved in the maturation 
of sympathetic activity to reflex activation. 
ABSTRACTS 245A 
946·112 
Flecainide Acetate InhIbits CalcIum-Independent Tranlient Outward 
Potassium Current in Single Rat Ventricular Myocytes 
Jacques Mansourati, Bruno Le Grand, Edith Deroubaix, Edouard 
Coraboeuf. Physlologie Comparee, University of Paris XI, Orsay, France. 
A novel effect of flecalnlde acetate (F), the inhibition of calclum•
independent component of transient outward potassium current, Ito 1 or 
110' was investigated in Single rat ventricular myocytes using the whole cell 
patch clamp technique. 
Under current clamp conditions, therapeutic equivalent 
concentration of F (5 10-6 M) prolonged markedly the action potential 
duration. At higher doses (10-4 M) myocytes where no more excitable but 
F effect was still reversible. In voltage clamped myocytes, F, In the 
concentration range 10-8 M- 10-2 M, reduced 110 In a dose-dependent 
manner (apparent dissociation constant = 3.510.5 M ; Hili coefficient = 
0.75) and accelerated the decay of the current at all potentlels. This effect 
display little or no use·dependence and was slowly reversible. At 5 10-6 M, 
5 min after washout, current recovered by .. 75 '!Eo. At this concentration, F 
did not modify current time to peak and did not affect steady-state 
Inactivation curve. 
Our results show that, In addition to Its effects on the fast sodium 
current and the slow Inward calcium current, F reduces the calclum•
Independent component of transient outward potassium current. This 
effect must be taken Into account In the comprehension of the anti and 
prosrrhythmlc properties of F. 
946·113 
Comparison of ATP·sensltive K Channel In Atrial vs Ventricular 
Myocytes of Guinea-pig, 
Robert T, Tung, Win K, Shen, Yoshihisa Kurachl. 
Mayo Clinic, Rochester, MN 55905 
Depletion of Intracellular ATP activates a specific K+ channel 
(KATP) In cardiac myocytes, To elucidate the possible differences 
of the channel in cerdiac atrial and ventricular tissues, we studied 
the density and properties of KATP channel In gulnea·plg atrial 
and ventricular cells, using the Inside-out patch clamp technique, 
Upon formation of Inside-out patch, spontaneous KATP channel 
activity rarely appeared In atrial cells (5/40 patches), 
However, UDP (10 mM) consistently Induced 1-2 level openings 
of KATP channel In the same patch, In ventricular cells, 4-7 
levels of spontaneous openings were usually observed Initially 
when inside-out petches were formed. The spontaneous channel 
openings ran down gradually In ATP·free Internal solution, 
probably due to channel de-phosphorylation. After complete 
rundown, UDP (10 mM) Induced 4-7 levels of the channel, The 
unitary conductance and the kinetlcel properties (mean open and 
close times) were similar in both atrial and ventricular cells, In 
conclusion, (1) KATP channel In atrial cells may be mostly de•
phosphorylated, (2) the density of KATP channel Is significantly 
smaller in atrial than in ventricular cells. (3) conductance and 
kinetic properties are the same. These findings suggest that 
ischemia and various potassium channel openers may have 
different effects on atrial and ventricular cells, 
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947·89 
Negligible EfI'ects of Moderate Food Intake and Meal Composition 
on Exercise Performance 
Khusrow Niazi, Susan Wetherbee, Kim Bonzheim, Ronald Bestervelt, 
Seymour Gordon, Barry Franklin, Gerald Timmis, William O'Neill. 
William Beaumont Hospital, Royal Oak, Michigan 
Previous exercise studies suggest that food intake may alter substrate 
utilization, functional status, and ischemic EOO threshold. Methods: To 
clarify the effects of moderate food intake (- SOO calories) and meal 
composition on exercise performance, we studied 8 men with ischemic 
heart disease (i:t SD age = 68:t 8 yrs) who performed the Bruce treadmill 
protocol after fasting, high carbohydrate (CHO) and high fat (>60 % 
calories) meals, presented in randomized order. Exercise tests were 
conducted at the same time on different days, 30 min after eating. 
Metabolic data were obtained by an automated gas analysis system. 
Results: Mean (:t SD) aerobic capacity (VO iDax), peak respiratory 
exchange ratio (RER), double product at the onset of ischemic ST 
depression (DP at ST ~), peak DP, time to onset of ST ~ (T to ST ~), and 
peak exercise duration (PED) were: 
VariablelCondition· EM!i!!&. ...9IQ. .hL-. 
VOiDax (METs) 4.8tO.9 5.2tO.8 5.1tO.9 
RER 0.9tO.l LOt 0.1 0.9t0.1 
DP at ST ~ 181:t28 162t33 167t32 
Peak DP 206:t20 203:t42 210:t38 
T to ST ~ (sec) 264t65 269:t9O 214:1:89 
PED (sec) ~!Z2illl 443t 155 
·For all variables, P = NS for fasting vs CHO or faL 
Cardiorespiratory, hemodynamic, and ECG responses, including ST ~ and 
arrhythmias, were unaffected by the ingestion of food. 
Conclusion: Moderate food ingestion has little if any effect on 
submaximal and peak exercise performance, regardless of the meal 
composition. These fmdings challenge a widely held methodologic 
proscription. 
947·90 
Significance of Exercise Induced ST Depression in Patients 
with Mitral Stenosis. Anil Mehra, William Stellar, Julio F. 
Tubau, Y. Jeffrey Chen, David T. Kawanishi, Shahbudin H. 
Rahimtoola. LAC+USC Med. Center. Los Angeles, CA. 
Exercise induced ST depression (ST .I.) is not uncommon in 
PTS with mitral valve (MV) stenosis (MS) but its significance 
and causes remain unknown. Therefore, we studied 22 
consecutive PTS with clinically significant MS using 
symptom limited treadmill exercise and invasive cardiac 
hemodynamics obtained during the same hospitalization. 
Excluded were PTS not in sinus rhythm and those on 
digitalis. All PTS had normal coronaries at angiography. 
PTS with STJ. (Group 1) were of similar age (3U10 vs 
38±11 years) and exercised similarly (37U180 vs 449 
±182 seconds) than those without ST J.(Group 2). Group 1 
PTS exhibited significantly smaller MV area (MVA) than 
Group 2 PTS (0.9 ±0.22 cm2 vs 1.2±0.27 cm2 respectively, 
p<0.02). Out of 17 PTS with rest and exercise 
hemodynamics only MVA and baseline MV gradient 
differentiated both groups but none of the exercise 
hemodynamic variables did. 
Group 1 Group 2 
(n-7) (n=10) 
Peak heart rate (beats/min) 109±14 114±20 
Peak BP (mmHg) 124±15 139±18 
Peak PAP (mmHg 90±13 82±32 
Peak PAWP (mmHg) 45±8 42±11 
Peak CI (Vm2) 3.5±O.56 3.8±0.56 
Peak MV gradient (mmHg) 29±7 26±8 
Thus, MVA but none of the exercise hemodynamic 
variables was predictive of the development of STJ. during 
exercise. Its mechanism, however, remains unresolved. 
947·114 
JACC Vol. 19, No.3 
March 1, 1992:246A 
Left Ventricular Hypercontractility and ST Segment 
Depression in Patients with Syndrome X 
Dimitris Tousoulis, Tom Crake, David Lefroy, Juan Carlos 
Kaski, Eugene McFadden, Alfredo R. Galassi, Altilio Maseri. 
Royal Postgraduate Medical School, London, England. 
The pattern of left ventricular function, exercise capacity and 24 
hour ambulatory electrocardiographic monitoring were studied in 
37 patients (pts) (9 male, 28 female, mean age 52±7 years) with 
syndrome X (angina with nonnal coronary arteries and a positive 
exercise test) and in II nonnal subjects (6 male, 5 female, mean 
age 49±4 years). All pts had nonnal echocardiograms and resting 
electrocardiogram (ECG). All treatment was discontinued for ~48 
hours. Left ventricular ejection fraction was detennined by 
computerized analysis (CAAS system). In pts with syndrome X 
exercise duration and heart rate were measured at 1 mm ST 
segment depression and at peak exercise. Left ventricular 
hypercontractility (ejection fraction ~80%) was observed in 12 
(32%) pts (group 1) whereas 25 (68%) had nonnalleft ventricular 
contraction (group 2). The time to Imm ST depression was 
significantly earlier in pts with left ventricular hypercontractility 
than the remaining pts with syndrome X (5.13±1.03 vs 
1O.76±0.63 min. p<O.OOI). Similarly the ST segments 
depression at peak exercise was significant greater in the 12 pts 
with left ventricular hypercontractility compared with the 
remaining pts with syndrome X (2.03±O.2 vs 1.33±O.05 mm 
respectively, p<O.05). Linear regression analysis showed a 
significant correlation between the magnitude of ST segment 
depression on exercise testing and the ejection fraction (r=0.53, 
p<O.OOI). Mean circadian variation of heart rate and episodes of 
ST segments depression on 24 h ambulatory ECG monitoring 
were similar in the two groups of syndrome X. 
These findings indicate that in patients with syndrome X left 
ventricular hypercontractility predicts a greater severity of ST 
segment changes during exercise test. 
947·115 
Gender and Onset of Significant ST Depress'on in Relation to 85% Predicted 
Maximal Heart Rate as Predicton of Exerd; ! Thallium Results 
Neil Coplan, J1isa Wallach, Mark Eskenaz" Eugene DePasquale, Gilbert 
Gleim. NISMAT and Cardiology Section, Lenox Hill Hospital, N.Y. , N.Y. 
Abnormal EKG stress tests are often followed-up with exercise thallium 
tests. This study evaluated how the onset of significant ST depression 
above or below 85% predicted maximal heart rate (PMHR= 220-age) 
affects the likelihood that EKG abnormalities are associated with 
reversible thallium defects. The SPECf Thallium-201 scans of 250 patients 
undergoing symptom-limited exercise were reviewed. The study group 
included 125 men (mean age 57) and 125 women (mean age 59); men and 
women had similar incidence of prior MI, FTCA, CABG, hypertension, and 
use of cardiac medications. Admission criteria included the absence of 
baseline ST abnormalities and the presenre of Significant exercise-related 
ST depression ~1 nun horizontal or downsloping ST depression). Patients 
were stratified according to gender and whether onset of Significant ST 
depression was first noted above 85% PMHR (ST>85%, n -126) or below 
85% PMHR (ST<85%, n=124). The pr~sence of reversible thallium 
abnormalities (POS) or absence of reversib', thallium abnormalities (NEG) 
was determined for each group: 
Women 
Men 
POS 
NEG 
POS 
NEG 
SI'>85% PMHR 
10 
53 
26 
37 
ST<85%PMHR 
28 
34 
44 
18 
Women with ST>85% were significantly more likely to have ST depression 
in the absence of reversible thallium defe.:ts than women with ST <85% 
(84% vs 55%, P<.OI). Men with ST<85% were significantly more likely to 
have ST depression asSociated with reversible thallium defects than men 
with ST>85% (71% vs 41%, P<.OI). Qmciui.QD.: Noting whether onset of 
significant ST depression occurs above or below 85% PMHR significantly 
improves the ability to predict likelihood of abnormal thallium scans, 
particularly for women with onset 'If Significant ST depression 
>85%PMHR and for men with onset of Significant ST depression <85% 
PMHR. This should be considered when <leciding whether patients with 
an abnormal exercise EKG need additional testing. 
JACC Vol. 19, No.3 
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947·116 
Should ST Depression be Measured at Zero (STO) or Sixty 
Milliseconds (ST60) After QRS? 
Michael Rodriguez, Minas Kochumien, Jeffrey Froning, 
Victor Froelicher. Long Beach VA Medical Center, Long Beach, 
California 
Differences In the diagnostic performance of ST scores could be 
due to the choice of the point for measuring ST displacement. 
In order to evaluate this, we analyzed the stored digital exercise 
data on 147 men who had undergone exercise testing and 
cardiac catheterization. With significant CAD defined as > 70% 
stenosis, 95 patients had one or more vessel diseased. None 
were receiving digoxin, had a myocardial infarction, or exhibited 
LBBB, LVH, Q waves or ST depression on their resting ECG. ST 
measurements were made at STO and ST60 with slope 
measured between. Anaiysis was performed using our own 
averaging and measurerr ent software at rest, two minutes before 
max, maximal exercise, and 3.5 minutes into recovery in leads II, 
V2, and V~. ROC curves were formed for measurements at max 
for STO and ST60 withoUt slope considered, after dividing by 
delta heart rate (ST/HR index), forthe greatest depression at STO 
in exercise or recovery when slope was abnormal (traditional 
method) and for the ST60/HR slope over the last two minutes of 
exercise. The following areas were obtained: 
STO .5926 
ST60 .6326 
STO HR Index .6352 
ST60 HR Index .6593 
ST60/HR Slope .5680 
Traditional Method .7196 
Conclusion: The measurement point does not appear to affect 
performance of the ST/W~ index, however traditional methods 
considering slope outper'orm all other methods. 
947·117 
Exercise Induced QRS Prolongation In Coronary Artery 
Dlsease·A Marker of Myocardial Ischemia. 
Andreas Michaelides, James M. Ryan, Douglas VanFossen, 
Harisios Boudoulas. The Ohio State University, Columbus, 
Ohio. 
Although It is known that myocardial ischemia may 
decrease conduction velocity, the effect of myocardial ischemia 
on ORS duration has not been completely evaluated. 
One hundred and fifty patients who had coronary 
arteriography and exercise radionuclide ventriculography for 
evaluation of chest pain were studied. 
The ORS duration decreased with exercise in patients with 
normal coronary arteries (n=40) but prolonged in patients with 
coronary artery disease. ORS prolonged in 50% (n=32), 53% 
(n=40) and 63% (n=38) of patients with 1, 2, and 3 vessel 
disease respectively. 
Likewise the ORS duration decreased with exercise in 
patients with normal exercise radionuclide ventriculography 
(n=93) but prolonged in patients with exercise induced 
segmental contraction abnormalities. ORS prolonged in 68% 
(n=22); 92% (n=25); and 100% (n=10) of patients with 1, 2, 
and 3 segmental contraction abnormalities respectively. ORS 
prolongation was best related to segmental contraction 
abnormalities than to number of vessel disease (p < 0.01). 
Thus, exercise induced ischemia decreases conduction 
velocity in the ischemic myocardium which is manifested on the 
electrocardiogram as ORS prolongation. 
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948·82 
prognostic Value of Exercise 'rtIa1liUIII Testinq in 
WClDen with Normal Rest Electrocardiograms 
Gail E. Semigran, Natalie R. Trudeau, 
Marc J. Semigran, Charles A. Boucher 
Massachusetts General Hospital and Harvard Medical 
School, Boston, MA 
The low overall prevalence of coronary disease (CAD) 
in women may lead to underestimation of itl presence 
in women presenting with suspicious Iymptoms. To 
assess the prognostic value of exercise (ex) ECG VI. 
thallium imaging (THAL) in women with normal rest 
ECG, 156 such patients (pts) were followed 37 ± 13 
(mean ± SO) months after testing. Eighty percent had 
anginal history and 14% had chest pain during ex. Pts 
achieved 94 ± 12% of age predicted maximum heart rate 
(HR). Of 19 with abnormal 'I'IIAL (persistent or 
redistributing defect), 8 (42%) had abnormal ex ECG 
(> 1 mm ST seqment depression). Of 136 with normal 
THAL, 36 (26%) had abnormal ex ECG. Seven of 156 pts 
(4%) had events during follow-up (1 myocardial 
infarct, 6 angioplasty or bypass surgery and no 
deaths). The relation of test results to events was: 
Sensitivity 
Ex ECG 28% 
THAL 71%* 
('p < 0.05) 
Specificity 
72% 
90%* 
Predictive value 
+ 
5% 
26%· 
95% 
99% 
All events occurred in the 44 women with ex HR < 90% 
of age predicted maximum. In this group, predictive 
value positive increased for both ex lCG to 14% and 
for THAL to 45% (p < 0.001). Therefore, in women 
with suspected CAD and normal rest ECG: 1) Cardiac 
events are rare, particularly if > 90% predicted HR 
is achieved with ex; 2) THAL had acceptable 
sensitivity and specificity; 3) Ex ECG alone had too 
many false positive and negative results to have 
prognostic value. 
948·83 
247A 
SIGllEHTAl. AJIl) DIAGIIOSTIC COMPARISON or ''-orC-DBOROltIlIB 
AJIl) 2°1.:uu.IUN PLANAR 1Ilr00000IAL PBIlPUSION IMAGING 
(CANADIA!I NUI.TICEIITRIl CLINICAL TRIAL) 
Raymond Taillefer, Michael Freeman, David Greenberg, 
Michel Picard, Felipe Chen, Fran~oi. Lamoureux, Dennis 
Humen, Reinhard Kloiber, Juan Friede, Anthony Fung, 
Leonard Rosenthal, Mark Rabinovitch, Fran~oiB Sestier, 
David Greyson, Franchco Ing. HOtel-Dieu de Montr6al, 
Qu6bec, and other participating canadian centre •• 
99~c-Teboroxime (TIBO) was compared to 201Thallium (TL) 
planar myocardial perfusion imaging in a prospective study 
performed in 10 Canadian centre., to evaluate the .egmen•
tal and diagnostic agreement. One hundred and forty-two 
patients (mean age: 56 yr.) referred for the evaluation of 
chest pain (except for 6 normal volunteers) were submitted 
to two treadmill stress tests within 3 weeks. The level 
of stress was similar for the 2 testa. Planar imaging (3 
standard views) was performed at 5 minute. and 3.5 hours 
after injection of TL (2.3 mCi) and 2 minutes after injec•
tion of TIBO (13-23 mCi) at stress. Two hours later, a 
second injection of TEBO (16-28 mCi) was given for the 
study at rest. Blinded reading waa performed by 4 obeer•
verso The left ventricle was divided into 3 segments in 
each view. Segmental analysis and patient diagnosis were 
then compared using 3 categories: normal, iechemia, scar. 
There was agreement between both agents in 77' of the seg•
ments (978/1265) (13 segments not evaluable on the TlBO 
study). Segmental analyeis wu as follows (TL/TIBO): 
927/984 normal, 248/208 ischemic and 90/73 ecars. Pa•
tient diagnosis was concordant in 103/142 (73\). TL/TIBO 
studies were normal in 47/55 patient., ischemic in 82/75 
and scar in 13/12 patients. In conclusion, although this 
was an initial experience with TIBO, both agents showed a 
relatively good correlation. 
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948·84 
Detection of Reetenosis after PTCA: must Exercise ECG be 
supplemented by a more definitive test? 
Roberto Casanova,Elisabetta Varani,Marco Balducelli, 
Annalisa Patroncini,Mauro Fabbri,Aleardo Maresta 
Servizio di Cardiologia,Ospedale per gli Infermi,Faenza 
Italy 
The best non invasive test to detect restenosis after 
PTCA is still undefined as well as its exact timing after 
the procedure. This prospective study was aimed at the 
detection of restenosis assessed with coronary 
angiography utilizing angina,exercise Bnd Oypiridamole 
thallium scintigraphy (EX-TL and OP-TL) and exercise ECG. 
41 of 43 consecutive pts with successful I single vessel 
PTCA had reangiography at 6 months and EX-TL along with 
OP-TL shortly before angiography. Restenosis (~70% 
narrowing and/or). 50% loss of gain) wes present in 17 pts 
(41%);no progression of disease was detected.Angina, 
reversible thallium defects and ST depression). 1 mm were 
considered abnormal responses. 
SENS SPEC PPV NPV AC 
ANGINA 28% 96% 93% 63% 66% 
EX-ECG 22% 87% 57% 59% 59% 
OP-TL 100% 87% 86% 100% 93% 
EX-TL 67% 91% 86% 78% 80% 
SENS=sensitivity;SPEC=specificity;PPV,NPV=positive and 
negative predictive value;AC=accuracy 
Exercise ECG is the least whereas OP-TL is the most 
predictive of all tests. Since the latter reveals hypo•
perfusion rather than ischemia, it seems the better tool 
to discover less than critical narrowing. Positive EX-TL 
is a marker of ischemia and is required to identify 
lesions that need redilation. 
948·85 
Comparison of Exercise ST Segment Depression and SPECT 
Thallium Imaging in Diagnosis of Coronary Artery Disease in 
1I0men 
Joseph Lemlek, Jaekyeong Heo, Virginia Cave, Abdulmassih S. 
Iskandrian, Philadelphia Heart Institute, Presbyterian 
Medical Center, Philadelphia, PA 
This study using currently available technologies 
examined the results of exercise ECG response and SPECT 
thallium imaging in diagnosis of coronary artery disease 
(CAD) in 217 women who underwent both exercise testing and 
coronary angiography within six months. There were 147 
patients with CAD (~ 50% diameter stenosis of one or more 
coronary arteries) aged 63 ± 9 years and 70 patients with 
no CAD aged 61 ± 11 years. 
In patients who exercised adequately the sensitivity of 
the exercise ECG was 46% (12 of 26) in one-vessel CAD and 
63% (24 of 38) in multi-vessel CAD while the sensitivity of 
SPECT thallium was 58% (15 of 26) and 87% (33 of 38) 
respectively ( P:NS, P - 0.02 vs. exercise ECG). The 
specificity of the exercise ECG was 59% (22 of 37) and of 
SPECT thallium, 73% (27 of 37) (P - NS). 
The remaining 116 patients (53% of patients) had non 
diagnostic exercise ECG responses. In these patients the 
sensitivity of exercise SPECT thallium was 4S% (16 of 33) 
in one-vessel disease and 7S% (39 of 50) in multi-vessel 
disease. The specificity was 64% (21 of 33). 
Thus, the exercise ECG is a poor marker of CAD in women. 
SPECT imaging is more reliable especially in patients with 
multi-vessel disease and patients who attain a good level 
of exercise. The sole reliance on exercise ECG may explain 
why less women with CAD undergo coronary angiography. 
Further, the low sensitivity of SPEcr imaging in one-vessel 
disease and suboptimal exercise suggests the need for 
alterative techniques such as pharmacologiC stress testing. 
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·FALSE POSITIVE" THALLIUM-lOI SCANS ARE DUE TO EASILY 
DISCERNABLE ARTIFACTS AND DO NOT LEAD TO 
UNNECESSARY CORONARY ANGIOGRAPHY 
Rene L. Desmarais. Sanjiv Kaul, Denny D. Watson. George A. Beller. 
University of Virginia. Charlottesville, Virginia 
It has been argued that a high false positive rate on exercise TI-
201 imaging may lead to unnecessary coronary angiography. We 
hypothesized that most "false positive" TI-20t scans are due to artifacts 
which can readily be identified and do not lead to coronary 
angiography. Accordingly. we reviewed data from 338 consecutive pa•
tients with ~ I focal TI-201 defects on quantitative planar images. There 
were 265 patients with either known CAD. previous MI. or undiagnosed 
chest pain who demonstrated TI-201 defects judged to be considered 
nonartifactual readings. Of these, t67 had coronary angiography. with 
161 (96%) showing CAD (~SO% stenosis). Of the 6 patients with nor•
mal coronary angiography, 4 had prior documented MI. The remaining 
73 pts (85% female) had TI-201 defects thought to be artifactual on 
clinical readings. Chiefly due to breast and diaphragmatic attenuation. or 
variants of normal (e.g., exaggerated apical thinning). 
Of the 73 patients with "false positive" thallium-201. only 4 (5.5%) 
underwent coronary angiography; none had CAD. One had aortic 
stenosis and two had variant angina. Follow-up (7.4 months) of 66 of 
the 69 patients not having coronary angiography in this group revealed 
no deaths and I (1.5%) nonfatal MI. While the majority of all 
patients (58 % with documented CAD on angiography and 5 I % with 
"false positive" TI-201) had nondiagnostic exercise EKG, only 4% with 
"false positive" TI-201 had positive exercise EKG compared to 30% 
with true positive TI-201. p <0.001. 
Thus. we conclude that: a) most false positive tests on TJ-201 
imaging are due to artifacts which can be readily identified by 
experienced interpreters; b) such patients seldom undergo coronary 
angiography; and. c) the incidence of organic heart disease is high in 
patients with thallium-2ot images which are truly (not due to artifacts) 
false positive for angiographic evidence of coronary stenosis. 
948·87 
Tampo ... 1 Ralatlon 0' Chllng .. In Myocardial uctata .nd Nucleoside 
Metabollam, ECQ P .... mata .... nd Regional Cardiac Function during 
Plclng·lnduced St_. Velue 0' Radlonucllda Imaging In the Early 
Detection 0' \achamla. 
Louis Battell, Wlilam Remme, Dirk SchOnfeld. Mike PUlay, Pater Cox. 
Zuiderziakllllhuis and Stica,. Foundation, Rotterdam, The Nathet1ands. 
BasId.. ST Hgrnant chang.. (ST), generally conaIdared the gold llancl•
.rd for Ischemia dataclion, myocardial metabolic chang.. are particularly 
IIIIIsitive and apec:ific as indicators, but need some time to develop. To 
evaluate whather regional cardiac function changes determined by radio•
nuclide techniqU811 are more aenaitive In the eatty detection of Ischemia, 
26 nonnotensive patients with left CO/Onary artery disease und-.nt ill•
cramenteI atrial pacing (10 bealsl2 min) until definite angina, A-V block or 
• maximal rate of 170 mln-'. Paired attarlal .nd CO/Onary venous sam•
pling for lactate (Ll and hypoxanthine, ECG monitoring and multigated 
blood pool seaMing was carried out at control (C), at 100 and 120 min·', 
during maximal pacing and for 10 min after pacing. Nuclear angiographic 
paramaters included ejection fraction (EF, %), new wall motion abnonna~ 
Ities (NWMA: the number of legments with >5% points decrease In sec•
torial EF out of a total of 9 legments), peak ejection rate (pER,sec·'), time 
to PER (TPE,msec) , peak filling rate (PFR,sec·~ and time to PFR (TPF, 
mssc). AI baseline, none of the patients had ST or L release (LA). how•
ever,ll pis had. low EF«45%),17 systolic dysfunction (PER<2.5 sec·') 
and all patienls had diastolic dysfunction (TPF> 180 mssc in 26 pis, 
PFR<2.5 ssc·' In 20 pis). During pacing overall EF remained una~ered, 
whereas PER .nd PFR incr8IIsed and TPE .nd PTF shortened progres•
sively with lnc:r8ased heatt rate. In contrast, at 100 bpm 14 pis had 
NWMA, but only 7 ST and 2 LA. Also, at 120 bpm (n-18) 13 pis had 
NWMA (p<O.05) va 7 ST and 2 LA. During maximal pacing (145~20bpm) 
20 pis had NWMA (p<O.05), 22 ST (p<O.05) and 9 LA. Hypoxanthine 
and LVEDP were only significanUy changed immediately post-pacing. 
Thus, regional wall motion abnormalities are .Iready ObsllVed at low 
pacing rates, whereas ST or matabolic parameters only change at max~ 
mal pacing or immediately after pacing. Therefore, wall motion changes 
are clearly more IIIIIsitive In the eatty datection of Ischemia than ST 
legment deplMSion,the gold standard, or myocardial metabolic changes. 
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In!s the Miiticn of Radi.au::l.ide ArgiogIaJiIy to 
EIcercise Perfusicn Imaging IlIp:oYe Detecticn of 
om:rmy Artery Disease? 
BarIy S. Kessler, Vasken Dilsizian, Arshed A. QJyyumi, 
Jean G. Diodati, B. William O1oi, ROOert O. Bonc:M. 
NHI.BI, Bethesda, MD. 
'!he , perfusion agents have created interest in the 
CXIIIbined evaluation of myocardial perfusion am function. 
However, whether the addition of functional data to 
perfusion data enhances detection of CAD is not estab•
lished. We studied 173 pts with ~ CAD by exercise 
radiorlUClide an;Ji~y (RNA) am 01TI SPEC!'. Exercise 
RNA acquisition in the modified I.1ID view precluded 
evaluation of the right CXlronary distribltion. '!he 
sensitivity (sens) of RNA, TI, am RNAfTI for detectin] 
1,2, am 3 vessel disease (VO) are shown, alon:! with 
sensitivity am specificity (spec) for left anterior 
descen;lirn (00) am circumflex (LCX) stenoses: 
OVerall Sensitivity 00 LCX 
1VD 2VD 3VD Total ~ ~ ~ ~ 
(n) (64) (50) (59) (173) (122) (101) 
RNA(%) 84, 86, 95 88...... 84, 55, 62,&, 69,& 
Tl (%) 86 * 98/ 95 92 & 82. * 78-* 39 .... * 94 .... 
Tl+RNA(%) 97'::' 98 98 98;' 94f 5~& 76')&' 65;& 
*0<.05. '0<.01 
canbined RNAfTI increased the sensitivity cx:mpared to 
either RNA or Tl alone, but (as anticipated) at the 
expense of specificity. 'lhus, CXIIIbined functional am 
perfusion imagin] should be used with caution when a test 
with high specificity is needed (as in pts with a low 
likelihood of CAD); however, CXIIIbini1xJ RNA with perfusion 
imagin] has potential when high diagnostic sensitivity is 
needed or in pts with known CAD, by detenn.inin; the 
functional inpJrtance of a perfusion defect, am by 
providin;J the additional prognostic insights gained from 
the exercise eiection fraction. 
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949-43 
Doxorubicin Causes Release of Tc-99m-Sestamibi from 
Cardiac Mitochondria. 
Cesare Orlandi, Paul D. Crane, Stuart Heminway, Martin J. 
Thoolen. 
Du Pont-MercJc Pharmaceutical Co., Radiopharmaceutical 
Division, No. Billerica, MA. 
The use of Doxorubicin (Adriamycin; DR) in the 
treatment of solid tumors is limited by its cardiotoxic effects. 
It has been hypothesized that these effects may be 
mediated by mitochondrial calcium overload. Retention of 
TC-99m-Sestamibi (Sestamibi) -a new cardiac perfusion 
imaging agent- in the myocardium is also affected by 
mitochondrial calcium concentrations. We studied the 
effects of DR on Sestamibi mitochondrial retention in 
guinea pig heart homogenates. Animals were injected with 
Sestamibi (~1 mCi, i.v.) and euthanized five minues later. 
The hearts were then excised, minced and homogenated. 
The homogenates were incubated for 5 min with DR (0.02-
1.9 mM) at 4 and 37°C, and centrifuged to separate the 
mitochondria. At 4°C DR did not exert any significant effect. 
However, at 37°C the agent reduced the amount of MISI 
retained in the mitochondrial fraction in a dose-dependent 
fashion. MISI activity in the mitochondria was reduced from 
80.7 ± 3.2 % under baseline conditions to 34.3 ± 4.5 % by 
1.9 mM DR. Addition of ruthenium red -a mitochondrial 
calcium uniporter blocker- did not inhibit the DR-induced 
release of Sestamibi, indicating that Ca2+ overload is not 
the only mechanism of mitochondrial toxicity. The 
cardiotoxic effect of DR is effectively demonstrated in vitro 
with Tc-99m-Sestamibi. Potential in vivo use of Tc-99m•
Sestamibi perfusion imaging for titration of DR therapy 
should be evaluated. 
ABSTRACTS 249A 
949-44 
I-Methionine Augments Myocardial Contraction by 
Sensitizing the Myofilament for Calcium 
Yasuki Kihara, Moriaki Inoko, Shigetake 
Sasayama. Second Department of Internal 
Medicine, Toyama Medical & Pharmaceutical 
University, Toyama, Japan. 
I-Methionine is an essential amino acid which 
has been reported to have a potent positive 
inotropic effect in the mammalian myocardium. 
We studied the subcellular mechanisms of the 
inotropic effect in working myocardium isolated 
from the rabbit right ventricle. A 
bioluminescent protein, aequorin, was loaded 
into superficial myocytes of the preparation to 
monitor Ca 2+i' When the muscle was stimulated 
to contract isometrically at 0.33Hz; at 30·C in 
the presence of lrnM ca2~, 3rnM I-methionine 
increased the peak developed tension by 2l±9% 
(p<O.Ol, n=8). The inotropic response was 
associated with a prolonged tension time 
course; time to peak tension by 2±2% (p<O.05), 
and time to 80% tension regression from the 
peak by 7±5% (p<O.05). These changes in 
tension were not affected by pretreatment with 
l~M propranolol, l~M prazosin, or 3~M 
carbachol. By contrast, the simultaneously•
recorded Ca 2+ i signals did not increase in 
amplitude. The time course of the Ca 2+ 
transient was unchanged (n=6) or slightly 
abbreviated (n=2). In saponin (250~g/ml)­
treated skinned preparations, I-methionine 
shifted the force-pCa curves to the left by 
0.12 pCa units (n=6). We conclude that 1-
methionine directly acts on the myofilament and 
modulates the responsiveness to Ca2+, which 
causes the positiv~ inotropic effect. 
949-45 
Interaction of ~bromboxane B2 and Atrial Natriuretic 
Peptide on Perfused Rat Heart 
Zhongtuo Tan, Jiang Gu, 
Deborah Research Institute, Browns Mills, NJ 
The action of atrial natriuretic peptide (ANP) on the 
heart is controversial. Isolated perfused working 
adult rat hearts were perfused for 15 min by K-H 
buffer added with thromboxane B2 (TXB2, 0.2uM), ANP 
(60 nM) or a combination of both. Results are as 
follows (N=5, Mean ± SEll 
C 
T 
A 
T+A 
AO 
39U 
43U* 
38U 
47U* 
co 
15±1 
14±1 
15±1 
15U 
HR 
270±5 
268±4 
263±4 
265±5 
ASP 
135U 
140U* 
135U 
145±2* 
DP/DT 
29U 
34U-
29U 
37±1* 
CR 
5.l±0.2 
5.8±0.3-
5.0±0.1 
5.0tO.2* 
C=Control, no intervention; TzTXB2;AsANP; 
T+A=TXB2+ANP; AO=aortic output, ml/min; CO=coronary 
flow, ml/min; HR=heart rate, beat/min; ASP-aortic 
peak systolic pressure, mmHG; DP/DT-rate of ASP 
development, xlOOmmHG/sec; CR=coronary resistance, 
mmHG.min/ml. The significant changes are indicated 
by *. 
Thromboxane B2 alone significantly (P<O.OS) increased 
AO, ASP, DP/DT and CR from the control level, 
indicating that its short term effects are mainly 
positive inotropic and coronary vasoconstriction. 
While ANP alone had no measurable effect on the 
isolated intact heart, it enhanced the positive 
inotropic effect of TXB2 and antagonized TXB2-induced 
coronary spasm (P<0.05). This findings suggest that 
ANP has protective effects on the heart. 
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949-46 
PrqIafe::me ~ Necmatal but DDt Mllt 
AtriCMllltricular Node AUtaDaticity 
Kenneth W. Hewett, C-I Noh, Olarles H. Gaymes, Paul C. 
Gillette. Medical University of SC, Olarleston, SC 
We have previOlSly shown that the pacemaker site in the 
neCI'latal raJ:Cit atrioventrio.llar oode (AVN) was 
typically fam:i at a mre atrial location an:} was mre 
rapid than in adult preparations. 'lherefore, ~ stu:lied 
the effect of 5xlO-iM prqafenone (P) on autanaticity in 
adult an:} neCI'latal «10 clays old) AVN preparations 
usin;J elect:rograms an:} transmeIIilrane recorc:tin:Js. P 
significantly increased the autanatic interval in 
neonates fran 957±1l4 to l505±249 IllS (X±S.E.) in 12 
experiments but autanaticity in the adult preparations 
was ~ fran l559±247 to l721±327 IllS after drug 
(~12). '1he pacemaker escape time follorNiJ'g overdrive 
pacin;J (400 lIS oct., 1 min) was increased fran 7 • 99±1. 77 
to l4.1±4.2 sec by P. In adult tissue, the escape time 
was un::harged fran 20.4±5.8 S before drug to 22.9±4.9 S 
followin;J P in the neonate. APQ., was significantly 
prolonged in only atricn:xlal celfs of both age grwps 
by P (5xlO~). Haoever, ~ obseIved that rapid pacing 
prolonged a rate dependent increase in APQ;o of N cells 
fran both age grwps before drug. '1he rate dependent 
increase in N cell AP!:>w was enhanced by P an:} was 
correlated with the drug related decrease in Wenkebach 
rate. 
Conclusions: (1) '1he subsidiary atrial pacemaker in 
the neonatal AVN preparations was suwressed by P am 
the adult AVN pacemaker was not. 'lbis difference in 
pacemaker sensitivity to P suggests maturational 
charges in the cmrent(s) responsible for autanaticity. 
(2) Action potential duration ~es produced by P are 
not age-related but are specific to in:iividual regions 
of the AVN. 
949-47 
Misleadin& Correlations Between Effects of Procainamide on 
Canine Atrial Reentry Tachycardia Cycle Len&th and Effects on 
Atrial Effective Refractory Period. 
Teresa Kus, Katayoun Derakhchan, Caroline Bouchard, 
Pierre L. Pag6, Research Center, Sacre-Coeur Hospital and 
University of Montreal, Montreal, Canada 
The effects of procainamide (p A) on atrial effective refractory 
period (ERP) were studied in a model of atrial flutter around the 
tricuspid valve in 7 open-chest, chloralose-anesthetized dogs (31 ± 
3 kg). A Y -shaped incision in the intercaval area extending to the 
right atrial appendage was made and 5 bipolar electrodes were 
sutured on the atrial epicardium around the tricuspid valve. Reentry 
tachycardia was induced in the absence and presence of drug by 
burst pacing. PA (15 mg/kg BOLUS followed by 0.075 mg/kg/min 
INFUSION) produced stable plasma levels (38 ± 9 I'moIlL) during 
the study. PA prolonged the cycle length (CL) of atrial flutter from 
144 ± 10 to 160 ± 13 ms (p < 0.05). At a pacing CL of 200 ms, 
PA prolonged the mean ERP of the 5 sites from 128 ± 9 to 140 ± 
16, the minimum ERP from 120 ± 10 to 126 ± 12 ms and the 
maximum ERP from 136 ± 7 to 154 ± 15 ms (p < 0.05). A 
significant correlation was observed between drug-induced 
prolongation of flutter CL and change in maximum ERP (r = 0.89; 
p < 0.01), a lesser correlation with change in mean ERP (r = 
0.69; p < 0.05) and no correlation with change in minimum ERP 
(r = 0.17; NS). Reset-response curves determined by introducing 
premature stimuli during atrial flutter showed that PA prolonged 
ERP during flutter from 101 ± 13 to 116 ± 17 ms, but did not 
change the duration of the excitable gap (38 ± 9 vs 40 ± 18 ms). 
PA also did not change the mixed nature of the reset-response 
curve. 
In conclusion, PA prolongs atrial flutter CL by slowing 
conduction through fully excitable tissue. While PA prolongs atrial 
ERP, correlations of effect on ERP with prolongation of flutter CL 
are entirely fortuitous and likely reflect (especially at sites of 
maximum ERP) the effect of an unchanged excitable gap duration. 
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Is Quinidine and Sotalol Combination More 
Arrhythmogenic Than Sotalol Alone in Dogs ? 
Fr6derique Chezalviel, Valerie Deplanne, Jean-Marc Davy, Jacques 
Weissenburger, Jean-Marie Poirier, Gilbert Mone, Georges Cheymol. 
Faculte de M6decine St-Antoine, Paris (France). 
Electrophysiologic effects of antiarrhythmic drugs association are not 
fully evaluated, and possible proarrhythmic potency of these 
combinations is unknown. 
Arrhythmogenic and electrophysiologic properties of sotalol (S) and 
sotalol / quinidine (S+Q) combination were compared on 7 
hypokalemic (K+: 3±O.1 m\1/1) conscious dogs with chronic AV 
block (RR = 1210±71 msec). Dogs were submitted to a crossover 
randomized study. S (4.5mg/kg+1.5mg/kg/h) was given during 2 
hours associated to saline or quinidine (lOmg/kg+ 1.8mg/kglh). A 25 
bpm rate demand pacing was provided. RR, QT interval and 
ventricular refractory period (VERP) were measured at baseline and 30 
min after S infusion. ECG was continuously monitored for 
spontaneous torsades de pointes ~ 8 beats) (TdP). 
: vanauon rom baseline m msec. n: num r 0 ogs wah . 
S+saline and S+Q exhibited significant (p<0.05) and similar 
electrophysiologic effects. Furthermore, TdP occured more frequently 
after S+saline than after S+Q during the first hour (p=0.014). 
Concentrations of sotalol were similar in the 2 experiments (4.43±O.2 
~g/ml and 3.97±O.5 ~g/ml). Mean concentration of quinidine was 
3.56±O.4 ~g/ml. 
Conclusion: Quinidine did not enhance the effects of sotalol on 
ventricular repolarization. Moreover, torsades de pointes were less 
numerous when quinidine was combined to sotalol in this canine 
model. This result is consistent with recent in vitro studies suggesting 
a class I / class ill antiarrhythmic drugs antagonism. 
949-76 
Lack of Efficacy of Magnesium in Experimental 
Atrial Fibrillation. 
Elias Dalloul, Boward Friedman, Evens Rodney. 
Department of Medicine, Long Island College 
Hospital and SUNY Health science Center at 
Brooklyn, New York. 
Mg deficiency has been suggested as a cause 
of atrial fibrillation (AF)_ The influence of 
Mg sal ts on AF has not, however, been 
reported. Accordingly, in anesthetized dogs 
hemodynamic and electrophysiologic studies 
were performed before (serum Mg=1.5~0.4 
meq/L) and after the IV administration of 8 
meq of MgS04 (3.5.:!:O.7 meq/L) or its vehicle (1.8+meq/L). These studies were then 
repeated after IV administration of 10 meq 
KCl (Mg=2.2.:!:0.6 meq/L; K=6.9.:!:1.2 meq/L). 
Heart rate, cardiac output and pressures, and 
arterial pH and gases were not changed in 
these experiments. Moreover, Mg 
administration did not change intraatrial 
conduction, atrial refractory periods. the 
atrial strength-duration relation, AF 
inducibility (by an extrastimulus ~ lOrnA), or 
AF duration. By contrast, K prolonged atrial 
refractory period for stimuli between 2-8mA 
and reduced AF inducibility (from 14+5 to 7+4 
sec/A, p<O. 02) • Dogs given vehicle also 
showed a reduction of AF inducibility (20+5 
to 7+4 sec/A, p<0.01). Conclusion: 1) at-a 
clinically-relevant serum concentration Mg 
does not influence atrial refractoriness or 
conduction. 2) Mg does not have a favorable 
effect on AF inducibi 1 i ty or duration. 
Indeed, a time-dependent attenuation of AF 
inducibility observed in this model was 
obscured by Mg. 
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949·77 
Bay K 8644 Is a Negative Inotrope In The Presence of Arachidonic 
Acid 
Mitchell S. Finkel, Ryan C. Romeo, Theresa L. Hartsell, Carmine V. 
Oddis. University of Pittsburgh, Pittsburgh, PA. 
The activation of phosphollpases by endogenous hormones and 
Ischemia appears to play an Important role In signal transduction In 
heart. Arachidonic acid (APII Is a product of phospholipase activity and 
the precursor for prostaglandin and leukotrlene formation (eicosanoids). 
Previous studies have emphasized the Important physiologic effects of 
the elcosanolds as mediators of phospholipase activity. The physiologic 
role of AA as a second messenger has only recently recieved greater 
attention. 
The Inotropic and radio ligand binding characteristics of AA In ham· 
ster cardiac muscle were studied. AA alone or In the presence of 10uM 
Indomethacin (prostaglandin Inhibitor) had a dose dependent negative 
Inotropic effect In Isolated papillary muscles. The addition of 10uM caf· 
felc acid ~eukotrlene Inhibitor) to AA resulted In a dose dependent 
positive InotropiC effect. The dihydropyridine calcium channel agonist, 
Bay K 8644 alone had a dose dependent positive Inotropic effect. The 
addition of 10uM AA to Bay K 8644 resulted In a dose dependent 
negative inotropic effect (Fig. A ; p< .01 ; n = 5). Scatchard analyses of 
13H] nltrendlplne (dihydropyridine) binding In the presence of 50uM AA 
revealed competitive Inhibition as evidenced by an Increase In the KO 
(-1/slope) with no effect on Bmax (X-Intercept) (Fig. B). 
- .. I: 
f. .. 
I: 
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THI!se data support a potentially Important role for arachidonic acid as 
an endogenous regulator of contractility In mammalian heart. 
949·78 
Amiloride's Effect as a Muscarinic Antagonist 
on Single Atrial and Ventricular Myocytes of 
Guinea Pigs '" "'''' '" 
Kazuo Matsumoto, Achilles J. Pappano, Yutaka Dohi. 
The Second Department of Internal Medicine, Saitama 
Medical School~ Moroyama, Saitama, Japan an2", 
The University of Connecticut Health Center, Farmington, 
CT. 
Amiloride is well known as a potassium-sparing diuretics 
and has been used as a sodium-calcium exchange blocker 
in various experiments. We report that amiloride has a 
muscarinic antagonistic effect on the cell membrane of 
single atrial and ventricular myocytes of guinea pigs by 
the method of whole cell clamp. With atrial cells, the 
outward current was induced by carbachol 10-6 M at -65mV 
of voltage clamp level, then amiloride was applied with 
various concentrations to see the effect of amiloride on 
this current. With ventricular myocytes, the inward 
current was induced by carbachol 3xl0-4M in existence of 
20 mM CsCI ( K. Matsumoto and A.J. Pappano. Molecular 
Pharmacology, 39:359-363,1991 ), then amiloride was also 
applied in the same manner. Amiloride showed the sup•
pressive effect to the outward current from the c~~cen­
tration of 10. 7 M and completely suppressed by 10 M,and 
to the outward current from the concentration of 10-5 M, 
blocked completely by 10-2 M. The antagonist concen•
tration for 50 % inhibition of the carbachol effects were 
70 ~ and 200 ~M respectively. 
Thus amiloride has a property of muscarinic antagonist 
in atrial and ventricular myocytes of guinea pigs, that 
should be considered in case of using amiloride for 
experiments. 
ABSTRACTS 
949·79 
Increased Cardiac Vagal Tone by CeDtraJ Nervous B-Blockade iD CODscious 
Pigs DuriDg CNS Arousal 
fflffi!&'!r" Ewa Forshult, Gunnar Olsson. Astra Hassle Cardiovascular Research. o • weden. 
251A 
10 anesthetized rabbits with CNS arousal the lipophilic B-blocker metoprolol (M) 
(concentration same in CSF and plasma) increased cardiac vagal tone (CVT) and 
prevented ventricular fibrillation (VF) after coronary occlusion. while the 
hydrophilic atenolol (A)(CSF concentration 10% of that in plasma) did not affect 
CVT or VF iDcidence despite similar heart rate reduction and antiischemic effects 
(Ablad et aI. rACC 1991).10 the present study we have tested the effects ofM and A 
on CVT in unanaesthetized pigs at different CNS arousal states. S freely moving pigs 
were studied during 3 weeks with continuous telemetry ofECG and respiration 
(intra-pleuraJ pressure). and videotaping for behaviour analysis. M and A were 
(randomly cross-over) given for 1 week by s.c. osmotic minipumps (plasma levels 
SIW90 and 2160±390 nM, respectively). The 24 h rccordings on the Sth day of the 
initial control (C) week. and each of the B-blocker weeks WC'lC subjected to power 
spectrum analysis of heart rate variability related to respiration (HRV). Mean 24 h 
heart rate was less (p<O.OS) in M (9 ItS bIm) and A periods (92±S bIm) than in C 
(103±6 bIm). The table shows results during sleep (3-4 a.m.) and 2 levels of activity 
in the awake stale rccorded for 3 h after each of 2 feedings. 
Behaviour Heanrate HRV Respiration 
cycleslmin 
Calm sleep 
Idling awake 
Rooting 
C 
M 
A 
C 
M 
A 
C 
M 
A 
bIm s.d. ofRR (msec) 
79±6 178±27 
77tS 203±21 
79±S 180±26 
1~~lp<O.OI I 21.S±3.0]p<O.OS 
94tS
- p<O.~1 41.2±7.1]p<005 
27.1i4.S . 
1
1
26i8
11
± ] p<O.OS.Js 9.4±1.0] p<O.OS 
p<O 18.3±2.8] p<O.OS 
1I3±7----'--' 12.6±2.2 
14±1.7 
14iO.6 
13iO.9 
21±2.7 
19iO.9 
19±1.2 
27±1.9 
26±1.I 
28±2,S 
~: The reduced HRV in CNS arousal probably reflects decreased CVT. but 
changes of respiration and heart rate may contribute. At equal heart and respiratory 
rates M was more effective than A in conunteracting CNS arousal dependent reduc•
tion in HR V. This finding supports the idea of a CNS B,-adrenoceptor dependent 
nodulation of CVT during CNS arousal. 
949·80 
Isradipine Alters Ventricular Energetics by Decreasing Load 
Independent Oxygen Demands 
Daniel Burkhoff, Gary Gerstenblith. The Johns Hopkins Medical 
Institutions, Baltimore, Maryland 
Isradipine IISR), a new dihydropyridine derivative, has been 
shown to enhance ventricular performance while reducing 
myocardial oxygen consumption (MV02) in intact animals. This 
could result from direct. energetically beneficial effects of ISR on 
myocardial metabolism, or from extra-cardiac effects of ISR. To 
test the direct myocardial effects of ISR on energetics, developed 
pressure (OP) and MV02 were measured at varying ISR 
concentrations in 5 isolated, isovolumically contracting rat 
hearts. DP averaged 104 ± 12 mmHg and MV02 averaged 
0.18 ± .04 ml 02/min at baseline. The impact of ISR 
(mean±SD). summarized as percent of control values, was as 
follows (" p<0.05 vs control by ANOVA with Duncan test): 
ISR: 4nM 8 nM 16 nM 32 nM 
DP 95±4 90±6 " 75±10" 65±6" 
MV02 89±5 81±11" 72±12" 70±6" 
To determine whether the ISR induced decrease in MV02 was 
related to a workload-dependent reduction in energy demands, 
the impact of ISR (16nM) on the slope (0) and intercept (/1) of the 
relationship between MV02 and work, indexed by pressure•
volume area (n = 5), was also determined. 0 was not changed by 
ISR (control 1.37 ±.18 vs ISR 1.44± .31 mI02·mmHg·l.ml·1.10·&). 
p, which equals MV02 of unloaded contractions, decreased from 
.54±.13 to .33±.07 ml 02·bear'·g·1.10·3 (p<0.01). Thus, the 
direct myocardial effects of ISR are to depress contractile 
strength and MV02 in a concentration dependent manner; the 
decrease in MV02 is independent of workload and is accounted 
for by a decrease in unloaded MV02• 
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949·81 
Skeletal Muscle Digitalis Receptors in Relation to Digitalization of 
Heart Failure Patients 
Thomas A. Schmidt and Keld Kjeldsen, Department of Medicine B, 
Division of Cardiology, Rigshospitalet, University of Copenhagen. 
Denmark 
Speculations about development of tolerance to digitalis treatment have 
been engendered due to reports of various in vitro systems showing 
receptor upregulation in response to digitalis exposure. However, on 
samples obtained postmortem as well as in life we have shown that 
digitalis exposure is not associated with left ventricle digitalis receptor 
upregulation in man. Nevertheless, in response to treatment with 
cardiac glycosides tolerance might evolve due to skeletal muscle Na,K•
pump upregulation with resulting decreased blood digitalis level. Hence, 
the aim of the present study was in man to evaluate whether long term 
digitalization causes skeletal muscle digitalis receptor upregulation. 
Vastus lateralis samples were postmortem obtained from II long-term 
(9 months - 9 years) digitalized (125 - 187.5 ILg daily) and 8 non•
digitalized subjects. In intact samples from digitalized patients vanadate•
facilitated 3H-ouabain binding increased 15% (p < 0.02) from (mean :!: 
SEM) 150 :!: 18 to 173 :!: 13 pmol/g wet wt. after clearing receptors of 
bound digoxin by wash of samples in excess specific digoxin antibody. 
3H-ouabain binding in the untreated group was 257 :!: 28 and 274 :!: 26 
pmol/g wet WI. (7%. P > 0.30) before and after wash in specific digoxin 
antibody respectively. Occupancy of skeletal muscle digitalis glycoside 
receptors with digoxin during digitalization was around 13'1:. The 
skeletal muscle Na,K-A TPase pool hence, constitutes a major distrihu•
tion volume for digoxin during digitalization. Digitalis receptor con•
centration in vast us lateralis of digitalized patients was significantly 
lower than in controls (37%, p < 0.05). There was therefore no 
evidence for development of tolerance to digitalis due to upregulation 
of skeletal muscle digitalis receptors during digitalization. The observed 
decrease in skeletal muscle Na,K-ATPase concentration of heart failure 
patients may be of importance for digitalis therapy. 
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950·48 
ErrECTS or PROPRANOLOL ON CARDIAC 
NEUROCHEMICAL MARKERS IN A CANINE MODEL or 
HEART rAILURE. 
Jame~ Levett, Simone Nader, Carlos Marinelli, Donald 
Lund, Benet Pardini, Phillip Schmid, Jr. VA Med. 
Ctr, Cardiovascular Ctr. and Depts. of Internal Med. 
and Surg., Univ. of Iowa, Iowa City, IA 52246. 
It ha~ been reported and we have confirmed that 
rapid ventricular pacing in dogs produces conge~tive 
heart failure associated with increases in plasma NE 
a~ well a~ depletion of cardiac NE. The purpo~e of 
this study was to investigate effects of propranolol 
on cytosolic and vesicular markers of cardiac 
sympathetic innervation in this model. Dogs were 
randomly divided into 4 groups: Unpaced control, n·6; 
Paced only, n-6; paced and treated with propranolol 
LA (4mg/kg/day), n-6; and Paced with total 
intrapericardial denervation, n-6. Pacing rate was 
200-240 bpm and pacing time averaged 32.1 days. 
Results: Cardiac NE and NPY were consistently 
depleted in all heart chamber~ of paced animals. 
Cardiac Tyro~ine Hydroxylase (TH) and Dopamine Beta•
Hydroxylase (DBH) in the groups·were compared using 
ANOVA (*p< 0.005 vs control): (nmol/chamber/hr) 
TH DBH 
GROUP RV LV RV LV 
Unpaced control 982 2111 785 1156 
Paced only 989 1305* 658 805 
Propranolol, paced 1006 1456* 892 1109 
Denervated. paced 300* 319* 428* 607 
CpDclp3ion: Except for TH in the paced LV, 
significant depletion of TH and DBH was observed only 
in denervated dogs. Loss of TH in paced LV appear~ 
to be a selective change possibly related to more 
pronounced myocyte dy~function or ischemia. The 
mechanism(~) accounting for differences in RV and LV 
need further study. Propranolol treatment did not 
detectably alter this response. 
950·49 
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Improvement In Lal'Jle Artery Function FoUowIng Acute Diuresis In Patients 
with Severe Chronic Heart Failure 
Arnold J M 0, Marchiori G E, Burton G 1., University of Western Ontario, 
London, Ontario, Canada. 
Large artery compliance is reduced in heart failure especially in patients with 
severe symptoms. To determine if these changes can be acutely reversed, we 
studied 11 patients (61 ± 3 years) admitted to hospital with severe peripheral 
oedema and a history of chronic heart failure. Patients were studied on the 
first morning of admission and after 3.4 :!: 0.4 days of diuresis. Cardiac 
medications other than diuretic dose were not altered. Mean weight loss was 
6.5 ± 0.9 kg (range 2 • 12 kg). Brachial artery internal diameter (D) was 
measured by a bidimensional pulsed Doppler system. Pulse wave velocity 
(PWV) was measured noninvasively with paired transducers over the brachial 
and radial arteries. Brachial artery compliance (COMP) was c:alculated as 
(ff /p) (D/2PWV)2 where p is blood density. Changes in brachial artery 
function resulting from diuresis were compared between patients with pre•
diuresis PWV «nES) or >(n z 6) the mean brachioradial PWV (11.7 m/s). 
PWV WEIGHT MBP D PWV COMP 
kg mmHg mm mls an4/d,re/lCl 
<11.7 -6.3:!: 1.1 -2.5:!:6.3 -O.2±0.2 2.3:!:0.'t, -O.7:!:0.2 •• 
>11.7 -6.6±1.4 -4.7:!:3.2 0.6±0.3 -3.4±1.1 1.2:!:0.4 
mean :t s.e. •• p< 0.01 
Patients with increased PWV pre-diuresis (reflecting increased stiffness of 
brachioradial arteries) had a significant reduction in PWV and improvement in 
COMP post-diuresis compared to patients with normal PWV despite a similar 
weight loss and no significant change in MBP. Also, brachial artery D tended 
to increase (p. 0.07). Thus, these results demonstrate that brachial artery 
function can be improved acutely by diuresis in some patients with chronic 
heart failure presenting with severe peripheral oedema. This suggests that salt 
and water retention may be one factor contributing to reduced large artery 
compliance in heart failure. 
950·50 
Positive Inotropic Actions of Vasodilator Drugs on 
Mammalian Myocardium: Implications for the 
Development of New Drugs for Heart Failure 
Lin Miao, Cynthia Perreault, Milton Packer, James Morgan. 
Harvard Medical School, Boston, MA. 
Because the cardiotonic agent, milrinone (MIL), J. survival in 
heart failure (CHF), concerns have been raised that all drugs with 
positive inotropic actions carry a similar risk, whereas vasodilators 
(hydralazine &: nitrates) prolong life. Yet, many vasodilators exert 
positive inotropic effects. To clarifY this issue, we evaluated the inotro•
pic actions of 3 vasodilators (MIL, flosequinan [FSQ] &: hydralazine 
[HYD]) on ferret papillary musclea stimulated to contract at 0.33Hz 
and 30·C. Studies were carried out with atropine (lQ-6M), propranolol 
(6 x 1Q-7M) &: phentolamine (l0-6M) to J. the effects o(neurotransmitter 
release, and in the presence (+Fsk) and absence of forakolin (·Fsk): 
Minimally effective dose Maximally effective dose 
n Min Dose % Max Ca++ Max Dose % Max Ca++ 
MIL -Fsk 6 1O-6M 65±2% 104M 89±5% 
HYD 
FSQ 
+Fsk 
-Fak 
+Fsk 
-Fak 
8 1O-7M* 62±3% 3x 10-'M* 89±5% 
6 104 M 43±S% 10-3M 59±4% 
4 104 M 47±3% 1O-3M 70±4% 
6 lO-SM 61±6% 104 M 78±8% 
+Fsk 8 10-'M 68±4% 104 M 79±5% 
where Min = minimum; Max = maximum; % Max Ca++ = % of 
maximal response to calcium; * = P < 0.01 (-Fsk va +Fak) 
HYD, like MIL, exerted positive inotropic effects (both nearly as 
great as those of Ca++), but the adenylate cyclase activator, forskolin, 
only potentiated the response to MIL, but not to HYD or FSQ, suggesting 
that only the inotropic effects of MIL were cyclic AMP dependent. 
In conclusion, lome vasodilators that prolong life (e.g., HYD) 
exert positive effects in mammalian hearts, but unlike MIL, such 
agents exert inotropic actions that are not t by forskolin. These data 
suggest that t intracel1ular cyclic AMP rather than t inotropy may be 
the mechanism by which some cardiotonic drugs J. survival in CHF. 
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950·51 
eo.paratiY. Bff.cta of th. Vaa04ilatora PloaaquiDaD aDd 
B,dralaaiD. 011 th. COntractil ....... ction of laolatad .\IIIaD 
carcliac lluacl. 
Ronald I. W.i.haar'. Annette H. Wallace'. Timothy A. 
Quinn'. Victor A. Ferrari.'. Malcolm P. Sim'. Div. of 
Biol. R •••• OOromed. Inc •• Troy. NY'~ Div. of Thoracic 
Surg •• Albany Hed. 0011 •• Albany. NY". and Res. D.pt •• 
Boot. Pharm.. Ingland' 
I'lo.aquinan (F) and hydralazine (H) are va.odilators that 
have prov.n .ff.ctiv. in tr.ating h.art failure patients. 
Th. goal of thia .tudy waa to d.termin. wh.th.r these 
ag.nt. po ••••• cardiotonic activity in addition to th.ir 
.ff~ct. on va.cular mu.cl.. In addition to I' and H. the 
inotropic activity of BTS 53 554 (BTS, the major 
metabolite of 1'). and the CAMP-PDI inhibitor milrinon. 
(H) waa al.o .valuatad. All four ag.nts r.producibly 
incr.a •• d contractility of fib.r. from non-h.art failure 
pati.nta (non-HI'). Th. ord.r of pot.ncy was H (IC •• - 1.8 
WI) > I' (leo. - 32 WI) > BTS (leo. - 85 WI) > H (IC •• - 750 
WI) • Pretreatment with 1 WI carbachol att.nuat.d the 
r •• pon ••• to all four agents. Pretr.atment with all four 
agent. alao potentiatad the r.sponse to iaoprot.renol. 
Inter.atingly. pretr.atment with a thr.ahold 
conc.ntration of for.kolin pot.ntiated the re.pona. to H 
but not F. H or BTS. Th. re.pon •• of cardiac fiber. from 
h.art failure (81') patient. to I' and H varied 
con.id.rably. The r •• pon •• to P wa. reduced or abolish.d 
in fiber. from 7 of 20 81' patient •• while the response to 
H waa dimini.hed in 4 of 9 HI' pati.nts. In contraat. no 
aubset of H-in.en.itiv. HF pati.nts was identifi.d. Th. 
re.ulta of th •••• xperiment. demon.trate that at high 
concentration. I' and H can exert a positive inotropic 
effect on human cardiac muacle. Similariti.a also exiat 
between I' and H and agent. that incr.a.e cAMP. However. 
the finding that a .ub.et of 81' patient. exists in which 
the inotropic reapons. to I' and H but not M is diminished 
.ugg.ata that the.e agent. are acting via diff.r.nt 
machani.ma. 
950·52 
Does Dobutamine Tolerance Result From Myocardial B· 
Receptor Down·Regulatlon? 
Edward M. Gilbert, Patricia A. Larrabee, A. Kirk Volkman, Patrice 
C. Mealey, Dale G. Renlund, Stephanie L Olsen, Michael R. Bristow. 
University of Utah, Salt Lake City, UT 84132. 
Tolerance to the hemodynamic effects of dobutamine (OBT) develops 
during chronic infusion. We evaluated mechanisms of OBT tolerance 
in 12 subjects with class IV heart failure. Baseline measurements 
were the hemodynamic response to OBT, central venous, arterial, 
and coronary sinus (CS) norepinephrine (NE) concentrations (to 
assess systemic and cardiac adrenergic drive), and myocardial B•
receptor density (Bmax). oBT was then infused at a dose which 
increased cardiac index by 25-40% over baseline for 48 hours 
(mean dose-7±1 ltg/kg/min) after which the baseline 
measurements were repeated. Results are given as mean±SEM 
(·p<0.05 vs baseline): 
~ Post-Infusion 
Venous NE: 1050±197 71 0±164' _ 
(pg/ml) E 
Arterial NE:1382±465 788±158' C 3.0 
(pg/ml) E 
CSNE: 1146±261 790±112 ::; 
(pg/ml) - 2.5 
Bmax: 18±3 28±8 )( 
(fmol/mg protein) ~ 
2.0 
POST-INFUSION" 
Conclusions: 1) OBT tolerance .5 
occurs as early as 48 hours. 2) 
Treatment of heart failure with OBT ~ 
is associated with a reduction in :a 
systemic and cardiac adrenergic :a 
drive. 3) OBT infusion for 48 CJ 
hours does not down-regulate 
myocardial· B-receptors. 
1.5 +-"""T-,.--.,..--r 
0.0 2.5 5.0 7.510.0 
OBT Dose (ltg/kg/min) 
These observations suggest that other mechanisms, such as B•
receptor uncoupling, may be responsible for OBT tolerance. 
ABSTRACTS 
950·53 
Hemodynamic EttIlClB of Long-Term Treatment with Coenzyme Ql0 
In PatIents with Cong.tlve Heart failure. 
C Hofman.Ban~ K. Schenck-Gu&Ia!saon, M.D., Ph.D., G. ForsseII, 
M.D., Ph.D., H., M.D., Ph.D., DIpaI1ment of Cllrdiology and 
CliillcaJ PhysIology, Thoracic Clinics, KaroIinska HoepItaJ, Stockholm. 
Coenzyme Ql0 (Co Ql0) Is praRnt In raIaIIveIy high OCI1OIII'IIIaIIns In 
CIIIs with high energy turn over (heart muscle, skeletal muscle,IivIr). 
,.. a member In \he "electron llallllport chain" Co Ql0 plays III Important 
role In \he IIIlIII'QY transformation In \he mitochondria of \he calls (ATP). 
It has been claimed \hat \he heart muscle CIIIs In congestive heart failure 
(CHF) are "8IlIIIlIY staMId". Data has been publ8hed \hat Ihowa IowIIr 
ocncsntnllions of Co Ql0 In heart muscle In patlen1S with CHF compared 
to controls. Theoreticelly treatment with Co Ql0 could ImprtMI cardiac 
function in CHF by restortng \he -uy supply In \he "exhIustecI" 0811s. 
,.. a substudy In a double blind CI'OS& over placebo controlled multioenf8r 
study 18 patien1S with moderate to ___ CHF were randomlz.ed to 
to either 100 mg Co Ql0 daily or placebo (P). The patients were IlCamlned 
with clinicel status, ejection frae1lon (EF), maximal 8)l8f'C1se 18BI (Wmax), 
right sided heart caIh8tarIzation at rest and 8IilmaxImai work before and 
altar 3 months of maintananoe therapy. 
11 patlen1S with meII/l age 64 years reoeh.9d active drug (7 men, 4 
wcmenwllh EF 25:tlO%, Wmax88:t30 Watts, cardiac output (CO) 
4.3±1.1 ~In, right atJ1aI pressure (RAP) 7±2 mm Hg and capillary wadgI 
pressure (PCW) 16±6 mm Hg). 7 patients with mellllige 53 years 
reosived pIaoebo (5 men, 2 women, mean EF 111:!9%, Wmax 8O::W 
Walts, CO o4.1±1.o4 ~in, RAP 6±3 mm Hg and PCW 20:1:8 mm Hg. 
BIiu.!lI; AAer 3 months of treatment \here were no algnflcant 
hemodynamic changes In either of \he groups .-pi for a alight 
rise in EF at exercise (p<O.05) and arterio-venous oxygen 
difference (p<O.05) In \he active group. 
Conclusions' This study IIhowB no Iong-tsrm hemodynamic etfec18 of 0l'Il 
traaIment with Co Q 1 O. 
950·54 
Effect of Intravenous Magnesium on Ventricular Arrhythmia In 
Patients with Heart Failure 
Carla A. Sueta, Susan W. Clarke, Stephanie H. Dunlap, Stephen V. 
O'Quinn, Gary Koch, J. Herbert Patterson, Kirkwood F. Adams, dr. 
Univers~y of North Carolina, Chapel Hill, NC 
We studied the effect of Intravenous magnesium on the frequency of 
simple and complex ventrlcular arrhythmia In patients w~h heart failure. 
Interim analysis was undertaken of the first 16 patients who had a mean 
New York Heart class of 2.3.± 0.5 and left ventricular election fraction of 
.26.1.10. No patient had a history of symptomatic arrhythmia or was 
receMng antiarrhythmic agents. Patients were hospitalized for 4 days 
of continuous cardiac mon~orlng. After a baseline day, patients were 
randomized to receive placebo or magnesium given as a bolus of 0.3 
mEq/kg/hr followed by a maintenance Infusion of 0.08 mEq/kg/hr for 
24 hours. After a washout day, a second bolus and Infusion were 
repeated In a crossover fashion. No adverse effects sufficient to 
Interrupt the Infusion occurred. Initial serum magnesium concentration 
(mEq/L) did not differ on the baseline, magnesium, and placebo days 
(1.7.1 0.2 vs 1.7.1 0.2 vs 1.8.1 0.2). The concentration 30 minutes 
after the magnesium bolus was 3.1 .1 0.4 and remained relatively 
constant during the Infusion. Ventricular ectopy was quantified for 
each mon~orlng period without knowledge of the treatment given. The 
log of premature ventricular contractions/hour (2.5.1 0.7 vs 3.1 .± 0.7, 
p < .05) and log of couplets/day (I. 7 .± 0.4 vs. 2.5.1 0.6, P < .05) were 
significantly less on the magnesium than the placebo day. Likewise, 
there was a Significant reduction In the number of episodes of 
nonsustalned ventricular tachycardia per day (0.3.1 0.2 vs. 2.9.± 1.6, p 
< .05) on the magnesium compared to the placebo day. 
Conclusion: These results suggest Intravenous magnesium reduces 
the frequency of ventricular arrhythmia In patients w~h heart failure. 
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950·55 
CliDical and Prognostic Importance ofSenun Magnesium 
Concentration in Patients with Severe Chronic Heart 
Failure: The PROMISE Study 
Eric J. Eichhorn, Robert DiBianco, Paul E. Fenster, P. K. Tandon, 
James Shannon, Milton Packer on behalf of the PROMISE Study. 
University of Texas Southwestern Medical School and Dallas 
Veterans Administration Medical Centers, Dallas, TX. 
Since changes in magnesium (Mg) metabolism may play a role in 
the arrhythmias of heart failure (CHF), the measurement of serum Mg 
levels may be prognostically important. To evaluate this possibility, 
we measured serum Mg levels in 1068 CHF pts enrolled in the 
PROMISE Study. All pts had class III or IV CHF, were treated with 
digoxin, diuretics and converting-enzyme inhibitors and were 
followed for up to 20 months. Pts were divided into high-Mg (n=537) 
and low-Mg groups (n=531) based on median Mg level of 1.8 meq/l. 
Contrary to expectations, high-Mg pts had worse survival than low•
Mg pts (49% t risk in high-Mg pts, P=0.008). Even when the mode of 
death was compared in the 2 groups, low-Mg pts did W have a higher 
risk of sudden (presumably arrhythmic) death. The lack of t sudden 
death in low-Mg pts was consistent with the finding that a similar 
fraction of low-Mg and high-Mg pts had> 30 ventricular premature 
beatslhr (63% vs 58%) and a similar fraction had ventricular tachy•
cardia (64% vs 59%), even though (as expected) low-Mg pts had lower 
serum potassium concentrations (4.36 vs 4.52 mmolll), P < 0.001. 
The t risk of death in high-Mg pts was related to the greater 
severity of CHF in this group. At baseline, the high-Mg group was 
older (66 vs 61 years), had worse renal function (t BUN [34 vs 26 
mgldll and t Cr [1.6 vs 1.3 mgldl]), had more class IV pts (45% vs 38%) 
and had more previous myocardial infarctions (63% vs 51%), all P < 
0.05. These baseline differences entirely explained the difference in 
survival between high-Mg & low-Mg pts, since after adjustment for 
these differences, the risk of death was similar in 2 groups (P = 0.19) . 
In conclusion, Mg levels are prognostically important in CHF 
because they reflect the severity of CHF rather than because they 
indicate the presence or absence of a specific arrhythmogenic state. 
950·56 
DIGITALIS IMPROVES MYOCARDIAL RELAXATION 
IN PATIENTS WITH HEART FAILURE. 
Eric 1. Eichhorn. M D" FAC C, Luis G. Alvarez, M.D., John E. 
Willard, M.D., Paul A. Graybum, M.D., E.A.C.C. University of 
Texas Southwestern and Dallas VA Medical Centers, Dallas, Tx. 
Digitalis preparations have been demonstrated to improve myocardial 
contractility and sensitize baroreflexes, both beneficial effects in hean 
failure. However, their effect on myocardial relaxation in humans is 
unclear. We assessed changes in end-systolic elastance (Ees) and the 
slope (R) of the tau-end-systolic pressure (ESP) relation before and 
30 minutes after deslanoside (0) 0.8 mg IV in 12 patients with hean 
failure. Hean rate was maintained constant (9O±12 min-I) before and 
after D by atrial pacing. Ees was assessed by simultaneous digital 
ventriculography and micromanometer pressure measurements. Tau 
was assessed by digitizing the pressure waveform at 200 Hz and 
assuming a non-zero asymptote. Mean± S.D.: 
w.. .B... LYEE 
(mmHg/ml) (ms/mmHg) 
Pre D 1.59±O.81 0.83±O.60 0.32±O.1O 
Post D 2.15±O.99 0.54±O.42 0.39±O.09 
p-value 0.0074 0.04 0.0014 
L 
(ms) 
72±12 
76±16 
0.16 
~ 
(mmHg) 
74±17 
83±18 
0.0043 
~~~~!~f;~~3e~~:~retnu~:eon in 0.4 -----p-:-0-.O-1"'t 
patients with the highest baseline R 
value (see graphic). 
Conclusion: 1) Peslanoside acutely im•
proves myocardial contractility and in-
creases ESP in hean failure. 2) D .1.6"'0'--...... ,..a.. ....... '---i 
acutely improves myocardial relaxation, i,pr;'O D.~I~n:~~d;·5 
an effect which may be masked if T is 
not normalized for ESP 3) Peslanoside 
may have the greatest effect on relaxation 
in the patients with the most impaired baseline lusitropy. 
950·57 
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Amelioration oC the Heart Failure State with Left Ventricular 
Assist System Support 
Tulio Estrada-Quintero, Barry E. Uretsky, Srinivas Murali, Anita 
R. Betschart, TammyR. Tokarczyk, Yvonne M. Cannon, Robert 
L. Kormos, Bartley P. Griffith, University of Pittsburgh, 
Pittsburgh, PA 
The heart failure syndrome (CHE) is characterized by 
neurohormonal activation and exercise intolerance. To determine 
if augmentation of cardiac performance using a left ventricular 
assist system (LV AS) improves these abnormalities in NYHA IV 
pts, we compared plasma norepinephrine (NE, pg/ml), renin 
activity (pRA, ng/ml/h), atrial natriuretic peptide (ANP,pg/ml), 
submaximal exercise tolerance using the 6 minute walk test (W, 
meters) and maximal exercise capacity using peak oxygen 
consumption (YO" ml/kg/min) in LV AS and NYHA III and IV pts 
on standard CHE therapy. 
LVAS NYHAm NYHA IV 
(n=7) (n=58) (n=76) 
NE 327±227 742±554* 1058±564#+ 
PRA 6.5±9.2 9.9±9.8 18.2±18.2#+ 
ANP 92±67 337±317* 482±361#+ 
p<O.OI * III vs LVAS; # IV vs LVAS; + III vs IV 
All NYHA IV pts and LV AS pts prior to device insertion were 
dyspneic at rest and unable to exercise. W test in LV AS group 
was 373±158 m and 353±93 m in NYHA III (p=ns). Peak VO, 
in LV AS pts was 13.0±6.3 and 12.5±4.0 in NYHA III pts 
(p=ns). Conclusion: LVAS ameliorates neurohormonal 
activation and exercise intolerance characteristic of the CHF state. 
951 Epidemiology/Prevention 
Wednesday, April 15, 1992 
9:00 AM-Noon 
Dallas Convention Center 
Lower Level Exhibit Hall 
Presentation Hour: 9:00 AM-IO:00 AM 
951·14 
Prognosis in Patients with Angina-like Chest 
Pain and Normal Coronary Arterioqrams, a 10-
Year Follow-up study 
Klaus Bargheer, Hans-Joachim Trappe, Paul 
Wenzlaff, Matthias Tritschler, Paul Lichtlen. 
Hannover Medical School, Hannover, Germany 
To determine the long-term prognosis of 
patients with angina-like chest pain and normal 
coronaryarteriograms (CA), 178 patients (pts) 
(61 women, 117 men; mean age 48.1 years) were 
followed for an average of 118 months (66 to 
157). Follow-up is based on patient's 
questionnaires, hospital case-histories and 
reports from physicians. 
Eight pts died (1 from acute myocardial 
infarction (AMI), 1 suddenly, 1 with chronic 
cor pulmonale, 5 from non-cardiac ,reasons). Of 
the 170 survivors, 137 pts (80.6 %) still 
complained of chest pain at the time of follow•
up. Thirty-five pts were still on antianginal 
medication (20.6 %). Only 9 pts developed a 
manifest new CAD, 4 of them (2.2 %) suffered an 
AMI, 33, 93, 107 and III months after CA, 5 had 
typical angina. From the 14 pts with a second 
CA (including 3 of 4 with AMI) 8 pts showed 
CAD. Two pts underwent PTCA, 1 CABG. All pts 
with manifest CAD had one or more risk factors: 
6 were severe smokers, 2 had elevated 
cholesterol levels (>7.5 mmol/l), 3 elevated 
triglycerid levels (>2.4 mmol/l) and 6 were 
hypertensives. 
We conclude that a normal CA in the presence of 
angina-like chest pain has an excellent long•
term prognosis (0.51 % of pts with manifest new 
CAD per year). However, angina-like chest pain 
in the majority of the pts persists over years. 
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951·15 
Syndrome X In Women: the Importance oC O.arlan Hormones 
Giuseppe Rosano, David Lindsay, Juan Carlos Kaski, Philip 
Sarrel, Philip Poole-Wilson. 
Departments of Cardiac Medicine, National Heart & Lung 
Institute and Hammersmith Hospital, London, UK 
Syndrome X (angina pectoris, positive exercise test, normal 
coronary arteries) occurs predominantly in women. The aim of the 
present study was to evaluate the relative importance of ovarian 
hormones in this condition. 99 patients with syndrome X were 
reviewed in our departments (mean age 54.9±7 yr), of whom 78 
were women. Hysterectomies had been performed in 35/18 women 
(44.9%), whilst the prevalence of hysterectomies in the general 
UK population is 8-12%. The mean age at hysterectomy was 
40.6±5.7 yr and the delay between the hysterectomy and onset of 
symptoms was 8.68±7 yr. Thirty female patients were investigated 
in more detail to document the presence of symptoms and signs of 
ovarian hormonal deficiency. The mean age of this group was 52 
(46-53 yr), and 18 had a previous hysterectomy. All the women 
were found to be experiencing moderate to severe hot flushes. 
Hormone assays showed all of the women to be severely 
hypoestrogenic (estradiol- I 78 <25pg/ml). 
In conclusion, women with syndrome X have a high prevalence 
of hysterectomies, and frequently display symptoms of ovarian 
hormonal dysfunction. Ovarian hormones are known to be 
vasoactive, and many of the climacteric symptoms are caused by 
vasomotor instability. The pathogenesis of the syndrome in women 
may be due to a generalised alteration of vasomotor control, 
including dysfunction of the coronary microcirculation, secondary 
to ovarian hormonal deficiency. 
951·16 
Baseline Fibrinolytic State and the Risk of Future Venous 
Thrombosis 
Paul M Ridker, Douglas E Vaughan, Meir J Stampfer, JoAnn E 
Manson, Caifang Shen, Laura Newcomer, Samuel Z Goldhaber, 
Charles H Hennekens. Harvard Medical School, Boston, MA 
Although isolated abnormalities of plasminogen activation and 
inhibition have been reported among selected patients with 
venous thrombosis, whether these deficiencies of fibrinolysis are 
important risk factors for future thromboembolic disease remains 
uncertain. To evaluate whether baseline levels of endogenous 
tissue plasminogen activator (tPA) and plasminogen activator 
inhibitor type·1 (P AI· 1 ) predict the future occurrence of venous 
thrombosis, levels of these proteins were measured in 
prospectively collected plasma samples from SS participants in 
the Physicians Health Study who later developed deep venous 
thrombosis or pulmonary embolism, and from an equal number 
of age and smoking matched controls who remained free of 
vascular disease during the follow-up period of 60.2 months. 
Overall, no statistically significant differences in baseline levels 
of PAI·1 (SO.5 ng/ml vs S9.5 ng/ml, p=0.26), tPA (13.4 ng.ml vs 
13.3 ng/ml, p=O.94), or PAI·1:tPA ratio (6.84 vs 6.S8, p=0.82) 
were observed between cases and controls, respectively. There 
was no evidence of a threshold effect or trend in analyses by 
increasing quartiles of PAI·1, tPA, or the PAI·1:tPA ratio, nor 
were these results changed by multivariate analyses which 
simultaneously controlled for other baseline cardiovascular risk 
factors. 
In contrast to previous uncontrolled case series, these 
prospective data provide evidence against screening for baseline 
fibrinolytic capacity to predict future venous thrombosis. 
ABSTRACTS 255A 
951·17 
Comparative Mortality Analysis of the Inter•
national TPA/STK Trial. An Unexplained Variance 
Gabriel I. Barbash, Harvey D. White, 
Frans Van de Werf for the Investigators of the 
International TPA/STK Trial. 
Despite uniform inclusion and exclusion 
criteria and treatment protocol in the 
International TPA/ STK trial, 30-day mortality 
rates (irrespective of treatment allocation) 
ranged from 4.2% to 14.8t in the different 
countries. A multivariate logistic model 
analysis identified older age, entry systolic 
hypotension «95mmHg), Killip class> 1, 
history of antecedent angina, diabetes 
mellitus, previous infarction, and non-smoking 
as associated with higher mortality. To 
explain mortality variation, the logistic 
model calculated the expected and observed 
mortality rates were calculated for each 
decile of the study population. Mortality 
among the 1612 pts in deciles 9-10 was 26.0t 
whereas among the 1606 pts in deciles 1-2 it 
was 1.2t with a sensitivity and specificity of 
58.6% and 83.7%, respectively. Expected 
mortality efficiently predicted actual 
mortality in most countries. However, there 
was an overall significant difference between 
country specific observed and expected 
mortality rates (p < 0.001). When the 2 
countries with the highest and lowest 
mortality were excluded, - this overall 
difference became non-signiicant. These 
findings suggest that the recognized risk 
factors associated with increased mortality in 
AMI are insufficient to account for 
differences across populations. 
951·18 
Changes in Lipid profile and fibrinogen with Bezafibrate 
and Maxepa (fish oil) in dyslipidaemic cardiac transplant 
recipients. 
Mahmud Barbir, Beverly Hunt, Andrew Mitchell, Magdi 
Yacoub. Harefield Hospital, Harefield, Middx UB9 6JH UK 
Lipid abnormalities are common in cardiac transplant 
recipients and hyperlipidaemia but the optimal lipid 
lowering therapy is unknown. We have therefore compared 
the efficacy and safety of two lipid lowering drugs in 
87 cardiac transplant reCipients receiving Cyclosporin 
and Azathioprine. All 87 patients had dyslipidaemia, 
total cholesterol T.C. > 6.5 and/or triglycerides T.G. 
> 2.8 and/or HDL <0.8 mmol/l and were randomised to 
receive Bezafibrate 400 mg or Maxepa 10 mg daily for 
three months. Serum values mean ±SD in all patients 
before treatment and changes in each group were: 
Pre on bezafibrate on maxepa P 
TCmmol/l 7.3:':1.3 -0.87:':1.0 0.01:':0.9 0.0003 
TGmmol/l 3.1:':1.4 -0.94:':1.1 -1.1 :!:1.3 NS 
LDL-C 5. 2:!:1. 2 -0. 90:!:1. 0 0.03:!:0.8 0.0001 
HDL-C 1.07:':0.3 0.30:':0.4 -0.02:':0.2 0.0002 
Creat. 
umol/l 140:':27 35:':23 12:':21 0.0001 
Fibrinogen 
gil 4.97 -0.33:':.14 0.11:':0.12 0.02 
Bezafibrate reduced total cholesterol TC, LDL-C and 
fibrinogen levels and increased HDL-C levels and creat•
inine to a significantly greater extent than maxepa, 
without increasing serum cyclosporin levels. Both drugs 
decreased T.G. in a comparable manner. We conclude that 
Bezafibrate is more effective than maxepa in treating 
dyslipidaemia and reducing fibrinogen levels after card•
iac transplantation but requires monitoring of renal 
function. 
256A ABSTRACTS 
951·19 
Effects of Intensive Physical Exercise and Low Fat Diet on 
Anaerobic Threshold and Myocardial Perfusion in Patients with 
Stable Coronary Artery Disease 
Rainer Hambrecht, Thomas Muth, Martin Grunze, Christian 
Marburger, Josef Niebauer, and Gerhard Schuler. 
Med. Uni·K1inik Heidelberg, Germany. 
The effect of intensive phvsical exercise and low·fat diet on 
ventilatory anaerobic threshold and myocardial perfusion was 
studied iii 77 patients (pts) with symptomatic coronary artery 
disease (CAD). Pts were randomIZed between a supervised 
training group (Training) with daily exercise and a control group 
(Control) on usual care and non·supervised physical activity. 
Exercise·induced myocardial ischemia (EMI) was assessed by 
TI-201 scintigraphy before and after 12 months of participation. 
Myocardial oxygen consumption was determined by rate· 
pressure product (RPP) at peak exercise. Ventilatory anaerobic 
threshold (VT) was defined by ventilatory parameters (VEjV02; 
VEjVC02; RQ). In pts on 'Training' there was a significant 
improvement of oxygen uptake at VT (from 1.01 ±.2 to 1.13 
L/min; p<.05) and peak exercise (from 1.8 to 1.95 L/min; 
p<.05). Furthermore, EMI was significantly reduced (from 
47±41 to 38±39; p<.05), while maximal RPP had increased 
(from 26±5 to 29±5; p<.01), indicating a significant 
improvement of myocardial perfusion. These parameters 
remained essentially unchanged in pts on usual care. 
Conclusions: In pts with stable angina pectoris regular physical 
exercise causes an improvement of myocardial perfusion and 
functional aerobic capacity. Non·supervised phYSical activity on 
pts own initiative is adaequate only for maintaining a state of 
conditioning. 
951·20 
Factors Predicting Multlve.el Coronary Disease In Postmenopausal 
Women 
Kathleen Voigt. Robert Short. Marcus DeWood. The Heart Institute of 
Spokane, Deaconess & Sacred Heart Medical Centers, Spokane, WA. 
To determine the relationship between risk factors and coronary artery 
disease (CAD) in postmenopausal women, 307 consecutive women 
undergoing coronary arteriography for angina were studied 'or cholesterol 
(CHOl), age, diabetes, weight, marital status, and number of coronary 
vessels diseased (CVD). Subjects were 43 - 90 years and 17% diabetic. 
CAD was defined as ~ 50% stenosis. 
75 
If 60 • 40-49 Vrs. 45 • 50-59 Yrs. II • 60-69 Yrs. 30 ~ 70-79 Yrs. 15 0 80 + Vrs. 
0 
0 2 2:3 
,CVD 0 1 2 ~3 
CHOl" 211±47 230±45 241±43 228±41 
AGE" 63±10 67±09 SS±11 70±09 
" MeantSO 
Multiple regression showed age (p<.OOI) and CHOl (p<.002) to be the only 
predictive factors of CAD with diabetes (p<.056) marginally predictive. The 
additive effects of age and CHOl were more predictive of CVD than either 
lactor alone. In conclusion, 1) CHOl and age were Significant factors in 
prediating the extent of CAD in postmenopausal females and 2) the 
incidence of CAD in the 40 and 50 year group confirms the combined 
protective role of young age and gender. 
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Ventricular Arrhythmias by Passive Smoke in Patients 
with Pre-existing Myocardial Infarction 
Aurelio Leone, Franco Bertanelli, Lino Mori, Paolo 
Fabiano, Gildo Bertoncini. 
Medical Division City Hospital Pontremoli, Italy 
Aim of the study was to assess the effects of exposure 
to passive smoke on ventricular arrhythmias (VA) 
of 10 nonsmoker patients with pre-existing myocardial 
infarction (mean age:53.8~5.3 years) undergone exercise 
stress testing twice: on first time in sixty cubic 
metres indoor space not polluted by cigarette smoke 
and on second time in indoor carbon monoxide concentra•
tion 30-35 ppm reached by a method of cigarette 
combustion described previously. The previous day 
of exercise ambulatory monitoring did not show complex 
VA (only a few isolated extrasystoles) and baseline 
carboxyhemoglobin mean level measured 1.2~0.1%.During 
exercise in indoor passive smoke 6/10 people (60%) 
showed significantly greater number of VA (a total 
of 1156 extrasystoles- multiform extrasystoles, 
couplets, salvos- and 4 episodes of ventricular 
tachycardia) if compared to themselves in a smoke•
free ambient (a total of 142 isolated extrasystoles,no 
ventricular tachycardia, P less than 0.01). In 4<40%) 
cases we stopped exercise in smoke ambient because 
of these arrhythmias. Mean post-exercise carboxyhemo•
globin level was increased significantly (2.3~0.4%, 
P less than 0;01). Passive smoke increases VA by 
exercise in patients with pre-existing myocardial 
infarction. 
951-22 
Improvement of Myocardial Perfusion and Progression 
of Coronary Artery Disease in Patients on Physical Exercise 
Gerhard Schuler, Rainer Hambrecht, Giinter Schlierf, Wolfgang 
Kiibler. Med. Uni·Klinik Heidelberg, Germany 
Regular physical exercise in patients (pts) with coronary artery 
disease has been shown to reduce exercise induced myocardial 
ischemia. In order to define the underlying mechanism 50 pts 
participating in an intervention program (regular physical 
exercise/low fat diet) were studied by digital coronary 
angiography at baseline and 1 year. Stress induced ischemia was 
assessed by lOln·scintigraphy (juring maximal stress and 
expressed in a score point system. Erythrocyte aggregation rate 
(EAR) was determined as a measure of blood rheology. Results 
were compared to 50 pts on 'usual care'. In the intervention 
group stress induced ischemia improved from 1.95±1.2 to 
1.48±0.9 score points (p<0.05). Regression of coronary lesions 
was observed in 9 pts (=18%), coronary morphology remained 
unchanged in 34 pts (68 % ), or deteriorated in 7 pts (14 % ). EAR 
decreased from 0.34±0.1l mPa to 0.26±.07 mPa (p<0.002) 
indicating improvement of blood fluidity. Reduction of stress 
induced ischemia occurred independently from changes of 
coronary morphology, and was not limited to pts showing 
regression of coronary lesions. In the control group stress 
induced ischemia (1.59±1.2 vs. 1.60±1.l points) and EAR 
(0.35±0.10 mPa vs 0.34±0.09 mPa) remained essentially 
unchanged; there was regression of coronary lesions in 2 pts 
(4%), no change in 26 pts (52%) or progression in 22 pts (44%) 
(different from intervention p<O.OI). 
CONCLUSIONS: In pts on regular physical exercise and low fat 
diet coronary artery disease seems to progress at a slower rate as 
in pts on usual care. Reduction of stress induced myocardial 
ischemia, however, does not depend on regression of stenoses 
and may be observed even in pts with progression of coronary 
lesions. Different mechanisms, such as improvement of blood 
fluidity, are likely to be activated in order to achieve this 
beneficial effect of exercise. 
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951·23 
Dep...u.e SymplOml in Cardiac Rehabilitation Patienll CornIates with Bluntec 
Tralnlna Ell'eet 
Jill DowDiDa. ADdrew UItmIn. Judy Scbeer. BellI Peu 
MUlKhUMIII Geaera1 HOIpital. BoIIoD. MuuchUMIII 
Delpile limi1ar raIeI of COIOIIII')' artery di_ (CAD). iDformatioo available IhoWi 
-- panioipatiDa leu frequendy &lid beina 1_ complimt than mea ill c:ardiao 
rebabililaiioo (CR) propama. To defiDe !hi. experiClllOll. 746 pII. (aae 59 ± 12) 
referred for CR __ proIpeOtively IIIIOUed ill a multiceaw daIIbue. Thi. aroup 
iDoluded 533 mea (72") &lid 212 _mea (28"). Womea entered with pater 
IIlIIDber of riIk ficton &lid more fuDctioaal impairmeot. &en:iJe toleranoe differed 
ICCOI'cIiDa to ap &lid aender with _mea 60 yean or older cIemooItratiIIa the IhorIeII 
InIIdmill IiD* &lid lowell maimum Olyaen OOIIIIImpliOll (VOl). PoUDWina ao 
avenae of 10weeb oflrliDiDa. mea aod _. both <60 aod~6O YR. mowed 
lipifioaot improvemeat in exerei. duntiOD (ex dur) aod V02 (p < 0.0001). a1thouah 
older _mea Ihowed the larpel relative improvemeat in both el dur aod VOl. 
DeprelliOll IICOreI were oaIoulated wa the Symptom (Kellner) 
QueatiOIlIIaire. Data OIl 249 panicipaoll were obtaiDed UPOll exit from the CR 
proaram. The foUDWina wu demoDltrated. 
Enlnllce Deprellioo SoaIe (pre) Exit Dep,...iOll SoaIe (POll) 
leI II mean + •. d. .1 II meaD + I.d. 
M 442 4.65±5.21 M 185 2.59:1:,4.04 
P 159 6.23 ;1:5. 72 P 62 4.52;1;5.00 
Men demoo8trated fewer deprellive .ymptoml than _men upon entry to 
CR propama (p<0.001). While both aroupalowerecltheir deprellive au durina 
the inlerveatiOll lipifioaotly (M pre v pOll p<O.OOOI; P pre v pOll p<0.03). 
womea llill reported more claprellive I)'mptomlthan mea at exit (p < 0.003). When 
claprelliOD au were oorrelated with exercile performaooe. thOle individuals 
lICOrina within the normal raop. or ODe IIaodard cIevi.tiOll above the meaD for 
normal IUbjeoll demonatnted a areeter lrIinina effeot than thOle with IICOreI 
lUaplliDa IUbIIaotial to leVere diatrees. 
Purther aoa1ysi. mould better defiDe behavioral predictoR of IUccessful 
outcome from IIICb risk fIcIor modification efforll u CR. 
951·24 
Relatlonlhlp Between LAft Ventricular "I .. end C8rdloVilcullr 
RHctlvlty In Children 
·Francls M. McCaffrey. MarUyn C. Meeks. 
Ronald Vandemoord. Frank A. Treiber. WUllam B. Strong. 
Medical College 01 Georgia. Augusta. GA 
Cardiovascular raactMty (CVR) to stress has been Identlfled as a 
possible mechanism In the development 01 essential hypertension 
(EH). It Is also known that Increased left ventricular mass (LVM) 
predates EH In adolescents with famly histories 01 EH. This study 
Investigated the relatJonshlp between LVM and CVR to laboratory 
81ressora (forehead cold stlmulatlon and video game challenge). In a 
group 01 normotensive chDdren with positive family histories 01 EH. 
LVM was derived using m-mode echocardlography via the formula 
(0.8 )( [1.04 )( (septal thickness + left ventricular end diastolic 
dimension (LVEDD) + posterlal wall)3. (LVEDD)~ + 0.6) and adjusted 
for height via a regression formula (LVM adj). 
There were 68 chldren studied. with a mean age 01 10.5 ± 2.6 
yesrs and a mean weight 0144.9 kg ± 18.7 kg. They were equally 
distributed by race Q.e .. whtte. black) and gender. 
Slgnlflcant posttlve Pearson correlations were observed between 
LVM adj and systolic pressure (SBP) at rest. peak SBPs during 
forehead cold stimulation and to video game challenge. peak cardiac 
output (CO) and peak total peripheral resistance (TPR) during forahead 
cold. amount of vigorous activity and age adjusted weight (r range = 
.23 to .50). 
A stepwise multiple regression using these slgnlflcant variables as 
predictors of LVM adj was performed. The first predictor to entar the 
equation was peak SBP during forehead cold (model R2 •. 25). 
followed by CO during forehead cold (model R2 •. 35). and. finally. 
vigorous physical activity (model R2 - .39). No other variables added 
sIgnHlcantly to the model (p s 0.05). Given that CVR was the largest 
concurrent predictor of Incressed LVM In chUdran. prospective studies 
are warrantad to determine the potential etiologic role of CVR upon the 
development of left ventricular hypertrophy and EH. 
ABSTRACTS 
951·25 
Determinants of Left Ventricular Mass in the Treatment 
of Mild Hypertension Study (TOMHS). 
Philip R. Liebson, Ronald J. Prineas, Greg A. 
Grandits, Sinda S. Dianzumba, Jeremiah Stamler, 
Richard H. Grimm for the TOMHS Research Group, Rush· 
Presbyterian·St. Luke's Medical Center, Chicago, 
Illinois. 
Left ventricular mass index (LVMI) was. assessed by 
echocardiogram (ECHO) for 511 men and 333 women with 
mild hypertension (mean diastolic blood pressure 91 
mmHg) at entry into TOMHS. LVMI was determined by M· 
Mode ECHO criteria using Penn convention formulae 
indexed to body surface area (g/m2). The relationship 
between LVMI and the following factors was assessed 
using multiple linear regression analysis: systolic 
blood pressure (SSP), age, smoking, total cholesterol, 
alcohol use, urinary sodium and previous 
antihypertensive monotherapy. 
For both men and women. SSP and urinary sodium were 
positively related to LVMI with 9 10 mm Hg difference 
in SSP associated with a 4·5 g/m difference \n LVMI. 
Smoking was related to LVMI in men (LVMI 12 g/m higher 
for smokers than non·smokers) but not women. 
Cholesterol was inversely related to LVMI In women 
onlY'2with a 10 mg/dl difference, associated with an 
8 g/m difference in LVMI. 
These findings indicate that for these factors, SSP is 
the strongest predictor of LVMI In both men and women 
and that urinary sodium is also an independent 
predictor of LVMI. Smoking and cholesterol may have 
different associations with LVMI, depending on sex. 
951·26 
ECHOCARDIOGRAPHIC SMY OF HYPERTENSIVE STRESS 
TEST RESPONSE SUBJECTS. 
Jose Azevedo,Paule Amado.Isabel Arroja,Jose Casta 
nhaira.Jose Carmona,Jose Marques,Vasco Araujo. -
Cardiology-Egas Moniz Hospital-lisbon-Portugal. 
We studied agroup of 60 n01'lllal subjects (Group H, 
mean age 50~18 yrs,7OX males)with no history of 
cardiovascular disease.normal systolic function 
and basal BP but hypertensive BP response to nega 
tiva treadmill exercise stress test. This group was 
compared with 100 normal subjects (Group H,mean a 
ge 48±15 yrs.6BX .. les) with normal BP response to 
exercise stress tes.We·performed a echocardiograp•
hic study to all subjects and measured:left atrial 
diameter (LAD/ .... ) ,Left atrial index (LAI/an/ .. 2 ) 
Left atrial aorta cross sectional ratio (LAA) and 
Left ventricular .. ss index (LVMI/g/m").All subje 
cts were subnaited to IIIIbulatory BP IIOnitoring (AD" 
PM) and calculate .. ximum «MSBP) ,1liiian (SBP) systo 
lic BP and ABPM Heart rate/BP product (HRBP). the•
following chart reBUllleS our results:: 
H H P 
LAD 33i4 45*3 0.001 
LAI 1.78*0.09 2.28*0.35 0.005 
LAA 1.13*0.07 1.3B*o.20 0.01 
lVMI 134*13 149*17 0.001 
R Pearaon coefficient between LVMI and MSBP (0.59) 
SBP (0.79) and HRBP (0.B7).We conclude that in spi 
te of nOI1Dal BP hypertensive stress test response•
aubjects have already abnormal echocardiogrephic 
findings end hypertensive ABP" profile in 8iX 
and 74X respectively. 
257A 
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951·58 
JroqDo.tio Rol. ot L.tt V.ntrioular Hyp.rtrophy 
Ind.p.nd.nt ot coronary Art.ry Di ..... 
Jalal K. Ghali, Richard S. Coop.r, Youlian Liao. 
Loyola Univ.r.ity, M.dical c.nt.r, Maywood IL 
In ord.r to examine the association of 
Ichocardioqraphically det.rmined LVH with total 
mortality indep.nd.nt of CAD, 949 predominantly 
black patient. (mean aq. 55.3 yrs)who underwent 
coronary arterioqraphy for pr •• umed CAD and in 
whom echocardioqram. have been obtained were 
followed for a mean period of 4 years. Patients 
with IF <50' were excluded. Patients with LVH 
had a siqnificantly worse survival experience 
compared to those without LVH, whether CAD was 
pre.ent (P<0.05) or absent (P<O.Ol). 
~ Re1atiye Risk 
N n , Unadjusted IIdjusted 
No CAD 
LVH 163 
No LVH 255 
CAD 
18 
9 
11.0 
3.5 
3.34 3.08+ 
(1.50-7.43) (1.37-6.90) 
LVH 175 40 22.9 1.92 
No LVH 241 33 13.7 (1.21-3.05) 
+ Adju.ted for aqe and hypertension 
1.77+ 
(1.11-2.82) 
'!'!. •••••••••••••••••••••••• 110 CAD, 110 ~VII 
- No CAD, ~VH 
• ........................ -.---_. CAD, No ~ va 
• ......... CAD, ~va .. 
-. . ........... .. 
Conclu.ion:Echo-LVH retains its value as 
proqno.tic marker even in the absence of CAD. 
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a 
Anllolraphic Predictors of Restenosis: Analysis of Initial 
Lesion Characteristics and Arterial Remodelling Six Months 
After Anaiopla.ty in a Stable Population. 
Ezra Deutsch, John W. Hirshfeld Jr, Carl J. Pepine, Alfred A. Bove, 
for the M-HEART 5tudy Group. Temple University and the University 
of Pennsylvania, Philadelphia, PA. 
5pecific morphologic variables may predispose cenain coronary lesions 
to reslCnosis following PTCA. To detennine whether the absolulC 
diameu:r (0) of a slCnosis (5) in mm pre·PTCA would independently 
predict the likelihood of subsequent renarrowing, we examined 
quantitative angiographic data from 234 pts enrolled in a prospective, 
multicenter restenosis trial who underwent elective follow-up 
angiography at 6 months. No pts who underwent clinically indicated 
repeat angiography earlier than 6 months were included. Quantitative 
coronary angi0vsphy (QCA) was perfonned by a core laboratory. Pts 
were separated Into 3 groups based upon % diameter 5 at the PTCA site 
at 6 month follow·up. Pre-, immedialCly post-PTCA, and 6 month QCA 
data for each subgroup were compared by t-ICSts. The overall restenosis 
ralC (pts with %5 ~ 50) was 39.7%. The distribution of pts was 141 for 
0·49%5,62 for 50-70%5 and 31 for 71·100%5. Arterial D proximal to 
the lesions were similar in all 3 groups (2.93, 2.97, 2.99 mm;p=ns), as 
was 5 length (11.97, 10.7, 12.7 mm,p=ns). SD post-PTCA were also 
equivalent (1.99, 1.97,1.97 mm;p=ns). 
%s 6mo Sp r.:8 %S pre distal p SD 6mo 
0-49% 0.59 ± ~3 78.9 ± 1.03 2.64 ± 0.09 1.90 ± 0.04 
50·70% 0.52 ± 0.06 82.4 ± 1.95 2.46 ± 0.14 1.22 ± 0.05+ 
71·100% 0.33 iO.05·* 87.7 ± 1.70· 2.05 ± 0.20* .45 ± 0.1 *# 
·p<.OOl 0-49% vs 71-100%; +p<.03 0-49% vs 50-70%; 
*1'<.00150-70% vs 71-100%; data are mean ± scm 
5ICnosis D pre·PTCA was significantly narrower in pts with the most 
severe reSlCnosis, despilC equivalent arterial recanalization immediate 1 y 
post-PTCA. 58% ofpts with 71-100%S at 6 months had an initial SD 
< 0.5 mm, compared to 37% of pts with 0-49% SD at 6 months 
(p<.001). In this clinically stable population restenosis is more likely 
when the initial slCnotic lumen diamelCr is < 0.5 mm. 
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The New Angiotenlln ConYll1ing Enzyme Inhibitor CII,zaprll Does 
not Prevent Rlltlnolll After Coronery Angloplaaty: thl Results of 
thl MERCATOR Trial 
Patrick W Serruys. Walter RM Hermans. On beha~ of the MERCATOR 
study group. 
CUazapril Is a novel angiotensin converting enzyme Inhlbttor wtth anti· 
prolHeratlve effects In the rat model following balloon-Injury. We have 
conducted a randomized. double-blind, placebo-controlled trial to assess 
the effect of cUazapril In anglographlc restenosls prevention after 
percutaneous translumlnal coronaryangloplasty (PTCA). Patients received 
etther cllazaprll, 2.5 mg In the evening after successful PTCA. then 5 mg 
bid for 6 months, or matched placebo. In addttlon, all petlents received 
aspirin for 6 months. Coronary anglograms before PTCA. after PTCA and 
81 6 month foIlow·up were quantitatively analyzed using an automated 
edge detection technique. In 94% 01 735 recrutted patients, PTCA was 
successful and all In- and exclusion criteria were mel. For the per•
protocol analysis, quantitative angiography at post-PTCA and follow·up 
was avaUabie In 595 patients who compiled with the treatment regimen 
(309 control, 286 cUazaprll). The mean difference In minimal coronary 
lumen diameter between post·PTCA and follow-up angiogram (primary 
endpoint) was .Q.29 :t 0.49 mm In the control group and .Q.27 :!: 0.51 mm 
In the cliazaprU group (p-ns). Clinical events during 6 month follow·up. 
analyzed on an Intentlon·to-treat basis. ware ranked according to the 
most serious clinical event ranging from death (control 2, cllazapril 3). 
non-fatal myocardial Infarction (control 8. cUazaprU 5), coronary 
revascularlzatlon (control 51. cUazapril 53). recurrent angina requiring 
medical therapy (control 67. cllazaprll 68) to none of the above (control 
224, cliazaprU 2t2). There were no slgnHlcant differences In ranking. 
Conclusion Long term angiotensin converting enzyme Inhibition 
wtth cliazaprilin a dose of 5 mg bid does not prevent restenosls and does 
not favorably Influence the overall clinical outcome follOWing PTCA. 
783·3 11:00 
!nozapariD, a Low Ko1ecular Veight HepariD, in the 
PreventioD of lesteDosis After Aogiop1asty: lesults of 
a Double Blind landa.ized Trial 
David Faxon, Theodore Spiro, Steven Minor, John Douglas, 
Gilles Cote, Khosrow Dorosti, Ronald Gottlieb, Robert 
Califf, Eric Topol, John Gordon. Boston University 
Medical Center, Boston, Massachusetts 
Enoxaparin, a low molecular weight heparin, possesses 
antipro1iferative properties and prevents restenosis in 
the hyperlipidemic rabbit restenosis model. To evaluate 
its clinical safety and efficacy, a multicenter, random•
ized, double-blind, placebo-controlled clinical trial 
comparing enoxaparin 40mg qd sc for 1 month versus 
placebo was conducted in 9 centers in North America and 
Canada. 459 patients were randomized into one of two 
treatment groups. The primary endpoint was angiographic 
restenosis at 6 months as determined by a core laborat•
ory using the Computerized Angiography Analysis System. 
Restenosis was defined as the loss of 501 of initial 
luminal gain (NHLBI IV). In addition, the absolute loss 
of minimal luminal diameter (mm) was analyzed. Clinical 
endpoints included death, acute myocardial infarction, 
emergency or elective CABG or PTCA, recurrent angina and 
angiographic restenosis analyzed as an ordinal rank•
adjusted clinical event index. The study population had 
an average age of 57.8 years, 378 were male. Canadian 
Cardiovascular Society anginal class was class I in 41 
patients, II in 173, III in 94, IV in 126. A history of 
myocardial infarction occurred in 155 patients while 44 
had unstable angina and 223 had stable angina. All had 
significant CAD with single vessel disease in 222 and 
multivessel disease in 232. One lesion was dilated in 
339 patients and 2 or more lesions in 118. The final 
results of this clinical trial will be presented. 
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The GRASP Study: Ule of a 1'IIrombcIzaDe A2 Receptor Bloc:ker To 
Reduce Ad_ CiDical EftDlI After Conmary Aqiopluty 
Robert L. Feldman, James R. Bengtson, David B. Pryor, Mark B. 
Zimmerman for tbe GRASP Study Group. Ocala Heart Institute, Ocala, 
FL. 
Advene clinical events after coronary anlioplasty (PTCA) may be 
mediated, In part, by platelet-derived tbromboxane A2 (TXA2). To 
determine wbetber TXA2 inbibition reduces sucb events after PTCA, we 
conducted a multicenter, double-blind clinical trial witb GR32191, a 
TXA2 receptor antagonist. After stratification for recent MI before tbe 
PTCA, 1192 patients were randomized to (1) aspirin 325 mg before 
PTCA, then placebo (Placebo); (2) GR32191 80 mg, tben 20 mg BID 
(GR 20); or (3) GR32191 80 mg, tben 40 mg BID (GR 40). PTCA was 
done in 1089 (91%) of randomized pts. Treatment was continued for 6 
montbs, at wbicb time follow-up anliograpby was performed in 936 pta 
(86%). Clinical event rate (CER) was usessed by rank according to 
severity, with deatb > non-fatal MI > CABG > re-PTCA. No differences 
between GR32191 Iroups were present, but compared to placebo, 
GR32191 reduced CER by 21% (PL 33%, GR32191 26%; p-.02). The 
number of pts in eacb event category was: 
Placebo GR20 GR40 
lbmIl (N"3eiS) (ti-3Cij) (N-3ei!!) 
Deatb 1 (.3%) 2 (.5%) 1 (.3%) 
MI 19 ( 5%) 14 (4%) 12 ( 3%) 
CABG 32 ( 9%) 32 ( 9%) 27 ( 8%) 
Re-PTCA 67 (18%) 44 (12%) 53 (15%) 
Total CER 119 (33%) 92 (25%) 93 (26%) 
Tbe reduction in CER in tbe GR32191 group was primarily due to 
reduction in MI and re-PTCA. 
Thus, a TXA2 receptor antagonist, GR32191, appean to reduce advene 
clinical events, especially MI and re-PTCA, in patients undergoing 
coronary angioplasty. 
783·5 11:30 
Effects of Selective ad Non-lelective ThrombaaDe A2 Blockade on 
RestenOIla After PTCA: Jot-HEART n. 
Alfred Bove. Michael Savage. Ezra Deutsch. Robert Macdonald. 
Theodore Bass. George Vetrovec. Hall Whitworth. Michael Cowley. 
Sheldon Goldberg. James Margolis. James Hill. John Hlrshfeld. 
Jeffrey Grandt. Carl Peplne. for the MHEARI' Investigators. Temple 
University. Philadelphia. Pa. 
Thromboxane A2 tTXA2) has been implicated In smooth muscle 
proliferation and vasoc:onstrlctlon after PTCA. SulotrobanR Is a 
new specific and potent TXA2 receptor antagonist. To study the 
effects of selective (Sulotroban) and non-selective (aspirin) TXA2 
blockade on the prevention of restenosls follOwing PTCA. 755 
patients were randomized to a Sulotroban (S) group (3200 mg/day). 
an aspirin IA) group (325 mg/day). and a placebo (P) group. 415 pts 
who had successful PTCA and were compliant. returned at 6 months 
for followup angiogram. Symptomatic pts studied before 6 mos were 
excluded. Coronary stenosis sizing was done by a core laboratory 
USing Quantitative Coronary Angiography. The table below provides 
% stenosis data (mean ± SEM). 
PRE POST 
% ItenOIla PTCA PTCA 
X 64.4£1.6 29.9£1.3' 
8 82.7±I.O 32.2±1.0* 
P 83.0±1.2 3O.9±1.4· 
• p<O.OOl vs PRE. t p<o.ooi vs P6§f 
42.912.2f' 
49.Q!:2.4t· 
48.3±2.4t· 
Two way ANOVA shows no effect of either A or S on restenosls. 
Changes over 6 months were similar for the three groups. StenOSiS 
diameter changes (table below In mm) confirm absence of a drug 
effect on restenosls. 
IteDOlia PRE POST 
diameter PTCA PTCA 
X 6.49±O.M 1.9l±6.65· 
8 O.5ItO.03 1.88±O.04· 
P O.51tO.04 1.9ItO.05· 
: P<O.&h VS PRE. t P<O.&h vs POST 
em 
1.54±O.66t· 
1.43±O.07t· 
1.43±O.07t· 
Neither selective TXA2 receptor antagonism with Sulotroban nor 
non-selective TXA2 receptor antagOnism with aspirin affected 
restenosts 6 months after PTCA. 
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PrewIIltive Efrect on JWt.enoeII Aftsr Pl'CA by m.eJen :A Newly 
Synthellzecl Anti·lnflammation Apnt 
Ataushi Hirayama, Shinluke Nanto, Tomoki Ohara, Kuuhiko 
Nishida, Yuuji Okuyama, Kazuhisa Kodama. 
Cardiovascular Division, Osaka Police Hoapital, Oaaka, Japan. 
It is hypothesized that reltenoeia after PTCA i. a manife.tation 
of the general wound healilli responle expressed elpecially in 
vascular tissue, which il initiated by the inflammatory responae. 
To prevent reltenosis after PTCA, thia initial innammatory 
responses Ihould be inhibited. Ebselen (2-phenyl-l, 2· 
benzisoselenazol-3(2H)-one), a aelenium-containing heterocyclic 
compound exhibiting an unique anti·innammatory and anti•
oxidant activity as shown by the prevention of inflammatory cell 
activation as well aa lipid peroxidation, might have a preventive 
effect on reatenoaia after PTCA. We randomized 79 patient. to 
Ebselen 200 mg p.o. bid (29 pta) verlUl placebo (50 pta) for 3 
months following elective PTCA. Treatment was ltarted 3 days 
before PTCA. The two groUpl were 8imilar with respect to age 
(6lHI va 60:1:7, NS) and other demovaphic characteristica. 
Complete quantitative angiographic measurementa were 
performed using video densitometry. Quantitative measurement 
was obtained in 2 orthogonal viewl on the 127 legionl dilated 
with baseline (pre-PTCA) immediate after PTCA (po.t-PTCA) 
and 3 months follow-up (3M) angiographic ruml. 
Placebo 
Ebse1en 
Lesions (n) 
43 
84 
Quantitative Luminal Diameter 
Pre-PTCA Poet·PTCA 3 M 
87:1:11 ~ 7at39 
89±10 3&i28 M:l:31* 
(*p<o.ol5 VB Placebo) 
The lesion restenoais rate (defined as loel of ~ 50% of the initial 
gain) was 38.2% in placebo voup and 18.6% in Ebaelen 
Voup.Using Chi aquare analy.ia, for the patients treated by 
Ebselen the occurrence of restenoeil was ligniftcantly reduced 
(p<O.OI5). Thus, it appearl that inhibition of innammatory 
procesa after PTCA may lignificantly reduce the incidence of 
restenoeis after succesBful PTCA. 
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MUL TICENTER. DOUBLE -BLIND. PLACEBO-CONTROllED RANDOMIZED WITHDRAWAL TRIAL 
OF THE EFFICACY AND SAFETY OF DIGOXIN IN PATIENTS WITH MILD TO MODERATE 
CHRONIC HEART FAILURE NOT TREATED WITH CONVERTING ENZYME INHIBlTORS 
J.mes B Young. Berry F. Ur.tsky. F. Eden Sh.h1dl. Llrry G. Yellin. Morl1 
C. H.rrlson. M. King Jolly on behllf of the PROVED Study InvI.tlgltors. 
B.ylor College of Medicine. Houston. TX. 
We conducted I multicenter. double-bllnd. pllcebo-controll.d 
r.ndomlzed withdrawil study of tho IfficlCY Ind saflty of digoxin In B8 
ph with mild to moderate chroniC hoart flilure (CHF) end normol sinus 
rhyttm (HSR). Prior to randomization, III ph had In LV rejoctlon frac•
tion (LVEF) ! 3S%. Ind were rlcelvlng digoxin (0.125-0.5 ma delly) end 
diuretics. No pt WIS tre.ted with converting Inzyme Inhibitors. Th. 
study beg.n with .n B-wk b ... llne phas •• during which digoxin doses were 
.djusted to .chleve serum concentrations of 0.7-2.0 ma/m1. After the 
b .. ellne ph .... pts were randomly ... Igned to continued thorapy with 
digoxin (n-42) or withdr.w.l of digoxin to pl.cebo (n-46) for 12 wk •• 
while diuretics remained constant. Pr.~randomll1tlon charecterist1cs were 
slmil.r in tho two groups. Moxlmal tr •• ,*"lll time. dlst.ncl w.lked In 6-
min. NYHA cl .... LVEF, .nd the frequency of wors.nlng CHF were .ss •••• d 
perlodlc.lly during the wlthdraw.l phIS •. 
By the end of the 12-wk wlthdraw.l pha.e. worsening CHF .,v.r. 
enough to require In increase in diuretics. eme"'Sleney room cerl, or 
ho.pita llut ion occurr.d twice .s often In ph withdrawn onto p l.cebo than 
In those continu.d on digoxin (18/46 vs 8142. respectively; P-0.D2). 
Comp.red with pts maintained on digoxin. tho placebo group show.d 
slgnlfic.nt deterioration In tr .. ,*"lll time ~by 101 •• c. P-D.OOS) and 
LVEF !j.by 4.3%. P<O.OS). There was no slgnlflclnt difference betw .. n 
tre.tment groups in 6-mln w.lk distance or NYHA cl.... Two pts in the 
p l.cebo group .nd one pt In the digoxin group withdrew from the study due 
to adverse effects. 
In conclusion. tho wlthdr.w.l of digoxin In CHF pt. treated with 
diuretics .nd digoxin resulted In signlflc.nt and .... nlngful cllnlc.l 
deterioration. These data conftrm the efficacy and safety of digoxin In 
pts with mlld-to-moderote CHF Ind NSR with systollc dysfunction. 
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Randomized, Double.Bllnd, Placebo·Controlled, 
Withdrawal Study or Digoxin In Patients with Chronic 
Heart Failure Treated with Convertlna.Enzyme Inhibitors 
Milton Packer. Mihal Gheorghlade. lames B. Young. L. Kent Smith. 
Peter I. Costantini. Kirkwood F. Adams. Robert I. Cody. Samuel M. 
Butman. Lynn A. Gourley. M. King lolly on behalf of the 
RADIANCE Study. Mt. Sinal School of Medicine. New York. NY 
Previous studies have shown that digoxin is effective in pts with 
heart failure (CHF) when added to diuretics. but its role in CHF 
treated with converting-enzyme inhibitors (CEI) remains unknown. 
We conducted a double-blind. placebo-controlled withdrawal trial of 
digoxin in 178 CHF pts. Before randomization. all pts had class I-m 
symptoms. LV ejection fraction (L YEF) $ 35% and were receiving 
digoxin (0.125-0.50 mg daily). diuretics and CEI. During an 8-wk 
run-in phase. digoxin doses were adjusted so that levels were 0.7-2.0 
npm!. Pts were then randomly assigned to continued therapy with 
digoxin (n-85) or the withdrawal of digoxin onto placebo (n=93) for 
12 wks. while diuretics and CEI remained constant. All pretreatment 
variables were similar in the two groups. Symptoms (NYHA class). 
LVEF. maximal treadmill time and distance traversed during a 6-min 
walk were assessed before randomization and after 12 wks. 
During the 12-wk withdrawal phase. CHF symptoms deteriorated 
in 28% of digoxin-withdrawal pts vs 6% of digOXin-continuation pts 
(placebo vs digoxin. p .. 0.048). Worsening CHF was severe enough 
to require more diuretics. emergency room care or hospitalization in 23 
of 93 pts withdrawn from digoxin. but in only 4 of 85 pts continued on 
digOXin (25% vs 5%. P < 0.001). Compared with pts maintained on 
digoxin. the placebo group showed a significant .I. in treadmill time (.I. 
by 43 sec. p. 0.003). a .I. in the 6-min walk distance (.I. by 133 ft. p .. 
0.001) and a.j. in the LVEF (.I. by 3.3%. p. 0.01) after 12 wks. Five 
pts in each group withdrew from the study due to adverse effects. 
In conclusion. the withdrawal of digoxin in CHF pts with mild-to•
moderate symptoms treated with CEI results in significant hemodyn•
amic. symptomatic and functional deterioration. These data strongly 
support a continuing role for digoxin in CEI-treated CHF. 
784·3 11:00 
Eft'eet or Captopril and Digoxin on Quality or Life and Clinical 
Symptoms in Patients with Coronary Artery Disease and mild 
Heart Failure 
Helmut Drexler. Martin Schumacher. Jurgen Siegrist and 
Hanjl>rg Just for the CADS Multicenter Study Group. Germany 
We conducted a double-blind. placebo-controlled trial to 
evaluate the longterm effect of captopril (CAP. 25 mg bid). 
digoxin (DIG. 0.25 mg daily) and placebo (PL) on quality of life 
(assessed by a detailed. standardized interview). clinical 
symptoms and exercise tolerance (bicycle ergometry). Patients 
with documented myocardial infarction ( > 2 month old) 
resulting in regional wall motion abnormalities and mild heart 
failure (NYHA cl~s. D-m without digitalis. diuretics. or 
vasodilators) were eh81ble for the study and were randoIIl1Zed 
to either DIG (n=66). CAP (n=63) or PL (n=67) and treated 
for 1 year. Baseline characteristics in the three treatment 
~oups were comparable including ... ejection fraction CAP DIG/PL: 55:!: 10/48:!: 10/50:!: 10 • NYHA class class D 1.5~/93.5%/90.6%). age. infarct loc~tion and inciJence of 
angina. After one year of therapy. DIG significantly improved 
~eneral well-being (p< 0.05 versus CAP) and symptom score p< 0.05 versus C~ and PL). NYHA class was improved in 6.5% of patients with CAP. 45.5% of patients on DIG and 
28% with FL (p< 0.05 DIG versus PL). No differences were 
observed in baseline and follow-up exercise tolerance in the 
three groups. Concerning side effects (any time any degree). 
coulth (CAP/DIG/PL 29.4/17.3/13.9%) and dizziness 
(36.'8/24/11 %) were more frequent with CAP as com{lared to 
DIG or PL We conclude that in .this patient I?!lpulatlon w,ith 
coronary artery disease and mild heart failure foll~wmg 
infarction, only digoxin exerted a beneficial effect on qualIty oT 
life and clinical symptoms. 
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Characterization of the Pro arrhythmic Effects of Oral 
Mllrlnone in Severe Heart Failure: 'Ibe PROMISE Study 
Marrick L. Kukin. Barry M. Massie. Grady H. Hendrix. John F. 
Moran. Pitambar Somani. Philip J. Podrid. Richard J. RodehefTer. 
Gordon L. Pierpont. Udho Thadani. John H. Wertheimer. James 
Shannon. P. K. Tandon. Milton Packer on behalf of the PROMISE 
Study. Mount Sinai School of Medicine. New York. NY 
The PROMISE Trial ahowed that oral milrinone wal asaociated 
with a 28% t in mortality in cia .. III-IV heart failure. To aileSI why 
milrlnone t mortality. we analyzed the arrhythml .. leen during 
lerial 24·hr Holter monitoring in 986 pta in the trial. Holters were 
recorded at baseline and after 1 week. 1 month and 6 months of placebo 
(PBO. n .. 480) or milrinon. (MIL. 40 mglday. n-1506) and were read 
blindly. Proarrhythmia criteria included t frequency (freq) of vent· 
ricular premature beats (VPBI). t pai,. &.: t runl of ventricular tachy. 
cardia (VT) [defined by Morganroth criteria]; proarrhythmia was alao 
identified if length of longest VT was t 2-fold (f VT length) . 
Milrinone Ihowed conliatent and persistent proarrhythmic effects. 
After 1 wk. 29% of MIL ptl va 15% of PBO pts fulfilled ~ 1 proarrhyth· 
mia criteria (P<O.OOl). After 6 mos. proarrhythmia was seen in 27% of 
MIL pts vs 19% ofPBO pts (P < 0.05). despite an t withdrawal of MIL pts 
due to death or Iyncope. Shown below are % of pts in each group who 
fulfilled each Droarrhythmia criteria where'. P<0.05 (PBO VI MIL): 
Week 1 Month 1 Month 6 
--Criteria PBO MIL PBO MIL PBO MIL 
IfVPB freq 4.4% 8.3%' 5.4% 7.6% 9.1% 9.9% 
t Pain + VT 6.5% 11.0%' 7.5% 10.8% 9.9% 12.8% 
t VT eventa 1.5% 6.5%' 1.4% 3.8%' 1.3% 4.5%' 
t VT length 6.7% 13.8%' 6.1% 9.2%' 3.9% 10.3%" 
Proarrhythmia riak did not depend on functional c .. s and was not 
by use of anti·arrhythmic.. Of note. MIL did not t supraventricular 
arrhythmias. &.: actually .I. the risk of linus arrest &.: pauses (P < .001). 
In conclusion. long·term oral MIL therapy produces early and 
persistent proarrhythmic efTects in pta with clall III and IV heart 
failure. Theae effects may explain the t mortality with the dl'llg. 
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ContraaUng Etllcacy and Bar-ty of Law V.,..,. Hlllh Degree of 
PhoaphocIlMtlra.. Inhibition In Mild HMrt Failure. 
Willem Remme, PIt·Aka Bostr6m, Ama W8lthelm. Mlka Hayden, John 
Collllt, for the Eurol*" UK-61.260 Study GrouP. Rotterdam The 
Nelharllndl. 
Eftleacy and, pllllcularly. "'tty of poaItlv. inotropic agents. which act 
through predominant phoaphodlelt_lnhlbltlng (POEI) propertl.. ara 
dlsputad. ,... raportad negatlva .... ultt may relata to the deg .... of POEl, 
dOH levels ulad and lIIIIartty of CHF pia lludlacl. the dedi of low Vfll•
_ ('Is) high dOHg.. UK-61.260. a novel podIva Inotropa with only 
partial. rnodeIt POEl, wu WIIuatad In 138 pia with mild. >3 rno old. 
CHF (NYHA d. II 109 pia. d. III 29 pis). pradomlnant lIchemlc 
cardiomyopathy (>80%) and LV ejec:tIon fraction <4S%. Following a 4 wk 
~out and 2 wi< 1In1l1.bllnd placebo phaH. 130 pia __ randomlzad 
to 0.5. 1 or 2 mg UK tcId (34 pia .. ch) or placebo (P. 28 pis) In addition 
to baHllne dluratlc IhIrapy and _Iualad In a 12 wi< parallel, doubl. 
blind lludy. Eftleacy vartabI8I (bicycle • .a .. duration (EfT.aec). cI~ 
nical ICOra (Lea criteria). cointarvantion and IIfel)' criteria (ilda dedi, 
discontinuation rate. 24 hr H~ __ IIIHIIed at baHllne and at 4 
and 12 wk, Of traallnenl. Baseline clinical and demographic criteria and 
EfT __ comparable betw.n groups. In contrast. allfll 4 and 12 wk, 
EfT Improvad Ilgn/llcantiy In 1 mg (75 aec) and In 0.5 mil UK (38 aec), 
but not In placebo or 2 mg UK (11 and 28 NC, .... p .• nI). Chang .. In 
clinical acore and cointarventlon rate __ IImllar (3 pis In .. ch group), 
but 19% and 16% dlscontlnuad in 2 mg UK and P .... p. VI 9% In both the 
0.5 and 1 mg UK. SIde dedi __ more prominent. but comparable In 
an UK groups (14, 19 and 13 pis In 0.5. 1 and 2 mil UK .... p. VI 5 in Pl. 
However, the only 2 deaths occurred with 2 mg UK. MoraoVfll, In the 2 
mg UK IlrouP 3 pis developad abnormal laboratory valu.. (hypergly. 
cemla, lymphocytopenia and transamloase IIkMItion .... p.). Also. pro•
antlyIhmlc chang.. as dellnad by Morganroth criteria occurred In 48% 
and 4S% of 2 mg UK and P pis .... p. VI 12% and 25% In 0.5 and 1 mg 
groups. Thill, In mild CHF. rnodfIIate POEI. lnIrDducacl by relatively low 
dOHg .. UK-61.260 (1.5 - 3 mg dally) Improv ... .a .. capacity com•
parad with placebo and IpI*I1 IIf.. In contrast, both efficacy and g'. 
ty .,. loti at the higher dOlI l8vel and the Inherent greater POEI dect. 
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EflIcacy and s.t.ty of Plmobendan In Moderate CHF. A Double-Blind 
Parallel 8 Month Comparlaon wtth Enalapril. 
Willem Remme, Hans Krayenbiihl, Gerd Baumann, Helkki Frick, Manfred 
Haehl, Ger Nehmiz, for the European Pimobendan-Enalapril Study Group. 
lnodilator therapy for heart failure (CHF) with predominant cAMP-phos•
phodiesterase Inhibition (POEQ, eg milrinone, enoximone, has met with 
growing scepticism as to IIfIicacy and safety. As these negative results 
may relate to the degree of POEl, Pimobendan (P), a novel oompound 
with partial, moderate POEl and calcium-sensitizing dects, was com•
pared with enalapril (E) In a 6 mo, randomized, doubl&-blind, parallel 
design In 242 CHF pts( 124 NYHA cUI, 118 cUIQ, due to idiopathic 
dilated (38%) or ischemic (62%) cardiomyopathy and abnormal cardiac 
hemodynamics at baseline (C) desp~e chronic, continued diuretic the•
rapy. After a 2-wk placebo run-In period pts were randomized to 10mg P 
(119) or E (123) with titration to 5-2Omg depending on clinical status after 
1 mo. Average daily dosages were 10,3 mg (P) and 10,7 mg (E). Efficacy 
variables, assessed weekly before and 1, 3 and 6 mo after randomization, 
included bicycle lIXercise duration (ETT, primary variable), NYHA cI, car•
diothoracic ratio, weight and coIntervention. 87 pts were retrospectively 
excluded by the Steaing Committee due to improper Inclusion (39 P, 48 
E, no baseline difference). Efficacy was evaluated In ail and Included 
(incQ pts. All pts considered, 42 (P) and 37 (E) discontinued, 10 (P) and 
8 (E) due to worsening of CHF, whereas 14 (P) and 8 (E) died (both ns). 
Serious side effects occurred In 38 P and 33 E (ns). Hotter analysis at 6 
mo did not reveal proarrhythmic effects (Morganroth criteria) in PorE. 
NYHA cI changed equally from 2.51 to 2.13 (P) and from 2.47 to 2.06 (E) 
(both p<.OO1). Also, the need for coIntervention was comparable, 37 P vs 
28 E. ETT (msec) in aU and incl pts (*p<O.05 vs C): 
All C 1mo 3mo 6mo Iinci C 1mo 3mo Smo 
P 379 415* 424* 421 (p=.09) P 364 414* 425* 422* 
E 396 428* 449* 448(p=.07) E 405 427 465* 464 
Cardiothoracic ratio decreased in E (-2.8*), but not In P, whereas weight 
did not change In Mher group. Thus, both in all and included pts, thera•
peutic efficacy and safety of long-term plmobendan oompared well with 
_lapril, Indicating the potential usefulness of partial, moderate POEl, 
oombined with calcium sensitization in moderate heart failure. 
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The Timing of Changes in Left Ventricular Area by 
Echocardiography Derived From a Real· Time Automatic 
Border Detection Algorithm: Comparison with 
Cineventriculography. 
Peter M. Sapin, Gungyuan Xie, Mikel D. Smith, Oi Ling Kwan, 
Anthony DeMaria. University of Kentucky, Lexington, Kentucky. 
Recently an automatic endocardial border detection algorithm (ABO) 
which produces a continuous graphic display of left ventricular (LV) 
area has been incorporated into standard echocardiographic 
equipment No data exist comparing the time-area curves generated 
by ABO with time-volume curves obtained by standard techniques. 
Therefore we performed both echocardiography with ABO in shon 
axis (SAX)and apical 4 chamber (A4C) and cineventriculography 
(VG) within 1 hour in 17 consecutive pts. Acoustic propenies were 
analyzed from the RF echo signal and utilized to construct a blood•
tissue border from which LV area was continuously determined. 
LV volumes were obtained from frame-by-frame analysis of single 
plane RAO VG at 30 frames/sec, computing volumes using 
Simpson's rule. Time-volume curves were then plotted from these 
data. Both methods demonstrated systolic ejection, early diastolic 
rapid filling, diastasis, and atrial filling. From VG and ABO, the 
times from end diastole to the following points were measured : 
Peak emptying rate (PER), end systolic volume or area (ESV), peak 
rapid filling rate (pFR), end of rapid filling (ERF), and onset of 
atrial filling (AF). Results as follows: (mean±.SO time in 
milliseconds normalized to HR=60) 
Time to' PER ESA PFR ERF 
VG 170±60 360±60 600±90 690±60 
SAX 180±70 4IO±IO 550±70* 630±80* 
A4C 160±70 4OO±80 590±130 66O±12 
* = p<.Ol vs VG 
AF 
820±60 
850±40 
890±40 
Conclusion: In individual patients, the time-area curve generated by 
the ABO display is comparable to the time-volume curve derived by 
VG as assessed by the normalized time intervals from end diastole to 
specific points on each curve. 
ABSTRACTS 
785-2 
Assessment of Left Ventricular Dlestolle Function WHh a Naw 
Automated Echocardiographlc Border Detection System: 
Comparison With Doppler 
David A. Foley, James B. Seward, and A. Jamii Tajik 
Mayo Clinic and Mayo Foundation, Rochester, MN 
10:45 
The assessment of ventricular diastolic fundion is essential to understand•
ing cardiac pathophysiology. Volumetric methods and Doppler echocar•
diographic flow measuremenlS have been used to assess left ventricular 
filling patterns. Left ventricular cavity cross-sectional area can be obtained 
in real time with a newly developed echocardiographic system. This sys•
tem utilizes quantitative differences in acoustic properties to differentiate 
between myocardium and blood. Previous studies have demonstrated that 
this system accurately assesses left ventricular systolic performance. We 
investigated whether this system would also accurately assess the pattern 
of left ventricular filling. 
Echocardiographic examinations were performed on 20 patienlS (10 nor•
mal, 7 systemic amyloidosis, 2 Friedreich Ataxia, and 1 hypertensive left 
ventricular hypertrophy). All patients were in sinus rhythm. No patients 
had regional wall motion abnormalities or significant valvular heart disease. 
Automated tracings of the left ventricular cross-sectional area were obtained 
from the parasternal short axis view. Changes in cross-sectional area were 
measured for the early filling period and for the atrial filling period over 6 to 
10 consecutive bealS and were averaged. Pulsed wave Doppler measure•
menlS of diastolic trans-mitral flow velocities were made from the apical 
four chamber view. The maximum flow velocities and the time velocity 
integrals were measured for the early (E) and atrial (A) filling waves on 5 
consecutive beats and were averaged. The ratio of ea~y to atrial filling 
by automated cross-sectional area measurement was strongly correlated 
to the E: A velocity ratio (r - 0.92. P < 0.00001) and the ratio of early and 
atrial time velocity integrals (r - 0.86, P < 0.0001). The atrial filling fractions 
determined by cross-sectional areas and Doppler time velocity integrals 
also were well correlated (r - 0.82, P < 0.001). 
Conclusion: In patienlS without regional contraction abnormalities, the 
global pattern of left ventricular filling can be accurately assessed with a 
newly developed automated echocardiographic border detection system. 
785-3 11:00 
261A 
Rate of Traasmlssloa of Doppler Velocity' A' Waye to tbe Left Veatrleular 
Outflow Tract: A New Iadex of Myocardial Stlffaess 
Makoto Suzuki, J Thomas Heywood, David R Ferry, Pravia M Shah, Loma 
Linda University Medical Center, Loma Linda, CA 
The transmitral Doppler velocity A wave is directed toward the left 
ventricular (LV) apex and is subsequently registered in reverse direction 
in the LV outflow tract (LVOT). The time taken for the velocity A wave 
to be reversed in the LVOT (Ar wave) is defined as A-Ar interval. We 
hYPOthesized that the velocity wave propagation follows the same principle 
as velocity of pressure wave propagation (c) in a thick walled elastic tube 
of radius r and thickness h, as per Moens·Korteweg equation which states 
that c - EL/2dr where E - Young's modulus of stiffness, d - density of 
fluid. The present study in 20 patients examines the potential of the A-Ar 
interval as an index of LV stiffness. Simultaneous recordings of high 
fidelity pressures using manometer tip catheters and pulsed Doppler 
spectral tracings with the sample volume placed in mitral orifice and in 
L VOT were obtained. LV angiography was performed immediately 
thereafter. The A-Ar interval was measured using peak of A wave and 
nadir of Ar with R wave as a reference. A/E ratio and deceleration time 
(DT) from mitral inflow velocity waveforms were also measured. The 
pressures and volumes were measured at mid-diastole, pre A-wave and at 
end diastole. dp/dv were computed from mid-diastole to end diastole 
(dp/dv-M) and from pre A to end diastole (dp/dv-A). The correlations of 
A-Ar interval, A/E ratio and DT with end diastolic pressure (EDP), end 
diastolic volume (EDV), Tau, dp/dv·M and dp/dv·A were determined. 
Parameter EDP EDV Tau dp/dv-M dp/dv-A 
A-Ar Interval r--0.08+ -0.43+ 0.26+ -0.56· -0.68·· 
A/E ratio r--.37+ -0.08+ -0.14+ -0.36+ -0.23+ 
DT r--0.36+ -0.30+ 0.07+ 0.11+ 0.14+ 
.p <0.01, **p <0.001, +P - NS 
Conclusion' The A -Ar interval correlated with direct measures of late 
diastolic stiffness, where as A/E ratio and DT did not. It did not correlate 
with rate of early diastolic relaxation but correlated significantly with late 
diastolic stiffness. The A-Ar interval is a new index of myocardial 
stiffness and may be superior to commonly used Doppler parameters of LV 
diastolic function. 
262A ABSTRACfS 
785-4 11:15 
Echocardlographlc Automated Border Detection for On-Line 
Determination of Left Ventricular Function During Acute Alterations 
In Preload 
John Gorcsan III. Lee G. Oeneault. Michael R. Pinsky. 
University of Pittsburgh. Pittsburgh. PA 
Echocardlographlc automated border detection (ABO) can provlde on•
line measurement of LV cavity area. The objective was to determine If 
ABO echo can determine rapid changes In LV function Induced by 
acute alleratlons In preload In an animal model. Accordingly. 7 open•
chest dogs were studied by ABO echo at baseline and during Inferior 
vena caval (IVC) occlusions. Epicardial echo Images at the mid-LV level 
were obtained In the short-axis plane. Simultaneous electromagnetic 
flow measurements of stroke volume (SV) were made from the ascend•
Ing aorta. In 2 dogs. simultaneous mlcromanometer LV pressure was 
recorded. On-line Integration and display of ABO echo area and LV 
pressure was carried out by a computer workstation through a custo•
mized Interface with the ABO echo system. An example of consecutive 
'" on-line pressure-area loops from 
an Ive occlusion Is shown. Beat•
by-beat ABO echo stroke area 
(SA) was calculated as end•
diastolic area· end-systolic area. 
';':fr,' Stroke force (SF). an Index of 
stroke work (SW). was calculated 
in 2 dogs from the pressure-area 
loops. Linear regression analysis 
was used to correlate SA with 
electromagnetic SV and SF with 
-,.', SW during baseline and Ive 
occlusion. The results were as follOWS: Baseline variation of SA with SV 
was <8%. and SF with SW was < 14%. The correlation of SV with SA 
was r - 0.90. SEE 8%. and SW with SF was r = 0.87. SEE 16%. 
In conclusion. ABO echo appears to detect acute alterations In LV 
function Induced by rapid changes in preload. On·llne derivation of LV 
pressure·area relationships using ABO echo appears to be a promising 
new method to evaluate LV function. 
785-5 11:30 
Lataral GaiD COlDPaD.atioD. A ..... athod to 
Impro.a TWo Dim.D.ioDal 8chocardiographic 
ImagiDg aDd racilitat. OD-LiD. 8dg. Dat.ctioD 
aDd QuaDtificatioD of VaDtricular rUDctioD 
Julio E. Perez. Alan D. Waggoner. Benico Barzilai. 
Victor G. Davila-Roman. Hiram Cardona. David M. Prater. 
Carrie Fraser, James G. Miller, Washington University, 
St. Louis, MO and Hewlett-Packard, Andover, MA 
Conventional two-dimensional echocardiography provides 
adequate images for interpretation in 85-90% of patients 
with transthoracic approach and nearly 100% of Cases 
with transesophageal imaging. Nevertheless, there is 
limited visualization of specific structures due in part 
to the anisotropic ultrasonic properties of myocardium. 
Time-gain compensation (TGC) enhances detection of 
structures situated at a given depth. To determine 
whether visualization can be also selectively enhanced 
in radial sections of the field of view lateral gain 
compensation (LGC) has been developed. This methodology 
permits enhancement of receiver gain in any of 8 
selected triangular-shape radial sectors of a 90· field. 
with incremental gain from 1-40 dB in a manner 
orthogonal to TGC. We have evaluated LGC in 30 patients 
and subjects (transthoracic and transesophageal) and 
have found it extremely useful to improve visualization 
of lateral endocardial-blood borders from short axis and 
four chamber views. This improves automatic edge 
detection and quantification of ventricular cavity areas 
and functional indices on a beat-by-beat basis based on 
the tiSSUe-blood acoustic properties. Thus, LGC 
represents a major improvement in echocardiographic 
imaging to enhance detection of endocardium and 
facilitate quantitation of global ventricular function 
and assessment of segmental function on-line. 
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Pressure-Dimension Analysis of Regional Left Ventricular Performance 
Using Ecbocardiographic Automatic Boundary Ddection: Validation in an 
AoimaI Model of looIropic Modulation 
John P Fisher, Joseph S Mikan, Eric Rossow, Joseph P Nagle, Daniel B 
Fram, Laura M Maffucci, Raymond G McKay, and Linda D Gillam. 
Hartford Hospital and University of CODDecticut, Hartford, CT. 
While the analysis of pressure-<iimension relations under changing loading 
conditions provides a sensitive index of myocardial contractility, the 
approach has been limited by the lack of a practical means of rapid on·line 
dimension determination. Recently a means of 2D echocardiographic 
automatic boundary detection (ABD) has been shown to provide accurate on•
line tracking of ventricular areas. To determine the feasibility of applying 
this technology to pressure-<iimension analysis, we obtained short axis 
echocardiograms with ABD at the apex, low papillary, and midpapilJary 
levels in 8 open-chest anesthetized pigs. The resultant area·time curves 
correlated with area·time curves obtained with simultaneous intracardiac 
ultrasound imaging at the same level (r= .89-.99). The area-time curves 
generated with ABO were combined with simultaneous micromanometer 
pressure to obtain instantaneous ventricular pressure-<iimension curves. 
Families of curves were obtained from up to 18 cardiac cycles during acute 
changes in loading conditions achieved with inferior vena cava (IVC) 
occlusion (n=42). As an index of contractility, the end·systolic pressure•
dimension relationship (ESPOR) was derived by the time-varying elastance 
method at baseline and following the administration of dobutamine. The 
slope of ESPOR (mean±SO) was 6.8±2.2, 4.6±2.3, and 6.8±2'! 
cm'/mmHg at the apex, low papillary, and midpapillary levels, respectively 
(p=NS). After dobutarnine administration the slope increased to 14.2 ± 3.9 
cm'/mmHg (p < .(01). Conclusion: Instantaneous pressure-<iimension 
relations can be assessed with cardiac ultrasound incorporating ABO 
technology. The slope of ESP OR derived with this method is unaffected by 
the level of the LV imaged and responds reproducibly and as predicted to 
inotropic modulation. This technique may therefore be useful in the 
assessment of end·systolic contractile indices. 
786 The Use of New Interventional Techniques in Saphenous 
Vein Grafts 
Wednesday, April 15, 1992 
10:30 AM-Noon 
Dallas Convention Center 
East Ballroom B 
786·1 10:30 
Multicenter Experience of Atherectomy of Saphenous Vein 
Grafts: Immediate Results and Follow-up 
Thomas Heany, Barry Kramer, William Knopf, Augusto 
Pichard, Michael Sketch Jr, Nadine Juran, Richard Stack, 
William W O'Neill, U.S. Transluminal Endarterectomy 
Catheter Investigational Group. 
William Beaumont Hospital, Royal Oak, MI 
Balloon angioplasty of stenotic saphenous vein grafts, 
particularly old vessels with extensive atheromatous 
degeneration or thrombosis, is associated with a high 
incidenc~ of acute complications and restenosis. We have 
evaluated the efficacy, safety and long term results of 
atherectomy utilizing the Trans luminal Extraction 
Endarterectomy (TEC) catheter in the management of 
diseased saphenous vein grafts. 
Atherectomy has been performed for 348 lesions in 278 pts 
(male: 81%; mean age: 66; range 37-81). Mean graft age 
was 8.8 years (range 0.3-20) with 237 (85%) > 3 years. 
Previous PTCA had been performed on 74 (19%). 116 (33%) 
lesions were considered unsuitable for PTCA due to lesion 
length (>20mm) or presence of thrombus. The target lesion 
was located at the ostium (10.6%), proximal (38%), 
mid/distal (48%) and distal anastomosis (1%). The success 
rate was 89% (248/278) per patient and 94% (329/348) per 
lesion. TEC alone was performed on 100 lesions (29%). 
Complications included death 1 (0.3%), perforation 1 
(0.3%) AMI 1 (0.3%), CABG 2 (0.7%), no reflow 7 (2%), 
distal embolization 10 (3.5%). Clinical restenosis has 
occurred in 48 of III (43%). Angiographic follOW-Up in 83 
of 111 eligible lesions confirmed restenosis in 44 (53%). 
CONCLUSION: TEC atherectomy can be performed in patients 
with saphenous vein graft disease with a high primary 
success rate and low complication rate. However, 
restenosis in this group remains a significant limitation. 
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Comparison of Stent Implantation in Native Coronaries 
and Saphenous Vein Grafts 
Martin B. Leon. Kenneth M. Kent. Donald S. Bairn. Craig M. 
Walker. Michael W. Cleman. Maurice Buchbinder. Richard R. 
Heuser. Charles Curry. Richard A. Schatz. and JJIS Stent 
Investigators. Washington Hospital Center. Washington. D.C. 
To compare the efficacy and safety of stent implantation in native 
coronaries (NC) and saphenous vein grafts (SVG). we analyzed data 
from parallel consecutive series of 738 NC patients and 277 SVG 
patients treated with ~ one Palmaz-Schatz stent. SVG patients were 
older (66 vs 59 years. p<O.OOl). had a higher frequency of 
multivessel disease and reduced LV function (p<O.OOI). less 
commonly had previous PTCA restenosis (Res) (45% vs 67%. 
p<O.OOI). and stent vessels were larger (3.6mm vs 3.2 mm. 
p<O.OI). with more focal lesions (length 7.7mm vs 9.0mm. 
p<O.O I). Comparative procedure results. important complications. 
and Res frequencies are below: * p < 0.001 vs SVG 
SVG NC 
Diamerer SrellOsis (%) 6 4 
Minimal Lumen Diamerer (mm) 3.3 3.2 
Subacure Thrombosis/Deatb/Ml (%) 1.1/5.515.5 6.0*/I.S-/1.9-
Res- Overall (%) 31/110(28) 144/488(30) 
Sin Ie Sten! De Novo % 860 13 17 119 14 
pOrtant y. e Ig er uency 0 major comp Icanons (mcluding 
death and MO in SVG patients usually were late follow-up events 
and reflected a higher acuity level of disease rather than deteriorating 
stent function. In conclusion: a multicenter comparison of stents 
in NC and SVG reveals (1) similar acute procedure results 
(minimum lumen diameter and % diameter stenosis); (2) fewer early 
subacute thrombotic events in SVG patients but more common late 
major complications (death and MI); (3) Res frequency for both 
groups was fewest in de novo lesions treated with single stents; and 
(4) unlike PTCA. Res was equivalent in SVG and NC. perhaps due 
to a combination of larger reference vessel size and a preponderance 
of de novo lesions in the SVG patients. 
786·3 11:00 
Which Complex Lesions Are Suitable for Excimer Laser Coronary 
Angioplasty7 Multivariate Analysis in 701 Patients 
John A. Bittl, Timothy A. Sanborn, Robert M. Siegel. Barry Kramer, 
Jeffrey M. Isner, Stephen G. Ellis, James M. Tcheng, Michael D. 
Winniford, Linley E. Watson, John A. Power, Robert Ginsburg, and the 
PELCA Registry. Brigham &: Women's Hospital, Boston, MA 
Although excimer laser angioplasty shows promise for the treatment 
of complex coronary artery disease, not all Type B and C leSions (ACC•
AHA Task Force) are amenable. To refine the indications for excimer 
laser angioplasty, we analyzed our results in 701 patients (61±11 years; 
77% men; 77% with Class III or IV angina) who had 764 lesions treated 
with excimer laser angioplasty at 308 nm with an overall procedural 
success rate of 89%. Selected odds ratios (OR) from multivariate analysis 
of 40 clinical and angiographic variables indicate that certain high-risk 
~ Multivariate P Values: 1illi Multi 
Bifurcation c:J:::I 0.001 0.06 
Tortuous r:::::I:l 0.04 0.04 
Calcified CIJ 0.04 0.04 
RCA 0.29 
Eccentric 0.65 
LAD 0.98 
Length>2Omm 0.93 
Ostial 0.28 
Circumflex 0.36 
SVG 0.03 0.02 
Prior laser 0.05 0.22 
0.01 0.1 1 1 
Odds Ratio (95% Confidence Interval) 
variables, such as lesions at bifurcations (OR=O.3) or in tortuous vessels 
(OR=0.5), should not be treated with excimer laser. On the other hand, 
ostial stenoses (OR=I.5) and saphenous vein graft lesions (SVG, OR=2.7) 
have acceptable Success rates. 
Thus, this analysis defines the profile of risk for excimer laser angio•
plasty and now provides a sound basis for future, rigorous comparison of 
excimer laser and balloon angioplasty. 
ABSTRACTS 
786·4 11:15 
IlIIDediate Results of Ron-Bal.loCIl Deri.oes (Directimal. 
Atherect:any am El:c1mer Laser JlDjiq>lasty) in 
~rto-ostial Coronary am ~ Graft Lesicns 
M Nagui sabri, George W. Vetrovec, Michael Cowley, 
Germano DiSCiascio, Evelyne Goodreau, Mark warner, 
Ravinder Kohli, David DeBottis, Kim Kelly. 
Medical College of Virginia, Richroril, Virginia 
Pn:A of aorto-ostial lesions (OL) involving native 
coronary arteries (OCA) aril vein grafts (VG) often 
yields suboptimal results. To assess the efficacy of new 
devices in OL, "'" catpared the imnediate results of 
directional atherectany (OCA) in 13 pta (5 K:A, 8 VG) 
aril of excimer laser angioplasty (ElCA) in 18 pta (11 
N:A, 7 VG) with those of Pn:A in 17 consecutive pta (15 
N:A, 2 VG) performed before the availability of these 
devices. Angiographic success (islIl% residual stenosis) 
was OOtained in 12/13 (92%) OCA, 16/18 (89%) ELCA aril 
15/17 (88%) Pn:A pta. Adjunct Pn:A was necessary in 2/13 
OCA pts (pre-OCA dilatation) aril in 14/18 pts post-ELCA. 
Device selection was based on vessel size, tortuosity, 
calcification aril device availability. 
&lccessful 
OCA (n=12) 
EICA (n=16) 
Pn:A (n=15) 
Pre %stenosis Final %stenosis 
75±12 9+7* 
83+5 23±12* 
76+13 36+9 
*p<1Il:-1Il1 catiJClred to-Pn:A 
% reduction 
66+15* 
59+14* 
43il1 
Carplications: 1 pt (OCA of N:A) had erergency bypass 
aril 1 (ELCA of OCA) had non-Q ~I.I. 'nlere were no 
deaths. Although the overall success rate is similar for 
all devices, the % reduction in stenosis severity was 
greater with OCA or EICA. 'n1erefore, in ostial disease, 
OCA or ELCA (with adjunct Pn:A when necessary) has high 
success aril low carplication rates aril the residual 
stenosis is significantly less than with Pn:A alone. 
786·5 11:30 
Vascular Recoil in Saphenous Vein Graft Stenoses After 
Investigational Angioplasty 
Mun K. Hong. Jeffrey J. Popma. Martin B. Leon. Augusto D. 
Pichard. Lowell F. Satler. Peter D. Cospito. Michael B. Keller and 
Kenneth M. Kent. Washington Hospital Center. Washington. DC. 
Vascular recoil occurs commonly after balloon angioplasty and 
potentially limits the long-term benefit of the procedure. To defme 
the degree of vascular recoil after investigational angioplasty of 
saphenous vein graft (SVG) stenoses. we analyzed cineangiograms 
of 121 SVG lesions (97 patients) treated with transluminal extraction 
atherectomy (TEC). balloon expandable stent. directional coronary 
atherectomy (DCA). or PTCA. Lesion morphology was scored 
using standard criteria. % diameter stenosis and minimal lumen 
diameter were determined before and after SVG angioplasty using 
quantitative methods. % recoil was defined as [(balloon diameter -
final minimal diameter)/bal1oon diameter) x 100. SVG age and pre•
procedure % diameter stenoses were similar among the grOUps. 
TEC PTCA DCA Stent 
(N=23) (N=45) (Na?) !N=46) 
Diffuse SVG Disease (%) 78 34 14 24 
Thrombus (%) 3S 31 14 2 
Final leSion Diamerer (mm) 2.4±0.8 2.6±O.6 3.0±0.8 3.3±0.6 
Final Diameter Stenosis (%) 31±20 18±10 13±12 10±14 
Largest Balloon/Artery 1.2±0.2 1.l±O.3 O.9±0.2 1.0±0.2 
Adjunctive Balloon (%) 87 43 71 
% Recoil 38±21 IS±2S 1 13 
Y muluvanate analysIs. I se sease was y re a to 
vascular recoil (p < 0.00 I) and the use of stent or DCA was 
inversely related to vascular recoil (p < 0.001). We conclude that 
1) the degree of vascular recoil after various angioplasty techniques 
in SVGs ranges from 14 to 38%; 2) vascular recoil is highest in 
lesions within diffusely diseased SVGs; and 3) balloon-expandable 
stents and DCA may result in less vascular recoil than PTCA. This 
variability in elastic recoil may influence acute and chronic vessel 
wall responses. 
263A 
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Flexible Coil Stent (Cook Inc. I in Saphenous Vein Grafts: 
Clinical and Anglographlc Follow·up 
Luc Bilodeau, Sriram Iyer, Adam D. Cannon, Subodh K. Agrawal, 
James A. Hearn, Larry S. Dean, William A. Baxley, Peter J. Macander, 
Jenny Breland, Gary S. Roubin. Division of Cardiovasculac Disease, 
University of Alabama, Birmingham, Alabama 
From October 1989 to July 1991, 40 flexible coil stents (Cook Inc.) 
were successfully placed In 37 saphenous vein bypass grafts (SVG). 
SVG's were 2. 3 years old in 27 (71 %) and 22 (58%) had undergone 
prior PTCA. Indications for stenting were elective to prevent restenosis 
in 18 (49%) and for dissection or threatened closure in 19 patients 
(51 %). Ostial-proximal sites were stented in 19 (51 %), graft body in 6 
(16%) and distal anastomosis in 12 patients (33%). Stents were 4.0 
mm diameter in 40%, 3.5 mm in 19%, 3.0 mm in 14%, 2.5 mm in 
27%. Multiple stents were placed in 3 patients. 
There were no in-hospital deaths and only 1 Q wave myocardial 
infarction (2.7%). Non-Q wave myocardial infarction occurred in 4 
patients (10.8%). All these acute events were seen in patients stented 
for dissection or threatened closure. Local complications included 
bleeding (blood transfusion 2. 2 units) in 8 patients (21.6%) and 1 
pseudoaneurylm (2.7%). Angiographic follow-up was available in 32 
of 33 patients (97%) who had completed 6 months follow-up. 
Rest.no,i •• al defined by 2. 50% diameter stenosis was observed in 
13 patients (35%). During clinical follow-up. available for all patients, 
11 patient. had recurrent angina (29.7%), 7 had repeat PTCA at stent 
site (18.9%),3 had lurgery (8.1%) and 1 died after surgery. 
We conclude that use of the stent for threatened closure in vein grafts 
produce. satisfactory results. Randomized trials are needed to 
determine effects on reatenosis. 
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Does 'l'hEoIIbolya1e Reduce the Value of Late Potentialll 
for IUaJt StratWcat10n After Myocardial. InfarctIon? 
Pietro Santarelll, Gaetano A. Lanza, Andrea Matale, 
Francesco 811sc1one, Giancarlo Cora1n1, Carmine Riccio, 
Paolo R08111. Ilraldo Occhetta. Maurizio Gronda, Roberto 
Me;ri. Marco Zanetta. Salvatore Toscano. 
From the LAPIS Multicenter Study, Rome, Italy, 
Thrombolyllill has been shown to improve prognosis after 
myocardJal infarction. Late potentialll (LP), detected on 
the signal-averaged (SA) BCG, predict arrhythmic eventl 
after myocardial infarction. To determine whether the 
pro;nostic value of LP is reduced after thrombolysis, 
we .tudied 648 ptl by SA-ECG one week after myocar•
dJal infarction. On the whole, 1621648 pts (25\, Group1) 
.howed LP (ORS duration >115 maec, Last40 <25 
uV,Under40 >32 msec, 25Hz), and 486/648 (75\, Group2) 
did not. Durin; a mean follow up of 12t7 months (range 
3-36), a total of 24 arrhythmic eventl (10 sustained 
ventricular tachycardias and 14 sudden deaths) was ob•
.erved. 13 (8\) in Group1 and 11 (2.3\) in Group2 
(pc.002). Thrombolysis (streptokinase or rt-PA) was given 
within 6 hra of symptoms onset to 234 Ptl (36\). Among 
Group1, 55 pta (34\) received thrombolysis (Group1A) and 
107 pts (66\) did not (Group1B), whereas in Group2 179 
ptl (37\, Group 2A) received and 307 (63\, Group2B) did 
not receive thrombolysis. The incidence of arrhythmic 
eventl was 7.3\ (4 ptl) in Group1A and 8.3\ (9 pta) in 
Group1B (paNS). On the other hand, arrhythmic events 
occurred in 2.2\ of Group 2A and 2.3\ of GroupB (paMS). 
We conclude that, after myocardial infarction. 1) the pre•
sence of LP is associated with a significantly higher 
risk of arrhythmiC eventll 2) LP can be used for risk 
stratification both in ptl undergoing and not undergoing 
thrombolysil. 
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Quantitative Perfusion and Sympathetic Nerve Defect Size 
After Myocardial Infarction In Humans 
J. Marcus Wharton, Ina M. Friedman, Ruth A. Greenfield, 
Raymond N. Vitullo, Harold C. Strauss, R. Edward Coleman. 
Duke University Medical Center, Durham, NC. 
The cardiac sympathetic nerves in canine species course in 
the subepicardium from the AV groove to the apex and 
transmural myocardial infarction (MI) results in regional 
sympathetic denervation both at. and apically to, the site of 
Mi. To quantitate the difference in area showing perfusion and 
innervation defects in humans. 12 patients (mean age 55+9 
yrs; 11 males) underwent cardiac SPECT scintigraphy w~h 
1-123 metaiodobenzylguanidine (MIBG) and T1-201 within 10 
days of their first MI (5 anterior and 7 inferior). Both MIBG 
and TI images were normalized. displayed on polar maps, 
and the size of defects, defined as pixel density of <2.5 SO 
of distribution in normal TI studies, was estimated by a 
computer algorithm. Mean MIBG defect size (35.5±16.9% 
total area) was Significantly greater than TI defect size 
(24.0±13.8%). In only one pt was the TI defect greater than 
MIBG defect (38% and 26%, respectively). The area of 
perfused but denervated myocardium ranged from -1~k to 
36% and was similar for anterior (15.0±16.~k) and inferior 
(9.0±5.5%) Mis. In 5 pt (420/0) the MIBG defect extended 
more apically than the TI defect; and in 7 pt (58%) the MIBG 
defect extended medially and/or laterally to the TI defect. 
Thus, MI, regardless of location, results in areas of 
denervation in excess of areas of perfUSion defect; whether 
the area of denervated but perfused myocardium alters the 
risk of post-MI arrhythmias is not known. 
787·3 11:00 
Antiarrhythmic Drug Suppression of Inducible Sustained 
Ventricular Tachycardia at Electrophyslologlc Study: 
Relation to Infarct Artery Patency 
John T.Y. Hii, Mouhieddin Traboulsi, L. Brent Mitchell. D. George 
Wyse, Henry J. Duff, Anne M. Gillis. 
University of Calgary. Calgary. Alberta, Canada 
Infarct-related artery patency may portend a more favourable 
clinical outcome in patients after myocardial infarction. We 
hypothesized that. for patients with ventricular tachycardia 
following myocardial infarction, infarct-related artery patency is 
associated with a greater likelihood of finding predicted effective 
antiarrhythmic drug therapy by electrophysiologic study. Forty•
seven consecutive patients with symptomatic ventricular 
tachycardia post myocardial infarction who had undergone 
coronary angiography were evaluated. All patients had inducible 
sustained monomorphic ventricular tachycardia at drug-free 
electrophysiologic study. Infarct artery status was independently 
assessed by an observer blinded to the outcome of 
electro physiologic studies. Overall, predicted effective 
antiarrhythmic drug therapy could be found for 11 patients 
(23%). Predicted effective antiarrhythmic drug therapy was 
found for 41 % of the 22 patients with a patent infarct-related 
artery and ~/o of the 25 patients with an occluded infarct-related 
artery (p=0.01). The sensitivity and specificity of infarcted•
related artery patency for the likelihood of subsequent 
identification of predicted effective antiarrhythmic drug therapy 
were 82% and 64%, respectively. Thus, the probability of finding 
effective antiarrhythmic drug therapy for ventricular tachycardia 
patients by electrophysiologic testing is heavily dependent upon 
the patency status of the infarct-related coronary artery. 
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Fractal Clustering of Ventricular Arrhythmias as a 
Predictor of Arrhythmic Events After Myocardial Infarction 
Jeffrey L Anderson. Fidela U Moreno. Labros Karagounis. Ronald L 
Menlove. Kenneth M Stein. J Thomas Bigger. for the CAPS 
Investigators. University of Utah. LOS Hospital. Salt Lake City. Utah 
Chaos theory has recently been applied to cardiovascular patho•
physiology. Including arrhythmia analysis. A fractal dimension (D) is 
derived. describing the clustering of ventricular premature complex· 
es (VPCS) In time. D Is the slope relating the logs 01 the total number 
01 VPCs that can be paired within a series of Increasing times to the 
logs 01 those times. D ranges from 0 (extremely high clustering 01 
VPCs) to 1 (VPCs uniformly distributed In time). To determine 
whether clustering of VPCs assessed by fractal D can be used to 
identify patlenls (pis) at high risk for sudden death/cardiac arres\' we 
studied 46 post· myocardial Infarction (MI) pis on placebo (37 males; 
mean age 63 ± 7; mean VPCslhr 104 ± 122) from the previously 
published Cardiac Arrhythmia Pilot Study (CAPS). divided Into: Grp 
I • 23 pis that had evenls (death, 10; cardiac arrest, 2; ventricular 
tachycardia. 11) wtthln 4 to 369 days (mean,109 ± 131) from MI; and 
Grp II • 23 age· and sex·matched pts that did not have events. All 
pis were followed lor 1 yr from MI. Fractal D's were successfully 
determined for 200 (D200; N-43) and 500 (D500; N.28) VPCs; the 
smaller N for D500 resulted because some pis had fewer than 500 
VPCs/day. RESULTS (mean ± SD, (range)): D200. 0.85 ± 0.17 
(0.33 tol.05) and D500 • 0.91 ± 0.13 (0.42 to 1.03), p • 0.19. D200: 
Grp I • 0.86 ± 0.16 (0.33 to 1.04, N. 22); Grp II • 0.85 ± 0.18 (0.36 
to 1.05, N. 21). p.0.74. D500: Grp 1.0.92 ± 0.10 (0.64 to 1.03, 
N .. 15); Grp II. 0.89:1: 0.16 (0.42 to 1.02. N-13). p-o.50. lVEF: Grp I 
.. 0.36 ± 0.09 (0.21 to 0.52): Grp II • 0.47 ± 0.125 (0.24 to 0.7), p " 
0.001. Event·lree survival curves. defining high and low risk based 
on the median D, were not significantly different for Grp I vs Grp II by 
log-rank test for D200 (p.0.27) and D500 (p .. 0.l0). 
CONCLUSIONS: Departures from randomness of VPC frequency 
may not be a strong predictor for distant evenls In low·rlsk post·MI 
pts. Future studies of fractal D might assess larger groups of pis at 
higher risk for primary arrhythmic evenls. 
787·5 11:30 
Nonsustained Ventricular Tachycardia: Differences in 
Left Ventricular Endocardial Mapping Between 
Patients with Anterior and Inferior Infarcts 
Robert B. Kleiman. Mark E. Josephson, Alfred E. Buxton. 
Hospital of the University of Pennsylvania, Philadelphia, PA. 
Endocardial sinus mapping of the left ventricle (L V~ was 
performed in 36 patients (pts) with non sustained ventncular 
tachycardia (VT·NS) and coronary artery disease (CAD) to 
assess the relationship of LV activation abnormalities and infarct 
site to induction of sustained uniform VT (VT·S). Fourteen pts 
had anterior MI (AMI), 18 had inferior MI (IMI). 2 had multiple 
sites of infarction and 2 had no prior MI. VT·S was induced in 
6 pts with AMI 9 with IMI and 1 with mUltiple infarct sites. 
For the group' as a whole. pts with inducible VT·S had 
significantly greater evidence of slow conduction and delayed 
endocardial activation. Among pts with IMI, pts with inducible 
VT-S had a greater % of sites with abnormal electrograms 
(EGM) (58:1:15 vs 30±18%. p=.(03), fractionated EGM (10±10 
vs 0%, p=.007), and late EGM (19±16 vs 4±6 %. p=.02); 
greater total endocardial activation time (169±23 vs 125±23 ms, 
p= .(01) and greater duration of the longest EGM (145±24 vs 
102±18 ms, p<.OOI). For pts with AMI, the only endocardial 
mapping parameter which differentiated pts with and without 
inducible VT·S was the % of sites with fractionated EGM 
(12±12 vs 1±3%. p=.03). 
Conclusion: Among pts with CAD and VT·NS, 
endocardial mapping parameters differ between those with and 
without inducible VT-S in the presence of IMI but not AMI. 
This dichotomy suggests inherent differences in the substrate for 
inducible VT·S in pts with spontaneous VT·NS and AMI vs IMI. 
ABSTRACTS 
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Self·Terminating Ventricular Fibrillation 
Richard Clayton, Daniel Higham, Alan Murray, Ronald Campbell. 
Freeman Hospital, Newcastle upon Tyne, UK. 
Ventricular fibrillation (VF) usually requires DC cardioversion, 
but there are anecdotal reports of self·terminating VF (STVF). 
This study was designed to determine the incidence of STVF in a 
Coronary Care Unit (CeU) population and to compare the signal 
characteristics of STVP with those of more common sustained VF. 
In a 13 month period, 1731 consecutive CCUpatienls were 
monitored prospectively using a frequency based VF detector 
triggering a computer data acquisition system. 10 episodes of 
STVF (7 patients) and 36 episodes of VF requiring DC 
cardioversion (20 patients) were recorded. The mean duration of 
STVF was 19.1s (range 5.2-49.5) whilst the mean duration of 
sustained VF was 54.6s (range 19-104). 
The signal charactersitics of STVF and sustained VF 
recordings were compared by frequency analysis on successive 4s 
epochs of data. The dominant frequency component, f, in the first 
3 epochs (0-12s) and the epoch immediately preceding termination 
was identified: 
STVF f(Hz) 
VF f(Hz) 
0·4s 
5.1±0.5 
4.7±0.7 
4·8 s 
5.3±0.6 
5:0±0.9 
8·12 s 
5.0±0.5 
5.1±0.8 
final 
5.0±0.5 
5.2±1.2 
STVP is not as rare as is often believed, accounting for 22 % of all 
VFs recorded in this study. Frequency analysis, which was hoped 
would separate sub· types of VF perhaps involving a small number 
of re-entrant circuits (and therefore a greater chance of self 
termination), was not able to distinguish between STVF and 
sustained VF. 
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Percutaneous Balloon Pericardiotomy for the Treatment of 
Pericardial Effusion and Tamponade: Report of the Registry 
Andrew A. Ziskind, A. Craig Pearce, Steven Burstein, Howard C. 
Herrmann, Lawrence W. Gimple. Peter C. Block. Howard M. 
Waldman. E. Murat Tuzeu, Cyndi Lemmon. Igor F. Palacios. Univ. 
of Maryland, Baltimore, MD and Mass General Hospital, Boston. MA 
For seriously ill patients with pericardial tamponade, it is desirable to 
avoid the risks and discomfort of surgery. We report 35 patients who 
underwent percutaneous balloon pericardiotomy (PBP) as an alternative 
to surgical pericardial windowing. 
In the multicenter registry. 35 pts (mean age 62±12 yrs) underwent 
PBP using a 20 mm x 3 em dilating balloon (Mansfield) introduced 
over a guidewire via a percutaneous subxiphoid approach. Following 
PBP. a pericardial catheter was left in place for 48 hrs to monitor 
drainage. In 16 pts. PBP was performed at 2 sites. Serial chest x·rays 
and echocardiograms were obtained during followup. 
Thirty-two pts had known malignancy. Three pts had nonmalignant 
pericardial disease including uremia (1), idiopathic (1). and pericarditis 
during warfarin therapy (1). Twenty-three pIS had pericardial 
tamponade. the remainder had recurrent effusions after 
pericardiocentesis or large effusions felt to be at risk for pericardial 
tamponade. 
PBP was successful in 33 pts (94%). There were no recurrences of 
pericardial effusion/tamponade during a mean followup of 3.4 (range 
0-11) months. All 17 pts who died from malignancy had no clinical 
evidence of tamponade (mean survival 3.7±3.5 mos). Following PBP. 
thoracentesis or chest tube placement was required in 48% of pts with 
preexisting pleural effusions as compared to 8% of pts without 
preexisting pleural effusions (p<.05). Minor complications were seen 
10 11 pts (31 %) with the most frequent being transient fever. One pt 
with unsuccessful PBP also failed surgical windowing. The only 
major complication was seen in a pt with uremic pericarditis who 
required surgery for bleeding from a pericardia! vessel. 
Conclusion: PBP offers an effective nonsurgical alternative for the 
management of refractory pericardial effusiOn/tamponade. 
266A ABSTRACTS 
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The Prognoltlc Value of EchOClrdlography In HOlpltallzed 
PltI.ntl with Perlcardlll Effullonl 
Mark J. Eisenberg. Ke~h Oken. Salvador Guerrero. Mohammad Ali 
Sanlel. Nelson B. Schiller. Unlvera~y of California. San Francisco. CA 
Blckground: Echocardlography Is frequently used to diagnose 
perlcardlal effusions. but the prognostic value of echocardiographlc 
Ilgnl seen at the time of diagnosis Is unknown. 
Methodl: We studied the prognostic value of echocardlographlc signs 
(elluslon size. right-aided chamber collapse. Inferior vena cava 
plethora with blunted response to respiration) In a cohort of 187 
hospitalized patients who were diagnosed with perlcardlal effusions 
over a 1 year period. 
R.lulll: The Index echocardlogram showed that 11 effUSions were 
large (6%). 39 were moderate (21%). and 137 were small (73%). 
Right ventricular collapse was present In 7% of cases (13/178). 
right atrial collapse In 12% (211168). and Inferior vena cava 
plethora with blunted response to respiration In 35% (461132). 
During the courae of hospitalization. 9 patients (5%) had cardiac 
tamponade and 16 patients (9%) fulfilled criteria for a combined 
endpoint which Included cardiac tamponade. perlcardlocentesls. or 
surgical drainage. Univariate analysis showed that each of the 
echocardlographlc signa was associated with both cardiac tamponade 
and the combined endpoint (p£O.OOI for comparisons with size and 
right-sided chamber collapse; P£0.03 for comparisons with inferior 
vena cava plethora). When the data were analyzad with logistic 
regression modeling. however. after elluslon size was entered. 
neither right-aided chamber collapse nor Inferior vena cava plethora 
retained significant aSSOCiatIOns. 
Conclullonl: We conclude that 1) echocardlographlcally· 
determined effUSion size Is a powerful predictor of outcome In 
hospitalized patients with perlcardlal effusions. and 2) right-sided 
chamber collapse and Inferior vena cava plethora add little If any 
prognostic Information. 
788·3 11:00 
Incidence and prognostic significance of pericardial 
involvment In acute myocardial infarction treated with 
fibrinolytic agents: GISSI·l data. 
Ernesto Correale, Vincenzo RicciardielJo, Rossano Battista, 
Gregorio Salvarola, Eugenio Santoro, Aldo P Maggionl. on behalf 
of GISSI Investigators, Milano, Italy. 
To establish incidence, relationship with myocardial infarction (M!) 
extension and prognostic significance of pericardial involvment (PD 
in pts with MI treated with fibrinolytic treatment, data of GISS1-1 
trial were reviewed. The incidence of PI was significantly lower in 
the streptokinase (SK) group in comparison with the conb'Ol group 
(6.7% vs 12.0%, RR 0.54 9S%CI 0.47·0.61). A definite 
correlation was found between PI and MI extension evaluated by 
the number of ECG leads involved (2·3 leads-6%, 4-5=8.4%, 6-
7=13.4%,8-9=18.5%). PI occurred in 14.2% ofpts with anterior 
site, 8.3% in multiple site, 6.8% in inferior MI with ST depression 
in precordial leads, 4.5% in lateral site, 4.5% in inferior AMI 
without ST depression in precordial leads, 3.2% in pts presenting 
with ST depression. A statistically significant difference in PI 
incidence was found between pts in Killip class 1 vs pts in KilJip 
2+3+4 (8.8% vs 10.6%, RR 0.81 9S%CI 0.70-0.93). PI occurred 
in 17.9% and in 8.0% of pts with and without clinical signs or 
symptoms of cardiac failure (RR 3.20 9S%CI 2.64-3.86). 
Presence of PI was related to a I·year higher monality in the 
univariate analysis (22.0% vs 17.9%, RR 1.31, 95%CI 1.11-
1.55) but it did not retain its prognostic significance when the 
analysis was adjusted for other epidemiological and clinical 
variables (Cox model), including markers of MI extension or signs 
of heart failure (RR 1.13 9S%CI 0.98-1.30). In conclusion: - PI 
occurs in 6.7% of pts with AMI treated with SK, this incidence is 
about the half of that of non·thrombolyzed pts; - PI may be 
considered a reliable clinical marker of MI extension, strongly 
associated with a poor haemodynamic state but not an independent 
prognostic predictorofa higher l·yearmona!ity. 
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PerIcardia I 01 ..... In AIDS: Frequency of Tamponad. and 
Therapeutic and DiagnostiC U .. 0' Perlcardlocentesls 
Frank C. Gall. Melvin D. Chellin. San Francisco G_ral Hospgl and 
Univ~ d California. San Francisco. San Francisco. CA 
Pericardial effusions are a well recognized complication of acquired 
immunodeficiency syndrome (AIDS) but acute pericard~is and tamponade 
are less frequent. In add~lon, pericarditis is frequently noted to be 
associated w~h tuberculosis. To Investigate the manHestations of 
perlcardial diseases In patlenta (pta) w~h AIDS or AIDS-related complex 
(ARC) a retroapective review of all pts discharged from San Francisco 
General Hoap~al with diagnoses of AIDS or ARC and pericardial effuslona. 
pericarditis or tamponade was performed. Results: Between JQnusry 
1984 and September 1990. 25 pts were found: 21 with AIDS and 4 w~h 
ARC. The avnge age was 38 years; 92% ware homosexual men. Among 
these pts. 10 presented with Incidental perlcardlal effusions (40%). 10 
with clinical pericarditis (40%). and 8 had tamponade (32%). 2 pts initially 
with pericarditis and 1 with an Incidental ellusion developed tamponade. 
All 25 pts had echocardiograms which revealed 4 pts with no effusion 
Initially (2 developed ellusions later). 5 with decreased left ventricular 
function and 4 with right ventricular enlargement. 24 had ECG's with only 3 
having diffuse ST segment elevations. 10 pts had perlcardiocentesis. 2 
had pericardial windows and 3 had autopsies. Fluid and tissue analysis 
provided no etiologic diagnosis In any of th_ pts. All fluid sell1lles were 
exudates. Pericardiocentesls relieved tamponade In all 8 pts; however. 
tamponade recurred In twe requiring a pericardial window. Concurrent 
diagnoses at the time of discharge Included lymphoma (7). Kaposi's 
sarcoma (7). congestive heart failure (6). Mycobacterium avium•
Intracellulare (4). lobar pneumonia (3), Pneumocystis pneumonia (2). and 
Toxoplasmosis (1) and Cytomegalovirus (1) Infections. ConclusIon: 
Perlcardial disease is not uncommon In AIDS and tamponade is frequent. 
Pericardiocentesls. although net helpful diagnostically. appeara to be very 
effective In relieving tamponade physiology with a low Incidence of 
recurrence. The etiology is largely unknown. but may be secondary to 
HIV. other viral Infections or concurrent IIIne8ses; however. M. 
tuberculosis was no! a cause of perlcardial di_ in this group of pts. 
788·5 11:30 
Ma\LIGlWfl' PmICARDIAL BPP'l:lIICfiI stJ(VIVAL MSED tJFaI 
P!RIaRDIAL PWID Clt"lt1UX;Y 
John R. Daley, James B. seward, Kent R. Bailey, Luanne 
SCllnidt, tarry J. Sinak, John A. callahan, A. Jami1 
Tajik. M!yo Clinic, ~hester, MiMesota 
Malignant pericardial. effusion (MPE) associated with 
advanced metastatic disease is equated with a I,XlOr 
prognosis. It has been irlplied b.lt never CX>tIc1usively 
shown that MPE with a negative cytology has a better 
survival. we describe survival data for a large series 
of MPE. Between April 1980 and M!lrch 1991, as put of 
an CXlgoing registry of 2-D echo-directed pericardio•
centesis, 145 pta unden.oent 179 centeses for MPE. 
CalIp1ete survival data for 140 pta (9")/174 centeses 
are described. 'lbere were 75 fEIIB1e and 65 male, mean 
age 54 yrs (range 15-82 yrs). Malignancy: lung 62 
(36'), breast 51 (29%), helMto1ogical 33 <19'), and 
other 28 <16'). At follow-up, 10% of pta were alive. 
Fluid cytology 10ItlS available on 158 MPE (91%) and mean 
survivals t:.o-<Iate shown: 
survivals 'l\:)-Dlte in Dlys 
MalignanCf ffi01~ (pta) 
Hem&to1og1C ~ +~( 8) 
Breast 272 +319 (29) 
Other 108 +130 (14) 
Lung 98 + 99 (44) 
'rol'AL: 175 !226 (95) 
Cyto1ogye (pta) 
764 +1052 (21) 
691 + 744 (16) 
443 + 525 (10) 
515 + 824 (16) 
631 ! 844 (63) 
P.ifue 
.048 
.077 
.061 
(.0001 
Pericardial. fluid cytology ia a powerful predictor of 
survival. Negative cytology status iIIplrts a 3.6x 
increased mean survival. Knowledge of pericardial. fluid 
cytology assists in predicting survival and JIEly playa 
role in subsequent clinical decisions. 
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Feasibility of Percutaneous Pericardial Biopsy and 
Pericardioscopy as an Adjunct to Balloon Pericardiotomy for 
the Diagnosis and Treatment of Perlcardial Disease 
Andrew A. Ziskind, A. Craig Pearce, Cyndi Lemmon, Jeffrey G. 
Knox, Glenn J. Beauman, Wolfgang J. Mergner, William R. Herzog, 
Samuel Rodriguez, Paul A. Gurbel, J. Lawrence Stafford. University 
of Maryland, Baltimore, Maryland 
Percutaneous balloon pericardiotomy (PBP) may provide a less 
invasive alternative to surgical pericardial windowing for the treatment 
of refractory pericardial effusion/tamponade. One drawback of this 
technique is that diagnostic tissue is not obtained. We report the 
feasibility of using flexible fiberoptic pericardioscopy and percutaneous 
pericardial biopsy as an adjunct to PBP to aid in the diagnosis of 
pericardial disease. 
Seven patients referred for PBP to manage refractory pericardial 
effusion were studied. Six underwent percutaneous pericardia! biopsy, 
3 had fiberoptic pericardioscopy. To perform percutaneous biopsy, the 
pericardial space was entered via a subxiphoid approach and a serrated 
Jaw bioptome was introduced through an 8F vascular introducer. 
Under fluoroscopic guidance, multiple samples were obtained from the 
pericardium. Percutaneous flexible fiberoptic pericardioscopy was 
perfonned with an Olympus hysterofiberscope measuring 3.6 mm 
0.0. delivered through a 14F vascular introducer (UMI). 
Tissue suitable for pathologic evaluation was obtained in all 
biopsies. In 2 patients, pericardial biopsies revealed sampling of 
adjacent lung tissue which in one case was diagnostic of 
adenocarcinoma. The remaining biopsies demonstrated nonspecific 
inflammation and fibrosis. One patient later underwent surgical 
pericardial sampling with concordant pathological findings. 
Pericardioscopy revealed beefy red hemorrhagic pericardial surfaces 
in the patient with uremia, nodular studding in the patient with 
metastatic adenocarcinoma, and unremarkable pericardial surfaces in a 
patient with small cell carcinoma. 
This preliminary series suggests that percutaneous pericardia! biopsy 
and fiberoptic pericardioscopy may be clinically useful tools in the 
percutaneous management of pericardial disease. 
789 Radionuclide Imaging-Myocardium at 
Risk and Reperfusion 
Wednesday, April 15, 1992 
10:30 AM-Noon 
Dallas Convention Center 
W116 
789·1 10:30 
1D.:tIm A ..... m.nt of Myocardial Salvag. In R.p.rfu •• d 
Canln. H.art. U.lng SPECT of Te·99m SeltaMIBI Distribution 
Chrlslopher L Wolle, Richard E Sievers, J William O'Connell, Carole Cobb, 
Michael W Oae. Ell H Botvlnlck. 
University 01 CalHornia, San Francisco, CA 
To test the hypothesis that the myocardial distribution of Technetium-99m 
Hexakls 2-Methoxylsobutyl Isonitrile (Tc-MIBI) can be used to accurately 
measure myocardial salvage after Ischemia and reperfusion, we acquired 
serial Tc-MIBI tomographic (SPECT) images In canines (1) during LAD 
occlusion, (2) after reflow, and (3) after acute reinjection of an addhional15-
18 mCl Tc-MIBI (n.12). In all ischemic studies, Te-MIBI (5-6 mCi) was in"lally 
Injected after LAD occlusion but prior to reflow. In each study, the left 
ventricular (LV) distribution mass of Tc-MIBI was calculated from the total 
number of voxels demonstrating Tc-MIBI uptake x voxel volume (cm3) x 
specHIc gravhy of myocardium (1.05 g/cm3). The boundaries of LV Te-MIBI 
uptake were defined using an automatic edge detector. After Imaging, the 
Infarct size and the risk area were determined by slmulataneous dual 
perfusion wHh phthalocyanlne blue dye and trlphenyhetrazollum chloride 
(TIC) of the excised hearts. 
Prior to reinjection, we found good correlation between cardiac Tc-MIBI 
distribution before and after ref low (Tc-MIBI distribution lII1a! refiow-1.1 x 
Tc-MIBI distribution IWQm reflow - 8.0, gms Tc-MIBI uptake, n-12, r.0.88) 
indicailng that Tc-MIBI does not redistribute Into reperfused myocardium 
sfgnfflCantiy. After Tc-MIBI reinjection In acutely reperfused canines, there 
was good correlation between the distribution mass of Tc-MIBI and the 
mass of viable myocardium by nc staining (Tc-MIBI distribution mass.0.61 
x viable LV mass + 34.2, n.12, r.O.77). Furthermore, the apparent 
myocardial Tc-MIBI "redistribution" between pre- and post-reinjection 
Images correlated closely whh myocardial salvage wHhln the Ischemic risk 
area, determined by histochemical staining (Post-reinjection Tc-MIBI 
"redlstributlon.0.85 x salvaged LV mass by nc T 2.0, gms salvaged LV 
mass, n-12, r.O.65). 
In conclusion, same day SPECT Te-MIBllmages acquired after raflow and 
again after ralnjectlon can be used to accurately measure myocardial 
salvage In the canine model of myocardial Ischemia and reperiuslon. 
ABSTRACTS 267A 
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Is Angiographic Assessment of Myocardial Area at Risk 
During Coronary Angioplasty Reliable?: A Potential New 
Role For Tc·99m·Sestamibi Imalinl 
Howard L. Haronian, Michael S. RemelZ, Alben J. SinuSlS, Barry L. 
Zaret, Frans J. Th. Wackers. Yale University, New Haven, CT 
Among other clinical variables, the area It risk (AR) as estimated from 
the coronary angiogram is ~!!1)' employed as an indication to 
perform coronary angioplasty ~~~t is diff'u:ult to validate in 
patients. Since Tc·99m·Sestamibi (MlB1) shows neaJigible 
redistribution and quantif1C8lion of perfusion defects correlates well 
with AR at post mortem, MIBI imaP.1 following injection durinl 
PTCA balloon occlusion (DO) prcMdes a means for accurately defininl 
AR. Accordingly, AR estimated from angioAhy was compared to 
MIBI AR. Planar M1BI imaging was performed in 18 pts at 2.3±1 hrs 
after intravenous injection of M1BI during PTCA 80 (mean BO 
time: 153±46 s), and repeated at rest post-PTCA (mean 38±10 hrs). 
MIBI defect size was quantified using circumferential profiles. Defect 
size on BO images, representing AR of the vessel undersoinl PTCA, 
was large (19±16). However; there was wide variation (ranee 0 to 53). 
In 6 pts without prior myocardial infarction (MI), MIBI defect durinl 
BO was 6±8 ,whereas at post-PTCA rest imaging no defect was 
present. In 12 pts with prior MI, defect size during 80 was 26%16 and 
at rest 11±12 (p<.OO5). Angiographic AR was semiquantitatively 
scored by an independent observer based upon anatomic location of 
target lesion: 0 = no AR, 14. maximal AR. Angiograpbic AR score 
correlated poorly ( ..... 18) with 80 MIBI defect size. There was only 
slight improvement ( ..... 54) when the presence of collateral vessels was 
considered. When AR was compared for tareet vessel (LAD vs non•
LAD), there was no difference for angiographic score (Sfl vs 3± 3; 
p=NS); however, MIBI defect size was different (26±15 va 11±16; 
p=.05). Thus, angiograpbic estimation of AR is distinctly different 
from MIBI AR. Despite relatively brief occlusion time, the AR of a 
coronary lesion can be quantified with MIBI imaging. Consequently, 
MIBI AR obtained during PTCA BO has potential as a new method for 
evaluating PTCA efficacy. 
789·3 11:00 
Initial Extant of Myocardium at lliak Datermin .. Sub.equent 
Left Ventricular Function in Patlanta with Acute Myocardi· 
al Infarction (MI) 
Carlo. M. Duncker, Alan D. ClSarci, Terry Frank, Hi.ato 
Takatsu, Lewis C. Beck.r. 
The John. Hopkins M.dical In.titution., Baltimore, !!D. 
Experi~enta1 animal studies have shown that the amount of 
~yocardium ~ade ischemic by coronary art.ry occluaion is 
the single most important det.rminant of .ubs.quent 
infarct size and left v.ntricu1ar (LV) function. To study 
whether this is also true in man, w. meaaur.d the initial 
extent of ischemia in 31 pati.nts (pta) pr ••• nting with a 
first transmural MI. Tl-201 was injected on arrival to the 
hospital and SPECT imaging was p.rformed 1-2 hr later, 
followed by coronary arteriography. Blood pool .cans were 
performed before discharge. A quantitative isch.mia .core 
(IS) Was computed taking into account the .ev.rity and 
extent of the Tl-201 abnormalities. IS ranged from 0 to 
528, indicating marked differenc.s among pat1entl in 
myocardium initially at risk. Mean IS waa larger for pts 
with anterior than inferior MI (187±185 vs 51±60, 
p-O. 007). IS correlated with an angiographic a ..... ment of 
, LV perfused by the infarct related artery (r-O. 52, 
p-0.003), and with several measures of subsequ.nt infarct 
size: peak CK (r-O. 64, p- 0.0001), QRS score (r-O. 61, 
p-0.0004) , and predischarge global and r.giona1 infarct 
zone ejection fraction (r--0.70, p<0.0001 and r--0,50, 
p-0.009 respectively). Importantly, no oth.r variables, 
including infarct location, ag., .ex, treatment given, or 
infarct artery patency improv.d the relationship between 
IS and predischarge LV ejection fraction. Thu., tha most 
importent determinant of po.t-MI ventricular function 
appears to be the extent and severity of iachemic myocar•
dium present at the time of hospital admi.sion. 
268A ABSTRACTS 
789·4 11:15 
Rul .. Out of Myocardial Infarct In the Emergency 
Room with Tc·llm·Se.tamlbl Scintigraphy. 
Tereslo Varetto, Concetta Decicco, Darlo cantalupi, Alberto 
Altieri, Glamplero Leone, Giovanni Devotl, Cesare Orlandi. 
Nuclsar Msdicine and Cardiology Depts., Ospeda/e 
Reglonale, Aosta, Italy and Du Pont Merck 
Radlopharmaceuticals, Billerica, MA. 
Rule·out of Mlln patients presenting to the ER with 
chest pain of presumably cardiac origin but without positive 
ECG and enzymes Is problematic. We studied 36 patients 
without prior MI, presenting to the ER with chest pain and 
normal enzymes and Inconclusive ECG. Te-99m· 
Sestamlbl (740 MBq, I.v.) was Injected at rest 7.3±4 hr after 
onset of pain, and SPECT scintigraphy was performed 90 
min later. An additional SPECT perfusion study was 
performed 48 hrs later in patients showing perfusion defects 
but with no clinical diagnosis of MI. Patients were strictly 
monitored during hospitalization and a 3 months follow·up 
was carried out for major cardiac events. Twenty one 
patients showed a perfusion defect in the ER. Of these, 
eleven developed an MI within 12 hrs. CAD was diagnosed 
In 9 of the remaining 10. One patient with a perfusion 
defect at admission had no CAD. Normal parfusion scans 
were observed in 15 patients. Chest pain of non·cardiac 
Origin was diagnosed in 10. Five patients had no clear 
diagnosis but had provocative tests negative for myocardial 
Ischemia. Patient with normal perfusion scans at admission 
had no major cardiac events 3 months after discharge. Tc· 
99m·Sestamlbl perfusion imaging allows MI rule·out in the 
emergency room. Significant reductions In hospitalization 
costs and more efficient utilization of Intensive therapy beds 
may be expected with this approach. 
789·5 11:30 
The Prediction of Infarct Related Arterial Patency 
Following Reperfusion Therapy Using Technetium 99m 
Sestamibi 
Wayne Gibson, Timothy Christian, Raymond Gibbons, 
Mayo Clinic, Rochester, MN 
During acute myocardial infarction (MI), 102 
patients (46 anterior, 51 inferior and 5 lateral) 
had technetium 99m sestamibi imaging acutely and at 
18-48 hours following reperfusion therapy 
(thrombolysis and/or PTCA). Coronary angiography 
performed within 48 hours, demonstrated patency of 
the infarct related artery (IRA) in 95 patients and 
perSistent occlusion in 7 patients (5 with inferior 
MI). Circumferential count profiles were generated 
for 5 short axis slices. Defect size was measured 
using previously reported techniques. Defect area 
was measured as the integral of the count profile 
below a 60S threshold. The change ~) in defect 
size and area between acute and 18-48 hour imaging 
varied with MI location and patency. 
Location IRA n ASize .bArea 
Anterior Patent 44 1'8"+16 .1""+"":"07 
Inferior Patent 46 6 + 8 .02; ! .03 
Inferior Occluded 5 -3 + 9 .004 + .024 
By 2 factor analysis of variance, Aarea varied 
with both location (p·.OOOI) and IRA patency 
(p·.036). For inferior MI, barea of <0.015 
correctly identified 27/46 (59S) of patent arteries 
and 4/5 (80S) occluded arteries. 
Conclusion. Infarct location and arterial 
patency are both independently associated with the 
magnitude of early changes on perfusion images. The 
change in defect area is a promising non-invasive 
indicator of arterial patency following reperfusion. 
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-.id.nc. of .yocardial daaag. with In-Ill ADtiayoaiD 
lciDtigrapby aft.r UDcoaplicated COronary ADgioplaaty 
"lation witb tb. Mlocardial area at aiak 
ado.rdo V.rn. , Rugg.ro C.aucci , Luc. C.ri.ni , S.rgio 
Repetto , M.rco Onofri .nd Giovanni linaghi 
Divi.ion of Cardiology,O.pedal. Multizonal.,V.r •• e,ITALY 
A du.l i.otope 99m-Tc-MIII (MIll) .nd In-lll-Antimyo.in 
.ntibodi.. (AM) .tudy w •• performed in 20 pt. undergoing 
.ucc ••• ful coronary .ngiopla.ty (PTCA) to •••••• if 
.hort but r.pe.t.d bout. of i.chami. during b.lloon 
infl.tion (II) may h.v •• cumul.tiv •• ff.ct .nd c.u •• 
myoc.rdi.l damag •• ft. with un.tabl •• ngin. and pr.viou. 
~ocardial inf.rction were .xclud.d.R.peat.d II of 60 to 
170 •• c. were u •• d. An .utoperfu.ion cath.t.r (APC) 
.y.tam w •• u •• d in 7 pt.. MIll wa. inj.ct.d during the 
fir.t 81 .nd SPECT im.ging wa. performed to d.t.rmin. 
.iz •• nd location of the j.opardiz.d myocardium <, ar •• 
.t ri.k). In-lll-AM (SO Mlq) w •• inj.ct.d 24 hr. aft.r 
PTCA .nd imaging performed 24 hr. lat.r. Th. r.lativ. AM 
upt.k. wa. a •••••• d .ubj.ctively .nd by h.art/lung 
count d.n.ity ratio(H/L). 
Mo pt. Bhowed n.w Q w.v. on ECG aft.r PTCA. Fiv. pt. h.d 
minor ST-T w.ve chang.. .nd 2 .howed a mild ria. in 
CK-MI l.v.l.. How.v.r. focal uptake of AM (H/L>l.55) 
wa. pr ••• nt in 7 pta (35') and wa. int.na. (H/L>1.9) 
in 4 pt. (20'). AM upt.k. wa •• lway •••• n in th ••• qment 
.howing the perfu.ion d.f.ct on MIII-SPECT imag ••• 
Th. '.iz. of MIll perfu.ion d.f.ct (ar.. .t ri.k) 
wa •• ignificantly low.r in pta in whom • APC .yatam 
wa. u •• d (9 ± 6' V8 28 i 8' ,p<O.Ol). In thi. group the 
H/L ratio waa aignific.ntly low.r (p<O.Ol) .nd only on • 
• ubj.ct ahowed • mild AM uptake. 
In conclu8ion. focal AM uptake may be ob •• rv.d .ven 
aft.r Bucce •• ful PTCA indic.ting myocardial c.ll damag •• 
Thi. can b. prev.nt.d by limiting the .iz8 of the ar.a 
.t ri.k i.e. with the u.e of a ACP .ylteme. 
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Do Patients With Microvascular Angina Have lschaemia 
Ann C. Tweddel, William Manin, Ian Hutton. Department of 
Medical Cardiology, Royal Infinnary, Glasgow, Scotland, U.K. 
Patients who have typical anginal chest pain but who have 
angiographicaIly normal coronary vessels present a major clinical 
problem. Fifteen patients, 4 male and 11 female, with typical 
exertional angina and abnonnal exercise thallium scans undeIWent 
angiography and were found to have entirely nonnal vessels, with 
no evidence of coronary anery spasm. Myocardial flow was 
assessed using Xenon washout. Xenon was injected intracoronary 
under direct vision and scans obtained with a mobile gamma 
camera fitted with a biplane collimator, which allows simultaneous 
acquisition of 30° and 70° LAO projections. Distribution within 
the myocardium was assessed, and flow calculated from washout 
curves using peak to 30 seconds and applying the Kety fonnula. 
At rest RCA and LCA distribution and flows were within nonnal 
limits; RCA flow SS.S±8.8, LAD 66.6±1 1.3, ex 62.3±9.9 
ml/lOOg/min. With atrial pacing to a hean rate similar to that 
achieved during exercise, chest pain occurred in all patients. 
Distribution volume fell in at least one coronary distribution in all 
patients and this was associated with reduced coronary flow by a 
mean of 28.6±9.8%, p<O.OS. By gating the scans to the 
electrocardiogram and re-constIucting 1istmode data into a 
representative cardiac cycle, wall motion can be obtained from the 
same data that produced the washout curves. Areas of reduced 
distribution and flow were associated with reduced wall motion in 
all I S patients. These results, a combination of reduced 
myocardial flow and associated wall motion abnorma1ities, suggest 
an ischaemic response, presumably at the microvascular level. 
lACC Vol. 19, No.3 
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790·2 10:45 
Role of EDRF in tbe Abnormal Endotbelium-Dependent 
Vascular Relaxation of Patients witb Essential Hypertension 
Julio A. Panza, Philip R. Casino, Crescence M. Kilcoyne, Arshed A. 
Quyyumi, Stephen E. Epstein, NHLBI, Bethesda, MD 
Pts with essential hypertension (HT) have impaired endothelium•
dependent vascular relaxation. To investigate the role of endothelium•
derived relaxing factor (EDRF) in this abnormality, we studied the 
vascular effect of N" monomethyl-L-arginine (L-NMMA; 4 
"mol/min), an inhibitor of the syntbesis of EDRF, under baseline 
conditions and after infusion of acetylcholine (Ach), an endothelium•
dependent vasodilator, and sodium nitroprusside (SNP), a direct 
smooth muscle dilator, in 11 HT pts (7 men; age 46.5±9 years) and 
10 normal controls (7 men; age 45.7±7 years). Ach (7.5, 15, 30 
"g/min) and SNP (0.8, 1.6, 3.2 "g/min) were infused into the 
brachial artery in conjunction with 5% dextrose or L-NMMA. 
Forearm blood flow (mIImin1100 ml volume) was measured by strain 
gauge plethysmography. Basal blood flow was similar in HT pts and 
controls (3.0± 1.7 vs. 2.4±0.5). As previously shown, the 
vasodilator response to Ach was reduced in HT patients (max. flow 
8.2±4.4 vs. 13.4±4.7; p<0.02). After L-NMMA infusion, blood 
flow was higher in HT pts (2.7±1.3 vs. 1.7±0.4; p<0.05). L•
NMMA blunted the vasodilator response to Ach in controls (max. 
flow decreased from 13.4±4.7 to 6.8±3.3; p<O.OOI); however, L•
NMMA did not alter the response to Ach in HT pts (max. flow 
8.2±4.4 vs. 8.01 ±5.3). L-NMMA did not produce any difference 
in the vasodilator response to SNP in either controls or HT pts. 
Hence, inhibition of EDRF synthesis produces less reduction in basal 
blood flow and in endothelium-dependent vasodilation in HT pts than 
in controls. These fmdings are compatible with the concept that the 
abnormal endothelium-dependent vascular relaxation of pts with 
essential hypertension is due to decreased EDRF production. 
790·3 11:00 
Impaired Immediate Vasoconstrictor Response to Head· 
Up Tilt: New Insights Into the Pathophysiology of 
Vasovagal Syncope 
James F Sneddon, Peter J Counihan. Vaver Bashir. Guy A 
Haywood. David E Ward and A John Camm. SI. George's Hospital 
London UK. 
Upright tilt testing in the evaluation of unexplained syncope is now 
accepted as a valuable diagnostic technique. However. the precise 
mechanism of neurally mediated syncope and the factors 
determining individual susceptibility to orthostatic stress remain 
obscure. The aim of this study was to examine the vascular 
responses to head up tilt in patients with unexplained syncope. 
Forearm blood flow and forearm vascular resistance (FVR) were 
measured by strain gauge plethysmography in 39 consecutive 
patients with unexplained syncope undergoing tilt testing at SOolor 
a maximum 01 45 minutes. 19 patients developed syncope 
between 9 and 38 minutes (mean 19 min) following till. 20 pts had 
negative tilts. There was no difference in age between the groups 
and none of the patients had significant structural heart disease. 
diabetes or evidence of neuropathy. Supine and after 2 min and 5 
min 01 tilt there were no differences in heart rate. pulse pressure or 
mean arterial pressure between the groups. 
Results. mean ± standard deviation. 
FVR supine FVR 2 min tilt FVR 5 min tilt 
Non syncopal 34.5 ± 15.4 83.9± 37.2 7S.0± 31.7 
Syncopal 35.2± 15.71 56.7± 15.14 52.5 ± 19.5 
Significance NS p<o.02 p<o.02 
Conclusions: 
Patients with neurally mediated syncope exhibit an impaired 
immediate vasoconstrictor response which is clearly manifest well 
before the onset of the vasovagal reaction. This suggests that 
Individual susceptibility to orthostatic stress may be related to 
deranged low pressure cardiopulmonary baroreceptor activity. 
ABSTRACTS 
790·4 11:15 
Profound Electroencephalographic Abnormalities During 
Neuromediated Syncope Induced by Tilt Table Testing 
Robert S. Sheldon, Willlam F, Murphy. University of 
Calgary, Calgary, Alberta, Canada. 
Although neuromedlated syncope is a common clinical 
problem the degree of cortical dysfunction ln this 
syndrome is unknown. The purpose of this study was to 
determine the nature and prevalence of 
electroencephalographic abnormalities in patients durlng 
syncope induced by tilt table testing. 21 patients 
(pts) wlth continuous EEG monitoring (12 male, 9 female, 
age 32 t 20 y, median 4 syncopal episodes) developed 
syncope during isoprotereno1-headup tilt table testing. 
Syncope developed after 3.1 t 1.9 min of headup tilt in 
the absence of isoproterenol (ISO) (1 pt), with 2 
mcg/min ISO (3 pts) and 5 mcg/min ISO (17 pts). Mean 
peak and trough heart rates, systolic blood pressure, 
and rate-pressure products were 129 t 22 bpm and 71 t 
23 bpm, 115 t 18 mm and ~2 t 24 mm, and 14.6 t 2.4 x 103 
mm-mln-', and 4.4 t 2.1 x 103 mm-min·', respectively. 
All patients regained conSC10usness wlthin 30 sec of 
the onset of syncope and 20/21 pts had abnormal EEGs. 
The range of duratl0n of abnormal EEG findings was 5-
15U sec. 12 pts had delta waves and 8/12 pts had 
suppresslon of background rhythm after delta waves. 7 
pts had theta waves of whom 3 pts had suppression of 
background actlvity prior to onset of theta waves. 6 
pts had a characteristic theta-de1ta-background 
suppression progression of EEG changes in keeping with 
progresslve cortical disturbance. 1 pt had only 
suppreSSlon of cerebral background activity. Thus most 
patients have EEG signs of severe diffuse cortical 
dysfunction, despite the generally benign clinical 
appearance of syncope. 
790·5 11:30 
A Randomized, Crossover Comparison of a Ten Minute Tilt 
Table Test With a Conventional Multistage Test 
Robert S. Sheldon, universlty of Calgary, Calgary, 
Alberta, Canada 
Neuromedlated syncope lS a common syndrome with 
uncertal n pathophys io logy, prognosi s, and treatment. 
A very brlef isoproterenol (ISO)-headup tilt (HUT) table 
test would be useful for investigations of this 
syndrome. To assess a single stage lSD-HUT (5 meg/min 
ISO for up to 10 min HUT) we compared the clinical, 
temporal and hemodynamlC findlngs Detween 8 3 stage ISD•
HUT lU, 2, and 5 mcg/min ISO for up to 10 min) and a 
s1ng1e stage ISO-HUT ln 40 patlents (19 male, age 50tlS 
y, medlan 30 syncopal spells over median 48 months) who 
underwent both tests l1t13 days apart in a prospective, 
randomized, crossover trial. The 3 stage lSD-HUT was 
positive in 24 pts and negative in 16 pts. There were 
no comp 1 i cat ions and the pos i t i ve and negat i ve 
concordances for clinical outcomes between the 2 tests 
we re 79% and 81%, respect i ve 1 y. Symptoms deve loped 
rapid 1 y and monoexponent 1 a 11 Y durl ng 5 mcg/mi n ISO 
during both the single stage test (t;, 1.3 min) and ~ 
stage test (t;, 2.0 min) and symptom onset times 
correlated well Detween tests (n:16, r:0.74, p:.OO1). 
In hemodynamlc comparisons we found that peak heart 
rate, blood pressure and rate-pressure products were 
s1milar ln both tests and correlated well, with peak 
heart rate 133t18 and 13~t25 bpm during 1 stage and 3 
stage tests. Trough values were similar and trough 
heart rate correlated well between tests (r:O.86, n:16, 
p<0.001). Thus a single stage HUT with 5 mcg/mln ISO 
has very Simi 1ar c1 lnica1, temporal and hemodynamic 
flndings as a longer conventional test. Adoption of 
this protocol would faci 1 itate investigation of 
neuromediated syncope. 
269A 
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790·6 11:45 
Determination of Sympatho-Vagll Tone end Optimum Duration of Head-Up 
Tit Table Testing Using Heart Rate Variabnity Parameters 
John M. Fontaine MD FACC, Carlos Cuello MD, Jeanne DeCaro BS and lisa 
Ney RN 
Medical College of Pennsylvania, Philadelphia, Pennsylvania 
Tilt table testing has been useful in the evaluation of neurocardiac syncope, 
however, no standard protocol for tilt angle or duration of tilting exist. To 
determine the optimum duration for head-up tilt (HUT) table testing, 12 
normal volunteers underwent HUT at 60· for up to 42 minutes. Time 
domain (TO) and power spectral (PS) analysis of heart rate variability (HRV) 
were measured in 7 minute intervals using the Corazonix Analyzer. There 
were 6 men and 6 women, with a mean age of 26i 9 years. TO 
parameters measured were: I} mean heart rate (MHR), 2} standard 
deviation (SO) of the MHR, 3} mean of the differences of successive RR 
intervals (MSSD) and 4} PNN50. PS energy in the low frequency (LF) (0.02 
- .1 OHz) and high frequency (HF) range (0.20 - 0.40Hz) were measured. 
TO and PS energy values between successive intervals were compared. TO 
parameters revealed an increase in the mean MHR (14 bpm) and decrease 
in the mean PNN50 (88%) during the first 7 minutes of tilt, when compared 
with the values in the supine position. The change in the MHR and PNN50 
associated with tilting peaked at 21 minutes. When the 7 minute tilt 
intervals were compared with adjacent intervals no significant change in 
the mean MHR or PNN50 occurred beyond 21 minutes. The mean SO and 
MSSD varied sporadically throughout HUT. A significant change in LF and 
HF energy occurred between the supine and 1 st 7 minutes of tilt. 
Differences in LF and HF were significant in the 1 st 3 intervals. However, 
the difference between the 3rd and 4th 7 minute intervals (mean LF 21 
minutes = 316244, LF 28 minutes = 369980ms2/Hz, p = .35; mean HF 
21 minutes = 45839, HF 28 minutes = 39642ms2/Hz, p = .50) and 
beyond 28 minutes were not significant. 
We conclude: HRV parameters may be used to assess sympathovagal tone 
during HUT. TO and PS parameters indicate that maximum adaptation to 
HUT occurs at 21 minutes in normal individuals. Protocols for 60· HUT 
should be at least 21 minutes before other provocative measures, such as 
Isoproterenol infusion, are undertaken. 
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791·1 10:30 
Radiofrequency Catheter Ablation of Accessory 
Pathways: Is the Efficacy and Difficulty of the 
Procedure Related to Accessory Pathway Location? 
Hugh Calkins, Rafel EI-Atassi, Angel Leon, Steven KalbflC!isch, 
Mark Borganelli, Jonathan Langberg, and Fred Morady 
University of Michigan Medical Center, Ann Arbor Michigan 
The aim of this study was to detennine if the difficulty or efficacy of 
radiofrequency (RF) catheter ablation of accessory pathways (AP) 
is related to AP location or the presence of manifest preexcitation. 
The success rate, procedure duration, fluoroscopy time, number of 
RF applications, and number of ablation sessions were compared 
for APs located in the right free wall (RFW), left free wall (LFW), 
posteroseptum cPS), anteroseptum (AS), and midseptum (MS). 
Two hundred sixty-two consecutive patients (llOF,152M, 36±15 
yrs) with 278 APs were included. The AP locations were LFW in 
166, PS in 49, RFW in 46, AS in 12, and MS in 5 patients. RF 
energy (25-36 Watts,1O-30 seconds) was delivered with a 4mm•
tipped deflectable 7F electrode catheter. Results: Two hundred 
sixty-five of 278 APs (95%) were successfully ablated. Twenty 
patients required more than one session. The success rate and 
number of sessions were independent of AP location, type of 
conduction, and the presence of multiple APs. The procedure 
duration and fluoroscopy time was greatest in pts with multple APs 
(l94±88 & 65±38 min), shortest in pts with midseptal APs (78±37 
& 22±14 min), and similar for AP in all other locations (134±60 & 
42±33 min). The number of RF applications was greatest during 
ablation of AS APs (l4±8) and in pts with multiple AP (l5±7) but 
was similar for all other AP locations (7±7). In conclusion, the 
overall efficacy of RF ablation is equally high for all locations of 
APs and is not influenced by whether the AP is concealed or 
manifest. However, the duration the procedure may be significantly 
shorter in pts with midseptal APs and significantly longer in pts 
with multiple APs. 
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Cardiac "Memory" of Repolarlzation After Radiofrequency Catheter 
Ablation of Accessory Pathways 
Hue-Teh Shih, William M. Miles, Douglas P. Zipes, F. Kevin Hackett, 
Lawrence S. Klein. Krannert Institute of Cardiology, Indiana University 
School of Medicine, VAMC, Indianapolis, IN 
Transient repolarization abnormalities have been observed in patients 
following surgical ablation of manifest accessory pathways (APs). We 
investigated whether transient repolarization changes occur after 
radiofrequency (RF) ablation of APs and whether this phenomenon was 
due to myocardial injury induced by RF energy or cardiac "memory" of 
repolarization ("T-wave memory"). Serial 12-lead ECGs were analyzed 
for T-wave changes in 71 pts (21 concealed, 50 manifest) with successful 
RF ablation. None of the pts with concealed APs had new T-wave 
changes. Six of the pts with manifest APs were excluded due to bundle 
branch block. Of the remaining 44 pts, 17 (38.6%) transiently developed 
inverted or isoelectric T waves after ablation, mostly in leads II, m, aVF, 
and more commonly in pis with APs closer to the septum: posteroseptal 
4/5 pts; septal 2/2; left posterior 6/8; left posterolateral 2/10; left 
anterolateral 1/2; left lateral 0/11; right posterolateral 1/1; right 
anteroseptall/1; right posterior 0/1; right lateral 0/2; and right 
anterolateral 0/1. There was more preexcitation (difference of QRS 
duration pre- vs post-ablation; QRSpre-post) in pts with T-wave 
changes. Peak total CK, peak CKMB, and number of RF pulses were not 
different. (mean ± s.d.) 
QRSpre-post (msec) 
number of RF pulses 
peak CK (IU /I} 
ak CKMB (lU /I} 
T changes Cn= 17) 
39.4 ± 14.5 
10.5 ±12.2 
468±581 
15.7± 24.0 
no chan&!! (n=27) 
26.2± 22.1 (p<O.05) 
7.4±9.7 
416 ± 814 (n=26) 
22.1 ±49.3 (n=25) 
Thus, transient T-wave changes occur after RF ablation, especially in pts 
with APs closer to the septum, and are related to the degree of 
ventricular preexcitation, but not the degree of myocardial injury. This 
suggests that the T-wave changes are caused by cardiac "memory" of 
repolariza tion. 
791-3 11:00 
Radiofrequency Catheter Modification of the Sinus Node for Inappropriate 
Sinus Tachycardia 
E. Wayne Grogan Jr., Michael de Buitleir, Gene Musser. 
University of Wisconsin Medical School, Madison, Wisconsin 
Patients with inappropriate sinus tachycardia (ST) have persistently rapid sinus 
rates without a definable cardiac or non-cardiac cause. Such patients may be 
qu~e symptomatic, are often drug-refractory, and are in some cases treated 
with AV junctional ablation and permanent pacemaker implantation. We 
sought to investigate an alternative approach to this disorder. Two multiply 
drug-refractory patients with this syndrome underwent radiofrequency (RF) 
catheter modification of the sinus node; (1) a 38 YO female without structural 
heart disease, and (2) a 26 YO female who had undergone VSD repair in 
childhood. Goals were to lim~ the sinus rate and the frequency of 
spontaneous episodes of ST while preserving AV conduction. The sinus node 
region was localized by right atrial endocardial mapping during spontaneous 
ST, and RF energy (25-37 applications at 51 t 3 volts for 39 t 12 seconds) 
was applied at and in close proximity to the site of earliest activation. During 
RF delivery the sinus rate accelerated by a mean of 12%, suggesting thermal 
stimulation of the sinus node. On occasion, trans-atrial phrenic nerve 
stimulation required immediate discontinuation of RF delivery. In each case, 
there was no immediate effect on HR, but within 24 hours both patients 
experienced a decHna in HR and reduced frequency and severity of bouts of 
ST. Symptomatic bradycardia did not occur (follow-up 7 and 4 weeks). 
Results of 24 hour ambulatory ECG's and axercise tests performed under 
identical conditions pre and post ablation are shown: 
I LESIONS 24 HOUR HR (AVG/PEAKl EXERCISE HR (REST/PEAK) 
fI ~ fQST. ..PBE fQSI 
1 37 92/147 671115 115/188 88/146 
2 25 92/170 79/102 134/180 99/131 
Conclusions: (1) RF catheter modification of the sinus node slows the sinus 
rate in patients with inappropriate ST, while preserving exercise rate response; 
(2) Acceleration of HR during RF delivery may signify proximity to the sinus 
node; (3) Care must be taken to avoid phrenic nerve stimulation or injury 
during RF delivery; and (4) RF modification of the sinus node may be 
preferable to AV junctional ablation in this disorder, since AV synChrony is 
preserved and permanent pacemaker implantation may be avoided. 
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Adenosine and Accessory Pathways: Iaplications for 
Assessing Catheter Ablation 
Villiam A. DeLacey, David E. Haines, Michael J. Barber, 
John P. DiMarco. University of Virginia Health Sciences 
Center, Charlottesville, Virginia 
Earlier studies have used intravenous (IV) adenosine 
(ADO) in patients (pts) with accessory pathways (AP) 
to maximize preexcitation (preex) or to unmask "latent" 
preex. Ye reviewed responses to IV ADO in 85 pts with 
APs to determine if production of AV or VA block after 
IV ADO could be used to assess successful ablation of 
AP conduction. Pts were classified as having constant 
manifest preex, intermittent preex or concealed preex, 
based on review of all prior 12-lead ECGs. Increasing 
doses of ADO were injected until preex increased or AV 
block occurred. The mean (± SD) dose used was 112.5 ± 
37.5 ~g/kg. Results are shown below: 
Constant preex (n.53) 
Intermittent preex (nc18) 
Concealed preex (n.14) 
Increased Preex 
50 
11 
5 
AV Block 
3 (6%) 
7 (39%) 
9 (64%) 
AP anterograde effective refractory periods were longer 
in the 10 pts with constant or intermittent preex who 
manifest block than in the 61 pts who had increased preex 
(679 ± 175 msec vs 267 ± 72 msec, p (0.0001). Forty pts 
underwent apparently successful catheter or surgical AP 
ablation and had AV or VA block with ADO immediately 
postprocedure, but 4/40 pts later recovered AP conduc•
tion. Conduction was then not blocked by ADO. These 
data demonstrate that ADO can be used in many but not all 
manifest preex pts to maximize preex but only 50% of pts 
with intermittent or concealed preex will be unmasked. 
Postablation AV or VA block after ADO does not preclude 
late recovery of AP conduction. 
791·5 11:30 
Scintigraphic Comparison of Perfusion and Sympathetic 
Innervation Abnormalities after Radiofrequency and 
Surgical Ablation of Accessory Pathways 
Raymond N. Vitullo, Martin E. Bacon, William L. Barrington, 
Ruth Ann Greenfield, Richard L. Page, Joyce C. Pressley, 
James E. Lowe, R. Edward Coleman, J. Marcus Wharton, Duke 
University Medical Center, Durham, NC 
Little is known about the comparability of the effects of 
radiofrequency (RF) and surgical ablation of accessory 
pathways on regional sympathetic innervation and myocardial 
perfUSion. To test the hypothesis that RF ablation causes less 
myocardial injury than surgical ablation, planar and SPECT 
thallium-201 (TI) and 1-123 metaiodobenzylguanidine (MIBG) 
cardiac scintigraphy were performed in 22 pts who underwent 
ablation for septal or left-sided accessory pathways. There was 
no demonstrable evidence of structural heart disease in any of 
these pts. Eleven pts with RF ablation (mean age 35.5± 13.0 
yrs) and 11 surgically ablated pts (mean age 35.3±8.6 yrs) 
were scanned at a mean of 0.3+0.3 mos and 20.1 + 14.3 mos 
following accessory pathway ablation, respectively:•
Although TI perfusion defects were demonstrated in 9 (82%) of 
surgically treated pts, only 2 (15%) of the RF pts had abnormal 
thallium scans (p<0.01). Ten (91%) of the RF pts and all 
surgically ablated patients had abnormal MIBG scans with large 
defects present more commonly in the surgically treated pts. 
These data suggest that both surgical and RF ablation result in 
regional myocardial sympathetic denervation. Surgical ablation 
appears to be more commonly associated with demonstrable 
myocardial perfUSion abnormalities and with qualitatively larger 
area of sympathetic nerve disruption probably related to the 
extent of surgical dissection in the atrioventricular groove. 
ABSTRACTS 
791·6 11:45 
Dual Versus Multiple Atrioventricular Nodal Pathways 
in Patients Undergoing Selective Fast or Slow Pathway 
Ablation 
Jasbir Sra, Mohammad Jazayeri, Boaz Avitall, Anwer 
Dhala, Sanjay Deshpande, Zalmen Blanck, Mita Sheth, 
Masood Akhtar. 
Sinai Samaritan Medical Center, Milwaukee, VI 
Duality versus multiplicity of AV nodal pathways in 
Patients (Pts.) with AVNRT is still controversial. 
Ve have made the following observations in 22 of 
57 Pts. undergoing successful AV node modification for 
AVNRT: 1) Abolition of ante grade fast pathway (FP) 
with intact retrograde FP (4 Pts.). 2) Loss of 
retrograde FP with intact ante grade FP (3 Pts.). 
3) Unmasking AV nodal dual pathways following 
successful FP ablation in Pts. without dual pathway 
physiology at baseline study (2 Pts.). 4) Manifes•
tation of AVNRT of uncommon variety subsequent to FP 
ablation (2 Pts.). 5) Persistence of the dual pathway 
physiology following successful slow pathway (SP) 
ablation (11 Pts.). 6) Residual retrograde conduction 
with a different atrial activation pattern following 
ablation of SP and FP (1 Pt.). 7) Demonstration of 
common and uncommon AVNR at identical HI H2 
interval during atrial extrastimulation (1 Pt.) and 
AVNR process utilizing antegrade and retrograde slow 
pathways in the same Pt. 
Conclusion: These electrophysiologic phenomena suggest 
a broad spectrum of the AV nodal physiology in patients 
with AVNRT undergoing selective fast or slow pathway 
ablation and favor the presence of multiple AV nodal 
pathways in some of these individuals. 
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792·1 10:30 
Identification of Two Mutations in the Beta Myosin Heavy 
Chain Gene in Hypertrophic Cardiomyopathy: a 403 ... ~ ... 
Mutation Associated with a High Incidence of Sudden Death 
and a 908 .... ~v .. Mutation in a Family with Infrequent Sudden 
Death 
Neal Epstein, Gabriel Cohn, Francis Cyran, Wen-Si Zhu, Lameh 
Fananapazir, National Institutes of Health, Bethesda, Maryland 
Two different mutations in the 6 myosin heavy chain (6MHC) 
gene on chromosome 14q have been identified in two families with 
hypertrophic cardiomyopathy (HeM). We report another kindred 
with the codon 403 ... ~ ... mutation in the head of the cardiac 
6MHC molecule, and a new codon 908 .... ~VoI mutation whicb lies 
at the junction of the bead and the tail of the 6MHC molecule. 
271A 
The mutant messenger RNA has been detected in skeletal muscle of 
pts with the 908 mutation. The 403 mutation is present in a 19-
member kindred with a high incidence of sudden death (n=6), and 
syncope or presyncope (n=5). Cardiac catheterization and electro•
pbysiologic studies in affected family members suggest that the 
primary abnormalities associated with this mutation are left 
ventricular diastolic dysfunction and myocardial iscbemia. More 
than 230 individuals of the kindred with the 908 mutation have 
been evaluated. Both adults and children wbo have the disease 
gene but who show no signs of HCM have been identified. Only 2 
premature sudden deaths have occurred in this four generation 
family. The description of the molecular defect in these ldndreds 
has allowed identification of children with an HCM gene prior to 
the clinical expression of the disease. This provides the opportunity 
to study the natural history of these mutations and in the case of the 
403 mutation, assess the ability of anti-ischemic therapy to alter the 
I)rogression of the disease. 
272A ABSTRACTS 
792·2 10:45 
DtIecIlon of a New Mutation In the p.MyOlin Heavy Chain Gene in a 
Family wnh Hypertrophic Cardiomyopathy 
Ali JaINian Marian, Qun-tao Yu, Adolph Mares, Benjamin Perryman, 
Robert Roberts. 
Baylor College c:A Medicine, Houston, Texas. 
Results from two Independent groups show the gene for famnial 
hypertrophic cardlomyopethy (FHCM) maps to chromosome 14ql in many 
Iam.1es with FHCM. Two mutations have been found in the p-myosln heavy 
chain (PMHC), the candidate gene, one a fusion between the a and P 
myosin genes end a point mutation in exon 13 c:A pMHC. We screened 43 
lamlles with FHCM, one had the point mutation in exon 13 and none had 
the hybrid gene. We did, however, find a new and unique restriction 
fragment length poiymorphlsm (RFLP) identified by a PMHC probe In a 
proband with FHCM. On Southem blots the RFLP was Inherited In 
Mendelian fashion In two subsequent generations. To determine the 
molecular basis for the RFLP the fragment of the PMHC gene detected by 
the probe and edjacent regions consisting of 11 kbp (10,788 bpI was 
amplified by poiymerase chain reaction (PCR). Primers were designed to 
amplify fragments varying from 590 bp to 4748 bp. PCR of the distal 3' 
region c:A the PMHC gene yielded two products, an expected 4.748 kbp 
product and an unexpected truncated product of 2.3 kbp. The smaller 
product was detected only In Individuals with the unique RFLP on Southem 
blots. Presumably one product Is of the normal allele (4.7 kbp) and the 
smaller product c:A the other allele, the laner having undergone a deletion of 
2.4 kbp. Restriction mapping analysis of the normal and the abnormal PCR 
products was used to further delineate the location c:A this deletion. PCR 
primers were designed to flank the deleted region, and the amplified 
product was subsequently cloned and sequenced. Sequence analysis 
confirmed a 2379 bp deletion located from nucleotide 23793 through 
nucleotide 26171 c:A the PMHC gene. The deletion Included part of Intron 
41, all of exon 41 and the entire 3' untranslated region including the poiy A 
addition signal. This deletion Includes the sequences that encode for the 
carboxy terminus (taU) of PMHC which are known to be essential for the 
interblnding c:A the myosin molecules. Thus, disruption of the taU of the P•
myosin heavy chain molecule should prevent spontaneous assembly of the 
myosin moIec~es Into thick myofibrUs and impair their contractUe function. 
792·3 1l:00 
Purification of A Defective SR Calcium Rel.a.e Chlnnel Protein In 
The CardlomyoplthlC Syrlln Hlmster 
LI Shen, Mitchell S. Finkel. University of Pittsburgh, Pittsburgh, PA. 
We have previously reported defective Inotropic responsiveness to 
ryanodlne (A) In Isolated papillary muscles and anhanced (3H) ryano•
dine binding to cardiac and skeletal muscle membranes In the Bio 14.6 
eardlomyopathlc Syrian hamsler (CMH). Accordingly, we purified the 
450 kOa sarcoplasmiC reticulum calcium release channel (SACAC) 
from 4 month old CMH and F,B controls (F,B) using sucrose gradient 
ultracentrifugation of CHAPS-solubllzed skeletal muscle. Scatchard 
analyses of (3HI ryanodlne binding to the purified preparation revealed 
the parslStance of the Increase In binding capacity (Bmaxl noted In the 
membrane preparations (Sma. - 202 ± 15 vs. 340 ± 24 pmoles/mg 
prot. ; KO - 1'.5±2 vs. 10.2±2 nM ; FIB vs. CMH) (p<.OI : n=5). 
Similar results were obtained In 2 week old pre-necrotic hamsters 
(Sma. - 327±13 vs. 408±9 pmoles/mg prot. ; KO - 5.4±0.3 vs. 
5.8±0.3 nM ; FIB vs. CMH) (ns3). Limited proteolytic digestion of the 
purified 450 kOa protein with trypsin and endoprotelnase Arg-c (but not 
Lys-c or Glu-c) demonstrated the presence of an additional fragment 
(m.w. approx. 210 kOa) in the F,B not seen In the CMH. .r-----------........ --.... ~ 
i 
.. - ... _ eM" .. 
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Cardiac membranes pre-labeled with (3HJ ryanodine following sucrose 
gradient ultracentrifugation revealed a Similar increase in total (3Hl 
ryanodlne binding In purified fractions from the CMH vs. F,B. These 
findings support the presence of a defect in the SACRC In the CMH. 
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Lack of Mutation at !he Coclina Site for Residue 403 (AI'I to Gin) in Exon 13 
of !he 8-Myosin Heavy Chain in 17 Autopsy Specimens of Hypertrophic 
Cardiomyopathy. 
E. Rene Rodriguez·, Allen P. Burke', Renu Virmani'. Josepb E. ParriUo'. Rush 
Presbyterian St. Luke's Medical Center· Chicago, IL and Armed Forces Institute 
of Pathology'. Washington D.C. 
~: Seventeen autopsy beartB from randomly selected patients with clinical 
and/or pathologic diagnosis of bypertrophic cardiomyopathy were studied 10 
define the frequency of the previously described mutation in exon 13 of the 
B-Myosin Heavy Chain Gene (8-MyHCG). Mn!JRIll.: Four women aDd 13 men 
were studied, their ages ran&ed from IS 10 83 yean (mean 39.4). Using the 
poly~ chain reaction, a 330 bue-pair-f'rasment was amplified encompassing 
part of exon 13 the intron aDd the beginning of oxon 14. Primers ASH 30 
cagtcalctctttaccaacttlgc aDd ASH 40 agtgccccagtggcatatatcacc were used. Subse•
quently an 83 base pair f'rasment intemallo the first set of primers was amplified 
with primer ASHI0 BCtcaagggecIgtgccaccctcG whicb matches the 7 codoDS 
preceding the mutation and the codon wbere the mutation occurs. And with 
primer ASHli gctcaaggegctgtgccaccctcA whicb bas a mismatcb at its 3' end thus 
transforming the native codon TCil; 10 TCA. The antisense primer for ASH 10 
or ASH 11 was ASH 20 atggacccacctgclggacattct. Further analysis included the 
use of restriction enzymes Ava I and Dde 110 digest the amplified DNA. All a 
control, in all tissues a different fragment of exon 1 of the B-MyHCG was ampli•
fied. BuMllJ.: Eleven of 17 cases showed no evidence of mutation wben the 
targot area was amplified with the ·DOn-mutant· primer pair. The 6 cases which 
did not amplify, also failed 10 amplify with the ·mutant' primer pair. Digestion 
with restriction endonuclease Ava I produced a single cut of the target product in 
the region of the wild type codon. However, digestion with Dde I which recog•
nizes the mutant codon did nOI. Conc/usio": Archived tissue from aulopsy 
specimens was successfully amplified. There was lack of amplification of a 
specific targot product in the region of exon 13 of the B-MyHCG in 6 of these 
randomly selected patients. The use of another region of the gene as a control for 
the PCR suggests that the lack of amplification of the target in exon 13 represents 
a real defect. The nature of the defect may represent a different mutation. 
Sequencing experiments should further characterize the nature of the changes that 
prevent amplification of this region of this gene in the 6 negative patients. 
792·5 1l:30 
Reversible Alterations in Cardiac Gene Expression in a 
Patient With Dilated Cardiomyopathy and Hypothyroidism: 
Serial Measures by Quantitative Polymerase Chain Reaction 
Arthur M. Feldman, Phillip E. Ray, Steven I. Sherman, 
Kenneth L. Baughman, Paul W. Ladenson. The Johns Hopkins 
University School of Medicine, Baltimore, Maryland 
Although the effects of thyroid hormone on cardiac gene 
expression in animals is well known, the fundamental 
pathogenesis of hypothyroidism in man is uncertain. We 
evaluated a young man with a dilated heart and profound 
hypothyroidism. During 9 mos of thyroid hormone therapy, 
serial cardiac assessments documented substantial 
improvement in myocardial performance. Left ventricular 
ejection fraction improved from 16% to 37%, left 
ventricular end-diastolic size by echo decreased from 7.8 
cm to 5.9 cm, and cardiac index increased from 1.4 to 2.7 
1/min/m2. Steady state levels of mRNAs encoding selected 
cardiac proteins were measured in biopsy samples obtained 
prior to start of therapy and after 9 mos of treatment 
using the polymerase chain reaction and an internal RNA 
control. Non-failing human hearts obtained from potential 
organ donors served as controls. Results: 
Transcript HypothyrOid Euthyroid Non-FailingCn-7l 
a-myosin He 3.5 x 10· 39 X 10· 4l±16 x 10· 
p-myosin He 1. 5 x 10' 1. 2 X 10' O. 9±0. 2 x 10' 
ANF 6.0 x 107 ** ** 
Phospholamban 0.5 X 10' 1. 0 X 10' O. 8±0.1 x 10' 
P2-receptor 1.7 x 107 1.9 X 107 1.5±0.04 X 107 
p-actin 1.2 x 10· 1.7 x 10· 1.2±0.1 x 10· 
mRNA/pg total RNA; values are mean ± SE,** <2.8 x 10· 
This application of quantitative peR represents the 
first prospective serial characterization of thyroid 
hormone effects on myocardial gene expression in man and 
demonstrates that altered gene expression in a dilated 
myopathic heart may be reversible with appropriate 
therapy when a potential etiology is recognized. 
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INCREASED BETA·1 RECEPTOR EXPRESSION AT mRNA LEVEL IN 
DILATED CARDIOMYOPATHY 
Chrlster Sylv6n MD PhD FACC, Mlkael BlOnnegArd MD PhD. Eva Jansson 
MD PhD. Peter Sotonyi MD. Uang-Xiong Fu MD. Finn Waagstein MD PhD. 
Me Hjalmarsson MD PhD. Karolinska Institute at Huddinge University 
HOSpital, Huddinge. Sahlgrenska Hospital. Gothenburg, Sweden and 
Semmelwelss Institute. Budapest. Hungary. 
Backgroynd: Beta-1 but not beta·2 receptor activity (BAR-1, BAR-2) have 
with Dgand methods been demonstrated to be specifically decreased In 
dilated cardiomyopathy (DCMP). 
Aim 01 study: Is this adaptation also present at the level of gene 
expression? 
Material and methods: Gene expression of BAR-1/BAR-2 was investigated 
with solution hybridization for the determination of mRNA. Labelled cRNA 
probes were used. Left and right ventricle was analyzed from organ donor 
hearls (n-6) and from explanted hearts (DCMP. n-6). Moreover. papillar 
muscles from 7 patients operated for mitral Insufficiency (MI) were analyzed. 
.BuIIIla: The table shows that In MI both BAR-1 (p<o.o001) and BAR·2 
(p<o.o08) were depressed. In DCMP BAR-2 was depressed (p<o.o01) In 
right ventricular myocardium. In left ventricular myocardium BAR-1 was 
profoundly upregulated (p<O.004). 
Conclyslon: While both BAR-1 and BAR-2 mRNA appear to be 
downregulated In MI. there appear to be specnic and pronounced 
Increased gene expression of BAR-1 mRNA In left ventricular myocardium 
In DCMP. 
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Catheter Manipulation ror Ablation Procedures: 
Use or Long Sheaths and the Left Posterior "End Run" 
J. Philip Saul, J. Edward Hulse, James E. Lock 
Edward P. Walsh. Children's Hospital, Boston, MA. 
10:30 
. Ouri.ng 71 radiofrequency ablation procedures for elimina•
non of either accessory A V pathways (AP) or ectopic atrial ta•
chycardia (EA 1'), total procedure times have ranged from 2-9.5 
hours. (median· 4.5), .w~th flouros~opy times from 16·178 min 
(median • 63). To opnnuze these nmes and improve success, we 
have developed a number of techniques which employ long vas•
cular sheaths and take advantage of the mitral-aortic anatomic re•
lation. A deflectable tipped catheter has been used with the fol-
10wi.ng. sheath configura~o~s: 1) long ".transseptal" type sheath to 
maxlnuze torque transnusslon and redirect the catheter tip for a 
retro~de left .ventricular approach, 2) a stiff straight sheath to 
prOVide a rotational fulcrum for a transseptal atrial approach to 
left lateral AP's, 3) a soft "transseptal" sheath to redirect the 
catheter from RV apex to the TV ring for a retrograde RV ap•
proach, and 4) a stiff "multipurpose" tipped sheath to provide 
coaxial steering for atrial ablation in EAT or right sided AP's. In 
addition, for left posterior AP's, a retrograde approach has been 
used with and without a sheath to directly advance the catheter 
tip behind the mitral valve at the point of mitral-aortic continui•
ty. The procedure which we have labeled the "End Run" allows 
for mapping of the left A V groove from septum to the mid•
lateral position, but is most useful for ablation in the difficult to 
reach left posterior septal area. These techniques alone or in 
combination have contributed to success in 43 (60%) of all pro•
cedures, with overall success rates for ablation of both AP's and 
EAT foci> 90%. 
Novel catheter manipulation techniques using vascular 
sheaths and knowledge of valvar anatomy improve success and 
may shorten procedure times. 
ABSTRACTS 273A 
793·2 10:45 
Factors Related to Successful Radiofrequency Ablation or 
Concealed Accessory Pathways in Children 
Steven M. Schwartz, Macdonald Dick, n, Gerald Serwer. University 
of Michigan, Ann Arbor, Michigan 
To test the hypothesis that catheter placement for successful radiofre•
quency ablation of concealed accessory cOMections can be deter· 
mined by the atrial and ventricular electrograms (AB, VE) as recorded 
through the electrodes on the ablating catheter with comparison to the 
electrograms recorded with the exploring catheters used to map the 
accessory cOMcction, we measured the AE and VE amplitude, the 
ventriculo-atrial conduction intervals (V AC) at the ablating electrode 
and the shortest V AC recorded through the exploring catheter elec· 
trodes before both successful and unsuccessful radiofrequency 
ablation attempts. The interval between the VE and AE during V A 
conduction was evaluated for electrical activity suggestive of a Kent 
bundle potential. The study group consisted of 9 children with con· 
cealed accessory coMections. One hundred ten total radiofrequency 
triB;ls were exami~ed. The time from onset. of radiofrequency energy 
delivery to cessation of retrograde conduction in successful attempts 
was 2.8 ± 1.1 (SO) scconds. AE amplitude in successful and unsuc· 
cessful attempts (0.22 ± 0.2 mv vs. 0.22 ±O.S mv, p-o.99) and VE 
am.plitude (0.95 ± 0.6 mv vs. 1.51 ± 1.5 mv, p •. 44) and the AENE 
ratio (0.27 ± 0.2 vs. 1.69 ± 5.9, p-o.64) were not different. In 
contrast to our experience with manifest pathways, the presence of 
electrical activity between the VE and AE did not correlate with 
successful ablation. The V AC at the ablating catheter before success· 
ful radiofrequency (12 ± 18 ms) and unsuccessful radiofrequency (54 
± 54 ms) trials approached statistical significance (pa 0.06). In suc· 
cessful attempts the V AC at the ablation catheter was less than the 
VAC of the exploring electrode by 26 ± 21 ms. We conclude that 
successful radiofrequency ablation of concealed accessory connec· 
tions is characterized by a prompt response time and by short V AC as 
measured through the ablating electrode. 
793·3 
The Natural History of Arrhythmias In Ebsteln's Anomaly 
Jan Till, David Celermajer, John Deanfieid 
The Hospital for Sick Children, The Royal Brompton and St 
Bartholomew's Hospital, London, England 
11:00 
We reviewed 140 patients with Ebstein's anomaly of the tricuspid 
valve. Excluding 9 who died with haemodynamic problems within the 
first week (none with pre-excitation (PE) or arrhythmia) follow-up 
ranged between I month and 49 years. 26 (19%) had PE. 36 (26%) 
patients experienced supraventricular arrhythmias; junctional 
tachycardias (JT) 28; atrial flutter 7, and atrial fibrillation (AF) 3. 
Those presenting with arrhythmia are shown: 
Age(years) No. JT Atrial Flutter AF 
<I 92 4(4%) 0 0 
1-12 34 6(18%) 0 I 
>12 14 6(43%) 1 2 
JT was increasingly common as a presenting feature with older age 
whereas incidental PE was found more frequently in the young 7/92 
«I year), S/34 (1-12 years) and 1/14 (>12 years). Of the II with 
incidental PE identified before 12 years of age, 7 have developed JT 
at a median age of 12 years (2 to 46 years) and 4 remain symptom 
free. Of the 19 patients who suffered JT before 12 years of age, 18 
had recurrences. Once JT occurred, in the majority it was recurrent 
and difficult to control. 19 patients underwent electrophysiologic 
study which revealed a single accessory connection in 12 and multiple 
in 6. Connections were located on the right free wall in II, 
posteroseptal 10, left free wall in 2 and of Mahaim type in 2. 
Catheter ablation was successful in 1/3 (2 residual connections, 0 
deaths) and isolated arrhythmia surgery was successful in 3/6 (2 
residual connections, 0 deaths). In combination division of accessory 
connections with tricuspid valve surgery was successful in 2/3, 
whereas isolated corrective surgery in patients with arrhythmia was 
only successful in 1/6, (I residual JT, 4 deaths). 
Arrhythmias are the most common presenting problem in older 
patients with Ebstein's anomaly. In all age groups JT is recurrent and 
refractory. Corrective surgery with uncontrolled arrhythmias is 
associated with a high mortality and should not be undertaken. 
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1Iadio~ C&tb8tar Ablation of SUpraventricular 
~. ill tM '-4iatric l'Opulation via tM Atrial 
 
0lri.atqi1ar case, Paul. Gillette, BaIbara IOUck, Hemy 
Blair. Medical UUversity ot SC, Cllarleston, SC 
D.Ia to ocncem about the potential lcn;r tam sequelae 
of IILIltiple radiofraquency (RF) lesions in the 
wntricle, we haVe attaaptad RF catheter ablatial ot 
.upravantrlcular tadlycardia in the pediatric 
pc:p1l.atial via the atrial~. 'lbe procedure 
involve. the use of tranaseptal pmcture tor left sided 
aa.u an1 the cmtIlaIY sirals ~ tor moat septal 
IRIbrtratas. 'lhe atudy pc:p1l.atial ccnsists of 26 
patients who had a total ot 28 attalpts at radio•
frequelx::y catheter ablatial. Diagnosis includes 12 
with WiW/SI.'l', 14 with SI.'l' via UI'lidi%ectialal. retrograde 
ao::.sory pathways, an:i 2 with atrial ectc:pic 
tadlycardia. 'DIe mean patient aqe was 10.6 years with 
a ~ of 2 IIICI1ths to 18 years. 'lhe locatial of the 
c IRIbrtrates in the 26 patients were: 
IILIltiple sites in 4 patients, right sided in 3 
patients, septal in 10 patients an:i left sided in 9 
patienta. '!he procedure was considered successful. in 
15 cut ot 26 patients (58\). 'lhere was no aqe 
ditference between the sucoessful. an:i the unsuooessful. 
qrcups. SUccass rates tor substrates with dual 
locatiCl'lS was 25\, septal 40\, right sided 66\, an:i 
left sided 78\. '!he average fluoroscopy time in the 
aucxaasful. groop was 52 mirrutes (~e 15 to 112 
m1nttes) an:i in the failure groop was 71 minutes (rarge 
19 to 130 minutes). 'lbere were no acute carplicatialS 
in either groop. C»nc1usion: 'lbe atrial awroach for 
radiotraquency ablatial of anhythmcgenic substrates is 
a viable altemative in pediatric patients. success 
rates in this study with this awroach ten:led to be 
higher tor lett sided substrates. 
793·S 11:30 
Effects of 0Il'alic ~ 'l'IIdI,ycardia at JJI 
VOl.~, ... an1 lI\Jncticn DD:ing GraWth in NaIxIm Pigs 
Ryuhei TaMka, Francis Spinale, Fred Crawford, Michael 
Zile, Medical UUversity ot Scuth carolina,Charleston,SC 
Altho.lgh chralic supraventrio.1l.ar pacin;J tachycardia 
(SI.'l') hall been IIbaWn to cause a dilated cardianycpathy in 
experilllants usin;J adult animals, clinically, SI.'l' occurs 
moat trequantly in c:hll.dran an1 nr..txm'Is. 'lhis study was 
cSesigned to evaluate the effects of chronic SVT al rN 
volume, IIIIUIII an1 tun::tial in newboJ:ns in light of the 
sillLll.tanac:lls eftects of physiologic growth. Serial 
chan;Ias in rN volume (an:! diastolic cUmensial, Oed, an), 
mau (U'M, 9IIl) an1 tun::tial (fractialal 1IIlort.enirq, FS,\) 
ware examinad usin;J edlocal:di~ in 2 gl'Q.1pS of 
COI'lIICious newbom pigs(3 wk old); 6 pigs were subjected 
to 3 weeks ot SI.'l' (240 tpn) an:i 6 littemate ocntrols 
(C'IR) ware tollowed for 3 wk. Mean ± _, * - p<0.05 VB 
C'IR, h,lr - wall thic.kr-. to radius ratio. 
ArIel :1m 1 1iIIBk 2 1o!BE!IcB 3 weeJcs 
C'IR Dad 2.6±0.1 2.9±0.1 3.0±0.1 3.l±0.1 
h,lr 0.37±0.02 0.36±0.01 0.37±0.02 0.39±0.02 
LVM 19±1 22±2 28±2 34±2 
FS 33±l 37±l 37±1 33±1 
SI.'l' Oed 2.8±0.l 3.2±0.2 3.9±0.3* 4.4±0.3* 
h,lr 0.35±0.02 0.3l±0.Ol 0.26±0.02* 0.22±0.02* 
LVM 2l±2 25±2 3l±3 39±4 
FS 31t1 27+1 24±3 19+2* 
rN IIIIUIII increued in a atap-wise fashial in both C'IR an:i 
SI.'l'. In C'IR the increued JIIIISS was associated with an 
\II'dIan;Jed h,lr an1 nomal FS, suggestin;J the develqment 
ot P'lYlIiologic hypertrqily. In SI.'l' the extent ot 
increue in IIIIUIII was similar to C'IR, however, it was 
associated with an eccentric distril:utial (decreased h/r) 
an1 a markad fall in FS, suggestin;J the develc:pDel'lt of 
pathologic hypertrq:tly. 'ltnIs, SI.'l' caused pathologic 
hypertrq:by an:i a dilated cardianycpathy in newborns. 
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Differences In the Frequency Spectrum of the InItial QRS 
Induced by Epicardial Versus Endocardial Padng In Children 
Parvin C. Dorostkar, Gerald Serwer, Macdonald Dick n, 
Univ. Of Michigan, Ann Arbor, MI. 
The high frequency content of the QRS complex is detenruned by a 
combination of wavefront conduction velocity and de~ of 
fragmentation and by upstroke velocity of the depolarizing cells. 
Whether epicardial pacmg (EP) versus endocardial pacing (EN) 
produce differences in the high frequency content of the initial QRS 
of children implying changes in the above factors was investigated 
using signal averaged EKG (SAEKG). We hypothesized that EP 
produces slower initial activation of the myocardium than does EN 
resulting in decreased high frequency content of initial QRS. 
Fourteen children ages 3 to 25 yrs with pennanent pacemakers 
underwent 16 SAEKGs. Nine studies were with EN and 7 were with 
EP. Three pts were studied with EP and again after conversion to EN. 
SAEKGs were recorded using an orthogonal X. Y, Z lead system and 
an ART 1200EPX SAEKG with a bandwidth of 0.04 to 500 Hz 
sampling at loo0/sec. The initial 60 ms of the QRS was analyzed to 
confine analysis to initial QRS and maximize spectral resolution. A 
512 point FF1' was perfonned following application of a Hanuning 
window function. The spectral amplitude at 200 Hz and 300 Hz and 
the spectral bandwidth defmed as the frequency below which 95% of 
the spectral energy was contained were detennined. Spectral 
amplitude at 200 Hz was ·27±II(SD) db for EN and ·38±10 db for 
EP. p=.054; at 300 Hz amplitudes were ·34±10 versus ·46±II, 
p=.049. Yet the differences were less than the spectral resolution. The 
bandwidth was 289±88 Hz for EN and 145±43 Hz for EP. p=.OOIS. 
All patients studied both with EN and EP showed an increase in 
bandwidth with EN. Thus, the bandwidth of the initial 60 ms of the 
QRS is increased for pts with EN over EP showing increased high 
frequency components implying more rapid initial activation of the 
myocardium. We speculate that these changes reflect less 
fragmentation of initial wavefronts resulting in fewer pacing 
prorhythmic effects with EN. 
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Double bolus of r-PA in the Dosage Finding. R-..lts of the 
Creco II-Study 1 1 
Rainer von Essen1, Karl·Ludwig Neuhaus
2, Martin Markrelter , 
Horst Nebelsleck , Albrecht Vogt2, Karl·Frledrlch Appel2, 
Reinhard Konlg3, Wolfgang Meyer·Sabellek3, Ulrich Tebbe 
for the CRECO·Study Croup 1 
Stiftskllnlk Augustinum Munchen , Stidt. Kllnlken Kassef2, 
Boehringer Mannhelm CmbH!, FRC 
The novel recombinant plasminogen activator BM 06.022 [r·PA) 
is a variant of human t·PA expressed in E. coli with a pro· 
longed half·llfe. In a multicenter dosage finding trial after a 
single bolus dose of 10 megaunlts [MU) [n = 42) or 15 MU 
en = 100) angiograms at 30. 60 and 90 min after onset of 
treatment revealed a high 30 min patency rate but also a high 
percentage of very early reoccluslon (20 , at 30 min. 12.5 , 
at 90 min rp). Therefore a double bolus design was tested In 
42 patients 10 MU followed by 5 MU 30 min later: 
Dose of r-PA 
10 MU 
15 MU 
10+5 MU 
, Patency (TIMI !p"ade 2 and 3) 
Patients 
n = 42 
n = 100 
n = 42 
30 min 
63 
65 
52 
60 min 
73 
74 
74 
90 min 
63 
75 
83 
Early reoccluslon between the 30· and 90 min angiogram was 
observed In 4 patients [9,5 '). 
One cerebral bleeding. 2 severe bleedings [one esophageal 
bleeding after additional thrombolysis, one hemopericardium) 
and only 5 deaths were reported In all treated 184 patients. 
Conclusion: The double bolus design seems to reduce early 
reoccluslon rate [between 30 and 90 min) and provides a high 
90 min patency rate. 
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Early Patency and Dose Response Relationship of Bolus 
Alteplase in Acute Myocardial Infarction 
John Purvis, Michael Roberts, Tom Trouton, Michael Cave, 
Norman Campbell, Mazhar Khan, George Patterson, Carol 
Wilson, Samuel Webb, Jennifer Adgey. Royal Victoria 
Hospital, Belfast, Northern Ireland 
Animal models of rt-PA thrombolysis suggest rapid.clot 
dissolution with IV bolus therapy. We treated 107 pat•
ients (68M, 39F, mean age 56.2 years) presenting up to 6 
hours after the onset of an acute myocardial infarction 
(44 anterior, 63 inferior) with l50mg aspirin and either 
a single IV bolus of 50 mg rt-PA (Group S) or 2 bolus 
injections separated by 30 minutes (m), totalling 
either 70mg (Groups A and S) or 100mg or rt-PA (Group C). 
Sixty-five patients received their first bolus outside 
hospital. Infarct-related coronary artery (IRCA) patency 
was assessed by coronary angiography 60 and 90 m after 
the first bolus. 
Group Total Dcse Regimen % Patency (TIMI 2 or 3) 
60m 90m 
S 50mg 50mg 50 (5110) 45 (9/20) 
A 70mg 2Omg/50mg 75 (18/24) 77 (23/30) 
B 70mg 5Omg/20mg 76 (19125) 72 (21/29) 
C 100mg 5Omg/50mg 89 (16118) 93 (26/28) 
These results show a correlation between total dose and 
the extent of thrombolysis as measured by IRCA patency 
at 6Om(r.0.937,p.0.03l) and 90m (r.0.95,p.0.025). Each 
regimen achieved its full lytic potential rapidly with no 
further increase in patency at 9Om. Group C produced 89% 
patency (95%CI.66-99%) at 60m and 93% patency (95%CI=77-
99%) at 9Om. Bleeding episodes were minor and mostly 
confined to arterial puncture sites. Five patients 
suffered reocclusion by 48 hours and there was a 1 month 
mortali ty of 5' .. 
794-3 2:30 
Does Reperfuslon Depend on Body Walght? Results of a 
Randomized Comparison of Anlstreplase (APSAC) And 
Alteplase (t-PA). 
Labros Karagounls, Ronald L Menlove, Jeffrey L Anderson, for the 
TEAM-3 Investigators, University of Utah, LOS Hospital, Salt Lake 
City, Utah. 
Adjustment In dose Is currently not recommended for thrombolytic 
regimens. except for a reduction In t-PA dose for salety reasons In 
low body weight (eW) pts. Recently. It has been suggested (T-PA 
APSAC Patency Study. TAPS) that for pts >85 kg, patency may be 
suboptimal for standard doses of APSAC but not for t-PA (front•
loaded regimen), suggesting that APSAC dose may need to be 
Increased In obese pts. In order to assess this hypothesis In a 
separate data set, we evaluated patency results by ew In a double•
blind randomized study of APSAC (30U/5 min; n_161) versus t-PA 
(100 mg/3 hr. adjusted down for ew <65 kg; n .. 164). together with IV 
heparIn and aspirin. Stable ('plateau') patency rates were assessed 
at 1 day In a blinded fashion. Interventions were prohibited before 
the patency assessment. Patency success, defined as either TIMI 3 
or TIMI 2/3 perfUSion. was correlated with ew, divided Into quintiles: 
Quantile BW APSAC t-PA 
(kg) n TIMI3 TIMI 2/3 n TIMI3 TIMI 2/3 
<67 27 67% 89% 29 79% 93% 
67-76 32 72% 91% 24 79% 88% 
76-83 36 78% 89% 27 70% 85% 
83-94 31 77% 90% 34 79% 91% 
>94 22 82% 86% 34 59%' 74%' 
'p<O.05. stepwise logistic regression 
Thus, no evidence for a reduction In patency rates with Increasing 
ew was observed alter APSAC, whereas lower patency was 
observed after t-PA for pt In the highest BW qulntile. In conclusion: 1) 
Adjustment In dose of APSAC by BW Is not required to achieve 
optimal stable (1 day) patency rates. 2) Factors other than tPA dose. 
such as dose 01 heparin. may also need to be considered In 
explaining the suboptimal late patency result In obese pts given t-PA. 
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TINI Perfua10n Grade 3 !)ut Hot Grade 2 Reaulta 
in IlIIIu:oved OUtcome after lIyocarc11al 
Infarction: Ventr1culOllraph1c, _nay_tic and 
Electrocardiographic Evidence fzom the HAII-3 
Study 
Jeffrey L Anderson, Labros Karagounis, Sherman G 
Sorensen, Ronald L Menlove, for the TEAM-3 
Investigators, University of Utah, Salt Lake City, 
utah 
Coronary patency has been used as a measure of 
thrombolysis success in myocardial infarction (MI). 
TIMI Study Group grade (gr) 0 (no perfUSion) and 1 
(minimal) have been designated thrombolysis failure 
and gr 2 (partial) or 3 (complete perfUSion) as suc•
cess. To evaluate their functional significance, we 
compared 1 day (plateau) patency with ventriculo•
graphic, enzymatic and electrocardiographic (ECG) 
indexes of MI in 325 patients (pts) treated in <4 
hrs with anistreplase (APSAC) or alteplase (tPA). 
Enzymes and ECGs were assessed serially. 
Radionuclide ejection fraction (EF) was determined 
at <4 hr, 1 wk, and I mo. Patency in the 2 arms was 
similar and was combined. Patency was distributed 
as gr 0-8%(n-24), gr 1-4%(13), gr 2-13'(40), and gr 
3-74\(221). Interventions were performed after 1 
day in 42% (in 38%, 46%, 48%, 41%, respectively, of 
gr 0, 1, 2, 3 pts). The outcome of gr 0 and 1 pts 
did not differ (method of orthogonal contrasts). 
Similarly, gr 2 pts did not differ from gr 0,1 pts 
in indexes of ejection fraction, enzyme peaks, or 
ECG markers. In contrast, gr 3 pts, compared with 
gr 0-2 pts showed: 1) greater EF at 1 wk (54% vs 
49%, p<.007) and 1 mo (54% va 49%, p<.04); 2) 
smaller peak LDH (by 29%, p<.005) and LOH-l (by 29%, 
p<0.1) and shorter times to peak CK, LOH, and LOH-l 
(pS.01-.000l); and 3) smaller QRS acore at discharge 
and 1 mo (pS.02-.005). Thus, only gr 3 flow results 
in better outcomes and alone may be the best measure 
of reperfusion success. 
794-5 3:00 
Early Intarct Arter,y Patency Atter Intravenous 
Streptokinase. Intracoronar,y Contrast And Intracoronar,y 
Rt-PA. 
Harvey D White. David B Cross. Robin M Norris. 
Barbara F Williams. 
Green Lane Hospital. Auckland. New Zealand. 
In a significant proportion of patients. intravenous 
thrombolytic therapy fails to achieve patency of the 
infarct-related artery. In this study, 38 patients 
presenting within 6 hours with ST-segment elevation 
received intravenous streptokinase 1.5 million units 
over 30-60 minutes. Angiography was performed at 2.6 
hours (range 1.7-3.2 hours). Initial patency on the 
first contrast injection was graded according to the 
TIMI criteria. If the infarct-related artery was still 
occluded after contrast injections. intracoronary rt-PA 
50mg was infused over 10-15 minutes. Patency was 
assessed 30 minutes later. 
Results n % 95% eI 
Initial patency 28 74 (57-87) 
Patency after contrast 33 87 172-96) 
3/10 (19-81%) 
Patency after rt-PA 36 95 (82-99) 
3/5 (15-95%) 
Only 2 patients. both with right coronary artery 
occlusions, left the catheterization laboratory with 
occluded arteries. Heparin was begun at the end of 
catheterization and coontinued for 24 hours. There was 
no major bleeding. 
Conclusion: High early patency rates can be achieved by 
this regimen which also appears Bafe. 
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Spontaneous Reperfusion as a Determinant of Myocardial 
Salvage 
Ian P. Clements, Raymond J. Gibbons, Bernard J. Gersh. 
Mayo Clinic and Foundation, Rochester, Minnesota 
73 patients (pts) with a first episode of symptoms 
and electrocardiographic evidence of an evolving 
myocardial infarction (39 anterior and 34 inferior) 
underwent successful angioplasty for primary revascu•
larization. At the initial coronary arteriogram 
(364t314 min after symptom onset), the infarct related 
artery was occluded in 51 pts (Group 1) and was patent 
but showed a high-grade stenosis (93t7, range 70-99%) 
in 22 pts (Group 2); the interval between angioplasty 
and symptom onset was similar in the two groups. All 
pts underwent tomographic imaging with Tc-99m sestamibi, 
acutely to assess myocardium at risk (% MYO.RISK) and 
at discharge to assess infarct size (% INFARCT), by 
previously described quantitative techniques. Salvage 
index was calculated as (%MYO.RISK - %INFARCT)/%MYO.RISK. 
% MYO.RISK 
% INFARCT 
SALVAGE INDEX 
Grout 1 
34£ 8 
18t17 
• 51:t.38 
Grou~ 2 
36£ 3 
13t19 
.70t.35 
p 
NS 
NS 
.04 
After adjustment for infarct location, there was 
still a significant difference in salvage index (p=.04) 
between groups. 
Conclusion: The presence of antegrade flow in the 
infarct-related artery before direct angioplasty for 
acute myocardial infarction was associated with signi•
ficantly less infarction of the myocardium at risk. 
Minimal flow in an infarct-related artery prior to an 
intervention appears to be an important determinant of 
eventual myocardial salvage. 
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795·1 2:00 
Directlollli Corolllry Athertclomy V .... u. Balloon Angloplasty: A 
Matched Com.,.rativi QuantitativI Anglographlc Analysis 
VIctor Umans. Walter Hermans, Benno RensIng, Plm de Feyter, Patrick 
Serruya. Thoraxcenter, Rotterdam,the Netherfands. 
Umlted comparative data concerning the efficacy of atherectomy (ATH) and 
angloplasty (PTCA) In the tr .. tment for coronary artery stenosis exists. 
Therefore we compared the acute and long·term effects of ATH wtth those of 
PTCA In 200 patients using quantitative coronary analysis (OCA). For this 
purpose, 100 native coronary stenoses were selected from a consecutive 
aerlel 01 auccessfully dUsted PTCA lesions and were matched wtth 100 
auccalSfully tr .. ted native ATH lesions. To obtain patients with comparable 
balellne stlnoM', the 11.lon8 were matched according to the stenosis 
location, raterence diameter (AD) and minimal luminal diameter (MLD). 
Matching was conaIderad adequate since RD (mean :t ed: 3.0 :t 0.6 mm.) and 
MLD (1.2 :t 0.4 mm) war. equal In both groups. QCA was performed pre and 
post Interv.ntlon (n-2OO) and alfollow·up (n-l00, 94% of eligible patients). 
ATH reeUted In an Increase In MLD twice larger than PTCA. P: follow-up there 
wa. a decr .... In MLD which wes more pronounced In the ATH group 
compared wkh the PTCA group (0.8 mm VS 0.3 mm;p<O.OOl). The changes 
In MLD are shown In cumulative distribution curves: 
100' 100' o. •• •• '0 
70 70 
.0 I. 
I. I. 
4. 4. I. .. 
I. ~ .. ~ I. "PTCA I • -PTCA 
• • 0 ... I I.. 4 • ... , ,I I I.' • ... 4 IILO( ... ) WL.D (mm) 
In conclusion, ATH Is a more effective device wHh a higher InKla1 gain than 
what can ba achieved with PTCA. But H appears to be a potent stimulator of 
the lIIIenoaIs proceea since at follow-up thJs initial favorable result Is lost and 
thl MLD at follow·up Is comparable to that observed after PTCA. 
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Restenosis After Directional Coronary Atherectomy: An 
Analysis of Factors Influencing Late Quantitative Coronary 
Dimensions 
Jeffrey 1. Popma. Nicoletta De Cesare, Cass A. Pinkerton, Dean J. 
Kereiakes, Patrick Whitlow, Spencer B. King, Eric J. Topol, 
Martin B. Leon, and Stephen G. Ellis. Washington Hospital 
Center, Washington, DC. 
To assess the late clinical and angiographic results of directional 
coronary atherectomy, we reviewed the cineangiograms obtained 
during 318 procedures at 5 clinical sites. Successful atherectomy, 
defined as a < 50% residual diameter stenosis, tissue retrieval, and 
the absence of in·hospital ischemic complications, was perfonned 
in 274 (86%) procedures. In those patients with successful 
atherectomy, clinical and angiographic follow·up 4·6 months after 
atherectomy were available in 262 (96%) and 212 (77%) patients, 
respectively. During the follow· up period, 175 (67%) patients 
remained asymptomatic. Angiographic restenosis, defmed as a ~ 
50% diameter stenosis at follow·up, developed in 93 (44%) 
patients. Restenosis was highest in restenotic lesions of saphenous 
vein grafts (78%) and lowest in de novo lesions of the left anterior 
descending (27%) and circumflex (14%) coronary arteries. Using 
logistic regression analysis, restenosis was correlated with 
restenotic lesions (p < 0.00 1), lesion length ~ 10 mm (p = 0.018), 
saphenous vein graft lesion location (p = 0.025), and male gender 
(p = 0.045). In 162 patients in whom serial quantitative 
angiography was available, intimal hyperplasia/recoil. defined as 
the loss of minimal lesion diameter during the follow·up period, 
was directly correlated with lesion diameter immediately after 
atherectomy (p < 0.00 I), male gender (p = 0.028), and saphenous 
vein graft lesion location (p = 0.029). We conclude that restenosis 
after directional atherectomy is lowest in de novo lesions of the left 
coronary artery. The degree of intimal hyperplasia/recoil after 
directional atherectomy relates 10 certain clinical and angiographic 
factors, including the residual lesion diameter immediately after 
the procedure. 
795·3 
Exclmer Leaer Coronary (ELCA) Registry: Report of the Firat 
Consecutive 2080 Patients 
Frank Litvack, James Margolis, Frank Cummins, John 
Bresnahan, Tsvi Goldenberg, Donald Rothbaum, 
Martin Leon, William Untereker, Kenneth Kent, 
Spencer King, David Holmes, Peter Block, John 
Douglas, James Forrester for the ELCA 
Investigators. 
Cedars·Sinai Medical Center, Los Angeles, 
California 
We report our oonseoutive experienoe of the first 
2080 patients entered into the ELCA registry from 
7/88 to 8/91. We used an exoimer laser operating 
at 308nanometers with sequential generations of 
multifiber coaxial oatheters (1.3,1.6~2.0,2.2 and 
2.4mm). Patients were: 76% male, 68% ~CSFC III·IV 
and 35% had prior CABG. Fifteen percent of 
lesions were in SVGs, 8% were total ooclusions and 
52% were >10mm long. Laser success (>20% gain) 
was 83% and procedure sucoess was 91%. Major in 
hospital complioations were: Q and non·Q MI 3.5%, 
CABG 3.4%, death 0.4%. Follow·up events on 1085 
patients who completed 6 month evaluation were: 
death 1.8%, MI 2.3%, CABG 7.9%, repeat 
intervention 20%. Overall restenosis was 46%. 
Success rate in calcified lesions was 85% and 92% 
in non·calcified (P<.OI). Success was 89% in de· 
novo lesions and 93% in restenotio lesions 
(P<. 005) . There were no significant effects on 
success due to lesion length, ecoentrio vs. 
conoentrio, native vs. SVG, ostial vs. non·ostial. 
Reo~nt experience ( 504 PTS in 199.1) showed 
lndlcations to lnolude fewer restenotio lesions 
and fewer tortuous lesions (P<.05) and more ostial 
lesions (P<.001) and no significant differenoes in 
ma j or com plica tions . CONCLUSIONS: ELCA is being 
performed with high acute success and acoeptable 
oomplication rates despite a trend towards more 
complex lesions. Sufficient experience has 
developed to j usti fy randomized trials vs. PTCA 
for several indicatlons inoluding long, diffuse, 
SVG, ostial and totally occluded lesions . 
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R.estenosis FoUov.ing Coronary Transluminal Extraction-Endarterectomy: The 
Final Analysis of a Multicenter R.egistry 
Michael H. Sketch, Jr., William W. O'Neill, Joseph P. Galichia, Robert C. 
Feldman, Craig M. Walker, Steven R. Sawchak, Thomas B. Meany, Thomas C. 
Wall, Christopher M. O'Connor, James E. Tcheng, Harry R. Phillips, and Richard 
S. Stack. Duke University Medical Center, Durham, NC 
The Duke Multicenter Coronary Transluminal Extraction-endarterectomy 
Catheter (TEC) Registry was begun in July 1988 and dosed in April 1991. A 
total of 351 lesions in 313 patients were treated with the TEC at 5 centers. 
Primary success (.90% residual diameter stenosis) was achieved in 94% 
(180/191) native coronary artery and 96% (1531160) vein graft lesions. 
Six-month angiographic follow-up has been obtained in 215 of 256 (84%) 
eligible patients. The patient restenosis rale was 48% (103/215), v.iIiIe the lesion 
restenosis rate was 45% (native artery. 45%; vein graft: 46%). In comparison, 
a restenosis rate of 43% was obtained in 2,191 consecutive PTCA pts with an 84% 
6-month angiographic follow-up rale. A subgroup analysis revealed: 
Native arteries 
TEC Alone 
TEC & PTCA 
TEC Alone and 
< 25% residual stenosis 
TEC & PTCA and 
< 25% residual stenosis 
Vein grafts 
De novo lesions 
Body of the graft 
Restenosis Rate 
N(%) 
20/53(38%) 
40/81(49%) 
3/17(18%) 
19/44(43%) 
38188(43%) 
28175(37%) 
In condusion, the overall restenosis rate follov.ing transluminal extraction•
endarterectomy is similar to PTCA. The location of the lesion within the body 
of the vein graft and the attainment of a minimal residual stenosis with the TEC 
alone in native coronaries appears to result in a lower restenosis rate. 
795·5 3:00 
a.steaosis aisk of Single Palaaz-Schatz StaQts in Bati.e 
Coronarie •• aeport froa the Cora Aogiographic Laboratory 
Michael Savage, David Fischman, Martin Leon, Stephen 
Ellis, Richard Schatz, Sheldon Goldberg, Jefferson 
Medical College, Philadelphia, PA 
The goal of this prospective study was to assess the 
effect of intracoronary stenting on restenosis. After 
placement of single Palmaz-Schatz stents, follow-up (F/U) 
angiography was performed at 6 mo. The present report 
represents an interim analYSis from the core laboratory 
on quantitative coronary angiography using an automatic 
edge detection system in 222 patients. Minimal lumen 
diameter (HLD) and % diameter stenosis (DS), mean ± SD, 
were as follows: 
HLD (mm) 
DS (I) 
Baseline 
0.77±41 
75±13 
Post-PTCA 
1.59±53 
49±16 
Post-Stent 
2.58±46 
l7±1l 
FlU 
1. 74±71 
42±22 
Restenosis (DS~50I at F/U) was less common after stenting 
of de novo lesions (18/85, 21%) than for restenotic 
lesions (50/137, 36%), pm.016. However, stent restenosis 
was not increased further by prior repeated restenoses; 
restenosis rates after 1,2, and ~3 previous PTCA were 43% 
(26/60), 33% (16/48), and 27% (8/29), respectively. 
Baseline angiographic factors, including stenosis 
severity and LAD location, were not predictive of 
restenosis. Importantly, the presence of a complex 
ulcerated lesion or the development of a post-PTCA 
dissection (prior to stent) were not associated with 
increased restenosis risk. In conclusion, restenosis in 
native coronary arteries after placement of a single 
stent: (1) Is less common in de novo lesions; (2) Does 
net progressively increase as a function of the number of 
previous angioplasty procedures (suggesting a restenosis 
'plateau' for stents). 
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Anglogrephlc PredIctors for RIlllnosl1 FollOwing Wllrtor St.nt 
Implantation 
Peter de Jaegere, Michel Bertrand, Volker Wiegand, Gilbert Kober, Jean 
Francois Marquis, Bernard Valelx, Rainer Uebis. Jan Plessens, Plm de Feyter, 
Patrick W Serruys. Thoraxcenter, Ronenlam, The Netherlands. 
To detennlne the anglographlc predictors for restenosls following W1ktor 
stent Implantation, the angiograms Immediately following stent Implantation 
and at follow-up of the first 62 consecutive patients, In whom the stent was 
successfully Implanted -. compared using automated edge detection. In 
all patients, a single Wlktor stent was Implanted because 01 restenosls 01 a 
native coronary anery lesion following balloon angloplasty. 
The selected parameters (Table) -. compared using an unlvariateanaJysis 
and expressed as odds ratio with corresponding 95% confidence Int.rvaI. For 
all parameters, except the LAD, the median value was taken a8 cutoff point. 
Two sets 01 restenosls criteria were used: 1) a reduction 01 the minimal 
luminal diameter (MLD) >0.72 mm at FU and 2) an Increase In the diameter 
stenosis (OS) 01 < 50% Immediately after stent Implantation to ~50% at FU. 
Resutts: 
0.72 criterion 50% criterion 
Odds Ratio 95% CI Odds Ratio 95% CI 
LAD 2.0 0.7-5.9 2.6 0.8- B.l 
relative gain >0.48 2.5 0.9-7.0 
MLD pre <1Il9 mm 2.5 0.9-7.0 
MLD post >2.37 mm 1.5 0.5-4.0 
Refdiam ::-2.79mm 1.1 0.4-3.1 
Stent/anery > 0.98 1.5 0.5-4.0 
1.4 0.5- 4.3 
5.7 1.8-20.2 
0.4 0.1-1.3 
1.9 0.7-6.0 
1.3 0.4- 3.B 
(relative gain ~ MLD post - MLD pre/Ref.Olam) 
A recent study (Schwartz,Clrc.90) suggests a relation between the degree of 
Injury following coil Implantation In porcine coronary aneries and the extent 
01 the vessel wall prolHeratlve response. This concept was tested In this study 
by analyzing the relation between the relative gain and relative loss 
(MLDpost-MLDIu/Ref.Oiam) using a regression analysis. A Pearson product•
moment correlation coefficient 01 0.39 was found. 
Conclusion: these data Indicate that lesions located In the LAD and wtth a 
MLD < 1 mm are associated with a higher probabUlty 01 restenosls following 
Wiktoi' stent Implantation. There Is a weak but positive relation with the 
relative gain and loss In MLD et FU. 
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Tbe Sarety or Dipyridamole.Ecbocardiolrapby Test 
2:00 
Eugenio Picano, Cecilia Marini, Giampaolo Chiriatti, Salvatore PireIU, Stefano 
Maffei, Massimo Quartacolosso, Franco Torre, Franca Margaria, Giovanni 
Seveso, Manrico Ciuti. 
On behalf of the EPIC study group,ltaly. 
Clinical data on 10451 high dose (up to 0.84 mg/Kg over 10') 
dipyridamole-echocardiography tests (DEl') perfonned in 9122 patients were 
prospectively collected from 33 echocardiographic laboratories, each one 
contributing with> 100 tests. All patients were studied for documented or 
suspected coronary anery disease, 1117 early «18 days) after an acute myocsrdial 
infarction, 293 had unstable angina. Major adverse reactions occurred in 7 cases 
(0.07 %). In 6 cases, they were associated with echocardiographically assessed 
ischemia and consisted of: 1 prolonged cardiac asystole (complicated by acute 
myocardial infarction and coma, which evolved to death after 23 days); I shen 
lasting cardiac asystole; 2 myocardial infarctions; I pulmonary edema; I 
sustained ventricular tachycardia. In all 6 complicated tests, the 
cardiologist-echocardiographer perfonning the study had a limited experience 
«100 tests) with DET, and at off line reading· in 5 out of 6 cases- the obvious 
echo positivity preceded the onset of complications of 1 to 5 minutes. The only 
ischemia - independent major side effect was a shan lasting cardiac asystole, 
reversed by aminophylline and atropine. Significant side effects associated with 
echocardiographically assessed ischemia occurred in 21 additional cases, including 
8 patients with prolonged myocardial ischemia resistant to aminophylline and 
nitrates, 6 hypotension and/or bradycardia reaction, 1 atric-ventricular dissociation, 
I atrial fibriilation, 2 supraventricular tachycardias, 2 unsustained ventricular 
tachyarrhythmias (of 5 and 4 beats), I pulmonary subedema. In other 69 DET 
studies significant side effects (the most frequent being hypotension andl or 
bradycardia in 40 patients) occurred in spite of the echocardiographic negativity. In 
ail cases, side effects promptly subsided after aminophylline. The overall 
feasibility of high dose DET was 99 %. 
Thus, high dose DET is reasonably safe and well tolerated, even early after acute 
myocardial infarction and in patients with unstable angina, when selectively 
applied to those patients in whom the lower dose did not induce either 
echocardiographic signs of ischemia or limiting side effects. 
278A ABSTRACfS 
796·2 2:15 
Dynamic Left Ventricular Obstruction During Dobutamine 
Stress Testing. 
Luc A. Pierard, Christian Berthe, Marc Deleixhe, Henri 
E. Kulbertus, University of Liege, Belgium. 
Dobutamine stress testing is increasingly performed. 
We studied LV flows by pulsed, continuous wave DO'ppler 
(CWO) and color Doppler flow mapping (CDFM), in 80 COn•
secutive patients (pts) during dobutamine stress echo•
cardiography. Evidence of dynamic LV obstruction was 
found in 7 (9 %) pts (mean age 70 years; range 53-84). 
No pt had clinical or echocardiographic signs of hyper•
trophic cardiomyopathy; 5 of the 7 pts were hyperten•
sive. Mean septal end-diastolic thickness was 14 mm 
(range 10-18 mm). Mean value of peak systolic LV flow 
velocity was 1.7 m/s in basal conditions. During dobu•
tamine infusion (mean maximum dose: 30 meg/kg/min), a 
high-velocity jet was recorded in systole using 
steerable CWO, with an abnormal shape and a maximum in 
late systole. Peak LV flow velocity ranged from 2.5 to 
m/s (mean 4.7 m/s), coresponding to a calculated 
pressure drop ranging from 25 to 200 mmHg (mean 96 mmHg) 
With pulsed Doppler and CDFM, the obstruction was loca•
ted at the level of the papillary muscles in 2 pts who 
had no systolic anterior motion (SAM) of the mitral 
valve and was located in the LV outflow tract in the 5 
remaining pts. SAM was found in all these 5 pts; a 
decrease in systolic arterial pressure was observed with" 
dobutamine in 3 of them, of 10, 20 and 60 mmHg 
respectively. There was no complication as a result of 
the test. 
Thus, a marked increase in LV flow velocity may be 
observed during dobutamine infusion in some pts, in the 
absence of hypertrophic cardiomyopathy. LV outflow tract 
obstruction induced by dobutamine may be accompanied by 
systemic arterial hypotension. 
796·3 2:30 
Beta Blockade Blunts Heart Rate and Blood Pressure Response 
but Not Contractility Augmentation During Incremental 
Dobutamlne Inrusion 
Pamela A. Marcovitz, David S. Bach, Maria Markarian, William F. 
Annstrong. University of Michigan, Ann Arbor, MI. 
Dobutamine (DOB) stress echocardiography (DSE) is an accurate, clinically 
feasible method for detecting coronary artery disease. Accuracy of DSE is 
not reduced by concurrent beta blocker therapy despite blunted bean rate 
(HR) or systolic blood pressure (SBP) responses. The purpose of this 
study was to investigate the differential effectS of beta blocker therapy on 
HR, SBP and contractility in nonnal volunteers during dobutamine infusion 
(S, 10, 20 and 3Oug/kg/min in 3 min stages). HR, SBP, ejection fraction 
(EF), shon axis fractional area change (FAC), fractional shonening (FS), 
velocity of circumfrential shonening (VCf) and mean centerline chordal 
shonening (CS) were measured in 6 nonnal volunteers at each stage. DSE 
was repeated after treatment with metoprolol (Met) sOmg BID for 48 hours. 
Hemodynamic and contractility parameters at baseline, low and peak DOB, 
on and olf Met are shown below: 
Baseline 5 ug/kg/mln 30 ug/kg/min 
olfMet on Met olfMet onMet olfMet on Met 
HR 6S±7 49±6* 62±6 49±S* 95±lS 65±12* 
SBP l23±l2 l04±9* l23±9 107±1l* l60±29 l41±l7 
FS .26±.6 .31H .32±.S .26±.7 .37±.9 .38±.ll 
EF .S4±.04 .S2±.06 .S9±.OS .S6±.OS .70±.1O .62±.05 
FAC .41±.7 .36±.9 .43±.7 .42±.l3 .S5±.l .54±.1I 
va 1.5±.3 1.2±.4 1.6±.4 1.5±.4 2.3±.9 2.0±.5 
CS .56±.04 .52±.06 .59±.07 .53±.07 .73±.16 .69±.07 
*p<.02 compared to values off metoprolol, Other comparisons p=NS 
HR was significantly reduced on Met at base, low dose and peak DOB 
compared with values off Met (p<.02). SBP was significantly reduced on 
Met at base and low dose DOB but not peak DOB (p<.02). No measures of 
contraCtility were Significantly different on or off Met at any level of DOB 
(P=NS). We conclude that beta blockade sufficient to blunt HR at base, 
low dose or peak DOB or SBP at base and low dose DOB does not reduce 
contraCtility augmentation to an equivalent degree.The preserved contractility 
response to DOB increases myocardial oxygen demand and may explain 
DSE's preserved accuracy in patients on 8-blockers. 
JACC Vol. 19, No.3 
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Identification of pre.ence and .ite of re.idual 
jeopardized _yocardiua in patient. with recent 
tran._ural _yocardial infarction u.iDg Zco-pacing 
Maurizio Anselmi, GiorgiO Golia, Paolo Marino, Antonia 
Prioli, Lorenzo Franceschini, Emanuele Carbonieri, 
Piero Zardini. university of Verona, Verona, ITALY. 
In order to aasesa if Eco-pacing (EP) ia useful to 
identify presence and aite of reaidual jeopardized 
myocardium (JM) after myocardial infarction, we 
performed EP and coronary angiography (CGF) in 31 
consecutive patienta (pts) with recent transmural 
myocardial infarction (22 inferior, 9 anterior). 26/31 
pts had JM at CGF, defined as area of myocardium 
perfused by a stenotic (~75\), but not occluded, 
vessel or by a collateral circulation supplying the 
zone of distribution of an occluded vessel. All 5 pts 
without JM at eGF had a negative EP, while in 24/26 
pts with JM at eGF EP was positive:in 2 for EeG only, 
in 6 for development of new asynergy, and in 16 for 
both (sensitivity 92\, specificity 100\, accuracy 
93\). To evaluate the possibility of EP to identify 
the site of JM, we analyzed the 22 tests positive for 
new asynergy, distinguishing if new asynergy 
developed in the infarct region (worsening or 
extension of basal asynergy) or in the remote region. 
B/9 pts who developed new asynergy in the remote 
region during EP had JM outside of the vascular 
territory of the infarct related vessel, while only 
3/13 pts who developed new asynergy in the infarct 
region had JM outside of the vascular territory of the 
infarct related artery (p<0.01). Thus EP correctly 
predicted the site of JM in IB/22 pts (accuracy B2\). 
In conclusion Eco-pacing allows the correct 
identification of presence and site of residual JM 
after transmural myocardial infarction. 
796·5 3:00 
DOBUTAMINE ECHO CAN BE USED TO DETERMINE THE 
EXTENT Of VIABLE MYOCARDIUM fOLWWING REPERfUSION, 
AN EXPERIMENTAL EVALUATION. 
Jjrj Sklegar. Flordeliza S. Villanueva, William P. Glasheen, 
Sanjiv Kaul. 
University of Virginia. Charlonesville, VA 
To test the hypothesis that dobutamine echo can be used to assess 
myocardial viability following reperfusion, we performed experiments on 
9 open-chest dogs. Dobutamine echo was performed at baseline, 
following 3 to 6 hrs of coronary occlusion. and following 15 minutes of 
reperfusion. Radiolabeled microspheres were injected into the left 
atrium at each stage to measure regional myocardial blood flow. 
Twenty mci of technetium-99m was injected intravenously 30 min prior 
to reperfusion and risk area was defined post-mortem by technetium 
autoradiography. Infarct size within the myocardial slice corresponding 
to the echocardiographic short axis view was measured post-mortem by 
staining the slice with triphenyltetrazolium chloride. Percent regional 
wall thickening was measured within the risk area during dobutamine 
infusion using a computer-assisted program that utilizes the entire sys•
tolic contraction sequence. 
Infarct size (as a percent of risk area) varied from 0 to 80% in the 
9 dogs. There was an inverse correlation (r - -0.85) between this rat•
io and wall thickening during dobutamine echo; the greater the extent of 
necrosis, the worse the wall thickening. Following reperfusion, there 
was also a linear correlation (r - 0.69) between regional myocardial 
blood flow and wall thickening during infusion of dobutamine. 
We conclude that dobutamine echo can provide an indirect estimation 
of the spatial extent of viable myocardium within the risk area after 
reperfusion. Wall thickening in this region relates inversely with the 
spatial extent of myocardial necrosis. The degree of wall thickening 
also correlates linearly with the magnitude of myocardial blood flow to 
this region during dobutamine infusion following reperfusion. 
JACC Vol. 19, No.3 
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796·6 
Myocardial Hibernation Identified by Biplane Trans•
esophageal Echocardiography Polloving Hyperbaric 
OEygen Treatment 
3:15 
Keith Woollard, Peter Swift, Harvey Turner, Harry Oxer, 
Geoffrey Lane, John O'Shea. 
Fremantle Hospital, Fremantle, W.A., Fremantle 
Hyperbaric oxygen (HBO) can reverse hypoxia in ischaemic 
myocardium and may restore the function of hibernating 
myocardium postinfarction. 
Hyperbaric oxygen treatment and biplane transesophageal 
echocardiography were used to identify recoverable 
myocardium in 24 patients within I week of acute MI. 
Findings were compared with SPEer thallium (Tl) exercise 
SCintigraphy. Results - Echocardiography demonstrated 
improved contraction following HBO in 20 of 62 damaged 
LV segments, in 12 of 24 patients. Thirteen of the 20 
segments and 9 of the 12 patients improving with HBO 
showed reversible ischaemia on Tl imaging. There were 
also 8 segments with normal resting contraction with a 
reversible Tl defect. Of 42 segments with impaired 
contraction and no improvement following HBO, 8 had 
reversible Tl defects, 4 had normal Tl kinetics and 30 
had fixed Tl defects. These combinations were inter•
preted as re~esenting five states of ischaemia in early 
post MI patients: myocardial hibernation and additional 
ischaemia on exercise: ischaemia on exercise without 
hibernation: nonrecoverable contraction and ischaemia on 
exercise: myocardial stunning: and infarction. 
Conclusion-Improved myocardial contraction demonstrated 
on echocardiography immediately following HBO identifies 
hibernating myocardium and may predict improvement in 
left ventricular function on subsequent mechanical 
intervention. Integration of Tl exercise results 
enhances the description of myocardial outcomes 
following infarction. 
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Are the Doppler Chlrleterlatlcs of the Entry Site of An Inti mil Flip 
UHluiln the EVlluatlon Ind Follow Up of Aortic: Dlaleetlon? 
Kaliprasad Ayala, Krishnaswamy Chandrasekaran, Jens Otto, Dean 
Karalis, Vincent Quinn, John Ross, Ramesh Bansal, Natesa Pandian. 
Hahnemann University, Philadelphia, PA 
Transesophageal ec:hoc:ardiography (TEE) is an established diagnostic 
tool in aonic dissection (AD). Clinical outcome in pts w~h AD largely 
depends on the patency of the false lumen (FL). Thrombus formation 
indicates a favorable outcome. Rec:ognizing the patency of FL is crucial 
in the management of Type B AD since medical management is still an 
option. Thrombus formation In the descending aona is often difficu~ to 
visualize beyond the diaphragmatic level by TEE. Progressive 
thrombosis of FL will a~er the flow characteristics across the entry s~e. 
Therefore, we evaluated pulsed and color flow Doppler characteristics 
across the entry stte in 52 pts, 26 male and 26 female (mean age 69 
years), wtth AD (23 Type A and 29 Type B). 
Resutts: Triphasic flow across the entry stte as characterized by 
systolic flow into Flo early and late diastolic flow into true lumen (TL) 
was seen in 21 pts (13 Type A and 8 Type B). These pts demonstrated 
etther no or minimal thrombus in FL BiphasiC flow across the entry stte 
as characterized by systolic flow Into FL and early diastoliC flow into TL 
was seen in 21 pIS (7 Type A and 14 Type B). All of these pts 
demonstrated significant thrombus In FL In 10 pts (3 Type A and 7 
Type B), no flow into FL was demonstrated; 8 of these pts had 
complete thrombosis of FL Among 8 pts wtth Type B AD wtth triphasic 
flow seen on Inttial TEE, 2 pts died of rupture, 2 underwent surgical 
repair, and 4 pts demonstreted etther biphasic or no flow during the 
follow-up TEE wtthin three months. These last 4 pts demonstreted 
progressive thrombosis of FL 
Conclusion: Doppler flow characteristics of the entry s~e is related to 
thrombus formation In the FL and may be useful In pts where the distal 
aona is poorly visualized. Funher, it is of value in the serial follow up of 
patients with Type B aonic dissection. 
ABSTRACTS 279A 
797·2 2:15 
Atherosclerotic Plaque Evolution in the Descending Thoracic 
Aorta in Familial Hyperlipidemic Patients: 
A Transesophageal Echo Study 
Cesar J Herrera, Lee J Frazin, Peter C Dau, Michael J 
Vonesh, Bonnie J Kane, Ko-Hwee Ng, David J Mehlman, 
James V Talano, David D McPherson. 
Northwestern University, Chicago, IL 
Aggressive therapy of familial hyperlipidemia (FH) including 
LDL-apheresis may alter its progression. Transesophageal 
echocardiography (TEE) can be used to evaluate 
atherosclerotic changes in the descending thoracic aorta 
(DTA). Baseline (Tl) and follow-up (1'2) (mean 10 months) 
TEE studies were performed in 7 FH patients (4 M, 3 F), mean 
age 47 + 11 yrs, mean LDL cholesterol 240 mg/dl, receiving 
standard treatment, (n=2), or LDL-apheresis (n=5). 
Atherosclerotic elaque area (PA), aortic wall area (WA), total 
arterial area (TAA) and plaque to wall ratio (P/W) 
measurefQknts were compared. 
Results: (X.±.SD) (* p<0.05 vsT1) 
TAAcm2 PAcm2 P!W 
Standard ~ 5.5.±.2.l 0.58.±. 0.09 0.11.±.0.03 
Treatment 2 6.3.±.0.01 0.75.±.0.07 0.15.±.0.06 
+23% +32% +33% 
Apheresis T 1 4.2.±.0.74 0.55.±.0.08 0.13.±.0.03 
T2 5.5.±.1.09* 0.41.±.0.26 0.08.±.0.07* 
+34% - 25% - 42% 
Although LDL cholesterol decreased in both ~roups, in the 
standard treatment group TAA, PA and P(W increased 
although not significantly. In the LDL-apheresls group, TAA 
increased and P /W fell. These preliminary data demonstrate 
that TEE is a useful tool to study atherosclerosis evolution in 
the DTA. LDL-apheresis caused decreased plaque 
progression compared to standard therapy. 
797·3 
The Role of Tranesophageal Echo in Patients with 
Suspected Traumatic Transsection of the Aorta 
2:30 
Mikel D. Smith, J. Michael Cassidy, Melanie D. Mattson, 
Friederike Jochimsen, Peter M. Sapin, D. Wesley Smith, 
Paul A. Kearney, and Anthony N. DeMaria. University of 
Kentucky Medical Center, Lexington, KY 
Transsection of the thoracic aorta (Ao) is a common and 
often fatal injury requiring a quick and accurate 
diagnosis in pts with chest trauma. Transesophageal echo 
(TEE) provides effective imaging of the Ao arch and 
descending aorta at the bedside. Therefore, we assessed 
the role of TEE in the recognition of trans section of the 
Ao. Urgent TEE studies were performed on 25 patients 
referred to the Trauma Service for blunt chest injury in 
whom the chest x-ray manifested: mediastinal widening 
(14), blurred aortic knob (6), fracture of 1st or 2nd rib 
(6), apical capping (3), or mediastinal air (2). Single 
or biplane TEE was compared to angiography, surgery, or 
necropsy. The site of TEE examination was: emergency 
room (12), intensive care unit (11), operating room (2), 
and angiography suite (1). Mean time for TEE studies 
including Ao assessment, pericardial effusion, valvular 
disruption, and myocardial contusion was 24 min (range 
12-45), while aortography required 90 min (range 30-180). 
TEE demonstrated a normal aorta in 18 pts, but showed a 
localized intimal flap at the aortic isthmus indicative 
of trans section in 7 of 25 (28%) patients. All TE~ 
abnormalities were confirmed by surgery (5) or necropsy 
(2). Aortography confirmed the absence of abnormalities 
in all 18 pts with normal TEE. For the 7 pts with 
documented transsection, aortography was either positive 
(3), equivocal (1), or not performed (3). Thus, TEE 
provides a safe, accurate, and rapid means of identifying 
Ao transsection in pts with chest trauma. TEE should be 
considered part of the emergency evaluation of these 
critically ill pts. 
280A ABSTRACTS 
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Age Related Normal Values tor the Descending Thoracic 
Aorta Analyzed by Biplane Tran.elophageal Echocardio•
graphy 
Susanne Kohr-Kahaly. Raimund Erbel. Nina Schart. Jargen 
Keyer. II. Kedical Clinic. University Kainz. FRG 
Biplane transesophageal echocardiography (TEE) represents 
an excellent method for the evaluation of thoracic aortic 
pathology. Age related normal values have not been 
established so far but have to be considered when 
arteriosclerotic changes are evaluated. 
For this purpose. the dimensions of the descending 
thoracic aorta were analyzed in 100 patients (pts). aged 
IS to 79 years. divided into four age groups. whose TEE 
studies had been judged as normal by two independent 
observer.. Parameters evaluated two perpendicular aortic 
diameters in the transverse plane (d,. d.) and one dia•
meter in the longitudinal plane (d3) as well as wall 
thickness (w, .W3). all values were related to body sur•
face area (BSA). A S KHz biplane TEE probe attached to an 
Aloka 870 sector scanner was used. 
Results (in mean values): 
age groups IS - 31 32 - 47 48 - 63 64 - 79 
d, 1.07 1.16 1.38 1.45 mm/m 2 
d. 1.08 1.18 1.40 1.46 mm/m 2 
d3 1.11 1.1S 1. 31 1.45 mm/m 2 
w, 0.19 0.21 0.24 0.27 mm/m 2 
W3 0.20 0.21 0.23 0.27 mm/m 2 
These results demonstrate progressive diameter 
enlargement of the thoracic aorta by 36% from age group 1 
to 4 accompanied by an increase in wall thickness of 42\ 
leading to an increase in lumen area of 84\. These 
results have to be considered when acrtic pathology is 
evaluated. 
797·5 3:00 
Transe.ophageal Ichocardiography Identifie. 
patients at High Risk of Arterial Embolis. 
During Inva.ive Aortic Procedure. 
Dean G. Karalis, Vincent J. Quinn, John J. 
Ross Jr., Krishnaswamy Chandrasekaran. 
Hahnemann University, Philadelphia, PA 
Transesophageal echocardiography (TEE) can 
easily detect protruding atherosclerotic 
debris (AD) in the thoracic aorta. To assess 
the risk of embolism when performing 
catheterization or intraaortic balloon pump 
(IABP) plac!ement in pts with TEE detected AD, 
we compared 48 pts with AD to 70 pts without 
AD who underwent such procedures. By TEE, AD 
was defined as intimal disruption with 
atheroma protruding >5 mm into the aortic 
lumen. Embolism occurred during femoral 
catheterization in 7/48 (15%) pts with AD 
compared to 2/70 (3%) pts without AD 
(p<0.05). During IABP placement, embolism 
occurred in 4/7 (57%) pts with AD compared to 
0/10 (0%) pts without AD (p=0.03). Embolism 
occurred in 2/27 (7%) pts with layered AD 
compared to 9/21 (43%) pts with mobile AD 
(p=O.Ol). Ten pts with AD underwent brachial 
catheterization without embolization. 
Conclusion: Protruding atherosclerotic 
debris in the thoracic aorta increases the 
risk of catheter related arterial 
embolization. The risk is significantly 
increased if the aortic debris is mobile. 
Substituting brachial for femoral 
catheterization and avoiding IABP placement 
may reduce the risk of embolization. 
797·6 
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Aortic Geo.etry and Bla.tance in Relation to Age a. 
Bvaluated with ~raD.e.ophageal Bchocardiogrephr 
Tomasz Pasierski, Philip Binkley, Anthony c. Pearson. 
Ohio State University, COlumbus, Ohio 
Transesophageal echocardiography offers a unique window 
to evaluate the thoracic descending aorta. As such it 
may prove useful in clarifying the contribution of in•
creased wall thickness and altered aortic wall elastic 
properties to decreased aortic distensibility observed 
in the elderly. Thus, thoracic aorta diameter and 
intimal-medial wall thickness were evaluated by M-mode 
measurements during transesophageal echocardiography in 
23 subjects (6 women, 17 men) 16 to BO years old (mean 
47 years). Simultaneously brachial artery cuff pressure 
was measured. Aortic stress/strain modulus (Ep) was 
dSfi~ed as ApxAD·/{2AOxh). where AP-pulse pressure. AD•
aort~c diameter in diastole. AO-difference between 
aortic systoliC and diastolic diameter and h-aortic 
thickness. Ep was lB. 6±14. 0 10' dyn/cm', ADz22±4 I11III, 
h=0.B±0.3 I11III. aortic thickness to radius ratio=0.07 
±0.02. Significant correlations were found between age 
and systoliC blood pressure (rc O.46, p<O.OS), AD (r= 
0.72, p<0.001). h (r-O.BS, p<0.0001), and Ep (r=6S, p 
<0.01). Aortic wall stress did not change significantly 
with aging (r=0.22, p=NS). No difference in aortic 
thickness and elasticity was found between men and 
WOmen. 
we conclude that aging is associated with dilatation, 
intimal-medial thickening and decreased intrinsic 
distensibility of the thoracic descending aorta. 
Increased aortic wall thickness results in normalized 
aortic ~a:~ btr~~~ however it may contribute to age•
related reduction in aortic distensibility. Trans•
esophageal echocardiology is an excellent tool for 
studying in vivo characteristics of the descending 
aorta. 
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Assessment of the functional Severity of Coronary 
Stenoses in Humans with a Digital Angiographic Index of 
Myocardial Perfusion From a Single Contrast Injection Under 
Resting Flow Conditions • 
Helmut Schuhlen. Andreas M. Zeiher, Meinrad R. Rombach. 
Helmut Wollschlager. Hanjorg Just. 
Department of Cardiology, University of Freiburg. Germany 
Previously described digital angiographic techniques to 
assess myocardial perfusion require resting and hyperemiC 
imaging and measurements. We applied a technique deter•
mining compartmental contrast media mean transit time by 
impulse response analysis of a single coronary injection 
under resting flow conditions. Studies in dogs have shown a 
linear correlation of the inverse of the mean transit time for 
the microcirculatory compartment (Tmic,o·') with flowmeter 
coronary flow reserve (r = 0.81) for a wide range of 
proximal coronary stenoses. indicating that T micro·' reflects 
autoregulatory adjustments of the microvascular bed. To 
assess the applicability in the human coronary circulation. 
we determined T micro·' in 14 patients immediately pre and 
post PTCA of single vessel disease (7 RCA. 5 LAD, 2 CX). 
Tmicro·' increased from 9.4±3.6 to 30.3±13.8 sec·' with a 
close correlation (r = 0.89, SEE = 1.13) with measurements 
of minimal cross-sectional stenosis area obtained by biplane 
quantitative angiography (0.53± 0.21 to 4.13± 2.66 mm2). 
The closely corresponding changes of microcirculatory 
contrast media mean transit time and minimal stenOSis area 
suggest that this compartmental model is applicable in the 
human coronary circulation to assess autoregulatory 
adjustments of the microcirculation in response to proximal 
stenoses. Thus. this model could be a very promiSing tool to 
determine the functional severity of stenoses. requiring only 
a single contrast injection under resting flow conditions. 
JACC Vol. 19, No.3 
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Evaluation of CFR by Means of Digital Angiography at 
Different Heart Rate and Blood Pressure Conditions in 
Normal Coronary Arteries of the Dog 
Ulrich Solzbach, Jason Liao, Susan V. Schauer, Shelly 
Gu, James S. Whiting, Neal L. Eigler. Cedars-Sinai 
Medical Center, Los Angeles, CA. 
Direct flow measurements of the coronary flow reserve 
(CFR) are strongly influenced by heart rate (HR) and 
blood pressure (BP). Regional myocardial flow reserve 
(MFRI can be estimated by the mean transit time (TM) of 
the contrast media across the distribution volume (VOL) 
of the microcirculation under resting flow conditions. 
The inverse of VOL reflects the vasodilatory capacity 
(CFR) of the microcirculation. TM and VOL were 
calculated by digital angiographlc impulse response 
analysis of 300 injections of contrast media into the left 
coronary artery In 20 open-chest dogs with flowmeter on 
the circumflex artery. BP was controlled by stepwise 
inflation of a balloon in the descending aorta (60-160 
mmHg). HR was altered by atrial pacing (80-150/min). 
Results: CFR increased by 20% with increasing BP at 
each level of HR. At constant BP, CFR was 25% 
diminished with rising HR. TM as a measure of MFR was 
found to be independent upon HR. 1/TM was weakly 
correlated with BP (r .. 0.36). VOL during resting and 
hyperemic flow conditions was not affected by changing 
BP. 1NOL is weakly correlated with CFR (r =0.39). 
Conclusions: 
1. Flow derived measurements of CFR are significantly 
affected by underlying hemodynamic conditions (i.e. HR 
and BP). 
2. Angiographic measurement of regional myocardial 
flow reserve is a more robust assessment of the 
vasodilatory capacity of the microcirulation. 
798·3 2:30 
DSA Measurement of aegional Myocardial Floy 
a •• erve - Micro.phere Validation of Parametric 
Imaging 
Jack T. Cusma, Laurence A. Spero, Jian Zhang, 
Thomas M. Bashore, Kenneth G. Morris. Duke 
and VA Medical Centers, Durham, NC 
The validity of digital subtraction angiogra•
phy (DSA) for the measurement of regional 
changes in myocardial blood flow and flow 
reserve has been investigated in an animal 
model using microsphere measurements of myo•
cardial blood flow. An improved parametr ic 
imaging algorithm was used to obtain images of 
blood flow in 8 chronically instrumented dogs 
during baseline blood flow and during adeno•
sine infusion. Each animal was instrumented 
with flow probes and varying degrees of fixed 
stenosis to provide a range of flow reserve 
values (0.5-7.7). Parametric images of blood 
flow were formed using an interpolation algo•
rithm in order to improve the temporal resolu•
tion compared to earlier methods and result in 
more accurate measurements of blood flow 
parameters at maximum flow conditions. Flow 
measurements in parametric image regions of 
interest were compared with actual flow re•
serve values from corresponding tissue samples 
(0.5-3.0g). Image measurements of flow reserve 
agreed well with microsphere measurements: r = 
.82, accuracy .. -.02, precision" .82 flow re•
serve units. This demonstrates that regional 
myocardial flow reserve can be measured from 
DSA image sequences with a parametric imaging 
method. 
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798·4 2:45 
1nfIuenc:e of CoroIW)' CoDateral Blood Flow on Hlp RIIolatlOD DJaItIl 
Radlopaphlc IDdk:ea of MJocudlal PwfualOD 
Kazuya Murata, Valmik Bhargava, Francois Ricou, Masashi Kambayashl, Byung•
Hee Oh, Shiro Ono, Kirk L Peterson. University of CaUfornia San Diego and 
V A Medical Center, San Diego, CA 
To assess the validity of digital radiographic indices of myocardial perfusion In 
the presence of coronary collateral flow (CCF), a distal arterial shunt was 
created into the left anterior descending (LAO) coronary artery bed (LAB) in 
7 anesthetized pigs. The LAO and shunt were pump perfused. Doppler 
flowmeters were placed in each circuit and total LAB Doppler flow durIng pump 
perfusion was controUed and measured. Time density curves were derived and 
regional segment shortening (ultrasonic gauge) calculated for the LAB region. 
Time to peak amplitude (TP), mean transit time (Tmn: from Gamma flt) and 
(peak amplitude)/(time to 50% peak ampUtude) (Cmax{I'a), were computed 
from the time density curves. Data were acquired at 5 levels of total flow (100, 
85, 70, 55, & 40% of basal flow) and at 4 CCF ratios: 0, 10, 25, & 50%, deflned 
as collateral (Shunt) to total flow, providing 20 observations/anImaL Results of 
lInear regreSSion between total flow and digital Indices are tabulated below. 
%CCF n Cmaxffa l/Tmn 1/TP 
ia bra bra b r 
o 35 iO.38 -5.24 0.91 0.92 14.27 0.94 0.16 2.24 0.96 
10 35 iO.35 -5.33 0.88 0.93 8.50 0.95 0.15 2.04 0.95 
25 35 iO.31 -4.20 0.84 0.S7 7.17 0.93 0.14 2.21 0.93 
50 35! 0.21 -3.46 0.83 0.85 -5.26 0.91 0.12 1.06 0.90 
AU i 140 ;0.31 -4.61 0.77, 0.90 6.0 0.85, 0.14 1.87 0.8S 
n: number of data poInts, a: slope, b: Intercept, r: correlation coefficient AU: 
values for total pooled data. 
Percent segment shortenIng decreased as total flow fell, and was not changed 
significantly when CCF ratio was altered at each total flow level. Regression 
lines for 10%, 25% and 50% CCF showed a successive significant downward 
displacement (p<O.OI), documentIng an underestimation of flow by aU digital 
Indices. In the seilIng of coronary artery disease with coUaterals, changing CCF 
ratios will lead to operation on different regression lines and to a nonlinear 
relationship between total flow and digital Indices. Thus, digital Indices of 
myocardial perfUSion have limited utility in the presence of coUateral flow. 
798·5 3:00 
Measurement of Regional Myocardial Bed Size 
Distal to any Point In the Coronary Vascular 
Tree for Asusslng Myocardial Zone at Rllk 
QvilJB1 SeEr, L.ln2Glutl, FtiladKlkeelle, '1I.omeSkJal, Ve«lnt:aP\'B 
l.hMlIslyolTexalMedi:3Sdloo\I-busDn,Texas 
The regional myocardial mass distal to any point In the coronary artery tree 
indicates the zone at risk for myocardial Infarct size. We hypothesized that 
regional distal myocardial mass (M) is closely related to and can be determined 
from the sum of coronary arterial branch lengths distal to any point In the 
epicardial arterial tree. To obtain M, we Injected Intracoronary radlolabeled 
microspheres at different locations (n062) In the left coronary artery treel of 10 
normal dogs. The location of mlcrosphere Injection was documented by In 
vivo coronary arteriograms. Postmortem coronary arterlograms were obtained 
after 'unrolllng" the heart, wfth the epicardial surface laid directly on the X-ray 
film cassette. From portmortem coronary arterlograms, M distal to each 
injection sfte determined by microspheres was correlated wfth the sum of 
coronary artery branch lengths (L) distal to the Injection sfte. From M and L, 
the ratios of regional M to lolal LVmass (MIM~ and of regional L to total left 
coronary artery branch lenghts (LILtltl were calculated. lA.tot was obtained at 
two different X-ray 'magnHicatlons" by summing lengths of all visible coronary 
artery branches (IJLtotall) and by summing lengths of only the 1 st and 2nd 
generation branches (IJLta1st-+2ndJ. We correlated M to L (1st-+2nd genelllbn 
rs~~ ULtotali to lA.tot1t~lk2nd and M/Mtot to lJLt .. ~
i ,,' . e u. . e u. 
~ 100 I, iI ' 
. ! OJ '" ,." ;.. ... . ~,. - I'· " .. I 0 • ~~~ ! 0 ~_.4.GOf.t~ • MV •• O'OW,IIlA. ... _ 
DIIT .... II.MIEDIIWCHLBrIGlHI,l.. I DIITALL.£Na1'IoIIM"I'1O,IA....... DlaTALLINCITH.MTlO.IA. ..... 
Conclusions: (1) Regional distal myocardial LVmass, M, In dogs Is closely and 
linearly related to distal summed branch lengths, L, and therefore can be 
determined for any point in the coronary artery tree. (2) The distal lengths 
ratiO at any point, ULtot, remains the same for the sum of all branch lengths or 
only the 1 st and 2nd generation branches of the coronary artery tree. (3) 
Therefore. the fraction of LVmass at risk, M/Mtot, can be described by the 
fraction of total coronary artery tree length, lA.tot, relatively Independently of 
the scale or X-ray magnification used to measure absolute lengths, L. 
282A ABSTRACfS 
798·6 3:15 
A simple ADqioqraphic Method for the B.timate ot 
Myocardium at Ri.k rrom a coronary steno.i. 
Kenneth G. Morris, Laur.nce A. Spero, Jack T. 
Cu.ma, Duke , VA Medical Centers, Durham NC 
The sum of the l.ngths of a coronary artery and 
its branches di.tal to a stenosis (EL) should be 
directly related to the mass of myocardium per•
fused by the st.nosis (MM). Six dogs w.re in•
.trument.d with surgical clips creating 8 coro•
nary .tenos.s in the LAD and/or circumflex 
v •••• l •• Digital coronary angiography (DCA) was 
performed in two sel.cted vi.ws at known imaging 
angle.. Th. l.ngth of each segment (SGT) was 
calculat.d from DCA by applying a spatial trans•
formation to measurements made in the two views. 
Th. coronary vasculature of .ach dog was cast 
with a BaSO. and RTV .ilicone mixture at 100 mm 
Hg. The cast. of the epicardial coronary arter•
ies w.re then dissect.d from the heart. The 
lengths of 38 SGTs in 7 vessels were measured 
both from the DCA and by direct measurement of 
the SGT lengths on the casts. Regression analy•
sis (r-.94) confirmed the validity of the DCA 
length measurements. The actual )1M distal to 
.ach .t.nosis was determined by tracing the 
epicardial and intramural vasculature using 
radiograph. of thin cross sections of the ven•
tricl. to separate areas at risk trom the re•
mainder ot the ventricle. The risk region was 
sectioned and weighed. Regression analysis 
comparing the actual MM with EL revealed a good 
correlation (r-.80). ThUS, this technique ap•
pears to be a valid method for estimating the 
mass of myocardium distal to a stenosis. 
799 Efficacy of Invasive Electropbysiologic Testing 
Wednesday, April 15, 1992 
2:00 PM-3:30 PM 
Dallas Convention Center 
WIOI 
799·1 
Sarial Ilactrophyaiolosic Te.tins of Antiarrhythmic 
Drusa: Whan ia lnouSh, Enough? 
2:00 
Peter J. Kudenchuk, Charles G. Wa1ance, Jack Kron, Blair 
D. Halperin, John H. McAnulty. Oregon Health Sciences 
University, Portland, OR. 
Serial testing by programmed electrical stimulation 
(EPS) of from 2-6 (mean 3) antiarrhythmic drugs (RX) was 
performed in 389 patients (Pts) with clinical sustained 
ventricular tachycardia (VT, 241 Pts) or fibrillation 
(VF, 148 Pts) to assess similarities in RX response. All 
Pts, whether inducible or not in response to any RX test, 
were serially tested with other RX including: IA RX 
(procainamide 322 Pts, quinidine 229 Pts, disopyramide 
109 Pts), IB RX (phenytoin 170 Pts, mexi1etine 146 Pts, 
tocainide 42 Pts), and/or IC RX (f1ecainlde 89 Pts, 
encainide 31 Pts). All EPS tests were identical, using 1-
4 extrastimu1i from the right ventricle. 
Results: VTfVF was induced in 78% of Pts when RX-free. 
Concordance was defined as VTfVF remaining persistently 
inducible or remaining noninducib1e during serial RX 
trials using RX of the same or different class. 
Induced 
Serial ax Tested Pts en) ax Trials YILYI Concordance 
Any IA and any IA 218 352 36% 78% 
Any IB and any IB 34 34 50% 74\ 
Any IC and any IC 2 2 50% 100% 
Any IA and any IB 314 623 43% 77% 
Any IB and any IC 92 106 42% 75% 
Any IA and any IC 115 158 37% 73% 
The EPS response to one RX predicted s concordant 
response to all other tested RX in most Pts, regardless 
of RX class. Protracted serial RX testing is unnecessary 
for identifying RX-responders versus nonresponders. 
Single RX testing can identify most Pts who are likely to 
require nonpharmaco1ogic treatment of their VTfVF. 
799·2 
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2:15 
Effects of Myocardial Revascularization by Either PTCA or 
Bypass Surgery on the Inducibility of Ventricular 
Tachycardia or Ventricular Fibrillation 
MartIn Borggrefe, Franz Roithinger, Michael Block, Thomas 
Fetsch, Toni Iwa, Wilhelm Haverkamp, Giinter Breithardt. 
Westf. Wilhelms-University Munster, Germany 
The influence of sole myocardial revascularization (REV) on the 
inducibility of ventricular tachycardia (VT) or ventricular 
fibrillation (YF) was prospectively studied in a large cohort of 
patients (pts) with coronary artery disease without resectable 
aneurysm. In 46 pts (39 male, mean age 59, EF 46%) with 
documented YF or sustained VT programmed ventricular 
stimulation was performed before and after REV (PTCA n = 13, 
CABG n = 33)_ Overal~ following REV alone, inducible VT or VF 
were suppressed in 25/46 pts (54%). In 14/16 pts (87%) with 
inducible YF no VT/YF was inducible following REV as 
compared to 11/30 pts (37%) with inducible monomorphic VT 
(p<.05). The mode of REV (PTCA vs CABG had no impact on 
arrhythmia suppression (PTCA (n=13): 5/13 (28%) no inducible 
VT/YF vs CABG: 16/33 (48%) no inducible VT/YF, (n.s.». 
During mean follow-up of 2 years, arrhythmia free survival was 
94% and cardiac death free survival 95%, res~ctively. 
By discriminant analysis, the type of Induced arrhythmia 
(YF/VT), EF (:>:40% vs >40%), sex (p<.Ol) and presenting 
tachyarrhythmias (p < .05) were the Significant independent 
predictors of post-operative arrhythmia suppression. Inducible VT 
vs YF alone had a sensitivity of 90%. By including EF and 
presenting arrhythmia, the specifity rises from 56% to 84% and 
the predictive accuracy from 72% to 85%. 
Thus, pts with inducible YF as compared to VT benefit predomi•
nantly from myocardial REV alone. The inducibility of YF vs VT, 
preserved left ventricular function and the presentmg arrhythmia 
predict the outcome after REV with an accuracy of 85%. 
Therefore, selected pts with VT IYF in the absence of discrete 
aneurysm, may respond favourably to coronary revascularization. 
799·3 2:30 
Is Sustained Ventricular Tachycardia Without Hemodyoamlc Impairment a 
Less Dangerous Form of Ventricular Tachycardia? 
Greg Larsen, Charles Walance, Karen Griffith, Jack Kron, Joel Cutler, John 
McAnulty. The Oregon Health Sciences University, Portland, Oregon. 
We wondered whether patients (pts) presenting with sustained ventricular 
tachycardia (Yr) without hemodynamic impairment (unimpaired Yr) have a 
lower risk of subsequent sudden cardiac death (SCD) than pts who present 
with hemodynamic impairment (impaired Yr). Among 284 pts undergoing 
electrophysiologic (EP) study for VT at our hospital since 1979, 118 (42%) 
presented without and 166 (58%) presented with impairment. Both groups 
had similar proportions of men (86% unimpaired vs 78% impaired), mean 
ages (59 vs 61 1's), ejection fractions (44% vs 41%) and frequency of 
coronary disease (71% vs 65%). Sustained Yr was induced at baseline EP 
study with equal frequency (76% vs 69%) at similar ventricular rates. 
Treatment was guided by EP testing. At discharge, more unimpaired than 
impaired pts remained inducible (35% vs 15%, p- .06) and received 
conventional antiarrhythmic drugs (57% vs 43%, p •. 03). Similar proportions 
of unimpaired (25%) and impaired (32%) Pts received amiodarone (p= .26); 
6% of each group received implantable cardioverter-defibrillators (ICDs). 
FoUowup extended to 124 months (median = 19). During foUowup 23 of 
118 (20%) unimpaired and 38 of 166 (23%) impaired Yr pts died of SCD. 
By life table analysis, 5 year freedom from SCD was no different in 
unimpaired (72%) than impaired (63%) Yr pts (p-.14 by Mantel Cox). In 
addition, when all sudden arrhythmic events (SCD, recurrent Yr, ventricular 
fibrillation, syncope and ICD discharge) were considered as endpoints, 5 year 
event free survival by life table analysis was similar among unimpaired and 
impaired pts (36% vs 37%, p- .35). 
In summary, sustained Yr without hemodynamic impairment is not a 
"safer" form of Yr, and pts presenting with it, even when treated by EP 
guided therapy, are at the same risk for SCD as Yr pts who present with 
hemodynamic impairment. Thus, aggressive treatment of unimpaired Yr pIS, 
including implantation of an lCD, may be warranted. 
JACC Vol. 19, No.3 
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799·4 2:45 
Electrophyslologlc Observations and Long·term Follow·up In Eleven 
Patients WIth idiopathic Ventricular Fibrillation 
Marc Roelke, Anne C. Powell, Richard R. Liberthson, Hasan Garan, 
D. Ross Brooks, Jeremy N. Ruskin, Brian A. McGovern 
Massachusetts General Hospital, Boston, Massachusetts 
Idiopathic ventricular fibrillation (VF) is rare. The natural history, 
response to programmed cardiac stimulation, and outcome during chronic 
therapy are poorly defined. 
From 5na to 8/91, eleven patients aged 3·57 (mean 26 years) presented 
with VF without evidence of structural heart disease. Six patients were 
under age 23 (3,9,14,14,19,23). All had normal ECGs or nonspecific SH 
wave changes, normal echocardiograms, normal coronary arteriograms 
and ventriculography. Patients with known or suspected mitral valve 
prolapse, myocarditis, long aT intervals, or coronary vasospasm were 
excluded. All underwent electrophysiologic study. Sustained ventricular 
tachycardia (VT) or VF were not induced in 10 patients (91%), and VF 
was induced in one. All patients were treated: 6 with an automatic 
defibrillator (AI CD) and 5 with empiric antiarrhythmic therapy. After 
follow·up from 3 to 147 months (mean 62), one patient died suddenly, and 
two had recurrent VF. Two of three had stopped recommended therapy. 
One patient has subsequently had an AICD implanted, and has experienced 
an AICD discharge. Thus, 1/9 (11%) patients on appropriate therapy have 
had recurrent VF. 
We conclude that in this rare population, sustained VT or VF is 
infrequently inducible by programmed electrical stimulation; therefore, 
management with antiarrhythmic drugs is problematic, and implantation of 
the AI CD should be strongly considered. 
799·5 3:00 
Safety of Reusing Cardiac Electrophysiology Catheters 
Elizabeth Aton, Victoria Fraser, Larry Conaway, Michael 
Cain. 
Barnes Hospital, Washington University, St. Louis, MO. 
Although electrophysiology (EP) catheters are manufactured 
for one time use, many laboratories reuse catheters after 
ethylene oxide (ETO) sterilization. Data supporting this 
practice, however, are limited. Accordingly, resterllized 
EP catheters were tested for sterility, residual ETO, and 
mechanical Inte9rlty. A total of 27 segments from 3 EP 
cat~eters were Immersed In a solution of Bacillus subtilis 
(10 CFU/ml) and then subdivided Into 3 groups of 9 
segments each and gas sterfl I zed for 2, 4, and 6 hrs, 
respectively. After ETO sterilization, catheter segments 
were cultured In tryptic soy broth for 5 days. All cultures 
were negative. To detect residual ETO, 3 groups of 2 EP 
catheters each were gas sterilized for 2, 4, and 6 hrs, 
respectively, aerated for 24 hrs and placed In water for 8 
hrs at 37·C. Extraction liquid was analyzed by gas 
chromatography. ETa concentrations averaged 69, 94, and 204 
ppm for sterilization times of 2, 4, and 6 hrs, 
respectively. These levels exceed the residual ETO 
concentration requirement of <25 ppm Imposed on 
manufacturers of these medical devices. Concentrations of 
ethylene chlorohydrln and ethylene glycol were, however, 
within acceptable levels. Microscopic and x-ray analyses 
demonstrated Inconsequential metal and fiber particulates 
on the catheter surface. Fluid entrainment around the 
distal pole may occur In EP catheters with tip electrodes. 
Thus, reprocessed EP catheters are sterile, structurally 
Intact but contain Increased levels of ETa even after only 
2 hrs of sterilization. These elevated ETa concentrations 
mandate that these methods of ETa sterfl Izatlo" be 
modified. 
ABSTRACTS 
799·6 3:15 
Predk:tion of Arrhythmic: EveDII III abe FiIIt Year FoUowiJII Myocudla1 
IDfIn:tloD by EIedrophyslologk: TCltlDg: DcfIDitioll of • Ncpthe Rlsult 
John P. Bourke"; David A.B. Richards; David 1.. Ross; Mark A. McQuire; 
John B. Uther • Westmead Hospital, Sydney, Australia and "Freeman 
Hospital, Newcastle upon Tyne, U.K. 
Confusion about the significance of the IIIduction of various arrhythmias 
at electrophysiologic testlllg [EP) explains much of the controversy about the 
value of prognostic EP testing of Infarct [MI) survivors. It is already 
established that patients wlth inducible monomorphic ventricular tachycardia 
[VTJ are at high risk of spontaneous VT and sudden death [SO) in the IIrst 
two years of follow.up. This study examined the implication of the induction 
of ventricular flutter (VF1] or fibrillation [VF) at post·MI prognostic EP 
testing. 
PrognostiC EP was performed in SOl patients 11 ± 4 days after 
uncomplicated MI using a standard stimulation protocol (RV apex; twice 
diastolic threshOld; drive cycle [CLJ 600ms; 4 extrastlmull). VFwas Induced 
III 164 (32%), VFIin 134 (27%), VT in 44 (9%) and no arrhythmias in 160 
(32%). All groups were similar in age, sex, incidence of mUltiple MI and 
location of index MI. Those wlth inducible VT had a higher peak enzyme 
release for index MI (p < 0.001) and worse left ventricular function 
(LVEF%] (p < 0.001) at time ofEP. 
Follow·up was for 1 year. Without antiarrhythmic drugs, 8 (18%) of those 
wlth inducible VT experienced spontaneous VT, VF or SO in the absence 
of ischemic symptoms. Three (38%) IIrst arrhythmic events were 
Instantaneously fatal. By contrast only 1 (0.6%) wlth inducible VF, 1 (0.7%) 
with inducible VFI and 1 (0.6%) wlth no inducible arrhythmias experienced 
similar events in the same period [Fisher's exact: p < O.OOS). Nor did the 
level of stimulation required to Induce VF or VFI add prognostic 
Information. By relating the CL of the induced VT or VFI [n - 178] to later 
spontaneous VTISD [n - 9), it was evident that induced monomorphiC 
arrhythmias wlth CL as shon as 230ms stili indicated patients a high risk of 
spontaneous VTISD. 
Only the induction of sustained monomorphic VT of CL ~ 230ms 
Indicates MI survivors at high risk oC SUbsequent VTISD. The induction of 
VF or VFI represents a negative result wlth no adverse long· term prognostic 
significance. 
800 Clinical Studies of Silent Ischemia 
Wednesday, Apri) 15, 1992 
2:00 PM-3:30 PM 
Dallas Convention Center 
Wl16 
800·1 
Prevalence of Ambulant Silent Iachemia in 
Aaymptomatic and Minimally Symptomatic CAD 
Patienta 
2:00 
Carl J. Pepine, MD, Peter F. Cohn, MD, Prakash 
C. Deedwania, MD, Robert S. Gibson, MD, Udho 
Thadani, MD, Eileen Handberg, MSN, James A. 
Hill, MD, for the ASIST study Group; 
UniverSity of Florida, Gainesville. 
283A 
Ambulant silent ischemia (AI) is a risk factor 
for adverse events in patients with coronary 
artery disease (CAD) but its' prevalence in 
various patient subsets is unknown. To assess 
the prevalence of AI in asymptomatic or mildly 
symptomatiC (e.g., requiring only nitrates) 
patients, 1001 patients with CAD and ischemic 
ST segment depression >l.Omm on exercise test•
ing were studied by 48~hour ambulatory ECG 
recordings. AI was defined as >2 episodes of 
asymptomatic ST segment depreSSion >l.Omm 
lasting ~l minute or a single episode >5 ~in­
utes. A total of 230 patients had AI for a 
prevalence of 23%. This rate was relatively 
constant (3 month moving averages) throughout 
15 months. Comparison of patients with and 
without AI showed no significant difference in 
age (63 both groups), male/female ratiO, diabe•
tes (20% vs. 18%), prior infarction (56% vs. 
53%), prior revascularization (26% vs. 32%) or 
prior cardiac drug use (36% vs. 41% for beta•
blockers, 11% vs. 10% ACE inhibitors, 43% vs. 
44% calcium antagonists). 
In summary, the prevalence of AI in this pa•
tient subset is 23%. Neither demographic nor 
nistorical data allows identification of pa•
tients with AI among asymptomatic or minimally 
symptomatic CAD patients with positive exercise 
tests. 
284A ABSTRACTS 
800·2 2:15 
Forced Titration of Diltiazem yersus Metoprolol can be of Benelit in 
InI1uenclna Circadian Pattem and Total Ischemic burden In Patients with 
Stable Analne 
Arnaud Aerta, Wim AenaevureD,Rob de Vries and Peter Dunselman. 
Depar1ment of Cardioloay, University Hospital Groningen, University Hospital 
NijmellOll and lanatiWl Hospital Breda The Netherland •. 
Routine anti-anainsl treatment,1n symptom derived dosage, might not be sufficient 
to ameliorate total ischemic burden and its circadian pattern. We studied the effects 
of biah dou.es of diltiaz.em (D) versus metoprolol 300 ma controlled release (M) 
on cifCldian pattern and total ischemic burden win. forced titration up to M 300 
me o.d. and D 120 mil t.i.d. In a double blind, randomized crosso()ver trial 60 
patienll with stable anains, a positive exercise test and transient myocardial 
iscbemia (TMI) durina 48-hour ambulatory 5T -segment monitoring were 
Investiaated off anti-anainal therapy and after 3 weeks medication. 
II b.~e1iD~ I!illiam M~IDI![gIDI 
Holter (48h) data: 
number of TMI episodes 10 3,8* 2,6* 
duration of TMI episodes (min) 26 6,3* 8,S* 
Exercise data: (min) 
time until cbest pain 6.1 7.4* 7.1* 
time until end of exercise 7.1 8.2*/1111 7.4 
*p<0,05 va baseline/I/I/- <0.01 vs.metoprololl 
Analysis of the circadian pattern of duration and number of TMI, at baseline, 
showed a peak between 7-12 am and 5-8 pm. D reduced the morning peak and to 
leaser extent the afternoon peak. Metoprolol eradicated both peaks. 
ConclWlions: 
1: Hiah dou.es of botb D and M reduced exercise induced ischemia, D more than 
M. 2: M eradicates the circadian pattern of TMI whereas D bas ooly a modest 
influence. 3: Forced titration of D and M to a level above symptom derived dosage 
can be of benefit in treatment of patients with stable angina and transient myocardial 
ischemia. 
800-3 2:30 
Under-Reporting of Somatic Symptoms In Patients With Silent 
lithemia 
Richard F. Davies, Wolfgang Linden, W. Peter Klinke, Habibullah 
Habib~ Jennifer A. Buttars, Pierre Dessain, and CASIS Investigators. 
University of Ottawa Heart Institute, Ottawa, Ontario, CANADA. 
We evaluated the influence of psychological traits on the reporting of 
angina in patients with known coronary disease and positive off drug 
treadmill tests (Bruce protocol, average ST depression 2.2 :I: 0.8 mm) 
were studied. Those with angina (N aS8) and without angina (N =49) 
during treadmill exercise were compared using standardized measures 
of the tendency to report somatic symptoms (Pennebaker), type A 
trait (Framingham), anger expression (Spielberger), hostility (Cook•
Medley), depression (Beck), marital adjustment (Dyadic Adjustment 
Scale), and deception (Sackeim & Gur). Severity of ischemia was 
quantified by exercise time and double product at the onset of 
ischemia, and by the maximal ST depression during exercise. 
Association with angina was assessed by logistic regression. 
ST depression at angina onset (1.5 :I: 0.8 mm) was significantly less 
than peak values in patients without angina (2.3 :1:0.7 mm, p < 0.001). 
Patients with silent ischemia showed a markedly lesser tendency to 
report somatic symptoms in general (t a 3.98, p < 0.0001). Silent 
ischemia showed weaker independent associations with exercise time 
at ischemia onset (p < 0.01) and hostility (p < 0.01). There was no 
association with and type A trait, anger expression, or tendencies 
toward self- or other- deception. These results show that patients 
with silent ischemia have 8 generalized deficit in the reporting of 
somatic symptoms. 
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800·4 
Ventricular Tachycardia and Ventricular Fibrillation 
and Transient Myocardial Ischemia 
2:45 
Manfred Zehender, Stefan Hohnloser, Armin Furtwllngler, 
Annette Geibel, Hanjorg Just. lnnere Medizin Ill, Univ. of 
Freiburg, FRG. 
In a prospective study using 24h-Holter monitoring 200 pts with 
ventricular tachycardia (vr, >4 consecutive ventricular beats) 
and with different heart diseases (HO) (group I: CAD'" 100 pts, 
group II: IDe .. 40 pts, group III: no organic HD .. 30 pts, group 
IV: left ventricular hypertrophy. 30 pts) were studied for the 
relevance of symptomatic and asymptomatic ST segment depres•
sion (ST-O > =0.2 mV) preceeding or following vr. Per patient 
a maximum of 5 episodes were considered, mean incidence of 
episodes was 2.8.±.1.6 vr Iper pI. Altogether, 22 episodes of 
sustained vr were documented; in 16% ST-O (mean duration: 
9.8.±.11.7 min, 6% symptomatisch) was present before vr onset 
(only pts in group I), 6% symptomatisch) and 64% after vr 
(highest incidence: group I and IV). When ST-O was present 
prior to vr, single polymorphic ventricular beats were more 
common (76% versus 33%) and the incidence of degeneration 
of vr into VF was 4 times higher when the vr was preceeded 
by ST-O. Of 528 non-sustained vr, 10% of episodes were 
associated with pre-vr ST-O, 11% had post-vr ST-O, closely 
related to vr rate and duration and heart disease. In 
conclusion, silent ST-O prior to spontaneous vr are common 
(8-14%) in pts with CAD and of clinical relevance for 
degeneration into VF. In contrast, post vr ST-O are unspecific 
findings in up to 64% of pts with all types of heart diseases and 
were most common in hypertensive heart disease. 
800-5 3:00 
Value of Very Prolonged (l20hr) Ambulatory ECG 
Monitoring for Ambulatory Myocardial Ischemia 
Erwin Raymenants, Kenneth Henson, Roben Kolb, Alice Boyette, 
Cynthia Hoffman, Carl Pepine. University of Florida, Gainesville, FI 
Studies comparing the effects of antiischemic agents on the frequency 
and duration of ambulatory myocardial ischemia (AMI) using 24-48 hr 
ambulatory EeG monitoring (AEM) have been hampered by a large 
day to day variation in AMI within individuals and between different 
subjects, reducing the statistical power of the study, thus requiring a 
larger sample size. To investigate whether very prolonged (120 hr) 
AEM in a more limited number of patients would have statistically 
better results we studied 5 patients with documented coronary artery 
disease, exercise induced ischemia and AMI in a randomized, double 
blind, placebo controlled trial, using two placebo phases and two active 
treatment phases, each of two weeks duration. Patients underwent 120 
hr AEM during the last 5 days of each treatment phase. After two 
weeks of placebo, patients were randomized to either atenolol (200 mg 
once a day) or diltiazem (120 mg three times a day) and were then 
crossed over to the alternative treatment after another two weeks of 
placebo. Those patients who did not have their ischemia eliminated 
with either treatment, received combination treatment with atenolol 
(100 mg once a day) and diltiazem (60 mg three times a day). The 
number of ischemic episodes decreased from 3.9±0.5 (mean ±SEM) 
per 24 hr during the placebo phases to l.5±O.4 during diltiazem 
(p,,0.OO4) and 0.5±O.2 during atenolol treatment (p==O.OOI), which 
was significantly lower than during diltiazem (p==O.Ol). Total ischemic 
duration decreased from 31.2±7.1 min per day during the placebo 
phases to 8.8±4.1 min on diltiazem (p<O.OOl) and 1.7±O.9 min on 
atenolol (p<O.OOI), which was lower than during diltiazem. Three 
patients had their ischemia completely eliminated on atenolol, the 2 
remaining patients had a further reduction of ischemia on combination 
treatment.We conclude that both atenolol and diltiazem are very 
effective in the treatment of AMI, although atenolol is considerably 
more effective, eliminating >85% of ischemic episodes and >95% of 
total ischemic time. Prolo.lged AEM is a statistically powerful tool in 
the assessment of the efficacy of antiischemic agents. 
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800·6 3:15 
Mental Stress is an Uncommon Trigger of Myocardial 
Ischemia in Patients With Severe Stable Angina. 
Thomas Gumbrielle, Diana Noyce, Phillipa Sobb, Kerry McMiken, 
Rosa Bestak, David T. Kelly, S. Ben Freedman. Hallstrom Institute of 
Cardiology, Royal Prince Alfred Hospital, Sydney, New South Wales, 
Austra1ia. 
In order to determine how often mental stress triggers myocardial 
ischemia in daily life, we studied 26 medically treated patients with 
severe but stable angina pectoris awaiting bypass surgery. All patients 
had a strongly positive exercise test (mean time to Imm ST depression 
3.9 ± 0.5 mins). Ischemia was detected by a 2 channel ambulatory 
recorder (QMed) programmed to deliver a beep when ST depression of 
~ Imm was detected. Patients were asked to enter in a diary details of 
their symptoms if any, what they were doing and their emotional and 
physical state at the time of each beep. During monitoring for 51 ± 5 
hours, 16 of the 26 patients (61%) demonstrated ischemia (mean 13 ± 
3 episodes /24 hours) and at least one diary entry which corresponded 
to a monitor beep. Patients responded to a mean of 6 ± 1 episodes of 
ischemia (mean duration 6.6 ± 0.5 mins), representing 48 ± 10% of all 
ischaemic episodes. Ischemia occurred during physical effort in 7 
(43% of patients and 58% of total reported episodes), during rest in 9 
(56% of patients and 38% of episodes), and during mental stress in 
only 3 (18% of patients and 6.8% ofreported episodes). Mental stress 
was associated with all ischemic episodes in one patient, 14% of 
episodes in the second and 13% of episodes in the third. In patients 
with mental stress associated ischemia, exercise time to Imm ST 
depression was significantly shorter (2.6 vs 6.3 min p<0.03) but 
ischemic episodes per 24 hours were no more frequent than in those 
without. Two of the 3 patients with mental stress associated ischemia 
were not receiving beta-blockers. 
We conclude (i) mental stress is an uncommon trigger of myocardial 
ischemia in daily life in medically treated patients with severe coronary 
disaese (ii) compared to those without, patients with mental stress 
associated ischemia have a poorer exercise tolerance but no greater 
frequency or duration of ischemia. 
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801·1 2:00 
Structural Correlates of Hibernating Myocardium in man. 
Marcel Borgers, Wun Flameng. 
Janssen Research Foundation, 2340 Beerse and University of 
Leuven, Belgium. 
There is, as yet, little quantitative infonnation available on the 
structural changes the myocardium undergoes during hiberna•
tion. Li~t- ana electron microscopy was performed on trans•
mural bIOpsies from chronically ischemic myocardium obtained 
from patients during CABG. Biopsies were taken from severely 
hypol<inetic areas of 65 LV without previous anterior wall in•
farction. Detailed morphometric analysis showed a limited in•
crease in connective tissue and a varymg ratio of altered versus 
normal cardiomyocytes (CM). The main change seen in a 
substantial part (up to 6O%) of CM was that cells switched from 
a functional to a survival state, morphologically characterized 
by dedifferentiation. The changes were not atrophic in nature. 
Such CM showed a complete or partial loss of sarcomeres and 
sarcoplasmic reticulum, presentEici numerous healthy-looking 
mini-mitochondria, large areas of glycogen, a tortuous nucleus 
and an intact sarcolemma. The tremendous accumulation of 
glycogen in these cells might be related to the abnormally high 
glucose uptake in such areas as seen with PET. The number of 
these typical hlbernating cells was consistently higher in suben•
docarcfuil than in subepicardial regions. We propose that the 
above structural adaptations might be held responsable for the 
lack of immediate recovery of ilie LV function after revasaJIari•
zation as seen in a number of patients. In addition, 24 biopsies 
were examined from hypokinetiC LV areas of patients with pre•
vious anterior wall infarction. Isolated CM within or at the 
border of the fibrotic area and more compacted CM fibers lining 
the healed infarcted zone were also of the hibernating type. 
These ob;ervations raise the obvious ~tion as to whether or 
not such cells upon restoration of bloOd flow are able to differ•
entiate again and hence contribute to increased LV contractile 
performance. 
ABSTRACTS 
801-2 2:15 
Ischemia in Collateral· Dependent Myocardium: Effects of 
Calcium Channel Blockers in Man 
Giuseppe Pupita, Domenico Mazzara, Ornella Manei, Carla Rimatori, 
Gino F. Ferretti, Maurizio Centanni, P{U)lo Dessl-Fulgheri, P{U)/o 
Russo, Alessandro Rappelli. University of Ancona, Italy 
Dilatation of coronary collateral vessels with improved myocardial 
perfusion has been shown to occur in response to several stimuli (e.g. 
nitrates). Whether calcium channel blockers can increase flow to 
collateralized myocardium is still controversial. To evaluate this aspect 
in man, we selected 9 patients (pts) with stable angina in whom 
ischemia could only develop in collateral-dependent myocardium. AIl 
pts had a single coronary occlusion with collaterals, no other coronary 
stenosis, normal left ventricular function and reproducibly positive 
exercise tests. Pts performed - at 2-days intervals - exercise tests off 
therapy and after acute randomized administration of nifedipine (N, 10 
mg sIl), diltiazem (D, 120 mg p.o.) and nitroglycerin (GTN) (0.5 mg 
of sm. Following N, time to 1 mm sn and to peak exercise 
Significantly increased (430±176 vs 576±204 s and 499±170 vs 
612±181 s, p<.OI and <.05), while ischemic threshold (expressed by 
the rate-pressure product at 1 mm STJ.) remained unchanged 
(199±29.102 vs 204±44·102 beats/min.mmHg, p=NS). Similarly, 
after D time to 1 mm ST J. and to peak exercise significantly increased 
(to 611±132 sand 647±141 s, p<.OI for both) but no significant 
changes in ischemic threshold were detected (193±3S.102 
beats/min·mmHg). Conversely, GTN administration resulted in a 
significant increase of time to 1 mm ST J. and to peak exercise 
(674±121 and 744±136 s respectively, p<.OOl for both) altogether 
with an improved ischemic threshold (197±31'102 vs 239±42.102 
beats/min'mmHg, p<.OOI). Thus N and D improve ischemia arising 
in collateral-dependent myocardium by increasing exercise duration; 
ischemic threshold however is only modified by GTN. These 
findings suggest that collateral blood flow can be improved by GTN 
and that changes in exercise tolerance induced by N and D appear to 
be related to a reduction in myocardial oxygen consumption rather 
than to an increase in collateral blood flow. 
801·3 2:30 
Intracoronary Phentolamine Reverses Cigarette SmOking· 
Induced Epicardial Coronary Vasoconstriction in Humans 
Robert L. Minor Jr.. Helgi Oskarsson, James E. Quillen. James D. Rossen 
FACC. Michael D. Winniford FACe. University of Iowa College of 
Medicine and VA Medical Center, Iowa City, Iowa. 
Cigarette smoking produces constriction of proximal epicardial coronary 
arteries in humans. We hypothesized that alpha-adrenergic stimulation 
plays an important role in smoking-induced coronary vasoconstriction. 
METHODS: The diameters of angiograpbically normal coronary segments 
were measured in 12 chronic smokers before (CONTROL) and immediately 
after smoking one cigarette (SMOKE). following regional alpha-adrenergic 
blockade with intracoronary phentolamine at S minutes after smoking 
(pHENTOL. 2 mg), and following intracoronary nitroglycerin (NTG, 200 
Ilg). Left anterior descending (LAD) and left circumflex (LCx) proximal 
and distal coronary segments (> I 0 mm length) were analyzed by 
computerized quantitative angiography employing automated edge 
detection. Previous studies from our laboratory have demonstrated 
equivalent epicardial coronary vasoconstriction immediately after smoking 
and at S minutes. Vasoactive medications were discontinued at least 12 
hours prior to study. 
RESULTS: (Mean ± SEM) 
Condition CON1ROL SMOKE eHEl:iIQL HrQ 
prox LAD (mm) 2.97±.1O 2.88±.09* 3.00±.11 3.43±.20t 
dist LAD (mm) 1.78±.O7 1.6S±.07t 1.79±.O7 2.06±.lOt 
prox LCx (mOl) 3.06±.14 2.93±.14* 3.16±.16 3.S6±.23t 
dist Lex (mOl) 1.73±.O7 1.43±.07t 1.68±.07 2.11±.12t 
RPP 7099±<i38 8460±589* 77S3±64S* 67S7±670· 
• p<O.05 vs. CONTROL. t p<0.01 vs. CONTROL. 
Rate pressure product (RPP) = heart rate X mean arterial pressure. 
n=12 for all conditions except NTG where n=8. 
The vasoconstrictor effect of smoking was more pronounced in distal as 
compared to proximal coronary segments (p<O.OI). 
CONCLUSIONS: Cigarette smoking-induced epicardial coronary 
vasoconstriction is reversed by intracoronary phentolamine. This suggests 
that alpha-adrenergic stimulation is an important mechanism in the effect of 
smoking on the coronary circulation. 
285A 
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801·4 2:45 
Benefi~ial Effeets of Nitroglyeerin on Botb Platelet 
and Vea.el Wall in Deereasing Mural Thrombosis 
Jules Y. T. Lam. Lueie L-Lseoste. Yabye Kerbi. 
David Waters. 
Kontreal Heart Institute. Kontreal. Quebec. Canada 
Nitroglycerin inbibits platelet aggregation in vitro. 
and platelet-arterial wall interaction under flowing 
blood conditions in vivo and ex vivo. Whetber tbese bene 
ficial aetions of nitroglyeerin (RTG) are related to an 
effeet on platelets. the vessel wall or both was stu•
died in pigs using an ex vivo flow ehamber of 1 mm 
diameter. Femoral arterial blood was drawn over exposed 
aorlie media in the flow ehambers at 20 ml/min for 5 min 
at 37·C. The media was pretreated vitb either RTG or RTG 
vebicle. and either RTG or its vehicle was infused into 
tbe pig. The RTG dose was titrated to produee a l~ fall 
in mean arterial pressure. Quantitative autologous 
111Indium-labelled platelet deposition (xl06) on 
the aortic media are: (mean ± SEK) 
Kedia pretreated 
Vehicle 
RTG 
n 
32 
16 
Venous Infusion 
Vehiele RTG 
37.S±3.6 17.3±O.9 
10.8±O.4 10.1±O.4 
p value <0.001 <0.001 
n p value 
34 <0.001 
3. NS 
Relative to vebicle-treated media. aortic media pre•
treated with RTG inhibils platelet deposition. No addi•
tional antithrombotie effeet is observed in the presence 
of circulating RTG. However. cireulatint RTG. which 
signifieantly increases plasma eGMP. inhibits platelet 
deposition onto untreated media. and an additional anti•
thrombotic effect is observed using media pretreated 
vith RTG. Thus. the beneficial effect of nitroglyeerin 
on botb platelets and vessel wall may eontribute to its 
inhibition of platelet-vessel vall interactions. al•
though an enhaneed antitbrombotic activity may be 
observed vith its effect on the media alone. 
801·5 3:00 
Intravascular Ultrasound in Patients with Vasospastic 
Angina Pectoris. 
Mikihiro Kij:ima,Noboo KaratSU.Takayuki CMada,Shuichi 
Matsuroto,Kiyohiro lkeda,Yukio Maruyama. 
Ihshi General K:>spital.Fukushima Medical College • Japan. 
We have many patients with vasospastic angina pectoris 
(VSA) who have noI!llal coronary artery on coronary angio•
grams.It is difficult to discriminate noI!llal sites fran 
vasospasn sites on =ronary angiograms.We studied the 
vessel wall pathoanatany in patients with VSA and chest 
pain syndrane using intravascular \utraSOl.ID1(CVIS;30MHz, 
5.6F) .24 patients who had chest pain and noI!IIal coronary 
arteries were included in this st\Xly.50 ug of acetyl•
choline was injected to both left and right coronary 
arteries.l1 patients(13 coronary arteries) had positive 
response (group A:rore than 99% of red\X:tion in cli.aI!eter 
was induced) aM. 13 patients (21 coronary arteries) had 
negative response(group B:1ess than 50% of reduction). 
patients who had equivocal response(50-90% of reduction) 
were exclooed in this st\Xly.We evaluated the follCMing 
three parameters;l)the thickness of int:ima(mn) :fran the 
inner echo of adventitia to the inner echo of int:ima,2) 
echo density: soft, fibrous or calcification,3~xtension of 
atherana in the vessel circl.mference:less than 1/4,1/4-
1/2,rore than 1/2 of the vessel circl.mference.Result:The 
thickness of int:ima was significantly higher in the group 
A(12.1ntn) than the group B(3.1ntn).Echo density was soft 
in 11 of the 13 spasm sites in the group A. The distribu•
tion of athercma was rore than 1/2 of the vessel circum•
ference in all the patients in the group A and less than 
1/2 in 17 of the 21 coronary arteries in the group B. 
Conc1usion:Coronary vasospasm terrls to develop in the 
soft aM. thick atherana. 
801·6 
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Intravascular Ultrasound Precisely Detects, Localizes, 
and Quantifies Coronary Artery Calcification 
Gary S. Mintz, Philippe C. Douek, Gad Keren, Sharon L. Eldredge, 
Kenneth M. Kent, Lowell F. Satler, Augusto D. Pichard, Manin B. 
Leon. Washington Hospital Center, Washington, D.C. 
The presence, magnitude, and distribution of coronary calcification 
(Ca) may importantly influence transcatheter treatment strategies. 
Intravascular ultrasound (IVUS) was used to study lesion 
morphology in 70 native coronary aneries before and/or after 
transcatheter therapy (29 PTCA; 4 stent placement; and 18 
directional, 14 rotational, and 3 extraction atherectomy). Ca was 
detected by IVUS in 56 target lesions (80%). Clinical parameters 
associated with Ca included smoking (p<0.02), multivessel CAD 
(p=O.065), and previous CABG (p=O.067). The magnitude of Ca 
was assessed by computing the circumferential intimal arc of Ca 
(from 0 to 360°). At lesion sites, the arc of Ca averaged J{)()±IOOO 
and was <900 in 33% of sites, 91-180° in 26%,181.270° in 9%, and 
271-360° in 13%. Within angiographically normal proximal vessels 
(n=38), IVUS detected Ca in 31%, measuring 45±39° (both 
p<O.OOI compared to lesion sites). Similarly, in 10 angiographically 
normal left main coronaries, Ca was present in 5 (50%) and 
measured 21±22°. The transmural location of plaque Ca was almost 
always superficial (near the lumen interface) and rarely deep (at the 
plaque-media border); and the patterns of Ca (single large or multiple 
small deposits) could be differentiated easily. Importantly, 
fluoroscopy detected coronary Ca in only 50% of pts (p<O .00 I 
compared to IVUS); both magnitude and location was imprecise, 
correlating poorly with IVUS. In conclusion: IVUS evaluation of 
coronary vessels treated using transcatheter techniques: I) 
demonstrates a striking frequency (80%) of plaque Ca at the lesion 
site and even at angiographically normal proximal reference sites 
(31 %); and 2) more accurately detects, localizes, and quantifies 
plaque Ca than fluoroscopy. Thus, since the presence and magnitude 
of coronary lesion Ca may influence procedure outcome, IVUS may 
play an important role in proper transcatheter device selection. 
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802·1 2:00 
Tachycardia Detection and Treatment With a Third-Generation Implantable 
Cardioverter-Defibrillator: An International Experience 
Sanjeev Saksena. Richard Stout, Michael Poliseno. Ryszard B. Krol. Davendra 
Mehta. and Worldwide Guardian 4210 Phase I Investigators. UMDNJ-NJ Medical 
Scbool. Newark. NJ and Telectronics Pacing Systems. Denver. CO. 
We examined the incidence of spontaneous tacbycardia detection and frequency of 
use of antitacbycardia tberapies after bospital discbarge in pts implanted with a 
third·generation pacemaker-<:ardioverter-defibrillator [lCD] baving staged 
detection and therapy algorithms. 138 pts with malignant ventricular 
tacbyarrhytbmias [VT] and cardiac disease. mean age 58 years, implanted with a 
Telectronics Guardian model 4210 ICD had device data logs analyzed. Detechon 
algorithms provide initial tachycardia detection, reconfirmation prior to ICD 
tberapy activation and during staged tberapy. Tiered anti tachycardia therapy 
included antitachycardia pacing [ATP] and up to 7 sbocks. ICD followup ranged 
from I to 8 months. 
RESULTS: VT events accounted for 17902 (53.2%) of33651 tachycardia 
detections recorded by the ICD. Data logs and clinical observations indicated the 
remainder to be due to sinus taChycardia, atrial flutter/fibrillation. or oversensing 
due to individual instances of lead system malfunction. Spontaneous or late 
reversions of VT events unrelated to pacing or sbock therapy accounted for 12706 
(71 %) of all VT episodes. these being 31.2 % of total untreated events recorded in 
data logs. ATP therapy reverted 12.4% of all remaining VT events or 59.5% of 
all treated VT events. The remainder (7.6% of all VT events or 36.7% of all 
treated VT events) required sbock therapy. Two or more shocks were necessary 
for only 38 events (0.7% of all VT events or 3% ofall treated VT events). ATP 
therapy for VT accounted for 45.7 % of all A TP usage. The pattern and 
effectiveness of ATP therapy was unchanged at 2. 4 and 6 months of followup. 
There was no difference in patterns of ICD behavior in U.S. and nOD-U.S. centers. 
CONCLUSIONS: I) A high frequency of initially detected tachycardia events do 
not initiate staged electrical therapy due to inability to satisfy newer detection 
algorithms. 2) ATP followed by a single shock in staged electrical therapy 
algorithms terminated the majority of treated VT events in this third-generation 
lCD. 
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ECG·DOCUMENTED UNNECESSARY, SPONTANEOUS 
SHOCKS IN 206 PATIENTS WITH IMPLANTABLE 
CARDIOVERTER DEFIBRILLATOR (ICD) 
Wonram Grimm, Belinda F. Flores, Francis E. Marchlinski, Hospital of the 
University 01 Pennsylvania, Philadelphia, Pennsylvania 
Two hundred and six patients (pts, 38 lemale) with a total of 265 
ICD implalltalions were lollowed lor 21 +1- 19 months (range 3 to 92 
months). ICD implanted was a CPI AID B/BR device in 45 pts, CPI 
Ventak 1510120 In 74 pts, CPI Ventak 1550/1600 In 100 pts, Medtronic 
PCD in 5 pts, CPI PRX in 3 pts, and Ventritex Cadence in 38 pts. The 
latter device has electrogram (EG) storage capability lor events causing 
a shock . 
.B.e.sul1s.; During fOllow-up 47 01 206 patients (23 %) received ICD 
shocks confirmed by surtace ECG (36 pts) or stored EG (11 pts) lor 
rhythm other Ihan VT. Criteria for diagnosis 01 VT and Afib using stored 
electrograms include EG morphology, rate and R-R interval, as 
previously described. Unnecessary spontaneous shocks could be 
documented more frequently (p < 0.05) in pts with a device with EG 
storage capabilities (11 0138 pts, 29 %), than in pts with other devices 
(36 of 227 pts, 16 %) despite a shorter mean duration 01 follow-up, 12 
mos vs. 17 mos (p < 0.05). 
Cause of spontaneous unnecessary shocks' Number 01 patjents 
Atriallibrillation 30 (15 %) 
Sinus tachycardia 5 ( 2 %) 
Supraventricular tachycardia (other) 3 ( 1 %) 
Non-sustained ventricular tachycardia' 5 ( 2 %) 
Others (T-wave oversensing, magnet misdirect, 6 (3 %) 
insulation break, loose set screw, pacemaker programming) 
, Two pts had shocks for Afib or SVT and for non-sustained VT 
We conclude' 1. Unnecessary shocks are a Irequent complication 
01 ICD therapy occurring in at least 23 % of pts. 2. The cause 01 these 
shocks is most Irequently atrial fibrillation or sinus tachycardia. 3. Stored 
electrograms in 3rd generation devices improve the ability to document 
the presence and cause of unnecessary shocks. 
802·3 2:30 
Failure or Defibrillation Due to Loss or Sensing Signals Using an 
Integrated Sensing, Pacing and Defibrillating Lead 
Werner Jung, Matthias Manz, Berndt Liideritz. Department of 
Cardiology University of Bonn, Germany 
The delivery of defibrillation shocks of a transvenous integrated 
lead system, which has a very close spatial proximity of the right 
ventricular defibrillation coil and the distal sense/pace tip, may 
affect endocardial sensing signals (ESS). The aim of this study 
was to evaluate the effects of defibrillation shocks applied via an 
integrated sensing, pacing and defibrillating lead (Endotak, CPI) 
on the ESS in 6 patients_ The ESS were measured prior to ap· 
plication of shocks, immediately and two minutes after shock 
delivery. ·Results: The ESS decreased from 18+ /-6 mY prior to 
defibrillation to 5+ /.2 mY immediately after shock delivery. 
Even after two minutes of shock discharge, the ESS did not show 
complete recovery. In one of the patients, reduction of ESS 
occurred following delivery of an unsuccessful shock with an 
energy of 20 J. Due to the long duration of undersensing and due 
to the programmed cut-off rate of 170 bpm, the redection crite· 
rion for delivery of the second therapy was not fulfilled. After 
recovery of the ESS, the device delivered again the first therapy 
with an energy of 20 J which failed to defibrillate. For successful 
defibrillation a rescue shock had to be applied by an extema! 
manual defibrillator. -Conclusions: (1) Following shock delivery, 
a significant reduction of the ESS occurred in all patients using 
an integrated sensing defibrillating lead. (2) The reduction of the 
ESS caused undersensing and led to inability of defibrillation in 
one patielt. (3) To minimize the possibility of a device failure, 
we strongly recommend to program the first shock therapy to a 
maximum energy and to set the the cut-off rate for detection of 
ventricular fibrillation as low as possible. 
ABSTRACTS 
802·4 2:45 
A Detection Algorithm for the Automatic Dlscrlmlnetlon of Ventrlculer 
Tachycardia from Ventricular FIbrillation. 
Gust H. Bardy, Walt Olson, Bob Taepke, George Johnson. University 01 
Washington, Seattle WA. 
Current tiered therapy Implantable cardlovener-delibrillators do not 
allow differentiation 01 monomorphic ventricular tachycardia (VT) from 
ventricular f1brUlatlon (VF) within a panlcular rate detection zone. This 
limitation restricts the use of antltachycardla pacing therapies on fast 
monomorphic VTs (300-250 ms) that presenUy would be treated wtth high 
energy pulses. The purpose of this Investigation was to develop a VT-VF 
discrimination algorithm Indepandent of arrhythmia cycle length that takes 
advantage of the Intrinsic varlabUIty 01 wavefront propagation during VF 
compared to that observed with VT. 
Using two bipolar sense electrodes and a patch electrode in nine 
patients wtth both VT and VF, differences In wavefront arrival time for two 
different electrograms was compared over 11 arrhythmia cycles for both VT 
and VF In each patient. The rank order differences of successive activation 
arrival times for each beat were then calculated and compared for VT and 
VF In each patient using a metric called the discrimination ratio, t.. 
A A 2 20 was selected as a strict performance ratio that would maintain a 
high degree of VF sensttivity yet offer good VT detection sensttivity. In 8/9 
patients, the A criterion was satisfied sufficiently well to allow for the clear 
separation of VT from VF Irrespective 01 arrhythmia cycle length, p=0.OOO2. 
In the remaining patient, VT was treated as VF thereby maintaining high VF 
detection sensttlvity. 
ThuS, this discrimination algorithm allows more rhythm specific 
therapy with no apparent reduction in VF detection sensttivity. In essence, 
VT and VF rate detection zones can overlap. The beneftt to the patient may 
be a reduced Incidence of shocks for monomorphic VT. 
802·5 3:00 
Wedge Coronary Sinus Pressure During Ventricular 
Fibrillation Reflects Left Heart Hemodynamics 
Douglas G. McLellan, Raymond Yee, Donna Cade, Gerard M. 
Guiraudon, Richard A. Leather. 
University Hospital, London, Ontario, Canada 
287A 
Previous studies have shown that "wedging" a luminal 
catheter in the coronary sinus records a pressure (CSP) that 
reflects left ventricular phasic contraction. We evaluated the 
characteristics of CSP recorded using a solid state Millar 
catheter to assess the potential value of CSP as a phYSiologic 
marker of hemodynamic stability for implantable defibrillators. 
Pressure recording catheters were placed in the distal 
coronary sinus and aorta (AO) in 5 anesthetized pigs. CS 
pulse pressure (CSPP=systolic-diastolic) and AO pulse 
pressure (AOPP) were monitored during 1) sinus rhythm (SR), 
2) atrial pacing (AP at cycle length 350 ms) to simulate 
supraventricular tachycardia 3) ventricular pacing (VP at cycle 
length 400 ms) to simulate ventricular tachycardia, and 4) 
induced ventricular fibrillation (VF). CSPP fell from 38±20 
mmHg to 26±14 (p=0.1) with AP350 and decreased further to 
25±17 (p=.01) with VP400. AOPP fell from 48±7 mmHg to 
35±7 (p<.001) with AP350 and to 24±10 (p<.001) with VP400. 
There was a close correlation between CSPP and AOPP 
(r=.80) during AP350 and VP400. 
During VF, both CSPP and AOPP fell to 0·1mmHg and CSPP 
phasic pressure waveform returned promptly upon 
defibrillation (14±7 mmHg). 
We conclude that coronary sinus wedge pressure reflects 
changes in systemic pressure during pacing induced 
tachycardia and VF. CSPP reflected hemodynamic 
improvements following successful defibrillation. CSP 
monitoring may be useful as a physiologic sensor in 
implantable defibrillators and warrants further study. 
288A ABSTRACTS 
802·6 3:15 
A New Sensor for Tachyarrhythmia Differentiation .- the Paced 
Depolarization Integral? 
Koonlawee Nademanee, Richard Lu', William Bailey. Denver Gen•
eral Hospital, Denver, Telectronics Pacing Systems', Englewood, CO 
Fast ventricular responses due to sinus tachycardia (ST), supra•
ventricular tachycardia (SVT) and atrial fibrillation/flutter (AF) can be 
incorrectly detected as ventricular tachycardia (VT) by implantable 
defibrillators. Based on the effects of exercise, and changes in pacing 
rate on the paced depolarization integral (POI) in rate responsive 
pacemakers, a hypothesis has been made that the POI can be used for 
tachyarrhythrnia differentiation. This study was designed to test this 
hypothesis. The POI is the area of the ventricular F 
electrogram at the stimulus site during depolarization 
(Fig. 1). POI measurements were obtained during POt 
overdrive pacing (10 paces!measurement) using a 
PC-based external pacemaker which also performed 
automatic threshold tracking and charge balancing Fig. 1 
procedures to remove polarization artefacts priorto POI measurements. 
Nineteen patients were studied during standard electrophysiological 
studies. POI data were collected during 7 episodes ofVT from 5 patients, 
5 episodes ofST induced by isuprel infusion from 5 patients, 30 episodes 
of SVT from 2 patients, and 6 episodes of AF from 3 patients. The POI 
values obtained during these induced tachyarrhythmias were compared 
with POI values obtained during normal sinus rhythm (NSR) just prior 
to the arrhythmias or immediately after reversion. The mean ± SO of 
% changes (%~) from baseline are summarized (' P<0.02). Unstable 
baseline POI data during NSR were also observed 
Mean±SO VT ST SVT AF 
of%~ ~7.9±38.8' -31.5 ± 10.9' -7.2 ± 14.8' -9.2 ± 18.6 
In conclusion, the POI significantly increased during VT whereas 
it significantly decreased or had no significant change from NSR during 
ST, SVT or AF. Thus, the POI can potentially be used to improve the 
specificity of VT detection in implantable defibrillators. 
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Congenital Coronary Artery Anomalies in the Young: Risk 
for Sudden Death 
Allen J. Taylor, Renu Virmani, Kevin M. Rogan. 
The Armed Forces Institute of Pathology and Valter Reed 
Army Medical Center, Vashington, District of Columbia 
Congenital coronary anomalies (CCA) are a well-known 
cause of sudden cardiac death (SCD) and are found rela•
tively more frequently in young individuals who die dur•
ing exercise (ED). To clarify the risk of SCD in young 
patients (pts), we reviewed the clinicopathologic records 
of 197 pts with CCA and compared the younger «30 years 
of age, n=73) to the older pts (>30 years of age, n~124). 
Overall, 45/73 young pts died suddenly (62%). SCD was 
classified as ED in 29 of these cases (64%). Anomalous 
origin of the left coronary artery (LCA) from the right 
sinus (RS) was the most frequent CCA observed (26/73) and 
most frequently resulted in SCD (24/26; 92%) and in ED 
(17/24; 71%). Anomalous origin of the right coronary 
artery (RCA) from the left sinus (LS) was associated with 
SCD in 8 of 16 cases (50%) and with ED in 5/8 (62%). 
Other anomalies observed in association with SCD included 
hypoplastic coronary arteries, RCA and/or LCA from poste•
rior sinus, single RCA, and left anterior descending from 
RS. High-risk anatomy for SCD included acute-angle take•
offs, ostial valve-like ridges, or coursing of the artery 
between the aorta and pulmonary trunk. All young SCD pts 
with LCA from the RS or RCA from the LS had at least one 
of these findings. Young pts, compared to older pts with 
the same anomalies, were more likely to die suddenly (62% 
vs 12%) and during exercise (40% vs 2%), despite a lower 
incidence of atherosclerotic coronary artery disease (1% 
vs 40%). 
Thus, young pts with CCA more frequently die suddenly 
and with exercise than older individuals with CCA. This 
is especially true when the LCA rises from the RS, which 
was the most frequent and lethal anomaly. 
803-2 
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2:15 
Pregnancy in Cyanotic Congenital Heart Disease: Maternal Complications 
and Factors lnnueneing Successful Foetal Outcome 
Patrizia Presbilero, Jane Somerville, Susan Stone, Eno Aruta, David 
Spiegel halter. Royal Brompton & National Hean Hospital, London, & MRC 
Biostatistics Unit, Cambridge, England and Hospital G.Bosco, Torino, Italy. 
416 patients (pts.) with congenital hean disease (CHD) had 822 pregnancies; 
45 pIS. who were cyanosed. operated and unoperated, age 15-41 (mean 24) 
years had 96 pregnancies. Medical terminations were excluded. Prenatal 
maternal complications occurred in 10 patienlS (22'J'c) from failure (8 pIS.) and 
supraventricular arrhythmias (2 pts.) and perinatal complications in 4 pIS. (9%); 
bacterial endocarditis in 2 (one death after late diagnosis), pulmonary embolism 
(1 pt.) and cerebral embolism (I pt.). 40 of 96 pregnancies (42%) resulted in a 
live infant, 2 with CHD. 24 were premature. Mean weight of fulltenn infants 
was 2575 grams. 54 (56%) miscarriages occurred at 6 weeks-5 months. 
There were 2 stillborn babies with CHD at 8 months. 
The following factors were examined for their predictive relationship 
with successful outcome; 1] Basic anomaly in mother, divided into 4 groups: 
AJ single ventricle or tricuspid atresia; BJ tetralogy of Fallot or pulmonary 
atresia; C] Ebstein's Anomaly + atrial septal defect; DJ corrected transposition 
+ ventricular septal defect and pulmonary stenosis; 2J Haemoglobin (Hb.) at 
beginning of pregnancy; 3J Systemic anerial oxygen saturation; 4J Age; 5J 
Ability Index; 6J Previous surgical shunt. In a univariate analysis, age and 
presence of a shunt were nOl significantly associated with foetal outcome, while 
Hb. and anerial oxygen saturation were each strongly related (p<.OOOI). From 
multivariale logistic regression analysis we derived an adjusted Hb. value, in 
which disease group A was equivalent to an additional 2 g/dl, while presence of 
a shunt was equivalent 10 a reduction of I g/dl. The resulting score was 
strongly associated with the risk of miscarriage. A similar rule was derived 
for anerial oxygen saturation, confirming thal it is the lack of oxygen rather 
than hyperviscosity thal is the cause of foetal death. There is a high 
complication rale in the pregnant cyanotic pt. but the risks 10 the mother and 
foetus may be minimized with optimal, combined ~ cardiological and 
obstetric care. 
803-3 2:30 
Myocarditis in ~-Thalassemia Major, A 5-Year 
Follow Up Study. 
Dimitrios Kremastinos, Elias Rentoukas, Sofia 
Mavrogeni, George Theodorakis, Pavlos Toutou•
zas. Cardiac Depts of Athens General - Hippo•
kratio Hospitals -Athens University -Greece. 
Iron deposition in the myocardium is traditio•
nally accepted as the cause of congestive heart 
failure (CHF) in ~-thalassemia major (~-th). 
However, half of the patients approximately, 
develop acute myopericarditis (AM). In this 
study 47 ~-th patients (pts) with AM, mean age 
15.04 ± 2,5 years and 47 non AM ~-th pts age 
and sex matched, were followed for 5 years, in 
order to evaluate the influence of AM on CHF 
development. AM was finally established by 
endomyocardial biopsy. Doppler echocardiography 
was used as the main method for the following•
up. In AM ~-th group 13 pts developed CHF 
within 3±1,3 years, compared to 3 pts belonging 
to non AM group (p<O.Ol). No significant 
correlation was found between CHF and non CHF 
pts regarding blood units transfused (CHF 
350±25-non CHF 375±20) and serum mean ferritin 
(CHF 2500 ± 250-non CHF 2300±350). Echo-Doppler 
features in CHF pts of myocarditis group were 
similar to dilated type cardiomyopathy (LVDd: 
6.1 ± 1.8 em, %FS: 25.2±3.l, E/A: 1.1±0.3, 
DT:150 ± 31ms). In contrast the 3 pts belonging 
to non myocarditis group had a restrictive LV 
inflow pattern (LVDd < 4.8 cm, E/A>2.2, DT<110 
ms). Thus, acute myocarditis seems to play the 
main role in dilated type CHF development, 
while iron deposition a minor one. 
JACC Vol. 19, No.3 
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803·4 
Determinants of Cardiac Autonomic Function In 
Type 1 Diabetes: Information from MonozYll0tlc 
Twins 
2:45 
Simon SS Lo. R David G Leslie. Manin G St 10hn Sutton 
Diabetic Unit. Westminster Hospital and Royal Bromptom 
National Heart and Lung Hospital. London. U.K. 
Cardiac autonomic dysfunction is a recognised complication 
of diabetes mellitus due to an altered balance between the 
sympathetic and vagal innervation of tbe heart. We 
examined autonomic function in 34 monozygotic twin pairs 
(mean age 29) who were discordant for Type 1 diabetes 
(mean disease duration 14 years) to establish whether 
changes in autonomic function are genetically determined. 
due to diabetes. its duration or to the tightness of glycaemic 
control. Autonomic function was assessed by resting heart 
rate (RHR) and heart rate variability with I) deep breathing 
(HRB). 2) Valsalva manoeuvre (HRV) and 3) standing (HRS). 
Glycaemic control was assessed as Haemoglobin-A 1 levels. 
RHR and HRB were significantly different between the 
diabetic nnd their non-diabetic co-twins (79±.12 vs 70±.1 I 
bpm. p<L.OOOI and 15±.12 vs 18±.13 bpm. 1'<0.007); while HRV 
and HRS were similar. Despite these differences. there were 
strong correlations in HRB. HRV and HRS between the 
diabetic and non-diabetic co-twins (r=O.91. r=0.75 and r=0.73 
respectively. all p<O.OOOI). Autonomic dysfunction was also 
detected in 4/34 (12%) of the non-diabetic twins whose 
diabetic co-twins all had impaired autonomic function. 
Abnormal autonomic function was more common when 
disease duration was greater rather than less than 10 years 
[13/23(57%) vs 2111(18%). p<0.05]. We conclude from this 
study of monozygotic twins that I) cardiac autonomic 
function is genetically determined; 2) autonomic 
dysfunction occurs in more than 50% of diabetics with a 
disease duration > 1 0 years and 3) autonomic dysfunction in 
diabetics is not causally related to the tightness of glycaemic 
control. 
803·5 
Transcatheter Closure of Atrial Septal Defects in 
Adults with Platypnea-Orthodeoxla Syndrome 
Michael 1 Landzberg. Nancy D Bridges. 10hn A Bittl. John F 
Keane. Paul N Casale. Chris E Faherty. James E Lock. Children's 
Hosp .• Boston MA 
Platypnea-ortbodeoxia (PO) syndrome (dyspnea and arterial 
desaturation in the upright position) caused br intracardiac 
shunting. is a rare clinical disorder with devastating motbidity. 
Most affected patients (pts) have severe comotbid disease and are 
at a high risk for corrective procedures. Between 9/87 and 9/91. 
transcatheter closure (TCC) of patent foramen ovale (PFO). with a 
Oamshell (C) double umbrella, was attempted in 4 adult pts. ages 
36-77. with PO syndrome. All patients had significant thoracic 
structura1 abnormalities-- 3 had partial or total pneumonectomy for 
therapy of carcinoma. and 1 had severe kyphoscoliosis. 
Hypoxemia in the upright position. due to R-L shunting via PFO. 
was incapacitating and required continuous 02 administration. in 
all. Each pt was felt to be at prohibitively high risk for surgical 
closure. At catheterization. PFO were sized (11-20 mm). and C 
devices (28 mm-I. 33 mm-I. 40 mm-2) were successfully 
deployed on the attial septum--with immediate rise in 02 saturation 
>95%--ln all pts. Device malpositioning (requiring immediate 
retrieval because of umbrella induced mitral regurgitation. with 
subsequent redeployment of a second device) occurred in I pt. 
There was no other procedural complication. No pt subsequently 
required 02 as therapy for shunting. and all achieved marked 
improvement in their subjective exercise capacity. Dyspnea. 
considered to be secondary to tumor burden. recurred in I pI, who 
expired soon thereafter. No embolic event or endocarditis has 
occurred in 2-24 months of follow-up. 
This experience suggests the safety and utility of TCe of PFO 
in the adult pt with PO syndrome. despite high surgical risk. 
Short-term follow-up of this therapy reveals a marked 
improvement in subsequent quality of life. 
3:00 
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803·6 3:15 
Effectiveness of Intravenous rt-PA in the Treatment of 
Massive Pulmonary Embolism and Right Atrial 
Thromboemboli. 
C.Cuccia. P. Franzoni, M. Volterrani, S. Scalvini, G. 
Musmeci, M. Volpini, M. Campana, P. Faggiano. Fondazio•
ne Clinica del Lavoro, Medical Centre of Gussago, 
Cattedra di Cardiologia, University of Brescia and S. 
Orsola Hospital, Brescia ITALY. 
In 6 consecutive patients admitted for massive pulmona•
ry embolism 2-dimensional echocardiography showed large 
right atrial migrant thromboemboli in transit, floating 
and prolapsing into the right ventricle in diastole. 
This pattern was always associated with the echocardio•
graphic signs of pulmonary hypertension. All the 
patients were treated with intravenous infusion of 100 
mg of rt-PA in 3 hours in the first 4 patients and in 2 
hours in the last 2 patients. rt-PA determined the 
dissolution and disappearance of the right atrial 
thromboemboli (it took 3 hours in 1 patient, 4 hours in 
3 patients and 5 hours in the remaining 2), and the 
concomi tant disappearance of the echocardiographic 
signs of pulmonary hypertension; at a 24 hours later 
scan, all the patients showed a marked improvement in 
pulmonary perfusion. During and after the rt-PA therapy 
there was no evidence of further pulmonary embolism. 
The fibrinolytic treatment for right atrial 
thromboemboli during multiple pulmonary embolism is a 
promiSing alternative to right atrial thrombectomy: our 
results indicate that rt-PA acts rapidly and is 
effective and safe. 
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Hibernating Myocardium: Mechanism ror a Self·Regulating 
Protective Process 
J. Yasha Kresh, Matthew J. McVey, H. Frederick Frasch, 
Stephen Kaminski. Hahnemann University, Philadelphia, PA 
We tested the hypothesis that the mechanical and metabolic conditions 
associated with "hibel7lllting myocardiwn" are the result of a self•
regulating protective process. Coronary blood flow (CBF), regional 
intramyocardial tissue systolic-pressure (IMP 1)'.)' its derivative (dMP) 
and myocardial oxygen consumption (MVO~ were analyzed as 
functions of a 100min, 20-mmHg s\ep:-(1rop from 90 to 30 mmHg 
(with recovery to control between steps) in coronary perfusion 
pressure (CPP), in isolated, Krebs-Henseleit-F1uosol perfused, rabbit 
hearts (n =7). Results are presented in the Table as % of control 
(mean ± SD). CPP is in mmHg; control variables taken at CPP=90. 
err CBrm.... IMP... dMPmu MYQ, 
70.0 79.0 ± 6.7 88.7 ± 6.4 83.1 ± 8.0 87.8 ± 9.8 •• 
50.0 54.7 ± 7.6 69.7 ± 6.6 61.8 ± 5.9 71.8 ± 10.2 
30.0 35.7 + 14.1 49.0 ± 8.8 39.1 ± 6.0 50.6 ± J3 9 
•• p<0.05 VS. control. All othen; p<O.OOI VI. control. 
Linear regression analysis showed MVOl to be highly correlated with 
CPP (slope= +0.85, r=0.992) and IMP (slope= +0.95, r=0.998). 
Metabolic requirements diminished proportionally with reduced 
perfusion, confirmed by an insignificant net lactate production « 35 
I'moUmin per gm. dry wt. at all CPP levels); with full recovery of 
function (to control level) between successive CPP steps. 
Importantly, the hibel7lllting myocardiwn is characterized by a 
matching decrease in 0 1 delivery with a proportional reduction in rate 
of 0 1 consumption. In this model of "hibernating myocardiwn", the 
confirmation of balance in energy demand and supply provides the 
basis for the hypothesis of a "self-regUlating' protective process. 
290A ABSTRACfS 
804·2 2:15 
Maximal Coronary Vasodilation Normalizes Systolic 
Function in Postischemic Stunned Myocardium. 
Paolo Marzullo.*Robert M. Weiss. A. L·Abbate. CNR Institute 
Clinical Physiology. Pisa. Italy and *University of Iowa. Iowa City. 
Reversibility of depressed wall motion by maximal augmentation of 
coronary blood flow (CBF) has not been previously investigated in 
postischemic stunned myocardium. 
Nine open-chest. anesthetized dogs underwent complete coronary 
occlusion for 15 minutes followed by 30 minutes of reperfusion. After 
recovery period. 0.84 mg/kg of dipyridamole were infused 
intravenously for 10 minutes to induce maximal coronary vasodilation. 
CBF was assessed by microsphere technique and sectional 
tomographic systolic thickening (ST) by ultrafast computed 
tomography. Preload did not change during the study (baseline and 
dipyridamole end-diastolic volumes: 57±12 and 55±7 cc. p=NS. 
respectively) and afterload was mantained constant by a mechanical 
aortic snare (baseline and dipyridamole mean aortic pressures: 86 and 
85 mm/hg. p=NS. respectively). 
In the control area. ST increased during occlusion by 12% and was 
unchanged during reperfusion and following dipyridamole. CBF in 
this area was unchanged in all conditions and increased to 505 
ml/min/lOOg following dipyridamole (p<.05). 
In the occlusion area. ST decreased from 48±4% to 20±4% following 
reperfusion (p<.05). Baseline CBF (I07±4 ml/min/IOOg) was 
unchanged during reflow (112±8 ml/min/IOOg. p=NS) and increased 
to 458±36 ml/min/lOOg following dipyridamole inducing a 
normalization of ST in the stunned area (49±7%. p= NS versus 
baseline value). 
In conclusion: 
A) Stunned myocardium shows a normal coronary reserve. 
B) The dipyridamole induced increase in flow is the mediator of the 
normalization of depressed ST in stunned myocardium. 
C) Beyond catecholamine infusion. dipyridamole can be considered as 
an alternative "inotropic" challenge in the identification of viable 
myocardium. 
804·3 2:30 
Inhibition of Excitation·Contraction Coupling Enhances 
Recovery of Contractile Function of Postischemic, 
Reperfused Myocardium. 
Patrick D. O·Brien. Zeljko J. Bosnjak. David C. Warltier. Medical 
College of Wisconsin, Milwaukee. WI 
Inhibition of mechanical activity during ischemia may improve 
recovery of stunned myocardium and could be useful as an adjunct to 
cardioplegia. The effects of2.3-butanedione-2-monoxime (BDM). an 
agent that disrupts excitation-contraction coupling. on the time course 
of recovery of myocardial segment shol1ening (%SS) and regional 
stroke work area (RSWA) of postischemic. reperfused myocardium 
was studied in 20 open-chest, anesthetized dogs subjected to 15 min 
of coronary occlusion (OCC) followed by 180 min of reperfusion 
(REP). Each dog received an intracoronary injection (6ml) of either 
0.9% NaCI (control experiments. C) or 100 mM BDM immediately 
after OCC. Hemodynamics were similar in both groups. %SS 
(expressed as % of pre-OCC value. PO) and RSWA (mm x mmHg) 
were significantly (p<O.05 vs PO) reduced throughout REP in C 
experiments. %SS and RSWA during REP were increased in BDM 
experiments compared to C (*p<D.05 vs C). 
'!!SS PO 
C (n=IO) 100 
BPM (n=lffi 100 
RSWA PO 
C (n=IO) 199124 
BPM (n=lffi 182±19 
REP<30 min 60 min 
16±9 21±9 
57±1I* 72±1I" 
REP(3Q min 60 min 
3O±20 5S±23 
1!2±25" 142±21" 
120 mjn 
30±9 
74+11" 
120 min 
SS±IS 
I 32±23" 
ISO min) 
36±9 
83+10* 
ISOmin) 
72±17 
J39±23" 
Conclusion: Inhibition of excitation-contraction coupling by 
intracoronary administration of BDM during coronary artery occlusion 
markedly enhances the recovery of contractile function of 
postischemic. reperfused myocardium. 
JACC Vol. 19, No.3 
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RegUlation of Left Ventricular Relaxation by Free 
Cytosolic Calcium in Whole Hearts 
S. Alben Camacho. Vincent M. Figueredo. Rolf Brandes. Michael 
W. Weiner. University of California. San Francisco. CA 
The generally accepted hypothesis that left ventricular pressure 
(L VP) relaxation is regUlated by the rate of free cytosolic calcium 
([Ca2+]i) decline has not been previously tested. Therefore. we 
determined the exponential time constants of L VP relaxation 
(LVPR-t) and diastolic [Ca2+]i decline ([Ca2+]i-t) in isovolumic 
perfused rat hearts during baseline and low flow ischemia. L VP 
was measured using a solid state transducer and the [Ca2+]i transient 
was monitored using the indo-l fluorescence ratio method during 
reductions of coronary flow to 20% of baseline (BL). Furthermore. 
it has been suggested that sarcoplasmic reticulum uptake of calcium 
primarily determines diastolic [Ca2+]i decline and is regulated by 
free energy change of A TP hydrolysis (.6.G) or intracellular pHi. 
Therefore. we determined these parameters using 31p NMR 
spectroscopy in a parallel series of experiments. 
;:-::----=:: 
Coronary Flow (% of BL) ~ ~ 
Developed Pressure (mm Hg) 81± 10 18 ± 3 
LVPR-t (ms) 31 ± 7 82 ± 38 
[Ca2+]i-t (ms) 68 ± 3 153 ± 43 
.6.G of ATP (kJ/mol) -61±.3 -52 ±.4 
pHi 7.03±.03 6.91±.02 
RESULTS: LVPR-t and [Ca2+]i-t both increased -2.5 fold 
during low flow ischemia. .6.G of ATP decreased significantly 
during low flow ischemia; pHi decrease was small but statistically 
significant. 
CONCLUSIONS: These data are consistent with the hypothesis 
that L VP relaxation is regulated by the rate of diastolic [Ca2+] i 
decline in whole hearts. Funhermore. prolongation of dilistolic 
[Ca2+]i decline during ischemia may be due to a reduction of .6.G of 
ATP that impairs sarcoplasmic reticulum uptake of [Ca2+]i. 
804·5 3:00 
Blood Flow and Metabolism in Non·lschemic Myocardium 
During Coronary Artery Occlusion and Reperfusion 
Denis B. Buxton. Freny Vaghaiwalla Mody. Janine Krivokapich. 
Heinrich R. Schelbert. 
UCLA School of Medicine. Los Angt<les. California. 
To characterize the effects of coronary artery occlusion on non•
ischemic myocardium. myocardial blood flow (MBF) and metabolism 
were studied serially with PET in 16 closed chest dogs at baseline. 
during a 3 hr intracoronary balloon occlusion of the LAD. and 
following reperfusion. Tissue with normal blood flow during 
occlusion was also subdivided into sectors adjacent to (AD) and remote 
from (RM) the risk zone. To normalize for changes in cardiac work 
between studies. MV02• measured with [J-11C]acetate. was divided 
by the rate pressure product (RPP). During occlusion and 1-2 hrs post•
reperfusion. MVO:z/RPP in non-ischemic sectors increased 22±26% 
(meaniSD) and 21±20% respectively (p<O.OI) relative to baseline. 
Follow-up studies in 10 dogs I day. I week and 1 month post•
reperfusion showed no difference in MVOz/RPP in non-ischemic 
sectors overall relative to baseline. Occlusion MBF was similar in AD 
and RM (J.26±O.35 and 1.31±0.37 ml/min/g respectively. n.s.). 
MV02 was also similar in AD and RM during occlusion and 1-2 hrs 
post·reperfusion. but decreased in AD relative to RM by 16±15% 
(p<O.OOI) I day and 3±4% (p<0.05) I week post-reperfusion. 
Glucose metabolic rates. measured with 18F-deoxyglucose. were 
similar in AD and RM 3 hrs post-reperfusion. but increased 67±78% 
(p<0.02) in AD relative to RM I day post-reperfusion. Transmural 
MBF. measured with 13NH3 or microspheres. was similar in AD and 
RM at all times. but the subendo/subepicardial flow ratio tended to be 
lower in AD relative to RM (1.2±O.3 vs J.4±0.3; p=0.06) during 
occlusion. Thus non-ischemic tissue shows a compensatory increase in 
MV~ during occlusion and early reperfusion. Myocardium adjacent to 
the risk zone during occlusion reveals metabolic changes resembling 
those in reversibly injured post-ischemic tissue. decreased oxygen 
consumption and increased glucose utilization. despite normal 
occlusion and reperfusion MBF. 
JACC Vol. 19, No.3 
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Temperature and Coronary Flow Eft'ects on Metabolic 
Regulation ofBeart Function 
Haywood Blum, Tamas Ivanics, Danning Zhang and Mary 
Osbakken, University of Pennsylvania, Philadelphia, PA 
19104 
3:15 
A number of cardiac metabolic intermediates; namely, 
ATP, pH, PCr, Pi, ADP; and related functions of these inter•
mediates, the free energy of ATP hydrolysis (t.G), and phos•
phorylation ratio (ATP/(ADP·Pi», are thought to adjust mito•
chondrial oxidative phosphorylation rates to conform to me•
chanical demand. The effects of hypothermia and low perfu•
sion pressure (PP) on these parameters were evaluated in six 
hearts from Sprague-Dawley rats perfused in the LangendorfT 
mode. 31p NMR spectra were obtained at cardiac tempera•
tures (T) between 20 and 37°C, and coronary PP between 20 and 
100 cm H20. Coronary flow (CF) varied between 0.5 and 11 
mllmin throughout this range of intervention. Heart rate 
(HR), left ventricular systolic pressure (LVSP), and CF were 
determined for each T and PP. 
The product HRxLVSP directly correlated with CF and T. 
Furthermore, CF and coronary PP were linearly related with 
constant slope for temperatures above 25°C. Of all the NMR 
and analytic biochemical parameters which were measured, 
only t.G and ATP remained constant when T was decreased at 
constant PP. Other intermediates and parameters changed as 
the T was lowered. Since metabolic supply (oxygen and 
substrate) remained constant at constant PP, and demand 
decreased with decreasing T, this result suggests that t.G 
and/or ATP may be regulated quantities and any of the other 
intermediates could function as regulators. In the constant T 
experiment, reducing PP maintained ATP but the other 
intermediates varied. CF and HRxLVSP fell linearly with 
decreasing PP. Quantitative evaluation of the relationship 
between cardiac function and metabolic intermediates defined 
some of these intermediates as nonregulatory. 
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Serial Angiographic Observations After Successful Directional 
Coronary Atherectomy 
Alfonso Medina, Enrique Hernandez, Manuel Pan, Francisco 
MeHan, Djordje Pavlovic, lose R Ortega, Miguel Romero, Dolores 
Mesa, Juan Morales, Amador L Granados, Jose SuMez de Lew. 
Pino Hospital, University of Las Palmas and Reina Sofia Hospital, 
University of Cordoba, Spain. 
Late results after directional coronary atherectomy (DCA) have 
shown a similar restenosis rate to that observed after balloon 
angioplasty (PTCA). However, the timing of restenosis following 
DCA is not well known. In the present study we analyzed early 
(after DCA, 24 hours and 1 month) and late (6 ± 1.5 months) 
quantitative angiographic observations in 62 patients (pts) who were 
treated successfully by DCA, without adjunctive PTCA (80% de 
novo lesions and 20% restenosis). 
At 24 hours study, 1 pt developed a small aneurysm at the 
site of treatment and 2 had a silent total occlusion with distal 
collateral flow. In the remaining 59 pts we did not observe any 
degree of elastic recoil and their minimal lumen diameter (MLD) 
was almost identical (2.7 ± 0.8 mm vs 2.7 ± 0.6 mm) to that 
observed immediately after DCA. 
At 1 month anal~sis, only 2 pts (3.3 %) had restenosis (loss of 
50% or more of the mitial gain). In the remaining 57, a smooth 
appearance of the treated segment was observed, with no significant 
changes in MLD (2.5 ± 0.9 mm). 
At 6 months, 19/36 pts (53 %) showed restenosis. In 15 of 
them (79 %) the angiographic appearance of the restenosed lesion 
differed from that observed before treatment. In the remaining 20 pts 
a slight renarrowin~ was observed (MLD 1.9 ± 0.7 mm) 
(p<O.OOl). The panent with early aneurysm persisted with no 
further expansion of the wall, but developed restenosis proximally. 
We conclude that early elastic recoil is not a component of the 
restenosis mechanism following DCA. However, after one month, 
renarrowing or restenotic processes develops frequently, suggesting 
in them late proliferative mechanisms. 
ABSTRACTS 
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Low Molecular Weight Heparin Reduces Intimal 
Proliferation After Coronary Stenting. 
Christina Unterberg, Arnd B Buchwald, Klaus 
Nebendah1, Volker Wiegand 
University Clinic, Gottingen, FRG 
We implanted balloon-expandable tan tal stents 
in coronaries of hypercholesterolemic mini•
pigs. Animals were given orally 100 mg 
acety1sa1i-cy1ic acid (ASA) per day orally 
(n=6, group A), or both ASA and subcutaneous•
ly 200 U anti-Xa/kg low molecular weight 
heparin per day (n = 6, group B). Angiography 
after 4 weeks showed all stents patent. 
Significant stenosis (>50%) was found in 2 
stents in group A and none in group B. 
Morphometric analysis of sections through the 
stent (n=5/stent) after perfusion fixation 
(100 rnrnHg) showed a reduction of free luminal 
area compared to the stent-free proximal seg•
ment to 41i6% (mean i SD) in group A. In 
Group B, reduction was 22i4% (p<O.Ol). 
Maximal neointimal diameter between stent 
strut and lumen was 0.93±0.11 mm in group A 
vs 0.44±0.14 rnrn in group B (p<O.Oll. The area 
covered by the vessel wall (VWA) in normal 
segments averaged 18±4% of the total vessel 
area. In group A, VWA increased to 87± 9% -
due to intimal smooth muscle cell prolifera•
tion, associated with a 54±11% increase in 
total vessel area. In group B, VWA increased 
only up to 48±12% (p>O.Ol vs group A), 
associated with a total vessel area increase 
of 22+8%. We conclude, that LMWH reduces 
intimil proliferation after coronary stent 
implantation in minipigs. 
952·4 
Reslenosis at the Slent Articulation: Is This a Design Flaw? 
Ian M. Penn, Luke Ga1Iigan, Robert I.G. Brown, Nancy Murray-Parsons, 
Jerome B. Foley, Joanne White. Victoria Hospital, London, Ontario, Canada 
Coronary artery stents (CAS) have been proposed as a method of preventing 
acute closure and reducing restenosis by mechanica1ly buttressing the artery 
post PTCA. The PaImaz-SchalZ stent (PSS) is a 15 mm stcnt with two 7 mm 
mesh box cars COMected by an articulation 1 mm in diamcter that is free of 
metal. 
From a nonrandomized pilot study, the first SO consecutive paticnts under•
went 6 month FlU angiography. There was no difference in baseline 
demographics, procedural details or 4 week treadmill data between the 
patients developing angiographic restenosis (n - 10) (> SO% diameter 
stenosis) and those with no restenosis (n - 40). Quantitative arteriography 
was performed using digital electronic calipers. 
ANGIOGRAPHY Pre Post 6 Month 
Artery Diameter (mm) p Value (post vs. 6 month) 
minimum .32 2.7 1.9 < .01 
reference 3.1 3.1 3.0 NS 
Stent Body 3.1 2.4 < .01 
Stent articulation 2.7 2.0 < .01 
% Stenosis Max. 75% 11% 34% < .01 
Stent Body -.6% 17% < .01 
Articulation 10.4% 31% < .01 
The overaII restenosis rate was 20%. The restenosis rate was simiIar in 
patients with prior PTCA (23%) vs. de novo lesions (19%). There was a 
trend to reduced restenosis in larger vessels> 3 mm (16%) vs. sma1Ier vessels 
< 3 mm (27%). In all patients immediately post PTCA the articulation was 
the site of maximum stenosis with a 'napkin ring' indentation. The articula•
tion was the site of maximum restenosis in 9/10; in the total population it was 
also the site of minimum lumen diameter at 6 months. 
CONCLUSION: CAS does improve on published restenosis rates for both 
de novo and restenosis lesions especia11y with larger target vessel size. The 1 
mm articulation gap prevcnts complete endoluminaI coverage of the injured 
area aIlowing prolapse of the vessel contents providing a potentia1 focus for 
restenosis. 
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Late Follow·up of Patients with Totally Occluded 
Saphenous Vein Bypass Grafts Treated by Prolonged 
Selective Urokinase Infusion 
Daniel J. Levine. Barry L. Sharaf and David O. Williams. Rhode Island 
Hospital and Brown University. Providence. RI 
Totally occluded saphenous vein bypass grafts (TOVG) are a 
common but challenging clinical problem. Combined mechanical and 
thrombolytic modalities have been employed successfully to restore 
graft patency. Little or no data are available. however. regarding long 
term follow-up in successfully treated TOVG. Accordingly. we 
obtained clinical and angiographic follow-up in a consecutive series of 
patients (pts) treated with a prolonged selective urokinase (UK) infusion 
with or without an adjunctive mechanical procedure. 
Ten pts received 2.7 ± 0.5 million units of UK (mean ± SD) infused 
intragraft over 24 ± 4 hrs. Each pt had rest or disabling angina pre•
procedure. Clinical follow-up was obtained in each pt (100%) at an 
average of 13 ± 6 months. Cardiac death occurred in two of ten (20%). 
One of 10 (l 0%) had a late myocardial infarction in the vein graft 
territory at 14 months. Two of 10 (20%) underwent "re-do" CABG. 
Eight of 8 survivors are NYHA Class I or D on medical therapy. 
Late angiographic follow-up in 5 of 8 (63%) pts who achieved initial 
patency. at an average of 6 months (range 3.5 - 9). revealed 4 of 5 
(80%) with total graft occlusion (TIMI 0 flow) and 1 of 5 with > 50% 
stenosis. In the 3 of 8 pts (37%) without angiographic follow-up. 2 had 
embolic myocardial infarctions in the vein graft territory during UK 
infusion and 1 died a cardiac death. There were no pts who were free of 
either reocclusion or a clinical end point of myocardial infarction or 
death. 
We conclude that although early patency of TOVG can be achieved 
with prolonged selective UK infusion with or without adjunctive PTCA. 
the overall value of this treatment strategy is limited. 
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Clinical Experience Using a New Three·Dimensional 
Intravascular Ultrasound System Before and After 
Transcatheter Coronary Therapies 
Gary S. Mintz. Martin B. Leon. Lowell F. Satler. Kenneth M. Kent, 
Jeffrey J. Popma. Sharon L. Eldredge. Augusto D. Pichardo 
Washington Hospital Center. Washington. DC. 
Technical limitations have inhibited more widespread use of 
intravascular ultrasound (IVUS) during interventional coronary 
procedures. Therefore. we configured a new system consisting of 
(1) a 25 MHz imaging catheter rotating at 1800 rpm attached to (2) a 
motorized handle that withdraws the imaging catheter within a low 
profile (3.9F) rapid-exchange monorail sheath at 0.5 mm/sec and 
interfaced with (3) an image processing computer capable of stacking 
>200 images for near real-time 3-dimensional (D) reconstruction of 
an arterial segment up to IOcm long. 27 pts were studied during 
conventional and investigational angioplasty procedures. The 
imaging catheter crossed all (even tortuous and distal) lesions 
successfully; pre-intervention imaging was performed when 
appropriate. Qualitative and quantitative 3D image analysis included 
1) vessel. plaque. and lumen volumes; 2) intimal surface 
architecture; and 3) plaque composition and distribution. For 
example. after intevention. intimal architecture exhibited 3 distinct 
surface patterns. Directional atherectomy (7 pts) in non-calcified and 
rotational atherectomy (4 pts) in calcified lesions produced a smooth 
surface with decreased plaque volume and minimal tissue disruption. 
PTCA (4 pts) and excimer laser angioplasty (6 pts) caused frequent 
superficial and deep dissections; the 3D course and penetration depth 
of dissection planes were imaged graphically. Stents (6 pts) were 
imbedded into atherosclerotic plaque producing a "quilted" intimal 
surface with precise defined stent geometry. expansion patterns. 
stent-vessel wall contact, and relationships to branch vessels. In 
conclusion: This user-friendly and practical 3D IVUS system can 
be applied routinely in pts during coronary interventions. It provides 
useful information which may help select or alter specific 
transcatheter treatment strategies. 
952·8 
Percutaneous Angloscopy Versus Angiography for 
Detecting Lesion Morphology In Saphenous Vein Coronary 
Bypass Grafts 
Christopher J. White, Stephen R. Ramee, Tyrone J. Collins, Juan E. 
Mesa, Ashit Jain, Joseph P. Murgo, Ochsner Medical Institutions, 
New Orleans, LA 
We performed percutaneous coronary angioscopy in 
conjunction with balloon angioplasty of saphenous vein bypass grafts 
In 21 patients. The age of the vein grafts was 10.a 2.4 (mean ± sd) 
years (range 5 to 15 years). One of the patients had stable angina, 
and 20 had unstable angina (new onset angina, rest pain, accellerated 
angina, or post-Infarction angina). Angioscopy and angiography were 
perfonmed before and after angioplasty. Findings of intravascular 
thrombi, dissection and graft friability at angiography and angioscopy 
were compared. 
(n.21) 
Angioscopy 
Angiography 
Thrombus 
15 (71%)" 
4 (19%) 
Dissection 
14 (66%)" 
2 (10%) 
Friability 
11 (52%)" 
5 (21%) 
": p < 0.01 
Bailoon angioplasty was successful in each case. One patient 
experienced distal embolization that resolved with thrombolytic 
therapy. The presence of graft friability did not correlate with graft 
age. The superior sensitivity of angioscopy for detecting lesion 
morphology In these bypass grafts when compared to angiography is 
consistent with findings In native coronary arteries when angioscopy 
is compared to angiography. 
We conclude that angioscopy Is more sensitive for surface 
morphology features in saphenous vein coronary bypass grafts than 
is angiography. Thrombi, vascular dissection, and graft friability 
are significantly more common in this predominantly unstable angina 
population of patients undergoing balloon angioplasty of older 
saphenous vein grafts than would be expected based upon angiographic 
findings alone. 
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Combined Intravascular Ultrasound and 
Intravascular Doppler Wire Provide 
Complementary Anatomic and Physiologic Imaging 
During Percutaneous a.vascularization 
Jenifer Kaufman, Kenneth Rosenfield, Ann Pieczek, 
Jeffrey Isner. Tufts University School of Medicine, St. 
Elizabeth's Hospital, Boston, MA 
Previous work has demonstrated that intravascular 
ultrasound (IVUS) provides hiqh-resolution cross•
sectional area images of anatomic alterations resulting 
from perc\~taneous revascularization. To acquire 
complementary physioloqic data, we studied 11 patients 
with PVD usinq an .018" Doppler (12MHz) quidewire to 
advance a 6.2F. (20MHz) IVUS catheter. The 11 patients 
were treated with balloon anqioplasty (8), directional 
atherectomy (5) or excimer laser anqioplasty (5) alone 
or in combination for disease involving the superficial 
femoral/popliteal (9), external iliac (1) and tibio•
peroneal (1) arteries. In each case the 6. 2F. IVUS 
catheter tracked easily over the .018" Doppler 
quidewire. Resolution of each imaqe was compromised by 
interference of siqnals when the two modes were used 
simultaneously; this was eliminated by using each 
system serially and independently. Fiq. 1 illustrates 
the change in diastolic and systolic blood velocities 
compared with the change in arterial area: cross•
sectional area measured by IVUS tracked with the 
systolic component of velocity, while the diastolic 
component was relatively unaffected. These findings 
indicate that it is feasible to obtain simultaneous 
i:~--:::" . ~-.. -----•
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952·10 
anatomic and physiologic data by 
combined use of IVUS and Doppler 
guidewire. Specifications of the 
Doppler quidewire and IVUS 
catheter at this time, however, 
require independent serial 
recording to achieve optimal 
resolution. 
INOUE'S BALLOON IN CASES OF BIFOIL BALLOON 
INSTABILITY DURING PERCUTANEOUS MITRAL 
VALVOTOMY. 
ROCHA Paulo MD, BERLAND Jacques MD. RlGAUD Michel MD. 
STRUMZA Pierre MD. LEFEBVRE Jean Marie MD, LETAC Brice 
MD FACe from Paris and from Rouen Universities. 
In our group. the last 121 percutaneous mitral balloon 
valvotomies (PMB V) were carried out with a less time-consumming 
and a lower cost·bifoil pigtail-catheter-balloon (Twin-at, Mansfield). In 
61121 cases. Twin balloons were unstable. balloons sliding back to the 
left atrium during inflation. Bifoil stability was not improved by stiffer 
guide wires ; particularly in patients with a short left ventricle and with 
a rigid funnel·shapped mitral valve. Mitral valve areas obtained with 
Twin balloons for theses 6 patients were considered insufficient. Bifoil 
balloons were replaced by 30mm Inoue balloons. These last balloons 
were stable until full inflation in all cases. 
Mean data of the 6 patients 
CONTROL Cv.B BIFOIL Bvsl INOUE IvsC 
P.A. rrunHg 27 ± 15 NS 24 ± II NS 16 ±6 NS 
LA. nunHg 24 ± to NS 21 ± 8 < 0.05 10± 5 < 0.Q2 
M.G. mmIIg 16± 8 NS 12± 7 < 0.05 4±3 < om 
C.O. Vmin 4 ± I NS 4.5 ± 0.9 NS 4.8± 1.1 NS 
HMVA cm2 0.9 ± 0.3 NS 1.2±0.3 < 0.001 2.2 ± 0.2 <0.001 
EMVA cm2 0.9 ± 0.4 NS 1.BO.4 <0.001 2.4 ± 0.3 <0.001 
Abbreviations; BvsI ; p Birail versus Inoue ~ CvsB : p Control: versus Bifoil ; 
CO : cardiac output ; EMVA : ecbographic mitral valve area ; HMV A : 
hemodynamic mitral valve area (Gorlin) ; InC: p Inoue versus Control; MG : 
mean diaslolic mitral valve gradienl : LA : mean lefl alrial press"", : PA : mean 
pulmonary art<ry mo.ure. 
Data obtained with Inoue's balloon were similar to the data obtained 
for the other 115 patients when the bifoil balloons were stable. Mitral 
regurgitation increased in 2/6 patients - in I of them from I to 3 + in 
Seller'squolation (not needing surgical correction). Inoue's balloon 
seems to be a good solution for two cylindrical balloon instability 
during PMBV. Especially when the left ventricle is shorter than usual 
or when the mitral valve is rigid and funnel-shlipped. 
ABSTRACTS 
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Myocardial Protection with the ACS RX Perfusion Balloon 
Catheter. Ischaemic or Non-Ischaemic ? 
John Coghlan, William Flitter, Vincent Paul, Debbie 
Kennedy, Trevor Slater & Charles IIsley. 
Harefield Hospital & BruneI University, Middlesex, U.K. 
Eight patients (7 male, mean age 55) undergoing 
percutaneous transluminal coronary angioplasty to left 
anterior descending lesions for stable angina pectoris, 
were studied. Two balloon inflations were performed, 
293A 
one using a conventional balloon system (mean inflation 
time l52s) and one using the RX perfUSion system (mean 
inflation time 1765). Ischaemia was assessed by pain 
score (visual analague scale), cumulative ST shift on a 
12 lead ECG, arterio-coronary sinus lactate difference, 
free radical (FR) production (spin trapping electron spin 
resonance), left ventricular ejection fraction (LVEF) 
and end diastolic pressure (EDP). Both perfusion and 
conventional inflations were associated with significant 
ischaemia. While mechanical and electrical abnormalities 
were less during perfusion inflations, there was no 
difference between the systems in terms of biochemical 
abnormalities - see table (data: mean ± SEM). 
LVEF EDP ST Pain Lactate FR 
% mmHS mrn mrnol/l runol/l 
1 Baseline 74±2 10±1.8 0 0 .09±.3 3±2 
2 Perfusion 5l±3 l4±2.l 7±2.S 1.4±1 -.6±.6 !l±2 
3 Conventional 4l±3 l7±2.5 lOt3 3.2±1.3 -.6±.6 !l±2 
p value 1 vs 2 (.001 <.001 <.001 <.001 <.001 <.001 
P value 2 vs 3 < .001 < .05 <.05 <.001 NS NS 
Though partial myocardial protection has been documented 
with the RX perfUSion system, a significant ischaemic 
insult is still present. Caution is advised when using 
these systems for very prolonged inflations. 
952·12 
E.ergent Percutaneous Cardiopulaonary Bypaa. Support 
Following Cardiac Arre.t 
Fayaz A. Shawl, Michael J. Do.anski, Marc H. Wish. 
Washington Adventist Hospital, Takoaa Park, Maryland 
Percutaneous cardiopulaonary bypass support (PCPS) was 
placed in 30 patients in cardiac arreat (CA) 
unresponsive to advanced cardiac life support. PCPS 
was placed in the cath lab (241, CCU/ER (4), outpatient 
cath lab (2). CA occurred with failed PTCA (13), 
cardiogenic shock (8), LV rupture during aitral 
valvuloplasty (2), during aortic valvuloplasty (2), 
with throabosed stent (2) and during diagnostic 
angiography (3). PCPS was successfully begun early 
(10·25 ain; avg 14) after CA in 23 and late (30-85 ain; 
avg 56) in 7. Flow rates were 4.0-5.2 L/ain. with .ean 
blood pressure of 65·110 a. Hg on PCPS. Thirteen 
patients regained consciousness within 20 ainutes of 
PCPS institution. Patients in ventricular fibrillation 
were defibrillated. Two patients could be 
defibrillated only after LV venting with a 10 Fr 
pigtail catheter attached to the bypa.s circuit. 
Subsequent therapy: PTCA (7), cardiac surgery (16), 
none (7). 
Hospital survival: 
PCPS Time ~ No Therapy 
Early 12/18 (67%) 0/4 (0X) 
Late 115 (20X) 0/3 (0X) 
All 13 hospital survivors are alive at aean follow up 
of 13 .onths. Conclusion: PCPS can .tabilize patients 
in cardiac arreat. Survival is aaxiaized when PCPS is 
instituted early followed by definitive therapy. 
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In Vitro Model to Test the Thrornbogenicity of Coronary Stents. 
Christian Beythien. Christian W. Hamm. Wolfram Terres. Wolfram 
Kupper. University Hospital Eppendorf. Hamburg. Germany. 
Early thrombotic occlusion is a major complication limiting the 
application of stents in coronary arteries. We developed an in vitro 
model to test thrombogenicity of stent material and investigate 
different medical regimens to prevent thrombus formation. 
The experiments were conducted in a closed system of silicon 
tubing with circulating citrated platelet rich plasma (PRP). In healthy 
volunteers (n=7) after placement of stainless steel (n=4) or tantalum 
wire (n=7) stents into the tubing platelet aggregates occurred after 
13.S ± 3.0 min OW) and 13.0 ± 3.S min (SS). the system occluded 
after lS.0 ± 3.S min (TW) and 14.S ± 3.5 min (p < O.OS vs control 
without stent). Labeling of platelets with acridine red revealed on 
microscopic examination combined platelet fibrin thrombi occluding 
the lumen. Labeled platelet components predominantely covered the 
wire material. particularely at crossing points. whereas the spaces 
between the mashes were filled with fibrin and less platelet 
fragments. 
Experiments were also conducted with PRP of patients (N=7). 
receiving high dose heparin (HHEP) or low dose heparin (LHEP) in 
combination with aspirin 100 mg (ASA-l00) or 990 mg ASA plus 
dipyridamole (ASA-DP). In all experiments HHEP prevented 
platelet aggregate formation and stent occlusion independent of 
ASA-l00 or ASA-DP; perfusion> 60 min (p < O.OS vs no heparin). 
LHEP could not prevent occlusion. With ASA-l00 aggregate 
formation occurred after 16.0 ± 4.0 min and occlusion after 29.0 ± 
S.O min. with ASA-DP aggregate formation after 15.S ± 5.0 min and 
occlusion after 21.0 ± 4.0 min (n.s.) 
Conclusions: Platelets and platelet aggregation play an important 
role for in vitro stent clotting. Only HHEP prevented aggregation 
and clotting. LHEP was less effective and could not prevent clotting 
despite the addition of ASA-lOO or ASA-DP. 
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Clinical Results or Heart TransplutatloD Wltll Older Doaors. 
Giovanni Battista Luciani. Ugolino Livi. Giuseppe Faggian. Bartolomeo 
ChiominlO. Uberco BortoIoui. Alessandro Mazzucco. 
Department of Cardiovascular Surgery. University of Padova. Padova. Italy 
In order 10 delermine whether older donors can be accepled without adversely 
affecting the prognosis of hean transplantation (HTx). the results obtained in HTx 
with donors >40 yrs were analyzed. Between November 1985 and August 1991.28 
pts. 25 males and 3 females. received donors >40 (group 1); they were compared 
with 34 pts. 31 males and 3 females. matched for age and heart disease who had 
donors<40 yrs (group 2). Mean recipient age was S4±8 (range 30-64 yrs) vs S6±2 
(range SO-68 yrs) (p=ns). while indication 10 HTx was primitive cardiomyopathy in 
42% vs 50% ofpts and ischemic cardiomyopathy in SO% vs 41% ofpts (p=ns) in 
group I vs 2. respectively. Mean donor age differed. 46±4 (range 41-55 yrs) vs 23±7 
(range 8-38 yrs) (p<0.01). and so did cause of brain death in donors. cerebrovascular 
accident in 61% vs 18% and traurns in 32% vs 82% of donors (p<O.OI) in group I 
vs 2. respectively. No difference was noled in donor sex nor in ischemic time 
(13Q±49 vs 151±52 min. p=ns). Two pts (7%) in group I and 3 (9%) in group 2 
had heterotopic HTx; all others underwent orthotopic HTx. Early (30 days) mortality 
was comparable: 4 pts (14%) in group I died because of graft failure (3) and non•
diagnosed pre-operative aortic dissection (I) vs 5 pts (15%) (p=ns). because of right 
venuicular failure (2). poor preoperative conditions (2) and graft failure (I). Mean 
ICU assistance lasted 7.0±4.2 vs 6.9±S.l days (p=ns) in group 1 vs 2. Follow-up of 
survivors averaged 24±16 (range 3-63 mos) vs 22±15 (range 249 mos) (p=ns). Lale 
deaths were one because of chronic rejection 15 mos and one sudden death 2 mos 
aflef HTx. in groups 1 and 2 respectively. Actuarial survival was 82±7% vs 84±6% 
and 78±.8% vs 80±.8% (p=ns) at I and 4 yrs. in group 1 vs 2. respectively. 
Angiographic conuol was performed in 20 vs 22 pts at I yr and 2 vs 3 pts at 4 yrs. 
in group 1 vs 2. Left ventricular ejection fraction (L VEF) was comparable (p=ns) in 
the 2 groups. 62±8% vs 66±8% and 64±9% vs 62±10% at 1 and 4 yrs. Freedom 
from chronic rejection was 90± 7% and 88±6% (pons) at 4 yrs in group I and 2 
respectively. The L VEF at last echo follow-up was also similar (68;t5% vs 65;t9%. 
p=ns). with most of the pts in the two groups (96% vs 97%) in NYHA class J. 
Since comparison with pts matched for age and hean disease using donors<40 
showed equivalent early and lale pts survival. ICU stay. early and late graft 
performance. and incidence of chronic rejection. we conclude that older donors can 
be used for HTx. Ihus allowing for an expansion of the donor pool. 
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Donor/Recipient Weight Ratio Is Not Related to Post· 
Cardiac Transplant Exercise Tolerance or Oxygen 
Consumption 
Deborah Morley. Susan Brozena. Henry F. Fesniak.. Peter Brubaker, 
James Walter. Joann Smith, Andrew L. Smith. Jeffrey B. Alpern. 
Temple University Hospital. Philadelphia. PellllSylvania 
In order to determine if donor/recipient weight mismatch affects post•
cardiac transplant exercise tolerance. we exercised 2 I consecutive 
orthotopic heart transplant (TX) recipients. free of rejection. and 
compared donor/recipient weight ratio (DRWIj to exercise time and 
relative oxygen consumption All patients exercised using the Modified 
Naughton Protocol with on-line collection of expired gases to 
determine oxygen consumption. 
~(Reported values are mean ± SEM; ·p<.OS): 
Variable 
DonorlRecipjem Wej &hI Ratio 
60- 79 80- 99 >1 0 
N 5 9 7 
Exercise Time (mins) 13.0±1.3 14.6±1.S 14.0±I.3 
Relative V02(ml/kglmin) 16.S±2.I 19.7±.9 17.8±1.5 
JschcmicTime(mins) 12S.6±22.7172.2±17.I IS7.S±16.S 
Reperfusion Time(mins) 62.4±9.I 6S.2±6.8 S3.2±2.S 
Time post-TX(days) 9S.S±9.4 ISO.7±44 I 84.0±8I 
Graft preservation was not felt to be a factor in that ischemic and 
reperfusion times were not significantly different among the groups. 
Conclusjon' Our data show that DRWT is not related to post-cardiac 
transplant exercise time or oxygen consumption. even in those with a 
low ratio. i.e .• donor body weight 2040% less than recipient body 
weight. 
953·28 
High.r Incidence of Malignant N.oplasms in Chagas1c 
Patients Following Cardiac Transplantation. 
Maria de Lourdes Higuchi. Vera Aiello. Paulo Gutierrez. 
Edimar Bocchi. Adib Jatene. Fulvio Pileggi. 
Heart Institute of S.Paulo University - Sao Paulo Brazil 
Heart Transplantation (HT) in pts with Chagas' disease 
results in a more disturbed outcome than in non-chagasic 
(NCh) pts, including a high incidence of parasitism of 
the tissues. More frequent Malignant Neoplasms (MN) are 
reported in this study. The incidence of MN in the 67 
NCh pts after HT was 3%. In the 8 chagasic (Ch) pts. the 
incidence was 50%, conSisting of 3 lymphoproliferative 
disorders (LPD). affecting skin and/or bowell (after 4-
6m) and bilateral Kaposis's Sarcoma of the lung (after 3 
yr). all of which regressed with diminished immunother•
apy. We have demonstrated that chronic Ch pts are defi•
cient in helper T cells. Thus. the use of immunodepres•
sive therapy may favour abnormal proliferation of B 
cells. Counts of T cells in endomyocardial biopsies from 
one Ch pt submitted to HT showed that helper T cells 
were almost absent until the appearance of the LPD. and 
that their number increased with reduction in immunother 
apy. Trypanosoma cruzi. in acute experimental infection~ 
is known to induce immunodepression which also seems to 
occur in the chronic human disease. 
Ch pts exhibit earlier and more frequent MN after HT. 
and less intense immunotherapy is recomended. 
Qu~ification of the number of T cells in the myocardium 
would be useful to monitor this adjustment. thus avoiding 
extreme immunodepression. 
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953·29 
Demonstration of Proliferating Cell Nuclear Anti 
gen in Myocardial Biopsy Specimens after Cardiac 
Transplantation 
Jessica M Mann, Stephen H Jennison, Michael J 
Davies 
St George's Hospital Medical School, London, U.K. 
Proliferating cell nuclear antigen (PCNA) is the 
polymerase accesory protein required for nucle 
ar DNA synthesis. Specific monoclonal antibodies 
to PCNA can be used on histological sections to 
identify cells that are about to proliferate. 
PCNA containing cells were counted in the myocar 
dial biopsy specimens taken in the management of 
cardiac transplantation. Positive marking was ob 
served in up to 5% of myocyte nuclei, beginning 
with the first biopsy specimen taken at 2 weeks 
and continuing until a steady clinical state was 
reached. Positive nuclear marking was also seen 
in the interstitial connective tissue cells and 
in lymphoreticular cells during episodes of rejec 
tion. The number of positive cells correlates 
with the degree of rejection by conventional his 
tological criteria. Severe rejection with myocyto 
lysis was associated with positive counts up to 
200 nuclei/mm2 of tissue. Initiation of treatment 
caused a rapid decline in the number of positive 
cells and occurred before the interstitial cellu 
larity declined. Analysis of biopsy specimens 
preceding an episode of rejection did not show 
an increase of positive cells. 
The presence of PCNA positive cells is thus not 
a sensitive means of predicting subsequent rejec 
tion but can confirm that rejection has been 
controlled. 
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953·31 
Major Hlstocompatlb1l1ty Complex Regulated 
Differences In Cellular RejectIon MechanIsms 
In MurIne CardIac Allograft Models 
John F. Carlquist, Jane Shelby, Jay H. Greenwood, M. 
Elizabeth Hammond, Jeffrey L Anderson. 
LOS Hospital and university of Utah, Salt Lake City, Utah 
RejectIOn of allografts may proceed via different mech•
anisms governed by the degree of donor/recipient MHC 
disparity. We studied murine cardiac allograft rejection 
in 3 models of MHC disparity: class I plus class II (CI+II), 
class I only (Cil and class II only (CII). CI and CI+II models 
did not differ with respect to graft survival: 9.0±0.7 days 
(mean±SE) and 7.8±0.7 days respectively. CII mismatched 
grafts survived Significantly longer (14.1 ± 1.S days) than 
CI (p-0001) or CI + CII (p-O 02) mismatches respectively. 
Cultures of IL-2 expanded, graft infiltrating lymphocytes 
(Gill showed Phenotypic variations between models stud•
ied serially post-transplantation with CD8 dominating 
CI and CI+II models and a prolonged CD4 response for CII. 
'00 
Phenolype of GIL from Murine Cardiac 
Allograft Models,CI'1I (0). CI (.) and'CII (t.). 
eoe+ C04+ 
50 
.~~~~~~~~ 
, Ie: 15 C , Ie 15 
DIY (Post-Transplantation) Day (Post-Transplantalon) 
ThuS, graft survival, GIL phenotype and presumably 
rejection mechamsms are regu;ated at least in part by 
the nature of the donor-reCipient mismatch. 
953·32 
Bacterial Infection Alters Cellular Rejection and Graft 
Survival After Rat Heterotopic Cardiac Transplantation 
Junjiro Kobayashi, Constantine Mavroudis, Susan E. 
Crawford, Carl L. Backer, Vincent R. Zales. 
The Children's Memorial Hospital, Chicago, Illinois 
Infectious disease complications continue to impact on the 
long-term survival in patients after cardiac transplantation 
and immunosuppression (1M). The purpose of this study is 
to assess the effect of bacterial infection on the immune 
response to heterotopic cardiac transplantation (HCT) in 
the rat. 
Sixty-one Lewis rats had HCT from ACI rats without 1M. 
Group I IN = 21) was the control. Group II (N = 40) had 
concomitant cecal ligation to induce bacterial sepSis. 
Mortality (48 hrs) was low in Group I (2 of 21) and high in 
Group II (14 of 40). The remaining rats (Group I, N = 1 9 
and Group II, N = 26) were sacrificed at various times to 
determine differences in graft survival (by palpation), 
histologic grading of cellular rejection and necrosis. 
295A 
Graft survival was longer in Group II, 7.3±.5 days 
(N=7), over Group I, 6.4±.5 days (N=8), p<.05. Cellular 
rejection and myocyte necrosis scores were respectively 
less severe in Group II (2.5 ± .3, 1.5 ± .5) compared to 
Group I (3.0±0, 2.6±.8), p<.05, at 6 days. Bacterial 
cultures in 4 animals confirmed abscess formation caused 
by gut flora isolates. 
Concomitant bacterial infection in rats with HCT 
increases graft survival time and decreases the cellular 
rejection response when compared to rats without 
infection. This altered immune response supports the role 
for modified 1M management of transplant patients with 
bacterial sepsis. 
296A ABSTRACTS 
953·33 
Expression of Ventricular ANF and Assessment of ANF 
Activity Following Cardiac Transplantation. 
Sanjay S. Srivatsa, Margaret A. Lloyd, Sharon M. 
Sandberg, Lyle J. Olson, Margaret M. Redfield, Richard 
J. Rodeheffer, Brooks S. Edwards. Mayo Clinic, 
Rochester, Minnesota. 
In congestive hean failure [CHF], elevated plasma atrial natriuretic 
factor [pANFJ correlates well with atrial pressures. Following 
cardiac transplantation [CT), despite near normal cardiac 
hemodynamics, pANF is elevated. We hypothesized that the 
ventricle may be a source of ANF following CT. The objectives of 
the current study were to evaluate after CT (1) the presence of 
ventricular ANF [V-ANFJ (2) the relationship between pANF and 
cardiac hemodynamics and (3) the biological activity of ANF to 
stimulate its second messenger cyclic guanosine monophosphate 
[cGMPJ. In 6 CT recipients, all withdrawn from nitrates and 
diuretics, and 5 normal subjects [NORM), pANF, pcGMP, urinary 
cGMP excretion [UcGMP·V), nephrogenous cGMP generation 
[NcGMPgen) and fractional excretion of sodium [FeNa) were 
evaluated. The presence of V-ANF was evaluated by 
immunohistochemistry, utilizing tissue obtained by right ventricular 
biopsy. The second messenger pcGMP, was significantly elevated 
in CT recipients compared to normals (p=O.OO2). CT pANF did not 
correlate with right atrial pressure (R=O.13,p=Non-significant). 
Urinary cGMP excretion, and nephrogenous cGMP generation, were 
elevated in CTrecipients .... V-ANF was detected in all RV-biopsies 
obtained from CT recipients . 
ll.ANE ~ UcGMP V cr 63.3±22.7 5.1±O.8'" 655.1±114.7'" 
NQRM 1O.4±O.6 1.4±O.2 283.l± 77.5 
*p<O.OS cr vs NORM 
NcGMP&en && 
434.l±66.7'" 2.2±0.5 
173.3±89.l 1.2±O.5 
This study demonstrates that following CT 1) there is expression of 
ventricular-ANF in the transplanted heart 2) nonhemodynamic factors 
may stimulate ANF following CT and 3) circulating ANF retains its 
biologic activity to stimulate cyclic GMP and promote sodium 
excretion. 
953·34 
Plasma Endothelln Is Increased In PatIents Following 
Successful Cardiac Transplantation 
Garrie J. Haas, Margaret Wooding·Scott, Philip F. Binkley, P. 
David Myerowitz, Robert Kelly, Robert J. Cody. The Ohio State 
University, Columbus, OH 
Following cardiac transplantation, cyclosporine (CSA) treated 
patients have a high incidence of systemic hypertension, the 
mechanism of which is not known. Endothelin (8) is a potential 
mediator of post transplant hypertension in that it is a potent 
vasoconstrictor and may be activated by CSA·induced endothelial 
injury. We tested if ET could be detected by radioimmunoassay 
in the plasma of cardiac transplant patients and if levels 
correlated with hemodynamic characteristics, CSA level or serum 
creatinine. Twenty·two stable cardiac transplant patients were 
studied at the time of routine heart biopsy. Fifteen patients were 
on chronic therapy for hypertension consisting primarily of 
angiotensin-converting enzyme inhibitors, calcium channel 
blockers, and diuretics. Plasma ET was significantly elevated 
(10.42 :t 3.7 pg/ml; range 6 - 16.7) compared to 12 normals (3.7 
:t 0.6 pg/ml; range 2.8 - 4.7). Mean arterial pressure was mildly 
increased (110 :t 10 mmHg); pulmonary pressure and cardiac 
output was normal. ET did not correlate with any hemodynamic 
variable, CSA level, or serum creatinine. 
Thus, ET is increased following cardiac transplantation. In the 
absence of discrete correlations with hemodynamic variables or 
CSA level, both the characteristics and mechanisms for increased 
ET in cardiac transplant reCipients requires further evaluation. 
953·35 
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PROGRESSIVE MYOCARDIAL CALCIFICATION ASSOCIATED 
WIlli HYPOMAGNESEMIA AND MYOCARDIAL MAGNESIUM 
DEPLETION AFTER CARDIAC TRANSPLANTATION 
Teri Millane, Stephen H Jennison, Amanda J Wilson, Monaj K Patel, 
Ray F Moss, David W Holt, William J McKenna 
St George's Hospital Medical School, London, United Kingdom 
Myocardial calcification secondary to magnesium depletion in the 
normal hean is well documented in animal models. We have reponed a 
high incidence of hypomagnesemia associated with myocardial 
magnesium depletion in cardiac transplant recipients receiving 
cyclosporin A. We now report the first in vivo study of the calcium 
content of the transplanted human heart 
Serum and tissue levels of magnesium (Mg) and calcium (Ca) were 
measured in 30 patients at the time of each endocardial biopsy over the 
first year following cardiac transplantation. Myocardial Ca and Mg 
were measured from a single biopsy using a newly developed enzyme 
digestion technique. A further biopsy was collected for histological 
examination by electron microscopy. 
Persistent hypomagnesemia «0.7 mmolll for more than 4 weeks) 
developed in 70% of patients associated with severe myocardial Mg 
depletion «26 umol/g) in 15/30 patients (50%). Myocardial Ca 
content was significantly higher in these patients vs those with normal 
myocardial Mg content (mean (SE) 42.7 (3.7) v 35.4 (1.7) umol/g; 
p<O.03). The Ca/Mg ratio was similarly elevated (1.8 v 1.0; 
p<O.OOOI). In Mg-deplete patients, electron microscopy demonstrated 
mitochondrial deposits shown quantitatively to be composed of calcium 
and phosphate; abnormalities of mitochondrial morphology were also 
observed. 
Conclusions' Myocardial magnesium depletion in the denervated 
human hean results in a reciprocal increase in myocyte calcium content 
associated with progressive mitochondrial calcification. In animal 
models, such findings are associated with myocyte necrosis, 
accompanied by an accelerated vasculopathy similar to that seen in the 
transplanted human hean. 
953·36 
Noninvasive Detection of Heart Transplant Rejection 
using Frequency Analysis of Single-beat High 
Resolution ECG Recordings 
Michael Oef!, Christian Burchardi, Henning Warnecke", 
Tamara Cohnert", Roland Hetzer", Rolf Schroder, 
Cardiopulmon. Dept., Klinikum Steglitz, FU Berlin and 
German Heart Center Berlin', F.R. Germany 
Single-beat recording of the high resolution ECG was 
performed in 14 patients after orthotopic heart transplantation 
weekly immediately before biopsy up to 13 ± 3 weeks after 
transplantation. After spatial averaging of multiple synchro•
nously recorded leads the minimum noise level was 3 - 5 
I1V/"Hz. Each of the 80 - 120 consecutive ORS-complexes 
was analyzed using the Fast Fourier Transform Analysis 
(FFTA, 128 ms incl. 30 ms of the terminal ORS, Hanning-win•
dow), and the calculated power spectra were averaged, thus 
retaining the original single-beat frequency content, and the 
power spectrum integral (PSI, range 60 to 130 Hz) was 
calculated. 
Biopsy was graded in normal or minimal rejection and 
moderate or severe rejection requiring therapy. 
~ 46 % of the biopsies showed moderate rejection re•
quiring therapy. 81 % of these were accompanied by an in•
crease of the PSI from 1265 ± 279 to 1480 ± 253 (p=0.0002), 
and a decrease to initial values after successful treatment. In 
95 % of normal biopsy results, the PSI revealed constantly 
low values. Despite a large interindividual variation of the PSI, 
its intraindividual change revealed a positive predictive value 
for detection of rejection episodes of 94 %. 
Conclusions' FFTA of single-beat ECG recordings are 
suitable for non·invasive diagnosis of heart transplant 
rejection and for the control of therapeutic effects. 
JACC Vol. 19, No.3 
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953·37 
Flow PuIsatiIity aud wan DiItaJsibiIity Measured by Magnetic 
Reamumce Imaging in the Central PuImmuuy Arteries of Patients 
with Single Lung Transplantation. 
Raad Mohiaddin, Rami paz, Stergious Theodoropolous, Donald 
Longmore, Magdi Yacoub. The Royal Brompton National Heart & 
Lung Hospital, London UK 
A noninvasive method of monitoring pulmonary function following 
lung transplantation is required. We have used cine magnetic 
resonance imaging with velocity mapping to measure arterial wan 
distensibility and pulsatility of flow in the central pulmonary arteries 
of twelve patients fonowing single lung transplantation. Nine healthy 
volunteers were studied for comparison. Flow waveforms in the 
native main (MP A), right (RP A) and left (LPA) pulmonary arteries 
were studied 2cm on either side of the pulmonary bifurcation. 
Instantaneous flow was calculated from mean velocity and the cross 
sectional area of the vessel. Peak forward flow (Qr), Peak backward 
flow (Qb)' time-averaged flow (Qm) and the pulsatility index of the 
flow (Qr+Qb)/Qm were derived. Arterial distensibility was calculated 
from the change in cross sectional area between diastole and systole. 
Pulsatility index (mean:!:SD) ofMPA, RPA and LPAofcontrols was 
4.5:1:0.8, 5.1:1:0.6, 4.6:1:1.5 and wan distensibility was 27:1:8%, 
48:1:10%, 48:1:19% respectively. In patients with single lung 
transplantation MPA pUlsatility index 3.6:1:0.7 and wall distensibility 
23:1:11% were similar to those of controls. The arteries to native 
lungs had a higher pulsatility index 7.4:1:2.4 than those to transplanted 
lungs 2.8±0.8 (P< 0.(01). The distensibility of arteries to native 
35±16% and to transplanted lungs 28±26% were similar while both 
were significantly lower than RPA and LPA of controls (P< 0.05). 
The ratio of flow (Qm) between RP A and LP A of healthy volunteers 
was 1:1 while that between transplanted and native lungs was 3:1. 
These differences are most likely related to the relative resistance 
in the native and the transplanted lung and may be an additional 
index for monitoring patients with lung transplantation. 
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954·38 
Application of Color Doppler Flow Imaging to Calculate 
Effective Regurgitant Orifice Area: an Assessment of 
Valvular Incompetence Independent of Hemodynamics. 
Pieter M. Vandervoort, J. Miguel Rivera, David H. 
Thoreau, Donato Mele, Arthur E. Weyman, James D. Thomas. 
Massachusetts General Hospital, Boston, MA 
The effective area of a regurgitant orifice (ROA) is 
a fundamental measure of valvular incompetence. It is a 
superior parameter to follow in the serial assessment of 
valvular degeneration, since it reflects true changes in 
valve geometry independent of hemodynamic changes. 
Currently, however, calculating ROA is cumbersome and 
time-consuming. To make this parameter more available 
clinically, we evaluated the feasibility and accuracy of 
calculating ROA based on the analysis of the proximal 
flow convergence displayed by color Doppler flow mapping. 
Four circular orifices (O.1-l.0 cm2) were studied in vitro 
with steady flow rates ranging from 15 to 305 cm3/s. ROA 
was calculated as 211r2v/vo ' where r is the radius from 
the orifice to the isovelocity surface, v the 
corresponding aliasing velocity in the color display, and 
Vo the orifice velocity measured by continuous wave 
Doppler. The true ROA was obtained by Q/v , where Q is 
true flow, measured by timed collections. 0 
RESULTS: 43 combinations of orifice size, v and v were 
analysed. Calculated ROA (y) correlated clos~ly wit~ true 
ROA (x): y-l.024x·O.011 and r=0.99. The difference (AROA~ 
between calculated and true ROA was -O.3±1.9 mm 
(meantSD). 
CONCLUSIONS: 1) It is possible to calculate accurately 
ROA based on the analysis of the proximal flow field. 2) 
This method provides a noninvasive way to assess valvular 
incompetence, independent of hemodynamic changes, which 
is of particular interest for serial follow-up. 
ABSTRACTS 
954·39 
IIIKI7mi\MIC PI!m'CRII\JQ OF 'DIE ~ SCPRA 
ANI«JIAR lII:RrIC 1"RSlHIiSlS: A C
S'ltJD!C 1a SIX JDmIS ~ 1a RI!ST J\NI) EXm:!ISE 
Wybren Jaarsma, Maart:en 8uttoxp, Annette Brauns, Jose 
Gadellaa, Jo Ilefauw. Dept. of cardiology, st. Antonius 
Hospital, Nie.IWegein, 'lhe Netherlams. 
'Ib assess the heaxxiynamic perfotmanee of the carpentier•
Fdwards SUpra AnrAll.ar porcine valve in the aortic 
positioo we studied 46 pta with normal JJI functioo at 6 
m:nths postiJIplant. D:ppler-edlocaltliograJily was used 
for measurin;J peak velcx:ity (pV) ani mean gradient (I!G) 
fran the m:xiified Bel'1'n1lli equatioo, at rest ani 
directly postexercise. 'lhe effective orifice area (Em) 
was calal1ated usin;J the cxntinuity equation. 
~: 
~: 
(N) 
B=t: 
pV (DV's) 
I!G (1II!Hg) 
Exercise: 
pV (DV's) 
JIG (1II!Hg) 
Em (an2) 
92nclusion: 
19 
(2) 
21 
(7) 
23 
(14) 
25 
(16) 
27 
(7) 
3.3±O.5 2.5±O.2 2.3±O.4 2.3±O.4 2.l±O.3 
22±2 14±3 12±4 13±4 10±3 
3.9±O.1 3.O±O.4 2.8±O.5 2.6±O.4 2.7±O.4 
34±1 22±6 17±6 15±4 16±4 
1.3±O.1 1.6±O.4 1.9±O.4 2.3±O.5 2.7±O.3 
1. Peak velcx:ity ani mean gradient of the carpentier•
Fdwards SUpra Annular aortic valve bath at rest ani 
durin;J exercise, were highly inversed related with 
prosthetic size. 
2. '!he Em shc1Ned good relatioo with prosthetic size. 
3. o:.parin;J to the literature of porcine biqn:-ostheses 
the in vivo heaxxiynamic perfotmanee of the carpentier 
Fdwards SUpra Annular aortic valve apars to have 
significant advantages regaIdin;J transvalvuJ.ar 
gradient ani Em. 
954·40 
Calculation of Mitral Valve Area in Mitral Stenosis 
Using the Proximal lsovelocity Surface Area Hethod 
Koji Oku, Toshinori Utsunomiya, Hideki Mori, Mitsuaki 
Ishijima, Taira Kuriya, Yasuhiko Oku, Katsusuke Yano, 
Shiro Yamachika, Julius M. Gardin The Third Department 
of Internal Medicine, Nagasaki University, Nagasaki, 
Japan and University of California, Irvine, California 
In vitro models, the color Doppler (CD) proximal 
isovelocity surface area (PISA) method is accurate in 
estimating the volume flow rate (Q) across the narrowed 
orifice. Q is calculated as PISA times isovelocity. The 
PISA method is also accurate in estimating the area of 
narrowed orifices of various shapes in planar and non•
planar orifices. ~: We compared PISA method for 
estimating mitral valve orifice area (MVA) to Doppler 
mitral pressure half-time (PHT) method and to 2D echo 
planimetry method. Eighteen patients, ages 40 to 72 
years, with mitral stenosis (MS) were studied: 7 had 
mitral regurgitation and 5 had aortic regurgitation. In 
all patients, PISA could be recorded from apical 4-
chamber view using aliasing velocity (V)e14 cmlsec 
produced by CD zero-baseline shift technique. Volume 
f~ow rate (Q) across mitral orifice calculated by Q a 2~ 
r V(9/180), where r= aliasing radius (distance from 
orifice to blue-red aliasing interface) measured from CD 
M-Q display and 9= valvular orifice angle. MVA was cal•
culated as Q (by PISA) I peak jet velocity (by CW 
Doppler). ~: MVA calculated by the PISA method 
correlased well with both PHT method (r- 0.88, SEE = 
0.25 cm ) and 2D planimetry method (ra 0.89, SEE. 0.05 
cm ). ConclUSions: 1) Calculation of MVA using the PISA 
method was accurate in patients with MS. 2) The PISA 
method may be applicable for estimating the aortic valve 
area in aortic stenosis and the defect size in atrial or 
ventricular septal defect. 
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954-41 
Absolute Mitral DIastolic Doppler Indices Fall to Change With Acute 
A1tel'lltion of Loading Conditions Iu the Denervated Heart 
Todd D. Edwards, Douglas S. Schulmau, Oalal Ziady, Sriuivas Murali, Connie 
Matesic, Alfred Ceecheu~ Barry F. Uretsky. 
University of Pittsburgh, Pittsburgh, PA 
Non-invasive measurements of diastolic function are influenced by left 
ventricular relaxation, heart rate (HR), loading conditions, and autonomic tone. 
Left atrial pressure and the doppler E velocity have been shown to correlate 
significantly in man. Since HR and autonomic alterations affect Doppler 
indices of diastolic function, we studied the relationship between pulmonary 
artery wedge pressure (PAW) and Doppler indices of diastolic function in the 
human denervated heart in which changes in load do not influence HR or 
autonomic tone. Simultaneous right heart catheterization and Doppler studies 
were performed in seven recent heart transplant recipients. HR, PAW, systolic 
blood pressure (SBP), E velocity, A velocity, and the E/ A ratio were obtained 
at baseline and during load alteration with intravenous administration of 
nitroglycerin, volume, and methoxamine. (·p<.OS, ··p<.01 from baseline). 
HR PAW SBP E-Velocity A-Velocity E/A 
b/min mmHg mmHg cm/s cm/s 
Baseline 83..±.7 lS..±.6 140..±.13 .8O..±..19 .63..±..3 1.53..±..70 
Nitroglycerin 83..±.7 ·1t±.6 139..±.2S .76..±..18 .61..±..23 1.44..±. 6S 
Volume 8t±.7 18+7 14S..±.U .8S..±..26 .6S..±..24 1.48..±..6S 
Methoxamine 82..±.6 IS..±.6 ··173..±.14 • 7l!..±..2S .68..±..29 1.43..±..SS 
Despite significant differences in PAW and SBP, there was no significant 
change in HR, E velocity, A velocity, and E/ A. The load induced changes in E 
and A velocities correlated weakly with the change in PAW (r=0.39, p<O.09 
and r=0.33, p<O.lS respectively). There was no correlation between the 
changes in E/A and PAW (r=.().OI). Thus, unlike the iunervated heart, the 
changes in E velocity with load alterations in the denervated heart are only 
weakly associated with changes in PAW. These fmdiogs suggests that HR and 
autonomic alterations may be important determiuants of changes in E-velocity 
when load is altered in the iunervated heart. 
954-42 
Abnormal Pulmonary Artery Pressure Response and 
Other Hemodynamics In Adults with Congenital Heart 
Disease: An Exercise Doppler Study 
Jeffrey D. Kaplan. Elyse Foster. Rita F. Redberg. Nelson B. 
Schiller. University of California, San FranCisco. California 
Exercise (Ex) testing in adults with palliated and nonpalliared 
congenital heart disease (CHD) has demonstrated reduced Ex 
capacity. but the contributing factors have been partially explored. 
We hypothesized that abnormal exercise parameters such as 
pulmonary artery pressure (PAP) response would help explain the 
reduced Ex capacity. We performed symptom-limited supine 
bicycle exercise with continuous 2-D and contrast-enhanced 
Doppler echocardiography (ECHO) in 18 pts and compared them to 
14 age-matched controls. The CHD group included: Tetralogy of 
Fallot (TOF)(n-3). Ebsteln's anomaly ± atrial septal defect 
(n-3). atrial septal defect (n-3). ventricular septal defect (VSD) 
and/or great artery transposition (n=8) and pulmonic stenosis 
(n=I). Six pIS had shunting, 5 right to left and 1 left to right. 
Fourteen pts had had surgical palliation. Left ventricular (LV) and 
right ventricular (RV) contractile function. double product (DP). 
and oxygen saturation (Sat) were monitored in pts who all stopped 
due to fatigue. Resting and peak PAP were recorded in 14 pts. 
Results Imean+SQ) control CHQ p 
Peak DP 24955±6041 1939S±71SS .03 
Rest PAP(mmHg) 25.S±4.1 42.9±17.0 .001 
Peak PAP(mmHg) 4S.S±7.2 70.0±3S.4 .03 
peak workloadlwatts) 1494t51 6 690+380 0001 
Two pts (1TOF, 1VSD) had a fall in RV and LV function with Ex; 
both had severely decreased peak workloads. Sat decreased in only 
2 pIS but both achieved workloads above average for this group. 
Conclysions' Although most pIS had nl LV and RV function during 
exercise. the peak workload and DP were decreased compared to 
normals. Baseline and exercise PAP are elevated in these diverse 
CHD pts. unrelated to oxygen desaturation. Exercise 2-D and 
Doppler ECHO provides new hemodynamic information for 
evaluating functional limitations in adults with CHD . 
• This session is continued on page 39SA. 
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955-63 
Evaluation of Post-operative Flow of Internal 
Mammary Artery Coronary Graft by Two•
Dimensional and Color-Doppler Echocardiography. 
Antonio Pezzano, Giovanni Cali, Gabriella Cataldo. Angela 
Milazzo, Robeno Como, ManIio Cipriani, Antonio Mantero, 
Alessandro Dabala. 
Department of Cardiology. Niguarda Hospital Milan, Italy. 
Internal manunary anery (IMA) coronary anery grafts are widely 
used: non invasive methods for evaluation of their patency 
would be clinically useful. 
Aim of this study was to assess the accuracy of combined Two•
Dimensional and Color-Doppler Echocardiography (ECHO) 
evaluation of IMA graft flow . 
Eighteen patients (13 men, 5 women. aged 52.9 ± 8.1 yrs) who 
had an IMA graft placed on the left anterior descending coronary 
anery (LAD) (+ 27 saphenous vein grafts to other coronary 
vessels in 16 cases) underwent ECHO evaluation of IMA flow 
under basal conditions and after Dipyridamole (DIP) infusion 
(0.54 mg/kg i.v.). All pts underwent selective angiography 
(ANGlO) of native coronary vessels and grafts. 
ANGlO showed patency of all IMA grafts. One patient had a 
90% stenosis of the LAD, distally to the graft insertion. A 
typical biphasic flow pattern with predominant diastolic 
component was detected in 15/18 pts (86.6%) in the expected 
location ofIMA graft. Peak flow velocity (PFV) (40.1±18 cm/s 
in systole and 20.6±7 cm/s in diastole under basal conditions) 
increased significantly (p < 0.05) after DIP infusion in all piS but 
one by 52% in systole and 93% in diastole. No increase in PFV 
was observed after DIP in the pt. with 90% distal LAD stenosis. 
ECHO seems an ideal method for non invasive evaluation of 
IMA grafts; DIP infusion helps in identifying the graft and 
provides useful functional infonnations. 
955-64 
Pul.ed Wave Doppler i. Superior to COntinuou. wave 
Doppler for Honinva.ive Deteraination of Aortic 
Iapedance Spectra 
Anthony C. Pearson, TomaBz Pasieraki, Karen Ruschart, 
Philip Binkley. 
Ohio State univeraity, Columbus, Ohio 
Great vessel high-fidelity tonometry combined with 
continuous wave (CW) Doppler recording of aortic flow 
has been proposed as an accurate totally noninvasive 
method for determination of aortic impedance spectrum 
(AIS). Theoretically, pulsed Doppler of ascending aortic 
flow (PDAF) should be more accurate for impedance deter•
mination since CW Doppler lacks range resolution. We 
compared 3 methods for the measurement of noninvasive 
AIS using Millar carotid artery tonometry in conjunction 
with flow derived from (1) PDAF from the suprasternal 
notch (SSN) (2) continuous wave (CW) Doppler from SSN 
and (3) CW from apex in 21 normal volunteers ranging in 
age from 16 to 78 years. From the AIS the following 
parameters were calculated: characteristic impedance 
(zc), reflectance (R) and normalized reflectance (NR) 
results I Pulsed-SSN CW-SSN CW-apex 
ZC (dynes/sec/cm~) 86±49* 48±24 4l±21 
R 365±24l* l77±63 l83±133 
NR 1.9±1.1* 1.6±0.67 1_6±0.44 
*p<0.05 vs CW-SSN, cw-apex. There was no significant re•
lationship between age and Zc, R or NR with CW-apex or 
CW-SSN, however ZC and R derived from Pulsed-SSN 
correlated significantly with age (r-0_57, p<0.05). 
Direct measurement of aortic distenSibility from SSN M•
mode recordings of aorta, correlated well with zc from 
pulsed-SSN (r-0.68, p<O.05) but not with CW ZC. We 
conclude that pulsed Doppler flow recordings provide AIS 
which are significantly different from CW spectra. They 
appear superior to CW in reflecting known age-related 
changes in aortic distensibility. 
JACC Vol. 19, No.3 
March 1, 1992:299A 
955·65 
Two·Dlmenslonal Echocardlogrephlc Automated Border Detection 
Accurately Reflects Changes In True Left Ventricular Volume 
John Gorcsan 111. Lee G. Deneault, Shlgekl Morita, A. Kawai, Bartley P. 
Griffith, Robert L. Kormos. 
University of Pittsburgh, Pittsburgh, PA 
Two-dimensional echocardiographic automated border detection (ABD) 
can provide objective on-line measurement of left ventricular (LV) cavity 
area by defining endocardial borders. The aim of this study was to de•
termine If ABD echo measurements accurately detect precise changes 
In true ventricular volume. Accordingly, an Isolated, suspended, and 
Isovolumlcally contracting canine heart preparation was used whera ab•
solute LV volume was controlled by an Intravantrlcular balloon. The 
echo transducer was placed on the epicardial LV surface at the mld•
ventricular level and aligned In the short-axis plane. Simultaneous ABD 
echo area measurements were made while LV volumes were varied 
from 5 to 35 ml at 1 ml Increments. To Insure obJectivity. ABD echo 
measurements were directly recorded on-line by a computer worksta•
tion through a customized Interface. Four hundred fifty simultaneous 
measurements were made on 15 runs from 3 dogs. 
7 Linear regression analysis was 
... ' used to correlate ABD echo area 
!. with absolute volume from each 
preparation. The results are as 
follows: r~ 0.98, with SEE~ 2 ml 
for all runs on all dogs. The data 
o -I-..ofI:;....._~ ___ ~ from the 5 runs on dog 112 ap-
o '0 20 ao 00 pears as an example In the In-
True Volume (mil serted figure. In conclusion: ABO 
area measurements were closely correlated with changes In true LV 
volume. Two-dimensional echo ABO appears to be a highly accurate 
method to reflect changes In absolute ventricular volume. 
955·66 
Short Axis 2·Dimensional Echocardiographic Calculation or Left 
Ventricular Chamber and Muscle Area Using a Fully Automated 
EpicardiallEndocardial Contour Detection Algorithm 
David C. Wilson and Edward A. Geiser, University of Florida, 
Gainesville, Florida 
Purpose: To validate a fully automated computer algorithm for detection 
of epicardial and endocardial boundaries in short axis 2-D echo images of 
the left ventricle (LV) in normal subjects. 
Methods: Sequences of 16 frames from each of 23 normal subjects with 
2-D echo studies of varying quality ( 1 excellent, 10 good, 6 poor) were 
acquired in digital polar format. A fully automated contour detection 
algorithm then finds the centerpoint of the LV and • based on large 
matched filters, radial histograms, morphologic operations, and cost 
functions - estimates the position of the complete epicardial and endocardial 
contours at end diastole (ED) and end systole (ES). A blinded observer 
then used a cursor to define the same boundaries. The area enclosed by 
the epicardial and endocardial contours and the difference between the two 
(muscle area) for both the computer and observer were calculated at ED 
and ES and compared USing linear regression. 
Results: Correlation of the computer vs observer 
epicardial and endocardial areas was excellent with 
correlation coefficients, r, of 0.904 and 0.931 
respectively. Correlation of the muscle areas was 
somewhat lower at 0.650. Since these were normal 
subjects, the muscle areas were clustered in one 
portion of the distribution. If the muscle area 
regression is forced through zero, r '" 0.990 showing 
that the estimates are close to the line of identity. 
Conclusion: This fully automated contour detection 
algorithm produces accurate epicardial and endocardial 
[2]- . -. ' ... ' . ~ '. .." .. ~. ,-
','Ii-.' .. 
boundaries which can be utilized to calculate muscle t'==~==J 
area. 
ABSTRACTS 
955·67 
Factors Affecting the Determination of Left Ventricular 
Area by Acoustic Quantitation 
299A 
Mikel D. Smith, Gong-Yuan Xie, Peter M. Sapin, Stephen 
Reed, Annette Cater, Sharon Mahoney, Oi Ling Kwan, 
Anthony N. DeMaria. University of Kentucky, Lexington, KY 
Acoustic quantitation(AQ) is a new method for displaying 
tissue-blood boundaries during 2D-echo which allows on•
line graphic record of LV areas. However, no data exist 
on how machine and operator factors influence AQ measure•
ments. Therefore, we evaluated the effect of system gain 
and interoperator variability on AQ LV end-diastolic 
(EDA), end·systo1ic(ESA) area, and fractional area 
change(FAC) in 20 normals. LV areas were quantified from 
AQ images performed from mid·LV short-axis(SAX) and 
apical 4·chamber(4C) views. Optimal gain settings were 
determined at baseline exam(G-O), and exam was repeated 
with overall gain reduced SdB(G-S) and increased SdB 
(G+S), and EDV, ESV and FAC compared. (*=p<.OOOl vs. G·O) 
Gain: Go G-S G+S 
SAX: cm2 EM 20.6+6 25.1+6* 11.2+6* 
ESA 10.1+4 16.9+5* 4.0+5* 
FAC 51.2+11 32.8+12* 72.1+20* 
4C: cm
2 
EDA 33.9+7 40.0+8* 23.3+8* 
ESA 24.8+6 34.8+7* 13.3+6* 
FAC 26.9+7 12.8+5* 43.9+11* 
For variability, AQ was done by 2 operators (T1, T2). 
T1 T2 p-va1ue (vs. T1) r 
SAX: cm2 EOA 20.6+6 16.6+4 .003 .60 
ESA 10.1+4 7.5+3 .0009 .74 
2 FAC 49.4+12 56.1+12 .05 .45 
4C: cm EDA 33.9+7 28.3+8 .0001 .92 
ESA 24.8+6 19.7+8 .0001 .89 
FAC 26.9+7 31.9+10 .03 .42 
Thus, gain exerts an-important influence upon the quanti•
tat ion of LV EDA, ESA and FAC by AQ. Operator variability 
may impact on AQ measurements, particularly in SAX views. 
955·68 
Utility of Combined Intravascular Ultrasound Imaging and 
Balloon Dilatation Device In the Performance of Balloon 
Angloplasty of Aortic Coarctation and Pulmonary Artery 
Branch Stenosis • Experimental Studies 
Tsui-Lieh Hsu, Steven Schwartz, ai-Ling Cao, Andrew Weintraub, 
Mark Aronovilz and Natesa Pandian 
Tufts-New England Medical Center, Boston, Massachusetts. 
Current developments In intravascular ultrasound (IVUS) has 
pointed to the promise of this technique In guiding catheter-based 
therapeutic procedures for various obstructive lesions. However the 
use of IVUS during such procedures has required the introduction of 
IVUS catheters before and after the procedure and thus the need for 
multiple catheter exchanges. Also, Simultaneous visualization of the 
procedure has not been possible. Recently, the utility of a combined 
balloon ultrasound imaging catheter has been demonstrated during 
coronary angioplasty. To assess whether such a concept could have a 
role in other interventional procedurs, we studied the potential of a 
combined IVUS and balloon dilatation (IVUSIBD) prototype catheter 
(20 MHz) during angioplasty of experimentally created aortic co•
arctation and peripheral pulmonary artery (PA) branch stenosis in 
8 dogs. In all instances of aortic coractation, IVUS/BD catheter de•
picted the site of coarctation, the degree of narrowing and the chan•
ges in the wall architecture. it also aided in the optimum pOSitioning 
of the dilatation balloon. Continuous visualization of the process of 
dilatation could be observed during balloon inflation and deflation by 
IVUS monitoring. The effects of dilatation, the degree of stenOSis 
reduction and occurance of intimal tears could be instantly detected. 
IVUS/BD catheter was similarly useful in depicting the site and 
degree of PA branch stenosis, the process of the dilatation procedure 
and its effects. The maximum extent of dilatation and degree of recoil 
could be descerned immediately and over time. Contrast angiography 
before and after dilatation procedures yielded limited Information, 
only about the changes in luminal diameter, and also required mUl•
tiple contrast injections. We conclude that the combined IVUS/BO 
catheter could play a valuable role In the treatment of aortic coarc•
tation and peripheral pulmonary artery stenosis. 
300A ABSTRACfS 
955-69 
Quantitative Assessment of the Elastic Properties of Human 
Arteries In' Intravascular Ultrasound: Pathological Arterial 
StitTening Proximal to the Aortic Bifurcation 
Rolf Doerr ·Bernhard Heintz, Winfried Krebs Rainer Uebis, 
Silvia Nase-Hueppmeier, Thomas Gillessen, Frauke Walkenhorst, 
··Helmut Reul "Peter Hanrath. 
Medical Clinic I: ·Medical Clinic II, and • ·Helmholtz-Institute for 
Biomedical Engmeering, RWTII Aachen, Germany 
28 normotensive pts without evidence of extensive atherosclerosis 
were studied by intravascular ultrasound (Sonicath 6.2 F/20 MHz, 
Boston ScientIfic; lVUS/ Diasonics/Sonotron). Systolic-diastolic 
changes of cross-sectionru luminal area (M) and arterial pressure 
(~p) were measured at 5 different sites in the aorta and in the iliac 
arteries. The local pulse wave velocity PWV, calculated from the 
Moens-Korteweg equation PWV = VElP (E = elastic modulus, 
derived from IlA and ~p; p = density of human blood = 1.06 g/ml), 
was used as an indicator of arterial wall stiffness . 
PWV 
Imls) 
15 
10 
A (n = 5): illje" 45 vrs 
Group Bin = 16): 'g. 46·64 Vrs 
C In = 1) :age ~ 65 Vrs 
Thor. Abd. Aortic Com. iliac Ext. iliac 
aorta aorta bifurcation artery Irterv 
Conclusions: An increase of wave front velocity proximal to the 
aortic bifurcation, indicating pathological walf stiffness, was a 
common finding in all age groupsl and i:letectable even in younger 
pts. Arterial bIfurcations, inducmg pulse wave reflections, are 
likely to be an independent cause oflocal arterial wall stiffening. 
955-70 
Finite Element Modeling of Circumferential Stress in 
Atherosclerotic: Vessels: Implications for Intravascular Ultrasound 
Richard T. Lee, Howard M. Loree, Richard G. Stringfellow, Roger 
D. Kamm. Harvard Medical School and Massachusetts Institute of 
Technology, Boston, MA. 
It is likely that factors other than stenosis severity predispose some 
atherosclerotic plaques to rupture. Because circumferential stress 
may be an important mechanism of plaque rupture, we examined 
the effects of varying luminal diameter reduction and lipid pool size 
on peak circumferential stress using finite element computer 
analysis. Finite element modeling was based on two-dimensional 
cross-sections of diseased vessels similar to intravascular ultrasound 
images; vessel biomechanical properties were obtained from 
measurements on fresh human atherosclerotic tissues. The model 
determined peak circumferential stress (amax) at luminal internal 
pressure of 100 mmhg. Results: With a constant luminal area 
reduction of 70%, a max increased from 440 to 1640 mmHg as the 
thickness of the lipid pool was increased from 38 to 54% of the 
plaque thickness due to the thinner fibrous cap. Holding the lipid 
pool thickness constant, increasing stenosis severity from 70 to 91 % 
decreased amax from 1640 mmHg to 350 mmHg. When no lipid 
pool was present and the stenosis severity was increased from 70 
to 99%, a max decreased from 400 mmHg to 230 mmHg. 
Conc:1usion: Increasing the size of the subintima1lipid pool and 
reducing the fibrous cap thickness dramatically increases peak 
circutnferential stress in the plaque, while increasing stenosis 
severity actually decreases stress. Because intravascular ultrasound 
may allow imaging of subintimal plaque structure, it may have 
greater potential for evaluating plaque stability than angiography. 
955-71 
JACC Vol. 19, No.3 
March I, 1992:300A 
In Vivo Correlation of Intimal Proliferation by 
Intracoronary Ultrasound witb Angiograpbic Evidence of 
Coronary Disease Progression 
Fausto J. Pinto, Frederick O. StOoar, Shao-Zhou Oao, Hannah A. 
Valantine, Edwin L. Alderman, Edward B. Stinson, John S. 
Schroeder, Richard L. Popp 
Stanford University, Division of Cardiovascular Medicine and 
Department of Cardiovascular SurgeI)', Stanford, CA. 
Serial quantitative angiography is the standard for assessing 
progression of coronary artery disease. Intracoronary ultrasound 
(ICUS) defines vessel wall architecture and provides unique 
morphometric information. Twenty-six cardiac transplant recipients 
(mean age 47 yrs) had annual angiography and follow-up ICUS using 
a 30 MHz ultrasound catheter (1 patients at one yr, 9 at 2 yrs, 4 at 3 
yrs and 6 at 4 yrs after transplantation). Results of serial quantitative 
angiographic lumen measurements of 42 left anterior descending 
coronary artery segments were compared with follow-up ICUS 
measurements of thickness and intim.al index (intim.al area divided by 
intimal and lumen area) in the same segments. Angiographic mean 
luminal diameter decreased 8.1% (3.03:tO.50 mm to 2.76:tO.44 mm; 
p<O.OO6). Angiographic changes correlated with ICUS intim.al index 
(r=0.67;p<0.0001). Segments exibiting rapid angiographic 
progression, defined as a change since the last previous angiogram 
exceeding three SD of the group mean estimate, had a ICUS mean 
intimal thickness of 0.43:tO.2S mm and a mean intimal index of 
0.29:tO.l3, which was greater that segments without evidence of 
progression, 0.22±O.1l mm (p=0.OO6) and 0.15±0.07 index 
(p=O.OO09). 
In conclusion, intrac:oronary ultrasound demonstrates marked intimal 
proliferation in patients with evidence of atherosclerotic progression 
by angiography. This new coronary imaging technique provides 
quantitative assessment of disease progression complimentary to 
angiography. 
955-72 
Ultrasound Guidewire Directed Stent Deployment 
Alan N. Tenaglia, Katherine Kisslo, Susan Kelly, Hark A. 
Hamm, Robert Crowley, Charles J. Davidson 
Duke University Medical Center, Durham, NC 
Utilizing conventional angiography proper stent 
placement may be difficult due to the inability to 
appreciate the extent of atheroma or the entry and exit 
sites of dissection. To determine if stents could be 
alternatively deployed, a new mechanically rotated 20 MHz 
intravascular ultrasound guidewire with a transducer core 
(0.035 inches) (Boston Scientific) was placed through the 
central lumen of a peripheral arterial balloon expandable 
stent. Using an anaesthetized canine model, 5 stents 
were then deployed into the iliac or femoral artery. 
After placing the stent and ultrasound guidewire 
through the femoral arterial sheath, the ultrasound 
guidewire was advanced to the distal aorta. Clear images 
were obtained once the guidewire tip exited the stent 
catheter and entered blood. The guidewire was withdrawn 
until it reached the desired location for stent deploy•
ment. Arterial side branches were used as landmarks. 
The stent was advanced over the guidewire and its 
position verified by loss of the image when the distal 
tip of the catheter covered the transducer. With balloon 
inflation, the contrast and saline mixture created a 
fluid interface providing clear images of the arterial 
wall and stent coils. After stent deployment, the 
balloon was deflated and withdrawn. Proper stent 
location and full expansion were verified by the 
ultrasound guidewire using the blood interface. 
Thus, this study demonstrates an effective 
combination of diagnostic and therapeutic devices which, 
with further refinement, may allow more precise placement 
of intravascular stents. 
JACC Vol. 19, No.3 
March I, 1992:301A 
955·73 
Coronary Intimal Thickness Increases with Age: Evidence 
from Intravascular Ultrasound in Normal and CAD Patients 
Steven E. Nissen, Masakazu Yamagishi, David C. Booth, John C. 
Gurley, Martin R. Berk, Mark Bates, Mark Fausch, Gary Grigsby and 
Anthony N. DeMaria, U of Kentucky and VA, Lexington, Ky. 
Although necropsy studies have described an increase in coronary 
intimal thickness with advancing age, no data exist describing the 
prevalence of such findings in vivo. Therefore, we performed 
intravascular ultrasound in 15 nonnal subjects, ages 31 to 72, and 67 
patients with coronary artery disease (CAD) ages 33 to 77, to determine 
the relationship between age and intimal thickness. Normal subjects 
consisted of patients with atypical chest pain, no luminal irregularities 
on angiography, nonnal LV wall motion, ejection fraction ~ 55%, 
LVEDP::;; IS, and no valvular or congenital heart disease. The CAD 
cohort consisted of patients with at least one angiographic lesion. A 5.5 
Fr, 64 element, 20 MHz intravascular ultrasound probe was used to 
image coronary sites. Images were digitized and the maximal thickness 
of the intimal leading-edge was measured with an electronic cursor. In 
the normal cohort, 7/15 were <45 years old, and exhibited a intimal 
leading-edge was visible at only 14/31sites (44%) with a maxirnium 
thickness averaging 0.12 ± .05 mm. Eight of 15 nonnals were> 45 
years of age and an intimal leading·edge was apparent at 27/37 sites 
(73%), averaging 0.21 ± .07 mm (p<.OI compared to younger 
nonnals). Regression analysis revealed a positive correlation between 
age and maximum intimal thickness in nonnals, r '" 0.68. In 24/67 
CAD patients <45 years of age, an intimal leading edge was visible at 
83/107 sites (77%) averaging 0.31 ±.12 mm. In 43/67 CAD patients 
>45 years of age, a leading-edge was present in 144/162 sites (89%) 
with a maximal thickness averaging 0.39 ± 0.17 mm (p< .05 compared 
to younger CAD patients) and a positive correlation between age and 
maximum intimal thickness, r = 0.58. These data demonstrate that a 
visible intimal leading-edge is more common in older nonnal subjects 
and progressively increases in thickness with advancing age. A vi~ible 
leading-edge is more prevalent in CAD patients than nonnals and also 
increases in thickness with age. These findings must be considered in 
the evaluation of intimal thickness in vivo by intravascular ultrasound. 
955·74 
In Vivo Evidence for Plaque Fracture Following YI'CA: Intracoronary 
IJItrasound Imaging of ArterIal Distensibility 
Karan G. Reddy, Randeep SUIleja, Ravi N. Nair, Helen M. Sheehan, 
Edward J. Lesnefsky, John MeB. Hodgson, University Hospitals of Cleveland 
and Case Western Reserve University, Cleveland, OH. 
Two mechanisms for vessel lumen improvement during PTCA include 
stretching and plaque fractures. Prior patbologic studies bave documented 
plaque fractures in the majority of successful PTCA. We sought to determine 
whether such fractures eould be detected during life by using intraeoron&ry 
ultrasoUlld whicb allows defmition of plaque morphology, extent of atheroma, 
and vessel distensibility. Distensibility factor (DF) was defmed as percent 
change in lA during a cardiac cycle. We postulated that plaque fractures 
would increase distensibility. Atheroma was quantified by cross-sectional area 
narrowing (%XA) defmed as tbe wall area (intima and media) as a percent 
of total vessel area (lumen and wall). Three groups were studied: normal 
vessels (Group I; n=16), diseased vessels (Group II; n=25: 19 soft and 6 
mixed plaque), and angioplastied lesions (Group Ill; n=1O: 6 soft, 1 fibrous 
and 4 mixed plaques). Group III imaging was performed following PTCA. 
GROUP I GROUP II GROUP III 
N=16 N=25 N=10 
%XA 18±6 45±8' 53±Ut' (mean±SD) 
DF 14±4 4±2' mt' 
<' p<0.05 vs Group I, tp<0.05 vs Group II) 
As expected, extent of atheroma and distensibility were closely eorrelated 
(P = 0.0001; r=-O.71, DF=-O.27 %XA+l7) in UIldilated vessels (Group I and 
II). This eorrelation was 110 longer seen following PTCA (P" NS, r = -0.17, 
DF=O.04 %XA+7.4). Despite a greater plaque burden, DFwas greater in 
Group III than Group II vessels. Only two Group III lesions had large 
dissections. There was no difference in DF between non-soft and soft 
plaques in Group II (4±1 vs 5±1), or in Group III vessels (10±1 vs 8±1). 
Thus, l)atherosclerosis reduces distensibility 2)distellsibility is reduced in 
lesions with both soft and non-soft plaque morphology 3)YI'CA increases 
vessel distensibility. This occurs despite large residual plaque, and likely 
represents biomechanica1 evidence of micro and/or macro plaque fracture. 
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956·59 
Reocclusion without reinrarction after successful thrombolysis 
Albert Meijer. C.J.P.J. Werter. F.WA Verheugt. J.M.J. van 
der Pol, KJ. Lie, H de Swart. Free University Hospital, 
Amsterdam and Interuniversity Cardiology Institute. The 
Netherlands 
Reocclusion (R) remains a major problem after successful 
thrombolysis (T). We prospectively studied 284 patients (pts) 
with a patent infarct artery (IA) at angiography (AG) <48 
hours after T. Conservative treatment was intended and AG 
was repeated after 3 months, except in pts who refused 
(n=28), or had bypass surgery (n=6). Two pts died. In 71 of 
the 248 (29%) available second AG's R had occurred. From 
these 71 pts with R of the IA, 56 pts (79%) had no 
reinfarction (NMRI) while only 16 (11%) did (RMI). The 
characteristics of these 2 groups were compared to study the 
effects of silent R on ejection fraction (L VEF) and its relation 
to the presence of collaterals at second AG. Maximum 
creatine kinase of the index infarction was comparable in both 
groups (RMI 1086±1146 Ujl; NRMI 1696±1466 Ujl; p=n.s). 
as was baseline LVEF (RMI 52±15; NRMI 52±12). In neither 
group recovery of LVEF was observed (second LVEF values: 
NRMI 50.1.13%; RMI 52.1.15%), whereas in the 177 pts with 
persistent patency LVEF increased from 51.1.10% to 55.1.11% 
(p<0.OOO03, paired analysis). Collateral score at second AG 
was not significantly different (RMI 11/16 (69%); NMRI 
53/56 (95%). 
We conclude that 1: R is a frequent finding after successful 
T, occurring in 29% of pts. 2: R predominantly occurs without 
RMI 3: R precludes recovery of LVEF. irrespective of the 
occurrence of RMI. 
956·60 
Isolated Recurrent Ischemia After Thrombolytic Therapy is a 
Frequent, Important and Expensive Adverse Clinical Outcome 
Robert M. Califf, Eric J. Topol, E. Magnus Ohman, 
Dean J. Kerieakes, Barry S. George, Jeffrey D. Leimberger, 
Daniel B. Mark, Kimberly A. Klinker and the TAMI Study Group 
Duke University Medical Center, Durham N. C. 
In order to evaluate tbe importance of recurrent ischemia (RI) after 
administration of thrombolytic therapy we studied 1221 patients 
enrolled in tbe TAMI Studies. Patients were treated with t-PA, 
urokinase or both thrombolytic agents. Recurrent ischemia was 
defined as symptoms in association with ECG changes and 
reinfarction (MI) was defined as re-elevation of creatine kinase in 
association with appropriate clinical findings. RI and MI occurred 
in 31 (2.5%) of pts, RI without MI occurred in 226 (18.3%), wbile 
neither occurred in 964 (78%). Baseline characteristics (medians) 
were remarkably similar in tbe 3 groups, but clinical outcomes 
were quite different 
RI and MI 
Age (Median) 61 
Male gender 58% 
Heart rate 80 
Blood pressure 130 
Anterior location 45% 
Multivessel disease SO% 
Ejection fraction 52% 
Death· 23% 
Heart failure·· 48% 
ICU stay (days) 6 
Hospital stay (days) 14 
Charges $24,690 
·p<o.OOO 1 (2df) 
"p<O.OOOI (2df) 
Rlonly 
60 
74% 
75 
130 
48% 
48% 
51% 
11% 
31% 
4 
10 
$23,609 
Neither 
57 
80% 
76 
130 
42% 
46% 
51% 
4% 
17% 
3 
9 
$19,721 
Pts with RI and MI have the worst outcomes but RI without MI 
occurs in a large number of pts and leads to poor outcomes and 
higher cost. 
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956-61 
Antithrombotic Therapy in the Prevention of Reocclusion after 
Successful Thrombolysis In Acute Myocardial Infarction: Role of 
the Culprit Lesion Morphology and Stenosis Severity 
Christ }.P.J Werter, Albert Meyer, Freek WA Verheugt, Hans de 
Swart. Free University Hospital, Amsterdam and Interuniversity 
Cardiology Institute, The Netherlands. 
The optimal antithrombotic treatment in the prevention of 
reocclusion after successful thrombolysis (T) is still under debate. 
In the APRICOT-trial (Antithrombotics in the Prevention of 
Reocclusion in Coronary Thrombolysis) angiography (AG) within 
48 hours after T showed a patent infarct related vessel (IRV) in 
300 patients (pts), after which pIS were randomised to either 
aspirin 300 mg qd, coumadin (INR 2.5 to 4.0) or placebo. Stenosis 
severity of the culprit lesion (CL) was judged <90% or >90%, and 
CL morphology was scored as smooth or complex. Second AG was 
done after 3 months in 248 pts (aspirin 93 pIS, coumadin 81 pts 
and placebo 74 pts), during which IRV reocclusion was seen in 
41/176 (23%) pIS with a CL <90% vs 30/72 (42%) pts with a CL 
>90 % (p<O.Ol), and in 48/144 (33%) pts with a smooth CL vs 
23/104 (22%) pIS with a complex CL (p=0.05). 
Reocclusion rate on ... aspirin coumadin placebo 
1st AG CL <90% 11/66 (17%). 14/56 (25%) 16154 (30%) 
>90% 12/27 (44%) 10/25 (40%) 8/20 (40%) 
1st AG CL smooth 17/49 (35%). 15153 (28%) 16/42 (38%) 
complex 6/44 (14%) 9/28 (32%) 8/32(25%) 
• p<O.Ol • p<0.02 
Thus, reocclusion after successful T is significantly reduced in pts 
with a CL stenosis <90% and, unexpectedly, in those with a com•
plex CL These differences are the greatest in pts on aspirin and 
emphasize' the role of platelet activation in the CL following T. 
956-62 
New Antiplatelet Asent, Cilostazol (Phosphodiesterase 
InhibitorJPrev.nts R.occlusion in lIyocardial Infarct!on 
lIodel 
Shuichi Saitoh, TONiyoshi Saito, Minoru Mitsuli, 
HiroNichi HashiNoto, Yukio MaruyaNa. 
FukushiNa M.dical Colleae, FukushiNa, Japan. 
We tested in a conine Nyocardial infarction Nadel 
whether a new antiplatelet alent, ci lostatol (Cl. 
prevents reocclusion of reperfused vessels with cONbi· 
notion of t·PA and heparin. Coronary artery throNbosis 
luperiNPosed on hi,h',rade stenosis(n-27) was used. 
Following the injection of heparin(150IU/kg), t·PA(o.5 
N,/k, for 30Nin, i.v.) W08 odNinister.d alon. or with 
cOllb i not i on of two d i Herent concentrat ions of c i I 09ta' 
zol (C, 0.6 and 1.8Nl/k, for 60 Nin, i .v.) and aspirin 
(35Nl/ka,i.v.), a well known antiplatelet aaent. Plate· 
I.t allrlatian(PA), bleeding tiN.(BT) and plosNa 
cilostazol level (PCl) were lIeaaured, and stenosed 
vease Is were invest i ,oted potho I 0, i co II y. The resu I ts 
were; Reperfuaion Reocclusion 
Group n tille(lIin) n tille(lIin) 
t·PA alane(n-8) 1 20±5 6 9±2 
t·PA+C 0.6I1,/k, (n-5) 5 7± 2 4 38± 18 
t-PA+C 1.8N,/ka (n-7) 7 14± 4 1* 63 
t,PA+Aspirin(n z 7) 7 32±9 6 12±2 
(lIean±SEII, *:p<0.05 vs t·PA alone) Ci lostazol prevent· 
ed coronary reocclusion after reperfusion in a dose 
dependent fash i on as we I I as sl i ,ht i nh i bit i on of ex 
vivo PA and lIodest prolonaation of BT. In C 1,8mg/kg 
aroup "ith t·PA, PCL(589±32,lna/l1Il) corresponded .ell 
to the plasma lellel after oral administration of this 
agent in clinically accepted dose (lOOms B.I ,0,). in 
which dose blood pressure is not significantly decreas•
ed. We conclude that cilostazol is a new potent anti· 
platelet a,ent in prevent in. reocclusion after coronary 
throllbolysis. 
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957-91 
A New Non-Invasive Marker for ReperfusioD lDjury 
-A Study on Myosin light Chain Releasing Curve In Acute 
Myocardial Infarction-
Takashi Furuno, Shunichi Miyazaki, Kazuo Haze, Tsunehiko 
Nishimura. National Cardiovascular Center, Osaka, Japan 
To assess the effect of reperfusion on serum myosin light chain 
(MLC) releasing curve in acute myocardial infarction (AMI), MLC 
and creatine kinase activity (CK) were measured in 32 patients (pIS) 
with AMI, every 3 hours (hrs) in the first 24 hrs, every 6 hrs in the 
next 48 hrs, and once a day until MLC returned to the normal value. 
Patients had an intra-coronary thrombolysis and/or angioplasty at 
6.5:1:4.9 (mean:l:SD) hrs after the onset of AMI. Infarct-related 
coronary arteries were reperfused in 20 pts (Group A) and were not 
reperfused in 12 pts (Group B). Two types of time-concentration 
curves of MLC were identified in Group A Eight of 20 pts showed 
early and late peaking (Group AI) and other 12 pts showed only late 
peaking (Group A2), whereas nobody showed such a biphasic pattern 
in Group B. Peak CK was higher in Group Al than in Group A2 
(5720:1:3747 vs 2748:1:1687 lUlL, p<0.05). Time to peak CK from the 
onset of AMI was shoner in Group Al than in Group A2 (11.4:1:4.4 
vs 18.7:1:7.8 hrs, p<0.025). Improvement of left ventricular ejection 
fraction (EF) in Group A2 was higher than that in Group Al 4 
weeks after the onset (6EF 8.1:1:7.4 vs 0.0:1:7.0%, p<0.05). 
Immediately after reperfusion, five pts in Group Al showed either 
further ST elevation, ventricular arrhythmias or block, which were 
not observed in Group A2 and B. 
Conclusion 
Biphasic pattern of MLC releasing curve is an indicator for 
reperfusion injury in AMI, and is a useful non-invasive marker to 
estimate the efficacy of reperfusion therapy. 
957-92 
The Earliest Diagnostic Marker of Acute Myocardial 
Infarction -The Ratio of Serum MItochondrial to Soluble 
Cytoplasmic Aspartate Aminotransferase-
Takashi Furuno, Shunichi Miyazaki, Hiroshi Nonogi, Yoichi 
Goto, Satoshi Daikoku, Katsumi Saitoh, Kazuo Haze, National 
Cardiovascular Center, Suita, Osaka, Japan 
Importance of cardiac enzyme in the diagnosis of acute 
myocardial infarction(AMI) has been well documented. However, 
the time of earliest appearance in the serum, which has been 
reported in serum myoglobin so far, is still long (3 to 20 hours) 
to determine the indication of reperfusion therapy. We 
measured serum mitochondrial and soluble cytoplasmic 
aspartate aminotransferase (m-AST, and s-AST) activity serially 
in 22 patients (pts) with AMI and in pts with unstable angina 
pectoris(UAP). In pts with AMI the ratio of m-AST to s-AST 
reached to peak value very early after the onset (less than 
3.1 :1:0.4 hours), despite the normal level of other cardiac 
enzymes (Creatine phosphokinase was 158.6:1:23.5 lUlL and 
AST was 28.2:1:1.9 lUlL). In 16 pts (72%) with AMI the ratio of 
m-AST to s-AST had already increased at admission and its 
peak value (40.4:1:3.9x10·2j was higher than that in UAP 
(p<0.001). In all 32 samples in pts with UAP the ratiO of m-AST 
to s-AST was 23,5:1:2.2 (x10-2, mean:l:SE). After the admission, 
the ratio of m-AST to s-AST rapidly decreased during several 
hours and gradually increased in the following days. Thus, in 
acute myocardial infarction, especially when electrocardiogram 
shows no definite signs of AMI, measurement of the ratio of 
m-AST to s-AST is useful information for the earliest diagnosis 
of AMI and hence for the determination of performing 
reperfusion therapy. 
JACC Vol. 19, No.3 
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957-93 
Relationship Between Infan:t Related Coroiwy Artery Flow Arter 
Thrombolytic Therapy IJId ReIeaIe of Taue Specific IaoCorms of 
Creatine Kinase 
Robert H. ChristellSOl1, E. Magnus Ohman, Thomas C. Wall, Kristina 
N. Sigmon, Linda H. Martin, Anthony T. Cbapekis, Eric 1. Topol, 
Robert M. Califf, for the T AMI Study Group. 
Duke University Medical Center, Durham, North Carolina 
To evaluate the association between flow in the infarct-related artery 
(IRA) after thrombolytic therapy and the tissue specific creatine 
kinase (CK) isoforms of MM3, MB2, the MB2/MBI & MM3/MMI 
ratios, we analyzed blood samples from 109 pts taken within 10 mins 
of acute cardiac catheterization (CA TH). Pts were enrolled in a study 
assessing thrombolytic therapy where CATH was performed at a 
median (25th-75th percentile) of 137 (97·184) mins after treatment. 
Flow in the IRA was assessed using the TIMI classification. At 
CA TH the TIMI flow was 0 in 26 (24%) pts, 1 in 2 (2%) pts, 2 in 22 
(20%) pts, and 3 in 59 (54%) pts. Results were: 
TIMI Grade MB2 MM3 MB2/MBI MM3/MMI 
in IRA (ng/ml) (ng/ml) ratio ratio 
o 8 (0-53) 61 (28-198) 2.8 (0-4.5) 0.9 (0.4-1.9) 
2 33 (8-63) 138 (52-359) 3.1 (2.2-4.5) . 2.2 (0.7-4.3) 
3 38 (19-128) 219 (94-820) 3.3 (2.7-4.1) 2.6 (1.1-4.7) 
P·value: 0.0042 0.0041 0.53 0.011 
Associations between MB2 & MM3 release and IRA flow were 
identical because release of the tissue isoforms is simultaneous after 
myocardial infarction. The MB2/MB 1 ratio is not associated with 
coronary flow because MB2 to MB 1 seroconversion is slow in the 
acute period; thus this ratio remains constant regardless of the 
amount of MB2 released. MM3 seroconversion is relatively brisk, 
accounting for its greater association with coronary flow. 
Thus, the release of tissue specific CK isoforms are associated with 
coronary flow, whereas isoform ratios have a relatively weak 
association. 
957-94 
Dialnosll of Subacute Ventricular Wall Rupture after Acute 
Myocardial Infarction: Sensitivity and Specificity of Clinical, 
Hemodynamic and Echocardiolraphic Criteria 
Jose L6pez·Send6n, Esteban LOpez de sa. Ana Gonzalez, Isabel Coma-Canella, 
Inmaculada Rold8n, Isidoro G Maqueda, Luis Martin.Jadrsque. La paz Hospital, 
MadrId, Spain 
Ventricular free wall rupture is the second cause of death in patients (pts) after 
acute myocardial infarction (AMI), but it is not always followed by sudden death 
and is then referred to as subacute ventricular rupture (SVR) and at least III pts 
wjlo survive this episode are reported in the literature. With all, the diasnosis of 
SVR is seldom made and the accuracy of tbe different diagnostic criteria remain 
completely unknown. The diasnostic value for SVR of 29 clinical, bemodynamic 
and ecbocardiographic parameters were prospectively studied in two groups of pts 
from a series of 1247 consecutive pts with AMI: Group A: 33 pts with SVR 
confmned at surSery and group B: 1214 pts without ventricular rupture (surSery, 
postmortem or discbarsed alive). 
The incidence of syncope, recurrent chest pain, bypotension, electromechanical 
dissociation, cardiac tamponade, pericardial effusion, hip acoustic intrapericardial 
ecboes, riSbt atrial and ript ventricular wall compression identified in two· 
dimensional ecbocardiosrams and hemopericardium demonstrated during pericardia•
centesis was bigber in STouP A than in B (p<O.OOOI). The presence of either 
cardiac tamponade, pericardial effusion, hip density intrapericardial ecboes, ript 
atrial or ript ventricular wall compression showed a hip diagnostic sensitivity 
(:070%) and specifiCity (>9S%). ConsiderinS that the diasnosis of ventricular wall 
rupture should always lead to a surgical decision the number of false positive 
diasnosis was always hip for every sinsle diasnostic parameter (>20%), but the 
combination of clinical (bypotension), bemodynamlc (cardiac tamponade) and 
ecbocardiosraphic parameters allowed a sensitive diagnosis (:070%) with a small 
number of false positives « 10%) and provide useful information for therapeutic 
decisions. 
Twenty five of the 33 patients (7S,8%) with subacute ventricular rupture survived 
the surpcal procedure and 16 (48,S%) are Ions term survivors. 
Thus subacute ventricular wall rupture is a relatively frequent complication after 
acute myocardial infarction that can be accurately diagnosed and successfully 
treated. 
ABSTRACTS 
957-95 
Serial Electrocardiograms as Indicators of Patency of 
the Infarct-Related Artery 
Ian P. Clements, Timothy F. Christian, Raymond J. 
Gibbons. Mayo Clinic and Foundation, Rochester, MN 
In order to assess if serial 12-lead electrocar•
diograms (ECG) were associated with infarct-related 
artery patency, a first ECG was obtained 143 ± 142 min 
and a second ECG 372 t 320 min after symptom onset in 
46 patients (pts) with a first evolving myocardial 
infarction (30 anterior, 16 inferior). Patency was 
determined at coronary angiography 439 ± 345 min after 
symptom onset prior to direct angioplasty. The infarct•
related artery was occluded in 30 pts (OCCLUDED) and 
patent with antegrade flow but a high-grade stenosis 
(range 70-99%) in 16 pts (PATENT). The differences 
between the second and first ECG in magnitude (mm) of 
Q, Rand T wave in infarct leads and ST elevation (STt) 
and depression (STi) in all leads were compared in the 
OCCLUDED d PATE T an N groups (Table). 
DIFFERENCE OCCLUDED 'IDtrrr P 
Q +3.Zt9.7 +7.7t9.0 .13 
R -3.4t6.1 -16.8t26.0 .009 
T -3.4t9.1 -lD.U11.0 .03 
STt -1. 6t6. 8 -4. 2tl2.1 .37 
SH +.3t6.6 -2.8t4.5 .10 
Conc1uslons: In patients wlth evo1vlng m ocardial 
f 
. y 
ln arctlon, changes on serial ECGs were related to the 
status of the infarct-related artery. When the second 
ECG was compared to the first, patency was associated 
with marked decreases in Rand T waves and occlusion 
with the lack of such changes; the differences in Q wave 
a~d ~T.segment be~ween the groups were not statistically 
slgnlflcant. Serla1 reductions 1n Rand T wave during 
acute infarction may indicate infarct-related artery 
patency ratber than infarct progression. 
957-96 
303A 
Triage of Patients with Chest Pain in the Emergencv Room 
Guided by MB Creatine Kinase Subform Assay • 
Peter R Puleo, Cheryl Wathen, Roben Robens, M Benjamin Perryman 
Baylor College of Medicine,Houston, Texas 
Fewer than 30%. of patients (pts) with chest pain (cp) admitted to a 
coronary care umt (CCU) have acute myocardial infarction (1\M!); the 
annual cost of care for the remaining 70% of pts without AMI exceeds 
$4 billion. Because con~entio~al I-1~ cr.eatine kinase (CK) assays 
requIre 12 hours to be reItable, IdentifICatiOn of pts with AMI in the 
emergency room (ER) has not been possible. We recently developed an 
assay for the 2 subforms of MB CK that reliably detects AMI within 6 
hours of onset. The purpose of this prospective study was to assess the 
efficacy and safety of direct triage to non-CCU care of pts having 
normal plasma MB CK subform activity 6 hrs after cp onset. 
952 consecutive pts With. cp at rest were enrolled. Blood samples were 
obtamed at 30 mInute Intervals until 6 hours from the stan of cpo 
Subfo":" as~ay (SFA) of plasma MB2 and MBI activity was performed 
b~ rapId h~gh voltage electrophoresis; assay time is 25 minutes. 
DIscharge dIagnosis was detennined using a conventional MB CK assay 
by physici.an~ blinded to the MB SFA. 109 pts had AMI; 77% were in 
the ER wIthIn 6 hours of symptom onset. Sensitivity of SFA by 6 
hours after symptoms was 97.2% (106/109); 68 (64%) were abnormal 
In the fIrst sample. The mean interval from ER arrival to diagnosis of 
AMI was 1.22±1.l7 hours. 31 pts suffered death or a serious 
complication; SFA was abnormal by 6 hours in 87%, including 13 of 14 
pts who dle~. No patient with normal SFA died before hospital day 4. 
The speCIficIty of SFA among the 843 pts without AMI was 94.4'7c; 25 
o~ the 4? pts In whom SF.A was a "false positive" received a discharge 
dIagnOSIs of unstable angma. The mean interval from ER arrival to the 
"diagnostic negative" sample was 2.18±1.95 hrs. This admission 
p~licy would. have resu!ted in the admission to CC.U of 97.2'7c of pts 
with AMI whIle decreasmg the number of CCU admIssions from 470 to 
lSI, a 67.9% reduction. Definitive diagnostic results were available in 
samples obtained by 2 hours after ER arrival, with no decrease in 
safety. Triage from ER directed by SF A is safe and would resul t in a 
substantial reduction in health care expenditures. 
304A ABSTRACfS 
957·97 
Acute Myocardial Infarction, Reperfusion and QT Dispersion 
Stephen Furniss, P. Daniel Higham & Ronald W. F. Campbell 
University Cardiology Department, Newcastle upon Tyne U.K. 
OT dispersion (OTd = OT max minus OT min) is increased in 
patients following acute myocardial infarction (AMI) and higher 
still in those patients who develop ventricular fibrillation (VF) 
reflecting the dispersion of ventricular recovery that underlies 
this arrhythmia. In animal models reperfusion is associated with 
a high incidence of VF but this complication is not seen in man. 
To explore this paradox we retrospectively studied the effect of. 
reperfusion upon OTd. 
36 patients admitted within 6 hours of onset of AMI (16 
inferior, 20 anterior) and given anisolyated plasminogen 
streptokinase activator complex had ECGs recorded on 
admission and after angiography performed at 3 hours. Analysis 
was performed using a digitiser based computer program, all 
values rate corrected. 24 patients reperfused (TIMI ~ grade 2), 
10 inferior (62%) and 14 (70%) anterior. Mean OTd on 
admission was 75 ± 4 ms falling by a mean of 19 ± 6 ms in 
those who reperfused compared to a rise in those who 
remained occluded of 13 ± 11 ms, p<O.Ol. There was no 
significant difference in OTd between anterior and inferior 
infarcts on admission (73 ± 6 v 78 ± 4 ms) but the mean OTd 
results were different at 3 hours (57 ± 5 v 78 ± 8 ms, p<O.OS) 
because of the higher reperfusion rate in anterior infarcts. 
Conclusion : Successful thrombolysis is associated with a 
reduction in OT dispersion whereas persistent occlusion is 
associated with increasing OT dispersion during the very early 
phase of AMI. This finding may help explain the lack of 
reperfusion VF seen in man. 
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958·98 
The Effect of Chronic Right Ventricular Pressure Overload 
on Left Ventricular Diastolic Function 
Jason M. Lazar, Douglas S. Schulman, Angel Flores, 
Judith E. Orie. University of Pittsburgh and Medical 
College of Pennsylvania, Pittsburgh, PA 
The relation between right ventricular (RV) overload and 
left ventricular diastolic function has been demonstrated 
in acute settings and with chronic RV volume overload. 
Whether such a relationship exists during chronic RV 
pressure overload is unknown. Hemodynamics and radio•
nuclide angiograms were obtained in 48 patients with 
chronic pulmonary artery hypertension secondary to 
pulmonary vascular or parenchymal disease. We studied the 
relationship between RV ejection fraction, left ventricular 
peak filling rate (PFR) and pulmonary artery mean (PAP) and 
wedge pressures. All patients were being considered for 
heart-lung transplantation. Their age was 37±11 years and 
all had normal left ventricular ejection fractions (63±8%). 
The patients were divided into 2 groups according to 
baseline RV ejection fractions. Group 1 had RV ejection 
fractions >30% (mean 4l±5) and Group 2 had RV ejection 
fractions <30X (mean 19±5). PFR was normalized to end•
diastolic volume (EDV/s) and stroke volume (SV/s). 
PFR PFR PAP wedge pressure 
*p<0.05 (EDV/s) (SV/s) (mmHg) (mmHg) 
Group 1 2.87±.74* 4.52±1.0* 42±19* 8±2* 
Group 2 2.09±.60 3.31±1.0 59±14 10±2 
RV ejection fraction was directly related to PFR (R-0.48, 
p<O.OOOl) and inversely related to wedge pressure (R--0.42, 
p-0.02) and PAP (R--0.43, p<O.OI) Thus, in chronic RV 
pressure overload from pulmonary artery hypertension, 
abnormal RV systolic function is related to increased RV 
after load (PAP). RV dysfunction in turn is associated with 
decreased LV filling manifested by an abnormal PFR and an 
elevated wedge pressure. This phenonemon is most likely 
mediated via ventricular interaction. 
958·99 
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Right Ventricular Dysfunction: An Independent Predictor 
of Outco.e in Patients Vith Acute Myocarditis 
Lisa A. Hendes, G. Villiam Dec, Igor F. Palacios, 
Hichael H. Picard, Thomas J. Ryan, Ravin Davidoff, 
Boston University Hedical Center; Massachusetts General 
Hospital, Boston, MA 
The clinical course of patients with myocarditis (H) 
is highly variable, and initial left ventricular 
ejection fraction (LVEF) and hemodynamic parameters 
often fail to predict outcome. To assess the prognostic 
value of right ventricular (RV) systolic dysfunction we 
reviewed the echocardiograms of 23 H patients which were 
performed within 6+1.0 days of a positive biopsy. RV 
function was assessed qualitatively by evaluation of 
wall motion, and quantitatively by a previously 
described technique utilizing descent of the RV base. 
Patients were divided into those with RV dysfunction 
(Group I), in whom RV descent was 0.8+0.1 em, and those 
with normal function (Group II), in whom RV descent was 
1.9+0.1 cm (p<O.OOI). There was no difference in age, 
baseline hemodynamics, or duration of symptoms between 
the two groups. Adverse outcome was defined as death or 
cardiac transplantation. 
Group I(n.15) Group II(n.8) E 
Lymphocytic H 11 7 NS 
Giant Cell H 4 1 NS 
Initial LVEF(%) 27.5+4.0 47.5+6.3 p.O.Ol 
Adverse Outcome 10 1 p.0.04 
Hultivariate analysis revealed that RV dysfunction was 
the most important predictor of adverse outcome. 
Conclusion: RV dysfunction, although associated with 
more severe LV dysfunction, is an independent and 
powerful predictor of death or the need for cardiac 
transplantation in patients with acute myocarditis. 
958-100 
Cardiac AutOlntibodl81 are Commonly Observed In Patients WIth 
Myocarditis or Cardiomyopathy, Including Those With Negative 
Endomyocardlal Bloplles. 
Mark Yeager 
Scripps CliniC and Research Foundation; La Jolla, CA 
The demonstration 01 cardiac autoantibodies in patients (pis) w~h 
Idiopathic cardiomyopathy and myocard~is has primarily relied on 
Immunohistochemical procedures and cytotoxic assays. In this study we have 
used Westem immunoblot analysis to examine the prevalence 01 
autoantibodies in 20 adult patients (pts) with myocarditis or cardiomyopathy 
enrolled in the NiH sponsored multicenter study: "Immunosuppressive 
Therapy for Biopsy-Proven Myocarditis·. Serum samples and interpretation of 
endomyocardial biopsies were provided by the coordinating center (U. 01 
Utah). PIs ranged In age from 3Nl8 yrs (mean 52), and included 14 males 
and 6 females. By histopathologic analysis, 10 pts had negative and 10 had 
positive biopsies ~nflammatOlY infiltrate with focal necrosis). 
Proteins in a human heart homogenate were size-separated by SOS 
gel electrophoresis and then electrotransferred onto nitrocellulose. 
Nonspecific binding sites were blocked using 0.1'lb Tween and 1'lb (w Iv) 
nonfat dried milk. Blots were then Incubated ovemight at .f C with serum 
(dilution range 1:50 to 1 :200). Binding oIlgG antibodies to protein antigens 
was detected by autoradiography using ""I-protein A. All 20 sera contained 
antibodies that reacted with a variety 01 cardiac proteins over a wide molecular 
weight range ("10-200 kO). The pattem and number 01 autoantlgens as well 
es the titer of autoantibodies varied considerably between pts. SpecifICity 01 
the autoantibodies for cardiac proteins was suggested by minimal cross· 
reactivity In Western Immunoblots using tissue homogenates from 
Immunogenic organs (thyroid, lung, and kidney). 
Conclusions: 
(1) Autoantibodies directed against a variety of cardiac proteins are a 
common feature In pts with myocarditis or cardiomyopathy. 
(2) Autoantibodies are observed, even when the endomyocardial 
biopsy Is negative. 
(3) Western blotting may be more sensitive than endomyocardial biopsy 
for detecting Immune system activation targeted for cardiac antigens. 
JACC Yol. 19, No.3 
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958·101 
Effects of RegIessial of IJl Pressure Overload Hypert:lqilj 
m Diastolic f\Jnct:.icn 
Ryuhei Tanaka, Kazuaki Ishihara, Shigeo Kanazawa, Blase 
carabello, Michael zile, Medical university of Salth 
carolina, Gazes Institute, Qlarleston, SC 
PressUre overload hypel:trqily (FtH) causes aI:Ilonna1 
diastolic functim: haM!ver, .nether diastolic function 
returns to noraal after regression of FtH is unclear. 
Cllan;es in diastolic function durin3' develcpnent of FtH 
(3 JIDS. after aortic baJ'Xii.n;J of 9 wk. old p.lR)ies) am 
regression of FtH (6 JIDS. after surgical debarDirg am 
balloon aortq>lasty) were assessed usin3' sinultanerus 
edlocardi~/catheterization in 7 oonscioos dogs. 
Irdioes of active relaxatim: time constant of isavolumic 
pressure decline (1, IllS), fillin3' rate (peak rate of 
ircrease in dimension [+dD/dt/D, sec-l) & peak thinnirg 
rate [~dt/h, sec-l )): ani passive stiffness: dIantler 
stiffness (Ke), 11IJSCle stiffness (I<m): ani the hem:>•
dynamicjmedlanical detenninants: en:l diastolic diJnension 
(Ded,Q11), fractional shortenin;J (Hl,%), en:l systolic 
stress (o,gnVan2), left atrial-LV transmitral gradient 
(IA-LV, mnHg) ani LVjb::rlj weight ratio (LV/fJN, gnVkg) 
were measured 3 JIDS. after banli.rY:J (bani) ani 6 JIDS after 
clebarxlirg (deban:l). Debaro/aoI'tqllasty caused the aortic 
gradient to decrease to 0 in 5 dogs (mean aortic gradient 
fell fran l06±lO to 4±l lII1fig) *p=<O.05 vs bani. 
-L- tdD/dtIP =di/d/th..--&<.. IlIL 
Band 30±3 2.9±O.2 2.S±O.2 9.5±l S.l±l 
Deband 35±2 3.9±O.2* 4.O±O.3* 4.l±l* 4.5±l* 
--t!!l!L...l§... --11..- lA'::I!7 JJlLJI!1 
Band 3.7±O.l 32±2 127±l9 5±l 7.6±O.5 
Deband 3.9±O.l 35±l l34±12 lO±l* 5.2±O.2* 
Regression of FtH was associated with an ircreased 
fillin3' rate ani decreased LV stiffness. '1hese dlarqes 
were caused by an ircreased left atrial drivin3' force ani 
the regression of LV hypertrqily. 
958·102 
Ele,'ated Outflow Tract Velocities Alone Do Not Produce Systolic 
Anterior Motion of the Normal Mitral Valve: Clinical Studies 
Albert A. Ha~ege. Michel Desnos. Claude Guerot. Robert A. 
Levine. Bouclcaut Hospital. Paris, France and Massachusetts 
General Hospital. Boston. MA 
Systolic anterior motion (SAM) of the mitral valve (MY) in 
hypertrophic cardiomyopathy (HCM) has generally been attributed 
to increased outflow tract (OT) velocities (Venturi). Alternative 
mechanisms. however. implicate primary MV abnonnalities which 
lIermit anterior motion. The purpose of this study was to 
etennine whether increased OT velocities alone could induce 
SAM of a normally tethered MV. We therefore mfused 
Isoproterenol (ISO. 4 mcg/mm) into 12 patients (mean age 53) 
with structurally normal hearts by echo. (This dose produces 
obstructive SAM in HeM patients without SAM at rest; it avoids 
the severe tachycardia and superimposed hypovolemia often found 
in prior high-dose models of dynamic obstruction.) Patients were 
studied by echo· Doppler before and 5 min into ISO infusion. when 
HR stabilized. RESULTS: Despite peak OT velocities up to 3.2 
m/s. no SAM ""'liS observed. 
Heart rate (bpm) 
L VOT velocity (m/sec) 
(ranges) 
% Increase velocity 
LY apex obliteration 
Leaflet SAM 
BASAL ISO 
~ * 109+14 
.8 +".2 * 2.1 '+ .6 
(.6 :-1.2) (1.3 :-3.2) 
142+66% 
0/12 pts 7/12 pts 
0/12 pts 0/12 pts 
(*: p<.OOI) 
CONCLUSION: Increased OT velocities per se, up to 3.2 mls 
(300% increase). do not produce SAM of a normally tethered 
MV. These veIocllJes exceed those reported at the onset of SAM 
Tii'llCM, and predict an anteriorly-directed lift of up to 41 mm 
Hg. These results suggest that. for ISO to produce SAM in 
HCM. other abnormalities of the MV apparatus or LV must also 
be present that would alter the position of the MV in the flow 
field or its ability to move in response to flow. 
ABSTRACTS 
958·103 
Papillary Muscles Do Not Sborten Conlhluously Tbrougbout 
Isovolumlc Relaxation 
Stephen C. Raybill, Luis Castro, Marek A. Niczyporuk, Neil B. Ingels, 
George T. Daughters, Kwok L. Yun, Ann F. Bolger, Geraldine C. 
Derby, D. Craig Miller. Stanford University and Palo Alto Medical 
Foundation, Stanford, CA. 
Previous studies bave shown that papillary muscles (PM) sborten 
continuously throughout isovolumic relaxation (IVR), and suggested 
that PM may be actively involved in opening tbe mitral valve. To 
analyze PM motion in the intact dog, we placed 3 tantalum markers 
on the long axis of each PM in 5 dogs, and 7 additional markers in the 
LV wall for computation of LV volume. After 14-18 days, tbe dogs 
were sedated and computer-aided biplane vidcofluoroscopy was used 
to track the markers. Control (C) recordings were made, followed by 
recordings after 2 min of circumflex artery occlusion (ClIO). Change 
in PM length was calculated as a percentage of their initia1length at 
the time of maximum LV volume for 2 intervals: 1. from End Systole 
(ES) [17msec before minimum LV dp/dt) to the time of minimum 
PM length (MIN), and, 2 during the IVR [from ES to the time when 
LVP fell to 10% of maximum (PlO»). MIN always occurred during 
the IVR, except for the posterior PM during ClIO, when MIN always 
exceeded PlO. Percentage changes were (mean:t sd): 
.lnk!:mI A!IWW 1M .biW:IlIr 1M 
C CxO C CxO 
ES to MIN .1.0+0.9· .0.5+0.2· -1.1+0.7" ·3.8+2.0· 
ES to PlOt .o.1~1.4 +1.3:tl.l .o.6~0.9 -2.9~1.1· 
[ Significantly different from zero (p<0.03).) 
ConclusIons: 1. Control PM do not shorten continuously throughout 
the IVR, but shorten to MIN and then lengthen, so that at PIO, their 
lengths are not different from those at ES; 2. With CxO, the posterior 
PM shorten throughout and beyond the IVR, suggesting that the 
previous studies may have involved ischemic PM. 
958·104 
Mitral Valve PositIon And Flow Are Related To RIght 
Ventricular FunctIon During Cardiopulmonary RHuacltatlon In 
Humans 
Thomas Porter, Joseph P. Omato, Carolyn Bums, Catherine 
Guard, Valerie Roy, J.V. Nixon, Medical College of Virginia and 
McGuire VA Medical Canter, Richmond, Virginia 
Mitral valve closure during chest compression In cardiopulmonary 
resuscitation (CPR) correlates with improved coronary and 
cerebral blood flow In animals. The mechanism for mitral valve 
closure during CPR remains controversial. Direct left ventricular 
compression has been postulated as one mechanism, but others 
have demonstrated mitral valve closure Independent of direct 
cardiac compression. We assessed mitral valve position, right 
(RVFS) and left (LVFS) ventricular fractional shortening, and left 
upper pulmonary venous flow with transesophageal 
echocardlography during closed chest CPR in nineteen patients 
using a mechanicel Thumpe" at a compression force of 120 
pounds and compression rate of 90/minute. Of the nineteen 
patients, the mitral valve closed with compression In 14 (MYe), 
and remained open In 5 (MYO). There was significantly higher 
peak transmitral flow in the group with mitral valve closure 
(38.8:1:9.4 cm/sec MVC vs. 21.5:1:5.8 cm/sec MVO, p<O.05). 
There was no difference In LVFS between the two groups 
(28:1: 11 % MVC vs 24:!:9MV9;p=N$), but there was a significant 
difference In RVFS between groups (60:f12'lb MVC vs. 42:1:10% 
MYO, p<0.05), In 4 petients (3 MYC, 1 MYO), the magnitude 
and timing of left upper pulmonary venous flow into the left 
atrium highly correlated with RVFS (r=O.9B, p=0.02). These data 
suggest that direct ri9!l1 ventricular compression may play an 
Important role In left ventricular fllllng and mitral valve position 
during CPR in humans. 
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958·105 
Control Mechanisms for Physiological Hypertrophy of Pregnancy. 
Suzanne M. Mone. Sleven D. Colan. Stephen P. Sanders. Children's 
Hospital. Boston. MA. 
Pregnancy represents an excellent model of acute physiologic LV 
hypertrophy and atrophy secondary to a transient. reproducible 
hemodynamic load. Load-modulation of LV mass is believed to 
represent a servo-controlled mechanism with wall stress as the 
feedback variable. To test this hypothesis. serial Echo-Doppler studies 
were performed in 33 women at 6 time periods during and shortly 
after normal gestation 19-12. 18-20. 28-30. and 36-38 weeks of 
gestation. and 2-4 and 8-10 weeks postpartum). A total of 144 
studies were obtained with 3-6 exams Imean = 4.4) in each subject. 
LV mass increased by 17% from study 1 1138±32 gm) to study 
41161 ±31 gm), and returned to initial levels 1139±36 gm) by 8-10 
weeks post-partum. However. when adjusted for alterations in body 
mass the change in LV mass index was not statistically significant. 
Systolic and diastolic blood pressure did not change. Cardiac index ICI) 
was elevated throughout pregnancy compared with the postpartum 
exams, rising most rapidly in early pregnancy and falling shortly 
postpartum. Peak wall stress Igm/cm2) was highest in early pregnancy 
1154 ± 39), was normal at study 3 and 4 1140 ± 36), fell to subnormal 
levelS at the first post-partum study 1127 ± 37), and returned to normal 
by the last study 1144±36). The increased peak wall stress in early 
gestation was due to increased dimension prior to compensatory rise 
in wall thickness, and was coincident with the rapid rise in CI. The 
post-partum fall in peak wall stress was due to more rapid reduction in 
dimension than thickness, corresponding to the rapid fall in CI. The 
change in LV mass closely followed the elevation or reduction in peak 
wall stress, but correlated poorly with mean, total, or end·systolic wall 
stress. 
Thus. myocardial remodeling is rapid during pregnancy as LV 
hypertrophy and atrophy attempt to keep pace with changes in 
hemodynamic load. The timing of the physiologiC hypertrophic 
response in pregnancy is consistent with a tightly-coupled servo 
mechanism transduced by peak wall stress with a 0-4 week 
compensatory response time. 
958·106 
Organ-specific Cardiac Antibodies as Early Diagnostic Markers of 
Familial Dilated Cardiomyopathy 
Alida LP Caforio, Elisabelta Zachara, Ezio Bonifacio, Daniela Baragli, 
Pier Luigo Prali, Gian Franco Boltazzo, William J McKenna. St George's 
Hospital & London Hospital Medical College, London, England & St 
Camillo Hospital, Rome, Italy. 
Autoimmune diseases frequently have familial aggregation; circulating 
antibodies to the target organ are detected years before clinical onset of 
disease and may be early markers for unaffected relatives at risk. To assess 
the role of organ-specific cardiac antibodies (o-s cardiac Abs) as diagnostic 
markers of early familial dilated cardiomyopathy (FDC) we studied II 
patients (probands) with FDC (7M, 4F, mean age 51±14 years) and 24 
apparently healtbY relatives (R) (11M, 13F, mean age 30±12 years). The 
presence of FDC was assessed in all probands according to WHO criteria 
by ventricular angiography, endomyocardial biopsy and accurate pedigree 
analysis. All 24 R were screened with standard 12 lead ECG and 2 
dimensional ecbocardiogram (2D-E). R were classified either as 
unequivocally normal or as carriers. The latter had either abnormal ECG 
and/or at least one 2D-E measurement of LV cavity dimension or 
fractional shortening outside 2 SD of normal. Carrier status was found in 
12/24 (50%) asymptomatic R (5M, 7F, mean age 28±9 years). O·s cardiac 
Abs were detected by indirect immunofluorescence on human heart. 
Skeletal muscle was used to identify cross-reacting antibodies. Sera from 
patients and R were tested blindly from clinical diagnosis. O-s cardiac Abs 
were found in 3/11 probands (27%) and in 8/24 R (33%). The finding of 
o-s cardiac Abs was more common among carriers (7/12, 58%) thaD in R 
classified as normals (1/12, 8% p=0.03). Sensitivity, specificity and 
predictive value for o-s cardiac Abs as markers of carrier status were 58%, 
92% and 87% respectively. 
The finding of o-s cardiac Abs in a sizeable proportion of patients with 
FDC and of their relatives supports the involvement of autoimmunity in 
this condition. Such antibodies may be diagnostic markers of disease at 
preclinical stage and identify relatives at risk of developing dilated 
cardiomyopathy. 
958·107 
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Exercise Induced End Diastolic Volume Changes in 
Obstructive Hypertrophic Cardiomyopathy with Dual 
Chamber Pacing 
B. William Choi, Dorothy Tripodi, Lameh Fananapazir. 
NHLBI, Bethesda, MD 
Previous studies have indicated that dual chamber 
pacing (DOD) significantly improves symptoms and 
reduces outflow pressure gradient in obstructive 
hypertrophic cardiomyopathy (HCM). 
To characterize hemodynamic improvement in 
obstructive HCM with DOD, we investigated 21 HCM 
patients at rest (R) and exercise (Ex) with 
radionuclide angiography to measure exercise induced 
changes (A) in ejection fraction (EF). end diastolic 
volume (EDV) stroke volume (SV) and cardiac output 
(CO) about a month before the pacemaker implantation 
(B) and, with DOD on and off (NSR). 
B 
DOD 
NSR 
EF(R) EF(EX) AEDV(\) .SVC') 
60±12 60±12 -S±13 -S±21 
S9±13 S6±14 14±26* 9.4±30 
62±12 60±14 -3±20* -8±22* 
* p<O.OS 
COC') 
47±27 
62±Sl 
31±32* 
.SV showed a significant correlation with .EDV during 
DOD pacing (r:0.94 p<O.OOl). 
Therefore, the improvement in cardiac reserve with 
Ex, i.e. SV and CO increase was related to Ex induced 
EDV increase rather than EF changes. 
Peak filling rate at rest did not show any 
significant changes at B, with and without pacing 
(2.7±1 vs. 2.4±1 vs. 2.8±1.4, p:NS). 
Outflow pressure gradient decreased from 104±S8 
mmHg at B to 63±41 mmHg at NSR (p<O.OS) and 46±51 mmHg 
with ODD (p<O.Ol). Thus, increased EDV with Ex by DOD 
pacing may explain the hemodynamic improvement by 
decreaSing outflow obstruction and increasing cardiac 
reserve during Ex. 
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959·108 
Transesophageal Defibrillation for Treatment of 
Refractory Ventricular Fibrillation 
Todd J. Cohen, Kelly J. Tucker, Michael C. Chin, Diane G. Oliver, 
Rija F. Redberg, Nelson B. Schiller. Michael L. Callaham, Melvin M. 
Schein man, Jerry C. Griffin. University of California. San 
FranciSCO. CA 
The purpose of this study was to compare trans esophageal with 
transthoracic shocks for defibrillation (defib). Two 300 mm2 
electrodes were mounted 8 cm apart on an esophageal probe and 
inserted 38 em from the mouth. Defib was performed between 
distal electrode (anode) and anterior skin patch (cathode). 
Animal Studies: After 15 s of Induced ventricular fibrillation (VF). 
transesophageal and transthoracic defib thresholds (OFT) were 
determined in random order in 14 anesthetized dogs. OFT was 
defined by the 2 lowest defibs without failure. OFT testing was 
performed by a test (and rescue) shock sequence, with 5 min 
between test shocks. The iMial test shock was 50 J. If successful, 
30 and 20 J were tested. If unsuccessful. a rescue shock was 
delivered and 100. 200, and 300 J were tested. Transesophageal 
OFT (90±15 J) tended to be lower than transthoracic OFT 
(115±35 J; p=Ns). One dog could not be defibrillated by trans•
thoracic defib but responded to transesophageal defib. Esophageal 
electrodes were also useful for arrhythmia discrimination and 
atrial pacing (threshold:38±5 mA; pulse width=2.5 ms).ln 10 dogs 
(total=600±150 J; range-250-1600 J), acute esophageal histo•
pathology showed focal mucosal/myocyte Injury. However, esophagi 
in 4 chronic dogs (4 wks post defib. total=470±110 J; range= 
130·600 J) showed no gross mucosal damage, perforation, or 
stricture. Histopathology showed focal myocyte atrophy and repair. 
Human Studies: As last resort, transesophageal defib was attempted 
in 2 patients. VF was successfully terminated in both patients with 
30 and 300 J respectively. The latter patient had been refractory 
to >7 transthoracic shocks of 360 J. 
ConclUSions: 1. In animals. transesophageal delibrillation is at least 
as effective as transthoracic defibrillation. and safe up to a total 
energy of 600 J. 2. This technique may prove of value for patients 
JACC Vol. 19, No.3 
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959·109 
DIFFERENTIATION BETWEEN MONOMORPHIC VENTRICULAR 
TACHYCARDIA AND SINUS TACHYCARDIA BASED ON THE 
RIGHT VENTRICULAR EVOKED POTENTIAL 
Michael Belz, Kenneth Ellenbogen, Vince Paul, AJ 
Carom, Albert Dawson, Regina Rogers, Medical 
COllege of Virginia, McGuire VA Medical Center, 
Richmond, VA and St.George·. Hospital, London, 
England 
The differentiation between ventricular 
tachycardia (VT) and sinus tachycardia (ST) is 
problematic in some patients with implantable 
defibrillators or antitachycardia pacers. Based 
on prior .tudie. of the effects of 
catecholamine., exerci.e, and changes in pacing 
rate on the POI, we hypothesized that the evoked 
potential (or paced depolarizstion integral, POI) 
recorded from a unipolar transvenous right 
ventricular catheter would differentiste between 
these tachycardias. The POI was calculated from 
a unipolar pacing stimulus, cathode at the RV 
apex, and the reference electrode, a quadripolar 
catheter in the superior vena cava. POI's were 
measured in 7 patients with coronary artery 
disease during VT, sinu. rhythm (SR) and ST 
induced by catecholamine infusion or exercise. 
The results are shown below: 
(oP<0.05, and #p<0.01 vs. SR) 
SR 
Heart Rate (bpm) 
POI (uV aec) 
75+9 
645±-295 
Y! n: 
179±-26# 99±-9# 
915±-380# 588±-308* 
In summary, POI increases during VT, while it 
decreases or remains unchanged during ST. We 
conclude that the POI may be of use in the rapid 
differentiation of VT from ST. 
959·110 
BURST Versus RAMP Pacing for Termination of Ventricular 
Tachycardia 
Michal J. Kantoch, Martin S. Green, Anthony S.L. Tang. 
University of Ottawa Heart Institute, Ottawa, Ontario, Canada 
Two pacing methods for termination of sustained monomorphic 
ventricular tachycardia (VT) were compared in 27 matched pairs of 
VT episodes with the same morphology and cycle length in 18 
patients (14 males), mean age of 61 yrs and with past history of 
myocardial infarction, both on (18) and off (9) antiarrhythmic 
therapy. Patients were randomly allocated to receive either RAMP or 
BURST therapy first and were crossed over to the other method if 
the same VT could be reinitiated. BURST pacing began with a train 
of 7 stimuli, each CL = 91% VT-CL. If it failed to terminate VT, 
subsequent BURST train CL was reduced by 10 ms to a total of 5 
trains and CL not < 200 ms. RAMP pacing began with a train of 5 
stimuli at a first CL = 91% VT-CL and the interval of subsequent 
paced beats within the train progressively shortened by 10 ms per 
paced beat. If it failed to terminate VT another stimulus was added 
to the next train to a total of 5 trains and CL not < 200 ms. During 
54 VT episodes in 27 matched pairs (CL 270-500, mean 362 ms), VT 
was terminated in 19 RAMP and 17 BURST cases (CL 270-450, mean 
340 ms). VT accelerated in 2 RAMP and 1 BURST case, and 
required DC shock for termination. Fewer RAMP (mean 1.6) than 
BURST (mean 2.2) trains were required to terminate VT (p<0.05). 
The overall mean time from VT onset to termination was 15.5 sec. 
When both pacing methods were successful ( 17 pairs), the time to 
termination did not differ by more than 2 sec in 10 RAMP/BURST 
pairs and was shorter for RAMP pacing by more than 5 sec in the 
remaining 7 pairs. 
Conclusions: 1. RAMP or BURST pacing were 69% (36/54) 
successful in terminating VT; 2. RAMP tended to terminate VT 
faster and with fewer trains; 3. VT acceleration was infrequent with 
both pacing methods. 
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960·111 
Criteria to Distinguish Slow Conduction Zones from Bystander 
Pathways in Ventricular Tachycardia Reentry Circuits 
Hafiza Hassan, William G. Stevenson, UCLA Medical Center, Los 
Angeles, CA. 
Entrainment of ventricular tachycardia (VI) with long stimulus to (S•
QRS) interval and no change in QRS may identify a reentry circuit 
slow conduction zone (SCZ) or a bystander pathway. Two criteria to 
differentiate SCZs from bystanders were assessed in computer 
simulations of figure eight circuits: 1) the electrogram to QRS (EG· 
QRS) during vr compared to the S'QRS interval during entrainment, 
2) The post·pacing interval (PPI) at the pacing site which should 
equal one circuit revolution, vr cycle length (VfCL) at circuit sites. 
RESULTS: These criteria distinguished SCZ circuit sites from 
bystander sites (table). However, when rapid stimuli caused 
deere mental con-
Site S-ORS/EG-ORS PPIIVrCL duction slowing, 
vr·SCZ 1 1 both S-QRS/EG·QRS 
Path to QRS-C 1 > 1 and PPllVI'CL ratios 
Bystander path A > 1 or < 1 > 1 at circuit sites could 
Bystander path B > 1 > 1 exceed 1. With dec-
'-'-----'-------------... rementalconduction 
S·QRS increased with pacing rate, 
occurred after pacing. 
CONCLUSION: Using 
entrainment, SCZs in vr reentry 
circuits can be distinguished from 
bystander pathways. R·R interval 
oscillations and S·QRS increases 
with pacing rate indicate 
decremental conduction in the 
circuit and reduced reliability of 
entrainment criteria. 
960·112 
and R-R interval oscillations 
Observations on the In Vivo Epicardial Activation of the 
Normal Human Heart 
Carl F. Pieper, ScD, Antonio Pacifico, MD. Baylor College of 
Medicine, Houston, Texas 
Using serial hand mapping techniques in man, three to 
5 sites of epicardial breakthrough (EBT) have been described. 
However, transmural epicardial excitation from the widely 
distributed His/Purkinje system suggests a more complicated 
pattern may exist. The purpose of this work is to examine 
epicardial activation in the normal human heart using 
multichannel computer mapping requiring only a single beat, 
and rigorously defined and applied activation algorithms. 
Eighteen subjects undergoing surgery for Wolff•
Parkinson-White Syndrome were recorded with a 119 site sock 
array during non-preexcited sinus rhythm. None had evidence 
of coronary artery disease and all exhibited a normal 12 lead 
ECG except during periods of preexcitation or tachycardia. 
Each was recorded bipolarly and 3 also were recorded 
monopolarly. 
Recordings revealed 6.9±I.S EBTs (range 4 to 12). 
Closely spaced, multiple EBTs often were observed which 
would not have been seen using serial techniques. The earliest 
EBT always occurred over the anterior right ventricle (ARV) 
at l4.S±S.S ms (range 4 to 29 ms) after QRS onset. Total 
activation required an additional S7.8±8.8 DIS (range 43 to 77 
ms). Subsequent EBTs occurred over the ARV (28.6%), 
inferior RV (5.9%), anterior LV (30.3%), inferior LV (20.3%), 
and anterior paraseptal region (4.1%), inferior paraseptal 
region (10.8%). 
In contrast to previous reports descrihing epicardial 
spread of activation from a few foci, a mosaic of epicardial 
activation emerges. These data, obtained in vivo, are 
consistent with endocardially initiated transmural activation 
of the epicardium suggested by the anatomy of the 
His/Purkinje system and intramural recordings. 
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960·113 
Fatal and nonfatal recurrences after catheter 
ablation of ventricular tachycardia: role of 
the underlying etiology and the site of energy 
delivery 
Hans-Joachim Trappe. Helmut Klein. Paul 
Wenzlaff. Jerg Trester. Paul R. Lichtlen 
University Hospital Hannover. Germany 
We studied the follow-up of 49 patients (pts) 
who underwent DC catheter ablation (CA) due to 
recurrent sustained monomorphic ventricular 
tachycardia (VT) refractory to antiarrhythmic 
drugs. There were 33 pts with coronary disease 
(CAD) and 16 pts with arrhythmogenic 
ventricles (ARV). CA was performed at the 
earliest endocardial activation (EEA) or at 
the area of slow conduction (ASC). ASC was 
defined as an area with mid-diastolic 
potentials, maximal delay between stimulus and 
QRS complex and identical QRS morphology 
during pace mapping. In all pts CA was 
performed using DC energy (300-400 Joule). 
During the mean follow-up of 51±12 months. 8 
pts died (16%): 2 pts (4%) suddenly (SO) and 6 
pts (7%) from cardiac causes (CD). Nonfatal 
recurrences (REC) occurred in 29 pts (59%). 
SO CD REC 
CAD (33) 2 (6%) 4 (12%) 18 (55%) 
ARV (16) 2 (13%) 11 (69%) 
EEA (34) 1 (3%) 4 (12%) 23 (68%J 
ASC (15) 1 (7%) 2 (13%) 6 (40%) 
There is a low incidence of SO after CA. The 
results of CA are better in pts with CAD 
particularly when DC energy is delivered at 
the ASC. Due to a high incidence of REC CA 
should not be performe in pts with ARV. 
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961·87 
IS HYPOMAGNESEMIA ARRHYTIlMOGENIC? 
Teri Millane, Stephen H Jennison, Michelle Leigh-Jones, A John 
Camm 
St George's Hospital Medical School, London, UK 
Hypomagnesemia as a cause of cardiac arrhythmia has been reported 
frequently in the literature; recent or ongoing potassium depletion is an 
associated feature in each such report. To investigate the influence of 
hypokalemia on the occurrence of such arrhythmias, we performed 
ambulatory electrocardiography (amECG) in cardiac transplant 
recipients in whom serum potassium is usually normal, despite 
persistent hypomagnesemia associated with myocardial magnesium 
depletion. 
AmECGs were obtained from orthotopic transplant recipients within 
one year of operation; ventricular (V A), and supraventricular (SV A), 
ectopic activity were assessed using standard monitoring equipment. 
Serum potassium, serum magnesium (seMg) and myocardial 
magnesium (myoMg) were measured concuITently. 
27 AmECGs from 21 patients, recorded 4·52 weeks (median 22) post•
transplantation, were available for analysis. Concurrent 
hypomagnesemia (seMg <0.7 mmol/l) was present in 14/27 records 
(group S), myocardial magnesium depletion (myoMg<30.2 umol/g) in 
11/27 (group M), occurring simultaneously in 6 patients (group SM). 
SeMg and myoMg were normal in 6 patients (group N). Mean serum 
potassium was 4.1 mmol/l; hypokalemia did not occur. Symptomatic 
arrhythmia was not reported and the incidence of recorded arrhythmia 
was very low. Non-sustained VT/frequent V A was recorded in only 
one patient (group N). Significant V A (> 10 VEs/hour) occurred in one 
other patient (gp SM); significant SV A occurred in one patient (gp S). 
Median V A and SV A were not significantly different among the 
groups. 
Conclusion: Hypomagnesemia and/or myocardial magnesium 
depletion, in the presence of a persistently normal serum potassium, is 
not associated with significant cardiac arrhythmia in the den~r:vated 
heart. This study throws further doubt on the arrhythmogemclty of 
hypomagnesemia. 
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961·88 
Significance of Double Potentials Recorded During Ventricular 
Tachycardia 
John M. Fontaine MO FACC and Carmen Perri RN 
State University of New York Health Sciences Center and the 
Veteran's Administration Medical Center. Brooklyn. New York 
Fractionated electrograms recorded during endocardial mapping in 
patients with sustained ventricular tachycardia (VT) are thought to 
represent areas of slow conduction that may participate in the 
genesis and maintenance of the reentrant tachycardia. The 
mechanism of double potentials (OP), defined as a double spike 
potential separated by an i~oelectric period of 30ms or more is not 
clear. To evaluate the significance of OP, we studied the response 
to overdrive pacing. entrainment and pacing from sites near where 
OP were recorded. OP were recorded during endocardial mapping of 
the left ventricle. The VT cycle length was 330ms. The earlier 
potential designated V occurred 50ms prior to the onset of the 
surface ORS complex. The second potenial was designated V'. The 
interpotential duration measured 120ms. During the administration 
of 2. 3 and 4 extrastimuli from the right ventricular outflow tract, 
the V-V' interval gradually increased in a Wenckebach fashion from 
120-250ms and returned to its baseline value upon discontinuation 
of pacing and resumption of the tachycardia. Pacing from a site in 
the left ventricle. during VT. resulted in narrowing and abolition of 
OP. which would then recur upon the cessation of pacing. PaCing 
from the right ventricle produced a wave front that appeared to 
collide with the antidromic wave front and activated the orthodromic 
wave front, producing fragmentation and further delay in the 
inscription of V'. hence prolongation of the V-V' interval. 
Conclusion: OP recorded during VT appear to occur as a result of 
electrograms recorded on either side of an area of slow conduction. 
Pacing proximal and distal to the area on either side of the region of 
slow conduction may be used to either prolong or abolish the double 
spike potential. 
961·89 
Diurnal Variations in Ventricular Refractoriness 
Thomas Kong, Jeffrey Goldberger, Alan Kadish 
Northwestern University Medical School, Chicago, Illinois 
We evaluated diurnal variations in ventricular effective 
refractory periods (VERP) by using noninvasive programmed 
stimulation in 3 subjects with permanent transvenous pacemakers. No 
patient had structural heart disease or autonomic dysfunction. After a 
one minute conditioning period, VERPs were determined hourly in 
duplicate to an accuracy of 2 ms using 8-beat trains at drive cycle 
lengths (DeL) of 400 ms and 600 ms with 4 second intertrain pauses. 
Stimulation was performed at twice the late diastolic threshold. 
Results: At DCLs of 400 ms and 600 ms, respectively, minimum 
and maximum VERPs were 241±15 ms vs 264±12 ms (p=.003) and 
278±5 ms vs 303±4 ms (p=.007). The shonest VERPs and the 
greatest hourly decrement between VERPs (mean decrement = 9.3 ms), 
occured between 7 AM and lOAM. The figure shows mean hourly 
VERPs, normalized to the mean noon VERP, at a DCL of 400 ms: 
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Capture thresholds, electrogram amplitudes and durations, and serum 
potassium did not demonstrate circadian variations. 
Conclusion: Our study demonstrates a significant diurnal 
variation in ventricular refractoriness. The early morning decline in 
VERPs coincides with the increased morning incidence of sudden 
cardiac death and may be one potential mechanism for this observation. 
JACC Vol. 19, No.3 
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961·90 
The Mechanism of Ventricular Tachycardia Induced by 
Tricyclic Antidepressant Toxicity 
Gary Ansel, Kelly Coyne, Steven Arnold, Steven Nelson. 
The Ohio State University, Columbus, Ohio 
Previous studies have attributed the ventricular 
tachycardia (VT) of high dose tricyclic antidepressants 
(TCA) to a quinidine like effect with the generation of 
repolarization abnormalities and after depolarizations. 
To further characterize TCA induced VT, amitriptyline 
(O.S-lmg/kg/min) was infused in 17 chloralose anesthetized 
dogs with crushed SA nodes and monophasic action potential 
(MAP) catheters positioned in the left ventricle. Heart 
rate was kept constant by continuous atrial pace (600 
msec). During infusion, Group A (n=12) was burst paced 
every 4 minutes while Group B was not burst paced. All 
group A dogs (100%) had VT (9 monomorphic, 3 polymorphic, 
11 sustained) induced by burst pacing (mean pace interval 
3l3±lS ms) at a mean infusion time of 39.6±26.S minutes. 
Mean VT cycle length was 367±19 ms. QRS duration increase 
from 96.1±4.2 ms to l6l.S±6.6 ms (P<.OS) prior to onset of 
VT. VT did not occur in group B. No significant changes 
occurred in the QT interval nor were after depolarizations 
detected by MAP in either group. 
Conclusion: Unlike quinidine mediated VT, TCA induced VT 
is due to tachycardia mediated conduction delay without 
repolarization abnormalities. Relative bradycardia 
prevents conduction delay and the initiation of VT. 
961·114 
Ventricular Tachycardia Entrainment with Simultaneous Pacing and 
Recording at Separate Sites: Relation of the Post·Pacing Interval to 
Recording Site Location in Computer Simulations 
Hafiza Hassan. William G. Stevenson. UCLA Medical Center. Los 
Angeles. CA 
DUring ventricular tachycardia (VI) entrainment. the post-pacing 
interval (PPI) between the last entrained electrogram and the next 
electrogram at vr circuit sites = the revolution time through the 
reentry circuit. i.e. the vr cycle length (VTCL). To determine if the 
relation of the PPI to the vrCL can be used to distinguish sites in the 
vr circuit from bystander areas adjacent to the circuit when pacing 
and recording sites are separate. computer simulations of figure eight 
reentry circuits were analyzed. 
RESULTS: 1) Pacing outside the circuit and recording inside the 
circuit. PPJ=vrCL at sites activated orthodromically (in the same 
direction as during VT). Antidromic activation of circuit sites shortens 
the PPI which can become < vrCL. 2) Pacing inside the circuit and 
recording outside the circuit. the PPI=vrCL during orthodromic 
capture. 3) Pacing at a bystander path and recording at 
orthodromically activated sites in the same bystander path the 
PPI > vrCL, and the PPI increases with increasing distance of the 
recording site from the vr circuit. 4) Pacing at one bystander path 
and recording at a different orthodromically activated bystander path 
(both outside the circuit) the PPI = vrCL. 5) If conduction in the 
circuit slows in response to premature stimuli (decremental 
conduction) the PPI varies with the pacing rate. 
CONCLUSION: The PPJ during vr entrainment depends on the 
pacing and recording site location relative to the vr circuit. When 
pacing and recording sites are separate. the PPI alone cannot 
distinguish bystander paths from sites in the reentry circuit. At sites 
in the circuit. antidromic capture shortens and decremental 
conduction lengthens the PPI. 
ABSTRACTS 
961·115 
Determinants of Torsades-de-Pointes in Patients 
with Prolonged Repolarization: A Computerized 
Quantitative AnalYBis of 24-Hour KCG Recordings 
Emanuela H Locati. Pierre Maisonblanche, Bruno 
Cauchemez. Philippe Coumel. Univ of Milan, Clin 
Med 2, Italy; Hop Lariboisiere, Paris, France. 
309A 
Computerized analysis of 24-hour ECG recordings 
was performed by ATREC II system in 11 patients 
(73% females, age 67±19 yrs) with acquired long 
repolarization (QTc 557±66 msec) and Torsades•
de-Pointes (TdP). Three classes of ventricular 
arrhythmias were computed. The mean (±SD) num•
ber of events per patient were: a) 4105±12Il9 
premature beats (VPB); b) 160±375 brief repeti•
tive forms (BRVF, 2 to 4 beats); c) 8±10 TdP (~ 
5 beats). The mean R-R intervals (msec) of the 
10 minutes (MIO-Ml) and 10 cycles (Rl0-Hl) pre•
ceding the event onset (VI) in each class were: 
~ lillL:JU lill!=..Il..a ll..a.=.Ii2. E2..=..Rl lll.::Y.l 
VPB 855±255 899±159 688±79 1097±234 613±85 
BRVF 1032±234 9~~4±162 609±76 1226±260 635±75 
TdP 1108±335 896±177 580±99 1315±185 642±90 
Typical short-long-short patterns preceded not 
only TdP but also VPB and BRVF. By 2-way ANOVA, 
shorter R3-R2 (p<.Oll and longer R2-Rl interv•
als (p<. 0(5) preceded more cO,mplex arrhythmias. 
Multiple regression showed a significant relat•
ion among cycle lengths and class of subsequent 
arrhythmias (r'.44, pc.(05). By discriminant 
analysis, RIO-Rl cycle values allowed a correct 
classification of 73% of the events (pc.0001). 
Thus a quantitative analysis of ambulatory re•
cordings may enable the detection of patterns 
favouring the genesis of malignant arrhythmias 
associated with acquired long repolarization. 
961·116 
THE ANTIARRHYTHMIC ROLE OF SELECTIVE PROLONGATION OF 
REFRACTORINESS: SUPRESSION OF INDUCIBLE VT WITH 
SEMATILIDE. Philip Sager. Koonlawee Nademanee. Mike 
Antimisiaris. Terrie Neiditch. Richard Taylor. Clara Pruitt. Bramah 
Singh. West LA VAMC and UCLA Med Centers. Los Angales. CA. 
It has been hypothesized that selective lengthening of 
repolarization and prolongation of action potential duration by 
"pure" Class III antiarrhythmic agents is a potent antiarrhythmic 
mechanism. We evaluated this hypothesis by studying 24 pts with 
clinical VTNF and baseline inducible (I) sustained VT (SUSVT) 
during electrophysiologic study who were treated with oral 
sematilide (SEM) (mean dose 390 mg/d). The mean increase in RV 
monophasic action potential duration by SEM was 10%. The 
predictors of suppression of I SUSVT by SEM were also examined. 
Pts in whom SEM supressed I SUSVT were defined as drug 
responders. RV ERP was measured at a cycle length of 400ms. 
N 
Age 
History of MI 
LVEF 
Baseline VT cycle length 
I!. Sinus aRS duration 
Baseline RV ERP (ms) 
Sematilide RV ERP (ms) 
I!. RV ERP from baseline (ms) 
% Change in RV ERP(ms) 
Increase in RV ERP > 30ms 
Responders Nonresponders f 
10 (42%) 14 (68%) NS 
57:t13 58:t7 NS 
64% 60% NS 
35:t 12 36:t 12 NS 
249:t 49 226:t 36 NS 
1.3% ·7.0% NS 
227:t 25 235:t 19 NS 
260:t23 250:t21 NS 
33:t13 16:t15 .01 
15% 7% .01 
50% 0% .01 
Conclusion: Selective prolongation of ventricular refractoriness 
by sematilide resulted in suppression of I SUSVT in 42% of pts. 
The degree of SEM induced prolongation of RV ERP was the only 
predictor of I SUSVT suppression. Thus. prolongation of ventricular 
refractoriness is a critical determinant of the effectiviness of drug 
induced prevention of I SUSVT with selective Class III agents. 
310A ABSTRACTS 
961·117 
Effects of Beta-Adrenergic Blockade on Transcardiac 
Potassium and Magnesium Differences During Simulated 
Ventricular Tachycardia 
Keijo Peuhkurinen, Heikki Huikuri, Juha Takkunen. 
Department of Internal Medicine, Oulu University 
Central Hospital, Oulu, Finland 
Changes in transcardiac electrolytes may play a 
specific role in the degeneration of ventricular 
tachycardia (VT) to ventricular fibrillation (VF). In 
this study VT was simulated by rapid ventricular pacing 
(150 bpm) and femoroarterial-coronary sinus (FA-CS) 
differences in serum potassium and magnesium were 
measured before and after beta-blockade with 
propranolol (PRO) in 12 patients with and 6 without 
coronary artery disease (CAD). During the 3 minute 
pacing period the FA-CS differences in lactate turned 
negative (from 0.21 to -0.19 mM, p<0.05) in CAD 
patients. CS potassium decreased (from 4.0 to 3.7 mM, 
p<0.05) with simultaneous increase in the FA-CS 
difference (from 0.09 to 0.36 mM, p<0.05). Magnesium 
difference also tended to increase, but the change was 
not statistically significant. All the changes 
disappeared within 2 minutes after pacing. Acute 
beta-adrenergic blockade with PRO did not affect the 
pacing-induced efflux of lactate, but totally prevented 
the changes in electrolytes. In the no CAD group 
lactate and electrolyte FA-CS differences did not 
change during the pacing period. 
Thus, the changes in transcardiac electrolytes 
during simulated VT in CAD patients appear to be 
mediated by sympathoadrenergic activation, and this may 
explain the beneficial effect of beta-adrenergic 
blocking agents in preventing sudden death. 
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962·82 
Ventricular Fibrillation Amplitude Does not Decrease Over 
Time in Pre-Hospital Cardiac Arrest 
Donald D. Brown, Lor; Hartley, Richard E. Kerber, 
University of Iowa, Iowa City, Iowa 
Ventricular fibrillation amplitude (VFA) has previously 
been shown to be a powerful predictor of success in 
resuscitation from pre-hospital cardiac arrest; a lower 
VFA predicts failure to achieve defibrillation. A 
prevalent assumption has been that VFA declines parallel 
to duration of VF. To evaluate this assumption, we 
reviewed basic ambulance dual channel tapes of voice and 
continuous EeG monitoring from seven patients in pre•
hospital cardiac arrest due to VF. The only 
resuscitation performed was basic CPR. We measured VFA 
initially (range 0.4-1.1mV, mean 0.6) and then at one 
minute intervals until hospital arrival (range 3 to 11 
minutes). VFA is expressed as mV at each time period/mY 
of ini1iil VFA (mVT/mVI). Results: 
Time: 
#patients 
mVT/mVI 
1.0 min. 
5 
1.01 
z.."QhQ!....Q~§.J! 
6 6 5 6 5 
.99 .97 .95 .93 .79 
Time: 7.0 min. U M .l.Q 11 
#patients 4 3 4 1 2 
mVr/mVI .72 .86 .83 .9 .95 
Our data suggest that VFA in pre-hospital cardiac 
arrest is not influenced by duration of VF during the 
first few minutes after arrival of rescuers. Thus, VFA 
may be used as a relatively independent predictor of 
resuscitation succcess. 
962·83 
JACC Vol. 19, No.3 
March 1, 1992:31OA 
Identification of Ventricular Tachycardia Patients by 
Hi&b·Resolution Magneto- and E1ectrocardio&I'8phy 
Markku Milijarvi, Lauri Toivonen, Pentti Siltanen, luha 
Montonen·, Matti Leinio·, Toivo Katila·. 
Helsinki University Central Hospital, Helsinki, Finland· 
'Helsinki University of Technology, Espoo, Finland 
In order to evaluate the capability of the high-resolution 
magnetocardiography (MCG) and electrocardiography (ECG) to 
recognize patients with malignant arrhythmias, we studied 30 
patients: 10 patients with ventricular tachycardia (VT) after 
myocardial infarction, 10 patients with myocardial infarction 
without VT (MI), and 10 normal controls (C). The duration of 
the signal-averaged QRS complex (in vector magnitude) after 25 
Hz filtering was longer for the VT group compared with the MI 
group and the C group both in MCG and in ECG. The root 
mean square (RMS) of the last 40 ms of the end of QRS was 
smaller for the VT group compared with the MI group also 
both in MCG and in ECG: 
VT MI C p-value 
QRS/MCG (ms) 137-34 108-10 106-8 0.0168 
QRS/ECG (ms) 160-33 98-14 95-11 0.0001 
RMS/MCG (PT) 585-478 785-424 1295-651 0.0390 
RMS/ECG (uV) 14-17 41-26 51-29 0.0047 
The best criteria for an abnormal finding in MCG were: 
QRS duration > 120 ms and RMS < 700 pT. The sensitivity 
of MCG was 75 % and the specificity 78 %. 
Thus the results of this study show that MCG is a new 
noninvasive technique for identification of patients at risk of 
malignant arrhythmias after myocardial infarction. 
962·84 
Ambulatory Recording of Intracardiac Electro•
grams in tbe Diagnosis of Complex Arrbythmias: 
a Novel Application of Bolter Monitoring. 
J Paul Mounsey, Janet M McComb. 
Freeman Hospital, Newcastle upon Tyne, UK. 
The mechanism of paroxysmal arrhythmias 
cannot always be defined from surface ECGs, and 
the arrhythmia may not be observed at electro•
physiologic study (EPS). Ambulatory recordings 
of intracardiac electrograms and surface ECGs 
may be diagnostic in such arrhythmias. 
24 hour recordings were obtained in 3 
patients (pts) with frequently occurring 
paroxysmal arrhythmias by connecting the distal 
pole of an indwelling bipolar atrial electrode 
to one channel of a standard Holter recorder 
(Tracker, Reynolds Medical). The surface ECG 
was simultaneously recorded on the second 
channel. Electrograms suitable for analysis 
were obtained during tachycardia in all pts. 
Analysis of the relationship between the atrial 
electrogram and QRS complex was diagnostic in 
all pts and in 2 pts, additional arrhythmias 
not observed at EPS were recorded. 
The arrhythmias recorded using this technique 
were atrial tachycardia conducted over an 
accessory pathway and AV reciprocating 
tachycardia (pt 1); atrial flutter with 1:1 AV 
conduction (pt 2); and ventricular tachycardia 
with 1:1 VA conduction, with paroxysmal atrial 
flutter (pt 3). 
Ambulatory recording of intracardiac 
electrograms is a simple and effective 
modification of a standard technique, which may 
be diagnostic in pts with complex paroxysmal 
arrhythmias. It has particular application when 
arrhythmias cannot be demonstrated at EPS. 
lACC Vol. 19, No.3 
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962·85 
'lbe 12-Iead m; can Differentiate True ~ 
fran Mi.d-sEpt:al hrEssory Pathways. 
ll.lZ-Maria Rodriguez, Jilrg Schlapfer, Olristian de 
OUllou, Joep Smeets, Hein Wellens. 
Dept. of cardiology, Academic Hospital, Maastricht, The 
Netherlarxis . 
In an attelTpt to establish ECX; features which can dif•
ferentiate tJ:ue posteroseptal (PS) from mid-septal (MS) 
acx::essory pathways (AP), the 12 lead Eo;'s of 17 pa•
tients (pts) with a sin:Jle anterogradely conductin:J AP 
were analyze:i. AP location was confinned by surgery. 
Bffil1Jts: 
PS MS P-Value 
Nbm; 2 8 aQRS +30'to -60' +30'to +60' <0.001 
a Delta Wave O'to -60' O'to +45' <0.001 
R/S >1 (lead >V2) 0% 87% =0.002 
Delta Negativity: II 78% 0% =0.006 
AVF 89% 0% =0.001 
III 100% 25% =0.002 
Delta Negativity in at 
least 01 IDj;eri,.or lea9§ 100% 0% <0.0001 
Ccn<lusioos: 1) The 12-lead EO; allows differentiation 
between true PS and MS AP. 2) These ECX; features are of 
value when ablative procedures are considere:i. 
962·86 
The Effect of High Energy Epicardial Defibrillation Shock 
on the 12 Lead Surface Electrocardiogram In Patients with 
and without Coronary Artery Disease 
Geoffrey A. Rose and Francis E. Marchlinski 
Universily of Pennsylvania. Philadelphia. Pennsylvania 
ECG changes following transthoracic cardioversion have been 
described. but the spectrum and time course for resolution of 12 Lead 
ECG changes after a direct shock to the epicardium from an implantable 
defibrillator (ICO) are not known. ECG changes are of particular concern 
In patients (pts) with ICOs because of the high incidence of coronary 
disease in these pts and the vasospastic potential of direct application 
of shock current to coronary vessels. To document the incidence. 
magnitude. time course. and type of ECG changes after ICO shock. we 
prospectively obtained serial 12 lead ECGs in 48 post-operative pts 
prior to and at 1. 3. 5. and 10 minutes after termination of induced 
ventricular arrhythmias by a 25-30 joule AICO TM shock. Shocks were 
delivered directly to the epicardium through intrapericardially located 
anterior and posterior patCh electrodes. In 34 pts. coronary disease 
(N.33) or documented vasospasm (N=l) was present. In 14 pts. 
nonlschemic cardiomyopathy (N.l0) or primary electrical disturbance 
(N.4) was present. Only 2 pts had nonsupraventricular rhythms at 1 
minute and were excluded. No new A-V conduction disturbances or 
isolated T wave changes were seen. Isolated ST segment depreSSion 
(> 1 mm) occurred in one patient. ST segment elevation (in at least 2 
leads) of lto 15 mm occurred in 26 pts (56%). with ~ 4mm change in 16 
pts (35%). These changes were confined to the anterior precordial 
leads in 25 of 26 pts. ST elevation was as common in pts with fixed or 
vasospastic coronary disease (19/32 pts. (59%)) as those without fixed 
or vasospastic coronary disease (7/14 pts. (50%)); (p=NS). All ECG 
changes resolved within 10 minutes. There was no correlation 
between the magnitude of ST elevation and time course to resolution. 
In conclusion. 25-30 joule ICO shocks delivered via the described 
lead system frequently (>50%) results in transient «10 minute) ST 
segment elevation but rarely causes other ECG abnormalities. 
Although the basis for the ST segment elevation is not known. it does 
not appear to be due to the presence of fixed coronary disease. 
Persistent ST segment changes after ICO shocks should raise 
suspicion for significant ischemia. 
ABSTRACTS 
963 Radionuclide Imaging-Pharmacologic Stress 
Wednesday, April 15, 1992 
2:00 PM-5:00 PM 
Dallas Convention Center 
Lower Level Exhibit Hall 
Presentation Hour: 3:00 PM-4:00 PM 
963·43 
Bow Well Does MenOime ThaUlWD 8clnttaraphy Chancterize 
Eztent aDd LocatloD of CoraaaJy Artery DJseue? 
Kevin Allman. Jonathan Beny. Lisa Sucharski. Kate Stafford. Nell 
Petry. Wanda Wysor. Markus Schwalger. 
University of Michigan. Ann Arbor Michigan. 
Adenosine Is a potent vasodUator now avaUable for Intravenous 
use In cardiaC stress perfUSion scintigraphy. We determined Its 
diagnostic perfonnance combined with thallium tomography to 
assess extent and location of coronary artery disease (CAD) In 76 
patients without prtor myocardtaJ infarction or revascularizatlon. 
There were 43 males. 33 females. age 63 ± 13 yrs who were unable to 
exercise and underwent adenosine thallium tomography and 
coronary angiography within 14 ± 12 days. This group was a subset 
from the first 790 patients undergoing adenOSine perfusion 
SCintigraphy at our InStitution. Sclntlgrams were scored visually by 
two observers (agreement 89%) and by a quantitative program 
generating polar maps of left ventrtcular tracer dlstrtbuUon 
compared statistically with gender specific databases of subjects 
with <5% likelihood of CAD. Sixty patients had anglographlc 
lesions ~ 50% which were considered significant. Receiver operating 
charactertsUc (ROC) curves were generated for the visually scored 
sclntlgrams against the anglographlc gold standard. From these 
curves optimal predictive accuracies for disease detection. vessel 
localization and Identification of multlvessel disease (MVD) were 
determined and compared with the quantitative results as shown: 
Detection Detection 
of CAD lAD OCA LCK of MVD 
Visual 0.79 0.66 0.71 0.72 0.46 
Computer 0.00 0.61 0.70 0.01 0.47 
Visual and quantitative analySIS perfonned comparably. These 
findings for CAD detection and lOCalization are slmUar to those 
reported using exercise and dipyridamole stress. However. 
adenOSine thallium studies are of ilInlted value In differentiating 
single from multlvessel CAD. Thus. adenOSine thallium 
scintigraphy prOvides clinically useful Infonnatlon regarding 
presence and localization of CAD. but accurate assessment of 
disease extent may require absolute measurements of coronary 
reserve. which are not possible with this technique. 
963·75 
lrJt:rcMlrlaJs adenosine veJ:SUS int:rawn:alS high dose 
dipyridr:Jm:lle, bath in 0CIIbim:t.icn with lCii l.evel. 
exercise, in the SiDe patiEnts usiD] tec.tmetiUllt-99m 
sm'lMIBI SPEX!l' ~ perfusicn ~ 
Paul Vermeersch, Fred Verzijl.bergen, Maarten-Jan 
Cramer, carl Ascoc::p. st Ant:.caU.us Hospital, Nieuwege.in, 
'!he Netherlarxis 
We performed mtravencus (IV) adenosine (AD) (0.14 
Dg/kg/minf durin:J six miraItes) and IV high dose 
dipjridam:lle (HID) (0.84 Dg/kg), bath in ClCllbination 
with low level bicycle exercise, usilq 'ro-99m SESTAMIBI 
SPEX:T, in the same 15 pts, in whan oorooary angi~ 
was performed. 13 had significant cortn!ry artery 
disease (> 70% stenosis). 
'!here was an excellent agreement between the sum of 
semiquantitative segment score of perfusion defects (1-= 
lXI defect, 2= possible defect, 3= definite defect): 1624 
of 3510 (234 segments x 15 pta) after AD and 1665 after 
HID, and for the ischemia score (1" lXI reversibility, 2= 
possible reversibility, Js definite reversibility) 
respectively 1522 and 1546. 
!loth Plarmacologic stress lICdal.ities correc:t1y predicted 
the presence or abseooe of significant coronary artery 
disease in the 15 pts. Non-aIrtllac side effects were 
seen in 4 pts after AD and in one after HID. Severe 
hypotension was only seen in two cases after HID. 
Arqina pectoris an3,Ior isdIemic S'lT segment c::tlarr.;1es 
eventually requirilq lIIIli.nc:PtYlline, occurred 5 times 
after AD and 8 times after HID. Mean duration of 
ischemia was shorter for AD cx:mpared to HID: 5 min 
versus 7 min. '!he mean duration of the stress test was 
14 mirAltes for AD and 20 mirAltes for HID. 
In CCI'X:lusion: AD with low level exercise resulte:l in 
highly ocn::ordant results with HID, with less severe 
cardiac effects and with a shorter isdIemia and study 
period. 
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963·76 
DatQbIDine stress 'Dlallium and Bchocardiogr~ for 
the Detection of Coronary Artery Disease 
Mark F. Warner, John J. PiWin, James A. Arrowood, 
walter H.J. Paulsen, James L. Tatum, Evelyne Qludreau, 
George W. Vetrovec, Medical College of Virginia, 
Rictmond, VA 
We performed dobutamine infusion with SPOCT 
thallium (00') and echocardiography (DE) in 15 pts who 
had undergone cardiac catheterization. There were 9 
fatales and mean age was 6l±12 yrs (43-77 yrs). 
Dobutamine was begun at 5 mcg/kg/min and increased 
every 3 min until symptoms or a maximal dose of 50 
mcg/kg/min. 10 studies were terminated early and mean 
peak dobutamine dose was 33±8 mcg/kg/rnin. Average 
resting heart rate (HR) was 80±16, and peak HR was 
123±20. In 3 pts there were EX:G changes of ischemia; 
5 pts had angina. Coronary artery disease (CAD) was 
defined as 5il% luminal reduction measured by calipers 
in a non-bypassed vessel. 00' was abnormal in all 13 
pts with CAD. 00' detected major vessel involvement 
(lAD, rex, RCA) in 28/31 distributions (9il%); 
specificity was 93%. DE was available in 13/15 pts. 
Of 12 pts with CAD, 1 had worsening in segmental wall 
motion with DE, while 6 had improvement in baseline 
abnormal wall motion; 4 pts had no change, and 1 study 
was uninterpretable. Sensitivity of DE for CAD 
detection was 58%. We conclude that 00' is an excellent 
test for the detection and localization of CAD. DE is 
less useful as a screening test for CAD but may detect 
viability in areas of segmental myocardial 
dysfunction. 
963·77 
Implication. of Early Onset and Degree of ST Depression 
During Adeno.ine SPECT Thallium Imaging 
Joseph Lemlek, Jeffrey Kegel, Virginia Cave, Basil 
Iskandrian, Jaekyeong Heo, Abdulmassih S. Iskandrian, 
Philadelphia Heart Institute, Presbyterian Medical Center, 
Philadelphia, PA 
This study examined the implications of degrees and 
onset of ST depression during adenosine infusion (140 
pg/kg/min for 6 min) in 232 patients (pts) with coronary 
artery disease (CAD); 78 with 1-; 72 with 2-; and 82 with 
3-vessel disease (VD). Of these, 91% had abnormal SPECT 
thallium images and 29, had ST depression. The ECG 
response showed early ST depression (within 3 min of 
infusion) in 40 pts (17%) and markedly positive changes (~ 
2 mm) in 19 pts (8%). The pts were older in the early or 
markedly positive ECG groups than those with no ST 
depression (68 t 9 vs 71 t 5 vs 83 t 10 years, P - 0.007). 
The decrease in blood pressure during adenosine infusion 
was -15 t 18 mmHg in pts with early ST depression, -10 t 18 
mmHg in pts with marked ST depression, and -1 t 19 mmHg in 
pts with no ST depression (P < 0.05). The number of 
diseased vessels was 2.3 to. 8 in pts with early ST 
depression, 2.5 t 0.7 in pts with marked ST depression, and 
1.9 t 0.8 in pts with no ST depression (P < 0.007). The 
extent of ischemia assessed by the number of segments with 
reversible defects (maximum - 20/pt) was 7.2 t 4 in pts 
with early ST depression, 7.5 t 4.1 in pts with marked ST 
depression and 5.9 t 4.7 in pts with no ST depression (P-
0.09). Although most pts with early ST depression (48%) or 
strongly positive ECG response (52%) had 3-VD, most pts 
with 3-VD did not have ST depression. Using multivariate 
analYSiS, the number of segments with reversible defects 
was the only predictor of 3-VD (F - 5.5, P < 0.02). 
Thus, early and strongly positive ECG response are rare 
during adenosine infusion but when present are predictive 
of extensive CAD and ischemia. 
963·78 
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Side Effects During Adenosine Thallium Imaging Using Single 
or Double Port Infusion Protocols 
Virginia Cave, Jaekyeong Heo, David Cassel, Basil 
Iskandrian, Abdu1massih S. Iskandrian, Philadelphia Heart 
Institute, Presbyterian Medical Center, Philadelphia, PA 
Double port infusion protocol during adenosine thallium 
imaging involves the use of two infusion systems; one for 
adenosine, and one for thallium. In single infusion 
protocol one infusion system is used and both adenosine and 
thallium are injected via "Y" connection. This study 
examined the pOSSibility that the single infusion system by 
displacing a column of blood filled with adenosine may be 
responsible for higher incidence of side effects. This was 
a parallel study in 123 patients (pts) using the single 
port system (group 1) and 130 pts using the double port 
system (group 2). Both groups were comparable in age (64 
t 11 vs. 66 ± 11 years), gender (men comprised 67% of pts 
in group 1 and 55% in group 2) and the resting heart rate 
and systolic blood pressure. Chest pains were more common 
in group 1 (56% vs. 42%, P - 0.03), as were ST segment 
depression (24% vs. 10%, P - 0.005). nausea (12% vs. 4%, P 
- 0.03), and second or third degree atrioventricular block 
(10.7% vs. 4.8%, P - 0.08). The other side effects were 
similar and the peak heart rate and systolic blood pressure 
were also similar. The SPECT thallium images were abnormal 
in 65% of pts in group 1, and 59% in group 2 (P - NS). The 
images were of high quality in all but two pts, both in 
group I, who had poor images because of low counts, 
possibly because of back flux of thallium into the 
adenosine infusion tubing. 
Thus. the use of a single port infusion system during 
adenosine thallium imaging is associated with a higher 
incidence of side effects possibly because of bolus effect, 
a slower rate of thallium injection, the use of a double 
lumen catheter, or preferably the use of double infusion 
systems is suggested to decrease the side effects. 
963·79 
preoperative Adenosine Thalllum·201 Myocardial Perfusion 
Imaging PredIcts Perloperatlve CardIac Events 
leslee J. Shaw, D. Douglas Miller, Thomas C. HiHon, Karen S. Stocke, Arthur 
M. Stelken, Barbara A. Kong, Bernard R. ChaHman. SI. louis University 
Medical Center, SI. Louis, MO. 
We have previously demonstrated the clinical utiIHy of adenosine (Ad) 
thallium·201 (Tl) defect redistribution for predicting surgical co"l'lications in 
pts who do not undergo preoperative coronary revascularization. In order to 
determine the relative predIctive value of Ad· Tl variables compared to 16 
recognized clinical risk markers for perioperative cardiac events (CE), 58 
consecutive patients (aged 63±12 yrs, 58% male) being evaluated for 
vascular (25), orthopedic (14) or general (19) surgery had eHher tomographic 
(0-50) or planar (n.8) Ad-Tllmaging (Ad=140 lIQIkglmin x 6 min). During 8±3 
mos of follow-up (97% complete), 80% proceded to surgery and 46% 
underwent preoperative coronary angiography. Blinded expert observers 
graded Ad-TI studies as normal (34%), fixed defect only (2%), reversible 
defect only (46%) and combined (fixed + reversible) defects (18%). Pis wHh 
normal scans (n.19) and 10 abnormal but revascularized patients underwent 
surgery without CE (myocardial infarction, death), while 6/8 nonrevascularized 
pts wHh l!1 reversible Ad-T! defect had CE (myocardial infarction-4, death~2). 
Stepwise logistic regression analysiS of clinical and imaging variables defined 
the relative risk of CE as: 
CLINICAl VARIABLES 
Diabetes meliHus 
left bundle branch block 
Three-vessel coronary disease 
ADENOSINE-TL VARIABLES 
.Jl. 
21 
5 
9 
Relatjye Risk 
2.6 
2.2 
2.9 
~ 
0.01 
0.04 
0.001 
Fixed defect 1 <1.0 NS 
ECG ST depression 12 2.3 0.009 
1 reversible defect 13 2.9 0.001 
l! 2 reversible defects 25 4.4 0.0004 
Fixed + reversible defects 10 4.8 0.0007 
We conclude that the presence of l! 2 reversible defects or a combined 
(fixed + reversible) Ad-T! defect are more predictive of perioperative CE than 
other clinical, imaging or stress ECG risk markers. Preoperative Ad· Tl 
myocard'aal perfusion imaging is an aHemative to dipyridamole in this setting. 
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963·80 
Prognostic Value of Dipyridamole Thallium Scintigraphy in 
Patients with Coronary Artery Disease Treated Medically 
Taishiro Chikamori, Yoshinori Doi, Mitsutoshi Yamada, Yoshihiro Yonezawa, 
Hiromi Seo, Toshio Ozawa. 
Kochi Medical School, Kochi, Japan 
Although the usefulness of dipyridamole thallium scintigraphy in the 
prediction of cardiac events in patients with coronary artery disease (CAD) 
was reported, its prognostic value in relation to established angiographic 
markers is unclear. Accordingly, 277 consecutive patients with CAD who 
were treated medically after initial thallium and angiographic studies were 
followed prospectively. Scintigraphic findings were evaluated visually with the 
help of circumferential profile curve; the extent and the severity of washout 
abnormality, diffuse slow washout and negative washout rate, respectively, 
were analyzed automatically. During 2.8±1.8 years, 21 patients experienced 
nonfatal myocardial infarction or cardiac death. Patients with cardiac events 
had a higher prevalence of multi·vessel CAD (67 vs 38%; p<0.05), ST 
depression during dipyridamole loading (57 vs 31%; p<0.02), extensive 
reversible defects (29 vs 12%; p<0.05), diffuse slow washout (43 vs 24%; 
p<0.06) and negative washout rate (67 vs 29%; p=0.0003) compared with 
those without events. Left ventricular (LV) score was worse in patients with 
events than in those without (16±7 vs 12±5; p=0.05). The negative washout 
rate was the best single marker in the prediction of cardiac events with 
sensitivity of 67% and specificity of 71 %. Stepwise discriminant analysis 
using clinical and angiographic variables revealed that the combination of 
number of diseased vessels, LV score and previous myocardial infarction was 
most statistically significant (chi·square=20, p=0.0002) in the prediction of 
events. After including the findings of dipyridamole scintigraphy, the analysis 
revealed that the combination of negative washout rate, number of diseased 
vessels, LV score, ST depression during dipyridamole loading, previous 
infarction, and chest pain during loading was the best (chi·square=33, 
p<0.0001) predictor of cardiac death or myocardial infarction. These results 
indicate that the addition of dipyridamole thallium scintigraphic data to 
established angiographic markers can help better identify the patients with 
CAD who are at high risk of cardiac events. The prognostic value of negative 
washout rate, the best predictor of cardiac events, demonstrated in this study 
also underscores clinical usefulness of thallium washout analysis. 
963·81 
COLLATERAL STEAL BY DIPYRIDAMOLE·Tc·99m MIBI 
SPECT: IMPACT ON SUCCESS OF MECHANICAL RE· 
CANALIZATION OF OCCLUDED CORONARY ARTERIES. 
Christol1h A. Nienaber, Catarina Todd, Jens de la Roche, Ricardo 
Montz. University Hospital Eppendorf, Hamburg, FRG. 
In search for predictors of success or failure of percutaneous translu•
minal coronary recanalization (PTCR), 26 patients (57±11 yrs) with 
collateral supply to total coronary obstructions [TOO] were subjected 
to biphasic Tc-99m MIBI SPECT in vasodilation and at rest prior to 
attempted PTCR. The perfusion territory of the TOO was analyzed 
for evidence of collateral steal as defined by a net decrease in myo•
cardial Tc-99m MIBI uptake on circumferential profiles during 
vasodilation as compared to Tc-99m profiles at rest. Scintigraphic 
evidence of Tc-99m-MIBI steal was predominantly found in well 
collateralized myocardial segments as compared to patients with faint 
or no collaterals, who revealed baseline and vasodilation-induced 
relative hypoperfusion, but no net decrease in Tc-99m counts. 
~: Evidence of Tc-99m MIBI steal in the territory of the TCO 
had a sensitivity of 87.5% and a specificity of 90% to predict an 
unsuccessful PTCR due to long-standing occlusions and well•
developed collaterals. Logistic regression analysis confirmed TC-
99m MIBI steal (8=4.1; p<.01) and the angiographic presence of col•
laterals (8=2.4; p<.05) as significant predictors of failed PTCR. 
Conclusions: (1) Evidence of collateral steal by biphasic dipyrida•
mole/resting Tc-99m MIBI SPECT is likely to predict unsuccessful 
PTCR. (2) The assessment of Tc-99m MIBI steal may be helpful in 
preselecting patients and avoiding unsuccessful attempts of PTCR of 
long-standing total coronary obstructions. 
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964·44 
Evaluation of Leg Perfusion During Exercise Using 
Tc99m Sestamibi - A New Test for Peripheral Vascular 
Disease 
L. Samuel Wann, Charles Hellman, Gerald Dorros. 
St. Luke's Medical Center, Milwaukee, Wisconsin 
313A 
Functional evaluation of the muscular perfusion of the 
lower extremities is important in the differential 
diagnosis of leg pain and is potentially valuable in 
guiding interventional therapy of occlusive arterial 
disease. Currently used non-invasive methods provide 
only indirect information regarding the functional 
consequences of diminished arterial blood supply to the 
legs. We, therefore, used a new radionuclide to evaluate 
leg perfusion during exercise in 20 patients undergoing 
arteriography for suspected peripheral vascular disease. 
30mCi of Tc99m Sestamibi was injected IV during maximal 
treadmill exercise. Anteroposterior scintigrams of the 
thighs, calves and feet were obtained immediately 
following exercise using a high resolution collimator. 
An acquisition time of less than 2 minutes per view 
produced high quality images with excellent resolution 
of individual muscle groups. A quantitative method 
b3sed on pixel intensity was developed to compare areas 
of regional perfusion. Arteriography confirmed the 
presence of >70% luminal obstruction in arteries leading 
to all 34 muscle segments found to be hypoperfused on 
exercise scintigraphy. Reasonably good agreement also 
existed between the distribution of areas of muscular 
hypoperfusion during exercise and results of ultrasonic 
vascular imaging and color Doppler flow mapping and 
segmental blood pressure determinations performed in a 
subset of patients. 
We conclude that perfusion imaging of the legs with 
exercise using Tc99m Sestamibi can detect regions of 
reduced muscular perfusion secondary to arterial 
occlusive disease. 
964·45 
safety and Efficacy of Bolus Urokinase in Acut. 
Deep Venous Thrombosis 
Samuel Z. Goldhaber, Joseph F. Polak, Michael 
F. Meyerovitz, Mark A. Creager, Brigham and 
Women's Hospital, Harvard Medical School, 
Boston, MA 
In the U.S.A., thrombolytic therapy for acute 
deep venous thrombosis (DVT) has not gained 
wide acceptance because of its associated 
bleeding complications_ Bolus thrombolytic 
therapy, in lieu of prolonged continuous 
thrombolysis, has gained increasing recognition 
as a strategy for improving safety without 
compromising efficacy. Therefore, we tested a 
novel dosing regimen of bolus urokinase (UK): 
1,000,000 U/I0 minutes administered 3 times 
over 24 hours via a peripheral vein in 19 
patients, 12 women and 7 men, with leg (14) or 
upper extremity (5) DVT_ Average age was 47.3 
(range 27-75) years, and 10 patients were 
receiving treatment for cancer. Clot lysis was 
evaluated with ultrasonography or venography. 
All patients received heparin and warfarin 
after UK. Overall, 58% of patients had 
evidence of clot lysis; 37% were unchanged; and 
5% worsened. None had major or minor bleeding 
complications. Average nadir fibrinogen 
decreased to 37% of the baseline level. 
Bleeding time (upper limit of normal=9.5 
minutes) increased from 6.3 to 8.2 minutes 
immediately after the final bolus of UK. The 
results indicate that the efficacy of bolus UK 
in DVT is similar to that of continuous 
infusion of thrombolytic agents, but the safety 
profile may be improved. 
314A ABSTRACTS 
964·46 
Thromboembolic Risk of Atrial Flutter 
Ian W. Black, Andrew P. Hopkins, Lincoln C.L. Lee, Warren 
F. Walsh. Prince Henry Hospital, Sydney, Australia. 
The potential thromboembolic risk of atrial flutter is 
not well known. We compared the findings in 20 pts with 
non-valvular atrial flutter (flutter) and in 150 pts with 
non-valvular atrial fibrillation (fibrillation) referred 
for transesophageal echocardiography (TEE). Five pts 
(40%) with flutter and 62 pts (41%) with fibrillation were 
referred following embolic events. The presence of left 
atrial spontaneous echo contrast (LA SEC), a marker of LA 
stasis and thromboembolism in pts with fibrillation, and 
LA thrombi were specifically assessed. 
LA SEC was detected in 6/20 (33%) pts with flutter and 
80/150 (53%) pts with fibrillation. LA SEC was more 
frequent in pts with recent embolism in flutter pts (2/5 
pts (40%) vs 4/15 pts (27%» and in fibrillation pts 
(47/62 pts (76%) vs 33/88 (38%) pts). LA appendage 
thrombi were detected in 1/20 (5%) pts with flutter and 
18/150 (12%) pts with fibrillation. The single flutter 
pt with LA thrombus was referred prior to cardioversion, 
had no history of embolism, and was not receiving 
anticoagulant therapy. In pts with fibrillation, LA 
thrombi were detected in 14/62 (23%) pts with and in 4/88 
(5%) pts without recent embolism. 
Conclusions: LA SEC and LA thrombi may be detected by 
TEE in pts with atrial flutter, with a lesser incidence 
than pts with atrial fibrillation. These findings suggest 
that atrial flutter is associated with a potential risk 
of thromboembolism. 
964·47 
Intravascular Ultrasound in Patients with Acute 
Pulmonary EIIbolism: comparison to Angiography. 
GUnter Gorge, Raimund Erbel, Stefan Schuster, 
Thomas Gerber, Junbo Ge, and Jurgen Meyer; II. 
Medical Clinic, University of Mainz, FRG. 
Aim of the study was to verify the role of 
intravascular ultrasound (IVUS) in acute 
pulmonary embolism. In 10 consecutive patients 
(pts.) with suspected pulmonary embolism, a 
4.8F, rotational tip, 20 MHz ultrasound catheter 
was advanced over an 8F introducing sheath 
either from the left or right arm, after biplane 
pulmonary angiography was performed and thrombo•
lytic therapy initiated by 2·10· Units Urokinase 
as a bolus and 1·10· Units over 1 hour. In all 
pts., pulmonary vessels down to a minimal 
diameter of 3 mm could be imaged. All pts. 
showed free floating and/or adherent thrombi. In 
2 pts. obstructing thrombi could be perforated 
by the IVUS catheter. In 5 pts., thrombi ad•
herent to the vessel wall accounting for an area 
reduction of ~ 25% were detected by IVUS, but 
overseen by biplane angiography. Picture quality 
in the proximal parts of the pulmonary arteries 
was inferior because of the limited far field 
resolution of the IVUS catheter. No adverse side 
effects occured. 
CONCLUSION: In pts. with pulmonary embolism, 
IVUS is a save method and provides precise 
information about the extent of the disease. 
IVUS provides additional information in pts. 
wi th wall adherent thrombi, which are often 
overlooked otherwise. Monitoring the effect of 
lytic therapy with an IVUS catheter in place 
seems to be possible. 
964·48 
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Glide Wire and Luer in Angloplasty of the Superficial Femoral 
Artery: InItial Outcomes and Complications in 222 Patients 
Craig Walker, Richard Abben, Gary Chaisson, William Ladd, Joseph 
Kowalski, Wayne Pharo, David Allie. Tommy Fudge, Vance Frickey, 
and Samuel Stagg ill. 
Cardiovascular Institute of the South. Houma, Louisiana 
We compared initial outcomes of 147 PTA cases with the "glide" wire 
(GW) with 130 laser or laser-assisted PTA (LPTA) cases with/without 
GW in 222 pts. with 371 lesions of the SFA. All pts. had claudication 
and/or limb-threatening ischemia. 
Initial success was dermed as < 50% residual stenosis post-PTA. 
InItial Success [successes/attempts per lesion (%)] 
PTAlGW LPTAlGW LPTAlno GW LPTAltotai 
1751203 (86%) 6Sn5 (87%) 75193 (80%) 1401168 (83%) 
Comps. [leases (%)] PTAlGW LPTAlGW LPTAlno GW 
Major perforation 8/147 (5%) 5/S0 (10%) 14/80 (17.S%) 
reocclusion 31147 (2%) 0 4/80 (5%) 
A-V fistula 01147 (0%) 0 1180 (1 %) 
total major comps. 11/147 (7.S%) 5/S0 (10%) 19/80 (24%) 
Minor dissection 121147 (8%) 6150 (12%) 3/80 (4%) 
embolization 3/147 (2%) 0 4/80 (S%) 
vasospasm 11147 (0.7%) 0 1180 (1%) 
total minor comps. 16/147 (11 %) 6150 (10%) 8/80 (10%) 
The primary success rate and minor complication rates of PT NGW 
are comparable to that of LPT A. The major complication rates of 
PTNGW and LPTNGW are comparable. but both PTNGW (p < 
.005) and LPTNGW (p < .OS) demonstrated reduced major 
complication rates versus LPT Nno GW. GW improves outcome of 
PTA, resulting in excellent success rates and reduced complications. 
964·49 
A New Rheolytic Catheter for Percutaneous 
Thrombectomy 
Philippe C. Douek. Amir Gandjbakhche. Martin B. Leon, Robert F. 
Bonner. National Institutes of Health, Bethesda, Maryland 
Phannacologic treatment of intravascular thrombus is limited by 
delayed time to effect, incqmplete lysis, and drug-related side•
effects. Therefore, we investigated a new flexible 6F over-the-wire. 
double-lumen rheolytic catheter system with six-60~m radially 
disposed orifices at the tip which delivers pulsatile high pressure 
(S,OOO-15,OOO psi) jets of saline and results in 1) fragmentation of 
material at the catheter tip by creating a trapping vonex and 2) 
particle removal via suction through the central lumen. In vitro 
studies were performed to define optimal working conditions for 
varying target substrates and to determine particle size distribution 
and removal efficiency. Experiments were on large occlusive targets 
(8 cm length, 1 em diameter) using fresh and organized thrombus 
(n=20) or collagen gels (n= 10) of varying stiffness (5% to 20% + 
formalin cross-linking). Target extraction efficiency was assessed 
using video recorders and particle analyses were performed by 
filtration and light scattering techniques. Results: At low 
pressures (SSOO psi). fragmentation efficiency was adequate only for 
fresh thrombus and loose (5%) gels but particle size distribution was 
unfavorable. At high pressures (11000 psi), fragmentation 
efficiency was optimal (speed O.Scm/sec) with complete removal of 
occlusions but was strongly dependent upon thrombus composition 
(fresh vs organized) and gel stiffness. Particle distribution analysis 
indicated that 99% of the occlusion volume was extracted and only 
I.S% of removed particles were >4Ollm in size. Approximately 1 % 
of the occlusion volume escaped distally. For the oldest organized 
thrombus (6 months) and stiffest gels (+ formalin cross-linking), 
complete fragmentation and removal of material was not achieved. 
In conclusion: This new rheolytic thrombectomy catheter 
efficiently fragments and removes large volume thrombi and gel 
occlusions with minimal distal particle embolization. In vivo studies 
are required to establish clinical applications. 
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964·50 
Pilot study of 8 50mg over 10 milaltes Alteplase regimen in 
massive pulmonary embolism 
G.Pacouret, B.Charbonnier, B.Delahousse, P.Fournier. 
Cardiology. Trousseau University Hospital. Tours (F) 
We previously reported a 42+5 % decrease of total pulmonary 
resistances (TPR) with SOmg Alteplase (A) over 2 hrs in massive 
pulmonary embolism (MPE). In order to assess the efficacy 
of a shorter intravenous (iv) infusion, 21 patients (pts) with 
recent «Sdays) MPE (Miller's index >20/34, mean pulmonary 
arterial pressure (MPAP) >20mmHg) were treated with a 50 
mg iv A infusion over 10 minutes with iv Heparin (500 
lU/kg/day). Results of MPAP, cardiac index (CIl, and TPR 
were as follows (meantSD) 
Time MPAP(mmHg) C.W/min/m!) TPR(U/m!) 
Baseline 33.8± 9.7 2.26±0.S4 - IS.7±5.8-
O.SH 31.3±1l.1 2.47±0.47 13.1±S.S 
1 H 28.5±10.2 2.47±0.56 12.3±6.0 
2H 29.2±10.9 2.49±0.56 12.3±5.8 
12H 23.2± 9.4 2.46±0.48 9.7t3.9 
TPR decrease rate was respectively 17.3£11.3 (p<.OOll, 24.6±13 
(p<.OOI), 26.2±16.5 (p<.Oll and 37 .3il7.1 % (p<.OOI) at 0.5, 
1,2 and 12H. Miller's index diminished from 24.7±2.4 at baseline 
to 22.2±3.8, 25±8H after A (l4.1±22 % reduction rate, p<.OOll. 
Results of fibrinogen (F), plasminogen (P), alpha2 antiplasmin 
(A2AP) and D.dimere (DD) monitoring were: 
~ F(gn) P(%) A2AP(%) DD(ug/mll 
Baseline 4.43±1.27 115±24 83tll 7 .0±7.0 
IH 1.54±1.54 52±28 10±20 87.7±88.1 
12H 1.75±1.77 89:!;22 42±17 68.7±64.4 
24H 2.51±1.46 94±32 62±12 23.2:t23.1 
8/21pts (38%) had a F level below Igll at 1 H. Neither death 
nor serious bleeding occured. Bleeding rate was 23.8% (5/21). 
Thus, 50 mg A over 10 minutes provided a fast decrease of 
TPR but below the haemodynamic response observed with 
previously tested A regimens. Randomized stUdies are mandatory 
to evaluate the interest of A short iv infusion in MPE. 
964·51 
Thrombolytic Thet'lpy in Severe Acute Pulmonary Emboliam. Efficacy 
Ind Safety in Elderly Pltienta. 
Reml Schultz, Nlcoias Meneveau, Frant;ols Schiele, Thierry Anguenot, 
Yvette Bernard, Jean-Pierre Bassand. 
H6pltai Unlversltaire Salnt.Jacques - F 25000 BESANCON 
Thrombolytic therapy In severe acute pulmonary embolism Is usually 
not administered to elderly patients since It Is thought to be potentially 
hazardous because of the incree,sed risk of bleeding complication. In 
order to verify whether thrombolytic therapy rnay be justWied In elderly 
patients, we prospectively submitted to thrombolytic therapy all patients 
with documented severe acute pulmonary embolism (Miller score ~ 17/34) 
free of contraindication to thrombolytic therapy without taking the age 
into consideration. Over a 2 1/2 years period, 72 patients were admitted 
Into the trial, 46 s 75 years and 26 > 75 years. The two groups were not 
different In terms of average Miller score, mean pulmonary pressure and 
mean pulmonary resistance. FHty-elght received Streptokinase, 100000 IU 
per hour over a 6 to 24 hours period and 4 received etther Urokinase or 
Alteplase. 
Group A Group B P 
N 26 46 
Age 78.±.6 56.±.13 <0.01 
Miller score 22+3 21.±.3 NS 
Mean PA 37±8 34.±.7 NS 
Hemorrhage 6 7 NS 
Tranfusions 4 4 NS 
Death 2 2 NS 
There were no difference In the clinical evolution as well as In the Miller 
score and pulmonary pressure regimen evolution after thrombolytic 
therapy. Bleeding complications were not more frequent In elderly 
patients. No Intracranial bleeding was observed. 
We concluded that thrombolytic therapy was as efficient and safe In 
elderly patients as In non elderly patients. 
ABSTRACTS 
964·52 
von Wille~rand Factor and Plasminogen 
Activator Inhi~itor as Predictors of Cardio•
vascular and Thro~oembolic Events in 
Rheumatoid Arthritis 
Torbjorn K. Nilsson, Gosta Dahlen, solveig 
W!llberg Jonsson, Solbritt Rantapaa Dahl•
qvist, Mats R!nby. Departments of Clinical 
Chemistry and Rheumatology, Ume! University 
Hospital and Department of Medical Biochemis•
try, Ume! University, Sweden 
The excessive death rate in rheumatoid 
arthritis (RA) is partly due to cardiovascu•
lar/thromboembolic disease (CVD). We studied 
the predictive impact of the endothelial•
derived haemostatic factors, von willebrand 
factor (vWF) and plasminogen activator inhi•
bitor, as well as serum lipids, in 74 conse•
cuti ve RA patients (mean age 63.5 yr, range 
27-82, RA duration 21.9 yr). In a 2-yr 
follow-up, 8 had had CVD (1 DVT, 2 PE, 3 AMI, 
1 thrombosis of the superior mesenteric 
artery). This subgroup had significantly 
higher vWF, PAI-1, and triglycerides (TG) 
than those without events, and lipoprotein 
Lp (a) also tended to be higher. Except for 
the strong association between PIA-1 and TG, 
the risk associations appeared independent in 
multiple logistic regressions. Patients with 
extra-articular manifestations differed only 
in having significantly higher PAI-1 than 
those without. 
We conclude that vWF and PAI-1 are new addi•
tional risk factors for CVD also in RA 
patients. 
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965·21 
A ROLE FOR ATRIAL NATRIURETIC FACTOR (ANF) AS A 
MODUlATOR OF TIlE SYSTEMIC VASOCONSTRICTOR 
RESPONSE TO ENDOTIlELIN IN A LOW CARDIAC OUTPUT 
(CO) MODEL OF HEART FAILURE. 
&. Dent Underwood, Lawrence I.. Aarbus, and John C. Burnett, Jr. 
Mayo Clinic and Foundation, Rochester, MN 
Plasma Endothelin-l (ET), a potent vasoconstrictor, has been 
demonstrated to be increased in CHF. Despite this increase, studies 
bave demonstrated a hypo-responsiveness to ET infusion in 
experimental CHF associated with elevated ANF. This study was 
designed to determine if a) circulating ET is increased in a model of 
low CO and low ANF produced by thoracic inferior vena caval 
constriction (TIVCC), b) the TIVCC model has an intact 
vasoconstrictor response to ET infusion (5 nglkg/min IV), and c) if 
ANF (10 nglkg/min IV) infused to mimic concentrations as seen in 
CHF would attenuate the systemic vasoconstrictor response to ET. 
Anesthetized dogs were studied 8 days after TIVCC. Compared to 
controls, plasma ET was increased in the TIVCC model (40.5±6.6 vs 
17.9±1.6 pg/ml). ANF levels in the TIVCC were 11±1, compared to 
183±23 pg/ml in TIVCC w/ANF. 
Groups: TIVCC (n=7) TIVCC w/ANF (n=7) 
Baseline ET Baseline ET 
MAP (mmHg) 106+6 124+9· 102±9 110±12 
CO (Umin) 1.7±.2 1.2±.2· 1.5±.2 1.3±.2· 
SVR (RU) 67±7 107±14· 69±7 89±13 
Values are mean ± SEM: RU, nunHg/l1min; ·p<0.05 vs Baseline. 
With exogenous ET infusion, a potent systemic vasoconstrictor 
response is present in tbe TIVCC dogs and is not different from 
controls (SVR: 36±5 to 83±9 RU, p<0.05). In the presence of 
pathopbysiologic concentrations of ANF, the SVR and MAP responses 
to ET were attenuated These studies suggest that ANF may playa 
counter-regulatory role upon the vasoconstrictive actions of ET in 
beart failure, a state of increased circulating ET. 
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965·22 
Endothelin, Angiotensin n and Coagulation in Heart Failure. 
Eftichia Sbarouni, Anne Bradshaw, Jo Good, Celia Oakley, Mike 
Rampling, Ted Tuddenharn, John Cleland. Dept. Medicine 
(Cardiology), R.P.M.S. Hammersmith Hospital, London. U.K 
Arterial and venous thrombo-embolism cause substantial 
morbidity and monaIity in patients with heart failure. 
Angiotensin n is often increased in heart failure, is associated 
with a poorer prognosis and could activate coagulation systems. 
Accordingly, plasma angiotensin n, endothelin, noradrenaline, 
fibrinopeptide A (FPA), D·Dimers, beta·thromboglobulin 
(BTG), von Willebrand's factor (vWF) and blood viscosity were 
measured in patients with severe heart failure, 13 of whom had 
dilated cardiomyopathy and 9 coronary disease. 
All patients showed evidence of abnormal coagulation. 
Mean Range Normal Range 
Angiotensin II (pmol/L) 38 12·73 < 12 
Endothelin (pg/ml) 2.1 0.5-6.7 < 1.0 
FPA (ng/ml) 4.0 0.4·18 <3 
D-Dimers (ng/ml) 673 95-2,000 <400 
BTG (IU/mI) 158 73·316 <40 
vWF (u/ml) 1.8 0.5-4.3 <2 
Viscosity (mPas) 51 36-78 <55 
Plasma endothelin was related to plasma angiotensin II and vWF 
(both r = 0.54; P < 0.Q1). Abnormalities of coagulation correlated 
poorly with exercise capacity, ventricular function and other 
indices of neuroendocrine activation. 
These data suggest that there is activation of the coagulation 
system in heart failure which is balanced by increased 
fibrinolysis. Increases in endothelin and vWF may be a result of 
endothelial damage in heart failure. 
965·23 
Prostaglarrlins Specifically Attenuate Endothelium•
Depenjent vasodilation in Patients with Congestive Heart 
Failure 
stuart D. Katz, Michael Schwarz, Paola I.evato, Thierry 
LeJentel, Albert Einstein College of Medicine, Bronx, NY. 
1loetylcooline (J\ch) -mediate:i, endothelium-dependent vas•
odilation is reduced in patients with oongestive heart 
failure (QIF). To detennine whether prostaglarrlins con•
tr:ib.lte to reduced endothelium-dependent vasodilation in 
QIF, the local vasodilatory responses to brachial art•
erial infusion of graded ooncentrations of Ach (10-7M to 
10-"M) arrl an endothelial-independent vasodilator, nitro•
glycerin (NI'G, 10-8M to 10-sM), \>leI'e studied in the 
foreann circulation of 10 patients with QIF (mean age 50, 
mean EF 22%) prior to arrl 1 lDlr follCMing oral adminis•
tration of 50 nq ilrlc:rtethacin. Foreann blood flow (mll 
100ml) was measured by venous occlusion plethysrography. 
Indanethacin did not chan;Je resting foreann blood flow 
fran baseline (3.2 vs 3.4, poNS). Foreann blood flow 
responses to J\ch \>leI'e as follows: 
Ach 10-7M 10-6 M 
Baseline 3.4 4.1 
Post-Indomethacin 5.8* 6.9* 
* p<. 05 vs baseline 
l'lesponses to NI'G prior to arrl after indomethacin 10Iere 
similar. In 5 control patients, response to J\ch after 
placel:o did not chan;Je. In conclusion, acute cyclooxy•
genase inhibition with indomethacin potentiates endothel•
ium-dependent vasodilation in patients with QIF. Sinoe 
the response to NI'G was unaffected, prostaglandins spec•
ifically attenuate endotheliurn-dependent vasodilation by 
either directly reducing production or release of endo•
theliurn-derived relaxing factor (nitric oxide) or 
through J\ch-stim1late:i synthesis of a prostanoid-con•
stricting factor. 
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FOREARM VASCULAR RESPONSIVENESS TO ~. 
ADRENOCEPTOR STIMULATION IN PATIENTS WITH 
CONGESTIVE HEART FAILURE. 
Ciro Indolfi, Antonio Rapacciuolo, Vittorio Ambrosini, Antongiulio 
Maione, Giuseppe Gargiulo, Massimo Chiariello. 
Division of Cardiology, University of Naples, ITALY. 
While it is described that desensitization of cardiovascular S•
adrenoceptors occurs in patients with congestive heart failure (CHF), 
it is unknown whether the functional integrity of the ~-adrenoceptors 
is preserved in this condition. To clarify this issue, we studied 12 
patients with CHF (due to primary dilated cardiomyopathy, mean 
ejection fraction= 29±9 %, NYHA class nom) and 8 age-matched 
normal subjects. All drugs were withheld at least 72 hours before the 
study. Forearm blood flow was measured by venous occlusion 
plethysmography. Three intra-arterial doses of BHT 933 (a selective 
~-receptor agonist agent, 0.1, I, 10 Jlg/Kg/min) were infused in the 
2 groups of subjects. In CHF, forearm blood flow (FBF, ml/l00 mI 
of tissue) was reduced from 3.8±2.3 to 2.7±1.4, 2.3±1.5 (p<O.OI), and 
to 2.O;t1.5 (p<O.OI), respectively, with the increasing doses of BHT 
933. In control subjects, FBF was reduced from 5.O;t1.8 to 3.9±1.5 
(p<O.OI), 3.4±1.7 (p<O.OI), and 2.3±1.2 (p<O.OI). The dose-response 
to BHT 933 was not different in the two groups (by ANOVA). The 
intraarterial infusion of a selective ~-adrenoceptor blockade 
(Yohimbine,5 JIg/min for 4 minutes) increased FBF from 2.9±0.9 to 
4.6±1.7, (p<O.OI) in CHFpatients as well as in controls (from 3.9±Q.6 
to 4.6±2.6, p<0.05). 
Thus, our data demonstrate that functional integrity of the ~­
adrenoceptors is preserved in patients with congestive heart failure. 
965·25 
Stress-induced Changes in Forearm Vascular Dynamics in Heart 
Failure: Distinction between Ischemic and Dilated 
Cardiomyopathy. 
Patricia Cavero, Krishnankutty Sudhir, Frank C. Calli, Teresa 
DeMarco, Kanu Chatterjee. 
Cardiovascular Research Institute, University of California at San 
Francisco, San Francisco, California. 
Peripheral vascular function is abnormal in heart failure, but the 
relation of etiology to these abnormalities has not been fully 
studied. We studied patients with idiopathic dilated 
cardiomyopathy (lOC, n=8) and ischemic heart failure (lHF, n=8), 
and 8 age-matched control subjects (C, n=8) to identify specific 
differences in vascular function. Using venous occlusion 
plethysmography, forearm vascular resistance (FVR) was measured 
in response to 4 stresses: cold, hyperemia (Hyp) induced by ischemic 
cuff occlusion, hand-grip exercise (Exer), and mental stress (MS). 
FVR at baseline was not significantly different in the 3 groups. 
Results' C IDC IHE 
Cold (FVR % rise) 76.3±13.5 151.8±29.8t 93.8±22.8 
Hyp (FYR % baseline) 15.2±2.8 25.6±3.7 30.9±4.4* 
Exer (FVR at max, R units) 7.7±1.5 6.9±1.4 8.5±O.9 
MS IFYR at max R units) 16 8±2 0 20 8±3 0 16,6+1 8 
Differences from C are idicated by * (p<O.05). and t (p=O.07) 
Thus, cold-induced reflex sympathetic activation is enhanced in 
IOC but not IHF, whereas the hyperemic response is impaired in 
IHF. The responses to exercise and menial stress are similar to 
control in both categories. These findings suggest that abnormal 
peripheral vascular responses in heart failure vary with etiology. 
Enhanced reflex sympathetic activation appears to be part of the 
syndrome of IOC, while structural changes in IHF that impair the 
hyperemic response could reflect widespread atherosclerotic 
disease. 
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965-26 
Central Fatigue is Not Responsible for Skeletal Muscle 
Dysfunction in CHF 
John R. Minotti, Prem Pillay, Lauren Wells, Linda Chang, Barry 
M. Massie, VAMC and University of California, San Francisco, 
CA 
We have previously demonstrated that skeletal muscle endurance 
is impaired in patients with congestive heart failure (CHF). 
Potential sites that could be responsible for accelerated fatigue 
include the central nervous system, neural transmission from nerve 
to muscle, and changes within the muscle itself. The goal of this 
study was to determine whether increased "central fatigue", defined 
as an abnormality proximal to the neuromuscular junction, is 
present in CHF. Therefore, we performed tetanic stimulation (200 
volts, 240 msec train at 50 Hz) of the peroneal nerve superimposed 
on maximal voluntary isometric contraction (MVC) of the tibialis 
anterior muscle in 8 NYHA Class II and III CHF patients and 8 
seden~ age-matched controls. Force potentiation by nerve 
stimulation during MVC indicates a "central" component of 
fatigue. During 3 brief MVC's, force was not significantly 
different in the CHF patients and controls (102±37 vs 93±22 Ibs, 
respectively), and was not potentiated in either group by tetanic 
nerve stimulation. Fatigue, defined as time to 40% decline in 
force during sustained MVC, occurred more rapidly in CHF 
patients (28±12 vs 53±23 sec, P <0.05). Tetanic stimuli 
superimposed when force had declmed to 40% produced slight 
potentiation of force, but the magnitude (13 ± 7 % in the CHF group 
vs 20±13% in controls, p =NS) was similar in both groups. 
These findings confirm that skeletal muscle fatigue occurs more 
rapidly in CHF, that the more rapid fatigue in CHF is not due 
decreased central motor drive. Thus, we conclude that skeletal 
muscle fati!:ue most likely reflects an alteration in muscle cross•
bridge cychng or activation. 
965-53 
Mechanical Restitution Patterns Predict Transition From Stable 
Left Ventricular Hypertrophy to Decompensated Failure 
Robert M. Lust, W Rando/ph Chitwood, Jr., Department of Surgery, 
East Carolina Universiry School of Medicine, Greenville NC 
The ability to predict the transition from stable compen.sated left 
ventricular hypertrophy (L VH) to decompensated heart failure is 
important in determining optimal timing for valve replacement 
operations. In this study, 22 mongrel dogs with severe LVH (LV 
wtlbody weight, 8.95 vs 4.65 g/kg, P < 0.01) 2° to critical valvular 
aortic stenosis were chron:cally instrumented with pacing leads, LV, 
LA, and arterial pressure lines. Every 2 weeks the animals were 
studied (awake, conscious). Mechanical restitution curves were 
generated by pacing at a fixed rate and interposing an extrasystole in 
the basic cardiac cycle. The duration of the extrasystolic interval 
(ESI) was progressively expanded until it equaled the basic cycle 
length. Then the ESI was fixed, the postextrasystolic interval was 
increased to twice the basic cycle length, and postextrasystolic 
potentiation (PESP) was assessed. The heart rate was changed and the 
procedure was repeated. A ratio of LV pressure, induced 
systolelbasic beat (%), was plotted versus ESI/basic cycle length (%). 
General LV function (evaluated by 2D-echo; ejection fraction, preload 
recruitable work, wall motion, chamber diameter, LV and LA 
pressure) was normal with stable L VH, but a fixed defect in restitution 
patterns was demonstrated (% of basic cycle required for 100% 
recovery of basic function increased 13%. p < 0.01) and PESP also 
was depressed. 210-270 days after aortic stenosis. 13/22 animals 
developed heart failure (LVEDP, LAP. chamber diameter; EF. wall 
motion). A further decrement in mechanical restitution and PESP 
preceded general LV dysfunction by an average of 42 ± 7 days (p < 
0.01). None of the animals that remained in stable, compensated LVH 
demonstrated the second decrement in restitution or potentiation. 
These findings may be important in evaluating progression to heart 
failure. predicting optimal timing for valve replacement, and 
understanding the mechanisms for decompensation. 
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965-54 
Diverse Metabolic Response Of cardiac Versus Skeletal 
lohlscle In Experillental Heart Failure 
Gordon W. lot:le, Etienne A. Grima, Runjan Seth, lChursheed 
Jeejeebhoy, Robert J. Howard, Paul W. Al:mstrong. 
University of Toronto, Toronto, cntario, CI1Mda 
Chronic RV pacing (250 beats/min) in:Iuces severe heart 
failure (HF) with reduced myocardial ATP in dogs after 
5 weeks. HcMever, the rapidity with which it occurs and 
what ensues in the skeletal 1lUSC1e are unclear. 'lbere•
fore, we studied metal:lolic variables fran the LV and 
soleus RIlScle (SM) in conjunction with assessment of LV 
contractile function in 5 dogs paced for only 1 week (1 
Wk) • Five DOnnal dogs served as controls (C). Data 
(It.±5[l) for ATP, creatine phosphate (CP), lactate (all 
urool/g) fran the LV ancI SM are shomo * p<0.05 VB C. 
LV SM 
ATP ~ lactate ATP ~ ~ 
C 22+1 24+5 2.6+1.9 17+2 50+8 6+5 
1 Wk 14+4* 7+5* 1.4+0.7 17+2 48+3 12+2 
At 1 Wk, - ATP am CP iii LV were r8:1uced Carpareci-to C 
while lactate was similar. LV dP/dt (DIll fig/sec) and 
cardiac outp.1t (l/min) declined fran 2570±646 and 4.8;t 
1.3 at baseline to 1438±265 and 1.9;tO.7 respectively 
(both p<0.05) indicating inpaired contractility rut the 
peak dP/dt increase with dobutamine was similar to base•
line (43;t33 VB 51;t25%, NS) indicating presmved contrac•
tile reserve. By contrast, ATP " CP in SM were similar 
to C, yet there was a trend for increased lactate (p= 
0.09), likely reflecting reduced peripheral perfusion. 
'nIese findings of reduced LV energy substrate ancI 
contractility in the face of preserved contractile 
reserve in early HF, coupled with our previous studies 
indicating a capacity for recovery after cessation of 
pacing, suggest a fom of "hibernation". By contrast, 
energy substrate is maintained in SM. 
965-55 
Clinical and Neurohumoral Response of Patients 
With Severe Congestive Heart Failure Treated 
With Two Different Captopril Dosages 
Richard Pacher l , Sebastian Globils I, Jutta Bergler-Klein I, 
Christoph Kratochwill l , Thomas Stefenelli I, Wolfgang 
Baumgartner l , Sehdi Sannini l , Emil Ogris3, Dietmar 
G1ogarl. 
Dept. of Cardiology I and Surgery n2, University of 
Vienna. and Dept. of Nuclear Medicine. KH Lainz3, Vienna. 
Although ACE-inhibitor therapy is an established 
approach in the treatment of hean failure. the required 
dosage remains unclear. 85 pts with heart failure NYHA 
II-IV receiving digitalis. diuretics and captopril :! 3 
months (28±14 mg/day) were divided to obtain either 
"high dose" (~75 mgld) or "low dose" « 75 mgld) 
captopril. At baseline. both groups were comparable in 
etiology. NYHA class. hemodynamic dala and plasma levels 
of atrial natriuretic factor (ANF), renin and aldosterone. 
At baseline 51 pts. were considered as heart 
transplantation candidates ("high dose" group n = 20 , "low 
dose" group n = 31. p = n.s.) After 6 months. only pts 
receiving captopril :! 75mg / day showed a significant 
improvement of NYHA class (p = 0.0001) accompanied by a 
significant decrease of aldoslerone (p < 0.01) and ANF (p < 
0.01). Renin significantly increased in both groups (p < 
0.01). Pts of the "low dose" group showed no change in 
clinical and neurohumoral parameters. 8 pIS died (I pI 
sudden death, 7 pts progression of heart failure). No 
deaths were observed in the "high dose" group (p = 
0.000 I). In 15 pIS heart transplantation was perfonned 
("low dose" n = 12. "high dose" n = 3. p < 0.(01). These 
findings emphasize the importance of suppressing 
neurohumoral overactivation with adequate dosages of 
ACE-inhibition. 
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Lac.It of CorreIalion BetweeD EjecIioD Fraction aad M}uaudial A 11' In 
Cantiom,opalby 
Randall C. Starling, Douglas B. VanFossen, Robert E. Kelley, Donald F. 
Hammer 
The Ohio State University, Columbus, Ohio 
Previous reports In small numbers of pIS. have Indicated Ibat there is a 
linear relationship between LVEF and myocardial A11' In pIS with dilated 
cardiomyopathy (DCM). The purpose of Ibis investigation was to examine 
the relationsbip between A11', LVEF and pulmonary artery wedge 
pressure (PAW) is pIS witb cardiomyopathy. In 48 pIS cardiac cath, 
coronary arteriography and endomyocardial biopsy (EBX) were performed. 
Myocardial A 11' was performed on EBX samples that were rapidly frozen 
after acquisition and assayed witb high performance liquid 
chromatography. Fony-three pIS had DCM, tbe mean L VEF was .28±.11 
(.11-.41), PAW 18±9 mmHg, CI 2.7±.7 Uminlm2 Five pIS bad 
restrictive cardiomyopathy (RCM), the mean LVEF were compared with 
a group of 12 pIS with normal (NL) cardiac function tbat bad myocardial 
A11' assayed at the time of EBX. Mean PAW was 12±3 mmHg in the 
NL group. Analysis of variance (ANOVA) demonstrated that tbe PAW 
was significantly > in Ibe RCM vs Ibe DCM group. ANOV A 
demonstrated a significant difference (p<.05) in LVEF in tbe RCM (.53) 
vs the DCM (.28) group. Myocardial A 11' values nm/mg protein were: 
13.3±8 in RCM; 24.4±8.4 in DCM and 31.9±13 in NL. ATP was 
significantly lower in the ReM pIS compared to DCM (ANOVA p<.05). 
Linear regression between L VEF and A TP revealed no correlation 
(roo.OS). However, a significant correlation between PAW and ATP was 
::1 .• ' demonstrated (r=.47 p<.OOI). In conclusion, 
" ,'::.. we bave demonstrated a lack of correlation .:~~.: •• ,: :  between LVEF and ATP in a large group of 
'" : r • ., pIS with cardiomyopatby. The lowest ATP 
:; " . ~'. • • values were present in the group with the 
: • • bighest EF (RCM). PAW bas a good 
• • " ':.-::." " " .... correlation witb ATP. We believe that an 
Increased PAW is associated witb increased wall tension, decreased 
subendocardial blood flow and decreased A TP. 
965·57 
Cardiac Troponln T Isoform Expression In Patients wtth Heart Failure 
Andrew Remppls. Thomas Scheffold. Sibylle Schleich. Hugo A. Katus 
University of Heidelberg, Heidelberg. FR-Germany 
It has been suggested that changes In the Isoform expression of cardiac 
troponln T (TnT) may be related to depressed cardiac contractile function 
observed In patients wtth end-stage heart failure. 
Methods: The Immunoreactivity of anti-cardlac TnT antibodies was assessed 
by Western-Blotting using TnT of human. beef. rat. and rabbit skeletal and 
cardiac muscle. respectively. The monoclonal antibody 1 Bl0 reacting wtth a 
conserved epttope of all TnT Isoforms of these different tissues was used to 
test the myocardiallsoform composition In 5 organ donors. In 16 patients 
with suspected dilative cardiomyopathy. and In 13 patients undergoing 
cardiac transplantation. Myofibrillar proteins were homogenized and ex•
tracted In 5 M Urea buffer (5 M Urea. 1 M KCI, 0.025 M Trls-HCI. pH 7.0. 
0.001 M EDTA) and centrifuged (20000 x g. 15 minutes. 4°C). The extracts 
were analysed on 1 and 2 dimensional SDS-polyacrylamidegeis and West•
em-Blots. 
Results: In contrast to myocardium of animals and to human skeletal muscle 
only one Isoform of TnT Is found In human myocardium on Western-Blots 
from l-d-polyacrylamidegeis wtth 9% and 12% polyacrylamide concentra•
tion. In Westem-Blots from 2-d-gels two TnT Isoforms with Identical molecu•
lar weight but different Isoeiectric points can be found both in myocardium 
from healthy and diseased myocardium. Purification of TnT results In the 
appearance of a lower molecular weight Isoform (37.5 KD) which Is not 
found In fresh human myocardium and therefore appears to be a degrada•
tion product, 
Thus. we did not find any evidence for a TnT Isoform shift In patients with 
end-stage heart faOure. 
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Myocardial Stunning In Hypertrophied Gulnea·Plg Heart after 
Inotropic Stimulation: A 31·P NMR Study 
Hirosumi Sakai. Nancy Ball. Elwood E. Brooks. George P. Kreishman. 
Richard A. Walsh. University of Cincinnati. Cincinnati,OH 
To characterize metabolic and mechanical changes during development 
of pressure overload hypertrophy (POH) in gUinea-pig hearts. we' evaluated 
responses of perfused hearts (constant-flow:10mVgr heart wt) to inotropic 
stimulation (INS; isoproterenol O.OS 11M). Hearts studied at 4 (n:7). and 
S(n=6) weeks after aortic banding (BAND) had 14% (p<O.OS), and 37% 
(p<0.01) increase in LV wtIbody wt vs sham operated controls (SHAM; 4w: 
n-6. Sw: n-6). 31-P NMR spectra of high energy phosphates were acquired 
every six minutes. At LV end-diastolic pressure of 10mmHg. LV Systolic 
Pressure (LVSP). and LVSP x Heart Rate (RPP) at rest were higher in BAND 
vs SHAM at 4w(143.1±4.3 vs 123.3±6.9 mmHg • 31.7 ±0.7 vs 2S.6±1.S 
mmHg°bpml1000; p<O.OS). but similar at Sw (120.3±7,9 vs 11S±9.4mmHg, 
26.1±2.2 vs 23.4±2.4 mmHgObpml1000; p=NS). LVSP and RPP were 
depressed in Sw BAND vs 4w BAND (p<O.05). The ratio of PVPCr at rest was 
increased in BAND vs SHAM at 4w (0.43±0.03 vs 0.33±0.02; p<O.OS) and 
Sw (0.39±0.02 vs 0.29±0.03; p<O.OS). RPP increased immediately. and 
remained almost constant during 30 min INS. PCr level decreased 
temporarily. but thereafter gradually increased and immediately reached the 
baseline value w~hout signijicant change in ATP level. Pi level temporarily 
increased and then remained constant. All of these changes during INS 
were similar in SHAM and BAND. at both 4w and Sw. Immediately after 
cessation of INS. signijicant depression of L VSP and RPP occured similarly 
in SHAM and BAND. accompanied with similar PCr overshoot at both 4w 
(S1.4±4.S vs 7S.S±17.S % over the baseline value; p-NS) and Sw (3S.6±4.9 
vs 48.7±S.0 %; p=NS). Thereafter. PCr level gradually decreased following 
recoveries of LVSP and RPP for 40 min recovery time (REC), but still 
remained over the baseline value during REC. Recoveries of LVSP and 
RPP during REC were signijicantly smaller in BAND vs SHAM at 4w (LVSP: 
68.7±2.6 vs 7S.1±2.3 %; RPP: 6S.3 ±3.7 vs 7S.4±2.7 % of baseline value; 
p<O.OS) and Sw ( 63.S±3.3 vs 79.1±5.1 %; SB.4±3.5 vs S1.7±6.S %; 
p<O.05) atthough ATP level, PCr level. and Pi level were similar (p=NS). 
Conclysions: 1) Oxidative phosphorylation is anered w~h POH at rest. 2) 
POH metabolic response to INS is similar to control. 3) Post INS myocardial 
stunning was more severe in hypertrophied vs normal hearts. 
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966·14 
Differential Effects or Right and Left Unilateral Eel on Heart Rate 
Richard Lane, M.D. (I), Richard Abrams, M.D. (2), Conrad Swartz, 
M.D. (2), M. Andrew DuBois, M.A. (2), and Ashok Van. M.D. (2). (I) 
University of Arizona School of Medicine, Tucson, AZ and (2) 
UHS/Chicago Medical School and Nord! Chicago Veteran's Affairs 
Medical Center, Nord! Chicago, IL 
To compare the HR effects of right and left unilateral 
electroconvulsive therapy (ECn. we studied 21 male veterans 
consecutively referred for ECT. Patients with a history or ECG evidence 
of cardiovascular (including hypertension) or neurological disease were 
excluded. Each patient received his first treatment with bilateral electrode 
placement, after which the second and third treatments of the course were 
administered alternately with left and right unilateral ECT according to a 
randomized, balanced design. Anesthesia was always induced with 
glycopyrrolate, methohexital, and succinylcholine. ECG tracings were 
examined blind to treatment electrode placement. 
A repeated measures analysis of variance performed on HR elevation 
over baseline at each IO-second interval for 90 seconds post-stimulus 
showed a significant electrode placement by time interval interaction 
(F=2.136; df=8,160; p=.035). Mean HR elevations for right unilateral 
ECT exceeded those for left unilateral ECT at each 1000000nd interval 
post-stimulus starting with the third, demonstrating a significantly greater 
mean postictal HR elevation with right than left unilateral. 
Since parasympathetic activity was substantiaUy attenuated if not 
eliminated by glycopyrrolate, HR changes were largely if not exclusively 
due to sympathetic effeclS. Given that the sympathetic innervation of the 
SA node is predominantly right-sided, these data are consistent with 
ipsilateral transmission of asymmetrical hemispheric activation. Since a 
Iateralized sympathetic imbalance, particularly to the left, lowers the 
ventricular fibrillation threshold, these findings are consistent with the 
hypothesis that trait hemispheric activation asymmetry, particularly to the 
left, constititutes a neuropsychological risk factor for sudden cardiac death. 
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Angioscopic Evaluation of Saphenous Vein Grafts 1ong•
Term After Coronary Artery Bypass Grafting. 
Nobuyuki Komiyama, Shigemoto Nakanishi, Shinichiro 
Nishiyama, Katsuo Fuse, Akira Seki. 
Toranomon Hospital, Tokyo, Japan 
The aim of this study was to evaluate the 
characteristics of stenotic lesions of saphenous vein 
grafts (SVGs) after operation by percutaneous 
transluminal angioscopy (PTAS) and to compare them with 
angiographic findings. 127 cases with 267 SVGs underwent 
follow-up angiography within 1 year and 5 to 8 yesrs 
after grafting. 243 of 267 SVGs hsd neither significant 
(275 percent) narrowing nor totsl occlusion in the 
early angiography. 25 of 243 SVGs had newly appeared 
significant narrowings and 22 had total occlusions in 
the late angiography. Percutaneous transluminal coronary 
angioplasty (PTCA) was performed to 36 lesions of the 25 
SVGs and PTAS was performed to 14 lesions of them just 
before PTCA. For PTAS O.5mm or O.7mm in diameter 
angiofiberscopic catheters were used with inner guide 
catheters. Results: 1) In angiography 27 of the 36 
lesions were localized, short and eccentric narrowings 
in shafts of SVGs. In PTAS yellow (lipid-rich) 
atheromatous plaques or ulcerations with new thrombi 
were showed in the lesions. All procedures of PTCA of 
them were successful and restenosis rate was 15 percent. 
2) 1 lesion was a diffuse, tubular and concentric 
narrowing in shaft of SVG in angiography. PTAS showed 
white and concentric tapered lumen suggestive of 
fibrointimal hyperplasia in the lesion. PTCA was 
successful but restenosis occurred. 
Conclusions: The PTAS can make clear the characteristics 
of SVG lesions in long-term after operation and suggest 
different mechanisms of appearance of the lesions. The 
PTAS may be useful for prediction of restenosis after 
PTCA of SVGs. 
966·16 
A Validation Study of A Doppler-tipped Angiographic 
Catheter For Measurement of Coronary Flow Velocity and 
Coronary Flow Reserve 
Anoop Chauhan, Paul Mullins, Gerard Taylor, Simon 
Kendall, Roy Gill, Michael Petch, Peter Schofield. 
Pap worth Hospital, Cambridge, UK. 
We assessed whether Judkins-style Doppler (JSD) catheter 
measurements are comparable to those achei ved wi th the 
intracoronary Doppler (ICD) teChnique in 19 patients with 
angiographically normal coronary arteries (9 Syndrome X 
and 10 heart transplant). Coronary flow velocity at rest 
(RFV) and at peak hyperemia after 12 mg intracoronary 
papaverine, (PFV), was measured with a SF JSD catheter 
positioned in the left coronary ostium and a 3.6F ICD 
catheter posi tioned in the proximal left anterior 
descending artery. Mean RFV was significantly higher 
with the JSD catheter (9.S cm/sec SD4.S) than the ICD 
catheter (5,9 cm/sec 505, p = 0.02). The mean PFV was 
also significantly higher with the JSO catheter (35 
cm/sec 5015 versus 19.9 cm/sec 50n p< 0.001). Coronary 
flow reserve (mean PFV:mean RFV ratio) was 4.04 (501.3) 
with the J50 catheter and 4.12 (SD1.3) with the ICO 
catheter (r=0.96). To offset any changes in the mean 
arterial blood pressure (MAP) during the study, a 
coronary vascular resistance index (CVRI) was calculated 
: (MAP at peak flow/PFV) / (MAP at rest/RFV). The CVRI 
was 0.254 (500.09) for the J50 catheter and 0.253 (500.1) 
for the ICO catheter (r=O. 94) . We conclude that the 
coronary flow velocity and flow reserve measurements 
obtained wi th these two catheter techniques correlate 
strongly. The Judkins-style Ooppler technique appears to 
be a quick, safe and accurate alternative to the 
intracoronary Doppler technique. 
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966·17 
Volume-Induced Secretion or Atrial Natriuretic Factor : 
Regulation by Calcium Influx or Intracellular Calcium Release ? 
Julian Donckier, Claude Hanet, Laurence Galanti, Liviu Stoleru, 
Henri Van Mechelen, Jean·Marie Ketelslegers, Hubert Pouleur. 
University of Louvain, Mont-Godinne, Belgium. 
To clarify the respective roles of extracellular calcium (Ca) or of Ca 
release from intracellular stores on volume-induced secretion of ANF, 
7 conscious instrumented dogs received a 40-min saline infusion 
(10% body weight), IS min after intravenous injection of either 
placebo or verapamil (y, Ca entry blocker, 0.2S mg/kg) or during 
continuous endothelin-I (ET -I) infusion (trigger of intracellular Ca 
release, at S ng/kg.min). In the 3 groups, saline produced a significant 
(p<O.OOI) rise of left atrial pressure (LAP) from 1.4±0.4 to 
12.2±1.4 mmHg in placebo, from 2.0±1.l to 12.9±0.7 mmHg in 
V and from S.0±2.1 to 16.S±1.3 mmHg in ET·1. During volume 
loading, ANF rose (p<O.OOl) from 2S.1±6.3 to SO.4±12.9 pmolll 
after placebo, from 30.2±6.1 to Sl.l±S.S pmolll after V and from 
31.2±6.1 to SI.0±12.9 pmolll with ET-l. This increase, similar with 
placebo and V, was greater with ET-l (p<0.02). However, within 
similar ranges of LAP, the relationship between ANF and LAP was 
not affected by V or ET-l. During hypervolemia, plasma ET-I 
remained unchanged after 
placebo but rose (p<O.OOI) 
from 1.7±0.S to 3S.3±9.2 :;; .. 
pmol/l with ET-I (concentra- ~ .. 
tions observed in some patho- ! 
logical states). Thus, ANF ~ .. 
levels are primarily determined 
by atrial pressure but are not 
affected by drugs modulating 
free intracellular Ca in vivo. 
966·18 
. ,. .. 
LE" ATRIAL PRESSURE (mm Hg) 
Safety or Cardiac Catheterization via Aorta-Femoral Grafts 
Edward J. Lesnefsky, Frank P. Carrea, Bertron M. Groves, Univ. 
of Colorado Health Sciences Center, Denver, CO 
There is little information concerning the complications and 
technical difficulties encountered when the femoral site is used for 
arterial access in the presence of aorta-femoral bypass grafts 
(AFBG). All cardiac catheterizations performed at the University 
of Colorado Health Sciences Center from 1/1/84-4/1/91 were 
retrospectively reviewed to assess the in-hospital clinical outcomes 
of patients who had AFBG and underwent prosthetic graft 
punctures to obtain arterial access. Twenty·three patients had 
percutaneous puncture of an AFBG from a total of 2929 arterial 
catheterizations performed. The average patient age was 61.S±2.7 
yrs (±SE). The interval from graft placement to catheterization 
was 9.3±1.3 yrs. Arterial sheaths were employed in all cases and 
corresponded to the catheter size with 14/23 (61%) using 5 Fr. 
and 9/23 using 7 Fr. systems. Heparin was administered in 23/24 
(96%) cases with 16/23 (70%) receiving 2S00 units i.v. bolus and 
the remainder 3000 units. Aspirin use (at least 325 mg/day) prior 
to catheterization was present in 18 patients. Protamine sulfate 
was not used post-procedure. Twenty to 60 minutes of manual 
compression was required to achieve hemostasis. There were no 
changes in distal pulses nor any incidents of clinically identified 
vascular insufficiency following cath. There were no infections, 
transfusions, need for surgical repair, or clinically significant 
hematomas. Technical difficulties occurred in two patients 
(inability to selectively cannulate a coronary). Percutaneous 
introduction of an arterial sheath and left heart catheterization via 
remotely implanted AFBG grafts is not associated with an 
increased risk of vascular complications. 
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Evolution and Prognosis of Dysthyroidism Occuring 
During Amiodarone Therapy. 
Eric D. Tison, Pascal Degroote, Christophe Loubeyre, 
Gerard Ducloux. University Hospital, Lille, France. 
To aBsess the prognosis and evolution of dysthyroidism 
occuring under Amiodarone (Am) therapy, we followed 
250 patients regulary treated, the diagnosis being 
assessed by TSH radioimmunometric test. Am was 
discontinued in each dYS~id case. 19 Hyperthyroid 
(H) and 27 hypothyroid (h) cases appeared and were 
followed by TSH tests for two years. Spontaneous 
recovery occured in 13 H patients, on an average 9 
months after Am discontinuation. 2 were h under 
Carbimazole, 3 others were will H without any treatment. 
The remaining patient was cured after radioactive iodine 
administration. 6 H patients deceased during the study. 
17 out of the 27 h patients remained h more than 18 
months after Am discontinuation. Recovery was obtained 
without treatment in the other 10 patients on an average 
11 months. 14 deaths were registered during the 
follow-up of h patients. 
Conclusion: (1) Dysthyroidism is a COmmon side-effect 
on Am therapy. (2) Recovery is common and most often 
spontaneous in H patients, while hypothyroidism 
frequently pursues its course. (3) No difference could 
be found, in terms of mortality, between Hand h 
states. 
966·20 
Presystolic Sounds Due to Flow Reversal in the Superior Vena 
Cava. 
Stephen J. Brecker, Han B. Xiao, Derek G. Gibson. The Royal 
Brompton National Heart & Lung Hospital, London, United 
Kingdom. 
The classical S. is due to atrial flow into a diseased ventricle, but for 
some presystolic sounds (PSS), venous origin has been postulated. 
We therefore recorded phonocardiograms over the precordium, upper 
right sternal edge and jugular veins with simultaneous ECGs, Doppler 
flow in the superior vena cava (SVC), and atria-ventricular (A V) 
valve flow in all patients referred for echocardiography over a six 
month period. In 21 patients (10 pulmonary hypertension, 3 dilated 
cardiomyopathy, 3 pericardial constriction, I aortic stenosis, I 
subaortic stenosis, I hypertrophic cardiomyopathy, I cardiac amyloid 
and I post Mustard operation) PSS were recordable from a localised 
area (only over the SVC or jugular veins). Each was associated with 
a rapid blood flow reversal in the SVC, evident on Doppler. PSS 
occurred at a point of change in acceleration (mean change = 
16.7±6.4 mis' =1.7g). The onset of the sound coincided with peak 
retrograde velocity in 13 cases, peak forward velocity in 5, and with 
the onset of retrograde flow in 3. In 16 cases no atrial flow across 
either A V valve could be detected, excluding a classical S.. In 5 
cases with atrial tricuspid flow, the sounds could only be recorded 
over the jugular veins. 
Conclusion: Presystolic sounds may be recorded over the SVC and 
jugular veins from patients with ventricular disease. They appear to 
originate from a rapid blood flow reversal in the SVC rather than A V 
flow, and are thus quite different from the classical S •. 
• This session is continued on page 39SA. 
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805·1 4:00 
Analysis of Restenosis Following Percutaneous Balloon Mitral 
Valvotomy: An Echo Doppler Study 
Habib Garnra, He Ping Zhang, John W. Allen, Francis Y.K. Lau, 
Carlos E. Ruiz. 
The Heart Institute-HGS-LDma Linda University, Los Angeles, CA. 
We analyzed restenosis (RS) in 156 pts who underwent percutaneous 
balloon mitral valvotomy (PMV) and followed by seria1 echo 
Doppler studies. The mean follow-up period was 15 ± 11 (1-63) mos. 
The overall RS rate was 14%. Seven variables--age, sex, pre NYHA 
functional class, rhythm, echo score, valvular calcification and post 
mitral valve area (MY A)-were used in the Cox proportional hazard 
regression analysis to determine which factors may affect RS at 
follow-up. Age, calcification and post MV A were found to be the 
determinant predictors of RS. Life-table analysis provided the 
following graphics: 
- =:::::,r. P'O.CM5 -== p<O.CM5 
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The risk ratio for RS was 1.8 in pts older than 55 yrs, 2.2 in pts 
with valvular calcification ~ 2 + and 2.0 in pts with post MV A 
< 1.6 cm2• Conclusions: (I) The overall RS rate at 4 yrs follow-up 
is low and the freedom of long-term RS after PMV is encouraging; 
(2) Older age, heavy calcification and suboptimal immediate results 
increase by at least 2 fold the risk of RS at 4 yrs follow-up. 
805·2 4:15 
Mitral Calcification Is The Best Predictor of 
Symptomatic Mitral Regurgitation Requiring Valve 
Replaceaent Following Balloon Mitral Valvota.y 
Paul N. Casale, Thomas H. Marwick, William J. Stewart, 
Fernando Grigera, Patrick L. Whitlow 
Cleveland Clinic Foundation, Cleveland, Ohio 
Development of progressive mitral regurgitation (MR) is 
a known complication of percutaneous balloon mitrsl 
valvotomy (PHV). Of 69 patients (pts) followed 19 + 10 
months after PHV, 7 pts (10%) required mitral valve 
replacement (MVR) because of symptomatic MR. Trans•
esophageal (TEE) and transthoracic (TTE) echocardio•
grams were performed prior to PHV in all pts. TEE and 
TTE were graded independently for leaflet mobility, 
thickening, calcification and subvalvular disease on a 
scale of 1-4 with a maximum score of 16. Fluoroscopic 
calcium was graded 0-4 at the time of PHV procedure. 
Of 24 clinical, echocardiographic, hemodynamic, 
angiographic and procedural variables, univariate 
predictors of symptomstic MR requiring MVR were: 
No MVR(n-62) MVR(n-7) p 
TEE calcium 1.3 + 0.7 2.2 + 0.9 <.001 
Fluoro calcium 0.5 +.0.9 1.7 + 1.7 <.01 
TTE calcium 1.6 + 0.8 2.3 + 0.8 <.05 
MR pre PHV 0.5 + 0.6 1.0 + 0.8 <.05 
The standard score by TTE was- not a predictor of 
symptomatic MR requiring MVR (p-.lO). Multiple logistic 
regreSSion analysis revealed leaflet calcification by 
TEE as the only independent predictor of symptomatic MR 
requiring MVR at follow-up (p < .001). Using a cutoff 
value of 2 for TEE calcium, sensitivity and specificity 
for symptomatic MR requiring MVR are 57% and 94% res•
pectively with an accuracy of 90%. 
Conclusion: Severity of mitral calcification, beat 
assessed by TEE, predicts development of symptomatic MR 
requiring MVR during follow-up after balloon valvotomy. 
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805·3 4:30 
TRANS ESOPHAGEAL ECHOCARDIOGRAPHY IN 
CANDIDATES FOR BALLON MITRAL VALVULOPLASTY 
Dirk Hausmann, Bernd Heuhlein, Andreas Miigge, 
Hans-Jiirgen Engel, Jochen Grote, Werner G. Daniel. 
Hannover Medical School, Hannover, Germany. 
In 57 candidates (9 m, 48 f; age 55±12 yrs.) for percutaneous 
hallon mitral valvuloplasty (BMV), the role of transesophageal color 
Doppler echocardiography (TEE) was studied. All patient~ (Pt~) 
were suitahle for BMV according to transthoracic color Doppler 
echocaruiography (TIE) (i.e. mitral regurgitation (MR) ~ 1+, no 
thromhi, no or only mild valve calcifications). Rcsult.i:. In 18/57 
(32%) pt~, TEE added new information: In contrast to TIE, TEE 
revealed thromhus (THR) in the left atrium (LA; n=13, including 
12 THR in LA appendage). THR in right atrium (n= I), mitral 
valve vegetation (n= I), cor triatriatum (n= I). In 2 other pt~, LA•
THR was suspected hy TIE hut could he excluded hy TEE. Calcifi•
cation of mitral apparatus and MR severity were comparahly clas•
sified hy TEE and TIE. Pt.~ with vs. without LA-THR showed no 
significant differences regarding the presence of atrial fihrillation 
(92% vs. 77%), NYHA class (2.8±0.3 vs. 2.7±0.4), LA-diameter 
(59±9 vs. 54±8 mm), presence of spontaneous LA echo contrast 
(100% vs. 80%), history of previous arterial embolism (46% vs. 
22%). In pt~ with LA-THR, repeated TEE documented THR•
resolution after coumarine therapy (n = I) or arterial embolization 
(n=l), and THR were confirmed in all 9 pt~ undergoing surgery. 
In 35 pt~, BMV (33 Inoue-, 2 Trefoil-technique) was performed 
without emholic complications or increment of MR > 2 + . 
Conclusjoos' In candidates for BMV, TEE frequently provides new 
important information not revealed hy TIE. TEE is mandatory in 
all pt~ prior to BMV, even in the ahsence of previous embolic 
event~ and in the presence of sinus rhythm. 
805·4 4:45 
Influence of Mitral Valve Morpholo8Y by Transesophageal 
EchocardloJI'Bphy on Immediate and Long· Term Outcome of 
Balloon Mitral Valvuloplasty 
Gregory Pavlides, Andrew Hauser, Patricia Dudlets, and Gerald C 
Timmis, William O'Neill. William Beaumont Hospital, Royal Oak, 
Michigan 
Transesophageal echocardiography (TEE) allows better visualization of 
mitral valve morphology; however, its value in predicting the outcome 
of balloon mitral valvuloplasty (BMV) has not been assessed as 
adequately as for transthoracic echocardiography (TrE). Prior to BMY 
in SO pta (mean age 59 yean), leaflet mobility, thickness, calcification 
and subvalvular disease were subjectively scored 1-4+ by both TI'E and 
TEE. Mitral valve arca (MY A) was hemodynamically calculated pre•
and post-BMY in all pIS, and by TTE in 21 pts at 7 ± 4 months post•
BMY. 
The TI'E scores while slightly higher, correlated well with TEE scores 
(r-0.51,p<0.OOI). PIS' age correlated positively with both TI'E (r=0.41, 
p<O.OI) and TEE scores (r-O.34, p<O.OI). There was no differencc in 
final MY A nor MY A increase between pIS with total scores .s.. 8 and 
>8, by either TTE or TEE. The increase in MY A did not relate to 
total TTE or TEE scores. By multiple regression analysis, the increase 
in MY A correlated negatively to valve calcification by TTE 
(r-0.29,p<0.05) and mobility by TEE (r .. 0.59,p<0.02). 
The % reduction in MY A at follow-up was greater with age 
(r-0.5,p<0.02), time to follow-up (r-0.67,p<0.002), valve mobility by 
TTE (r=0.59, p<O.OI) and valve calcification by TTE (r-0.37, p=O.09) 
and TEE(r=0.4,p.0.07). NODSUrvivors (7) at follow-up had higher total 
scores by either TTE (p<O.OOl) or TEE (p<0.05) compared with 
survivors. 
Asseasment of mitral valve morphology by TEE is complementary and 
not superior to assessment by 1TE. Mitral valve calcification and 
mobility arc the most important morphological predictors of immediate 
and long-term outcome following BMY. Age and post-BMY interval 
are the strongest determinants of restenosis. 
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ABSTRACTS 
4:00 
Inhibition of Factor Xa Attenuates Procoagulant Activity of Whole 
Blood Clots Incubated with t-PA In Vitro 
Nelson A. Prager, Evan S. Wasserman, Dana R. Abendschein, and 
Paul R. Eisenberg. Washington University, St. Louis, MO 
Procoagulant activity of thrombi can impede arterial thrombolysis 
and promote early rethrombosis. To determine the relative 
contribution of prefOlIlled clot-bound thrombin compared with de 
novo activation of prothrombin by factor XI, human whole blood 
clots formed in Chandler tubes were incubated at 37'C in human 
plasma containing t-PA (1.5 j.lglrn1), with either heparin (0.5 U/mI); 
recombinant hirudin (0.1 j.lM); recombinant tick anticoagulant 
peptide (TAP, 0.1 11M), a specific factor Xa inhibitor; or no 
inhibitor added. After 30 min, the plasma was recalcified and 
thrombin activity was measured by generation of fibrinopeptide A 
(ng/mI) in samples obtained serially: 
TIme (mjp) ~ .l!l .u 
Controls 
(-) clot (n=4) 
(+) clot (n=2) 
heparin (n=4) 
hirudin (n=4) 
TAP (n=2) 
x±SD 
80±39 
620 ± 493 
217 ±60 
217 ±55 
215±24 
157 ± 100 
1925 ± 1133 
268± 72 
228±50 
364±32 
SOO±256 
18615 ± 4504 
358±84 
485±24 
284±34 
Clots exposed to t-PA have marked procoagulant activity. 
Inhibition of activation of prothrombin is as effective as direct 
inhibition of thrombin for attenuating procoagulant activity. Thus, 
de novo activation of prothrombin accounts for a substantial 
fraction of procoagulant activity of clots incubated with t-PA. 
Inhibition of factor Xa may provide an effective approach for 
reducing procoagulant activity of thrombi in vivo during and after 
thrombolysis. 
806·2 
Thrombogen.sis In Patients With Q Wave and Non Q 
Myocardisl Infarction 
4:15 
321A 
Syed M. Jafri, Gerardo Polanco, Mihai Gheorghiade, 
Tsunenori Ozawa, Eberhard Mammen, Sidney Goldstein, Henry 
Ford Heart and Vascular Institute, and Wayne State 
University, Detroit, Michigan 
The degree of thrombogenesis may be an important 
determinant of the extent of myocardial infarction. 
Patients with Q wave myocardial infarction (QMI) and Non Q 
myocardial infarction (NQMI) differ with respect to the 
angiographic identification of intracoronary thrombi and 
infarct size (CPK). To document the extent of ongoing 
thrombogenesis, plasma levels of thrombin-antithrombin III 
complexes (TAT), an index of thrombin generation and 0-
Dimers (D-Di), a marker of fibrinolysis were determined 
12-24 hours sfter onset of symptoms in patients not 
receiving thrombolytic therapy or heparin. Findings were 
compared to normal volunteers of similar age. 
Normals Non QMI QMI 
N 18 8 13 
Age (yrs) 61 + 2 64 + 4 63 + 4 
CPK (IU/1) - 590 + 118 1356 + 303** 
TAT (~g/l) 2.40 + 0.1 13.8+ 11 33 ± 23 
D-Di (ng/ml) 216 + 23 303 + 83 793 + 222* 
*p <0.05 vs normals; **p <0.07 QMI V8 NQMI -
Increased plasma levels of TAT or D-Dimer indicating 
ongoing thrombosis and fibrinolysis were present in 53% 
(7/13) of patients with QMI and only 25% (2/8) of patients 
with NQMI 12-24 hours after onset of symptoma. Ongoing 
thrombogenisis in patients with QMI when compared to NQMI 
may contribute to the large infarct size in QMI. 
Conclusions: Our findings suggest that thrombogenesis is 
completed earlier in the course of NQMI and is a 
continuing phenomenon in QMI. Ongoing thrombogenesis in 
QMI may contribute to the greater extent of myocardial 
damage in QM1. 
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Coronary Artery Narrowing Distal to tbe Tbrombus After 
Tbrombolysia: Primary Vasospasm or Platelet Activation 
Jawabar L Mehta. Franccsca A. Nicolini, Wilmer W. Nichols, Saeed 
Khan, Tom GP Saldcen, University of Florida and VA Medical Center, 
Gainesville, FL 
Dynamic coronary artery constriction distal to the site of 
narrowing has been observed in dogs witb cyclical flow reductions 
(CFRs). We have observed similar CFRs and coronary artery 
narrowing distal to tbe site of coronary artery thrombus on scanning 
electron microscopy (SEM) in dogs with electrically-induced coronary 
thrombus and subsequent thrombolysis with tissue plasminogen 
activator (t-PA). SEM shows extensive endothelial disruption and 
deposition of platelets and fibrin in the region of tbrombus as well as at 
sites distal to the tbrombus. To determine the contribution of dynamic 
primary vasoconstriction (vasospasm) vs. platelet activation, 33 dogs 
with electrically-induced stable thrombus were treated with t-PA alone 
(n-I I), t-PA+ nitroglycerin (n-7) ort-PA+i1oprost, a syntbetic analog 
of potent platelet inhibitor prostacyclin (n=9). Other 7 dogs were given 
nitroglycerin (n-4) or i1oprost (n-3) immediately after t-PA had 
restored flow. Concurrent administration of nitroglycerin or i1oprost 
with t-PA decreased time to reflow, peak reflow as well as duration of 
reflow (all P<0.02 vs_ t-PA alone). Plasma levels oft-PA were lower 
(P<O.O J) in dogs given nitroglycerin or i1oprost concurrently with 
t-PA, presumably due to enhanced liver blood flow and accelerated 
catabolism oft-PA. In dogs given nitroglycerin after t-PA-induced 
reflow, CFRs continued to occur and the reperfused coronary artery 
reoccluded in all instances. Ex vivo platelet aggregation was 
unaffected by nitroglycerin administration. In contrast, i1oprost 
(lOOng/min) given after t~PA-induced restoration of flow resulted. in 
sustained flow in all instances. CFRs were abolished and ex \IlVO 
platelet aggregation decreased markedly. These data suggest .that 
platelet deposition may be an important basis of CFRs and distal 
coronary artery narrowing after t-PA-induced tbrombolysis. Primary 
dynamic vasospasm is an unlikely mediator of coronary artery 
narrowing after restoration of flow with t-PA. 
806·4 4:45 
The Effect of Cocaine on Human Platelets 
Shereif Rezkalla, Joseph J. Mazza, Robert A. Kloner, Veronica Pillema, 
Sheng-Hsiung Chang. Marshfield Clinic, Marshfield, Wisconsin, Hospital 
of the Good Samaritan, Los Angeles, California 
Clinical reports have documented acute myocardial infarction following 
recreational use of cocaine. Coronary angiograms or autopsies have 
revealed thrombus, but in about 40% of cases, no atherosclerotic 
narrowing. Thrombo-embolic events occur in other organs as well. 
However, while coronary artery vasospasm has been suggested to be one 
potential mechanism whereby cocaine might induce myocardial 
infarction, another potential mechanism might be related to altered 
platelet function. The effect of cocaine on human platelets is unknown. 
Therefore the purpose of this study was to determine whether cocaine 
increases human platelet aggregation. Forty ml of blood was withdrawn 
from 10 healthy volunteers and platelet rich plasma samples were 
prepared. ADP platelet aggregation (lI'M) was tested in these samples 
with saline, after incubation with cocaine (.005mg/ml), and followed by 
a second control incubation with saline. 
Saline (mean of Cocaine p 
2 controls) 
peak 29±6% 47±8% <.02 
aggregation% 
15 min 18±6% 39±10% <.02 
aggregation% 
Five patients had a marked increase in peak platelet aggregation with 
cocaine, (range 55% to 272% increase, mean of 135% increase compared 
to control). We conclude that ADP-induced platelet aggregation is 
enhanced with cocaine; the mechaniiijll of myocardial infarction and 
thromboembolic events associated with cocaine may be due, in part, to 
increased platelet aggregability. 
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Vasodilator Capacity of Epicardial Artery Segments Directly 
Relates to the Extent of AtherosclerotIc lesion Area In Patients 
with Coronary Artery Disease 
Andreas M Zeiher, Rainer Fritz, Thomas Bleile, Volker Schachinger, 
Stefan Hohnloser, Hanjiirg Just. Medical University, Freiburg, F.R.G. 
Experimental studies demonstrated that arterial pliability is 
decreased at sites of atherosclerotic plaques. Intracoronary 
ultrasound (ICUS) enables the in vivo evaluation of coronary arterial 
(CA) wall architecture and dimensions. We, therefore, compared the 
vasodilator response (quantitative biplane angiography) to 0.2-0.3mg 
intracoronary nitroglycerine (NTG) with CA wall morphology and 
atheroma area. High-quality digitized ICUS images (30mHz, 5F 
catheter, CVIS Inc.) were analyzed for 98 angiographically normal or 
minimally diseased «30% area reduction by angiogrpahy) sites in 
35 patients with coronary artery disease. The media-adventitia 
interface was traced to obtain total CA area. Wall area was 
quantitated as total CA minus lumen area. NTG-induced dilation 
ranged from 3% to 46% (mean 21.1%) increas!1. in luminal CA are.ll. 
Wall area ranged from 2.8 to 17.5mm<: (mean 8.9mm<:) 
corresponding to a mean of 43.1±17% of the available CA cross•
sectional area. There was a close, inverse relation between NTG•
induced dilation and wall area expressed as percentage of total 
available CA cross-sectional area (r=-0.83, p<0.0001). Eccentric 
lesions were in general distributed above the regression line 
indicating a greater dilatory capacity to NTG. Proximal segments 
dilated significantly less than distal CA segments (17.8±9.1% vs. 
29.3±10.1%, p<0.01). However, when corrected for wall area, no 
difference was observed between proximal and distal segments 
anymore. Thus, the vasodilator capacity of epicardial artery 
segments declines with increasing extent of atherosclerosis in 
patients with early stages of coronary artery disease. The well•
known greater reactivity of distal CA segments compared to proximal 
segments in response to nitroglycerine appears to be related to the 
smaller atheroma area in distal coronary artery segments. 
807·2 4:15 
WHY DOES CORONARY FLOW RESERVE VARY SO WIDELY AMONG 
PATIENTS WITHOUT EVIDENCE OF CARDIAC DISEASE? 
Robert M. Weiss, Maleah Grover-McKay, James E. Quillen, 
James D. Rossen, William Stanford, and Michael D. 
Winniford 
U. of Iowa and VA Med Ctr, Iowa City, Iowa 
Assessment of coronary flow reserve (CFR) is cited 
as a "gold standard" for the physiologic assessment of 
coronary stenosis. Yet studies with intracoronary 
Doppler catheters (DC) have shown wide patient to 
patient (Pt) variability in CFR, even among those 
without evidence of cardiac disease. The relative 
contributions of 2 factors - perfUSion (Perf) at rest 
and vasodilator Perf - can't be discerned with DC since 
it yields only a relative flow ratio. The purpose of 
this study was to assess absolute Perf at rest and 
during vasodilation (dipyridamole [Dip 1 0.56 mg/kg iv) 
with cine CT using an algorithm previously validated in 
animals and humans. Seven Pts without hypertrophy or 
infarction were studied follOWing coronary angiography. 
Results: CFR (- Perf-Dip / Perf-rest) ranged 2.3 - 5.3 
in zones served by angiographically normal arteries. 
Regression analysis revealed that most of the 
variability in CFR was due to differences in Perf-rest 
(range 70 - 170 m1/min/100g; R - -0.81). There was less 
relative variation in Perf-Dip (345 - 537 m1/min/100g; R 
- 0.17 vs CFR). A Pt with CFR - 2.3 and another with 
CFR - 5.0 had nearly identical Perf-Dip (368 vs 354 
ml/min/100g) indicating similar vascular capacity. CFR 
correlated poorly with resting HR (R - -0.17) and HR x 
SP (R - -0.09). Conclusion: Perf at rest is highly 
variable in Pts without evidence of cardiac disease. 
Thus, some Pts with low CFR actually have normal 
absolute perfusion during vasodilation. This could 
complicate assessments of coronary stenoses unless 
absolute perfusion is also measured. 
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Close parallelism between the coronary vasomotor 
responses to acetylcholine and to serotonin. 
Chris Vrints, Johan Bosmans, Hidde Bult, Marc Claeys, Arnold 
Hennan and Joseph Snoeck. 
University Hospital of Antwerp, Belgium. 
An impainnent of endothelium-dependent vasodilation could be 
responsible for the paradoxical vasoconstrictions to serotonin 
(5-HT) in diseased coronary arteries. The responses to selective 
intracoronary infusion of acetylcholine (Ach) and 5-HT and to 
isosorbide dinitrate were assessed by quantitative coronary 
arteriography in 16 patients with angiographically nonnal coronary 
arteries, in 10 patients with minimal «30% narrowing) and in 5 
patients with more advanced (>50% narrowing) coronary artery 
disease (CAD). 
Ach caused constrictions in diseased coronary arteries. In the 
patients with nonnal coronary arteries Ach caused dilatations in 7 
patients (smooth dilators) and constrictions in 9 patients (smooth 
constrictors). The changes in the vasomotor responses to S-HT 
mimicked closely those to Ach (r2=O.60, p<O.OOI). 
smooth ddators 
smooth constrictors 
CAD < 30% 
CAD> 50% 
Ach -SM S-HI' -6M 
4.5±2.S 2.4±3.0 
-14.7±6.2* -11.7±4.3 
-12.l±2.6* -14.5±3.4* 
-6.3±6.4 -6.6±7.6 
S-HI'-SM 
1.4±4.1 
-21.S±6.S* 
-26.S±4.7* 
-30.9±5.3* 
% diameter change from baseline. *p<O.05 vs smooth dilators (Scheffe's test) 
5-HT caused a temporary thrombotic occlusion in one patient with 
CAD. In all other patients isosorbide dinitrate reversed rapidly the 
vasoconstriction induced by S-HT. 
The endothelium-dependent vasodilator response to Ach is thus 
impaired both in early and advanced coronary atherosclerosis. The 
close parallelism in the changes of the coronary vasomotor 
responses to Ach and S-HT suggests that impainnent of 
endothelium-dependent vasodilation accounts for the abnonnal 
vasoconstrictor responses to S-HI' in diseased coronary arteries. 
807·4 4:45 
Endothelial Dysfunction In Coronary Arteries Precedes Ultrasonic or 
AnaiCJtll1lphic Evidence or AlhtrOlclerosis In Patients with Risk Fadon 
John McB. Hodgson, Ravi Nair, Helen M. Sheehan, Karan G. Reddy, 
University Hospitals of Cleveland and CWRU, Cleveland, OH. 
Patients with chest pain syndromes and normal coronary angiography may 
have abnormal endothelial function. The purposes of Ibis study were a) to 
determine whether such angiograpbically normal coronaries were also 
normal when examined by intracoronary ultrasound (ICUS) and b) to 
determine whether patients with coronary risk factors (RF) (hypertension, 
hyperlipidemia, family history, smoking) had endothelial function different 
from those without RF. Eighteen patients were studied at coronary 
angiography. Lumen area (lA) was determined ~ ICUS at baseline and 
during intracoronary acetylcholine (ACH) (10', 10-6, and 10.5 M), 
papaverine (PAP, 14 mg) or adenosine (ADE, 400 meg/min.) and 
nitroglycerin (NTG, 20().300 meg). This protocol was repeated with Doppler 
to determine coronary flow velocity (CFV). Coronary flow index (CFI) is the 
product of CFV and lAo Coronary vascular resistance index (CYRI) is the 
ratio of CFI and mean aortic pressure. Patients without RF (n=7, age 
53±l5) had normal study vessels by angiography and ICUS, and had normal 
responses to the endothelium dependent vasodilator ACH. Patients with RF 
(n = 11, age 50±9) all had an abnormal response to ACH. Only four (28%) 
had minor atherosclerosis by ICUS. Their responses were not different from 
the 7 with normal ICUS. Responses to the non-endothelium dependent 
agents PAP or ADE and NTG were normal in both . groups. Data is 
expressed as % change from baseline (mean±SD) ('P= <0.05, vs baseline; 
tP<O.01 vs RF absent) 
RF ABSENT (N=7) RF PRESENT (N=11) 
ACH NTG PAP OR AnE ACH NTG PAP OR AnE 
LA 6.1±3.5' 9.7±3.6' 3.111.1' .15±13.1 t 15.5±47' 5.7±8.5 
CFI 3851172' 36±30 3671177' 901116t 18124 3341101" 
CVRI ·76110' -31±14' .76±8' -33115t .19±11' .74±9' 
We conclude that 1) angiograpbically normal coronary arteries may have 
atherosclerosis by ICUS, 2) in patients with RF for atherosclerosis, 
endothelial dysfunction may occur prior to clinically measurable 
atherosclerosis. These changes may represent the initial manifestations of 
atherosclerosis. 
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TRANSESOPHAGEAL DOPPLER EVALUATION OF 
CORONARY BLOOD FLOW VELOCITY IN HYPERTROPHIC 
OBSTRUCTIVE CARDIOMYOPATHY 
Cataldo Memmola, Sabino Iliceto, Luigi Carella, Venanzio F 
Napoli, Giulia De Martino, Vito Marangelli, Paolo Rizzon. 
Institute of Cardiology. Bari University. ITALY 
To assess the potential of Transesophageal Doppler (TED) in 
evaluating coronary blood flow velocity (CBFV) characteristics 
and coronary flow reserve (CFR) in pts with hypertrophic 
obstructive cardiomyopathy (HOC) 18 pts were studied. 9 were 
normal (N) and 9 had HOC, alI had normal coronary arteries at 
angiography. TED of left anterior descending coronary artery was 
performed in baseline conditions and after Dipyridamole (D) 
administration. In N pts CBFV was biphasic: the 2 components 
(greater diastolic, smaller systolic) being homodirectional and 
without interruption. In HOC 4 CBFV patterns were 
identified.Type 1 (1 pt): normal CBFV pattern. Type 2 (5 pts): 
systolic flow confined to early systole with no flow between the 
end of the systolic and beginning of the diastolic phase. Type 3 (I 
pt): midsystolic reduction of CBFV. Type 4 (2 pts): reversed 
systolic flow . In HOC pts diastolic/systolic CBFV ratio was 
greater than in N both in baseline conditions (3.1.±..0.9 vs 
1.8.±..0.7, p<O.OOl) and after D (S.0.±..1.7vs 
2.3.±,0.4, p < 0.001). CFR (expressed by 
D-CBFV Ibaseline-CBFV ratio) was 
reduced in HOC (2.2.±..0.5 vs 3.2.±..0.96, 
p<O.OI). CONCLUSION: CBFV 
characteristics as well as CFR are altered 
in HOC pts; TED is a useful tool to 
investigate CBFV and CFR in HOC. 
808·2 4:15 
ENHANCED DOPPLER SIGNAL INTENSITY IN CORONARY 
ARTERY AFTER INTRAVENOUS INJECTION OF A LUNG 
CROSSING ECHOCONTRAST AGENT (SHU 508 A) 
Carlo Caiati*, Reinhard Schlief;P. Luigi Aragona, Lucia Sublimi, 
Paolo Rizzon. Institute of Cardiology, University of Bari, Clinica 
del Lavoro', Cassano, Italy; Schering AG; Germany. 
SHU S08A is a lung crossing contrast (C) agent able to increase 
doppler signaVnoise ratio in right and left cardiac chambers. To 
verify if peripheral intravenous injection of SHU SOSA could 
enhance doppler signal intensity also in coronary arteries 20 pts 
were studied during transesophageal echocardiography (TEE). 
TEE was performed in baseline (B) conditions and after C 
injection. Color doppler of blood flow within left main coronary 
artery (LMCA), left anterior descending (LAD) and circumflex 
(CX) was judged by 2 expert observers as being optimal (OPT) or 
sub-OPT. OPT = strong and we)) delineated color doppler 
signal. SUB-OPT = doppler signal not delineated and weak or 
absent. Before C color Doppler was OPT in LMCA, LAD and 
CX in 30%, 20% and 0% of pts, while after C it was OPT in 90%, 
90% and 40% of pts respectively. On the other hand color 
doppler was SUB-OPT before C in 70%, 80% and 100% of pts, 
while after C was SUB-OPT in 10%, 10% and 60%. After C 
injection length and width of color doppler increased from 
6.0.±.5.3 and 1.6.±,1.4 mm to 16.±..6 and 4.8.±..1 mm (p<O.OOI) 
respectively. 
Conclusion: intravenous injection of SHU SOSA enhances color 
doppler signal intensity and size in coronary artery, thus 
increasing feasibility of TEE evaluation of coronary blood flow. 
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808·3 4:30 
Tran.e.ophageal Echocardlography In the Detection, Charac· 
terlzatlon and Quantltotlon 01 Atherosclerotic Lesions 01 Lett Main 
Coronary Artery: strengths, UmIIotlons and Cautions 
Tsul-Ueh Hsu, WiINam Katz, John Goresan, Andrew Weintraub, Bart Denys, 
Steven Schwartz and Natesa Panellan. 
Tufts· New England Med Center, Boston, MA and Univ of Pittsburgh, PA. 
Previous studies have Buggested that atherosclerotic lesions of left main 
coronary artery (LMCA) can be identified by the use of transesophageal 
echocardlography (TEE). Requests from cath laboratOries for TEE to ex•
clude LMCA lesion after pts have already had coronary angiography (Anglo) 
prompted us to prospectively examine the value of TEE in the detection, 
characterization and quantltation of LMCA lesions. In 2 centers, we perform•
ed TEE In 65 pts who have had adequate Anglo and were undergoing 
CABG surgery. Careful attention was paid to Image the LMCA with appropri•
ate uHrasound techniques. For want of a better gold standard, Angio was 
used as the independent standard excluding cases where angio was ambl•
gous. Angio and TEE Images were Interpreted Independently and blindly. 
From both, data on the presence of LMCA lesion, % diameter stenosis and 
the character of the plaque were derived and compared. Results: Among 
the 65 pts, LMCA could not be Imaged well In 5 pts. In the remaining 50 pts, 
soms degree of ANGlO abnormaHty of the LMCAwas found In 19. The sen•
sitivity of TEE In Identifying significant LMCA leSions (50% or more steno•
sis) was 78%, the specificity 96%, positive pred accuracy 87%, and nega•
tive pred accuracy 92%. In the Identification of all LMCA lesions (% steno•
sls,10% to 70%), the sensitivity and specificity were 65% and 73%. Besi•
des depicting LMCA stenosis, TEE was useful In demonstrating the possi•
ble nature of the plaque (soft vs. fibrocalcific). There was a statistically signi•
ficant but not a close relation between Angio and TEE in the estimation of 
% stenosis (r-O.58 11<0.05). Reexamination of the TEE images after comp•
letion of the (above shown) data analysis Indicated that following factors 
ware responsible for falsa positives and falsa negatives noted in this series: 
aortic wall disease, distal location of the lesion, diffuse LMCA wall disease, 
Inappropriate beam orientation and suboptimal gain/gray scale adjustments. 
Flow disturbance seen on color Doppler was more specific but less sensi•
tive. We conclude that TEE Is useful In identifying significant LMCA lesions 
but not In precise quantltatlon. Judicious technical adjustments and probe 
manipulation, awareness of the Impact of aortic wall disease and diffuse 
disease process, and added care to Image the distal LMCA could potentially 
further Improve the utility of TEE in the evaluation of LMCA disease. 
808·4 4:45 
Tl'lnIOtIOphaOMI Ech0C8rdlogl'lphlc EVitUitlon 01 Coronary Artery 
Flltul .. 
George R Sutheriend, Oliver StOmper, Alan G Fraser, Jos RTC Roeland!. 
Westem General Hospital, Edinburgh, UK; UniversHy Hospital, Cardiff, UK; and 
Thoraxcenter, Rotterdam, The Netherlands. 
Fifteen patients (pts.); 12 adults, 3 children, were Identified at a 
trans08sophageal echo (TEE) study to have a fistulous communication 
between the coronary circulation and a cardiac chamber. These Included: 
2 left maln->pulmonary artery; 2 left maln->Ieft atrium; 2 circumfiex->Ieft 
atrium; 2 clrcumfiex->pulmonary artery; 1 clrcumfiex->coronary sinus; 1 
antarior descendlng-> pulmonary artery; 1 right coronary-> left atrium; 1 right 
coronary-> right ventricle; 1 right coronary-> right atrium and 2 right coronary•
> neo-Ieft atrium (both In post-Fontan patients). All had had prior praecordial 
echo studies and 11 had had prior catheterisatlon. In 8 cases, the diagnosis 
of a coronary fistula was known prior to the TEE study and, In 7, was made 
only by TEE. In 5/8 cases In whom coronary angiography had demonstrated 
a fistulous communication, the precise drainage slte(s) had not been defined. 
In only 3 cases could TEE 2-D Imaging define the entire course of the fistulous 
vassel and define Its drainage site. In contrast. colour flow mapping could 
correctly (correlative angiography - 8 pts, correlative surgery - 4 pts) 
demonstrate tha turbulent flow associated with the exit polnt(s) of the fistula 
In all 15 (multiple sites In 3). In 2 cases, (1 left maln->left atrium, 1 right main•
> left atrium) there was a large, atrial sized chamber interposed between the 
two normal atrie through which fistula flow occurred. In 1 case, this cavity 
was partially thrombosed. TEE pulsed doppler studies defined three basic 
patterns of fistula exit flow which were related to fistula size: I) continuous flow 
with a dominant diastolic phase (large fistulae); II) continuous flow with a 
dominant systolic phase (moderate fistulae); and III) flow only In systole 
(filamentous end stage connections). In summary, the combination of 
coronary angiography and TEE colour flow Imaging would appear to offer the 
optimal combination for the complete preoperative evaluation of coronary 
fistulae. TEE alone can be used to monitor In reet-tlme Intraoperative or coli 
embollsatlon closure. 
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809·1 4:00 
.iqDal-Averaqe4~lectroaar4ioqr .. iD Priaary 
Aliyloi4osb 
Seth Bilazarian, Akber Mohammed, Mary H. Coats, 
Rodney H. Falk. 
soston City Hospital, SOston, MA 
Primary amyloidosis (amy) involves the heart in 
> 90t of patients (pt) at autopsy but only 60t 
have clinical evidence durinq life. To 
determine the prevalence and aiqnificance of 
late potentials (LP) in primary amy and their 
ability to detect early cardiac involvement we 
prospectively studied 64 pts with biopsy-proven 
amy. Usinq a 25 Hz filter LP was defined as ~ 2 
of the followinq: filtered QRS ~ 115 msec, RMS 
voltaqe < 25 uv, and low amplitude siqnals > 38 
.sec. Of 39 (61t) pt with echo evidence of 
cardiac amy, LP were present in 14 (36t), 
compared to LP in 1 of 25 (4t) with no echo 
siqns of amy (p<.Ol). DUrinq a 2.2 yr follow-up 
34 pt died and cause of death was known in 25. 
Death from CHF (6) or sudden death (11) occurred 
in 17 pt. Of whom 16 (95t) had abnormal echo. 
LP was present in only 6 (Sst) sudden death pt. 
We conclude that, in systemic amyloid, 1) LP are 
markers for overt cardiac involvement but are 
rarely .een if echo i. normal. 2) Sudden death 
is common in primary amy occurrinq in pt with 
abnormal echo but 3) The sensitivy of LP is low 
(Sst) for predictinq which pts with cardiac amy 
are at risk of sudden death. 
809·2 4:15 
Signal-Aver.ged ECG In Ch.gal Di ..... : Incld.nce of Lite Potentlall end 
R.lationlhlp to Cardl.c Involvement. 
Cristian M.doery, Jo .. P Guindo, Edu.rdo Esparza', X.vier Villolaa, 
Wojcieck Zareba, Antonio Martinez", Branco Mautner', Roberto 
Madoery' ", Gunther Breithardt·· ,Antonio Bay .. de Luna. 
Hospital de Sant P.u (Spain). ·H.Fernandez, Buenos Aire •. ' 'H. University 
of Munster (Germany). ···H.Privado, Cordoba (Argentina). 
Chagls disease is responsible of more than 6.000 audden deaths yearly 
in Argentin.. The aim of this Itudy was to .n.lyze the incidence of 
Ventricular Lite Potentials (LP),the degree of cardiac Involvement and its 
relationship. We Itudied 84 patients (pts) (60 female, mean age:48 ± 16) 
with chaga. disease. Phy.icalexamination,conventional ECG, chest X-ray, 
echocardiogram, 24-h Holter ECG, .nd lignal-averaged ECG ISA-ECG) 
were done. SA-ECG WIS made uaing an ART 1200 EPX device. In pts 
without bundle branch block (BBBHn - 81) LP were analyzed in time 
domain. The presence of LP was defined by 2 or more of the following 
criteria: ORS duration >115 ml, RMSs20 ,LAS2:38. In pts with BBB, 
frequency domain Ifaat fourier transform) using 120 malegment(-20/1 00) 
was done with several .r .. ratio calculations. We considered abnormal 
mean area ratio (20-50/0-20) 2: 270 or (60-120/0-30) 2: 80 or 
150-150/0-30) 2: 140. 
We considered that cardiac involvement WII present when one or more 
of the following abnormalities were present: conduction disturbances in 
ECG, left ventricular ejection fraction <50%, frequent VPB 1>3 per hour) 
in Holter monitoring. W. compare the incidence of LP between pIS with 
cardiac involvementlGroup II and without (Group II). 
Results:Cardiac involvement was present in 71 % of our pts. 
LP was present in 40% of pts. The incidence of LP in Group I pts was 
significativelv higher than In Group II (40% versus 12.5%, p<0.02) 
CONCLUSIONS: I.LP are frequent in pts with cardiac involvement due to 
Chagas disease (40%), similar to reports of postinfarction pta. 
2.Even in pIS without any evidence of cardiac involvement (Group II) 
incidence of LP Is greater than reported in healthy subjects. 
3. Follow-up of theae pts il necessary to determine the prognostic 
significance of LP in pts with and without cardiac involvement. In Group 
II pts, LP may be an early marker 01 cardiac involvement 
JACC Vol. 19, No.3 
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Significance of Late Potentials in Post Myocardial 
Infarction Patients With Left Bundle Branch Blocl< 
Ma Hong, El i S. Gang, Werner Peters, Carol Vaughn, 
Thomas Peter. 
Cedars-Sinai Medical Center, Los Angeles, California 
To assess the prevalence and prognostic significance of 
late potentials(LP) in post MI patients(pts) with left 
bundle branch block(LBBB), we studied 281 of 391 
consecutive pts with uninterrupted acute MI (no 
thrombolysis, no PTCA/bypass surgery before LP 
recordings): group 1 without bundle branch block (BBB) 
(n=252) and group 2 with LBBB (n=29). LP were defined 
in group 1 as filtered (25 - 250 Hz) QRS ~ 120 msec, or 
a terminal 40 msec root mean square voltage (RMSV) ~ 25 
uV and in group 2 as a terminal RMSV ~ 20 uV. 258 pts 
were discharged alive and 254 (98%) were followed for 1 
year. 
Results: The prevalence of LP in groups 1 and 2 was 
similar (26% and 28%). The incidence of LP in acute 
VT/VF and late sudden death is shown below: 
ill! 
Acute 
VT/VF 
LP+: 5/6(83%) 
No 
VT/VF 
3/23(13%)* 
ti!!....n8. 
Acute No 
tlill VT/VF 
12/20(60%) 53/232(23%)* 
~ No SO J..ill..jll ~ 
53/217(24%)** LP+: 3/4(75%) 2/19(11%)** 7/14(50%) 
SO=sudden death; *p<O.OI; **p<0.05 
CONCLUSIONS: (1) LP are a rel iable marker for 
identifying pts with acute MI and LBBB prone to early 
VT/VF and late sudden death. (2) The sole criterion of 
a RMSV ~ 20uV seems to be suitable. 
809·4 4:45 
Usefulness of Spectrotemporal Mapping of the Signal.Averaged 
ECG for Predicting Inducible Ventricular Tachycardia in Pa· 
tients With Bundle Branch Block 
Jiirgen Tebbenjohanns, Matthias Manz, Berndt Liideritz. Dept. of 
Cardiology, University of Bonn, Germany 
Prior studies using analysis of the signal·averaged ECG (SaECG) 
for predicting inducible ventricular tachycardia (VT) at electro· 
physiologic study showed difficulties in patients (pts) with bundle 
branch block (BBB). With the introduction of spectrotemporal 
mapping (stm) of the SaECG pts with BBB are no longer ex· 
cluded from the analysis. To evaluate the efficacy of stm we 
investigated consecutively 24 pts with BBB (right 3, left 21) who 
underwent programmed ventricular stimulation in the drugfree 
state. Coronary artery disease was evaluated in 13 pts, cardiomyo· 
pathy in 7 pts and no structural heart disease could be defined in 
3 pts. 
Results: VT was induced in 15 pts and 9 pts were not inducible 
during programmed ventricular stimulation.Abnormal findings in 
stm (factor of normality <30% in at least one signal-averaged 
lead) (stm+) were found in 10 pts (66%) with inducible VT and 
in one without VT. In 5 pts with VT stm showed false negative 
results. Abnormal stm was present in 30% of pts with coronary 
artery disease, in 70% of pts with cardiomyopathy and in 50% of 
pts without structural heart disease. Ejection fraction was 44,9 + /. 
14,2% in stm+ and 63,5+ /-11,1% in stm-. 
Conclusion: In patients with BBB spectrotemporal mapping 
allows the identification of pts with inducible VT during pro•
grammed stimulation. Concerning the incidence of late potentials 
no statistical differences were observed with regard to the under•
lying heart disease. Pathological findings in stm were more often 
in pts with impaired left ventricular ejection fraction. 
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Long-Term Surviyal in Paced Patients with Sick Sinus 
Syndrolle is Determined by Underl)'!ng Clinical Status 
Elena B. Sgarbossa, Sergio L. Pinski, Lon W. Castle 
Richard G. Trobman, James D. Maloney 
The Cleveland Clinic Foundation, Cleveland, Ohio 
The illpact of dual-chamber and atrial vs. ventricular 
pacing 1I0des on mortality in sick sinus syndrome (SSS) 
is uncertain. Determinants of survival in 507 con•
secutive patients (pts) (llean age ± SD: 66 ± 12) who 
received their initial paceJllaker (PM) for SSS from 
January 1980 to DeceJllber 1989 were analyzed. Pta in 
established atrial fibrillation at tille of PM implant 
were excluded. Ventricular PMs were implanted in 112 
pts, atrial PMs in 19 pts and dual chamber PMs in 375 
pta. Follow-up (mean: 66 ± 36 1I0nths) wal cOllplete for 
98% of pta. Actuarial survival at I, 5 and 10 years 
was 95%, 80% and 61% respectively. By univariate 
analysis, age) 70 years, organic heart disease, coro•
nary disease (CAD), heart failure, peripheral vascular 
disease (PVD) , intraventricular conduction defect 
(IVCD) , (p < 0.001 for all), complex ventricular 
ectopy (p=0.05) and cerebrovascular disease (p=0.027) 
were associated with increased 1I0rtality. Ventricular 
PM had marginal significance (p=0.06). By multivariate 
analysis (Cox's proportional hazard 1I0del), IVCD 
(p < 0.001, hazard ratio (HR)=2.3), CAD (p < 0.001, 
HR=1.9) , PVD (p < 0.006, HR-1.9) , diabetes (p=0.009, 
HR=1.75) and age) 70 (p,,0.002, HR=1.73) were inde•
pendent predictors of total mortality. Pacing mode was 
not an independent predictor. 
Conclusions: 1) Mortality is associated with clinical 
lIarkers of cardiac and vascular disease, not with the 
pacing mode; 2) Studies suggesting benefits of 
"'physiologic pacing"' in SSS do not control for these 
IIarkers and are at variance with our study. 
810·2 4:15 
Permanent Pacemaker Therapy for Hypertrophic 
Obstructive Cardiomyopathy (HOCM) 
Xavier Jeanrenaud. Pierre Vogt. Jean-Jacques Goy. Manin 
Fromer. Lukas Kappenberger 
Division of Cardiology. CHUV. Lausanne. Switzerland 
Beneficial hemodynamic effects of pacing in HOCM have 
been reported but the clinical value of an implanted 
pacemaker (PM) is not known. After initial (I) evaluation 
by cardiac catheterization and documentation of a 
significant reduction of the subaonic pressure gradient 
(SPG) compared to nonnal ventricular activation (NA) we 
implanted a DDD-PM in 13 patients (9 male. 4 female. aged 
40 to 73). Doppler-echo-cardiographic parameters were 
similar to the hemodynamic values. They were assessed 
during mid (11 months) (M) and' long-tenn (44 months) 
(L) follow-up. Clinical follow-up was also obtained. 
Results: 
Number of pts 
SPO (mmHg) 
Angina (NYHA) 
Dyspnea (NYHA) 
1 
NA PM 
13 
82±42 47±34 
3.l± 0.4 
2.6±,0.S 
M 
NA PM 
6 
77±44 44±,29 
0.9-Hl.8 
1.8±0.3 
L 
NA PM 
6 
42±26 26±,9 
1.4+0.8 
1.9±0.3 
There is a significant longlasting beneficial effect of 
pacemaker therapy in HOCM. The reduction in SPG 
improves symptoms. especially angina. Moreover no pts 
died during follow-up. The decremental SPG during NA 
over time might be explained by a regression of the 
septal hypertrophy as observed in 2 pts. This therapy 
merits further allention in pIS with severe HOCM 
refractory to medical therapy. 
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Ventricular Pacing-Induced Histopathology in 
the Young with congenital Heart Block 
Peter P. Karpawich, Chung-Ho Chang, Dianne L. 
Cavitt, Children's Hospital of Michigan, wayne 
state University, Detroit, MI 
Previous animal studies have shown that ventri•
cular (VVI) pacing (P) alters myocardial stress 
and contraction patterns causing histopatho•
logic (HP) changes comparable to those seen in 
cardiomyopathy (CM). such changes, if found 
clinically, may contribut~ to dysrh¥thmias ~nd 
depressed cardiac functlon assoclated wlth 
chronic VVI P. To evaluate presence of HP 
effects of VVI P in the young, multiple sample 
endomyocardial biopsy (bx) results from 8 
patients (pts), 4-25y, with normal hearts and 
congenital complete heart block (CCHB) (pre-P, 
n=2; post-P (mean P duration 6y), n=6) were 
reviewed and compared for HP changes (+) seen 
in 4 pts with idiopathic dilated CM: myofiber 
(M) hypertrophy (H), endocardial sclerosis 
(ES), subendocardial (SE) fibrosis. (F! ,.SE fat, 
M variation (Vr). Results showed slgnlflcant (p 
<.01)* HP differences among all CM and post-P 
CCHB compared with pre-P CCHB bx samples: 
MH ES SEF SEfat MVr 
pre-P + 0 0 0 0 
post-P* + + + + + 
CM* + + + + + 
This first study shows that chronic VVI P 
may adversely alter cardiac histology in the 
young with CCHB, producing HP changes found in 
CM pts. The protracted duration anticipated for 
P initiated in childhood would argue against 
VVI and shows the need for continued evaluation 
of pacing mode effects in the young. 
810·4 4:45 
Serial Evoked T Wave Amplitude in Assessment or Cardiac 
Transplant Rejection measured using an implanted QT 
driven Rate Responsive Pacemaker 
Andrew A Grace, Stuan A. Newell, Paul A. Mullins, Wim Boute, 
Nat R. B. Cary, Stephen R. Large, John WallwoIk, Peter M. Schofield 
Transplant unit, Papwonh Hospital, Cambridge, United Kingdom 
We recendy reported preliminary data demons~g a fall in ~icardial 
evoked T wave amplitude (ElW A) ~ured uSIng ~ ~xtemall~ QT 
driven rate responsive pacemaker preceding and predicbng cardiac 
transplant rejection. To test the hypothesis that long term assessment of 
E'IW A could be clinically useful in deteeting rejection we have now 
implanted the same pacemaker (Rhythmyx, Vitatron) in 18 patients (16 
male; median age, 47 (28-58) years) at the time of cardiac . 
transplantation. 3 patients were excluded from further analysIs (2 early 
deaths 1 persistent tachycardia> 1 OObpm). Serial E'IW A and QT interv~ were measured daily using a TP2 analyser during initial hospital 
admission. E'IW A prior to biopsy was compared to that at the time of 
biopsy. 36 endomyocardial biopsies were obtained in these patients 
(Histological ~es, (n): 0, ~22~; 11, (8);.2, P); 31, (3». The ~/15 
patients with biOpsy proven significant .reJecbon showed a fall ID E'IW A 
of respectively, mV (% related to baseline): 2.4 (75%); 1.5 (36%); 1.7 
(43%). Enhanced immunosuppression with ~ days methylprednisolone 
(lg iv) resulted in a return of ElW A to baseline. There was no change 
during rejection of the QT interval1IlCll;Sured at decrem.en~ p~g rates. 
The remaining 12115 patients had no biopsy proven reJCCbon episodes 
during their initial stay with no major deviations in measured E'IW A. 
Conclusions: 1] E'IW A measured using ~ imp~ted QT drive~ ra~e 
responsive pacemaker appears to fall dunng cardiac allograft reJecbon; 
2] Significance could not be assessed in this study in view of the limited 
number of rejection episodes; 3] The method ~ n~ yet ~ . 
recommended as a routine method for the non-IDvaslve diagnOSIS of 
cardiac allograft rejection. 
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Apolipoprotein(a) Levels and Susceptibility To 
Coronary Artery Disease In Patients With Peripheral 
Vascular Disease 
Peter H Groves, Alan Rces, Alison Bishop, Ruth Morgan, 
Michael S T Rutdey, Neil P Lewis, Ian F Lane, Roger J C Hall 
University Hospital of Wales, Cardiff, UK 
Apolipoprotein(a) [Apo(a)] levels are genetically determined and 
high levels are associated with the presence of coronary anery 
disease (CAD) in the general population. We have studied 
whether a similar association between Apo(a) levels and CAD 
exists in patients with peripheral vascular disease (PVD). 
Coronary arteriography was performed in 38 consecutive patients 
undergoing peripheral vascular surgery. Fasting serum. was 
obtained for lipid analysis and Apo(a) was measured u~ng an 
immunoradiomenic assay utilising monoclonal antibodies to two 
different epitopes of Apo(a). 27 patients had significant CAD C2: 
one vessel> 50% diameter stenosis) while 11 did not Age, sex, 
smoking habits and the disnibution of PVD were similar in these 
two groups. Hypertension was more common in the group with 
CAD (p<O.OI). Apo(a) levels were significandy greater in 
4:00 
patients with CAD· median (range) 328 UII (33-1638) vs 122 UII 
(19-206) (p<O.OO2). Patients with Apo(a) levels greater than the 
cohort median (193 UII) had a 20 fold increase in the prevalence of 
CAD. HDL-cholesterollevels were lower in the group with CAD 
- mean + SD 0.97 mmolsll ± 0.22 vs 1.25 mmols/l ± 0.49 
(p<O.05), but no difference was observed in the distribution of 
total cholesterol, apoprotein A·I, apoprotein B or niglyceride 
between the two groups. Perioperative cardiac complications 
occurred in 7 patients all but one of whom had CAD and Apo(a) 
levels >193 UII (sensitivity 86%). We conclude that high levels of 
Apo(a) are associated with the presence of CAD in patients with 
PVD and that Apo(a) may be an important factor in the 
development of CAD in those susceptible to atheroma elsewhere. 
Measurement of Apo(a) may prove to be a simple and reliable 
means of identifying patients at greatest risk in those undergoing 
peripheral vascular surgery. 
811-2 4:15 
Circadian Pattern of Endothelial·Derived Hemostatic Factors in 
Patients With Extensive Peripheral Atherosclerosis 
Felicita Andreotti. Richard Prevost. Anne Bradshaw, Jim Hamilton, Anton 
C.W. de Ban, Graham J. Davies, Cornelis Kluft. Attilio Maseri. Cardiovascular 
Unit, Hammersmith Hospital. London, UK and Gaubius Laboratory IVVO· 
TNO. Leiden, NL. 
Endothelial·derived hemostatic factors were measured 3-hourly for 24h in 
plasma samples from 7 patients with extensive peripheral atherosclerosis (AS) 
and 10 control subjects of similar age (C). The plasma activity (act) and/or 
antigen (Ag) levels of tissue·type plasminogen activator (t·PA). von Willebrand 
factor (vWF) and plasminogen activator inhibitor-) (PAl) were measured by 
functional or immuno·assay. t-PA Ag (ng.ml· l ) showed a significant (p<O.05) 
circadian fluctuation in C but not in AS. The 24h mean value and amplitude of 
variation (mean±SEM) were significantly greater in AS vs C (l3.6±1.5 vs 
6.6±0.7. p<0.OOO5, and 8.2±1.2 vs 4.8±0.8. p<0.03). vWF Ag (% reference 
plasma) did nOl fluctuate significantly during the 24h in either group. Th~ 24h 
mean value and variability around the 24h mean were SIgnIficantly greater ID AS 
vs C (l1O.8±13.2 vs 60.9±9.8. p<O.O). and 83.7±13.4 vs 46.2±9.9, p<0.05). 
Both AS and C showed a significant circadian variation of PAl act, PAl Ag and 
t·PA act levels. No significant differences in 24h mean. amplitude. or phase of 
the fluctuation of these 3 parameters were found between the 2 groups. Both AS 
and C showed a significant inverse relation between t-PA act and PAl act, and a 
direct relation between vWF Ag and t·PA Ag. In C, but not in AS, t·PA Ag 
was significantly correlated with t·PA act, PAl act and PAl Ag. 
These data suggest that chronic atheromatous disease is characterised by an 
enhanced and disorganised endothelial production of t-PA and vWF. In AS. 
circulating t·PA Ag shows a disrupted circadian pattern and Joss of a direct 
relation with t·PA act and PAl act or Ag. The absent circadian variation of 
plasma vWF suggests that the fluctuations of t·PA and PAl during the 24h do 
not merely rcOcct changes in global endothelial function. 
JACC Vol. 19, No.3 
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Prevalence and Prognostic Relevance of Silent Ischemic 
Heart Disease in Patients Undergoing Carotid 
Endarterectomy 
Stefano Urbinati, Giuseppe Di Pasquale, Alvaro Andreoli, Anna Maria 
Lusa, Giuseppe Lanzino, Giuseppe Pinelli. Depts of Cardiololy and 
Neurosurgery, Bellaria Hospital, Bologna, Italy. 
We prospectively investigated 106 consecutive pts (aged 42-73 yrs; 
mean 58.7 yrs) undergoing carotid endarterectomy (CE) for 
symptomatic high-grade carotid stenosis (70-99%), who had no 
history, symptoms or ECG signs of ischemic heart disease (IHD) and 
who were able to perform adequate exercise ECG testing. 
Pts were stratified as to the presence (n=27; 25%) or absence (n=79; 
75%) of silent IHD (positive exercise ECG testing and exercise 
thallium myocardial imaging) at the time of CEo A more extensive 
carotid atherosclerosis was present in pts with silent IHD: severe 
contralateral carotid lesions were present in 17 pts (63%) with silent 
IHD, and in 30 (38%) without silent IHD (p<O.05). 
No deaths or cardiac events occurred in the perioperative period. 
Follow-up was 100% through 7 years. Nine pts died: fatal myocardial 
infarction in 5 (all with silent IHD), cancer in 3 and vertebra-basilar 
stroke in 1. Non fatal events occurred in 9 pts: myocardial infarction in 
1 pt (without silent IHD), unstable angina in 3 (all with silent IHD), 
and cerebral ischemic attacks in 5. Kaplan-Meyer estimated 7-year 
survival free of coronary events was 98% in pts without silent IHD, 
but only 51 % in those with silent IHD (p<O.Ol). 
In conclusion in our study, silent IHD is detectable in 25% of pts with 
cerebral ischemia undergoing CE. Silent IHD does not seem to be a 
risk factor for perioperative complications, but strongly influences the 
long-term follow-up. A systematic noninvasive screening for silent 
IHD identifies pts at high long-term risk of coronary events, in whom 
a more aggressive management of IHD is warranted. 
811·4 4:45 
Predictors of Patent Foramen Ovale In Ischemic Stroke Patients 
Marco Di Tullio, Ralph Sacco, JP Mohr, Shunichi Homma. 
Columbia Presbyterian Medical Center, New York, NY 
A patent foramen ovale (PFO) is a potential cause of 
paradoxical embolization, especially in patients (pts) with 
Ischemic stroke (IS). Its prevalence IS high in young pts with 
unexplained (cryptogenic) IS, but its association with other 
patient characteristics has never been systematically evaluated. 
To determine the variables associated With PFO, we studied 146 
consecutive pts with acute IS (73 M, 73 F; mean age 61.8 ± 15.3 
yrs, range 18-90 yrs). Using established NIH Stroke Data Bank 
criteria, 101 pts (69%) were classified as IS of determined cause 
(DIS) and 45 pts (31%) as cryptogenic (CIS). Saline contrast 
echocardiography was blindly performed to assess for the 
presence of PFO. Demographic variables, stroke risk factors 
and IS subtypes were chosen as possible predictors of PFO 
and entered in a stepwise logistic multiple regression analysis. 
A PFO was detected in 26 (18%) of all pts. PFO was more 
frequent in CIS (42%) than in DIS pts (7""'; p<0.OO1) and in 
whites (33%) than in non-Whites (12%; p<0.OO5). Hypertensives 
had lower PFO prevalence (11%) than non-hypertensives (31%; 
p<0.OO5), as did diabetics (5%) compared to non-diabetics 
(23%; p<0.05). RegreSSion analysis identified independent 
predictors of PFO as: 
Variable Odds Ratio 95%CI 
CIS B.9 3.3 - 24.0 
White race 3.0 1.1 - B.O 
Age was not significantly associated with PFO. 
Conclusions: 1) The presence of a PFO should be strongly 
suspected in CIS and white pts 2) Age is not predictive for 
presence of PFO in IS pts. 
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Non-Q-Wave Myocardial Infarction (NQMI) in the Elderly: 
Clinical Course and Predictors of Mortality 
Mina Chung, Matthew Basner, John McKenzie, Jason Shen, 
Michael Rich, Jewish Hospital at Washington University 
Medical Center, St. Louis, MO 
The clinical course of NQMI in the elderly has not been 
well characterized. We prospectively studied 261 
consecutive pts with acute MI over a I-yr period. Strict 
criteria for NQMI were fulfilled by 131 pts, including 70 
pts ~ 70 yrs old (mean age 78.6 ± 6.1 yrs; 49% male). 
Older pts were more likely (p<.05) to have 1° AV block on 
admission EeG, indeterminant MI location, higher BUN, and 
no prior smoking history. Although LVEF was similar (51% 
age ~ 70, 55% age < 70), older pts were more likely to 
develop CHF (53% vs 30%, p-.012) and atrial fibrillation 
(23% vs 8%, p-.041), and less likely to receive thrombo•
lytic therapy (9% vs 28%, p •. 0067), cardiac catheteriza•
tion (41% vs 72%, p •. 0008), or PTCA (20% vs 39%, p-.025). 
Hospital mortality was 10% in pts ~ 70 yrs vs 3% in pts 
< 70 yrs (p=.24), and l-yr mortality was 35% in the 
elderly vs 16% in younger pts (p=.02). One-year mortality 
in elderly NQMI pts was comparable to elderly pts with Q•
wave MI (30%, N=S6). Univariate predictors of hospital 
death in elderly NQMI pts included elevated jugular venous 
pressure (JVP), pulmonary rales, and lower serum K'. 
Uni vari ate predi ctors of post-di scharge mortality among 
hospital survivors included older age, history of COPO, 
higher NYHA or Killip class, elevated JVP, lower diastolic 
BP, reduced LVEF, and lower peak CK. Multivariate analysiS 
se 1 ected advanced age, NYHA cl ass and el evated JVP as 
independent predictors of I-yr mortality. 
Conclusions: NQMI in elderly pts is associated with a 
less aggressive therapeutic approach and a higher 
complication rate than in younger pts. Late mortality is 
2-fold higher than in younger pts and is comparable to 
that of Q-wave MI in the elderly. 
812·2 4:15 
Dobutamine Stress Echocardiography in Elderly Patients • Is 
it Safe and Is Imaging Essential? 
Michael M. Lee, Cheryl L Reid, David Abrahamson, Donald 
J. Mahon, Nathan D. Wong. Julius M. Gardin. University of 
California, Irvine, CA 
Dobutamine stress echocardiography (DSE) has been 
increasingly utilized in elderly patients (pts) who cannot 
exercise. To evaluate the safety and necessity of imaging in 
DSE, 109 pts were studied retrospectively. Forty-six pts>65 
years (Group I, mean age=72 years) and 63 pts<65 years 
(Group II, mean age=53 years) received incrementa! IV 
dobutamine with electrocardiography (ECG) and two•
dimensional echocardiographic (2DE) views recorded at each 
stage. Both groups achieved a similar maximum age-predicted 
heart rate (Group I 88%, Group II 89%) and had a similar 
incidence (Group I 15%, Group II 13%) of transient arrhythmia 
or hypotension. No pt required acute medical intervention 
except 5 pts who received beta blockers without complication 
(no difference between Groups I and II). Stress-induced LV 
wall motion abnormalities (WMA) developed in 28% of Group 
I and 11% of Group II pts (p= 0.04). Combined chest pain 
and ST-Twave changes were 84 and 71% sensitive, and 60 and 
46% specific for predicting ischemic WMA in Group I and 
Group II, respectively. CONCLUSION: 1) DSE has a similar 
safety profile in older compared with younger adult pts. 2) 
Stress-induced WMA are more prevalent In older pts. 3) In 
older pts, when 2DE imaging is unavailable, chest pain and 
ECG changes offer acceptable sensitivity, but not specificity, for 
detecting stress-induced LV wall motion abnormalities. 
328A ABSTRACTS 
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Predicting Outcome of PTCA in The Elderly 
Randall C. Thaupson, David R. HolJDes, Jr., Bernard J. 
Gersh, Kent R. Bailey, Mayo Clinic, Jacksonville, FL 
and Rochester, MN. 
While the technical success rate of PTCA in the 
elderly is high, very old patients (pts) have an 
increased risk of procedure related death and late 
recurrence of severe angina. The purpose of this 
study was to determine the baseline variables which 
predict early and long-term failure of PTCA in pts 
over age 65 in order to effectively stratify their 
risk. 
We studied 982 pts ~ 65 years old who had non•
emergent PTCA between 1980-1990. Followup was 
obtained in 100%. Multiple baseline variables were 
analyzed using univariant and rnultivariant logistic 
regression to select independent ones to fit 
predictive models for (1) death or MI; (2) Adverse 
in-hospital outcome (MI, death, unsuccessful PTCA, 
repeat PTCA, or CABG); and (3) poor early or late 
outcome (death, MI, early or late CABG, repeat PTCA, 
or recurrent severe angina). 
The parameter which was found to be most heavily 
weighted in the probability regression equation for 
each end point was the number of coronary segments 
with ~ 70\ stenosis. Age was significantl~ 
associated with procedure related death (X =25.3) but 
not other adverse events. The highest risk quintile 
vs, lowest risk quintile event rate was 2.9% VS. 14% 
for acute MI/death, 17.2% VS. 29% for cumulative in•
hospital events, and 33% VS. 66% for cumulative early 
and late events. 
Our results stratify patients at high and low risk of 
early and long-term success after PTCA and identify 
elderly patient sub-groups in whom PTCA is most 
appropriate treatment. 
812·4 4:45 
Coronary Angioplasty in Elderly Patients 
Multivariate Analysis of Factors Influencing 
Early Results and Long Term Outcome 
Philippe Buffet, Nicolas Danchin, Christine 
Selton-Suty, Joseph Anconina, Luc Feldman, Yves 
Juilliere, Fran90is Cherrier. Dept of 
Cardiology, CHU Nancy, France 
To determine possible factors influencing early 
results and long term outcome of PTCA in pts > 
70 years, we analyzed 215 PTCA procedures which 
were performed on 276 lesions in 186 pts during 
a 4-year period. The mean age was 76±4 years 
(70-89 years), 63% were men. Most pts (69%) had 
unstable angina and 52% had multi vessel 
disease. Primary success rate was 83% 
(230/276), Complications were 4 deaths 
(2,1 %), 17 procedural MI (8%) and 2 emergency 
CABG. After multivariate analysis, primary 
success was independently related to 1 0) 
absence of coronary calcifications and 2°) no 
prior MI i peri-procedural MI or death was 
related to 1°) age> 75 years and 2°) prior MI. 
During follow-up (range 8-61 months, mean 
25±14 months), 16 pts died (11 of cardiac 
cause) i 30 had angiographic restenosis, 2 had 
non fatal MI and 13 had elective CABG. The 
estimated 5-year survival was 85±6% (91% when 
PTCA was successful and 73% after failed PTCA, 
p<0.01). Among survivors, 76% were free of 
angina and 97% were in NYHA class' II. 
In elderly pts, PTCA has an acceptable 
success rate and when successful, is associated 
with perSistent long term benefit. The risk of 
procedural failure/complication, however, is 
increased in pts > 75 years, and in those with 
prior MI or calcified coronary arteries. 
JACC Vol. 19, No.3 
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RESTENOSIS and HOMOZYGOUS von WILLEBRAND'S 
DISEASE: STUDIES IN A PORCINE CORONARY MODEL 
Roben S. Schwartz, Kenneth C. Huber, William D. Edwards. EJW Bowie. 
William L. Nichols, Allan R. Camrud, Michael A. Jorgenson, David R. 
Holmes Jr. Mayo Qinic and Foundation, Rochester, MN 55902 
Platelet adhesion to sites of coronary artery injury may be a 
major determinant of restenosis following coronary angioplasty. Von 
Willebrand's factor is critical to platelet adhesion in both humans and 
pigs. To test the dependence of neointimal proliferation on von 
Willebrand's factor, 19 lesions in the arteries of 10 pigs homozygous 
for von Willebrand's disease (vWD) were studied and compared with 
17 lesions from 9 normal control (C) pigs. 
Severe coronary injury was induced in alI animals by placement 
of severely oversized (balloon/artery ratio 2: 1) tantalum metal stents 
inflated to 8 atm for 15 seconds. At 28 ± 2 days, the animals were 
sacrificed. Mean proliferative thicknesses were measured and 
compared histopathologically with a mean quantitative vessel injury 
score following pressure perfusion fIXation. Regression lines for 
neointimal thickness vs. injury score was used for direct comparison 
of proliferative response. 
Results showed a modest but statistically significant (p< .(01) 
reduction in neointima for a given amount of vessel injury. 
f: ,.: 
I:: .. 
CONCLUSION; Congenital 
absence of von Willebrand' s 
factor modestly reduced 
neointimal proliferation 
following coronary artery injury 
compared to controls. '.~~~~.~~~~ 
Wlan I nJ ury Scor-. 
813·2 
Cell Proliferation in Primary and Restenotic Human 
Coronary Atherosclerosis 
4:15 
Edward O'Brien, David Gordon, SUK Yoon, Steven Schwartz, 
Douglas Stewart, University of washington, seattle, 
Washington 
Human coronary atherosclerosis is assumed to be a proli•
ferative process, that is particularly acute amongst 
restenotic tissue. A novel monoclonal antibody to the 
proliferating cell nuclear antigen (PCNA), allows direct 
measurement of proliferation in human tissue. Therefore, 
we used PCNA to quantify cellular proliferation in native 
human coronary atherectomy tissue obtained from 9 primary 
and 8 restenotic lesions. 
PCNA-positive cell indices ranged from 0-0.26% (mean 
+ SO, 0.07 + 0.09) in primary lesions versus 0-0.54% 
(0.10 + 0.19%) in restenotic lesions, p=0.6. The high•
est PCNA index was seen in a patient who underwent an 
atherectomy 24 hours post PTCA. The PCNA indices of 
restenotic tissue were inversely related to time from 
primary dilatation, with no proliferation being detected 
beyond 6 months. Patient profiles, including the use of 
angiotensin converting enzyme inhibitors, had no appar•
ent relationship with the proliferation index. 
Conclusion: 1) Low rates of cellular proliferation 
are seen in hemodynamically significant primary and re•
stenotic coronary atherosclerosis, 2) cellular prolif•
eration in restenotic lesions can be detected as early 
as 24 hrs and appear to cease by 6 mos post dilatation. 
These findings provide a useful time frame to direct 
therapeutic and clinical management of restenosis. 
JACC Vol. 19, No.3 
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Transforming Growth Factor.Bela I: A Peptide Growth Factor with 
Increased Espresslon In Vascular Restenosls 
Sigrid Niko~ Jeffrey Isoer, Oeoffrey Pickering, Marianne Kearney Ouy Leclerc, 
Lawrence Weir, Tufts University, SL Elizabeth's Hospilal, Boston, MA 
Transforming growdl factor (fOF)-betal is a peptide growth factor whicb is well 
cooserved in different species and is known to have diverse effects an cell growth 
depending on cell type. cell density,cell age and other interacting factors. Its 
presence in smooth muscle cells (SMCs) bas previously been reponed. In die 
current study. we studied buman atheroma obtained percutaneously in vivo for 
evidence that TOF·belal plays a role in the development of vascular restenosis. 
We obtained 24 specimens from patients with primary alberosclerotic or restenotic 
lesions. 180 frozen sections of. toIaI of 30 specimens were examined using in situ 
bybridization. Conltol tissues (6) included operatively excised segments of 
mammary artery and its subconfiuent cultared SMCs, as well as myocardium and 
unused portions of vein graft obtained inlr8Dperatively. Expression of TOF·betal 
mRNA was lowest in non-atherosclerotic tissues (S±6 grains/Ducleus). 
Sianificantly bigber expression was observed in primary alberosclerosis (9±8 
grainsloucleus, pc:O.OI). Expression was eveD bigher in restenotic tiSsues (23±iO, 
pc:O.OOI vs. primary alberosclerotic tissues). Maximum expression was observed 
in subconfiuent cultured SMCs (176±grainslnucleus, p<O.OOI vs. primary 
a1berosclerotic tissues) Parendletica1ly. the size of the nuclei of cultared SMCs was 
estimated to be about IG-fold greater than diose fran the retrieved specimens. 
47 adjacent sections of selected II specimens were examined witb 
immunobistocbemistty. Two separate antibodies wbicb were reported to detect 
TOF-betal protein in two different epitopeS demonstrated that TOF-betal protein 
remains principally widlin the SMCs. Staining with anti-alpha-actin identified 
SMCs for ISH and immunobislOCbemiSlry. 
These findings suuest dlat in buman vascular disease, particularly vascular 
restenosis, TOF-betal plays an important role, apparently in an autocrine fasbion. 
Tbe precise function of TOF-belal in the development of the restenotic -or even 
primary atherosclerotic- lesion. bowever. remains to be clarified. 
813-4 4:45 
Expression of Transformin, Growth Factor beta 1 in 
Human Atherectomy SpecImens from Primary. and 
Restenotic Coronary Artery Lesions 
Hiromi Rakugi, Gary Gibbons, Dale Wang, Margaret Billingham, 
Kathy Vershave, James Ferguson, Paolo Angellini. Patrick 
Hogan, Ali Mussumy. L. Maximilian Buja, Fred Clubb. Hugh 
McAllister, James Willerson, Victor D18u. 
Stanford University School of Medicine, Stanford.CA; Texas 
Heart Institute, Houston. TX. 
Atherectomy provides a means to study the pathogenesis of 
atherosclerosis and restenosis after angioplasty of coronary 
arteries. In this study we compared the histopathol~gy and mRNA 
expression of transforming growth factor beta 1 (lUFS) in cryo•
preserved atherectomy specimens. Smooth muscle cells (SMC) 
and monocyte/macrophages (Mo) were defined by 
immunohistochemical criteria. Light microscopy revealed that 
restenosis lesions consisted of myointimal hyperplasia. 
Superficial specimens from primary lesions included the fibrous 
cap, whereas other specimens contained abundant Mo and 
mesenchymal-appearing intimal cells (MIC). In situ hybridization 
of S restenosis specimens with an antisense TOFS cRNA probe 
revealed high TGFS mRNA signals in all samples. especially 
localized to discrete areas of MIC adjacent to foamy macrophages. 
Primary atheromatous lesions that contained abundant Mo and 
MIC (n=4) also expressed elevated levels of TOFS mRNA. In 
contrast, specimens of primary atheromatous lesions that 
consisted primarily of the fibrous cap contained sparse numbers 
of Mo and SMC (n'"'3) and had minimal levels of TOFS 
expression. Similarly, SMC that stained positive for alpha-actin 
also showed minimal levels of TOPS mRNA. It is intriguing that 
TOFS mRNA expression was focal and primarily associated with 
regions that contained both MIC and Mo. We speculate that these 
cells may interact via a potent chemoatttactive effect of TOPS and 
contribute to the development of the myoproliferative lesions. 
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synergistic Action of Bevere wall Injury and Sheor Porces 
on 'rtlrOlllbus Formation in Arterial Stenosis: Definition of 
a Shear Rate 'rtlreshold. 
Alvaro Merino, Marc Cohen, Juan Badimon, Valentin P'Uster, 
Lina Badimon. Mount Sinai Hospital, New York, NY. 
The contribution of progressive increases in shear rate 
to platelet deposition and thrombus formation on a 
severely damaged vessel wall substrate was studied in a 
canine model_ Carotid angioplasty with oversized balloons 
was performed in 23 vessels. In 14 of them (group II), 
after the angioplasty, various degrees of stenosis were 
created by an external ring in the center of the damaged 
area. Thrombus formation in response to injury was 
evaluated by angiography at the tiPf: of angioplasty, 
platelet deposition quantified by 1 Indium one hour 
after the procedure. 
Histologically documented severe wall damage (group I) 
produced an increase in platelet deposition compared to 
coptrol artery segments (8.19+-3.82 vs 3.62+-2.52 ptl x 
10/cm 1 p<0_05), but the presence of a stenosis (group 
II) increaseq even more the platelet number (36.98+-21_36 
ptl x 106 /cm 1 p<0.05). Angiographic filling defects or 
total occlusion were found in 7 arteries of grollp II vs 
none of group 11 p<0.05. An approximate shear rate of 
5000 S-l, corresponding to a stenosis of 70% and 1.5-1.6 
nun diamter, was found to separate the arteries in which 
thrombosis would occur. Four out of of 5 arteries with 
less than 1.5-1.6 nun diameter had angiographic filling 
defects or occlusion, compared to 1 out of 12 with less 
severe stenosis (p<O.Ol). 
These data suggest that, in low shear conditions, 
plaque damage or rupture will lead to DD.lral thrombosis 
without further thrombus growth. When plaque damage or 
rupture occurs in geometrically narrowed areas, at high 
shear condi tions, platelet deposition will be enhanced 
and thrombosis may progress to total occlusion. 
814·2 4:15 
Combined Thrombin Inhibition and Thromboxane ~ Synthesis 
and Receptor Blockade Enhances Thrombolysis and Delays 
Arterial Reoccluslon 
Sheng-Kun Yao, Judy C. Ober, H. Vernon Anderson, James J. 
Ferguson, John Maraganore, L Maximilian Buja, James T. 
Willerson, Texas Heart Institute and UT Medical School, 
Houston, TX and Biogen, Cambridge, MA 
We tested the hypothesis that combined thrombin 
inhibition and thromboxane Al (~) synthesis inhibition and 
receptor blockade enhances tissue plasminogen activator (t·PA)•
induced thrombolysis and delays arterial reocc\usion. Thrombi 
were induced in the coronary or femoral arteries of 22 dogs by 
electrical injury to the endothelium. Three hours later, animals 
were treated with t·PA (SO IIg/kg + 8 IIg/kg/min, Group I); t-PA 
and hirulog, a hirudin·based thrombin inhibitor, (2 mg/kg + 2 
mg/kg/hour, Group II); t·PA and ridogrel, a combined TXA2 
synthetase inhibitor and receptor antagonist, (5 mg/kg + 2.S 
mg/kg/hour, Group ill); or t·PA and hirulog and ridogrel (Group 
IV). None of the arteries was opened at 90 minutes in Group I 
and III dogs, whereas 70% of them were opened in Groups II and 
IV dogs. 
Lysis nme (miD) 
Reocclusloa Thoe (miD) 
lII:wIaJ 
>90 
• Compared to Oroup I, P < 0.01. 
+ Compared to Group n, P < 0.01. 
Gmu.JI 
6S.±.4· 
67.±.20 
Gwa.lIl 
>90 
~ 
32.±.1·+ 
>180+ 
Thus, inhibition of thrombin enhances thrombolysis with t·PA 
Combined inhibition of thrombin and inhibition ofTXAl synthesis 
and antagonism of TXAl receptors enhances thrombolysis with 
t-PA further and delays arterial reocclusion in this experimental 
model. 
330A ABSTRACfS 
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The 7E3 Glycoprotein liB/iliA Antibody Prevents Reoccluslon 
and Death Post-tPA-lnduced Thrombolysis In a Chronic Canine 
Model of Coronary Thrombosis 
Danial Walsh, §William Rote, Eric Bates, §Dun-Xue Mu, -Mark Nedelman, 
§Benedict Lucchesi. Univers~y of Michigan, Departments of §Pharmacology 
and Internal Medicine, Ann Arbor, Michigan; -Centocor, Malvern, 
Pennsylvania 
Reocclusion post~ronary artery thrombolysis is, in part, related to continued 
platelet reactiv~y at the s~e of thrombus formation. The 7E3 monoclonal 
antibody completely inhibits platelet aggregation via the glycoprotein IIBIlIiA 
receptor. This study examines the acute and long term effects of a single 
dose of7E3 used as an adjuvant alter tPA-induced thrombolysis in a chronic 
canine model of coronary thrombosis. The circumflex coronary artery (CX) 
was isolated and Instrumented with a Doppler flow probe, a stimulating 
electrode and a noncritical ligature stenosis. Alter 9 postoperative days, 
coronary thrombosis was Induced w~h a 100 llA anodal current applied to the 
Intimal surface of the CX. Thrombolytic therapy with tPA was begun 30 min 
post-CX occlusion using a 0.22 mglkg bolus followed by 0.72 rng/kg over 30 
min, then O.S mglkg over 60 min. The 7E3 (O.S rng/kg) was given S min alter 
completion of the tPA Infusion. Ex vivo platelet function and blood flow were 
checked daily and the survivors were euthanized S days later. Platelet 
aggregation was abolished with 7E3 and did not return to normal for 72 hrs. 
Cyclic flow variations, present alter tPA thrombolysis, did not continue alter 
7E3. 
tPA tPA + 7E3 P 
Time to Occlusion 142.6±12 12S.D±22.7 0.66 
TIITle to reperfusion 17.4±3.7 3S.0±6.6 0.14 
Mortal~y <24hrs 3/S OS O.OS 
Patency Day S O/S 5-5 0.004 
Infarct sizelL V % 1S.2±3.S 7.4±5.S 0.020 
COnclusions: Reocclusion alter treatment with 7E3 was abolished over a 5 
day period of observation. Alter thrombolysis with tPA, 7E3 significantly 
reduced Infarct size with no early mortality. 
814·4 4:45 
The Directional Dependence of Augmented Secretion of 
Plasminogen Activator Inhibitor Type-l in Endothelial 
Cells Induced by Platelets 
Satoshi Fujii, Burton E. Sobel. Washington University, 
St. louis, Missouri 
We have shown previously that platelet lysates. augment 
synthesis of plasminogen activator inhibitor type-I 
(PAl-I) in human umbilical vein endothelial cells (HUVEC). 
To determine whether platelet products modify secretion 
directionally thereby potentially inducing increased 
luminal activity of the inhibitor, HUVEC were grown to 
confluence in transwell dishes. PAl-I secretion over 24 
hr in both apical and basal directions was assayed by 
enzyme-linked immunosorbent assay. Under control condi•
tions PAI-l was secreted predominantly basally (363 ± 34 
(SO) ng/lO cell compared with ap}cal secretion of 168 ± 
18; n • 6). lysates from 4 x 10 plateletslml of media 
increased apical PAl-I release markedly (499 ± 42) with a 
more modest increase in basal release (594 ± 67; n • 6). 
Transforming growth factor-, (TGF-,; 0.5 ng/ml), present 
in platelets, and thrombin (1.0 U/ml), present in clots, 
elicited similar effects (apical to basal ratio 1.2 ± 0.2 
and 1.6 ± 0.1; n· 8). Incubation of the ce11s with 
colchicine (0.25 ~M) did not reduce total baseline 
secretion but did reduce platelet lysate, TGF-p and 
thrombin induced apical secretion by 45 ± 4, 48 ± 9 and 47 
± 7% with a concomitant increase in basal secretion (n = 
9). Thus: 1) under baseline conditions PAl-I is prefer•
entially secreted basally; 2) products of platelet 
activation induce apical secretion and hence may potenti•
ate elaboration of PAI-} intraluminally; and 3) apical but 
not basal secretion depends on microtubular function. 
These results imply that pharmacologic modulation of 
augmented apical secretion of PAl-I is feasible and may 
diminish the likelihood of early thrombotic reocclusion 
after initially successful thrombolysis. 
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815·1 4:00 
AllOJenlc Effects of Ihe Inln-Femoral Infullon of Adenosine 
Achille Gaspardone, Filippo erea, Fabrizio Tomai, Maria l&meIe, Palrizio 
PoIisc:a, Fraacesco Versaci, Luigi OUariello, Pier A. Gioff~. 
Department of Invasive Cardiology, 2nd University. Rome. Italy 
The intracorooary infusion of adenosine (Ado) causes chest pain very similar 
10 the anginal pain. Although Ado-induced chest pain frequelldy occun in the 
absence of ECG changes, it might be caused by a localized subendocardial 
ischemia secondary to coronary "blood steal', not detected by the surface 
ECG. rather than by a primary stimulation of cardiac pain receptors. In order 
to establish whetber Ado can di=tly stimulate muscular pain receptors, the 
algogenic effects of this substance were srudied in a human model in which 
"blood steal' is unlikely to occur. To this' end 18 patients with ankle-brachial 
index >1. were selected for the study. Inaeasing doses of Ado (125 JIg/min, 
250 JIg/min, 500 JIg/min, 1 mg/min. 2 mg/min) were infused into the right 
femoral artery for periods of 3 minutes each. Ado infusioo was repeated in 10 
patients after intra-femoral administration of Theophylline (Theo) (3.5 
mg/Kg/min in 10 min), a potent Ado antagonist. In the remaining 8 patients 
Ado iofusion was repeated during intra-femoral infusioo of Nifedipine (N) 
(0.05 mg/min), as recent experimental daIa suggest that N JDay antagonize 
Ado receptors. Arterial blood pressure was continuosly I'C(l()I'ded throughout 
the study. Time to onset od Ado-induced pain and pain severity at the end of 
the infusion period (assessed by means of a visual analog scale) were 
recorded. Ado infusion was then discontinued. Owing Ado infusion all the 
patients experienced pain localized in the rigbt leg (time to onset 414±143 
sec, range 215-740; pain severity 45:1:17 mm, range 34-68). After Thco 
administration. 9 patients did not experienced any pain at all even during the 
infusion of the bighest dose of Ado. In the remaining patient Theo increased 
time to pain from 345 to 630 sec and reduced pain severity from 48 to 23 
mm. Conversely, N did not affect Ado-induced pain althougb it decreased 
mean arterial pressure from 103:1:11 to 89:1:13 (p<O.OOI). Time to OIISet and 
pain severity were 399:1: 128 sec and 43:1: II mm during Ado infusion and 
389:1:119 sec (p NS) and 37:1:18 mm (p NS) during combined Ado and N 
infusions. Thus, Ado causes pain by direct stimulation of muscular pain 
receptors. The dramatic elT ect of Thco confirms that the pain is due to 
stimulation of Ado receptors. Our findings do not support the experimental 
observation that N antagonius Ado receptors. 
815·2 4:15 
selective Pulmonary Vasodilation with Adenosine 
In Humans 
David B. Utterback, E.D. Staples, Donald R. 
Dugger, James A. Hill, Luiz Belardinelli. Uni•
versity of Florida, Gainesville, Florida. 
Adenosine(Ado), with its vasodilatory prop•
erties and short half-life, has the potential to 
reduce pulmonary vascular resistance (PVR) without 
lowering systemic vascular resistance (SVR) • 
Increasing doses of Ado (10,20,30, and 45 ~g/kg/­
min) were administered into the right ventricle 
of twelve adults with nOl'lllal pulmonary artery 
pressures undergoing coronary artery bypass 
surgery. Pulmonary and systemic hemodynamics, as 
well as, left atrial(LA) and superior vena cava 
(SVC) plasma Ado levels were measured. At ~20 
~g/kg/min, LA Ado increased significantly from 
baseline *(p<0.05). A reduction in SVR occurred 
at LA Ado levels greater than 1.2~M. No evidence 
of recirculation of infused Ado was noted (SVC 
Ado levels remained unchanged). At 30 ~g/kg/min, 
PVR index decreased 49% (p<O. 001), while SVR 
index remained unchanged. Thus, central infusion 
of Ado can selectively lower PVR in humans. 
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Haemodynamlc Assessment of A1 and A2 Effects of 
Adenosine In Patients With Blventrlcular Failure. 
4:30 
Guy Haywood, James Sneddon, Yaver Bashir, Stephen Jennison, 
William McKenna. St George's Hospital, London. UK. 
The therapeutic potential of the vasodilatory action of adenosine at 
pulmonary A2 receptors has been demonstrated in small numbers of 
patients with primary pulmonary hypertension. However. in animal 
studies A 1 activation has been shown to be negatively chronotropic 
and negatively inotropic. We hypothesised that the wider clinical 
value of adenosine infused into the right atrium, would depend on the 
relative balance of activation between A1 and A2 receptors. Twenty•
one patients with severe biventricular failure were given an 
adenosine infusion over 15 minutes into the right atrium. Ten 
recieved 50 ~g/kg/min (Ad 50) and 11 received 100~g/kglmin (Ad 
100). (* P < .01) 
Vasodilatory effects on pulmonary and systemic vasculature: 
PVR (dyne.s.cm-5) SVR (dyne.s.cm-5) MABP mmHg 
Baseline 270 ± 144 1689 ± 640 81 ± 13 
Ad 50 197 ± 112* 1674 ± 504 87 ± 16 
Ad 100 168± 154* 1790±884 79± 12 
Cnronotropic and inotropic effects: 
Heart Rate Cardiac Index RAP PCWP 
(t p < .05) (bpm) (11m2) (mmHg) (mmHg) 
Baseline 86±23 1.B4±0.4 14±8 29± 10 
Ad 50 83 ± 19 2.06 ± 0.6 13 ±10 30 ± 14 
Ad 100 90±23 1.89±0.5 15±6 33± 11t 
Thus the combination of very short half-life and vasodilatory action at 
the pulmonary A2 receptors. results in powerful selective pulmonary 
vasodilatation. However, the negative inotropism ariSing from A 1 
activation prevents improvement in cardiac output. The negative 
chronotropic effects are too weak to result in a fall in heart rate. 
Conclusions: In patients with severe heart failure adenOSine is a 
potent selective pulmonary vasodilatator. but its therapeutic value is 
limited by its negative inotropic effects. A2 selective adenosine 
analogues with a short half-life, may have important therapeutic 
potential. 
815·4 4:45 
Failure of Aminophylline to Blunt Adenosine 
Induced Coronary Vasodilation In Humans 
James D. Rossen, Robert L. Minor Jr, Helgi Oskarsson, 
James E. Quillen, Charlotte L. Talman, Michael D. Winniford. 
University of Iowa and VA Medical Center, Iowa City, Iowa 
Acute IV aminophylline increases treadmill exercise time 
and reduces ST segment depression during exercise in 
patients with CAD. This anti-ischemic effect has been 
attributed to adenosine receptor blockade. To evaluate this 
putative mechanism, the extent of aminophylline induced 
blockade of adenosine receptors mediating coronary 
vasodilation was assessed in 10 patients during cardiac 
catheterization. Coronary blood flow velocity (CFV) was 
measured in a non·stenotic artery using a 3F Doppler 
catheter. The ratio of peak! resting CFV (P/R CFV) after a 
maximally dilating bolus of IC adenosine (15.1±1.8 Ilg, 
m±s.d.) was measured before and after aminophylline 6 
mg/kg IV over 10 minutes. An index of change in coronary 
vascular resistance (CVRI) was also calculated. Heart rate 
was held constant by atrial pacing. Blood theophylline level 
after aminophylline was 12.0±2.2 Ilglml (range 10.4-16.1). 
Results: (mean±s.d.) 
Condition MAP frrmI::tll 
control 97±12 
aminophylline 96±11 
p=ns for all parameters 
fL.B.ml 
3.4±0.7 
3.3±1.0 
QY.BJ. 
0.30±0.07 
0.35±0.19 
Conclusion: Acute aminophylline does not decrease IC 
adenosine induced coronary vasodilation. This finding 
suggests that mechanisms other than adenosine receptor 
blockade may be responsible for the anti-ischemic effect of 
aminophylline. 
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816·1 8:30 
Marked Concentric Left Ventricular Hypertrophy is 
Associated With High In· Hospital Mortality Following 
Aortic Valve Replacement For Aortic Stenosis 
David Orsinelli, Gerard Aurigemma, Stephen Battista, Anne Pryor, 
Andrea Sweeney, Steven Krendel, Linda Pape, William Gaasch. 
University of Massachusetts Medical Centet, Worcester, Massachusetts 
We have recently described a group of patients with aortic stenosis (AS) 
who had evidence of intracavitary flow acceleration on postoperative 
Doppler echocardiography and high in-hospital mortality following 
aortic valve replacement (AVR). We hypothesized that marked 
concentric LV hypertrophy (LVH), characterized by a small LV cavity 
and increased diastolic relative wall thickness (RWT) was related to 
mid-cavity obstruction and poor surgical outcome. To evaluate the 
impact of LV geometry on surgical outcome in patients with severe AS, 
we examined the following preoperative echocardiographic (echo) 
variables: LV end-diastolic and systolic dimensions (EDD,SD), septal 
and posterior wall thickness (ST, PWT), RWT, LV mass index (LVM\), 
as well as various catheterization and clinical variables in 54 consecutive 
patients who had preoperative echocardiograms and subsequently 
underwent AVR. 
*p<.05 LYEOD. LYSUSI em &w:*LYMl EE Q 
survived (n=42) 48 30 15 13 .56 157 .59 2.2 
died (n=12) 46 26 16 15 .72 166 .65 2.5 
There were no differences between groups with regard to age, sex, 
valve area, trans-valvular gradient or presence of CAD. Of the echo 
variables only RWT was significantly related to monality. Moreover, 
RWT values >.66, reflective of severe concentric LVH, were associated 
with a doubling of monality (42 vs. 17 %, p=.07). This association 
was panicularly striking in women in whom RWT values >.66 were 
associated with a four-fold increase in monality (63% vs. 14%, 
p=.OO7). The mechanism for this increased monality is unclear; it may 
be related to impaired LV fllling in the early postoperative period 
resulting in systemic hypotension. Thus, severe concentric LVH, with 
markedly increased RWT, panicularly in women, identifies high risk AS 
patients. 
816·2 8:45 
The Rate and Pattern of Change of Valve Area in Aortic 
Stenosis: Long Term Doppler Follow-up 
Wendy A. Thoreau, Samuel C. Siu, David H. Thoreau, Pieter 
M. Vandervoort, James D. Thomas, Arthur E. Weyman. 
Massachusetts General Hospital, Boston, MA. 
We have previously shown that the rate of change of 
echo-Doppler derived aortic valve area (AVA) in pts with 
AS is significantly predicted by the initial AVA, and 
have suggested a curvilinear change in AVA over time. To 
investigate this further, 25 adult AS pts (14M, IIF, mean 
age 63 yrs) with long-term follow-up and multiple (~4) 
studies were selected, and quadratic functions were 
fitted to the series of AVA's for each pt. ~: 118 
studies were analyzed (4_72 per pt), and AVA was cal•
culated using the conti~uity equation. The mean decreas~ 
in AVA was O.29±0.36 cm, from 1.29±O.56 to 1.0±0.37 cm 
(p<O.005) over a mean period of 57 months. Multiple 
linear regression analYSis revealed initial AVA as a 
significant predictor of the change in AVA (~AVA) over 
time (p<O.OOS). Pt age, sex, etiology of AS, presence or 
degree of regurgitation, and duration of follow·up were 
not predictive. Fitting the data to a quadratic function 
of time (tAVA • A t 2 + A,t + /\oj showed that: 1) the 
initial rate of AV( change (linear term A,) averaged 
-O.15±.04 cm2/yr (paO.OOI) and was more rapid for larger 
initial AVA's; 2) A~ was significantly positive (p<O.OOI), 
indicating a curvilinear relationship, with progressive 
slowing of the rate of decrease of AVA over time. 
CONCLUSIONS: 1. The initial rate of progression of AS is 
faster when the AVA is larger. 
2. The rate of progression of AS slows with 
increasing severity of stenosis, and this is best fit by 
a curvilinear model. 
332A ABSTRACTS 
816·3 9:00 
DYl1llmlc Filling Characteristics of the Left Ventricle Fulfill Hydrody. 
I1IImlc Constraints for Efficient Energy Transfer 
Morteza Gharlb. Takahlro Shlota. Soon U. Kang. Hugh McCann. David J. 
Sahn. Univ of CaIW. San Diego. Ca. 
Maximal efficiency of cardiac filling requires that blood entering tl)e left 
ventricle (LV) decelerate and mix evenly before energy Is spent deforming 
the cardiac apex. This requires a rapid rollup of the flowing blood into 
vonlcal structures wnhln the left ventricular body. It hes been demonstrat· 
ed that for pulsating jets. this maximal rollup and the most rapid decelera· 
tlon wHI occur when a 'Strouhal number' (HR x flow dlameter)/(average 
velocny for the filing period) Is between 0.25 and 0.3 under which condl· 
tlons for rollup will occur maximally at a distance between 2-4 orWlce dia· 
meters from the Inlet. To test whether normal mnral flow fulfills these 
crnerla for efficient utilization of driving or draw· 
Ing pressure to achieve filling. we measured L V APEX 
mnral annulus diameter (D) and LV chamber 
dimensions. mean filling velocity and hean rate 
In 32 healthy children and 18 adu~s who ranged 
In age from 1 mo. to 85 yrs and who had hean 
rates (sinus rhythm) 54·162 beats/ min. Over 
the wide ranges of valve and ventricular dlame· 
ters and hean rate encountered. a near const· 
ant result for Strouhal number was obtained: a 
mean of .30. SE ~ ± .09 and mean LV length to 
MV·D was 2.3 for children and 2.9 in adults. 
These values were constant wnh little variation 
throughout the population range of hean rate 
and body size wnh the exception of the slightly longer ventricles In the 
adults. Our measurements show that under resting condnions wnh the 
timing of flow over diastole present in normal Sinus rhythm. the combina· 
tion of valve diameter to hean rate products present in healthy subjects 
fulfill crnerla for effiCient utilization of diastolic filling gradients for ventricular 
fUling and mixing. Changes in these parameters during exercise condnions 
or wnh arrhythmias should allow characterization of the efficiency of 
cardiac filling under these altered conditions. 
816·4 9:15 
IXlPPU!:R ~~ r;, RI!G!,R:;!TANl' VCWIB AND l'RACl'I~ 
IN VALvtJraQ Rl!G!,R:;ITATI~1 P1'l'FALL AND RBPIIOIU:IBILIT 
Maurice E. Sarano, James B. Seward, A. Jamil Tajik. 
Mayo Clinic, Itx:hester, Minnesota 
Reliability of Doppler quantification of mitral and 
aortic regurgitation (MR, AR) is controversial. 
Quantitative Oqlpler WIlS thus performed prospectively in 
120 pts: 20 normal, 19 with AR, and 81 with MR. U!ft 
ventricular vollmeS were calculated using 2-D echo 
biapical Sillpson's rule (2I>-vol). Regurgitant volune 
and regurgitant fraction were obtained by DJppler and 
20-vol methods. In normal pta, DJppler regurgitant 
volune and fraction were respectively 4 +4 ml and 5 +5%. 
In pta with AR, DJppler and 20-vol methOOs showed -
excellent correlations for regurgitant volune (rc.95, p 
<.000l) and regurgitant fraction (re.93, p <.0001) 
without significant difference between the 2 methods. 
In pta with MR, DJppler overestimated regurgitant volune 
(10 ml/beat, P <0.0001) and regurgitant fraction (5%, p 
<0.0001) cxupared to 20-vol method, with a systematic 
trend of greater overestimation for larger regurgitant 
vollmeS. fbwever, in last 54 cxupared to first 27 pta 
with MR, overestimation decreased for regurgitant vo11.llE 
(5 +10 vs. 18 +27 ml, p <.05) and regurgitant fraction 
(3.3 +6.7% vs.-6.2 +6.8%, p-O.05), and systematic 
overeStimation trend disaweared. Good oorrelations 
between DJppler and 21>-vol methods for regurgitant 
volune (r-<>.93, p <0.001) and fraction (r-<>.94, p 
<0.001) were noted. Interobserver reproducibility W!lS 
excellent in 19 pta for regurgitant volune (r-<>.96, SEE 
17 ml) and regurgitant fraction (r-. 97, SEE 6%). 
Conclusion: Quantitative IlCppler (1) gives excellent 
assessment of AR severity, (2) shows overestimation of 
regurgitation severity in fit which becaIes clinically 
insignificant with increasing expertise, and (3) should 
be used in c:x:uprehensive AR and fit assessment. 
816·5 
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The Effect of Different Shaped Adjacent Surfaces on Regurgitant Jet Area: 
Comparison aetween Color Doppler 11I1IIges and Laser./nduced Fluor ... 
cent Dye VlsuallZltlon 
Jun Zhang. Takahlro Shlota. Robin Shandas. Roben Weintraub. 
David J. Sahn. Dorian Lieprnann. Univ of Calif. San Diego. CA 
We evaluated the effect of different typas of adjacent surfaces on jet flow 
areas Imaged on color Doppler (CD) and laser induced fluorescent dye flow 
visualization In a pulsetlle flow model. For CD visualization. a HnBchi EU6·165 
system was used under constant settings at 5 MHz and a 41 cm/sec Nyquist 
lim~. The jet entered at distances (D) of O. 2 and 4mm from orWice to flat, or 
equally curved concave and convex surfaces. Peak pulsatile jet velocnies for 
the 3 stroke volumes we used were 4.2. 5.8 and 6.6 m/sec. The maximum 
jet areas (cm2) for Doppler study were: (mean ± SE) 
4mm 
o 
2 
4mm 
o 
2 
4mm 
p< . 
11.2% .39 
N AV 
4.8%.3~ 
5.h.32: 
5.8%.18t 
5.9%.34:t 
10.3% .49" 6.8%.4O:t 
8.2%.57" 
8.5%.42:t 
10.9%.63 
11.5%.69 7.h.49:t 12.9t.48:t 
14.6%.43 12.0t.44:t 7.2%.44:t 10.0r.38:t 
13.h.32t e.3:t.44:t 14.1 %.35" 
14.7% .52 8.6 % .44:t 15.6 % .66:t 
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The fluorescent dye visualization yielded similar results to CD. However. the 
areas of Doppler jet images on concave and convex surfaces were slgn~icant· 
Iy smaller than the areas on fluorescent dye visualization (p<0.05). Fluores· 
cent dye fills In angled and low velocity flows better than CD such that dye 
visualized jet area was less reduced by surface Interactions. Both types of 
flow visualization showed that flow ~ by concave surfaces yieldS the 
smallest jets. Surface ~ to convex surfaces also reduces jet size. Our 
results have imponant implications for CD studies In patients with valvular 
regurg~ation. 
816·6 
'l'BB J:I.IPI!x::'l'I RI!G!,R:;ITANl' CIU7ICB AlUmI a.INICAL 
APPL.ICATI~ IN MI'mAL AND N:Rl'IC RI!G!,R:;~ 
Maurice E. Sarano, A. Jamil Tajik. *yo Clinic, 
Rochester, Minnesota 
9:45 
The effective regurgitant orifice area (ERQA.) can be 
calculated by DJppler using continuity equation as the 
ratio of regurgitant volane to the time velocity 
integral of the regurgitant jet. In a consecutive 
series of 100 patients, EROA. oould be calculated in 
11/19 patients (57%) with aortic regurgitation (AR), 
34/57 patients (60%) with organic mitral regurgitation 
(MR org), 20/24 patients (S3%) with ischemic/functional 
mitral regurgitation (MR isch). POor regurgitant jet 
envelope explained the nonobtainability of EROA. in 
35/100. the mean +SO of EROo\ were 31 +27 um2 in AR; 45 
+37 nm2 in fit org;-22 +8 um2 in fit iscK. lIbr the same 
ERa.\, patients with AR-had higher regurgitant vo11.llE 
than patients with MR org or fit isch (p <0.04 and 0.001, 
respectively). ~e WI!I.S no correlation between EROo\ 
and ejection fraction or cardiac index in the 3 groups. 
There were significant correlations between EROo\ and the 
following parameters: 
MR l.sch 
til 
til 
til 
R-.55 
.02 
we conc ude that EROA. (1) can ca IlCpp er 
USing continuity equation in a large percentage of pta, 
(2) shows strong correlations to hanodynamic parameters 
in pta with AR and fit, and (3) may provide iIrportant 
inSight on regurgitation pathophysiology. 
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817·1 8:30 
Eff.ct of COronary Rotational Ath.r.ctoar Abra.ion on 
V •••• l Sag.ant. Adjac.nt to Tr.ated Lasions 
Michael Cowley, Mauric. Buchbinder, David Warth, 
Gerald Dorroa, Nadim Zacca, C. TocId Sherman, Martin 
McDaniel, Kirk L. Peteraon. Medical COllege of 
Virginia, Richmond, Virginia 
The Rotablator uaes a high apeed burr coated with 
diamond microcrystals to remove plaque from 
atheroscl.rotic arterie.. Since intimal abrasion in 
animal mocIels i. known to procluce atheroscleroais 
there ia concern that Rotablator abraaion might induce 
diseaae in area. initially free of aignificant 
narrowing. To evaluate thia, quantitative coronary 
angiography (QCA) was done in 52 pts who had aerial 
angiographic follow up at 24 hra and 3-6 mo after 
coronary rotational atherectomy (PTCRA) using the 
Rotablator. QCA waa don. at an independent core lab. 
Minimal lumen diameter (MLD) at treated aites and 
adjacent proximal (Prox) and distal segments was 
measured using a geometric methocl baaed on orthogonal 
views. Angiograms were optically magnified, digiti:ed 
and atored in an image processor interfaced to a VAX 
11/780 computer. Exact le8ion location was determined 
using computer generated histogram •• 
Lumen Piam Pre 24 hr 3-6 mo 
Prox (mm) 2.62 ± 0.6 2.71 ± 0.6 2.69 ± 0.7 
L.aion 0.75 ± 0.3 1.70 ± 0.3 1.45 ± 0.5 
Distal 2.36 ± 0.5 2.53 ± 0.5 2.49 ± 0.6 
\ Sten 70 ± 9\ 33 ± 13' 44 ± 16' 
There were no aerial changes in mean MLD at prox and 
distal sites at 24 hr or long-term (3-6 mol a.aociated 
with PTCRA. The.. data indicate that use of the 
Rotablator is not associated with significant 
induction of new atherosclerotic disease on either 
side of the treated lea ion. 
817·2 
Differentiation of the Effects of Balloon and 
Frequency Rotational Coronary Angioplasty 
Intravascular Ultrasound and Angiography 
Junbo Ge, Raimund Erbel, Hans J. Reppredn, 
Diet z, Thomas Gerber, Gunter Gii~ge, J\irgen ~le"i'r. 
II. Medical Clinic, Cniversity Mainz, Germany 
8:45 
Hi~h 
by 
The purpose of this study was to compare th" 
consequences of balloon angioplasty' (PIC.~) ar.d hi gh 
fr~quency rotationai angioplast)" (HFRA) by intravascular 
ultrasound DVlS) and angiography. I\'lS was performed 
in 43 pts who underwent PTCA, in 3 pts who underwent 
HFR~ and in 4 pts underwE'nt PTeA and HFRA. 
Resul ts: Thi rt~'-seyen of the PleA peS (82%) , tf,E' 
pr~sencE' of the intimal and lor medial tears or cracks 
"pre detectE'd by' 1\'\:S, of "hich 28 pts showed single 
intimal or medial tears and 8 f,ts showed multiple tE'ar~. 
Of the 28 pts "ith single tears, the torn ends occured 
at the edge of the eccentric plaques in 20 (i1%). Of the 
8 pts "ith multiple tears, 5 (62.5%) had concentric 
pl~ques. In pts with HFRA, the lumE'n was relular without 
tE'ars if no additional PTCA was performed. All the ~ 
pt s .. i th PICA after HFR~ were found to haye plaqu,' 
cracks or tears. Angiographically', 20/45 PTCA pts 
(H%) sho .. 'ed intimal flaps and dissections, 16 (%%! 
had intraluminal haziness and 9 (20%) were four.d 
smooth-walled dilatation. 
Conclusion: ncs proYides more information about the 
results of intenentional procedures than con\'ention.'ll 
angiography. The post PICA consequences of the plaques 
arp closely- related to their character. HFRA creates R 
regular ]umel. when TiO addi tional PTeA is hold. 
ABSTRACTS 
817·3 9:00 
Success, Complications and Restenosis FollOwing Rotational 
Atherectomy of Coronary Ostial Stenoses 
Patrick Koller, Mark Freed, Khusrow Niazi, Cindy Grines, William 
O'Neill. William Beaumont Hospital, Royal Oak, Michigan 
Balloon angioplasty of coronary ostial stenoses has been associated with 
a low technical success, high complication and high restenosis rates when 
compared to nonostial lesions. Therefore, we examined the efficacy, 
safety, and outcome of rotational atherecto~ing both the transluminal 
extraction catheter (TEC) and Rotablator (R) in 72 pts with ostial 
lesions (TEC 48; R 24). Mean age was 63 and 22% of Pts' were female. 
67% of lesions were aorto-ostial in location, 33% were branch ostial and 
22% of lesions treated were in grafts. Adjunctive balloon angioplasty was 
used in 81 %. Success was defined as <50% residual stenosis without 
major complications [MI, CABG, death] and restenosis as <50% post•
procedural stenosis to > 50% at follow-up. Of those eligible for 6 month 
follow.up cath, data is available and has been analyzed by quantitative 
methods in 47/58 pIS. (81 %) 
Success 
Major Complications 
Restenosis - Overall 
Grafts 
Natives 
Aorto·Ostial 
Branch Ostial 
67{l2 (93%) 
4{l2 (5.5%) 
6/9 (67%) 
12/38 (32%) 
4119 (21%) 
8/19 (42%) 
Mean stenosis severity (%) pre, post, follow-up was (72%/24%/38%). 
No significant differences were found between TEC and R groups 
(exception: all ostial vein graft stenoses were treated by TEC). 
Conclusions 1. Elective treatment of coronary ostial stenoses with 
rotational atherectomy can be performed with high success' and low 
complication rates. 2. Restenosis remains a significant problem although 
initial results in native coronary arteries appear promising. 
817·4 9:15 
MULTI-CENTER REGISTRY OF PERCUTANBOUS COROllARY 
ROTATIONAL ABLATION USING THE ROTABLATOR 
Maurice Buchbinder, Martin Leon, David Warth, Jean 
Marco, Gerald Dorros, Nadim Zacca, Raimund Erbel 
UniverSity of California Medical Center San Diego, CA 
To date, Percutaneous Coronary Rotational Ablation 
(PTCRA) has been performed in 745 patients with 874 
lesions. From January 1988 to April 1991, all patients 
undergoing PTCRA were entered in a multi-center 
registry (Heart Technology, Inc.). There were 576 males 
and 169 females with an average age of 62. Lesions 
were located in the LAD/Diag 50\, RCA/PDA 30\, CX/OM 
18%, and other 2\. Acute procedural success defined as 
<50\ final residual stenollis was achieved in 95\ of 
patients. Adjunctive PTCA was performed in 44\ of 
lesions; in 30\ of lesions to maximize final luminal 
diameter in order to match nominal artery size. 
Complications included non-Q MI in 4.2\ of patients, Q•
wave MI in 0.9\, urgent CABG in 2.1\ and death 0.8\. 
Long term (>6 months) angiographic follow-up was 
performed in 78% of eligible patients treated with the 
Rotablator (348/449) showing a restenosie rate (defined 
as >50\ residual stenosis at the treatment site) of 
39\. 
Conclusion: PTCRA is a safe and effective treatment 
modality with excellent immediate results and 
acceptable long term patency. 
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817·5 
Myocardial Injury Following Coronary Rotational 
Ablation I Mechanis.. and Incidence 
9:30 
Michael A. Basnight, Robert E. Zipkin, Simon H. 
Stertzer, Joseph Rosenblum, Richard E. Shaw. Kathleen 
Ward, Mary C. Murphy, Richard K. Myler, San Francisco 
Heart Institute, Seton Medical Center, Daly City, CA 
Creatinine kinase (CK) release following temporary 
arterial occlusion associated with balloon angioplasty 
is well known. We retrospectively analyzed 149 
sequential. Percutaneous Transluminal Coronary 
Rotational Aulation (PTCRA) procedures. CK was measured 
prior to the procedure, immediately post PTCRA (POST), 
and at 6, 12, 18 and 24 hours (hrs) thereafter. CK ~ 
200 UfL with myocardial (MB) counts of ~ 7.5 ngfml were 
considered positive. Excluded were procedures where 
arterial flow was significantly compromised or major 
complications rendered the procedure unsuccessful. CK 
rise (referenced to the pre-PTCRA CK value) for the 
entire group (ALL, n-146), those with negative CK/MB 
(NEG, n=127), and those with positive CKfMB (POS,n=19), 
was as follows: 
POST 6hrs I 12hrs 1Bhrs I 24hrs 
ALL -3i113 -B±1171 ll±95 21±142 I 32±137* 
NEG 3UOO 1-l3UOO I l±36 2±39 I 73±lOB 
POS 7±4B 1114±22911B6±Z72 1191±255* I 215±123B* 
* P < 0.05 POS versus pre proceuural CK 
In conclusion, significant CK rise occurs in 
approximately 13% of PTCRA procedures, similar to that 
previously reported for balloon angioplasty. These 
results may be influenced by the advanced nature of 
some of the lesions treated by PTCRA where balloon 
angioplasty would not normally be used. The apparent 
continued enzyme rise at 24 hrs may indicate a 
mechanism of cellular damage which is different for 
PTCRA than acute periprocedural occlusion of a vessel. 
817.6 9:45 
Coronary Rotational Atherectomy: Angiographi~ Risk 
Factors and Their Relation to Success/ComplicatIOns 
Patrick L. Whitlow, Maurice Buchbinder, Kenneth Kent, Roben 
Kipperman, Theodore Bass, Michael Oeman. 
Oeveland Oinic Foundation, Oeveland, Ohio. 
To detennine the effect of angiographic risk factors on the outcome 
of coronary Rotoblator procedures, coronary angiograms were 
evaluated for specific lesion and anery characteristics (AHA! ACC 
criteria). Elective procedures were performed on 874 lesions in 
745 patients between January,1988 and April 1991. The overall 
procedure success rate was 95% /lesion. Lesion calcification, 
eccentricity, length >10 nun, stenosis 90-99% versus S90, vessel 
tonuousity and bifurcation point did not lessen success (94%-
96%, all subgroups). Cumulative effects of angiographic risk 
factors on success were not apparent: zero factors = 96% success, 
one factor = 95% success, two factors = 95% success, and three 
factors = 97% success. However, lesion length > IOmm was 
associated with a higher rate of death: 1.9% vs 0.7% for lesions 
<IOmm. Emergency surgery was more frequent when eccentricity 
was present, 2.6%, than absent, 1.1%. Type A, Bl, B2, and C 
lesions had angiographic success rates of 97%, 94%, 95%, and 
95%, respectively.Major complications of death, MI, and bypass 
surgery occured in 0 Type A lesions, 7% Bl lesions, 8% B2 
lesions and 15% C lesions. 
10 summary, coronary rotational ablation has a high su~ess rate 
even in lesions with multiple angiographic risk factors which have 
been related to success with balloon angioplasty or directional 
atherectomy. However, major complications are increased with 
more complex lesion morphology, especially with length> IOmm 
and eccentricity. 
JACC Vol. 19, No.3 
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818·1 8:30 
Poloxamer 188, a Hemorheologic Agent, Reduces Experimental Myocarclial 
Infard Size: Importance of Prolonged Tbenlpy for Reperfusion Injury 
Gary L. Schaer, Tony L. Hursey, E. Rene Rodri£ll"z, Edward A. Telfer, Bruce 
M. Etmis, Venkat Thota, NaDcy C. Manabat, 10seph E. Parrillo. Rush Heart 
Institute, Chicago, IL 
Reperfusion after coronary artery occlusion may be followed by myocardial injury 
persisting for hours 10 days. To investigate Ibe effect of timing of Iberap~ f~r 
reperfusion injury, we studied Ibe effects of poloxamer 188 (P-lS8), • nODloDlc 
mICe active agent in 3 groups of dogs uadergoing 90 min LAD occlusion 
(aDgioplasty balloon) and 72 hrs of reperfusion. P-IS8, fotmuIated as RheothRxe 
(Burroughs Wellcome Co.), was given as a 1S tnglkg iv bolus IS min before 
reperfusion followed by ISO mg/kg/hr iv for 4 hrs (n=9) or 48 hts (n=9): control 
dogs (n= 11) rereived Vehicle for 48 hts. Area It risk (AR, as % of LV) aDd 
infarct size (I, as % of AR) were determined at 12 hrs of reperfusion by post•
mortem dual perfusion using moDlStral blue dye aDd tripbenyl tetraZDlium chloride. 
LV ejection fraction was measured before occlusion (baseline) and at 12 hts of 
reperfusion by contrast ventriculograpby. Collateral flow (colored microspberes), 
hemodynamics aDd baseline ejection fraction were not significantly different 
between groups. 
Interim Results (*=p< .OS vs control): 
ARIL V II AR LV Ejection Fraction 
(%) (%) (% change baseline to 72 hr) 
Control 29 ±2 43 ±S -36 ±S 
P-I884hrs 33±1 3S±6 -26±3 
P-I88 48 hrs 31±2 27 ±S* -16±6* 
P-188 (48 hrs) caused I 82±4% reduction (p< .01) in neutrophil chemotaxis 
(Boyden chamber) from baseline to 24 hts post-reperfusion. Bolb P·188 (4 hrs) 
aDd Ibe control group showed aD increase in neutrophil cbemotaxis at 24 hrs. 
Conclusions: 1) A 48 be infusion of P-188 caused a 37% reduction in infarct size 
aDd superior LV function compared 10 controls, whereas a 4 be infusion of P-I88 
showed no significant benefit; 2) In addition 10 its bOWD beneficial hemorbeolog•
icaJ properties, P-188 (48 hrs) may reduce infarct size by sustained inhibition of 
neutrophil chemotaxis: 3) These data demonstrate that I substantial component of 
injury occurs between 4 aDd 48 hours of reperfusion aDd suggests that therapy for 
reperfusion injury should be continued for longer Iban 4 hours. 
818·2 8:45 
Attenuation of MYocardial Ischeaic and Reperfusion Damage 
by Exogenous Adenosine 15 Mediated by Adenosine Receptors 
Marc Janier, Jean l. Vanoversche1de, David Whe11an, David 
R. Marshall, James E. Bakke, Steven R. Bergmann. 
Washington University, St. louis, MO 
Although exogenous adenosine (ADO) protects both'ischemic 
and reperfused myocardium. its mechanism of action is con•
troversial. To evaluate the role of ADO receptors, IS paced 
isolated rabbit hearts were perfused at constant flow with 
1 ~M ADO starting 15 min before 1 hr of low flow ischemia 
followed by reperfusion. Results were compared with those 
from 20 control hearts (C) and 13 hearts perfused with both 
1 ~M ADO and 10 ~M of the ADO receptor blocker 8-pheny1-
theophyll ine (SPT). ADO delayed the time of onset of 
ischemic contracture (TOIC) compared with C (30 ± 20 (SD) 
compared with 13 ± 11 min), and decreased the amplitude of 
ischemic contracture (IC) (29 ± 19 compared with 48 ± 14 mm 
Hg, p < 0.01 for each). This protection was accompanied by 
an increase in tissue ATP content (1.9 ± 0.9 vs. 1.07 ± 
0.23 ~mol/g, p < 0.05) and stimulation of anaerobi~ glyco· 
lysiS (lactate production of 0.S7 ± 0.4 compared wlth 0.53 
± 0.23 ~m01/g/min, p < 0.002). With reperfusion, developed 
pressure (DP) was better in hearts receiving ADO (88 ± 16 
compared with 57 ± 23' of baseline) and tissue necrosis 
assessed by creatine kinase release was decreased (41 ± 47 
vs. 100 ± 53 U/g, p < 0.01 for each). 8PT blocked all of 
the beneficial effects of ADO (TOIC - 11 ± 4 min. IC - 50 
± 15 mm Hg, CK release - 84 ± 70 U/g, ~P - 47 ± 25%, and 
lactate production - 0.37 ± 0.08 ~mo1/g/min. ATP - 1.28 ± 
0.29 ~m01/g, p • NS vs. Cj. The results indicate that 
exogenous ADO attenuates ischemic injury and enhances the 
effects of reperfusion by a receptor-mediated mechanism, 
most likely stimulation of anaerobic glycolysis. According•
ly agonists of ADO may be useful adjuncts in the treatment 
of'patients with myocardial ischemia. 
JACC Vol. 19, No.3 
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818·3 9:00 
Failure of Human Superoxlde Dlsmutase (SOD) to Reduce 
Infarct Size Following Reperfuslon After 90 Minutes 
of Coronary Artery Occlusion. Local Application of 
SOD to Only Half of the Reperfused Territory. 
Dong·Sun Han, Hok Chong Leong, Vasushi Wakida, 
Juliana Vano, Michael C. Fishbein, William Ganz. 
Cedars-Sinai Medical Center and University of 
California, Los Angeles, CA. 
To avoid the marked variability of infarct size 
caused by variability of collateral circulation, we 
used a method whereby dogs serve as thei r own 
control. We studied the effect of SOD on infarct size 
in open chest anesthetized dogs. A 2.SF size catheter 
was inserted into the LAD and advanced halfway 
between the last diagonal branch and the apex. The 
LAD was occluded for 90 min proximal to the last 
diagonal branch. One min before and for 60 min after 
reperfusion h-SOD was infused into the distal half of 
the reperfused region at a rate 16.7 ug/min. At the 
end, the perfused half was outlined by Monastral blue 
dye, the heart arrested with KC1, cut into 1cm thick 
slices parallel to the LAD and placed into triphenyl 
tetrazolium chloride for delineation of necrosis. In 
6 dogs there was no difference in the transmurality 
of necrosis between the proximal control regi on and 
the distal h-SOD treated region: 42.9±16.6% vs 
46.S±13.8% of the wall thickness respectively; p=0.41 
by paired t-test. 
Conclusion: Human superoxide dismutase applied to one 
half of the ischemic territory did not reduce infarct 
size compared to the untreated half. 
818·4 9:15 
EFFECTS OF RECOMBINANT HUMAN ElTRACELLULAR-SUPEROXIDE 
DISHUTASE TYPE C ON MYOCARDIAL NECROSIS IN PIGS. 
Nobuo Hatori, Per-Ove Sjllquist, Stenhan L. MarklUI}d, 
Hiroshi Yoshizu*, Susumu Tanaka*" and Lars Ryden. 
Karolinska Hospital/Stockholm,Sweden and National Defense 
Medical College, Sa1tama, Japan* 
The efficacy of recombinant extrace11ular-superoxide 
dismutase type C (EC-SOD C) to limit the extent of 
myocardial necrosis after acute ischemia followed by 
reperfusion was explored. The effect was also compared to 
that of EC-SOD C combined with catalase (CAT). EC-SOD C 
binds to heparan sulfate proteoglycan on the cell 
surfaces. Thirty-two open chest pigs were subjected to 45 
min of LAD occlusion followed by q hours of reperfusion. 
The pigs were randomly' assi~ned to one of four treatment 
arms. Pigs in group A (n=~) received 300 ml of saline 
into the great caraiac vein during a 30 min long period 
started 5 min Qrior to reperfusion; pigs in groJ B (n=8) got 48,000 U 01 EC-SOD C while pigs in .s..rou'p. C n-8) got 48,000 U of EC-SOD C together with 1,b:>0,OUO of CAT. 
Pigs in group D (n=8) received 1,650,000 U of CAT. In 
group B,l: and D drugs were dissolved in saline and 
1nfused 1nto the great cardiac vein in the same manner as 
saline in group A. Infarct size measured by triphenyl 
tetrazolium chloride ( C) is tabulated; 
Group Area at risk AR Necrotic area(NA) NA(AR 
A 19.3+4.5% 15.2+4.2% 78.8+8.6% 
B 22.1+6.9% 11.0+7.0~ 46.5+16.7%*# 
C 22.2+4.3% 9.7+4.4~ 40.8+13.3%*# 
D 20.0+1.7 13.6+4.3 67.2+18.6 
(*P<0.05 VB. group A, #P<O.05 vs. group D, meaniSD) 
Creatine kinase (CK) activity 0' ischemic myocardium w/as 
higher in group B (1740+548 U g) and C (1729+358 U g) 
tnan in ,groups A (lIE4+23 U/g) and D 0251+434 
U/g:p<0.05). There was an "inverse relation (r=-(I.83) 
between infarct size measured by TTC and CK content in 
the ischemic ml"0cardium. Plasma SOD concentrations did 
not change sign1ficantly despite EC-SOD C administration. 
Conclusion: Tne results indicate that the presence of SOD 
on ehe cell surfaces are of crucial imp'ortance in the 
Qrevention of reperfusion injury rather than circulating 
SOD. Retrograde infusion of CAT had no additional 
effects. 
ABSTRACTS 
818·5 
Intramyocardial Potassium Changes During 
Myocardial Ischemia and Reperfusion 
9:30 
Robert J. Hariman, Eric K. Louie, King H. 
Hwang, Henry S. Loeb, Patrick J. Scanlon, Hines 
VA Hospital, Hines IL and Loyola University 
Medical Center, Maywood IL 
335A 
Inhomogeneous distribution of potassium and 
other ischemic products may play a role in the 
genesis of arrhythmias during ischemia (ISCH) 
and reperfusion (RPF). Therefore, we studied 
in 11 dogs the changes in extracellular 
potassium concentration, [K+1 o, during ISCH due 
to 20 minutes of LAD occlusion and during one 
minute of RPF. [K+1o was measured using up to 
15 intramyocardial K-sensitive electrodes. 
Regional myocardial blood flow (RMBF) was 
measured using 15p radioactive microspheres in 
1.0 g full thickness myocardial samples at the 
sites of the K-electrodes. During RPF, RMBF in 
different sites of ISCH increased over a wide 
range (2-7 x control). Related to the varia•
tions of RMBF during RPF, rate of decline of 
(K+1o, d[K+1o/dt, at different sites varied mark•
edly ranging from -2.0 to +3.4 mEg/l minute. 
Following 1 minute RPF, (K+ 10 at various sites 
of LAD territory was 9.1±5.8 mEg/l not signifi•
cantly different from (K+1o of 9.5±4.5 mEg/l 
prior to RPF. However, following 1 minute RPF, 
coefficients of variation for [K+1o increased 
from 39.7±8.8% to 44.7±10.1% (p<0.05). Thus, 
during ISCH and especially during RPF various 
sites show an increase in spatial heterogeneity 
of [K+1 o, which may be important in the genesis 
of arrhythmias. 
818·6 9:45 
Increasing Glycolytic Flux During Ischemia Limits Tissue 
Damage and Enhances Functional Recovery With Reperfusion 
Jean L. Vanoverschelde, Marc Janier, James E. Bakke, David 
R. Marshall, Steven R. Bergmann. WaShington University, 
St. Lou! s, HO 
Although anaerobic glycolysis 15 the primary source of 
energy when oxygen is limited, its capacity to preserve 
myocardial viability remains controversial. Accordingly, we 
eva 1 uated the effects of selected bi ochemi ca 1 maneuvers 
aimed at increasing glycolysis during ischemia on the 
development of ischemic contracture (IC) and on functional 
recovery with reperfusion. Paced, isolated rabbit hearts 
(perfused at constant flow with buffer containing 0.4 RIM 
palmitate and equimolar albumin, 5 RIM glucose and 70 mUll 
insulin) were subjected to 1 hr low flow ischemia followed 
by reperfusion. Glycolytic ATP production was increased by 
doubling perfusate glucose and insulin (Glu, n-ll), by 
stimulating phosphofructokinase with 1.0 RIM dichloroacetate 
(DCA, n-10) or by increasing glycogen stores before 
ischemia (Glyc, n-18), and results were compared with those 
from 20 control hearts (C). Each of the diverse approaches 
for enhancing glycolysis delayed the time of onset of IC 
{DCA - 45 ± 14, Glyc - 31 ± 19 compared with 11 ± 10 min in 
C (p < 0.01 for each». Hearts perfused with Gl u never 
developed IC. The severity of Ie was related to tissue ATP 
(r--.96) and lactate production (r.·.B4). Functional 
recovery (developed pressure) during reperfusion was 56 ± 
23% of baseline in C, 90 t 8% in Glu, 92 t 5% in DCA, and 
79 ± 19% in Glyc (p < .05 for each). Creatine kinase 
re 1 ease was reduced by > 55% in treated hearts. Thus, 
enhancement of glycolysis during ischemia delays the onset 
of IC, preserves AlP content, decreases necros is, and 
improves functional recovery with reperfusion. It is best 
achieved by augmenting exogenous glucose supply, an 
approach amenable for treating patients with myocardial 
ischemia who are candidates for revascularization. 
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Dyna.ic Alterations in Regional Myocardial Blood Flow in 
Response to Exercise and Mental Stress Assessed by 
Positron E.ission TOIOgraphy 
James A. Arrighi, Arshed A. Quyyumi, Jose A. Marin-Neto, 
Stephen L. Bacharach, Jean G. Diodati, Pasquale Perrone•
Filardi, Vasken Dilsizian, Robert O. Bonow. 
NIH, NHLBI, Bethesda, Maryland 
Myocardial blood flow (MBF) in patients with coronary 
disease (CAD) usually increases in the ischemic zone (IZ) 
in response to dynamic exercise (Ex) and mental stress 
(MS). However, in some patients MBF may actually decrease 
with Ex or MS. To determine the magnitude of MBF responses 
in the IZ, we studied 13 patients with chronic CAD by 
positron emission tomography, using 8zRb at rest, during 
supine Ex, and during MS. Absolute regional MBF reserve 
was computed quantitatively from the regional myocardial 
uptake of 82Rb corrected for the arterial input function, 
and was expressed relative to resting MBF. In 9 patients 
(group 1) Ex caused an attenuated increase in MBF in the 
IZ, and in 4 patients (group 2), MBF decreased in the IZ 
during Ex. Despite these different responses to Ex, MBF 
increased similarly in both groups during MS: 
Groyp 1 In=9) Groyp 2 In=4) 
.-NL -.-l.L .-NL-.-l.L 
MBF Response (Ex) I.S±.3 I.4±.2 I.6±.I .9±.2 
MBF Response (MS) I.2±.3 I.I±.3 I.2±0 I.I±.2 
Both groups achieved similar rate pressure products with 
Ex (I9.0±3.4, group 1, vs 2I.S±3, group 2) and with MS 
(I2.I±2.S, group 1, vs IS.4±3.I, group 2). On treadmill Ex 
test ing, patients in group 2 had the 4 lowest ischemic 
thresholds (defined as Ex workload at Imm ST depression) 
of the 13 patients (mean 6.9±3.S mets group 1 vs 2.7±0 
mets group 2, p=. 01). Thus, the subset of pat ients who 
manifest Ex-induced reductions MBF have severely reduced 
ischemic thresholds on Ex testing. Despite Ex-induced 
vasoconstriction, MBF does not decrease with MS. 
819·2 8:45 
Se~ Apolipoprotein B Level ia the Beat Overall 
Predictor of Severity of coronary AtheroBcleroBis (CA) 
Michel Karcil, Lucien Campeau, Jacques Lesperance, 
B. Charles Solymoss. 
Montreal Heart Institute, Montreal, Quebec 
In 1299 male and 621 female patients undergoing 
diagnostic coronary arteriography we studied by the 
likelihood ratio (LR) x2 test, the relations 
between quintiles of lipoprotein levels and four grades 
of severity of CA (normal arteries; < or ~5~ 
Btenoses; complete occlusion). We noted significant 
clusterin& of patients with various grades of severity 
of CA in function of the quintiles of the lipoproteins 
listed below; the figures indicate the p<O.OS LR x2 
values for younger and older men (H yrs) and women 
(W yrs). 
Apolipoprotein B 
Apo-Al / Apo-B 
lon-HDL-C 
LDL-C / HDL-C 
Tolal-C / HDL-C 
LDL-C 
Tolal-C 
Triglycerides 
Lp(a) 
M <55 H ~55 W <60 W ~60 I x2 
58.4 22.1 77.9 36.6 z 195.0 
49.0 24.6 71.7 43.7 z 180.0 
38.1 24.4 80.4 30.6 = 173.5 
38.2 22.2 63.0 29.7 = 153.1 
40.9 VS 69.9 34.6 = 145.4 
38.3 32.1 67.2 IS = 137.6 
35.2 VS 72.0 VS = 107.2 
VS VS 47.7 42.8 = 90.5 
26.7 ~ 42.8..!L = 69.5 
324.8 125.4 592.6 218.0 
Accordin& to I x2 the best overall test for 
severity of CA was apo-B. The first 4 tests were 
8ignificantly related to severity of CA in each 
subgroup. The LR values indicate a stronger 
relationship in women than in men and in youn&er than 
in older patients; total-C and Lp(a) were predictors 
only in youn&er patients and triglycerides only in 
women; HDL-C and apo-AI levels were contributors in 
ratios but not as a single test. 
819·3 
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Transmural coronary steal is the predominant mechanism of dipyridamole 
induced myocardial ischemia in patients with single vessel coronary artery 
disease. 
Luis I Araujo MD. AttiIio Maseri MD FACC. Edward 0 McFalls MD. Alfredo 
Galassi MD. Adriaan Larnmensma PhD and Terry Jones DSc. MRC and 
Cardiovascular Research Units, Hammersmith Hospital. London. UK 
Vasodilation induced myocardial ischemia may result from intercoronary sJeal in 
the presence of collateral circulation. Transmural redistribution of myocardial 
blood flow. transmural sJeal. with subendocardial ischemia may also occur but 
is difficult to demonsttate in humans. To investigate whether this mechanism of 
myocardial ischemia operates in humans. we measured myocardial blood flow 
(MBF) and myocardial glucose mrtabolism as an index of myocardial ischemia 
with Positron Emission Tomography (PET) at baseline (b) and after 
dipyridamole infusion (d) in patients with I vessel disease and normal resting LV 
function. Group 1 comprised 6 patients with a total occlusion and collateral 
circulation to the territory at risk (intercoronary steal) and Group 2 included 5 
patients with a single stenosis (> 75% diameter reduction) and no 
angiographica1ly visible coUaterals (transmural sJeal). MBF was measured using 
0·15 labeled water and dynamic PET scanning with a technique previously 
validated in our laboratory. Myocardial glucose metabolism was assessed 
employing F-18 fluoro deoxyglucose (FOG). MBF results are expressed in 
mVg/min at baseline and the ratio of MBF d to b (dIb). FOG as a ratio of 
stenotic (s) to normal (n) fractional uptake. Results are as follow: 
group 
I mean 
sd 
2 mean 
sd 
bMBFn 
0.80 
0.12 
0.86 
0.17 
d/bn 
2.59 
1.27 
2.35 
0.56 
bMBFs d/bs bFDG 
0.84 1.49 1.47 
0.18 0.59 0.28 
0.77 1.29 1.06 
0.12 0.24 0.28 
dIb n. dIb s. r s FOG group 1 vs 2 P=NS; dIb s vs dID n pSO.Ol 
dFDG vs rFOG pSO.05. 
dFDG 
3.1 
1.15 
2.74 
1.15 
Thus. the full thiclcness MBF increased in the territory at risk but significantly 
less than that in control areas. In spite of this increment, metabolic changes 
indicative of myocardial ischemia were found and were not different between the 
two groups. These findings indicate that ttansmural redistribution of MBF 
leading to subendocardial ischemia distal to coronary stenosis is the predominate 
mechanism of dipyridamole induced myocardial ischemia in this group of 
patients. 
819·4 9:15 
RecbJed Regia'lal. wall 'JhicJmess and Absent Systolic wan 
'l!I.i.ckenin:J do mt AI:D.Irately Identify Hcnviabl.e ~
in Cllralic IsdIani.c left Vent:riallar Dysfurx::t.i.tn 
Pasquale Perrone-Filardi, steplen L. Badlarach, Vasken 
Dilsizian, simone Maurea, Jose A. Marin-Neto, James A. 
Arrighi, JClSEPl A. Frank, Rd::lert O. Banc:M. NHl.8I, 
Bethesda, MaIyland 
Reduced em-diastolic wall thickness (EOl') with absent 
systolic wall thickenin;J (W1') has been reported to 
represent myocardial. fibrosis in patients with dlrcnic 
coronary artery disease. To assess 10hether reduced 
regional EOl' and absent wr acx:urately identify nawiable 
myocardium, 25 patients with ischemic LV dysfunction ~W 
ejecti~ fraction at rest 27±10%) un:lenient PEl' with ~ 0 
arxi ' fluorodeoxygluoose (Frx;) to assess metabolic 
activity, and spin-ed1.o gated magnetic resananoe imaqin:} 
to measure regional EOl' arxi wr. Preseooe of metabolic 
activity was defined as Frx; uptake (corrected for partial 
volume) >50% of that of nonnal regions. Of 355 myocardial 
regions evaluated, 266 were hypokinetic or nonookinetic at 
rest, arxi 89 were akinetic (i.e., absent wr). Frx; uptake 
was observed in 97% of the hypokinetic arxi oom:lkinetic 
regions, Wt also in 66 (74%) of the akinetic regions. EDl' 
was greater in akinetic regions with Frx; uptake cx:mpared 
to those withaIt (11±4 vs 7±3 mn;p<O.Ol). '1he best 
sensitivity arxi specificity of EOl' in predictin:} the 
absence of metabolic activity in akinetic regions were 74% 
and 79%, respectively, and correspon:ied to an EDl' 
threshold of BImn. However, the positive predictive 
accuracy was only 55%, arxi did mt inprove for other EDl' 
values. In all regions there was only a weak correlation 
between Frx; activity and either EDl' (r=.17) or wr (r=.32). 
'lhus, metabolic activity is present in many regions with 
reduced EDl' and absent wr. 'Ihese data irxticate that 
assessment of regional anatany arxi function may be 
inaccurate in distin;Jui.shing asynergic blt viable 
myocardium fran necrotic myocardium. 
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Accuracy of Exetcl .. Echocardlogrlphy for the Detection of 
Coronlry Anery Dlaaa .. II not Impllred In Petlenta with Left 
Ventrlcullr Hypenrophy. 
Julius Torelli, Thomas H. MalWick, James Nemec, Loretta Isada, William J. 
Stewart, Emesto E. salcedo. 
Cleveland Clinic, Cleveland, OH. 
Left ventricular hypertrophy (LVH) exerts an adverse irriluence on the 
accuracy of exercise EKG and perfusion sclntlgrephy in diagnosing CAD. 
This study examined the effect of L VH on the accuracy of exercise 
echocardiography (EE) in 158 pts w.h suspected CAD, all of whom also 
underwent coronary arteriography. 
LV mass was calculated from resting measurements of the septum (S), 
posterior wall (P), and end-dlastolic dimension (EDD) using the formula: 
Mass(g)al.04((S+P+EDD)3_EDD3). Post-treadmill EE was then performed 
using on-line dig"lzation. 
LVH (echo mass >131 wm21n males, and >100 wm2 In females) was 
present in 87 pts, and absent (NLV) in 71 pts. These groups did not differ 
In age, gender, past Q-wave irriarction, drug therapy, or Image qual"v. The 
frequency of slgnHicant (>50%) coronary stenosis was similar between the 
LVH (47 of 87 pts, 54%) and NLV groups (35 of 71 pts, 49%), paNS. 
MuHlvessel disease was more common in LVH (25 of 87 pts, 29%) than 
NLV (8 of 71 pts, 11%). p.O.Ol. EE noted wall motion abnormal~ies at rest 
or wnh exercise In 69 pts: 
LYH In.871 NLY (n-Zll Jl 
Sensltiv"v 42147 (89%) 27/35 (77%) NS 
SpecHic~y 39/40 (98%) 30/36 (83%) 0.05 
Pos Pred Value 42143 (98%) 27/33 (82%) 0.04 
Neg Pred Value 39/44 (87%) 30/38 (79%) NS 
Accuracy 81187 (93%) 57171 (80%) 0.02 
LV mass In pts wnh correct EE was 137:49 vs 111:35 In pts wnh incorrect 
EE (pa O.05). 
CONCLUSION' The diagnostic accuracy of EE for the detection of CAD is 
not Impaired by the presence of LVH as ~ is wnh other diagnostic 
modalnies. In fact. ~s presence was linked wnh Improved accuracy. Thus 
EE may be the technique of choice for detecting CAD in pts w~h LVH. 
819-6 9:45 
Earty-Phaaa Poat-Paclng Myourdlal Laotate Praduotlon. A New Gold 
Standard for the Datactlon of Iaohamla In Man? 
Willem Remme, Dick KruljlHn, Henno Krauss. Pat RlllTlme, Dieclerik van 
Hooganhuyze. SIIca.... Foundation. Rotterdam. The Netherlands. 
Anleroblc glycolylll it an obIigaloly and aafly want In myocardial ls•
chemia. NeverthlllSl. In man the UHfulnlSl of myocardial lactate pro•
duction II ilchlmlc marker it daballd. With atrial pacing sensltlv"v it 
approxlmatlly 50-80%. not comparing favourably with other marklrl. AI 
anhanced wash-out of lactate In the poat-paclng period may Improve Its 
delactlon. 161 pis with >70% 11ft-CAD (4. 48 pis with <25% 11ft-CAD (M) 
and 23 pis without CAD (N) u~ Incrernantal atrial pacing (10 
billa (b)/2mln). All were lludled for anglna(-lIke pain). but ne~er N nor 
M had background cerdlac dl..... or positive preatudy exercl .. teats. 
HlIITIOdynamic variables. ST-aagmant chang .. (Illds 1.11 and V5) and 
paired arterial and coronary vanoul lactate were determined at contrcl 
(C). at 100. 120,140.160 b1mln. at maximal ralll (max) and at 15 sac, 1. 
2 and 5 min poat-paclng (pop). Although mex hIIrt rate was 1% Ills In L 
(p<.05 VI M and N). hIIIIIodynamicll including double products were 
otharwisa comparable betwaan group'. Angina-like pain occurred In 52% 
(N).69% (M) and 80% (4. Also. maximal ST-dlprellion was comparable 
(0.16. 0.14 and 0.16 mV In N.M and L,reep). Howwer. LVEDP only In•
creeled In L. Arterial lactate _ined unchanged In all group'. In con•
trail. coronary vanoua lactate Increeled In L, but not In N or M with slgn~ 
ftcant chang_ al .... dy at l00b/mln. peek valu .. at 15 sac pop (0.82 VI 
0.53 mmolJl(C») and 11111 IIgnificant lIIYationa at 5 min pop. Subgroup 
lnalysis Indlcetld mexlmal lactate production at 15 and 30 sec pop com•
pared with mex. 0 and 45 sac pop and 1 min pop. In 28 L pta lactate pro•
duction occurred only It 15 sac pop. thus Incraaling Its Incidance from 
80% (max) to 78% (15 sac pop). which compared favourably to ST d. 
p ..... lon (60%) and LVEOP IIlVIIIons (50%) In L. In Nand M lactate pro•
duction occurred In 9% and 10% only. In contrail. ST depression was 
obsarved In 51% and 29% and abnormal LVEOP Increes .. In 46% Ind 
39% of N and M. reep. Thus. In pacing models myocardial lactate pro•
duction I, highly apeclfic and more sensitive In lcIantifylng ,Ignificent CAD 
than commonly applied criteria u ST deprISIIon or angina. provided that 
lactate mataboIitm II .-"ajuated betwaan 15 and 30 saconds Ifter pacing. 
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Comparllon of Tc·llllm·Seltlmlbl Ind Thllllum-201 
Myocardial Retention Chltlcterlltici 
Pierre Melon. Rob Beanlands. Ngoc Nguyen. Timothy DeGrado. Neil Petry. 
Markus Schwaiger. 
University of Michigan Medical Center. Ann Artlor. MI. 
The purpose of the study was to compare the myocardial ratention of Tc-
99m-Sestamibi (MIBI) and Thallium-201 (TL) In an open chell dog model 
uSing an IV dipyridamole InfUSion (0.56 mWkg over 4 min). and LAD 
occlusion to Induce a wide range of flows. Racliolabeled microspheres (MS). 
MIBI and TL were Injected IImuHaneously Into the left atrium. The dogs were 
then sacrificed at 2. 5 and 20 min post injection. The myocardial ratention of 
MIBI and TL was expressed in IIbHrary units after being normalized for the 
arterial Input function which was datermlned from the Integral of the tracer 
act!v"v In the arterial blood. In 114. 222 and 218 myocardial segments at 2. 5 
and 20 min post Injection respectively. retention of each tracer was 
compared to blood flow determined by MS (flow range: 0.01-7.13 mVglmln). 
For each time point. the retention-flow relationships were best fitted by non 
linear functions. The table shows the absolute retention and the 'relative' 
retention (In brackets) expressed IS I percent of retention at a flow rate of 1 
mVminig. for a 1 to 5 mVminlg flow range: 
Flow ImVmjMll 1 2 3 4 !j 
2min MIBl2.6(100%) 4.3(165"10) 5.6(214%) 8.6(256%) 7.7(293"10) 
TL 8.1(100%) 14.8(182%) 20.5(253%) 25.8(317"1.) 30.7(378"10) 
5min MIBI2.3(100%) 4.2(179%) 5.7(244%) 7.1(301%) 6.3(352%) 
TL 9.0(100%) 16.5(184%) 23.1(257%) 29.1(325%) 34.9(389"10) 
20min MIBI3.2(100%) 5.3(163%) 6.6(203%) 7.4(230%) 8.0(249%) 
TL 7.2(100%) 12.1(169%) 15.8(220"10) 18.8(260%) 21.0(294%) 
As previously reported. MIBI demonstrated a lower absolute tissue 
retention and a longer tissue haH-life. MIBI tissue retention Increased 
proportionally to flow suggesting only small changes In retention fraction at 
higher flow rates. At all time points. TL demonstrated larger increments of 
relative tracer retention between various flow levels Indicating a larger 
dynamic range of flow estimates provided by TL. Future clinical studies have 
to address the question whether these dHlerences in tracer kinetics result In 
lower sensnlv"v for detection of CAD by MIBI as compared to TL. 
820-2 8:45 
Comparison of Thallium and Tc·Sestamlbl In Isoproterenol 
Induced Subendocardial ischemia In Rat Myocardium 
Michael W. Oae, Sara J. Velazquez-Rocha, Elias H. Botvinick, John 
W. O·Connell. University of California, San Francisco. CA 
We have previously shown a comparable distribution of 
thallium-201 (Til and Tc99m-sestamibi (MIDI) during acute 
coronary occlusion and following reperfusion in rat myocardium. 
To evaluate the relative uptake of T1 and MIDI during ischemia, 
in the presence of continuous but relatively reduced flow, we 
compared the myocardial distribution of T1 to MIDI during 
isopruterenol induced subendocardial ischemia in nine tats. A 
mixture of 7 MCi of MIBI and 80 uCi T1 was injected twenty five 
minutes after 0.7 mg/kg isoproterenol given I.P. Five minutes 
after injection, the heart was excised. Twenty micron frozen 
sections were applied to x-ray film for I.S hours for MIDI 
exposure, removed for 3 days for MIDI decay. and reapplied for 
3 days for T I exposure. Color computer functional maps were 
generated from digitized autoradiographs to display the 
distribution of both radionuclides in a single image. 
In seven of nine hearts, small focal areas of absent activity 
were present in the subendocardium (ENOO). with a surrounding 
subendocardial area of relatively reduced uptake. Maximal uptake 
occurred at the subepicardium (EPI). T1 uptake was less than that 
of MIDI in the region of relatively reduced flow (ENOOjEPI 
ratio: T1 - .38 ± .12. MIDI - .56 ± .19, p < .02). Two animals 
Showed no perfusion abnormality. 
As opposed to the situation with total cessation of flow 
(occlusion) and restoration of flow (reperfusion). T1 and MISI 
distribution are different during ischemia with continued but 
relatively reduced flow. The extent and severity of the 
subendocardial perfusion defect was greater with thallium than 
with MIBI. The mechanisms may relate to differences in 
extraction fraction or metabolic effects on membrane transport. 
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Comparison or Tecbnetium-99m-Teboroxlme and Tballium ror 
Assessment or Relative Coronary Flow Reserve in tbe Presence or 
Coronary Artery Stenosis 
Steven F. Berman, William A. Gray, Henry Gewirtz. 
Brown University and Rhode Island Hospital, Providence, R.I. 
Previous animal srudies indicate myocardial extraction of Teboroxime (TEBO) 
exceeds that of Thallium (TI) at high flows and that n underestimates flow at 
levels> 2-3 mllmin1g. Thus we tested the hypothesis that regional tracer contrast 
and hence detection of coronary artery stenosis (CAS) over a range of 
hemodynamic severity would be improved with TEBO versus n Srudies were 
performed in separate groups of swine prepared with a CAS wbich reduced vessel 
diameter by:SO% (n=7), 70% (n-7), or 80% (n-8). Measurements of 
hemodynamics and regional myocardial blood flow (RMBF; microspheres) were 
made at I) baseline; 2) stress ",iCIIV adenosine plus phenylephrine and 3) 2-3h 
post stress. Both TEBO and 'J i .... ere given IV at peak stress after which planar 
myocardial scans were mad ...... iLI each isotope. Images were analyzed with 
operator dermed regions-of·interest over stenosis and reference zones (IZ,NZ 
respectively) and results (mean .=SO) compared with RMBF ratio (IZ:NZ). 
IZ:NZ Ratio - Adenosine plus Phenylephrine 
£tcn.a1i1 I.EIIQ II RMBE 
SO% .67±..OS· .7S.t.-04 .7S±..11 
70% .SI±..I1· .68±..06# . SS±..17 
80% .SO±.o14· .62±..OS# .4S±..17 
• - P<.OS vs n # - P<.OS vs RMBF 
Thus at each level of flow deficit TEBO IZ:NZ was less than n. Further, with 
70% and 80% CAS, TEBO IZ:l'<Z at sa-ess more closely mirrored RMBF IZ:NZ 
than n. In addition, lower TEBO IZ:NZ vs n for SO% CAS permits more certain 
defect recognition. The data ind;~ate TEBO may be superior 10 n for assessment 
ufrelative coronary flow reser·: over a broad range of CAS severity. 
820·4 9:15 
Comparative Analysis of Teboroxime and Thallium 
Uptake By Quantitative Dual Isotope Autoradiography 
Howard Weinstein, Christopher Reinhardt, Robert Siwko and Jeffrey 
Leppo, University of Massachusetts Medical Center, Worcester, MA 
Extraction of teboroxime (Tebo) in isolated hearts has been shown to 
exceed that of n, suggestini an enhanced ability to delineate flow. 
Accordingly, we compared the iIllOO! pattern of uptake of Tebo and n in 
forty rabbits. Animals were intubated, ventilated and their LV pressures 
monitored. A left thoracotomy was performed in all animals. n, Tebo or 
both agents were injected after ligation of a major branch of the circumflex 
artery and in a control group. Hearts were frozen, 301' slices taken, and Tc 
and 11 images produced by autoradiography. Selected images were digitized 
and converted from film intensity to activity units using tissue standards 
specific for each film. Distribution and defect size for the two agents were 
compared. Fig I, a representative profile across a defect, shows the 
n .. n.,.,.. 2 ~-~ .. ~ 8-
Tebo TI-201 
increased contrast and sharper transition zone of Tebo vs n. Mean defect 
size was 16.1 ~ of the myocardium for Tebo and 13.8~ for 11 (p< .05). 
The normal zone to defect activity contrast for Tebo and 11 in the dual 
isotope hearts is shown in Fig 2. We conclude that Tebo possesses a 
substantially greater capacity than n to differentiate nonnal from 
hypoperfused tissue. 
820·5 
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Tc99m· Teboroxime is a Marker of Reperfusion Flow 
Early After Acute Myocardial Infarction, 
Paul I. Chang, MD, QingXin Shi, MD,PhD, Piotr Maniawski, MS, 
Peter Vitols, Frans J. Th. Wackers, MD,FACC, Barry L. Zaret, 
MD,FACC, Albert J. Sinus as, MD,FACC. Yale University, New 
Haven, CT 
Tc99m-Teboroxime(TB) is a purported flow tracer with high 
myocardial extraction. Ischemic conditions may alter the myocardial 
clearance of TB. However, the dependence of TB retention on 
myocardial viability remains undefined. To evaluate whether the early 
myocardial distribution of TB reflects flow in the presence of 
myocardial necrosis, myocardial TB activity was correlated with 
microsphere flow in 6 open chest dogs subjected to 180 min of LAD 
occlusion (OC) followed by 90 min of reperfusion (RP). 
Radiolabeled microspheres were injected during OC and after 90 min 
of RP. TB was injected immediately following the RP microsphere, 
and the hearts were excised 2 min later. The infarct size detennined 
by postmortem TIC staining was 21 ± 7 % (mean ± SD) of left 
ventricular(L V) mass. The LV was cut into 96 segments for 
determination of flow and TB activity, and data normalized to a 
control non-ischemic(NI) region (15 segments). There was an 
excellent correlation of normalized TB activity and myocardial flow 
(FL) among all segments (r = 0.93; n = 576; TB = 0.91 FL + 2%) . 
Importantly, TB activity in the completely necrotic segments as 
defined by TIC staining also correlated well with flow (r = 0.87; n = 
60; TB = 0.69 FL + 1 %). In the infarcted segments, RP flow was 28 
± 18 %NI, significantly greater (p<O.OOI) than OC flow (2 ± 4 
%NI). In these necrotic regions, TB activity was 21 ± 14 %NI, 
lower (p<O.OOI) than RP flow. 
Thus, TB activity 2 min after injection correlated with flow even in 
reperfused necrotic regions. These experimental data suggest that the 
initial distribution of TB reflects predominently flow and not 
viability. Hence, perfusion imaging 2 min after TB injection may be 
useful in the early assessment of reperfusion following thrombolytic 
therapy, in acute myocardial infarction. 
820·6 9:45 
Myocardial Tc-99.-Teboroxiae (CardioTec) Clearance ia 
Affected by Myocardial Metabolic Status and Myocyte 
Membrane Integrity 
Gerald Johnson III, Jeffrey D. Moffett, Connie B. 
Hebert, Robert D. Okada. Saint Francis Hospital Medical 
Research Inetitute of the University of Oklahoma Health 
Sciencea Center, Tulsa, OK. 
The purpose of this study was to investigate the role of 
cell viability and metabolism on the myocardial 
clearance kinetics of CardioTec (CT) in an isolated, 
perfused heart model. 
~: After being loaded with CT for 1 hr, clearance 
was monitored using a NaI detector for an additional 1 
hr in 18 isolated, perfused rat hearts. All groups 
received a constant flow of 12 ml/min. Krebs-Henseleit 
(KH) buffer was perfused throughout clearance in 7 
control hearts (Group A). In 4 hearts (Group B), 
rotenone (10 micromolar) was infused at the onset of 
clearance with KH buffer. Rotenone is a relatively 
specific inhibitor of mitochondrial electron transport. 
In 7 hearts (Group C), KH buffer with Triton X-100 (0.5\ 
by volume) was continuously infused throughout 
clearance. Triton X-100 is a non-ionic detergent which 
lyses cell membranes_ 
Results: Fractional CT clearances for 1 hr were: 
!U:QYl2 HeAD ± S!iO!:I Si9!lHLs;a!lce !l 
A: control .61 ± .02\ 7 
B: rotenone .29 ± .06\ 4 
C: triton x .96 ± .01% 7 
( . = p < .01 from control (Group A» 
Conclusions: CT clearance is significantly greater than 
control when myocyte membranes are disrupted by Triton 
X-100 and significantly less than control when myocytes 
are metabolically inhibited by rotenone. Thus, CT 
cle .. rance kinetics may h .. ve utility in determining 
functional status of the myocardium. 
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Longterm Effectiveness of Beta Blockers ror the Treatment 
or Recurrent Vasodepressor Syncope 
Freddy M. Abi-Samra, Nancy M. Davison, Douglas C. Gohn, Karen 
A. Vincent 
Depanment of Internal Medicine, Section on Cardiology, Ochsner 
Medical Institutions, New Orleans, LA., USA 
Cardiac sympathetic over-stimulation appears to be at least partially 
responsible for the genesis of vasodepressor syncope (VDS). The 
h¥p?thesis that beta-blockers may provide effective relief for pIS with 
disabling recurrent VDS (with or without attendant bradycardia) was 
tested in 46 such pts (36 F, 10 M; mean age 32 yrs) with at least 
twice-weekly symptoms. 
Baseline head up-tilt (HUT) testing displayed exaggerated chronotropic 
responses followed by VDS in all 46 pIS. Mechanisms underlying 
excessive hean rate response to HUT included excessive venous 
pooling (without visible varicosities) in 27 PIS, hyper beta-adrenergic 
reactivity in 14 pts (as demonstrated by response to graded 
isoproterenol stimulation), and both in 5 pIS. There were no instances 
of hypovolemia, dehydration, endocrine disturbances, anemia, hean 
failure, or substance abuse (0146 pIS). 
Pts were treated initially with long-acting propranolol 60-80 mg/day or 
Betaxolol 10 mg/day. During follow-up (mean: months), dosages 
were adjusted according to clinical response and results of HUT and 
Holter monitor (circadian pattern of sinus rates). Twelve pts had 
intolerable side effects to propranolol and were switched to selective 
Beta-blockers. Complete prevention of VDS was eventually achieved 
in 45/46 pts. The lone failure has not responded to either propranolol, 
nadolol, atenolol or Betaxolol. When performed in apparent early 
responders, follow-up HUT and Holter monitors accurately predicted 
future breakthrough VDS and were useful in dose titrations and 
subsequent control of symptoms. 
Conclusion: Long term treatment with Beta-blockers appears to be 
very effective prophylaxis for VDS irrespective of the underlying 
"hemodynamic' anomalies (ie, excessive venous pooling or hyper beta•
adrenergic reactivity). 
821·2 8:45 
Bimodal Pattern of Response to Atenolol in 
Patients with Neurocardiogenic syncope 
Marilyn M. Cox, Lynn Pringle, Manuel Mayor, 
Alberto Interian, Jr., Agustin castellanos, 
Kenneth M. Kessler, Robert J. Myerburg, 
University of Miami, Miami, FL. 
Sixty patients (pts) with unexplained syncope 
were referred for head-up tilt testing (HUT), 
with and without isoproterenol. Of the 31 pts 
who had a positive (+)HUT, 24 pts converted to 
a negative (-)HUT after treatment with IV 
propranolol (P). IV P decreased resting 
heart rate (HR) by 7±13 (P:.04) and blood 
pressure (BP) by 13±21mmHg (P:.02) in all pts 
whose HUT became (-). Sixteen pts underwent 
repeat HUT on oral Atenolol (A): 5 pts had a 
(+)HUT on A, and 11 pts had a (-)HUT on A. Of 
the 5 pts who had a (+)HUT on A, 4 underwent 
repeat HUT on P and converted to (-)HUT. BP 
and resting HR were not significantly 
different in the 3 groups of pts before 
therapy. Resting HRs before and after oral 
therapy were as follows: 
mrr QJ:Al. ~ HE ~ ~ HE ~ ~ 
(+) A 70±15 56±5 (P=.07) 
(-) A 70±11 54±11 (P=.OOl) 
(-) I 77±7 64±4 (P=.Ol) 
BP was not significantly changed by oral 
therapy in any group. In conclusion, a 
beneficial response to IV P is 100% predictive 
of a beneficial response to oral P. However, 
a beneficial response to IV P failed to 
predict the response to A, a cardio-selective 
beta-blocker, in 25% of pts. The bimodal 
response pattern suggests two different 
mechanisms for neurocardiogenic syncope. 
ABSTRACTS 
821·3 9:00 
Beta Blockade Is Not EffectIve In Treating Neurally 
MedIated Syncope. 
Mark Linzer, Paul Wang, Nicholas Mandalakas, Arthur 
Comegno, Laurie Butts, Carol Colburn, Christopher Clyne, N. 
A. Mark Estes III. New England Medical Center, Boston, MA 
To investigate the efficacy of beta blockade in treating 
neurally mediated syncope (hypotension/bradycardia 
syndrome) during head up tilt, we subjected 73 patients with 
recurrent, unexplained syncope to head up tilt at SO degrees 
for 20-30 minutes without and then with isoproterenol. Thirty 
patients (mean age. 42 years) had a positive test; 21 were 
treated with beta blockade (metoprolol, atenolol, or inderal), 
retilted on therapy, and followed up for a median duration of 
6 months. Ten patients had a negative retilt on therapy, while 
, 1 failed (mean time to faint during retilt = 1S min). Seven of 
9 patients (7S%) with asystole during the first tilt failed retilt, 
vs 4/12 (33%) nonasystolic patients (p = O.OS). Of 10 patients 
who had negative retilts, 5 did not tolerate drug therapy 
(either beta blocker alone or in combination with 
anticholinergic therapy) and 1 had recurrence of symptoms 
and another cause for syncope determined during follow-up. 
Ten of 11 patients failing retilt were discharged on oral beta 
blockade. Of these 10, 5 did not tolerate the drug due to side 
effects, and 3 other patients had recurrence of syncope. We 
conclude that beta blockade does not prevent recurrence 
during retilt in the majority of patients with neurally mediated 
syncope, and is poorly tolerated during long term therapy in 
these young subjects. Asystole during head up tilt may 
define a high risk group for failure of beta blockade. New 
drug therapy for neurally mediated syncope is needed. 
821·4 9:15 
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The Head'up nltT est on Isoprol8renol is Associal8d With Left Ventricular 
Cavity Oblil8ration and is Frequently Positive in Healthy Adults 
Eugene A Nwosu. Peter S Rahko, Peter Hanson, E Wayne Grogan Jr. 
cardiology Section, University of Wisconsin Medical School. Madison, Wi 
The head'up tilt test (HUT) is frequently used to diagnose vagal syncope. 
However, protocols vary. few healthy controls have been studied, ~d varying 
doses of isoproterenol (ISO) are used to increase sensitivity. This study 
evaluates the response of normal subjects to HUT with and without ISO and 
correlates outcome with measurements of LV volume and function. Ten 
healthy adults (mean age 31.7 years, range 20'41) on no medication and with 
no history of syncope were studied. Two-dimensional Doppler 
echocardiography (apical 4-chamber) was performed at baseline, 10 minutes 
of SO' tilt (HUT'B), supine on ISO (SUP'ISO) and at the time of symptoms or 
at 10 minutes of SO· tilt on ISO (HUT·ISO). ISO was given to achieve a HR 
of 120 or to a maximum of 51og/min. The LV end·diastolic volume (EDV), end, 
systolic volume (ESV). ejection fraction (EF) and presence of cavity oblitera' 
tion were evaluated. Results: (Mean :I: SO, 'p<0.05 by ANOVA repeated 
measures vs baseline) 
BASELINE HUT'B SUp·ISO HUT-ISO 
EDV (ml) 93.S .19.1 61.0 <13.5' 83.8 :t25.1 46.4:1: la.S' 
ESV (ml) 34.4 .11.5 19.5:1: 5.S' 19.6 • 13.S' 10.6:1: 6.7' 
EF (%) 64.1 :I: 6.6 67.3 :I: 10.2 n.7 :I: 11.2' 7S.9 :I: 10.4' 
Eight subjects had a positive HUT (symptomatic bradycardia andlor 
hypotension). 1 during HUT·B. 7 during HUT·ISO. In HUT'positive subjects, 
6/S had LV cavity obliteration by Doppler and 7/8 increased EF >5%. In 
HUT -negative subjects there was no rise in EF and no cavity obliteration. 
Conclusions: 1) HUT reduces EDV and ESV. Addition of ISO to HUT 
reduces EDV and ESV further, frequently causing cavity obliteration. 2) A 
positive HUT is assOCiated with a high EF and cavity obliteration. 3) ISO 
frequently produces a positive HUT in normals and may reduce test specificity. 
4) These findings support the hypothesis that vagal syncope results from 
stimulation of LV mechanoreceptors. 
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821·5 9:30 
D.y-to-D.y V.riability in the Re.ponee. to Upright Tilt 
T.ble Te.ting in P.tiente With Unexpl.ined Syncope 
Roee Brooke, Bri.n A. McCovern, Anne Powell, Haaan 
C.r.n, Jeremy N. Ruekin. o.rdiac Unit, M .... chu.ett. 
Cener.l Hoepitel, loeton, MA 02114 
To examine the d.y-to-day reproducibility of the 
reeponeee to upright tilt table teeting, 80 patients 
(pte) with unexpl.ined eyncope [S] (me.n # epi.odes • 
6.3) ware proepectively etudied on two consecutive daye 
ueing • uniform protocol. 29 pt. (36') had • 
v.eodepre.eor (VD) reepon.e on one or both day. of 
teeting, while Sl pt. (64\) h.d two negative tilt 
teete. Of the 29 p.tiente with VD Syncope, a majority 
(20 pte or 69') h.d non-reproducible VD re.ponses 
during two d.ye of teeting. Fifteen/20 pte (75') with 
non-reproducible reeponeee h.d a poeitive followed by • 
neg.tive teet, while 5/20 (25') h.d • negative followed 
by • poeitive te.t. Selected re.ults are shown in the 
teble: A I 0 
Outcome-day l/d.y 2 -/- +/- +/+ 
No. 51 20 9 
# Syncop.l evente 4.7 5.0" 17· 
Dur.tion Sx (ye.re) 5.0 2.1+ 16. 
Il.peed time between 40 34 42 
l.et S .nd TT (d.ye) 
• p<0.008, 0 ve A, •• p<0.02 0 ve B, + p<O.OOl 0 va B 
Oonclueione: (1) In • majority of pt., VD reaponses are 
non-reproducible during teeting on two eeparate days. 
(2) Pte with reproducible VD reeponses tend to have 
more frequent S evente .nd • longer duration of 
clinic.l eymptome rel.tive to pts with non-reproducible 
or two negative teste. (3) The f.ctors responaible for 
non-reproducible VD reeponsee rem.in. unclear. 
821·6 9:45 
The Reproducibility of the westminster Tilt 
Test Protocol 
Mark Petersen, Rafe Chamberlain-Webber, Adam 
Fi tzpatrick, Richard Sutton. Westminster 
Hospital, London, united Kingdom. 
The Westminster Tilt Test Protocol (WP) is 
commonly employed in the investigation of 
unexplained syncope (UES) and pre-syncope (PS) 
to ielentify vasovagal syndrome (60· Head-Up 
with footplate for 45 minutes or to symptoms: 
no drug challenge). Serial tilt testing has 
been advocated to assess the efficacy of 
therapeutic interventions. It was therefore 
necessary to document the reproducibility of 
this protocol in patients and normal controls 
(HC). 118 subjects (80 UES, 18 PS, 20 HC) 
underwent paireel tests separated by a minimum 
of 1 day (Range 1-1133, Mean 94 Standard 
Deviation 185) • Concordant resul ts were 
obtained in 101 of all subjects (86%), 66 of 
the UES group (83%), 18 of the PS group 
(100%), and 17 of the HC group (85%). Of 44 
positive outcomes in the first tilt (38 UES, 
'4 PS, 2 HC) 35 had a concordant outcome in the 
second test (80%). Of 74 negative outcomes in 
the first tilt 66 had a concordant outcome in 
the second tilt (89%). 
It is concluded that the WP provides an 
aelequate reproelucibility for the clinical 
setting. These reproducibility rates must be 
considered in the design of tilt studies for 
assessment of therapeutic interventions. 
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822·1 8:30 
Resetting of Cardiopulmonary Baroreflex Control of 
Sympathetic Nerve Activity by Propranolol In Humans 
Paul Lindower, Mary P. Clary, Robert F. Rea. University of 
Iowa, Iowa City, IA 
In experimental animals, propranolol (PROP) decreases the 
sensitivity of cardiopulmonary mechanoreceptors that inhibit 
central sympathetic outflow. To test the hypothesis that PROP 
decreases the sensitivity of the cardiopulmonary baroreflex in 
humans, we compared changes in central venous pressure 
(CVP) and muscle sympathetic nerve activity (SNA) provoked 
by lower body negative pressure (LBNP) at·5 and ·15 mm Hg 
before and after IV PROP (0.15 mg/kg) or vehicle in 10 normal 
subjects in a double-blind crossover study. PROP decreased 
baseline heart rate (60±2 to 55±2 beats/min [mean±SE]. 
p<0.05), increased baseline CVP (5.6±0.7 to 6.3±O.7 mm Hg. 
p<O.OS) and tended to increase baseline SNA (390±79 to 
525±130 units/min, p=0.08). Arterial pressure was unchanged. 
Responses to LBNP are shown below (mean±SE, " p=NS 
before vs. after PROP): 
Before Propranolol After propranolol 
LBNP -5 LBNP -15 LBNP -5 LBNP -15 
A CVP -1.3 -3.3 -1.5 -3.S 
(mm Hg) ±0.4 ±0.6 ±0.3" ±0.4" 
A SNA 61 270 81 290 
(units/min) ±20 ±79 ±21· ±53" 
Baseline CVP, SNA, and responses to LBNP were unaffected 
by vehicle infusion. These data show that although IV PROP 
alters the resting relationship between CVP and SNA, it does 
not affect increases in SNA during unloading of 
cardiopulmonary baroreceptors. This suggests that acute B 
blockade induces a resetting without change in the sensitivity 
of the cardiopulmonary baroreflex in humans. 
822·2 8:45 
cross-regulation of ~-Adrenoreceptor Su~tYP.s 
in the Human Heart 
Jim Hall, Albert Ferro, Morris Brown Clinical 
Pharmacology Unit, University of Cambridge 
cambridge UK 
In vitro studies of human myocardium have shown 
that ~-blocker therapy produces unexpected 
cross-regulation of ~-adrenoreceptor (~-AR) 
subtypes. To investigate whether such effects 
occur in vivo we performed a placebo controlled 
study of 14 days bisoprolol treatment in 6 
hsalthy male volunteers. Three days after the 
end of each treatment they underwent treadmill 
exercise and salbutamol infusion. Exercise 
induced increase in heart rate after placebo 
(87±4 bpm) was similar to that after bisoprolol 
(86±3 bpm) p=O.8. In contrast salbutamol 
induced increase in heart rate after bisoprolol 
treatment was greater (66±6bpm) than after 
placebo (51:6 bpm) p=O.002. The fall in mean 
and diastolic blood pressures during salbutamol 
infusion was not significantly different after 
bisoprolol than after placebo. 
The greater salbutamol induced tachycardia 
following bisoprolol treatment indicates 
cardiac ~-2AR sensitisation whilst the lack of 
difference in exercise induced tachycardia and 
salbutamol induced blood pressure changes 
indicates unaltered sensitivity of cardiac 
~-lAR and vascular ~-2AR. The selective 
alteration of cardiac ~-2AR sensitivity by ~-1 
blocker treatment indicates receptor subtype 
cross regulation in the heart. The enhanced 
cardiac responsiveness to ~-2AR stimUlation 
will sensitize the heart to adrenaline which 
may have important therapeutic implications. 
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Which Patients with Chronic Heart Failure Are Most 
Likely to Show Hemodynamic and Functional 
Improvement Following Long·term Beta·Blockade? 
Brian M. Schwartz, Jonathan Sackner-Bernstein, Joshua Penn, Henry 
Krum, Norma Medina, Madeline Yushak, Rochelle L. Goldsmith, 
Marrick L. Kukin, Milton Packer. Mt. Sinai School of Med, NY, NY 
Previous studies have suggested that beta-blockers (~b]) may be 
useful in selected pts with heart failure (CHF), but the predictors of 
response to ~bl have not been systematically evaluated. To do so, we 
measured cardiac index <CI, IIminlm2), pulmonary wedge (PWP) & 
right atrial pressures (RA, mm Hg), heart rate (HR, bpm), systemic 
vascular resistance (SVR, dos-c), maximum oxygen consumption 
(v02m) & the magnitude of exercise-induced overventilation (assess•
ed by ventilatory equivalent for C02 [VEq), VE/VC02) in 13 CHF pts 
before & after 3-4 mos of therapy with the ~bl, carvedilol (25 mg BID). 
By stepwise regression analysis, the most powerful noninvasive 
predictor of the response to carvedilol was pretreatment HR. Shown 
below are changes in key hemodynamic and functional variables for 
pts with low & high baseline HR based on median HR of 85 bpm: where 
"= P < 0.05 (vs retreatment); t = P < 0.05 (between 2 sub ups): 
CI PWP RA HR SVR V02m V 
-0.2 -2 0 -1.5 -8.6 
HR> 85 +0.9"t -ll"t -10"t -26"t -38%"t +2.8· -21.0" 
Although in HR with P-bl in both groups, only pts with high 
baseline HR showed t in CI and .j. in PWP, RA and SVR after 3-4 mos 
(P < .05 between the 2 groups for all variables). In addition, only pts 
with high baseline HR had improvement in V02m and VEq. Pretreat•
ment HR was linearly related to l! in CI (r=0.89), PWP (r=0.74), RA 
(r=0.73) & SVR (r=0.75). In contrast, the degree of~bl (assessed by l! 
in HR during maximal exercise) was not significantly related to l! in 
CI (r=0.26), l! PWP (r=0.37), l! RA (r=0.46) or l! SVR (r=0.43). No rela•
tion was also observed between ~bl response and age or CHF etiology. 
The finding that baseline HR (rather than changes in HR) predicts 
the response to P-bl suggests that patient selection may be more 
important than dose titration in the successful use of ~bl in CHF. 
822·4 
Mechanism of AV Node Blockade by Adenosine is Independent of its 
Inhibition of g-Adrenergic Activation 
9:15 
Michael R. Lauer, Charles Young, L. Bing Uem, M.G. Sanathana Murthy, 
Wen-Ter Lal, Ruey J. Sung. 
Stanford University School of Medicine, Stanford, California. 
Evidence from cellular electrophysiology suggests that adenosine (ADO) 
exerts its depressive effects on the AV node by either enhancing an 
outward G-protein-dependent K+ current or inhibiting an inward G•
protein-mediated Ca++ current stimulated by l\-adrenergic activation. 
Which of these mechanisms is responsible for A V node depression in 
humans is not known. To examine this question, we studied the effect of 
ADO on termination of supraventricular tachycardias (SVT) in 21 pts - 9 
with A V reciprocating tachycardia and 12 with AV node reentrant 
taChycardia. Group 1 consisted of 13 pts who had SVT induced in the 
absence of exogenous catecholamines, while group 2 consisted of 8 pts who 
required isoproterenol (ISP) 0.6 ± 0.4 meg/min) for induction. Serum 
norepinephrine (NE) and epinephrine (EPI) were measured during sinus 
rhythm (SR) and SVT. ADO dose (to the nearest 1 mg) which terminated 
the SVT was determined. There was no statistical difference amongst the 
two groups in terms of patient age, weight, mean arterial pressure during 
SR and SVT, cycle length of SVT, or NE and EPI levels during SR and SVT. 
Cycle length during SR differed between the two groups (766 ms in group 1 
and 628 ms group 2; P<O.05). The mean ADO dose required to terminate 
SVT was 51.6 ± 5.9 meg/kg body weight in group 1 and 60.7 ± 11.5 meg/kg in 
group 2 (P>0.05). Not only did ISP fail to alter the minimum ADO dose 
necessary to terminate SVT, but there was also no correlation between the 
ADO dose of each of the 21 pts (Mean = 55.1 ± 5.6 meg/kg) and the 
corresponding endogenous EPllevel during SVT (273 ± 59 pg/m1) (r=-O.19), 
the endogenous NE level during SVT (400 ± 58 pg/m1) (r=O.01), or cycle 
length of SVT (323 ± 9 ms) (r=-O.35). Failure of exogenous catecholamines 
or increased levels of endogenous catecholamines to be associated with an 
increased ADO requirement to terminate SVT in humans, suggests that 
ADO exerts its effects on AV node conduction primarily through its effects 
on K+ channels and not by inhibition of Ca++ channel activation through 
antagonism of the S-adrenergic system. 
ABSTRACTS 
822·5 9:30 
Role of Changes in Pre and Postsynaptic 8 Receptors Responsiveness 
and Arterial Baroreflex on Cardiac Chronotropic Response With Agina 
Michel White. Donna Holliwell. Frans H. H. Leenen. University of Ottawa 
Heart Institute. Ottawa. Ontario. Canada 
Aging decreases S-adrenoreceptors (Sar) mediated cardiac chronotropic 
(CHR) responses to isoproterenol (ISOP). Decrease sensitivity to 
sympathomimetic amines in vivo. may result from changes in anerial 
baroreflex response and/or changes occuring either before or after the 
presynaptic nerve ending. There is no uptake of ISOP by adrenergic 
neurons. but there is active uptake of epinephrine (EPI) by myocardial nerve 
tenninals. In the present study we assessed 1) the effect of age on cardiac 
CHR response to ISOP (postsynaptic Sar response) and EPI (pre and 
postsynaptic Sar responses). 2) the potential contribution of the anerial 
baroreflex on these responses by the administration of ISOP and EPI before 
and after post ganglioniC blockade. trimetaphan (TM). 12 young [YI, mean 
age = 30 ± 5 years and 12 old [01. age = 60 ± 8 years healthy volunteers 
were studied. Each dtug was infused in incrementa! doses for 6 minutes 
each. Differences from baseline are presented: 
lsop lsop + TM 
Group Dose HR Dose·HR 
Y om +11 ± I 0.0025 +8 ± 3 
o 
0.02 +23±2 0.005 +14±1 
0.03 +32±4 0.01 +25±3 
0.01 +11 ± I 
0.02 +23 ± I 
0.03 +29±3 
0.0025 .-I ± I 
0.005 +9±3 
0.01 +19 ± 3 
Epi 
Dose HR 
40 +8±1 
80 +11 ±3 
120 +15 ±I 
40 +S±I 
80 +13± 2 
120 +15±2 
Epi+TM 
Dose HR 
20 +9±1 
40 +19±2 
2D +7±2 
40 +18±3 
Data are in mean ± SEM. " P < 0.05 for the dose-response curves. 
Conclusions: I) There is a decrease in CHR response to ISOP only apparent 
after ganglioniC block.ade. suggesting lesser vagal activation during 
S-agonist infusion with aging. 2) There is no age related change in CHR 
response to EPI. Decreased EPI presynaptic uptake may compensate for 
postsynaptic Sar subsensitivity. Thus. the aging human heart may be 
characterized by both pre and postsynaptic subsensitivity. 
822·6 9:45 
341A 
Comparison of the Bffect of Xamoterol and 
Atenoiol on Human Beta Adrenoceptor Subtype 
Density in Vivo 
Ian Arnold. David Barnett 
Department of Therapeutics. Leicester Royal 
Infirmary. Leicester, UK. 
The effect of partial agonists on human cardiac 
a Adrenoceptors (AR) is poorly understood. 
We obtained right atrial biopSies from 40 
patients with angina randomly allocated double 
blind to take either the el selective partial 
agonist Xamoterol (X) 200 mg bd (n=19) or 
Atenolol (A) 100 mg od (n=21) for at least 5 
weeks prior to coronary artery bypass surgery_ 
Total a AR densi ties (BMax, fmols/rng protein). 
dissociation constants (Kd) and subtype 
densi ties in crude membrane preparations were 
estimated from saturation binding experiments 
with 125-lodopindolol in the presence and 
absence of a 100nM concentration of the e 1 
selective antagonist CGP20712A. 
The two groups were evenly matched for age, 
sex. left ventricular ejection fraction and 
concomi tant therapy wi th calcium antagonists_ 
There were no significant differences in total 
BMax (X=63.37 ± 2_37. A=65.90 ± 2.93; mean 
± S EM) , a 1: e 2 AR rat i 0 ( X = 6 8 : 32 • A= 67 : 33 ) 
or Kd between the groups. 
As Atenolol has previously been shown to either 
upregulate or not affect eAR densities, these 
data provide the first direct evidence that 
chronic oral Xamoterol in therapeutic doses 
does not down regulate human cardiac eAR. 
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823·1 8:30 
Ventricular Characteristics of Sgge 18 Unoperated, Sham-Operated and 
Cardiac NC\Ilal Crest-Ablated Chick Embryos 
Hitoshi Tomita, Linda Leatherbury and David M. Connuck. 
Medical College of Georgia, Augusta, Georgia. 
Neural crest-ablated chick embryos, which are used as a model for 
congenital cardiovascular malformations, have a high mortality by the 
looped tube stage of cardiac development (stage 18). We hypothesized 
that this mortality is associated with alteration of ventricular function. 
In this study of ventricular characteristics we used maximal ventricular 
pressure-area ratio (P / Amax) and peak systolic pressure (PSP) as indices 
of systolic function, while ventricular end-diastolic pressure (VEDP) and 
the time constant of isovolumic relaxation (t) were used as indices of 
diastolic function. At stages 8-10 embryos underwent no operation 
(Controls), sham-operation (Shams) or cardiac neural crest ablation 
(Exper). All eggs were reincubated until stage 18. Simultaneous pressure 
and ventricular area measlllements were made using a servo-null pressure 
system and microcinephotography, respectively. We calculated t using 
pressure data from the point of dP/dt minimum to 10 msec. Results 
(mean±SEM) were analyzed by ANCOVA and Fisher's PLSD test to 
allow for differences in heart rate between embryos. 
Group N HR P / Amax PSP VEDP t 
(mrnHg/mm2) (mmHg) (mmHg) (msec) 
Controis 20 162±2 8.7±O.6 1.64±.04 037±.05 54.3±3.0 
Shams 20 157±2 9.0±0.4 1.71±.04 039±.07 63.4±2.3 
Exper 21 156±2 8.7±O.5 1.66±.04 .0.41±.06 81.3±3.7 
P values 0.07 0.89 0.48 0.21 <0.0001 
No difference was detected in P / Amax, PSP or VEDP among groups. 
There was a significant sham effect (p<0.05, Controls vs Shams), 
indicating that operation alone affects t. There was also a significant 
effect of neural crest-ablation (p<O.Ol, Shams vs Exper). We conclude 
that neural crest ablation causes an increased t in stage 18 chick embryos, 
but that P / Amax is unaffected. This observation suggests that neural 
crest ablation results in increased ventricular afterload. Inability of the 
embryonic ventricle to compensate for higher afterload could account for 
increased mortality in these embryos. 
823·2 
Left ventricular pressure in the fetus 
Allan LD, Tynan M, Jobnson P, Maxwell DJ. 
Guy's Hospital. London. UK 
Of a series of 34 cases of critical aortic stenosis seen in fetal 
life, neonatal death occurred in all the pregnancies reaching 
term despite postnatal treatmenL We therefore explored the 
possibility of firstly, delivery of a balloon catheter inlO :he 
left ventricle and secondly of aortic balloon valvoplasty 
prenatally in four fetuses. In all four, an 18 gauge needle was 
inserted through the maternal abdominal wall into the left 
ventricle of the fetus by direct puncture of the anterior 
chest wall allowing delivery of the ba1100n catheter. In two, 
there proved to be aortic atresia and the aortic valve could 
not be crossed; in the remaining two, the balloon was inflated 
when positioned within the aortic orifice. The left 
ventricular pressure was recorded in all patients during 
these procedures by a fluid-ft1led manometer attached 10 the 
intracardiac needle. Left ventricular syslOlic pressures 
varied between 45 and 9OmmHg, with 40-50 being the normal 
range established in previous data The diastolic pressures 
ranged from IS to 3OmmHg. The pressures were zeroed at 
amniotic fluid pressure. The systolic pressure generated by 
the left ventricle may reflect the left ventricular reserve. 
The diastolic pressure may reflect the extent of endocardial 
fibroelastosis as the fetus with the diastolic pressure of 
30mmHg had the most severe EFE. These pressure 
measurements may be useful in selecting patients for 
valvoplasty attempts and also belp us to further understand 
left ventricular function in this condition as it occurs in the 
fetus. 
8:45 
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9:00 
Isolated Discrete Subvalvular Aortic Stenosis Is caused by 
Turbulence, by Preference In a long Narrow Outflow Tract 
Marc Gewillig. Wim Daenen, Monique Dumoulin, Luc Van der 
Hauwaert. Gasthuisberg University Hospital, Leuven, Belgium. 
The underlying disorder in discrete subvalvular aortiC stenosis is 
ill defined. Abnormal flow patterns and turbulence have been 
suggested to lead to abnormal proliferation of subvalvular tissue. We 
studied 26 patients (pts)(age 19.8±10.3 years, range 3.4-53 y) at 
least 6 months after resection of an isolated discrete subvalvular 
aortiC stenosis. The aortic root and the mitral-aortic separation were 
measured with echo. Flow disturbances were identified in the left 
ventricular outflow tract with a color flow mapping system optimized 
for detection of turbulence. both in pts and age matched controls. 
The aortiC root diameter was 84±10% of BSA predicted values, 
with 10 patients below the third centile (p<O.OOl). The mitral· 
aortiC separation was long (9.3±3.6 mm) with only 5 pts in normal 
range (p<0.001). We found no evidence of turbulence or flow 
separation in the outflow tract of the controls. By contrast, 
significant turbulence originating from well below the Site where 
previously the crescentic or annular shelf had been resected. was 
observed in 20/26 (77%) of the pts. In 16/20 pts this turbulence 
was caused by a ridge, which in 13 pts could be identified as the 
offshoot of a ventricular band. In 4 pts the turbulence was caused by 
malalignment of the muscular and membranous septum. resulting In a 
protrusion of the muscular septum into the outflow tract. The 
turbulence was found to adhere to the septal surface, reaching the 
subaortic area where previously the subvalvular shelf had been 
resected. 
These data support the theory that a discrete subvalvular aortic 
stenosis may be caused by a chronic flow disturbance. by preference 
in a relatively long and narrow outflOW tract. Left ventricular bands. 
if reaching the outflow tract. may not be innocent. As recurrence of 
sub aortic stenosis is a frequent problem. these findings argue in 
favor of a careful echocardiografic and surgical exploration well 
below the subaortic stenosis in order to detect and resect structures 
that cause turbulence. 
823·4 9:15 
The Fetul with Hypertrophic ClrdiOll)'Opathy Related to Maternal Dl.betes: A Pre 
and Postnatal Analysis of the Associated Factor •. 
Paulo Zi.lin,ky,M,D.,Ph.D., Lauro L.HageuM,M.D., Liane D8OOt,I1.D., Iva 
8ehLe,ft.D.,Ph.D, RubeII Rodrigue., M.D.,F.A.C.C. 
Innitut. of CIIrdiology of Rio Grando do Sul- Porto Alegr., RS. Braz; I. 
In proviou, 'tudie" .,. already dHon'trated tho high pr.valenc. of hypertrophic 
cardi_thy in f.tu, •• of diabetic _hero. Tho ai. of thi, papar .... to 
evaluate the foctor. a •• ociated to di.proportionat. hypertrophy of the 
int.rventricular .opt .. in a group of f.tu,e. who.e oath.rs .howed .Ievated 
blood I.vel, of glucon during pregnancy. OUr populotion .... .e up by 159 
pregnant __ in _ diegno.tic criteria for pr.viou. or gestational diabetes 
were fulfilled. FI'OII this group, it .... pollible to ootl;n accurat. data of 
.. ternal age, fa.ting and postprandial gluco.e level., .eru. glycosHated 
hoeooglobin, in.ulin .... ini.tr.tion during g •• tation, previous utilization of 
inlutin, hi.tory of anterior gestational diabet •• , nUliber of previous 
pregnanci •• , obe.ity, hyperten.ion and ge.tational urinary infection in 1 subset 
of 72 patients, a. well as parinatal info .... tion. obout the concopt in 70. Ev.ry 
fetul wa, .... ined by prenatal Doppler echocardiography, with color flow 
_pping, between 18 and 38 _ks of genation (ltan- 28.7 week.). Chi-aquar. 
t •• t wo. applied for paired _ri.ion between oach one of tho above para.ter. 
and the pr •• enco of hypertrophic cardi_thy, di.closed in 19 of the 70 
f.tu... (27. 1X). lleternal data foiled to .how .ignificant correlation with 
.yocardial hypertrophy in the fetus. AI far I. neonatal features were concerned, 
there w., .ignificant ... oci.tion (p<D.OS) with the 2:1 f ... I.'oole r.tio and 
with birth w.ight greater then 4.0 kg. Howev.r, when the birth weights .... r. 
analy.ed according to its adequacy for ge.tational age, the prevolenc. of 
hypertrophic cardi_thy "",. not .ignificantly highar allOllg tho •• considered 
-large" for gestationaL age. It 11 noteworthy, in this retrospective study, that 
tho degree of diabet.s control, I ....... ed by .eru. glucose and glycooi loted 
haeqlobin levell I did not lee. to have any effect on the prevalence of fetal 
hypertrophic cardiooyopathy. IIoroov.r, even though loptal hypertrophy was IIOre 
frequent 1n fetuI" Larger than 4 kg at birth, we .ugg •• t thet this feature is 
not an .)Cpr ... ion of "cI"08OII1., but an independent phenoI!enon. Prospective 
.tudi .. , with ,i .. lt..-. evaluation of fetal and _ternal levels of glucose 
and insulin, ar. necHHry for I better understanding of the Hchanialls involved 
in the gen •• i. of hypertrophic cardiooyopathy in the fetu •. 
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823·5 
Endothelium-Derived aelazing Factor and the 
Xechanism of Endothelin-Induced Pulmonary 
Vasodilation in Ne.born Piglets 
Linda M. Bradley and Robert E. Goldstein. 
CNMC, Washington, DC, and USUHS, Bethesda, Me 
9:30 
Endothelin-l is an endothelial cell product that 
affects tone in many vascular beds. Recent studies 
have shown that this 21-amino-acid peptide exerts a 
potent vasodilator action on pulmonary resistance 
vessels of the newborn piglet. However, the mecha•
nism of this action is unknown. Several important 
vasodilator responses are mediated by release of 
endothelium-derived relaxing factor (EDRF). To 
determine whether endothelin-induced pulmonary vaso•
dilation is mediated via the release of EDRF, we 
studied 8 open-chested, anesthetized newborn piglets 
given endothelin-l (100 pmol/kg IV bolus) before and 
after infusion of an inhibitor of EDRF synthesis, L•
nitro-arginine (LNA) , 3 mg/min for 30 min. We mea•
sured pulmonary and systemic arterial pressures, 
right and left ventricular pressures, cardiac out•
put, and heart rate. Endothelin-l decreased pulmo•
nary vascular resistance index by 44 ± 8% (SE) 
before LNA (74 ± 18 to 44 ± 14 mmHg/L/min'kg, 
p<0.05) vs. a decrease of 44 ± 11% (158 ± 38 to 69 ± 
21 mmHg/L/ min'kg, p<0.05) after LNA. Following LNA 
infusion, endothelium-dependent pulmonary vaso•
dilation with acetylcholine chloride (2-10 ~g/kg/min 
IV) was attenuated while endothelium-independent 
pulmonary vasodilation with sodium nitroprusside 
(0.5-2.0 ~g/kg/min IV) was preserved. Thus, LNA 
blocked vasodilation requiring EDRF synthesis but 
did not interfere with dilator response to nitrates. 
We conclude that endothelin-induced pulmonary 
vasodilation is not mediated by EDRF release. 
Mechanisms of pulmonary vasodilation not dependent 
on normally-functioning endothelium may have 
important therapeutic potential in managing newborns 
with elevated pulmonary vascular resistance. 
823·6 
Preload Reserve of the Fetal Lamb Heart 
Sharon R. Weil James L Heckman, Rohinton K. Balsara, 
Pierantonio Russo, Valarie Pasiecki, Jeffrey M. Dunn 
9:45 
St. Christopher's Hospital for Children and Temple University 
School of Medicine, Philadelphia, PA 
In contrast to the adult heart, the fetal heart reportedly has little 
functional reserve. Therefore, in order to demonstrate the extent 
of fetal cardiac preload reserve, we studied 7 fetal lambs at 
129·135 d gestation (term = 150 d) using an isolated, isovolurnic, 
blood perfused heart preparation. We maintained constant 
afterload (non·ejecting), motropic state (no innervation. or 
circulating catechols), coronary blood flow (constant perfuSion 
pressure and maximal oxygen content), heart rate (pacing), and 
perfusate blood gas values. In order to vary LV volume, an 
mdicator of preload, an LV balloon mounted on a catheter was 
placed via a left atriotomy. As LV balloon volume (preload) was 
mcrementally increased, LV end diastolic pressure (L VEDP) and 
LV peak systolic pressure were recorded. LV developed pressure 
was calculated, by subtracting simultaneous L VEDP from systolic 
pressure. Our results generated a typical Starling curve for each 
fetal heart. As LV volume was increased, developed pressure 
increased 80-424% above baseline (mean 223%), demonstrating 
the presence of the Frank-Starling mechanism. Each curve 
reached a peak developed pre~sure at an. LVEDP ?f 
approximately 10 mmHg. linear regressIOn analYSIS 
cfemonstrated that LV developed pressures were predicted by the 
LV volume. In summary, the fetal heart possesses substantial 
preload reserve, in that it can generate h~modynarnicaJly 
significant increases in developed pressure m response to 
increases in volume, although peak developed pressure occurs at 
a lower LVEDP than expected in adults. 
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ABSTRACTS 
Detection and 1'reat.ent ot Hypercbole8terole.ia in 
PersonB With II.nown Heart Diaeaee: A Population-baaed 
Study. 
tllzabeth Tan. Tho.as A. Pearson, 
M.I.Bassett Hospital, Cooperstown, New York 
Clinical trials have shown that the treat.ent of 
hypercholesteroleaia (HC) in patients with 
establishedcoronBry heart disease (CHD) will prevent 
recurrent CHU events and death. However, the extent 
to which CHU patients bave been screened or treated 
for HC in the general population is poorly defined. 
To study this, we exuined the results of a 1989 
health census of a rural upstate New York county, in 
which 8li. 6% of hou8e-holds participated. Fro. the 
20.169 persons over the age of 35 yearB, 1316 sen and 
1271 wOllen reported tbat they had been told by a 
physician to have heart diseaee 8uch 88 heart attack 
or cardiac chest pain. Of tbose with CUD, 21.71 of 
men and 26,5% of wo.en reported that they had not bad 
their Cholesterol checked in the previouB two years. 
or those who were tested and told their cholesterol 
levels were elevated (N=774), 11.51 received no 
treahent. 53% were treBted with diet and exercise 
alone. and 35.5% were treated with drugs. PersonB 
unlikely to have had cholesterol8 checked and treated 
included those with low educational attainaent, no 
health insurance, and no re~ular 80urce of health 
car.. (p<, 051. No differenceB were obBel'Ved in 
persons receiving .edieal vs surgical treat.ent for 
CHD. These population-based data indicate a sizeable 
proportion of CND patients have not received 
cholesterol screening or ag~resaive therapy. Any 
new, BOre aggressive guidelines for HC treat.ent of 
CND patients would i.pact on a large nu.ber of people 
in the typical co .. unity, 
824·2 
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Secular Changes in Post·Infarction Lipids Between 1978 and 1987: Comparison 
of the Beta-Blocker Heart Attack Trial (BRAT) n. Multicenter Diltiazem Post•
Infarction Trial (MDPIT) 
William E. Boden, Peter N. Herbert, Arthur J. Moss, Ann Saritelli. Mark 
Andrews, Richard S. Shulman. Boston V A Medical Center and Tufts University 
School of Medicine, Boston, MA 
EpidemiOlogic studies and community-based surveys indicate favorably changing 
trends in serum total cholesterol durin, Ibe last decade, but Ibere bave been limited 
observations of secular lipid changes in plst-MI survivors. We performed a 
retrospective comparison of study closeout lipid valuea in two large post-MI 
secondary intervention trials of similar study desian and patient enrol1ment between 
1978 and 1987. In Ibe BHAT, 3731 post-MIptswere enrolled between 1978-1981, 
whereas in the MDPIT 2466 plst-MI pts were enrolled between 1983-1987. Lipid 
measurements for both plst-MI trials were performed, in blinded fashion, in Ibe 
same research laboratory utilizing identical standardiz.ed analytical methods. To 
assess long-term post-MI lipid trends, DOD-fasting study termination samples for Ibe 
BHAT placebo cohort (24±9 mo post-MI) were compared to Ibe MDPIT placebo 
cohort (25 ± 11 me plst-MI), who were likewise taking DO beta blockers (DO BB). 
Mean results for total C and triglycerides (TG) (ma/dl), for these comparative post•
MI subsets, were: "1><0.01 
# Subjects 
Total C 
TG 
BHAT <Placebo) 
Mm Women 
1247 195 
259 291 
217 221 
MOPIT INo BB) 
him ~ 
602 146 
"220 "239 
215 219 
Conclusions: 1) Compared to the BHA T placebo group, mean total cholesterol in 
the MOPIT cohort On DO beta blockers was IS .. lower in men and 18 .. lower in 
women during a comparable 2 year plst-MI follow-up period; 2) These salutary 
secular changes in post-infarction cholesterol concentrations during the last decade 
suggest probable alterations in plst-MI diet andlor lifestyle. 
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'I1Ie E/fect or LaboNtOry DrIft of Cholesterol Meas_ent OD 11me Truds: 
'I1Ie MiDDesots Heart Health i'rop'am (MHHP) 
Paul G. McGovem, David 11lac:obs, lr, 10hn D. Belcher, Russell V. 
Luepker,l. Michael Spralka, aDd Hemy Blackbum, UDivcrsity of Mmnesota, 
School of Public Health, Mmneapolis, MN 
Strict 1aboratory comparability of ICfIIIII cho1e&terol (TC) measures over 
10 years or more is tcDtral to ewluatiOD of populatiOD time treads. We 
aamiaed the effect of daily TC quality coDtrol adjustmeDt on TC estimation 
based OD 3 CODtrol commUllitie6 of the MHHP. III a CODtiDuously CDC 
certifiecllaboratory, S quality CODtrol bloods (4 replicates of 2 pools, with TC 
value a&&igDed by repeated Abell-KeDdall evaluation) were I1IlI each day of 
TC measuremeat.. FJgUre 1 allows daily biases from the Abell Kendall 
ItIDdard aDd 10DS term TC drift during 1980-90 using the AAU aaalyzer•
aDother aDalyzer was used in 1989. FJgUre 2 allows the estimated 1980-90 TC 
trends based on the oriaiaal or bias·adjusted city·meaDS. !be daily quality 
control correctiOD dew iJlClividual means, ,ubslaDtiaUy chaages the time 
trend slope estimate, aDd increases precisiOD by decreuiDg the slope estimate 
variance by 24.5%. 
'--tngIdI) ----- "'"n OrIginal Te 1I,"n AdJ.llld Te Te.205·0.nR Ted1'·1.nR 
Tbese results point to the imporlaDce of the use of laboratory OC data in 
estimating loDS-term popuiatiOD TC time treads. 
824·4 9:15 
Exercise Threshold For Favorable BDL-C Change. 
In Middle-Aged Men 
Peter Kokkinos, John Holland, John Colleran, 
Puneet Narayan, Vasilios Papademetriou. 
VAMC & NDU, Washington, D.C. 
Plasma HDL-cholesterol (HDL-C) levels are 
associated inversely with the incidence of 
CAD. Aerobic exercises increase HDL-C levels. 
However, an exercise threshold necessary for 
such increase has not been established. We 
examined the relationship between miles run 
per week and plasma lipoprotein-lipids on 1205 
non-smoking males (mean age=42±3). Five groups 
(G), established according to average miles 
run/wk, were contrasted (0, 9, 14, 24 & 35 
miles/wk for G1-G5 respectively). Age and 
alcohol consumption were similar across 
groups. Significant differences were observed 
in ~o~ax across all groups, and in Body Mass 
Index (BMI) when comparing G1 & G5 (P<.05). 
After adjusting for BMI, there were 
significant differences in HDL-C and TC/HDL-C 
ratio when comparing groups averaging ~14 
miles/wk (G3-G5), and those below this mileage 
(G1 & G2) (P<.05). HDL-C levels were also 
significantly higher in G5 when compared to 
G3. No changes in HDL-C levels or TC/HDL-C 
ratio were observed in groups running s9 
miles/wk. Our results suggest that the 
exercise threshold for significant increases 
in HDL-C levels is running an average of 14 
miles/wk (14±2), with little or no further 
improvements occurring beyond this mileage. 
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Cbanaes iJI Coronary Arteriography and Uplds iJI Post-Myocardial 
lDfarction Women iJI the Program on the Surgical Control of the 
Hyperllpldemlas (POSCH) 
9:30 
Laurie L. Fitch, John P. Matts, James W. Johnson, Christian T. Campos, 
Henry Buchwald 
University of Minnesota, Minneapolis, MN 
Tbe effect of lipid lowering on arteriographically documented coronary artery 
disease was examined in women randomized into the POSCH trial. All the 
subjects had survived one myocardial infarction, were between the ages of 
30-64 years, and had elevated total cholesterol (CHOL) and/or LOL 
cholesterol (LDL). Tbe women were randomized to low-fat diet (0) [n=32] 
Or partial ileal bypass plus low·fat diet (P) [n-46]. Coronary arteriogram, 
were obtained at entry and 3, 5, and 7 or 10 years of follow-up and evaluated 
for change from entry by 2 cardiologists who were masked as to the subject's 
group and the temporal order of the films. CHOL and LOL at 1 through 10 
years of follow·up were reduced (p<0.01) for P compared to D. At 5 years 
CHOL aDd LOL showed net decreases of 24% aDd 35% for P as compared 
to D. Arteriography results for P vs D showed less progression in P when 
aaalyzed by repeated measures analysis (p =0.002). 
Percent Worse on Coronary Arteriography 
3yr 5yr 7yr 10yr 
%00 %00 %00 %00 
D 
P 
32 (25) 
19 (37) 
57 (21) 
29 (35) 
75 (12) 
35 (17) 
100 (4) 
55 (11) 
Conclusion: Partial ileal bypass lowered CHOL aDd LOL aDd appeared to 
slow the rate of coronary atherosclerosis progression in women in the 
POSCH trial. Comparable data for the men in POSCH were also highly 
signilicaot. Larger numbers of women should be included in randomized 
clinical tria1s of lipid lowering and coronary heart disease to confirm the 
POSCH findings. 
824·6 9:45 
Role of Serum Ubiquinone in Coronary Heart Disease 
Yoshihiro Hanaki, SalOru Sugiyama, Kazuki Hattori, Miyoshi 
Ohno·, Takayuld Ozawa 
University of Nagoya, Nagoya 466, and ·The Japanese Red Cross 
Nagoya First Hospital, Nagoya 453, Japan 
It has been postulated that oxidatively modified LDL contributes to the 
genesis of atherosclerosis. Ubiquinone has been suggested 10 be an 
imponant physiological lipid-soluble antioxidant and is found in LDL 
fractions in the blood. We measured serum levels of ubiquinone 
using high performance liquid chromatography, and serum levels of 
total cholesterol and high density lipoprotein (HDL) in 245 normal 
subjects (186 men; 59 women) and in 72 patients (38 men; 34 
women) who had coronary heart disease. None were receiving drugs 
that lower serum lipid or Ubiquinone levels. In the normal subjects, 
serum ubiquinone levels were similar in men and women and did not 
vary with age. In the patient group, the serum total cholesterol, and 
LDL levels were higher and the serum ubiquinone level was lower 
than in the normal subject group. The LDUubiquinone ratios were 
higher in the patient group. We found that ubiquinone levels, either 
alone or when expressed in relation to LDL levels, were significantly 
lower in the patient group than in the normal subject group. ~e 
LDUubiquinone ratio is likely to be a risk factor for atherogenesIs, 
and administration of ubiquinone to patients at risk might be 
considered. 
Total cholesterol (mmol/!) 
LDL cholesterol (mmol/!) 
Ubiquinone ().UnoI/!) 
Total cholesterol! HDL 
LDL! ubiquinone (x 103) 
Normal Subjects 
5.10 ± 0.88 
3.21 ± 0.84 
0.86 ± 0.28 
3.99 ± 1.12 
3.99 ± 1.21 
• : P < 0.01, versus the normal subjects 
Patients 
5.78 ± 0.97* 
3.74 ± 0.90* 
0.70 ± 0.18* 
4.66 ± 1.24* 
5.63 ± 1.72· 
mean±SD 
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Sotalol Exhibits Reverse Use·Dependent Action on 
Monophasic Action Potentials in Normal but not in 
Infarcted Canine Ventricular Myocardium 
8:30 
Claus Schmitt. Thorsten Beyer. Martin Karch, Thomas Hilbel, 
Johannes Brachmann 
Dept of Cardiology. University of Heidelberg. Germany 
In 12 anesthetized dogs (30 mg pentobarbital/kg) a thoracotomy was 
performed and the left anterior descending coronary artery (LAD) 
proximally ligated. 8·12 days after LAD ligation monophasic action 
potentials (MAP) were recorded endocardially from the apex of the 
non-infarcted right ventricle (RV) and the infarction zone of the left 
ventricle (LV). Programmed ventricular stimulation was performed 
with single extrastimuli (S2) at a basic drive cycle length of 300 msec 
(Sl). MAP-duration was measured at 90% repolarization (MAPD90) 
before and after 1.5 mg/kg i. v. Sotalol. 
Control 
LV RV 
S1S2290 161±22 156±20 
SIS2200 155±17 150±19 
*=p<O.05 Con vs. Sot 
Sotalol 
LV 
183±24* 
173±18* 
RV 
180±25* 
157±18 
After premature extrastimuli MAPD90 decreased by a comparable 
order both in the RV and LV during control stimulation. However. 
there was a significant increase of MAPD90 of the LV but not the RV 
using shorter coupling intervals after sotalol. These data indicate a 
differential effect of sotalol on repolarization of normal and infarcted 
myocardium demonstrating reverse use dependency of sotalol in 
normal cardiac tissue but not in abnormal myocardium. 
825·2 8:45 
Determination of Procainamide Blocking Kinetics With a Protocol 
Feasible in Man 
Christine Villemaire. Pierre Savard. Mario Talajic. Stanley Nattel. 
Montreal Heart Institute. Montreal, Canada 
The uptake and release of antiarrhythmic drugs by cardiac sodium 
channels can be characterized by a piecewise exponential analysis. The 
purpose of the present experiments was to evaluate the feasibility of 
applying this approach in vivo. The onset of procainamide-induced 
conduction slowing was analyzed by 56-electrode epicardial mapping 
in 10 anesthetized dogs with formalin-induced A V block. Fractional 
sodium block (b) was calculated from conduction changes assuming IN. 
a 9 2• Results after a prolonged pause (P) allowing for diSSipation of 
use-dependent b were compared with changes seen after an abrupt 
change (AC) to a shorter basic cycle length (BCL). a protocol feasible 
in man. The onset of block was monoexponential with a rate constant 
(). *) that was linearly related to BCL (figure). As predicted by the 
underlying theory. A* and bat. AC 
steady state (b.) were not""'" 0 P 
significantly different for AC vs i 0.5 -P. Uptake and release rate ..c 
:;Sr:~~gfO:nri~~~t7:!~e s::~ ~ 0.4 
of the sodium channel were 0.3 
calculated using values of b ... A *. 
and monophasic action potential 
duration (Franz-type contact 300 400 500 
electrodes) at each BCL. The BeL (msec) 
resulting values were of the same order as previous estimates in vitro. 
Conclusions: 1) The kinetics of onset of conduction slowing after P and 
AC obey the predictions of underlying molecular theory. and 2) it may 
be feasible to estimate state-dependent uptake and release rate constants 
for antiarrhythmic drugs in man. 
ABSTRACTS 345A 
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I.oproterenol D.cr..... Conduction Velocity at 
Depolarlz.d M.mbrane Pot.nUal. In the Canine Purklnj. 
Flb.r 
Thomas M. Munger. Susan B. Johnson. Douglas L. Packer. Mayo 
Foundation. Rochester. MN. 
To determine if the previously observed Isoproterenol (150)•
Induced decrease in sodium current at Inactivated membrane 
potentials (Vm) translates Into decreased squared conduction velocity 
(92). a dual mlcroelectrode technique was applied to 8 nonbranched 
canine Purklnje fibers at pH • 7.40 ± 0.05. T • 37°C. The voltage•
dependence of changes In Vrnox and 92 were assessed using an extemal 
potaSSium ([K.lo) titration from 5.4 to 12.0 mM with and without 
1 0·8M ISO. At V m. -88 mV ([K+ 10 • 5.4 mM). the addition of ISO 
increased 92 from 3.44 ± 1.02 to 3.90 ± 1.17 M2/S2 (p < 0.05). At 
Vm = -65 mV. ([K+lo. 12.0 mM). 62 decreased to 0.73 ± 0.44 
M 2/S2. The addition of ISO produced an additional 33% decrease In 62 
to 0.49 ± 0.33 M2/S2 (p < 0.05). which was directionally opposite 
the ISO effect at normal Vm. The addition of ISO produced a 3 mV 
hyperpolarizing shift (-71 ± 2 mV to -74 ± 3 mV at h_O.5 (p < 
0.05)) of Inactivation curves generated from 92 and Vmax as Indices 
of net membrane currents. In 7 additional fibers. 10·8 M nisoldlpine 
(NIS) only partially modulated the slowing of 92. From this. we 
conclude that ISO decreases 92 in parallel to Vmax at depolarized Vm• 
opposite the effect at normal Vm. However. the minor change in 
inactivation kinetics and Incomplete reversal of the effect by NIS 
suggest that other Important contributing factors. such as passive 
membrane property alterations. may be operative. These results 
also suggest that local catecholamine release associated with 
myocardial ischemia in vivo. might further aggravate conduction 
slowing and contribute to arrhylhmogenesls. 
825·4 9:15 
Different effect. of dobutamlne on repolarlzatlon In Ischemic compared 
to nonnal human v.ntrlcl •. 
Roy M. John. Peter Taggart. Peter Sutton. Peter J. Ell. Howard Swanton. 
The Middlesex HospHal and UCMSM. London. U.K. 
The arrhythmogenic effect of B adrenceptor stimulation is complex and 
maybe different in the ischemic myocardium. We have examined the effects 
of dobutamine (D). a widely used therapeutic and diagnostic B adrenergic 
agent. on the action potential duration (APD) in ischemic and non-ischemic 
areas of the human ventricle. Biventricular monophasic action potentials 
(MAPs) were recorded in 14 patients undergoing routine cardiac 
catheterization for chest pain. 0 was administered I.v. in incremental doses 
to the point of angina (dose range 5to 20llQlkglmin; low dose. 
5-10IJ/kglmin. high dose .11-20 I1QIkg!min).lschemic sHes were identified 
using 99mTc-MIBI injected at peak dose of D and subsequent scintigraphic 
imaging. Recordings of MAPs during D infusion w.re matched to control 
recordings wHh comparable atrial paced rates in the absence 01 D. The 
addHive effect 01 D on the APD at comparable steady state pacing rates is 
shown below: 
30 
20 
10 
AAPD 0 
(ms) 
-10 
-20 
-30 o 0 
o 
Dobutamln. dO: -L.r..~---H.I~-h---LO"· w---H .... ~-h-
Normal zone /IChemic zone 
When controlled lor heart rate. 0 produced a bimodal.ffect (either 
lengthening or shortening) on the APD in non-ischemic myocardium 
consistent with laboratory studies of B agonism on the APD. However. in 
Ischemic myocardium. high doses of 0 consistently sholtened the APD. 
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Dlldue. _.cw T-Wa.e A1teraadoa .. d Valoerablllty to 
JIIbrilladoa DIorio. Botb CoroUfJ Arter, Oeelasloa .. d ReperfasioD 
Bruc:e D. Nearlol, Rlc:hard L. Verrier. Department of Pharmac:ology, 
Georaetowo Uol.erslly School of Medicine, Washington, DC 
It Is well-established that dlCCerlol mec:hanlsms can elicit ventricular 
flbrlllatioo (VF) durlnl c:orooary artery oc:cluslon and reperfuslon. We 
examined whether the c:alc:lum c:hannel bloc:klnl properties of 
dlltlazem, whlc:h reduce adreoeralc:lnCluences and myocardial Ischemia, 
would c:onfer protec:tloo durlol both oc:c:luslon and reperfuslon. To 
quaotlfy the drul'santlCibrlllatory ac:tloo, we employed the method of 
c:omplex demodulatloo of the T -wave, whlc:h permits dynamic: tracking 
of susc:eptlbllity to VF durlnl both c:oronary artery occ:lusion and 
reperfusloo (Sclenc:e 252:437, 1991). The results were correlated with 
spontaneous oc:c:urrenc:e of VF. The experiments were conducted In 6 
chloralose-aDesthetlzed dogs during fixed rate pacing at 180 bpm. 
Dlltlazem was IDJec:ted (0.02 mg/kl/mln) for 45 min. AID recording 
of electroc:ardlOlraphlt and hemodynamic signals was Initiated 2S 
mlDutes after the start of the 
ID'usloo. The left anterior 
coroDary artery was oc:c:luded for 
10 mlDutes and abruptly released. 
Dlltlazem produced a marked 
reduc:tloo ID T -wave alternatloD 
durlDIL both oC:c:lusioo and 
reperfusloD and decreased the 
IncideDct of spontaDeous VF from 
4 of 6 to 1 of 6 dOls. Values are 
means ± SEM, ·p<0.05, ··p<O.OI. 
Conc:lyslon; Dlltlazem siIDICi•
decreases T -wave alternatioD and 
susceptibility to VF durlnl both 
coronary artery occ:luslon and 
reperfusloD. The suppressloD of T -wave alternatioD may Indicate 
reduced dlspersloD of repolarlzation due to the antladrenerglc and antl•
Ischemic effects of calcium channel blockade by dlltlazem. 
825-6 9:45 
Adeno.ine SUppre •• e. AV Reentrent Tacbycardia by 
Caueina Bate-dependent Increaaes in Wavelengtb 
Mobs en Rayebpour, Jacques Billette, Farid Amellal, 
Stanley Rattel. 
University of Montreal, Montreal, Quebec, Canada 
Adenosine (Ad) is widely used to treat reentrant 
tacbycardias involving tbe AV node (AVR). To evaluate 
tbe possible role of rate-dependent mecbanisms, we used 
a pacing circuit to m1m1C a retrograde accessory 
patbway in isolated, superfused rabbit bearts. AV 
reentrant tacbycardias (AVRT) were induced at a variety 
of VA intervals, and tbe effects of Ad (0.5 WI, Adl; 
1 WI, Ad2) studied. Results: Ad's ability to suppress 
AVRT increased as AVRT rate increased. This action was 
due to rate-dependent increases by Ad in AVR refractori•
ness and consequently in lbe minimum wavelenglb for 
reentry (k) divided by patblengtb (PL, figure). When 
k/PL exceeded I, AVRT was stopped by Ad. These rate•
dependenl effects were due to modulation of AVR func•
tional properties - Ad 1.2..--------r---, 
increased AVR conduction 
slowing (fatigue) at 
rapid rates from 17:t2 IllS 
(conlrol) to 29:t5* (Adl) NPL 
and 32:t4 ms** (A 2), and 
slowed tbe recovery time 
conslant from a byper-
... 
... 
bolic fit of tbe H1A2_ .~~ 
A2H2 curve from 42:t6 IllS 
to 50:t6 (Adl) and 51:t6 (Ad2). 
1IPl.1 
, .. 2CIO ... 
RATE (/mln) 
Conclusions: (1) Ad substantially increases rate•
related AVR fatigue, witb minor effects on recovery; 
(2) Modulation by Ad of AVR functional properties sup•
presses AVRT by causing increases in wavelengtb due to 
tacbycardia-dependent increases in AVR refractoriness. 
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A Novel Functioaal Characterisation of ~+ Channel Opener. 
Win K. Shen, Robert T. Tung, Yoshihisa Kurachi. 
Mayo Clinic, Rochester, MN 
Pinacidil, lemakalim, nicorandil, and ER-001533 are new 
pharmacological agents known as K channel openers (KCOs). 
KCOs activate the cardiac ATP-sensitive K channel (KATP)' 
however, the mechanisms are unknown. We examined effects 
of KCOs by using inside-out patch clamp technique in 
guinea pig ventricular myocytes based on a four-state 
model of this channel recently established in our labora•
tory. The KATP channel can be maintained in an operative 
state not only by phosphorylation but also by nucleotide 
diphosphates (NDPs)-binding to the channel even after 
"run-down" (dephosphorylated). Thus, the KATP channel 
can be distinguished by four functional states: 1) phos•
phorylated (before run-down), 2) dephosphory!ated (after 
run-down), 3) dephosphorylated in presence of NDPs, and 
4) phosphorylated in presence of NDPs. We have made the 
following observations: 
State Phos NDP Pinacidil 
1 + t 
2 0 
3 + t 
4 + + NE 
Lemakalim 
t 
o 
t 
NE 
NicorandU 
o 
o 
t 
ER 
t* 
o 
t* 
NE 
+,-, presence or absence; t, significant activation; 0, 
no significant activation; NE, not examined; *, presence 
of ATP or its analogues. 
Pinacidil and lemakalim activate the KATP channel in 
state 1 and 3. NDPs are essential for nicorandil-acti•
vation of the channel. ER activates the channel only in 
the presence of ATP or its analogue in both state 1 and 
3. No KCO activates the channel in stste 2. In conclu•
sion, distinct molecular mechanisms underlie various KCD•
mediated activation of the KATP channel. These activa•
tion profiles of the KCOs may facilitate their thera•
peutic applications in various cardiovascular diseases. 
826-2 8:45 
M2 MUSCARINIC RECEPTORS ARE COUPLED TO A 
POSITIVE INOTROPIC REPONSE IN HUMAN VENTRICULAR 
MYOCARDIUM 
Glenn E. Meixe", Mary M.wollmering. Ray E. Hershberger. Michael R. 
Brislow, Univ. of Utah, san Lake City, UT. 
We have previously shown that a homogenous population of 1.12 
rruscarinic receplors exists in human ventriaJlar myocardium. We have also 
demonstrated that these 1.12 receplors are coupled to adenylate cyclase via 
the InhibHory G-protein (Gi), and to phosphoinosltide hydrolysis. In sub•
micromolar concentrations the 1.12 agonist carbachol's action occurs via the 
~ pathway. mediating a negative inotropic response in trabeculae pre•
incubated with ll-agonist or forskolin. Howerver, wHh higher concentralions 
of carbachol a small poSHive inotropic response is usually observed alter the 
maximum negative inotropic effect.The present study was undertaken to 
further document this posHive inotropic response and to determine which 
signal transduction pathway is involved. Right ventricular trabeculae from 
patients wHh idiopathic dilated cardiomyopathy were preincubated with' 
pertussis toxin (PTX) to Inactivate Gi' Under these condHions the addition of 
carbachol produced a posHive inotropic effect. compared to a negative 
inotropic effect in controls not incubated wHh PTX. The EDso for the 
posHive inotropic response was 5·'0 11M. These observations are 
consistent with a human myocardial 1.12 receplor that is positively coupled 
r 
i 
to 
CARB PTX. + CARB. 
to contraction,via Gjindependent 
phosphoinositde hydrolysis. The 
figure shows the maximum tension 
developed upon stimulation of 
human right ventricular trabeculae 
wih carbachol ( n-21 ), and 
trabeculae pre-Incubated for 4 
hours with pertussis toxin, ( n=25 ). 
p < .05 vs. carbachol 
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Positive Inotropic Effect of Acetylcystelne In The Cardlomyopathlc 
Syrian Hamster 
Mitchell S. Finkel. Carmine V. Oddls, Ryan C. Romeo. University of 
Pittsburgh, Pittsburgh, PA. 
We have previously reported evidence supporting the presence of a 
defect In the ryanodlne·sensltlve sarcoplasmic reticulum calcium reo 
lease channel (SRCRC) In the Blo 14.6 cardlomyopathlc Syrian ham· 
ster (CMH). Sulfhydryls appear to play an Important role In the 
endogenous regulation of the SRCRC. Accordingly, we studied the In· 
otroplc and radlollgand binding effects of the sulfhydryl donor, 
acetylcystelne (AC), In the CMH. Continuous Infusion of AC resulted In 
a reversible blphaslc low dose, positive Inotropic effect followed by a 
high dose negative Inotropic effect In Isolated papillary muscles pre•
pared from the CMH, but not In tha FIB controls (Fig. 1 ; p< .01 ; 
n _ 6). This blphaslc low dose positive Inotropic effect, followed by high 
dose negative Inotropy In the CMH Is also seen with ryanodlne and 
verapamll, but not with nlfedlplne and dlltlazem. Increasing the fre•
quency of stimulation resulted In less of a decrease In the tension gen•
erated (blunted "negative staircase" effect) In the CMH vs, FIB 
controls. The addition of AC resulted In almost completely eliminating 
the frequency-force relationship In the CMH (Fig. 2 ; p<.OI ; n-6). 
Radioligand binding studies with AC revealed the complete displace•
ment of (3H) ryanodlne binding to the SRCRC with little effect on (3H) 
nltrendlplne binding to the sarcolemmal L-type calcium channel. .. Fig. 1 
1= I: 
t- t" 
i: - .. I" - .... \!! .. --_QWM+NJ . .+---------------~ IMIUNI.14,,10 1 I J 4'
-LOG 1AC1T'tLC'I"11HI1 IfoII ,,,QU&NCY CPpII 
These findings support the presence of a defect In sulfhydryl gating of 
the SRCRC In the CMH. 
826·4 
Interaction of Amiodarone with T3 on Na+ Current in 
Guinea-pig Cardiac Myocytes 
Guanggen Cui, Luyi Sen, Bramah N. Singh. VAMC and 
UCLA, Los Angeles, CA 
Amiodarone not only structurally resembles thyroxine, but 
many of its actions mimic hypothyroidism. To elucidate 
amiodarone interaction with thyroid hormone on 
electrophysiologic properties in cardiac myocyte membrane, the 
effects of AM and T3 on TTX-sensitive NaH current (INJ was 
investigated in guinea-pig ventricular myocytes by whole-cell 
patch-clamp technique. Amiodarone produced concentration and 
use-dependent block in TTX-sensitive IN. (65 ± 7%), and 
shifted the steady-state inactivation curve to more negative 
potential (-18 ± 2 mY, n = 15, P < 0.01). ICso ofamiodarone 
was 98 ± 15 nM. T3 caused a graduated increase in INa about 
38 ± 5%, n = 15, P < 0.01. ECso of T3 was 33 nM. T3 also 
shifted the steady-state inactivation curve in the negative 
potential direction (-7.6 ± 1 mY, n = 15, P = 0.01). The 
increase of INa by T 3 was completely abolished by further 
addition 'of I /LM amiodarone, and the INa further decreased to 
the level when amiodarone was used alone. The T3 
concentration-response curve in INa was significantly shifted to 
the right by 10 nM amiodarone (p < 0.05). Howerver, when 
cells pretreated with I /LM amiodarone, T3 did not increase IN. 
even in saturation concentration (10 /LM). These results provide 
the direct evidence that amiodarone block the IN. and T3 
increase the INa in ventricular myocytes. The T3 and amiodarone 
interaction on NaH currents suggest that amiodarone may be 
a T3 antagonist. 
9:15 
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Characterization of Canine Cardiac Angiotensin II Receptors end their 
Role in the Regulation of Contractility in Vivo 
Mauro Moscucci, Roberto lang, Richard Marcus, Joachim Osinski, 
Claudia Korcarz, Michael Murphy. University of Chicago, Chicago, IL 
We have used newly available Angiotensin II (Alii receptor antagonists 
to characterize All receptors in canine left ventricular (LVI membranes 
and to assess their role in the regulation of LV contractility in vivo. 
Radioligand binding assays were performed on canine LV membrane 
preparations. Data revealed DuP753 sensitive, PD123319 insensitive 
binding sites for All, consistent with an AT, receptor subtype (Kd 
2.28±0.64 nM, n=51. To determine the biological significance of All 
receptors in the regulation of LV contractility the hemodynamic 
response to DuP753 (1 mg/kg I.V.I was studied in 7 anesthetized a-, 
p- adrenoreceptor blocked mongrel dogs. LV pressures and volumes 
were measured With Millar micromanometers and conductance 
catheters. Data were acquired over a range of loads generated by 
inferior vena cava balloon occlusion. The slope of the end-systolic 
pressure-volume relation (Emaxl was used as a load independent index 
of LV contractility. Adequacy of All receptor blockade was 
documented by demonstrating a shift of the pressor dose response 
curve to All. 
HR bpm ESV ml EDV ml LVEDP mmHg Emax 
BASELINE 74±7 49±8 80±12 1.9±.3 1.6±.3 
DuP753 71±10 63±1594±19 2.5±.5 1.2.±.2· 
Values are mean ± SE; • - p < 0.05 vs. baseline 
DUP753 had a mild negative inotropic effect, evidenced by a decrease 
in Emax. This effect was associated with a trend toward an increase 
in end-diastolic and end-systolic volume (EDV, ESVI and LV end•
diastolic pressure (LVEDPI. Conclusion: these results are consistent 
with the presence of AT, receptors on canine cardiac membranes. AT, 
receptors may playa role in the regulation of l V contractility through 
an a-, or p-adrenoreceptor independent mechanism. 
826-6 9:45 
347A 
Anti-Arrhythmic and Electrophysiologic Effects 
of R56865: A New Class of Anti-Arrhythmic 
Drugs? 
Ronald van Deursen, Marc Vos, Jet Leunissen, 
Anton Gorgels, Hein J. Wellens_ Academic Hospi•
tal Maastricht, The Netherlands. 
R56865 (R), a new anti-arrhythmic drug, has 
been described to be effective in vitro against 
ouabain-induced tachycardias (OVT) Which are 
due to intracellular calcium overload. The 
hemodynamic and electrophysiologic effects of 
R were stUdied in 6 anaesthetized dogs. Anti•
arrhythmic effect of R (0.48 mg/kg) was eva•
luated in conscious dogs on 10 OVT and 6 spon•
taneous VT (SpT) occurring 20 hrs after LAD•
occlusion. 
Results: R increased (p<0.05) cycle length (CL) 
of sinus rhythm, QTc-duration (+8%), a,nd VERP 
(+16%). The latter two without any rate depen•
dency. R had no effect on blood pressure nor on 
conduction or refractoriness of AV-node or con•
duction in the ventricle. The CL of the 5 slo•
wer OVT (335±30 ms) was increased by R (+55%) 
followed by termination, while the 5 faster 
OVT (285±10 ms) were only slowed to 330±30 ms 
(+16%). Finally, R had no effect on SpVT. 
In summary: 1) R56865 has under normal physio•
logic conditions class III effects, 2) Rsup•
presses ouabain induced VT in a reverse-use 
dependent way, which is a new pharmacologic 
observation, and 3) R does not affect SpVT. 
Because pure class III agents do not affect OVT 
and R demonstrated absence of effect on AV•
nodal or intraventricular· conduction, we con•
clude that the anti-arrhythmic action of R does 
not fit the Vaughan-Williams classification. 
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SiJpificance of SmaD VL Large V_I Cmooary DiIeuc III Renal VL 
CIrdiK Trllllplmt Rcc:ipicntL 
Sandeep Bajaj, Ravinder Kohli, Germano DiSciascio, George Vetrovec, 
Michael Cowley, Ann King, Rebecca Quigg, Hassan Ibrahim, Albert 
Guerraty, Pramod Mohanty. Medical College of Virginia and V AMC, 
Richmond, VA 
Immunosuppressive therapy (IT) with cyclosporin and prednisone and 
coronary risk factors, particularly serum cholesterol (chol) levels, have 
been implicated in the development of accelerated coronary artery 
disease (CAD) in cardiac transplant (CT) patients. With this 
backaround, we analyzed the pattern of CAD in 2S patients after a mean 
of 3.5.±1 yrs following renal transplantation (RT; Group 1) on triple IT 
(cyclosporin, prednisone, immuran) and compared them with 61 CT 
patients with similar IT who had coronary angiogram5 at 2-3 years after 
CT (Group 2). The aim was to determine the impact of IT on 
accelerated CAD in CT pts. We used a modified Stanford University 
classification for arading CAD. Type Bl, B2 and C lesions were arouped 
as small vessel disease (SVO). Type A lesions were grouped as large 
epicardial vessel disease (L VO). The results (mean,±SEM) are 
summarized in the table. 
Age 
Group N Cyrs) 
1 (RT) 2S 49.±4 
2 (CT) 61 44.±6 
• p<O.OI 
Plasma Chol. 
(mg%) 
266.±20 
2S6.±16 
SVO 
(%) 
1(4) 
37(61)· 
LVO 
(%) 
20(80) 
5(8)· 
No CAD 
(%) 
4(16) 
19(31) 
There is a strikingly lower occurrence of SVO (4% VI. 61 %) and 
predominance of LVO (80% VI. 8%) in RT despite similar cholesterol 
level and IT between the two aroups. These results suggest that 
accelerated CAD (mainly SVO type) seen in cr is independent of IT. 
Immune mediated vascular injury in cr, as opposed to its absence in RT 
patients may account for accelerated CAD following CT. 
827·2 8:45 
Fuactloaal Dlsturbaac:e& la Early Stqes 01 Accelerated CoroaDry 
Atlael'OKlel'Olll. la Cardiac Traasplaat Patleats 
Todd J. Anderson, Thomas J. Ryan Jr., Ian T. Meredith, Gilbert H. 
Mudae, Andrew P. Selwyn, Peter Ganz, Alan C. Yeung. Brigham & 
Women', Hospital and Harvard Medical School 
Early staaes of coronary atherosclerosis in cardiac transplant patients 
may be related to recurrent intimal damage and subsequent intimal 
proliferation. Recently, intravascular ultrasound (IVUS) has found a high 
incidence of intimal thickening in angioaraphically normal vessels; 
however its relationship to functional disturbances of the intima 
(endothelium) is unknown. We studied morphology by IVUS and 
functional integrity of the intima by acetylcholine testing (ACH 10"M, 
lo-1M, lo.aM) in the left anterior descending artery of 14 patients. Of 
21 seaments analyzed, 19 seaments appeared normal and 2 irregular by 
anaioaraphy. Intimal thickenina was quantified using an intimal index 
(Ii, % area of intimal thickening/area of total lumen) and the maximal 
intimal thickness (Mt). Among 10 seaments without intimal thickening 
by IVUS, 5 dilated to ACH or did not change (Grp I, -1±9%) and 5 
seaments abnormally constricted (Grp 2, -20± 13%). Among 11 seaments 
with intimal thickening by IVUS, 4 seaments (Ii=16%, Mt=430I£M) 
dilated to ACH or did not change (Grp 3, 0±8%) and 7 segments 
(Ii-20%, Mt-5OO!£M) abnormally constricted (Grp 4, -17±7%). The 
differences in ACH response between groups could not be accounted 
for by age of donor or recipient, cholesterol levels or blood pressure. 
The occurrence of endothelial dysfunction and intimal thickening were 
significantly related to length of time since transplantation (Grp 1: 1.0 
yrs, Grp 2: 1.8 yrs, Grp 3: 2.5 yrs, Grp 4: 3.4 yrs; p<0'05)' Conclusions: 
Early atherosclerosis after transplantation cannot be well detected by 
angioaraphy, but in this study intimal thickening and endothelial 
dysfunction was commonly seen. These abnormalities generally increase 
over time, but the variability in the relationship between intimal function 
and structure in patients may reveal the episodic nature of this process 
before advanced disease with luminal narrowing develops. 
827·3 
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Ability of Coronary Endothelium to Secrete Nitric Oxideis 
Diminished but not Abolished in Cardiac Transplant 
Recipients with Accelerated Coronary Disease. 
Sudhir Kushwaha. Mahmud Bustami, David Lythall. Charles 
Ilsley, Andrew Mitchell. Magdi Yacoub. NHLI and Harefield 
Hospital. Middlesex. England. 
Previous studies with the endothelium-dependent vasodi•
lator substance P (SP) have shown that endothelial funct•
ion is preserved in cardiac transplant recipients (TxR) 
with angiographically normal coronary arteries when com•
pared to non-transplant patients with normal coronary 
arteries. Eleven TxR with coronary disease present in all 
3 major coronary arteries underwent SP infusion (lml/min) 
for 2 minutes in increasing doses in the left coronary 
circulation in 9 TxR and right coronary artery in 2 TxR 
followed by 2mgs isosorbide dinitrate (ISDN) infused over 
2 minutes. Coronary artery diameters were measured in 23 
vessel segments in 11 TxR. The mean % increase in diameter 
to increasing SP dose were as follows: 
SP (pmol/min) saline 1.4 2.8 5.6 11.2 22.4 ISDN 
% increase 0 0.93 6.0 11.1 22.6 20.1 22.0 
SEM 0 1.1 1.9 3.9 5.9 5.3 4.9 
SP caused much less vasodilatation at lower concentrations 
when compared with previous studies using SP on TxR with 
no coronary disease, the dose response curve being shifted 
to the right with a significant increase in half maximal 
dilatation dose (p<0.05). However. the response at the 
maximal SP dose was not significantly different from the 
nitrate response. Thus, although there is a decreased 
sensitivity to SP. the L-arginine - nitric oxide pathway 
is preserved. 
It is concluded that in TxR with accelerated coronary 
disease. the functional vasodilatory ability of the 
endothelium is impaired and this may increase resting 
coronary tone. 
827·4 9:15 
Substance P-Induced IIIcrease ia Coronary Flow is Attenuated 
in Patients witb Coronary Vasculopatby After Heart 
Transplantataion 
Andreas Miigge, Bernd Heublein, Carsten Nolte, Michaela Kuhn, 
Axel Haverich, Paul R. Lichtlen. 
Hannover Medical School, Hannover, Germany 
Coronary vasculopathy (CVP) is a frequent finding in patients after 
heart transplantation (HTx). We tested the hypothesis that CVP is 
associated with disturbed coronary endothelial function. Study 
group consisted of 16 patients (pts) who underwent routine cardiac 
catheterization 2.5 years (mean) after HTx. Eleven pts showed 
angiographical1y normal coronary arteries (N), five pts showed 
CVP. Left anterior descending blood flow velocity was measured 
by intravascular Doppler (Millar, 20 MHz, 3F). The endothelium•
dependent vasodilator substance P (SP, 20 pmole), and papaverine 
(PA, 8 mg) were injected successively as a 1.0 m1-bolus through 
the Doppler catheter. Table summarizes maximal flow velocity 
changes ('IIi baseline, mean ± S.E.M.) in response to SP and PA 
(*P~0.05 versus N): 
N (n=l1) 
CVP (n=5) 
SP 
186 ± 13 
140 ± 24* 
PA 
364 ±40 
404 ± 30 
Conclusion: Whereas PA-induced increase in coronary flow 
was of similar magnitude in pts with and without CVP, SP•
induced flow changes were attenuated in pts with CVP. These 
results support the hypothesis that endothelial function is disturbed 
in pts with CVP. 
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Plasma Dehydroepiandrosterone (DHEA) and Coronary Disease in 
Cardiac Transplant Patients. 
David M. Herrington, Kenneth L. Baughman, Nazeem Nanjee, Gary 
D. Walford, Barbara Dobbs, Stephen C. Achuff 
The Bowman Gray School of Medicine, Winston-Salem NC, and 
The Johns Hopkins Medical Institutions, Baltimore MD 
Conventional coronary disease risk factors do not predict the 
diffuse proliferative coronary atherosclerosis commonly seen 
following cardiac transplantation. DHEA, an adrenally secreted 
steroid hormone, has profound anti-proliferative effects which 
inhibit fibroblast growth in vitro and the development of coronary 
atherosclerosis in rabbit cardiac allografts. To determine if total 
plasma DHEA, DHEAS or free DHEA (ie. DHEA not bound to sex 
hormone binding globulin) are associated with development of 
coronary disease in human cardiac transplant patients, these 
hormones were measured in recipients of 65 cardiac allografts 48 
± 19 (mean ± SD) months after transplant and compared to 
results from annual angiographic follow-up. Patients with at least 
one ~ 50% stenosis (CADHn = 12) had less total and free DHEA 
than those with no CAD (n = 53). 
total DHEA 
free DHEA 
DHEAS 
Mean (ng/mll ± SD 
CAD + CAD--
2.89 ± 0.86 3.79 ± 2.37 
2.39±0.78 3.31 ±2.09 
446.4 ± 294.2 441.3 ± 256.7 
~ 
0.03 
0.02 
0.78 
After adjustment for age, sex, and months since transplant 
using multiple logistic regression, total (p =0.09) and free 
(p=0.05) DHEA remained inversely associated with CAD. 
Low plasma levels of DHEA are associated with CAD in 
transplant patients and may contribute to its pathogenesis through 
a relative reduction in the anti-proliferative effects of this steroid 
hormone. 
827·6 9:45 
Coconut Oil and Fish Oil Accelerate Rahhlt Graft COI'OIIlI1')' Atherosclerosis 
Stephen C. Rayhill, Kwok L. Yun, Marek A. Niczyporuk, Margaret E. 
Billingham, Loren G. Fong, Lee H. DeBroff, Fariba Nasserbakbt, D. Craig 
Miller. StllDford University and Palo Allo Medical FOUDdaticm, StllDford, CA. 
Graft coronary atberosclerosis (GCA) limits cardiac allograft longevity. FISh 
Oil (FO), whicb protects against atberosclerosis and suppresses tbe immUDe 
system, should protect against GCA. Coconut oil (CO), in contrast, accelerates 
atberosclerosis. To elucidate GCA mecbanisms and to test FO treatment, 39 
NZW rabbits were divided into 3 groups, 1. fed rabbit chow oJliy [Control (C»), 
2. fed rabbit cbow and FO [2ml/kg/day) (FO), or 3. fed rabbit cbow and CO 
[2mI/kg/day) (CO), and transplanted heterotopically with Dutcb Belt rabbit 
bearts. Each rabbit received 5 mg/kg/day of cyclosporin A. Eight weeks 
following transplantation, lipoprotein levels (mg/dl) and plasma LDL 
oxidation potentials (DlDol MDA/mg LDL protein) were obtained, tbe rabbits 
were sacrificed, and histologic and computer analysis were performed yielding 
rejection scores (RS) [0 (none), 1, 2, 3 (severe») and normalized quantitative 
morphometric indices [percent intimal occlusion (%10»). The %10 was 
derived by dividing the intimal area (the area between tbe internal elastic 
lamina and tbe lumen) by the total area within tbe internal elastic lamina 
(times 100%). In all diseased grafts, normal arteries coexisted witb diseased 
arteries, and clinically, severely diseased arteries limit graft longevity, 
tberefore, tbe largest %10 from eacb graft was used to represent tbe graft for 
analysis. Because this incompletely described tbe extent of disease, another 
index was derived to simultaneously quantify both the extent and the 
frequency of GCA in eacb graft, this index, tbe 'GCA Index' (GCAlDX), was 
determined by multiplying the %10 by the fraction of arteries in eacb graft 
"ith GCA. Results were (mean:!: sd, statistics for C vs. FO or CO): 
.!I!:w!P .RS .Q!m.LDL Jml. ..QxflIJ .H) ~ 
C 1.1+1.1 47+34 21+31 21+6 45+19 61+36 32+31 
FO 1.2+1.2 59+29 28+27 22+4 150+29+ 81+33 50+38 
CO 1.6+1.1 58+18 22+16 31+81 36+11 93+15· 74+30* 
[. p=O.oo4 (Mann-whitney U); * p=O:OO2,+ p-O.OOO1,1 pc O,03 (t-tesl)) 
We conclude tbat for rabbits: 1. Coconut oil significantly worsens GCA; 2. FO 
may also exacerbate GCA; 3. Alterations in rejection or, significantly, in 
plasma lipoprotein concentrations are not responsible for increased GCA with 
lipid consumption. 4. Increased lipid peroxidation does not appear to be a 
crucial mechanism in GCA. 
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Prophylactic Percutaneous Cardiopulmonary Bypall Venus 
Intra-aortic Balloon Pump Support for High Risk 
Angioplasty 
Thomas Heany, Gregory Pavlides, David Craig, Sue Glazier, 
Ann Harguilis, Theodore Schreiber, Cindy L Grines, William 
W O'Neill. 
William Beaumont Hospital, Royal Oak, HI 
The optimum method of hemodynamic support in high risk 
patients undergoing PTCA due to either multivessel disease 
and/or severely compromised LV function remains 
undetermined, We have compared baseline clinical 
parameters, outcome and complications in patients 
undergoing prophylactic hemodynamic support with either 
CPS or IABP at a single institution. 
Supported intervention was utilized in 72 pts (IABP:27 
CPS:45) mean age 67 years (IABP:72 CPS:63, p<.OOOl). Hean 
number of diseased vessels was 2.68 (NS) with a mean 
ejection fraction of 29% (NS). The target vessel was LK 
in l4(IABP:4, CPS:I0, NS), LAD in 19, (NS). Procedural 
success rate «50% residual stenosis without AMI, death or 
CABG) was 96% (NS). Diameter stenosis reduced from 90% 
(NS) to 23% (NS). One patient in the IABP group needed 
emergency CPS and 8 patients in the CPS group needed IABP 
to wean from CPS. In hospital mortality was 8% (NS). 
Blood transfusion rate was 32% (IABP:25%, CPS:35%, NS) and 
vascular surgical repair was required in 11 pts (IABP:2, 
CPS:9, NS). Duration of stay was 9.2 days (IABP:8.3, 
CPS:9.9, NS). 
CONCLUSION: Successful angioplasty in similar high risk 
patient groups can be achieved utilizing either 
prophylactic CPS or IABP. A randomized trial comparing 
the two techniques should be undertaken. 
967·8 
continuous Infusion of Urokinase Through an 
Intracoronary Perfusion Catheter: Overnight 
Thrombolytic Infusion Improves Angiographic 
outcome. 
steven Yakubov, Mark Gonzalez, David Engleman 
Connie Zimmerman, Nathan Kander, Richard 
Candela, Barry George, Anthony Chapekis, 
Riverside Methodist Hospital, Columbus, Ohio. 
continuous infusion of urokinase (UK) through 
an intracoronary perfusion catheter was perfor•
med in 94 patients sUspected to have thrombus 
in native coronary arteries or saphenous vein 
coronary bypass grafts. Mean infusion dura•
tion was 20.4 ± 3.7 hrs. All perfusion cathe•
ter placements were successful and only one in•
stance of catheter migration occurred on an•
giographic followup. No patients developed 
acute hemodynamic instability, major bleeding, 
or required emergent coronary bypass grafting. 
In those with less than TIMI-3 flow at the time 
of perfusion catheter placement, flow improved 
an average of 85% (p<.OOl) and visual angiogra•
phic evaluation of thrombus present demonstra•
ted 36% (p<.Ol) improvement following treat•
ment. Visual estimation of residual stenosis 
decreased by 16% (88.8 ± 19.8% to 74.14+30.9%) • 
sustained vessel patency, complete thrombus 
resolution and subsequent successful PTCA was 
achieved in 85% of patients. 
Therefore, constant UK infusion through an in•
tracoronary perfusion catheter is a safe and 
effective technique in establishing adequate 
angiographic outcome in coronary vessels with 
significant stenoses and thrombus burden. 
350A ABSTRACfS 
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PTCA of Totally Occluded Saphenous Vein 
Grafts: Safety and Success 
Joel K. Kahn. Barry D. Rutherford. David R. 
McConahay. Warren L. Johnson. Robert 
Ugon. Geoffrey O. Hartzler. Mid America Heart 
Institute. Kansas City. MO. 
Total occlusion of saphenous vein grafts (SVG) after 
coronary artery bypass surgery often causes 
recurrent ischemia. The safety and results of PTCA 
in occluded SVG are controversial, We performed 
elective PTCA of 82 totally occluded SVG. The 
mean age of pts was 61 yrs. 23% were ~70 years 
old. 89% were men. 73% had prior infarction, and 
83% had 3 vessel coronary disease. The time from 
bypass surgery ranged from 1 to 226 months with a 
mean of 84 months. In 31 attempts the SVG was 
the only site dilated and in 51 (62%) from 1 to 6 
additional sites (n=lOl) were dilated. Thrombolytic 
infusions were not used. Angiographic success 
(S40% residual luminal stenosis) was achieved in 69 
SVG (83%) and in 97 (96%) of the additional Sites 
(p<O.OI). Complications were low with no urgent 
bypass operations or vascular complications. 1 
hospital death and 2 g-wave infarctions. Follow-up 
over a mean of 26 months demonstrated a 1 and 3 
year actuarial survival of 94% and 81%. At 3 years. 
only 33% of patients were free of repeat PTCA or 
surgery. Thus. elective PTCA of selected totally 
occluded SVG is safe. Strategies for sustained 
patency following PTCA may improve the long term 
results. 
967·10 
The Influence of Angioplasty Balloon Material on the 
"Dog·bone" Phenomenon 
William A. Gray, Shirley Emin, and David O. Williams, Rhode Island 
Hospital, Brown University, Providence, RI 
We evaluated the effects of angioplasty balloon (B) material-•
polyethylene (PE), polyethylene terephthalate (PET). and 
polyolefincopolymer (POC)--on the unconstrained B diameter (OrA) 
adjacent to a fixed stenosis. For each B material, a 5 mm constrictor 
with a 1 mm internal diatneter was positioned in the middle of 20 mm 
long, 3.0 mm DIA B. Incremental 1 atmosphere (atm), 60 sec inflations 
(lNF) were perfonned to 10 atm, followed by deflation. The protocol 
was then repeated once for each B. Using a laser micrometer, DIA of 
the B segment extending beyond the constriction were measured after 
each atm increment. Results for both INF are displayed over the range 
of P: (@=recommended (REC) P for nominal (NOM) DrA) 
Bt::;P!!:::::;'---PET 
2345678910 2~45678910 
Pressure (atm) l'ressure (atm) 
For unconstrained B segments INF to 10 atm: 1) PET demonstrates 
no dog-boning (DrA greater than NOM) on either 1st or 2nd INF, but 
are undersized until REC P on first INF, 2) PE dog-bones on 1st INF 
only above REC P, and at REC P on 2nd INF. On both INF to 10 atm, 
fmal DrA is moderately increased (0.25 mm) over NOM DrA, 
3) POC dog-bones at 1 atm less than REC P on 1st INF and 2 atm less 
than REC P on 2nd INF, and final DrA is markedly increased 
(0.55 mm) at 10 atm P. 
These results suggest that in resistant coronary lesions, B material 
characteristics may need to be considered for the selection of proper 
angioplasty equipment. 
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Angloplasty of Older Sapbenous Vein Grafts Continues to be a 
Sound Tberapeutic Option 
Cres P. Miranda, Barry D. Rutherford, David R. McConahay, Warren L. 
Johnson, Lee V. Giorgi, Thomas M. Shimshak, Robert W. Ligon, 
Geoffrey O. Hartzler 
Mid America Heart Institute ofSt Luke's Hospital of Kansas City, MO 
As the population of patients who have undergone previous coronary 
artery bypass grafting (CABG) grows, the use ofPTCA to treat stenotic 
saphenous vein grafts (SVG) will increase as well. This retrospective 
analysis was performed to ascertain the effect of SVG age on the efficacy 
of PTCA Between 1980 and 1991,2668 patients with prior CABG 
presented with recurrent symptoms and underwent elective PTCA; of 
these 440 (17%) had only SVGs dilated and not native arteries. A total 
of 576 SVGs were dilated (1.3/patient). Patients were divided into 3 
groups depending on the time interval between CABG and attempted 
PTCA: Group I had 58 (13%) patients.s. 1 year after CABG, Group II 
had 31 (7%) patients> 1 year but < 3 years after CABG, and Group III 
consisted of 351 (80%) patients ~ 3 years out from surgery. The 
angiographic success rate for Group I SVGs was 89%, Group II 94%, 
and Group III 94% (p = 0.30). Peri procedural complications such as 
myocardial infarction, urgent CABG, or death all occurred in Group III 
patients at a rate of 5% (191351) (p = 0.01); however, there were only 5 
deaths (1.4%, 51351). Actuarial survival over a cumulative 5.0 years of 
follow-up was 86% for Group I, 64% for Group II, and 72% for Group 
III (p = 0.15). Cardiac event-free survival for the 3 groups was 80%, 
40%, and 34%, respectively (p = 0.002). Multivariate analysis identified 
decreased left ventricular function, advanced age, and multivessel disease 
as negative predictors of long-term survival; graft age was not an 
independent factor. PTCA of SVGs is accomplished with a high degree 
of success and low morbidity and mortality regardless of graft age. 
967·12 
Gradual, Low·Pressure and Sustained Inflations With the 
Physiologic Anteroperfusion System Improve the 
Immediate Results of LAD Angioplasty. 
Jacques Berland, Jean C. Farcot, Gunter Stix, Alain Cribier, Jean P. 
Bourdarias, Brice Letac, Rouen and Paris-Ouest, France 
Sustained inflations (INF) (10 min) are expected to improve the 
results of PTCA, but for proximal LAD angioplasty no data exist 
because current perfusion catheter (CAT) do not achieve sufficient 
long-tenn ischemic protection. Therefore, we compared the results of 
LAD PTCA in 2 groups (Gr) of patients (PIs) treated during the satne 
10 months period of time. In Gr I (29 Pts), one gradual (1 
Attn/minute) low pressure (5.1 ±.8 Atm) and prolonged (596 ± 131 
sec) INF was performed using the Physiologic Anteroperfusion 
System (PAS) which delivers autologous blood flow (45 ± 8 ml/min) 
in diastole through PTCA CAT. In Gr II (60 Pts), multiple (3.2 ± 
1.9) short (101 ± 72 sec) INF were perfonned at standard balloon 
pressure (7.9 ± 3 Atm, p<.01 vs Gr I). Pre-PTCA clinical data, 
location and type of LAD lesions, and balloon (BaI) sizes were 
comparable in 2 Grs. Coronary (Cor) angiogratns were reviewed by 
3 independent observers to assess the presence of intimal (Int) 
disruption (Dis) and to caliper % diameter (D) stenosis (St) and % 
Cor recoil (Area Bal - Area St post-PTCA/ Area Bal) using a 
computer assisted sytem. 
Results: Gr I (PAS) Gr II 
%DSt 
pre-PTCA: 
post-PTCA 
% recoil 
Cor. Int. Dis. 
85±8 
14±8 
35 ± 18 
1(4%) 
8U8 
34±26 
52±20 
19(31%) 
NS 
p<.OI 
p<.OI 
p<.OI 
Conclusjons : Gradual, low-pressure and sustained inflations (10 
min), allowed by PAS. decrease coronary intimal disruption rate and 
significantly improve the angiographic results of LAD angioplasty. 
JACC Vol. 19, No.3 
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967·13 
Outcome Following Prolonged Balloon Int\ations of over 20 
Minutes After Unsuccessful Coronary Angioplasty 
John D. Jackman, Jr., James P. Zidar, James E. Tcheng, Michael 
H. Sketch, Jr., Robert K. Stack, Harry R. Phillips, Richard S. Stack. 
Duke University Medical Center, Durham, North Carolina 
Perfusion angioplasty is often pursued after balloon 
inflations which are unsuccessful or lead to major dissection. We 
studied 40 pts from 1/91 - 7/91 receiving prolonged balloon 
inflations (PBI) of over 20 min after initially unsuccessful 
angioplasty. 
The pts (median age 59) underwent coronary 
angioplasty (PTCA) for progressive or unstable angina in 16 
(40%), symptomatic or asymptomatic residual stenosis after 
myocardial infarction in 10 (25%), acute myocardial infarction in 3 
(8%), stable angina in 3 (8%), reinfarction in 2 (5%), and other 
indications in 5 (12%). Lesions were primarily in the proximal and 
mid portions of the right coronary (53%), left anterior descending 
(3O%) and left circumflex (17%). 
Prior to PBI, the longest single inflation was 10.5 ± 5.7 
min and total time of all inflations 17.4 ± 8.4 min (mean ± std 
dev). Stenosis was reduced from 90 ± 9.4% to 68 ± 16% before 
PBI. After PBI of 29.8 ± 9.2 min, the residual stenosis was 47.4 ± 
20.7% (p = .003 vs. pre-PBI). Furthermore, improvements in the 
appearance of filling defects andlor dissections occurred in 19 
pts (48%). Angiographic success was obtained in 32 pts (80%). 
Coronary bypass grafting was performed in 8 pts (20%); 4 after 
unsuccessful PTCA (3 emergently) and 4 electively after initially 
successful PTCA. Although 6 pts had CKMB elevations> 20 lUll 
post procedure, only 1 pt sustained a a-wave myocardial 
infarction following PTCA. There were no deaths in-hospital. 
In summary, prolonged balloon inflations of over 20 min 
are successful in 80% of cases in which initial angioplasty 
attempts are not. Prolonged inflations may thus be desirable 
prior to consideration of bypass grafting or stenting. 
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968·1 
Factors Associated with the Outcome of Directional 
Coronary Atherectomy: NACI Registry Experience 
Michael Cowley, Tomoaki Hinohara, Kenneth Kent, Spencer King, 
William O'Neill, Donald Baim, Ann Steenkiste and the NACI DVI 
AtheroCath Investigators 
Medical College of Virginia, Richmond, Virginia 
The purpose of this New Approaches to Coronary Intervention 
(NACI) Registry report is to evaluate and identify factors associated 
with the outcome of directional coronary atherectomy (DCA). DCA 
was performed on 435 lesions in 385 patients at 11 centers. 
Distribution of lesions were left main 3%, left anterior descending 
50%, right coronary 21%, circumflex 9% and vein graft 16%. 
DCA was successful «50% final stenosis, >20% reduction of 
stenOSis) in 77% and an additional 10% were successfully treated 
by PTCA with an overall procedure success rate of 87%. Significant 
complications occurred in 6.2%; death 0.8%, myocardial infarction 
4.9% and CABG 1.6%. Univariate analysis including 14 
angiographic and 20 clinical characteristics demonstrated that 
severity of pre procedure stenosis, age ~65, severe concomitant 
disease and number of vessels diseased were associated with 
unsuccessful procedures. These 4 factors were independent 
predictors of unsuccessful outcome by multivariate analysis. 
Factor Risk 
% stenosis before treatment 
70 - 89% (vs <70%) 2.61 
90 - 100% (vs <70%) 2.08 
Age 265 2.10 
Severe concomitant disease 3.93 
Vessels diseased (Triple vs single) 2.05 
In conclusion, early experience of the NACI Registry suggests 
favorable outcome for DCA. Severe pre procedure stenoses, age 265, 
concomitant disease and number of vessels diseased were predictors 
for failed DCA procedures. 
ABSTRACTS 
968·2 
The Effect of Age on the Outcome of Dlractlonal Coronary 
Atharactomy 
Tomoaki Hinohara, James Vetter, Matthew Selmon, Gregory 
Robertson, Bruce McAuley, Dennis Sheehan, Franklin Fleischhauer, 
Son Le, Lissa Braden, Deborah Doran, John Simpson 
Sequoia Hospital, Redwood City, California 
The aim of this study is to evaluate the influence of age on the 
outcome of directional coronary atherectomy (DCA). Between April 
1988 and June 1991, 1014 lesions in 869 patients were treated 
electively. Of these, 132 patients (154 lesions) were >70 years 
old (OLD). 516 patients (610 lesions) were between 51 and 70 
years old (MIDDLE) and 221 patients (250 lesions) were .s. 50 
years old (YOUNG). Comparison of patient and lesion 
characteristics revealed that OLD had more unstable angina (OLD 
52%, MIDDLE 40%, YOUNG 40%, p=0.05), vein graft lesions (OLD 
22%, MIDDLE 16%, YOUNG 6%, p<O.OOOI) and calcified lesions 
(OLD 35%, MIDDLE 21%, YOUNG 8%, p<O.OOI). The outcome in 
each group was as follows: 
a.o MIDDLE YOJ\G 
DCA Success 88% 91% 92% 
DCA & PTCA Success 92% 96% 96% 
Significant complication" 9.8% 3.3% 2.7% 
Death 1.5% 0.2% 0% 
Q wave infarct 1.5% 0.4% 0% 
Bypass surgery 5.3% 1.9% 1.8% 
Stroke 0.8% 0.2% 0.4% 
Groin repair 2.3% 1.2% 0.5% 
" p=O.OOI 
In conclusion, lesions in elderly patients can be treated as 
effectively as younger patients by DCA, however the risk of 
significant complications is higher among the elderly. 
968·3 
Adjunctive Angioplasty Berore or After Directional Atberectomy 
Donald S. Baim, Kenneth M. Kent, Michael J, Cowley, Spencer B. King, David 
R. Holmes, Ann R. Sreenkiste, Tomoaki Hinolwa, for the NACI Atherectomy 
Investigators. Harvard Medical School and Beth ISIlICI Hospital, Boston 
While directional coronary atherectomy (DCA) is usually considered an 
alternative to conventional PTCA in the definitive creatment of selected lesions, 
in practice many DCA patients undergo conventional PTCA before or after 
passage of the atheroCath. To investigate the role of adjunctive PTCA we 
compared cases in which DCA was planned as the lIIIh...creatment, to those in 
which pre-djlawjon was planned before DCA (PTCA-+DCA): 
Lesion Number 
Reason fer selecting DCA (%) 
discrete 
calciflCd 
resaenotic 
eccentric 
ostial 
Lumen pre (mm) 
Stenosis (%pre-t%post) 
DCA Success 
DCA ONU PICA-tDCA 
0=267 11=113 
80 
14 
30 
82 
7 
0.9 
73-+17 
p<.OS 
p<.OI 
p<.OOI 
p<.OOI (pre) 
73 
27 
21 
84 
10 
.06 
80-+18 
DCA alone 186(70%) 
PTCA before DCA 7 (3%) 68 (60%) 
PTCA after DCA 22 (8%) 14 (12%) 
PTCA success (DCA failure) 23 (9%) 12 (11 %) 
Complications death 2 (0.7%) 0 
em-CABG 4 (1.5%) 2 (1.8%) 
MI 11(4.1%) 11 (9.7%) 
In conclusion: I) In the DCA only group, use of unplanned adjunctive 
angioplasty increased the DCA success from 70 to 81 %, and procedure success 
(including PTCA after unsuccessful DCA to 91 %; 2) Planned pre-dilatation in 
113 patients with lighter, more calcified, and less discrete lesions allowed a DCA 
success of 72 % and a procedure success of83%, not significantly different than 
DCA only; 3) It might thus be reasonable to reserve pre-dilaration for difficulty 
in passing the DCA catbe/er, or failure of DCA to provide an adequate result. 
351A 
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%8·4 
Outcome of Directional Coronary Alherectomy by New 
OperalOl1: Comparison with Experienced Operators 
KIrk N. Garrott. Malcolm R. Bell. Peter B. Berger. John F. Bresnahan. 
David R. Holmes. Jr.,Tomokal Hlnohora. and US Directional 
Atherectomy Study Group. Mayo Clinic. Rochester. MN 
Clinical outcome data hove been reported for centers hoving 
prior experience with directional coronary otherectomy (DCA). 
With the release of DCA catheters for general use. an Increase In 
the number of new operators Is anticipated. To determine the 
outcome of pts treated with DCA by operators with no prior 
experience. procedural results from 8 original Investigative 
centers (Gr 1) and 11 Investigative centers first using DCA after 
1/90 were analyzed for the period 1/90 - 9/90. All centers hod a 
high annual VOlume of catheter procedures and operators with a 
brood PTCA experience and formal DCA training. Pts In Gr 1 
(n=510 pts) and In Gr 2 (n=270 pts) were similar except that Gr 1 hod 
more males and pts with cholesterol >250 mg/dl. heart failure or 
prior bypass surgery (BS). and Gr 2 had more pts with unstable 
angina or acute myocardial infarction (MI). DCA was successful 
In 87% of Gr 1 and 82% of Gr 2 pts (p=NS). There was no slgnlficant 
difference between Gr 1 and Gr 2 in success rates for native 
arteries (86% vs 82%). saphenous vein bypass grafts (92% vs 
80%). ostial (9O'l. vs 85%). eccentric (86% vs 83%). primary 
atheromatous (84% vs 78%) or restenosis (91% vs 9O'l.) lesions. 
Gr 1 was more successful with noncalcified (91%% vs 83%. 
p:.(04) and right coronary (86% vs 75%. p:0.05) lesions. Major 
complications (MI. CABG. death) occurred In 3.8% of Gr 1 and 
4.1% of Gr 2 pts (p=NS). 
Conclusions: The safety and efficacy of DCA by new operators 
having PTCA experience and DCA training does not appear to be 
slgnlficantly different from that associated with DCA performed by 
operators with prior DCA experience. 
968·5 
Increased Medial Smooth Muscle Cell Profiferation Followillg Expe•
rimental Holmium Laser Angioplasty in Comparison to Excimer Laser 
Ablation. 
St.f.n H .... n.t.in1.H.rtmut H.nkel.Jo.chim K.m.nzl . Sybill. H.nk.I.M.rtin 
Ob.,hoffl.K.rl K. H .... I. Eb.rh.rd e.u' .K.rl R.K.rschl D.pt. of Cardiolol)'(l) 
.nd Dept. of Physiolol)'(2), University of Tubin,en; F.R.G. 
Smooth muscl. c.1I (SMC) profif.r.tion is known to be.n import.nt f.ctor for the 
development of rest.nosis followin, p.rcut.neou •• ncioplasty. Aim of this study 
w.s to compar. two difT.rent la •• r sourcu in r.,ard of medial SMC prolif.r.tion. 
After production of. fibromu.cular plaqu. by electrical stimulation of the carotid 
artery in 70 r.bbits. either tr.n.luminal Excim.r I ... r anciopla.ty (ElA, n=25) or 
Holmium las.r angioplasty (HlA, n=25) of the pr.formed plaqu. w •• performed. 
10 r.bbits (sh.m) und.rw.nt c.th.t.r ins.rtion without .n.rl)' d.liv.ry .nd 10 
addition.1 anim.ls served as a control ,roup without I ... r tr .. tment. In the ElA 
,roup. multifiber c.theter w.s us.d to d.liv.r.40rnJ/mm' (308 nm. pulsedur.tion 
60 ns). The Holmium las., .nerl)' (2.121'm, 350mJ/mm'. pulse dur.tion 1501'S) 
was coupled in • b.r. fiber with 800l'm di.m.ter. Th. v .... I. w.re excised .t time 
int.rv.ls of 1.2.4.6 w •• ks post intervention (p.i.). To d.t.rmin. the .xtent of pro•
lifer.tin, cells immunohistologic.1 .t.ining .fter I.beling with bromodeoxyuridine 
w.s p.rformed. St.ining of Q-Ictin w •• used to id.ntify SMC's in m.dil. 
Results: Medial SMC Proliferation 1"1 
Complred to ElA the medi.1 
SMC profif.ration aft.r HlA is 
consid.rably incr .... d .t 7 days 
(ElA: 5 ± 3%. HlA: 10 :I: 9%) 
.nd even high.r incr .... d .t 14 
dlYS p.i. (ElA: 1.3 ± 0.7%, HlA: 
12 ± 8%). M.di.1 SMC prolifera•
tion .ft.r sh.m treatm.nt is low: 
n.7 :I: 0.5 % (ElA). 0.5 :I: 0.3 % 
_Excimer 
c::J Holmium 
(HlA). .";'101 _ T 14 28 
Summary: Compared to ElA. HlA induces. con.ider.bl. incr •••• d prolif.ration 
of m.dial SMCs. Thil r.sults in .n incr .... d steno'" six we.ks Ift.r int.rvention 
(ElA: 41 ± 21 %. HlA: 58 ± 18%). Compared to ElA the response of m.di.1 
SMCs .ppears to b. pronounced .nd prolon,ed .nd r.flects probably In incr .... d 
vascular injury. 
968·6 
JACC Vol. 19, No.3 
March 1, 1992:352A 
Holmium Laser Angloplasty In Coronary Arteries 
William Knopl, Kirk Parr, Jeffrey Moses. Christopher Cates, 
William Groh, Craig Stark, Ray Johnson, Edward Harlamert, 
Arnoldo Fiedotin, Douglas Murphy-Chutorian. 
Saint Joseph's Hospital. Atlanta. Georgia 
Holmium laser is a ·cold·, pulsed laser that has been under .clinical 
Investigation in coronary arteries since May 1990. In total, 239 
patients (avg. 60 yrs) with symptomatic coronary disease were 
studied and 270 lesions were treated. Average lesion length was 1.2 
cm. Sixty-one (23%) lesions were due to angioplasty failure 
(restenosis) and 81 (30%) lesions were calcified. By ACC/AHA 
lesion classification system, 27% were Type A, 60% were Type B 
and 13% were Type C. In all cases. a guidewire was placed across 
the lesion and a 1.4, 1.5. 1.7 or 2.0mm multifiber catheter 
(Eclipse. Palo Alto. CAl was advanced over the wire while emitling 
250-600 mj/pulse at 5 Hz. 
Res u Its: The laser catheter successfully reduced the severity 01 
225 (83%) lesions. Mean % stenosis decreased from 87.6% to 
56.5% after lasing with a mean of 139 pulses (28 seconds). Most 
cases had adjunctive PTCA. Procedure success (S50% residual 
stenosis without major complications) was achieved III 254 (94%) 
cases. Mean % stenosis after the combined approach was 19.8%. 
Complications were as follows: 
% Dissections 
% Perforations 
% Thrombosis 
% Distal emboli 
% Myocardial infarcts 
(Q and non-Q wave) 
% Death 
2.2% 
1.1% 
1.1% 
0.4% 
1.8% 
0.4% 
Conclusions: 1) Holmium laser angioplasty is capable of reducing 
the severity of coronary stenoses with a low rate of complicalions. 
2) Follow up studies are in progress to assess long lerm efficacy of 
this procedure. 
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969·27 
Feasibility of Chemical Ablation of WPW Accessory 
Pathways With 100% Ethanol 
Lawrence L. Creswell, James L. Cox, John S. Pirolo, 
Jeffrey E. Saffitz, and Michael Rosenbloom 
Washington University, St. Louis, Missouri 
We explored the feasibility of chemical ablation of canine 
conductive tissues by direct injection of 100% ethanol into 
the atrioventricular (A V) groove. In previous studies, 
injection of Lugol's solution into the A V groove produced 
fibrosis of the epicardium and fat pad, but significantly 
altered the morphology of adjacent coronary arteries. In 8 
adult mongrel dogs, 100% ethanol (10 ml) was injected into 
the left A V groove. No complications were noted. After 6 
weeks (n=6) or 12 weeks (n=2), the hearts were excised and 
examined. Grossly, the left A V fat pad was fibrotic. 
Histologic examination demonstrated localized fibrous 
replacement of injured epicardial muscle, but only scant 
inflammatory infiltrate. Mild intimal fibrosis and intimal 
proliferation were present in the circumflex artery and its 
larger branches, but no luminal narrowing was evident. 
Angiograms at 12 weeks (n=2) demonstrated no significant 
narrowing of the circumflex artery. In summary, injection 
of 100% ethanol into the AV groove is capable of locally 
ablating myocardial tissue, presumably including conductive 
tissues, while sparing the coronary arteries. These findings 
suggest that accessory AV pathways responsible for the 
WPW syndrome might be treated under direct vision by 
closed-chest techniques. 
JACC Vol. 19, No.3 
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969·28 
Myaclaxd1al. Pmt8ct1:ve Effect and its IIIIcbani.III\ of LeuJro•
cy\:8-Ilaplet8d'la:ll1nal 111m. Blood Cardicpl.agia: Expari•
IBltAl. study tJaiDg a Pail1ng Baart Madel. 
Akira Amemiya, SUSumu Nakano, Mitsunori Kaneko, Mo1:alol:u 
Nishimura, Hikaru Matsuda. 
Osaka University Medical School, Osaka, Japan. 
Although leukocytes are known to be involved in reperfu•
sion injury, the effect of leukocyte~pleted (ID) 
reperfusion (Rep) is still controversial in cardioplegic 
arrest. In this study, its role as ID terminal blood 
cardioplegia (~) was evaluated in a failing heart 
model. 41 isolated blood perfused rabbits' hearts were 
subjected to cardioplegic arrest for 2 hrs at 10oC. '!he 
subjects were divided into 2 groups: control (intact) 
hearts (n .. 20) and failing hearts with a preceding 20 min 
of warm ischania (n .. 21). Rep was made by one of the 
following methods for each group: whole blood (G-1), TC 
(G-2) or r.tm:: (G-3). TC and r.tm:: were done for initial 
10 minutes. At 30 min after Rep, , recoveries of LV de•
veloped pressure (LVDP), coronary flow (CF) and ultras•
tructural change (Score) in terms of capillary err:1othe•
lial cellular damage (CeS) were canpared. In intact 
hearts, 'recoveries of LVDP and CF were significantly 
higher in G-2 and G-3 than those in G-1, b.lt no signifi•
cant differences were fcum between G-2 and G-3. In the 
failing hearts, , recoveries of LVDP and CF were signif•
icantly higher in G-3 than those in G-2 (LVDP; 74:1:4' VB 
86:1:5', CF; 78:1:8' VB 93:1:8', p<0.05). , recoveries of 
LVDP and CF were significantly higher in G-2 and G-3 
than those in G-1. cas in G-3 (1.4:1:0.1) also showed 
significantly less injuries than G-2 (1.7:1:0.2, p<O.OS). 
'!his study denalstrated the benefit of additional ID in 
terminal warm blood cardioplegia for hearts vulnerable 
to reperfusioo injury after cardioplegic arrest with 
possible attenuation of capillary err:1othelial cellular 
injury and subsequent no-reflow phenanenon. 
969·29 
Acute DyDamic Cardiomyopluty Impain Left Ventricular 
DiastoUc FuDction 
William J. Corin, David T. George, James D. Sink, William 
P. Santamore. Philadelphia Heart Institute, Philadelphia, 
Pennsylvania. 
Dynamic cardiomyoplasty is presently being investigated as 
surgical therapy for patients with congestive heart failure. 
In this procedure. the latissimus dorsi muscle (LDM) is 
wrapped around the ventricles to improve left ventricular 
(LV) systolic function. To evaluate the effect of acute 
dynamic cardiomyoplasty (ADCM) on diastolic function, we 
instrumented 7 dogs by sonomicrometry and 
micromanometry. LV diastolic function was evaluated by 
calculating the peak rate of diastolic pressure decay (·dP/dt, 
mm Hg/sec), constant of pressure relaxation (Tau, sec), 
peak normalized filling rate (PNFR, lIsec), and end· 
diastolic pressure (EDP, mm Hg). These were determined 
at baseline (B), after LDM wrap but without stimulation 
(W), and with synchronized cardiac·LDM stimulation (S). 
#p<O.05, &p<O.Ol vs baseline. 
·dP/dt 
Tau 
PNFR 
EDP 
Base1iue Wrap 
l560±370 l26O±33O& 
38±5 53±lO# 
2.8±l.l 2.l±l.2 
3:t2 6±l# 
Stimulation 
ll2O±42D& 
62±11& 
2.2±1.1 
7±l& 
With LDM wrap, ·dP/dt decreased, while Tau and EDP 
increased. S did not improve these diastolic parameters. 
Conclusions: Acutely, dynamic cardiomyoplasty causes a 
decline in active diastolic function. Synchronous LDM 
stimulation did not improve left ventricular diastolic 
function in this model. 
ABSTRACfS 
969·30 
Efteds of left ventricular reconstruction usociated with 
non·llu1ded endocardectomy on Indudble, sustained 
ventricular tachycardia In posUnfarcdon LV aneurysm. 
Michel Sabatier, Vincent Dor, Fran~oise Montiglio, Fran~ois 
Bourlon.Philippe Rossi. Marisa Di Donato*. 
Cardiothoracic Center. Monaco.*Dept of Cardiology, University 
of Florence. Italy 
121 consecutive pts (55:t8yr) with postinfarction LV aneurysm 
(LV A) underwent reconstructive surllery consisting in 
endoventricular circular patch plasty with septal exclusion, after 
aneurysmectomy. No pI had acute or recent MI (<3Odays). 
Coronary artery bypass grafting was performed concurrently in 
96% of pts; non·guided endocardectomy was performed in pts with 
inducible ventricular tachycardia (VT).There were 4 posterior and 
117 anterior LV A. In order to evaluate the efficacy of this 
intervention on inducible, sustained VT, 97 pts underwent 
complete hemodynamic study including prollrammed right 
ventricular stimulation (PVS) using up to 3 extrastimuli. before 
and early after surgery (9·12 days). 32 pts had hemodynamic and 
PVS studies after 1 year from surgery. Perioperative mortality was 
1.6%; 1 pI died after 1 year. Before surgery VT was induced in 
37/97 pts; 12197 had spontaneous VT; mean EF was 38:t14%. 
Early after surgery VT was induced in 6197pts; 1 pt had 
spontaneous VT; EF Significantly increased (49:1:13%;p<.Ol). 
35/37 pts with preop inducible VT had no inducible VT after 
surgery (Fisher exact test p<.OOI). At 1 year VT was induced in 
1/32; EF was 47:1:13%, p<.01. We conclude that this kind of LV 
reconstruction for postinfarction LV aneurysm, associated with non 
guided endocardectomy and myocardial revascularlzation 
significantly decreased early and late occurrence of inducible. 
sustained VT. 
969·31 
a.gional '.rfudon of t.atiuiau. Dorai ,.did. flap. in 
Dynaaic C.rdio.yopl •• ty 
Lucian A. Durham, XII, Lloyd H. Michael, Gerald M. 
Lawrie. 
Baylor colle;. of Medicine, Hou.ton, Texa. 
The u.e of lath.imu. dorai mu.cle for dynamiC 
cardicmyopla.ty ha. led to report. of di.tal i.chemia 
of the mu.cle and decna.eel contractility of the d18tal 
portion of the flap. Xn order to evaluaU the regional 
perfu'ion of Lati •• imu. Dor.i 'edicl. Flap. (LDPF) in 
canine cardiomyopla.ty. we injected 25-35 kQ d09' with 
50 Ci of .ith.r 85Sn or 95Mb labelleel micro.ph.r ••• t 
variou •• t.;e. of the procedur.. The 851n micro.ph.r. 
w.r. inj.ct.eI in control animal. without m.nipul.tion 
of the l.ti •• imu. dor.1 mu.cl... Th. left LDPF w •• 
then rai •• d and the an1m.l wa. injectt.d with 85 5n 
l.b.ll.d micro.ph.r... Th •• nimal und.rw.nt a .in;l. 
l.ft cardiomyopl •• ty .nd upon compl.tion wa' inj.ct.d 
with 95Mb micro.ph.ra both with and without mu.cl. 
.timulation. Aft.r the proc.dur., the anim.l w •• 
.uth.niz.d anel both lati .. imu. dor.i mu.cl.. w.r. 
r.mov.d, cut by zon •• , and count.d in a ;amm. count.r. 
Ther. w.. no differ.nc. in the d18tdbution of the 
95Nb-micro.ph.r.. in the .timulat.d and un.timul.t.d 
LDP'.. Th.r. w.r. r.;ion.l diff.r.nc.. in the 
di.tribution of the lab.ll.d micro.ph.r.. aft.r 
di ••• ction of the LDPF. corr •• pondin; to a d.cr.... in 
perfu'ion of 40' in the proximal portion of the flap 
and 70' in the d1ltal .nel of the LDPF. Afur 
cardiomyoplalty, perfulion of the LD" d.cr .... d to 30\ 
of control in the proximal flap .nd 18' in the di.t.l 
portion of the flip. Th.r. .r. al.o .mall ar.a. cf 
normal perfu.ion in the eli.tal end of the LDP' which 
m.y account for the .urvival of the fl.p. Th ••• 
factor. mu.t b. con.id.r.d wh.n performing the 
proc.dur. to 'VOid di.tal flap n.cro.i. and' failure cf 
the proc.dur... Th. d.;r •• of di.tal i.chemia al.c 
rai... qu •• tion. a. to the ultim.t. .xt.nt of di.tal 
contractility of the LD" and the role of dinct 
c.rdiac compr ••• ion in the ben.ficial .ff.ct. of 
cardiomyopluty. 
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969·32 
Acute Dy'namic Cardiomyoplasty Augments Left 
Ventricular Systolic Function 
David T. George, William J. Corin, Gioia V. DiLoreto, 
James D. Sink, William P. SantamOl'e. 
Philadelphia Heart Institute, Philadelphia, PA 
Dynamic cardiomyoplasty (DCM) is a proposed surgical 
approach using a latissimus dorsi muscle (LDM) wrap around 
tfie heart, to improve left ventricular (LV) systolic function in 
patients with congestive heart failure. To evaluate the 
assistance provided by acute DCM, we instrumented 4 
mongrel dogs with sonomicrometry and micromanometry. 
LV pressure·short axis area relationships, fractional ejection 
al'ea (FE, %), maximal pressure-area ratio (P A, mm Hg/ cm2), 
and area stroke work (SW, mmHg " cm2) were calculated after 
1 mg/kg intravenous propranolol and LDM wrap without 
LDM stimulation (W), ana with synchronized cardiac-LDM 
stimulation (S). "p<.05 compared to W. 
W 
S 
.. 
Area (sq. em) 
FE 
24.5+5.0 
37.3±:11.5" 
PA 
32.4+17.9 
45.8:±26.3" 
i 
I-\.Insll'rlllloted" 
\ ... -SlwnuJCted 
SW 
70.0+36.4 
114.8+56.5 
Conclusions: Acute DCM augments LV systolic function. 
This acute model may be useful to evaluate modifications in 
LDM stimulation protocol and surgical technique. 
969·33 
Post-Infarction Left Ventricular Free Wall 
Rupture (LVFWR): 70% Survival with Echocardio•
graphy and Prompt Surgical Intervention. 
Jos Maessen, Emiel Cheriex, Hauw Sie, Kees 
Prenger, Vincent van Ommen, Olaf Penn. 
Rupture of the left ventricular free wall is 
an important cause of death following myocar•
dial infarction. Only case reports describing 
successfull surgical repairs can be found in 
the literature. Therefore, little is known 
about surgical morbidity and mortality from 
larger series of patients. We report a group 
of 10 consecutive patients with LVFWR who were 
treated in our department from 1986 to 1991. 
All patients presented with signs of cardiac 
tamponade. We considered tamponade as a (tem•
porarily) stabilizing factor of the balance 
between intracardial and intrapericardial 
pressure, offering an opportunity for emergen•
cy surgery. The diagnosis was confirmed with 
immediate echocardiography. The average time•
interval between echocardiography and cardi•
opulmonary bypass was 90 min. All surgical 
repairs were performed using a patch. Three 
patients died during hospitalization: one 
during surgery, one twelve hours following 
surgery, and one patient on day six because of 
recurrent myocardial infarction. At discharge, 
6 out of 7 patients had a fair or good LV 
rest-function. The mean postoperative hospital 
stay was 22 days. 
Conclusion: a patient with LVFWR has a fair 
chance to survive if his tamponade is recogni•
zed and confirmed by immediate echocardiograp•
hy followed by prompt surgical intervention. 
In this view, 'shock' treatment is obsolete. 
969·34 
lACC Vol. 19, No.3 
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Is There Sex Bias 1n Referral for Coronary Bypass 
Surgery? 
James Slater, Phil ip Rowan, John Perez, Larry A. 
Chinitz, Howard E. Winer, Howard A. Levite, Ephraim 
Glassman. New York University Medical Center; New 
York, New York 
Coronary bypass surgery (CBS) has been reported to 
be less successful in women than in men. To 
determine whether physician perception of this 
controversial result produced a gender bias in 
referral rates for CBS, we analyzed 461 male/female 
pairs (MFP) drawn from 4,542 patients referred for 
cardiac cath. Patients with valvular disease, left 
main coronary stenosis, previous angioplasty or 
bypass surgery were excluded. MFP were matched for 
coronary anatomy, LV funct i on, symptoms and age. 
Women with 2 vessel disease were more often treated 
medically than men (p <.05). There were no 
differences in referral rates for MFP with 1 or 3 
vessel disease. Subgroup analysis failed to 
identify LV function or symptom status as separate 
predictors of gender differences. Analysis of 
variance showed that women treated surgically were 
older and smaller than women treated medically. 
(Mean age: 66±7 vs 61.±S.6, P <.001, mean body 
surface area 1.69iO.2 vs 1.73±0.2, p <.05.) Once 
referred for cardiac cath, most women are not denied 
the opportunity to benefit from CBS despite reports 
of less favorable outcome. 
969·35 
Effect of Valve Size and Position of Normally Functioning St. 
Jude Medical and Medtronic·Hall Prostheses on Degree of 
Intravascular Hemolysis. 
John Skoularigis, Vania Sinovich, Rafique Essop, Shirley 
Middlemost, Thomas Wisenbaugh, Pinhas Sareli. 
Baragwanath Hospital, SOWETO, South Africa. 
Subclinical intravascular hemolysis occurs in the majority of 
patients with St Jude Medical (SJM) and Medtronic Hall (MH) 
prostheses and is known to be higher in the fonner. The purpose 
of this study was to detcnnine if the degree of hemolysis depends 
on valve position and valve size. Hemolysis was assessed in 129 
pts with SJM valves (mitral 86, aonic 43) and 65 patients with MH 
valves (mitral 35, aonic 30) with nonnal mechanical function on 
cinefluoroscopy and echo doppler. Other causes of anemia were 
excluded. The following table summarizes the results 
(* p<O.05 vs MH) 
MITRAL AORTIC 
Size 27mm 29mm 21-23mm 25-27mm 
SJM (no. of pts) 52 34 28 15 
LDH (units/L) 694 652* 624 670* 
Haptoglob (gIL) 0.4* 0.5* 0.6 0.4 
MH (no. ofpts) 19 16 14 16 
LDH (units/L) 594 546 527 470 
Haptoglob (gIL) 0.7 0.8 1.1 0.6 
CONCLUSIONS: Evidence of hemolysis was similar among the 
different valve sizes studied, is similar between aortic and mitral 
prostheses, but tends to be greater with SJM compared to MH 
valves. 
JACC Vol. 19, No.3 
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970·36 
A Model State Funding Program for Aduitl with Congenital 
Heart Dllease: COlt·Benefit Analysll of Job Training and 
Payback 
Arthur Garson. Jr.. Charles E. Begley. Baylor College of 
Medicine and University of Texas School of Public Health. 
Houston. Texas 
Adults with congenital heart disease (CHD) In many 
states have access to cardiology followup care only If they are 
Insured or disabled; state Chronically III and Disabled 
Children's (CIOC) funding ends at 21 yo. These pts may be III 
prepared for seeking and keeping appropriate jobs. and as 
such uninsured for medical care. A model program Is proposed 
In which job training and medical care are funded by CIOC; the 
cost Is provided by those who become employed. both from the 
state and local taxes they generate. and the remainder from a 
payback plan for their previous training and health care. 
Essentials of the program are: 1. All pts With a cardiology Ox 
covered by CIOC who are 18 yo without work are eligible; 2. 
Program provides job training for 1 yr at age 18 and again at 
21 for those who continue without a job with job placement 
assistance through age 27. 3. CHD related expenses are 
covered during the program and for previous enrollees through 
adulthood. without upper age limit. 4. Five year payback for 
Job training and medical care after employment. Cost benefit 
analysis Is based on one cohort followed for 15 years with 50% 
employed after 2 years and 80% after 10 years. Estimated 
costs (per pt. per yr): job training $1500. job placement $60. 
CHD related expenses $1087. Estimated benefits: sales + local 
tax " $625. payback $600. ApprOximately 1500 Texans per 
year with CHD become 18 years of age. with 35% (525) eligible 
for the program. Compared with the present program without 
Job training. the proposed program has a net cumulative 
benefit of $1. 71 million after 15 years. The greatest Intangible 
benefit Is that an adult who spent early life dependent on 
SOCiety. will be able In later life to give to that same society. 
970·37 
Congenital Heart Disease After Pediatrics: A Quantitative 
Hodel of the Challenge - Patients and Providers 
Milton H. Paul. M.D •• Merl L. Kardatzke. B.S •• Phil R. Gold•
berg, B.S. Willis J. Potts Children's Heart Center, The Chil•
dren's Memorial Hospital. Chicago, IL. 
This study examines quantitatively for several congenital 
heart malformations, and in particular transposition of the 
great arteries (atrial/arterial repair) and single ventricle 
(Fontan repair). the increasing number of adolescent and 
adult patients that represent natural and operative surviv•
al patterns. Such patients present for care at the Intersection 
of pediatric and adult cardiology providers. Reparative surgery 
and passage of time have generated "complicated" subgroups 
with special diagnostic and care needs. 
We have constructed multi-parameter models, based on 
patient access and survival statistiCS, which Indicate that from 
1970, even for a limited study group represented by simple 
transposition there will be by the year 2000 approximately 
10.000 surviving USA-born target-patients (16 years of age or 
older) for continuing care. Even extrapolating for the increas•
ing arterial repair rate, abnormal cardiac rhythm will be pres•
ent in approximately 4,500 and significant right ventriCUlar 
dysfunction In 1,500 patients. 
The provider side of the equation has been extrapolated from 
examination of board-certified adult cardiologist and cardio•
vascular surgeon populations. Consultation with representa•
tives suggests a present-day "PIEE" (Primary Interest, Experi•
ence and Expertise) factor of perhaps 0.05 for adult cardiolo•
gists (USA 1989; 12,000 x 0.05 = 600) and 0.02 for CV surgeons 
(USA 1988; 5,000 x 0.02 = 100), In comparison with board 
certified pediatric cardiologists (USA 1988; 884). 
Optimum care for these older patients requires organized 
"bridging" pediatric-adult cardiac medical delivery systems 
to share experiences and expertise In managing the late 
appearing problems for these relatively small and heterogene•
ous patient populations. 
ABSTRACfS 
970·38 
Congenital Heart Disease: Prevalence and Outcome, 1980·89 
Lowell W. Perry, Charlotte Ferencz, Catherine A. Neill, Joel!. Brenner, 
Gerard R. Martin, John Downing, Mohammed Mardini and the 
Baltimore-Washington Infant Study (BWlS). Georgetown University, 
Washington, DC and University of Maryland, Baltimore, Maryland 
Between 1980-89, 4390 cases of congenital heart disease (CHD) were 
registered by the BWIS, a case·controlled study of environmental risk 
factors in CHD in Maryland, the District of Columbia and 6 counties of 
Northern Virginia. All regional pediatric cardiology programs and 52/53 
area hospitals cooperated in the study. 
The prevalence of CHD increased from 3.7 to 5.311000 Jive births due 
to increased detection of ventricular septal defect (VSD); there was no 
change in prevalence of CHD without VSD. The percentage distribution 
of CHD was: ventricular septal defect (VSD) 32.1, pulmonary stenosis 
9.0, atrial septal defect 7.7, endocardial cushion defect 7.4, tetralogy 6.8, 
coarctation 4.6, d-transpoeition 4.3, hypoplastic left heart 3.8, aortic 
stenosis 2.9, patent ductus arteriosus in term infants 2.4, other CHD 
19.0. Of CHD, 98% were referred to pediatric cardiology centers. 
During the study CHD not diagnosed prior to death decreased from 3.5 
to 1.5%, diagnosed without echocardiography (E) decreased from 10.6 to 
.2%, diagnosed by E alone increased from 21 to 61 %, requiring 
catheterization during 1st year decreased from 70.6 to 29.1%. Of CHD, 
60% were diagnosed by 1 month, 90% by 6 months. The annual % of 
CHD requiring surgery during 1st year decreased from 40 to 28, but the 
total undergoing surgery (S) rose from 147 to 18O/year. S was required 
in 45% of severe CHD; S survival increased from 71 to 80%. 
Of total CHD, 19% did not survive 1st year. Of deaths, 54% occurred 
by 1 month and 85% by 6 months of age. Mortality varied inversely 
with age of diagnosis and S. 
Between 1980·89, prevalence of CHD not associated with VSD was 
stable; prevalence of VSD increased. Of CHD 90% were diagnosed and 
85% of mortality occurred by 6 months. The absolute number of cases 
of CHD undergoing S increased, but the % of cases requiring surgery 
decreased due to increased prevalence of small VSD. 
970·39 
The Etiology of Cardiovascular Malfonaations: A Ten•
Year Population-Based Study 
Charlotte Ferencz, Joel I. Brenner, Catherine A. Neill, 
lowell W. Perry, Gerard R. Martin, John W. Downing, 
Mohamed K. Mardini, Seymour 1. Hepner and the Ba It imore•
Washington Infant Study (BWIS) Group. University of 
Maryland School of Medicine, Baltimore, Maryland. 
From 1981 to 1989 the BWIS, an etiologic study of 
cardiovascular malformations (CVM) collected clinical 
and interview data on 3377 infants with confirmed (echo, 
cath, surgery, autopsy) CVM and on 3572 controls 
representative of the birth cohort. Associated non•
cardiac abnormalities (NeA) of genetic origin occurred 
in 24% vs 3.4% in controls: chromosomal (11.5% vs 0.1%) 
and heritable syndromes (7.0 vs 0.6%) and multifactorial 
organ anomalies (4.9% vs 1.0%) constituting 26% of the 
attributable risk. Nuclear family CVM (4% vs controls 
1.2%) was prominent in left-sided lesions and rare in 
conotruncal defects. Familial herUable disorders (2.3% 
vs 1.4%) suggest genetic predisposition to CVM with 
hematologic and mesenchymal abnormalities as variable 
expressions of cardiogenic genes. Environmental risks 
differed by diagnosis and developmental mechanisms. 
Multiple logistic regression analysis revealed possible 
associations of CVM with toxic exposures (solvents, 
lead, pesticides), diabetes, viral infections and some 
drug therapies with a total attributable risk of 11%. 
Genetic-environmental interaction was evident in the 
increased risk of anomalous pulmonary venous return with 
pesticide exposure in the presence of familial CVM/NCA. 
Future collaborative studies should explore genetic 
mechanisms leading to susceptibility to xenobiotic 
exposures. 
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971·40 
Normal Transvalvular Pressure Gradients of Aortic Prosthetic 
Valves: Doppler Echocardiographic Study at Rest and During 
Exercise. 
Angelika Costard-llckle. Anke Temmel. Wolfgang Neumann, Georg 
Kreymann. Winfried RHdiger, Peter Kalmar. Heiner Greten. Univer•
sity Hospital Hamburg, Germany. 
To evaluate the influence of prosthesis size and type of aortic valve 
prosthesis on transvalvular gradients. we studied 210 consecutive pts 
5tl months after aortic valve replacement. 2D- and Doppler echocar•
diography were obtained both at rest and during supine bicycle exer•
cise (up to 85 % of age-predicted maximal heart rate). Pts with pros•
thesis dysfunction or reduced LY-contractility were excluded from 
analysis. Technically good Doppler tracings could be obtained in 98% 
of resting and 94% of exercise (ex) studies. Pressure gradients were 
not different for same-size Hancock (n=76) and Carpentier Edwards 
(n=54) tissue valves (TV) and were therefore summarized. The fol•
lowing table sho ... ·s mean and peak gradients at rest (rest) and at peak 
ex for both TV aJ.,i mechanical valves (MY. Carbomedics, n=47) in 
relation to prosthesis size. (* p < 0.01 vs same-size TV). 
Size (mm) 21 21 23 23 25 25 27 27 
Type TV MY TV MY TV MY TV MY 
Mean rest 17±4 21±8 16±3 11±2* IS±4 10±3* 12±2 7±2* 
Peak rest 30±8 3St12 28±S 20±3* 2St7 18±S* 21±4 15±3* 
Meanex 29±6 35±6* 26±s Im* 23±7 19±3* 18±3 IS±3 
Peak ex 48±9 S8±14* 43±8 36±6* 41±1O 32±6* 32±s 26±s* 
Conclusjon$' Excellent Doppler tracings can be obtained in 94% of 
ex studies. Prosthesis size affects mean and peak transvalvular gradi•
ent for both TV and MY at rest and during ex. Large- and middle-size 
MY (23. 25. 27 mm) have significantly smaller gradients than same•
size TV. However, in small-size MY (21mm. n=IO), pressure gra•
dients are unproportionally higher and exceed gradients measured 
through same-size TV. 
971-41 
Non-Invaslvely Derived Right Ventrleular Basal Short·Axls 
Dimension Accurately Rellects RV Volume In Vivo. 
Stephen P.F. Gordon, Sarah E. Katz, and Pamela S. Douglas. 
Beth Israel Hospijal, Harvard-Thorndike Laboratory, Boston, MA. 
In vivo studies of RV function have been extremely limijed, 
particularly due to difficutties in detennining RV volume. To determine H 
a single echocardiographically derived RV dimension could be used to 
IICQJrately represent RV volume, we studied 19 adutt human subjects (S 
normals, 14 wtth heart disease) and 14 mongrel dogs (Weights: 17-30 
kg; 11 wffh experimental hypertrophy, 3 sham). Two-dimensional images 
were acquired of the basal RV short axis (SAX) and a SAX cavffy 
dimension measured from the septal endocardium to the RV free wall 
endocardium at the point of maximal RV cross-sectional diameter. RV 
volume was detennined by a previously validated method where 
planimetered basal RV cavffy area is integrated over the RV length as 
the cawy width decreases from base to apex in a parabolic manner. 
~ There was a strong linear relation between the basal RV cavijy 
dimension and volume In both dogs (r •. 91 ;P..OOOI ;SEE.S.9) and 
humans (r •. 85; P..0001; SEE.17.8) at end-diastole and end systole. 
(Figs 1 and 2). 
Fig 1 RV Vol va Dimension Fig 2. RV Vol vs Dimension 
Dogs • II '50 Humens 
:i 
A 100 
! 
II End-Oilli. ~ 10 
• EndoSyst. 
a.oo 0.60 1.00 1.10 2.00 2.50 
DIilENSION LENGTH (em) 
0.0 1.0 2.0 3.0 ".0 
DIMENSION LENGTH (em) 
CoDQbIS!pn' This non-Invaslvely derived dimension accurately reflects 
RV volume and should allow more widespread study of right ventricular 
size and function In vivo in both dogs and humans. 
971-42 
EcholDoppler Screening in High School Athletes 
lACC Vol. 19, No.3 
March I, 1992:356A 
Timothy Hart, Daniel Kraeger. Jeffrey Boyd, Craig Stevens, Richard Pustka, 
Timothy Nelson, Mark Harry, The Iowa Heart Center and Lutheran Hospital 
Des Moines, Iowa. 
According to reports, college athletes appear to have a low incidence of 
structural heart abnonnalities found during echo screening studies. Similar 
systematic studies of high school athletes have not been reponed and were 
Wldenaken in this study. 
Echocardiographic and color flow Doppler screening of S 13 male high 
school candidates prior 10 fal! sports provided the following results: 
Pulmonic regurgitation 
Tricuspid regurgitation 
Mitral regurgitation 
Aortic regurgitation 
Mitral valve prolapse 
Bicuspid aortic valve 
Atrial septal defect (ASO) 
Coronary 10 pulmonary 
anery fistula 
360 
197 
141 
26 
4 
2 
2 
70% 
38% 
27% 
S% 
1% 
0.4% 
0.4% 
0.1% 
Overall, ten participants (2.0%) required funherevaluation or follOW-Up. 
Two (0.4%) required cardiac catheterization 10 funher deliniate the extent of 
their cardiac abnonnality. One participant was found 10 have a large ASO 
without pulmonary hypertension and required surgical repair. One study 
showed a coronary to main pulmonary artery fistula which was confinned at 
selective coronary arteriography. No candidate was foWld to have an aortic 
root abnonnality or cardiomyopathy. We found "physiologic" valvular 
regurgitation to be a common color Doppler finding. 
Conclusjon' The use of echocardiography with color flow Doppler as a 
screening tool for high school athletes can uncover significant cardiac 
abnonnalities in a small percentage of exams. Color flow Doppler proved 10 
be a rapid and accurate modality which enhanced the screening process. 
971-66 
500 Consecutive Echo-directed Periclrdiocenteses 
James B. Seward, John A. Callahan, Lawrence J. Sinak, 
John R. Daley, Luanne Schmidt, A. Jamil Tajik. 
Mayo Clinic, Rochester, Minnesota. 
Cognizant of the risks of blind pericardiocentesis, 
echo-directed pericardiocentesis (EP) was introduced as a 
preferred procedure at the Mayo Clinic in 1980. The 
results of 500 consecutive clinical EP, performed by 
multiple echocardiographic physicians, are presented. Of 
the 500 EP, 78 (16%) were repeat procedures. This series 
included 284 male, 216 female; age range <1 to 91 yr, 
mean 52 yr. On the basis of pre-EP examination, the 
selected entry site for EP was other than subcostal in 
76% of pts. An anterior precordial site was selected in 
64% of pts. Etiology: Malignant 179 (36%), post•
surgical 113 (23%), idiopathic (15%), ischemic comp1i· 
cation (5%), cardiac catheterization complication (5%), 
infected (4%), and misc (12%). Indication: Therapeutic 
344 (69%), diagnostic 86 (17%), or both 70 (14%). 
Complications: Serious 8 (2%), [death 0 pt, pneumothorax 
2 pt. arrhythmia 6 pt]; minor: 24 pt, (5%) [e.g., 
transient entry into cardiac chamber IS, vasovagal 
syncope 1 pt]. Pericardia1 catheter (PC) drainage was 
part of the EP in 186 procedures (38%). PC was in place 
from 1 to 18 days with 90% removed within 5 days. PC 
complications: (seriOUS: 1 pt bleeding) (minor: 9 pt, 
e.g., catheter occlusion). Subsequent pericardial 
surgery in 81 pt (pericardiectomy 55, limited pericardial 
surgery 26 pt). Tetracycline sclerosis in 26 pt for 
malignant effusions. Conclusions: EP complications are 
rare (no deaths), PC drainage is safe, and subsequent 
surgical exploration is necessary in only a small per•
centage of pts. EP is a preferred initial means of 
safely managing a clinically indicated 
pericardiocentesis. 
JACC Vol. 19, No.3 
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971·67 
tw1RGI!MI!Nl' ~ MM.IGNANl' PBRICARDIAL EP'P'tlSICH3: 'mE R][B 
OF 2-D PCD-D1k1Cl'!D CI!N1'J!'SIS AND CATIIE'l'BR I1IAIN1!GE 
John R. Otiey, Janes B. seward, Luanne Sclmidt, Larry J. 
Sinak, John A. callahan, A. Jamil Tajik. M:lyo Clinic, 
Rochester, Minnesota 
Optimal nanagaIe11t of malignant pericardial effusions 
(MPE) retains controversial. Oltcane based on reported 
small series oakes conclusions difficult. At the M:lyo 
Clinic, MPE are initially nanaged with 2-D echo~rected 
pericardiocentesis with/without indwelling catheter 
drainage, with subsequent therapy pursued electively. 
Between April 1980 and M:lrch 1991, 145 pts underwent 179 
centeses for MPE and o::mplete survival data are 
available in 140 pts (75 fatale, 65 male; uean age 54 
yrs, range 15-82). Malignancy: Lung 36%, breast 29%, 
hematological 19%, and other 16%. In 95 centeses with 
positive fluid cytology (C), the uean survival to date 
(Sur) was 175 days, and in 63 centeses with C-, sur was 
631 days. sur for centesis without catheter drainage 
(33 pts) for 09 was 127 days and C- 593 days. sur for 
centesis with catheter drainage (34 pts) for CI& 154 days 
and C- 449 days. sur for surgical Clecarpression (31 
pts) for OIl 159 days and C- 950 days. sur for sclerosis 
(29 procedures) for ce 231 days and C- 64 days. '!be 
overall sur for MPE was 345 days, substantially greater 
than previously reported. Recurrent effusions requiring 
intervention: 5/34 pts (15%) after catheter centesis/ 
drainage; 5/31 (16%) after surgery; 3/29 (10%) after 
sclerosis. 
COnclusions: (1) 2-D echo centesis with/without 
catheter drainage is associated with longer than the 
reported survival with other therapy, (2) 2-D echo 
centesis with/without catheter drainage is as effective 
as nore invasive surgery/sclerosis in the nanagaIe11t of 
MPE, and (3) negative fluid cytology is associated with 
increased survival. 
971·68 
Noninvasive Evaluation of Left Ventricular Relaxation 
Based on Aortic Regurgitant Flow Velocity Measured With 
Continuoua-wave Doppler Echocardiography 
Shiro Nozaki, Hirohide Matsuo, Hisaki Morita, Katsufumi 
Mizushige, Koji Ohrnori, Yoshihiro Wada. 
Kagawa Medical School, Kagawa, Japan 
A new Doppler-derived index of the changing rate of left 
ventricular (LV) pressure fall (IRT &/ll.t) was applied 
to evaluate LV relaxation in pts with chronic aortic 
regurgitation (AR). It has been reported that AR flow 
velocity curve measured with continuous-wave Doppler 
(CWD) allows accurately aorto-ventricular pressure 
difference during the isovolumic relaxation time (IRT). 
Assuming that aortic pressure change is minor compared 
to the fall in LV pressure (LVP) during IRT, the initial 
up slope of AR flow velocity should be comparable to the 
LVP decay. IRTll.PI ll.t was calculated by dividing 
magnitude of the LVP decay (ll.P= 32 mmHg ) corresponding 
to the increase in AR flow velocity from 1 to 3 m/s by 
the time taken (ll.t) during this change. We measured IRT 
/:).P I ll. t and other echocardiographic indexes of LV 
function [LV end-diastolic and end-systolic dimension 
(LVEDd, LVESd), fractional shortening (FS) 1 in 40 pts 
with chronic AR not accompanying Significant coronary 
artery and/or myocardial diseases. RESULTS: IRT ll.PI ll. t 
was significantly lower in pts with dilated LV 
(LVEDd>6Smm, LVESd>SSmm) and poor pump function 
(FS<30%).CONCLUSION: AR flow velocity measurement by CWO 
is feasible and promising for the assessment of LV 
relaxation in pts with AR. 
ABSTRACTS 357A 
971·69 
A MATHEMATICAL MODEL FOR TIlE CUANTlTATlOO OF MITRAL RE•
GURGITATION: EXPERIMENTAL VALlDATlOO IN TIlE CANINE MODEL 
USING COOTRAST ECHOCARDIOGRAPHY. John M. Dent, Ananda R. 
Jayaweera, William P. Glasheen, Stanton P. NOlan, William 
D. Spotnitz, Flordeliza S. Villanueva, Sanjiv Kau!. 
university of Virginia, Charlottesville, Virqinia 
CUrrently, there is no clinically applicable technique 
that can be used to quantitate of mitral requrqitation 
(MRl. Since, the clearance of contrast from the LA rela•
tive to the LV depends on the severity of MR, we develo~ 
ed a mathematical model that calculates requrgitant frac•
tion (RF) from the relative clearance of contrast from 
the two chambers. To test this model, we performed ex•
periments in 2 groups of dogs usinq contrast echo. Group 
I consisted of 9 dogs in Whom different deqrees of MR 
were produced by creating ischemic LV dysfunction. Con•
trast was injected into the LV and MR was visually qraded 
as 0 to 4+. Videointensity plots qenerated from the LA 
and LV were provided to the model. 'nlere was excellent 
correlation between visual assessment of MR and model•
derived RF in the ~8 stages in this group of dogs: 
(y-0.20x + 0.03, r -0.94, p<0.001, SEE -0.08). To obtain 
a more quantitative validation, we placed electromaqnetic 
flow probes on the aorta and just behind the mi tral annu•
lus in 6 dogs (Group II). Different degrees of MR were 
produced by chordal traction and myocardial ischemia. Rl' 
was calculated at each staqe from the flow data and the 
model calculated RF from videointensity curves obtained 
from the LV and LA. 'nlere was excellent correlation be•
tween flow probe and model-derived Rl': (y -0.87x + 0.05, 
r -0.93, p<O.OOl, SEE -0.09). 'nlere was close inter- and 
intra- observer correlation for the flow probe (r -0.99 
and r -0.99) and nodel-derived Rl' (r -0.97 and r -0.99). 
We conclude that a mathematical model that utlizel the 
clearance of contrast from the LA relative to the LV can 
be used to accurately measure the severity of MR. 'nlele 
findinqs may have practical clinical implications. 
971·70 
Noninvasive Quantification of Regurgitation by Conservation of 
Momentum: Can It Be Applied at Rapid Heart Rates? 
Armelle Cagniot. Edward G. Cape, Ajit P. Yoganathan. Rohert A. 
Levine, Massachusetts General Hospita1. Boston, MA and Georgia 
Institute of Technology. Atlanta. GA 
A technique has recently been proposed for noninvasive 
quantification of regurgitant flows based on conservation of 
momentum within free turbulent jets. The basic principle that 
allows this calculation is that. as the jet expands and entrains more 
mass. its centerline velocity (CLVEL) decays inversely with 
distance from the orifice because momentum is conserved. In 
pulsatile flow at a slow HR. however. it has been shown that this 
inverse relation is only fully established by the time of peak flow 
rate because of the finite interval required for jet penetration into 
the receiving chamber. It is conceivable, therefore, that at a rapid 
HR. this inverse relation is never fully established. The purpose of 
this study was to determine Wliether the inverse relation of peak 
CL VEL to distance holds over a WIde ran e of HRs. so that 
uantllallve tec nJ ues ase on t at eca wou e a Icable. 
ySIO oglc pu sail e ow was pumpe t roug ctrcu ar on Ices (4-
6 mm) at 60-150 heats/min: at each HR. peak VEL was varied 
from 2-5 m/s. CLVELS were recorded by laser and echo Doppler. 
averaged over multiple beats and compared to steady flow values. 
RESULTS: Peak CL VELS in the fully developed turbulent jet 
decayed inversely with distance at all HRs studied. The 
proportionality constant of the decay curve. required for 
calculating flow rate (from orifice VEL. a downstream VEL and 
the intervening distance). was not significantly different compared 
to the steady flow value of 6.3 by laser Doppler (6.4 + .5. p> .2) 
or echo Doppler (6.4 + .3. p>.I). CONCLUSION:Over a 
wide PhYSiOlo~c rangeof HRs. full jet development occurs with 
suffiCIent spee so that the expected CLVEL decar curve is established at peak flow rate. The conservation 0 momentum 
tfiChldguh for calculatmg onfice flow rate based on these tLVEL~ 
s ou t erefore he aiffllicable. with averaging of multiple beats to 
account for turbulent uctuatlOns. 
358A ABSTRACTS 
971·71 
Influence of OrIfIce Shape on Color Doppler Flow Convergence: An In•
VHro Study 
Takahlro Shlota, Valdlr Moises, David J. Sahn, Robin Shandas, Jun Zhang, 
Robert Weintraub. Unlv of CalW, San Diego, CA 
The regurgitant orifices r:A diseased heart valves are often non-clrcular. The 
purpose 01 this study was to explore the Influence 01 orffice shape on the 
patterns of the lsovelocity surfaces used to calculate flow convergence (FC) 
regurgitant flows. We studied a constant flow model with three different 
shaped orffices oItha same effective orifice area (16 mm'): circular (C), ovoid 
with a ratiO 01 major to minor axis 2:1 (0), and rectangular with the ratio 4:1 
(R). We varied flow rate from 2.7 to 5.6 IImln with maximal jet velocttles 2.9 
to 6.6 m/sec. Color Doppler Images were obtained with a Toshiba SSH65A 
for Nyquist IImtts (NL) r:A 54, 41, 27, and 14 em/sec to measure 3 different 
radII (a = aliasing distance In a direction parallel to Interrogation, b = transverse 
radius In the plane 01 and parallel to the major orifice axis, c=transverse 
radius parallel to the minor axis) and calculated b/c(%) and c/a(%). FC flow 
volumes were calculated wtth a hemlspherlcallsovelocity FC assumption (HS) 
using only 'a' and a heml-elliptlcal model (HE) using 'a', 'b', and 'c'. 
Variations wtth NL averaged over all volumes and variations with volume 
averaged over all NL are shown in table (1) and (2), respectively. 
e m or, ,a u erestmat t eactua owv ume yas 
much as 41 %, 44%, and 48%, raspectlvely, whereas all the calculated flow 
volumes using HE correlated well with the actual flow volume (r = 0.94, 0.92, 
0.95, respectively, p<O.OOI) with percent differences between calculated and 
actual flow 8%, 6%, and 4% for C, 0, and R, respectively. Especially for the 
most asymmetrical orifices and for low flow volumes and high NLs, the actual 
geometry of FC flow streaming should be determined and a HE method used 
for an accurate estimation 01 regurgitant flows by FC methods. 
971·72 
Characterization of Energy and Mass Transfer in Jets: Revelations of 
Radial Events: Sludies by In-Vitro Flow Visualization Techniques and 
New Color Doppler Ultrasound Methods With Enhanced Low Velocity 
Sensitivity 
Dorian Lleprnann, Moneza Gharib, David J. Sahn, Robin Shandas. Univ of 
CaIW, San Diego, CA. 
In order to study vortic~y and other mechanisms by which jets dissipate 
energy into the surrounding medium, we used laser induced fluorescence 
(LlF) and ultrasound methods optimized for defining low velocity flow to 
image pulsatile jets, both longttudinal and transverse to their direction of 
motion. The LlF technique of dye visualization allows characterization of 
the scalar mixing rates and concentration distributions. Pulsatile jets with 
Reynolds numbers 5,000 to 50.000 were also studied by laser illuminated 
computerized traCking 01 LCD particles labelled thermally to illuminate 
entrainment and provided actual veloctty vector measurements. The 
thermally labelled particles could be tracked as separate streams. As the 
jet penetrates the surrounding medium, UF images demonstrated instan· 
taneously developing Instabilities in flow which entrain additional mass. 
Growth of these instabil~ies, redistributes vortic~y and produces swirling as 
the jet becomes fully turbulent. On transverse images perpendicular to the 
direction of jet motion, wtthin 2-4 diameters from their origin, we could 
show that jets developed radial instabilities which entrained fluid from the 
outside into the jet in a spiral fashion. Having defined • 
these flow phenomena, we next set up a new high frame' '; 
rate parallel processing color Doppler system (Hitachi . ~.:" .. ") 
EUB·165) to enhance low velocity events by running it at .. ~I 
very low PRF's but high frame rates. With this new}' .' 
instrument, we could image Iree vortex swirling and radial , 
vorticity previously not demonstrable with routine color . 
Doppler methods. Our work provides comprehensive descriptions of jet 
behavior in terms of mass and energy transfer In addition. our studies 
yield visualization 01 previously undescribed radial events and provide new 
methods lor color Doppler flow studies of low velocity events. 
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Advantages of High Frame Rate Color Doppler Scanning for 
Displaying Color Jet Areas: In Vitro and Clinical Studies 
Shiro Yamachika, Toshinori Utsunomiya, G.Wayne Moore, 
Christopher M.Meckel, Devang Savani, Julius M.Gardin. 
University of California, Irvine,CA 
Color Doppler flow mapping is performed clinically at relatively 
low frame rates (FR: 6·22 frames/sec). However,since scanning 
is not truly real-time, oolor jet area (JA) recorded at low FR 
may be inaccurate due to undersampling. We evaluated the 
effect of FR on in ritm and clinical JA using a Hitachi (EUB· 
165) with simultaneous parallel-processing and high FR 
capabilities. ~: Color Doppler scanning of free jets was 
performed in forward (F)--followingjet--and reverse(R )--against 
jet--directions. JA was calculated in Yi1m 200ms after 0.5-3cc 
injections. Maximum JA was also calculated in 8 valvular 
regurgitation pts. ~: Table shows JA at jet angle 15°, 
In vitroOc;c) 
JA in F scan (cm2) 
JA in R scan (cm2) 
Qi.niW 
Frame rate (frames/sec;) 
~ ~ ~ BQ 
3.93" 2.83" 2.40 2.05 
1.85 2.40 2.60 2.15 
JA in F scan (cm2) 7.43" 6.71" 5,97 5.77 
JA in R scan (cm2) 4,62" 5.52 5.77 5,80 
"p<O.OI vs at 80 frames/sec 
Condusion: 1) At lower FR, recorded JA overestimates true JA 
in forward direction (overlap time between ultrasound beam 
and jet is longer). 2) At higher FR, measurements of JA in both 
scanning directions are more reproducible, High frame rate 
color Doppler improves quantitation of jet areas. 
971·74 
Exercise Doppler Echocardiography in Patients With Mitral Pros· 
thetic Valves: Influence of Prosthesis Size and Type on Transval· 
volar Gradients 
Angelika Costard-Jlickle, Anke Temmel, Wiebke Bruhn, Georg Krey•
mann, Winfried RtXliger, Peter Kalmar, Heiner Greten. University 
Hospital Hamburg, Germany. 
To evaluate the influence of mitral valve prosthesis size and type on 
transvalvuJar gradients, we studied 70 consecutive pts 5 ± 1 months 
after mitral valve replacemcnt. 20- and Doppler echo were obtained 
both at rest and during submaximal supine bicycle exercise (ex). Tech•
nically good Doppler tracings were obtained in 99% of ex studies. 
Submaxirnal cx (60% of age predicted hean rate) were achieved in 56 
pts (80%). The following table shows mean and peak gradients at rest 
(rest) and at peak ex for both tissue valves (TV, Carpentier Edwards, 
Hancock) and mechanical valves (MV, CaIbomcdics) in relation to 
prosthesis size. (* < 0.01 vs TV 23-27mm; § <: 0.02 vs TV 31-33mm). 
Type TV MV TV MV TV MV 
Size (mm) 23-27 23-27 29 29 31-33 31-33 
Mean rest 
Peak rest 
Mean ex 
Peak ex 
6±2 7±2 
IH3 15±5 
15±5 12±3 
26±7 23±6 
7±4 HI 
l5±7 8±2 
lH5 9±4 
2H7 19±4 
4± 1 7±2 
W±3 13±4 
9±3* 14±5§ 
19±4* 2H6 
Conclusions: 1. At rest, prosthesis size does not affect mean or peak 
transvalvuJar gradient for either TV or MV. 2. During/after submaxi•
mal bicycle ex, small-size TV (23-27mm) have significantly higher 
gradients than large-size TV (31-33mm). 3. Ex gradients ofMV, how•
ever, are not significantly influenced by prosthesis size. 4. Compari•
son of gradients of same-size TV vs MV reveals no difference at rest. 
During ex, mean gradients of large-size (31-33mm) TV are smaller 
than same-size MY. 
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972·61 
Color Flow Doppler in the Diagnosis and Non-8urgical Management 
of Femoral Artery Pseudoaneurysms Complicating Coronary 
Angioplasty. 
Luiz Pinheiro, Subodh K. Agrawal, Suresh Jain, Adam D. Cannon, 
Peter J. Macander, Jennifer Barnes, Gary S. Roubin, Navin C. 
Nanda. University of Alabama at Birmingham, AL. 
We examined color flow Doppler (CD) characteristics of femoral 
artery pseudoaneurysms (PSA) developing after percutaneous 
transluminal coronary angioplasty over the past 1.5 years. Out of 1338 
pts, 118 pts were refered for CD evaluation of clinically suspected PSA. 
Nineteen PSA were found in 16 pts (mean age= 66.0±10.0 yrs). An 
were followed by serial CD for up to 6 weeks. One pt with PSA did not 
return for follow up. Surgery was performed in 6/1S (33%, group A) 
while non· surgical management was successful in PSA closure in 
12118 (66o/cl. In 6/18 (33%, group B) spontaneous closure occurred 
between 5 and 7 days with bed rest and low therapeutic levels of 
anticoagulation. In the remaining 6/1S pts (33%, group C) CD guided 
external compression of PSA was performed for periods of 20 to 30 
min. (total compression time= 20 to 120 min) and closure was 
achieved in 5/6 within 24 hrs. One pt with no PSA communicating 
tract required the longest total compression time (120 min.). CD 
characteristics of PSA in the 3 groups were compared. Results are as 
follows: 
PSA size Tract width Tract length Thrombus 
Group A 4.34±1.32 em .27±.06 cm 1.95±1.55 cm 66% 
Group B 4.28±2.12 cm .22±.09 cm .SS±.35 cm 100% 
Group C 3AO:!: 1.37 cm .28±.04 cm 1.4±.95 cm 50% 
p values = NS NS NS NS 
Conclusion: Since CD characteristics of PSA were not significantly 
different in the 3 groups, CD guided external compression should be 
attempted in all pts with PSA before considering surgical repair. 
Although spontaneous PSA closure occurs in some pts, CD guided PSA 
compression, even in these pts, will be expected to shorten the 
hospitalization time and reduce the possibility of complications such 
as increase in PSA size and rupture. 
972·62 
Dobutamine Echocardiography in Coronary Artery Disease: 
Comparison with Coronary Angiography and Exercise 
Electrocardiography 
Barbara Reisenhofer, Elena Moscarelli, Mino Zanchi, Eugenio Picano. 
Alessandro DiSlallte 
Institute of Clinical Physiology, CNR, and Institute of Patologia Medica. 
University of Pisa, Pisa, haly 
Aim of the study was to assess the feasibility and accuracy of dobutamine 
echocardiography test (DOBET) for the evaluation of presence and severity of 
angiographically assessed coronary artery disease (CAD, <:50% lumen reduction 
of at least one major coronary vessel). Sixty four patients (pts) with acceplable 
acoustic window underwent DOBET, while off beta-blockers therapy, starting 
with an infusion rate of 5 mcg/kg/min and increasing infusion rate by 5 
mcg/kg/min every 3 minutes up to 40 mCg/kg/min. Interprelable echo images 
could be obtained during DOBET in all pts; however, in 6 pIS the maximal 
dobutamine dose was not reached for limiting side effects (repetitive and/or 
polymorphous ventricular ectopic beats in 4, frequent atrial ectopic beats in 1, 
paroxysmal supravenrricular tachycardia in 1). Thus, overall feasibility was 
91 %. Of the 58 DOBETs completed up to echo positivity and/or maximal dose, 
47 were positive (new or worsening wall motion asynergy) and 11 were 
negative. All patients underwent coronary angiography independently of test 
results: 8 had no significant CAD, 21 had 1-, 19 had 2- and 10 had 3-vessel 
disease. DOBET showed a sensitivity of 86% and a specificity of 62%. Pts with 
multi vessel disease reached a lower dobutamine dose in comparison with pts 
with 0- and I-vessel disease (25.8±7.5, mean±SD, vs 30.2±8.7; p< .05). Fifty 
three patients performed a bicycle exercise electrocardiography test, which 
resulted positive (ST segment depression <! .lmV from baseline) in 33 and 
negative in 20 pts. PIs with low dose ($20 mcg/kg) DOBET positivity had a 
shorter exercise duration than pts with high dose (25-40 mcg/kg) DOBET 
positivity (S.7±2.4 minutes vs 8±2.S; p< .05). 
Therefore. DOBET has a high feasibility, an excellent sensitivity with a limited 
specificity for detecting CAD. The dose of dobutamine necessary to induce 
ischemia is lower in pts with more extensive CAD and/or lower exercise 
tolerance. 
ABSTRACTS 
972·63 
IMPROVED REGIONAL WALL MOnON AFTER CORONARY 
ANGIOPLASTY: DEMONSTRATED BY DOBUTAMINE STRESS 
ECHOCARDIOGRAPHY. 
Kwame Akosah, Tom Porter, Ramona Simon, John Funai, Carolyn 
Burns, Pramod Mohanty, Med. Coli. of Virginia, VAMC, Richmond, 
VA. 
Oobutamine stress echocardiography (OSE) has been shown to be 
capable of detecting Significant coronary artery disease (CAD). The 
extent to which improvement in stress Induced regional wall motion 
abnormalities (RWMA) following percutaneous coronary angioplasty 
(PTCA) can be detected by OSE has not been studied. We 
hypothesized that OSE can detect improvement in RWMA after 
successful PTCA. Accordingly, we evaluated 15 patients with normal 
resting left ventricular (LV) wall motion undergoing elective PTCA. 
Oobutamine (peak dosage: 20-40 meg/kg/min IV) stress 
echocardiography was performed to study LV regional wall motion 
within 24 hours pre-PTCA'sricfZ4-48 hours post PTCA. Regional (16 
segment model) wall motion was scored (1 =normal, 2=hypo, 
3=akinesis, 4=dyskinesis) in the standard manner. RWMA were 
scored by blinded reviewers pre and post PTCA and compared 
(score of 16=normal; abnormal= 17-64). Of the 15 patients studied, 
PTCA was successful in 11. In this successful PTCA group, peak 
dobutamine Induced wall motion score Improved from 21 ±4 to 17±3 
(p< 0.01 ) after PTCA without change In resting score or rate 
pressure product 19637±6853 (pre-PTCA) to 21013±5615 (post•
PTCA); p= NS. 
These results demonstrate that OSE is a potentially useful technique 
to detect improvement in regional wall motion and that the 
improvement is detectable as early as 48 hours post PTCA. Thus, 
OSE may be a valuable diagnostic test in assessing outcome of 
coronary reperfusion following PTCA. 
972·64 
Comparison of Exercise Stress Test, DipyrIdamole anel Dobutamlne Stress 
~bOOlrdiograpby for the Detection of Multivessel Disease After Myocardial 
Infarction 
Alessandro Boccanelli, Daniele Pontillo, Cesare Greco, Egidio Zancbi, Gian 
Piero Carboni, Corrado Ceccbetti, Anna Lisa Risa. Divisione di CardioIogia 
A. Ospedale S.Camillo, Rome,Italy. 
The purpose of the current study was to compare exercise stress test (EX), 
dipyridamole (DI) and dobutamine (DO) stress ecbocardiograpby for tbe 
detection of multivessel disease (MVD) in 56 pre-discbarge patients(pts) after 
acute myocardial infarction(AMI). EX,DI and DO were performed during the 
third week after AMI in a random order and coronary angiograpby was 
obtained within the following week. EX was performed according to the Bruce 
protocol; 0.56 mg/Kg of DI were injected in 4 minutes, followed, if the test 
was still negative, by a second dose of 0.28 mg/Kg in 2 minutes. DO was 
infused in incremental doses of 5 meg/Kg/min in 5 min stages to a peak dose 
of 30 meg/Kg/min or until an end-point was reacbed. DI and DO were 
considered positive if new 2D-ecbo wall motion abnormalities appeared at a 
distance from the infarcted or adjacent segments. Significant coronary artery 
disease was defmed as a lesion ),70%. According to this, 15/56 pts bad MVD. 
EX was positive in 5/15 pts (33%) and negative in 10/15 (67%). False positive 
pts were 14/41 (34%). DI was positive in 10/15 pts (67%) and negative in 
5/15 (33%). 1/41 pts (2%) was false positive. DO was positive in 13/15 pts 
(87%) and negative in 2/15 (13%). False positive pis were 4/41 (10%). 
Sensitivity Specificity Accuracy 
EX [33% ••• [66%J [57%]. 
DI • 67% 98%" • 89% 
DO 87% 90% 89% 
• p<.01;·· p<.OO5; ••• p<.OO1 
DO bad a significantly bigber sensitivity in detecting MVD as compared to 
EX.Specificity and accuracy of DI and DO were significantly higher than tbose 
of EX. Our data confirm the low diagnostic value of EX in detecting MVD 
after AMI and that DI and DO provide a safe, effective means for tbe 
diagnosis ofMVD. 
359A 
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972·65 
Implications of a Hypotensive Response During 
Dobutamine Stress Echocardiography 
Pamela A. Marcovitz, David S. Bach, Maria Markarian, Wilson S. 
Mathias, William F. Annstrong. University of Michigan, Ann Arbor, 
Michigan. 
Dobutamine stress echocardiography (DSE) accurately detects patients 
with coronary artery disease (CAD). Most patients have an increase 
in heart rate, systolic blood pressure (SBP) and contractility in 
response to the graded infusion (5,10,20, 30ug/kglmin, 3 min 
stages). The purpose of this study was to define the prevalence, 
magnitude and implications of hypotension (~2Omm falI in SBP) 
during DSE. Hypotension was classified as precipitous (PHT) or 
gradual (GHT) depending on whether it occurred over one stage or ~ 
2 stages of infusion. Hypotension was seen in 115/567 (20.3%) 
patients, was PHT in 42 (36.5%) and GHT in 73 (72.5%). The falI in 
SBP was 37±13mmHg for the whole group (range 20-90); 43±14 for 
PHT and 34±12 for GHT. LYH was present in 31 patients (26.9%), 
including 11 (26%) with PHT and 20 (27%) with GHT. EF at 
baseline, peak SBP and hypotension was 51%, 60% and 64% for 
patients with PHT and 48%, 56% and 54% for GHT. In 30n3 
(41%) patients with GHT, EF felI ~5% at the time of hypotension 
while only 5/42 (12%) in the PHT group had a declining EF 
(p ... OO2). Coronary arteriography was performed in 41 patients. (25 
with GHT and 16 with PHT). In the GHT group, 40% had single 
vessel disease (SVD) and 60% had muItivessel disease (MVD), 
including 6 with 3 vessel disease. In the PHT group, 70% had SVD 
and none had 3 vessel disease. Resting and/or inducible wall motion 
abnormalities were seen in 83/115 patients (72%), including 55n3 
(75%) with GHT and 28/42 (67%) with PHT. We conclude that 
hypotension during DSE is not uncommon, may be associated with 
increased or decreased ejection fraction, and MVD is more common 
when GHT is seen. Severe left ventricular dysfunction is not 
frequently present at rest or during infusion. Non-ischemic 
mechanisms may underly hypotensive responses in some patients. 
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973·59 
LeH Ventricular Size and Function In Man Before and 
AHer Myocardial Infarction: Effect of Patency of the 
Infarct-Related Artery 
Eli R. Farhi and Robert R. Vannozzi, Jr., State University of 
New York at Buffalo, Buffalo, NY 
Previous studies of the effects of myocardial infarction on 
left ventricular size and function have not included ventricular 
measurements from the pre-infarction period. These studies 
have thus been unable to determine the effects of acute 
myocardial infarction or to assess the amount of ventricular 
remodeling that occurs that occurs during (as opposed to 
early or late after) an acute infarct. We therefore identified 50 
patients who had ventriculography performed before 
(620.±.94 days; mean.±.SEM) and after (13.±.3 days) myocar•
dial infarction. After infarction, end systolic vOlure index 
(ESVI) rose significantly (from 31.±.2 to 43.±.3 ml/m , p < .05), 
as did end ~iastolic volume index (EDVI) (from 70.±.3 to 
79.±.3 ml/m , p<.05); stro~e volume index did not change 
(from 39.±.1 to 37.±.2 ml/m , p = NS). Ejection fraction (EF) 
fell (from .56.±..02 to .47.±..02, p<.001) and LVEDP rose 
(from 19.±.1.1 to 23.±.1.1 mm Hg, p<.01). 
Patency (P) of the infarct-related artery was associated 
with preservation of EF (which fell by .04.±..01 (P) vs .10.±..01 
(non-P), P<.Oi), ESVI (which increased by 7.±.3 (P) vs 17.±.3 
(non-P) ml/m , p<.02S), and EDVI (which increased by 6.±.3 
(P) vs 13.±.3 (non·P) ml/m2, p<.025). Conversely, the 
presence of Q vs non-Q wave infarction, the location of the 
infarction, the presence of collaterals, and the peak CPK or 
CPK MB fraction were not correlated with ejection fraction or 
ventricular volumes. Acutely, then, patency of the infarct•
related artery appears to bea major determinant of ventricu•
lar remodeling and of preservation of systolic function. 
973·60 
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Thrombolytic Therapy and Immediate Catheterization ror Triage to 
Rescue Angioplasty: Is Improved Inrarct Zone Wall Motion After Rescue 
PTCA Sustained at Six Weeks? 
Joseph M. Sutton, Roben M. Califf, Lynn Woodlief, Nancy A. Higby, Sharon 
L. Kamash, Markus Schwaiger and Eric J. Topol 
The Cleveland Ginic Foundation, Geveland, Ohio 
In the prospective, multicenter TAMI-5 trial, 288 acute MI pts randomly 
received one of 3 iv thrombolytic regimens: tP A, urokinase (UK) or combined 
therapy (Comb), followed by either acute (<90 min) cath for triage to rescue 
PTCA for thrombolytic failure (n=136), or deferred (7-10 day) cath (n=152), 
and underwent rest and exercise gated blood pool analysis (MUGA) 6 weeks 
after therapy. 1be acute cath ± rescue PTCA cohort had early improved infarct 
zone (IZ) wall motion by contrast ventriculography (-2.1 v. -2.5 SO/chord for 
deferred cath; p=O.OO4). There was a lower reocclusion rate reponed for Comb 
(2% v. 12% for tPA and 7% for UK; p=O.04), and fewer recurrent ischemic 
events were noted with this regimen. Global rest and exercise LV ejection 
fraction at 6-week MUGA, however, was similar across all treaunent strategies, 
and semiquantitative analysis of IZ wall motion among 219 interpretable 
studies revealed worse IZ function among pts undergoing rescue PTCA (n=22; 
score 3.0±0.9), compared with delayed cath (n=110; score=-2.1±1.0) or acute 
cath without rescue PTCA (n=87; score=2.1±O.9); p=O.OOI: 
6-WHk S .... IIUQA ",oults 
Reg_lIZ W." MoIlon -' 6-W_ 
aAnllVEF C Ex ... LYEf Interventlorllli Strategy 
Despite initial early benefits of acute cath and triage for rescue PTCA with 
respect to improved IZ wall motion by contrast ventriculogram, 6-week 
followup MUGA analysis reveals no difference in global LV systolic function, 
and significantly worse regional IZ function when rescue PTCA was necessary 
for failed thrombolysis. Although there was some preservation of IZ wall 
motion in the rescue PTCA group, residual hypokinesis at 6 weeks was less 
when thrombolytic therapy was successful; this discrepancy may be a result of 
ongoing myocardial necrosis during the time lag to recanalization inherent to 
failed or delayed thrombolysis. 
973·91 
Benefits of Late Reperfusion on Left Ventricular 
Function and Survival 
Masaharu Ishihara. Hikaru Sato. Hironobu Tateishi. 
Takuji Kawagoe. Yuji Muraoka, Mitsuisa Yoshimura. 
Hiroshima City Hospital, Hiroshima, Japan 
To assess whether late reperfusion (6·24 hours after 
symptom onset) is beneficial as a treatment of acute 
myocardial infarction (AMI). 189 patients with 
anterior AMI were studied. Cardiac catheterization was 
performed within 24 hours after symptom onset. All' 
patients had a total occlusion oi the left anterior 
descending artery and reperfusion therapy was 
performed. Patients were divided into the following 3 
groups: 116 patients with successful reperfusion 
achieved within 6 hours after symptom onset (ER), 45 
patients with late reperfusion (LR), and 28 patients 
without reperfusion (KR). The left ventricular 
ejection fraction was assesed by serial 
ventriculograms. Survial was assessed by the Kaplan· 
Meier method. 
Results: An increase in the left ventricular ejection 
fraction was similar between ER and LR (7± 12% and 
7 ± 12%). and both were significantly higher than KR 
(- 2 ± 9%. p<O.OI and p<O.05, respectively). Short· term 
(50 days) survival was comparable in ER and LR (87% 
and 83%). Although there was no significant 
difference, they were higher than NR (71%). Long·term 
(4 years) survival was also comparable in ER and LR 
(78% and 74%), and both were significantly higher than 
NR (44%. p<O.OI and p<0.05, respectively). 
Conclusion: These results suggest that coronary 
reperfusion improves left ventricular function and 
survival even in patients with anterior AMI presenting 
greater than 6 hours after symptom onset. 
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973-92 
A Quantitative Comparison of PrImary Angloplasty Versus 
Thrombolysis In Acute Myocardiallnfamlon Utilizing Exercise 
Thallium Scintigraphy 
Steven AjluDi, Edward Terrien, Jack JuDi, Sylvia Puchrowicz, Gerald 
Timmis, Cindy Grines, William O'Neill. William Beaumont Hospital, 
Royal Oak, Michigan 
To assess the impact of different reperfusion strategies on infarction 
size, residual peri-infarction ischemia, and exercise capacity, we studied 
46 consecutive patients (pts) using submaximal, exercise thallium studies 
before discharge. These pts had been randomly assigned to either 
angioplasty of the infarct-related coronal)' artel)' (PTCA; n=20) or 
primal)' thrombolysis with tissue-specific plasminogen activator (tP A; 
weight-adjusted dosing, n=26) following entl)' into the multi•
institutional PAM! trial (Primal)' Angioplasty in Acute Myocardial 
Infarction). Thallium perfusion defects were measured from a bullseye 
plot, identifying as abnormal, those areas with scintigraphic counts > 
2.S standard deviations below the mean of similar areas obtained from 
a database of normal pts. 
Results: Time from onset of chest pain until initiation of reperfusion 
occurred at a mean of 3S :I: 19 min earlier in the tP A group than in the 
PTCAgroup (p<O.Ol). Quantified % fixed and % reversible perfusion 
defects did not differ between groups (tPA 25%, S%; PTCA 24%, S%, 
respectively). There was a weak correlation between the reversible 
component of the overall perfusion defect (area of redistribution/fixed 
defect x 100), and the workload achieved on exercise testing (r=.33, 
p<O.OS). The cardiac workload, as estimated by the predicted 
maximum heart rate (PMR) achieved was higher after angioplasty than 
tPA (63% PMR versus 56% PMR, p<0.05; rate pressure product=.07). 
Conclusion: The advantage accruing to earlier reperfusion with 
thrombolytic therapy is apparently offset by the more complete 
reperfusion (less residual stenosis) resulting from angioplasty. 
Angioplasty allowed for an increased pre-discharge exercise threshold. 
973-93 
Protection of Rabbits against Catecholamine-induced Lethality by 
Nucleoside Transport Inhibition. 
Herman Van Belle, Kris Ver Donck, Willy J. Verheyen, Janssen 
Research Foundation, B-2340 Beerse, Belgium. 
Nucleoside transport inhibition (NTl) is well.docume~ted to 
prolong the accumulation of adenosine within the ischemic•
reperfused myocardium, where it may exert a whole range of 
interesting and protective pharmacological effects. To test this 
principle, we looked for cardioprotection by NTI in 
catecholamine-induced cardiotoxicity in rabbits, a well•
established model for myocardial damage. The drug used was 
R 75 231, a recently developed mioflazine analog, which, within 
the very few existing transport inhibitors, has unique 
pharmacokinetics for potential use in man. When infusing 
norepinephrine (20 ~g/kg/min; i.v.) in conscious rabbits the 
LD50 in solvent-treated animals was reached after 190 min (n =0 
7) but at more than 8 hours when R 75 231 was given at the start 
of the challenge (0.1 mg/kg; i.v.; n = 7). A similar protective 
effect was seen also against I-epinephrine (10 ~g/kg/min), where 
the time-to-LD50 was changed from 105 min in controls (n =0 7) 
to 330 min when treated (n = 7). The involvement of nucleoside 
transport inhibition was further clarified by applying the two 
stereoisomers of R 75 231. The d-enantiomer, devoid of any 
effect on the nucleoside transporter, was also ineffective in rabbits 
given epinephrine. The active l-enantiomer, R 88 021, postponed 
the time-to-LD50 of l-epinephrine (10 ~g) dose-dependently from 
160 min (solvent; n " 16) to 192 (not significant), 370 and> 480 
min at respectively 0.025 (n = 8), 0.050 (n = 8) and 0.1 (n = 8) 
mg/kg (i.v.). Since no other class of drugs thus far has shown 
any benefit in similar models, it is suggested that efficient NTI 
may become an interesting approach to limiting myocardial 
damage ~nd death. 
ABSTRACfS 
973-94 
Temporal Distribution Of Treatment To Reperfusion 
Times In Patients With Acute Myocardial Infarction:The 
Effect of Tissue Plasminogen Activator vs. 
Streptokinase. 
Will iam Ganz, Prediman K. Shah, Cedars-Sinai Medical 
Center and University of California at Los Angeles, 
CA. 
Angiographic reperfusion or patency rates at 90 min 
after initiation of treatment have been substantially 
higher after tissue plasminogen activator (t-PA) than 
after streptokinase (SK). However, at 24 hrs the 
patency rates have been similar. The purpose of this 
study was to determine when between 90 min and 24 hrs 
does equal ization of patency rates occur. We used 3 
criteria to recognize reperfusion (1) rapid 
progressive resolution of ST segment elevation (2) 
near simultaneous rapid and complete relief of chest 
pain (3) near simultaneous abrupt increase in serum 
creatine kinase activity by ~ 13% of the total 
activity in the first hour. All 3 criteria had to be 
present. Of the 82 t-PA patients 72 (87.8%) 
reperfused. This was confirmed by angiography within 
24 hrs. Of the 162 SK patients 144 (88.9%) reperfused. 
The table presents the temporal distribution of 
reperfusion times (RT) in % of the total population. 
RT(min) 0-30 0-60 0-90 0-120 0-lS0 0-180 0-210 0-256 
t-PA % 36.7 64.682.985.4 87.8 
SK % 22.2 47.2 60.7 74.8 79.1 84.0 85.9 88.9 
Treatment to reperfusion times were an average of 28 
min shorter after t-PA. 
Conel us ions i The reperfus i on rate after SK becomes 
similar to that after t-PA 4 hours after treatment 
onset. Treatment to reperfusion times were an average 
of 28 min shorter after t-PA. These results explain in 
part the findings of recent trials. 
973-95 
361A 
CAPTOPRIL BEFORE THROMBOL VSIS IN ACUTE MVOCARDIAL 
INFARCTION: SHORT TERM AND LONG TERM EFFECTS. 
Pietro Di Pasquale,Salvatore Paterna,Mario Valenza,Giuseppe 
licata, Sergio Cannizzaro,Giuseppe Barone; 
G.F .Ingrassia Hospital,Palermo University,Palermo, Italy. 
The aim of our study was to verify if it i5 useful to utilize 
Captopril(C)before thrombolysis treatment in acute myocar•
dial infarction(AMI),at present investigated only in experi•
mental studies.128 patients(101M and 27f),who arrived in 
our hospital within 4 hours from the onset of symptoms 
were randomized in 2 groups: the first group 68 patients 
(group A) received C (6.25 mg)orally about 15 min before 
the intravenous administration of Urokinase(2 million),the 
second group 60 patients(group B) received C three days 
after thrombolysis.C doses were later increased in both 
groups according to blood pressure.All patients were subdi•
vided according to the localization of the infarction in 
anterior AMIs 89 patients (47 group A and 42 group B) and 
inferior AMIs 39 patients (21 group A and 18 group B).Ventri•
culm' hypel-kinetic arrhythmias(VHA) due to reperfusion 
have b!!en evaluated during the first 2 hours and showed 
in pat.ients with anterior AMi an incidence of 10% in group 
A vs 47% in the group B (p< .001). The normalization tirnc 
of the CPK peak in the group with antllrior AMI was achie•
ved after 58-2 h in the group A vs 71-2 h in the group 
B.(P< .00).In the group with anterior AMI was recorded in 
the predischarge Holter test an incidence of 19% of IDte 
arrhythmias,higher than LQIo,n's class lI,in the group A vs 
40% in the group B(P<.05).Jn the subgroup with inferior AMls 
the differences were no\' statistically significant. The f01low•
up was carried out on 115 patients. There 61 patients in 
the group A (anterior AMIs 41,inferior AMIs 20) and 54 pts 
ill the group B (anterior AMis 39,inferior AMls 15).The mean 
pel"iod observation was 18-2 months.The mortality in the 
antel"ior group was 4.9% in -group A vs 17.9% in group B (p 
NS). 
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974·96 
Transthoracic Echocardiographic Evaluation of Post-Infarction 
Left Ventricular Remodeling in the Rat 
Sheldon E. UIWin, Sarah E. Katz, lames P. Morpn, Pamela S. Douelas. 
The Harvard·Thorndike Laboratory ofBeth Israel Hospilal, Boston, MA. 
The rat with chroDic coronary occlusion is a valuable model of post-infarction left 
ventricular (LV) remodeling. Unfortunately, noninvasive assessment has been 
limited by small animal size and npid heart rate. To determine the feasibility and 
value of transthoracic echocardio,nphy in followin, post-infarction remodeling, 
rats had echoes preoperatively, and 1 and 6 weeks after left coronary artery 
Ii,ation (n=9) or sham sureery (n= 11). Sbort axis images at the level of the 
pspillary muacles were obIainecI with a 7 MHz transducer. 2 D euided M mode 
imalles were uaed for measurement of poaterior wall thickness (WT), LV end•
diastolic chsmber diameter (0) and fractional shortening (FS). Reliability of echo 
data was confirmed by the sillUificant correlation of calculated LV mass (ASE cube 
formula) and post-mortem LV mass in rats without infarctions (r=0.83, 
slope=1.2S, y intercept=-.19, p < 0.00(1). Pulsed Doppler mitral inflow(E, A) 
and LV outflow (Ao) were recorded from apical views. Infarct size measured as 
akinetic circumference on midventricular short axis images (mean: 55 % LV 
perimeter) was similar to scar area of pathologic specimens (mean: 53 % LV 
perimeter). All values are mean+SD. • p < 0.05 vs pre for infarcted rats. -
D ... wr ... FS l! E mi. A mi. Ao mI, 
Pre 8.0+1.0 1.3+0.2 38+4 .74+.15 .34+.09 .95+.10 
1 wi< 9.4+.6' !.S+0.2 14+2' .91+.15' .23+.17 .91+.18 
6wk 10.4+.9' 1.7+0.4' 12+6' 1.03+.16' .03+.07' .96+.30 
o cbanges were evIdent to sbsm-<>perated rats. 
Conclusions. 1. Serial transthoracic ecbocardiograpby is technically feasible in 
this small animal model of myocardial infarction. 2. Following infarction, there 
is progressive remodeling of the left ventricle characterized by chamber dilatation 
and hypertropby of the noninfarcted wall. These structural ebanges are 
accompanied by impaired systolic function and alterations in diastolic filling. 3. 
This technique provides a new method to noninvasively assess the effects of 
different interventions in rats following myocardial infarction. 
974·97 
The Impact of Right Ventricular Dysfunction on the 
Prevalence of Atrial Arrhythmias During Inferior Wall 
Myocardial Infarction 
Eldad Rechavia, Boris Strasberg, Aviv Mager, Nili Zafrir, 
Jairo Kusniec, Alex Sagie, Samuel Sclarovsky 
Cardiovascular Division, Beilinson Medic.l Center and the 
Tel-Aviv University Sackler Scbool of MediCine, Israel 
Atrial arrhythmias (AA) profile during inferior wall MI 
has not been systematically examined with respect to RV 
involvement. To this end, 62 consecutive pts with no 
prior MI or other conditions known to increase 
susceptibility for rythm disturbances and/or to impose a 
hemodynamic burden on the RV were studied by 24-hour 
Holter monitoring during the first and tenth day of 
inferior wall MI. Based on nuclear studies performed on 
day 2 of MI, pts were allocated into 2 groups: Gr.A;36pts 
with RVEF <40%(mean 31+6%); Gr.B;26 pts with RVEF ~40% 
(mean 47+5%). There were no differences between the two 
groups regarding age, sex, LVEF and thrombolytiC therapy. 
In the group as a whole, ectopic activity in the different 
categories was significantly higher during the first than 
in the tenth day. 33 pts in Gr.A (92%) had a mean hourly 
frequency of ~1 APC's during the first day of MI as 
compared with 18 pts (69%) in Gr.B (p <0.001). PAT and SVT 
were recorded more frequently in Gr.A pts (16/36[44%] vs 
8/26[31%];p-NS) as well as AF (7/36J19%] vs 1/26[4%];p-NS). 
In each category of AA, a significantly higher rate of 
events was evident in Gr.A pts. AA profile was neither 
influenced by LVEF nor by age and was not related to the 
occurrence of AV block. Stepwise multiple regression 
analysis revealed that RVEF was independently related to 
the prevalence of APC's and AF. Late AA were comparable 
among Gr.A and B pts. These data imply that pts with 
inferior wall AMI accompanied by RV dysfunction are more 
prone to develop AA. An associated right atrial infarction 
and/or a raised pressure may account for this finding. 
974·98 
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Direct Coronary Angloplasty combined with Aortic Balloon 
Counterpulsation In Cardlogen!c Shock due to Acute MyocardiallnfarcUon: 
Preliminary Results of an Aggressive Treatment Strategy. 
Jan C.A.Hoorntje. Felix Zijlstra, Menko-Jan de Boer. 
Hospital De Weezenlanden, Zwolle, The Netherlands. 
Aggressive treatment for Cardiogenic Shock (CS) due to acute myocardial 
infarction (AMI) w~h either coronary angioplasty (PTCA) or aortic balloon 
counterpulsation (IABP) alone compared to conventional drug reginens 
has only resuked in a moderate increase in sU"Vival. To determine the place 
of the combined use of direct coronary recanalization with PTCA and the 
combined effects of inproved coronary perfusion pressll'e and decrease 
of afterload with IASP in this patient group we set up a new prospective 
treatment strategy. After establishing the diagnosis of CS caused by AMI all 
the patients (pts) were directly send to the catheterization laboratory. After 
dilatation of the infarct related vessel (IRV) an lABP was inserted at least for 
the first 48 tvs after PTCA. Besides iloIropic drug support pts were treated 
with heparin and asperine. Prinary end points Included slJ'Vival, recurrent 
ischemia, ejection fractions (EF) before discharge and clinical events. 
28 Pts, 21 male (75%), Age:41·76 yr, mean 69.t9 yr, were included in the 
study with a follow-up of 2·29 mos, mean 14±8 mos. TllTle from onset of 
symptoms to start of treatment was 30-360 min., mean 140±66 min. In 
25128 pts the IRV was occluded, prinary success rate of PTCA was 93%. 
Triple vessel or left main disease was present in 23/28 (82%) pts. IABP 
duration was 1-10 days, mean 3.6 ± 2.3 days with a complication rate of 
13%. 
Results: 22128 (79%) pts survived with a mean foIlow·up of 14±8 months, 
5 pts died in hospital. A validity classification 1·2 NYHA was assessed in 
21122 pts. EF ranged from 12·41%, mean 27±8%. In 17/23 (74%) pIS 
additional major cardiac interventions were necessary because of rewrent 
or persisting ischemia: 4123 pIS underwent a second PTCA, in 13123 pts 
coronary by-pass sll'gely (CABG) was performed. 
Conclusions: 1. PTCA and IABP is an effective combination in the initial 
treatment of AMI with CS. 2. Additional major cardiac interventions (PTCA, 
CASG) are often necessary to obtain optimal results. 
974·99 
HemOdynamic Parameters 12-Hours After Onset of 
Cardlogenlc Shock Can Predict Survival 
Ramon Raneses, Cindy Grlnes, Steven Almany, Gerald Timmis, 
William W. O'Neill. William Beaumont Hospital, Royal Oak, Michigan 
In spite of recent therapeutiC advances, cardiogenlc shock still 
carries a high In-hospital mortality. To determine whether serial 
Invasive hemodynamic parameters are of prognostic value in 
cardiogenlc shock, we evaluated measurements obtained q4h in 58 
pts with cardiogenlc shock treated between 1985-1990. Shock was 
defined as recent myocardial infarct with systolic BP s: 80 mmHg 
unresponsive to fluids or s: 90 mmHg with inotropic support. In•
hospital mortality was 40/58 (69%) and the median time to death 
was 50 hrs. Survivors (n= 18) and non-survivors (n =40) were similar 
in age (67 vs 70 yrs), sex, past medical history, location of infarction 
(Ant. 39 vs 38%), attempts at reperfusion with thrombolytlcs (22 vs 
15%), angioplasty (33 vs 28%) or CABG (6 vs 15%) balloon pump 
(56 vs 63%) or use of pressor agents; Dopamine (89 vs 78%), 
Epinephrine (6 vs 15%), Dobutamine (56 vs 48%). At onset of 
Shock, hemodynamic parameters including arterial, PA pressures, 
CO, SVR and MV02were similar for both groups. At 8-12 hrs, when 
90% of pts were still alive, hemodynamics began to Improve in 
survivors compared to non·survivors; SBP (100 vs 85 mmHg, 
p=.06), MAP (71.4 vs 60.5 mmHg, p=.08), MV02 (70.8 vs 55.6%; 
p=.04) and PA systolic pressures (35 vs 40 mmHg, p=.06). 
Between 16 and 20 hrs. these differences became more significant 
and improvements in wedge pressures (12 vs 20 mmHg, p=.ool) 
and cardiac index (2.6 vs 1.9, p=.03) were noted in survivors. 
These data suggest that although baseline parameters are similar, 
12 hrs after onset of cardiogenic shock invasive hemodynamics may 
predict prognosis. If no improvement In serial hemodynamiCS occur 
within 12 hrs, triage to cardiac assist devices may be indicated. 
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975·100 
Is Severe Pulmonary Hypertension a Risk Factor for Poor 
Outcome With Balloon Mitral Valvotomy? 
Thomas Wisenbaugh, Rafique Essop, Shirley Middlemost, John 
Skoularigis, Pinhas Sareli. 
Baragwanath Hospital, Johannesburg, South Africa. 
The results of balloon mitral valvotomy (BMV) in patients with 
severe pulmonary hypertension have been reponed to be 
suboptimal, but this may in pan be related to coexisting factors 
such as old age and valve calcification. In our experience of ~IOO 
BMV procedures, we have identified 24 young patients (mean age 
25±1O, range 14-40 yrs) with severe pulmonary hypertension 
(mean P AP>50 mrnHg) all of whom had echo valve scores :;:8 on a 
scale of 16. All but one were in sinus rhythm. All but 2 were in 
functional class III.lkWls: Five (21 %) developed significant 
~3+) new mitral regurgitation (MR) and are excluded from further 
hemodynamic analysis; none of these five have yet required 
surgery. There were no other complications related to the 
procedure. In the 19 without new MR, mean pulmonary anerial 
and mean left atrial pressure (PAP and LAP), mean mitral valve 
gradient (MVG), cardiac output (CO) and mitral valve area (MVA) 
all improved significantly: 
BMV PAP LAP MVG CO MVA 
(mrnHg) (mmHg) (mrnHg) (LImin) (cm2) 
pre- 58±11 25±7 15±4 3.2±.6 0.74±.24 
post- 36±12 15±6 4±2 3.6±.6 1.80±.89 
In all but 2 patients, both of whom had significant new MR, 
symptoms improved. Conclusion: BMV can be both safe and 
effective in severe pulmonary hypertension, but the risk of MR 
may be greater than in patients without pulmonary hypertension 
for reasons that are uncertain - but not related to valve score. 
975·101 
Prediction or Outcome or Percutaneous Balloon Mitral 
Valvotomy with the Inoue Single Balloon 
Diane Falkin, Paul Roy, John Morgan, Michael Feneley 
St Vincent's Hospilal, Sydney, Australia 
In 35 consecutive patients (pts) with rheumatic mitral stenosis 
undergoing percUla/leous balloon ntitral valvotomy (PBMV) using 
the Inoue single balloon, mitral valve morphology was examined to 
ascertain factors predictive of outcome. Patients were aged 2S • 73 
(mean 46.3) years; 30 female; 10 pts in atrial fibrillation. Mean 
mitral valve area (MV A) increased from 1.2 ± .3 10 2.1 ± .5 cm'. 
Mean mitral valve gradient (MVG) decreased from 9.9 ± 4.2 to 4.9 
± 2.0mmHg. An echo scoring system allocating scores 0 • 4 for 
valve leaflet mObility, thickening. calcification and submitral 
thickening has been previously used 10 predict outcome of PB MV, 
with unfavourable outcome associated with scores >8. We found 
scores >8 were not discriminative of poor outcome in individual pts, 
with no statistical difference in mean change in MV A (84% £f 41 %) 
or MVG (45% £f 45%) in valves with scores <8 and >8, and marked 
variability within each group. Successful PBMV resulted from 
commissural splitting (CS). MV A increased by 82% if one or both 
commissures (C) split £f 13% if neither split (p < .001). MVG 
decreased by 46'* with CS £f 31 % without spliuing. The likelihood 
of CS could be predicted accurately pre·PBMV by assessment of C 
morphology: 91 % single CS, 75% both CS, 100% neither CS. Post· 
PBMV. new MR occurred in 10 pts that was mild and directed 
through the split C; severe MR due 10 chordal rupture occurred in 
one pI. Because single CS limited eflicacy of subsequent inflations 
due to balloon prolapse, adequate balloon size and initial inflation 
volume are imporla/lt for optimal outcome. 
Conclusion: Evaluation of C morphology is more useful then echo 
score in prediction of ouocome. 
ABSTRACTS 
975·102 
Percutaneous Balloon Mitral Valvuloplasty: A 
Comparison of Double and Single (Inoue) Balloon 
Techniques 
Charanjit S. Rihal, Rick A. Nishimura, Guy S. Reeder, David R. 
Holmes, Mayo Oinic, Rochester, MN 
To address the relative merits of double and single balloon 
approaches to percutaneous balloon mitral valwloplasty (p8MV) for 
the treatment of mitral stenosis we compared 33 patients dilated with 
two balloons (mean age 46.7) to 28 dilated with the Inoue balloon 
(mean age 53.4). To ensure comparability, patients with mitral 
valve scores ~IO were excluded from analysis. The majority of 
patients in each group were female and had class m or IV 
symptoms. There were no baseline differences in mean left atrial 
pressure (LAP: 33 vs 31 mm Hg, p=O.23), mean mitral gradient 
(GRAD: 16 vs 14 mm Hg, p=O.l5) orcalcuiated mitral valve area 
(MVA: 1.17 vs 1.04 cm2 p=O.l5) between the double and Inoue 
groups. 
Following PBMV, final MVA (2.24 vs 1.73 cm2, p=O.OO4). and 
absolute increase in MVA (1.00 vs 0.69 cm2, p=O.02) were 
significantly larger in the double balloon group. Fmal LAP (20 vs 
23 mm Hg, p=O.08) and GRAD (7,0 vs 6 mm Hg, p=O.6) were not 
different. Three patients in the double balloon group and one in the 
Inoue group had an increase in mitral regurgitation of ~+. One 
patient in each group required mitral valve replacement. Two 
patients in the double balloon group and none in the Inoue group had 
oximetric evidence of a >25% left to right shunt (p=NS for any 
complication). We conclude that the double balloon technique 
affords superior valve opening in P8MV but may be associated 
with a greater incidence of complications. 
975·103 
Inoue Balloon Mitral Valvotomy in Patients Age 75 or 
Older 
Ted Feldman, John D. Carroll, Thomas M. Bashore, David 
Holmes, Howard C. Herrmann, Gerald Dorros, and the 
North American Inoue Investigators. 
The University of Chicago, Chicago, Illinois 
Balloon mitral valvotomy (BMV) yields good immediate 
and long-term results in patients with symptomatic 
mitral stenosis and moderate valve deformity. 
Procedure outcome is less well characterized in elderly 
patients with more severe valve deformity who have a 
limited surgical option. Of 260 BMV patients in the 
Inoue registry, 240 were < 75 yrs (mean age 51 % 13 
yrs), and 20 were ~ 75 years (mean age 81 % 4 yrs). 
NYHA ECHO Pre-BMV Post-BMV 
Class Score Area Area 
Age < 75 2.8 % .6 7.0 ± 2.6 1.0 ± .3 1.8 ± .6 
Age ~ 75 3.3 ± .8* 11.1 % 2.5* 0.9 :t .2 1. 5 :t .6 
* - p<.OOl vs age < 75 yrs 
Older patients were more symptomatic with higher 
NYHA class and had more severe valve deformity (Table). 
Valve area increase ~ 50\ or area ~ 1.5 was achieved in 
83\ of pts < 75 yrs vs 60\ of pts ~ 75 yrs (p-.007). 
There was an increase in mitral regurgitation ~ 2+ in 
3/20 pts ~ 75 yrs vs 18/220 (8%) < 75 yrs (p-NS). 
Failed procedures were more common in the older 
patients (5/20 age ~ 75 vs 11/240 age < 75, p-.006). 
Conclusion: Technical procedure failure and 
suboptimal increase in mitral valve area are not 
uncommon in pts age 75 or older, but 60% still have 
procedure success. 
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975·104 
Six Month Follow-up After Inoue Balloon Mitral 
Valvotomy 
Ted Feldman, John D. Carroll, Jeffrey Isner, Robert 
Chisholm, Howard C. Herrmann, Augusto Pichard, Thomas 
M. Bashore, David Holmes, Gerald Dorros, Ali Massumi, 
Simon Stertzer, Stephen Ramee, Donald A. Rothbaum, 
Robert C. Feldman, Jonathan Tobia, Kanji Inoue. 
The University of Chicago, Chicago, Illinois 
Six month valve area or NYHA class wal evailable in 
107 patients following Inoue balloon ••• I MOO"'" 
mi tral valvotomy (BMV). Mean age IIYIIA 
was 51 t 15 yrs. 84, were female IV 
and mean NYHA class was 2.8 t 0.8. 
67' of these pts were NYHA 
class III-IV pre BMY, and 92t 
NYHA class I-II after 6 months 
(Figure). 89' were improved by 
~ 1 class after 6 months. Initial 
results showed valve area increase 
from 1. 0 :t O. 3 to 1. 9 :t O. 6 em'. 
1/1 
" 
87' of procedures were successful (post BMY area ~ 
1.5 or increase ere a ~ 50'). Mean area at 6 months was 
1.7 :t 0.6 em'. Of pts with initial success and no 
significant procedure complication, 21t had 6 month 
restenosis (> 50, loss of initial gain and area < 1.5 
em'). 88, of restenosis pts still had lower NYHA class 
than pre SMY. ECHO score was 6.7 ± 2.7 for opts with 
restenosis vs 6.3 :t 2.5 for pts without restenoois 
(NS). Age, atrial fib, and prior commissurotomy were 
not different in restenosis pts. 
Conclusion: Six months after Inoue balloon mitral 
valvotomy 89' of patients remain symptomatically 
improved. Anatomic restenosis occurs in 21', many 
without worsened symptoms. 
975·105 
Percutaneous Balloon Pulmonary Valvuloplasty Using 
Inoue Balloon Catheter: A New Method 
Kean Wah Lau, Jui-Sung Hung, Ming-Shyan Chern, Tong•
Jen Wu, Kou-Ho Yeh, Sara Chua, Morgan Fu. 
Chang Gung Memorial Hospital, Taipei, Taiwan, ROC 
Balloon Pulmonary Valvuloplasty (BPV) using Inoue's size•
adjustable balloon catheter (IB) has not been reported. We 
hereby present our experience of BPV using IB in 12 pts with 
congenital pulmonary stenosis. They were 8 women and 4 
men, aged 18 to 47 yrs (mean 27). BPV was done with the 
stepwise dilatation technique. The final balloon:pulmonary 
annulus diameter ratio was 0.87±0.03. There were no compli•
cations. Right ventricular systolic pressure (RVSP) and trans•
valvular gradient (TVG) decreased after BPV in all pts. Only 
1 pi had infundibular gradient (IG) of 20 mm Hg before BPV. 
After BPV, IG developed or increased in all pts. The results 
expressed as range (mean) in mm Hg were as follows: 
RVSP TVG IG 
Pre-BPV 60 - 200 (98) 38 - 182 (78) 
Post-BPV 30 - 90 (48)~ 0 - 22 (7)~ 8 - 64 (25) 
~p<0.05 pre- vs. post-BPV 
Serial EKGs at 3-month intervals showed regression of right 
ventricular hypertrophy in all 7 pts who had follow-up> 3 
months. Repeat catheterization (12 to 30 months post-BPV) 
in 5 pts showed no evidence of valvular restenosis. There 
was further reduction in RVSP as a result of reduced IG in 
ailS pts. RVSP ranged 36 - 55 post-BPV, and 24 - 48 mm Hg at 
follow-up; IG, 10 - 40 post-BPV, and 0 - 22 at follow-up. 
Thus BPV using IB is safe and effective in relieving pul•
monary valvular obstruction in the short- and long-term. 
975·106 
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Acute Mitral Insufficiency Following Percutaneous Mitral 
Valvulopluty: Anatomic Lellons, Surgical Implications and 
Relulll 
Christophe Acar, Victor A. lebara, Alec Vahanian, Philippe 
Grare, lean Noel Fabiani, Alain Deloche, Alain Carpentier. 
HOpital Broussais, Paris, France. 
Percutaneous mitral valvuloplasty (PMV) Is a universally 
accepted technique to treat pure mitral stenosis. Traumatic mitral 
insufficiency (!Mil may occur secondary to PMV. The aim of this 
study Is to analyze the anatomic lesions encountered, the specific 
surgical Implications and the results of surgery. 
Twenty patients (pts) were operated on for TMI following PMV. 
Three pts required emergency operation «6 hrs.). In the other cases 
surgery was performed within the following days. Operative 
analysis of the mitral valve showed: tear of the anterior leaflet 
(n-4), tear of the posterior leaflet (n-2), paracommissural tear 
(n=13) and papillary muscle rupture (n"1). Associated chordal 
rupture was found In 3 pIS. Septal perforation secondary to the 
trall5Septal puncture was found in all cases and was> 10 nun In 4 pIS. 
Mitral valve reconstruction was performed in 12 cases and mitral 
valve replacement in 8. All pts survived and none required 
reaperation. Follow-up was complete with a mean of 14.9 mos. All 
pIS are ali ve and free of symptoms. 
In conclusion, anatomic lesions following PMV may interest all the 
elements of the mitral valve apparatus. The possibility of valve 
repair depends mainly on the degree of calcification. The extent of 
the leaflet tear does not preclude mitral valve reconstruction. 
Surgery offers excellent results. 
975·107 
Doe. TIE Change the Outcome of Poetoperative Mitral 
Valve Repair patient •• 
Carol I. Duffy, Allan L. Klein, Gerald I. Cohen, Ernesto 
E. Salcedo, William J. Stewart, Cleveland Clinic 
TEE has been used intraoperatively to guide mitral 
valve repair. In the postoperative setting, the utility 
of TEE has not been described. Therefore, in 42 pte (18 
female, age 25 - 82), we performed 50 TEES, done an 
average of 15 months after valve repair for mitral 
disease, the etiology of which was ischemic (8/42, 
19.0'), degenerative (47.6\), rheumatic (26.2,) or other 
(7.2\). Indications for TEE were to quantitate mitral 
regurgitation (MR) or murmur in 14 of 50 (28'), routine 
postoperative in 10 (20t), and transthoracic (TTE) 
inadequacy in 11 (22'), and other 15 (30\). 
RESULTS: Of 50 TEES, 16 (32') resulted in a change in 
management/outcome (Group A), in 5 of Which, the TTE was 
inadequate. Management changes included reoperation in 
5, change in medical therapy in 7, and decision not to 
operate in 4. Changes due to TEE occurred in SOt of 
iachemics, 30, of degeneratives, and 18, of rheumatics. 
The average interval from operation to TEE in the Group 
A patients was 157 vs 638 days in the 34 in whom TEE did 
not change outcome (group B). With Ischemic MR, the 
interval from surgery-to-TEE was lower in Group A pta 
(36 days) vs Group B pts (282 days). In degenerative MR 
pts, the surgery-to-TEE interval was 233 days for group 
A vs 354 days for group B. The interval from surgery to 
TEE was longest in rheumatic pts (average 1455 days) but 
this did not affect the liklihood of TEE changing plans. 
Conclusion: TEE has a strong impact in the management of 
clinical problems after mitral valve repair, resulting 
in a change in outcome in 32\ of cases. This effect is 
more common in patients whose MR is due to ischemia and 
more common in pts whose clinical problems occur early 
after surgery. 
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975·108 
Fixation or tbe Mitral ADnulus by Rigid or Flexible RIDg 
AnDuloplasty Doe. Not Impair Global LV Systolic Function or 
Energetics in the CODsclous Closed Cbest Dog _ 
Luis J. Castro, Stepben C. Raybill, Marc R. Moon, Marek Niczyporuk, 
Neil B. Ingels, George T. Daugbters, Geraldine C. Derby, D. Craig 
Miller. Stanford University, Stanford, CA 
Studies assessing tbe effect of rigid fIXation of tbe mitral annulus on 
systolic LV function bave yielded disparate results. Sixteen dogs were 
randomized to undergo annuloplasty witb a Carpentier-Edwards rigid 
ring, Duran flexible ring, or 'sbam' procedure. Twenty·eight 
miniature tantalum markers were inserted into tbe LV wall for tbe 
computation of LV volume and ~eometry. After 7-10 days of 
recovery, atrial pacing at 120 min' with autonomic blockade was 
performed, and computer· aided biplane videofluoroscopic marker 
images were obtained (with caval occlusion). Left ventricular pressure 
was measured with a micromanometer. Systolic LV function was 
assessed using the end systolic elastance (Ees' V p}and preload 
recruitable stroke work (M", V,,) co~cepts. The effiCiency of energy 
transfer from PYA (total mechaDlcal energy as represented by 
pressure volume area) to external mechanical pressure volume work 
(SW /PVA) Was also calculated. Results (mean :!: SO): 
E"" 
k 
V" 
SW/PVA 
.sbI!!l .I!n!.b!f .Bi&id 
2.68 + .99 2.37 + .85 2.95 + 51 
18.7+13.3 18.2+13.0 18.7+13.3 
49.0+6.1 50.0+95 50.8+7.32 
49.8:;: 15.2 44.7+ 7.8 38.4+ 14.7 
0.46 + .09 051 + .06 052 + .05 
(p-vaiues for all indices :-N.S. (ANOVA)) -
Conclusion: Early postoperatively, rigid or flexible ring .mitral 
annuloplasty has no effect on global LV systolic function or energetics 
in chronic, consciouS, close-chest dogs with normal ventricles. 
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976·109 
The Value and Usage or Pro&rammability in a Tiered Therapy 
Defibrillator 
Roger A. Winkle Eric S. Fain, Michael L. Har~ge, Kathi M. 
Senelly and the Cadence- Investigators, Sequoia Hospital, 
RedwOod City, CA 
We examined the value of and use of programmability in 337 
patients receiving the Ventritex Cadence Implantable defibrillator 
which has antitachycardia pacing (ATP), cardioversion (CV), 
defibrillation (DF) and bradycardia pacing. Detection criteria 
and VTIVF therapies can be extensively programmed. In-hospital 
noninvasive arrhYthmia induction was utilized to optimally program 
the device for each patients' VT/VF. The success of VTIVF 
therapies used in 2,383 episodes induced during in-hospital 
testing was compared to therapies delivered for 4,583 episodes of 
recurrent spontaneous ventricular tachyarrhythmias. 
lst DF success 
lst CV success 
ATP success 
A TP unsuccessful 
ATP acceleration 
Spontaneous 
1003/1132 (89%) 153/164 (93%1 
1501172 (87%) 162/177 (92% 
20711079 19% 20014242 (5% 
738/1079 ~68%! 3982/4242 (94% 
134/1079 13% 60/4242 (1 %) 
p < .001 
p < .13 
P < .001 
P < .001 
P < .001 
After hospital discharge, 67.3 % of patients had at least one 
device parameter reprogrammed. Reprogramming was based on 
additional induction testing andlor review of telemetered 
diagnostic data and stored mtracardiac electrograms. There was 
no single pattern of device reprogrammint\. All II categories of 
detection parameters and 32 of 36 categones of therapy parameters 
were reprogrammed in one or more patients. We conclude that 
investigator-chosen programming baSed on EP te~ting results in a 
high success rate for DF, CV and A TP with a low rate of VT 
acceleration by ATP. Programmability is frequently utilized 
during long-term follow-up to further refine tJierapy or to 
compensate for changing clinical patterns of VTIVF. 
ABSTRACTS 
976·110 
Clinical Predictors of Successful Implant of Transvenous 
Defibrillator Lead System: The ENDOTAK Investigator 
Group Experience 
Stephen Ehrlich, for the EN DOT AI< Investigator Group. Hosp"al of the 
Good Samar~an, Los Angeles, .cal~omia 
We examined clinical parameters In 215 pts undergoing evaluation for 
imp! of TVS AICo lead system (ENDOT AI< - CPI) in order to Identify 
factors predicting successful implantation (ImpI)of transvenous (TVS) 
automatic Implantable cardioverter defibrillator (AICo) lead system Clinical 
variables include age, sex, coronary artery disease (CAD) vs other 
structural heart disease, presenting an11ythmia: monomorphic ventricular 
tachycardia (MVT) vs. polymorphic ventricular tachycardia (PVT) or 
ventricular fibrillation (VF), LVEF, antian11ythmic drug therapy, and 
amiodarone therapy alone were evaluated by univariate/muttlvariate 
analySiS. One hundred fifty-one (70"10) of 215 pIS had Inftial Imp\. Sixty 
(28"10) pts were not impl due to high defibrillation thresholds (>25J). Four 
(1.8"10) pts were not impl due to technical problems placing the lead. No 
pt failed impl due to an11ythmia sensing problems. PI characteristics, impl 
success and univariate analySis of available data are presented below' 
~TED ~ ~~ pvolue 
TOTAl. 2,5 '5, 64 
AGE 204 n-149; mean. 64 .. 55:..-..&! .38 
range: ,7-84 _37-83 
SEX 204 "2P1111e137' ....... S3maJe12' ...... .0036' 
lVEF ,116 .. ,016: moan 32.5% ... 50; ~. 26.5% .0057' 
PRIMARY 204 68INT 37INT .0068' 
ARRHYTHMIA 8' PVTIVF 18PVTIVF 
UNDERLYING 204 ,,6CAD oI6CAO .37 
STRUCTURAL 33non-CAO Onon-CAO 
DISEASE 
ANTlARRHYTHMICS 204 ,04'_wlM 37_ed .73 
45 not'_edwM 
,8 not ,_ 
AMIO THERAPY 204 2 ....... edw/Amio " ..... ed .5' 
125 not ._ed wlAm;' 44 not ,realed 
·denotes 5>gn,foc.n. variable (1'<.05) 
Finally, muHivariate analySis showed that the sign~lcant independent 
predictors of successful outcome were sex, LVEF , and PVT NF as 
presenting arrhythmia . 
976·111 
BaiIoc2yI:IImIic Bellefit of IJ:IW Baergy Dlafibrillation. 
Tetsuya Rata, George Vassolas, Zhi Qian;J Zhal, 
Ferdinani J. Veniitti, Jr. 
Lahey Clinic Medical Center, fmlin;Jtan, MA 
365A 
Previcusly we reported that hemxlynamic dIan;Jes durin;J 
sustained ventricular tac:hyanhythmias are reflected by 
dIan;Jes in mixed VeJnlS O2 sat (SV02). To evaluate 
potential heIoodynamic benefit of 10irl energy shocks for 
CUlVersion of arrhythmias, SV02, heart rate (HR), am mean aortic blood pressure (BP) were JlDlitored 
oontinuoJsly durin;J defibrillation threshold testirg at 
the time of illplantable cardioverter defibrillator (leD) 
iltplantation. Ninety-nine episodes of ventricular 
fibrillation (VF) were teJ:minated usin;J 0.5-30 jcWes in 
25 patients urdergoirr:J lc) ilIplantation. Cl:>ronaly artezy 
disease was present in 18 am ejection fraction was 35.6 
± 14.2% (~ 12-72). 'lhe retXNerj time (Rr) of SV02 
(fran defibrillation to return to baseline SV02) was used 
to define resuDption of nonnal. circulatory function. VF 
duration was 18.6 ± 3.7 sec. 'lhe Rr of HR, BP, am SV02 
were 8.3 ± 4.8, 14.4 ± 7.1, am 31.8 ± 7.2 sec 
respectively. '!he SV02 Rl' for 5 jcul.e shocks was 25.6 ± 
2.4 sec, am for 30 jcul.e shocks 40.3 ± 5.1 sec 
(P<O.OOOl). By univariate analysis Rl' of SV02 correlated 
with delivered energy (r=O.69, P<0.001). M.lltiple linear 
regression analysis evaluatin;J HR, cycle len;tb, VF 
duration, energy, nadir SV02, Rl' of HR am BP 
dem:mstrated delivered energy as an in:iependent variable 
correlated with Rl' of SV02~ '!he absolute decrease of 
SV02 (fran baseline to nadir SVO~) was 11.0 ± 4.5%, am 
was correlated with VF duration (r=O.44 p<O.OOl). 
cnlCWS1OO: Time to restoration of nonnal. cirallatory 
flm::tion detemined by SV02 Rl' is related to the atlOJI1t 
of energy delivered to CUlVert VF. ID« energy shocks 
result in faster cirallatory retXNerj post-internal 
defibrillation. 
366A ABSTRACTS 
976-112 
Low Energy Cardloverslon : Is H Really Worth? 
Olga Souza, Pedro Brugada, Sinan Gursoy, Jacob AM, 
Gunter Steurer, Erik Andries, Hugo Vanermen, Francis 
Wellens. Cardiovascular Center, Aalst, Belgium. 
In 10 consecutive patients (pts) undergoing implantation of a 
defibrillator, low energy shocks (LES) (0.1j) were given 
during sinus rhythm (SR), (8 pts) or during ventricular 
tachycardia (VT) (0.1 - 2 j), (5 pts with 12 VT's). During SR, 
atrial fibrillation was induced by the LES in 3 pts. During VT, 
LES terminated 6 VT's but accelerated the 6 others and 
induced atrial fibrillation in 2 pts. One VT was accelerated to 
VF by a 0.1 j shock. In 2 accelerated VT's, a second LES 
failed to terminate VT. All 6 accelerated VT's were 
successfully converted with a high energy (34 j) shock. In 
the 2 pts who were conscious both during the LES and high 
energy shocks during VT pain was subjectively similar. 
Conclusions : LES are effective in terminating 50% of VT's 
but accelerate VT as frequently and do not terminate the 
accelerated VT. LES frequently induce atrial fibrillation even 
with energies of 0.1 j. It seems that LES only delay effective 
therapy with a high risk of complications. 
976-113 
Effect of Changing Capacitors Between Phases of a Biphasic Shock on 
Defibrillation Emcacy 
GregorY P. Walcott, Dennis L. Rollins, William M. Smith, Raymond 
E. HleKer Duke Umv. Medical Center, Durham, N.C. 
Most defibrillation using truncated exponential biphasic waveforms 
(TEBW) has been done using one capacitor for both phases. By 
switching two capacitors from series to parallel it is possible ·to create 
a TEBW with phase I (PI) and phase 2 (P2) having different tilts. 
This study was undertaken to examine if changing the capacitance 
used for each phase would influence leading edge voltage (LEV) and 
total delivered energy to the heart(TDE) necessary for defibrillation. 
Six open-chested swipe, appr0"1 i5 kg, were studied. Two 
epicardial patches, 22 em and 20 em were sewn to the R.V. outflow 
tract and the L.V. freewall. TEBW were used. PI was 6 msec. P2 
varied from 0 to 8 msec in 2 msec steps. Three capacitor/waveform 
combinations were tested: 150:150 .... f (PI capacitor:P2 capacitor) 
with P2 LEV equal to PI trailing edge voltage (TEV), 15(f:300 .,.f 
with P2 LEV equal to 112 times PI TEV, and 300:150 .... f with P2 
LEV equal to PI LEV. 
300 
~ 200 I 6:0 6:2 .... ! 6:4 100 6:6 
0 
o 6:8 
Biphasic shocks were than monophasic (p < .05) for 
all three combinations. Increasing the size of the P2 capacitor did 
not change defibrillation efficacy. The waveforms using PI = 300.,.f 
defibrillated at a lower LEV than those using PI = 150 .... f except the 
6:8 msec. TDE necessary for defibrillation was not different for any 
biphasic waveform, mean TDE 2.36::.93J, except the 300:150 .... f 6:8 
msec, which was higher at 6.85:: 4.51J. 
Lowering the tilt of P2, at the cost of lowering LEV of P2, does 
not improve defibrillation efficacy. There are two energy values that 
are important in defibrillation: I) TDE and 2) the energy necessary 
to charge the capacitors in the device (ECC). Though TDE does not 
change, increasing the size of the PI from 150 .... f to 300 .,.f decreases 
PI LEV necessary for defibrillation. Since ECC is proportional to 
LEV, increasing the size of the PI capacitance decreases the ECC 
and thus improves the device's efficiency. 
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977-89 
Variability and Predictive Value of Fractal 0 for Future Events 
In Patients with Life Threatening Arrhythmias 
Labros Karagounis, Kenneth M Stein, Ronald L Menlove, Jeffrey L 
Anderson. University of Utah, Salt Lake City. Utah, and Comell 
University, New York, New York 
Chaos theory may provide new insights into apparently random 
biological events, Including cardiovascular events. A method has 
been developed that derives a fractal dimension (D), to describe the 
clustering of ventricular premature complexes (VPCs). in time. The 
value of 0 ranges from 0, In case of extremely high clustering of 
VPCs, to 1. In the case of VPCs uniformly distributed in time. To 
determine the variability and the prognostic value of VPC clustering, 
assessed by 0, we studied 33 consecutive patients (pt) with life 
threatening ventricular arrhythmias (indUCible sustained VT or VF), 
followed up to 5 y on "effective" antiarrhythmic therapy: group I =18 
pt (15 males; age [X±SO) 62±13) with recurrences of VTNF within 19 
to 1401 d (median=304). group II =15 pt (13 males; age 71±8) 
without recurrences during 65 to 1889 d (median=1127). 0 values 
were determined for 200, 500, and 1000 VPCs from each of 2 
consecutive days (dl and d2) of baseline ECG monitoring off drugs. 
o <0.91 (literature derived) was defined as high risk (increased 
clustering) and 0 ~ 0.91 as low risk. Variability of pt classification by 
o values was assessed by the kappa test (k) of agreement and 
McNemar test (z) of bias. Higher levels of agreement were found for 
within days (0200 vs 0500 vs 01000, k=0.36-0.92) than between 
days comparison (k=0.10-0.47). Agreement between days 
increased with the number of beats analyzed. Further, McNemar's 
test suggested that rates of clustering tended to be lower, ie higher 
0, with increasing numbers of beats analyzed. However. when low 
o values were required on both dl and d2. all pt (N=7) experienced 
VTNF within 4 y whereas pt with high 0 on at least 1 day (N=26) 
showed relatively high 5 Y event free survival (0200=52%. p=O.Ol; 
0500=53%, p=0.02; 01000=48%, p=0.10, vs low D). Conclusions: 
Fractal 0, a measure of VPC clustering 1) exhibits considerable 
variability. both day to day and with number of VPCs analyzed, but 
2) predicts events when pt consistently exhibit low O. 
977-90 
Risk stratification in Dilated cardiomyopathy 
and Honsustained ventriCUlar Tachycardia: 
utility of Bleotrophysiologic Testing Revisited 
Paul Tamburro, John Kall, Brian Olshansky, 
Jeffrey Baerman, David Wilber_ Loyola University 
Medical Center, Maywood IL. 
Forty consecutive patients (pts) with idiopathic 
dilated cardiomyopathy, asymptomatic nonsustained 
ventricular tachycardia, and ejection fraction < 
40%, underwent prospective risk assessment with 
electrophysiologic testing (EPT). The mean age 
was 49±15 yrs, mean ejection fraction 23±9%, and 
21 pts were functional class 3 or 4_ At baseline 
EPT (3 extrastimuli, 2 right ventricular sites), 
sustained monomorphic ventricular tachycardia 
(SMVT) was induced in 6 pts (15%)_ All other 
results were considered nondiagnostic_ 
pts with inducible SMVT at initial EPT received 
drugs which suppressed SMVT induction (N=2) or 
amiodarone (N=4). Remaining patients received no 
antiarrhythmic therapy. During a mean follow-up 
of 18.3 mo, 3 pts were resuscitated from cardiac 
arrest (CA) and 4 pts had sudden death (SO). 
Kaplan-Meier incidences of SO/CA were: 
lYB 2YR 
IPT-SMVT (X=&, SD/CA:3) 44±25% 72±23% 
BPT-XO SMVT (H=34, SD/CA=4) 7±5% 12±7% 
(p<O.022, log-rank). Cox analysis of clinical, 
hemodynamic, and EPT variables revealed only 
inducible SMVT at baseline EPT as a significant 
predictor of SO/CA (p=O.013, relative risk 2.2). 
Conclusions: In this population, the baseline 
induction of SMVT is uncommon, but is associated 
with a high risk of SO/CA. Absence of inducible 
SMVT using an aggressive EPT protocol identifies 
a subgroup at lower risk of SO/CA. 
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977-114 
Abnormal intraventricular conduction in patients with 
Hypertrophic Cardiomyopathy and out of hospital ventricular 
Fibrillation. 
RC Saumarez, A Panagos, M de Belder, I Simpson, AJ Camm 
and WJ McKenna. 
Department of Cardiological Sciences, St Georlle's Hospital 
Medical School, London SW17 ORE, United Kingdom. 
Although ventricular arrhythmias are implicated in sudden 
death in Hypertrophic Cardiomyopathy (HCM), no specific 
electrophYSlOlogicai abnormalities have been found in these 
patients. Disarray may cause dispersion of ventricular 
activation due to changes in fibre calibre, tortuosity and 
fibrosis and so create tbe substrate for reentrant tachycardia. 
This hypothesis has been tested using a novel method of 
characterising intraventricular conduction in 26 patients with 
HCM, four of whom survived out of hospital VF and 4 contois. 
Four bipolar electrodes were placed in the right ventricle 
(RV). Conduction curves were measure by pacing each 
electrode and recording from the other electrodes within the 
RV. The right atrium was paced synchronously. Each 
component of the high pass filtered electrogram was used to 
construct conduction curves of latency versus extrastimulus 
coupling interval. 
Results: Patients with VF had qualitatively different 
conduction curves with evidence of increased fragmentation, 
early increase in latency and widening of the electrogram with 
increasing stimulus prematurity. The rate at which latency 
increased was different in different recording channels 
indicating that ventricular decrement occurred. The other 
patients showed much later increases in latency and no change 
m electrogram width. The curves were characterised with two 
parameters: the point of increased latency (vf:375, rest: 270 
rns) and the increase in electrogram width at the refractory 
period(vf:27.8, rest7 rns) and discriminant analysis showed that 
these distinguished VF survivors from the remaining patients 
at a significance of P < 0.0001. 
977-115 
Age and Gender Differences in Congenital Long 
QT Syndrome: A study in 328 LQTS Families. 
EH Locati, AJ Moss, PJ Schwartz, WJ Hall, S 
Choi, JL Robinson, M Andrews, S Sala, and the 
LQTS Study Group. Univ of Milan, Milan, Italy; 
Univ of Rochester Med Center, Rochester, NY. 
The LQTS Study presently enrolls 3158 subjects 
from 328 LQTS families. Among index cases (pro•
bands), with 80% history of cardiac events, a 
female prevalence was observed (224/326, 69%, 
pc.0001). Proband males (M) were younger than 
females (F) at enrollment (15±13 vs 24±16 yrs, 
pc.0001) and at 1st event (9±10 vs 16.±13 yrs, 
pc.0001). Enrollment rate of M and F was equal 
until age 15 and 1 to 4 after. The probability 
of having a 1st event by age 15 (Kaplan-Meier 
survival analysis, birth as time of origin) was 
70% in M and 45% in F (pc.01) and 92% in both 
sexes by age 50. Among the 1674 family members 
with available ECG, gender distributioi was e•
qual. Corrected QT int.erval (QTc, msec"±SD) was 
longer in F (n=868, 446.±42) than in M (n=806, 
433±47, pc.0001) and long QT interval (QTc>440) 
was more frequent in F (409/868, 47%) than M 
(276/806, 34%, pc.0001). QTc was stable across 
ages in F, while it decreased after age 15 in 
M. History of cardiac event.s was more frequent 
among F (105/868, 12%) than M (71/806, 9%, pc 
. 05). Age distribution by gender was not equal, 
as 72% of M and only 45% of F (pc.01) had a 1st 
event by age 15 yrs. The QTc decrease in males 
after age 15, whose mechanism is unknown (male 
hormones?), may explain a prevalence of females 
of older age and may require a gender and age 
adjustment in the risk stratification of LQTS. 
ABSTRACfS 
977-116 
EXTRAC,llRDIAC ANI) INTRACARDIAC DELAYED ACTIVATION IN 
ARPHYTHt-'Of.ENIC RIGHT VENTRICUlJlR DYSPLASIA. 
Jun Umemura, Toru Twa. Gilles Lascault. Robert Frank. 
Joelci Tonet, Caroline Himbert. Guy Fontaine. 
Hopital Jean Rostand. Ivry, France. 
Twenty-one pati ents (pts) incl uding 14 ma les. olean 
age 39.6 years with arrhythmogenic right ventricular 
dysplasia (ARVDl who hac drug resistant sustained 
ventricular tachycardia (VT) undErwent 12 leads ECG 
recording with special attention to Post·excitation wave 
(PEH), Signal averaging was made with the /l.RT3 proces· 
sing machine and electrophysiologic study (EP\' Endo•
cardial delayed potential w~re recorded in sinus rhythm 
and Mid·diastolic (MDP) potentials during VT. 
Signal averaging technique disclosed late poten•
tials in 90% of ca~es. Delaved endocardial potentials 
were detected in sinus rhythm in 81% of cases. 
A close correlation was found between filtered QRS 
duration by signal-averaged ECG and endocardial delayed 
potentials duration EP. 
In the 7 pts exhibiting PEWs endocardial delayed 
potentials were observed in all and MDPs in 6. 
In thE: total series MDPs were ohserved i" 66.7%. 
The interval between MPP and QRS was 83 + 32 ms. In this 
zcre pacing at a rate slightly faster than the spor.ta•
neous tachycardia rate was performed. A spike to ORS 
interval of 81 t 35.5 msec was found. In 7 out of R pts, 
concealed entra'inment ~Iithout fusion was demonstrated. 
In 35 clinical VTs. a perfect pacemapping was 
obtained in 31 VTs. At that poi.nt. Endocardial-QPS 
interval. spike·QRS interval were similar and concealed 
entrainment phenomenon was demonstrated. 
Delayed activation plays an important role in ARVD 
and when properly located could be a marker for attemp•
ted ablation. 
977-117 
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Relationship Between Action Potential Duration and Cycle 
Length in Patients with the Idiopathic Long QT Syndrome 
(LQTS) 
Mario Facchini, Antonio Zaza. Carlo Napolitano, Oscar 
Bonazzi, Gaetano M De Ferrari, Peter J Schwartz. 
Clinica Medica 2. Univ. of Milan. and Dept. of Medicine 
Univ of Pavia, Italy. 
Inadequate shortening of repolarization during heart 
rate increases has been proposed by some as a primary 
defect in LQTS. To test this hypothesis. the steady-state 
relationship between the duration of a right ventricular 
endocardial monophasic action potential (APD) and cycle 
length (CL) and the kinetics of adaptation of APD to 
sudden change in CL were examined in 6 LQTS patients 
(pts) and in 8 control subjects. In the range of CL 
between 800 and 400 msec, the steady-state APD/CL 
relationship was fitted by the linear function APD-a+b 
CL. The slope "b" of the regression line was 0.24::t: 0.04 
msec/msec in LQTS pts and 0.22 ::t: 0.05 msec/msec in 
controls (NS). The adaptation kinetics of APD to CL was 
described by the sum of two exponentials: APD(n)- Al 
exp(-Bl.n) + A2· exp(-B2. n) + A3 where n is the 
sequential number of the beat. The first time constant (T 
fast) was < 3 beats and did not differ in the two groups • 
The second constant (T slow) was 34::t: 5 sec in LQTS pts 
and 35 ::t: 6 sec in controls (NS). Thus, in LQTS. APD 
shortens normally as CL decreases. This suggests that the 
intrinsic dependence of repolarization on heart rate is 
not defective. 
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978·78 
Lyinq an4 stan4inq Versus Passive Upright Tilt 
to A ••••• Autonomic Responsiveness 
Elizabeth S. Kaufman, J. Thomas Bigger, Jr., 
Joseph L. F1eiss, Linda M. Rolnitzky, Richard 
Steinman. Columbia University, New York, NY 
To determine if lying and standing were equi•
valent to upright tilt on a motorized tilt table 
as a barostress, we used heart period varia•
bility analysis to assess autonomic activity in 
8 normal subjects during tilt sessions (15 min 
at 0', 15 min at 60') followed by 5 min supine 
and 5 min standing. Changes in high frequency 
power (HFP), a measure of vagal activity, and in 
low frequency power (LFP), a measure of vagal 
and sympathetic activity, were examined. 
0' 
60' 
Li. 
Stan4 
HFP LFP LFP IHFP 
(mean, 95% CI) (mean, 95% CI) Ratio 
565(169,1884) 904(498,1640) 1.60 
156(60,402)** 821(510,1323) 5.28** 
648(214,1961) 2053(1149,3667) 3.17 
231(106,502)* 1657(873,3146) 7.17** 
* p<0.05 ** p<0.01 
The changes during 0'-60' tilt and lying-to•
standing were not significantly different. Both 
methods showed decreased vagal and increased 
sympathetic modulation during upright posture. 
Change in HFP with lying vs standing was as 
great as that observed with subjects asleep vs 
awake. Conclusions: (1) Quiet lying and stand•
ing, which can be performed easily in any of•
fice, can produce changes in autonomic activity 
analogous to those produced during passi~e 
upright tilting on a tilt table. (2) Change 1n 
HFP observed with subjects asleep vs awake may 
be predominantly due to posture. 
978·79 
sp.ctroteapora1 Mapping of the Siqna1-Average4 
BCG Pr.4ict. Bfficacy of Amio4aron. in Patients 
with In4ucib1. v.ntricu1ar Tachycar4ia 
Denise Janosik FACC, Terry Greenwalt, Preben 
Bjerregaard FACC, Carey Fredman, Thomas 
Buckingham FACC. Saint Louis University Medical 
Center, st. Louis, Missouri 
We performed spectrotemporal mapping (STM) of 
the signal averaged electrocardiogram (SAECG) in 
29 pts with inducible sustained monomorphic 
ventricular tachycardia (VT) on programmed 
electrical stimulation (PES) before and after 
13. 0±6. 0 days of oral Amiodarone (A) loading. 
The clinical arrhythmia was sustained VT in 15 
pts, sudden death in 9 and syncope in 5. The 
underlying cardiac disease was coronary artery 
disease in 24, idiopathic dilated cardiomyopathy 
in 4 and valvular disease in 1. STM was 
performed on the terminal QRS and ST segment 
producing 99 2ms slices for observation. The 
peak dB output was measured in the ST segment 
(125-250Hz). Twenty-three pts remained 
inducible on A (POS-PES) while 6 pts were 
noninducible (NEG-PES). The change in peak dB 
output on STM after A loading was -4.5±4.9 dB in 
pts with NEG-PES and + 2.0±3.9 in pts with POS•
PES (p=.002). using a change in peak output of 
o dB as a cutpoint, STM had a sensitivity of 78% 
and specificity of 83% for predicting PES 
noninducibility on A. In conclusion, pts with 
NEG-PES after A loading demonstrate different 
changes in STM of the SAECG compared to those 
with POS-PES. Further prospective studies are 
needed to determine if 5TM is a useful method of 
predicting drug efficacy. 
978·80 
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Fractal Geometry of Ventricular Ectopy Durlnll Ambulatory 
Monltorinl and Sudden Death ID Mitral ReauraltatloD 
Kenneth M Stein, Jeffrey S Borer, Clare Hochreiter, Peter M 
Okin, Edmund M Herrold, Richard B Devereux, Paul Kligfield, 
Cornell Medical Center, New York, NY. 
Fractal geometry, a mathematics of irregular objects. may 
be used to analyze patterns of ventricular ectopy (VE). The 
method yieldS a fractal dimension (D) which is a measure of the 
temporal homogeneity of a given patient's VE. D values of 1.0 
represent a uniform distribution of VE while lower values are 
inversely related to the extent of clustering: D < 0.90 makes a 
uniform random distribution of VE unlikely (p<0.05). Previously, 
we found low D to be a marker of poor prognosis in patients with 
dilated cardiomyopathy. To determine the physiologic correlates 
and prognostic value of the teChnique in a different population. 
we studied 39 patients with valvular causes of severe mitral 
regurgitation (MR) and at least 200 VPCs during a 24 hour period 
who were followed for up to 9.2 years. Radionuclide 
cineangiography was used to determine left ventricular (L VEF) 
and right ventricular (RVEF) ejection fractions. D was not 
significantly correlated with LVEF. RVEF. or conventional 
measures of frequency and complexity of VE. Patients were 
classified into groups according to ventricular performance 
("poor": LVEF ~ 45% or RVEF ~ 30%. 'normal" otherwise) and 
fractal dimension ('clustered VE': D < 0.90. "uniform VE" 
otherwise). By ANOVA. there was an excess of sudden cardiac 
death in the group with poor ventricular performance and 
clustered VE (4/7. 57%) compared to the group with poor 
ventricular performance and uniform VE (1/5, 20%, pzO.02) but 
no deaths in patients with normal ventricular performance 
regardless of the presence or absence of clustered VE (0/19 vs 0/8, 
pzns). In this MR population, all mortality was confined to 
patients with subnormal ventricular performance but, within this 
high risk subgroup, clustered VE further increases the risk of 
sudden cardiac death. 
978·81 
Circadian Variation of Ventricular Tachycardia in Patients 
After Myocardial Infarction 
Dirk Hausmann. Hans-J. Trappe. Klaus Bargheer. Werner G. 
Daniel. Paul Wenzlaff. Paul R. Lichtlen. Hannover Medical School, 
Hannover. Germany. 
Circadian variations are present in various cardiovascular disorders. 
The diurnal pattern of episodes of ventricular tachycardia (VT: 2.6 
consecutive beats. heart rate> lOO/min) was studied in 175 pts with 
angiographically proven coronary disease, prior myocardial in•
farction (MI) (> 3 months) and 2.1 VT during 24-hour ambulatory 
ECG monitoring without antiarrhythmic therapy. A total of 192 VTs 
were detected in 156 pts (19 pts with > 5 VTs were excluded for 
statistical reasons). Between 8 and 12 a.m., 42/192 (22%) VTs were 
observed (relative risk (RR) of 1.4 VS. the rest of the day). The 
morning peak increased in the presence of left ventricular (LV) 
ejection fraction (EF) <0.40 (RR 2.6) or VT length> 15 beats (RR 
3.0). Ten!l4 (71 %) episodes of VT > 30 heats occurred between 8 
and 12 a.m .. The diurnal variations for VTs in pts with EF 2. or 
< 0.40. and for VTs ~ and > 15 beats were: 
o EF~OAO 
• EF<O.40 
40 
~30 
> 
.. 20 
o 
~10 
0'16 bMta 
... 16 bMta 
o 4 8 12 18 20 24h 0 4 8 12 18 20 24 
In post-MI pts. the overall incidence of VTs increases only slightly 
in the morning. However. high-risk VTs (poor LV function or long 
VT duration) show a prominent morning peak: this may explain the 
similar diurnal variation of sudden cardiac death. 
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978·82 
Interchangabillty of Barorenex Sensitivity and Holter Derived 
Measures of Heart Rate Variability In Post Infarction Patients. 
Tom Farrell, Yaver Bashir, Osola Odemuyiwa, Peter Counihan, 
Marek Malik, Clare Fuller, David Ward, John Camm. 
St Georges's Hospital Medical School, London,UK. 
Spectral and temporal measures of heart rate variability (HR V) 
derived from Holter recordings were compared to arterial 
baroreflex sensitivity (BRS) in 63 post infarction patients. 
Arterial BRS, the pNN50 and HF components are said to be 
specific markers of vagal activity in contrast to global measures of 
HRV such as the SDRR and HRV index. A significant 
correlation was noted between the HF component of the heart 
rate spectra and arterial BRS (r = 0.6, P < 0.0001) but this was 
not strong enough to predict baroreflex sensitivity. Global 
measures such as the SDRR and HRV index correlated poorly 
with BRS and only weak correlations were noted bteween BRS 
and the pNN50 (r= 0.45, p <0.0001). However, significant 
correlattons were noted between the pNN50 and HF component 
(r = 0.8, p < 0.001) sugg~~ting that these indices may be use? 
interchangeable. 1n addltton there was a moderate correlatton 
between the LF component and arterial BRS (r= 0.45, p < 
0.001) suggesting a Significant parasympathetic component in its 
genesis. 
BRS 
SDRR 
HRVx 
PNN50 
BRS SDRR 
1.00 0.35 
1.00 
HRVx 
0.26 
0.75 
1.00 
PNN50 HF 
OS 0.50 
0.45 0.48 
0.02 0050 
1.0 0.77 
LF 
0.45 
0.45 
0.60 
0.57 
LF:HF 
0.30 
0.35 
0.40 
0.08 
Conclusion. Differing measures of HRV correlate poorly with 
BRS and are not interchangable. As only the SDRR and HRV 
index are known to have pro~ostic value, the role of spectral 
measures and the pNN50 which are specific for vagal activity 
requires prospective testing in post infarction risk stratificatton. 
978·83 
Long Tarm Reproducibility of Heart Rata V ..... blUty 
George Monlr, D.n Flntal, Jeny Weiss, Feng Zhang, Tim Bemauer, Nader 
Sahyounl, Donald Singer. Northwestem Medical School, Chicago, Illinois 
Heart rate variability (HRV) has been suggested as an Index of risk of mortality 
and of progression of structural heart disease (SHD). Optimal utRIty requires 
that HRV reftects changes In clinical atate. To test the hypothesis that HRV 
Is .constant during periods of clinical atability .nd decreases with malor 
cardiac events, we studied HRV values from forty.four 24 hour Holter 
monitoring records of 19 subjects. There were 7 normal volunteers with 2 
Holters aver .5- 4.5 (T:5) years and 12 patients with SHD with 2-4 Holters over 
0.5-10 (4.1') years with II generally stable clinical course punctuated by 
periods of lnatability due to the occurrenca of one or more malor 
cardiovascular events. Clinical stability was defined as no malor cardiovascular 
event within prior 6 months and no significant change In medication. Time 
domain HRV was defined as the mean of the standard deviation of all 5 min. 
parlods (SO measure, msec). High (.35-.5 Hz), middle (.15-.35 Hz), low (.05-
.15 Hz) .nd very low frequency (.017-.050 Hz) power spectrum bands 
(msec'/Hz) also were assessed. Group mean differences for each HRV 
measure were calculated during periods of clinical stabUIty and Instability. 
Group HRY differences dYring: 
HRY Measyre StabilItY Period InstabilItY Period 
~ ~ .§!:!Q 
SO measure 1.9 -2.2 -15.2 •• 
High frequen~ 0.0 -0.1 -0.5 • 
Middle frequency 1.4 -0.6 -1.6· 
Low frequency 2.5 -2.5 -4.4 •• 
Very Low frequency 2.4 -0.8 -5.1 •• 
• = P < .OS, •• = P < .008, All others not slgnWicant. 
Statistical analysis, using the WRcoxon sign rank test, showed; 1) HRV did not 
change during periods of clinical stability for both normals and SHD patients 
and 2) In conjunction with maJor cardiovascular events, HRV and all power 
spectrum bands declined significantly. These data support the use of serial 
determination of HRV to monitor progression of disease. 
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978·84 
A Multicenter Study Establishing Signal-Averaged ECG 
Criteria for Frank XYZ Leads Using Fourier Transform 
Filter 
Stephen Hammill, Michael Kienzle, Patrick Tchou, Donald 
Underwood, W. Kenneth Haisty, Yukio Ozawa, Mayo Clinic, 
Rochester, Minnesota 
Diagnostic criteria for signal·averaged ECG (SAECG) 
were developed using uncorrected bipolar XYZ leads and 
the bi-directional Butterworth (BB) filter. This study 
reports criteria for corrected Frank XVZ leads and 
Fourier transform (FFT) filter. 
Methods: SAECG criteria (40 Hz filter) were . 
deveropea-Qn 87 controls and validated on 182 pts, age 58 
+ 12 yrs, with coronary artery disease (CAD) and QRS <118 
ms. CAD pts were tested for ventricular tachycardia (VT) 
induction during electrophysiology (EP) testing (3 
stimuli, 2 drives, 2 RV sites, 30 sec monomorphic VT or 
intervention; 104 EP+, 78 EP-). 
Results: SAECG parameters that best characterized 
cont~O percentile) and separated EP- from EP+ 
patients (selected by logistic regression) were: filtered 
QRS duration <120 ms, low amplitude signal duration <38 
ms and root mean square voltage (40 ms) >20 ~V. The 
validation of the criteria versus EP outcome resulted in: 
SAECG criteria SN SP -PV +PV 
1 of 3* ID'% '65% 'SUf m 
2 of 3 73% 83% 70% 85% 
SN=sensitivity, SPzspecificity, PV=predictive value. 
*Number of criteria abnormal for SAECG to be 
pOSitive for late potentials. 
Conclusion: Criteria for SAECG with Frank XYZ leads 
using FFT filter give similar results as bipolar XYZ 
criteria using a BB filter. 
978·85 
Effect. of Thrombolytic Therapy on Late 
potentials after Myoc.rdial Infarction. 
Pierre Savard, John Ferguson, Richard F Davies, 
Martin Gardner, Claude Lauzon, Sylvain Plante, 
Duncan J Stewart, Bruce Sussex, Mario Talajic, 
wayne J Warnica. The Canadian Multi Centre ~AECG 
Study, HOpital du Sacr6-Coeur, Montr6al, Canada 
To assess the effects of thrombolytic therapy 
(TT) on late potentials (LP) after myocardial 
infarction (MI), signal-averaged 
electrocardiograms (SAECG) were recorded 5 to 15 
days after MI in 1181 patients (pts). A first 
group of 525 pts (57±11 yrs) received non•
randomized TT, and a second group of 656 pts 
(60±10 yrs) received conventional treatment. Left 
ventricular ejection fractions were the same for 
the two groups (48±12% and 48±13%). Three 
orthogonal ECG leads were averaged (noise <0.3 
~V) and high-pass filtered at 40 Hz. No 
significant difference was found in the average 
potential of the last 40 ms of the QRS (RMS40, 
35±26 vs 34±32 ~V) or in the duration of the 
terminal QRS (LAS40, 36±14 vs 37±15ms), but QRS 
duration was shorter (p<O. 01) in the TT group 
(QRSd, 105±16 vs 110±21 ms). Late potentials (LP) 
were defined as having QRSd >114 ms, RMS40 <20 
~v, LAS40 >38 ms and no bundle branch block 
(BBB). LP distribution was different (p<O.Ol) in 
the two groups: after TT, 439 pts (84%) had no 
LP, 46 (9%) had LP and 40 (7%) had BBB; in the 
other group, 492 pts (75%) had no LP, 51 (11%) 
had LP and 90 (14%) had BBB. In conclusion: 1) TT 
did not alter LAS40 or RMS40 values. 2) A reduced 
BBB frequency was observed in the TT group. 
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978·86 
Myocardial Ischemia and Mental Stress In Dally Activities 
Richard F. Davies, Habibullah Habib~ Wolfgang Linden, W. Peter 
Klinke, Claude Nadeau, Pierre Dessain, Jennifer A. Buttars, and 
CASIS Investigators. University of Ottawa Heart Institute, Ottawa, 
Ontario, CANADA. 
To study the role of myocardial demand in ischemia due to mental 
stress, we performed 48 hour Holter monitoring (HM) and laboratory 
psychological stress testing (PST) in 127 patients (pts) (age 61 years, 
17 women). With documented coronary disease and a positive 
exercise test (ETf). 
Eighty·five pts had 574 episodes of ST depression (STD) during 
HM. Of these, 8 patients had 24 ischemic episodes associated with 
mental stress noted in the diary, all associated with an increase in HR 
(p<.OOI). Data in the following table are from these 8 patients: 
Diary N HRI Time Lai Severltyl 
Stress 
Exercise 
None 
24 
20 
42 
97 
92 
87" 
7.5 
7.5 
7.5 
.7.6 :!: 9.7 
·7.0:!: 6.6 
·7.2:!: 11.4 
Ibpm at I mm ST depression 2Median (seconds) 3sr depression x time integral 
4p < O.oJ 
No ST depression occurred in any patient during PST. Peak HR 
during PST was lower than at ischemia onset during ETT and HM (ps 
< 0.001), while peak SBP and DBP were higher than at ischemia 
onset during ETT (p > 0.01). 
Conclusion: Ischemic episodes induced by mental stress have the 
same supply-demand relationship as other episodes, with no evidence 
for a lowered ischemic threshold. 
978·87 
A New Tecbnique ror Simultaneously Monitoring Gait and Ambulatory ECG: 
Assessing Effects or Walking on Heart Rate and ECG 
Jeffrey M. Hausdorff. Daniel E. Fonnan. David M. Pilgrim. Joseph E. Mietus. David 
R. Rigney, Jeanne Y. Wei. Beth Israel Hospital, Boston. MA 
The relationship between ECG changes and daily activity is poorly characterized. To 
study this relationship, we developed a technique that simultaneously records 
ambulatory ECG and footfall timing. Footfall is recorded using force sensitive 
switches placed inside each shoe. This IrQvides an indication of a subject' s activity 
(walking. running. siDing. standing) as well as the rate at which the activity is 
performed. The footfall signal is frequency modulated and recorded on one channel 
of a Holter monitor with the ECG on the other(s). All channels are subsequently 
digitized and analyzed by computer. With this technology, we objectively quantify 
the relationship between exercise and ECG changes (heart rate mean and variance. 
occurrence of arrhythmias. ST segment changes). As an example, the figure below 
shows heart rate (HR) and step rate during brief walks by young and elderly SUbjects. 
t-~--~------.-------r------r~0 
5 10 
Time (min) 
In 5 elderly (E) and 4 young (Y) subjects. data consistently show that the increase 
in HR from supine to standing is larger in the young subjects (A HR bpm: Y = 22.6; 
E " 6.1; P < .005), but the increase from standing to walking is larger in the elderly 
(A HR bpm: Y '" .03; E '" 12.6; P < .05). As illustrated above. HR variability. as 
reflected in total spectral power. is larger (Y " 135.9; E = 19.4; p < .05) and 
coeffICient of variation of the step rate is lower (Y = 4.1; E = 9.6; p < .05) in the 
young during walking. CONCLUSION: Tbese examples demonstrate the potential of 
this new technique; it provides objectivity and sensitivity in assessing normal and 
pathologic responses to hemodynamic stresses. It should also provide insight into the 
relationship between silent iscbemia, ST segment changes, arrhythmias and activity. 
978·88 
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Symptom Derived Dosage of Diltiazem Does Not Influence 
Circadian Distribution of Ischemia 
Pieter Sijbring, Erwin Giibe~ Mireille Portegies, Ad van Boven, 
Jan Willem Viersma, Henk Lie. 
Queen Beatrix Hospital Winterswijk and 
University Hospital Groningen, the Netherlands 
We assessed the effects of diltiazem 60 m~ q.i.d. and 
metoprolol CR 200 mg o.d. on the circadian distribution of 
symptomatic and silent ischemia in a randomized, double·blind, 
cross·over study of 32 patients with proven coronary artery 
disease and no treatment other than shortacting nitrates for 
relief of angina. Patients with a positive 24 hours Holter 
monitoring, defined as at least five minutes ischemic ST•
segment depression, were included. 72 hours ambulatory 
monitoring was performed at the beginning and end of each 
treatment period of two weeks. The results showed significant 
differences (p < 0.05) between the two treatments in 
percentual reduction compared to baseline per 24 hours of the 
number of silent ischemic episodes (53% for metoprolol versus 
29% for diltiazem) and mean duration of silent episodes (55% 
vs 22%). However, concerning symptomatic events both 
treatments were equally effective (91% vs 94%). In metoprolol 
treated patients there was a very strong blunting of the morning 
and late afternoon peak of number and duration of 
symptomatic ischemic episodes, while diltiazem did not change 
the circadian distribution of ischemic events. The circadian 
pattern of silent ischemic episodes was assessed for the same 
treatment periods. This was very similar to that of symptomatic 
ischemia. 
Conclusion: Although both drugs were hi~hly effective in 
eliminating symptomatic ischemic activity, dJltiazem did not 
reduce the frequency and severity of silent ischemia nor did it 
alter the circadian distribution of transient symptomatic or 
silent ischemia. 
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979·43 
Effect of Enhanced Preload In Head·Out Water Immersion 
on Exercise Response In Men WIth Myocardial Infarction 
Richard Hanna, Lois Sheldahl, Felix Tristan!. 
VA Medical Center and Medical College of Wisconsin, Milwaukee, 
Wisconsin 
We have previously shown in normal, middle-aged men that the 
central shift in blood volume with head-out water immersion (WI) 
results in an elevated cardiac output (CO) and stroke volume (SV) 
at rest and during exercise when compared to land-based activity at 
the same oxygen consumption (V02). Heart rate (HR) is similar at 
workloads < 50% peak V02 but lower at higher work intensities, 
while systolic blood pressure (SSP) does not differ In the two 
environments. To determine if patients with myocardial infarction 
(MI; ~ 2 months) show a similar response, 15 post-MI men 
exercised upright on a cycle ergometer in WI (32°C) and on land. 
No subject had angina or congestive heart failure and peak 
exercise was limited by fatigue. HR, CO (C02 rebreathing 
procedure), SV, SSP, and V02 were determined at rest and at 
workloads approximating 40, SO, and 75% peak V02. HR and SSP 
did not differ between the two environments at rest or during 
exercise. CO and SV were significantly increased with WI at rest 
but were not altered at any level of exercise by WI. The responses 
at SO% peak V02 were: (Values are means ± standard errors) 
HR CO SV SSP V~ 
(bpm) (1/min) (mllbeat) (mmHg) (mllkg/min) 
Land 102±3 10.S±0.5 105±4 14S±4 14.2±0.7 
Water 103±4 10.8±0.S 104±4 144±4 14.3±0.7 
No differences were seen when subjects on beta-blockers (n=8) or 
subjects with exercise-Induced ST segment depression (n=5) were 
separately excluded from the analysiS. These results suggest that 
myocardial infarction alters the cardiac response to an elevated 
preload stress during dynamic exercise. Near complete utilization 
of the Frank-Starling reserve during land exercise andlor reduced 
myocardial compliance may contribute to the altered cardiac 
response to exercise with WI In men with myocardial infarction. 
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979·44 
Short-Term Bedrest Deconditioning Causes A Loss of 
Complex Heart Rate Variability 
Ary L. Goldberger, Joseph E. Hietus, David R. Rigney, 
Margie L. Wood, Suzanne M. Fortney, Harvard-Thorndike 
Laboratory, Beth Israel Hospital, Boston, MA and Johnson 
Space Center, Houston TX. 
Head-down bedrest (BR) is used to model physiologic 
chages during space flight. BR deconditioning may be 
associated with perturbed autonomic function. We 
postulated that this effect would decrease the degree of 
complex, physiologic heart rate (HR) variability. We 
analyzed continuous HR data from digitized Holter 
recordings in 8 healthy female volunteers (age range 28-
34 yrs) who underwent a 13 day, 6° head down BR study 
with serial lower body negative pressure (LBNP) trials. 
HR variability was measured on 5 min. data sets using 
conventional statistics as well as with a new measure of 
"complexity," termed approximate entropy (ApEn). 
Results (at peak LBNP stage): 
HR Ingex (SQl Pre-BR BR 4d BR 9d Recover:/: 
Mean 116(15) 123(16) 130(14)* 126(14)* 
cv .06(.02) .08( .04) .07(.03) .06(.02) 
ApEn . 79(.31) .51(.26)* .43(.22)* .64( .11) 
* p<.05 vs. Pre-BR; cv- Coefficient of variation 
Conclusions: BR causes a decrease in the complex 
variability of HR during LBNP. Measurement of 
complexity, using a method derived from nonlinear 
dynamics ("chaos theory"), may provide a more sensitive 
marker of this loss of physiologic variability than 
conventional statistical measures. Assessment of HR 
complexity from short data segments may also be useful 
in quantitating deconditioning in other settings, such 
as space flight. 
979·45 
Exercise and Morphologic Comparison of Chronic Atrial 
Fibrillation and Normal Sinus Rhythm 
Kenji Ueshima, Jonathan Myers, William Graettinger, Charles Morris, 
Takeo Kawaguchi, Victor Froelicher. Long Beach VA Medical Center, 
Long Beach, CalHornia 
To evaluate the difference in the response to exercise of patients with 
lone atrial fibrillation (AF) and those in normal sinus rhythm (NSR), 20 
male NSR subjects and 20 male patients with AF of similar age were 
matched by left ventricular ejection fraction (LVEF). All subjects were 
free of morphological heart disease. Maximal treadmill testing using 
ventilatory gas analysis and resting echocardiography with measures 
of left atrial dimensions (LA!)), left ventricular end-diastolic diameter 
(LVDD), left ventricular end·systolic diameter (LVDS), and LVEF were 
performed: 
NSR 
(n=20) 
AGE 59.6±1.7 
LAD (mm) 40.5±1.2 
LVDD (mm) 51.0±1.4 
LVDS (mm) 36.3±1.4 
LVEF (%) 62.6±1.7 
HR supine (bJmin) 64.9±2.4 
HR max (b/min) 160.2±3.6 
V02max (ml/kg/mln) 28.1±1.3 
(* .. P < 0.05; Values are mean±SEM) 
AF 
(n=20) 
63.1±1.4 
46.8±1.9 
55.S±2.0 
39.4±1.8 
62.S±1.5 
92.4±4.4 
189.0±7.0 
23.4±0.8 
While stepwise regression demonstrated that age predicted 
0.12 
0.01" 
0.08 
0.19 
0.98 
<0.01* 
<0.01" 
<0.01* 
V02max In NSR subjects, no hemodynamic or morphological 
variables were signHicantl) related to V02max in AF. The lower 
V02max among patients w~h AF despite a higher maximal heart rate 
and normal resting LV fun .. 1ion suggests an attenuated stroke 
volume response to exerclee. Thus, the higher maximal heart rate In 
AF cannot adequately compensate for the loss of the atrial 
contribution to LV filling an"; thus cardiac output during exercise. 
ABSTRACfS 371A 
979·46 
Endurance Training Enbances Parasympathetic Activity: 
Possible Explanation for the Favorable Eft'ects of Exercise 
on the Survival ofPost-In&rction Patients 
Rochelle L. Goldsmith, Richard C. Steinman, Mark A. Apfelbaum, 
J. Thomas Bigger, Jr. Columbia University, New York, NY 
Enhanced parasympathetic nervous system activity (PNSA) is 
associated with a decrease in mortality in pta after myocardial 
infarction (MI), but it remains uncertain what therapeutic interven•
tions may be used to increase PNSA. Although it is assumed that 
exercise training can increase PNSA, studies have reported 
conflicting results· perhaps because PNSA was measured for only 
brief intervals and only during daylight hours (when PNSA is low). 
We therefore compared PNSA in 8 endurance-trained (T) men 
(V02max = 67 ml/kg/min) & 8 age matched (mean = 29 yra) untrained 
(UT) men (V02max = 36mIJkg/min). Two sensitive and specific 
indices of PNSA were assessed noninvasively (from 24·hour ECG 
recordings) by calculating beat-to-beat heart period variability (HPV): 
[1] in the time domain by root mean square successive differences 
[r-MSSD] to exclude the effects of gradual trends in heart period, and [2] 
in the frequency domain by high frequency power [HFP], (0.15-
0.40Hz). The data were analyzed separately for sleep hours, when 
PNSA is dominant, and for waking hours; "= p < .001 (UT VB T)' 
r-MSSD (msec) HFP (msec2) 
Untrained Trained Untrained Trained 
IWake 25±7 67±23" 225± 164 1065±661 " 
I Sleep 39±13 101±35" 516±352 2410± 1647" 
I 24-hour 30±8 75±22" 318±193 1399±776" 
Thus, PNSA is substantial1y greater in T than in UT, and this effect is 
present during both waking and sleeping hours. These data suggest 
that exercise training increases PNSA, and such an effect may help to 
explain why exercise decreases mortality in post-MI pts (conclusions 
based on published meta-analysis). This effect is maintained for the 
entire day and may provide an adjunct or alternative to drug therapy 
in achieving favorable alterations in autonomic balance. 
979·47 
Reduced Ventilatory Oxygen Uptake In Hypertensives 
William F. Graettinger, David H. Smith, Joel M. Neutel, 
Jonathan Mrers, Victor F. Froelicher, Michael A. Weber. 
VA Medica Center, Long Beach, CA and University of 
Califomia, Irvine, Irvine, CA 
To evaluate the effects of hypertension on maximal oxygen 
uptake (V02m), we studied 93 male volunteers, 55 
normotensive and 38 hypertensive (as defined by 24-hr DBP 
> 85 mmHg) with maximal treadmill testing including expired 
gas analysis, 2·0 and M·Mode echocardiography, and 24·hr 
automated blood pressure monitoring, The subjects were 
healthy and had normal physical examinations and 
echocardiograms. Reported activity levels were similar in 
both groups. The hypertensives were older (53±11 vs 46±12 
yrs, p<0.05) and had lower V02m (28±6 vs 34±11 mllkgJmin, 
p<0.002) than normotensives. As in previous studies, V02m 
was inversely related to age, r = ·0.57, p<0.0001 (V~m = 57 
• 0.48 * age). 24-hr DBP was inversely related to V~m and 
improved the fit of the multiple linear regression between 
V02m and age (r = ·0.64, P <0.0001), After the influence of 
age was controlled for by ANCOVA with age as a covariate 
allowing assessment of the influence of hypertension on 
V02m, the presence of hypertension was still associated with 
lower V02m, p<0.005. Therefore, after accounting for age, 
gender, and activity level, the presence of hypertension is 
associated with a lower V02m in male hypertensive subjects; 
the reduction in V02m is almost 2 METS. Moreover, the level 
of V02m was inversely related to 24·hr DBP. The 
mechanism of the reduced V02m in hypertensive subjects is 
unclear but may be due to myocardial or peripheral 
abnormalities secondary to hypertension. 
372A ABSTRACTS 
979·75 
Increased Plasma Vasopressin and Reduced 
Sympathoadrenal Response to Upright Exercise 
in Cardiac Transplant Recipients 
Arne Westheim, Ingrid Os, Gudmund Nordby, Arne 
Benestad, Sverre Kjeldsen, Ivar Eide. 
Department of Medicine, Ulleval Hospital, 
University of Oslo, Oslo, Norway 
To evaluate the neuroendocrine responses to an 
upright exercise test (EX) on bicycle in 
cardiac transplant recipients (Tx), 7 male 
patients (S6~1 years) with ejection fraction 70 
+2% and without coronary heart disease were com•
pared with 7 age-matched healthy control sub•
jects (e). Vasopressin (AVP) , epinephrine (E), 
norepinephrine (NE) in arterial plasma, heart 
rate (HR), and systolic blood pressure (SBP) 
were examined. Maximal oxygen consumption in Tx 
was 20+3 ml / / / / min kg, and 30+1 ml min kg in e. 
rest max Ex 
~x e Tx C 
HR (bpm) 99+3 72+4*** 141+6 160+S* 
SBP (mmHg) l3ft8 133+4 166+12 213+S*** 
AVP (pg/m1) S.1+2 6.S+1 44+11 17+3** 
E (pg/ml) 38+1 61+27* 197+80 309+139* 
NE (pg/m1) 171!:2E 229!:28 21S2!:36 2710!:S80* 
***)p<O.OOl **)P<O.Ol *) P <O.OS 
NE and HR were correlated during Ex in Tx (r= 
0.88, p<O.Ol), suggesting that the increase in 
HR may be mediated through increased NE. 
These data are compatible with both an affe•
rent denervation causing increased AVP due to 
reduced tonic inhibition through vagal afferents 
as well as with efferent denervation causing 
reduced sympathetic response during Ex in Tx. 
979·76 
Relationship aetveeD Heart Rate DuriDg Daily 
Activity aDd During Bxercise iD Patients With 
Atrial ~ibrillation. 
Rodney H. Falk, Nancy J. Battinelli, Arthur 
Pollak. 
Boston City Hospital, Boston, MA 
Wide heart rate (HR) swings may occur in pts 
receiving digoxin therapy for chronic atrial 
fibrillation (AF) despite adequate resting HR. 
To determine whether these swings represent an 
exaggeration of the normal HR variation seen in 
sinus rhythm (SR) we performed maximal exercise 
tests (ETT) and Holter monitoring in 11 pt with 
chronic AF receiving only digoxin and in 11 
controls in SR. Pre-ETT resting HR did not 
differ between AF and SR groups but mean peak 
exercise HR was higher in AF (190 VS 148, P < 
0.01) as was peak HR during daily activity (177 
vs 128, P < 0.01). The ratio of Holter peak/ETT 
peak HR did not differ between AF and SR groups 
(87% vs 93%, psNS). We conclude that while 
resting HR may not differ between pts with SR 
and AF, peak values during daily activity are 
much greater in AF. The finding that the ratio 
of peak daily HR to peak HR on maximal exercise 
in the 2 groups is similar suggests that 
excessive HR swings in patients with AF 
represent an exaggerated response to normal 
daily changes in autonomic activity and indicate 
the inefficacy of digoxin during surges of 
heightened sympathetic tone. 
979·77 
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Do Prejunctional Angiotensin II Receptors Modulate 
the Norepinephrine Response to Exercise? 
Urs Leuenberger. Steven S. Gubin. Howard Noack. Dwight 
Davis and Robert Zelis. Pennsylvania State University. 
Hershey. Pennsylvania. 
We have shown in normal subjects that there is a significant 
increase in Norepinephrine (NE) and NE spillover (SO) with 
submaximal bicycle exercise. The renin-angiotensin system 
is also activated. To test the hypothesis that part of the 
increase in NE SO may be due to stimulation of prejunctional 
angiotensin II receptors. we used a steady-state infusion of 
3H-NE and measured arterial plasma NE (pg/ml). NE SO 
(nmol'min- 1'm- 2) and NE clearance (eL) (I·min-1. m -2). 
Subjects exercised for 30 min at 25% of their predetermined 
maximal exercise capacity 'before and after intravenous 
enalaprilat (5-10 mg; n=8). placebo (n=4). or nitroprusside (0.5 
~g·kg-I.min -1; n=4). 
fwI.r..II.& Enalaprjlat 
Rest Exercise Rest Exercise 
260 539 418 689 
1.38 2.76 2.20 3.71 
0.91 0.87 0.90 0.95 
Two way ANOV A demonstrated a significant drug effect on 
NE and NE SO. Although we expected enalaprilat to inhibit 
angiotensin II formation and to attenuate the NE and NE SO 
response to exercise. baseline and exercise values were 
higher after drug. Since nitroprusside produced similar 
results. and placebo was without effect. the increased NE and 
NE SO with enalaprilat is most likely secondary to vaso•
dilation and a decrease in blood pressure (enalaprilat: -11 
mmHg; nitroprusside: -9 mmHg). These results suggest that 
prejunctional angiotensin II receptors do not facilitate NE 
release at this level of exercise. 
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980·48 
Influence of Histamine Receptors on Basal Left Ventricular 
Contractile Tone in Humans: use of the H2 receptor antagonist 
famotidine and the beta adrenoceptor antagonist esmolol as 
pharmacologic probes 
Kenneth M. Borow, Donna Ehler, Roger Berlin, Alex Neumann, B.S. 
The University of Chicago Medical Center, Chicago, IL 
Histamine has a positive inotropic action in humans. Recent 
controversial data have suggested that histamine2 (H2) receptor 
blockade depresses overall LV systolic performance in healthy 
volunteers. To explore the possibility that H2-receptors influence 
basal LV contractile tone, 10 normal subjects were studied using 
echo-Doppler and calibrated subclavian pulse data in a blinded, 
randomized, two period crossover trial with measurements 
obtained at the end of each 7 day period. Oral drug administration 
consisted of either the potent H2 antagonist famotidine (40 mg/d) 
or placebo. Left ventricular circumferential end-systolic wall stress 
- rate corrected velocity of fiber shortening (Vcfc) relations were 
generated over a range of loads with methoxamine. Contractility 
was assessed using Vcfc at a common end-systolic wall stress. 
During each study, data were obtained before and during high 
dose intravenous esmolol to determine the contributions, if any. of 
sympathetic reflex responses. Famotidine did not alter blood 
pressure, LV percent fractional shortening, end-systolic wall 
stress, stroke volume index, cardiac index, total vascular 
resistance or ventricular contractile state in comparison with 
placebo but did decrease heart rate by 3 bpm (p< .05). With beta•
blockade, no differences in contractility were evident between 
esmolol and famotidine plus esmolol. Thus, H2 receptor blockade 
with famotidine does not alter myocardial mechanics or cardiac 
sympathetic tone suggesting that in humans basal left ventricular 
contractile state is not physiologically dependent on the H 2 
mediated effects of histamine. 
lACC Vol. 19, No.3 
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980·49 
Effects or Angiotensin II on Plasma Endothelin Levels in Man. 
Joanna GOod, Mohammed Ghatei, steven Bloom, 
Petros Nihoyannopoulos, David Crossman, celia 
Oakley, John Cleland. 
Department of Medicine (Clinical Cardiology) 
RPMS Hammersmith Hospital, London, UK 
The increase in plasma endothelin levels found 
in heart failure correlates with plasma 
angiotensin II (A-II) levels (n=21,r=0.54; 
p<0.05) and in-vitro, A-II releases endothelin 
from cultured endothelial cells. Eight normal 
subjects, mean age 29 years, were studied for 
5 hours. Dextrose water was infused throughout 
and A-II was infused incrementally during the 
2nd, 3rd and 4th hours at 2,4 and 8ng/kg/hr. 
Peripheral venous samples were taken at the 
end of each hour for A-II and endothelin. BP 
was recorded at 15 minute intervals and left 
ventricular outflow tract velocity was 
measured by Doppler. 
Systolic SP and total vascular resistance 
increased (p<O. 001), while heart rate fell 
from 63±3 to 56±3 bpm (p<O.OOl). Plasma A-II 
rose with each increment from a baseline of 
19±14 to l15±50 pmol/l at the highest infusion 
rate. Plasma concentrations of endothelin were 
elevated during infusion of A-II compared to 
dextrose (p<0.05); (0.77±0.16, 0.97±0.24, 
1.03±0.3, 0.93±0.31 and 0.77±0.28pmol/1 at the 
end of the 1st to 5th hours respectively). 
A-II infused at these pressor doses produced 
circulating concentrations of A-II only 
observed in severe heart failure. These levels 
of A-II in the short term, however, produced 
only modest increases in plasma endothelin. 
980·50 
Effect of Intracoronary Diltiazem on Myocardial Ischemia 
during Coronary Angioplasty 
Katsumi Saito. Hiroshi Nonogi. Satoshi Daikoku. Shuichi 
Oshima, Keizaburo Ozono, Akira Itoh, and Kazuo Haze, 
National Cardiovascular Center, Osaka, Japan 
To evaluate the anti-ischemic efficacy of diltiazem to 
myocardial Ischemia during percutaneous transluminal 
coronary angioplasty (PTCA) , 20 patients were randomly 
assigned to receive placebo or diltiazem (2-3mg) in 
double-blind fashion. The drugs were given into the vessel 
through balloon catheters after control Inflation. Subjective 
(pain score: maximum pain=10) and objective (intracoronary 
and standard electrocardiography) parameters during 
second balloon inflation with the drug were compared with 
those during first control Inflation without the drug. 
.1DP .1CP(l10) .1ST(IClmm .1ST(S)mm 
Group A-1093:t1106 -1.1:t0.8 -9.3:t5.1 -2.0:t2.1 
Group 6 105:t884* -0.1:t0.7* -2.7:t2.3" -0.5±0.6* 
Group A(n=10):treatment with diltiazem, Group 6(n=10): 
treatment with placebo, d:changes from control inflation, 
DP:double product, CP:chest pain score, ST:magnitude of 
ST elevation, IC:intracoronary ECG, S:standard ECG, 
*p<0.05, ""p<0.01 vs Group A. 
Conclusjon' Pretreatment with a small dose of intracoronary 
diltiazem reduces myocardial Ischemia during PTCA without 
any complication, and enables to perform a longer balloon 
Inflation. 
ABSTRACTS 
980·51 
Complement Activation by Fluosolll> May Contribute to its 
Beneficial Effect In Myocardial Reperfusion Injury 
David A. Ingram. John J. Murray. Mervyn B. Forman. 
Vanderbilt University, Nashville, Tennessee 
Complement activation has been previously shown to reduce 
myocardial reperfusion injury. Fluosolll>, a complex preparation 
containing 2 perfluorocarbons and various emulsifiers including the 
detergent Pluronic F-68, significantly enhances myocardial salvage 
in both humans and animal models. Since in the dog transient 
hemodynamiC collapse invariably occurs with the test dose of 
Fluosolll>, we investigated whether complement activation was 
produced by Fluosolll> and which component contributes to its 
hemodynamic and cardioprotective effects. • p < 0.05 
CHso SBP Neutrophil Platelet 
1l!Lm!l (mmHg) ~ ~
Baseline 153±13 166±8 6.9±1.4 222±22 
Maximal.. 53±22' 48±4' 3.4±0.7· 55±20' 
Complement activation occurred rapidly; in contrast to the 
hemodynamic effects which reversed within 30 mins, the 
decreases in CHso• neutrophils. and platelets were markedly 
prolonged. In vitro studies with dog serum demonstrated that 
complement activation required the detergent F-68 in combination 
with either perfluorocarbon component; this was confirmed by in 
vivo infusions. Although hemodynamic effects are invariably 
absent in man. low-grade complement activation with the same 
components occurred in vitro. Conclusions: Complement 
activation by Fluosolll> may contribute to its beneficial effects in 
myocardial reperfusion injury. Although hemodynamic effects are 
not observed in humans. activation of complement by Fluosolll> 
occurs in vitro and is mediated by the detergent with either 
perfluorocarbon. Complement activation by Fluosolll> may be 
cardioprotective by sequestering neutrophils and platelets from the 
reperfused myocardium. 
980·52 
373A 
Gemfibrozil Reduces Intermediate Density lipoprotein (IDL) LeYeI 
in Familial Dysbetalipoproteinemia 
Shuiping Zhao. Augustinus Smelt*, Jan Gevers Leuven**. Arnoud van der 
Laarse. and Ferdinand van 't Hooft. 
Departments of Cardiology and Internal Medicine*, University Hospital 
Leiden, and The Gaubius Institute TNO**, Leiden, The Netherlands 
Increased serum IDL level is associated strongly with a high risk for 
coronary heart disease. Little is known about the change of serum IDL 
concentration during treaunent with lipid-lowering drugs. Eight patients with 
familial dysbetalipoproteinemia associated with apo E2(Arg,,,-oCys) 
homozygosity showed a markedly increased serum IDL-cholesterol 
concentration (2.47±0.66 rnmolll vs 0.39 rnmolll of5 normal controls), as 
analyzed by a newly developed density gradient ultracentrifugation 
technique. After 4 weeks of treatment with gemfibrozil (600 mg twice daily) 
mean concentrations of total cholesterol and total triglyceride in serum 
decreased by 45% (from 11.87 to 6.51 mmolll, P<O.OOI) and by 63% 
(from 6.08 to 2.23 mmol/l, P<O.OOI), respectively. Mean concentrations 
of IDL-cholesterol and IDL-triglyceride fell by 34% (from 2.47 to 1.62 
mmolll, P<O.OOI) and by 51 % (from 0.70 to 0.34 rnmolll, P<O.OOI), 
respectively. The observation that concentration of IDL in serum had 
decreased considerably was confirmed by electrophoresis of the same serum 
samples on 2-16% nondenaturing polyacrylamide gradient gels. However, 
the composition of IDL remained unchanged. In addition, the cholesterol 
concentrations of VLDLl (large VLDL) and VLDL2 (small VLDL) fell by 
71 % and 73 %, respectively, whereas the concentrations of HDL-cholesterol , 
apo A-I and apo A-II increased by 29%, 15% and 27%, respectively. The 
concentrations of LDL-cholesterol and apo B remained unchanged. These 
results demonstrate that treatment of familial dysbetalipoproteinemia with 
gemfibrozil induces marked changes in the lipoprotein profile, particularly 
concerning IDL, VLDLs and HDL, which are likely to be associated with 
a reduction of the risk for coronary heart disease. 
374A ABSTRACfS 
980·53 
Cardioselective and Non·Cardioselective Beta·Blockers Elicit Similar 
Adverse Errects on Serum Lipids In Post·Inrarction Patients: 
Multicenter Diltiazem Post·Inraretion Trial (MDPIT) 
William E. Boden, Anhur J. Moss, Peter N. Herbert, Ann Saritelli, David 
Oakes, Shirley Eberly. Boston VA Medical Center and Tufts University 
School of Medicine, Boston, MA 
The precise metabolic basis for the adverse effect of beta-blockers (BB) on 
serum lipids is unclear. Non-selective (NS) ti-receptor (ti, +ti') blockade 
may inhibit lipolysis, thus increasing triglyceride (TG) and decreasing high•
density lipoprotein (HDL) cholesterol (C) levels. For this reason, ti, 
cardioselective (CS) BB are frequently advocated as preferable to NS BB, 
although few, if any, studies have compared the effects of various BB on 
lipids in cardiac pts. Among post-MI pts randomized to the MDPIT, we 
analyzed closeout (mean 25 ± II mo) non-fasting serum lipids (total C, 
HDL-C, TG) on 1556 survivors of whom 748 were receiving no BB, 343 
a NS BB and 465 a CS BB. Lipid results (mg!dl; mean±SD) revealed: 
-L-
No BB 225±45 
NS BB *230±50 
CS BB *230±48 
~(vs. No BB) 0.001 
H.!&.C.. 
39±12 
*37±10 
*36±1O 
0.001 
---..TIL 
208±141 
*244± 154 
*244± 167 
0.0001 
-AIl2:Il 
II 8± 29 
*124±29 
*123±29 
0.0001 
Apolipoprotein (apo) A-I and apo-A-II levels did not differ significantly 
among the 3 groups. Multiple linear regression (BMDP-2R) analyses, 
adjusting for relevant clinical variables showed that, when either NS or CS 
BB were "stepped into" the model, HDL-C (p=0.0001), apo-B (p=0.01) 
and TG (p<0.0001) differed significantly from the No BB group, whereas 
C (p=0.06) and apo-A-II (p=0.04) concentrations for either NS or CS BB 
were of "borderline" significance compared to the no BB group. 
Conclusion: Both cardioselective and non-selective beta-blockers elicit 
similar adverse effects on post-MI lipids and lipoproteins. 
980·54 
Lovastatin - Niacin Ca.parative Trial 
Philip H. Frost, Evan A. Stein, Robert V. Zupkis, Yale B. 
Mitchel, Robert H. Knopp, D. Roger Illingworth, Roger A. 
Greguski, Carlos A. Dujovne, University of California 
School of Medicine, San Francisco, California. 
The lipoprotein altering efficacy and tolerability of 
10vastatin(L) and niacin(N) were compared in a 
randomized, open-label, 26 week study of 136 hyper•
cholesterolemic individuals. Patients received either 20 
mg of L or 1.5 g/day of N for 10 weeks and were titrated 
to 40 and 80 mg of L or 3 and 4.5 g of N based on LDL 
res~onse and tolerability at weeks 10 and 18. Maximal 
dose was achieved in 66% and 54% patients on L and N. 
Changes(%) from baseline were: 
wk 10 wk 18 wk 26 
N L N L N L 
T CHOL -4 -22* -11 -24* -15 -26* 
LDL-C -9 -28* -18 -33* -23 -36* 
Apo B -9 -24* -18 -29* -22 -33* 
HDL-C 18* 5 28* 4 29* 5 
TRIG -21 -13 -29 -18 -36* -20 
Lp(a) -14* 0 -28* 0 -33* 0 
* - significant difference between groups 
Discontinuations due to drug related adverse events(AE) 
occurred in 12%(8) and 6%(4) of patients on Nand L 
respectively(NS). Cutaneous effects (flushing,rash,dry 
skin) were the predominent drug related AEs with niacin. 
Although 8mall but significant rises in SGPT and SGOT 
were noted with Land N, only one patient on N exceeded 
3x ULN for SGPT. Treatment with N resulted in 
8ignificantly greater changes in CPK, fasting blood 
glucose and uric acid than L. 
L was more effective at reducing LDL-C and better 
tolerated than N while N was more effective at raising 
HDL and lowering triglycerides and Lp(a) than L. 
980-55 
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1C1tece_1,:, 1Ii,.I, fffectiYl Upi' Lrnri .. ,. .. 
Huaen Beer ,Denlele Jecubo'tflcz,Rivke Beer, Hospitel cia C1inlcas 
Caracas, Caracas, Venezuela 
Ketoconezole i nhi bits conversion of lanosterol to cholesterol by blockade 
of 14alfedemethvlatlon 'ilth subaequent Inhibition of Hrr;-~ 
reductase. Mditionellyit inhibits bile acid synthesis. Consequently .... 
considered the possibilitg that Ketocolll2OIe might be en effective lipid 
ICMring a9ent.We conducted e controlled randomized double blind study 
to evaluete the effect of Ketoconezol(K )on totel HDL, LDL Cholesterol 
(Chol) and tri9licerides in hypercholesterolemic patients (eve 51:t 12 
gr. 18 fernele, 11 rnelehl'hich .... re non responders to el~ cholesterol 
diet (2501119 clailv)for three months. The pta ..... re randomized to 
treatment 'ilth K for 90 clava 2001119 delly (n .. l 5) and to placebo 
(n-14). lifter treetment with K 81 compored to placebo totel Chol 
decreased by 36S (351 to 225rng/d1,p<0.005), LDL-Chol decreaed bg 
44S (270 to150rng/dl, p< 0,005); an tncreae of 5S In HDL -Chol 
(41 to 43rng/dl,pNS), end a 16S reduction in triglycerides (225 to 
189, p< 0.05) .Ketoconezo1e ...as .... ll tolerated by all potients. 
Thus Ketoconezole in the doses 9iven appears to be I potent end .... ll 
tolereted hypolipemic event. 
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981·21 
Low Dose Chlorpromazine Prol8cts Against Epinephrine Induced Acute 
Platelet Thrombus Formation in Stenosed Monkey Carotid Arteries 
John 0 Folts, Brian Bartha. 
Department of Medicina, University of Wisconsin and Mayo School of 
Medicine, Rochester, MN 
Aspirin (ASA) is the only oral agent approved as an antiplatelet agent (M) to 
prevent acute myocardial infarction (AMI) transient ischemic attacks (T1As), 
strokes and reocclusion after thrombolysis or angioplasty. Howaver, animal 
and human platelets inhibited with ASA can be reactivated with physiologic 
amounts of Epinephrine (E). In 10 anesthetized monkeys (M), carotid artery 
stenosis with intimal damage was produced by plaCing an external constricting 
cylinder around the outside of the exposed carotid artery and blood flow 
measured with EMF probe. Cyclical flow reductions (CFR'S) occurred due to 
acute platelet thrombus formation (APTF) followed by embolization to the 
brain. In 5 M CFR'S ware aboUshed with 5 mg/kg of ASA givsn IV but were 
renewed in 4 of the 5 M with the infusion of E 0.2 log/kg/min givsn IV for 20 
min. In 5 M, CFR'S were abolished with chlorpromazine (CPZ) (Thorazine." 
0.6 mg/kg IV. ASP declined by 10 ~ 8 mmHg, p<.05 and the CFR's were not 
renewed by an E infusion. CPZ is likely to be a better M than ASA since ~ 
has several properties ASA does not since ~: 
1) Is an alpha adrenergic receptor antagonist. 
2) Inhibits the calcium calmodulin complex and light-chain myosin kinase 
activity needed for platelet shape change. 
3) Stabilizes red call membranes thereby raducing hemolysis and ADP 
release in the turbulence of the stenotic lumen. 
CFR'S due to APTF have been observed in the arterias of patients on ASA, 
diazepam and heparin during angioplasty. Since plasma E is elevated in 
patients during angiography procedures, low dose CPZ which has been used 
orally for decades may be a better M than aspirin and protect against APTF, 
TIAs and reocdusion during arteriography procedures whUe also calming the 
patient. It may also be better than ASA for reducing the contribution of 
platelets to thrombotic reocclusion after coronary thrombolysis and! or 
angioplasty. 
JACC Vol. 19, No.3 
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981·22 
Endothelium·Derived Relaxing Factor Exerts Potent Antiplatelet Effects 
In Vivo 
Paolo GoUno, Maurizio Cappelli·Bigazzi, Giuseppe Ambrosio, Enrico 
Russolillo. Massimo Ragni. Massimo Oliariello. Division of Cardiology. 2nd 
School of Medicine. University of Naples. Italy. 
It has been shown that endothelium-derived relaxing factor (EDRF) may 
inhibit platelet aggregation in vi/roo Thislabile substance. released by endothelial 
cells. is indistinguishable from nitric oxide (NO). More recently. it has been 
suggested that EDRF might in fact be a NO-containing compound. such as S· 
nitroso-cysteine (S-NO-Cys). To assess whether NO or S-NO-Cys may also 
inhibit platelet aggregation in vivo, intravascular platelet aggregation was 
initiated by placing an external constrictor around endothelially-injured rabbit 
carotid arteries. Carotid blood flow was measured continuously by a Doppler 
flow probe placed proximally to the constrictor. Following placement of the 
constrictor. cyclic flow reductions (CFRs). due to recurrent platelet aggegation. 
developed at the site of the stenosis. After CFRs were observed for 30 min. NO 
(12 nmol/min for 10 min. n=7) was infused into the carotid artery via a small 
catheter placed proximally to the stenosis. Before infusion of NO. CFR 
frequency averaged 19±3 cycles/hr and CFR severity (lowest carotid blood 
flow as % of baseline values) was 6±1 %. NO completely inhibited CFRs in all 
animals. as carotid blood flow showed a normal and constant pattern (CFR 
frequency = 0 cycleslhr. p<O.OOI; carotid blood flow = 90±5%. p=NS vs 
baseline). These effects were transient. as CFRs returned spontaneously within 
10 min after cessation of NO infusion After CFRs returned. S-NO-Cys (0.3 
nmol/min for 10 min) was infused into the carotid artery. S-NO-Cys was also 
very effective in abolishing CFRs (frequency = 0 cyc1es/hr. carotid blood flow 
= 101±7%. p=NS vs baseline). The role of endogenously·released EDRF in 
inhibiting CFRs was also tested in 3 additional rabbits. In these animals 
endogenous release ofEDRF was stimulated by infusing acetylcholine (Ach) 
into the aortic root (up to 41Lg/min) during carotid CFRs. Infusion of Ach was 
also associated with a complete inhibition of CFRs. similarly to what observed 
during exogenous infusion of NO or S-NO-Cys. These data demonstrate that 
exogenous NO exerts potent antiplatelet effects and suggest that endogenous 
EDRF might importantly contribute to modulate platelet function in vivo. 
981·23 
Bi.topathological Correlation of Coronary 
Arteriographic Lesion Morphology Using Directed 
Atherectoay Derived Specimen.: Frequent Throabua in 
COIIplel: Lesions 
Christos P. Christou, Jacob I. Haft, Jonathan E. 
Goldstein, Raymond E. Carnes. Saint Michael's Medical 
Center, Newark, NJ 
To study the anatomy and pathology underlying the 
arteriographic morphology of occlusive coronary lesions 
the histology of specimens derived using the Simpson 
directional atherectomy device in 24 pts (20 men, 4 
women, age 58.3+13.6, range 30-80) was correlated with 
the coronary angiographic findings. Lesion morphology 
was characterized as irregular complex (eccentric, 
jagged, irregular, roughened lesions with overhanging 
borders or filling defects) or smooth (concentric or 
eccentric lesions with smooth walls). 17 pts had 
atherectomy of LAD lesions, 4 of RCA, 2 of LCF and 1 of 
a vein graft. 5 lesions were smooth: pathology showed 
fibrous plaque with sparse cholesterol clefts in all and 
calcification in I. 19 lesions were irregular complex: 
all had fibrous plaque, 8 had calcification, 3 had very 
prominent cholesterol clefts, 5 had numerous foam cells 
and 18 had thrombus present. These findings suggest that 
coronary lesions that appear irregular and complex on 
arteriography are usually active and are frequently 
associated with thrombus formation whereas smooth 
appearing lesions are mainly due to stable fibrous 
plaque. Use of the atherectomy device affords a unique 
opportunity for study of the dynamics of coronary 
lesions. 
ABSTRACTS 
981·24 
HEPARIN STIMULATES PLATELET AGGREGATION AT THE 
GP IIb/GP lila RECEPTOR INDEPENDENT OF TREATMENT WITH 
ACETYL SALICYLIC ACID. 
Christer Sylvan MD PhD FACC, Jihong Chen MD. Karl-Erik 
Karlberg MD. Karolinska Institute at Departments of Medicine and 
Clinical Physiology. Huddinge University Hospital. Huddinge. 
Sweden. 
Background: Heparin is a well established anticoagulant. 
Treatment might. however. be complicated by arterial 
thromboembolism. 
Ajm of study: To investigate whether treatment with acetyl salicylic 
acid inhibits the proaggregatory effect of heparin and by which 
mechanism platelets are activated. 
~: Blood from healthy volunteers was Investigated with 
whole blood aggregometry before and 3 hours after administration 
of O.S 9 acetyl salicylic acid per orally. Platelet aggregation was 
stimulated by collagen. Receptor mechanisms for platelet 
aggregation were studied after administration of RGDS peptide or 
aurin tricarboxylic acid or after administration of monoclonal 
antibodies against GP Ib and GP IIb/llla receptors. Furthermore. it 
was investigated whether hirudin that inhibits thrombin has any 
proaggregatory effect in this test system. 
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BlllitJ.t: Administration of acetyl salicylic acid partly inhibited platelet 
aggregation. In spite of such inhibition, the proaggregatory effect of 
heparin persisted. Hirudin did not affect platelet aggregation. 
Inhibition of GP Ib receptor by monoclonal antibodies or aurin 
tricarboxylic acid did not inhibit the heparin induced platelet 
aggregation. Also. RGDS or the monoclonal antibody 6D1 thai 
counteracts the GP IIblllla receptor did not interfere with the heparin 
aggregatory effect. However. the GP 1Ib1ll1a active monoclonal 
antibody 10ES counteracted the heparin aggregatory effect. 
Conclysjon: Heparin has a proaggregatory effect independent of 
ASA treatment. The proaggregatory effect is not mediated by the 
GP Ib receptor but by complex epitopes of the GP IIblllla receptor. 
981·25 
Platelet Depletion in Pi~ Inhibits Vasospasm and Neutrophil 
Deposition to Injured Artery by Angioplasty 
Yahye Merhi, Jules Y.T. Lam. Lucie L.·Lacoste, Jean-Gilles Latour, 
Robert Guidoin, David Waters. 
Montreal Heart Institute, Montreal, Quebec, Canada 
Platelets have been implicated in the vasoconstrictive response due to 
balloon arterial injury. This vasoconstriction can be decreased by in· 
hibitors of platelets or its mediators serotonin and thromboxane A,. 
However, the response to thrombocytopenia is unknown. Neutrophils 
also secrete vasoactive substances that can influence vasomotor tone. 
This study investigates the effect of platelet depletion and neutrophil 
depositions (ND) on arterial vasoconstriction (VC) in vivo in pigs after 
arterial injury by balloon angioplasty (5 inflations, 30 sec each at 
6 A TM pressure with 60 sec between inflations). Thrombocytopenia 
was produced by infusion of a rabbit antiplatelet serum which decreases 
platelet count to 14% of baseline while neutrophil count is unchanged. 
Quantitative simultaneous Cr"-Iabelled platelet deposition, PD 
(x l(l"/cm') and In'll-Iabelled ND (x 100/cm') at the site of angioplasty, 
and the degree of angiographic VC in the tapering distal site of balloon 
angioplasty of the common carotid arteries (n = 10 each) were studied in 
heparinized (100 U/Kg intravenous bolus) normal and thrombocytopenic 
pigs and are shown below: (mean ± SEM) 
Pigs % yc PD 
Normal 53.5±5.6 26.7±5.2 
Thrombocytopenic 37.0±5.2 
P < 0.05 
ND 
29.7±6.4 
13.9±2.8 
< 0.05 
As with the use of platelet inhibitors, thrombocytopenia significantly 
reduced but did not eliminate VC despite abolition of PD. In addition, 
neutrophils also accumulate at the site of arterial injury and there was a 
moderate correlation (r=0.56) between ND in thrombocytopenic pigs 
and VC, suggesting a possible role of both PD and ND in VC after 
angioplasty. Platelet depletion also appears to modulate ND. 
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981·26 
Structure and Cellular Composition of Aortic 
Atherosclerotic Plaques undergoing Ulceration 
Jessica M Mann, Michael J Davies, Neville Woolf, 
David R Katz, Peter D Richardson. 
St George's Hospital Medical School, London, U.K. 
Plaque fissuring is a precursor of acute thrombo 
sis in coronary arteries. The caps of aortic pIa 
ques undergo an identical process of tearing 
leading to ulceration but the time course is more 
prolonged. Aortic plaques undergoing ulceration 
were compared with intact plaques of equivalent 
size in the same aorta. The volume composition 
of the plaque for lipid and collagen was measured 
as well as the density of macrophages and smooth 
muscle cells after identification of the cells 
by double immunohistochemical staining. Smooth 
muscle cells were identified by the presence of 
actin and macrophages by the presence of the HAM 
56 antigen. Aortic plaques undergoing ulceration 
(n=24) when compared with intact plaques (n=62) 
had a higher proportion by volume of extracellu 
lar lipid (54,9% (SEM 3,S) vs 22,1% (2,4)). The 
mean macrophage density was increased (122,1% 
(13,3) vs 62,2% (S,S)) and the mean smooth muscle 
count was decreased (65,2% (13,2) vs 122,1% (13,3) 
in ulcerated plaques compared with intact plaques 
The ratio of smooth muscle cells to macrophages 
exceeded 5 in intact plaques but was often less 
than 1 in ulcerated plaques. The 2 major factors 
predisposing to plaque ulceration are an increase 
in the volume of extracellular lipid and a dec rea 
se in the ratio of smooth muscle cells to monocy 
tes in cap tissue. 
981·56 
Endogenously Produced EDRF Protects Against Platelet 
Aggregation and Cyclic Flow Variations In Stenosed and 
Endothelium· Injured Arteries 
Sheng-Kun Yao, Judy C. Ober, Ashok Krishnaswami, James J. 
Ferguson, 1.. Maximilian Buja, James T. Willerson, Tex.as Heart 
Institute and UT Medical School, Houston, TX 
We tested the hypothesis that endogenously produced 
EDRF provides protection against platelet aggregation in vivo. 
Eighteen anesthetized dogs were treated with NG.monomethyl-L•
arginine (~-MMLA), an inhibitor of nitric oxide (NO/EDRF) 
formation, after the endothelium of LAD (n=9) or femoral 
arteries (n=9) was mechanically injured and the arteries were 
slightly narrowed by external constrictors. This treatment induced 
cyclic flow variations (CFVs) caused by recurrent platelet 
aggregation and dislodgement in LADs of 4 of 9 dogs and in 
femoral arteries of 4 of 9 dogs. After the induction of CFVs, L•
arginine, the precursor for NO/EDRF, was administered to the 
animals and abolished CFVs in these 8 dogs. Saline infusion did 
not induce or change CFVs in any of the animals (compared to 
NG·MMLA and L-arginine, p<O.Ol). The diameters of the 
femoral arteries were measured by intravascular ultrasound 
imaging. No significant change in the cross·sectional area of the 
endothelium·injured site was shown after either NG-MMLA (16.4 
.±. 2.1 vs 16.4.±. 2.3 mm2) or L-arginine (16.6.±. 2.1 vs 16.7.±. 1.7 
mm2) a1thou~ a decrease caused by NG-MMLA (10.4 .±. 1.1 vs 
8.9.±. 1.2 mm , P<0.05) and an increase by L-arginine (10.4.±. 1.1 
vs 12.9 .±.1.7 mm2, p<0.05) were observed at arterial sites without 
endothelial injury. Thus, endogenously produced NO/EORF 
appears to protect against CFVs by inhibiting platelet aggregation 
in this experimental model. 
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The Correlation Between Lp(a) and other Hemostasis 
Factors in Patients with Accelerated Atherosclerosis 
Rodger L. Bick, Yahya A. Ismail. Peter K. Fung. T. Anthony Don 
Michael. Central California Heart Institute and Divisions of 
Hematology/Oncology and Cardiology. Department of Medicine. 
UCLA Center for the Health Sciences, Bakersfield and Los Angeles, 
California. 
The pathogenesis of accelerated atherosclerosis (AAS) in patients 
with precocious coronary artery disease (CAD) < SOy of age and 
patients with early restenosis after PTCA. is not clear. Thrombus 
formation was claimed responsible for early restenosis following 
PTCA. HemostaSis abnormalities that can cause. be associated with. 
or indicate a continuing thrombosis and Lp(a) were analyzed in 41 
patients (mean age 44 :t 9.1 y) in AAS and 24 age matched controls 
(mean age 44 :t S.6y) were investigated. The hemostasis factors 
inCluded protein S (PS). Protein C (PC). antithrombin III (ATIII). 
Antiphospholipid Antibodies (APA). Fibrinogen (Fib). Factor VII. 
Tissue Plasminogen Activator Inhibitor (TPA·I). Platelets Factor 4 
(PF4). Fibrinopeptide·A (FPA). plasminogen and Circulating Immune 
Complex (CIC). By using a paired t-test patients with accelerated 
CAD had a higher level of Lp(a). FPA. and lower level ofTPA·1. No 
correlation was found between Lp(a) and any of the analysed 
hemostasis factors. 
Conclusion: Patients with accelerated atherosclerosis have 
significantly high levels of Lp(a) and TPA-I which may predispose to 
thrombus formation. Lp(a) level was not found related to any of the 
analysed hemostasis factor that can explain its thrombotic activity. 
981·58 
Exogenous Nitric Oxide Inhibits Platelet Adhesion 
Following Balloon Angioplasty 
Peter H Groves, Malcolm J Lewis. Hilary A Cheadle, 
William J Penny 
University Hospital of Wales, Cardiff. UK 
Nitric oxide. produced by endothelium, has been shown to 
inhibit in vitro platelet adhesion. We have investigated the effects 
of SIN-I, a source of exogenous nitric oxide. on in vivo platelet 
adhesion following bilatcral carotid angioplasty in the pig. 
Heparinised pigs received SIN-1 (intravenous; 10!lglkg/min; 
n=5) or placebo (n=5) before and during the angioplasty 
procedure. Platelet deposition (PO) was quantified using the 
injection of autologous IlIIndium-labelled platelets. Following 
fixation at physiological pressure. the vessels were excised and 
each dilated area was divided into two segments (ie 4 segments 
from each pig). Depth of injury was detennined histologically 
and defined as superficial (endothelial denudation) or deep 
(rupture of the internal elastic lamina). SIN-I elevated platelet 
cyclic GMP - (mean ± SO) III ± 78% vs 2 ± 36% (p <0.05). 
and prolonged the bleeding time - 56 ± 33% vs 3 ± 12% (p 
<0.01). SIN-I also significantly inhibited PD in segments with 
either superficial or deep injury (see table). 
Segmental 
Injury 
Superficial 
Deep 
Uninjured 
SIN-I 
(pOx I Q6/cm2) 
1.75 ± 0.82 
6.52 ± 4.23 
0.18 ± 0.18 
Control 
(pDxl Q6/cm2) 
5.68 ± 3.38 
30.65 ± 19.52 
0.17 ± 0.09 
P 
<0.001 
<0.05 
NS 
Scanning electron microscopy confinned that the platelet 
monolayer adherent to areas of endothelial denudation was 
incomplete in the presence of SIN-I. These data provide the first 
evidence that nitric oxide inhibits platelet adhesion in vivo and 
imply therapeutic potential for SIN-I as an agent which may 
influence the vessel wall response to injury. 
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982·14 
Dietary Beta Carotene and Decreased Cardiovascular 
Xortality in an Elderly Cohort 
J. Michael Gaziano, JoAnn E. Manson, Laurence G. Branch, 
Frances LaMotte, Graham A. Colditz, Julie E. Buring, 
Charles H. Hennekens, Harvard Medical School, Boston, HA 
Recent evidence suggests that dietary antioxidants, such 
as beta carotene (BC), may reduce risks of 
cardiovascular disease (CVO). We examined the 
association between consumption of vegetables high in BC 
and CVO mortality in a prospective cohort of 1299 
elderly Massachusetts residents. Using aix items on a 
food frequency questionnaire administered at baseline, 
a BC vegetable score was derived corresponding to the 
number of servings per day of foods rich in BC. 
Mortality follow-up based on death certification coded 
by nosologists was 96\ complete. Ouring 4.75 years of 
follow-up there were 161 CVO deaths of which 48 were 
certified as due to myocardial infarction (MI). For CVO 
death the age and sex adjusted relative risks among 
those in the highest quartile of BC vegetable score 
compared to the lowest was 0.54 (95\CI - 0.34-0.87). A 
test for trend across quartiles was significant (P,trend 
- 0.044). For fatal MI the age and sex adjusted relative 
risk was 0.25 (95\CI - 0.09-0.67), and a test for trend 
was significant (P, trend - 0.0019). Adjustment for 
smoking and alcohol consumption did not materially alter 
the results. 
These observational data raise the possibility that 
increased dietary intake of beta carotene may be 
associated with reduced risks of CVO mortality and 
support the need for randomized trials of both primary 
and secondary prevention to address the questions 
definitively. 
982·15 
n.tcaDes of CardiopJlIImary l!esuscitatim (Cl'R) in bsing IbEs ~ 
9JaJld Receive QIR? 
JaI£S Neahring, 1Xlnald Tresch, David Mark, Ecmmd futhie, Susan Kartes, 
'Ihcmas Aufderlleide 
Medical College of Wisconsin, Milwaukee, Wisconsin 
IUring a 4 year period (1986-1989), there were 9487 pts in 66 
HilwaJkee lIJl"sing banes (m) who died, and 196 of the pts suseained caI•
disc arrest and received cardiop.1l.Donary resuscitation (CPR) by para1£•
dies. The mean age of the pts was 78.5 years, 31-107; 115 were females; 
81 males. In 49% of the pts the arrest was witnessed. At the time of 
the arrest, 99 (51%) pts dEmmstrated asystole (AS), 58 (30%) electnr 
mechanical dissociation, and only 39 (19%) ventricular fjj)rillation 
(VI'). Of the total 196 pts 37 (19%) were successfully resuscitated and 
hospitalized, however, only 10 (5%) survived to be discharged. Using 
univariate analysis, the mst significant determinant of survival was 
initial docuomted cardiac rhytlm: 14 (36%) of the 39 pts with VI' were 
resuscitated and hospitalized, and 6 (15%) survived to be discharged; 
in canparison, 28% of the 157 pts with AS or 00 were resuscitated and 
only 4 (2.5%) survived (P<O.OOJ). The other significant determinant of 
survival was ftther the arrest was witnessed: eignt (8%) of 96 pts 
whose arrest was witnessed survived, canpared to only 2 (2%) pts of 100 
pts whose arrest was un.ntnessed (p<0.03). \h!n both significant posi•
tive predictors (VI' and witnessed) were present survival increased to 
27%. Pts' age, mental or functional status, hEmatocrit, creatinine, or 
cardiovascular disorders (heart failure, arrhyttmias, coronary artery 
disease, hypertension, cerebrovascular disease) were rot significant 
determinants of survival. Of the 10 survivors, 2 were assessed to be 
mre functionally ~ired than their pre-arrest status; one of the 10 
survivors was classified by a fanily I18!ber to be mre functional than 
his pre-arrest state. Four of the 10 survivors lived for greather than 
12 tmnths. We conclude that only a small percentage of It! pts who sus•
tained cardiac arrest will benefit frcm QIR. Pts whose arrest are wit•
nessed and who dEmmstrate VI' at the time of the arrest have the best 
chance of surviving. Cl.lr data suggest that CPR in m shruld only be 
initiated in pts whose arrest is witnessed, and sOO.il.d only be con•
tinJed in pts whose initial docuomted rhytlm is VI'. 
ABSTRACTS 
982·16 
Rehabilitation of Older Female Coronary Patients: 
Referral Patterns and Exercise Response 
Philip A. Ades, Mary L. Waldmann, Janice T. Coflesky, 
Oonna·M. Polk. University of Vennont, Burlington, VT. 
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Gender-related differences In cardiac rehabilitation (CR) 
referral patterns and exercise conditioning response (In 
CR participants) w~re examined In a large population of 
hospitalized coronary patients (n • 226, mean age 70 ± 6 
years, range 62-92). Overall, outpatient CR participa•
tion rate was 21%. Older women were less likely to enter 
CR than older men (15% vs 25%, p • 0.06). Clinical pro•
files did not differ between sexes as there was no dif•
ference In cardiac diagnosis, left ventricular ejection 
fraction, duration of hospital stay or Incidence of non•
cardiac chroniC disease. Physicians recommended CR more 
strongly to male patients (scaled 1-5), mean score 3.0 ± 
1.8 vS 2.3 ± 1.7, than to women (p <0.05). In the 
overall population, physician recommendation was the most 
powerful predictor of participation. Prior to the aero•
bic exercise conditioning program, the older women (n • 
17) were less fit than the male patients (n • 37), with 
maximal 01 consumption 18% lower (16.1 ± 5 vs 19.5 ± 5 
ml/kg/mln, p • 0.02). However, both groups Improved 
aerobic capacity similarly after conditioning with maxi•
mal 01 consumption Increasing 17% In women, 19% In men 
(p • NS). Thus, older female coronary patients are less 
likely to be referred for cardiac rehabilitation, despite 
a similar clinical profile and a Similar Improvement In 
functional capacity from the training component. 
982·17 
Benefits of Cardiac Rehabilitation and Exercise Training 
in the Elderly 
Carl J. Lavie, Richard V. Milani. 
Department of I~ternal Medicine, SectiC!n. on Cardiolog>:, Ochsner 
Medical Institunons, New Orleans, LoUISiana, and Cardiovascular 
Health Center, Massachusetts General Hospital, Boston, 
Massachusetts 
Elderly patients are frequently not refemd for cardiac rehabilita~on 
and exercise training. We reviewed data from two cardiac 
rehabilitation and exercise programs to determine the benefits of 
rehabilitation in the elderly. Baseline and post rehabilitation data 
were compared in 69 elderly patients (~S years, mean 70%4 years) 
and 169 young patients «6S years, mean S4±7 years) enrollee! in 
phase n, cardiac rehabilitation and exercise programs. At baseline, 
body mass index (26.0±4.0 vs 27.9±4.2 units; p<O.OOS), 
triglycerides (l4S±S8 vs l76±98 mgld1; p<O.02) and METS 
(5.6±1.6 vs 7.9±3.0; p<O.OOI) were lower, and high-density 
lipoprotein cholesterol (HDL-C) was greater (40.0±12 
vs 36.9±10 mgldl; p=O.OS) in the elderly compared to younger 
patients. After rehabilitation, the elderl y demonstrated significant 
improvements in METS (+2S%; p<O.OOI) , body mass index (-2%; 
p<0.OO2), HDL-C (+9%; p<O.OOI), and low-density lipoprotein 
cholesterol (LDL-C)/HDL-C (-13%; p<O.OOI), but not in LDL-C 
(-4%; p=0.3l). Older and younger patients had statistically similar 
improvements in the following parameters: METS (+1.3±1.7 
vs +1.9±2.1), body mass index (-0.4±O.1 vs -0.5±l.6 units), 
HDL-C (+3.l±6.3 vs +2.3±6.5 mgldl), triglycerides (·20.5±37.8 
vs -20.6±74.0 mgldl), LDL-C (-3.S±27.3 vs 4.0±28.2 m~dl), 
and LDL-C/HDL-C (-0.4±l.0 vs -0. 3± 1.0). ConclUSIons; 
I) Despite baseline differences, improvements in exercise capacity, 
body mass index, ~nd lipi.ds arc ve!">: s~ar in older ~nd yo.u~ger 
patients enrolled m cardiac rehabilitation and exercise trammg; 
2) These data emphasize that elderly patients should not be de~ed 
the psychosocial, physical, and nslc factor benefits of cardiac 
rehabilitation and exercise training, in addition to secondary coronary 
prevention. 
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982·18 
Coronary Angiography and RevlScuJarization In Very Old PatienlS 
Early After Myocardiallnrarction: Early and Long·Term ResullS 
Daniel E. Forman, Harlan M. Krumholz, John Tselfes, Jeanne Y. Wei. 
Beth Israel Hospital and Harvard-Thorndike Laboratory, Boston, MA. 
The use of invasive cardiac procedures in very old AMI pis is 
controversial. We analyzed all elderly AMI pIS over a 6 year period who 
had peri-infarct coronary angiography. The short and long-term outcomes 
of pIS wbo then underwent coronary revascularization were also assessed. 
Of 4694 pIS diagnosed with AMI over a 6 year period, 1073 were at 
least 80 years. The rates of invasive cardiac procedures decreased 
significantly with increasing age (p < 0.001). While over 60% of pIS under 
65 years were referred to angiography, only 11.7% of pIS over 80 years 
old underwent catheterization. Comorbidity was minimal among this 
elderly subgroup (average Charlson scale of 2.0) and most (95.3%) of 
these pIS were living independently before admission. The most common 
indication for coronary angiography was post-infarction angina (79%), 
followed by congestive beart failure (9%) and cardiogenic shock (4%). 
Eighteen (17%) pIS died during the hospitalization, including three of four 
pIS with cardiogenic shock. Complications did not result in long-term 
sequelae. 
Sixty-three (59%) of the pIS then had coronary revascularization: 40 had 
PTCA, 24 had CABG, and I had both. Long-term follow-up (up to 66 
months) of the group that was successfully revascularized (61 pts) showed 
only 16 deaths, including 6 pts who died before discharge. Furthermore, 
of the 55 pts discharged alive, 47 (85%) achieved an excellent or good 
quality of life and 49 (89 %) obtained an excellent or good functional status 
after discharge. 
Conclusions: A select group of very elderly pIS that are targeted for 
coronary angiography and revascularization early after an acute myocardial 
infarction can survive with good quality, cardiac-event free lives after 
discharge from the hospital. These results suggest that age alone should not 
contraindicate the use of these procedures. 
982·19 
Eligibility of Thrombolytic Therapy in Older Persons: Implications 
of Electrocardiographic Findings and Time of Presentation 
Harlan M. Krumholz. Gottlieb C. Friesinger. E. Francis Cook. Lee 
Goldman. 
Brigham and Women's Hospital and Beth Israel Hospital. Boston. 
Massachusetts. Vanderbilt University Medical Center. Nashville. 
Tennessee 
The growing concensus that older patients with acute myocardial 
infarction (AMI) benefit from thrombolysis makes it important to 
learn if the treatment criteria used for younger patients (pts) 
change with advancing age. We evaluated prospectively collected 
clinical data on 12.140 pts seen in rooms (ER) with chest pain. 
Multiple features. including time of arrival at the ER and admission 
electrocardiographic (ECG) findings were coded and outcomes 
determined. The sensitivity. specificity. and predictive value (+) 
for pts arriving within six hours of the onset of their pain with ECG 
ST-segment elevation andlor new a waves are summarized in the 
table. 
~ 
30-59 
60-69 
70-79 
>80 
!fn 
6630 
2662 
1089 
907 
M! 
676 
492 
387 
212 
~ 
38% 
37% 
31% 
16% 
~ 
99% 
99% 
98% 
99% 
fY..±. 
76% 
88% 
84% 
81% 
CONCLUSION: Few older patients who prove to have AMI meet 
conventional criteria for the administration of thrombolytic therapy 
on ER evaluation. However. the specificity and predictive value of 
conventional criteria is as high in older as in younger pts. 
982·20 
JACC Vol. 19, No.3 
March 1, 1992:378A 
Immediate Resu1ts and 0inicaI Follow Up or Percutaneous Mitral 
Vahotomy in FJderIy Patients. 
Javier Goicolea, Carlos Macaya, Rosa Hernandez, Camino Banuelos, 
Andres liiiguez, Fernando Alfonso, Pedro Zarco. 
Hospital Universitario San Carlos, Madrid, Spain 
Old pIS with Mitral (Mi) stenosis are an atractive subset for the use of 
percutaneous mitral valvotomy (PMV) if success rate and complications 
are acceptable. We have analysed our experience in 235 PMV of 
which 39 (17%) were <:65 years old and 196 (83%) were <65. Both 
groups were sirnilar in gender and incidence of previous Mi surgery, 
but old pts had a greater functional impairment (74% vs 44% were in 
~; P < O,Cxn), and incidence of atrial fibrillation (87% vs 53% 
p<O.OOl). Old pts had also a higher echocardiographic score (95±2 
vs 7.3 ± 2;p < 0.0025) mainly because of more heavily calcified valves 
(2.4 ± 0.9 vs 15 ± 0.7 ;p < 0.005). Old pts had a lower cardiac index 
(204±0.3 vs 24±05;p<O.005), and tended to have smaller Mi area 
(0.83±02 vs 0.93±02;p<0.1). 
Mi Ar(p<0.1) SUcce5S(NS) OR(p < O-OS) 
Old 1.6±0.4 35 (92%) 60% 
Yamg 1.9±05 181 (94%) 79% 
Where: 1\1i Ar= Post-PMV Mi area (Gorlin), Success = increase <:50% 
in Mi area post-PMV, OR(Optimal result)= increase <:50% in Mi 
area and final area <:15 in the absence of major complications. Major 
complications were similar in both groups and included: Mi surgery 
(25% in both), severe Mi regurgitation (5.1 % vs 6.1 %) and tamponade 
(0 vs 15%). Six months follow up showed a similar % of pts with 
improved NYHA class (91% vs 92%) with 91% and 97% (NS) having 
mild or no symptoms (NYHMII). 
Elderly pts have poorer clinical, hemodynamic and echocardiographic 
baseline characteristics. Although OR are achieved less frequently in 
old pts, the rate of symptomatic relief after PMV was similar, sugges•
ting that a strict definition of OR may have limited value in these pts. 
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Three·Dimensional Orifice Geometry Correction Is Required for 
Calculating Orifice Flow Rate by Proximal Convergence 
Robert A. Levine. James D. Thomas. Edward G. Cape. Ajit P. 
Yoganathan. Arthur E. Weyman. Massachusetts General Hospital. 
Boston-. MA and Georgia Institute of Technology. Atlanta. GA 
JACC Vol. 19, No.3 
March I, 1992:379A 
828·2 10:45 
Regurgitant Orifice Area, a Fundamental Measure of Mitral 
Incompetence: Calculation by Proximal Acceleration 
J Miguel Rivera, Pieter Vandervoort, David Thoreau, 
Eleanor Morris, B Talbot Joziatis, Robert A Levine, 
Arthur E Weyman, James 0 Thomas. Massachusetts General 
Hospital, Boston, MA. 
The effective area of a regurgitant orifice (ROA) 
is a fundamental measure of valvular incompetence which 
to date has generally been unavailable clinically. It is 
a robust parameter to follow in the serial assessment of 
valvular disease, since it reflects true changes in valve 
geometry independent of hemodynamic changes. In vitro 
studies in our laboratory suggest that analysis of the 
velocity acceleration zone proximal to a regurgitant 
orifice should allow ROA to be readily calculated. To 
extend this principle clinically and determine relevant 
values for ROA in patients, we calculated ROA in 51 
patients with mitral regurgitation (MR). From a Doppler 
flow map, peak regurgitant flow rate Qo was calculated by 
identifying a cont~ur velocity VI at a radius r from the 
ori fice as Qo • 2l!r VI' ROA was cal cul ated as QoIvo' where 
Vo is peak orifice velocity (from continuous wave 
Doppler). ROA was compared with regurgitant fraction RF 
(by pulsed Doppler). RESULTS: Peak flow rate ranged 
from 14 to 176 cm3/sec with Vo • 5.0±0.5 mlsec 
(mean±S.D.). ROA ranged from 3 to 34 mm2 (12±7 mm2). ROA 
(x) was predictive of RF (y): y. 1.4x + .1, r· .81, p 
< 0.001. ROA ~ 8 mm2 (n-19) were associated with RF < 
20%, while ROA ~ 20 mm2 (n-8) were associated with RF > 
40%. CONCLUSIONS: 1) ROA is easily calculated from 
proximal velocity analysis and correlates well with 
standard indices of regurgitant severity; 2) ROA is a 
fundamental parameter of valvular incompetence, which may 
allow more quantitative assessment of valvular 
regurgitation over time. 
828·3 11:00 
Quantification of Mitral Regurgitant Volume Using Color 
Doppler PISA Method - A Clinical Study 
Gong-Yuan Xie, Martin R. Berk, Mikel D. Smith, Clair S. 
Hixson, Michael R. Harrison, Anthony N. DeMaria. 
University of Kentucky, Lexington, KY 
In vitro studies have shown that regurgitant flow 
rate (RFR) can be estimated by the color Doppler 
"proximal isovelocity surface area" (PISA) method. 
However, few data exist regarding the clinical assess•
ment of mitral regurgitation (MR) in pts. Therefore, we 
devised an algorithm to calculate mitral regurgitant 
volume (MRV) based upon PISA and compared it to cath•
eterization findings in 20 MR P2s. Since vi 2ro study has shown that RFR (m1/sec)=2wr 'V, MRV=2wr 'V'ET where 
r=distance from first jet alias to mitral leaflets in 
cm, v=a1iasing velocity in cm/sec, ET=systo1ic ejection 
time. In the clinical setting, the ratio of mean 
velocity (V) and peak velocity (PV) of MR jet from CW 
Doppler recording was usedoto account for the variable 
V during systole and e/180 (~=in1et angle of mitral 
leaflets) was used to correct mitral 1eaf2et g~ometry. Therebore'2MRV was ca1cu&ated as: MRV=2wr 'ET'V/PV' 
e/180 =2nr 'FVI/PV'e/180 , where FVI=f1ow velocity 
integral of MR jet in cm. From the apical 4-chamber 
view PISA was obtained during early to midsysto1e at 
aliasing velocity of 39-59 cm/sec. Nitral regurgitant 
jet PV and FVI were measured by CW Doppler recording. 
Angiographic (Angio) grade of MR was obtained from 
ventriculography. Results: r=0.77 (Speaman's rank) 
Angio Grade MR: 1+ 2+ 3+ 4+ 
MRV(ml) . PISA: 19+.2 18+2 25+5 44+2 
Thus, a formula was devised to calculate mitral 
regurgitant volume by the PISA method which 
distinguishes pts with moderate to severe grades of MR 
by angiography. This method provides an alternate 
approach to quantitate MR clinically. 
ABSTRACTS 
828·4 11:15 
Usefulness of Color Doppler 'Proxlmal lsovelocity Surface 
Area" Method in Quantitating Valvular Regurgitation: Clinical 
Studies of lU Regurgitant Lesions 
Shiro Yamachika, Devang Savani, Christopher M.Mecke~ 
Julius M. Gardin. University of california, Irvine, CA 
Doppler Color flow mapping of a proximal isovelocity surface 
area (PISA) has been validated experimentally for estimating 
regurgitant (REG) stroke volume (SV). To define the 
usefulness and limitations of PISA, we evaluated patients with 
mitral (MR), aortic (AR) and tricuspid (TR) regurgitation. 
~: Color Doppler was performed in 112 REG lesions at 
lower aliasing velocities (AV = 16·32 em/sec) to produce a 
hemispherical PISA shape. REG SV by PISA was calculated 
as 2'J1R2* A V* (TVI/PFV) [where R is maximum (max) aliasing 
radius, TVI (time velocity integral) and PFV (peak flow 
velocity) from REG jet were used to correct PISA for phasic 
flow). REG SV by PISA was compared to ratio of max REG 
jet area (RJA) to left (right) atrial area in MR (TR), and to 
ratio of jet height (JH) to LV outflow tract height (LVOH) in 
AR. ~: PISA was measurable (PISA+) in 42/51 cases, 
21/30 with TR, but only 9/31 with AR. REG SV by PISA 
correlated wel1 with other color Doppler ratios (MR:r=.83, TR: 
r=.79, and AR: r=.90, al1 P<.Ol). In MR (TR), RJA/atrial 
area was greater in PISA( +) than PISA(·) pts. (MR:.22vs.10, 
TR: . 19vs. 12, P<.OI). In AR, JH/LVOH was greater in 
PISA(+) than PISA(·) (.33vs .17, P<.OI). PISA(+) included 
mild cases in 73% of MR, 61% of TR but 0% of AR pts. 
Conclusions: I)PISA is clinically useful for estimating REG 
volume in MR and TR, including mild cases, 2) PISA is less 
useful in AR, possibly related to valve geometry. 
379A 
828·5 11:30 
The Proximal Flow Convergence Method for Calculation of 
Regurgitant Flow Rate in Patients with Mitral Regurgitation 
Chunguang Chen, Oietmar H. Koschyk, Christian W. Hamm, 
Wolfram Kupper. University Hospital Hamburg, Dept. of 
Cardiology, Gennany 
Recent experimental studies have shown that the flow isovelocity 
surface area (PISA) proximal to an orifice can be used to quantify 
regurgitant flow rate. To test this in patients (pts), we studied 21 pts 
with mitral regurgitation (MR). The maximal regurgitant flow rate 
(Max FR) was calculated using 2-D or M-mode color Doppler flow 
mapping assuming hemispherical shape of PISA: Max FR = 2 
7t*r2*V n' where r is a radius measured from the MR orifice to the 
first color alias and V n is the Nyquist Limit. Max FR were then 
compared to mean regurgitant flow rate (FR) derived from stroke 
regurgitant volume / systolic time using combination of M·mode, 2-
D and pulse wave Doppler echocardiography. 
Results: The correlations between Max FR by 2-D or M-mode 
PISA method and FR by the comined method were: 
Regression equation r p SEE (mVs) 
M-mode y = 1.49X -75 0.9 0.001 91 
2-D y = 1.20X -89 0.88 0.001 111 
Although Max FR (350 ± 340 ml) derived from 2·0 PISA method 
tended to underestimate FR (365 ± 268 mVs) calculated from the 
combined method and Max FR (470 ± 409 mVs) derived from M•
mode PISA method tended to overestimate FR derived from 
combined method, both differences were not significant (p = n.s.). 
Significant overestimation of FR (>400 mVs) by Max FR was 
observed in 2 pts with mitral valve prolapse. 
Conclusions: I) Both 2·0 and M-mode PISA methods for 
calculation of mitral regurgitant flow rate are feasible and relatively 
accurate in clinical settings; 2) Significant change of geometry of 
regurgitant valve as seen in mitral valve prolapse should be taken 
into account for intepreting Max FR. 
380A ABSTRACTS 
828·6 11:45 
E,tlmatlon of Cardiac Output and Mitral Orifice Area Using A Proximal 
Flow Convergence Method: Validation Studies In Animal Model with 
Chronic Mitral Stenoal, 
Takahlro Shlota, UUiam Valdes-Cruz, David J Sahn, Michael Jones", Robin 
Shandas, Azucena Murillo,lzumi Yamada", Robert Weintraub, Soon U.Kang, 
Jun Zhang. Department of Pediatric Cardiology, University of CalHornia, 
San Diego, CA. *NHLBI, Bethesda, MD. 
Recently the use 01 a color Doppler flow convergence (FC) method lor esti· 
mating or~lce area lor stenotic valves has been reported. The method 
Involves using an angular portion 01 the pre-mttral FC to calculate flow 
using a hemispherical (HE) surface model. This study was undertaken to 
compare the accuracy 01 two different surface models for flow volume 
quant~lcatlon through stenotic mitral valves and to validate this method lor 
the calculation of mttral or~lce area In an animal model. Chronic mttral 
stenosis was created surgically in 6 sheep and 3 or 4 stable hemodynamic 
states were obtained pharmacologically in each animal (19 hemodynamic 
states). We imaged m"ral valve inflow at Nyquist limits of 31, 41 and 52 
em/sec and mitral Inflow volume and mttral orHice areas (MOA) were cal· 
culated using two geometric assumptions HE and prolate hemlspheroidal 
(PHD), the laner requiring direct measurement 01 the transverse radius of 
the valve Inlet as well as the axial distance of aliasing. Calculated mitral 
inflow volume (CFV) using PHD correlated well with the cardiac output 
(CO) obtained by thermodilution method which, by continuity, should be 
the same as actual mttrallnflow volume (r=0.95, y= 672 + 0.75x, SEE = 
268 ml/mln, p<O.OOOI). The percent difference from actual CO was very 
small (0.4 :: 17% [SO]). In contrast, CFV using even a lull HE underesti•
mated CO by 56%. Calculated MOA using PHD (average: 1.24 :: 0.41 
em') also agreed wefl with MOAs obtained by post-mortem planimetry, the 
Gortin lormula and the Doppler pressure half-time method with correlation 
co-efficients of 0.87, 0.78, and 0.96, respectively. In contrast. MOA u~ing 
HE underestimated any reference area by over 50% (0.57 ! 0.19 em vs 
1.34:: 0.41 em' (post mortem), 1.48 ! 0.39 em' (Gortin) and 1.27 ! 0.44 
cm' (half-time), respectively, p<O.OOOI). These data indicate that in mitral 
stenosis, a PHD method requires 2 radial measurements but reliably 
estimates CO and MOA. 
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829·1 
Early Ceptoprll Treatment Reduc.. Angiotensin 1/ 
Levela after Acute Myocardial Infarction 
10:30 
Marcus D Flather Athanase Pipills, Michael Conway, Clare Fosler, 
John J Morlon, .flng-HOng Feng, Rory Collins for the ISIS Pilot 
Study Collaborators' Group, Oxford, UK. 
In order to study the effects of vasodilator therapy. on 
neuroendocrine activation following AMI, we studied 100 patients 
randomized at a mean of 11 hours from pain onset between 4 weeks 
of oral captopril (CAP: Initial dose of 6.25mg, stepping up to 50mg 
bid after 24 hrs), controlled release oral Isosorblde mononitrate 
(ISMN: 50mg or 60mg once daily), both active treatments, or 
placebo control, In a factorial deSign. Plasma angiotensin II (All) 
and renin concentrations were measured serially at trial entry 
(prior to the first dose on day 0), at day 2 and day 7. Results 
(median values and range) are given for the comparison of all 
patients randomlSed to receive CAP vs all no CAP: 
CAP (n=54) No CAP (n:46) 
Angiotensin I! (pg/ml) 
Entry (Ie day 0) 9 
Day 2 2 
Day 7 4 
BiJlln. (Ilu/ml) 
( 1 -11 7) 
(1- 220) 
(1 -47) 
11 (1 -1 82) 
22 (1-296)" 
10 (1-173)" 
Entry (ie day 0) 2 1 ( 4 - 1 5 0 ) 23 (1 - 1 2 7 ) 
Day 2 59 (5-1050) 37 (1-107)' 
Day 7 79 ( 3 - 1 350) 3 0 (1 - 1 2 9 ) , • 
"2p<0.0I, "2p<0.001 for CAP vs No CAP 
For the comparison 01 all on ISMN vs all on no ISMN there.were no 
significant differences In AI! or renin at any measurement time. 
These data show that CAP substantially reduces plasma All levels 
when started early after the onset of AMI, preventing the Incre.a~e 
typically seen during the first few days. This may have benefiCial 
effects on, for example, ventricular remodelling. Renin levels are 
raised by CAP which may be a reflex phenomenon. The effects ~I 
these agents on mortality and serious vascular events after AMI Will 
be assessed in the ongoing ISIS-4 study. 
829·2 
JACC Vol. 19, No.3 
March 1, 1992:380A 
Effects of Captopril on the Early Mortality and 
Complications in Patients with AMI(Pilot Study) 
Chinese ACEI·AMI Clinical Trial CoUaborative Group· 
10:45 
This multicenter larae-sca1e double-blind trial was desianed to explore 
the effects of captopril (capoten) in patients (pts) with acute myocardial 
infarction(AMI) treated within 36 hours after the onset of symptoms. 
Patients received either capoten(C) or placebo(P) beainnina with a 1st dose 
of 6.2Sma, a 2nd dose of 12.5ma 2 hours later, and if no hypotension 
occurred, a dose of 12.5ma tid to the end of 4 weeks. 
Of the 2,000 pis who completed the trial(I,486 males and 514 femates, 
age 60.4 .. 10.2 yrs), 1,007 were randomly assianed to group P and 993 to 
group C. Their baseline clinical characteristics were similar, and AMI was 
later confirmed in a 95" of pts. Thrombolytic therapy was Idministered to 
over 20" of patients. Intravenous or oral nitrates were given to over 80" 
of patients. No significant difference was found between aroups C and P in 
blood pressure (BP) pri(1[ and after the 1st and 2nd test doses, and on the 7th 
day, but BP difference on the 3rd day after treatment (C: 110.8/72.7 mmHa, 
P: 113.6/74.1 mmHg) was sipficant(P<O.OOllO.OO4). In the captopnl 
IrouP 97 patients and 63 patients in the placebo aroup had to have study 
treatment stopped due to hypotension. No other difference was found 
between the two ,roups in severe side effects. A data and safety monitoring 
committee is closely follOWing the data from the trial. The committee will 
periodically examine the data to determine whether termination of the study 
is warranted. 
Conclusion: Captopril therapy was not associated with an occurrence of 
obvious side effects. While early withdrawal due to hypotension was greater 
with caplopril. There was no evidence that this was related to hiaher 
mortality. 
• Chinese ACEI-AMI Trial Collaborative Center Office - Fu Wai 
Hospital, Beijina 100037, China (c/o Liu Lisbeng M.D.) 
829·3 11:00 
Effects of Pre-existing Beta-Blocker Therapy on Survival 
in 2946 Consecutive Patients with Myocardial Infarction 
Gerard Wilkins, Norma Restieaux, Peter Herbison, 
Elspeth Gold, Ralph Stewart. Dunedin Hospital, 
University of Otago School of Medicine, New Zealand. 
Beta-Blocker (BB) therapy given at the time of acute 
myocardial infarction has been widely investigated. 
Little is known however, about the effects of this therapy 
when the patient(pt) is coincidentally on BB as a regular 
medication at the onset of AMI. During a 15 year period 
from 1975 to 1990, clinical data was collected 
prospectively on all pts admitted to the coronary care 
unit of Dunedin Hospital, the only CCU serving a stable 
population of 100,000. Of 2946 pts with confirmed AMI, 
676 (25%) were already on BB at the time of infarction 
(Group A). In hospital events and mortality were 
compared with remainder (n= 2270, Group B). No 
Significant difference in mortality (A=11.4% vs B = 13%), 
occurrence of shock, heart failure, VF, VT, A·V block 
was noted. However, Group A were noted to have a 
higher incidence of poor prognostic factors such as 
previous AMI, older age and diabetes. Characteristics 
predictive of death were entered in a logistic regression 
analysis and the contribution of pre-existing BB assessed 
as a variable entered in the model. A significant 
survival advantage was demonstrated (z=2.12, p = 0.034, 
odds ratio = 0.65 (el 0.43, 0.97). This survival advantage 
was not evident for patients having a first AMI. 
Pre-existing BB therapy reduces mortality in AMI and 
appears to mainly reduce mortality in high risk patients. 
JACC Vol. 19, No.3 
March 1, 1992:381A 
829·4 11:15 
HIgIH>o.. Intravenoua DIHiazem Incl1lll_ Infarct SIze In Acute, 
Uncomplicated Myocardial Infarction. A Placeilo-Controlled Study. 
Louis Bartels, Willem Remme. Ana Wiesfald. Amoud van der I..aarse. 
Zuiderziakenhuis and Sticares Foundation, Rotterdam, The Nethellands. 
Secondary prevention subset analysis indicates a beneficial role fOf sub•
acute dilliazem (D) in non-a and uncomplicated, inferior a·wave myocar•
dial Infarction (MI). Whether early treatment with 0 during the acute 
phase of infarction may provide for additional benefit by reducing infarct 
size, is unclear in humans. As 0 dos&-dependently Improves coronary 
hemodynamics and ischemia, higlHlose 0 (0.5 mg/kg/Smin, followed by 
15 mg/hr fOf 48 hI'S) was compared to placebo {PI In a randomized, 
double-blind parallel design in 32 pts (150,17P) with a <12 hrs old, un•
complicated MI (87% inferior, 93% O-wave) otherwise untreated. exclu•
sion criteria included thrombolytic therapy, MIRU cI IIi/lV, systolic blood 
pressure <90 mmHg and anhythmlas. Hemodynamic variables were as•
sessed at 5, 15, 30, 60. 90, 120 min and every 6 hrs fOf 2 days after 
onset of infusion; enzymes ICK, CK-MS, SGOT and cumulative Q·HBOH 
release (072)) every 6hrs fOf 3 days. Both groups ware comparable as to 
age, sex, location of MI, time to antry of atudy and baseline CK. Plasma 
level of 0 Increased to 800 11g/1 (15 min D) and remained at this high 
leval throughout the Infusion period. During D 4 pis discontinued (pro•
gressive CHF 3/AV-dissociation 1) YS 2 pis on P (CHF 1/persisting angina 
1). 0 Immediately decreased systemic resistance by 20"'" for 6 hrs, ac•
companied by a sustained (48 hrs) 16% reduction in arterial pressures. 
Concomitantly heart rate decreased by 20% and pulmonary wedge and 
right atrial pressure were increased by 24% and 49% rasp. during the first 
12 hrs. During P, heart rate increased by 23% alter 6 hrs, right atrial 
pressure decreased by 69% alter 18 hrs and stroke volume index de•
creased by 15% alter 6 hrs. Other hemodynamic variables did not 
change. Infarct size following 0 was significantly greater than following P 
(median 072, 861 and 336 u/I rasp., p=O.OO9; peak CK, 1474: 176 u/I 
and 874:!:165 u/I rasp., p=O.027). Thus, despite arterial unloading and 
heart rate reduction, high-dose intravenous 0 in acute MI Increases In•
farct size and may possibly Induce early CHF. Potential underlying 
mechanisms may include decreased coronary perfusion pressure and In•
creased diastolic ventricular wall stress. 
829·5 11:30 
Hemodynamic Effects of Enalaprll after Myocardial 
Infarction Are Not Mediated Through Circulating Angio•
tensin II 
A Sigurdsson, E. Alfvagren, P. Enaroth, P. Held. K. Swedberg. Section of 
cardiology. Department of Medicine. Ostra Hospital, GOteborg and Clinical 
Research Center. Huddinge Hospital. Huddinge. Sweden 
To determine the hemodynamic and neuroendocrine effects of enalaprjl (E) 
in acute myocardial infarction we randomized patients with systoliC blood 
pressure 2. 105 mm Hg (age 38-84) in a double blind study comparing E 
and placebo (P) within 24 hours from onset of symptoms. Treatment was 
initiated with 1 mg intravenously given during 2-3 hours and continued 
Ofally for six months. The mean dose of E was 18 mg at 7 days and 1 
month. 
Besul!s; Hemodynamic variables are presented as mean values. 
hormones as median values. 
Baseline 5-7 days 1 month 
p E P E P E 
n~28 n=26 n=43 n=44 n=44 n=46 
Systolic blOod pressure 138 134 123 122 140 • 128 
Heartrate bpm 66 68 68 65 61 66 
ACE (U/m1nll) 35 32 28 .. 4 33 •• 2 
Aldosterone (pmoVI) 325 258 206 191 175 136 
ANP (pglml) 250 • 193 174 177 202 179 
Angiotensin II (pmoVI) 18 11 7 5 7 5 
• p<0.05 .•• p<0.01 (Between groups) 
Conclusjon'Neurohormonai levels decreased from baseline to 7 days 
independent of E. Despite ACE-inhibition and lower blood pressure at one 
month by E. there was no effect on neuroendocrine activation. This 
suggests that the hemodynamiC effects of E may be mediated through 
mechanisms such as tissue bound renin-angiotensin as well as circulating 
bradykinins and prostaglandins. 
ABSTRACfS 381A 
829·6 11:45 
Aor1ic Counterpulsation with Thrombolysis Cor Myocardial Infarction: 
Salutary ElIect on Reoa:Iusion of the Infarct Related Artely 
E. Magnus Ohman, Robert M. Califf, Eric J. Topo~ Jeffrey D. 
Leimberger, Barry George, Eric D. Berrios, Linda C. Anderson, Dean 
J. Kereiakes, Richard S. Stack, and the TAM! Study group. 
Duke University Medical Center, Durham, North Carolina 
To evaluate the potential benefit of aggressive management of acute 
myocardial infarction using counterpulsation (lABP) on coronary 
artery patency after thrombolytic therapy (TI), we studied 1331 pts 
enrolled into 6 different protocols. The studies used 3 different TI; 
tPA alone (n:838), urokinase alone (n:198), and combination of tPA 
and urokinase (n:285). All pts had acute cardiac catheterization 
(CAlli) and 81% had follow-up angiography. IABP was inserted in 
112 pIS during or before CAlli. PIS who had IABP were older (58 VI 
56 years), had more history of previous MI (24% VI 12%), more 
anterior infarct location (66% VI 41 %), and more heart failure (Killip 
class > 1; 48% VI 18%) compared with pts without IABP. At CAlli, 
pIS with IABP had more 3 vessel disease (44% VI 17%) and were 
more likely to have failed to reperfuse after TI (TIMI flow 0-1; 46% 
VI 29%). At repeat angiography, the reocclusion rate was lower in pts 
treated with IABP (2% '.'5 11 %). The effect of IABP on reocclusion 
rate was assessed using a logistic regression model that has previously 
been shown to accurately predict in-hospital reocclusion. The 
candidate variables were: TI, TIMI flow, infarct related artery and 
admission heart rate. When the contribution of each variable was 
considered, IABP was significantly associated with a lower reocclusion 
rate (Chi-square: 13.3;p=O.OOO3). The relationship between IABP and 
reocclusion was most pronounced in pts who had rescue PTCA after 
failed TI (Chi-square: S.8;p=O.016). 
Thus, IABP use in a high risk population can enhance coronary 
artery patency after thrombolytic therapy, which may improve 
Iongterm survival. 
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830·1 10:30 
Quantitative Reconstruction of the Left Ventricle Using a New 
Fully Integrated Three-Dimensional Echocardiographic System: 
Feasibility and Validation in Human Subjects 
Jean-Paul Lethor. Mark D. Handschumacher. Samuel C. Siu. J. 
Miguel Rivera. Michael H. Picard. Arthur E. Weyman. Robert A. 
Levine. Massachusetts General Hospital, Boston. MA 
Three-dimensional echocardiographic (3DE) reconstruction of the 
LV has been studied primarily in excised hearts and controlled 
experimental settings in which accuracy would not he affected by 
patient motion or respiration. despite typically slow acquisition of 
individual images and their positions. The purpose of this study 
was: I) to demonstrate the feasibilig of LV reconstruction by 
3DE in human subjects and 2) to va idate its auaDdtative 
accuracy for stroke volume (SV) versus pulse Doppler methods 
(as an mdependent nonmvasive measure). To overcome prior 
limitations of 3DE. we developed a computer-coordinated system 
(validated in vitro) that: I) permits ra id continuous ac uisition of 
multicle 2DE views and their spatia ocauons ID or er to minImIze 
scan Ume and decrease potential motion errors: and 2) 
automatically integrates locating data with images in real time by 
encoding them in binary format on the video image itself. without 
the need for manual coordination. This system was applied to 
reconstruct the LVs of 14 normal subjects from intersecting IDE 
vIews obtained dunng one qUIet end-expIration « 20 sec). 
Endocardial borders were traced at end-dIastole (Eb) and end•
systole (ES). and surfaces were generated using an algorithm that 
takes advantage of the full 3D data set. SV was calculated as ED -
ES volume. and compared to Doppler SV (time-velocity integral x 
area: mean of aortic and mitral flows [Fisher methodJ). 
RESULTS: In all subjects. coherent endocardial surfaces could be 
generated from the views obtained. SVs ranged from 32-66 cc. 
3D and Doppler SVs agreed well (y = .92x+4.3. r = .94. SEE 
= 3.1 cc. mean difference = 2.6 cc). CONCLUSION: 
Quantitative volumetric reconstruction of the LV can be achieved 
In human sublects. The results support the feaslblhty and accuracy 
of 3DE reconstruction. 
382A ABSTRACTS 
830·2 10:45 
three-Dimensional Echocardlography: In Vivo Comparison of Left 
Ventricular Volumes to Magnetic Resonance Imaging In Normals 
Aasba S. Gopal, Andrew M. Keller, Rlcbard Rlgling, Donald L King Jr., 
Donald L King, Columbia University, New York, NY and Danbury Hospital, 
Danbury,CT 
Current ECHO methods of LV volume determination require geometric 
assumptions and Inadequately represent tbe LV In tbree·dlmenslonal (3D) 
space. Hence, we bave developed a non-geometric method of volume 
measurement based on 6-8 non.parallel, non·lntersectlng sbort axis planes 
obtained by a 3D ecbocardlograpblc system (3DE) using an acoustic spatial 
locator and an a1goritbm based on polyhedral surface reconstruction (PSR). 
We bave previously sbown tbe 3DE/PSR metbod to be accurate for volume 
computation In vitro; tbus we bypotheslze that this metbod could also be used 
In vivo to accurately determine LV volumes. Fifteen normal subjects (7M, SF, 
age 23-41 yrs, BSA 1.38·2.17 mI) were Imaged and LV volumes In end·dlastole 
(EDV) and end·systole (ESV) computed by 3DE/PSR and compared to 
volumes measured from single spin-ecbo magnetic resonance Imaging (MRI). 
Results· 
Interobserver Variability r SEE p 
3DEEDV 4.99% 
0.92 7.65ml <0.001 MRlEDV 6.59% 
3DEESV 8.01% 
0.81 6.42ml <0.001 MRlESV 9.02% 
-MRI EDV 1.01 (3DE EDV) • 9.4 
MRI ESV = 1.30 (3DE ESV) ·9.7 
MRI volumes were systematically lower tban 3DE volumes. The MRI method 
excluded tbe LV outflow tract wbereas this volume was Included by the 3DE 
metbod. Greater variability and lower correlation for end·systolic volumes 
were due to technical limitations of botb metbods for selecting comparable 
end·systolic Images ror boundary tracing. Conclusions: 3DE/PSR LV volume 
determination Is associated with low Interobserver variability and accurately 
measures LV volumes when compared to volumes measured by MRI. This 
excellent performance Is achieved by eliminating geometric assumptions and 
image plane positioning error. 3DE/PSR Is a noninvasive, repeatable clinical 
metbod of ventricular volume determination wbicb greatly enbances tbe 
quantitative capability of echocardlography. 
830·3 
Th ..... Dlmenslonal Reconstruction of Trsnsesophagea' 
Echocardlogrsphlc Images 
11:00 
Marek Belohlavek, David A. Foley. Thomas M. Kinter, James F. Greenleaf. 
James B. Seward. 
Mayo Clinic and Mayo Foundation, Rochester. Minnesota 
Three-dimensional (3-D) image reconstruction and display prOvides im· 
proved spatial perception over standard two-dimensional (2-D) images. To 
date, 3-0 display of echocardiographic data has been hampered by cum· 
bersome image acquiSition, poor image quality, and the need for significant 
operator input into the image proceSSing. 
We have developed a method for 3-0 reconstruction of cardiac structures 
from transesophageal echocardiographic Images which employs commer· 
clally available image proceSSing equipment and which requires a minimal 
amount of operator interaction. Transesophageal images of the heart were 
obtained during the course of routine clinical studies using an Acuson 
128XP echocardiograph equipped with a biplane 5 MHz probe. Images 
were obtained in the longitudinal plane while the probe was mechanically 
rotated in 1.80 increments. The ECG gated images were digitized and 
transferred to a Sun 4 workstation using a Sony Still Video Recorder. 
The images were contrast enhanced, threshold ed, and processed with 
mathematical morphologic and median filters. This procedure generated 
binary masks which were used for object extraction to allow preservation of 
the original backscatter texture. The data set was converted from a 'Ian· 
like" arrangement to a rectangular 3-0 viewing environment. interpolated 
and volume rendered USing custom programs and the software package 
ANALVZE®. Operator interactivity was limited to selection of regions for 
analysis and appropriate border threshold values. 
The 3-D images obtained with this method demonstrated good anatomic 
detail, particularly of structures in the near field (atrial septum. mitral valve. 
aortic valve). Initial clinical applications include 3-0 display of normal and 
abnormal atrial septa, mitral valves. aortic valves. and thoracic aortas. 
In conclusion, we have developed eChocardiographic image proceSSing and 
display techniques that allow 3-0 image reconstruction from a series of 
longitudinal transesophageal 2-0 scans. These techniques provide unique 
views of intracardiac structures while preserving the original backscatter 
texture. 
830·4 
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11:15 
Three-Dimensional Transe.ophaqeal Echo 
Iaaqinq of the Descendinq Thoracic Aorta 
John J. Ross Jr., Chandra Sehgal, Arthur J. 
D'Adamo, Robert V. Foley, Dean G. Karalis, 
Krishnaswamy Chandrasekaran. 
Hahnemann University Hospital, Philadel~hia, 
PA 
To evaluate the feasibility and potential 
utility of three-dimensional (3-0) 
echocardiographic analysis of the descending 
thoracic aorta (OTA), transverse cross•
sectional transesophageal (TEE) echo images 
were obtained in 10 normals, 6·pts with 
aortic dissection, and 7 pts with aortic 
aneurysm and layered thrombus. Video images 
were digitized onto a 512x482 matrix having 
256 grey levels. 3-0 volume was generated 
and displayed using ANALYZE software 
specifically developed and validated for 
volumetric analysis. Results: 1) 3-D volume 
generated from TEE of DTA demonstrated 
anatomical and geometrical details in 
multiple planes simultaneously not feasible 
by TEE; 2) surface display of the aortic 
lumen allowed easier recognition of the 
geometrical changes in the lumen resulting 
from dissection and aneurysm formation which 
correlated well with angiography and 
pathological specimen. 
Conclusion: 1) Three-dimensional echo 
imaging of the OTA is feasible from two•
dimensional TEE images; 2) three-dimensional 
volume rendered imaging allowed visualization 
of the morphology and geometry of the aorta 
in multiple planes not feasible by single or 
biplane TEE imaging. 
830·5 11:30 
Three·Dimensional Intravascular Ultrasound: A New 
Standard for Vessel Lumen Volume Measurement? 
Fadi A. Malar, Gary S. Mintz, Philippe C. Douek, Andrew. Farb, 
Renu Vinnani, Martin B. Leon, Jeffrey J. Popma. Washmgton 
Hospital Center, Washington, D.C. 
Vascular lumen volume (Vol) measurement may be useful before and 
after transcatheter intervention to more accurately assess lumen 
compromise in pts with coronary artery disease. To measure Vol, we 
used a 3.9 F 25 MHz intravascular ultrasound (IVUS) probe rotating 
at 1800 rpm and withdrawn at 0.5 mm/sec by a prototype motorized 
pullback handle that allowed unifonned sampling of image slices 
every 17 microns. The IVUS system was interfaced wi~ an im.age 
proces~ing computer that. stacked> 200 ev.enly·~paced Image.s m a 
cylindrical format to proVide automated 3-dimenslOnal calculallOn of 
lumen Vol. Ten nonnal or diseased vessels (7 SVG and 3 RCA) 
were imaged in vitro. IVUS 3-dimensional Vol was compared with 
Simpson's rule Vol calculations from manual planimetty of both 
histologic cross sectional areas (CSA) taken every 2 to 5 mm of 
vessel length (r=.83) and previously validated manual planimetty of 
IVUS cross·sectional images of the same vessel taken every Imm 
(r=.94). Vessel length ranged from 6.3 to 35.2mm. CSA from 1.2 
to 8.9mm2, and volume from .019 to .111cc. Dynamic changes in 
Vol from pressure expansion of the vessel were easily calculated; the 
magnitude of Vol change depended on vessel compliance, presence 
or absence of atherosclerosis, and lesion composition. In 16 pts 
lumen Vol measured in vivo with the same 3-dimensional IVUS 
system correlated well with Vol measured by quantitative coronary 
angiography (using an orthogonal geometric technique) over a range 
of .023 to .147cc (r=.74).We conclude: Three·dimensional IVUS 
is a new. fully automated. extremely accurate ~hnique to measure 
coronary artery Vol in vitro and in vivo over a Wide range of lumen 
Vol. Since small changes in lumen Vol can be quantitated easily, 3· 
dimensional IVUS Vol calculations may be useful in studying 
disease progression and regression and transcatheter intervention in 
pts with coronary atherosclerosis. 
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830·6 11:45 
Three· Dimensional Reconstruction and Display of Forward 
Vie\\oing Intravascular Ultrasound Data. 
Kok-Hwee Ng, James L Evans, Michael J. Vonesh. Sheridan N. 
Meyers. Terri A. Mills. Bonnie J. Kane. William N. Aldrich. Yue· 
Teh Jang. Paul G. Yock. Michael D. Rold. Sanford I. Roth. David 
D. McPherson. 
Northwestern University Medical School. Chicago. IL 
Current intravascular ultrasound (IVUS) catheters provide 
transverse images at the level of the ultrasound transducer. We 
have developed a prototype 20 MHz forward viewing IVUS 
catheter (Cardiovascular Imaging Systems. Sunnyvale. CA) which 
provides 2D sector imaging planes distal to the catheter tIp. We 
have generated algorithms using an ImageComm workstation that 
provide three-dimensional volumetric reconstructions (3DR) of 
forward·viewing IVUS data. allowing for display. visualization 
and transverse slicin$' 
To test our algonthms. 3 arterial segments (2 canine aortas, 1 
human femoral artery) were evaluated in·vitro. ThirtY·six 
longitudinal slices were collected ahead of the catheter. digitized. 
processed and reoriented to produce a 3DR matrix. The matrix 
data was sliced into paranel transverse sections and 3DR 
generated cross-sections were compared to histology (HISTO). 
Results: Image data could be reconstructed for a distance of 10 
mm ahead of the catheter. 3DR easily demonstrated wall and 
luminal morphology and provided transverse IVUS images 
similar to the histologic specImens. A good correlation was noted 
between HISTO and 3DR determined luminal diameters (LD). 
3DR LD = 0.7 HISTO LD + 1.5. r = 0.77. 
3DR LD = 6.3 ±. 0.6 mm; HISTO LD = 7.1 ±. 0.7 mm (X ±. SD) 
These preliminary data demonstrate the feasibility of 3DR of 
forward VIewing IVUS data. This allows rapid. detailed analysis 
of diseased arterial segments previously unavailable with standard 
IVUS and may permit better targeting of interventional 
techniques. 
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831-1 10:30 
Contrast Effects On Platelet Aggregation During PTCA 
Christine M. Gasperetti. Steven L. Gonias. Lavrence Y. 
Gimple. Eric R. Povers. 
University of Virginia Health Sciences Center, 
Charlottesville, Virginia 
Contrast media (CM) are knovn to have effects on platelet 
function. To determine vhether different CM have differ•
ent effects during coronary angioplasty (PTCA) ve studied 
the effects of Iopamidol (Ip). Oiatrizoate (0), and Iox•
aglate (Ix) on platelet aggregation (PA) responses to 
AOP (10~M, l~M, 0.5~M, 0.25~M) epinephrine (5~M), colla•
gen (l~M), and serotonin (13~M) in 25 patients undergoing 
PTCA. Platelet rich plasma vas isolated from blood col•
lected in acid citrate dextrose. All patients vere pre•
treated vith aspirin and heparin (10K Units). Samples 
from the coronary sinus vere collected at baseline (B), 
after initial contrast injections before PTCA (post C), 
and after balloon inflation (post-PTCA). 
Results: 1) For all concentrations of AOP, the use of Ip 
vas associated vith an increase in PA - Eg.(10~M AOP): 
from 29.9t2.7 (B) to 40.7t4.3(post-PTCA, p<0.05) vhereas 
the use of 0 or of Ix vere not - Eg.(10~M AOP)j 0: from 
31.6t2.0 (B) to 32.1t2.4(post-PTCA) and for Ix: from 
30.9t3.9 (B) to 31.6t3.9(post-PTCA). 2) For epinephrine 
and collagen, no differences in PA from B vere seen 
either post-C or post-PTCA vith any CM. 3) For serotonin, 
an increase in PA vas seen post-PTCA compared to B vith 
all CM, but not post-CM alone - for Ip:from 24.2±9.3 (B) 
to 31.5±1.5 (post-PTCA), for 0:15.6t5.2 (B) to 23.8t7.9 
(post-PTCA), and for Ix:16.3±5.4 (B) to 31.5t6.6 (post•
PTCA) , all p<O.OOl). I/e conclude that 1) use of Ip re•
sults in increased PA responses to ADP, 2) use of Ip or 0 
or Ix does not differentially effect the increased aggre•
gability to serotonin seen post-PTCA. 
ABSTRACTS 
831-2 10:45 
Rapid and ACCDrate Calculation or Relative Coronary Flow Reserve 
and Collateral Blood Flow by Pressure Measurements 
Nico Pijls. Jacques van Son. Richard Kirkeeide. Bernard DeBruyne. 
Evert Lamfers. Karel van Leeuwen, K. Lance Gould. 
University of Nijmegen. The Netherlands. OLV Hospital. Aalst. 
Belgium and University of Texas. Houston TX. 
Quantitation of maximal coronary. myocardial and collateral blood flow 
would provide accurate evaluation of the functional significance of 
coronary artery stenoses and enable better on-line evaluation of PTCA 
results. 
We described the coronary circulation by a set of 3 equations which 
enable easy and rapid calculation of relative maximal coronary. 
myocardial and collateral blood flow (Q •• Q. and Q", respectively). 
These equations only contain terms of arterial. venous and distal 
coronary pressure (PI' P yo and Pd' respectively). The validity of these 
equations was tested experimentally in 5 instrumented dogs at 3 
different levels of arterial pressure with 12 different degrees of stenosis 
at each level. P d was measured using a new 0.015· pressure monitoring 
guide wire. Calculated Q •• Q. and Qc were compared to coronary flow. 
measured by an epicardial Doppler probe. Results: 
slope int 
Q. 0.99 0.98 0.02 
Q 0.98 0.73 0.26 
Qc 0.96 0.24 -0.24 
Conclusions: 1) Rapid and accurate calculation of relative maximal 
coronary. myocardial. and collateral flow is possible by pressure 
measurements only. 2) For the first time. quantitative contribution of 
collateral flow to total myocardial blood flow can be assessed in a 
clinically feasible way. 3) This approach can be applied in PTCA 
without complicating or prolonging the procedure and therefore may 
have important clinical implications. 
831·3 11:00 
Comparison of Hemodynamic and Pharmacologic 
Perturbations of Coronary Collateral Flow Velocity In 
Patients During Angloplasty 
Thomas J. Donohue, Morton J. Kern, Frank V. Aguirre. Calvin 
Bell. Danny Penick. Elizabeth Of iii. SI. Louis University Medical 
Center. SI. Louis, MO. 
The effects of hemodynamic and pharmacologic manipulations on 
established coronary collateral flow have been studied only with 
angiography. Recently, a more physiologic estimation of collateral 
flow is now available using Doppler derived measurement of 
Intracoronary retrograde flow velocity. To compare changes, 
coronary collateral flow velocity was measured (0.018" Doppler· 
tipped guidewire) in 6 patients undergoing angioplasty who had 
preexisting angiographic collateral flow to the vessel under study. 
The average coronary stenosiS was 89±8%. The antegrede peak 
velocity proximal and distal to the stenosis was 2S±14 and 4±1 
em/sec (p<.OS) respectively. Measurements of peak retrograde 
collateral flow velocity at baseline, at peak hyperemia following 
bolus IV adenosine (2.S mg) and during angioplasty balloon 
inflation were made BesyJls (mean ± lSm 
Bwlini Adenosine 
Peak Velocity(cm/sec) 19±17 17±17 
% change from base . 9 ± 1 4 
l'P< 05 ys baseline P< 05 ys Adengsine) 
Balloon Occlysign 
32±26· 
86±34· 
Adenosine produced no change in retrograde collateral flow despite 
its effect on coronary hyperemia. Balloon occlusion consistently 
produced a marked increase in collateral flow. These data 
demonstrate that the hemodynamic (coronary occlusion) effects 
produce greater flow response than the pharmacologic 
perturbations and may be the predominant controlling factor in 
coronary collateral flow. 
383A 
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831-4 11:15 
Impaired Coronary Flow Reserve After Coronary Angloplasty is 
DOt due to Impaired Nitric Oxide Synthesis 
Neal G. Uren. Tom Crake. David C. Lefroy. Graham J. Davies. Altilio Maseri. 
Hammersmith Hospital. London. UK. 
The coronary flow reserve (CFR) remains decreased immediately after successful 
coronary angioplasty (PTCA) and impaired production of nitric oxide (NO) has 
been implicated. The purpose of this study was to investigate the contribution 
of NO production to the decreased CFR after PTCA. Six male patients (mean 
age 54 years) were studied. All were undergoing proximal left anterior 
descending coronary artery (LAD) PTCA. None had suffered a previous 
myocardial infarction. All had a positive exercise test and all antianginal 
medication had been discontinued for >48 hours. Coronary flow velocity was 
measured after P'TCA (<20% residual stenosis) using a 3F Doppler flow catheter 
positioned 0.5-1.0 cm proximal 10 the site of the lesion and changes in LAD and 
lesion calibre were measured with quantitative angiography. Heart rate. systemic 
blood pressure (BP) and electrocardiogram were recorded continuously. After 
PTCA. intravenous dipyridamole. 0.5 mg/kg over 4 min. was infused to 
determine the coronary flow reserve (CFR). At the peak coronary flow velocity 
induced by dipyridamole. sodium nitroprusside (SNP). a donator of NO. was 
infused intracoronary at increasing incremental doses of 4. 8. 16. 32. and 50 
l1g/min. each dose for 1 min. The infusion of SNP was discontinued 
immediately BP decreased Results were (mean±SEM): 
Heart rate(bpm) 
BP(mmHg) 
CFR 
BIIiIII Pipyridamole ~ ~ 
64±3 76±5· 73±4· 80±4* 
136±S 13O±S 130±11 122±S* 
1.50±0.16 l.S2±O.23 1.53±0.22 
• p<0.05 vs. Basal 
In 4 of these patients. regional myocardial blood flow was measured I day post 
PTCA by multiple slice positron emission tomography with H2 150 at rest and 
after dipyridamole. 0.5 mg/kg over 4 min. CFR was 1.69±OJI (p=NS vs. 
CFR immediately after PTCA by Doppler) in the region subtended by the dilated 
artery and 3.74±O.37 (p<O.OOI) in the region subtended by angiographically 
normal arteries. 
Thus. following successful PTCA. the CFR is markedly impaired. The 
intracoronary infusion of SNP confers no additional increase in CFR. In 
~. there is a reduced CFR after successful PTCA but this is not due to 
impaired NO production in the coronary circulation. 
831-5 11:30 
Chest Pain After Successful Angioplasty: Evidence for 
Microvascular Dysfunction ' 
Timothy D. Henry. David D. Laxson. Andrew L. McGinn, Stevan 
D. Zimmer, Robert F. Wilson, Hennepin County Medical Center 
and University of Minnesota. Minneapolis, Minnesota 
Recurrent angina soon after coronary angioplasty (PTCA) is a 
common problem. Frequently, coronary angiography reveals 
widely patent coronary arteries without significant epicardial 
stenoses. Chest pain in these patients is often attributed to spasm or 
noncardiac causes. To determine if microvascular dysfunction 
might account for angina in this setting, we studied 8 patients who 
developed recurrent exertional angina 1 to 3 weeks after successful 
PTCA. In each patient, coronary angiography 1-5 months after 
PTCA revealed no angio~raphically significant stenosis (>50% 
diameter) and the transleslOnal pressure gradient (MI) across the 
dilated lesion was <15 mmHg. Coronary flow reserve (CFR) was 
measured in both dilated and nondilated vascular beds using a 
Doppler catheter and intracoronary adenosine or papaverine (normal 
value of CFR in our laboratory = 3.0-7.6 pealc/resting velocity). 
Immediately 
Results Before PICA After PICA 
% Stenosis 84±3 29±2* 
MI (mmHg) 42±8 7±1 * 
CPR (peilklrestjn & ratjo) 
All data mean±SEM, *p<O.Ol vs. before PTCA. 
Follow-Up 
33±2* 
8±2* 
2Q±1 
Although the residual luminal stenosis and translesional pressure 
gradient at follow-up after PTCA was minimal, CFR was markedly 
reduced in all patients (range 1.4-2.6 peak/resting ratio) and in both 
the nondilated and dilated arteries (2.2±.2l vs 2.D±.14, p=NS), 
indicating the presence of microvascular dysfunction. Abnormal 
CFR in the nondilated artery suggests that microvascular dysfuncion 
was not related to the prior PTCA and may have contributed to the 
pre-PTCA angina as well. Conclusion: microvascular 
dysfunction may be responsible for angina unrelieved by successful 
PTCA. 
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831-6 11:45 
A Prospective Study of the Effect of Coronary 
Angioplasty on Established Late Potentials After Acute 
Myocardial Infarction 
D. Brent Glamann, James D. Boehrer, Richard A. Lange, 
John E. Willard, W.C. Brogan, Eric J. Eichhorn, Paul A. Grayburn, 
Azam Anwar, and L. David Hillis 
U of Texas Southwestern Medical Center, Dallas, 'IX 
In previous studies, we have shown that survivors of acute 
myocardial infarction (AMI) in whom the infarct-related coronary 
artery (IRA) remains occluded often have (a) late potentials on signal 
averaged electrocardiography and (b) subsequent cardiac death. In 
contrast, those whose IRA has antegrade perfusion are unlikely to 
have late potentials, and their long-term prognosis is excellent. This 
study was done to assess the effect of mechanical restoration of 
antegrade flow -- accomplished 5-10 days after AMI -- on the 
presence of late potentials in patients with an occluded IRA. We 
prospectively identified 8 patients (7 men, 1 woman, aged 39 to 69 
years) with late potentials 5-10 days after their first AMI in whom the 
IRA was occluded. Six had successful angioplasty (PTCA) of the 
IRA, with restoration of antegrade flow, whereas the other 2 were 
assigned to conservative management (controls). Subsequently, 
signal averaged electrocardiography was done 1-3 months later. In 
the 2 controls, late potentials persisted at 1-3 months. In contrast, 
late potentials resolved by 1-3 months in all 6 PTCA patients. Thus, 
the mechanical restoration of antegrade perfusion in an occluded 
infarct-related coronary artery 5-10 days after acute myocardial 
infarction abolishes late potentials on signal averaged 
electrocardiography. As a result, these patients may be less likely to 
have subsequent cardiac death. 
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832-1 
Bffects of Exercise Training In cardiac Patients 
Stratified According To Age and Gender 
10:30 
Gary J.Balady, Jill Downing, Judy Scheer, Thomas J.Ryan, 
Alexander Leaf Boston University Medical Center and 
Massachusetts General Hospital, Boston, MA. 
To evaluate the influence of age and gender on baseline 
exercise tolerance and change in functional capacity 
with cardiac rehabilitation, 695 patients (age 59+12 
yrs) were prospectively enrolled in a multicenter-data•
base. Treadmill testing before training (pre) showed 
that both exercise time(TIHE) and oxygen consumption 
(V02) were greater in males(H) than females(F) 
(p(O.0001), & in younger«60yrs) vs.older(>60yrs) pts. 
(p(O.0001). After 10 weeks of training, 360 patients had 
repeat (post) exercise testing. Results on 235 pts who 
performed the same test-ing protocol on both tests are: 
<60 yrs >6Oyrs 
H F H - F 
TIHE(sec) 
pre' 518+155 381+1261 390+149 306+102 t 
post 657+153* 503+149*t 532!170* 436!106*t 
V02(ml/kg/min) - t 
pre 28.2+5.9 23.0+4.8 t 23.4+5.7 20.2+3.9 
post 33.5+5.8* 27.7+5.7*t 28.8+6.5* 25.1+4.0*t 
*p(0.0001 pre vs post, t p<O.01-M vs F -
The relative increases in exercise time and V02 were 
the greatest in older women, and the least in younger 
men. Among 26 patients with concordantly positive tests 
for ischemic 5T .,ischemia-free exercise duration in•
creased by 2.6+1.2 min (p(O.OOl), but HR at ST • did 
not change.Ve conclude: 1)exercise tolerance differs 
relative to age and gender,although all patients sig•
nificantly improve after training; 2)the most improve•
ment occurs in those with the lowest initial values; 
3)exercise training significantly increases 
ischemia-free exercise duration. 
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832·2 10:45 
Exercise Attenuates the Cardiac Chronotropic Response to Isoproterenol 
Susan B. Eysmann, Ernest Gervino, Dorothy Vatner, Sarah E. Katz, Pamela 
S. Douglas. Harvard· Thorndike Laboratory, Beth Israel Hospital, Boston,MA 
Although both brief and prolonged exercise have been shown to acutely 
Increase lymphocyte beta receptor density, their effects on cardiac adrenergic 
chronotropic responsiveness are less clear. Accordingly, we studied the heart 
rate (HR) response to the beta agonist isoproterenol (ISO) In 7 sedentary 
normals (4M, 3F;mean age 36:8 years; VOl max 33.8:1:8.7 ml/kg/min) at 
rest and following both brief (10 min) and prolonged cycle erllometry to 
fatigue (mean duration 88 ntin, range 36-125 min). During both brief and 
prolonged exercise the average VOl was 19.8 ml/kg/min, range 14.1·28.5, 
which was 59% VOl max, range 45-69. Plasma epinephrine (EPI) and 
norepinephrine (NE) were also measured USing a radioenzymatic assay. ISO 
was adntinistered after exercise, when HR had returned to resting levels, In 
IncreaSing IV boluses (0.5 mgm, 1.0, 2.0, 4.0, 6.0, etc) q5min until HR 
increased at least 30 bpm. For each subject, the relationship between 
Incremental HR and log dose ISO was used to calculate the dose required 
to raise HR to 15 and 25 bpm (tHR15, tHR25). Results (mean:l:5D, 
·p<0.05 vs rest, repeated measure ANOVA): 
tHR15 tHR2S EPI(pglml) NE(pg/ml) 
&l! .36:.16 1.15:1:.54 74:1:24 310:1:63 
I!!:W .82:.43 2.58:1:2.53 144:1:50· 845:1:326· 
J.Qng 1.04:1:.84· 3.49:1:3.29· 265:1: 164· 1106:1:551· 
In sum, both piasma catechols and the dose of 150 required to tHRl5 
and t HR25 increased after prolonged exercise compared to both brief 
exercise and rest. 
Thus, exercise Increases catechols and attenuates the cardiac chronotropic 
response to ISO In a dose (exercise duration) related fashion. These 
physiologic results demonstrate impaired beta adrenergic responsiveness after 
exercise, which is Inconsistent with previous reports of augmented receptor 
density. 
832·3 11:00 
Beneficial Effect of Moderate Exercl.. on High Density 
Lipoprotein (HDL)In Cardiac Rehabilitation Patients 
Paul M. Murray, David M. Herrington, Shala Davis, John W. 
Baker, Henry S. Miller, Bowman Gray School of Medicine, 
Wake Forest University, Winston·Salem, NC 
Exercise is a uniformly recommended Intervention for a 
low HDL cholesterol. However, most studies Indicate that 
high levels of physical training (PT) are needed to achieve 
meaningful increases in HDL. Patients with coronary disease 
(CAD) and low HDL (s 35mg/dl) need effective HDL 
interventions but are often unable to achieve high levels of 
PT. To determine the effects of mild to moderate PT in CAD 
patients with low HDL, 88 patients in a multidisciplined 
cardiac rehabilitation program with low (n - 32), or normal 
(n .. 56) HDL levels were followed for 1 year. Baseline, 6 
and 12 month plasma HDL and total cholesterol, weight, % 
body fat (%BF), and MET level achieved during maximum 
symptom limited treadmill testing were measured. 
Mean (SO) 
hu.Ii.n§. .6...oJ.Q .1.2...m2 % change ~ 
HDL s35 28.7 32.8 35.5 24% 
(4.9) (6.1) (8.5) 0.001 
HDL >35 46.3 47.0 47.7 3% 
(8.6) (8.8) (10.8) 
After adjustment for age, sex, change in weight or % BF, 
and maximal MET level, modest PT resulted in a 17% HDL 
increase in patients with low HDL over one year follow·up 
(p=0.006). The mild to moderate PT of a cardiac 
rehabilitation program is an effective method for increasing 
a low HDL in CAD patients. 
ABSTRAcrS 385A 
832·4 11:15 
Effect of Aerobic Tralnlnl on Barorenex Control 
Lois Sheldahl, Thomas Ebert, Bart Cox. Felix Tristani. VA Medical 
Center and Medical Colleae of Wisconsin. Milwaukee. WI 
A change in baroreflex control of cardiac function (R·R interval) and 
peripheral sympathetic nerve activity has been sunested in men who 
are aerobically trained. To investiaate the effect of 3 months of aerobic 
training on baroreflex control, II healthy men > 40 years of age 
(x-S4±2 years) underwent the followina battery of tests before and 
after 3 months of aerobic trainina: sequential intravenous bolus 
injections of nitroprusside (NP, 100 l1a) and phenylephrine (pHE. ISO 
I1g), cold pressor (I min). and isometric exercise (3 min). Tests were 
performed ~ 36 hours after an exercise session. Cardiac and peripheral 
sympathetic baroreflex gain (slope) were determined from the R·R 
interval (msec) venus systolic BP (SBP. mmH,) and peroneal MSNA 
(bursts/min) venus diastolic BP (DBP, mmHg). respectively. Results 
(X±SE): Maximal oxygen uptake increased significantly (29.9%1.4 to 
34.3±1.9 ml/kg/min) with training. Rest R·R interval (873±22 to 
9S2±3S), DBP (73±2 to 68±2). and SBP (l44±3 to 138±4) chanled 
(P<O.OS) with training while rest MSNA (23.l±2.lto 24.2 ±1.9) was 
not altered. The MSNA responses (change from baseline) with cold 
pressor (6.W.3 to 8.3±2.7) and isometric exercise (6.6±2.2 to 
4.2±3.0) tests were not altered significantly with training nor were the 
foreann vascular resistance (units) responses (change from baseline) 
with cold pressor (l2.2±4.3 to 12.2±4.8) and isometric exercise 
(0.9±2.1 to 2.9%2.3) altered. The following baroreflex slopes were 
also unchaM>cd wjth trajnjng; 
:RR VI SBP PHE: RR VB SBP SNA vs DBP 
m~Hg m~mHg mmwmwmmHg 
Before 8.6±0.9 9.7±1.9 ·3.3±O.3 
After 97±1 6 9 9fl 9 .3 3±O 6 
The results suggest that shon·term aerobic training does not 
significantly change resting MSNA or autonomic responses includinl 
baroreflex control of cardiac and peripheral sympathetic nerve activity 
in middle·age and older men. 
832·5 11:30 
Plasma Catecholamine Levels and Peak Heart 
Rate Response to Exercise Tralnln. In Heart 
Transplant Patients 
James D. Walter, Susan C. Brozen., Peter H. Brubaker, 
Deborah L. Morley, Mariell Jessup, Alfred A. Bove. 
Temple University Hospital, Philadelphia, Pennsylvania. 
Cardiac transplant patients have demonstrated an ability to 
improve functional capacity after exercise training, in pan 
due to an increase in the peak heart rate (HR) response. The 
mechanism for this increased HR is unknown. We examined 
HR, oxygen uptake corrected for body weight (V02), plasma 
norepinephrine (NE) and epinephrine (EPI) values from 8 
transplant patients during ,raded exercise teslin, before and 
after 14;!:.1. 7 weeks of exercise training. Trainin, was 
performed at home or in rehabilitation facilities. Intensity 
was monitored by perceived exertion (11·13 on the Borg 
scale). All patients completed both teslS within the first year 
after transplant. Values are presented as mean ;!:. SEM. 
Peak V02 Peak HR Peak NE Peak EPI 
'mll~llmiDl LU.Ml Wlm.ll WLmll 
Test 1 17.9±1.6 13S±6.2 22S9±3S3 IIS.8±,2S.6 
Test 2 20.l±2.1 144±,6.3 3204±,674 1 86.4±,48 .0 
P value p=.09 p=.02 p=.04 P'".04 
The correlation coefficients for NE and HR, and EPI and HR 
were ra.70 and r- .S7, respectively. Both were significant at 
p<.OS. The increased peak HR response can be attributed in 
pan to elevated plasma NE and EPI levels. 
386A ABSTRACfS 
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Cardiac Response to Oeconditioning in Older Athletes 
Steven P. Schulman, Andrew Goldberg, Lewis C. Becker, 
Loretta Lakatta, Vicki Coombs, Gary Gerstenblith. 
Johns Hopkins Hospital and Univ. of Maryland, 
Baltimore, Maryland 
The cardiovascular effects of physical deconditioning 
(OECON) associated with limited activity imposed by 
circumstance or illness may importantly influence an 
older individual's response to stress. The cardiac 
effects of OECON have been described only in young 
athletes (ATH). In a longitudinal study, six senior 
ATH (mean age 61.2 ± 8.4 years) underwent bicycle 
exercise (EX) gated blood pool scans while trained and 
after 12 weeks of OECON (VOZmax 50.5 ± 6.3 to 43.2 ± 7.3 ml/kg/min). Rest and maxImal EX (187.5 ± 24 and 
179.2 ± 22 watts for trained and OECON) cardiac volumes 
were evaluated. 
lr.i.i.!wI. EOV I 
REST: 75 ± 16 
MAX: 76 ± 15 
DELTA: 0.7 ± 8 
Detrained 
SVI 
51 ± 13 
66 ± 13 
15 ± 7 
EF 
68 + 6 
87 ± 5 
19 ± 5 
CI 
3.1 ± 0.8 
10.2 ± 1.9 
7.1 ± 1.2 
REST: 71 ± 7 46 ± 9. 63 ± 7. 2.8 ± 0.6. 
MAX: 67 ± 11 54 ± 9. 80 ± 4 8.4 ± 1.2. 
QELTA: ·4 ± 6 8 ± 5 17 ± 5 5.6 ± 0.8 
p < 0.05 compared to trained value; EOVI • end 
diastolic volume index, SVI • stroke volume index, EF • 
ejection fraction, CI • cardiac index. Rest and 
maximal EX heart rate did not change. Thus, OECON in 
older ATH results in a significant decrease in EF and 
eI; the latter is mediated by a decrease in SV rather 
than heart rate. 
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~, Iatt: \'a'ltrlaUar JlXpei:Ltqhy ani SIDien 
DIIIIth. DIS ~ ..s ~ gf Vent:riaUar 
~ with M:B-Dilihitars 
Ivan MIIndoza, Feciarioo Holeiro, Jt:Iises PUlido, JUan 
MIu:tpIB, Ana lOiriguez, Jose CCIldado, JUlio Acosta. 
Elcperimantal. CIm:l.iology Iaboratoly. Oent:ral 
University of V8lezUBla. caracas. Venezuela. 
Hyperta'1sive lett wnt:riC1IJ.ar hypertrqily (VJH) is a 
lethal. -.rlcar with a high risk of IIUdden death (SO), 
ancS wntriC1ll.ar arryt:h1IIias (VA) • CI:liective: To 
datetmhw the effact of ACE-imibitars as mcnotherapy 
in hypar\:.Inaiw UIH ani VA, in patianta with mild to 
IIIOr3et1lte ..-rt:1al high blc:x:d pt1IBSUr8 (HBP). ~: 
Analytical c:dlart. Patients: 100 pta. with HBP, ages 
~ 36 ani 69 years, withcut heart failure nor 
hist:.oxy of iscbaIIic cardicpathy. Interventioo: 
ACE-inhibitor (enal.april) at a dcsage of 2~0 Dg/day 
during 24 JID'lths. Measympents arrl J!esults: Clinical 
eval.uatiCll, EO::, torax X-ray, two-d.ilIiensia1al and M 
IIICda ect1ocardi~, ft:Ilter 48 hems, ani stress 
test at 3, 6, 9 ani 12 lIDlths after initiatirg 
treatmant. 46% of patients presented ocncentric LVH 
by e::ilO (VJH-eci1O) ani 2at by EO:: (LVH-EO::). Patients 
with VJH had a frecpancy statisc::ally signific:antly 
higher of VA, than those withalt VJH. 25t of patients 
with INH-EO::, at with INH-ec::ho arrl at withalt VJH had 
I.own 4 VA. D.Irizq the average follow-up at 12 lIDlths a 
decrease in the IN mass was cbaerved fran 277qr +/-
72.68 to 236qr +/- 50.02 ani abolitiCll of all VA l.own 
3 ani 4. O;n;lusiCll: Treatmant with lICE-inhibitors 
produced the reg:ressiCll of VJH ani the abolitiCll of 
CXIIplex VA. If this IIICXti.ficatiCll reduces risk of SO 
is atill to be deteImined. 
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Electrophysiologic Predictors of Flecainide's Proarrhythmia 
Mohammad Shenasa, Gerhard Hindricks, Wilhelm Haverkamp, 
Barbara Vogt, Martin Borggrefe, Gunter Breithardt. 
Westf. Wilhelms-University Miinster, Germany 
Of 85 patients with coronary artery disease and remote 
myocardial infarction (mean age: 59± 13 years) who were treated 
WIth oral flecainide for sustained monomorphic ventricular 
tachycardia (VT), 16 (19%) developed proarrhythmia (group I) 
and the remaining 69 patients did not (group II). Proarrhythmia 
was defined as presentmg with sudden cardiac death or incessant 
VT which were not present prior to therapy. All patients 
underwent programmed ventricular stimulation during baseline 
and followmg treatment with oral flecainide (200 mg/day). 
Stimulation protocol consisted of introduction of up to 3 
extrastimuli following basic drives of 600 and/or 400 ms at two 
right ventricular sites. vr cycle length and I::. % increase in 
ventricular effective refractory period (VERP) following 
flecainide therapy did not significantly differ between the two 
groups. The baseline values for VT cycle length were 315±45 ms 
for ~oup I and 305±49 ms for group II (p=n.s.) and after 
f1ecamide therapy was 390±55 ms for group I and 415±43 ms for 
group II (p=n.s.). The 1::.% increase in VERP (of S2 at 600 ms) for 
~oup I was 25±9% and for group II was 23±7% (p=n.s.). Drug 
mduced prolongation of paced QRS at ventricular paced cycle 
length of 400 ms (I::. % QRS) for group I was 28% and for group II 
was 15% (p<O.OOI). Thus, only increase in ventricular conduction 
time by more than 35 ms was the most powerful determinant of 
proarrhythmia. 
We conclude that flecainide's proarrhythmia can be best predicted 
by its excessive prolongation of ventricular conduction time 
irrespective of inducibility or non inducibility of sustained vr 
during flecainide therapy. 
833·3 11:00 
Electrophysloloalc E.aluatlon of Morlclzlne In Patients 
With Sustained Ventricular Tachyarrhythmlas: Low 
Efficacy and Hlah Incidence nf Proarrhythmla 
Anil K. Bhandari, Stephen S. Ehrlich, Josef Widerhorn, 
Cheryl Leon, Shahbudin H. RahimtOOla, David S. Cannom 
The Hospital of the Good Samaritan, Los Angeles 
In pts with history of sustained ventricular tachyarrhythmias. the 
efficacy and safety of moricizine have not been systematically 
evaluated by electrophysiologic studies (EPS). To determine this, 
22 pts with history of sustained ventricular tachycardia (VT) or 
fibrillation (V F) underwent serial EPS. The underlying heart 
disease was coronary in IS pIS, cardiomyopathy in 4. Chagas' 
disease in 2 and none in I pt. The left ventriCUlar ejection 
fraction ranged from 15% to 69% (mean 40% ± 17%) and the 
number of previously failed antiarrhythmic drugs 2.4 ± !.S. 
During the control drug-free EPS. sustained VT was inducible in 
18 pts, VF in I pt and reproducible nonsustained VT (10-20 sec) 
in 3 pts. All 22 pts received moricizine (dose. 782 mg ± 152 mg) 
to the maximum tolerated dose (900 mg) over a period of 3·to-5 
days. Six developed ventricular proarrhythmia (incessant VT 5, 
recurrent polymorphic VT I) within the first 4 days. This lasted 
from 6-to-24 hours, required multiple cardioversions in 3 pts, was 
associated with QRS widening but not QT prolongation, and 
spontaneously resolved 6-to-24 hrs after withdrawal of moricizine. 
Of the remaining 16 pts, I S underwent EPS on moricizine and 
only 3 pts (20%) were rendered noninducible. The VT cycle length 
in the other 12 PIS slowed from 274 ms ± 77 ms to 316 ms ± 66 ms 
(p<0.09). Three non inducible pts and 2 pts with inducible, but 
slowed, VT were discharged on moricizine. Of these 5 pIS, I 
developed syncope and complete A V block I week later, I had 
ventricular proarrhythmia 3 weeks later, and I had syncope with 
documented sustained VT 4 weeks after institution of moricizine. 
Only 2 PIS have continued to take moricizine without side-effects 
or recurrent arrhythmic events during a follow-up of 4 months 
and 9 months, respectively. Thus, moricizine is only rarely 
effective for long-term treatment of pts with spontaneous sustained 
ventricular tachyarrhythmias. It renders VT non inducible in a 
small minority (20%) and is associated with a high incidence (28%) 
of early ventricular proarrhythmias. 
JACC Vol. 19, No.3 
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Electrophysiologic Response to Moricizine in 
Patients with Sustained Ventricular Arrhythmias. 
Anne C. Powell, Michael R. Gold, Hasan Garan, Ross Brooks, 
Jeremy N. Ruskin, Brian A. McGovern. Cardiac Unit, 
Massachusetts General Hospital, Boston, MA 02114. 
Moricizine (M), a class I antiarrhythmic agent, has been 
shown to suppress premature ventricular contractions and 
nonsustained ventricular tachycardia (VT), but limited data 
are available regarding efficacy of M for sustained 
ventricular arrhythmias (V A) in patients with impaired left 
ventricular function. M was given to 21 pts (coronary artery 
disease 18 pts, dilated cardiomyopathy 2 pts, no structural 
heart disease 1 pt), age 62±12 yrs, LVEF 32±1l%, undergoing 
electrophysiology studies (EPS) for sustained VA. 
Presentation was VT(13 pts), cardiac arrest (CA)(4 pts) and 
syncope (4 pts). Pts had failed 2.1±1.1 previous EPS drug 
trials. At baseline drug-free EPS 20 pts (95%) had inducible 
(IN) sustained monomorphic VT (SMVT) CL 293±76 ms with 
2.3±0.6 extrastimuli (ES). On M (248±28 mg) tid 20 pts had IN 
SMVT CL 321±84 ms with 1.9±0.7 ES and 1 pt had spontaneous 
(SPONT) SMVT before EPS. Four pts had 6 episodes of SPONT 
SMVT on M. A proarrhythmic response occurred in 4 pts 
(19%); I pt had CA and IN SMVT on M and no VT at 2 drug-free 
EPS. SMVT was more easily IN(I ES) and incessant in 2 pts, and 
I pt with self-terminating exercise-induced SMVT had easily 
IN and SPONT SMVT on M. Ultimately, 9 pts received 
defibrillators, 5 pts had VT suppressed with class III drugs 
(sotalol 4 pIS, amiodarone I pt), I pt had radiofrequency 
ablation, I pt had left ventricular anneurysmectomy, 4 pts 
(including 2 pIS on M) were discharged with VT unsuppressed 
on drugs and 1 pt was discharged without antiarrhythmic 
drugs. 
CONCLUSION. In this population with left ventricular 
dysfunction and resistant VA, M showed low efficacy (0%) for 
suppression of IN V A at EPS and had a proarrhythmic effect 
in 19% of pts. 
833·5 
Loss of Emcacy, Proarrhythmla and Side Effects During 
Longterm Therapy with 3 Class I Antiarrhythmic Agents -
Multivariate Regression Analysis 
11:30 
Manfred Zehender, Armin Furtwiingler, Stefan HohnIoser, 
Sabine Eppinger, Manfred Olschewski, Thomas Meinertz, Han•
jorg Just. Dept. of Cardiology and Institut of Statistics, 
University of Freiburg, FRG. 
Using a double-blind randomized study design, 417 pts (59.3.±.9 
years) with symptomatic ventricular premature beats (> 30 
VPB/h, repetitive VPB: 342/417 pts, 83%) were evaluated to 
predict acute and longterm efficacy, proarrhythmia (PrO-A) and 
side effects (SE) of encainide (Enc: 70-150mg), pirmenol (Pir: 
200-400mg) and propafenone (Pro: 450-900 mg). At baseline, all 
pts underwent a 2-week placebo period with two 24h-Holter•
ECGs (H). Responders to therapy: reduction of VPB >-84%, 
repetitive VPB > -90%. When 150 responders to therapy (Pro > 
Enc>Pir) were restudied after 3,6,12 months by H, loss of anti•
arrhythmic efficacy was common. 
Multivariate 
~: 
Acute: .IoLa.swte ... :______ _ 
response inefficacy Pro-A SE 
(25%) (3%) (29%) 
VPB variability n.s. < .05 n.s. n.s. 
VPB >5000 /24h n.s. <.01 n.s. n.s. 
Pairs >20/24h <.01. n.s. n.s. n.s. 
Age <60 years <.01 n.s. n.s. <.05 
Heart disease n.s. n.s. n.s. n.s. 
Titration dose < .001 n.s. n.s. 
In 25% of patients per year class I antiarrhythmic beome 
inefficent, stressing the need for repeated H. The titration dose 
predicts best late loss of antiarrhythmic efficacy. 
ABSTRACTS 
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Incidence of Drug Efficacy Predictions in the Electrophysiologic Study 
Versus Electrocardiographic Monitoring Trial (ESVEM) 
The ESVEM Investigators, University of Utah, Salt Lake City, Utah 
The multicenter ESVEM trial compares the accuracy of 
e1ectrophysiological study (EPS) and Holter monitoring (HM) in 
predicting efficacy of antiarrhythmic drugs in patients with sustained VT 
or sudden death. Enrollment was completed on 2/14/91. 486 patients 
were randomized to undergo serial testing by EPS or HM of the 
efficacy of up to 6 drugs in random order. All patients had 
reproducibly inducible sustained ventricular tachyarrhythmia and at least 
10 PVCs per hour. An efficacy prediction was defined as suppression 
of inducible tachyarrhythmia at EPS or of spontaneous ventricular 
ectopy on HM. 
Patients 
Drug Trials 
EPS 
N Effimx 
242 45" 
744 15" 
HM 
N Effimx ~ 
244 77" lO-12 
483 40" 10'22 
Thus, efficacy for patients and for drug trials was predicted 
much more frequently in the HM than the EPS limb. Potentially 
relevant characteristics (CHF class, LVEF, presence of coronary 
disease, previous infarction, VT vs sudden death, PVC frequency, 
gender, age and induced arrhythmia) and frequency of testing of 
each of the six drugs were similar in the two groups. 
We conclude that predictions of drug efficacy by ESVEM 
criteria in patients with ventricular tachyarrhythmias are achieved 
much more frequently by HM than by EPS. The accuracy of 
these predictions remains to be determined when follow up in the 
ESVEM trial is completed in 1992. • 
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Differential Regional Left Atrial Distensibility 
Brian D. Hoit, Marjorie Gabel, Vanfu Shao, Richard A. 
Walsh, University of Cincinnati Medical Center, 
Cincinnati, Ohio 
To determine whether there are regional differences in 
left atrial (LA) distensibility in vivo, we measured 
LA body and appendage (APP) diameters with 
sonomicrometers over a wide range of intracardiac 
pressures and volumes obtained by intravenous saline 
infusion in 12 dogs. The monoexponential pressure•
natural strain relation of the APP was shifted to the 
right of the LA body in 11 of 12 ani .. 1s. The mean 
coefficient of the LA pressure-strain relation was 
greater for the body than APP (3.1 ± 1.1 ImHg vs 1.9 ± 
0.7 mmHg, p<0.01); the V intercepts were not 
significantly different (5.2 ± 1.7 ImHg vs. 4.9 ± 1.8 
mmHg). The maximum minus minimum LA dimension (RES), 
an index of the reservoir function of the atrium, and 
l atrial systolic shortening (l SS) were cempared at 
three levels of LA pressure: 
Low Mid High 
LA (mmHg) (7.2±1.4) (12.7±1.7) (18.6±2.7) 
BODV RES (mm) 1.7±1.1 2.2±1.1 2.5±1.2* 
APP RES (mm) 2.8±1.1t 4.0±1.8*t 4.2±2.0*t 
BODV'SS 3.0±1.6 4.2±2.6 4.7±3.0* 
APP , SS 8.7±3.1t 13.7±6.4*t 16.2±6.5*t 
*p<0.05 vs. low LA pressure, t vs body (± SO) 
Over the same range of LA pressure, the percentage 
increase in atrial dimension was greater in the 
appendage than body (28.7 ± 12.1' vs. 16.6 ± 7.5' 
p <0.02). Thus, the LA appendage is more distensible 
than the LA body in vivo. Our data suggests that this 
difference plays an important role in .adulating 
systolic and diastolic function of the left atrium. 
387A 
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EFFECf OF VOLUME LOADING ON PEAK EARLY DIASTOLIC 
TRANSMITRAL FLOW: SAUNE VERSUS BLOOD. 
Michael Counois; Carol] Mechem; Benico Barzilai, F.A.C.C.; Philip A 
Ludbrook, F.A.C.C. WashingtOn Univ., St. Louis, Mo. 
Volume loading with saline has been shown to increase early diastolic 
transmitral fillin~ rate. This increase has generally been attributed to 
increased left atrial (LA) pressure. To determine whether this increase 
may also be attributable, in part, to changes related to the anemia 
produced by this intervention, we measured LA and LV pressures with 
micromanometers, LV volume with contrast angiography, and peak 
transmitral flow (E) with transesophageal Doppler in anesthetized 
closed-chest dogs volume loaded (500-650 m1) by rapid infusion of 
either normal saline (S; n=7) or whole blood (B; n=7). Although LV 
filling load, as measured by LA pressure at the time of mitral valve 
opening (XI), increased less in the S group than in the B group 
(+4.1±1.0 versus +6.9±1.5 mm Hg; p<0.(02), the % change from 
control (~%) in E after volume infusion was greater in the S group than 
in the B group (+S±13% versus -IOtl1%; p<O.02). Other significant 
differences existed between the two interventions in terms of hematocrit 
(Hct); heart rate (HR); cardiac output (CO); end-systolic volume (ESV); 
mean aortic pressure (AOM); total systemic resistance (TSR); and the 
rate of jsoyolumjc pressure decay ITlm presented below as 4%: 
Hct HR CO ESV AOM TSR TI/2 
S(~%) -lS±6 +l2±lS +27±20 +8±11 -3±6 -23±13 +12±15 
B(4%) -w -22±lS Ot13 +3Ot18 +21±1O +22±17 +53±23 
p < 0 003 0.004 0.02 0.02 0 005 0.001 0 004 
Although volume loading with both Sand B increases LA pressure, S 
loading activates mechanisms that increase CO in response to anemia 
(HR increase, TSR decrease, maintenance of ESV), while B loading 
activates mechanisms that maintain CO (HR decrease, TSR increase, 
ESV increase). Thus, volume loading with S produces systemic 
changes that differ dramatically from those produced by B, producing 
opposite changes in E. Knowledge of these intervention-dependent 
changes are crucial for proper interpretation of changes in E. 
834·3 
Papillary Muscles Do Not Leqthen During Early Systole 
Stephen C. Rayhill, Luis Castro, Marek A. Niczyporuk, Neil B. Ingels, 
George T. Daugbters, Kwok L. Yun, Ann F. Bolger, Geraldine C. 
Derby, D. Craig Miller. Stanford University School of Medicine and 
Palo Alto Mediea1 Foundation, Stanford, CA. 
Previous studies bave sbown tbat papillary muscles lengtben 
during early systole, performing negative work. In order to analyze 
the motion of papillary muscles in the intact dog, 5 dogs were 
anestbe~ and had 3 subendocardial tantalum markers placed under 
direct visual observation on the long axis of each papillary muscle, and 
7 additional markers were placed in the LV wall to allow computation 
of LV volume. After 14-18 days, tbe dogs were sedated and 
computer-aided analysis of biplane videofluoroscopy was used to track 
the markers. After control (C) recordings, data were obtained 
following two "!linutes of proximal circumflex occlusion (CxO). 
Percentage change in papillary muscle length was ea1cu1ated from the 
initiallengtb at tbe time of maximum LV volume to tbe time wben 
LV pressure reacbed 90% of maximum. Mean beart rates were 
110:27 beats/min (C) and 113:20 beats/min (CXO). Percentage 
lengtb cbanges were (mean: sd): 
lWl!m ~ .cxQ 
Anterior -1.8+2.0+ -1.7+1.7+ 
Posterior -1.0~2.5+ +3.3+0.7· 
[+Not signiIi~tly different from ~ro (t-test): 
·Significantly different from zero (p<O.OOI).] 
We conclude that: 1. Non-iscbemic papillary muscles do not lengthen 
during early systole; 2. DuriDg Circumflex occlusion, posterior 
papillary muscles lengtben under tbe influence of rising systolic 
pressure. These results suggest that previous findings of early systolic 
papillary muscle lengthening may have been confounded by ischemia 
or stunning of the papillary muscles. 
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REMOVAL OF ENDOCARDIAL ENDOTHELIUM DOES NOT ALTER THE 
POSITIVE INOTROPIC EFFECT OF ENDOTHELIN IN ADULT RAT CARDIAC 
PAPILLARY MUSCLE. 
Sam Kazziha. Rakesh Kukreja. Kathryn Loesser. and Michael Hess. 
Medical College of Virginia. Richmond. VA. 23298. 
The role of endothelin interaction with endothelial endocardium (EE) in 
modulating myocardial function has not been defined. We have 
investigated the effect of endothelin on rat papillary muscle function in 
the presence and absence of 
endocardial endothelium. Left 
ventricular intact papillary 
(n - 8) muscle force frequency 
isometric contractions were 
recorded pre and post 
superfusion with 400 nM of 
endothelins 11.2 and 31. 
Selective stripping of 
endocardial endothelium was 
achieved by brief exposure to 
Triton X 10010.5% for 3 sec.l. 
Endocardial endothelium loss 
was confirmed in all muscles by 
electron microscopy. Papillary 
muscles. stripped of 
endothelium were superfused 
• Control 
mwltn [[ 
rzza .. it~ut[E 
FreQuency of stimulation 
Figure 1: Effect of IIIdothelin on paak 
developed tlll,lon with end without 
endocardium. 
with 400 nM of endothelin 3. Peak developed tension and - DT/dt were 
significantly (p <0.005; n ~ 8) increased in intact papillary muscles 
following superfusion with all three endothelin isoforms. The positive 
inotropic effect of endothelin was dose dependent (100. 200. 400 nM). 
Removal of endothelial endocardium significantly decreased Ip<0.005; 
n .. 8) peak developed tension and % DT Idt. Endothelin produced 
significant Ip <0.005; n .. 8) increase in both peak developed tension and 
-DT/dt in the absence of endothelial endocardium (Fig. 1). In conclusion 
endothelin has a significant positive inotropic effect on myocardial 
function. even after removal of endocardial endothelium. This is at least 
partially mediated by direct effect on the contractile apparatus. 
834·5 
Contractile Response to Increased Heart Rate in Di•
lated Cardiomyopathy - Influence of Isoproterenol 
11:30 
Burkert Pieske, Gerd Hasenfuss, Christian Holubarsch, 
Martin BUchler, Hanjorg Just 
Dep. of Cardiology, University of Freiburg, Germany 
Reduced contractile response to pacing tachykardia, 
as observed in clinical studies in heart failure, may 
be due to altered loading conditions or altered 
properties of the myocardium itself. 
Therefore, the mechanical response to increasing sti•
mulation rates (30-180 beats per minute, bpm) was in•
vestigated in isolated human papillary muscle strips 
from non-failing (NF, n;14) and failing (dilative 
cardiomyopathy, NYHA IV; n;7) hearts. 
In NF, force of contraction (FOC) increased continuous•
ly from 30 bpm (7.92~1.95 mN/mm2) to 120 bpm (17_00t 
2.41 mN/mm2). In contrast, in failing myocardium, FOC 
was maximal at 30 bpm (9.1tl.5 mN/mm2) and declined 
continuously with higher stimulation frequencies (6.0~ 
1.1 mN/mml at 120 bpm). Isoprenaline (0.03 Ilmol/l) ill•
creased FOC in NF by 131.4:36.1 % (p<O.OS) and in fai•
ling by 44.1±10.2 % (p<O.OS) at 60 bpm. However, it did 
not influence the shape of the force-frequency-relation 
in either groop. 
In conclusion, in heart failure due to dilative cardio•
myopathy, the positive force-~requency-~elati?nShip is 
inversed and cannot be normalIzed by stImulatIon of 
cAMP-production. Therefore, reduced contractile response 
to pacing tachykardia in patients with dilative cardio•
myopathy may originate from alterations on the myo•
cardial level. 
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sumant:h D. Pratiul, Rd::lert A. 0 'lb.IIXe, am Greg:u:y L. 
Freenan, t1IHSC am 1IM\TAH, San Ant:ari.o, 'IX 
l>Ilether IIrjtlQll"di.al energetics can be qJaI1tified I:¥ a 
linear rel.atial between OJ pres&Jre-'IIOlume aJ:ea (PolA) am 
~ in intact animals is 1.I!lkn:l.n. We stuiied 7 cklgs in•
st.rimalted with OJ man::met:ers, dimensial gauges, a:II'CI1aJ:Y 
flow prd:Jes, am a:II'CI1aJ:Y sirus (CS) ox.iuetric catheters. 
PI relatial, am MVO, fran i I. 
arterial to CS 0, dif{~ :[ " .. • 
~l= ~em-!:o~ ::;/;' " 
am a:II'CI1aJ:Y flow. As lJ1 9 .. • 
isolated hearts, MVO, (ml 0; ~ • • .... -
min) was linearly related to .. .. ::= 
PolA (mrH;J mljbeat), am was • =_ 
described I:¥ a slq:e (a, ml __ 
Oz beat.flmii:l ml min) am in- PVAI_""""') 
tercept (p, ml cymin). At higher heart rates, a in:::reased 
am {3 was urx:ilan:.Jed. 
CYcle lerxrt,h a l 
487 ± 9 msec 0.0030 ± 0.0005 2.33 ± 0.49 
378 ± 10 msec 0.0045 ± 0.0006* 2_62 ± 0.54 
316 ± 9 msec 0.0092 ± 0.0016* 2.49 ± 0.51 
(*P<O.02 o:mpared to 487 ± 9 msec) . 
For ~ per beat the data fell (Xl ale line regardless of 
heart rate. 'lhus, the PolA-+IVOz relatial is linear am can 
be aa::urately measured in closed-d1est cklgs. '!his metlxxi 
will provide useful insights into medlamenergetic 
a:upliIg of oonnal am diseased hearts in the intact 
cirallatory systan. 
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Ambulatory ST -segment Monitoring After Myocardial Infarction 
IdentHlea Pallente with. Reduced Hemodynamic R.sponse and Sev.r. 
Ischemia During Pr.dlacharg. Maximal Exercl •• Tesllng 
Hans Mickley. Peter Pless, Jens R. Nielsen, Mogens M0lier. 
Department of Cardiology, Odense University Hosp~al, Odense, Denmark 
The correlation between ambulatory 5T -segment mon~oring and exercise 
testing has been settled in pts w~h chronic coronary artery disease. 
However, the relationship between the two ECG methods in pts recovering 
from acute myocardial Inlarction (AMI) has not been established. We 
prospectively performed predischarge maximal exercise testing and 
postdischarge 5T -segment mon~oring in 123 consecutive men aged 55± 8 
years w~h a first AMI. Myocardial ischemia was defined as horizontal or 
descending 5T-segment depression (5T1)~1 mm, measured 80 ms alter 
the J-point on both exercise testing and ambulatory mon~oring (one 
episode ~ 1 min). During 36-hour ambulatory recording started at discharge 
on day 11 ±5 post AMI, 23 pts (19%) demonstrated episodes of transient 
ischemia (Group 1), while 100 pts (81%) did not (Group 2). 5ignrricant 5T1 
during stress testing was more frequent in Group 1 than in Group 2: 19/23 
(83%) vs 47/100 (47%) (p<O.OO5). Exercise·induced ischemia was more 
severe in Group 1 as judged from a lower ischemic threshold (number of 
minutes before 1 mm STI: 5.5±2.4 vs 7.7±4.1 in Group 2 (p<O.03), and 
the maximal depth of STI: 4.1 ±2.6 vs 2.6±1.6 mm in Group 2 (p<O.03)). 
The systolic blood pressure increase attained during exercise testing was 
signrricantly lower in Group 1: 41±24 vs 56±22 mmHg in Group 2 
(p<O.Ol). No difference between the groups was found regarding anti•
ischemic medication. 
From the resu~s 01 this prospective study we conclude that ambulatory 
5T-segment mon~oring in pts w~h a recent first AMI identrries pts wtth 
severe residual ischemia and a reduced hemodynamic response during 
stress testing. As these exercise findings are of considerable prognostic 
value, ambulatory 5T-segment monkoring may serve as an ~ernative in 
the risk-stratnication of survivors of AMI. 
ABSTRACTS 389A 
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Relative Prognostic Value of Ambulatory 
lIonitoring, Exercise Testing and l.adionucUde 
Ventriculography After lIyocardial Infarction 
Peter Currie, Deborah Ashby, Stephen Saltissi. 
Royal Liverpool Hospital, Liverpool, England 
The prognostic value of ambulatory ST segment 
monitoring (AM) in 177 pts at 4-8 weeks after 
myocardial infarction (MI) was compared with 
exercise testing (N-170) and radionuclide 
ventriculography (N-134). Cardiac events (re-
MI, death or coronary revascularisation) were 
documented during 1 year of follow-up. On AM, 
ST depression (STD) was only predictive of 
cardiac events when it was frequent L e. 3 
episodes per day (10/31 pta; 321 vs 18/146; 
12%) (P(O.Ol), prolonged Le. ),20 minutes per 
day (8/25; 32% vs 20/152; 131) (P(0.05) or 
severe ~1.5 mm (8/28; 29% vs 20/149; 131) 
(P(0.05). Frequent STD on AM had identical 
specificity (88% vs 881) but inferior 
sensitivity (31% vs 421) to pronounced (>2.0 
mm) ST deviation on exercise. Further, AM did 
not improve the predictive value of an exercise 
test. Left ventricular ejection fraction (501 
predicted death (4/49 pts; 81 vs 0/85; 01) 
(P=0.03) but not overall cardiac events whilst 
AM predicted cardiac events but not death. The 
results of AM and radionuclide ventriculography 
combined gave superior sensitivity (681) for 
predicting cardiac events than either test 
alone. Thus, radionuclide ventriculography and 
AM have additive predictive value after MI. 
However, AM is an inferior alternative to 
exercise testing rather than a complementary 
test and AM would only be indicated after MI in 
pts unable to perform an exercise test. 
835-3 11:00 
Ambulatory ST Sellment Monltorlnll Is of little use In Identlfylnll 
high risk subllroups In unselected ambulant patient. with anilina. 
David Mulcahy. Jayan Parameshwar, Jane Sparrow, Christine 
Wright, George Sutton·, Kim Fox. 
Royal Brompton National Heart and Lung Hospital, and 
Hillingdon Hospital·, UK. 
Recent studies have suggested that silent ischaemia during daily 
life identifies high-risk subgroups of stable angina patients, 
however pts were highly selected. and event rates were higher 
than that expected in an ambulant stable angina population. We 
performed 48 hrs of ambulatory ST segment monitoring (AM) and 
treadmill exercise testing on 172 stable angina patients receiving 
treatment and attending outpatients, and followed them for a 
mean of 24.5 months. Inclusion did not depend on prior 
documented ischaemia. ISS patients (90%) had evidence of 
coronary disease (+ Ex Test, + Tape, previous MI, CABG, PTCA, 
or catheter). 
103 pts (61%) had a positive Ex Test, and 72 pts (42%) had 
evidence of ischaemia on AM. 62 pts (36%) had both tests 
positive, and S9 (34%) both tests negative. During a mean of 24.5 
months follOW-Up, there were 5 deaths (2.9%), three being cardiac 
related (1.7%). Six patients (3.5%) suffered acute MI. There were 6 
admissions (3.5%) with unstable angina and 10 patients (5.8%) 
underwent revascularisation (9 electively). A total of 9 (5.2%) pts 
had a "hard" cardiac end-point (MI + cardiac death) over a mean 
of 2 yrs follow-up. Of these only 2 pts had evidence of ischaemia 
at initial AM, and only I of 6 pts with AMI had ischaemia on 
either Ex Test or AM. 
In such unselected pIS with stable angina. prognosis over the 
medium term is excellent, as previously shown in large scale 
studies. AM appears of little help in identifying high-risk 
subgroups; indeed only 2 of 62 pts with both tests positive for 
ischaemia had a hard end-point at a follow-up of >2 yrs. There is 
little indication to refer such patients for early intervention, unless 
symptoms dictate. 
10:45 
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'lHE PMJIlHil/SIOUX;Y AND IKXXBTIC SIGNIFIC7\ID OF 
n:>IlIm iEi1!X:rID m SI!XlMENl' lEH<i!SSlaf ~
JMXARlIAL ~CJoI 
Anatoly Ianger, JosePl Minkl::Mitz, Paul Dorian, Illigi 
casella, lalise Harris, C'lris D. Morgan, Paul w. 
ADIEtrcng. st. Michael '5 Hospital, To:ronto, Canada. 
JlIJmmj Detectioo of m segment depressioo (S'l'..l-) 
00 Holter JIIOI'Iitorin;J (Itf) follc:Mirr;J aOlte myocardial 
infarctioo (AMI) cx:nfers a poor prognosis. However, the 
pathqilysiology of m~ arxi, in partio.ll.ar its relation•
ship to patency of the infarct related arteIy .(IRA) arxi 
left ventrio.ll.ar furd:ioo is unknown. 
Mjettr;:lds: We perfomed 11M on day 4 arxi 7 arxi radio•
nuclide an;JiogI'alily 00 day 1 arxi 9 in 109 pts Who were 
part of a rardanized, double blini, placebo OXltrolled 
study of tpA in AMI. ()lantitative CXlrona:ty an;Jiography 
arxi deter.rninatioo of IRA cross sectiooal area (CSA) was 
perfonned in 88 pts on day 10. 
pepllts cit§Ql: Am:rg 109 pts, 35 (32%) had 3.5;t3.2 
episodes of m '" ~l DID, 21 min), with a duration of 
45;t52 min; no difference bet.'Neen day 4 arxi 7. Pts with 
arxi withcu:t m .. were similar in age, sex, previcus MI, 
peak CK MB, tpA treatment allcx:ation, arxi l'lUIItler of 
vessels 250% stenosis. '!he table cazpu-es day 1 arxi 9 
ejection fraction (EF), prc:portioo of pts with EF 
increase (ot) 25% arxi IRA CSA (*1><0.05, "p,O.Ol)!.. •• -2 
I:[ lZ AI:[ \pts El"hS ~l 
lQ.mI. 4i±12% 5~13% 4±lrt 47% 1.1±1.3 
With STW 47±14% 46±14%* 0±7%** 7%** 0.6±0.6* 
'l\Io year follow-up sl'nIed a two fold increase in death 
arxi recurrent AMI in pts with m .. (21% vs 9%, p=O.17). 
P:r!cl.usioo: sNo is frequent following AMI, hc1.Iever, 
its in:idence is nat increased in pts treated with tpA. 
'!he pathc:.Plysiology of m oJ- arxi its asscx:iation with 
lack of il!pl'Ollenent in LV function arxi poor prognosis 
is related to residual high grade stenosis in the IRA. 
835·5 11:30 
IEl'trl'ICJoI OF m SI!XlMENl' SHIl'T IN 8I!HXlIAIXSIS 
PATnN1S: A POOSIl!l.B IJJIK 'lO HIQ{ CARDIOIIASCIIIAR 
KRrAU'l.Y IN mo-sTAGE RI!lW. IlISFASE 
Narendra Singh, Lisa 'lhcIrpson, Mark B. Goldstein, 
Anatoly Ianger. Tora1to, c::ANAD.\. 
JlIJmmj Hanodialysis (HD) pts have a high 
in:idence of ooronaIY disease. '!he prevalence of m 
segment depressioo (m .. ) as a possible IMrker of 
myocardial isdlemia in these pts is unknown. 
Methods: 24 pts with a nonnal a::x; un::ieIwent 2 lead 
48 hr ani:W.atory a::x; m:xti. toring 00 the day of HD arxi 
the day after. Pts with m .. (21 DID, 21 min.) also had 
stress thallium-201 arxi 2-D edlo. 
pepllts ti+sol :Of the 24 pts (age 21-67 yrs), 11 
(46%) had 151 episodes of m ~, all asynptanatic. '!here 
was history of an;ina in 4/11 pts with arxi 2/13 withoot 
m'" (NS). pts with m~ were similar in age, diabetes, 
smoking, BP, lipids, volume dialyzed, Hgb, lytes, arxi 
b.uVcr rut were I!IX'e often female (82% vs 31%, p=O.02). 
'!he use of nitrates am ca antagonists was similar rut 
IlCre m. pts were 00 beta-blockers (82% vs 31%,p=O.02). 
LV hypert:rc¢y by 2-D edlo was faJl'Xi in 10/11 pts with 
arxi 9/13 pts withoot m~. In pts with m~ , stress 
thallium-201 sl'nIed defect in 5 pts; non-reversible in 
3 arxi reversible in 2 arxi 3 pts had LV dysfurd:ion by 
2-D edlo. '!he table shc:M; a greater in:idence of S'N on 
the day of HD as c:x:rrpared to the day after (*1><0.01): 
daY of HD daY after HD 
ST+ epi.mes 12.6±11.3* 1.3±2.0 
S'Nr cllratiooCmin) 163. 7±171. 0* 15. 2±41. 3 
on the day of HD, there was no differeooe in in:idence 
of m'" during HD itself arxi the rest of the day. 
OD:l.ysioo: HD pts have frequent m", ~dl. may be 
a IMrker of myocardial :isdlemia. However, future 
studies are needed to clarify the pathqilysiology of m'" arxi its clinical significance in these pts. 
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Incidence of Perioperative Myocardial Ischemia in Patients 
Undergoing Peripheral Vascular Surgery 
Edmund Hasche, David Brieger, John Hwa, Effy Savidis, John 
Harris, James May, Geoff White, Phillip Harris, S. Ben 
Freedman. Depts of Cardiology & Vascular Surgery, Royal 
Prince Alfred Hospital, Sydney, Australia. 
Ischemic cardiac events are the major cause of morbidity and 
monality in patients undergoing vascular surgery. Before 
evaluating interventions aimed at preventing ischemic events, it 
is imponant to determine the tlUe incidence of both 
asymptomatic and symptomatic events. We performed two 
channel ST-monitoring in 44 patients (30 male, 14 female, 
mean age 70 ± 8) before, during and after peripheral vascular 
surgery (femora-popliteal bypass 27, abdominal aortic 
aneurysm 8, iIio-femoral bypass 3, other 5). The mean 
duration of monitoring was 45 ± 8 hours. 15 patients (33%) 
had a history of prior coronary anery disease. Adverse cardiac 
events occurred in 6 pts during hospitalisation (13%): Fatal 
myocardial infarction in 2, ischemic pulmonary edema in 4, 
and unstable angina in 3 (3 pts had > 1 event). Ischemic 
episodes on ST monitoring occured in 27 pts (61%): before 
surgery in 13 (30%), during surgery in 9 (21 %) and after 
surgery in 27 (61%). Ischemic ST segmemt depression was .s 
2mm in 9 pts, > 2mm in 18 pts and lasted> 1 hour in 19 pts 
(41%). Patients with a past history of coronary disease were 
more likely to have ischemia than those without (81 %vs 51 % 
p<O.05). Adverse events occurred with equal frequency in 
those with and without ischemia on ST monitoring (14% vs 
13%, NS), but both patients who died had ischemia on ST 
monitoring prior to death. 
We conclude myocardial ischemia is common in patients 
undergoing peripheral vascular surgery but does not adequately 
distinguish those destined to have perioperative clinical events. 
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Determinants of Left Ventricular Hypertrophy and 
Ventricular Arrhythmias in a Hypertensive Population 
John Colleran, Puneet Narayan, Peter Kokkinos, Aldo 
Notargiacomo, Edward Freis, Vasilios Papademetriou, 
Dept. of Veterans Affairs Meical Center, Washington,D.C. 
Previous studies have shown an increased prevalence of 
arrhythmias in patients with left ventricular 
hypertrophy (LVH). However, no correlation has been 
demonstrated between the degree of LVH and the severity 
of arrhythmias. In order to assess this relationship we 
obtained 3 blood pressure recordings on 2 to 3 separate 
visits, an ECG, an echocardiogram, and 48 hour 
ambulatory ECG monitoring in 137 hypertensive men off 
medication or on placebo Mean values are as follows' 
n Age SBP DBP LVHI PW PVC C VT 
LVH 98 61 163 102 192 14 15 6 0.4 
Non LVH 39 52 149 94 125 10 11 4 0.8 
p values < .000 .000 .05 .000 .000 NS NS NS 
SSP-s2sto1ic BP, DSP-diasto1ic BP, LVHI-mass index (gm/m ), PW-posterior wa11(mm), PVC-PVCs per hour, 
C-couplets/48 hrs VT-ventricu1ar tachycardia/48 hrs 
Linear regression analysis of multiple variables 
revealed the following: LVH correlated significantly 
with SBP (r-0.42,p<0.001), age (r-0.39,p<0.001) and DSP 
(r-0.23,p<0.Ol). Stepwise regression analysis 
de~onstrated that the only p~edictors of LVH were SBP 
(r -0.24,p<0.OOO) and age (r -0.19,p<0.000). Prevalence 
of pts with PVC,C,VT alone and in combination was not 
significantly different between LVH and non-LVH groups. 
Age was the only variable that correlated significantly 
with ventricular arrhythmias (r-0.21, p<O.Ol). We 
conclude that in this population 1) age and SBP are the 
most important predictors of LVH and 2) age is the only 
determinant of ventricular arrhythmias. 
JACC Vol. 19, No.3 
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Malignant Arrhythmias and 'Silent Myocardial Ischemia' in 
Hypertensive Heart Disease • Prevalence, Spontaneous Varia•
bility, Interaction and Risk For Cardiac Death 
Manfred Zehender, Thomas Meinertz, Stefan Hohnloser, Ursula 
Koscheck, Charlotte Gerisch, Hanjorg Just. Depart. of Cardiolo•
gy, University of Freiburg, West Germany 
Due to the increased risk of sudden death in pts with hyperten•
sive heart disease (HHD), we prospectively studied 150 untrea•
ted, normokalemic pts with HHD (3 times> 160/95 mrnHg at 3 
days, mean: 175/98 mrnHg, 94 men, 56.±.9 years, without eviden•
ce of angina pectoris), for prevalence, severity and interaction of 
ventricular arrhythmias (VA) and transient, asymptomatic ST•
segment depression (ST-D) (>0.1 mV, > 1 min) during 24h•
Holter recording. Fifty patients were additionally randomized to 
placebo (P, 2x/ die) and restudied after 4 weeks to assess the 
spontaneous variability of ST-D and VA VA were present in 
129/150 pts (86%, repetitive VA; 42 pts); prevalence was hig•
hest in 47/150 pts with ST-D (p<0.05) and during or imme•
diately after episodes of ST-D (p<0.01). Both parameters show•
ed a similar circadian variation. After P, VA (-100%: 12% of 
pts, + >400%: 17%), repetitive VA (-100% or first episode: 
60%), but to a less extent ST-D had a high spontaneous variabi•
lity. During a 3-year follow-up, cardiac events (cardiac death: 5 
pts, non-fatal myocardial infarction: 8 pts) were best predicted 
by the baseline presence of left ventricular hypertrophy 
(p<O.OI), and to a less extent by transient episodes of asym•
ptomatic ST-D (p<0.05, Cox regression analysis). Thus, repeti•
tive VA and silent ST-D are common in pts with HHD, but only 
ST-D are of prognostic relevance. Therapeutic consequences, 
however, are limited for both parameters by a marked day-night 
and day/day variability. 
836·3 11:00 
Ventricular Arrhythmias in Asymptomatic Hypertensives are 
Associated With Both Silent Ischemia and Left Ventricular 
Hypertrophy 
Susan E. Ammon, Jadwiga Szlachcic, Julio F. Tubau, Brian F. 
O'Kelly, William L. Chin, Barry M. Massie. VAMC and 
University of California, San Francisco, CA 
Ventricular arrhythmias are not uncommon in patients with 
hypertension and have been considered an indicator of increased 
risk. Many investigators have felt that these arrhythmias were 
related to left ventricular hypertrophy (LVH). However, we 
previously reported that they were more closely associated with 
evidence of ischemia in a much smaller population. To further 
assess possible causes for ventricular arrhythmias, we prospectively 
studied 222 patients (age 61 ± 9 yrs; 69% White, 20% Black) 
without symptoms, history or ECG evidence of coronary disease. 
Medications were withdrawn at least 4 days, and patients underwent 
stress "'IT! scintigraphy, 48 hr ambulatory ECG and 2-D guided M 
mode echocardiograms. 18 % (411222) had reversible :!lITI 
abnormalities and 40% (73/183) had LVH, defined as LVMI 2-
134g/m' by echo (range 134-210g/m'). 
liilTI+ :!lITk LVH+ LVU-
n 41 181 73 110 
> 10 VPC's/hr 34% 19% 29% 16% 
VT 12% 5% 11 %* 3% 
* P < .05, # p < .10 T! + vs - or LVH + vs-
Thus, both evidence of silent ischemia and LVH are associated 
with a higher incidence of frequent VPC's and ventricular 
tachycardia (VT). By multiple regression, scintigraphic ischemia 
and LVH are independent predictors of V A, and one or both are 
present in 68% and 82% of PTS with frequent VPC's and VT's, 
respectively. 
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Chlorthalidone Does not Increase Ventricular Ectopic 
Activity in Isolated SystoliC Hypertension. 
John B. Kostis, Clifton R. Lacy, Alan C. Wilson, W. 
Dallas Hall, Nemat O. Borhani, Susan D. Krieger, Nora M. 
Cosgrove for the SHEP Study Group. UMDNJ -Robert Wood 
Johnson Medical School, New Brunswick, New Jersey. 
There is still disagreement on the effects of diuretics on 
ventricular ectopic activity (VEA). Twenty-four hour ambu•
latory electrocardiography was performed on 238 ~atients 
with isolated systolic hypertenSion (ISH) participating in 
the Systolic Hypertension in the Elderly Program (SHEP), 
and in 100 age and sex matched controls. VEA was defined 
as: number of PVC/24h, ln (PVC/24h+l); presence of at 
least one PVC; presence of 10 PVC/24h, and presence of 
pairs or ventricular tachycardia. 
At baseline, patients with ISH had more pronounced VEA 
than controls (P<O.OS) and showed a relationship (P<O.OS) 
of VEA to age, male gender, coronary artery disease and 
left ventricular mass. 209 patients had acceptable record•
ings at follow-up. Significant changes in VEA were not 
observed either in the 107 patients randomized to chlor•
thalidone stepped care (12.5 mg in 67 patients and 25 mg 
in 40) or in the 102 placebo-treated patients (P>0.2 for 
all VEA definitions and both groups). Potassium was 
prescribed routinely for confirmed hypokalemia <3.3 mEq/L. 
Serum potassium decreased from 4.4±0.3 mEq/L to 4.1±0.5 
(P-O.OOll) in the chlorthalidone group and did not change 
(4.4±0.5 to 4.4±0.4) in the placebo group. A relationship 
between serum potassium and VEA (P>0.4) or change in serum 
potassium and change in VEA (P>0.6) was not observed. 
Thus, in patients with ISH, chlorthalidone did not 
increase VEA in doses (12.5 or 25 mg daily) found effec•
tive in decreasing stroke and cardiovascular event rates. 
836·5 11:30 
Improvement of Dipyridamole-Induced ST Segment Depression After 
Cardiovascular Hypertropby Regression In Es_tlal Hypertensives 
M. Lorenza Muiesan·, A1essandra Lucarini, Mania Spessot, Roberto Zulli', 
Enrico Agabiti. Rosei·, Antonio Salvetti. 
·Cattedra di Medicin. Interna, Universita' di Brescia; Clinica Medica 
I,University of Pisa, Italy. 
In hypertensive patients (EHP) with angiogr.phically normal coron.ries and 
with left ventricular (LV) hypertrophy and/or vascular structural alterations, 
dipyridamole infusion can induce "ischemic-like' ST segment depression in the 
absence of echocardiographically detectable LV dysfunction. Aim of this study 
was to evaluate the effect of cardiovascular structural changes regression on 
these ECG changes to dipyridamole infusion in EHP. In 12 EHP (10 
asymptomatic, 2 with chest pain and normal coronary angiography) the 
following parameters were evaluated: 1) ECG-ECO dipyridamole test (TED, 
up to 0.84 mg/kg over 10 min), 2) LV mass index (LVMI, M-mode 2D-guided 
echocardiography), 3) Forearm minimal vascular resistances (minVR, strain 
gauge pletismography) taken as an index of vucular structural changes. These 
procedures were performed before and after 6 months of adequate (DAP < 
9OmmHg) antihypertensive treatment (captopril 50 mg bid, n = 6 and nifedipine 
20 mg bid, n=6) during a short pharmacological washout. Positivity of TED ( 
ST segment depresssion > Imm ) was observed in 9 EHP before and in 2 EHP 
after treatment ( 75% vs 16%,p < 0.05), and an increase of dipyridamole time 
(time to ST segment shift of Imm in at least 15 mins) was also observed (from 
8.2 .±.1.4 to 14.±.6 min). LVMI and minVR were significantly reduced (from 
130.7.±.9 to 114.±.7 g/m2, p<O.05 and from 3.0.±.2 to 2.4.±.2 U, p<0.05, 
respectively). In 9 EHP with positive basal TED there was a correlation (r= 
0.75, p<0.05) between changes of dipyridamole time and changes of 
cardiovascular structural changes (LVMI and minVR). In conclusion, 
regression of cardiovascular structural changes is associated to a significant 
improvement of ischemic-like ST segment depression during TED in EHP. 
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Coronary Reserve is Moderately Reduced in Hypertensive 
Patients Without Left Ventricular Hypertrophy and May Be 
Normalized by Antihypertensive Therapy. 
Isabelle Antony, Alain Nitenberg, Jean-Marc Foult. 
INSERM U.251 , CHU Xavier-Bichat, Paris, France. 
It has been evidenced that coronary reserve (CR) was reduced in 
hypertensive patients with L VH when antihypertensive therapy did 
not reduce myocardial mass. To assess whether or not CR was 
similarly impaired in hypertensives without L VH, peak-to· resting 
coronary flow velocity ratio (P/R) and minimal coronary vascular 
reSistance index (MCVRI) were measured using intracoronary 
Doppler catheter and maximally vasodilating dose of papaverine in 
16 control subjects (C), 13 untreated (G1a) and 9 treated (G1b) 
hypertensive patients with LVH, 7 untreated (G2a) and 7 treated 
(G2b) hypertensive patients without LVH. All patients had normal 
coronary arteriography. Aortic pressures, LV end-diastolic pressure 
and volume, ejection fraction and rate-pressure·product were similar 
in untreated patients (Gla vs G2a), and in treated patients (Glb vs 
G2b). Aortic pressures and rate-pressure-product were comparable 
to control values in treated patients (Glb and G2b). 
C Gla Glb G2a 
LVM 82:t9 139±30§ 131±13§ 94±11 
P/B 5.2±<l.8 2.5±0.4§ 2.7±O.4§ 3.6±0.7§ 
MCVRI o,18±.o3 0.36±.O7§ 0.33±.o5§ O,26±.o5§ 
(§ p<O.OOl vs C; LVM = LV mass, glm2). 
G2b 
97±12 
4.9±1.4 
O,20±.06 
Data evidenced that P/R reduction and MCVRI increase were of less 
extent in untreated hypertensive patients without LVH than in those 
with LVH. In addition, in treated hypertensive patients without LVH 
indices of CR were similar to those of control patients. 
In conclusion, these results suggest 1) that alterations of the 
coronary microvasculature occur in hypertensive patients prior to 
myocardial hypertrophy; 2), that antihypertensive therapy may 
restore a normal CR in hypertensive patients without LVH when CR 
remains impaired in treated patients with persistent LVH. 
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In VIVO Gene Transfer into the Arterial Wall without a T ransfection 
Vehicle. 
Gregory D. Chapman, Chang S. Um, Roger S. Gammon, Stephen 
C. Culp, Robert P. Bauman, Judith L. Swain, and Richard S. Stack 
Duke University Medical Center, Durham, NC 
Intravascular gene transfer Is an active area of interest given 
the potential benefit of site·specific production of therapeutic 
proteins for disorders such as post-PTCA restenosis. Our 
laboratory and other groups have previously demonstrated the 
feasibility of In vivo, intravascular gene transfer. To date these 
studies have used transfection vehicles such as retroviral vectors 
or IIposomes to effect transfer of DNA into the arterial wall. 
Concern exists for the cost of preparing or obtaining these 
transfection vehicles, as well as for the potential of their undesired 
side-effects if applied to human use. Previous studies using 
needle Injections of the myocardium have suggested the 
possibility of direct DNA transfer across the cell membrane 
without the need for a vehicle of transfection. Our goal was to 
directly compare the efficiency of in vivo, intravascular gene 
transfer In the presence or absence of a transfection vehicle. The 
reporter utilized was cDNA encoding for luciferase, since the 
protein produced is not expressed in mammalian cells and can be 
quantified using a sensitive assay (light production). Uposomes 
were utilized as vehicles of transfection. Mongrel dogs (n=5) had 
surgical transfection attempts with perfusion of DNA alone in one 
femoral artery and DNA plus liposomes in the other femoral 
artery. The transfection solution incubated in each artery for one 
hour. Arteries were assayed 2-3 days later. Luciferase activity 
was not above background in nontransfected arteries (n=5). 
Luciferase was expressed in all ten transfected arteries, with 
those transfected with DNA alone expreSSing 35.6 ±S picograms 
luciferase/lotal segment, while those transfected with DNA plus 
IIposomes 42.3 ±14 plcograms/lotal segment (p=O.70). These 
results sugQest that the efficiency of intravascular gene transfer 
may be similar whether or not a transfection vehicle is used. This 
finding may have important application in the reduction-to•
practice of intravascular gene therapy for the treatment of 
cardiovascular disease. 
JACC Vol. 19, No.3 
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837·2 10:45 
Particle Bombardment ("Gene Gun") Technology for 
Direct Gene Transfer In Normal and Atherosclerotic 
Vascular Tissue 
Guy Leclerc, Douglas Losordo, Dov Gal, Jeffrey M. Isner, Tufts 
University School of Medicine, St. Elizabeth's Hospital, Boston MA. 
Success of gene transfer depends in part on optimizing the delivery 
mode. In preliminary experiments, we have demonstrated that DNA•
coated micro projectiles can be delivered directly into intact vascular 
smooth muscle cells in culture using a "gene gun" and result in 
expression of foreign genetic material. The purpose of this study was 
to determine the applicability of this microprojectile delivery system to 
rabbit normal and atherosclerotic vascular tissue by analyzing the 
extent of particle delivery into vascular walls bombarded in vitro. 
Tungsten particles of I J.Illl in diameter were delivered at high-velocity 
to the tissues by a gun-powder driven accelerator (PDS-lOOO). 
Sections of rabbit normal arteries (A) and veins (V) and atherosclerotic 
(ATH) arteries were exposed in culture dishes so that the ballistic 
impact would be delivered directly to the intima (i) (5 A-i, 5 V -i and 1 
ATH-I) or the adventitia (a) (5 A-a, 5 V-a and 2 ATH-a). Immediately 
after bombardment, tissues were fixed and processed for histologic 
analysis. Macroscopically, no tissue trauma was evident other than the 
dark staining of the surface caused by the tungsten particle. 
Microscopically, in both initimal and adventitial bombardments, the 
intima did not disclose any tears. The media of normal vessels, as well 
as the plaque and media of ATH arteries showed only minimal cell 
damage. Microprojectiles detected within the layers of the vessels 
were most often clustered in groups of ten or more. They were 
detected in all 3 layers of the normal vascular wall; penetration into 
the thicker A TH arteries was typically limited to :s; 50% of total wall 
thickness. 
Conclusions: 1) microprojectile bombardment can deliver tungsten 
particles to all 3 layers of normal vascular tissue and 2) the delivery to 
ATH arteries appears to be limited up to 50% of total wall thickness. 
837-3 
Tlaaue Plasminogen Activator Ie Avidly Metabolized In 
Mlcrophages by the Mlnnoae Fucose Receptor 
11:00 
Joseph P. Hasapes, Burton E. Sobel, Alan Daugherty. 
Washington University School of Medicine, St. Louis, Missouri 
Though critical to Its potential use for Imaging, determinants of 
clearance of t-PA congeners have not been completely 
characterized. Mannose fucose receptors (MFR) have been 
Implicated In macrophage (M;) and endothelial metabolism of t-PA. 
To elucidate specific determinants of clearance, we Initially studied 
Interactions In vitro with cultured rabbit alveolar M;. t-PA was radio•
labeled by covalent conjugation to the residualizing label dilactitol-
125I-tyramine (t-DLT) and rendered enzymatically Inactive by 
attachment with D-Phe-L-Pro-L-Arg-chloromethylketone (PPACK). 
These modifications did not affect blood clearance or fibrin binding. 
However, inactivation with PPACK did preclude binding to PAI-1. 
Both *I-DLT-t-PA and *I-DLT-PPACK-t-PA were degraded by cultured 
M; in a concentration-dependent manner that was saturable at • 20 
~g/ml. Degradation of *I-DLT-t-PA by M; was competitively Inhibited 
by either mannan or mannosylated bovine serum albumin; specific 
ligands having high affinity for MFA. To define the role of MFA 
interactions in vivo, *I-DLT-t-PA and *I-DLT-PPACK-t-PA were 
administered i.v. Into rabbits and tissues harvested 30 min later. 
Overall catabolism was maximal in liver. In addition, spleen, bone 
marrow, lung, kidney, and adrenal contributed significant catabolism 
when normalized to tissue weight. Autoradiograms revealed high 
grain densities over M;. Further, in liver, similar grain densities were 
found in hepatocytes with either *I-DLT-PPACK-t-PA or *I-DLT-t-PA 
Indicative of PAI-l independent mechanisms of uptake, while M. 
uptake was far more substantial with *I-DLT-PPACK-t-PA compared 
to *I-DLT-t-PA. Thus, t-PA interacts avidly with macrophages via MFR 
and Its inhibition coupled with specific enhancement of hepatocyte 
uptake should facilitate Imaging of clots with t-PA congeners. 
JACC Vol. 19, No.3 
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837·4 11:15 
LDL FROM FH SUBJECTS INDUCES ARTERIAL SMOOTH 
MUSCLE (SMC) PROLIFERATION BY A CHOLESTEROL· 
INDUCED CA2+ INFLUX PATHWAY. 
Hiroml Tasakl and Thomas N. Tulenko. Medical College of 
Pennsylvania, Philadelphia, PA 19129 
We examined the effects of human low density lipoprotein 
(LOL) from familial hypercholesterolemic (FH) subjects on SMC 
cultured from rabbit aorta. Following Incubation In lipoprotein· 
deficient serum (72hrs), SMC were exposed to FH·LDL or 
control (NC) LDL for 24 hours. 3H-thymldine uptake Increased 
141% and 170% In SMC Incubated with FH-LDL (8 and 16 
I1g/ml respectively) over controls. This effect was Inhibited by 
the dihydropyridine (OHP) nlfediplne (EC IIO 0.Q1 11M), and was 
accompanied by a steady-state Increase In transmembrane '5Ca2• 
permeability (Influx and efflux; p<.OS) which was also Inhibited 
by nifediplne (EC50 0.Q1 11M). In addition, studies with Fura II 
indicated cytosolic Ca2• levels were elevated 48.3% (168 nM-
249nM) In the FH-LDL treatment group. The SMC free 
cholesterol/phospholipid (FC/PL) molar ratio increased from 
0.300 (NC-LDL) to 0.400 by FH-LOL Indicating enrichment of 
the SMC plasma membrane by this lipoprotein. The FC/PL molar 
ratio of the NC-LDL particle was 0.88 of that of the FH-LDL 
particle was 1.32. We have previously reported that FC 
enrichment of SMC plasma membranes Increases Ca2• influx 
through the expression of a ·new· or otherwise ·sllent" DHP•
sensitive calcium channel (elrc.Res.69:216, 1991). The 
results of the present study demonstrate that human FH-LDL 
Induces SMC proliferation by a cholesterol-Induced increase in 
Ca2• Influx through a DHP-sensitive pathway In SMC. Supported 
in part by NIH grant HL 30496, a Grant-In-Aid (TNT) and Post•
doctoral Fellowship (HT) from the Southeastern Pennsylvania 
Affiliate of the American Heart Association, and the Uehara 
Memorial Foundation. 
837·5 11:30 
Augmentation of Synthesis of Plasminogen Activator 
Inhibitor Type-l (PAI-l) by Insulin-like Growth Factor 
Type-l (IGF-l) in Endothelial Cells 
David J. Schneider, Burton E. Sobel. Washington 
University, St. Louis, Missouri 
We have previously demonstrated that insulin and IGF-l 
synergistically augment production of PAI·l protein and 
mRNA in HepG2 cells and have postulated that the augmen•
tation may predispose individuals with hyperinsulinemic 
states to increased cardiovascular mortality secondary to 
impaired fibrinolysis. To determine whether PAI-l syn•
thesis is influenced by insulin, IGF-l, or both in endo•
thelial cells, likely to be critical in pathogenesis of 
thrombosis and accelerated atherogenesis, swine aortic 
endothelial cells in primary culture were exposed to 
insulin and IGF-l. IGF-l (84.4 nM) increased PAI-l ac•
tivity in conditioned media in 4 hr and 8 hr by 2 to 3 
fold (n • 4 for each). Insulin alone (8.7 nM) did not 
increase PAI-l activity and the combination increased 
activity less than IGF-l alone (2 fold, n • 4 for each) 
indicating competition. The 3.2 kb species of PAI-l mRNA 
accounted for approximately 80% of the total PAI-l mRNA 
and the 2.2 kb spec i es accounted for the rem a i nder in 
swine aortic endothelial cells. IGF-l (84.4 nM) in•
creased total PAI-l mRNA 1.8 fold in 8 hr (by dot blot 
analysis) but insulin alone (8.7 nM) did not (n • 4 for 
each). The combination of both factors led to an in•
crease similar to that seen with IGF-l alone (1_6 fold, 
n • 4). The increase in the 2.2 kb species was greater 
than that in total mRNA with insulin alone (2.4 fold) and 
with insulin plus IGF-l (3.2 fold, n • 4). These results 
indicate that IGF-l increases PAI-l expression in endo•
thelial cells. The antagonism observed between insulin 
and IGF-l suggests that the two compete for a receptor or 
pathway. 
ABSTRACfS 393A 
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A Blspeclflc Antlflbrln-Antlplatelet Urokinase Conjugate 
Enhances Plasminogen Activation at Both Targets 
Christoph Bode, Matthias Wein, Thomas Nordt, Marschall 
Runge, Johannes Ruef, Renate Weber, Eberhard von 
Hodenberg, Wolfgang Kubler and Edgar Haber. Medical Clinic 
III (Cardiology), University of Heidelberg, Germany and Harvard 
Medical School, Boston, MA. 
A bispecific (Fab')2 (7E3-590S) was synthezised from the Fab' 
fragments of a monoclonal antibody specific for the platelet 
receptor GPlib/llla (7E3) and a monoclonal antibody specific for 
the amino terminus of the fibrin B-chain (590S). The product, 
7E3-590B was then covalently coupled to urokinase (UK) and 
comQared at equal amidolytic activity with a conjugate of 
7E3(Fab')2 and UK (7E3-UK), with a conjugate of 590S and UK 
(590B-UK) and with native UK. In the presence of immobilized 
GPlib/llla 7E3-590S-UK and 7E3-UK equally enhanced plasmin 
generation in comparison to UK, indicating receptor binding. In 
the presence of immobilized fibrin, plasmin generation by 7E3-
590B-UK is equal to that of 590S-UK, both exceeding that of UK, 
indicating fibrin binding by the bispecific molecule. A bispecific 
7E3-590S-UK conjugate containing both antigen combining 
sites lysed platelet-free fibrin-clots (FC) and platelet-rich clots 
(PC) in a plasminogen containing buffer more efficiently than an 
unconjugated mixture of 7E3-590S and UK or native UK alone. 
Lysis is given in percent of total clot. 
7E3-590S-UK 7E3-590S + UK UK 
FC 20 Units 23.1 ±3.3 7.9± 1.0 9.1 ± 1.0 
FC 5 Units 10.S±2.9 4.S±0.3 4.9±1.0 
PC 20 Units 33.3±3.B 13.S±1.5 1S.S±0.4 
PC 5 Units 17.9±2.2 4.0±0.5 4.5±0.5 
Lysis of FC and PC effected by 7E3-590B-UK in the presence of 
plasma was also enhanced when compared to unconjugated 
UK. These data indicate that a bifunctional conjugate in which 
urokinase is simultaneously tarQeted to both a platelet epitope 
and to fibrin is more effective In thrombolysis than urokinase 
alone. 
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838·1 10:30 
0Iarqes in Mjcau:di.al Blood Flow PI:olJced by the 
DeIIelqmrant and ReccMny FnlIIl ClIrcIlic ~
TadJyalrdi.a (SYT) IrdIced cardiaayqathy 
Ryuhei Tanaka, Francis Spinale, Fred Crawford, Mid1ael. 
zile, Medical University of 5o.1th carolina,<llIIrlest:al,SC 
Qlr previoos stlxUes demca1strated that d!rcnic SVT was 
associated with significant lIbnonnal.ities in myocardial 
blood flCM (MBF). 'lhese aI::s1ormalities in MBF have been 
iltplicated in the pathogenesis of the cardianycpathy 
prcduoed by SVT. '!his cardianyc:pathy is reversible if the 
SVT is tenninated; however, whether al:lnoxmalities in MBF 
are also reversible is \lI1Ianm. MBF (miC['()S(ilere 
tedmique) was examined in 3 groops (rF8/grcup) of 
conscioos, instrumented pigs: cart:rol (c:nq), after 3 wJcs 
of SVT, and 4 wJcs after tenninatial of SVT (PST). MBF 
(ml/lllinlg), echo-cath determined fractional sbortenin;J 
(FS,t), systolic wall stress (a, gnVc;m2), left atrial 
pressure (lAP, ~) were determined at rest, durin;J 
acute pacin;J (240 I:pn) and durin;J adenosine infusial 
(ADEN;lo5 !l9Il<q/min). CVR - cora'lII%Y vaswlar 
resistance, mrHgfml/lllinlg; *';><O.OS vs c:nq. 
FS q lAP MBF CVR 
REST-OaN 36±3 53±3 4±1 1.5±0.3 5l±4 
SVT 1l±2* 16l±25* 28±3* 0.8±0.2* 58±6 
PST 35±2 62±5 10±1* 1.3±0.3 59±6 
240 -caN 30±2 42±2 15±3 3.0±0.3 23±4 
SVT 10±2* 150±20* 30±3* 1.2±0.3* 33±6* 
PST 23±3* 45±5 27±3* 2.0±0.4* 30±6* 
ADEN-caN 4l±2 36±4 5±1 4.5±0.4 17±4 
SVT 16±3* 12l±7* 26±2* 1.5±0.2* 25±6* 
PST 36+2 38±7 14+2* 2.510.4* 24±6* 
Temination of dlronic SVT caused recovery of W fUnction 
and nonnal restin;J MBF. However, MBF resezve remained 
blunted, in part because of increased lAP and CVR. 
Persistent abnonnalities in MBF may have ilrportant 
clinical oonsequeooes durin;J the recovery fran SVT. 
394A ABSTRACTS 
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Wave Transmission Properties in Pulmonary Arterial 
Hypertension: Comparison to Normals 
Victor A. Ferrari, WillIiam G. Kussmaul, FACC, Harold I. 
Palevsky, Warren K. Laskey, FACC, University of Pennsylvania, 
Philadelphia, PA 
Measures of non· pulsatile pulmonary artety (PA) hemodynamics 
in pulmonary hypertension have been extensively characterized. 
However, little data are available describing the frequency•
dependent hemodynamic behavior of the P A. Funhermore, wave 
transmission propenies under exercise conditions have not been 
previously characterized. Using high-fidelity pressure (P) and 
velocity recordings from the PA and thermodilution cardiac output 
(CO, Vmin), we studied 10 normal subjects (N, age=46, PAP=14) 
and 8 patients with primary pulmonary hypertension (PPH, 
age=45, PAP=48) undergoing cardiac catheterization at rest (r) and 
during supine bicycle exercise (x). We derived pulmonary 
vascular resistance (PVR, dsc-S), indices of arterial wave reflection 
(RF, n), a measure of transmission velocity (BWAT, ms) and PA 
characteristic impedance (Zc, dsc-S). We found: 
En m IUYAI. B.I D. ~ 
Nr 73 7.4 399 0.33 0.41 22 
Nx 70 12.5· 385· 0.31· 0.33 26 
PPHr 880t 4.6t 312t 0.86t 0.89t sst 
PPHx 750 7.2· 240· 0.80· 0.81· 66 
·=p<O.05 (r vs. x); t=p<O.05 (N vs. PPH) 
Although CO increased significantly in PPH patients from r to x, 
this increase, in contrast to normals, occurred in the setting of an 
increase in HR with stroke volume (SV) not significantly changed 
(r=57 ml, x=67 ml; p=NS). We conclude that significant 
alterations in wave properties (transmission, reflection) exist in 
patients with PPH at rest and remain abnormal on exercise. These 
factors represent a deleterious increase in PA vascular hydraulic 
load and may in part explain the blunted SV with x. 
838·3 11:00 
Prolonged Right Ventricular Systole Impairs Left Ventricular 
Filling in Pulmonary Hypertension. 
Stephen J. Brecker, Bojan B. Stojnic, Han B. Xiao, Mouanodji 
Mbais80uroum, Derek G. Gibson. The Royal Brompton National Heart 
and Lung Hospital, London, United Kingdom. 
To examine the effects of pulmonary hypertension (PH) upon left 
ventricular diastolic events, we studied 29 patients (pts) with PH and 10 
controll with an enlarged right ventricle but normal pulmonary artery 
pressure, with .chocardiography, Doppler and phonocardiography. We 
measured septal thickness, cavity dimensions, right ventricular -atrial 
(RV-RAI gradient, iaovolumic relaxation time, and left ventricular filling 
patterns. The peak RV-RA gradient was 60 ± 16 mmHg in PH pts, and 
18:1: 5 mmHg in controls. The time intervals of pulmonary closure to the 
end of the tricuspid regurgitation and to the onset of tricuspid flow were 
both prolonged in pts with PH compared with controls (11 5 ± 60 ms and 
120:1:40 v140±15 and 45±10 (mean:l:SDI, p values <0.0011. On 
transmitral Doppler, 23 of 29 pts with PH had a dominant' A' wave, 
however In controls had a dominant 'E' wave. Left ventricular 
isovolumic relaxation time was prolonged in PH compared with controls, 
both as aortic closure to mitral valve opening (80 ± 25 ms vs 50 ± 151. 
and to the onset of mitral flow (1 05 ± 30 ms vs 60 ± 1 5, p values < 
0.0011. The delay from mitral opening to the onset of transmitral flow 
was longer in PH compared to controls (30 ± 15 ms vs 10:1: 1 0, 
p<O.OOll. At the time of mitral opening, there was a RV-RA gradient 
of 12:1: 10 mmHg in PH, and on M-mode, 20/29 pts had evidence of 
posterior septal displacement during isovolumic relaxation. The RV-RA 
gradient was negligible in controls (0.4 ± 0.3, p < 0.001), and none had 
septal displacement (0/10 vs 20/29, p<O.OOOll. 
Conclusions : Prolonged right ventricular tension decline, the direct 
result of severe PH, causes prolonged tricuspid regurgitation. It persists 
until after mitral opening on the left side of the heart, where events 
during isovolumic relaxation are disorganised, and subsequent filling 
impaired. These effects are likely to be mediated through the 
interventricular septum; this right / left ventricular asynchrony may 
represent an unrecognised mode of ventricular interaction. 
JACC Vol. 19, No.3 
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838·4 11:15 
Myocardial Hypertrophy in Valvular Heart Disease and 
Hypertension : Low PCr/ATP in Patients with Compensated 
Heart Failure 
Michael Conway, Ronald Ouwerkerk, George Radda. 
John Radcliffe Hospital, Oxford, U.K. 
To determine, non-invasively, whether there is 
a low phosphocreatine(PCr)/ATP ratio in left 
ventricular hypertrophy (LVH), we performed 
3lP magnetic resonance spectroscopy (MRS) on 23 
patients (aortic stenosis:6; aortic or mitral 
incompetence: 10; hypertension: 7) with LVH 
(VlS+VSR-ECG:46+/-l3mm; posterior LV wall thick-
ness (PWT): 1.3+/-0.36cm). MRS was done at 1.9 
Tesla in a 60 cm bore magnet using the phase 
modulated rotating frame imaging technique. 
Asymptomatic patients with LVH (VlS+VSR:48+/-lS 
mm; PWT:l.22+/-0.2cm; n=12) had normal PCr/ATP 
ratios (1.67+/-0.4**vs 1.63+/-0.37 in 9 controls 
NS). Patients with LVH and heart failure (VlS+ 
VSR: 48+/-lSmm; PWT:l.33+/-0.Scm; LVEDP: 19+/-
8 mmHg) requiring diuretics had low PCr/ATP 
(1.02+/-0.26; p< 0.01**). 
These findings demonstrate that the 
hypertrophied left ventricle in asymptomatic 
patients has normal high energy phosphorus 
metabolism whereas LVH with treated compensated 
heart failure is associated with low PCr/ATP. 
The cause of this may be a loss of myocardial 
creatine. 
838·5 11:30 
Effects of Altered Inotropy on Left Ventricular-Vascular 
Coupling Relations in the Human Heart 
Mark R. Starl ing. University of Michigan and the VA 
Medical Centers, Ann Arbor, Michigan 
Whether the theoretic predictions of the left ventricular 
(LV) -vascular coupling relations are maintained during 
altered inotropiC state in the human heart is unknown. 
To further assess the theoretic validity of this concept, 
seven patients (pts), who had normal LV volumes, ejection 
fractions, wall motion, and masses at cardiac 
catheterization, had micromanometer LV pressures and 
radionucl ide angiograms obtained under control (Ctrl) 
conditions and during a steady-state dobutamine (0) 
infusion at a constant heart rate. LV end-systolic 
pressure (P .. ) ·volume (Ves ) relations were calculated, and the slope (Ee.) was compared to arterial elastance 
(E.) calculated as Pe.lstroke volume. In comparison to 
Ctrl, 0 increased E$a from 2.71±1.16 to 4.93±3.73 mmHg/ml 
and E. from 2.02±0./~ to 2.92±1.33 mmHg/ml (p<0.05). The 
theoretic LV stroke volume was calculated as SV • (V~· Vp)/(I+E.lEe~) and compared to the radionucl ide C SV; and 
tne theoretlc LV SW/PVA ratio was calculated as SW/PVA 
• 1/[l+0.5(E.lEe~)] and compared to the radionuclide 
SW/PVA ratio. under Ctrl conditions, SVc and SW/PVA 
correlated with their corresponding radionuclide values 
(r • 0.99, y • -0.74 + 1.00x and r • 0.77, y. 0.26 + 
0.67x, respectively). Similarly, during 0, SV and 
SW/PVAc correlated with their corresponding radionJclide 
values (r • 1.00, y • 0.20 + 0.97x, and r • 0.94, y • 
0.15 + 0.84x, respectively), These data indicate that 
the theoretic predictions of this concept are maintained 
during altered inotropic states in the human heart. 
Therefore, they may be useful for asseSSing the 
interaction of the LV with the vasculature under 
conditions of altered inotropy in man. 
JACC Vol. 19, No.3 
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Influence of Collagen Network on Left Ventricular 
Function In Aortic Valve Disease 
Bruno Villari, Scott E Campbell', Otto M Hess, Karl T Weber', Hans 
P Krayenbuehl, Cardiology, University Hospital, Zurich, 
Switzerland and 'University of Missouri-Columbia, MO 
The collagen network of the left ventricle was assessed from LV 
endomyocardial biopsies obtained in 32 patients (pts) with aortic 
valve disease (AVO) (25 aortic stenosis, 7 requrgitation). Interstitial 
collagen volume fraction (ICVF,%), extension and thickness of 
orthogonal collagen fibers (cross-hatching, X-H, graded from 0 to 
3), and endocardial fibrosis (ECF, %) were determined by morpho•
logic-morphometric evaluation. Control biopsy data were obtained 
from 6 pre-transplantation donor hearts, whereas other 11 pts with 
normal LV function served as controls for LV hemodynamics (C). 
LV biplane cineangiography and high-fidelity LV pressure measu•
rements were carried out in all pts. Systolic function was asses-sed 
from ejection fraction (EF), relaxation by the time constant of LV 
pressure decay (t), passive diastolic properties by the constant of 
ABSTRACTS 
myocardial stiffness (b, stress-strain relationship), and LV hyper•
trophy by the angiographic mass (LMM). PIS were grouped accor•
ding to increasing severity of non-myocyte tissue alterations: G1 of 
10 pts with elevated ICVF (>2.7%, I.e. upper limit in C), G2 of 6 pts 
with normallCVF and presence of pathological X·H (>1.5) and/or 
ECF, G3 of 16 pts with elevated ICVF and X-H (>1.5) and/or ECF. 
ICVF(%) ECF(%) X-H (grade) EF (%) t (ms) b LMM(g/m2) 
C 1.6 0 0.8 66 43 10 88 
G1 7.3' 0 0.9 69 68' 12 171'" 
G2 2.2 7 2.2'" 52" 74" 28" 169'" 
G3 9.6** 12 1.9'" 53" 81" 31'" 187'" 
C'p<0.05, "p<0.01, ·"p<0.001 vs. C) 
thus, in AVO advanced 'interstitial heart disease' comprising an 
increased ICVF, increased density and thickness of collagen fibers 
and endocardial fibrosis Is associated with altered systolic function 
and paSSive diastolic myocardial properties. For the range of ICVF 
observed an increase In collagen concentration alone, without a 
change in architecture, leaves systolic and passive diastolic 
function unaltered. Prolongation of relaxation appears mediated by 
muscle hypertrophy per se. 
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lanueace of Left VeDtricular Morphology OD Mitral ADDuiar Size, Shape 
aad Plaa., OrleDtatloD 
Makoto Suzuki, Emesto A Tee, Michael A Plainse, Pravin M Shah, Loma 
Linda Univenity Medical Center, Loma Linda, CA 
Previous studies have demonstrated the mitral annulus (MA) in man to be 
oval in shape and nonpianar. The MA is subject to alterations secondary 
to changes in left ventricular morphology. Although effect of LV 
dilation on MA size bas been previously investigated, the effects of LV 
hypertrophy (LVH) and LV dilation (LVD) on shape and planar 
configuration are unknown. The present study was undertaken in 46 
patients, IS with LVH (age 61.3 ± 13.6 years), IS with LVD (6O.S ± 17.2 
years) and 16 normal (N) (34.9 ± IS.9). The subjects were placed in left 
lateral decubitus and a transducer mounted with protractor was oriented 
to provide apical four chamber plane. The transducer was then rotated 
radially at 30· increments to yield six cross sections providing 12 points 
of MA attachments to measure diameten and vertical distances. Three 
cardiac cycles were measured during held expiration at end systole, mid•
diastole, and end-diastole. The averaged diameten at each phase of the 
cardiac cycle described MA size and shape and the averaged vertical 
distance its planar orientation. Analysis of variance was performed to 
test differences in the measured values. ~ I. Average diameter of 
MA was significantly larger in LVD (39.1 ± 6.4 mm) as compared to N 
(31.2 ±S.I mm) and LVH (29.0 ± 3.S mm). 2. The MA shape was oval in 
N, L VH as well as in LVO. 3. LVH and N exhibited similar nonplanarity 
with the points of anterior leaflet attachment at MA as seen in apical four 
chamber plane being an average of 4 mm lower or apically placed. 4. 
L VO resulted in altered planar configuration with the posterior leaflet 
attachment at MA being apically displaced, but not the anterior. 
Conclusion· I. L VH did not influence MA size, shape and planar 
orientatio,n. 2. L VO resulted in dilation of MA without a change in 
shape. 3. L VO resulted in altered planar configuration of MA with a 
more apical displacement of posterior leaflet attachment. This may be a 
consequence of more lateral displacement of the papillary muscle and 
could influence valve competence. 
966 Miscellaneous Topics II 
(continued from page 320A) 
Wednesday, April 15, 1992 
2:00 PM-5:00 PM 
Dallas Convention Center 
Lower Level Exhibit Hall 
Presentation Hour: 4:00 PM-5:00 PM 
966-30 
Cost Of Abission To Repair Conaenital Heart Ditleaae 
(CBD) Can Be Predicted 
Douglas A. Shumaker, Adnan M. Cobanoglu, Michael 
Silberbach. 
Oregon Health Sciences University, Portland, Oregon. 
We studied the impact of pre-operative conditions (POC) 
on hospital charge (HC) and length of stay (LOS) in 311 
children with low risk CHD. Mean age was 2.5 ± 3.8 years 
(range 1 day - 16 years). Unsdjusted mortality among 
the 10 diagnostic categories was 3.1% (range 0 - 7.7%). 
323 consecutive surgical admissions occuring from 1985 
through 1989 were reviewed. HC was $35,697 t 25,603tand 
LOS was 10.2 t 9.2 days. Significance of 14 POC was 
explored by multiple regression. HC and LOS for 
individual POC was predicted. 
POC No. % Pred LOS Pred HQx !IOOO2 
hev Ht Surg 56 17.3 10.2 36.9* 
FTT 36 11.2 14.9* 41.5* 
Cong. Anomaly 25 7.8 15.6* 52.6* 
(non-cardiac) 
Respiratory 17 5.3 13.8* 42.8* 
Infection 9 2.8 20.0* 49.6* 
Neurologic 3 0.9 27.6* 74.8* 
+all HC adjusted to reflect 1991 dollars *p< .005 
No other POC, including pulmonary vascular disease, 
congestive heart failure, age, pre-op wt. or genetic 
syndrome, Significantly influenced HC or LOS. HC 
appears to be closely related to LOS for most POCo 
These data suggest that certain POC allow prediction of 
resource utilization. 
